Citrus Sinensis ID: 038934

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-
Protein Sequence
TTSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPESESSSSNQTFHSSNQITVSLIEGR
Secondary Structure (PSIPRED)
ccccccccccccccccccEEEccccEEEEEEcccccccccEEEEEEccccccEEEEEcccccccccccEEEEEEEcccEEEEEEcccccEEEEEcccccccccEEEEEccccEEEEEcccccccccccccccccccccccccEEEEEEccccEEEEEEEccccccccccEEEEEccccccEEEEEEccEEEEEEccccccEEEEcccccccccEEEEEEEcccEEEEEEEEcccccEEEEEEcccccEEEEEEEcccccEEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccEEEEccccccccEEEEEEccccHHHHHHHHHccccEEEEEccccccccccEEEEEEEEEEEEEEccccccEEEEEccccccccccccccccccHHHHHHHHHcccccccccccccccccEEEcccccEEEEEEccccccccHHHHHHHHHHHHHccccccccEEcccccccEEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccEEcccccccccccEEEEEcccccHHHHccccccccccccccEEEEEEEEEcccccccccccccccHHHHHHHHcccccccccccccccccccHHHHHHHHHHcEEcccccccccccHHHHHHHHcccccccccccccEEEcccccccccccccccccccccEEEEEEEcc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccEEEccccEEEEEEEcccccccEEEEEEEEcccccEEEEEEccccccccccEEEEEEccccEEEEEEccccEEEEEEcccccccccEEEEEccccEEEEcccccccccEEEEEccccccccccccEccccccccccEEEEEcccccccccccEEEEEccccccEEEEEcccEEEEEccccccEEEEcccccccccEEEEEEEEcccEEEEEEEEEcccEEEEEEEccccEEEEEEEEcccccEEEEEEccccccccccccccccccEEcccccccccccccccccccHHHHcccccccccEccccccccccccEEEEcccEcccccccEEcccccHHHHHHHHHccccEEEEEEcccccccccEEEEEccHHHHHHHHccccEEEEEEEcccccccccccccccccHHHHHHHHcccccccccccccccccEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEEccHHHcccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEcccHcccccccEEEEEcccccHHHHHHccccHHHHHHHHHHHHHHHEccccccccccccccccHHHHHHHHHHccccHHHHcHHHHccccHHHHHHHHHHHHHHHHccccccccccEEEEEcccccccccccccEEEEEcccccccccccccccccccEEEEEEEccc
Coil and Loop (DISEMBL)
ttstqdtlrlgqsirdgetlvsanesfelgffspgksksryLGIWYKKIANGTVTWVAnrnaplpdrsgvlsissqgngtlilqnstngivwssnasrtaqNPVAVLLESGnlvvksgndndsdnflwqsfdypthvllpgmklgVNLVTGLNRFISswksaddpaqddymyeidprgvpqamllkgstiryrpgswnglhwtgmpqlqpnpvytfeyvsneKEVFYRFTLIkssvpsmmvvsplgesqrYTWMEQTqkwapflsfsglidqcdnyalcGTYAICkmnsnsaececlegfepksprdwklldktdgcvrrtkldcergdgflkresvklpdtrfsrvdknisLFECkelcskncsctayanadvrgggsgcllwfheltdmkilsegGQDLYIRMATSelgnrkeemelpifdwKSIAnatdnfseenklgeggfgpvykgmliDGQEIAVKRLskssgqgveEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMliyeylpnksladfIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVlldnemnpkisdfgmarafgvdqteantnrvvgtygymppeyaidglfsvksdvFSFGVLVLELVYgtrnrgfhhvdhHHNLLGHAwrlwtedrpveliDKSLEDTYSLSEALRCIQVGLLCvqqrpedrpnMASVVLMLsgerslpqpkqpgffternlpesessssnqtfhssnqITVSLIEGR
Flexible Loop (DISEMBL)
ttstqdtlrlgqsirdgetlvsanesfelgffspgksksRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEgfepksprdwklldktdgcvrrtkldcergdgflkresvklpdtrfsrvdkniSLFECKELCSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAfgvdqteantnrVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPEsessssnqtfhssnqitvsliegr
Low Complexity Region (SEG)
TTSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKssvpsmmvvspLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFhhvdhhhnllghAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPesessssNQTFHSSNQITVSLIEGR
Disordered region (IsUnstruct)
**************************FELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLP***GVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGN**EEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRL******GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQ**************************************************************
Disordered Region (DISOPRED)
*TSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNAS*****PVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGF***********************ITVSLIEGR
Disordered Region (DISEMBL)
TTSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTER****************SNQITVSLIEGR
Disordered Region (DISPRO)
************SIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERN*************HSSNQITVSLIEG*
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
TTSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPESESSSSNQTFHSSNQITVSLIEGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	751	2.2.26 [Sep-21-2011]
O81832	783	G-type lectin S-receptor-	yes	no	0.984	0.943	0.573	0.0
O81833	815	G-type lectin S-receptor-	no	no	0.962	0.887	0.510	0.0
O81905	850	Receptor-like serine/thre	no	no	0.976	0.862	0.468	0.0
Q09092	857	Putative serine/threonine	N/A	no	0.973	0.852	0.444	0.0
Q9SXB4	820	G-type lectin S-receptor-	no	no	0.964	0.882	0.416	1e-170
O64770	804	G-type lectin S-receptor-	no	no	0.952	0.889	0.417	1e-166
O64777	806	G-type lectin S-receptor-	no	no	0.952	0.887	0.414	1e-165
Q9SXB5	820	G-type lectin S-receptor-	no	no	0.958	0.878	0.416	1e-165
O64781	831	G-type lectin S-receptor-	no	no	0.949	0.858	0.408	1e-165
O64782	805	G-type lectin S-receptor-	no	no	0.957	0.893	0.419	1e-165

>sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4

 Score =  868 bits (2243), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/766 (57%), Positives = 562/766 (73%), Gaps = 27/766 (3%)

Query: 6   DTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLP 65
           D L   Q+++DG+T+VS   SFE+GFFSPG S++RYLGIWYKKI+  TV WVANR++PL 
Sbjct: 25  DILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRDSPLY 84

Query: 66  DRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQ-----NPVAVLLESGNLVVKSGND 120
           D SG L +S   NG+L L N  N I+WSS++S ++Q     NP+  +L++GNLVV+  N 
Sbjct: 85  DLSGTLKVSE--NGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVR--NS 140

Query: 121 NDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVP 180
            D  +++WQS DYP  + LPGMK G+N VTGLNRF++SW++ DDP+  +Y  ++DP GVP
Sbjct: 141 GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVP 200

Query: 181 QAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMM 240
           Q  L K S + +R G WNGL +TGMP L+PNP+Y +EYV  E+EV+Y + L   SV + M
Sbjct: 201 QFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRM 260

Query: 241 VVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGF 300
            ++P G  QRYTW++  Q W  +LS   ++D CD Y LCG+Y  C +N + A C CL+GF
Sbjct: 261 QLNPNGALQRYTWVDNLQSWNFYLS--AMMDSCDQYTLCGSYGSCNINESPA-CRCLKGF 317

Query: 301 EPKSPRDWKLLDKTDGCVRRTKLDCERG-DGFLKRESVKLPDTRFSRVDKNISLFECKEL 359
             K+P+ W   D ++GCVRR KLDC +G DGFLK   +KLPDTR S  DKN+ L ECK++
Sbjct: 318 VAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKV 377

Query: 360 CSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSEL--------- 410
           C +NC+C+AY+  D+R GG GC+LWF +L D++  +E GQDLY+R+A+SE+         
Sbjct: 378 CLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESSR 437

Query: 411 -GNRKEE---MELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSK 466
             +RK+E   +ELP  D  +++ AT  FS  NKLG+GGFGPVYKG L  GQE+AVKRLS+
Sbjct: 438 VSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSR 497

Query: 467 SSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK 526
           +S QGVEEFKNE+ LIAKLQHRNLVK+LG C+  +ERMLIYEY PNKSL  FIFD  RR+
Sbjct: 498 TSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRR 557

Query: 527 LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV 586
            LDW KR +II GIARG+LYLH+DSRLRIIHRDLKASNVLLD++MN KISDFG+AR  G 
Sbjct: 558 ELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGG 617

Query: 587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN 646
           D+TEANT RVVGTYGYM PEY IDG FS+KSDVFSFGVLVLE+V G RNRGF + +H  N
Sbjct: 618 DETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLN 677

Query: 647 LLGHAWRLWTEDRPVELIDKSL-EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
           LLGHAWR + ED+  E+ID+++ E    +SE LR I +GLLCVQQ P+DRPNM+ VVLML
Sbjct: 678 LLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLML 737

Query: 706 SGERSLPQPKQPGFFTERNLPESESSSSNQTFHSSNQITVSLIEGR 751
           S E  L  P+QPGFF ERNL  S++ S N    S+N  T+S+I+ R
Sbjct: 738 SSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1

 Score =  751 bits (1940), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/797 (51%), Positives = 530/797 (66%), Gaps = 74/797 (9%)

Query: 14  IRDGETLVSANESFELGFFS---PGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGV 70
           ++DG+TL S ++ F+LGFFS     + + R+LG+WY  +    V WVANRN PL   SG 
Sbjct: 34  LKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVWVANRNNPLYGTSGF 91

Query: 71  LSISSQGNGTLILQNSTNGIVWSSNASRTA-----QNPVAVLLESGNLVVKSGNDNDSDN 125
           L++SS G+  L L +  +  +WSS++S T       NP+  +  SGNL+   G     + 
Sbjct: 92  LNLSSLGD--LQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLISSDG----EEA 145

Query: 126 FLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLL 185
            LWQSFDYP + +L GMKLG N  T +   +SSWK+  DP+  D+   +D RG+PQ +L 
Sbjct: 146 VLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILR 205

Query: 186 KG--STIRYRPGSWNGLHWTGMPQL-QPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVV 242
           K   S+  YR GSWNGL +TG P + + N ++ +++ S+ +EV Y +T  +  + S +V+
Sbjct: 206 KNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWT-PRHRIVSRLVL 264

Query: 243 SPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNS-NSAECECLEGFE 301
           +  G+  R+   +Q Q W   L+ +   D+CD Y++CG YA+C +NS N+  C CL+GF+
Sbjct: 265 NNTGKLHRFIQSKQNQ-W--ILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFK 321

Query: 302 PKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVD-KN-ISLFECKEL 359
           PKS R W +     GCV     +CE+ D F+K   +KLPDT +S  D KN ++L +CK  
Sbjct: 322 PKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIK 381

Query: 360 CSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSEL--------- 410
           CS NCSCTAYAN D+R GG GCLLWF +L DM+  S  GQD+YIRM  +++         
Sbjct: 382 CSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGREVVG 441

Query: 411 -----------------------------------GNRKEEMELPIFDWKSIANATDNFS 435
                                              G  +E+++LPIFD K+I+ ATD+FS
Sbjct: 442 MVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLPIFDRKTISIATDDFS 501

Query: 436 EENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
             N LG GGFGPVYKG L DGQEIAVKRLS +SGQGVEEFKNEV LIAKLQHRNLV+LLG
Sbjct: 502 YVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLG 561

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
           CC++ +E MLIYEY+PNKSL  FIFD  R   LDW KR  II G+ARG+LYLHQDSRLRI
Sbjct: 562 CCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRI 621

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDLKA NVLLDN+MNPKISDFG+A++FG DQ+E++TNRVVGTYGYMPPEYAIDG FSV
Sbjct: 622 IHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSV 681

Query: 616 KSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYS-L 674
           KSDVFSFGVLVLE++ G  NRGF H DH  NLLGH W++W EDR +E+ ++   +  S +
Sbjct: 682 KSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVI 741

Query: 675 SEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPESESSSSN 734
            E LRCI V LLCVQQ+PEDRP MASVVLM   + SLP P QPGFFT RN+P+  SS S 
Sbjct: 742 PEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQPGFFTNRNVPDISSSLS- 800

Query: 735 QTFHSSNQITVSLIEGR 751
               S N++++++++GR
Sbjct: 801 --LRSQNEVSITMLQGR 815

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  717 bits (1852), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 383/818 (46%), Positives = 511/818 (62%), Gaps = 85/818 (10%)

Query: 13  SIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLS 72
           +I    T+VS    FELGFF PG     YLGIWYK I+  T  WVANR+ PL    G L 
Sbjct: 39  TISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPLSSSIGTLK 98

Query: 73  ISSQGNGTLILQNSTNGIVWSSNASR-TAQNP-VAVLLESGNLVVKSGNDNDSDNFLWQS 130
           IS   +  L++ + ++  VWS+N +    ++P VA LL++GN V++   ++  D  LWQS
Sbjct: 99  IS---DSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDGVLWQS 155

Query: 131 FDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTI 190
           FD+PT  LLP MKLG +  TG NRFI SWKS DDP+  D+ ++++  G P+  L    + 
Sbjct: 156 FDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESR 215

Query: 191 RYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQR 250
            YR G WNG+ ++G+P++QP     F + ++++EV Y F + KS V S + +S  G  QR
Sbjct: 216 MYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQR 275

Query: 251 YTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKL 310
           +TW+E  Q W  F  +    DQCD Y  CG Y  C  N+ S  C C++GF+P++P+ W L
Sbjct: 276 FTWIETAQNWNQF--WYAPKDQCDEYKECGVYGYCDSNT-SPVCNCIKGFKPRNPQVWGL 332

Query: 311 LDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYA 370
            D +DGCVR+T L C  GDGF++ + +KLPDT  + VD+ I + EC++ C ++C+CTA+A
Sbjct: 333 RDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFA 392

Query: 371 NADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNRKEE-------------- 416
           N D+RG GSGC+ W  EL D++  ++GGQDLY+R+A ++L +++                
Sbjct: 393 NTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVL 452

Query: 417 --------------------MELPIFDWK-------------------SIANATDNFS-- 435
                               +E PI D +                   S  N TD+    
Sbjct: 453 LLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELP 512

Query: 436 ----EENKLGEGGF-----------GPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVL 480
               EE  +    F           G VYKG L+DGQE+AVKRLSK+S QG +EFKNEV 
Sbjct: 513 LMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVK 572

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           LIA+LQH NLV+LL CC+   E+MLIYEYL N SL   +FD +R   L+W  R  II GI
Sbjct: 573 LIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGI 632

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
           ARGLLYLHQDSR RIIHRDLKASN+LLD  M PKISDFGMAR FG D+TEANT +VVGTY
Sbjct: 633 ARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTY 692

Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP 660
           GYM PEYA+DG+FS+KSDVFSFGVL+LE++   RN+GF++ D   NLLG  WR W E + 
Sbjct: 693 GYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKG 752

Query: 661 VELIDKSLED---TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER-SLPQPKQ 716
           +E+ID  + D   T+   E LRCIQ+GLLCVQ+R EDRP M+ V+LML  E  ++PQPK 
Sbjct: 753 LEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKA 812

Query: 717 PGFFTERNLPESESSSSNQTFHSS---NQITVSLIEGR 751
           PG+  ER+L +++SSSS Q    S   NQITVS+++ R
Sbjct: 813 PGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2

 Score =  680 bits (1754), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/823 (44%), Positives = 510/823 (61%), Gaps = 92/823 (11%)

Query: 13  SIRDGETLVSANESFELGFFSPGKSKSR-YLGIWYKKIANGTVTWVANRNAPLPDRSGVL 71
           +I   +TLVS    FE+GFF   ++ SR YLG+WYKK+++ T  WVANR+ PL +  G L
Sbjct: 43  TISSNKTLVSPGSIFEVGFF---RTNSRWYLGMWYKKVSDRTYVWVANRDNPLSNAIGTL 99

Query: 72  SISSQGNGTLILQNSTNGIVWSSNASRTAQNPV-AVLLESGNLVVKSGNDNDSDNFLWQS 130
            IS  GN  ++L +S   + W++      ++PV A LL +GN V++  ++ND+  +LWQS
Sbjct: 100 KIS--GNNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFVMRDSSNNDASEYLWQS 157

Query: 131 FDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTI 190
           FDYPT  LLP MKLG NL TGLNRF++SW+S+DDP+  ++ Y+++ + +P+  L + +  
Sbjct: 158 FDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENFP 217

Query: 191 RYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQR 250
            +R G WNG+ ++G+P+ Q      + ++ N +EV Y F +  +S  S + +   G  QR
Sbjct: 218 MHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYFQR 277

Query: 251 YTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKL 310
            TW    + W  F S S +  QCD Y +CG YA C +N+ S  C C++GF P++ + W  
Sbjct: 278 LTWYPSIRIWNRFWS-SPVDPQCDTYIMCGPYAYCDVNT-SPVCNCIQGFNPRNIQQWDQ 335

Query: 311 LDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYA 370
                GC+RRT+L C  GDGF + + +KLP+T  + VD++I + ECK+ C  +C+CTA+A
Sbjct: 336 RVWAGGCIRRTQLSCS-GDGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFA 394

Query: 371 NADVRGGGSGCLLWFHELTDMKILSE---GGQDLYIRMATSELGNRKEE----------- 416
           NAD+R GGSGC++W   L D++  +     GQDLY+R+A +++  ++             
Sbjct: 395 NADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAKKRNASGKIISLTVGV 454

Query: 417 ---MELPIFD-WK-----------SIANATDN---------------FSEENKL------ 440
              + L +F  WK           SIAN   N               FS E K       
Sbjct: 455 SVLLLLIMFCLWKRKQKRAKASAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEELELP 514

Query: 441 --------------------GEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVL 480
                               G+GGFG VYKG L+DG+EIAVKRLSK+S QG +EF NEV 
Sbjct: 515 LIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVT 574

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           LIA+LQH NLV++LGCC++ DE+MLIYEYL N SL  ++F  TRR  L+W++R  I  G+
Sbjct: 575 LIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGV 634

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
           ARGLLYLHQDSR RIIHRDLK SN+LLD  M PKISDFGMAR F  D+TEANT +VVGTY
Sbjct: 635 ARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTY 694

Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP 660
           GYM PEYA+ G+FS KSDVFSFGV+VLE+V G +NRGF+++D+ ++LL + W  W E R 
Sbjct: 695 GYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRA 754

Query: 661 VELIDKSLEDT-------YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS-LP 712
           +E++D  + D+       +   E L+CIQ+GLLCVQ+  E RP M+SVV M   E + +P
Sbjct: 755 LEIVDPVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIP 814

Query: 713 QPKQPGFFTERNLPESESSSSNQTFHSS----NQITVSLIEGR 751
           QPK PG+   R+  E + SSS Q   +     NQ T S+I+ R
Sbjct: 815 QPKPPGYCVRRSPYELDPSSSWQCDENESWTVNQYTCSVIDAR 857

Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Brassica oleracea var. acephala (taxid: 3713)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1

 Score =  599 bits (1545), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 341/819 (41%), Positives = 467/819 (57%), Gaps = 95/819 (11%)

Query: 4   TQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAP 63
            Q+       + D ET+VS+  +F  GFFSP  S SRY GIWY  ++  TV WVAN++ P
Sbjct: 26  AQERAFFSGKLNDSETIVSSFRTFRFGFFSPVNSTSRYAGIWYNSVSVQTVIWVANKDKP 85

Query: 64  LPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASR--TAQNPVAVLLESGNLVVKSGNDN 121
           + D SGV+S+S  GN  L++ +    ++WS+N S   +A + VA LL+SGNLV+K  +  
Sbjct: 86  INDSSGVISVSQDGN--LVVTDGQRRVLWSTNVSTQASANSTVAELLDSGNLVLKEAS-- 141

Query: 122 DSDNFLWQSFDYPTHVLLPGMKLGVNL-VTGLNRFISSWKSADDPAQDDYMYEIDPRGVP 180
            SD +LW+SF YPT   LP M +G N  + G N  I+SWKS  DP+   Y   +     P
Sbjct: 142 -SDAYLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDPSPGSYTAALVLAAYP 200

Query: 181 QAMLLKG----STIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNE-KEVFYRFTLIKSS 235
           +  ++      ST+ +R G WNG  + G+P +    V+ + ++ N+        +    S
Sbjct: 201 ELFIMNNNNNNSTV-WRSGPWNGQMFNGLPDVYAG-VFLYRFIVNDDTNGSVTMSYANDS 258

Query: 236 VPSMMVVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECE 295
                 +   G   R  W E  + W   L       +CDNY  CG +A C    N   C 
Sbjct: 259 TLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPA--TECDNYRRCGEFATCNPRKNPL-CS 315

Query: 296 CLEGFEPKSPRDWKLLDKTDGCVRRTKLDCER------GDGFLKRESVKLPDTRFSRVDK 349
           C+ GF P++  +W   + + GC RR  L CER       DGFL+   +KLPD  F+R  +
Sbjct: 316 CIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGSADGFLRLRRMKLPD--FARRSE 373

Query: 350 NISLFECKELCSKNCSCTAYANADVRGGGSGCLLWFHELTDMK----------------- 392
             S  EC   C + CSC A A+    G G GC++W   L D +                 
Sbjct: 374 -ASEPECLRTCLQTCSCIAAAH----GLGYGCMIWNGSLVDSQELSASGLDLYIRLAHSE 428

Query: 393 -------------ILSEG--------------------------GQDLYIRMATSELGNR 413
                        IL+ G                           + ++ R+     GN+
Sbjct: 429 IKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAKKKGRDAEQIFERVEALAGGNK 488

Query: 414 KEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVE 473
            +  ELP+F+++ +A AT+NFS  NKLG+GGFGPVYKG L +GQEIAVKRLS++SGQG+E
Sbjct: 489 GKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQGLE 548

Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
           E  NEV++I+KLQHRNLVKLLGCC+  +ERML+YE++P KSL  ++FD  R KLLDW  R
Sbjct: 549 ELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWKTR 608

Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
             II GI RGLLYLH+DSRLRIIHRDLKASN+LLD  + PKISDFG+AR F  ++ EANT
Sbjct: 609 FNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANT 668

Query: 594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWR 653
            RVVGTYGYM PEYA+ GLFS KSDVFS GV++LE++ G RN        +  LL + W 
Sbjct: 669 RRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRN-------SNSTLLAYVWS 721

Query: 654 LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS-LP 712
           +W E     L+D  + D     E  +CI +GLLCVQ+   DRP++++V  MLS E + +P
Sbjct: 722 IWNEGEINSLVDPEIFDLLFEKEIHKCIHIGLLCVQEAANDRPSVSTVCSMLSSEIADIP 781

Query: 713 QPKQPGFFTERNLPESESSSSNQTFHSSNQITVSLIEGR 751
           +PKQP F +  N+PE+ESS ++    S N +T++ + GR
Sbjct: 782 EPKQPAFISRNNVPEAESSENSDLKDSINNVTITDVTGR 820

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64770|Y1649_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61490 OS=Arabidopsis thaliana GN=At1g61490 PE=3 SV=1

 Score =  585 bits (1507), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 329/788 (41%), Positives = 454/788 (57%), Gaps = 73/788 (9%)

Query: 18  ETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQG 77
           +TL S+N  +ELGFFSP  S++ Y+GIW+K I    V WVANR  P  D S  L+ISS  
Sbjct: 36  QTLSSSNGIYELGFFSPNNSQNLYVGIWFKGIIPRVVVWVANRETPTTDTSANLAISS-- 93

Query: 78  NGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHV 137
           NG+L+L N  +G+VWS   +  +    A L ++GNLVV    DN S   LW+SF++    
Sbjct: 94  NGSLLLFNGKHGVVWSIGENFASNGSRAELTDNGNLVVI---DNASGRTLWESFEHFGDT 150

Query: 138 LLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSW 197
           +LP   L  NL TG  R ++SWK+  DP+   ++ +I P+   Q ++++GST  YR G W
Sbjct: 151 MLPFSSLMYNLATGEKRVLTSWKTDTDPSPGVFVGQITPQVPSQVLIMRGSTRYYRTGPW 210

Query: 198 NGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWMEQT 257
               +TG+P +       F    +     +     +S   S +++S  G  +R+      
Sbjct: 211 AKTRFTGIPLMDDTYASPFSLQQDANGSGFFTYFDRSFKLSRIIISSEGSMKRFR--HNG 268

Query: 258 QKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKLLDKTDGC 317
             W   LS+    + CD Y +CG + +C + S   +C+CL+GF P S  +WK  + T GC
Sbjct: 269 TDWE--LSYMAPANSCDIYGVCGPFGLC-IVSVPLKCKCLKGFVPHSTEEWKRGNWTGGC 325

Query: 318 VRRTKLDCERGDG------FLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYAN 371
            R T+L C+          F    +VKLPD  F   + ++   EC + C  NCSC A+A 
Sbjct: 326 ARLTELHCQGNSTGKDVNIFHPVTNVKLPD--FYEYESSVDAEECHQSCLHNCSCLAFAY 383

Query: 372 ADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNRK----------------- 414
                 G GCL+W   L D    S GG+ L IR+A SELG  K                 
Sbjct: 384 IH----GIGCLIWNQNLMDAVQFSAGGEILSIRLAHSELGGNKRNKIIVASTVSLSLFVI 439

Query: 415 ----------------------------EEMELP---IFDWKSIANATDNFSEENKLGEG 443
                                       +  E+P    F+  +I  AT+NFS  NKLG+G
Sbjct: 440 LTSAAFGFWRYRVKHKAYTLKDAWRNDLKSKEVPGLEFFEMNTIQTATNNFSLSNKLGQG 499

Query: 444 GFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER 503
           GFG VYKG L DG+EIAVK+LS SSGQG EEF NE++LI+KLQHRNLV++LGCC++ +E+
Sbjct: 500 GFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEK 559

Query: 504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKAS 563
           +LIYE++ NKSL  F+FD  ++  +DW KR  I+ GIARGLLYLH+DSRL++IHRDLK S
Sbjct: 560 LLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVS 619

Query: 564 NVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFG 623
           N+LLD +MNPKISDFG+AR +   Q +  T RVVGT GYM PEYA  G+FS KSD++SFG
Sbjct: 620 NILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFG 679

Query: 624 VLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQV 683
           VL+LE++ G +   F + +    LL +AW  W E + ++L+D+ L D+    E  RC+Q+
Sbjct: 680 VLLLEIIIGEKISRFSYGEEGKTLLAYAWESWGETKGIDLLDQDLADSCRPLEVGRCVQI 739

Query: 684 GLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPESESSSSNQTFHSSNQI 743
           GLLCVQ +P DRPN   ++ ML+    LP PKQP F       + ESS S   F + N++
Sbjct: 740 GLLCVQHQPADRPNTLELLAMLTTTSDLPSPKQPTFVVHSR--DDESSLSKDLF-TVNEM 796

Query: 744 TVSLIEGR 751
           T S+I GR
Sbjct: 797 TQSMILGR 804

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64777|Y1643_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61430 OS=Arabidopsis thaliana GN=At1g61430 PE=2 SV=2

 Score =  583 bits (1502), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 328/792 (41%), Positives = 453/792 (57%), Gaps = 77/792 (9%)

Query: 17  GETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQ 76
           G+TL S+N  +ELGFFS   S+++YLGIW+K I    V WVANR  P+ D +  L ISS 
Sbjct: 35  GQTLSSSNGVYELGFFSLNNSQNQYLGIWFKSIIPQVVVWVANREKPVTDSAANLGISS- 93

Query: 77  GNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTH 136
            NG+L+L N  +G+VWS+     +    A L + GNLV     D  S   LWQSF++  +
Sbjct: 94  -NGSLLLSNGKHGVVWSTGDIFASNGSRAELTDHGNLVFI---DKVSGRTLWQSFEHLGN 149

Query: 137 VLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGS 196
            LLP   +  NLV G  R +++WKS  DP+  +++  I P+   Q ++++GST  YR G 
Sbjct: 150 TLLPTSIMMYNLVAGEKRGLTAWKSYTDPSPGEFVALITPQVPSQGIIMRGSTRYYRTGP 209

Query: 197 WNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWMEQ 256
           W    +TG PQ+  +    F    +     Y F+ ++   PS M+++  G  +    +  
Sbjct: 210 WAKTRFTGSPQMDESYTSPFILTQDVNGSGY-FSFVERGKPSRMILTSEGTMK--VLVHN 266

Query: 257 TQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKLLDKTDG 316
              W    ++ G  + CD Y +CG + +C + S   +C+C +GF PK  ++WK  + T G
Sbjct: 267 GMDWES--TYEGPANSCDIYGVCGPFGLCVV-SIPPKCKCFKGFVPKFAKEWKKGNWTSG 323

Query: 317 CVRRTKLDCE------RGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYA 370
           CVRRT+L C+        + F    ++K PD  F     + +  EC + C  NCSC A++
Sbjct: 324 CVRRTELHCQGNSSGKDANVFYTVPNIKPPD--FYEYANSQNAEECHQNCLHNCSCLAFS 381

Query: 371 NADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNRKEEME------------ 418
                  G GCL+W  +L D +  S  G+ L IR+A SEL   K +M             
Sbjct: 382 YIP----GIGCLMWSKDLMDTRQFSAAGELLSIRLARSELDVNKRKMTIVASTVSLTLFV 437

Query: 419 ------------------------------------LPIFDWKSIANATDNFSEENKLGE 442
                                               L  F+  +I  AT+NFS  NKLG 
Sbjct: 438 IFGFAAFGFWRCRVEHNAHISNDAWRNFLQSQDVPGLEFFEMNAIQTATNNFSLSNKLGP 497

Query: 443 GGFGPVYK---GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK 499
           GGFG VYK   G L DG+EIAVKRLS SSGQG +EF NE++LI+KLQHRNLV++LGCC++
Sbjct: 498 GGFGSVYKARNGKLQDGREIAVKRLSSSSGQGKQEFMNEIVLISKLQHRNLVRVLGCCVE 557

Query: 500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 559
             E++LIY +L NKSL  F+FD  ++  LDW KR +II GIARGLLYLH+DSRLR+IHRD
Sbjct: 558 GTEKLLIYGFLKNKSLDTFVFDARKKLELDWPKRFEIIEGIARGLLYLHRDSRLRVIHRD 617

Query: 560 LKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDV 619
           LK SN+LLD +MNPKISDFG+AR F   Q +  T RVVGT GYM PEYA  G+FS KSD+
Sbjct: 618 LKVSNILLDEKMNPKISDFGLARMFQGTQYQEKTRRVVGTLGYMSPEYAWTGVFSEKSDI 677

Query: 620 FSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALR 679
           +SFGVL+LE++ G +   F + +    LL +AW  W E R V  +D++L D+   SE  R
Sbjct: 678 YSFGVLLLEIISGKKISSFSYGEEGKALLAYAWECWCETREVNFLDQALADSSHPSEVGR 737

Query: 680 CIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPESESSSSNQTFHS 739
           C+Q+GLLCVQ  P DRPN   ++ ML+    LP PK+P F         + S SN +  +
Sbjct: 738 CVQIGLLCVQHEPADRPNTLELLSMLTTTSDLPLPKKPTFVVHT---RKDESPSNDSMIT 794

Query: 740 SNQITVSLIEGR 751
            N++T S+I+GR
Sbjct: 795 VNEMTESVIQGR 806

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1

 Score =  583 bits (1502), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 335/805 (41%), Positives = 463/805 (57%), Gaps = 85/805 (10%)

Query: 13  SIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLS 72
           ++ D ET+VS+  +F  GFFSP  S +RY GIWY  I   TV WVAN++ P+ D SGV+S
Sbjct: 35  TLNDSETIVSSFRTFRFGFFSPVNSTNRYAGIWYNSIPVQTVIWVANKDTPINDSSGVIS 94

Query: 73  ISSQGNGTLILQNSTNGIVWSSNASR--TAQNPVAVLLESGNLVVKSGNDNDSDNFLWQS 130
           IS  GN  L++ +    ++WS+N S   +A + VA LLESGNLV+K   D ++D +LW+S
Sbjct: 95  ISEDGN--LVVTDGQRRVLWSTNVSTRASANSTVAELLESGNLVLK---DANTDAYLWES 149

Query: 131 FDYPTHVLLPGMKLGVNLVTGL-NRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGS- 188
           F YPT   LP M +G N  TG  N  I+SW +  DP+   Y   +     P+  +   + 
Sbjct: 150 FKYPTDSWLPNMLVGTNARTGGGNITITSWTNPSDPSPGSYTAALVLAPYPELFIFNNND 209

Query: 189 --TIRYRPGSWNGLHWTGMPQLQPNP-VYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPL 245
                +R G WNGL + G+P + P   +Y F+ V+++       +    S    + +   
Sbjct: 210 NNATVWRSGPWNGLMFNGLPDVYPGLFLYRFK-VNDDTNGSATMSYANDSTLRHLYLDYR 268

Query: 246 GESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSP 305
           G + R  W E  + W   L       +CD Y+ CG Y  C    N   C C++GF P++ 
Sbjct: 269 GFAIRRDWSEARRNWT--LGSQVPATECDIYSRCGQYTTCNPRKN-PHCSCIKGFRPRNL 325

Query: 306 RDWKLLDKTDGCVRRTKLDCER------GDGFLKRESVKLPDTRFSRVDKNISLFECKEL 359
            +W   + + GC+R+  L CER       D FLK + +K+PD  F+R  +  S  EC   
Sbjct: 326 IEWNNGNWSGGCIRKLPLQCERQNNKGSADRFLKLQRMKMPD--FARRSE-ASEPECFMT 382

Query: 360 CSKNCSCTAYANA-------------------------------------DVR------- 375
           C ++CSC A+A+                                      D R       
Sbjct: 383 CLQSCSCIAFAHGLGYGCMIWNRSLVDSQVLSASGMDLSIRLAHSEFKTQDRRPILIGTS 442

Query: 376 -GGG----SGCLLWFHELTDMKILSEGGQD---LYIRMATSELGNRKEEMELPIFDWKSI 427
             GG    + C+L    +   K   + G D   ++ R+     G+R++  ELP+F+++ +
Sbjct: 443 LAGGIFVVATCVLLARRIVMKKRAKKKGTDAEQIFKRVEALAGGSREKLKELPLFEFQVL 502

Query: 428 ANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 487
           A ATDNFS  NKLG+GGFGPVYKGML++GQEIAVKRLS++SGQG+EE   EV++I+KLQH
Sbjct: 503 ATATDNFSLSNKLGQGGFGPVYKGMLLEGQEIAVKRLSQASGQGLEELVTEVVVISKLQH 562

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
           RNLVKL GCC+  +ERML+YE++P KSL  +IFD    KLLDW+ R +II GI RGLLYL
Sbjct: 563 RNLVKLFGCCIAGEERMLVYEFMPKKSLDFYIFDPREAKLLDWNTRFEIINGICRGLLYL 622

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H+DSRLRIIHRDLKASN+LLD  + PKISDFG+AR F  ++ EANT RVVGTYGYM PEY
Sbjct: 623 HRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEY 682

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
           A+ GLFS KSDVFS GV++LE++ G RN        H  LL H W +W E     ++D  
Sbjct: 683 AMGGLFSEKSDVFSLGVILLEIISGRRN-------SHSTLLAHVWSIWNEGEINGMVDPE 735

Query: 668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS-LPQPKQPGFFTERNLP 726
           + D     E  +C+ + LLCVQ    DRP++++V +MLS E + +P+PKQP F       
Sbjct: 736 IFDQLFEKEIRKCVHIALLCVQDAANDRPSVSTVCMMLSSEVADIPEPKQPAFMPRNVGL 795

Query: 727 ESESSSSNQTFHSSNQITVSLIEGR 751
           E+E S S     S N +T++ + GR
Sbjct: 796 EAEFSESIALKASINNVTITDVSGR 820

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64781|Y1639_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61390 OS=Arabidopsis thaliana GN=At1g61390 PE=2 SV=1

 Score =  581 bits (1497), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 327/801 (40%), Positives = 468/801 (58%), Gaps = 88/801 (10%)

Query: 17  GETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQ 76
           G+TL S +  +ELGFFSP  S+ +Y+GIW+K IA   V WVANR+ P+   +  L+ISS 
Sbjct: 53  GQTLSSPDGVYELGFFSPNNSRKQYVGIWFKNIAPQVVVWVANRDKPVTKTAANLTISS- 111

Query: 77  GNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTH 136
            NG+LIL + T  ++WS+  + T+    A LL++GNLVV    D+ S   LW+SF+   +
Sbjct: 112 -NGSLILLDGTQDVIWSTGEAFTSNKCHAELLDTGNLVVI---DDVSGKTLWKSFENLGN 167

Query: 137 VLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGS 196
            +LP   +  ++  G NR ++SW+S  DP+  ++  E  P+  PQ ++ +GS+  +R G 
Sbjct: 168 TMLPQSSVMYDIPRGKNRVLTSWRSNSDPSPGEFTLEFTPQVPPQGLIRRGSSPYWRSGP 227

Query: 197 WNGLHWTGMPQLQPNPVYTFEYVSN--EKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWM 254
           W    ++G+P +  + V  F  + +  +    + ++++++   S + ++  G+  +  W 
Sbjct: 228 WAKTRFSGIPGIDASYVSPFTVLQDVAKGTASFSYSMLRNYKLSYVTLTSEGK-MKILW- 285

Query: 255 EQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKLLDKT 314
              + W   L F      CD Y  CG + +C + S + +C CL+GF PKS  +WK  + T
Sbjct: 286 NDGKSWK--LHFEAPTSSCDLYRACGPFGLC-VRSRNPKCICLKGFVPKSDDEWKKGNWT 342

Query: 315 DGCVRRTKLDC----------ERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNC 364
            GCVRRT+L C          +  D F     VK PD    ++   ++  +C + C  NC
Sbjct: 343 SGCVRRTQLSCHTNSSTKTQGKETDSFYHMTRVKTPD--LYQLAGFLNAEQCYQDCLGNC 400

Query: 365 SCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELG--NR--------- 413
           SCTA+A       G GCL+W  EL D       G+ L +R+A+SEL   NR         
Sbjct: 401 SCTAFAYIS----GIGCLVWNRELVDTVQFLSDGESLSLRLASSELAGSNRTKIILGTTV 456

Query: 414 -------------------------------------KEEME------LPIFDWKSIANA 430
                                                 ++ME      + +FD  +I  A
Sbjct: 457 SLSIFVILVFAAYKSWRYRTKQNEPNPMFIHSSQDAWAKDMEPQDVSGVNLFDMHTIRTA 516

Query: 431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           T+NFS  NKLG+GGFGPVYKG L+DG+EIAVKRLS SSGQG +EF NE+ LI+KLQH+NL
Sbjct: 517 TNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKRLSSSSGQGTDEFMNEIRLISKLQHKNL 576

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+LLGCC+K +E++LIYEYL NKSL  F+FD T +  +DW KR  II G+ARGLLYLH+D
Sbjct: 577 VRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDSTLKFEIDWQKRFNIIQGVARGLLYLHRD 636

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
           SRLR+IHRDLK SN+LLD +M PKISDFG+AR     Q + NT RVVGT GYM PEYA  
Sbjct: 637 SRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQGTQYQDNTRRVVGTLGYMAPEYAWT 696

Query: 611 GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED 670
           G+FS KSD++SFGVL+LE++ G +   F   +    LL +AW  W E + V+L+D++L D
Sbjct: 697 GVFSEKSDIYSFGVLLLEIIIGEKISRFS--EEGKTLLAYAWESWCETKGVDLLDQALAD 754

Query: 671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPESES 730
           +   +E  RC+Q+GLLCVQ +P DRPN   ++ ML+    LP PKQP F     +   + 
Sbjct: 755 SSHPAEVGRCVQIGLLCVQHQPADRPNTLELMSMLTTISELPSPKQPTF----TVHSRDD 810

Query: 731 SSSNQTFHSSNQITVSLIEGR 751
            S++    + N+IT S+I+GR
Sbjct: 811 DSTSNDLITVNEITQSVIQGR 831

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64782|SD129_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-29 OS=Arabidopsis thaliana GN=SD129 PE=1 SV=1

 Score =  581 bits (1497), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 334/796 (41%), Positives = 459/796 (57%), Gaps = 77/796 (9%)

Query: 13  SIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLS 72
           SIR  +TL S    +ELGFFSP  ++++Y+GIW+KKI    V WVANR+ P+   +  L+
Sbjct: 30  SIR--QTLSSPGGFYELGFFSPNNTQNQYVGIWFKKIVPRVVVWVANRDTPVTSSAANLT 87

Query: 73  ISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFD 132
           ISS  NG+LIL +    ++WS+  + T+    A LL++GN VV    D+ S N LWQSF+
Sbjct: 88  ISS--NGSLILLDGKQDVIWSTGKAFTSNKCHAELLDTGNFVVI---DDVSGNKLWQSFE 142

Query: 133 YPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRY 192
           +  + +LP   L  +   G  R +++WKS  DP+  ++  EI P+   Q ++ +GS   +
Sbjct: 143 HLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSDPSPGEFSLEITPQIPTQGLIRRGSVPYW 202

Query: 193 RPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVF--YRFTLIKSSVPSMMVVSPLGESQR 250
           R G W    ++G+  +  + V  F  V +       + ++ +++   S + ++P G+  +
Sbjct: 203 RCGPWAKTRFSGISGIDASYVSPFSVVQDTAAGTGSFSYSTLRNYNLSYVTLTPEGK-MK 261

Query: 251 YTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKL 310
             W +    W   LS     + CD Y  CG Y +C + S+  +CECL+GF PKS  +W  
Sbjct: 262 ILW-DDGNNWKLHLSLPE--NPCDLYGRCGPYGLC-VRSDPPKCECLKGFVPKSDEEWGK 317

Query: 311 LDKTDGCVRRTKLDCER----------GDGFLKRESVKLPDTRFSRVDKNISLFECKELC 360
            + T GCVRRTKL C+            D F +   VK PD    +    ++  +C + C
Sbjct: 318 GNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRMTDVKTPD--LHQFASFLNAEQCYQGC 375

Query: 361 SKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGN-------- 412
             NCSCTA+A       G GCL+W  EL D       G+ L+IR+A+SEL          
Sbjct: 376 LGNCSCTAFAYIS----GIGCLVWNGELADTVQFLSSGEFLFIRLASSELAGSSRRKIIV 431

Query: 413 -----------------------------------RKEEMELPIFDWKSIANATDNFSEE 437
                                              R++   +  F+  +I  AT+NFS  
Sbjct: 432 GTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGFERQDVSGVNFFEMHTIRTATNNFSPS 491

Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           NKLG+GGFGPVYKG L+DG+EI VKRL+ SSGQG EEF NE+ LI+KLQHRNLV+LLG C
Sbjct: 492 NKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFMNEITLISKLQHRNLVRLLGYC 551

Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
           +  +E++LIYE++ NKSL  FIFD   +  LDW KR  II GIARGLLYLH+DSRLR+IH
Sbjct: 552 IDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHRDSRLRVIH 611

Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDLK SN+LLD+ MNPKISDFG+AR F   Q + NT RVVGT GYM PEYA  GLFS KS
Sbjct: 612 RDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPEYAWAGLFSEKS 671

Query: 618 DVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEA 677
           D++SFGVL+LE++ G R   F + D    LL + W  W E     L+D+ L DT    E 
Sbjct: 672 DIYSFGVLMLEIISGKRISRFIYGDESKGLLAYTWDSWCETGGSNLLDRDLTDTCQAFEV 731

Query: 678 LRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGF--FTERNLPESESSSSNQ 735
            RC+Q+GLLCVQ    DRPN   V+ ML+    LP PKQP F   T  ++P  +++S  Q
Sbjct: 732 ARCVQIGLLCVQHEAVDRPNTLQVLSMLTSATDLPVPKQPIFAVHTLNDMPMLQANS--Q 789

Query: 736 TFHSSNQITVSLIEGR 751
            F S N++T S+I+GR
Sbjct: 790 DFLSVNEMTESMIQGR 805

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	751
224122978	831	predicted protein [Populus trichocarpa]	0.978	0.884	0.630	0.0
224122958	812	predicted protein [Populus trichocarpa]	0.990	0.916	0.602	0.0
224122822	776	predicted protein [Populus trichocarpa]	0.990	0.958	0.613	0.0
224115102	784	predicted protein [Populus trichocarpa]	0.985	0.943	0.631	0.0
359493721	804	PREDICTED: G-type lectin S-receptor-like	0.992	0.926	0.602	0.0
224115106	755	predicted protein [Populus trichocarpa]	0.926	0.921	0.621	0.0
147799241	818	hypothetical protein VITISV_027305 [Viti	0.992	0.910	0.567	0.0
359493730	770	PREDICTED: G-type lectin S-receptor-like	0.982	0.958	0.589	0.0
224117344	780	predicted protein [Populus trichocarpa]	0.992	0.955	0.586	0.0
224110464	767	predicted protein [Populus trichocarpa]	0.992	0.971	0.598	0.0

>gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa]

 Score = 1004 bits (2596), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 504/799 (63%), Positives = 595/799 (74%), Gaps = 64/799 (8%)

Query: 3   STQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNA 62
           ++ DTL  GQSIRDG+ LVSA+ SFELGFFSPG SK RYLGIWY+KI+ GTV WVANR  
Sbjct: 24  ASTDTLTPGQSIRDGDLLVSADGSFELGFFSPGISKGRYLGIWYQKISAGTVVWVANRET 83

Query: 63  PLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDND 122
           PL D SG L ++ QG   LIL NS+   +WSSNASRTAQNPV  LL+SGNLVVK  NDN 
Sbjct: 84  PLNDSSGALIVTDQG--ILILLNSSKDAIWSSNASRTAQNPVMKLLDSGNLVVKDINDN- 140

Query: 123 SDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQA 182
           S+NFLWQSFDYP   LLPGMK G N+VTGL+R++SSWKS++DPAQ ++ + IDPRG  Q 
Sbjct: 141 SENFLWQSFDYPGDTLLPGMKWGRNMVTGLDRYLSSWKSSNDPAQGEFTFRIDPRGNTQM 200

Query: 183 MLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVV 242
           +L++G  I YR G+WNG  WTG PQL+PN +YT+ ++S   E++Y+F LI SSV S +V+
Sbjct: 201 LLMRGPKILYRTGTWNGYRWTGTPQLEPNMLYTYGFISTATEMYYKFDLINSSVASRIVM 260

Query: 243 SPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEP 302
           +  G +QR+TW+ +T  WA F +   L+DQCD+YALCG Y  C +N     C CLEGF P
Sbjct: 261 NSSGAAQRFTWITRTNSWARFSAV--LLDQCDDYALCGAYGSCNVNKQPV-CACLEGFIP 317

Query: 303 KSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSK 362
           KSP+DW + + +DGCVRRTKLDC++GD FL+   VKLPD   S VD +  L ECK+LC K
Sbjct: 318 KSPKDWSIQEWSDGCVRRTKLDCDKGDRFLQHGGVKLPDMIKSWVDTSKGLKECKDLCLK 377

Query: 363 NCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMA---------------- 406
           NCSC AYAN+D+RGGGSGCLLWF EL D + L+ GGQDLYIR+A                
Sbjct: 378 NCSCVAYANSDIRGGGSGCLLWFDELIDTRELTTGGQDLYIRIAASELYNIEKNRSSDKK 437

Query: 407 ------------------------------------TSELGN------RKEEMELPIFDW 424
                                               TS L N      RKE+MELP FD 
Sbjct: 438 QLGIIVGTIITIVGVLVLAFILYARRKKLKKQANMKTSHLQNYEDEDQRKEDMELPTFDL 497

Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
            +IANATDNFS  NKLGEGGFG VYKG LI+GQE+AVKRLSK+SGQG+ EFKNEV+LIAK
Sbjct: 498 STIANATDNFSSRNKLGEGGFGSVYKGTLIEGQEVAVKRLSKNSGQGLTEFKNEVILIAK 557

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           LQHRNLVKLLGCC++ DER+LIYEY+PNKSL  FIFD   R   DW     I+GGIARGL
Sbjct: 558 LQHRNLVKLLGCCIEGDERILIYEYMPNKSLDYFIFDKKTRNSSDWRIWINIVGGIARGL 617

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           LYLHQDSRLRIIHRDLKA+NVLLDN MNPKISDFG+AR FG DQTEANTN++VGTYGYM 
Sbjct: 618 LYLHQDSRLRIIHRDLKAANVLLDNGMNPKISDFGLARTFGGDQTEANTNKIVGTYGYMS 677

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI 664
           PEYA+DG FSVKSDVFSFGVLVLE+V G +NRGF+H DHHHNLLGHAWRLW E  P+ELI
Sbjct: 678 PEYAVDGFFSVKSDVFSFGVLVLEIVSGKKNRGFNHPDHHHNLLGHAWRLWNEGMPLELI 737

Query: 665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERN 724
           ++  +D+ +LSE +RCI VGLLCVQ+RPEDRPNM+SV++MLS   SLPQPKQPGFFTERN
Sbjct: 738 NEPEQDSCTLSEIIRCIHVGLLCVQKRPEDRPNMSSVIVMLSSGISLPQPKQPGFFTERN 797

Query: 725 LPESESSSSNQTFHSSNQI 743
           LPE ESSSSNQ   S+N+I
Sbjct: 798 LPERESSSSNQKSFSTNEI 816

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa]

 Score =  956 bits (2470), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 481/799 (60%), Positives = 570/799 (71%), Gaps = 55/799 (6%)

Query: 2   TSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRN 61
           +S  D +   QS+RDGETLVS   SFELGFF+P  S SRYLG+WYKK +  TV WVANR 
Sbjct: 20  SSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYKK-SPQTVVWVANRG 78

Query: 62  APLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDN 121
            P+ ++ G L+++SQG   L+L N TN IVWSSN S T QNPVA LL+SGNLVV+ GNDN
Sbjct: 79  IPISNKFGTLNVTSQG--ILVLLNGTNNIVWSSNTSTTVQNPVAQLLDSGNLVVRDGNDN 136

Query: 122 DSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQ 181
            +DNFLWQSFDYP   LLPGMKLG NLVTGLN F+SSWK  ++PA   +   ID +G PQ
Sbjct: 137 KADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAPGQFTLGIDVQGYPQ 196

Query: 182 AMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMV 241
            +L K + I YR GSWNG ++TG P+L+P+P+YTFE+V N  EV+++F L  SSV S + 
Sbjct: 197 LILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNEVYFKFELQNSSVFSRLT 256

Query: 242 VSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFE 301
           V+P G  Q +TW  QT  W  F +   ++D+C+NYALCG  A C  NS S  C+CL+GF 
Sbjct: 257 VTPSGLVQLFTWSHQTNDWYVFAT--AVVDRCENYALCGANARCDSNS-SPVCDCLDGFI 313

Query: 302 PKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCS 361
            KSP +W   + T GC+RRT LDC   DGF     VKLPDT  S  D + SL EC+ LC 
Sbjct: 314 HKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDSFSLVECEGLCI 373

Query: 362 KNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELG---------- 411
           +NCSC AYAN D RG GSGCL WF +L D + L+EGGQD+YIR+A S+ G          
Sbjct: 374 QNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEGGQDIYIRLAASQSGVTGEKKRKKK 433

Query: 412 --------------------------------------NRKEEMELPIFDWKSIANATDN 433
                                                  ++EEMELP+ D  +I +ATDN
Sbjct: 434 THAGVIGGAVILGSSILILGIVFCIRRRKHRKNGNFEDRKEEEMELPMLDLTTIEHATDN 493

Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           FS   KLGEGGFG VYKG LI+GQEIAVKRLSKSSGQG+ EFKNEVLLIAKLQHRNLVKL
Sbjct: 494 FSSSKKLGEGGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKL 553

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
           LGCC+  DE+MLIYEY+PN+SL  FIFD TRRK LDWSKR  II GIARGLLYLHQDSRL
Sbjct: 554 LGCCIHEDEKMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRL 613

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
           RIIHRD+KASN+LLDNE+NPKISDFG+AR FG DQTEANT RVVGTYGYM PEYA+DG F
Sbjct: 614 RIIHRDIKASNILLDNELNPKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHF 673

Query: 614 SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHH-NLLGHAWRLWTEDRPVELIDKSLEDTY 672
           SVKSDVFSFGVLVLE+V G +NRGF H D++  NLLGHAW LW    P+ELID+   D+ 
Sbjct: 674 SVKSDVFSFGVLVLEIVSGKKNRGFCHPDYNQKNLLGHAWMLWFNGIPLELIDECFADSC 733

Query: 673 SLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPESESSS 732
           + SEALRCI V LLCVQQRPEDRPNM+SVVLML  E  LPQPKQPGFF   N PE ++SS
Sbjct: 734 TPSEALRCIHVALLCVQQRPEDRPNMSSVVLMLGSENPLPQPKQPGFFMGSNPPEKDTSS 793

Query: 733 SNQTFHSSNQITVSLIEGR 751
           +    HS+N++TV+L++ R
Sbjct: 794 NKHQSHSANEVTVTLLQAR 812

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122822|ref|XP_002330372.1| predicted protein [Populus trichocarpa] gi|222871757|gb|EEF08888.1| predicted protein [Populus trichocarpa]

 Score =  955 bits (2469), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 466/759 (61%), Positives = 578/759 (76%), Gaps = 15/759 (1%)

Query: 2   TSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRN 61
           ++  D +   QSIRDG ++VSA+ SF++GFFSPG SK+RYLGIWY K++  TV WVANR 
Sbjct: 24  STAVDIINTTQSIRDGGSMVSADGSFKMGFFSPGSSKNRYLGIWYNKVSVMTVVWVANRE 83

Query: 62  APLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDN 121
            PL + SGVL I+  G G L L N    I+WS+N+SR+A+NPVA LL+SGNL VK   D+
Sbjct: 84  IPLTNSSGVLKIT--GEGILELLNQNGSIIWSTNSSRSARNPVAQLLDSGNLAVKEDGDD 141

Query: 122 DSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQ 181
           D +N LWQSFDYP   LLPGMK+G +L+TG +R++SSWKS DDP++ ++ +  DP G P+
Sbjct: 142 DLENSLWQSFDYPCDTLLPGMKMGRDLITGFDRYLSSWKSPDDPSRGNFTFRNDPSGHPE 201

Query: 182 AMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMV 241
            +L + S +RYR G WNGL ++G+PQL+PN +Y FE+V NEKE++YR+ L+ +S+ S +V
Sbjct: 202 QILTENSIVRYRSGPWNGLRFSGVPQLRPNTLYKFEFVFNEKEIYYRYQLLNNSILSRLV 261

Query: 242 VSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFE 301
           ++  G  QR+TW +QT  WA +L+     D C  YALCG Y  C + S S  C CL+GF 
Sbjct: 262 LTQNGNFQRFTWTDQTDVWAFYLAL--FDDYCSRYALCGAYGTCDITS-SPVCGCLKGFL 318

Query: 302 PKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCS 361
           PK P+ W ++D +DGC RRT L+C  GDGF K   VKLPD R S ++KN++L ECK +C 
Sbjct: 319 PKVPKVWDMMDWSDGCARRTALNCS-GDGFQKYSGVKLPDIRKSWLNKNMNLEECKSMCM 377

Query: 362 KNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELG---------N 412
           KNCSCTAYAN D+R GGSGCLLWF EL DM+ L+E GQD+YIRMA SELG          
Sbjct: 378 KNCSCTAYANLDIREGGSGCLLWFSELIDMRQLNENGQDIYIRMAASELGILKRSADDSC 437

Query: 413 RKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGV 472
           +KE  EL +FD+ +I+ +T+NFS  NKLG+GGFGPVYKG+L DGQEIAVKRLSKSS QG+
Sbjct: 438 KKEYPELQLFDFGTISCSTNNFSHTNKLGQGGFGPVYKGLLKDGQEIAVKRLSKSSRQGL 497

Query: 473 EEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK 532
           +EFKNEV+ IAKLQHRNLVKLLGCC++ DERML+YE++P KSL   IFD T+  LLDW K
Sbjct: 498 DEFKNEVIHIAKLQHRNLVKLLGCCIQADERMLVYEFMPKKSLDFLIFDRTQSTLLDWPK 557

Query: 533 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
           R  II GIARGLLYLHQDSRLRIIHRDLKASN+LLDN MNPKISDFG+AR+FG +QTE N
Sbjct: 558 RYHIINGIARGLLYLHQDSRLRIIHRDLKASNILLDNNMNPKISDFGLARSFGENQTEDN 617

Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW 652
           TNRVVGTYGYM PEYAIDGL+S+KSDVFSFGVLV+E+V G+RNRGF+H DH+ NLLGHAW
Sbjct: 618 TNRVVGTYGYMSPEYAIDGLYSIKSDVFSFGVLVIEIVSGSRNRGFYHPDHNLNLLGHAW 677

Query: 653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLP 712
            L+TE R  ELI + +E++ +L E LR I VGLLCVQ  P DRP+M SVVLML GE  LP
Sbjct: 678 GLFTEGRSCELITEPIEESCNLPEVLRSIHVGLLCVQCHPNDRPSMLSVVLMLCGEAKLP 737

Query: 713 QPKQPGFFTERNLPESESSSSNQTFHSSNQITVSLIEGR 751
           QPKQPGFFT+R L E+ SSS   T  S N  T++L+E R
Sbjct: 738 QPKQPGFFTDRALVEANSSSRKNTSCSVNDSTITLLEAR 776

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa]

 Score =  954 bits (2465), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 479/759 (63%), Positives = 568/759 (74%), Gaps = 19/759 (2%)

Query: 1   TTSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANR 60
            ++  D +  GQ I DG+T+VSA ++FELGFFSPG S  RYLGIWYKK + GTV WVANR
Sbjct: 27  VSNAPDIISPGQFIGDGDTIVSAGQNFELGFFSPGSSTRRYLGIWYKKFSTGTVVWVANR 86

Query: 61  NAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGND 120
             P+ D SGVL  ++QG  TL+L N T  +VWSSN +    NPVA LLESGNLVVK GND
Sbjct: 87  ENPIFDHSGVLYFTNQG--TLLLLNGTKDVVWSSNRTTPKNNPVAQLLESGNLVVKDGND 144

Query: 121 NDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVP 180
           ++ ++FLWQSFDYP    LP MKLG NLVTGL+  ISSWKS DDPA+ +Y   IDPRG  
Sbjct: 145 SNPESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISSWKSLDDPARGEYSLGIDPRGYQ 204

Query: 181 QAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMM 240
           Q +  KG  I++R GSWNG+ +TG  +L+PNPVY +E+V N+KEV++ F L+ SSV S  
Sbjct: 205 QLVYKKGRAIQFRAGSWNGIRFTGATRLRPNPVYRYEFVLNDKEVYFNFELLNSSVASRF 264

Query: 241 VVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGF 300
           VV+  G  +R TW+ Q  +W  + +     DQCD Y+ CG+ A C ++  S  C CL+GF
Sbjct: 265 VVNASGVVERLTWISQMHRWTRYFAVGE--DQCDAYSFCGSNAKCNID-KSPVCACLDGF 321

Query: 301 EPKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELC 360
           EPKS RDW   D + GCVRRT L C RG+GF+K   +KLPDT  S  + +ISL EC+ELC
Sbjct: 322 EPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGMKLPDTSSSWYNTSISLKECQELC 381

Query: 361 SKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELG--------- 411
            K CSC AYAN DVRGGGSGCLLWF +L DM+     GQDLYIRMA S LG         
Sbjct: 382 LKKCSCMAYANTDVRGGGSGCLLWFGDLIDMREFVNTGQDLYIRMAASYLGKMKNILEMD 441

Query: 412 ----NRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS 467
               +RKEE+ELPI D  +IA AT NFS   KLGEGGFG VYKG L  GQ+IAVKRLS  
Sbjct: 442 YDSHSRKEELELPIIDLSTIAKATGNFSSNKKLGEGGFGLVYKGTLY-GQDIAVKRLSMY 500

Query: 468 SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL 527
           SGQG+EEFKNEVLLIAKLQHRNLVKLLGCC++ DERMLIYEY+PNKSL  FIFD +R KL
Sbjct: 501 SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCIEGDERMLIYEYMPNKSLDYFIFDQSRSKL 560

Query: 528 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD 587
           LDW  R  II GIARGLLYLHQDSRLRIIHRDLKASNVLLD +MNPKISDFGMAR FG +
Sbjct: 561 LDWPTRISIIDGIARGLLYLHQDSRLRIIHRDLKASNVLLDTDMNPKISDFGMARIFGGN 620

Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL 647
           QTEANT RVVGTYGYM PEYA++GLFSVKSD+FSFGVLVLE+V G +NRGF   +HH NL
Sbjct: 621 QTEANTKRVVGTYGYMAPEYAVEGLFSVKSDIFSFGVLVLEIVSGRKNRGFFSHNHHLNL 680

Query: 648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG 707
           +GHAW+LW E+R +EL D +L  +++LSE +R I VGLLCVQQ+P+DRPNM++ VLML G
Sbjct: 681 VGHAWKLWMEERSLELTDNTLGASHALSEIIRYIHVGLLCVQQQPDDRPNMSTAVLMLGG 740

Query: 708 ERSLPQPKQPGFFTERNLPESESSSSNQTFHSSNQITVS 746
           E SLPQPKQPGFF ERN+P +ESSSSN    S+N IT++
Sbjct: 741 ESSLPQPKQPGFFLERNVPRTESSSSNYKSTSTNGITMT 779

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493721|ref|XP_002280717.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera]

 Score =  951 bits (2457), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 457/759 (60%), Positives = 583/759 (76%), Gaps = 14/759 (1%)

Query: 2   TSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRN 61
           ++  D++   Q I+DGET++SA  +FELGF   G SK++YLGIWYKK+   TV WVANR 
Sbjct: 51  STAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYKKVTPRTVVWVANRE 110

Query: 62  APLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDN 121
            P+ D SGVL ++ QG  +L++ N +NG++WSSN+SR+A+NP A LL+SGNLV+KSGND+
Sbjct: 111 LPVTDSSGVLKVTDQG--SLVILNGSNGLIWSSNSSRSARNPTAQLLDSGNLVIKSGNDS 168

Query: 122 DSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQ 181
           D DNFLWQSFDYP   LLPGMK G N VTGL+R++SSWKS DDP++ D+ Y +DP G PQ
Sbjct: 169 DPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSKGDFTYGLDPSGCPQ 228

Query: 182 AMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMV 241
             L  GST+ +R G WNG+ + G P+L+PNPV+ + +V NEKE+++ + L+ SSV S +V
Sbjct: 229 LFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEKEMYFTYKLVNSSVLSRLV 288

Query: 242 VSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFE 301
           ++P G  QR  W+ +T+ W  +   +   D CD+YALCG Y+ C ++  S  C C++GF 
Sbjct: 289 LNPNGNVQRLIWIGRTKSWNVY--STAYKDDCDSYALCGAYSTCNIH-RSPRCGCMKGFV 345

Query: 302 PKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCS 361
           PK P  W  +D ++GCVR+T LDC++GDGF+K   VKLPDTR S  +++++L EC  LC 
Sbjct: 346 PKFPYQWDTMDWSNGCVRKTSLDCQKGDGFVKCSGVKLPDTRNSWFNESMNLKECASLCL 405

Query: 362 KNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSEL---------GN 412
           +NCSC+AY N+D++GGGSGCLLWF +L D+K  +E GQD YIRMA SEL           
Sbjct: 406 RNCSCSAYTNSDIKGGGSGCLLWFGDLIDVKEFTENGQDFYIRMAASELELNNEGAETNE 465

Query: 413 RKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGV 472
           R+E++ELP+FD  +I NAT NFS  NKLGEGGFGPVYKGML DG+EIAVKRLSK S QG+
Sbjct: 466 RQEDLELPLFDLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESNQGL 525

Query: 473 EEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK 532
           +EFKNEV+ I+KLQHRNLVKLLGCC+  +E+MLIYEY+PNKSL  FIFDG +  +LDW K
Sbjct: 526 DEFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVLDWPK 585

Query: 533 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
           R  II GIARGLLYLHQDSRLRIIHRDLKA NVLLDNEMNP+ISDFGMAR+FG ++T+A 
Sbjct: 586 RFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNETQAR 645

Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW 652
           T RVVGTYGYM PEYAIDG++SVKSDVFSFGVL+LE++ G RNRGF+H DH  NLLGHAW
Sbjct: 646 TKRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVLLLEIISGKRNRGFNHPDHDLNLLGHAW 705

Query: 653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLP 712
            L+ E  P+ELID S+ DTY+ SE LR + VGLLCVQ+ P+DRPNM+SVVLMLS E +L 
Sbjct: 706 TLYMERTPLELIDASVGDTYNQSEVLRALNVGLLCVQRHPDDRPNMSSVVLMLSSEGALR 765

Query: 713 QPKQPGFFTERNLPESESSSSNQTFHSSNQITVSLIEGR 751
           QPK+PGFFTERN+ E++S        S N+ T++++EGR
Sbjct: 766 QPKEPGFFTERNMLEADSLQCKHAVFSGNEHTITILEGR 804

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115106|ref|XP_002316941.1| predicted protein [Populus trichocarpa] gi|222860006|gb|EEE97553.1| predicted protein [Populus trichocarpa]

 Score =  947 bits (2447), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 471/758 (62%), Positives = 546/758 (72%), Gaps = 62/758 (8%)

Query: 26  SFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQN 85
           SF LGFFSPG S +RYLGIWY KI  GTV WVANR  PL +R GVL+++  G G L+L N
Sbjct: 3   SFGLGFFSPGSSSNRYLGIWYNKITPGTVVWVANREQPLVNRLGVLNVT--GQGVLVLFN 60

Query: 86  STNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLG 145
           STN  VWSSN SRTAQNPV  LL+SGNL VK GNDN+ DNFLWQSFDYP+  LLPGMK G
Sbjct: 61  STNYAVWSSNVSRTAQNPVVQLLDSGNLAVKDGNDNNPDNFLWQSFDYPSETLLPGMKWG 120

Query: 146 VNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNGLHWTGM 205
            NLVTGL+R+ISSWKSADDPA+ D+ + +DPRG  Q +L++G TI YR G WNG  W G+
Sbjct: 121 KNLVTGLDRYISSWKSADDPARGDFTFRLDPRGYNQMLLMRGLTILYRTGIWNGFRWGGV 180

Query: 206 PQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWMEQTQKWAPFLS 265
           P+   N VY  ++VS   E +Y F L+ SSVPS +V++P    QR TW+ QT  W  +  
Sbjct: 181 PETISNTVYGEQFVSTATESYYTFDLLNSSVPSRLVINPSSIPQRLTWITQTNLWGSYSV 240

Query: 266 FSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKSPRDWKLLDKTDGCVRRTKLDC 325
               IDQCD Y LCG   IC  NSN A C CLE F P++P  W   D + GCVRRT+L C
Sbjct: 241 VQ--IDQCDTYTLCGANGICS-NSNGAVCSCLESFIPRTPESWNKQDWSGGCVRRTQLGC 297

Query: 326 ERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGGGSGCLLWF 385
           + GDGFL+   VKLPD   S V+ ++SL EC+ +C  NCSC AY N+D+R G SGC LWF
Sbjct: 298 KNGDGFLQITGVKLPDMSDSWVNTSMSLVECRNMCLSNCSCVAYGNSDIRRGASGCYLWF 357

Query: 386 HELTDMKILSEGGQDLYIRMATSELG---------------------------------- 411
            +L D K L  GGQDLYIRMA SEL                                   
Sbjct: 358 DDLWDTKHLPLGGQDLYIRMAASELSIYEKKSSSKRKRRRIIIGTLISAVVLLVLGFMLY 417

Query: 412 -----------------NRKEE------MELPIFDWKSIANATDNFSEENKLGEGGFGPV 448
                            N K+E      MELP FD+ +I NATD FS  NKLGEGGFG V
Sbjct: 418 MRRRRKTRQGKKSIRIDNLKDESGRKDDMELPAFDFITIKNATDYFSYNNKLGEGGFGSV 477

Query: 449 YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE 508
           YKG L DGQEIAVKRLSK+SGQG++EFKNEV+LIAKLQHRNLVKLLGCC++ DERMLIYE
Sbjct: 478 YKGTLTDGQEIAVKRLSKNSGQGLKEFKNEVILIAKLQHRNLVKLLGCCIEGDERMLIYE 537

Query: 509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 568
           Y+PNKSL +FIFD   R LLDW     IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD
Sbjct: 538 YMPNKSLDNFIFDKKSRNLLDWQTHMNIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 597

Query: 569 NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE 628
           N MNPKISDFGMAR FG DQ EANTNR+VGTYGY+ PEYA+DGLFS+KSDVFSFGVLVLE
Sbjct: 598 NSMNPKISDFGMARIFGGDQIEANTNRIVGTYGYISPEYAVDGLFSIKSDVFSFGVLVLE 657

Query: 629 LVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCV 688
           +V G +NRGF+H DH+HNLLGHAW+LW E RP+EL+D +++D+ SLSE LR IQVGLLCV
Sbjct: 658 IVSGKKNRGFYHPDHNHNLLGHAWKLWNEGRPLELMDITIDDSSSLSEILRHIQVGLLCV 717

Query: 689 QQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLP 726
           QQRP+DRP+M++VV+MLS E SLPQPKQPGF+TERN P
Sbjct: 718 QQRPDDRPSMSTVVVMLSSEISLPQPKQPGFYTERNFP 755

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera]

 Score =  926 bits (2394), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 456/803 (56%), Positives = 580/803 (72%), Gaps = 58/803 (7%)

Query: 2   TSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRN 61
           ++  D++   Q I+DGET++SA  +FELGF   G SK++YLGIWYKK+   TV WVANR 
Sbjct: 21  STAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYKKVTPRTVVWVANRE 80

Query: 62  APLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDN 121
            P+ D SG L ++ QG  +L++ N +NG++WSSN+SR+A+NP A LL+SGNLV+KSGND+
Sbjct: 81  LPVTDSSGXLKVTDQG--SLVILNGSNGLIWSSNSSRSARNPTAQLLDSGNLVIKSGNDS 138

Query: 122 DSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQ 181
           D DNFLWQSFDYP   LLPGMK G N VTGL+R++SSWKS DDP++ D+ Y +DP G PQ
Sbjct: 139 DPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSKGDFTYGLDPSGCPQ 198

Query: 182 AMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMV 241
             L  GST+ +R G WNG+ + G P+L+PNPV+ + +V NEKE+++ + L+ SSV S +V
Sbjct: 199 LFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEKEMYFTYKLVNSSVLSRLV 258

Query: 242 VSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFE 301
           ++P G  QR  W+ +T+ W  + +     D CD+YALCG Y+ C ++  S  C C++GF 
Sbjct: 259 LNPNGNVQRLIWIGRTKSWNVYST--AYKDDCDSYALCGAYSTCNIH-RSPRCGCMKGFV 315

Query: 302 PKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCS 361
           PK P  W  +D ++GCVR+T LDC++GDGF K   VKLPDTR S  +++++L EC  LC 
Sbjct: 316 PKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPDTRNSWFNESMNLKECASLCF 375

Query: 362 KNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMA--------------- 406
           +NCSC+AY N+D++GGGSGCLLWF +L D+K  +E GQD YIRMA               
Sbjct: 376 RNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTENGQDFYIRMAASELDAISKVTKRRW 435

Query: 407 -------------------------------TSELGN-------RKEEMELPIFDWKSIA 428
                                          T+EL N       R+E++ELP+F   +I 
Sbjct: 436 VIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNNEGAETNERQEDLELPLFXLDTIL 495

Query: 429 NATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR 488
           NAT NFS  NKLGEGGFGPVYKGML DG+EIAVKRLSK S QG++EFKNEV+ I+KLQHR
Sbjct: 496 NATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHR 555

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           NLVKLLGCC+  +E+MLIYEY+PNKSL  FIFDG +  +LDW KR  II GIARGLLYLH
Sbjct: 556 NLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLH 615

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           QDSRLRIIHRDLKA NVLLDNEMNP+ISDFGMAR+FG ++T A T RVVGTYGYM PEYA
Sbjct: 616 QDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNETIARTKRVVGTYGYMSPEYA 675

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL 668
           IDG++SVKSDVFSFGVL LE++ G RNRGF+H DH  NLLGHAW L+ E  P+ELID S+
Sbjct: 676 IDGVYSVKSDVFSFGVLXLEIISGKRNRGFNHPDHDLNLLGHAWTLYMEGTPLELIDASV 735

Query: 669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPES 728
             TY+ SE LR + VGLLCVQ+ P+DRPNM+SVVLMLS E +LPQPK+PGFFTERN+ E+
Sbjct: 736 GYTYNQSEVLRALNVGLLCVQRHPDDRPNMSSVVLMLSSEGALPQPKEPGFFTERNMLEA 795

Query: 729 ESSSSNQTFHSSNQITVSLIEGR 751
           +S        S N+ T++++EGR
Sbjct: 796 DSLQCKHAVFSGNEHTITILEGR 818

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493730|ref|XP_003634656.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera]

 Score =  926 bits (2393), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 449/762 (58%), Positives = 575/762 (75%), Gaps = 24/762 (3%)

Query: 2   TSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRN 61
           ++  DT+ + Q IRDGET+ SA  +F+LGFFSPG SK+RYLGIWYKK+A  TV WVANR 
Sbjct: 21  STAVDTINVNQHIRDGETITSAGGTFQLGFFSPGDSKNRYLGIWYKKVAPQTVVWVANRE 80

Query: 62  APLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDN 121
           +PL D SGVL ++ QG  TL++ + TNGI+W+SN+SR+AQ+P A LLESGNLV+++GND+
Sbjct: 81  SPLTDSSGVLKVTQQG--TLVVVSGTNGILWNSNSSRSAQDPNAQLLESGNLVMRNGNDS 138

Query: 122 DSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQ 181
           D +NFLWQSFDYP   LLPGMK G N VTGL+R++SSWKSADDP++ ++ Y ID  G PQ
Sbjct: 139 DPENFLWQSFDYPCDTLLPGMKFGWNRVTGLDRYLSSWKSADDPSKGNFTYGIDLSGFPQ 198

Query: 182 AMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMV 241
             L  G T+++R G WNG+ + G+PQL  N ++TF+YVSNEKE+++ + L+ SSV    V
Sbjct: 199 PFLRNGLTVKFRAGPWNGVRFGGIPQLTNNSLFTFDYVSNEKEIYFIYYLVNSSVFVRRV 258

Query: 242 VSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFE 301
           ++P G S+R+TW ++  +W   L  +   D CDNYA+CG Y ICK++  S +CEC++GF 
Sbjct: 259 LTPDGYSRRFTWTDKKNEWT--LYSTAQRDDCDNYAICGVYGICKIDE-SPKCECMKGFR 315

Query: 302 PKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCS 361
           PK   +W + D + GCVR T LDC++GDGF+K   VKLPDTR S  D++++L EC  LC 
Sbjct: 316 PKFQSNWDMADWSKGCVRSTPLDCQKGDGFVKYSGVKLPDTRNSWFDESMNLKECASLCL 375

Query: 362 KNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELG---------- 411
           +NCSCTAYAN+D+RGGGSGCLLWF +L D++  ++ GQ+ Y RMA SE G          
Sbjct: 376 RNCSCTAYANSDIRGGGSGCLLWFDDLIDIRDFTQNGQEFYARMAASESGYMDHKSKEGE 435

Query: 412 --NRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG 469
               +E ++LP+F+  ++ NAT+NFSEENKLGEGGFGPVYKG+L +GQEIAVK +SK+S 
Sbjct: 436 NNEGQEHLDLPLFNLATLLNATNNFSEENKLGEGGFGPVYKGILQEGQEIAVKMMSKTSR 495

Query: 470 QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD 529
           QG++EFKNEV  I KLQHRNLVKLLGCC+   ER+LIYEY+PNKSL  +IFD  R ++LD
Sbjct: 496 QGLKEFKNEVESITKLQHRNLVKLLGCCIHGRERLLIYEYMPNKSLDLYIFDHMRSRVLD 555

Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
           W KR  II GIARGLLYLHQDSRLRIIHRDLKA N+LLDNEM PKISDFG+AR+FG ++T
Sbjct: 556 WPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENILLDNEMTPKISDFGIARSFGGNET 615

Query: 590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLG 649
           EANT RVVGT GYM PEYA +GL+S KSDVFSFGVL+LE+V G RNR F H DH  NLLG
Sbjct: 616 EANTTRVVGTLGYMSPEYASEGLYSTKSDVFSFGVLLLEIVSGKRNRRFSHPDHDLNLLG 675

Query: 650 HAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER 709
           HAW L+ E   +E ID S+ +T +L E LR I VGLLCVQ+ P+DRP+M SV+LML  E 
Sbjct: 676 HAWTLYIEGGSLEFIDTSIVNTCNLIEVLRSINVGLLCVQRFPDDRPSMHSVILMLGSEG 735

Query: 710 SLPQPKQPGFFTERNLPESESSSSNQTFHSSNQITVSLIEGR 751
           + P+PK+P FFT+RN+ E+ SSS  Q        T++L+E R
Sbjct: 736 APPRPKEPCFFTDRNMMEANSSSGIQP-------TITLLEAR 770

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224117344|ref|XP_002317549.1| predicted protein [Populus trichocarpa] gi|222860614|gb|EEE98161.1| predicted protein [Populus trichocarpa]

 Score =  917 bits (2370), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 448/764 (58%), Positives = 574/764 (75%), Gaps = 19/764 (2%)

Query: 1   TTSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANR 60
           TT+  DT+   Q IRDG+T+VSAN SF LGFFSPG SK+RYLG+WY KI+  TV WVANR
Sbjct: 23  TTTAIDTVNTTQFIRDGDTIVSANGSFILGFFSPGMSKNRYLGVWYGKISVQTVIWVANR 82

Query: 61  NAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGND 120
             PL D SGVL +++QG   L +QN +  I+WSSN  R A+NP+  LL+SGNLVVK   D
Sbjct: 83  ETPLNDTSGVLRLTNQG--ILAIQNRSGSIIWSSNTLRPARNPIGQLLDSGNLVVKEEGD 140

Query: 121 NDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVP 180
           ND +N LWQSF+YP   L+P MK G N + G++ +++SWKS DDP++ +  Y + P G P
Sbjct: 141 NDLENSLWQSFEYPGDNLMPDMKQGRNRIAGMDWYMTSWKSPDDPSRGNISYILVPYGYP 200

Query: 181 QAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMM 240
           + ++++ S +++R G WNG  ++G+PQL+PNPVY+FE+V NEKE+FYR+ L+ SS+ S +
Sbjct: 201 EILVMEDSRVKFRSGPWNGKRFSGVPQLKPNPVYSFEFVFNEKEIFYRYHLLNSSMLSRI 260

Query: 241 VVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGF 300
           VVS  G+ QRYTW+++TQ W  +L+ +   D C+ YALCG   IC ++ NS  C+CL GF
Sbjct: 261 VVSQDGDIQRYTWIDRTQSWVVYLTANR--DNCERYALCGANGICSID-NSPVCDCLHGF 317

Query: 301 EPKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELC 360
            PK   DWK+ D + GCVRRT L+C   DGF K   VKLP T  S  +KN++L ECK  C
Sbjct: 318 VPKIESDWKVTDWSSGCVRRTPLNCSV-DGFRKLSGVKLPQTNTSWFNKNMNLEECKNTC 376

Query: 361 SKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGN-------- 412
            KNC+CTAY++ D+R GGSGCL+WF  L D+++  E   ++YIRMA SELGN        
Sbjct: 377 LKNCNCTAYSSLDIRDGGSGCLIWFGNLLDIRVFVENEPEIYIRMAASELGNMTGVFEGN 436

Query: 413 -----RKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS 467
                 KE+++LP+FD+ ++A AT+NFS  NKLGEGGFGPVYKG L DG+E+AVKRLSK+
Sbjct: 437 LQHKRNKEDLDLPLFDFGAMARATNNFSVNNKLGEGGFGPVYKGTLNDGREVAVKRLSKN 496

Query: 468 SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL 527
           S QGV+EFKNEV  I KLQHRNLVKLLGCC++ DE+MLIYE+LPN SL  F+F+ T R  
Sbjct: 497 SRQGVDEFKNEVKHIVKLQHRNLVKLLGCCIEVDEKMLIYEFLPNNSLDFFLFNETHRLQ 556

Query: 528 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD 587
           LDW KR  +I GIARGLLYLHQDSRLR+IHRDLKASNVLLD+EMNPKISDFG+AR+FG +
Sbjct: 557 LDWPKRYNVIKGIARGLLYLHQDSRLRVIHRDLKASNVLLDHEMNPKISDFGLARSFGGN 616

Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL 647
           +TEANTN+VVGTYGY+ PEYA DGL+S KSDVFSFGVLVLE++ G +NRGF H DH  NL
Sbjct: 617 ETEANTNKVVGTYGYISPEYASDGLYSTKSDVFSFGVLVLEIISGNKNRGFSHPDHQLNL 676

Query: 648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG 707
           LGHAWRL+ E +P+ELI +S+ ++ +L E LR I VGLLCVQ+ P DRP+M+ VVLML  
Sbjct: 677 LGHAWRLFIEGKPLELISESIIESCNLFEVLRSIHVGLLCVQENPVDRPSMSYVVLMLGN 736

Query: 708 ERSLPQPKQPGFFTERNLPESESSSSNQTFHSSNQITVSLIEGR 751
           E +LPQPKQPGFFTER+L E   SS+    +S+N+ ++SL+E R
Sbjct: 737 EDALPQPKQPGFFTERDLIEVTYSSTQSKPYSANECSISLLEAR 780

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224110464|ref|XP_002315527.1| predicted protein [Populus trichocarpa] gi|222864567|gb|EEF01698.1| predicted protein [Populus trichocarpa]

 Score =  915 bits (2364), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/760 (59%), Positives = 561/760 (73%), Gaps = 15/760 (1%)

Query: 1   TTSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANR 60
           T +  DT+   Q IRDG+T+VSA  ++ELGFFSPGKSKSRYLGIWY KI+  T  WVANR
Sbjct: 14  TATPTDTINTAQFIRDGDTIVSAGGTYELGFFSPGKSKSRYLGIWYGKISVQTAVWVANR 73

Query: 61  NAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGND 120
             PL D SGV+ +++  +G L+L N +  I+WSSN S  A+NPVA LL+SGNLVVK   D
Sbjct: 74  ETPLNDSSGVVKLTN--DGLLVLLNRSGSIIWSSNTSTPARNPVAQLLDSGNLVVKEEGD 131

Query: 121 NDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVP 180
           N+ +N LWQSFDYP++ LLPGMK+G N++TG +  ++SWKS DDP+  +    + P G P
Sbjct: 132 NNMENSLWQSFDYPSNTLLPGMKVGRNIITGTDWHLTSWKSQDDPSSGNVTGALIPDGYP 191

Query: 181 QAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMM 240
           +   L+ S ++YR G WNGL ++G+P+L+PNPVYTFE+V N+KE+FYR  L+ +S    +
Sbjct: 192 EYAALEDSKVKYRAGPWNGLGFSGLPRLKPNPVYTFEFVFNDKEIFYRENLVNNSTRWRV 251

Query: 241 VVSPLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGF 300
           V+S   +     WMEQTQ W  FL  +   D C+ Y LCG   IC ++ NS  C CL GF
Sbjct: 252 VLSQSCDFLLLLWMEQTQSW--FLYSTANTDNCERYNLCGANGICSID-NSPVCNCLNGF 308

Query: 301 EPKSPRDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELC 360
            PK PRDWK  D + GCVR+T L+C R DGF K   +K+P+TR S  +++++L ECK  C
Sbjct: 309 VPKVPRDWKKTDWSSGCVRKTALNCSR-DGFRKLRGLKMPETRKSWFNRSMNLEECKNTC 367

Query: 361 SKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNR------- 413
            KNCSCTAY N D+R GGSGCLLWF++L DM+  ++  QD++IRMA SELGN        
Sbjct: 368 LKNCSCTAYGNLDIRNGGSGCLLWFNDLIDMRTFTQIEQDIFIRMAASELGNLQRRSNKK 427

Query: 414 --KEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQG 471
             KEE+ELP F+   +A AT+NFS  NKLGEGGFGPVYKG L DG+EIAVKRLSK+S QG
Sbjct: 428 DLKEELELPFFNMDELACATNNFSVSNKLGEGGFGPVYKGTLSDGREIAVKRLSKNSRQG 487

Query: 472 VEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWS 531
           ++EFKNEV  I KLQHRNLV+LLGCC++RDE ML+YE LPNKSL  +IFD TR  LLDW 
Sbjct: 488 LDEFKNEVKHIVKLQHRNLVRLLGCCIERDENMLVYELLPNKSLDFYIFDETRSLLLDWP 547

Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
           KR  II GIARGLLYLHQDSRLRIIHRDLK SNVLLD EMNPKISDFG+AR+FG ++TEA
Sbjct: 548 KRYNIINGIARGLLYLHQDSRLRIIHRDLKTSNVLLDYEMNPKISDFGLARSFGENETEA 607

Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA 651
           NTN+V GTYGY+ PEYA  GL+S+KSDVFSFGVLVLE+V G +NRGFHH DHH NL+GHA
Sbjct: 608 NTNKVAGTYGYISPEYANYGLYSLKSDVFSFGVLVLEIVSGYKNRGFHHPDHHLNLIGHA 667

Query: 652 WRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSL 711
           W L+ + RP+EL   S  +T  LSE LR I VGLLCVQ+ PEDRPNM+ VVLML  E  L
Sbjct: 668 WILFKQGRPLELAAGSKVETPYLSEVLRSIHVGLLCVQENPEDRPNMSYVVLMLGNEDEL 727

Query: 712 PQPKQPGFFTERNLPESESSSSNQTFHSSNQITVSLIEGR 751
           PQPKQPGFFTER+L E   SSS     S+N  ++S++E R
Sbjct: 728 PQPKQPGFFTERDLVEGSYSSSQSKPPSANVCSISVLEAR 767

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	751
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.984	0.943	0.556	3e-227
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.450	0.414	0.652	7.2e-202
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.452	0.4	0.587	2.4e-201
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.462	0.409	0.591	6.3e-192
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.451	0.402	0.595	4.4e-191
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.452	0.400	0.605	1.5e-179
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.454	0.404	0.577	4.5e-176
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.479	0.433	0.515	2e-160
TAIR|locus:2200888	804	AT1G61500 [Arabidopsis thalian	0.436	0.407	0.553	5.5e-156
TAIR|locus:2197744	807	AT1G61420 [Arabidopsis thalian	0.438	0.407	0.519	1.9e-155

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 2193 (777.0 bits), Expect = 3.0e-227, P = 3.0e-227
 Identities = 426/766 (55%), Positives = 545/766 (71%)

Query:     6 DTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLP 65
             D L   Q+++DG+T+VS   SFE+GFFSPG S++RYLGIWYKKI+  TV WVANR++PL 
Sbjct:    25 DILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRDSPLY 84

Query:    66 DRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQ-----NPVAVLLESGNLVVKSGND 120
             D SG L +S   NG+L L N  N I+WSS++S ++Q     NP+  +L++GNLVV+  N 
Sbjct:    85 DLSGTLKVSE--NGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVR--NS 140

Query:   121 NDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVP 180
              D  +++WQS DYP  + LPGMK G+N VTGLNRF++SW++ DDP+  +Y  ++DP GVP
Sbjct:   141 GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVP 200

Query:   181 QAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKXXXXXXX 240
             Q  L K S + +R G WNGL +TGMP L+PNP+Y +EYV  E+EV+Y + L         
Sbjct:   201 QFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRM 260

Query:   241 XXXXLGESQRYTWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGF 300
                  G  QRYTW++  Q W  +LS   ++D CD Y LCG+Y  C +N + A C CL+GF
Sbjct:   261 QLNPNGALQRYTWVDNLQSWNFYLS--AMMDSCDQYTLCGSYGSCNINESPA-CRCLKGF 317

Query:   301 EPKSPRDWKLLDKTDGCVRRTKLDCERG-DGFLKRESVKLPDTRFSRVDKNISLFECKEL 359
               K+P+ W   D ++GCVRR KLDC +G DGFLK   +KLPDTR S  DKN+ L ECK++
Sbjct:   318 VAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKV 377

Query:   360 CSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSEL--------- 410
             C +NC+C+AY+  D+R GG GC+LWF +L D++  +E GQDLY+R+A+SE+         
Sbjct:   378 CLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESSR 437

Query:   411 -GNRKEE---MELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSK 466
               +RK+E   +ELP  D  +++ AT  FS  NKLG+GGFGPVYKG L  GQE+AVKRLS+
Sbjct:   438 VSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSR 497

Query:   467 SSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK 526
             +S QGVEEFKNE+ LIAKLQHRNLVK+LG C+  +ERMLIYEY PNKSL  FIFD  RR+
Sbjct:   498 TSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRR 557

Query:   527 LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV 586
              LDW KR +II GIARG+LYLH+DSRLRIIHRDLKASNVLLD++MN KISDFG+AR  G 
Sbjct:   558 ELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGG 617

Query:   587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXX 646
             D+TEANT RVVGTYGYM PEY IDG FS+KSDVFSFGVLVLE+V G RNRGF        
Sbjct:   618 DETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLN 677

Query:   647 XXXXAWRLWTEDRPVELIDKSLEDTYS-LSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
                 AWR + ED+  E+ID+++ ++ + +SE LR I +GLLCVQQ P+DRPNM+ VVLML
Sbjct:   678 LLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLML 737

Query:   706 SGERSLPQPKQPGFFTERNLPXXXXXXXNQTFHSSNQITVSLIEGR 751
             S E  L  P+QPGFF ERNL        N    S+N  T+S+I+ R
Sbjct:   738 SSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1159 (413.0 bits), Expect = 7.2e-202, Sum P(2) = 7.2e-202
 Identities = 223/342 (65%), Positives = 267/342 (78%)

Query:   411 GNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQ 470
             G  +E+++LPIFD K+I+ ATD+FS  N LG GGFGPVYKG L DGQEIAVKRLS +SGQ
Sbjct:   477 GIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQ 536

Query:   471 GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW 530
             GVEEFKNEV LIAKLQHRNLV+LLGCC++ +E MLIYEY+PNKSL  FIFD  R   LDW
Sbjct:   537 GVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDW 596

Query:   531 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE 590
              KR  II G+ARG+LYLHQDSRLRIIHRDLKA NVLLDN+MNPKISDFG+A++FG DQ+E
Sbjct:   597 KKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSE 656

Query:   591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXX 650
             ++TNRVVGTYGYMPPEYAIDG FSVKSDVFSFGVLVLE++ G  NRGF            
Sbjct:   657 SSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGH 716

Query:   651 AWRLWTEDRPVELIDKS-LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER 709
              W++W EDR +E+ ++  LE+T  + E LRCI V LLCVQQ+PEDRP MASVVLM   + 
Sbjct:   717 VWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDS 776

Query:   710 SLPQPKQPGFFTERNLPXXXXXXXNQTFHSSNQITVSLIEGR 751
             SLP P QPGFFT RN+P         +  S N++++++++GR
Sbjct:   777 SLPHPTQPGFFTNRNVPDISSSL---SLRSQNEVSITMLQGR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1033 (368.7 bits), Expect = 2.4e-201, Sum P(2) = 2.4e-201
 Identities = 204/347 (58%), Positives = 251/347 (72%)

Query:   412 NRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQG 471
             N  +++ELP+ +++ +A AT+NFS  NKLG+GGFG VYKG L+DGQE+AVKRLSK+S QG
Sbjct:   504 NNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQG 563

Query:   472 VEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWS 531
              +EFKNEV LIA+LQH NLV+LL CC+   E+MLIYEYL N SL   +FD +R   L+W 
Sbjct:   564 TDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQ 623

Query:   532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
              R  II GIARGLLYLHQDSR RIIHRDLKASN+LLD  M PKISDFGMAR FG D+TEA
Sbjct:   624 MRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEA 683

Query:   592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXA 651
             NT +VVGTYGYM PEYA+DG+FS+KSDVFSFGVL+LE++   RN+GF             
Sbjct:   684 NTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCV 743

Query:   652 WRLWTEDRPVELIDKSLED---TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE 708
             WR W E + +E+ID  + D   T+   E LRCIQ+GLLCVQ+R EDRP M+ V+LML  E
Sbjct:   744 WRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSE 803

Query:   709 RS-LPQPKQPGFFTERNLPXXXXXXXNQTFHSS---NQITVSLIEGR 751
              + +PQPK PG+  ER+L         Q    S   NQITVS+++ R
Sbjct:   804 STTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1054 (376.1 bits), Expect = 6.3e-192, Sum P(2) = 6.3e-192
 Identities = 210/355 (59%), Positives = 258/355 (72%)

Query:   404 RMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKR 463
             R  TS+  N+ + +ELP+ +WK++A AT+NFS +NKLG+GGFG VYKGML+DG+EIAVKR
Sbjct:   494 RSYTSK-ENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKR 552

Query:   464 LSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT 523
             LSK S QG +EF NEV LIAKLQH NLV+LLGCC+ + E+MLIYEYL N SL   +FD T
Sbjct:   553 LSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQT 612

Query:   524 RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 583
             R   L+W KR  II GIARGLLYLHQDSR RIIHRDLKASNVLLD  M PKISDFGMAR 
Sbjct:   613 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 672

Query:   584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXX 643
             FG ++TEANT RVVGTYGYM PEYA+DG+FS+KSDVFSFGVL+LE++ G RN+GF     
Sbjct:   673 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732

Query:   644 XXXXXXXAWRLWTEDRPVELIDK----SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMA 699
                     WR W E + +E++D     +L   +   E LRCIQ+GLLCVQ+R EDRP M+
Sbjct:   733 DLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMS 792

Query:   700 SVVLMLSGERS-LPQPKQPGFFTERNLPXXXXXXXNQTFHSS--NQITVSLIEGR 751
             SV++ML  E + +PQPK+PGF   R+          Q       NQ+T+S+I+ R
Sbjct:   793 SVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1033 (368.7 bits), Expect = 4.4e-191, Sum P(2) = 4.4e-191
 Identities = 206/346 (59%), Positives = 252/346 (72%)

Query:   413 RKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGV 472
             + E +ELP+ + +++A AT+NFS +NKLG+GGFG VYKG L+DG+EIAVKRLSK S QG 
Sbjct:   498 KSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGT 557

Query:   473 EEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK 532
             +EF NEV LIAKLQH NLV+LLGCC+ + E+MLIYEYL N SL   +FD TR   L+W K
Sbjct:   558 DEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQK 617

Query:   533 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
             R  II GIARGLLYLHQDSR RIIHRDLKASNVLLD  M PKISDFGMAR FG ++TEAN
Sbjct:   618 RFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEAN 677

Query:   593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAW 652
             T RVVGTYGYM PEYA+DG+FS+KSDVFSFGVL+LE++ G RN+GF             W
Sbjct:   678 TRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVW 737

Query:   653 RLWTEDRPVELIDK----SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE 708
             R W E   +E++D     SL   +   E LRCIQ+GLLCVQ+R EDRP M+SV++ML  E
Sbjct:   738 RHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSE 797

Query:   709 RS-LPQPKQPGFFTERN-LPXXXXXXXNQTFHSS-NQITVSLIEGR 751
              + +PQPK+PGF   R+ L         +    + NQIT+S+I+ R
Sbjct:   798 TTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1023 (365.2 bits), Expect = 1.5e-179, Sum P(2) = 1.5e-179
 Identities = 209/345 (60%), Positives = 253/345 (73%)

Query:   411 GNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQ 470
             G      ELP+F   +IA AT++F +EN+LG GGFGPVYKG+L DG+EIAVKRLS  SGQ
Sbjct:   506 GKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQ 565

Query:   471 GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW 530
             GV+EFKNE++LIAKLQHRNLV+LLGCC + +E+ML+YEY+PNKSL  F+FD T++ L+DW
Sbjct:   566 GVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDW 625

Query:   531 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE 590
               R  II GIARGLLYLH+DSRLRIIHRDLK SNVLLD EMNPKISDFGMAR FG +Q E
Sbjct:   626 KLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNE 685

Query:   591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXX 650
             ANT RVVGTYGYM PEYA++GLFSVKSDV+SFGVL+LE+V G RN               
Sbjct:   686 ANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGY- 744

Query:   651 AWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS 710
             AW L+T  R  EL+D  +  T S  EALRCI V +LCVQ    +RPNMASV+LML  + +
Sbjct:   745 AWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTA 804

Query:   711 -LPQPKQPGFF-TERN-LPXXXXXXXNQTFH-SSNQITVSLIEGR 751
              L  P+QP F  T RN +        +Q +  SSN+IT +++ GR
Sbjct:   805 TLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 1013 (361.7 bits), Expect = 4.5e-176, Sum P(2) = 4.5e-176
 Identities = 198/343 (57%), Positives = 252/343 (73%)

Query:   410 LGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG 469
             +G++ +  +LPIF + S+A+AT +F+EENKLG+GGFG VYKG   +G+EIAVKRLS  S 
Sbjct:   501 VGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSK 560

Query:   470 QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD 529
             QG+EEFKNE+LLIAKLQHRNLV+LLGCC++ +E+ML+YEY+PNKSL  F+FD +++  LD
Sbjct:   561 QGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLD 620

Query:   530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
             W KR ++IGGIARGLLYLH+DSRL+IIHRDLKASN+LLD EMNPKISDFGMAR F   Q 
Sbjct:   621 WRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQD 680

Query:   590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXX 649
              ANT RVVGTYGYM PEYA++G+FS KSDV+SFGVL+LE+V G +N  F           
Sbjct:   681 HANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGY 740

Query:   650 XAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER 709
              AW LW++ +  E+ID  ++DT  ++EA+RCI VG+LC Q     RPNM SV+LML  + 
Sbjct:   741 -AWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQT 799

Query:   710 S-LPQPKQPGFFTERNLPXXXXXXXNQTFHSSNQITVSLIEGR 751
             S LP P+QP F +  N              S N +T + I GR
Sbjct:   800 SQLPPPRQPTFHSFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 940 (336.0 bits), Expect = 2.0e-160, Sum P(2) = 2.0e-160
 Identities = 186/361 (51%), Positives = 249/361 (68%)

Query:   392 KILSEGGQDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKG 451
             ++L+E  + L      + L N+ +  ELP+F+++ +A AT+NFS  NKLG+GGFG VYKG
Sbjct:   470 RLLNERMEALSSNDVGAILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKG 529

Query:   452 MLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP 511
              L +G +IAVKRLS++SGQGVEEF NEV++I+KLQHRNLV+LLG C++ +ERML+YE++P
Sbjct:   530 RLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMP 589

Query:   512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM 571
                L  ++FD  +++LLDW  R  II GI RGL+YLH+DSRL+IIHRDLKASN+LLD  +
Sbjct:   590 ENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENL 649

Query:   572 NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY 631
             NPKISDFG+AR F  ++ E +T RVVGTYGYM PEYA+ GLFS KSDVFS GV++LE+V 
Sbjct:   650 NPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVS 709

Query:   632 GTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQR 691
             G RN  F            AW+LW     + L+D  + +    +E  RC+ VGLLCVQ  
Sbjct:   710 GRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDH 769

Query:   692 PEDRPNMASVVLMLSGERS-LPQPKQPGFFTERNLPXXXXXXXNQTFHSSNQITVSLIEG 750
               DRP++A+V+ MLS E S LP+PKQP F   R          +    S N ++++ I G
Sbjct:   770 ANDRPSVATVIWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITG 829

Query:   751 R 751
             R
Sbjct:   830 R 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)]

 Score = 924 (330.3 bits), Expect = 5.5e-156, Sum P(2) = 5.5e-156
 Identities = 185/334 (55%), Positives = 233/334 (69%)

Query:   419 LPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNE 478
             L  FD  +I NAT+NFS  NKLG+GGFG VYKG L DG+EIAVKRLS SSGQG EEF NE
Sbjct:   476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535

Query:   479 VLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG 538
             ++LI+KLQHRNLV++LGCC++ +E++LIYE++ NKSL  F+FD  +R  +DW KR  II 
Sbjct:   536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595

Query:   539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
             GIARGLLYLH DSRLR+IHRDLK SN+LLD +MNPKISDFG+AR +   + + NT RVVG
Sbjct:   596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655

Query:   599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTED 658
             T GYM PEYA  G+FS KSD++SFGVL+LE++ G +   F            AW  W+E 
Sbjct:   656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSEY 715

Query:   659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPG 718
             R ++L+D+ L D+    E  RCIQ+GLLCVQ +P DRPN   ++ ML+    LP PKQP 
Sbjct:   716 RGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTTSDLPSPKQPT 775

Query:   719 F-FTERNLPXXXXXXXNQTFHSSNQITVSLIEGR 751
             F F  R+         N    + N +T S+I GR
Sbjct:   776 FAFHTRD----DESLSNDLI-TVNGMTQSVILGR 804

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)]

 Score = 897 (320.8 bits), Expect = 1.9e-155, Sum P(2) = 1.9e-155
 Identities = 173/333 (51%), Positives = 229/333 (68%)

Query:   419 LPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNE 478
             L  FD  +I  AT+NFS  NKLG+GGFGPVYKG L DG+EIAVKRLS SSGQG EEF NE
Sbjct:   479 LDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 538

Query:   479 VLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG 538
             ++LI+KLQH+NLV++LGCC++ +E++LIYE++ N SL  F+FD  +R  +DW KR  II 
Sbjct:   539 IVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPKRLDIIQ 598

Query:   539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
             GIARG+ YLH+DS L++IHRDLK SN+LLD +MNPKISDFG+AR +   + + NT RVVG
Sbjct:   599 GIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 658

Query:   599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTED 658
             T GYM PEYA  G+FS KSD++SFGVL+LE++ G +   F            AW  W + 
Sbjct:   659 TLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEKTLIAYAWESWCDT 718

Query:   659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPG 718
               ++L+DK + D+    E  RC+Q+GLLCVQ +P DRPN   ++ ML+    LP P+QP 
Sbjct:   719 GGIDLLDKDVADSCRPLEVERCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPPPEQPT 778

Query:   719 FFTERNLPXXXXXXXNQTFHSSNQITVSLIEGR 751
             F   R          ++   + N++T S+I GR
Sbjct:   779 FVVHRR----DDKSSSEDLITVNEMTKSVILGR 807

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O81832	Y4729_ARATH	2, ., 7, ., 1, 1, ., 1	0.5731	0.9840	0.9438	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	751
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-51
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-46
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	2e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-38
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	2e-36
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-34
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-33
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	6e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-33
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-32
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	3e-32
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-28
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-28
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-28
pfam08276	66	pfam08276, PAN_2, PAN-like domain	1e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-27
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-27
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-26
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-25
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-25
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	6e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-24
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-24
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-24
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-23
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-23
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-23
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-22
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-22
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-21
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-21
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-20
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-20
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-19
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-17
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-14
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-10
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-09
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	4e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-06
cd00129	80	cd00129, PAN_APPLE, PAN/APPLE-like domain; present	4e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.002
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.002
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
cd00054	38	cd00054, EGF_CA, Calcium-binding EGF-like domain,	0.003
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  181 bits (462), Expect = 3e-52
 Identities = 97/282 (34%), Positives = 136/282 (48%), Gaps = 40/282 (14%)

Query: 437 ENKLGEGGFGPVYKGMLIDG-----QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNL 490
             KLGEG FG VYKG L         E+AVK L +  S Q +EEF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           VKLLG C + +  M++ EY+P   L D++    R K L  S        IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEY 607
                IHRDL A N L+   +  KISDFG++R    D  + +  +V G      +M PE 
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPES 175

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
             +G F+ KSDV+SFGVL+ E+       G                 +      E+++  
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIF----TLGE--------------EPYPGMSNAEVLEY- 216

Query: 668 LEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
           L+  Y L +   C     ++ L C  + PEDRP  + +V +L
Sbjct: 217 LKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  180 bits (460), Expect = 6e-52
 Identities = 93/282 (32%), Positives = 133/282 (47%), Gaps = 41/282 (14%)

Query: 437 ENKLGEGGFGPVYKGMLID-----GQEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNL 490
             KLGEG FG VYKG L         E+AVK L + +S Q +EEF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           VKLLG C + +   ++ EY+    L  ++     R  L  S        IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEY 607
                IHRDL A N L+   +  KISDFG++R    D  + +  R  G      +M PE 
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
             +G F+ KSDV+SFGVL+ E+       G               + +      E+++  
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIF----TLGE--------------QPYPGMSNEEVLEY- 215

Query: 668 LEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
           L++ Y L +   C      + L C  + PEDRP  + +V +L
Sbjct: 216 LKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  178 bits (453), Expect = 2e-51
 Identities = 73/194 (37%), Positives = 106/194 (54%), Gaps = 11/194 (5%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEGGFG VY       G+++A+K + K  S   +EE   E+ ++ KL H N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
              +   L+ EY    SL D + +      L   +  +I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 558 RDLKASNVLLDN-EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSV 615
           RDLK  N+LLD+     K++DFG+++    D++   T  +VGT  YM PE  +  G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 616 KSDVFSFGVLVLEL 629
           KSD++S GV++ EL
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  174 bits (444), Expect = 1e-49
 Identities = 89/294 (30%), Positives = 130/294 (44%), Gaps = 59/294 (20%)

Query: 438 NKLGEGGFGPVYKGMLIDGQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVK 492
            KLGEG FG VYKG L        E+AVK L +  S +  ++F  E  ++ KL H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFI------FDGTRRKLLDWSKRCQIIGGIARGLLY 546
           LLG C + +   L+ EY+    L D++      F    +  L           IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG----- 601
           L      + +HRDL A N L+  ++  KISDFG++R         +      T G     
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172

Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELV------YGTRNRGFHHVDHHHNLLGHAWRLW 655
           +M PE   DG+F+ KSDV+SFGVL+ E+       Y   +                    
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-------------------- 212

Query: 656 TEDRPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                 E+++  L   Y L +   C     ++ L C Q  PEDRP  + +V  L
Sbjct: 213 ----NEEVLEY-LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  169 bits (431), Expect = 6e-48
 Identities = 73/198 (36%), Positives = 103/198 (52%), Gaps = 12/198 (6%)

Query: 439 KLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           KLG G FG VYK      G+ +AVK L K S   +  +  + E+ ++ +L H N+V+L+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
               +D   L+ EY     L D++   +R   L   +  +I   I RGL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL-FS 614
           IHRDLK  N+LLD     KI+DFG+A+      +   T   VGT  YM PE  + G  + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYG 177

Query: 615 VKSDVFSFGVLVLELVYG 632
            K DV+S GV++ EL+ G
Sbjct: 178 PKVDVWSLGVILYELLTG 195

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (422), Expect = 1e-46
 Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 11/201 (5%)

Query: 434 FSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 491
           +    KLGEG FG VY       G+ +A+K + K   +   E    E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L       D+  L+ EY     L D +    +R  L   +    +  I   L YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              I+HRDLK  N+LLD + + K++DFG+AR     +        VGT  YM PE  +  
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171

Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +    D++S GV++ EL+ G
Sbjct: 172 GYGKAVDIWSLGVILYELLTG 192

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  165 bits (421), Expect = 2e-46
 Identities = 74/203 (36%), Positives = 106/203 (52%), Gaps = 17/203 (8%)

Query: 439 KLGEGGFGPVYKGMLID-----GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVK 492
           KLGEG FG VYKG L         ++AVK L + +  +  EEF  E  ++ KL H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
           LLG C + +   ++ EY+P   L DF+      + L      Q+   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG---YMPPEYAI 609
              +HRDL A N L+   +  KISDFG++R   + + +    R  G      +M PE   
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKR-GGGKLPIKWMAPESLK 177

Query: 610 DGLFSVKSDVFSFGVLVLELVYG 632
           DG F+ KSDV+SFGVL+ E+   
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score =  138 bits (349), Expect = 2e-38
 Identities = 57/116 (49%), Positives = 70/116 (60%), Gaps = 7/116 (6%)

Query: 51  NGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLES 110
           N TV WVANR  PL D S  L + S GN  L+L +    +VWSSN S      VAVL + 
Sbjct: 1   NQTVVWVANRLNPLTDSSYTLILQSDGN--LVLYDGNGRVVWSSNTSGKGSGCVAVLQDD 58

Query: 111 GNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPA 166
           GNLV+      +S   LWQSFD+PT  LLPG K G N+V G +R ++SWKS  DP+
Sbjct: 59  GNLVLYD----NSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  142 bits (360), Expect = 4e-38
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 17/200 (8%)

Query: 438 NKLGEGGFGPVYKGMLID-GQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
             LG G FG VY  +  D G+ +AVK   LS  S + +E  + E+ +++ LQH N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 495 GCCMKRDERML-IY-EYLPNKSLADFI--FDGTRRKLL-DWSKRCQIIGGIARGLLYLHQ 549
           G     ++  L I+ EY+   SL+  +  F      ++  +++  QI+     GL YLH 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR--QIL----EGLAYLH- 118

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
                I+HRD+K +N+L+D++   K++DFG A+  G  +T   T  V GT  +M PE   
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 610 DGLFSVKSDVFSFGVLVLEL 629
              +   +D++S G  V+E+
Sbjct: 177 GEEYGRAADIWSLGCTVIEM 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  141 bits (359), Expect = 5e-38
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 17/204 (8%)

Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           F    K+G+GGFG VYK      G+E+A+K +   S +  E+  NE+ ++ K +H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL----YLH 548
             G  +K+DE  ++ E+    SL D +   T + L +       I  + + LL    YLH
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTE-----SQIAYVCKELLKGLEYLH 115

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                 IIHRD+KA+N+LL ++   K+ DFG++            N +VGT  +M PE  
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVI 169

Query: 609 IDGLFSVKSDVFSFGVLVLELVYG 632
               +  K+D++S G+  +EL  G
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEG 193

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score =  132 bits (334), Expect = 2e-36
 Identities = 54/123 (43%), Positives = 69/123 (56%), Gaps = 8/123 (6%)

Query: 12  QSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVL 71
             +  G+TLVS+   FELGFF        Y  I YK   + TV WVANR+ P    S  L
Sbjct: 2   NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRDNPS-GSSCTL 59

Query: 72  SISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSF 131
           ++ S GN  L++ + +  +VWSSN +R   N V VLL+ GNLV+         NFLWQSF
Sbjct: 60  TLQSDGN--LVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYD----SDGNFLWQSF 113

Query: 132 DYP 134
           DYP
Sbjct: 114 DYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  131 bits (332), Expect = 3e-34
 Identities = 88/266 (33%), Positives = 125/266 (46%), Gaps = 48/266 (18%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG G FG V+ G      ++AVK L K      E F  E  ++ KL+H  LV+L   
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRK-----LLDWSKRCQIIGGIARGLLYLHQDS 551
           C + +   ++ EY+   SL DF+  G  +K     L+D +   QI    A G+ YL    
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA--AQI----AEGMAYLE--- 120

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
               IHRDL A N+L+   +  KI+DFG+AR    D+  A      G     P     PE
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GA--KFPIKWTAPE 174

Query: 607 YAIDGLFSVKSDVFSFGVLVLELV------Y-GTRN--------RGF------HHVDHHH 645
            A  G F++KSDV+SFG+L+ E+V      Y G  N        RG+      +  +  +
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY 234

Query: 646 NLLGHAWRLWTEDRPV-ELIDKSLED 670
           +L+   W    E+RP  E +   LED
Sbjct: 235 DLMLQCWDKDPEERPTFEYLQSFLED 260

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  130 bits (328), Expect = 1e-33
 Identities = 78/221 (35%), Positives = 114/221 (51%), Gaps = 28/221 (12%)

Query: 434 FSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
           F EE  LGEG FG VYKG L           +A+K L ++   +  +EF+ E  L++ LQ
Sbjct: 9   FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIF-------------DGTRRKLLDWSKR 533
           H N+V LLG C K     +++EYL +  L +F+              D T +  LD S  
Sbjct: 67  HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEAN 592
             I   IA G+ YL   S    +HRDL A N L+   +  KISDFG++R  +  D     
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183

Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV-YG 632
           +  ++    +MPPE  + G F+ +SD++SFGV++ E+  YG
Sbjct: 184 SKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFSYG 223

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score =  122 bits (308), Expect = 6e-33
 Identities = 55/122 (45%), Positives = 70/122 (57%), Gaps = 9/122 (7%)

Query: 12  QSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVL 71
            ++  G+TLVS N  FELGFF+       Y  I YK   + TV WVANR+ P+ D S  L
Sbjct: 2   NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSS-SRTVVWVANRDNPVSD-SCTL 58

Query: 72  SISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSF 131
           ++ S GN  L+L +    +VWSSN +    N V VLL+ GNLV+         NFLWQSF
Sbjct: 59  TLQSDGN--LVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD----SDGNFLWQSF 112

Query: 132 DY 133
           DY
Sbjct: 113 DY 114

Length = 114

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  128 bits (323), Expect = 7e-33
 Identities = 91/293 (31%), Positives = 135/293 (46%), Gaps = 39/293 (13%)

Query: 438 NKLGEGGFGPVYKG---MLIDGQ--EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 491
            +LGEG FG V       L D    ++AVK L+ S   Q   +F+ E+ ++  L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 492 KLLGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           K  G C K   R   LI EYLP+ SL D++    R ++ +  +       I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQI-NLKRLLLFSSQICKGMDYLGS 127

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT--EANTNRVVGTYGYMPPEY 607
               R IHRDL A N+L+++E   KISDFG+A+    D+             + Y  PE 
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN-------LLGHAWRLWTEDRP 660
                FS  SDV+SFGV + EL        F + D   +       ++G A       R 
Sbjct: 184 LRTSKFSSASDVWSFGVTLYEL--------FTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235

Query: 661 VELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLMLSGER 709
           +EL    L++   L     C      +  LC +  P+DRP+ A ++L++   R
Sbjct: 236 LEL----LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  126 bits (318), Expect = 2e-32
 Identities = 91/287 (31%), Positives = 125/287 (43%), Gaps = 52/287 (18%)

Query: 438 NKLGEGGFGPVYKGMLI--DGQEI--AVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVK 492
            +LG G FG V KG+ +   G+E+  AVK L +     G +EF  E  ++A+L H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDG---TRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           L+G C K +  ML+ E  P   L  ++          L + + +      +A G+ YL  
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP----- 604
                 +HRDL A NVLL N    KISDFGM+RA G             T G  P     
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
           PE    G FS KSDV+S+GV + E   YG +  G                   E +  E+
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG-------------------EMKGAEV 207

Query: 664 IDKSLEDTYSLSEALRCIQ----VGLLCVQQRPEDRPNMASVVLMLS 706
           I   LE    L     C Q    + L C + RPEDRP  + +     
Sbjct: 208 I-AMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  125 bits (317), Expect = 2e-32
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 15/205 (7%)

Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 489
           N+   + +G G FG VYKG+ L  G  +A+K++S      + ++    E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFI--FDGTRRKLLDWSKRCQIIGGIARGLLYL 547
           +VK +G     D   +I EY  N SL   I  F      L+        +  + +GL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-----AVYVYQVLQGLAYL 115

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H+     +IHRD+KA+N+L   +   K++DFG+A    ++    +   VVGT  +M PE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEV 170

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYG 632
                 S  SD++S G  V+EL+ G
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  126 bits (319), Expect = 2e-32
 Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 19/224 (8%)

Query: 415 EEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVE 473
           EE++  + D  S  +  + +    K+GEG  G VYK      G+E+A+K++ +   Q  E
Sbjct: 2   EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKE 60

Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE+L++   +H N+V      +  DE  ++ EY+   SL D I      ++      
Sbjct: 61  LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRM----NE 115

Query: 534 CQI---IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE 590
            QI      + +GL YLH      +IHRD+K+ N+LL  + + K++DFG    F    T+
Sbjct: 116 PQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTK 168

Query: 591 ANTNR--VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             + R  VVGT  +M PE      +  K D++S G++ +E+  G
Sbjct: 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score =  120 bits (303), Expect = 3e-32
 Identities = 41/113 (36%), Positives = 67/113 (59%), Gaps = 3/113 (2%)

Query: 192 YRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRY 251
           +R G WNG+ ++G+P++Q    Y + +  N +EV+Y + +  +S+ S + +S  G  +R+
Sbjct: 1   WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60

Query: 252 TWMEQTQKWAPFLSFSGLIDQCDNYALCGTYAICKMNSNSAECECLEGFEPKS 304
           TW+  +Q W  F S     DQCD Y  CG Y  C +N  S +C C++GF PK+
Sbjct: 61  TWIPNSQDWNLFWSAP--KDQCDVYGRCGPYGYCDVN-TSPKCNCIKGFVPKN 110

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 2e-31
 Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 20/200 (10%)

Query: 440 LGEGGFGPVYKGMLI-DGQ----EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKL 493
           LG G FG VYKG+ I +G+     +A+K L + +  +  +E  +E  ++A + H ++V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQ 549
           LG C+   +  LI + +P   L D++ +         LL+W  +      IA+G+ YL +
Sbjct: 75  LGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
               R++HRDL A NVL+    + KI+DFG+A+   VD+ E +         +M  E  +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 610 DGLFSVKSDVFSFGVLVLEL 629
             +++ KSDV+S+GV V EL
Sbjct: 185 HRIYTHKSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  126 bits (316), Expect = 3e-31
 Identities = 89/324 (27%), Positives = 139/324 (42%), Gaps = 25/324 (7%)

Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSK---SSGQGVEEFKNEVLLIAKLQH-R 488
           ++    KLGEG FG VY     D + +A+K L+K   S  + VE F  E+ ++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKL           L+ EY+   SL D +    R+  L  S+   I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 549 QDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEAN----TNRVVGTYGYM 603
                 IIHRD+K  N+LLD +    K+ DFG+A+      + ++     +  VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 604 PPEYAIDGLF---SVKSDVFSFGVLVLELVYG-TRNRGFHHVDHHHNLLGHAWRLWTEDR 659
            PE  +       S  SD++S G+ + EL+ G     G  +       L     L T   
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGERSLPQPKQP 717
              L   + E    +S+A   +   LL     P++R + +S +   +L+  +        
Sbjct: 236 ASPLSPSNPEL---ISKAASDLLKKLLAKD--PKNRLSSSSDLSHDLLAHLKLKESDLSD 290

Query: 718 GFFTERNLPESESSSSNQTFHSSN 741
               + + P   S   +     S+
Sbjct: 291 LLKPDDSAPLRLSLPPSLEALISS 314

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  120 bits (304), Expect = 2e-30
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 19/202 (9%)

Query: 439 KLGEGGFGPVYKGMLI-DGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
            LG+G  G VYK      G+  A+K++      +  ++   E+  +   +   +VK  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR----GLLYLHQDSR 552
             K  E  ++ EY+   SLAD +     +K+    +   ++  IAR    GL YLH    
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPE--PVLAYIARQILKGLDYLHTK-- 118

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG- 611
             IIHRD+K SN+L++++   KI+DFG+++   ++ T    N  VGT  YM PE  I G 
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPE-RIQGE 175

Query: 612 LFSVKSDVFSFGVLVLELVYGT 633
            +S  +D++S G+ +LE   G 
Sbjct: 176 SYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  119 bits (302), Expect = 3e-30
 Identities = 82/285 (28%), Positives = 128/285 (44%), Gaps = 49/285 (17%)

Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRN 489
            +    ++G+G FG VY      DG+   +K   LS  S +  E+  NEV ++ KL H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR-------KLLDWSKRCQIIGGIAR 542
           ++K      ++ +  ++ EY     L+  I    +        ++LDW    Q+      
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQL----CL 114

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
            L YLH  SR +I+HRD+K  N+ L +    K+ DFG+++        A T  VVGT  Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYY 169

Query: 603 MPPE------YAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWT 656
           + PE      Y      + KSD++S G ++ EL   T    F       NLL  A ++  
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELC--TLKHPF----EGENLLELALKILK 217

Query: 657 EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
              P       +   Y  S  LR +   LL  Q+ PE+RP++A +
Sbjct: 218 GQYP------PIPSQY--SSELRNLVSSLL--QKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 4e-29
 Identities = 70/201 (34%), Positives = 104/201 (51%), Gaps = 19/201 (9%)

Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           KLG G FG V++G+  +   +AVK L K      ++F  E  ++ KL+H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQDSRLRI 555
             +   ++ E +   SL +++  G  R L    K  Q+I     +A G+ YL   +    
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRAL----KLPQLIDMAAQVASGMAYLEAQN---Y 124

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEYAIDGL 612
           IHRDL A NVL+      K++DFG+AR    D  EA      G      +  PE A+   
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNR 180

Query: 613 FSVKSDVFSFGVLVLELV-YG 632
           FS+KSDV+SFG+L+ E+V YG
Sbjct: 181 FSIKSDVWSFGILLTEIVTYG 201

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  116 bits (292), Expect = 5e-29
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 7/200 (3%)

Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           F+ E KLG G FG V++G+  +   +A+K L        ++F+ EV  + +L+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
              C   +   +I E +   SL  F+      ++L  +    +   +A G+ YL +    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
             IHRDL A N+L+  ++  K++DFG+AR    D   ++  ++   Y +  PE A  G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 614 SVKSDVFSFGVLVLELV-YG 632
           S KSDV+SFG+L+ E+  YG
Sbjct: 182 STKSDVWSFGILLYEMFTYG 201

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  116 bits (292), Expect = 7e-29
 Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 30/216 (13%)

Query: 440 LGEGGFGPVYKG---MLIDGQE---IAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVK 492
           LGEG FG V+ G    L    +   +AVK L +++     + F+ E  L+   QH N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADF-----------IFDGTRRKLLDWSKRCQIIGGIA 541
             G C + D  ++++EY+ +  L  F               +    L  S+  QI   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +  RV G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185

Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL-VYG 632
               +MPPE  +   F+ +SDV+SFGV++ E+  YG
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYG 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  115 bits (290), Expect = 2e-28
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 33/227 (14%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-Q 486
           D+F     +GEG F  V         +E A+K L K      + V+  K E  ++ +L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC--QIIGGIARGL 544
           H  ++KL       +    + EY PN  L  +I     RK     ++C       I   L
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-----RKYGSLDEKCTRFYAAEILLAL 115

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV-------- 596
            YLH      IIHRDLK  N+LLD +M+ KI+DFG A+    + +  +            
Sbjct: 116 EYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 597 ----------VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
                     VGT  Y+ PE   +      SD+++ G ++ +++ G 
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  115 bits (289), Expect = 2e-28
 Identities = 73/210 (34%), Positives = 105/210 (50%), Gaps = 22/210 (10%)

Query: 440 LGEGGFGPVYK---GMLID--GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           LG+G FG V       L D  G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 495 GCC--MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
           G C    R    L+ EYLP  SL D++     R  LD  K       I +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYL---GS 126

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PEY 607
            R +HRDL   N+L+++E   KI DFG+ +    D+        V   G  P     PE 
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY----YKVREPGESPIFWYAPES 182

Query: 608 AIDGLFSVKSDVFSFGVLVLEL-VYGTRNR 636
             +  FSV SDV+SFGV++ EL  Y  ++ 
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFTYSDKSC 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  114 bits (286), Expect = 5e-28
 Identities = 85/303 (28%), Positives = 129/303 (42%), Gaps = 64/303 (21%)

Query: 430 ATDNFSEENKLGEGGFGPVYKGMLI----DGQEIAVK---RLSKSSGQGVEEFKNEVLLI 482
             D+ +    LG G FG VY+G+      D  E+ V         S Q   +F  E L++
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDG----TRRKLLDWSKRCQIIG 538
           +K  H+N+V+L+G   +R  R ++ E +    L  F+ +      R   L          
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMAR-AFGVDQTEANT 593
            +A+G  YL ++     IHRD+ A N LL  +  P    KI+DFGMAR  +         
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKG- 178

Query: 594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV------Y-GTRNR-------GFH 639
            R +    +MPPE  +DG+F+ K+DV+SFGVL+ E+       Y G  N+       G  
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238

Query: 640 HVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMA 699
            +D      G  +R+ T+                             C Q  PEDRPN A
Sbjct: 239 RLDPPKGCPGPVYRIMTD-----------------------------CWQHTPEDRPNFA 269

Query: 700 SVV 702
           +++
Sbjct: 270 TIL 272

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score =  105 bits (264), Expect = 1e-27
 Identities = 40/67 (59%), Positives = 50/67 (74%), Gaps = 1/67 (1%)

Query: 325 CERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGGGSGCLLW 384
           C  GDGFL+  ++KLPDT  + VD++I L EC++ C  NCSCTAYA AD+R GGSGCL+W
Sbjct: 1   CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59

Query: 385 FHELTDM 391
             EL DM
Sbjct: 60  TGELVDM 66

Length = 66

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 2e-27
 Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 19/194 (9%)

Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK 499
           +G+G FG V  G    GQ++AVK L K      + F  E  ++  L+H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG--IARGLLYLHQDSRLRIIH 557
            +   ++ EY+   SL D++    R  +   +   Q+     +  G+ YL +      +H
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVI---TLAQQLGFALDVCEGMEYLEEK---NFVH 125

Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY--GYMPPEYAIDGLFSV 615
           RDL A NVL+  ++  K+SDFG+A+       EA+  +  G     +  PE   +  FS 
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFST 178

Query: 616 KSDVFSFGVLVLEL 629
           KSDV+SFG+L+ E+
Sbjct: 179 KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  111 bits (279), Expect = 2e-27
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 10/200 (5%)

Query: 434 FSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           F    KLGEG +G VYK +  + GQ +A+K +     + ++E   E+ ++ +     +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
             G   K  +  ++ EY    S++D +      K L   +   I+    +GL YLH    
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
            + IHRD+KA N+LL+ E   K++DFG+  +  +  T A  N V+GT  +M PE   +  
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175

Query: 613 FSVKSDVFSFGVLVLELVYG 632
           ++ K+D++S G+  +E+  G
Sbjct: 176 YNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  110 bits (277), Expect = 4e-27
 Identities = 82/266 (30%), Positives = 126/266 (47%), Gaps = 39/266 (14%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +      KLG G FG V+ G      ++A+K L K      E F  E  L+ +LQH  LV
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFI-----FDGTRRKLLDWSKRCQIIGGIARGLLY 546
           +L    + ++   +I EY+ N SL DF+        T  KL+D + +      IA G+ +
Sbjct: 65  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ------IAEGMAF 117

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           +    R   IHRDL+A+N+L+   +  KI+DFG+AR    ++  A          +  PE
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPE 173

Query: 607 YAIDGLFSVKSDVFSFGVLVLELV-YG------------TRN--RGFHHV------DHHH 645
               G F++KSDV+SFG+L+ E+V YG             +N  RG+         +  +
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELY 233

Query: 646 NLLGHAWRLWTEDRPV-ELIDKSLED 670
            L+   W+   E+RP  E +   LED
Sbjct: 234 ELMRLCWKEKPEERPTFEYLRSVLED 259

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  110 bits (277), Expect = 4e-27
 Identities = 81/263 (30%), Positives = 124/263 (47%), Gaps = 29/263 (11%)

Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
             ++     KLG G FG V+ G      ++AVK L K      E F  E  ++ KL+H  
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           LV+L    +  +   ++ EY+   SL DF+ DG  R L        +   +A G+ Y+  
Sbjct: 63  LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE- 119

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
             R+  IHRDL+++N+L+ + +  KI+DFG+AR    ++  A          +  PE A+
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176

Query: 610 DGLFSVKSDVFSFGVLVLELVY-------GTRNRG-FHHVDHH-------------HNLL 648
            G F++KSDV+SFG+L+ ELV        G  NR     V+               H L+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236

Query: 649 GHAWRLWTEDRPV-ELIDKSLED 670
              W+   E+RP  E +   LED
Sbjct: 237 LQCWKKDPEERPTFEYLQSFLED 259

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 5e-27
 Identities = 81/285 (28%), Positives = 134/285 (47%), Gaps = 45/285 (15%)

Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V +G L + G++   +A+K L + SS +   +F  E  ++ +  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L G   K    M+I EY+ N SL  F+ +          +   ++ GIA G+ YL   S
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---S 123

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
            +  +HRDL A N+L+++ +  K+SDFG++R     +    T       G +P     PE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG-----GKIPIRWTAPE 178

Query: 607 YAIDGLFSVKSDVFSFGVLVLE-LVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID 665
                 F+  SDV+SFG+++ E + YG R                 W +  +D     + 
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPY---------------WDMSNQD-----VI 218

Query: 666 KSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLMLS 706
           K++ED Y L   + C     Q+ L C Q+   +RP  + +V  L 
Sbjct: 219 KAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  108 bits (272), Expect = 2e-26
 Identities = 73/246 (29%), Positives = 115/246 (46%), Gaps = 34/246 (13%)

Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           ++G G FG V+ G  ++ +++A+K + +      E+F  E  ++ KL H  LV+L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
           +R    L++E++ +  L+D++    +R          +   +  G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEYAIDGLFSV 615
           DL A N L+      K+SDFGM R    DQ  ++T    GT     +  PE      +S 
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180

Query: 616 KSDVFSFGVLVLEL---------------VYGTRNRGFHHV------DHHHNLLGHAWRL 654
           KSDV+SFGVL+ E+               V  T N GF            + L+ H W+ 
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKE 240

Query: 655 WTEDRP 660
             EDRP
Sbjct: 241 RPEDRP 246

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 2e-26
 Identities = 76/266 (28%), Positives = 119/266 (44%), Gaps = 41/266 (15%)

Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+G FG V      D G+  A+K L K      + VE    E  +++++ H  +VKL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 496 CCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLHQDSRL 553
              + +E++ L+ EY P   L   +   ++       +R +     I   L YLH    L
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALEYLH---SL 112

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            II+RDLK  N+LLD + + K++DFG+A+    + +  NT    GT  Y+ PE  +   +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGY 170

Query: 614 SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY- 672
               D +S GVL+ E++ G     F+  D                   E+ +K L+D   
Sbjct: 171 GKAVDWWSLGVLLYEMLTG--KPPFYAEDRK-----------------EIYEKILKDPLR 211

Query: 673 ---SLSEALRCIQVGLLCVQQRPEDR 695
               LS   R +  GLL  Q+ P  R
Sbjct: 212 FPEFLSPEARDLISGLL--QKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  109 bits (273), Expect = 2e-26
 Identities = 73/212 (34%), Positives = 108/212 (50%), Gaps = 28/212 (13%)

Query: 440 LGEGGFGPVYKGMLID-------GQEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G   D          +AVK L K ++ Q  +EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK----LLDWSKRCQIIGGIARGLLYL 547
           KLLG C+  + + +I E +    L  ++ D    +    LL   +   I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 548 HQDSRLRIIHRDLKASNVLL-----DNEMNPKISDFGMARAFGVDQTEANTNRVVGT--- 599
            Q   +  IHRDL A N L+     D +   KI DFG+AR    D  +++  R  G    
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEGLL 175

Query: 600 -YGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
              +M PE  +DG F+ +SDV+SFGVL+ E++
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 5e-26
 Identities = 75/277 (27%), Positives = 117/277 (42%), Gaps = 62/277 (22%)

Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK 499
           LG G FG V+ G      ++A+K + + +    ++F  E  ++ KL H NLV+L G C K
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 559
           +    ++ EY+ N  L +++    R+  L       +   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 560 LKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEYAIDGLFSVK 616
           L A N L+  +   K+SDFG+AR    DQ  ++     GT     + PPE      FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181

Query: 617 SDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSE 676
           SDV+SFGVL+                         W +++E        K   + +S SE
Sbjct: 182 SDVWSFGVLM-------------------------WEVFSEG-------KMPYERFSNSE 209

Query: 677 ALRCIQVGL-----------------LCVQQRPEDRP 696
            +  +  G                   C  ++PEDRP
Sbjct: 210 VVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRP 246

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  107 bits (269), Expect = 5e-26
 Identities = 79/267 (29%), Positives = 127/267 (47%), Gaps = 24/267 (8%)

Query: 437 ENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           ++KLG G +G VY+G+       +AVK L K     VEEF  E  ++ +++H NLV+LLG
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
            C +     +I E++   +L D++ +   R+ ++      +   I+  + YL + +    
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDL A N L+      K++DFG++R    D   A+         +  PE      FS+
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 184

Query: 616 KSDVFSFGVLVLEL-VYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSL 674
           KSDV++FGVL+ E+  YG        +   + LL   +R+   +RP    +      Y L
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM---ERP----EGCPPKVYEL 237

Query: 675 SEALRCIQVGLLCVQQRPEDRPNMASV 701
             A         C Q  P DRP+ A +
Sbjct: 238 MRA---------CWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  107 bits (269), Expect = 5e-26
 Identities = 74/200 (37%), Positives = 107/200 (53%), Gaps = 17/200 (8%)

Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           KLG G FG V+ G   +  ++AVK L K     V+ F  E  L+  LQH  LV+L     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 499 KRDERMLIYEYLPNKSLADFIF--DGTR---RKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
           K +   +I EY+   SL DF+   +G +    KL+D+S +      IA G+ Y+    R 
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIE---RK 122

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
             IHRDL+A+NVL+   +  KI+DFG+AR    ++  A          +  PE    G F
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSF 181

Query: 614 SVKSDVFSFGVLVLELV-YG 632
           ++KSDV+SFG+L+ E+V YG
Sbjct: 182 TIKSDVWSFGILLYEIVTYG 201

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 6e-26
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 43/216 (19%)

Query: 438 NKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEF----KNEVLLIAKLQHRNLVK 492
            ++GEG +G VYK      G+ +A+K++        E F      E+ L+ KL+H N+V+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 493 LLGCC--MKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSKRC---QIIGGIARGLL 545
           L        +    +++EY+ +    D   + D    K  +   +C   Q++     GL 
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH----DLTGLLDSPEVKFTESQIKCYMKQLL----EGLQ 114

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           YLH +    I+HRD+K SN+L++N+   K++DFG+AR +    +   TNRV+ T  Y PP
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170

Query: 606 E---------YAIDGLFSVKSDVFSFGVLVLELVYG 632
           E           +        D++S G ++ EL  G
Sbjct: 171 ELLLGATRYGPEV--------DMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 7e-26
 Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 38/217 (17%)

Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVK--RLSKSSGQGVEEFK----NEVLLIAKLQ 486
           + +  KLGEG +G VYK      G+ +A+K  RL        E        E+ L+ +L+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE----EGIPSTALREISLLKELK 56

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL-LDWSKR--CQIIGGIARG 543
           H N+VKLL       +  L++EY  +  L  ++ D     L  +  K    Q++    RG
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLL----RG 110

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L Y H     RI+HRDLK  N+L++ +   K++DFG+ARAFG+      T+ VV T  Y 
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLWYR 165

Query: 604 PPE-------YAIDGLFSVKSDVFSFGVLVLELVYGT 633
            PE       Y+     +V  D++S G +  E++ G 
Sbjct: 166 APEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  106 bits (265), Expect = 2e-25
 Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 20/208 (9%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG---------VEEFKNEVLLIAKLQHRN 489
           +G G FG VY GM    G+ +AVK++   S            ++    E+ L+ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +V+ LG  +  D   +  EY+P  S+A  +         + +     +  I +GL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD--QTEANTNR--VVGTYGYMPP 605
                IIHRD+K +N+L+DN+   KISDFG+++    +   T+ N  R  + G+  +M P
Sbjct: 125 RG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYGT 633
           E      ++ K+D++S G LV+E++ G 
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  104 bits (262), Expect = 4e-25
 Identities = 77/285 (27%), Positives = 129/285 (45%), Gaps = 41/285 (14%)

Query: 433 NFSEENKLGEGGFGPVYKGML-IDGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRN 489
           +F   NK+G+G FG V+K +   D +  A+K+  LSK + +  EE  +E  ++AKL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD---WSKRCQIIGGIARGLLY 546
           +++     + + +  ++ EY  N  L   +     R L +   W    QI+     GL +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL----LGLAH 116

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH     +I+HRD+K+ N+ LD   N KI D G+A+    +   ANT  +VGT  Y+ PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK 666
              D  ++ KSDV++ GV++ E   G            H         +  +    LI K
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTG-----------KHP--------FDANNQGALILK 212

Query: 667 SLEDTYS-----LSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
            +   +       S+ L   Q+   C+ +    RP+   ++   S
Sbjct: 213 IIRGVFPPVSQMYSQQL--AQLIDQCLTKDYRQRPDTFQLLRNPS 255

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  105 bits (263), Expect = 4e-25
 Identities = 77/228 (33%), Positives = 119/228 (52%), Gaps = 28/228 (12%)

Query: 427 IANATDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLS-KSSGQGVEEFKNEV 479
           I  +T  F EE  LGE  FG VYKG L         Q +A+K L  K+ G   EEFK+E 
Sbjct: 2   INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59

Query: 480 LLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIF-------------DGTRRK 526
           ++ ++LQH N+V LLG   K     +I+ Y  +  L +F+              D T + 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 527 LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFG 585
            L+ +    I+  IA G+ +L   S   ++H+DL   NVL+ +++N KISD G+ R  + 
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV-YG 632
            D  +   N ++    +M PE  + G FS+ SD++S+GV++ E+  YG
Sbjct: 177 ADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 223

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  104 bits (261), Expect = 5e-25
 Identities = 79/259 (30%), Positives = 124/259 (47%), Gaps = 29/259 (11%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 11  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 70  -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124

Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183

Query: 617 SDVFSFGVLVLELVYGTR---------------NRGFHH------VDHHHNLLGHAWRLW 655
           SDV+SFG+L+ EL    R                RG+         +  H+L+   WR  
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 243

Query: 656 TEDRPV-ELIDKSLEDTYS 673
            E+RP  E +   LED ++
Sbjct: 244 PEERPTFEYLQAFLEDYFT 262

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 98.7 bits (246), Expect = 6e-25
 Identities = 43/89 (48%), Positives = 52/89 (58%), Gaps = 8/89 (8%)

Query: 321 TKLDCERG---DGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGG 377
           T L+C      DGFLK   VKLPD   +     ISL EC+E C  NCSCTAYA  +   G
Sbjct: 1   TPLNCGGDGSTDGFLKLPDVKLPDN--ASAITAISLEECREACLSNCSCTAYAYNN---G 55

Query: 378 GSGCLLWFHELTDMKILSEGGQDLYIRMA 406
             GCLLW   L +++ LS GG  LY+R+A
Sbjct: 56  SGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  103 bits (259), Expect = 1e-24
 Identities = 83/280 (29%), Positives = 114/280 (40%), Gaps = 37/280 (13%)

Query: 439 KLGEGGFGPVYKG----MLIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKL 493
           KLG+G FG V +G           +AVK L        +++F  E  ++  L H NL++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
            G  +     M++ E  P  SL D +        L  S  C     IA G+ YL      
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLESK--- 116

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGV--DQTEANTNRVVGTYGYMPPEYAIDG 611
           R IHRDL A N+LL ++   KI DFG+ RA     D      +  V  + +  PE     
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTR 175

Query: 612 LFSVKSDVFSFGVLVLEL-VYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED 670
            FS  SDV+ FGV + E+  YG                   W   +  + ++ IDK  E 
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEE----------------PWAGLSGSQILKKIDKEGE- 218

Query: 671 TYSLSEALRCIQ----VGLLCVQQRPEDRPNMASVVLMLS 706
              L     C Q    V L C    P DRP  A++   L 
Sbjct: 219 --RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 1e-24
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 17/204 (8%)

Query: 434 FSEENKLGEGGFGPVYKGMLID---GQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHR 488
           F+    +G+G FG VYK   ID    Q +A+K   L ++  + +E+ + E+  +++ +  
Sbjct: 3   FTLLECIGKGSFGEVYKA--IDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
            + K  G  +K  +  +I EY    S  D +    +   LD +    I+  +  GL YLH
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLH 115

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           ++     IHRD+KA+N+LL  E + K++DFG++       ++ NT   VGT  +M PE  
Sbjct: 116 EE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVI 170

Query: 609 IDGLFSVKSDVFSFGVLVLELVYG 632
               +  K+D++S G+  +EL  G
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 5e-24
 Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 20/198 (10%)

Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLLGCC 497
           K+G+G FG VYKG+L    E+AVK    +    +  +F  E  ++ +  H N+VKL+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRK--LLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
           +++    ++ E +P  SL  F+    R+K   L   K  Q+    A G+ YL   +    
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFL----RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PEYAID 610
           IHRDL A N L+      KISDFGM+R     + E     V      +P     PE    
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNY 169

Query: 611 GLFSVKSDVFSFGVLVLE 628
           G ++ +SDV+S+G+L+ E
Sbjct: 170 GRYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  101 bits (253), Expect = 5e-24
 Identities = 83/268 (30%), Positives = 133/268 (49%), Gaps = 38/268 (14%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG G FG V+        ++AVK + K     VE F  E  ++  LQH  LVKL   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68

Query: 497 CMKRDERMLIYEYLPNKSLADFIF--DGTRR---KLLDWSKRCQIIGGIARGLLYLHQDS 551
            + ++   +I E++   SL DF+   +G+++   KL+D+S +      IA G+ ++ Q +
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN 122

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL+A+N+L+   +  KI+DFG+AR    ++  A          +  PE    G
Sbjct: 123 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 178

Query: 612 LFSVKSDVFSFGVLVLELV-YG-TRNRGFHHVDHHHNLLGHAWRLW-TEDRPVELIDKSL 668
            F++KSDV+SFG+L++E+V YG     G  + +     L   +R+   E+ P EL +  +
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEELYNIMM 237

Query: 669 EDTYSLSEALRCIQVGLLCVQQRPEDRP 696
                             C + RPE+RP
Sbjct: 238 R-----------------CWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  102 bits (255), Expect = 6e-24
 Identities = 73/217 (33%), Positives = 109/217 (50%), Gaps = 27/217 (12%)

Query: 434 FSEENKLGEGGFGPVYKGMLI-----DGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQH 487
           F EE  LGE  FG +YKG L        Q +A+K L   ++ Q   EF+ E  L+A+L H
Sbjct: 9   FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIF--------------DGTRRKLLDWSKR 533
            N+V LLG   +     +++EYL    L +F+               DGT +  LD    
Sbjct: 67  PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126

Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGVDQTEAN 592
             I   IA G+ YL   S    +H+DL A N+L+  +++ KISD G++R  +  D     
Sbjct: 127 LHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183

Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
              ++    +MPPE  + G FS  SD++SFGV++ E+
Sbjct: 184 PKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  101 bits (253), Expect = 1e-23
 Identities = 70/206 (33%), Positives = 120/206 (58%), Gaps = 30/206 (14%)

Query: 440 LGEGGFGPVYKGMLIDGQE-----IAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVKL 493
           LG G FG VYKG+ +   E     +A+K L++++G     EF +E L++A + H +LV+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIARGLLYLHQ 549
           LG C+    + L+ + +P+  L D++ +       + LL+W  +      IA+G++YL +
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-A 608
               R++HRDL A NVL+ +  + KI+DFG+AR    D+ E N +      G MP ++ A
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG-----GKMPIKWMA 179

Query: 609 IDGL----FSVKSDVFSFGVLVLELV 630
           ++ +    F+ +SDV+S+GV + EL+
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 2e-23
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 12/196 (6%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHRNLVKLLG 495
           K+GEG +G VYK    + G+ +A+K++               E+ L+ +L H N++KLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
               + +  L++E++ +  L   I D  R++ L  S     +  + +GL + H      I
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-DGLFS 614
           +HRDLK  N+L++ E   K++DFG+AR+FG       T+ VV T  Y  PE  + D  +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYS 177

Query: 615 VKSDVFSFGVLVLELV 630
              D++S G +  EL+
Sbjct: 178 TPVDIWSVGCIFAELL 193

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 99.7 bits (248), Expect = 3e-23
 Identities = 79/256 (30%), Positives = 124/256 (48%), Gaps = 29/256 (11%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           + KLG+G FG V+ G      ++A+K L K      E F  E  ++ KL+H  LV L   
Sbjct: 11  DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ E++   SL DF+ +G   K L   +   +   IA G+ Y+    R+  I
Sbjct: 70  -VSEEPIYIVTEFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIE---RMNYI 124

Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+ + +  KI+DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183

Query: 617 SDVFSFGVLVLELVYGTR---------------NRGFHH------VDHHHNLLGHAWRLW 655
           SDV+SFG+L+ ELV   R                RG+         +  H L+   W+  
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKD 243

Query: 656 TEDRPV-ELIDKSLED 670
            ++RP  E I   LED
Sbjct: 244 PDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 99.5 bits (248), Expect = 4e-23
 Identities = 80/289 (27%), Positives = 133/289 (46%), Gaps = 47/289 (16%)

Query: 440 LGEGGFGPVYKGMLI--DG--QEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LGEG FG V +G L   DG   ++AVK  +L   +   +EEF +E   +    H N++KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 494 LGCCMKRDER------MLIYEYLPNKSLADFIFD---GTRRKLLDWSKRCQIIGGIARGL 544
           +G C +          M+I  ++ +  L  F+     G   + L      + +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGVD---QTEANTNRVVGTY 600
            YL   S    IHRDL A N +L  +M   ++DFG+++  +  D   Q       V    
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---- 179

Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRG-FHHVDHH--HNLLGHAWRLWTE 657
            ++  E   D +++ KSDV++FGV + E+   TR +  +  V++H  ++ L H  RL   
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA--TRGQTPYPGVENHEIYDYLRHGNRL--- 234

Query: 658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
            +P + +D+  +  YS             C +  P+DRP    +  +L 
Sbjct: 235 KQPEDCLDELYDLMYS-------------CWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.0 bits (247), Expect = 4e-23
 Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 22/203 (10%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-----KSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG G FG VY+G+ L DG   AVK +S     ++  + V++ + E+ L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 494 LGCCMKRDERMLIY-EYLPNKSLADFI--FDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           LG   + ++ + I+ E +P  SLA  +  +      ++    R QI+ G+     YLH  
Sbjct: 68  LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLHDR 121

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
                +HRD+K +N+L+D     K++DFGMA+        +      G+  +M PE  A 
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 610 DGLFSVKSDVFSFGVLVLELVYG 632
            G + + +D++S G  VLE+  G
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATG 198

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 99.4 bits (248), Expect = 5e-23
 Identities = 73/214 (34%), Positives = 111/214 (51%), Gaps = 18/214 (8%)

Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRN 489
           ++++  K+GEG +G VYKG     GQ +A+K++  +S  +GV      E+ L+ +LQH N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 490 LVKLLGCCMKRDERMLIYEYLP---NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           +V L    M+     LI+E+L     K L            L  S   QI+ GI    L+
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LF 116

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L+DN+   K++DFG+ARAFG+      T+ VV T  Y  PE
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPE 171

Query: 607 YAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFH 639
             +    +S   D++S G +  E+   T+   FH
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMA--TKKPLFH 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 73/269 (27%), Positives = 123/269 (45%), Gaps = 31/269 (11%)

Query: 438 NKLGEGGFGPVYKGMLID-GQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           NK+G G FG VY  + +D G+ +AVK  R+  +  + ++E  +E+ ++  L+H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  + R++  +  EY    +L + +  G   ++LD          +  GL YLH      
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---G 119

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT--NRVVGTYGYMPPEYAIDGL 612
           I+HRD+K +N+ LD+    K+ DFG A     + T        + GT  YM PE    G 
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 613 FSVK---SDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV--ELIDKS 667
                  +D++S G +VLE+  G R   +  +D+   ++ H   +    +P   + +  S
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP--WSELDNEFQIMFH---VGAGHKPPIPDSLQLS 234

Query: 668 LEDTYSLSEALRCIQVGLLCVQQRPEDRP 696
            E                 C++  P+ RP
Sbjct: 235 PE----------GKDFLDRCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 99.4 bits (247), Expect = 7e-23
 Identities = 60/208 (28%), Positives = 113/208 (54%), Gaps = 10/208 (4%)

Query: 426 SIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           SI +    ++   K+G+G  G V+  + +  GQE+A+K+++       E   NE+L++ +
Sbjct: 13  SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           L++ N+V  L   +  DE  ++ EYL   SL D + +      +D ++   +     + L
Sbjct: 73  LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQAL 128

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH +   ++IHRD+K+ NVLL  + + K++DFG       +Q++ +T  +VGT  +M 
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +  K D++S G++ +E+V G
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 28/219 (12%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QH 487
           + T  F     +GEG +G VYK       ++   ++        EE K E  ++ K   H
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62

Query: 488 RNLVKLLGCCMKR------DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ------ 535
            N+    G  +K+      D+  L+ E     S+ D +     + L    KR +      
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAY 117

Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
           I+    RGL YLH++   ++IHRD+K  N+LL      K+ DFG++    +D T    N 
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNT 172

Query: 596 VVGTYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLEL 629
            +GT  +M PE        D  +  +SDV+S G+  +EL
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 98.2 bits (245), Expect = 9e-23
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 10/202 (4%)

Query: 438 NKLGEGGFGPVYKGMLIDGQE-IAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
             +G G    VY  + +   E +A+KR  L K     V+E + EV  +++  H N+VK  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYY 65

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
              +  DE  L+  YL   SL D +     R  LD +    ++  + +GL YLH + +  
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPEYAIDGL 612
            IHRD+KA N+LL  + + KI+DFG++ +   G D+T       VGT  +M PE      
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 613 -FSVKSDVFSFGVLVLELVYGT 633
            +  K+D++SFG+  +EL  G 
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 98.5 bits (245), Expect = 9e-23
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 30/217 (13%)

Query: 439 KLGEGGFGPVYKG---MLIDGQE---IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           +LGEG FG V+      L+  Q+   +AVK L ++S    ++F+ E  L+  LQH+++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFI-FDGTRRKLLDWSK-----------RCQIIGGI 540
             G C +    ++++EY+ +  L  F+   G   K+L   +              I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG-- 598
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R    D    +  RV G  
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 184

Query: 599 --TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL-VYG 632
                +MPPE  +   F+ +SD++SFGV++ E+  YG
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYG 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 98.8 bits (246), Expect = 1e-22
 Identities = 62/215 (28%), Positives = 112/215 (52%), Gaps = 24/215 (11%)

Query: 426 SIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+ +    ++   K+G+G  G VY  + +  GQE+A+K+++       E   NE+L++ +
Sbjct: 13  SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA--- 541
            +H N+V  L   +  DE  ++ EYL   SL D +           ++ C   G IA   
Sbjct: 73  NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----------TETCMDEGQIAAVC 121

Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVV 597
               + L +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++ +T  +V
Sbjct: 122 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MV 176

Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           GT  +M PE      +  K D++S G++ +E+V G
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 98.4 bits (245), Expect = 1e-22
 Identities = 74/204 (36%), Positives = 101/204 (49%), Gaps = 24/204 (11%)

Query: 440 LGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVKL 493
           LGEG FG V    Y       G+ +AVK L +  GQ     +K E+ ++  L H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            GCC ++  +   LI EY+P  SL D++     +  L+ ++       I  G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
               IHRDL A NVLLDN+   KI DFG+A+A      E +    V   G  P      E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAVE 180

Query: 607 YAIDGLFSVKSDVFSFGVLVLELV 630
              +  FS  SDV+SFGV + EL+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 10/200 (5%)

Query: 438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVE--EFKNEVLLIAKLQHRNLVKLL 494
             +G+G FG V K     DG+ +  K +   +    E  +  +EV ++ +L+H N+V+  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 495 GCCMKRD-ERMLIY-EYLPNKSLADFIFDGTR-RKLLDWSKRCQIIGGIARGLLYLH--Q 549
              + R  + + I  EY     LA  I    + RK ++     +I+  +   L   H   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
           D    ++HRDLK +N+ LD   N K+ DFG+A+  G D + A T   VGT  YM PE   
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLN 183

Query: 610 DGLFSVKSDVFSFGVLVLEL 629
              +  KSD++S G L+ EL
Sbjct: 184 HMSYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 98.0 bits (244), Expect = 2e-22
 Identities = 80/304 (26%), Positives = 135/304 (44%), Gaps = 60/304 (19%)

Query: 432 DNFSEENKLGEGGFGPVYKGM---LIDGQE---IAVKRLSK-SSGQGVEEFKNEVLLIAK 484
           +N      +G+G FG V++     L+  +    +AVK L + +S     +F+ E  L+A+
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR---KLLDWSKRCQIIGG-- 539
             H N+VKLLG C       L++EY+    L +F+   + R    L   +   +  G   
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 540 --------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AF 584
                         +A G+ YL   S  + +HRDL   N L+   M  KI+DFG++R  +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV-------YGTRNRG 637
             D  +A+ N  +    +MPPE      ++ +SDV+++GV++ E+        YG  +  
Sbjct: 182 SADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240

Query: 638 FHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN 697
             +     N+L        ++ P+EL        Y+L           LC  + P DRP+
Sbjct: 241 VIYYVRDGNVLS-----CPDNCPLEL--------YNLMR---------LCWSKLPSDRPS 278

Query: 698 MASV 701
            AS+
Sbjct: 279 FASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 17/210 (8%)

Query: 433 NFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLIAKL 485
           N  E   LG G FG V+    KG+  +G E  + VK L K+  + ++ EF+ E+ +  KL
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI------FDGTRRKLLDWSKRCQIIGG 539
            H+N+V+LLG C + +   +I EY     L  F+       +  +   L   ++  +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           IA G+ +L   S  R +HRDL A N L+ ++   K+S   +++     +     N ++  
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             ++ PE   +  FS KSDV+SFGVL+ E+
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 37/223 (16%)

Query: 432 DNFSEENKLGEGGFGPVYKGM---LIDGQ---EIAVKRLSKSSGQG-VEEFKNEVLLIAK 484
           +  +   +LG+G FG VY+G+   ++ G+    +A+K +++++      EF NE  ++ +
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYL-------------PNKSLADFIFDGTRRKLLDWS 531
               ++V+LLG        +++ E +             P       +   T +K +  +
Sbjct: 66  FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125

Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
                   IA G+ YL      + +HRDL A N ++  ++  KI DFGM R    D  E 
Sbjct: 126 ------AEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYET 172

Query: 592 NTNRVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
           +  R  G       +M PE   DG+F+ KSDV+SFGV++ E+ 
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 98.2 bits (244), Expect = 2e-22
 Identities = 83/298 (27%), Positives = 132/298 (44%), Gaps = 57/298 (19%)

Query: 437 ENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           + +LGEG FG V+           D   +AVK L   +    ++F+ E  L+  LQH ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADF----------IFDGTRRKL---LDWSKRCQII 537
           VK  G C   D  ++++EY+ +  L  F          + DG  R+    L  S+   I 
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVV 597
             IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D    +  RV 
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 182

Query: 598 G----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL-VYGTRNRGFHHVDHHHNLLGHAW 652
           G       +MPPE  +   F+ +SDV+SFGV++ E+  YG +                  
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----------------- 225

Query: 653 RLWTEDRPVELID-----KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
             W +    E+I+     + LE      + +  I +G  C Q+ P+ R N+  +  +L
Sbjct: 226 --WFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLG--CWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.0 bits (241), Expect = 3e-22
 Identities = 78/289 (26%), Positives = 141/289 (48%), Gaps = 50/289 (17%)

Query: 435 SEENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRN 489
           +++  +G G FG V++G+L + G++   +A+K L    + +  ++F +E  ++ +  H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLY 546
           +++L G   K    M+I EY+ N +L  ++    R    ++S   Q++G   GIA G+ Y
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYL----RDHDGEFSS-YQLVGMLRGIAAGMKY 122

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-- 604
           L   S +  +HRDL A N+L+++ +  K+SDFG++R    D     T     + G +P  
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIR 175

Query: 605 ---PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFHHVDHHHNLLGHAWRLWTEDRP 660
              PE      F+  SDV+SFG+++ E++ +G R                 W +   +  
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY---------------WDMSNHE-- 218

Query: 661 VELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
              + K++ D + L   + C     Q+ L C QQ    RP    +V +L
Sbjct: 219 ---VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 97.8 bits (243), Expect = 3e-22
 Identities = 66/212 (31%), Positives = 118/212 (55%), Gaps = 21/212 (9%)

Query: 434 FSEENKLGEGGFGPVYKGMLI-DGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQH 487
           F +   LG G FG VYKG+ I +G+++    A+K L + +S +  +E  +E  ++A + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARG 543
            ++ +LLG C+    + LI + +P   L D++ +         LL+W  +      IA+G
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + YL +    R++HRDL A NVL+    + KI+DFG+A+  G D+ E +         +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
             E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 96.6 bits (240), Expect = 4e-22
 Identities = 67/201 (33%), Positives = 113/201 (56%), Gaps = 20/201 (9%)

Query: 440 LGEGGFGPVYKGMLI-DGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG G FG VYKG+ I DG+ +    A+K L + +S +  +E  +E  ++A +    + +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQ 549
           LG C+    + L+ + +P   L D++ +   R     LL+W  +      IA+G+ YL +
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
              +R++HRDL A NVL+ +  + KI+DFG+AR   +D+TE + +       +M  E  +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 610 DGLFSVKSDVFSFGVLVLELV 630
              F+ +SDV+S+GV V EL+
Sbjct: 185 HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 31/207 (14%)

Query: 440 LGEGGFGPVYKGMLID-GQEIAVKR-----LSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG+G FG VY    +D G+E+AVK+      S  + + V   + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 494 LGCCMKRDERMLIY-EYLPNKSLADFI------FDGTRRKLLDWSKRCQIIGGIARGLLY 546
            GC ++ DE + I+ EY+P  S+ D +       +   RK   ++++      I  G+ Y
Sbjct: 70  YGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK---YTRQ------ILEGVEY 119

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR---AFGVDQTEANTNRVVGTYGYM 603
           LH +    I+HRD+K +N+L D+  N K+ DFG ++         T   +  V GT  +M
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWM 174

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE      +  K+DV+S G  V+E++
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 95.9 bits (238), Expect = 8e-22
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 11/201 (5%)

Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 491
           F++  ++G+G FG VYKG+    +E+ A+K +     +  +E+ + E+ ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +  G  +K  +  +I EYL   S  D +  G     L+ +    I+  I +GL YLH + 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE- 120

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
             R IHRD+KA+NVLL  + + K++DFG+A      Q + NT   VGT  +M PE     
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176

Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +  K+D++S G+  +EL  G
Sbjct: 177 AYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 95.6 bits (238), Expect = 8e-22
 Identities = 76/273 (27%), Positives = 127/273 (46%), Gaps = 52/273 (19%)

Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQH---RNLVKLL 494
           +G G +G VY+G  +  G+ +A+K ++  +    V + + EV L+++L+     N+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK---RCQIIGGIARGLL----YL 547
           G  +K     +I EY    S+         R L+       +   I  I R +L    Y+
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV---------RTLMKAGPIAEKY--ISVIIREVLVALKYI 117

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H+     +IHRD+KA+N+L+ N  N K+ DFG+A     +Q  +  +  VGT  +M PE 
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEV 172

Query: 608 AIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK 666
             +G  +  K+D++S G+ + E+  G  N  +  VD                R + LI K
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG--NPPYSDVDAF--------------RAMMLIPK 216

Query: 667 S----LEDTYSLSEALRCIQVGLLCVQQRPEDR 695
           S    LED    S+ LR       C+ + P++R
Sbjct: 217 SKPPRLEDN-GYSKLLREFVAA--CLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 95.8 bits (238), Expect = 9e-22
 Identities = 83/292 (28%), Positives = 136/292 (46%), Gaps = 50/292 (17%)

Query: 440 LGEGGFGPVYKGML--IDGQ----EIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVK 492
           LGEG FG V K     + G+     +AVK L +++    + +  +E  L+ ++ H +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFI------------FDGTRRKLLDWS--KRCQIIG 538
           L G C +    +LI EY    SL  F+             DG R      +  +R   +G
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 539 G-------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
                   I+RG+ YL   + ++++HRDL A NVL+      KISDFG++R    + +  
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY--GTRNRGFHHVDHHHNLLG 649
             ++      +M  E   D +++ +SDV+SFGVL+ E+V   G    G    +   NLL 
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERLFNLLK 243

Query: 650 HAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
             +R+   +RP    +   E+ Y+L          L C +Q P+ RP  A +
Sbjct: 244 TGYRM---ERP----ENCSEEMYNLM---------LTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 38/211 (18%)

Query: 438 NKLGEGGFGPVYKGMLI--DGQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVK 492
            +LG G  G V K +L    G+ +AVK +     +     K    E+ ++ K     +V 
Sbjct: 7   GELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVG 63

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ------IIGGIA----R 542
             G      +  +  EY+   SL   +            K  Q      I+G IA    +
Sbjct: 64  FYGAFYNNGDISICMEYMDGGSLDKIL------------KEVQGRIPERILGKIAVAVLK 111

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           GL YLH   + +IIHRD+K SN+L+++    K+ DFG++    V+ + A T   VGT  Y
Sbjct: 112 GLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN-SLAKTF--VGTSSY 165

Query: 603 MPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           M PE  I G  +SVKSD++S G+ ++EL  G
Sbjct: 166 MAPE-RIQGNDYSVKSDIWSLGLSLIELATG 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 36/272 (13%)

Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V  G      ++A+K + + S    +EF  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
           K+    ++ EY+ N  L +++ +  +R     S+  ++   +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEYAIDGLFSV 615
           DL A N L+D++   K+SDFG++R    D+  ++    VG+     + PPE  +   FS 
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180

Query: 616 KSDVFSFGVLVLELVYGTRNRGFHHVDHH----HNLLGHAWRLWTEDRPVELIDKSLEDT 671
           KSDV++FGVL+ E VY      +   ++         G   RL+   RP    +K     
Sbjct: 181 KSDVWAFGVLMWE-VYSLGKMPYERFNNSETVEKVSQGL--RLY---RPHLASEKVYAIM 234

Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL 703
           YS             C  ++ E+RP    ++ 
Sbjct: 235 YS-------------CWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 27/209 (12%)

Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G+G FG VY G LID  GQ+I  AVK L++ +  + VE+F  E +++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C+  +   +++  Y+ +  L +FI   T    +       +IG    +A+G+ YL   
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEYLASK 117

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
              + +HRDL A N +LD     K++DFG+AR     +  +  N    T   +P ++ A+
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH---TGAKLPVKWMAL 171

Query: 610 DGL----FSVKSDVFSFGVLVLELVYGTR 634
           + L    F+ KSDV+SFGVL+ EL+  TR
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELM--TR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 95.1 bits (236), Expect = 2e-21
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 11/201 (5%)

Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 491
           F++  K+G+G FG V+KG+    Q++ A+K +     +  +E+ + E+ ++++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           K  G  +K  +  +I EYL   S  D +  G     LD ++   I+  I +GL YLH + 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSEK 121

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
           +   IHRD+KA+NVLL      K++DFG+A    +  T+   N  VGT  +M PE     
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +  K+D++S G+  +EL  G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 19/211 (9%)

Query: 431 TDNFSEENKLGEGGFGPVYKGMLIDGQ-EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
            D   E   LG+G +G VY    +  Q  IA+K + +   + V+    E+ L + L+HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIARGLL 545
           +V+ LG   +     +  E +P  SL+  +    R K        Q I      I  GL 
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLK 122

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMA-RAFGVDQTEANTNRVVGTYGYM 603
           YLH     +I+HRD+K  NVL++      KISDFG + R  G++     T    GT  YM
Sbjct: 123 YLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYM 176

Query: 604 PPEYAIDGL--FSVKSDVFSFGVLVLELVYG 632
            PE    G   +   +D++S G  ++E+  G
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATG 207

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 29/210 (13%)

Query: 433 NFSEENKLGEGGFGPVYK-GMLIDGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRN 489
           +F    KLG+G +G VYK   L D Q  A+K   L   S +  E+  NE+ ++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 490 LVK-----LLGCCMKRDERMLIYEYLPNKSLADFIFDGTR-RKLLD----WSKRCQIIGG 539
           ++      L G  +      ++ EY P   L+  I    + RKL+     W    Q+   
Sbjct: 61  IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL--- 112

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
             RGL  LH+    +I+HRDLK++N+LL      KI D G+++   + +  A T   +GT
Sbjct: 113 -LRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT--QIGT 164

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             YM PE      +S KSD++S G L+ E+
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEM 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 19/206 (9%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           +++    ++G G +G VYK   I   E+ A+K +    G   E  + E+ ++ + +H N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR----GLLY 546
           V   G  ++RD+  ++ EY    SL D I+  TR  L +       I  + R    GL Y
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-----LQIAYVCRETLKGLAY 116

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH+      IHRD+K +N+LL  + + K++DFG++    +  T A     +GT  +M PE
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPE 171

Query: 607 YA---IDGLFSVKSDVFSFGVLVLEL 629
            A     G +  K D+++ G+  +EL
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 94.4 bits (234), Expect = 3e-21
 Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 48/296 (16%)

Query: 433 NFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 486
           N   + +LGEG FG V+           D   +AVK L  +S    ++F  E  L+  LQ
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI----------FDGTRRKLLDWSKRCQI 536
           H ++VK  G C++ D  ++++EY+ +  L  F+           +G R   L  S+   I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
              IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D    +  RV
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 178

Query: 597 VG----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL-VYGTRNRGFHHVDHHHNLLGHA 651
            G       +MPPE  +   F+ +SDV+S GV++ E+  YG +                 
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ----------------P 222

Query: 652 WRLWTEDRPVELIDKS--LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
           W   + +  +E I +   L+   +  + +  + +G  C Q+ P  R N+  +  +L
Sbjct: 223 WYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLG--CWQREPHMRLNIKEIHSLL 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 94.4 bits (234), Expect = 4e-21
 Identities = 59/208 (28%), Positives = 111/208 (53%), Gaps = 10/208 (4%)

Query: 426 SIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+ +    ++   K+G+G  G VY  + I  GQE+A+K+++       E   NE+L++ +
Sbjct: 13  SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
            ++ N+V  L   +  DE  ++ EYL   SL D + +      +D  +   +     + L
Sbjct: 73  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQAL 128

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++ +T  +VGT  +M 
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +  K D++S G++ +E+V G
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 93.7 bits (233), Expect = 4e-21
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 39/218 (17%)

Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRL---SKSSGQG-------VEEFKNEVLLIAKLQHR 488
           +G+G +G VY  + +  G+ +AVK++   +  +G+        V+  ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----FDGTRRKLLDWSKRCQIIGGIARG 543
           N+V+ LG     +   +  EY+P  S+   +     F+    +        Q++ G+A  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT----EQVLEGLA-- 122

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR----AFGVDQTEANTNRVVGT 599
             YLH      I+HRDLKA N+L+D +   KISDFG+++     +  DQ       + G+
Sbjct: 123 --YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ----NMSMQGS 173

Query: 600 YGYMPPEYAIDGL---FSVKSDVFSFGVLVLELVYGTR 634
             +M PE  I      +S K D++S G +VLE+  G R
Sbjct: 174 VFWMAPE-VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.4 bits (232), Expect = 4e-21
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 16/205 (7%)

Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLS------KSSGQGVEEFKNEVLLIAKLQHRNLV 491
             LG+G +G VY G+   GQ IAVK++        ++ +  E+ + EV L+  L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           + LG C+  +   +  E++P  S++  +    R   L     C+    I  G+ YLH + 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAF---GVDQTEANTNRVV-GTYGYMPPEY 607
              ++HRD+K +NV+L      K+ DFG AR     G+  T +N  + + GT  +M PE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYG 632
             +  +  KSD++S G  V E+  G
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATG 204

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.9 bits (231), Expect = 8e-21
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVE-EFKNEVLLIAKLQHRN 489
           +   E ++LGEG  G V K  L +   I A+K ++      ++ +   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 490 LVKLLGCCMKRDERML--IYEYLPNKSLADFIFDGTRRKLLDWSKRC--QIIGGIA---- 541
           +VK  G  +      +    EY    SL     D   +K+     R   +++G IA    
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVL 115

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL YLH     +IIHRD+K SN+LL  +   K+ DFG++         A T    GT  
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGT--FTGTSF 168

Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           YM PE      +S+ SDV+S G+ +LE+   
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.5 bits (230), Expect = 9e-21
 Identities = 61/208 (29%), Positives = 106/208 (50%), Gaps = 18/208 (8%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQ 486
             NF  E K+G+G F  VYK + L+DG+ +A+K++        +  ++   E+ L+ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI--FDGTRRKLLD---WSKRCQIIGGIA 541
           H N++K L   ++ +E  ++ E      L+  I  F   +R + +   W    Q+     
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
             L ++H     RI+HRD+K +NV +      K+ D G+ R F    T A++  +VGT  
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171

Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           YM PE   +  ++ KSD++S G L+ E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 69/268 (25%), Positives = 128/268 (47%), Gaps = 30/268 (11%)

Query: 440 LGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVK 492
           LG G F   Y+      G L+  +++   R + S  + V E  + E+ L+A+L H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFD-GTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LG   +     L  E++   S++  +   G  ++ +  +   Q++    RGL YLH++ 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHEN- 122

Query: 552 RLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGVDQTEAN--TNRVVGTYGYMPPEYA 608
             +IIHRD+K +N+L+D+     +I+DFG A       T A     +++GT  +M PE  
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL 668
               +    DV+S G +++E+             +H  L+   +++ +      + +   
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASATTAPSIPE--- 234

Query: 669 EDTYSLSEALRCIQVGLLCVQQRPEDRP 696
                LS  LR   V L C++ +PEDRP
Sbjct: 235 ----HLSPGLR--DVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.3 bits (229), Expect = 1e-20
 Identities = 83/287 (28%), Positives = 135/287 (47%), Gaps = 50/287 (17%)

Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V  G L + G+    +A+K L    + +   +F +E  ++ +  H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLH 548
            L G   K    M++ EY+ N SL  F+     RK        Q++G   GIA G+ YL 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFL-----RKHDGQFTVIQLVGMLRGIASGMKYL- 122

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP---- 604
             S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P    
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWT 176

Query: 605 -PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE 662
            PE      F+  SDV+S+G+++ E++ YG R                 W +  +D    
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---------------WEMSNQD---- 217

Query: 663 LIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
            + K++E+ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 218 -VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 27/204 (13%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVKLLG 495
           K+GEG +G VYK    + G+ +A+K++  ++  +GV      E+ L+ +L H N+V+LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC----QIIGG----IARGLLYL 547
                ++  L++E+L          D   +K +D S        +I      + +G+ Y 
Sbjct: 66  VVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H     R++HRDLK  N+L+D E   K++DFG+ARAFGV      T+ VV T  Y  PE 
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 170

Query: 608 AIDG-LFSVKSDVFSFGVLVLELV 630
            +    +S   D++S G +  E+V
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 92.5 bits (229), Expect = 2e-20
 Identities = 56/208 (26%), Positives = 110/208 (52%), Gaps = 10/208 (4%)

Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+ +    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
            ++ N+V  L   +  DE  ++ EYL   SL D + +      +D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQAL 129

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++   + +VGT  +M 
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA 184

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +  K D++S G++ +E++ G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 91.7 bits (227), Expect = 2e-20
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 11/201 (5%)

Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 491
           F++  ++G+G FG V+KG+    Q++ A+K +     +  +E+ + E+ ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           K  G  +K  +  +I EYL   S  D +  G      D  +   ++  I +GL YLH + 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLHSEK 121

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
           +   IHRD+KA+NVLL  + + K++DFG+A      Q + NT   VGT  +M PE     
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176

Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +  K+D++S G+  +EL  G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 91.7 bits (227), Expect = 2e-20
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 18/205 (8%)

Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCM 498
           +G G +G VYKG  +   ++A  ++   +G   EE K E+ ++ K   HRN+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 499 KR------DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
           K+      D+  L+ E+    S+ D I   T+   L       I   I RGL +LHQ   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI--- 609
            ++IHRD+K  NVLL      K+ DFG++    +D+T    N  +GT  +M PE      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 610 --DGLFSVKSDVFSFGVLVLELVYG 632
             D  +  KSD++S G+  +E+  G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 87/312 (27%), Positives = 143/312 (45%), Gaps = 60/312 (19%)

Query: 420 PIFDWKSIANATDNFSEENKLGEGGFGPVYKGML-IDG--QEIAVKRLSKSSGQG-VEEF 475
           P+ +W  I         ++ +GEG FG V K  +  DG   + A+KR+ + + +    +F
Sbjct: 2   PVLEWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 54

Query: 476 KNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-------------FD 521
             E+ ++ KL  H N++ LLG C  R    L  EY P+ +L DF+               
Sbjct: 55  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114

Query: 522 GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
            +    L   +       +ARG+ YL Q    + IHRDL A N+L+      KI+DFG++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171

Query: 582 RAFGVDQTEANTNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLELVY--GTR 634
           R   V         V  T G +P  + AI+ L    ++  SDV+S+GVL+ E+V   GT 
Sbjct: 172 RGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Query: 635 NRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPED 694
             G    + +   L   +RL   ++P+   D    + Y L            C +++P +
Sbjct: 224 YCGMTCAELYEK-LPQGYRL---EKPLNCDD----EVYDLMRQ---------CWREKPYE 266

Query: 695 RPNMASVVLMLS 706
           RP+ A +++ L+
Sbjct: 267 RPSFAQILVSLN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 91.1 bits (226), Expect = 3e-20
 Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 54/284 (19%)

Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++A+K +++ +    E+F  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR-----CQIIGGIARGLLYLHQDSRL 553
           ++    ++ E++ N  L +++    R++    SK      CQ    +  G+ YL ++S  
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLLSMCQ---DVCEGMEYLERNS-- 120

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
             IHRDL A N L+ +    K+SDFGM R + +D    +++       + PPE      +
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178

Query: 614 SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR-PVELIDKSLEDTY 672
           S KSDV+SFGVL+                         W ++TE + P E    + E   
Sbjct: 179 SSKSDVWSFGVLM-------------------------WEVFTEGKMPFEK-KSNYEVVE 212

Query: 673 SLSEALRCIQ----------VGLLCVQQRPEDRPNMASVVLMLS 706
            +S   R  +          V   C  ++PE RP  A ++  ++
Sbjct: 213 MISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 70/272 (25%), Positives = 121/272 (44%), Gaps = 31/272 (11%)

Query: 440 LGEGGFGP--VYK----GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG+G FG   +Y+      L+  +E+ + RLS+       +  NE+++++ LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
               M  +  ++  EY    +L D I    + +L +       +  I   + Y+H+    
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            I+HRD+K  N+ L      K+ DFG+++  G + + A T  VVGT  YM PE      +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178

Query: 614 SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYS 673
           + KSD+++ G ++ EL+  T  R F       N L    ++   +    +        YS
Sbjct: 179 NFKSDIWALGCVLYELL--TLKRTFDAT----NPLNLVVKIVQGNYTPVV------SVYS 226

Query: 674 LSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
                  I +    +QQ PE RP    V+   
Sbjct: 227 SE----LISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 89.6 bits (222), Expect = 6e-20
 Identities = 65/194 (33%), Positives = 102/194 (52%), Gaps = 19/194 (9%)

Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
            +GEG FG V +G    GQ++AVK +        + F  E  ++ KL H+NLV+LLG  +
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 499 KRDERMLIYEYLPNKSLADFIFDGTR-RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
             +   ++ E +   +L +F+   TR R L+   +  Q    +A G+ YL      +++H
Sbjct: 70  -HNGLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 558 RDLKASNVLLDNEMNPKISDFGMARA--FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           RDL A N+L+  +   K+SDFG+AR    GVD ++           +  PE      FS 
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKKFSS 176

Query: 616 KSDVFSFGVLVLEL 629
           KSDV+S+GVL+ E+
Sbjct: 177 KSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.9 bits (223), Expect = 8e-20
 Identities = 67/203 (33%), Positives = 109/203 (53%), Gaps = 13/203 (6%)

Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVK--RLSKSSGQGVEEFK-NEVLLIAKLQHR 488
           NF +  K+GEG +G VYK    + G+ +A+K  RL   + +GV      E+ L+ +L H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 172

Query: 609 IDG-LFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 90.6 bits (225), Expect = 9e-20
 Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 19/203 (9%)

Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRN 489
           F++  ++G G FG VY    +   + +A+K++S S  Q  E++++   EV  + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
            ++  GC ++     L+ EY    S +D +     +K L   +   I  G  +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLG-SASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE--Y 607
             R   IHRD+KA N+LL      K++DFG A         +  N  VGT  +M PE   
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVIL 184

Query: 608 AID-GLFSVKSDVFSFGVLVLEL 629
           A+D G +  K DV+S G+  +EL
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 90.3 bits (225), Expect = 9e-20
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 39/216 (18%)

Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN-----------EVL 480
            + +  KLGEG +  VYK      G+ +A+K++       + E K            E+ 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIK 54

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSKRCQIIG 538
           L+ +L+H N++ LL     +    L++E++      D   +       L     +   + 
Sbjct: 55  LLQELKHPNIIGLLDVFGHKSNINLVFEFME----TDLEKVIKDKSIVLTPADIKS-YML 109

Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
              RGL YLH      I+HRDLK +N+L+ ++   K++DFG+AR+FG       T++VV 
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV- 164

Query: 599 TYGYMPPEYAIDGLFSVKS-----DVFSFGVLVLEL 629
           T  Y  PE     LF  +      D++S G +  EL
Sbjct: 165 TRWYRAPEL----LFGARHYGVGVDMWSVGCIFAEL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 73/278 (26%), Positives = 128/278 (46%), Gaps = 31/278 (11%)

Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQHR 488
           NF  E K+G G F  VY+   L+D + +A+K++        +  ++   E+ L+ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFI--FDGTRRKLLD---WSKRCQIIGGIARG 543
           N++K L   ++ +E  ++ E      L+  I  F   +R + +   W    Q+   +   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
               H  SR R++HRD+K +NV +      K+ D G+ R F    T A++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
            PE   +  ++ KSD++S G L+ E+                   G    L++  + +E 
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA-----------LQSPFYGDKMNLFSLCQKIEQ 222

Query: 664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
            D     T   SE LR  ++  +C+   P+ RP++  V
Sbjct: 223 CDYPPLPTEHYSEKLR--ELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 63/212 (29%), Positives = 89/212 (41%), Gaps = 25/212 (11%)

Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHR 488
           +F     +G+G FG V      D +++ A+K ++K        V    NE  ++ +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ------IIGGIAR 542
            LV L      +DE      YL    + D +  G  R  L    +         I  I  
Sbjct: 61  FLVNL--WYSFQDEE---NMYL----VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVL 111

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
            L YLH      IIHRD+K  N+LLD + +  I+DF +A        +  T    GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGY 165

Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYGTR 634
           M PE      +SV  D +S GV   E + G R
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 90.1 bits (223), Expect = 1e-19
 Identities = 91/301 (30%), Positives = 138/301 (45%), Gaps = 65/301 (21%)

Query: 437 ENKLGEGGFGPVYKGMLI-DGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKL-QHRNLV 491
           E+ +GEG FG V + M+  DG ++  A+K L + +S     +F  E+ ++ KL  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDG-------------------TRRKLLDWSK 532
            LLG C  R    +  EY P  +L DF+                      T ++LL    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL---- 122

Query: 533 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
             Q    +A G+ YL   S  + IHRDL A NVL+   +  KI+DFG++R   V      
Sbjct: 123 --QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV------ 171

Query: 593 TNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLELVY--GTRNRGFHHVDHHH 645
              V  T G +P  + AI+ L    ++ KSDV+SFGVL+ E+V   GT   G    + + 
Sbjct: 172 --YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229

Query: 646 NLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
             L   +R+   ++P    D    + Y L            C + RP +RP  A + + L
Sbjct: 230 K-LPQGYRM---EKPRNCDD----EVYELMRQ---------CWRDRPYERPPFAQISVQL 272

Query: 706 S 706
           S
Sbjct: 273 S 273

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 90.1 bits (223), Expect = 1e-19
 Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 34/270 (12%)

Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAKLQHRN 489
           FS+  ++G G FG VY    +   E+ A+K++S S  Q  E++++   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
            ++  GC ++     L+ EY    S +D +     +K L   +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
            +   +IHRD+KA N+LL      K+ DFG A         A  N  VGT  +M PE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184

Query: 610 ---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK 666
              +G +  K DV+S G+  +EL    R     ++    N +   + +   + P      
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNM----NAMSALYHIAQNESPALQSGH 238

Query: 667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRP 696
             E   +  ++         C+Q+ P+DRP
Sbjct: 239 WSEYFRNFVDS---------CLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 34/217 (15%)

Query: 440 LGEGGFGPVYKGMLID------GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRNLV 491
           LGEG FG V K   +          +AVK L   ++ + + +  +E+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG------------ 539
            LLG C +     ++ EY  + +L DF+    R      S                    
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRA-RRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 540 --IARGLLYLHQDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAF-GVDQTEANTN 594
             +ARG+ +L      + IHRDL A NVL+  D+ M  KI+DFG+AR    +D     TN
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM--KIADFGLARDIHHIDYYRKTTN 193

Query: 595 -RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
            R+     +M PE   D +++ +SDV+SFGVL+ E+ 
Sbjct: 194 GRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 89.5 bits (222), Expect = 2e-19
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           D + +  K+GEG +G VYK    +  + IA+K++  +   +GV      E+ L+ ++QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 489 NLVKLLGCCMKRDERMLIYEYLP------NKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
           N+V+L           L++EYL         S  DF  +    K   +    QI+ GIA 
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY----QILRGIA- 116

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRVVGTYG 601
              Y H     R++HRDLK  N+L+D   N  K++DFG+ARAFG+      T+ VV T  
Sbjct: 117 ---YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLW 168

Query: 602 YMPPEYAIDGL-FSVKSDVFSFGVLVLELV 630
           Y  PE  +    +S   D++S G +  E+V
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 21/204 (10%)

Query: 440 LGEGGFGPVYKGMLI-DGQEI----AVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKL 493
           LG G FG V+KG+ I +G  I    A+K +   SG Q  +E  + +L +  L H  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDG----TRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           LG C       L+ +  P  SL D +         ++LL+W  +      IA+G+ YL +
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
               R++HR+L A N+LL ++   +I+DFG+A     D  +   +       +M  E  +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 610 DGLFSVKSDVFSFGVLVLELV-YG 632
            G ++ +SDV+S+GV V E++ YG
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYG 208

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 13/205 (6%)

Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNL 490
           NF +  KLGEG +  VYKG     G+ +A+K +   + +G       E+ L+ +L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+L       ++ ML++EY+ +K L  ++     R  LD +        + +G+ + H++
Sbjct: 61  VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT--NRVVGTYGYMPPEYA 608
              R++HRDLK  N+L++     K++DFG+ARAFG+     NT  N VV T  Y  P+  
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI---PVNTFSNEVV-TLWYRAPDVL 172

Query: 609 IDG-LFSVKSDVFSFGVLVLELVYG 632
           +    +S   D++S G ++ E++ G
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 87.7 bits (217), Expect = 3e-19
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 36/270 (13%)

Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVKLLGCCM 498
           LG+G FG V+KG L D   +AVK   +   Q ++ +F +E  ++ +  H N+VKL+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQDSRLRI 555
           +R    ++ E +P      F+     RK  D  K  Q++      A G+ YL   +    
Sbjct: 63  QRQPIYIVMELVPGGDFLSFL-----RKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDL A N L+      KISDFGM+R    D   +++        +  PE    G +S 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 616 KSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS 675
           +SDV+S+G+L+ E    T + G   V  +  +     R            + +E  Y +S
Sbjct: 174 ESDVWSYGILLWE----TFSLG---VCPYPGMTNQQAR------------EQVEKGYRMS 214

Query: 676 EALRC----IQVGLLCVQQRPEDRPNMASV 701
              +C     +V   C   +PE+RP  + +
Sbjct: 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 31/278 (11%)

Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQHR 488
           NF  E K+G G F  VY+   L+DG  +A+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFI--FDGTRRKLLD---WSKRCQIIGGIARG 543
           N++K     ++ +E  ++ E      L+  I  F   +R + +   W    Q+   +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
               H  SR R++HRD+K +NV +      K+ D G+ R F    T A++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
            PE   +  ++ KSD++S G L+ E+        F+         G    L++  + +E 
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFY---------GDKMNLYSLCKKIEQ 222

Query: 664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
            D     +   SE LR  Q+  +C+   PE RP++  V
Sbjct: 223 CDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 88.2 bits (218), Expect = 6e-19
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 19/203 (9%)

Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAKLQHRN 489
           F++  ++G G FG VY    +   E+ A+K++S S  Q  E++++   EV  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
            ++  GC ++     L+ EY    S +D +     +K L   +   I  G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
            +   +IHRD+KA N+LL      K++DFG A         +  N  VGT  +M PE  +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194

Query: 610 ---DGLFSVKSDVFSFGVLVLEL 629
              +G +  K DV+S G+  +EL
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 34/219 (15%)

Query: 439 KLGEGGFGPVY----KGML---------IDGQE--IAVKRL-SKSSGQGVEEFKNEVLLI 482
           KLGEG FG V+    +G+           DGQ   +AVK L +  +     +F  E+ ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL------------LDW 530
           ++L++ N+++LLG C+  D   +I EY+ N  L  F+   ++R++            +  
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTFTHANNIPSVSI 128

Query: 531 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE 590
           +    +   IA G+ YL   + L  +HRDL   N L+ N    KI+DFGM+R        
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               R V    +M  E  + G F+  SDV++FGV + E+
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 440 LGEGGFGPVYKGMLIDGQ------EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +G G FG V+       Q      +I V++++K      +   NE  ++  L H N+++ 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
               ++    M++ EY P  +LA++I       LLD          I   L ++H     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDTILHFFVQILLALHHVHTKL-- 121

Query: 554 RIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
            I+HRDLK  N+LLD ++M  KI DFG+++      +++    VVGT  Y+ PE      
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKP 177

Query: 613 FSVKSDVFSFGVLVLEL 629
           ++ KSD+++ G ++ EL
Sbjct: 178 YNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 13/202 (6%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           DNF    K+GEG  G V        G+++AVK++     Q  E   NEV+++   QH N+
Sbjct: 22  DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V++    +  DE  ++ E+L   +L D I   TR   ++  +   +   + + L +LH  
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIATVCLAVLKALSFLHAQ 134

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
               +IHRD+K+ ++LL ++   K+SDFG       +     +  +VGT  +M PE    
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISR 189

Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +  + D++S G++V+E+V G
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 22/211 (10%)

Query: 432 DNFSEENKLGEGGFGPVYKGM---LIDGQ---EIAVKRL-SKSSGQGVEEFKNEVLLIAK 484
           +N S    LG G FG V +     L       ++AVK L   +     E   +E+ +++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 485 L-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG 543
           L  H N+V LLG C      ++I EY     L +F+    R   L           +A+G
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +L   +    IHRDL A NVLL +    KI DFG+AR    D     +N VV     +
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMND-----SNYVVKGNARL 205

Query: 604 P-----PEYAIDGLFSVKSDVFSFGVLVLEL 629
           P     PE   + +++ +SDV+S+G+L+ E+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 67/248 (27%), Positives = 101/248 (40%), Gaps = 51/248 (20%)

Query: 433 NFSEENKLGEGGFGPVY------------KGMLIDGQE-----IAVKRLSKSSGQGV-EE 474
           NF E  KLGEG FG V+            K    +        +AVK L   +     E+
Sbjct: 8   NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65

Query: 475 FKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC 534
           F  EV ++++L   N+ +LLG C       +I EY+ N  L  F+    +         C
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL---QKHVAETSGLAC 122

Query: 535 Q-----------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 583
                       +   IA G+ YL     L  +HRDL   N L+      KI+DFGM+R 
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR- 178

Query: 584 FGVDQTEANTN-------RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNR 636
                    ++       R      +M  E  + G F+ KSDV++FGV + E++   R +
Sbjct: 179 ------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232

Query: 637 GFHHVDHH 644
            + H+   
Sbjct: 233 PYEHLTDQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 78/296 (26%), Positives = 120/296 (40%), Gaps = 36/296 (12%)

Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGFG V    +   G+  A K+L K      +G +   NE  ++ K+  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFD-GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
               +D+  L+   +    L   I++ G        ++       I  GL +LHQ    R
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEP--GFPEARAIFYAAQIICGLEHLHQ---RR 115

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           I++RDLK  NVLLD+  N +ISD G+A      +         GT GYM PE     ++ 
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYD 172

Query: 615 VKSDVFSFGVLVLELVYGTRNRG-FHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYS 673
              D F+ G  + E++ G   R  F        +     +  T +  VE  DK   +   
Sbjct: 173 FSVDWFALGCTLYEMIAG---RSPFR--QRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227

Query: 674 LSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPESE 729
           L EAL         +Q+ PE R        +     S  + ++   F + N    E
Sbjct: 228 LCEAL---------LQKDPEKR--------LGCRGGSADEVREHPLFKDLNWRRLE 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 31/213 (14%)

Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSG-QGVEEFK-NEVLLIAKLQ---H 487
           + E  ++GEG +G VYK   L  G+ +A+K++      +G+      E+ L+ +L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 488 RNLVKLLGCCM-KRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
            N+V+LL  C   R +R     L++E++ ++ LA ++     +  L       ++  + R
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ +LH     RI+HRDLK  N+L+ ++   KI+DFG+AR +  +   A T+ VV T  Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVV-TLWY 172

Query: 603 MPPE------YAIDGLFSVKSDVFSFGVLVLEL 629
             PE      YA      V  D++S G +  EL
Sbjct: 173 RAPEVLLQSSYA----TPV--DMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 69/208 (33%), Positives = 108/208 (51%), Gaps = 30/208 (14%)

Query: 440 LGEGGFGPVYKGMLID------GQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           LGEG FG V +    D      G+++AVK L  +S G  + + K E+ ++  L H N+VK
Sbjct: 12  LGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 493 LLGCCMKRDER--MLIYEYLPNKSLADFIFDGTR----RKLLDWSKRCQIIGGIARGLLY 546
             G C +       LI E+LP+ SL +++         ++ L ++ +      I +G+ Y
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ------ICKGMDY 124

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ----TEANTNRVVGTYGY 602
           L   SR + +HRDL A NVL+++E   KI DFG+ +A   D+     + + +  V  Y  
Sbjct: 125 L--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA- 180

Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV 630
             PE  I   F + SDV+SFGV + EL+
Sbjct: 181 --PECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.8 bits (212), Expect = 4e-18
 Identities = 67/214 (31%), Positives = 112/214 (52%), Gaps = 28/214 (13%)

Query: 440 LGEGGFGPVYK----GMLIDGQE----IAVKRLS-KSSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V +    G+     +    +AVK L   ++ + + +  +E+ L+  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLLDWSKRCQI 536
           ++ LLG C +     +I EY    +L +F+           FD T+   + L +      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVDQTEANTNR 595
              +ARG+ YL  +SR R IHRDL A NVL+  +   KI+DFG+AR    +D  +  +N 
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +    +M PE   D +++ +SDV+SFG+L+ E+
Sbjct: 197 RLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRL-----SKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG+G FG VY    +D G+E+A K++     S  + + V   + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 494 LGCCMKRDERML--IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            GC   R E+ L    EY+P  S+ D +        L  S   +    I  G+ YLH + 
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN- 125

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVDQTEANTNRVVGTYGYMPPEYAID 610
              I+HRD+K +N+L D+  N K+ DFG ++    +  +      V GT  +M PE    
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 611 GLFSVKSDVFSFGVLVLELV 630
             +  K+DV+S G  V+E++
Sbjct: 184 EGYGRKADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 85.8 bits (212), Expect = 4e-18
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)

Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAKLQHRN 489
           F   +++G G FG VY        E+ AVK++S S  Q  E++++   EV  + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
            ++  GC +K     L+ EY    S +D +     +K L   +   I  G  +GL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
            +   +IHRD+KA N+LL      K++DFG A         +  N  VGT  +M PE  +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVIL 190

Query: 610 ---DGLFSVKSDVFSFGVLVLEL 629
              +G +  K DV+S G+  +EL
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 84.7 bits (210), Expect = 7e-18
 Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 34/201 (16%)

Query: 430 ATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRL---SKSSGQGVEEFKNEVLLIAKL 485
              ++    KLGEG FG VYK   I  G+ +A+K++   ++  G  +   + E+ ++ KL
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64

Query: 486 QHRNLVKLLGCCMKR-----DERMLIYEYLP--NKSLADFIFDGTRRKLLDWSKRC---Q 535
           +H N+V L+   ++R      +R  +Y   P  +  L+  + +    KL +   +C   Q
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG-LLENPSVKLTESQIKCYMLQ 123

Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF----------G 585
           ++ GI     YLH++    I+HRD+KA+N+L+DN+   KI+DFG+AR +          G
Sbjct: 124 LLEGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 586 VDQTEANTNRVVGTYGYMPPE 606
              T   TN VV T  Y PPE
Sbjct: 177 GGGTRKYTNLVV-TRWYRPPE 196

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 84.2 bits (208), Expect = 7e-18
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 52/289 (17%)

Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V +G L + G+    +A+K L S  + +   +F +E  ++ +  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF--DGTRRKLLDWSKRCQIIG---GIARGLLY 546
            L G   K    M+I E++ N +L  F+   DG    +       Q++G   GIA G+ Y
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI-------QLVGMLRGIAAGMKY 121

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-- 604
           L   S +  +HRDL A N+L+++ +  K+SDFG++R    D ++      +G  G +P  
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIR 176

Query: 605 ---PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFHHVDHHHNLLGHAWRLWTEDRP 660
              PE      F+  SDV+S+G+++ E++ YG R                 W +  +D  
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---------------WDMSNQD-- 219

Query: 661 VELIDKSLEDTYSLSEALRCI----QVGLLCVQQRPEDRPNMASVVLML 705
              +  ++E  Y L   + C     Q+ L C Q+    RP    +V  L
Sbjct: 220 ---VINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 84.0 bits (207), Expect = 8e-18
 Identities = 86/297 (28%), Positives = 139/297 (46%), Gaps = 65/297 (21%)

Query: 440 LGEGGFGPVYKGMLI-DGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKL-QHRNLVKLL 494
           +GEG FG V K  +  DG  +  A+KR+ + +S     +F  E+ ++ KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDG-------------------TRRKLLDWSKRCQ 535
           G C  R    L  EY P+ +L DF+                      + ++LL ++    
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV- 121

Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
                ARG+ YL   S+ + IHRDL A N+L+      KI+DFG++R   V         
Sbjct: 122 -----ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------Y 165

Query: 596 VVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLELVY--GTRNRGFHHVDHHHNLL 648
           V  T G +P  + AI+ L    ++  SDV+S+GVL+ E+V   GT   G    + +   L
Sbjct: 166 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-L 224

Query: 649 GHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
              +RL   ++P+   D    + Y L            C +++P +RP+ A +++ L
Sbjct: 225 PQGYRL---EKPLNCDD----EVYDLMRQ---------CWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 25/209 (11%)

Query: 439 KLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLV 491
           +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++ +    ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF-------DGTRRKLLDWSKRCQIIGGIARGL 544
           +LLG   +    ++I E +    L  ++        +   +      K  Q+ G IA G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT----Y 600
            YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R  G      
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185

Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 52/179 (29%), Positives = 90/179 (50%), Gaps = 26/179 (14%)

Query: 439 KLGEGGFGPVYKGMLID-GQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRNLVKLL- 494
           ++GEG  G V+K    + G+ +A+K+  L +  G    +   E+  +   QH  +VKLL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 495 ----GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC---QIIGGIARGLLYL 547
               G        +L+ EY+P+  L++ + D   R L +   +     ++ G+A    Y+
Sbjct: 67  VFPHGSGF-----VLVMEYMPS-DLSEVLRD-EERPLPEAQVKSYMRMLLKGVA----YM 115

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           H      I+HRDLK +N+L+  +   KI+DFG+AR F  ++    +++ V T  Y  PE
Sbjct: 116 HA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 18/205 (8%)

Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCM 498
           +G G +G VYKG  +   ++A  ++   +    EE K E+ ++ K   HRN+    G  +
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 499 KR------DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
           K+      D+  L+ E+    S+ D +   T+   L       I   I RGL +LH    
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIAYICREILRGLAHLHAH-- 140

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI--- 609
            ++IHRD+K  NVLL      K+ DFG++    +D+T    N  +GT  +M PE      
Sbjct: 141 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDE 197

Query: 610 --DGLFSVKSDVFSFGVLVLELVYG 632
             D  +  +SD++S G+  +E+  G
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 59/193 (30%), Positives = 95/193 (49%), Gaps = 17/193 (8%)

Query: 440 LGEGGFGPVYKGMLID--GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +G+G FG V   ML D  G ++AVK +   +    + F  E  ++ +L+H NLV+LLG  
Sbjct: 14  IGKGEFGDV---MLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 498 MKRDERMLIY-EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
           ++    + I  EY+   SL D++     R +L      +    +   + YL  ++    +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124

Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL A NVL+  +   K+SDFG+ +     Q             +  PE   +  FS K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTK 179

Query: 617 SDVFSFGVLVLEL 629
           SDV+SFG+L+ E+
Sbjct: 180 SDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 14/203 (6%)

Query: 439 KLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +LG G FG V KG   M     ++A+K L   + + V +E   E  ++ +L +  +V+++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G C + +  ML+ E      L  F+    ++  +  S   +++  ++ G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY--GYMPPEYAIDGL 612
            +HRDL A NVLL N+   KISDFG+++A G D +     R  G +   +  PE      
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174

Query: 613 FSVKSDVFSFGVLVLE-LVYGTR 634
           FS +SDV+S+G+ + E   YG +
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 12/200 (6%)

Query: 439 KLGEGGFGPVYKGMLIDGQEI-AVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVKLLG 495
           K+GEG +G V+K    +  EI A+KR+      +GV      E+ L+ +L+H+N+V+L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
                 +  L++EY  ++ L  + FD     + D       +  + +GL + H      +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFS 614
           +HRDLK  N+L++     K++DFG+ARAFG+      +  VV T  Y PP+      L+S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 178

Query: 615 VKSDVFSFGVLVLELVYGTR 634
              D++S G +  EL    R
Sbjct: 179 TSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.7 bits (207), Expect = 3e-17
 Identities = 72/224 (32%), Positives = 109/224 (48%), Gaps = 36/224 (16%)

Query: 426 SIANATDNFSE---ENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVE-EFKNEVL 480
           S  +A  + SE    N++G G  G VYK +    G+  A+K +  +    V  +   E+ 
Sbjct: 65  SAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE 124

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTR----RKLLDWSKRCQI 536
           ++  + H N+VK         E  ++ E++   SL     +GT     + L D ++  QI
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVAR--QI 177

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
           + GIA    YLH   R  I+HRD+K SN+L+++  N KI+DFG++R   + QT    N  
Sbjct: 178 LSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSS 228

Query: 597 VGTYGYMPPEY--------AIDGLFSVKSDVFSFGVLVLELVYG 632
           VGT  YM PE         A DG      D++S GV +LE   G
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLG 269

Length = 353

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 81.5 bits (201), Expect = 4e-17
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 18/205 (8%)

Query: 433 NFSEENKLGEGGFGPVY--KGMLIDGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHR 488
            +    K+GEG FG +Y  K    D +   +K   L+K   +  E  K EV+L+AK++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLL 545
           N+V       +     ++ EY     L   I    R++ + +S+  QI+     I+ GL 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRI---NRQRGVLFSED-QILSWFVQISLGLK 115

Query: 546 YLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           ++H     +I+HRD+K+ N+ L  N M  K+ DFG+AR        A T   VGT  Y+ 
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLS 170

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLEL 629
           PE   +  ++ K+D++S G ++ EL
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 13/207 (6%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 487
           N  D +    +LG+G FG VYK      G   A K +   S + +E+F  E+ ++++ +H
Sbjct: 2   NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V L       ++  ++ E+    +L D I     R L +   R  +   +   L +L
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIR-YVCRQMLEALNFL 119

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H     ++IHRDLKA N+LL  + + K++DFG++ A     T    +  +GT  +M PE 
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKS-TLQKRDTFIGTPYWMAPEV 174

Query: 608 AI-----DGLFSVKSDVFSFGVLVLEL 629
                  D  +  K+D++S G+ ++EL
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 81.5 bits (201), Expect = 8e-17
 Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 43/229 (18%)

Query: 439 KLGEGGFGPVYKGMLIDGQE-----------------IAVKRL-SKSSGQGVEEFKNEVL 480
           KLGEG FG V+   +++ Q+                 +AVK L   ++     +F  EV 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD----------- 529
           ++++L+  N+++LLG C+  D   +I EY+ N  L  F+   +   L D           
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128

Query: 530 --------WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
                   +S    +   IA G+ YL   S L  +HRDL   N L+   +  KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
           R            R V    +M  E  + G F+  SDV++FGV + E++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 27/202 (13%)

Query: 443 GGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVKLLGCC 497
           G FG VY       G   A+K L KS      +  N      +++ + +   + KL    
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKL----LDWSKRCQIIGGIARGLLYLHQDSRL 553
             +D   L+ EYL     A  I     + L     DW+   Q I  +  G+  LHQ    
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWA--KQYIAEVVLGVEDLHQRG-- 117

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            IIHRD+K  N+L+D   + K++DFG++R    ++      + VGT  Y+ PE  I G+ 
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGVG 169

Query: 614 SVK-SDVFSFGVLVLELVYGTR 634
             K SD +S G ++ E ++G  
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 12/205 (5%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 487
           N  ++F    ++G G +G VYK   ++ G+  A+K +    G+     + E++++   +H
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V   G  ++RD+  +  E+    SL D I+  T    L  S+   +     +GL YL
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVT--GPLSESQIAYVSRETLQGLYYL 122

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H   +   +HRD+K +N+LL +  + K++DFG++    +  T A     +GT  +M PE 
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTPYWMAPEV 177

Query: 608 AI---DGLFSVKSDVFSFGVLVLEL 629
           A     G ++   D+++ G+  +EL
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 62/216 (28%), Positives = 111/216 (51%), Gaps = 29/216 (13%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFK----NEVLLIAKLQ 486
           D F    ++GEG +G VYK      G+ +A+K++   + +  E F      E+ ++ +L 
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64

Query: 487 HRNLVKLLGCCMKRDERM----------LIYEYLPNKSLADFIFDGTRRKLLDWSKR--C 534
           HRN+V L      + + +          L++EY+ +  L   +  G    L+ +S+    
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESG----LVHFSEDHIK 119

Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
             +  +  GL Y H+ + L   HRD+K SN+LL+N+   K++DFG+AR +  +++   TN
Sbjct: 120 SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176

Query: 595 RVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEL 629
           +V+ T  Y PPE  + +  +    DV+S G ++ EL
Sbjct: 177 KVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 29/207 (14%)

Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRL-----SKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG+G FG VY     D G+E+AVK++     S  + + V   + E+ L+  L H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 494 LGCCMKRDERML--IYEYLPNKSLAD-------FIFDGTRRKLLDWSKRCQIIGGIARGL 544
            GC     ER L    E++P  S+ D          + TR+    ++++      I  G+
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK----YTRQ------ILEGV 119

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVDQTEANTNRVVGTYGYM 603
            YLH +    I+HRD+K +N+L D+  N K+ DFG ++    +  +      V GT  +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE      +  K+D++S G  V+E++
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 25/209 (11%)

Query: 439 KLGEGGFGPVYKGM---LIDGQ---EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           +LG+G FG VY+G    +I G+    +AVK +++S S +   EF NE  ++      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF-------DGTRRKLLDWSKRCQIIGGIARGL 544
           +LLG   K    +++ E + +  L  ++        +   R      +  Q+   IA G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT----Y 600
            YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R  G      
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185

Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +M PE   DG+F+  SD++SFGV++ E+
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 51/274 (18%)

Query: 440 LGEGGFGPVYKGMLIDGQEI---AVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           LGEG FG V +G L     I   AVK  +++  +   +E+F +E + + +  H N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 495 GCCMKRDER------MLIYEYLPNKSLADFIFD---GTRRKLLDWSKRCQIIGGIARGLL 545
           G C++  E       ++I  ++ +  L  F+     G   + L      + +  IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGVDQTEANTNRVVGTYGYMP 604
           YL   S    IHRDL A N +L+  MN  ++DFG+++  +  D          G    MP
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ------GRIAKMP 177

Query: 605 PEY-AIDGL----FSVKSDVFSFGVLVLELVY-------GTRNRGFHH------------ 640
            ++ AI+ L    ++ KSDV+SFGV + E+         G  N   +             
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237

Query: 641 --VDHHHNLLGHAWRLWTEDRP-VELIDKSLEDT 671
             +D  ++L+   W L  +DRP  E +   LE  
Sbjct: 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 19/209 (9%)

Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRL-----SKSSGQGVEEFKNEVLLIAKLQ 486
           N+     LG G FG VY     D G+E+AVK++     S+ + + V   + E+ L+  L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 487 HRNLVKLLGCCMKRDERML--IYEYLPNKSLADFI--FDGTRRKLLDWSKRCQIIGGIAR 542
           H  +V+  GC    +E+ L    EY+P  S+ D +  +      +     R QI+ G++ 
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QILQGVS- 120

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA-RAFGVDQTEANTNRVVGTYG 601
              YLH +    I+HRD+K +N+L D+  N K+ DFG + R   +  +      V GT  
Sbjct: 121 ---YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
           +M PE      +  K+DV+S    V+E++
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 23/203 (11%)

Query: 440 LGEGGFGPVYKGML-IDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG GGFG V    +    +  A+K + K         E   +E  ++ +  H  +VKL  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 496 CCMK--RDER---MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
              +  +D++   ML+ EY     L   + D   R L D       I  +     YLH  
Sbjct: 59  --YRTFKDKKYIYMLM-EYCLGGELWTILRD---RGLFDEYTARFYIACVVLAFEYLH-- 110

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
               II+RDLK  N+LLD+    K+ DFG A+     Q    T    GT  Y+ PE  ++
Sbjct: 111 -NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILN 166

Query: 611 GLFSVKSDVFSFGVLVLELVYGT 633
             +    D +S G+L+ EL+ G 
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 10/195 (5%)

Query: 439 KLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           K+GEG  G V        G+++AVK +     Q  E   NEV+++   QH+N+V++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
           +  +E  ++ E+L   +L D I   TR   L+  +   +   + + L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALTD-IVSQTR---LNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K+ ++LL  +   K+SDFG       D  +  +  +VGT  +M PE      +  + 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198

Query: 618 DVFSFGVLVLELVYG 632
           D++S G++V+E+V G
Sbjct: 199 DIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 82/275 (29%), Positives = 124/275 (45%), Gaps = 33/275 (12%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFK-NEVL-------LIAKLQHR 488
           + +LG+G FG VY  ++ D + +A +RL       V E   NE +       L++KL H 
Sbjct: 5   QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR-KLLDWSKRCQIIGGIARGLLYL 547
            +VK     ++RD   +I EY   + L   + +     K L  ++ C+    +  G+ Y+
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           HQ    RI+HRDLKA N+ L N +  KI DFG++R        A T    GT  YM PE 
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEA 176

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
                +  KSD++S G ++ E+          H     N L    R+     P      S
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCC------LAHAFEGQNFLSVVLRIVEGPTP------S 224

Query: 668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV 702
           L +TY  S  L  I   +L   + P  RP+ A ++
Sbjct: 225 LPETY--SRQLNSIMQSML--NKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 29/224 (12%)

Query: 432 DNFSEENKLGEGGFGPVY----KGML--------IDGQE-----IAVKRLSKSSGQGVE- 473
              + + KLGEG FG V+    +GM         +D        +AVK L + + +    
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI--------FDGTRR 525
           +F  E+ ++++L+  N+++LL  C+  D   +I EY+ N  L  F+         +    
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 526 KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 585
             + +S    +   IA G+ YL   S L  +HRDL   N L+      KI+DFGM+R   
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                    R V    +M  E  + G F+  SDV++FGV + E+
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 83/310 (26%), Positives = 140/310 (45%), Gaps = 66/310 (21%)

Query: 427 IANATDNFSEENKLGEGGFGPVYKGMLIDG-----QEIAVKRLSKSSGQ-GVEEFKNEVL 480
           IA + D  +  + L EG FG ++ G+LID      +E+ VK +   + +  V     E  
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 481 LIAKLQHRNLVKLLGCCMKRDER-MLIYEYLPNKSLADFIFDG-----------TRRKLL 528
           L+  L H+N++ +L  C++  E   ++Y Y+   +L  F+              + ++L+
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVD 587
             + +      IA G+ YLH   +  +IH+D+ A N ++D E+  KI+D  ++R  F +D
Sbjct: 121 HMAIQ------IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Query: 588 Q--TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHH 645
                 N NR V    +M  E  ++  +S  SDV+SFGVL+ EL+               
Sbjct: 172 YHCLGDNENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELM--------------- 213

Query: 646 NLLGHAWRLWTEDRPVELID-----KSLEDTYSLSEALRC----IQVGLLCVQQRPEDRP 696
             LG          P   ID       L+D Y L++ + C      V   C    PE+RP
Sbjct: 214 -TLGQT--------PYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERP 264

Query: 697 NMASVVLMLS 706
           + + +V  L+
Sbjct: 265 SFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 63/196 (32%), Positives = 92/196 (46%), Gaps = 10/196 (5%)

Query: 440 LGEGGFGPVYK-GMLIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGFG V    M   G+  A K+L+K      +G E    E  ++AK+  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFD-GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
               + +  L+   +    L   I++           + C     I  GL +LHQ    R
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           II+RDLK  NVLLDN+ N +ISD G+A      Q++  T    GT G+M PE      + 
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYD 175

Query: 615 VKSDVFSFGVLVLELV 630
              D F+ GV + E++
Sbjct: 176 FSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 13/202 (6%)

Query: 432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           DNF    K+GEG  G V    +   G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V++    +  DE  ++ E+L   +L D I   TR      +  C     + + L  LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCL---AVLKALSVLHAQ 135

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
               +IHRD+K+ ++LL ++   K+SDFG      V +       +VGT  +M PE    
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISR 190

Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +  + D++S G++V+E+V G
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 79.3 bits (195), Expect = 4e-16
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)

Query: 439 KLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           K+GEG  G V        G+++AVK++     Q  E   NEV+++    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
           +  DE  ++ E+L   +L D I   TR   ++  +   +   + R L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K+ ++LL ++   K+SDFG      V +       +VGT  +M PE      +  + 
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 618 DVFSFGVLVLELVYG 632
           D++S G++V+E++ G
Sbjct: 200 DIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 13/195 (6%)

Query: 439 KLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVKLLGC 496
           ++G G FG V+ G L  D   +AVK   ++    ++ +F  E  ++ +  H N+V+L+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 497 CMKRDERMLIYEYLPNKSLADFI-FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
           C ++    ++ E +       F+  +G R K+    +  Q++   A G+ YL        
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV---KELIQMVENAAAGMEYLESKH---C 115

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMAR--AFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
           IHRDL A N L+  +   KISDFGM+R    GV  +     ++     +  PE    G +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRY 173

Query: 614 SVKSDVFSFGVLVLE 628
           S +SDV+SFG+L+ E
Sbjct: 174 SSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 30/207 (14%)

Query: 443 GGFGPVY---KGMLIDGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVKLLGC 496
           G +G V+   K     G   A+K + K+       V++   E  ++++ Q   +VKL   
Sbjct: 4   GAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61

Query: 497 CMKRDERMLIYEYLPNKSLADFI-----FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
              +    L+ EYLP   LA  +      D       D ++    I  I   L YLH   
Sbjct: 62  FQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS-- 111

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFG------MARAFGVDQTEANTNRVVGTYGYMPP 605
              IIHRDLK  N+L+D+  + K++DFG      + R   ++  E    R+VGT  Y+ P
Sbjct: 112 -NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E  +    S   D +S G ++ E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 7e-16
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 39/198 (19%)

Query: 434 FSEENKLGEGGFGPVYKGMLI---DGQEIAVKRL--SKSSGQGVEEFK-NEVLLIAKLQH 487
           +  E  +G G +G VYK       DG+E A+K+    K    G+ +    E+ L+ +L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 488 RNLVKLLGCCMKRDERM--LIYEYLPNKSLADF----IFDGTRRKLLDWSKRCQIIGGIA 541
            N+V L+   ++  ++   L+++Y      A+     I    R+     +KR  I   + 
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQ-----AKRVSIPPSMV 110

Query: 542 R--------GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVD-Q 588
           +        G+ YLH +    ++HRDLK +N+L+  E       KI D G+AR F    +
Sbjct: 111 KSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 589 TEANTNRVVGTYGYMPPE 606
             A+ + VV T  Y  PE
Sbjct: 168 PLADLDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 78.9 bits (194), Expect = 7e-16
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)

Query: 438 NKLGEGGFGPVYKGM------LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +KLGEG +  VYKG       L+  +EI   RL    G      + EV L+  L+H N+V
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            L           L++EYL +K L  ++ D      ++       +  + RGL Y H   
Sbjct: 68  TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH--- 121

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
           R +++HRDLK  N+L++     K++DFG+ARA  +  T+  +N VV T  Y PP+  +  
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGS 179

Query: 612 L-FSVKSDVFSFGVLVLELVYG 632
             +S + D++  G +  E+  G
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.5 bits (193), Expect = 8e-16
 Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 13/197 (6%)

Query: 439 KLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +LG+G FG VYK    + G   A K +   S + +E++  E+ ++A   H  +VKLLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
               +  ++ E+ P  ++ D I     R L +   +  I   +   L YLH    ++IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133

Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-----DGL 612
           RDLKA NVLL  + + K++DFG++ A  V +T    +  +GT  +M PE  +     D  
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS-AKNV-KTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 613 FSVKSDVFSFGVLVLEL 629
           +  K+D++S G+ ++E+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.9 bits (192), Expect = 9e-16
 Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 42/285 (14%)

Query: 440 LGEGGFGPVYK-------GMLIDGQEIAVKRLS-----KSSGQGVEEFKNEVLLIAK-LQ 486
           LG G FG VYK         L+  +EI V   +     +   + + +  +EV +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC-QIIGGIARGLL 545
           H N+V+     ++ D   ++ + +    L +       +K     +R   I   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           YLH++ R  I+HRDL  +N++L  +    I+DFG+A+     Q E+    VVGT  Y  P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGTILYSCP 182

Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID 665
           E   +  +  K+DV++FG ++ ++   T    F+      N+L  A ++      VE + 
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMC--TLQPPFYST----NMLSLATKI------VEAVY 230

Query: 666 KSL-EDTYSLSEALRCIQVGLL---CVQQRPEDRPNMASVVLMLS 706
           + L E  YS         V  +   C+    E RP++  V  M+S
Sbjct: 231 EPLPEGMYS-------EDVTDVITSCLTPDAEARPDIIQVSAMIS 268

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.0 bits (193), Expect = 9e-16
 Identities = 51/148 (34%), Positives = 75/148 (50%), Gaps = 10/148 (6%)

Query: 439 KLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEEFKN--EVLLIAKLQ-HRNLVKLL 494
           +LG+G FG VY     +  E+ A+K++ K      EE  N  EV  + KL  H N+VKL 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
               + DE   ++EY+   +L   + D  + K    S    II  I +GL ++H   +  
Sbjct: 65  EVFRENDELYFVFEYM-EGNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHIH---KHG 119

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMAR 582
             HRDLK  N+L+      KI+DFG+AR
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 12/205 (5%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 487
           N   ++    ++G G +G VYK   +  G+  AVK +    G      + E+ ++ + +H
Sbjct: 6   NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V   G  + R++  +  EY    SL D          L  +  C+      +GL YL
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR---ETLQGLAYL 122

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H   ++   HRD+K +N+LL +  + K++DFG+A    +  T A     +GT  +M PE 
Sbjct: 123 HSKGKM---HRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMAPEV 177

Query: 608 AI---DGLFSVKSDVFSFGVLVLEL 629
           A    +G ++   D+++ G+  +EL
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 80.7 bits (199), Expect = 1e-15
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 23/221 (10%)

Query: 418 ELPIFDWKSIANATDN-----FSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQG 471
           EL  FD K   + T N       EEN +  G  G  YKG  I +G +  VK ++  +   
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP 730

Query: 472 VEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWS 531
             E  +    + KLQH N+VKL+G C       LI+EY+  K+L++ + +      L W 
Sbjct: 731 SSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWE 780

Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
           +R +I  GIA+ L +LH      ++  +L    +++D +  P +    +      D    
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCF 839

Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            ++       Y+ PE       + KSD++ FG++++EL+ G
Sbjct: 840 ISS------AYVAPETRETKDITEKSDIYGFGLILIELLTG 874

Length = 968

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 24/208 (11%)

Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRL---SKSSGQGVEEFKNEVLLIAKLQHR 488
            F + N++GEG +G VY+       EI A+K++   ++  G  +   + E+ L+  L+H 
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66

Query: 489 NLVKLLGCCMKR--DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           N+V+L    + +  D   L+ EY   + LA  + D       +   +C ++  + RGL Y
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYC-EQDLASLL-DNMPTPFSESQVKC-LMLQLLRGLQY 123

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH++    IIHRDLK SN+LL ++   KI+DFG+AR +G+      T +VV T  Y  PE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKVV-TLWYRAPE 178

Query: 607 YAIDGLFSVKS-----DVFSFGVLVLEL 629
                L    +     D+++ G ++ EL
Sbjct: 179 L----LLGCTTYTTAIDMWAVGCILAEL 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 55/184 (29%), Positives = 98/184 (53%), Gaps = 23/184 (12%)

Query: 438 NKLGEGGFGPVYKGMLIDGQEI-AVKRL---SKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
            K+G+G FG V+K      ++I A+K++   ++  G  +   + E+ ++  L+H N+V L
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76

Query: 494 LGCCMK--------RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +  C          +    L++E+  +  LA  + +   +  L   K+  ++  +  GL 
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMKMLLNGLY 133

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN---TNRVVGTYGY 602
           Y+H   R +I+HRD+KA+N+L+  +   K++DFG+ARAF + +       TNRVV T  Y
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWY 189

Query: 603 MPPE 606
            PPE
Sbjct: 190 RPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 76.5 bits (188), Expect = 3e-15
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 37/210 (17%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKLQHRNLVKLLG 495
           KLGEG +  VYKG+  I+GQ +A+K +S  + +GV  F    E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI------------ARG 543
               ++    ++EY+ +  LA ++               Q  GG+             RG
Sbjct: 71  IIHTKETLTFVFEYM-HTDLAQYM--------------IQHPGGLHPYNVRLFMFQLLRG 115

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L Y+H      I+HRDLK  N+L+      K++DFG+ARA  +  ++  ++ VV T  Y 
Sbjct: 116 LAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYR 170

Query: 604 PPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           PP+  +    +S   D++  G + +E++ G
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 19/202 (9%)

Query: 438 NKLGEGGFGPVYKGM------LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
            KLGEG +  V+KG       L+  +EI   RL    G      + EV L+  L+H N+V
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            L           L++EYL +K L  ++ D     ++        +  I RGL Y H   
Sbjct: 68  TLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCH--- 121

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-D 610
           R +++HRDLK  N+L++     K++DFG+ARA  V  T+  +N VV T  Y PP+  +  
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGS 179

Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +S + D++  G +  E+  G
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 26/209 (12%)

Query: 439 KLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK----LQHRNLV 491
           +LG G FG V KG   M    + +AVK L   +       K+E+L  A     L +  +V
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +++G C + +  ML+ E      L  F+    + K +      +++  ++ G+ YL + +
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE-YAID 610
               +HRDL A NVLL  +   KISDFG+++A G D+          T+G  P + YA +
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPE 168

Query: 611 GL----FSVKSDVFSFGVLVLE-LVYGTR 634
            +    FS KSDV+SFGVL+ E   YG +
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 76.1 bits (188), Expect = 5e-15
 Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 36/215 (16%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRL---SKSSG---QGVEEFKNEVLLIAK 484
           D + + N++ EG +G VY+       EI A+K+L    +  G     + E    +LL  K
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI--NILL--K 60

Query: 485 LQHRNLVKL----LGCCMKRDERMLIYEYLPN--KSLADFI---FDGTRRKLLDWSKRCQ 535
           LQH N+V +    +G  +  D+  ++ EY+ +  KSL + +   F  +  K L      Q
Sbjct: 61  LQHPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL----MLQ 114

Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
           ++ G+A    +LH +    I+HRDLK SN+LL+N    KI DFG+AR +G    +  T  
Sbjct: 115 LLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQL 166

Query: 596 VVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEL 629
           VV T  Y  PE  +    +S   D++S G +  EL
Sbjct: 167 VV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 19/221 (8%)

Query: 425 KSIANATDNFSEENKLGEGGFGPVYK-GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIA 483
           +S+ + TD +     +G+G +G VYK     DG   AVK L   S    EE + E  ++ 
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQ 73

Query: 484 KL-QHRNLVKLLGCCMKRDERM-----LIYEYLPNKSLADFIFDGTRR-KLLDWSKRCQI 536
            L  H N+VK  G   K D+ +     L+ E     S+ + +       + LD +    I
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
           + G   GL +LH +   RIIHRD+K +N+LL  E   K+ DFG++      +   NT+  
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-- 188

Query: 597 VGTYGYMPPEY-----AIDGLFSVKSDVFSFGVLVLELVYG 632
           VGT  +M PE        D  +  + DV+S G+  +EL  G
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 76.2 bits (187), Expect = 5e-15
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 32/216 (14%)

Query: 440 LGEGGFGPVY--KGMLIDGQE------IAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V   + + +D ++      +AVK L S ++ + + +  +E+ ++  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR---------------KLLDWSKRC 534
           ++ LLG C +     +I EY    +L +++    RR               + L +    
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVDQTEANT 593
                +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D  +  T
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           N  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 201 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)

Query: 432 DNFSEENKLGEGGFGPVY--KGMLIDGQE------IAVKRLS-KSSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V   + + ID  +      +AVK L   ++ + + +  +E+ ++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 192 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 46/225 (20%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID--GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQH- 487
           ++  +  ++G G FG V K ML    G  +AVKR+ S    +  +    ++ ++ +    
Sbjct: 4   EDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62

Query: 488 RNLVKLLG-------C--CMKRDERMLIYEYLPNKSLADF---IFDGTRRKLLDWSKRCQ 535
             +VK  G       C  CM   E M I       SL  F   +++  +  + +     +
Sbjct: 63  PYIVKFYGALFREGDCWICM---ELMDI-------SLDKFYKYVYEVLKSVIPE-----E 107

Query: 536 IIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
           I+G IA    + L YL ++  L+IIHRD+K SN+LLD   N K+ DFG++    VD   A
Sbjct: 108 ILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSI-A 163

Query: 592 NTNRVVGTYGYMPPE----YAIDGLFSVKSDVFSFGVLVLELVYG 632
            T R  G   YM PE     A DG + V+SDV+S G+ + E+  G
Sbjct: 164 KT-RDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 75.2 bits (185), Expect = 8e-15
 Identities = 43/117 (36%), Positives = 66/117 (56%), Gaps = 12/117 (10%)

Query: 520 FDGTRRKLLDWSKRCQIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 575
            D   +K        +I+G IA     GL YL+  +  RI+HRD+K SN+L+++    K+
Sbjct: 90  LDRIYKKG--GPIPVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKL 145

Query: 576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            DFG++    +  + A+T   VGT  YM PE    G ++VKSDV+S G+ ++EL  G
Sbjct: 146 CDFGVSGE--LINSIADT--FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 13/205 (6%)

Query: 432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHR 488
           D++ +  KLGEG +  VYKG   ++G+ +A+K  RL +  G      + E  L+  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+V L      ++   L++EY+ +  L  ++         +  K    +  + RGL Y+H
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVK--LFLFQLLRGLSYIH 120

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           Q     I+HRDLK  N+L+ +    K++DFG+ARA  V  +   +N VV T  Y PP+  
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPDVL 175

Query: 609 IDGL-FSVKSDVFSFGVLVLELVYG 632
           +    +S   D++  G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 44/284 (15%)

Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           E  LG G FG + +G L +  +    +A+  L    S +    F  E L + +  H N+V
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK--LLDWSKRCQIIGGIARGLLYLHQ 549
           +L G   + +  M++ EY+ N +L  F+    R+    L   +   ++ G+A G+ YL  
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYL-- 123

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA--NTNRVVGTYGYMPPEY 607
            S +  +H+ L A  VL+++++  KIS F   +    D++EA   T        +  PE 
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEA 179

Query: 608 AIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK 666
                FS  SDV+SFG+++ E++ YG R                 W +  +D     + K
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPY---------------WDMSGQD-----VIK 219

Query: 667 SLEDTYSLSEALRCI----QVGLLCVQQRPEDRPNMASVVLMLS 706
           ++ED + L     C     Q+ L C Q+   +RP  + +  +LS
Sbjct: 220 AVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 74.6 bits (183), Expect = 9e-15
 Identities = 62/196 (31%), Positives = 96/196 (48%), Gaps = 16/196 (8%)

Query: 440 LGEGGFGPVYKGMLI----DGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +GEG FG   + +L+      Q+ A+K  RL KSS   VE+ + E +L+AK++H N+V  
Sbjct: 8   VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAF 63

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
                      ++ EY     L   I    R KL       Q    +  G+ ++H+    
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEK--- 119

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
           R++HRD+K+ N+ L      K+ DFG AR        A T   VGT  Y+PPE   +  +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPY 177

Query: 614 SVKSDVFSFGVLVLEL 629
           + KSD++S G ++ EL
Sbjct: 178 NNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 28/214 (13%)

Query: 440 LGEGGFGPVY--KGMLIDGQE------IAVKRLSK-SSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V   + + ID  +      +AVK L   ++ + + +  +E+ ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLLDWSKRCQI 536
           ++ LLG C +     ++ EY    +L +++           FD  +   + L +      
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANTNR 595
              +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D  +  TN 
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 197 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 15/201 (7%)

Query: 439 KLGEGGFGPVYKGMLIDGQ----EIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKL 493
            +GEG FG VY+G+ +  +     +AVK     +   V E+F  E  ++ +  H ++VKL
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 494 LGCCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
           +G     +  + ++ E  P   L  ++     +  LD +        ++  L YL     
Sbjct: 73  IGVI--TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES--- 125

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
            R +HRD+ A NVL+ +    K+ DFG++R    D++    ++      +M PE      
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRR 184

Query: 613 FSVKSDVFSFGVLVLE-LVYG 632
           F+  SDV+ FGV + E L+ G
Sbjct: 185 FTSASDVWMFGVCMWEILMLG 205

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 17/200 (8%)

Query: 440 LGEGGFGPV------YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG+GGFG V        G +   +++  KRL K SG+ +   + E+L   K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFD-GTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
                 +    L+   +    L   I++ G R   L+  +       I  G+L+LH    
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG--LEMERVIHYSAQITCGILHLHS--- 113

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
           + I++RD+K  NVLLD++ N ++SD G+  A  +   +  T R  GT GYM PE   +  
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQR-AGTNGYMAPEILKEEP 170

Query: 613 FSVKSDVFSFGVLVLELVYG 632
           +S   D F+ G  + E+V G
Sbjct: 171 YSYPVDWFAMGCSIYEMVAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 27/206 (13%)

Query: 439 KLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVKL 493
            +GEG +G V K      G+ +A+K+  +S     E+ K     EV ++ +L+H N+V L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFI------FDGTRRKLLDWSKRCQIIGGIARGLLYL 547
                ++    L++EY+  ++L + +            +   W    Q++  IA    Y 
Sbjct: 66  KEAFRRKGRLYLVFEYVE-RTLLELLEASPGGLPPDAVRSYIW----QLLQAIA----YC 116

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H      IIHRD+K  N+L+      K+ DFG ARA         T+ V  T  Y  PE 
Sbjct: 117 H---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPEL 172

Query: 608 AI-DGLFSVKSDVFSFGVLVLELVYG 632
            + D  +    DV++ G ++ EL+ G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 37/224 (16%)

Query: 438 NKLGEGGFGPVYKGM-LIDGQEIAVKRL--------SKSSGQGVEE----FK--NEVLLI 482
             LGEG +G V K    + G+ +A+K++             Q V      F    E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
            +++H N++ L+   ++ D   L+ + +    L   +    R  L +   +C I+  I  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR--LTESQVKC-ILLQILN 130

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD-------------QT 589
           GL  LH+      +HRDL  +N+ ++++   KI+DFG+AR +G               + 
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 590 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYG 632
           E  T++VV T  Y  PE  +    +    D++S G +  EL+ G
Sbjct: 188 EEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 22/208 (10%)

Query: 440 LGEGGFGPVYKGMLI----DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG+G FG V +  L       Q++AVK L     S   +EEF  E   + +  H N++KL
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 494 LGCCMKRDER------MLIYEYLPNKSLADFIFD---GTRRKLLDWSKRCQIIGGIARGL 544
           +G  ++   +      M+I  ++ +  L  F+     G     L      + +  IA G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGY 602
            YL   S    IHRDL A N +L+  M   ++DFG+++    G    +   +++     +
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVKW 181

Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV 630
           +  E   D +++  SDV++FGV + E++
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 68/229 (29%), Positives = 102/229 (44%), Gaps = 52/229 (22%)

Query: 432 DNFSEENKLGEGGFGPVYKGML--IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
           D+     +LG G +G V K M     G  +AVKR+  +             + ++ Q R 
Sbjct: 1   DDLEVIEELGRGAYGVVDK-MRHVPTGTIMAVKRIRAT-------------VNSQEQKRL 46

Query: 490 LVKL-----LGCC---------MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC- 534
           L+ L        C         + R+  + I   + + SL  F      +K+ D      
Sbjct: 47  LMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFY-----KKVYDKGLTIP 101

Query: 535 -QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
             I+G IA    + L YLH  S+L +IHRD+K SNVL++     K+ DFG++  + VD  
Sbjct: 102 EDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSV 158

Query: 590 EANTNRVVGTYGYMPPEYAIDGL-----FSVKSDVFSFGVLVLELVYGT 633
            A T    G   YM PE  I+       + VKSDV+S G+ ++EL  G 
Sbjct: 159 -AKTID-AGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 73.0 bits (179), Expect = 8e-14
 Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 21/202 (10%)

Query: 440 LGEGGFGPVYKGMLI----DGQEIAVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNL 490
           LG+G FG V   ML      G+  AVK L K        VE    E  +L +A+  H  L
Sbjct: 3   LGKGSFGKV---MLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFL 58

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
            +L  CC +  +R+       N    D +F   + +  D ++       I   L++LH  
Sbjct: 59  TQLY-CCFQTPDRLFFVMEFVNG--GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
               II+RDLK  NVLLD+E + K++DFGM +  G+      T+   GT  Y+ PE   +
Sbjct: 116 G---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GI-FNGKTTSTFCGTPDYIAPEILQE 170

Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
            L+    D ++ GVL+ E++ G
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 23/217 (10%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKR-LSKSSGQGVEEFK-NEVLLIAKLQHR 488
           D + +  K+GEG +G VYK      G+ +A+K+   +   +G+      E+ L+  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 489 N-LVKLLGCCMKRDERM------LIYEYLPNKSLADFIFDGTRRKL---LDWSKRCQIIG 538
             +V+LL      +E+       L++EYL +  L  F+ D   R     L        + 
Sbjct: 61  IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMY 117

Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRVV 597
            + +G+ + H   +  ++HRDLK  N+L+D +    KI+D G+ RAF +   ++ T+ +V
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV 173

Query: 598 GTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYGT 633
            T  Y  PE  +    +S   D++S G +  E+    
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.0 bits (176), Expect = 9e-14
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 13/197 (6%)

Query: 439 KLGEGGFGPVYKGMLIDGQEIAV-KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +LG+G FG VYK    +   +A  K +   S + +E++  E+ ++A   H N+VKLL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
              +   ++ E+    ++ D +     R L +   R  +       L YLH++   +IIH
Sbjct: 72  YYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126

Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-----DGL 612
           RDLKA N+L   + + K++DFG++      +T    +  +GT  +M PE  +     D  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 613 FSVKSDVFSFGVLVLEL 629
           +  K+DV+S G+ ++E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 72.0 bits (176), Expect = 9e-14
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)

Query: 438 NKLGEGGFGPVYKGML-IDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +KLGEG +  V+KG   +    +A+K  RL    G      + EV L+  L+H N+V L 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA-------RGLLYL 547
                     L++EYL          D   ++ LD       +  +        RGL Y 
Sbjct: 70  DIIHTERCLTLVFEYL----------DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H   + +I+HRDLK  N+L++ +   K++DFG+ARA  V  T+  +N VV T  Y PP+ 
Sbjct: 120 H---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDV 174

Query: 608 AIDGL-FSVKSDVFSFGVLVLELVYG 632
            +    +S   D++  G ++ E+  G
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 27/203 (13%)

Query: 439 KLGEGGFGPVYKGMLI----DGQEIAVKRL--SKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           K+GEG FG   K +L+    DG++  +K +  SK S +  EE + EV +++ ++H N+V+
Sbjct: 7   KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTR------RKLLDWSKRCQIIGGIARGLLY 546
                 +     ++ +Y     L   I +  R       ++LDW  +      I   L +
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQ------ICLALKH 116

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           +H     +I+HRD+K+ N+ L  +   K+ DFG+AR        A T   +GT  Y+ PE
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPE 171

Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  ++ KSD+++ G ++ E+
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 18/201 (8%)

Query: 439 KLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVKL 493
            +GEG +G V K    + GQ +A+K+  +S     +  K     E+ ++ +L+H NLV L
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65

Query: 494 LGCCMKRDERMLIYEYLPNKSLADF-IFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
           +    ++    L++E++ +  L D   +       LD S+  + +  I RG+ + H  + 
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCHSHN- 120

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-DG 611
             IIHRD+K  N+L+      K+ DFG AR       E  T+  V T  Y  PE  + D 
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELLVGDT 176

Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +    D+++ G LV E++ G
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 434 FSEENKLGEGGFGPV------YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 487
           F +   LG+GGFG V        G +   +++  KR+ K  G+ +    NE  ++ K+  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
           R +V L      +D   L+   +    L   I+        +  +       I  GL  L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDL 118

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           HQ+   RI++RDLK  N+LLD+  + +ISD G+A      QT       VGT GYM PE 
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEV 172

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYG 632
             +  ++   D ++ G L+ E++ G
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 66/203 (32%), Positives = 91/203 (44%), Gaps = 23/203 (11%)

Query: 440 LGEGGFGPV----YKGMLIDGQEIAVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNL 490
           LG+G FG V     KG     +  AVK L K        VE    E  VL +A  +H  L
Sbjct: 3   LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
            +L  C   +D    + EY+      D +F   R    D  +       I  GL +LH+ 
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNG---GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANTNRVVGTYGYMPPEYAI 609
               II+RDLK  NVLLD+E + KI+DFGM +       T   T+   GT  Y+ PE   
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILS 169

Query: 610 DGLFSVKSDVFSFGVLVLELVYG 632
              +    D ++ GVL+ E++ G
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAG 192

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 21/202 (10%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           KLGEG +  VYKG   + GQ +A+K  RL    G      + E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
               +    L++EYL +  L  ++ D      L        +  + RGL Y HQ    R+
Sbjct: 71  IIHTKKTLTLVFEYL-DTDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RV 124

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL--- 612
           +HRDLK  N+L+      K++DFG+ARA  V  ++  +N VV T  Y PP    D L   
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TLWYRPP----DVLLGS 178

Query: 613 --FSVKSDVFSFGVLVLELVYG 632
             +S   D++  G +  E+  G
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.3 bits (173), Expect = 3e-13
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 45/212 (21%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           LG G FG V         +  A+K LSK+      Q VE   NE  ++  ++H  LV L 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-GIAR--------GLL 545
           G     D+  L   YL    + +++  G   +L    ++       +AR         L 
Sbjct: 68  GSFQ--DDSNL---YL----VMEYVPGG---ELFSHLRKSGRFPEPVARFYAAQVVLALE 115

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           YLH    L I++RDLK  N+LLD++   KI+DFG A+     + +  T  + GT  Y+ P
Sbjct: 116 YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAP 167

Query: 606 EYAIDGLFSVK-----SDVFSFGVLVLELVYG 632
           E     +   K      D ++ G+L+ E++ G
Sbjct: 168 E-----IILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.0 bits (175), Expect = 4e-13
 Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 71/228 (31%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVLLIAKLQHRN 489
           +G G +G V   +    G+++A+K++S         F +         E+ L+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADF-----IFD----------GTRRKLLDWSKRC 534
           ++ LL             + L   S  DF     + +           + + L D     
Sbjct: 61  IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTD--DHI 105

Query: 535 Q-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN- 592
           Q  +  I RGL YLH      +IHRDLK SN+L+++  + KI DFG+AR    D+ E   
Sbjct: 106 QYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162

Query: 593 -TNRVVGTYGYMPPE---------YAIDGLFSVKSDVFSFGVLVLELV 630
            T  VV T  Y  PE          AI        D++S G +  EL+
Sbjct: 163 LTEYVV-TRWYRAPELLLSSSRYTKAI--------DIWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 17/209 (8%)

Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVE--EFKNEVLLIAKLQHRNLVKL 493
           LG+G FG V+   L    Q  A+K L K        VE    +  VL +A  +H  L  L
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
                 ++    + EYL      D +F        D  +       I  GL +LH     
Sbjct: 62  YCTFQTKENLFFVMEYLNG---GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG-- 116

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            I++RDLK  N+LLD + + KI+DFGM +   +   +A T    GT  Y+ PE  +   +
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPEILLGQKY 173

Query: 614 SVKSDVFSFGVLVLELVYGTRNRGFHHVD 642
           +   D +SFGVL+ E++ G     FH  D
Sbjct: 174 NTSVDWWSFGVLLYEMLIG--QSPFHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 64/200 (32%), Positives = 90/200 (45%), Gaps = 17/200 (8%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVE--EFKNEVLLIAKLQHRNLVKL 493
           LG+G FG V    L    E  A+K L K        VE    +  VL +A  +H  L  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHL 61

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLHQDSR 552
                 ++    + EYL    L   I    R        R +     I  GL +LH+   
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE----ARARFYAAEIICGLQFLHKKG- 116

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
             II+RDLK  NVLLD + + KI+DFGM +     + +A+T    GT  Y+ PE      
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQK 172

Query: 613 FSVKSDVFSFGVLVLELVYG 632
           ++   D +SFGVL+ E++ G
Sbjct: 173 YNESVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 43/214 (20%)

Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLL---IAKLQHR--NLVKL 493
           +G G  G VYK      G  +AVK++ ++   G +E    +L+   +    H    +VK 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ------IIGGIA----RG 543
            G  +   +  +  E      L     D    KLL   KR Q      I+G +     + 
Sbjct: 80  YGYFITDSDVFICME------LMSTCLD----KLL---KRIQGPIPEDILGKMTVAIVKA 126

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L YL +     +IHRD+K SN+LLD   N K+ DFG++    VD ++A T R  G   YM
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS-GRLVD-SKAKT-RSAGCAAYM 181

Query: 604 PPEYAID-----GLFSVKSDVFSFGVLVLELVYG 632
            PE  ID       + +++DV+S G+ ++EL  G
Sbjct: 182 APE-RIDPPDPNPKYDIRADVWSLGISLVELATG 214

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 31/227 (13%)

Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEV 479
           IFD  S  + +D +     +G+G +G V+K +   +G + AVK L        EE + E 
Sbjct: 9   IFD--SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEY 65

Query: 480 LLIAKLQ-HRNLVKLLGCCMKRDER-----MLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
            ++  L  H N+VK  G   K+D +      L+ E     S+ D +     +  L   +R
Sbjct: 66  NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGER 120

Query: 534 CQ--IIGGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD 587
            +  II  I      GL +LH +   + IHRD+K +N+LL  E   K+ DFG++      
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177

Query: 588 QTEANTNRVVGTYGYMPPEY-----AIDGLFSVKSDVFSFGVLVLEL 629
           +   NT+  VGT  +M PE       +D  +  + DV+S G+  +EL
Sbjct: 178 RLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 17/199 (8%)

Query: 439 KLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEEFK---NEVLLIAKLQHRNLVKLL 494
           ++G+GG+G V+     D  EI A+KR+ KS    + E +    E  ++   +   LVKLL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 495 GCCMKRDERMLIYEYLPNKSLADF-IFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
                 +   L  EY+P     DF         L +   R  +       +  LH    L
Sbjct: 68  YAFQDDEYLYLAMEYVPG---GDFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH---EL 120

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
             IHRDLK  N L+D   + K++DFG+++      T AN+  VVG+  YM PE      +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYMAPEVLRGKGY 175

Query: 614 SVKSDVFSFGVLVLELVYG 632
               D +S G ++ E + G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 40/238 (16%)

Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---EVL 480
           K+I    + +   + +G G +G V        G  +AVK+LS+   Q +   K    E+ 
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 68

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ- 535
           L+  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ 
Sbjct: 69  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 116

Query: 536 --------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD 587
                   +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR     
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----- 168

Query: 588 QTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG-TRNRGFHHVDH 643
            T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G T   G  H+D 
Sbjct: 169 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 61/188 (32%), Positives = 95/188 (50%), Gaps = 37/188 (19%)

Query: 438 NKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEEFKN---------EVLLIAKL-Q 486
            KLG+G +G V+K +    +E+ A+K++        + F+N         E++ + +L  
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65

Query: 487 HRNLVKLLGCCMKRDERMLIY---EYLPNKSLADFIFDGTRRKLL-DWSKRCQIIGGIAR 542
           H N+VKLL   +K +    IY   EY+    L   I    R  +L D  KR  I+  + +
Sbjct: 66  HPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQLLK 118

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV----VG 598
            L Y+H  S   +IHRDLK SN+LL+++   K++DFG+AR+   +  E   N V    V 
Sbjct: 119 ALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENPVLTDYVA 174

Query: 599 TYGYMPPE 606
           T  Y  PE
Sbjct: 175 TRWYRAPE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 24/204 (11%)

Query: 439 KLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-------EVLLIAKLQHRNL 490
           K+GEG +G V+K    + GQ +A+K+  +S     E+          E+ ++ +L+H NL
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62

Query: 491 VKLLGCCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           V L+    +R  ++ L++EY  +  L +   +   R + +   + +II    + + + H+
Sbjct: 63  VNLIEV-FRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCHK 118

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
                 IHRD+K  N+L+  +   K+ DFG AR   +     +    V T  Y  PE  +
Sbjct: 119 ---HNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLV 173

Query: 610 -DGLFSVKSDVFSFGVLVLELVYG 632
            D  +    DV++ G +  EL+ G
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 24/204 (11%)

Query: 440 LGEGGFGPV----YKGMLIDGQEIAVKRLSKS---SGQGVEEFKNE--VLLIA-KLQHRN 489
           LG G FG V    YK     G+  A+K L K    +   VE    E  +   A   +H  
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           LV L  C    D    + EY     L   I       +    +       +  GL YLH+
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHI----HTDVFSEPRAVFYAACVVLGLQYLHE 119

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANTNRVVGTYGYMPPEYA 608
           +   +I++RDLK  N+LLD E   KI+DFG+ +   G       T+   GT  ++ PE  
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLAPEVL 173

Query: 609 IDGLFSVKSDVFSFGVLVLELVYG 632
            +  ++   D +  GVL+ E++ G
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 69/283 (24%), Positives = 111/283 (39%), Gaps = 29/283 (10%)

Query: 438 NKLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKL 493
           +++G G FG V  G     +    + VK L  S+       F  EV    +L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGLLYLHQDS 551
           LG C++    +L+ E+ P   L +++            K     +   +A GLL+LHQ  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGVDQTEANTNRVVGTYGYMPPEYAI- 609
               IH DL   N  L  +++ KI D+G+A   +  D         V    ++ PE    
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176

Query: 610 --DGLFSVK----SDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
               L        S+++S GV + EL            D    +L    R    ++ ++L
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVLKQVVR----EQDIKL 230

Query: 664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
               L+  YS     R  +V   C    PE RP    V  +L+
Sbjct: 231 PKPQLDLKYS----DRWYEVMQFCWLD-PETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 66.9 bits (164), Expect = 5e-12
 Identities = 52/200 (26%), Positives = 98/200 (49%), Gaps = 18/200 (9%)

Query: 438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ-HRNLVKL 493
            K+GEG F  V K      G+  A+K + K   + +E+  N  E+  + +L  H N+++L
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +     R      L++E L + +L + I    R++ L   +    +  + + L ++H++ 
Sbjct: 64  IEVLFDRKTGRLALVFE-LMDMNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-D 610
              I HRD+K  N+L+ ++   K++DFG  R  G+      T   + T  Y  PE  + D
Sbjct: 121 ---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYT-EYISTRWYRAPECLLTD 173

Query: 611 GLFSVKSDVFSFGVLVLELV 630
           G +  K D+++ G +  E++
Sbjct: 174 GYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 67.3 bits (165), Expect = 6e-12
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 42/231 (18%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQH 487
           D +   + +G G +G V        G+++A+K+LS+   Q     K    E+ L+  + H
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDH 73

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-------FDGT-------RRKLLDWSKR 533
            N++ LL              + P  SL DF          G         +KL D    
Sbjct: 74  ENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD-DHI 120

Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
             ++  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T+   
Sbjct: 121 QFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEM 172

Query: 594 NRVVGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLELVYG-TRNRGFHHVD 642
              V T  Y  PE  ++ +   ++ D++S G ++ EL+ G T   G  H+D
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 66.2 bits (161), Expect = 9e-12
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 17/200 (8%)

Query: 440 LGEGGFGPV------YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG+GGFG V        G +   +++  KR+ K  G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
                 +D   L+   +    L   I++       D  +       +  GL  L ++   
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRE--- 121

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR-VVGTYGYMPPEYAIDGL 612
           RI++RDLK  N+LLD+  + +ISD G+A    V   E  T R  VGT GYM PE   +  
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEK 177

Query: 613 FSVKSDVFSFGVLVLELVYG 632
           ++   D +  G L+ E++ G
Sbjct: 178 YTFSPDWWGLGCLIYEMIQG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 28/207 (13%)

Query: 439 KLGEGGFGPVYKGMLID--GQEIAVKRL---SKSSGQGVEEFKNEVLL--IAKLQHRNLV 491
           ++GEG +G V+K   +   G+ +A+KR+   +   G  +   +   +L  +   +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 492 KLLGCC-MKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----R 542
           +L   C + R +R     L++E++ ++ L  ++      K+ +     + I  +     R
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-----DKVPEPGVPTETIKDMMFQLLR 121

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           GL +LH     R++HRDLK  N+L+ +    K++DFG+AR +     +     VV T  Y
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 175

Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             PE  +   ++   D++S G +  E+
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 63/199 (31%), Positives = 88/199 (44%), Gaps = 15/199 (7%)

Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+G FG V    L   G+  AVK L K        VE    E  ++A       +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 496 CCMK-RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLHQDSRL 553
           C  + ++    + E+L    L   I D  R  L     R       I  GL +LH     
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLY----RATFYAAEIVCGLQFLHSKG-- 116

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            II+RDLK  NV+LD + + KI+DFGM +        A+T    GT  Y+ PE      +
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKY 173

Query: 614 SVKSDVFSFGVLVLELVYG 632
           +   D +SFGVL+ E++ G
Sbjct: 174 TFSVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 16/201 (7%)

Query: 440 LGEGGFGPVY---KGMLID-GQEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQHRNLVKL 493
           LG+G FG V+   K    D GQ  A+K L K++ +  +    K E  ++A++ H  +VKL
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIARGLLYLHQDSR 552
                   +  LI ++L    L    F    ++++   +  +  +  +A  L +LH    
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH---S 116

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
           L II+RDLK  N+LLD E + K++DFG+++   +D  E       GT  YM PE      
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVVNRRG 174

Query: 613 FSVKSDVFSFGVLVLELVYGT 633
            +  +D +SFGVL+ E++ G+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGS 195

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 74/258 (28%), Positives = 113/258 (43%), Gaps = 34/258 (13%)

Query: 440 LGEGGFGPV------YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG+GGFG V        G +   +++  KR+ K  G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLHQDSR 552
                 +D   L+   +    L   I++       +  +R       I  GL  LH   R
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE--ERAVFYAAEITCGLEDLH---R 120

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR-VVGTYGYMPPEYAIDG 611
            RI++RDLK  N+LLD+  + +ISD G+A    V+  E  T R  VGT GYM PE   + 
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKNE 176

Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT 671
            ++   D +  G L+ E++ G                    ++  E+  VE   K  ++ 
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEG-----------KSPFRQRKEKVKREE--VERRVKEDQEE 223

Query: 672 YS--LSEALRCIQVGLLC 687
           YS   SEA R I   LL 
Sbjct: 224 YSEKFSEAARSICRQLLT 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)

Query: 434 FSEENKLGEGGFGPV------YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 487
           F +   LG+GGFG V        G +   + +  KR+ K  G+ +    NE  ++ K+  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
           + +V L      +D   L+   +    L   I++       +  +       I  GL  L
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDL 118

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H+++    ++RDLK  N+LLD+  + +ISD G+  A  + + E+   R VGT GYM PE 
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGL--AVKIPEGESIRGR-VGTVGYMAPEV 172

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYG 632
             +  +++  D +  G L+ E++ G
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 37/110 (33%), Positives = 59/110 (53%), Gaps = 26/110 (23%)

Query: 535 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG--------MAR 582
            I+G I+    RGL YL +  + +I+HRD+K SN+L+++    K+ DFG        MA 
Sbjct: 99  NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156

Query: 583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           +F            VGT  YM PE      ++V+SD++S G+ ++E+  G
Sbjct: 157 SF------------VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 13/198 (6%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+G FG V    L    E+ A+K L K        V+    E  ++A       +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 496 CCMKRDERML-IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           CC +  +R+  + EY+      D +F   R +  D  +       +   L++LH+     
Sbjct: 63  CCFQTKDRLFFVMEYVNG---GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--- 116

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           +I+RDLK  N+LLD E + K++DFGM +  G+      T    GT  Y+ PE   +  + 
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILN-GVTTTTFCGTPDYIAPEILQELEYG 174

Query: 615 VKSDVFSFGVLVLELVYG 632
              D ++ GVL+ E++ G
Sbjct: 175 PSVDWWALGVLMYEMMAG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 19/202 (9%)

Query: 439 KLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ---HRNLVK 492
           ++G G +G VYK      G  +A+K +   + +         EV L+ +L+   H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 493 LLGCCMK-RDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
           L+  C   R +R     L++E++ ++ L  ++ D      L       ++    RGL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H +    I+HRDLK  N+L+ +    K++DFG+AR +           VV T  Y  PE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEV 178

Query: 608 AIDGLFSVKSDVFSFGVLVLEL 629
            +   ++   D++S G +  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQH 487
           T+ + +   +G G FG V      + GQ +A+K++ K  S+    +    E+ L+  L+H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIARG 543
            N++ L    +   E +     L    L   +   T R L       Q I      I RG
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLHRLL---TSRPLEK-----QFIQYFLYQILRG 120

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L Y+H      ++HRDLK SN+L++   + KI DFG+AR     Q    T  V   Y Y 
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-YR 172

Query: 604 PPEYAID-GLFSVKSDVFSFGVLVLELVYG 632
            PE  +    + V+ D++S G +  E++ G
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 36/93 (38%), Positives = 49/93 (52%), Gaps = 5/93 (5%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           IA GL +LH      II+RDLK  NV+LD E + KI+DFGM +          T    GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGT 164

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             Y+ PE      +    D ++FGVL+ E++ G
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 58/283 (20%)

Query: 440 LGEGGFGPVYKGMLI----DGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQHRNLVK- 492
           +G+G +G V    L+    DG++  +K+L+   +S +  +  + E  L+++L+H N+V  
Sbjct: 8   VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 493 -------------LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG 539
                        ++G C   D    +Y  L  +          + KLL  ++  +    
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQ----------KGKLLPENQVVEWFVQ 110

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           IA  L YLH+     I+HRDLK  NV L      K+ D G+AR        A+T  ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR 659
             YM PE   +  ++ KSDV++ G  V E+   T    F+  D   N L   +R+     
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEM--ATLKHAFNAKD--MNSL--VYRIIEGKL 219

Query: 660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV 702
           P    D S E    L E +      +L   +RPE RP++ S++
Sbjct: 220 PPMPKDYSPE----LGELIA----TMLS--KRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.5 bits (157), Expect = 5e-11
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +ARG+ +L   SR + IHRDL A N+LL      KI DFG+AR    D            
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 5e-11
 Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 33/187 (17%)

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           LL +H      +IHRD+K++N+LL +    K+ DFG ++ +    ++       GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
            PE      +S K+D+FS GVL+ EL+  T  R F   +                   E+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELL--TLKRPFDGENME-----------------EV 253

Query: 664 IDKSLEDTY-----SLSEALRCIQVGLLCVQQRPEDRP------NMASVVLMLSGERSLP 712
           + K+L   Y     S+S  ++ I   LL     P+ RP      NM    L +SG   + 
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSD--PKRRPSSSKLLNMPICKLFISGLLEIV 311

Query: 713 QPKQPGF 719
           Q  QPGF
Sbjct: 312 Q-TQPGF 317

Length = 496

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 25/210 (11%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           D+      +G G FG V+     I     A+K ++       +  +   NE  ++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 488 RNLVKLLGCCMKRDERML--IYEYLPNKSLADFIFDGTRRKLLDWSKR---CQIIGGIAR 542
             +++L     + D+R L  + EY+P   L  F +     +  + +      +I+  +  
Sbjct: 61  PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCALE- 115

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
              YLH      I++RDLK  N+LLD E + K++DFG A+    D+T      + GT  Y
Sbjct: 116 ---YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT----LCGTPEY 164

Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           + PE       +   D ++ G+L+ E++ G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 8e-11
 Identities = 40/117 (34%), Positives = 69/117 (58%), Gaps = 12/117 (10%)

Query: 522 GTRRKLLDWSKRC--QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 575
           G+  ++L  +KR   +I+G ++    RGL YL +  + +I+HRD+K SN+L+++    K+
Sbjct: 88  GSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKL 145

Query: 576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            DFG++        ++  N  VGT  YM PE      +SV+SD++S G+ ++EL  G
Sbjct: 146 CDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 63.9 bits (155), Expect = 9e-11
 Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 40/229 (17%)

Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           + +   +G G  G V      + G  +AVK+LS+        F+N+    AK  +R LV 
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQNQTH--AKRAYRELV- 72

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------G 539
           LL C   ++   L+  + P KSL +F       +L+D +  CQ+I               
Sbjct: 73  LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSYLLYQ 131

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR        A TN ++  
Sbjct: 132 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-------ACTNFMMTP 181

Query: 600 Y----GYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTR-NRGFHHVDH 643
           Y     Y  PE  +   +    D++S G ++ ELV G+   +G  H+D 
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 24/199 (12%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVKLLGCC 497
           LG G  G VYK   L+  + +AVK +       ++ +  +E+ ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----RGLLYLHQDSRL 553
              +   +  E++   SL  +                 ++G IA    +GL YL     L
Sbjct: 69  FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
           +I+HRD+K SN+L++     K+ DFG++         +     VGT  YM PE      +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQY 170

Query: 614 SVKSDVFSFGVLVLELVYG 632
            + SDV+S G+  +EL  G
Sbjct: 171 GIHSDVWSLGISFMELALG 189

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE----IAVKRLSKSS----GQGVEEFKNEVLLIAK 484
           NF     LG G +G V+    + G +     A+K L K++     +  E  + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 485 LQHRNLVKLLGCCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIAR 542
           ++    +  L    + D ++ LI +Y+    L   +    R K     +  QI  G I  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVL 116

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
            L +LH   +L II+RD+K  N+LLD+  +  ++DFG+++ F  D+ E       GT  Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172

Query: 603 MPPEYAI--DGLFSVKSDVFSFGVLVLELVYG 632
           M P+     DG      D +S GVL+ EL+ G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 38/195 (19%)

Query: 456 GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN 512
           GQ +A+K+LS+   Q V   K    E++L+  + H+N++ LL              + P 
Sbjct: 41  GQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQ 87

Query: 513 KSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARGLLYLHQDSRLRIIHRD 559
           KSL +F       +L+D +  CQ+I               +  G+ +LH      IIHRD
Sbjct: 88  KSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRD 143

Query: 560 LKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSD 618
           LK SN+++ ++   KI DFG+AR  G       T  VV  Y Y  PE  I G+ +    D
Sbjct: 144 LKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE-VILGMGYKENVD 199

Query: 619 VFSFGVLVLELVYGT 633
           ++S G ++ E++ GT
Sbjct: 200 IWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 6/98 (6%)

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
           I  I   L +LHQ   L II+RD+K  N+LLD+E +  ++DFG+++ F  ++ E      
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSF 166

Query: 597 VGTYGYMPPEY--AIDGLFSVKSDVFSFGVLVLELVYG 632
            GT  YM PE      G      D +S GVL  EL+ G
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 64/237 (27%), Positives = 111/237 (46%), Gaps = 38/237 (16%)

Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSK--SSGQGVEEFKNEVLL 481
           K+I    D + +  ++G G +G V   +    G ++A+K+L +   S    +    E+ L
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67

Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-------FDGTRR-KLLDWSK- 532
           +  ++H N++ LL              + P+ SL  F        F GT   KL+   K 
Sbjct: 68  LKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115

Query: 533 ---RCQ-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
              R Q ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     Q
Sbjct: 116 SEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----Q 167

Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG-TRNRGFHHVDH 643
           T++     V T  Y  PE  ++ + ++   D++S G ++ E++ G    +G  H+D 
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 38/153 (24%), Positives = 71/153 (46%), Gaps = 9/153 (5%)

Query: 478 EVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQII 537
           E +L+  + H +++++    +      ++   LP+ S   + +   R + L   +   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVV 597
             I  GL YLH     RIIHRD+K  N+ +++     I D G A+ F V         + 
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPV--VAPAFLGLA 217

Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
           GT     PE      ++ K+D++S G+++ E++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 56.6 bits (137), Expect = 2e-10
 Identities = 23/43 (53%), Positives = 30/43 (69%), Gaps = 2/43 (4%)

Query: 711 LPQPKQPGFFTERNLPESESSSSNQTFHSS--NQITVSLIEGR 751
           +PQPKQPGF   R+  E++SSSS Q   S   NQ+TVS+I+ R
Sbjct: 6   IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 15/158 (9%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Query: 600 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED 658
           +GYM PE    G+ +   +D FS G ++ +L+     RG      H     H     T  
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-----RGHSPFRQHKTKDKHEIDRMTLT 213

Query: 659 RPVELIDKSLEDTYSLSEAL--RCIQVGLLCVQQRPED 694
             VEL D    +  SL E L  R +   L C+ +  ++
Sbjct: 214 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 14/198 (7%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVKLL 494
           +GEG +G V K    + +EI A+K+   S     EE K     E+ ++  L+  N+V+L 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
               +R +  L++EY+  K++ + + +       +  K    I  + + + + H++    
Sbjct: 67  EAFRRRGKLYLVFEYV-EKNMLELLEEMPNGVPPE--KVRSYIYQLIKAIHWCHKND--- 120

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           I+HRD+K  N+L+ +    K+ DFG AR    + + AN    V T  Y  PE  +   + 
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 615 VKSDVFSFGVLVLELVYG 632
              D++S G ++ EL  G
Sbjct: 180 KAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 37/225 (16%)

Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K++    + +     +G G +G V         Q++AVK+LS+     +   +   E+ L
Sbjct: 8   KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRL 67

Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P  S+ +F  ++  T     D +   +CQ  
Sbjct: 68  LKHMKHENVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKL 115

Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  + RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR     Q
Sbjct: 116 SDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----Q 167

Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
            +      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 168 ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 35/102 (34%), Positives = 61/102 (59%), Gaps = 10/102 (9%)

Query: 535 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE 590
           QI+G ++    +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        +
Sbjct: 103 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 156

Query: 591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           +  N  VGT  YM PE      +SV+SD++S G+ ++E+  G
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.9 bits (153), Expect = 5e-10
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 34/199 (17%)

Query: 456 GQEIAVKRLSKSSGQGVEE---FKNEVLLIAKLQHRNLVKLLGCCMKRDERML-IYEYLP 511
           G E+A+K L   + +   +   F+ E  L A+L H N+V LL         +  ++EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 512 NKSLADFI-FDG------TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 564
            ++L + +  DG      T R +L      Q++  +A      H      I+HRDLK  N
Sbjct: 63  GRTLREVLAADGALPAGETGRLML------QVLDALACA----HNQG---IVHRDLKPQN 109

Query: 565 VLL---DNEMNPKISDFGMARAFGVDQTEAN------TNRVVGTYGYMPPEYAIDGLFSV 615
           +++       + K+ DFG+         +A+      T  V+GT  Y  PE       + 
Sbjct: 110 IMVSQTGVRPHAKVLDFGIG-TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168

Query: 616 KSDVFSFGVLVLELVYGTR 634
            SD++++G++ LE + G R
Sbjct: 169 NSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 440 LGEGGFGPVYKGMLID----GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVK 492
           LG+G FG V   ML +     +  A+K L K        VE    E  ++A       + 
Sbjct: 8   LGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64

Query: 493 LLGCCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            L  C +  +R+  + EY+   +  D ++   +       +       I+ GL +LH+  
Sbjct: 65  QLHSCFQTVDRLYFVMEYV---NGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              II+RDLK  NV+LD+E + KI+DFGM +   VD     T    GT  Y+ PE     
Sbjct: 122 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGTPDYIAPEIIAYQ 176

Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +    D +++GVL+ E++ G
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 32/212 (15%)

Query: 438 NKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHR-- 488
           ++LG+G +G VYK      G+ +  +EI   RL       ++E K N++++   + H+  
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57

Query: 489 --NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
              +V   G         +  EY+   SL      G   + +      +I   + +GL +
Sbjct: 58  SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           L ++    IIHRD+K +NVL++     K+ DFG++    +  + A TN  +G   YM PE
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTN--IGCQSYMAPE 171

Query: 607 Y------AIDGLFSVKSDVFSFGVLVLELVYG 632
                    +  ++V+SDV+S G+ +LE+  G
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 60.8 bits (147), Expect = 8e-10
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 436 EENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLVKLL 494
           E  K+G G +G VYK    DG++     L +  G G+      E+ L+ +L+H N++ L 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64

Query: 495 GCCMKRDERM--LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY-----L 547
              +   +R   L+++Y  +       F    R      K  Q+  G+ + LLY     +
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKF---HRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGVD-QTEANTNRVVGTYG 601
           H      ++HRDLK +N+L+  E  P     KI+D G AR F    +  A+ + VV T+ 
Sbjct: 122 HYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 602 YMPPEYAIDGLFSVKS-DVFSFGVLVLELV 630
           Y  PE  +      K+ D+++ G +  EL+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.8 bits (147), Expect = 9e-10
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +ARG+ +L   SR + IHRDL A N+LL      KI DFG+AR    D            
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 20/148 (13%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Query: 600 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED 658
           +GYM PE    G  +   +D FS G ++ +L+ G      H     H +          D
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----------D 208

Query: 659 RPVELIDKSLEDTYSLSEALRCIQVGLL 686
           R    ++  L D++  S  L+ +  GLL
Sbjct: 209 RMTLTVNVELPDSF--SPELKSLLEGLL 234

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 3/90 (3%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +A+G+ +L   SR + IHRDL A N+LL      KI DFG+AR    D            
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 31/212 (14%)

Query: 440 LGEGGFGPVYKGMLID---------GQEIAVKR-LSKSSGQGVEEFKNEVLLIAKLQHRN 489
           LG+G F  +YKG+L           GQE++V   +  S  +    F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           LVKL G C+ RDE +++ EY+    L  F+        L W  +  +   +A  L YL  
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 550 DSRLRIIHRDLKASNVLL----DNEMNP---KISDFGMARAFGVDQTEANTNRVVGTYGY 602
               +++H ++   N+L+     NE      K+SD G+     V   E    R+     +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----PW 170

Query: 603 MPPEYAIDGLFSVKS--DVFSFGVLVLELVYG 632
           + PE   +G  S+    D +SFG  +LE+   
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.6 bits (145), Expect = 2e-09
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 51/226 (22%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
             +     +G G +G V   +    G+++A+K++  +          +V  +AK   R L
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTLREL 55

Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLAD---FIFDGTRRKLLDWSKRCQIIGG------- 539
            K+L    K D  + I + L P  +       + D      L  S    II         
Sbjct: 56  -KILRH-FKHDNIIAIRDILRPPGADFKDVYVVMD------LMESDLHHIIHSDQPLTEE 107

Query: 540 --------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
                   + RGL Y+H  +   +IHRDLK SN+L++ +   +I DFGMAR      TE 
Sbjct: 108 HIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164

Query: 592 NT--NRVVGTYGYMPPEYAIDGLFSV-----KSDVFSFGVLVLELV 630
                  V T  Y  PE     L S+       D++S G +  E++
Sbjct: 165 KYFMTEYVATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 5/92 (5%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           I RGL YLH      I+HRD+K  N+L+++    KI DFG+AR    D+++  T  VV  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 600 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLELV 630
           Y Y  PE  +    ++   D++S G +  EL+
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELL 199

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 76/281 (27%), Positives = 123/281 (43%), Gaps = 27/281 (9%)

Query: 439 KLGEGGFGPVYKGMLIDG---QEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLL 494
           ++G G FG V  G +  G    ++ VK L  S+  Q   +F  E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLL--DWSKRCQIIGGIARGLLYLHQDSR 552
           G C +    +L+ E+ P   L  ++    + +L+  D +   ++   IA GLL+LH+++ 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA--ID 610
              IH DL   N LL  ++  KI D+G++     +      +++     ++ PE    + 
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 611 GLFSV-----KSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID 665
           G   V     +S+V+S GV + EL         H  D    +L +  R      P   + 
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTVREQQLKLPKPRLK 236

Query: 666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
             L D        R  +V   C  Q PE RP+   V L+LS
Sbjct: 237 LPLSD--------RWYEVMQFCWLQ-PEQRPSAEEVHLLLS 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 2e-09
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 57/248 (22%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQ-----GVEEFKNEVLLI 482
           +    +   + +GEG +G V        G ++A+K++S    Q      + E K    ++
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57

Query: 483 AKLQHRNLVKLLG-----------------CCMKRDERMLIY-EYLPNKSLADFIFDGTR 524
            + +H N++ +L                    M+ D   LI  ++L N  +  F++    
Sbjct: 58  RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY---- 113

Query: 525 RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 584
                     QI+    RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR  
Sbjct: 114 ----------QIL----RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI- 155

Query: 585 GVDQTEANTNRV---VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLELVYGTRNRGFHH 640
             D    +T  +   V T  Y  PE  ++     K+ D++S G ++ E++  +    F  
Sbjct: 156 -ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML--SNRPLFPG 212

Query: 641 VDHHHNLL 648
            D+ H L 
Sbjct: 213 KDYLHQLN 220

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 13/95 (13%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +A+G+ +L   +    IHRD+ A NVLL +    KI DFG+AR         ++N VV  
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272

Query: 600 YG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                  +M PE   D +++V+SDV+S+G+L+ E+
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           IA GL +LH      II+RDLK  NV+LD+E + KI+DFGM +    D     T    GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             Y+ PE      +    D ++FGVL+ E++ G
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 436 EENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLVKLL 494
           E  K+G G +G VYK    DG++     L +  G G+      E+ L+ +L+H N++ L 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64

Query: 495 GCCMKRDERM--LIYEYLPNKSLADFIFDGTRRK-----LLDWSKRCQIIGGIARGLLYL 547
              +   +R   L+++Y  +       F    +       L  S    ++  I  G+ YL
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGVD-QTEANTNRVVGTYG 601
           H +    ++HRDLK +N+L+  E  P     KI+D G AR F    +  A+ + VV T+ 
Sbjct: 125 HAN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 602 YMPPEYAIDGLFSVKS-DVFSFGVLVLELV 630
           Y  PE  +      K+ D+++ G +  EL+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 3e-09
 Identities = 70/304 (23%), Positives = 113/304 (37%), Gaps = 85/304 (27%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG V+     D  ++ A+K L KS      Q +   + E  ++A      +VKL 
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKLY 67

Query: 495 GCCMKRDERM-LIYEYLPNKSLADF--------IFDGTRRKLLDWSKRCQIIGGIARGLL 545
               + +E + L+ EY+P     D         +F     +             IA  +L
Sbjct: 68  -YSFQDEEHLYLVMEYMPG---GDLMNLLIRKDVFPEETARFY-----------IAELVL 112

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-------------------- 585
            L    +L  IHRD+K  N+L+D + + K++DFG+ +                       
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 586 -------VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG------ 632
                    Q     N  VGT  Y+ PE      + ++ D +S GV++ E++YG      
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232

Query: 633 -TRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQR 691
            T    ++ + +    L           P        +   S  EA+  I   LLC    
Sbjct: 233 DTLQETYNKIINWKESLR---------FPP-------DPPVS-PEAIDLIC-RLLC---D 271

Query: 692 PEDR 695
           PEDR
Sbjct: 272 PEDR 275

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 32/220 (14%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID---GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL 485
            +F  ++ +G G FG V   ++ +   G   A+K + KS   + + V  F+ E  +++  
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLA------DFIFDGTRRKLLDWSKRCQIIGG 539
               + +L      +D   L+ EY P   L       +  FD    +             
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY----------- 107

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +A  +L +H   ++  +HRD+K  NVL+D   + K++DFG A     ++   N+   VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGT 166

Query: 600 YGYMPPEY--AIDG----LFSVKSDVFSFGVLVLELVYGT 633
             Y+ PE    ++G     + V+ D +S GV+  E++YG 
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 53.4 bits (128), Expect = 4e-09
 Identities = 27/81 (33%), Positives = 37/81 (45%), Gaps = 6/81 (7%)

Query: 326 ERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSK-NCSCTAYANADVRGGGSGCLLW 384
           +  D F++  + KLP      +    SL EC   C   NCSC ++       G  GCLLW
Sbjct: 1   KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTY---NNGTKGCLLW 56

Query: 385 -FHELTDMKILSEGGQDLYIR 404
               L D ++   GG DLY +
Sbjct: 57  SESSLGDARLFPSGGVDLYEK 77

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 28/210 (13%)

Query: 440 LGEGGFGPVYKGM---LIDGQ-----EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG+G F  ++KG+   + D       E+ +K L KS     E F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
              G C+  DE +++ EY+   SL  ++     + L++ S + ++   +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 552 RLRIIHRDLKASNVLLDNEM-----NP---KISDFGMARAFGVDQTEANTNRVVGTYGYM 603
              + H ++ A NVLL  E      NP   K+SD G++    V   E    R+     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT--VLPKEILLERI----PWV 171

Query: 604 PPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           PPE   +    S+ +D +SFG  + E+  G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.9 bits (142), Expect = 5e-09
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 21/160 (13%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +ARG+ +L   +    +HRDL A NVLL      KI DFG+AR    D    +       
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL--VYGTRNRGFHHVDHHHNLLGHAWRLWTE 657
             +M PE   D L++  SDV+S+G+L+ E+  + GT   G       +N +   +R+   
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM--- 359

Query: 658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN 697
            +P    D + ++ Y +          + C    PE RP+
Sbjct: 360 AKP----DHATQEVYDIM---------VKCWNSEPEKRPS 386

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 31/206 (15%)

Query: 457 QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLA 516
           + +A+K+LS+        F+N+    AK  +R LV L+ C   ++   L+  + P KSL 
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99

Query: 517 DFIFDGTRRKLLDWSKRCQIIG-------------GIARGLLYLHQDSRLRIIHRDLKAS 563
           +F       +L+D +  CQ+I               +  G+ +LH      IIHRDLK S
Sbjct: 100 EFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 155

Query: 564 NVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFG 623
           N+++ ++   KI DFG+AR  G   +   T  VV  Y Y  PE  +   +    D++S G
Sbjct: 156 NIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVG 212

Query: 624 VLVLELV-YGTRNRGFHHVDHHHNLL 648
            ++ E++  G    G  H+D  + ++
Sbjct: 213 CIMGEMIKGGVLFPGTDHIDQWNKVI 238

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 35/207 (16%)

Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 72

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P KSL +F       +L+D +  CQ+I               +  G
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 131

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 185

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 16/202 (7%)

Query: 440 LGEGGFGPVYKGMLIDGQE----IAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLV 491
           LG+GG+G V++   + G +     A+K L K+    + +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            L+       +  LI EYL    L   +    R  +      C  +  I+  L +LHQ  
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQ-- 118

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              II+RDLK  N+LLD + + K++DFG+ +    + T  +T    GT  YM PE  +  
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYMAPEILMRS 175

Query: 612 LFSVKSDVFSFGVLVLELVYGT 633
                 D +S G L+ +++ G 
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 49/220 (22%)

Query: 438 NKLGEGGFGPVYKGMLIDGQE-IAVKRLSKSSGQGVEEFKNEVLLIAK-LQHRNLVKLLG 495
           N +G G FG VY+ + ID  E +A+K++ +       ++KN  LLI K L H N++ L  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126

Query: 496 C----CMKRDERML----IYEYLP-------------NKSLADFIFDGTRRKLLDWSKRC 534
                C K++E+ +    + E++P             N +L  F+      KL  +    
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ--- 178

Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANT 593
                + R L Y+H      I HRDLK  N+L+D N    K+ DFG A+     Q   + 
Sbjct: 179 -----LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS- 229

Query: 594 NRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              + +  Y  PE  +    ++   D++S G ++ E++ G
Sbjct: 230 --YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 30/162 (18%)

Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL---LG 495
           LG G  G V+  +  D  + +AVK++  +  Q V+    E+ +I +L H N+VK+   LG
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 496 CCMKRDERML----------IYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIA 541
                    +          I +      LA+ +  G       +L  +    Q++    
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMY----QLL---- 124

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR 582
           RGL Y+H  +   ++HRDLK +NV ++ E +  KI DFG+AR
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 440 LGEGGFGPVYKGMLI----DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVK 492
           LG+G FG V   +L+     G+  A+K L K    +   V     E  ++   +H  L  
Sbjct: 3   LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLHQDS 551
           L      +D    + EY+    L    F  +R ++     R +  G  I   L YLH   
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG- 114

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
             +I++RDLK  N++LD + + KI+DFG+ +    D     T    GT  Y+ PE   D 
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDN 170

Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH 643
            +    D +  GV++ E++ G     F++ DH
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCG--RLPFYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 45/146 (30%), Positives = 69/146 (47%), Gaps = 8/146 (5%)

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H  LV L  C         + EY+      D +F   R++ L           I+  L Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFYSAEISLALNY 111

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH+     II+RDLK  NVLLD+E + K++D+GM +  G+   +  T+   GT  Y+ PE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGD-TTSTFCGTPNYIAPE 166

Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYG 632
                 +    D ++ GVL+ E++ G
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 13/198 (6%)

Query: 440 LGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVKLL 494
           +G+G FG V      +DG+  AVK L K      +E K+ +    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
                 ++   + +++    L    F   R +     +       IA  L YLH    + 
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           I++RDLK  N+LLD++ +  ++DFG+ +  G+ Q++  T    GT  Y+ PE      + 
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTT-FCGTPEYLAPEVIRKQPYD 174

Query: 615 VKSDVFSFGVLVLELVYG 632
              D +  G ++ E++YG
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 13/198 (6%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVKLL 494
           +G+G FG V       DG+  AVK L K +    +E K+ +    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
                 D+   + +Y+    L    F   R +     +       IA  L YLH    L 
Sbjct: 63  YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---LN 116

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           II+RDLK  N+LLD++ +  ++DFG+ +  G+ +    T+   GT  Y+ PE      + 
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GI-EHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 615 VKSDVFSFGVLVLELVYG 632
              D +  G ++ E++YG
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 28/232 (12%)

Query: 406 ATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQ--EIAVKR 463
            +++   RK +M+             ++F+    LG G FG V      +     +A+KR
Sbjct: 16  DSTKEPKRKNKMKY------------EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR 63

Query: 464 LSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIF 520
             KS     + V+   +E  ++  + H   V L G         L+ E++       F+ 
Sbjct: 64  FEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL- 122

Query: 521 DGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 580
              R K       C     I     YL     L I++RDLK  N+LLD +   K++DFG 
Sbjct: 123 --RRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGF 177

Query: 581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           A+       +  T  + GT  Y+ PE  ++      +D ++ G+ + E++ G
Sbjct: 178 AKV-----VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.8 bits (135), Expect = 3e-08
 Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 54/234 (23%)

Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN---------EVLLIAKLQHRN 489
           +G G +G V      +  +++A+K+++ +       F N         E+ L+  L H N
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65

Query: 490 LVKLLGCCMKRDERM------LIYEYL---------PNKSLADFIFDGTRRKLLDWSKRC 534
           ++ +    M    R       ++YE +          +++L+D                C
Sbjct: 66  VIAIKDI-MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSD--------------DHC 110

Query: 535 Q-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
           Q  +  + RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    ++ +  T
Sbjct: 111 QYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMT 166

Query: 594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL 647
             VV  +   P        ++   DV+S G +  EL+   R   F   D+ H L
Sbjct: 167 EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL--GRKPLFPGKDYVHQL 218

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 71/278 (25%), Positives = 117/278 (42%), Gaps = 43/278 (15%)

Query: 440 LGEGGFGPVYKGMLI----DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVK 492
           LG+G FG V   +L+     G+  A+K L K    +   V     E  ++   +H  L  
Sbjct: 3   LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLHQDS 551
           L       D    + EY     L    F  +R ++    +R +  G  I   L YLH   
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD 115

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              +++RD+K  N++LD + + KI+DFG+ +    D   A      GT  Y+ PE   D 
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDN 170

Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI-DKSLED 670
            +    D +  GV++ E++ G     F++ DH              +R  ELI  + +  
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCG--RLPFYNQDH--------------ERLFELILMEEIRF 214

Query: 671 TYSLSEALRCIQVGLLCVQQRPEDR----PNMASVVLM 704
             +LS   + +  GLL  ++ P+ R    P+ A  V+ 
Sbjct: 215 PRTLSPEAKSLLAGLL--KKDPKQRLGGGPSDAKEVME 250

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 17/210 (8%)

Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE----IAVKRLSKSS----GQGVEEFKNEVLLIAK 484
           NF     LG G +G V+    + G +     A+K L K++     + VE  + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 485 LQHRNLVKLLGCCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG 543
           ++    +  L    + + ++ LI +Y+    +   ++   +R      +     G I   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILA 117

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L +LH   +L I++RD+K  N+LLD+E +  ++DFG+++ F + + +  T    GT  YM
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173

Query: 604 PPEYAIDGLFSVKS-DVFSFGVLVLELVYG 632
            PE         K+ D +S G+L+ EL+ G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.4 bits (131), Expect = 9e-08
 Identities = 50/149 (33%), Positives = 73/149 (48%), Gaps = 14/149 (9%)

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTR-RKLLDWSKRCQIIGGIARGLL 545
           H  LV L  C         + E++      D +F   R RKL +   R      I+  L 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSG---GDLMFHMQRQRKLPEEHARF-YSAEISLALN 110

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           +LH+     II+RDLK  NVLLD E + K++D+GM +  G+   +  T+   GT  Y+ P
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDT-TSTFCGTPNYIAP 165

Query: 606 EY--AIDGLFSVKSDVFSFGVLVLELVYG 632
           E     D  FSV  D ++ GVL+ E++ G
Sbjct: 166 EILRGEDYGFSV--DWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 13/198 (6%)

Query: 440 LGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVKLL 494
           +G+G FG V       DG   AVK L K +    +E  + +    +L+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
                 ++   + +Y+    L  F      R  L+   R      +A  + YLH    L 
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARF-YAAEVASAIGYLHS---LN 116

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           II+RDLK  N+LLD++ +  ++DFG+ +  GV+  E  T+   GT  Y+ PE      + 
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEP-EETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 615 VKSDVFSFGVLVLELVYG 632
              D +  G ++ E++YG
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 8/143 (5%)

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           LV L  C        L+ EY+      D +F   R++ L           I   L +LH+
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNG---GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
                II+RDLK  NVLLD + + K++D+GM +  G+   +  T+   GT  Y+ PE   
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGD-TTSTFCGTPNYIAPEILR 169

Query: 610 DGLFSVKSDVFSFGVLVLELVYG 632
              +    D ++ GVL+ E++ G
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 13/95 (13%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D     +N VV  
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND-----SNYVVKG 274

Query: 600 YG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                  +M PE   + +++ +SDV+S+G+L+ E+
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 3/94 (3%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           IA  +L L    +  I++RDLK  N+LLD   +  + DFG+++A   D     TN   GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGT 159

Query: 600 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
             Y+ PE  +D   ++   D +S GVLV E+  G
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 53.6 bits (129), Expect = 3e-07
 Identities = 54/221 (24%), Positives = 84/221 (38%), Gaps = 66/221 (29%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-----GQEIAVKRLSKSSGQGVEEFKNEVLL----- 481
           D+F    KLGEG FG VYK  L++       +  +K+ +   G  VE + NE +      
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189

Query: 482 -IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFD------------------- 521
             A   +  L  +     K DE  L++ Y    +LAD +                     
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247

Query: 522 -GTRRKLLDWSKRCQIIGGIARGLLY----LHQDSRLRIIHRDLKASNVLLDNEMNP-KI 575
            G  R+        +II  I R +L+    LH      I+HRD+K  N++        KI
Sbjct: 248 KGLERE-------NKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKI 297

Query: 576 SDFGMAR--AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            D G A     G++              Y+P E+ +D  ++
Sbjct: 298 IDLGAAADLRVGIN--------------YIPKEFLLDPRYA 324

Length = 566

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 40/143 (27%), Positives = 59/143 (41%), Gaps = 25/143 (17%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +A G+ +L   +    +HRDL A NVL+      KI DFG+AR    D    +       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVL----------------ELVYGTRNRGF----- 638
             +M PE   + L++  SDV+SFG+L+                 E  Y    RG+     
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP 364

Query: 639 -HHVDHHHNLLGHAWRLWTEDRP 660
            H  D  + ++   W    E RP
Sbjct: 365 AHASDEIYEIMQKCWEEKFEIRP 387

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 19/201 (9%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVKLL 494
           +G+G FG V       + +  AVK L K +    +E K+ +    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLHQDSRL 553
                 D+   + +Y+    L    F   +R+      R +     IA  L YLH    L
Sbjct: 63  FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS---L 115

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN--TNRVVGTYGYMPPEYAIDG 611
            I++RDLK  N+LLD++ +  ++DFG+ +    +  E N  T+   GT  Y+ PE     
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +    D +  G ++ E++YG
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 31/252 (12%)

Query: 439 KLGEGGFGPVYKGMLIDGQEIA---VKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLL 494
           ++G G FG V    +     +A   VK L  ++  +   EF  +      LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFD-----GTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           G C++    +L++EY     L  ++          + LL     C+    IA G+ ++H 
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE----IAAGVTHMH- 116

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGVDQTEANTNRVVGTYGYMPPEYA 608
             +   +H DL   N  L +++  K+ D+G+  + +  D  E   ++ V    ++ PE  
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELV 173

Query: 609 I---DGLFSVK----SDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV 661
                GL + +    S+V++ GV + EL +    + + H+     +L H  +    D+ V
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL-FENAAQPYSHLS-DREVLNHVIK----DQQV 227

Query: 662 ELIDKSLEDTYS 673
           +L    LE  YS
Sbjct: 228 KLFKPQLELPYS 239

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 6/98 (6%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           IA  +L +H   +L  +HRD+K  NVLLD   + +++DFG       D T   ++  VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGT 166

Query: 600 YGYMPPEY--AID---GLFSVKSDVFSFGVLVLELVYG 632
             Y+ PE   A++   G +  + D +S GV + E++YG
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +A  +L +    +L  +HRD+K  NVLLD   + +++DFG       D T   +N  VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGT 166

Query: 600 YGYMPPEY--AID---GLFSVKSDVFSFGVLVLELVYGT 633
             Y+ PE   A++   G +  + D +S GV + E++YG 
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 27/215 (12%)

Query: 440 LGEGGFGPV----------YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
           LG+G FG V          Y  M I  +E+ V +        V     E  ++   +H  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK------DEVAHTLTENRVLQNSRHPF 56

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLH 548
           L  L       D    + EY     L    F  +R ++     R +  G  I   L YLH
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH 112

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
            +    +++RDLK  N++LD + + KI+DFG+ +  G+ +  A      GT  Y+ PE  
Sbjct: 113 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKTFCGTPEYLAPEVL 168

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH 643
            D  +    D +  GV++ E++ G     F++ DH
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCG--RLPFYNQDH 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 22/204 (10%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G FG V        Q++ A+K LSK     +    F  E   I    +   V  L C
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110

Query: 497 CMKRDERM-LIYEYLPNKSLADFI--FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
             + D+ + ++ EY+P   L + +  +D   +    W+K        A  +L L     +
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AEVVLALDAIHSM 161

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT-EANTNRVVGTYGYMPPEY----A 608
            +IHRD+K  N+LLD   + K++DFG      +D+T     +  VGT  Y+ PE      
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 609 IDGLFSVKSDVFSFGVLVLELVYG 632
            DG +  + D +S GV + E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.7 bits (124), Expect = 7e-07
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 27/210 (12%)

Query: 433 NFSEENKLGEGGFGPV----YKGMLIDGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL 485
           +F     LG G FG V    +KG    G+  A+K L K      + V+    E  ++ +L
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTR---RKLLDWSKRCQIIGGIAR 542
            H  +V ++      +    + E++    L    F   R   R   D +K       +  
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH--AELVL 129

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
              YLH      II+RDLK  N+LLDN+ + K++DFG A+     +    T  + GT  Y
Sbjct: 130 AFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEY 181

Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           + PE           D ++ GVL+ E + G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.8 bits (124), Expect = 7e-07
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G +G V   +    G+++A+K+LS+   S    +    E+ L+  +QH N++ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 497 CMKR---DERMLIYEYLPNKSLADFIFDGTRRKL---LDWSKRCQIIGGIARGLLYLHQD 550
                  DE    Y  +P      ++    ++ +   L   K   ++  +  GL Y+H  
Sbjct: 83  FTSAVSGDEFQDFYLVMP------YMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
               IIHRDLK  N+ ++ +   KI DFG+AR       +A     V T  Y  PE  ++
Sbjct: 137 G---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILN 188

Query: 611 GLFSVKS-DVFSFGVLVLELVYG-TRNRGFHHVDH 643
            +   ++ D++S G ++ E++ G T  +G  ++D 
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 223

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 45/180 (25%), Positives = 84/180 (46%), Gaps = 23/180 (12%)

Query: 461 VKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI---YEYLPNKSLAD 517
           + +  K+  +   + +NE+L + +L H N++K+           +I   Y++     L  
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYS 251

Query: 518 FIFDGTRRKLLDWSKRC------QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM 571
           F++D       DW  R        I+  +   + Y+H     ++IHRD+K  N+ L+ + 
Sbjct: 252 FMYDEA----FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304

Query: 572 NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE-YAIDGLFSVKSDVFSFGVLVLELV 630
              + DFG A  F   + EA     VGT     PE  A DG   + +D++S G+++L+++
Sbjct: 305 KIVLGDFGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362

Length = 501

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 30/148 (20%), Positives = 54/148 (36%), Gaps = 17/148 (11%)

Query: 435 SEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV--K 492
           S    L  G    VY     D  +  +K     S +   + + EV ++  L  + L   K
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDE-DYVLKI--NPSREKGADREREVAILQLLARKGLPVPK 57

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLHQDS 551
           +L          L+ E++  ++L             +     + +   +A+    LHQ  
Sbjct: 58  VLASGESDGWSYLLMEWIEGETL-------DEVSEEEKEDIAEQLAELLAK----LHQLP 106

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFG 579
            L + H DL   N+L+D+     I D+ 
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 8/98 (8%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN---TNRV 596
           I  GL Y+H  +   ++HRDLK  N+L++ +   KI DFG+AR F  +  E     T   
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-Y 169

Query: 597 VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLELVYGT 633
           V T  Y  PE  +      K+ DV+S G ++ EL+   
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 9/105 (8%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV-VG 598
           I   L YLH      +++RDLK  N++LD + + KI+DFG+ +      ++  T +   G
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCG 157

Query: 599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH 643
           T  Y+ PE   D  +    D +  GV++ E++ G     F++ DH
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG--RLPFYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 14/158 (8%)

Query: 478 EVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQII 537
           E  ++  + H ++++L G         LI   LP      + +   +R +      C I+
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI----AICDIL 185

Query: 538 G---GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
                + R + YLH++   RIIHRD+KA N+ +++  +  + DFG A  F VD       
Sbjct: 186 AIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYY 241

Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
              GT     PE      +    D++S G+++ E+   
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

 Score = 45.0 bits (106), Expect = 4e-06
 Identities = 22/87 (25%), Positives = 36/87 (41%), Gaps = 13/87 (14%)

Query: 322 KLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKN---CSCTAYANADVRGGG 378
              C+     L + ++K+  T+ +  D      EC   C KN    SC A+  A  R   
Sbjct: 2   DEFCKSAGTTLIKIALKIKTTKANTAD------ECANRCEKNGLPFSCKAFVFAKARK-- 53

Query: 379 SGCLLW-FHELTDMKILSEGGQDLYIR 404
             CL + F+ ++ ++     G DLY  
Sbjct: 54  -QCLWFPFNSMSGVRKEFSHGFDLYEN 79

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 48.5 bits (116), Expect = 5e-06
 Identities = 41/194 (21%), Positives = 79/194 (40%), Gaps = 35/194 (18%)

Query: 459 IAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLA 516
           +AVK+  L   S + ++  + E++   +LQH N++  +   +   E  ++   +   S  
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87

Query: 517 DFI---F-DGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 572
           D +   F +G     +       I+  +   L Y+H       IHR +KAS++LL  +  
Sbjct: 88  DLLKTHFPEGLPELAI-----AFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGK 139

Query: 573 PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL--------------FSVKSD 618
             +S    + +           RVV    +  P+ ++  L              ++ KSD
Sbjct: 140 VVLSGLRYSVSM---IKHGKRQRVV----HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSD 192

Query: 619 VFSFGVLVLELVYG 632
           ++S G+   EL  G
Sbjct: 193 IYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 9e-06
 Identities = 60/243 (24%), Positives = 93/243 (38%), Gaps = 66/243 (27%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG V      D   I A+K+L KS      Q V   + E  ++A+  +  +VKL 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKLY 67

Query: 495 GCCMKRDER--MLIYEYLPNKSLAD-------FIFDGTRRKLLDWSKRCQIIGGIARGLL 545
                +DE    LI EYLP   +         F  + TR               IA  +L
Sbjct: 68  --YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAETIL 112

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG----------VDQTEANTNR 595
            +    +L  IHRD+K  N+LLD + + K+SDFG+               +     +   
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 596 --------------------------VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                                      VGT  Y+ PE  +   ++ + D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232

Query: 630 VYG 632
           + G
Sbjct: 233 LVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEE---FKNEVLLIAKLQH 487
           ++F     +G G FG V        +++ A+K LSK       +   F  E  ++A    
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102

Query: 488 RNLVKLLGCCMKRDERML--IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
             +V+L      +D++ L  + EY+P   L + + +    +   W++        A  +L
Sbjct: 103 EWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KWARFY-----TAEVVL 153

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD-QTEANTNRVVGTYGYMP 604
            L     +  IHRD+K  N+LLD   + K++DFG       +     +T   VGT  Y+ 
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGTPDYIS 211

Query: 605 PEY----AIDGLFSVKSDVFSFGVLVLELVYG 632
           PE       DG +  + D +S GV + E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 2/93 (2%)

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
            A  L  L    +  +I+RDLK  N+LLD + +  + DFG+ +    D  + NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             Y+ PE  +   ++   D ++ GVL+ E++ G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 34/96 (35%), Positives = 46/96 (47%), Gaps = 10/96 (10%)

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANTNRVVGTY 600
           R L Y+H  +   + HRDLK  N+L + +   KI DFG+AR AF    T       V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 601 GYMPPEYAIDGLFSVKS----DVFSFGVLVLELVYG 632
            Y  PE    G F  K     D++S G +  E++ G
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.5 bits (113), Expect = 3e-05
 Identities = 55/250 (22%), Positives = 100/250 (40%), Gaps = 52/250 (20%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLSKS-SGQGV--EEFKNEVLLIAKLQHRNLVKLL 494
            +G+GG G VY     +  + +A+K++ +  S   +  + F  E  + A L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ-----------------II 537
             C   D    +Y  +P      +I   T + LL    + +                 I 
Sbjct: 69  SICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE------- 590
             I   + Y+H  S+  ++HRDLK  N+LL       I D+G A    +++ +       
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 591 ---------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL---VLELVYGTRNRGF 638
                        ++VGT  YM PE  +    S  +D+++ GV+   +L L +  R +  
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236

Query: 639 HHVDHHHNLL 648
             + +   +L
Sbjct: 237 RKISYRDVIL 246

Length = 932

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 3e-05
 Identities = 33/121 (27%), Positives = 51/121 (42%), Gaps = 36/121 (29%)

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA--------------------- 581
            L YLH    L I++RDLK  N+LL    +  +SDF ++                     
Sbjct: 115 ALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 582 ------RAFGVDQTEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLELVYG 632
                      ++    +N  VGT  Y+ PE  I G     +V  D ++ G+L+ E++YG
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAV--DWWTLGILLYEMLYG 228

Query: 633 T 633
           T
Sbjct: 229 T 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 4e-05
 Identities = 30/94 (31%), Positives = 41/94 (43%), Gaps = 7/94 (7%)

Query: 540 IARGLL----YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
           I R LL    YLH      IIHRD+K  N+ LD   N  + DFG A              
Sbjct: 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246

Query: 596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             GT     PE      +  K+D++S G+++ E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.8 bits (111), Expect = 4e-05
 Identities = 21/46 (45%), Positives = 31/46 (67%), Gaps = 3/46 (6%)

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 582
           I  +A  L YLH+     IIHRDLK  N+L+ NE + K++DFG+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 18/141 (12%)

Query: 500 RDERML--IYEYLPNKSLADFI--FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
           +D+R L  + EY+P   L + +  +D   +    W++        A  +L L     +  
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYT-----AEVVLALDAIHSMGF 163

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY----AIDG 611
           IHRD+K  N+LLD   + K++DFG       +      +  VGT  Y+ PE       DG
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +  + D +S GV + E++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 28/86 (32%), Positives = 48/86 (55%), Gaps = 6/86 (6%)

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY--AI 609
           +L  +HRD+K  N+L+D   + +++DFG       D T   ++  VGT  Y+ PE   A+
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAM 178

Query: 610 D---GLFSVKSDVFSFGVLVLELVYG 632
           +   G +  + D +S GV + E++YG
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.8 bits (108), Expect = 8e-05
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 4/163 (2%)

Query: 476 KNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ 535
           ++E+  +A   H  +VK        D+ +LI EY     L   I    +  L        
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
           ++    + +L L +    +++HRDLK++N+ L      K+ DFG ++ +    +    + 
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGF 638
             GT  Y+ PE      +S K+D++S GV++ EL+  T +R F
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELL--TLHRPF 271

Length = 478

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 43/238 (18%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           D+F     +G G FG V      D G   A+K L K+     + V   + E  ++ +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
             +VK+      +    LI E+LP   +   +    ++  L        I      +  +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAI 117

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVDQTE---------------- 590
           HQ   L  IHRD+K  N+LLD + + K+SDFG+        +TE                
Sbjct: 118 HQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 591 -ANTNR---------------VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             N+ R                VGT  Y+ PE  +   ++   D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 43/238 (18%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     +G G FG V      D G   A+K L K+     + V   + E  ++ +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
             +VK+      +    LI E+LP   +   +     +K     +  Q    IA  +L +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFY--IAETVLAI 114

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA----------------RAFGVDQTEA 591
               +L  IHRD+K  N+LLD++ + K+SDFG+                  +   D T  
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 592 NTN-----------------RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           N N                   VGT  Y+ PE  +   ++   D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 48/169 (28%), Positives = 68/169 (40%), Gaps = 34/169 (20%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           ++F     +G+G FG V      D G+  A+K L KS     E FK + L   K +   L
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAERDVL 55

Query: 491 --------VKLLGCCMKRDERMLIYEYLPNKSLAD-------FIFDGTRRKLLDWSKRCQ 535
                   V L           LI E+LP   L         F  D TR           
Sbjct: 56  AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY--------- 106

Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 584
               +A  +L +    +L  IHRD+K  N+L+D   + K+SDFG++  F
Sbjct: 107 ----MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.6 bits (102), Expect = 4e-04
 Identities = 35/119 (29%), Positives = 54/119 (45%), Gaps = 24/119 (20%)

Query: 554 RIIHRDLKASNVLLD-------------NEMN----PKISDFGMARAFGVDQTEANTNRV 596
           R++HRDLK  N+ L              N +N     KI DFG+++  G+   E+  +  
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSC 201

Query: 597 VGTYGYMPPEYAIDGLFSV--KSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWR 653
           VGT  Y  PE  +    S   KSD+++ G ++ EL  G     FH  ++   L+    R
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG--KTPFHKANNFSQLISELKR 258

Length = 1021

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.8 bits (99), Expect = 7e-04
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 13/147 (8%)

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           + N +KL          +LI +Y+ +  L D +    +   L  ++  +II  +   L  
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL---KKEGKLSEAEVKKIIRQLVEALND 124

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           LH   +  IIH D+K  NVL D   +   + D+G+ +  G            GT  Y  P
Sbjct: 125 LH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSP 175

Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E      + V  D ++ GVL  EL+ G
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 40/206 (19%), Positives = 91/206 (44%), Gaps = 26/206 (12%)

Query: 448 VYKGMLIDGQEIAVKRL---SKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM 504
           +YKG+  + +E+ ++      K     ++  +NE+  + ++   N++K+ G  +   + +
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 505 ----LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRD 559
               LI EY     L + +    + K L +  +  +     +GL  L++  ++    +++
Sbjct: 95  PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKN 148

Query: 560 LKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS---VK 616
           L + + L+      KI   G+ +       + N N +V    Y   +   D +FS   +K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFK-NVNFMV----YFSYKMLND-IFSEYTIK 202

Query: 617 SDVFSFGVLVLELVYGTRNRGFHHVD 642
            D++S GV++ E+   T    F ++ 
Sbjct: 203 DDIYSLGVVLWEIF--TGKIPFENLT 226

Length = 283

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 61/256 (23%), Positives = 99/256 (38%), Gaps = 77/256 (30%)

Query: 420 PIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG---------- 469
           P+ D  +   ++D+F   +KLG G FG  ++G+ +   +  V + SK +           
Sbjct: 133 PLADGANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLK 192

Query: 470 ------QGV---------------EEFKNEVLLIAKLQHRNLVKLLGCC----------- 497
                 QGV               E    E  + AK++ RN +    C            
Sbjct: 193 RVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIK-RNPIAAASCAEYLGYFTSNTA 251

Query: 498 ---MKRDERMLIYEYLPNKSLADFI------FDGTRRKLLDWSKRC-----------QII 537
                +  + L++++  + +L D +      F G   + +   K+             +I
Sbjct: 252 DGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVI 311

Query: 538 GGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ-TEAN 592
            G+ R    GL  LH   R+ I+HRD+K  N+L+  +   KI DFG A    VD  T  N
Sbjct: 312 KGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA----VDMCTGIN 364

Query: 593 TNRVVGTYG--YMPPE 606
            N + G     Y PPE
Sbjct: 365 FNPLYGMLDPRYSPPE 380

Length = 507

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 38/155 (24%), Positives = 69/155 (44%), Gaps = 10/155 (6%)

Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRN 489
           F +   LG G FG V     +D   + A+K L K    +   V   K E  ++A+  +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +VKL      +D    + +Y+P   +   +      ++  + +       IA   L +  
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-----RMEVFPEVLARFY-IAELTLAIES 116

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 584
             ++  IHRD+K  N+L+D + + K++DFG+   F
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 10/155 (6%)

Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSS---GQGVEEFKNEVLLIAKLQHRN 489
           F +   LG G FG V     +D + + A+K L K        V   K E  ++A+  +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +V+L      +D    + +Y+P   +   +    R  +         I  +   +  +H 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVH- 118

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 584
             ++  IHRD+K  N+L+D + + K++DFG+   F
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins

 Score = 35.7 bits (83), Expect = 0.003
 Identities = 9/35 (25%), Positives = 14/35 (40%)

Query: 270 IDQCDNYALCGTYAICKMNSNSAECECLEGFEPKS 304
           ID+C +   C     C     S  C C  G+  ++
Sbjct: 2   IDECASGNPCQNGGTCVNTVGSYRCSCPPGYTGRN 36

Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements. Length = 38

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 48/244 (19%), Positives = 91/244 (37%), Gaps = 51/244 (20%)

Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSS---GQGVEEFKNEVLLIAKLQHRN 489
           F +   +G G FG V     +D   + A+K L K+           K E  ++A+  +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +VKL      +D    + +Y+P   +   +    R  + +       I  +   +  +H 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVH- 118

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF------------------------- 584
             ++  IHRD+K  N+L+D + + K++DFG+   F                         
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 585 ----------------GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE 628
                                    + +VGT  Y+ PE  +   ++   D +S GV++ E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 629 LVYG 632
           ++ G
Sbjct: 237 MLVG 240

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	751
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
PRK10345	210	hypothetical protein; Provisional	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.72
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.72
smart00090	237	RIO RIO-like kinase.	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.69
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.58
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.45
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.44
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.28
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.28
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.22
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.13
KOG1243	690	consensus Protein kinase [General function predict	99.12
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.11
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.1
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.1
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.05
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.04
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.02
KOG3087	229	consensus Serine/threonine protein kinase [General	98.97
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.85
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.84
COG4248	637	Uncharacterized protein with protein kinase and he	98.78
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.63
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.6
PRK09902	216	hypothetical protein; Provisional	98.55
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.47
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.46
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.39
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.25
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.25
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.22
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.16
PF01636	239	APH: Phosphotransferase enzyme family This family	98.14
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.14
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	98.14
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.12
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.1
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.05
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.01
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.0
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.99
PLN02876	822	acyl-CoA dehydrogenase	97.98
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.9
PRK10593	297	hypothetical protein; Provisional	97.74
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	97.73
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.67
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.64
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.59
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.57
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.55
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.53
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.29
PRK05231	319	homoserine kinase; Provisional	97.29
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.25
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.23
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.0
PLN02236	344	choline kinase	96.93
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.93
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.89
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.82
PLN02756	418	S-methyl-5-thioribose kinase	96.69
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.39
KOG2270	520	consensus Serine/threonine protein kinase involved	96.28
PRK12396	409	5-methylribose kinase; Reviewed	96.2
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.99

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-52  Score=446.57  Aligned_cols=291  Identities=45%  Similarity=0.756  Sum_probs=257.6

Q ss_pred             cCCcccHHhHHHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEecee
Q 038934          418 ELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC  497 (751)
Q Consensus       418 ~l~~~~~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  497 (751)
                      ....|++.++..+|++|...++||+|+||.||+|.+.+++.||||++.....+...+|.+|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56779999999999999999999999999999999999999999988765433145699999999999999999999999


Q ss_pred             eeCC-ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEe
Q 038934          498 MKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  576 (751)
Q Consensus       498 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~  576 (751)
                      .+.+ +++||||||++|+|.++|+..... .++|..+++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999764433 88999999999999999999999988899999999999999999999999


Q ss_pred             eccCccccCCCCcccccccc-ccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh
Q 038934          577 DFGMARAFGVDQTEANTNRV-VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       577 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      |||+|+.....  ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+...+.....++.|++..+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999765431  1111112 89999999999999999999999999999999999999988776666666889999999


Q ss_pred             ccCChhhhcchhcc-CccCH-HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCC
Q 038934          656 TEDRPVELIDKSLE-DTYSL-SEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSL  711 (751)
Q Consensus       656 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  711 (751)
                      ..+...+++|+.+. +.+.. .+...+..++.+|++.+|.+||+|.+|+++|+.+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            99999999999987 55554 6788899999999999999999999999999665433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-46  Score=397.83  Aligned_cols=245  Identities=28%  Similarity=0.416  Sum_probs=215.7

Q ss_pred             cCccccccccccccccEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .+|...+.||+|||+.+|+++. ..|..||+|++.+.   .....+.+.+||+|.+.|+|||||+++++|++.+.+|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999996 77999999999874   4556788999999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      |+|+.++|.+++.   +++.+++.+++.+++||+.||.|||+++   |+|||||..||||+++.+|||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999994   7788999999999999999999999999   999999999999999999999999999998655


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      ....  .+++|||.|+|||++....++..+||||+|||||-||.|++||+....                   .+..+..
T Consensus       172 ~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-------------------kety~~I  230 (592)
T KOG0575|consen  172 GERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-------------------KETYNKI  230 (592)
T ss_pred             cccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-------------------HHHHHHH
Confidence            4433  458999999999999999999999999999999999999999764332                   2223332


Q ss_pred             ccCcc--CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          668 LEDTY--SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       668 l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ....+  +...+.+..+||.++|+.||.+|||+++|+.
T Consensus       231 k~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  231 KLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            22222  3345667889999999999999999999994

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-46  Score=378.62  Aligned_cols=247  Identities=26%  Similarity=0.398  Sum_probs=204.8

Q ss_pred             HhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcc-------cHHHHHHHHHHHHHhcCCcEEeEeceeeeCC
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQ-------GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD  501 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  501 (751)
                      ..+.|.+.+.||+|+||.|-+|.. ++++.||||++.+....       ....+++|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456788899999999999999994 56999999999765211       1223579999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC---CCeEEeec
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDF  578 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DF  578 (751)
                      ..|||||||+||.|.+.+.   ..+.+.+..-..+++|++.|+.|||++|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999995   4556788888999999999999999999   9999999999999765   77999999


Q ss_pred             cCccccCCCCccccccccccccCccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh
Q 038934          579 GMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       579 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      |+|+..+   ....+.+.+|||.|.|||++.+..   +..|+|+||+||+||-+|+|..||.-...+.            
T Consensus       324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------------  388 (475)
T KOG0615|consen  324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------------  388 (475)
T ss_pred             chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------------
Confidence            9999875   334456689999999999998764   3458899999999999999999986433322            


Q ss_pred             ccCChhhhcchhccCcc------CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          656 TEDRPVELIDKSLEDTY------SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                            .+.+....+.+      -....++..+||.+||+.||++|||+.|+++
T Consensus       389 ------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  389 ------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                  11222222222      2335668899999999999999999999985

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=371.13  Aligned_cols=247  Identities=27%  Similarity=0.361  Sum_probs=209.0

Q ss_pred             CccccccccccccccEEEEEEcC-CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc-eEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE-RMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~E~  509 (751)
                      +.+..+.||+|..|+|||++|+. ++.+|+|++... .+...+++.+|+++++..+||+||+++|+|..... ..++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            44566789999999999999864 778999999654 44556789999999999999999999999999994 9999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |++|||++++..   .+.+++....+|+.+|++||.|||+ .+   ||||||||+||||+..|.|||+|||.++.+... 
T Consensus       160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            999999999943   3669999999999999999999996 66   999999999999999999999999999876433 


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                         ....++||..|||||.+.+..|+.++||||||++++|+++|+.|+.......              ....++++.++
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~--------------~~~~~Ll~~Iv  295 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY--------------LDIFELLCAIV  295 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC--------------CCHHHHHHHHh
Confidence               4456899999999999999999999999999999999999999977541111              12233333333


Q ss_pred             cCc---cCH-HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          669 EDT---YSL-SEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       669 ~~~---~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .+.   .+. ..+.++..++..||++||.+||++.++++
T Consensus       296 ~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  296 DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            322   122 35678999999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=368.79  Aligned_cols=202  Identities=31%  Similarity=0.526  Sum_probs=182.9

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ..+|...++||+|.|++||+|+++ ++..||||.+.+.  .....+-+..|+.+|+.++|||||++++++..++.++|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            468888899999999999999976 4889999999876  5566777899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC------CCeEEeeccCc
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE------MNPKISDFGMA  581 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~------~~~kl~DFGla  581 (751)
                      |||.||+|.++|.   +++.+++..+..++.|||.||++||+++   ||||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999994   4557999999999999999999999999   9999999999999764      45899999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHV  641 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~  641 (751)
                      +.+.   ........+|++.|||||++..++|+.|+|+||+|++||+|++|+.||.....
T Consensus       163 R~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  163 RFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             hhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            9875   33444568999999999999999999999999999999999999999875443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-44  Score=379.18  Aligned_cols=253  Identities=32%  Similarity=0.485  Sum_probs=209.0

Q ss_pred             ccccccccccccEEEEEEcCCcEEEEEEeccCCcc--cHHHHHHHHHHHHHhcCCcEEeEeceeeeCC-ceEEEEEecCC
Q 038934          436 EENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQ--GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD-ERMLIYEYLPN  512 (751)
Q Consensus       436 ~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~~~  512 (751)
                      ..+.||+|+||+||+|.+.....||||++......  ..++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            34569999999999999955445999999764322  2569999999999999999999999999988 79999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC-CeEEeeccCccccCCCCccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~~~~  591 (751)
                      |+|.+++... ....+++..+++++.|||+||.|||+++.  ||||||||+||||+.++ ++||+|||+++......  .
T Consensus       125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            9999999754 46679999999999999999999999874  99999999999999998 99999999998764322  2


Q ss_pred             cccccccccCccCccccc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          592 NTNRVVGTYGYMPPEYAI--DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~--~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      ......||+.|||||++.  ..+|+.|+||||||++||||++|+.||......      ..+..         ++....+
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~---------v~~~~~R  264 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASA---------VVVGGLR  264 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHH---------HHhcCCC
Confidence            233378999999999999  669999999999999999999999997643321      11111         1111222


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...+......+..|+.+|++.||..||++.+++..|+.+
T Consensus       265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            233333567888999999999999999999999999976

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-45  Score=354.84  Aligned_cols=254  Identities=25%  Similarity=0.406  Sum_probs=209.7

Q ss_pred             cCccccccccccccccEEEEE-EcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEec-eeeeCCc-eEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLG-CCMKRDE-RMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV  506 (751)
                      .+|.+.++||+|.||.|||++ +.+|..+|.|.+.-.  ..+..+.+..|+.+|++|+|||||++++ .+.+++. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            468889999999999999999 567999999999743  4556678999999999999999999998 5555555 8999


Q ss_pred             EEecCCCChhHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          507 YEYLPNKSLADFIFD-GTRRKLLDWSKRCQIIGGIARGLLYLHQDS-RLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      ||++..|+|..+|.. ...++.+++..+++++.|+++||.++|++- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999965 345567999999999999999999999842 234999999999999999999999999999998


Q ss_pred             CCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ......  ....+|||.||+||.+.+.+|+.|+||||+||++|||..-+.||....                   ..++-
T Consensus       179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------------------~~~L~  237 (375)
T KOG0591|consen  179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------------------LLSLC  237 (375)
T ss_pred             cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------------------HHHHH
Confidence            654333  345899999999999999999999999999999999999999976431                   12222


Q ss_pred             chhccCccC----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          665 DKSLEDTYS----LSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       665 d~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      .++-++.++    ...+..+..||..|+..||+.||+...+++.+.
T Consensus       238 ~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  238 KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            222233332    345678999999999999999999655554443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=358.75  Aligned_cols=239  Identities=27%  Similarity=0.374  Sum_probs=205.2

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|++.++||+|+||+||.++.++ ++.+|+|++++.   .....+..++|..+|..++||+||+++..|++.+++|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4789999999999999999999655 888999999875   334567889999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      +||+.||.|.-+|   ++...+++..+.-++.+|+.||.|||+++   ||||||||+|||||++|+++|+|||+++..-.
T Consensus       104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999999   45667999999999999999999999999   99999999999999999999999999996532


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      .  ...+..++||+.|||||++.+..|+.++|.||||+++|||++|.+||...+.                   .+.++.
T Consensus       178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-------------------~~~~~~  236 (357)
T KOG0598|consen  178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-------------------KKMYDK  236 (357)
T ss_pred             C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-------------------HHHHHH
Confidence            2  2234458999999999999999999999999999999999999999764332                   222333


Q ss_pred             hccCc---cCHHHHHHHHHHHhhhcCCCCCCCC
Q 038934          667 SLEDT---YSLSEALRCIQVGLLCVQQRPEDRP  696 (751)
Q Consensus       667 ~l~~~---~~~~~~~~l~~li~~cl~~dP~~RP  696 (751)
                      .+.+.   .+.-...+..+++.+.|+.||++|.
T Consensus       237 I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  237 ILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            33222   1222456788999999999999995

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=360.73  Aligned_cols=256  Identities=32%  Similarity=0.483  Sum_probs=210.8

Q ss_pred             ccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCC
Q 038934          434 FSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      +...+.||+|-||.||.|.+.....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..++.++||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            3456789999999999999978889999999654 345578999999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccc
Q 038934          514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT  593 (751)
Q Consensus       514 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  593 (751)
                      +|.++|.. .....+.....+.++.|||+||+||++++   +|||||.+.||||+++..+||+|||||+....+......
T Consensus       287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~  362 (468)
T KOG0197|consen  287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE  362 (468)
T ss_pred             cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence            99999976 34567899999999999999999999999   999999999999999999999999999965544333222


Q ss_pred             cccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       594 ~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                       ...-...|.|||.+....++.|||||||||+|+||+| |+.|++.....                +..+.++.-.+-..
T Consensus       363 -~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev~~~le~GyRlp~  425 (468)
T KOG0197|consen  363 -GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EVLELLERGYRLPR  425 (468)
T ss_pred             -CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HHHHHHhccCcCCC
Confidence             2334567999999999999999999999999999998 55554322211                11122222222233


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCC
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSL  711 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  711 (751)
                      +..++..+.+|+..|+..+|++|||++.+...|+.+...
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            445677889999999999999999999999999886543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8e-42  Score=334.50  Aligned_cols=264  Identities=21%  Similarity=0.306  Sum_probs=204.5

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      +.|+...++|+|+||+|||+++++ |+.||||++....+  ...+-.++|+++|++++|+|+|.++++|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            467788899999999999999765 99999999976533  334557899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |++..-|+++=.   ....++.+.+.+++.|++.|+.|+|+++   +|||||||+||||+.++.+||+|||+|+.+....
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            999866666542   2234789999999999999999999999   9999999999999999999999999999876422


Q ss_pred             ccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhH--------HHHHHhccC-
Q 038934          589 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLG--------HAWRLWTED-  658 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~--------~~~~~~~~~-  658 (751)
                        ..-...+.|..|+|||.+.+ .+|...+||||+||++.||++|..-+.....-++-.++.        .-...+... 
T Consensus       156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence              22234688999999999988 689999999999999999999998776554432211111        111111111 


Q ss_pred             ChhhhcchhccCcc-----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          659 RPVELIDKSLEDTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       659 ~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ....+.-+......     -.....-+++++..||+.||++|++-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11111111111111     1223347789999999999999999999983

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-41  Score=351.04  Aligned_cols=267  Identities=24%  Similarity=0.367  Sum_probs=208.9

Q ss_pred             HHhcCccccccccccccccEEEEE-EcCCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--Cce
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DER  503 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  503 (751)
                      ...+.|+..++||+|.||.||+|+ ..+|+.||+|+++...  +.......+||.||++|.||||+++.+...+.  ..+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            445678888999999999999999 4569999999998654  44456678999999999999999999999887  689


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      |||+|||++ +|.-++.  ...-.+++.++..++.||+.||.|+|+++   |+|||||.+|||||.+|.+||+|||||++
T Consensus       194 YlVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceee
Confidence            999999987 7887773  23446899999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH-----HHhcc
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW-----RLWTE  657 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~-----~~~~~  657 (751)
                      +........+. .+-|..|+|||++.|. .|+.++|+||.||||.||+.|+..+.....-++...+...-     ..|..
T Consensus       268 y~~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~  346 (560)
T KOG0600|consen  268 YTPSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV  346 (560)
T ss_pred             ccCCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence            87655544443 5679999999999986 69999999999999999999998876655433221111110     01110


Q ss_pred             CChh--------hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          658 DRPV--------ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       658 ~~~~--------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .++.        .-....+.+. ........++|+..+|..||.+|.|+.++++
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            0000        0011111111 1223446788999999999999999999985

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.9e-41  Score=321.92  Aligned_cols=281  Identities=24%  Similarity=0.338  Sum_probs=216.0

Q ss_pred             cCccccccccccccccEEEEEE-cCCcEEEEEEeccCCc-c-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSG-Q-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|...++||+|.||+||+|++ .+|+.||||+++.... + ......+|+..|+.++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4788889999999999999994 5699999999975522 2 23467899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      ||+. +|+..|.+  +...+....+..++.++++||+|||++.   |+||||||.|+|++++|.+||+|||+|+.++...
T Consensus        82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9965 89999964  4457899999999999999999999998   9999999999999999999999999999987655


Q ss_pred             ccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC---hhhhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR---PVELI  664 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  664 (751)
                      .....  .+-|..|+|||.+.|. .|+..+||||.|||+.||+.|.+-+.....-++...+-.+........   +.++.
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            44433  3678999999999876 699999999999999999998776554443222221111111111111   11111


Q ss_pred             chh--------ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCCcc
Q 038934          665 DKS--------LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFT  721 (751)
Q Consensus       665 d~~--------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~p~~~~  721 (751)
                      |..        .....-......+.+|+..|+..||.+|++++|++++= -....|.|..|.-+.
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~lp  297 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSKLP  297 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhhCc
Confidence            111        11112234455779999999999999999999999762 234456555554443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=353.64  Aligned_cols=253  Identities=26%  Similarity=0.351  Sum_probs=211.3

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCce
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  503 (751)
                      +...+|..++.||+|+|++|++|+.. .++.||||++.+.   .+...+-+..|-.+|.+| .||.|++|+..|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            44578999999999999999999954 5899999999765   233445678899999999 799999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      |+|+||+++|+|.++|.   +.+.+++.-+..++.+|+.||.|||+.|   ||||||||+|||||+++++||+|||.|+.
T Consensus       150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999994   5577999999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCcc-----------ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH
Q 038934          584 FGVDQTE-----------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       584 ~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      +......           .....++||..|++||++.....+..+|+|+||||||+|+.|++||..........      
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq------  297 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ------  297 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH------
Confidence            8532221           11245899999999999999999999999999999999999999976443321111      


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                               ++++  +.-.++....+.+.+|+.+.|..||.+|++..+|-+.
T Consensus       298 ---------kI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  298 ---------KIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ---------HHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                     1110  1122333445778899999999999999999999864

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=326.44  Aligned_cols=235  Identities=27%  Similarity=0.352  Sum_probs=204.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|+..+.||.|+||.|.+++.+ +|..+|+|++.+..   -...+...+|..+|+.+.||+++++++.+.+...++||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            367888899999999999999965 48889999997652   23456678999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||++||.|..+++   +.+.+++..+..++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||.|+... 
T Consensus       123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-  195 (355)
T KOG0616|consen  123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-  195 (355)
T ss_pred             EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence            99999999999994   4556899999999999999999999999   9999999999999999999999999999753 


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                          ..+-+++|||.|+|||++...++..++|.|||||++|||+.|..||....+                   ..+.++
T Consensus       196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------------------~~iY~K  252 (355)
T KOG0616|consen  196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------------------IQIYEK  252 (355)
T ss_pred             ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------------------HHHHHH
Confidence                335568999999999999999999999999999999999999999753332                   334444


Q ss_pred             hccCc--cCHHHHHHHHHHHhhhcCCCCCCC
Q 038934          667 SLEDT--YSLSEALRCIQVGLLCVQQRPEDR  695 (751)
Q Consensus       667 ~l~~~--~~~~~~~~l~~li~~cl~~dP~~R  695 (751)
                      ++.+.  ++......+.+|+...|+.|-.+|
T Consensus       253 I~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 ILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            44444  344556688899999999999999

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=348.64  Aligned_cols=267  Identities=24%  Similarity=0.324  Sum_probs=208.1

Q ss_pred             HHhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHH-HHHHHHHHHHhc-CCcEEeEeceeeeCC-ceE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQ-HRNLVKLLGCCMKRD-ERM  504 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~  504 (751)
                      ...++|...++||.|.||.||+|+. ..+..||||++++......+. =.+|+..|++|+ |||||++.+++.+.+ .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3457899999999999999999994 468999999998765443332 368999999998 999999999999998 999


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +|||||+. +|.+++.+  +.+.+++..+..|+.||++||+|+|.+|   +.|||+||+|||+.....+||+|||+|+.+
T Consensus        87 fVfE~Md~-NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhhh-hHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            99999955 99999975  4778999999999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCccccccccccccCccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH-----HHhccC
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW-----RLWTED  658 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~-----~~~~~~  658 (751)
                      .....   -...+.|..|+|||++. ..-|+.++|||++|||++|+.+-+.-|.....-++-..+-...     ..|.++
T Consensus       161 ~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  161 RSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             ccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence            53322   23478899999999986 5679999999999999999999988876544322111000000     001110


Q ss_pred             -Chhhhcchhcc-------CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          659 -RPVELIDKSLE-------DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       659 -~~~~~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       .....+.-.+.       ...-.....++.+++.+|++.||++|||+++++++
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence             00111111110       01112256688999999999999999999999974

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=343.33  Aligned_cols=256  Identities=28%  Similarity=0.409  Sum_probs=203.4

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC--ceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD--ERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~E  508 (751)
                      .++...+.||+|.||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|.....+  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            456778899999999999999654 8999999997653333678999999999999999999999855554  6899999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-CCCeEEeeccCccccCC-
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGV-  586 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~-  586 (751)
                      |+++|+|.+++.....  .+++..+.++.+||++||+|||+++   ||||||||+||||+. ++.+||+|||+++.... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999964332  6999999999999999999999999   999999999999999 79999999999987653 


Q ss_pred             CCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ...........||+.|||||++.++ ....++|||||||++.||+||+.|+...     ..............       
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~-------  239 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED-------  239 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-------
Confidence            1122223357899999999999964 3446999999999999999999985432     00011111111111       


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                        ....++...+.+..+++.+|++.||++|||++++++..-
T Consensus       240 --~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  240 --SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             --CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence              111334445667889999999999999999999997543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=337.09  Aligned_cols=262  Identities=23%  Similarity=0.355  Sum_probs=210.4

Q ss_pred             hcCccccccccccccccEEEEE-EcCCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .+.|+..++||.|..++||+|+ .+.+..||||++... .....+.+++|+..|+.++||||++++..|..+..+++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4689999999999999999999 567899999999754 33346899999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      ||.+||+.++++..-..+ +++..+..|++++++||.|||.+|   .||||||+.||||+++|.|||+|||.+..+-...
T Consensus       105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999997644443 899999999999999999999999   9999999999999999999999999876553222


Q ss_pred             ccc--cccccccccCccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          589 TEA--NTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       589 ~~~--~~~~~~gt~~y~aPE~~~~--~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      .+.  +...+.||+.|||||++..  ..|+.|+||||||++..||.+|..||.-..+-      ......+....+.-. 
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp~~~-  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPPTLL-  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCCCcc-
Confidence            221  1146789999999999653  46999999999999999999999997633321      111122222222111 


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      -..+..+........+.+++..||+.||.+|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            112222223334457889999999999999999999984

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=352.97  Aligned_cols=247  Identities=23%  Similarity=0.360  Sum_probs=207.3

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC----Cc-ccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCC
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS----SG-QGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRD  501 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  501 (751)
                      ....+|...+.||+|.||+|++|.+. ++..||||.+.+.    .. ...+.+.+|+.+++.+. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34578999999999999999999854 5899999977653    12 34556778999999998 999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-CCeEEeeccC
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGM  580 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGl  580 (751)
                      +.++||||+.+|+|.+++..   .+.+.+..+..+++|++.|++|||+++   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999954   567889999999999999999999999   9999999999999999 9999999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL-FS-VKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      +....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...                  
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------------------  227 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------------------  227 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------------------
Confidence            99864  2223345589999999999999987 85 78999999999999999999987411                  


Q ss_pred             ChhhhcchhccCcc--CHHH-HHHHHHHHhhhcCCCCCCCCCHHHHH
Q 038934          659 RPVELIDKSLEDTY--SLSE-ALRCIQVGLLCVQQRPEDRPNMASVV  702 (751)
Q Consensus       659 ~~~~~~d~~l~~~~--~~~~-~~~l~~li~~cl~~dP~~RPs~~evl  702 (751)
                       ...+......+.+  +... ..++..|+.+||+.||.+|+++.+++
T Consensus       228 -~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  228 -VPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             -HHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence             1111111222222  1122 67889999999999999999999999

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=352.44  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=212.4

Q ss_pred             cCccccccccccccccEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      ..|....+||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.+...+.+++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            456677799999999999999 4568999999998877677788999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++|+|.|.+    ....+++..+..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+......
T Consensus       353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            999999998    3345899999999999999999999999   999999999999999999999999999887655443


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                        ....+|||.|||||++....|++|+||||||++++||+.|.+|+-.+.+-      ...+.....+.+        .-
T Consensus       426 --R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyLIa~ng~P--------~l  489 (550)
T KOG0578|consen  426 --RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGTP--------KL  489 (550)
T ss_pred             --cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHHHhhcCCC--------Cc
Confidence              34479999999999999999999999999999999999999997653332      111221222211        11


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..+...+..+.+++.+||+.|+++||++.|+|+.
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            2233445678899999999999999999999964

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.6e-40  Score=353.76  Aligned_cols=260  Identities=27%  Similarity=0.420  Sum_probs=204.1

Q ss_pred             hcCccccccccccccccEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCC-
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRD-  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-  501 (751)
                      .++|++.++||+|+||.||+|.+.      .++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            468899999999999999999742      24679999997542 23456789999999999 8999999999887654 


Q ss_pred             ceEEEEEecCCCChhHHHhccCC---------------------------------------------------------
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTR---------------------------------------------------------  524 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  524 (751)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999999864211                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCc
Q 038934          525 --RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY  602 (751)
Q Consensus       525 --~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  602 (751)
                        ...+++..+..++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134788899999999999999999998   999999999999999999999999999865432222222234567889


Q ss_pred             cCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHH
Q 038934          603 MPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCI  681 (751)
Q Consensus       603 ~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  681 (751)
                      +|||++.+..++.++|||||||+||||++ |..|+........      .......+...         ..+......+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRM---------RAPENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCC---------CCCCCCCHHHH
Confidence            99999999999999999999999999997 9988764322110      11111111110         11122345688


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          682 QVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       682 ~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      +|+.+|++.||++||++.++++.|+.+
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-40  Score=354.08  Aligned_cols=243  Identities=26%  Similarity=0.385  Sum_probs=211.8

Q ss_pred             HHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCc
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDE  502 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  502 (751)
                      ....++|...++||+|.||+|+++..+ +++.+|||.+++.   ....++..+.|.+|+..+. ||.|+.++.+|...++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            345589999999999999999999965 4789999999876   4567888999999999885 9999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      +++||||+.||++..+    .+...+++..+.-++..|+.||.|||+++   |||||||.+|||||.+|++||+||||++
T Consensus       444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999994443    35567999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      .....  ...+.+++|||.|||||++.+..|+.++|.|||||+|||||.|+.||...+                   -.+
T Consensus       517 e~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-------------------Eee  575 (694)
T KOG0694|consen  517 EGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-------------------EEE  575 (694)
T ss_pred             ccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-------------------HHH
Confidence            75322  234667999999999999999999999999999999999999999966433                   344


Q ss_pred             hcchhccCc--cCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 038934          663 LIDKSLEDT--YSLSEALRCIQVGLLCVQQRPEDRPNM  698 (751)
Q Consensus       663 ~~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~  698 (751)
                      +.|.++..+  ++.-.+.+.+.|+.++|..+|++|.-+
T Consensus       576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            555555544  566677899999999999999999887

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.8e-40  Score=346.71  Aligned_cols=263  Identities=25%  Similarity=0.383  Sum_probs=221.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|.+.+.||+|.||+||||+.+ +.+.||+|.+.+.  .+...+.+.+|+++++.++|||||.+++.|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999965 5789999999765  44456779999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+.| +|..+|.   ..+.++++.+..|+.++..||.|||+..   |+|||+||.|||++..+.+|++|||+|+..... 
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9988 9999995   4556999999999999999999999998   999999999999999999999999999976542 


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                       ......+.|||.|||||++.+++|+..+|+||+|||||||++|++||-.                   ....+++..++
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------------------~si~~Lv~~I~  213 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------------------RSITQLVKSIL  213 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------------------HHHHHHHHHHh
Confidence             2334568999999999999999999999999999999999999999642                   12223333333


Q ss_pred             cCc--cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhC-CCCCCCCCCCCCccc
Q 038934          669 EDT--YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSG-ERSLPQPKQPGFFTE  722 (751)
Q Consensus       669 ~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~-~~~~~~p~~p~~~~~  722 (751)
                      .+.  .+......+..++.-.|++||..|.+..+++.  +.++ +...+.|.+|++...
T Consensus       214 ~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~sp  272 (808)
T KOG0597|consen  214 KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSP  272 (808)
T ss_pred             cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCc
Confidence            332  34456778899999999999999999999985  3333 456666777776544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-39  Score=341.47  Aligned_cols=271  Identities=23%  Similarity=0.297  Sum_probs=216.4

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ..++|+.+++||+|+||.||+++.+ +|..+|+|++++.   ....++.++.|-.+|....+|.||+++..|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999955 5899999999876   34456778999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||++||++..+|   .+...|++..+..++.+++.|+..||+.|   +|||||||+|+|||..|++||+||||++-+.
T Consensus       219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999   46678999999999999999999999999   9999999999999999999999999986442


Q ss_pred             CC-----------------------Cc-----cc-----------------cccccccccCccCcccccCCCCCcchhhH
Q 038934          586 VD-----------------------QT-----EA-----------------NTNRVVGTYGYMPPEYAIDGLFSVKSDVF  620 (751)
Q Consensus       586 ~~-----------------------~~-----~~-----------------~~~~~~gt~~y~aPE~~~~~~~t~k~DVw  620 (751)
                      ..                       ..     ..                 .....+|||.|+|||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                       00     00                 01135799999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC---
Q 038934          621 SFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN---  697 (751)
Q Consensus       621 SlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---  697 (751)
                      |||||+||||.|.+||....+.+...-+..-...             +.-........+..+||.+||. ||++|.-   
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            9999999999999998876665432211111000             1111112223678899999999 9999976   


Q ss_pred             HHHHHHH-------HhCCCCCCCCCCCCCc
Q 038934          698 MASVVLM-------LSGERSLPQPKQPGFF  720 (751)
Q Consensus       698 ~~evl~~-------L~~~~~~~~p~~p~~~  720 (751)
                      +.||-++       .+.+.+.+.|..|...
T Consensus       439 ~~EIK~HPfF~~v~W~~l~~~~apfvP~v~  468 (550)
T KOG0605|consen  439 AEEIKKHPFFKGVDWDHLREMPAPFVPQVN  468 (550)
T ss_pred             HHHHhcCCccccCCcchhhcCCCCCCCCCC
Confidence            5555432       2345666666666654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-40  Score=349.92  Aligned_cols=255  Identities=27%  Similarity=0.388  Sum_probs=216.5

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .-|+.++-||.|+.|.|-+|++. +|+..|||++.+..   ......+.+|+.||+.+.|||+++++++++...++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45677889999999999999965 59999999997652   223456889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++|-|.+++   .+++.+++.++.+++.||+.|+.|+|..+   |+|||+||+|+|||..+++||+|||+|.+-   
T Consensus        92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe---  162 (786)
T KOG0588|consen   92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE---  162 (786)
T ss_pred             EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc---
Confidence            999999999999   46678999999999999999999999999   999999999999999999999999999863   


Q ss_pred             CccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      .......+.+|+|.|+|||++.|.+| +.++||||.|||||.||+|+.||+                   ++....++.+
T Consensus       163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-------------------DdNir~LLlK  223 (786)
T KOG0588|consen  163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-------------------DDNIRVLLLK  223 (786)
T ss_pred             cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-------------------CccHHHHHHH
Confidence            23334456799999999999999998 579999999999999999999976                   2333344444


Q ss_pred             hccCccCH--HHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCCCCCCCC
Q 038934          667 SLEDTYSL--SEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGERSLPQP  714 (751)
Q Consensus       667 ~l~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~p  714 (751)
                      .-.+.+.+  ....++.+|+.+||..||.+|.|+.||++  .|.+...++.+
T Consensus       224 V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  224 VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            44444433  34567889999999999999999999997  45565555554

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-40  Score=332.08  Aligned_cols=247  Identities=24%  Similarity=0.414  Sum_probs=211.6

Q ss_pred             hcCccccccccccccccEEEEE-EcCCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ..+|++.+.||+|.||.|-++. +..|+.||||.+++.   .++..-.+++|++||..|+||||++++.+|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            4578899999999999999999 577999999999875   445566789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||..+|.|.+++   ..++.+++.++.++++||..|+.|+|.++   ++|||||.+|||||.++++||+|||++.++..
T Consensus       132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999999   56677999999999999999999999998   99999999999999999999999999988753


Q ss_pred             CCccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      .   .....++|+|-|.+||++.|.+| .+.+|-|||||+||.|+.|..||+..+-                   ..++.
T Consensus       206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------------------k~lvr  263 (668)
T KOG0611|consen  206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------------------KRLVR  263 (668)
T ss_pred             c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------------------HHHHH
Confidence            3   33456899999999999999998 5789999999999999999999774332                   12222


Q ss_pred             hhccCccC-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          666 KSLEDTYS-LSEALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       666 ~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                      .+-.+.+. ........-||+|||..+|++|.|+.+|....
T Consensus       264 QIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  264 QISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             HhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            22233322 22234567899999999999999999998654

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=333.87  Aligned_cols=257  Identities=27%  Similarity=0.381  Sum_probs=207.0

Q ss_pred             HHhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCC--------------cccHHHHHHHHHHHHHhcCCcEEeE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSS--------------GQGVEEFKNEVLLIAKLQHRNLVKL  493 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l  493 (751)
                      +..++|++.+.||+|.||.|-+|+. .+++.||||++.+..              ...++.+.+|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            4457899999999999999999994 468999999997531              1125688999999999999999999


Q ss_pred             eceeeeC--CceEEEEEecCCCChhHHHhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC
Q 038934          494 LGCCMKR--DERMLIYEYLPNKSLADFIFDGTRRKL-LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE  570 (751)
Q Consensus       494 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~  570 (751)
                      +++..+.  +.+|||+|||..|.+...-    ..++ +.+.+++++++++..||.|||.++   ||||||||+|+||+++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence            9998765  5799999999998876643    3334 899999999999999999999999   9999999999999999


Q ss_pred             CCeEEeeccCccccCCC---CccccccccccccCccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCcc
Q 038934          571 MNPKISDFGMARAFGVD---QTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLELVYGTRNRGFHHVDH  643 (751)
Q Consensus       571 ~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~  643 (751)
                      |++||+|||.+..+...   ..........|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-.     
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-----  321 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-----  321 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-----
Confidence            99999999999876322   1122233478999999999998743    35789999999999999999999642     


Q ss_pred             ccchhHHHHHHhccCChhhhcchhccCc----cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCC
Q 038934          644 HHNLLGHAWRLWTEDRPVELIDKSLEDT----YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSL  711 (751)
Q Consensus       644 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  711 (751)
                                    +...++.++++...    ...++.+.+.+||.+||++||+.|.+..+|....--....
T Consensus       322 --------------~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  322 --------------DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             --------------chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence                          22233333333332    2334567889999999999999999999998876544433

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=345.32  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=208.7

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +++.+...||+|.||+||+|+|.  ..||||++...  .++..++|++||.++++-+|.||+-+.|+|..... .+|..+
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw  468 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW  468 (678)
T ss_pred             HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence            45567789999999999999973  36999999765  44577899999999999999999999999998888 999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      |+|.+|+.+|+.  .+..++..+.+.|++||++|+.|||.++   |||||||..||||.+++.|||+||||+.....-..
T Consensus       469 CeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  469 CEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             ccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence            999999999964  4456888999999999999999999999   99999999999999999999999999987554333


Q ss_pred             cccccccccccCccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          590 EANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ........|...|||||++..   .+|++.+||||||+++|||++|..|+.....++.--.+.       .+..  ..|.
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG-------rG~l--~pd~  614 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG-------RGYL--MPDL  614 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec-------cccc--Cccc
Confidence            333344668889999999974   379999999999999999999999977333332211111       1100  0000


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                         ..........+.+|+..|+..++++||.+.+|+..|+.+..
T Consensus       615 ---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  615 ---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence               01123345578899999999999999999999998876543

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.8e-38  Score=336.66  Aligned_cols=266  Identities=25%  Similarity=0.407  Sum_probs=202.7

Q ss_pred             cCccccccccccccccEEEEEEcC-----------------CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-----------------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKL  493 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  493 (751)
                      ++|.+.++||+|+||.||++.+.+                 +..||+|.+.... .....++.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999998532                 3369999987542 3345679999999999999999999


Q ss_pred             eceeeeCCceEEEEEecCCCChhHHHhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEE
Q 038934          494 LGCCMKRDERMLIYEYLPNKSLADFIFDGT----------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH  557 (751)
Q Consensus       494 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH  557 (751)
                      ++++.+.+..++||||+++++|.+++....                ....+++..+.+++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999985421                1134688899999999999999999998   999


Q ss_pred             ccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 038934          558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRG  637 (751)
Q Consensus       558 ~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~  637 (751)
                      |||||+|||+++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||+++..+..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543222222233455788999999998999999999999999999997544333


Q ss_pred             CCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          638 FHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      +...... .........+......      .....+......+.+|+.+|++.||.+|||+.+|.+.|+.
T Consensus       242 ~~~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDE-QVIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHH-HHHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            2222111 1111111111111000      0001112334578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=335.76  Aligned_cols=248  Identities=26%  Similarity=0.412  Sum_probs=208.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ..|...+.||+|.||.||+|... .++.||+|++... .+..++.++.|+.+|.+++++||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            35667789999999999999954 5888999999765 556678899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      |.+|++.+++.   ....+++..+.-|+++++.||.|||.++   .+|||||+.||||..+|.+||+|||.+-.+.....
T Consensus        93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999993   3344588888999999999999999999   99999999999999999999999999988754433


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      ..  ..++|||.|||||++....|+.|+||||||++.+||++|.+|+.-..+.                +..-++-+..-
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~P  228 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAP  228 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCC
Confidence            33  5589999999999999889999999999999999999999996533331                11112222112


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ..........+.+++..||.+||+.||++.++++
T Consensus       229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            2222345567889999999999999999999985

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.2e-38  Score=330.91  Aligned_cols=244  Identities=18%  Similarity=0.283  Sum_probs=198.0

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCccc---HHHHHHHHHHHHHhcCCcEEeEeceeee----CCceEEEEEec
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVKLLGCCMK----RDERMLIYEYL  510 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~  510 (751)
                      ..|++|+++.||+|.. +|+.||||++.......   .+.+.+|+.+|.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 78999999997653332   5678899999999999999999999877    34688999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      ++|+|.+++..   .+.+++..+..++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999953   34688999999999999999999985 6   8899999999999999999999999998653221 


Q ss_pred             cccccccccccCccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          590 EANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                          ....+++.|+|||++.+  ..++.++|||||||++|||++|+.||.......   +..   ......         
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~---~i~~~~---------  238 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYD---LIINKN---------  238 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHhcC---------
Confidence                12467889999999976  689999999999999999999999986432211   111   000011         


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .....+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus       239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            01112223456788999999999999999999999999864

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-38  Score=345.91  Aligned_cols=259  Identities=26%  Similarity=0.389  Sum_probs=203.2

Q ss_pred             cCccccccccccccccEEEEEE------cCCcEEEEEEeccCC-cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCce
Q 038934          432 DNFSEENKLGEGGFGPVYKGML------IDGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  503 (751)
                      ++|++.++||+|+||.||+|++      ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4788899999999999999974      235689999986442 33456789999999999 899999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCC-----------------------------------------------------------
Q 038934          504 MLIYEYLPNKSLADFIFDGTR-----------------------------------------------------------  524 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------------  524 (751)
                      ++||||+++|+|.+++.+...                                                           
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            999999999999999854211                                                           


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          525 -------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       525 -------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                                   ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                         124788899999999999999999998   9999999999999999999999999998764332222


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..|+.......  .    .......+..         .
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~---------~  336 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYKMIKEGYR---------M  336 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHHHHHhCcc---------C
Confidence            1222345678999999999999999999999999999998 777764322111  1    1111111110         0


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..+.....++.+|+.+|++.||++||++.+|+++|+..
T Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            01111235788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-39  Score=305.70  Aligned_cols=263  Identities=22%  Similarity=0.270  Sum_probs=213.1

Q ss_pred             hcCccccccccccccccEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc-----eE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE-----RM  504 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~  504 (751)
                      .++|++.+.||+|||+-||+++ ..+++.+|+|++.-...+.++..++|++..++++|||+++++++...+..     .|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4689999999999999999999 55688999999987777888999999999999999999999998765544     89


Q ss_pred             EEEEecCCCChhHHHhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRK-LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++++|...|+|.+.+......+ .+++.++++|+.+|++||.+||+.. .+++||||||.|||+.+.+.++|.|||.++.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence            9999999999999997654444 7999999999999999999999987 4799999999999999999999999999987


Q ss_pred             cCCCCccc-------cccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHH
Q 038934          584 FGVDQTEA-------NTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWR  653 (751)
Q Consensus       584 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~  653 (751)
                      ........       .-..-..|.-|+|||.+.   +...++++|||||||+||+|+.|..||+.....           
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-----------  247 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-----------  247 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----------
Confidence            54221110       001235688999999985   456789999999999999999999998743321           


Q ss_pred             HhccCChh-hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          654 LWTEDRPV-ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       654 ~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                         ++... .+....+.-......++.+.+++.+|||.||.+||++.+++..++.+
T Consensus       248 ---GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  248 ---GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ---CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence               11111 11111222222223677899999999999999999999999988765

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.4e-38  Score=345.33  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=203.7

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCce
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  503 (751)
                      ++|.+.+.||+|+||.||++++.      +++.||||++.... ....+.+.+|+++++.+ +|+||+++++++......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            47888999999999999998842      23579999997542 33456788999999999 899999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccC------------------------------------------------------------
Q 038934          504 MLIYEYLPNKSLADFIFDGT------------------------------------------------------------  523 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------  523 (751)
                      ++||||+++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999985321                                                            


Q ss_pred             -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccccccc
Q 038934          524 -------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV  596 (751)
Q Consensus       524 -------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  596 (751)
                             ....+++..+.+++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++..............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                   1124788899999999999999999998   999999999999999999999999999865433221112223


Q ss_pred             ccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHH
Q 038934          597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS  675 (751)
Q Consensus       597 ~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  675 (751)
                      .+++.|+|||++.+..++.++|||||||++|||++ |+.|+.......  .    ........         .....+..
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~---------~~~~~~~~  339 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRG---------YQMSRPDF  339 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcc---------cCccCCCC
Confidence            45678999999999999999999999999999997 999875432211  0    01111111         11111112


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          676 EALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       676 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ....+.+++.+|++.||++||++.+|+++|+.+
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            245788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=352.03  Aligned_cols=262  Identities=26%  Similarity=0.349  Sum_probs=213.7

Q ss_pred             cCccccccccccccccEEEEEEcCC-cEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEecee-ee------CCc
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDG-QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCC-MK------RDE  502 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~------~~~  502 (751)
                      .++++.+.|.+|||+.||+++...+ ..||+|++...++...+.+.+||++|++|+ |+|||.+++.. ..      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4667788999999999999997665 999999998888888999999999999997 99999999932 21      135


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      ++|.||||.+|+|-|++.+..... |++.++++|+.++++|+++||... .+|||||||-+||||..+++.||||||.|.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            789999999999999997644444 999999999999999999999875 789999999999999999999999999987


Q ss_pred             ccCCCC-cccccc------ccccccCccCcccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH
Q 038934          583 AFGVDQ-TEANTN------RVVGTYGYMPPEYA---IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       583 ~~~~~~-~~~~~~------~~~gt~~y~aPE~~---~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ...... ......      ...-|+.|+|||++   .+.++++|+|||+|||+||-|+....||+...            
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------  262 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------  262 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence            543221 111110      12458999999987   57899999999999999999999999976322            


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCCC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQP  714 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p  714 (751)
                             ...+++....-.........+.+||..||+.||++||++.+|+..+-.+...+.|
T Consensus       263 -------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  263 -------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             -------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence                   1223333222223356788999999999999999999999999988877555444

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=337.15  Aligned_cols=248  Identities=24%  Similarity=0.331  Sum_probs=214.0

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc-eEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE-RMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~  507 (751)
                      ++|...++||+|+||.++..+++ +++.+|+|++...  .....+...+|+.++++++|||||.+.+.+++++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            67889999999999999999965 4788999999754  33444578899999999999999999999999998 99999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      +|++||+|.+.|.+.. ...++++.+..++.|++.|+.|||++.   |+|||||+.|||++.++.|||+|||+|+.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999996533 567899999999999999999999887   999999999999999999999999999998644


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      .  .......||+.|+.||++.+.+|..|+|||||||++|||++-+++|..                   .++..++.+.
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-------------------~~m~~Li~ki  218 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-------------------SNMSELILKI  218 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-------------------cchHHHHHHH
Confidence            3  234458999999999999999999999999999999999999988543                   3344444444


Q ss_pred             ccCc---cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          668 LEDT---YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       668 l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ....   .+.....++..++..||+.+|..||++.+++..
T Consensus       219 ~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  219 NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            4333   455567789999999999999999999999853

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-40  Score=311.30  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=204.8

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ..++|++.+.||+|.|+.||++.+. +|+.+|+|.+...  .....+++.+|++|-+.|+||||+++++.+.+....++|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4578889999999999999999854 5999999988633  445778999999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC---CCeEEeeccCccc
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARA  583 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla~~  583 (751)
                      +|+|.|++|..-|.+   +..+++..+...++||+++|.|+|..+   |||||+||+|++|...   .-+||+|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999999776643   356788999999999999999999999   9999999999999543   4599999999998


Q ss_pred             cCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      +...   .......|||+|||||++...+|+..+|||+.||+||-||.|+.||....                   ...+
T Consensus       163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-------------------~~rl  220 (355)
T KOG0033|consen  163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------------------QHRL  220 (355)
T ss_pred             eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-------------------HHHH
Confidence            8622   22234789999999999999999999999999999999999999975322                   1222


Q ss_pred             cchhccCccC------HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          664 IDKSLEDTYS------LSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       664 ~d~~l~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .+.+..+.+.      ....++..+|+.+||..||.+|.|+.|.+.
T Consensus       221 ye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  221 YEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            2222333222      223457889999999999999999999874

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-37  Score=335.40  Aligned_cols=265  Identities=23%  Similarity=0.299  Sum_probs=205.2

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+... .....+++.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368999999999999999999965 5788999998754 23345679999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  +|+||||||+|||+++++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            9999999999853   345899999999999999999999853  3999999999999999999999999998765322 


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhcc-----------
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE-----------  657 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~-----------  657 (751)
                         ......|++.|+|||++.+..++.++|||||||++|||++|+.|+.....................           
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence               123357899999999999999999999999999999999999998643321110000000000000           


Q ss_pred             ----------------CChhhhcchhccCc----cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          658 ----------------DRPVELIDKSLEDT----YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       658 ----------------~~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                                      .....+.+......    .......++.+|+.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                            00001111111111    111245678999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-38  Score=333.72  Aligned_cols=245  Identities=21%  Similarity=0.241  Sum_probs=201.1

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.++||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999965 58899999986432   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999853   346899999999999999999999998   999999999999999999999999999865321


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                           .....|++.|+|||++.+..++.++|||||||++|+|++|+.|+........       ........        
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~--------  214 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-------YEKILAGK--------  214 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCC--------
Confidence                 2235789999999999999999999999999999999999999754322110       00011110        


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVLM  704 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  704 (751)
                        ...+......+.+++.+||+.||.+||+     ++++++.
T Consensus       215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              0112223457889999999999999995     8888754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-38  Score=340.35  Aligned_cols=253  Identities=22%  Similarity=0.326  Sum_probs=204.6

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.++||+|+||.||+|+.. +++.||||++.+..   ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 48899999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999994   3446889999999999999999999998   99999999999999999999999999986532 


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...........+.    .+..     .+...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~-----~~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK----YWKE-----TLQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH----hccc-----cccCC
Confidence                2234679999999999999999999999999999999999999986433321111000    0000     00000


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ............+.+++.+||+.+|.+||++.++++.
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0000012335678899999999999999999999964

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7e-38  Score=337.32  Aligned_cols=244  Identities=23%  Similarity=0.263  Sum_probs=200.7

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|.+.+.||+|+||.||++++. +++.||+|++.+.   .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57889999999999999999975 5889999998653   2234567899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999853   346889999999999999999999998   999999999999999999999999999865322


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .    .......+..       
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~----~~~~i~~~~~-------  232 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---R----IYEKILAGRL-------  232 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---H----HHHHHhcCCc-------
Confidence                 12357899999999999999999999999999999999999997532211   0    1111111110       


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                         ..+......+.+|+.+||+.||.+||+     +.+++.
T Consensus       233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence               111123456789999999999999997     677774

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-37  Score=326.23  Aligned_cols=251  Identities=25%  Similarity=0.344  Sum_probs=201.0

Q ss_pred             CccccccccccccccEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .|+..+.||+|+||.||++.. .+++.||+|++.+..   ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999995 468999999986532   2334567899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999999888542 2335899999999999999999999998   9999999999999999999999999998753221


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      .   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........   .......          .
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~----------~  220 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKE----------D  220 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhc----------c
Confidence            1   2235789999999999999999999999999999999999999864432111000   0000000          0


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                      ...++......+.+|+.+||+.||.+||+     ++++++
T Consensus       221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            01122234557889999999999999997     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-37  Score=350.22  Aligned_cols=252  Identities=19%  Similarity=0.211  Sum_probs=204.3

Q ss_pred             CccccccccccccccEEEEEEc-C-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-D-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .|.+.+.||+|+||.||++... + ++.||+|++..........+.+|+.+++.++|||||++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888899999999999999854 3 5778999876655555667889999999999999999999999999999999999


Q ss_pred             CCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          511 PNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       511 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      ++++|.+++.+. .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988643 23456889999999999999999999998   99999999999999999999999999987653322


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.|+......   .+..   . ...+..         
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~---~-~~~~~~---------  288 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQ---Q-VLYGKY---------  288 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhCCC---------
Confidence            22234467999999999999999999999999999999999999997532211   1000   0 000100         


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...+......+.+++.+||+.||++||++.+++.
T Consensus       289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            0111223457889999999999999999999864

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.1e-37  Score=326.11  Aligned_cols=257  Identities=30%  Similarity=0.479  Sum_probs=206.0

Q ss_pred             cCccccccccccccccEEEEEEcC-C-----cEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-G-----QEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      ++|++.+.||+|+||.||+|.... +     +.||+|.+.... ....+++.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999998643 2     579999986543 334567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC
Q 038934          505 LIYEYLPNKSLADFIFDGTR-------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  571 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~  571 (751)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999865321             145889999999999999999999998   99999999999999999


Q ss_pred             CeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHH
Q 038934          572 NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGH  650 (751)
Q Consensus       572 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~  650 (751)
                      .+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+.......   +   
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~---  235 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---V---  235 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---
Confidence            999999999986543322222233456788999999999999999999999999999998 988865322211   1   


Q ss_pred             HHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          651 AWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       651 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                       ........         ....+...+..+.+|+.+|++.||++||++.+|++.|+.
T Consensus       236 -~~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 -IEMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             11111111         111223345688899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.3e-38  Score=310.32  Aligned_cols=281  Identities=23%  Similarity=0.326  Sum_probs=210.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcc-c-HHHHHHHHHHHHHhcCCcEEeEeceeeeC--CceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQ-G-VEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  505 (751)
                      .++|+..++|++|.||.||+|+.+ +++.||+|+++-..+. + --.-.+||.+|.+++|||||.+..+....  +..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            467888999999999999999965 5888999999754321 1 12357999999999999999999887654  57999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |||||+. +|..++..  ..+++...++..+..|+++|++|||...   |+||||||+|+|+...|.+||+|||+|+.++
T Consensus       155 VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999977 88888853  3357889999999999999999999998   9999999999999999999999999999987


Q ss_pred             CCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHH-----HhccCC
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWR-----LWTEDR  659 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~-----~~~~~~  659 (751)
                      .....  ....+-|..|+|||++.+. .|+.++|+||+|||+.||+++++-|.....-++-..+.....     .|.+-.
T Consensus       229 sp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            55322  2346779999999999876 599999999999999999999988765443222111111000     011100


Q ss_pred             hh---------hhcchhccCccCHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCCc
Q 038934          660 PV---------ELIDKSLEDTYSLS-EALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFF  720 (751)
Q Consensus       660 ~~---------~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~p~~~  720 (751)
                      ..         +.....+...+... ....-.+|+..+|..||.+|.|+++.|+. .-..+.|.|..|.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-~~F~e~P~p~~P~~~  376 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-EYFRETPLPIDPSMF  376 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-cccccCCCCCChhhc
Confidence            00         01111122222222 33566789999999999999999999864 223666666555544

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-39  Score=322.41  Aligned_cols=271  Identities=22%  Similarity=0.307  Sum_probs=209.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeee-----CCc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK-----RDE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  502 (751)
                      ...|...+.||+|++|.|.++... +|+.||||++...  .....++..+|+.+|++++|+||+.+.+++..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            455666789999999999999954 5899999999743  44566788999999999999999999998865     356


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      +|+|+|+| +.+|...|.   ..+.++...+..++.|+++||.|+|+.+   |+||||||.|+|++.+..+||+|||+|+
T Consensus       101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            89999999 669999984   3444899999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCccccccccccccCccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH--------H
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW--------R  653 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~--------~  653 (751)
                      ..............+.|..|.|||++. ...||.+.||||+|||+.||++|+.-|...+.-.+..++....        .
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            876443334445578899999999886 4579999999999999999999999988766543333222111        1


Q ss_pred             HhccCChhhhcchhccC------ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCC
Q 038934          654 LWTEDRPVELIDKSLED------TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGE  708 (751)
Q Consensus       654 ~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  708 (751)
                      ..........+......      ..-.......++|+.+||..||.+|+|++|+++  .|+..
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence            11111111111110000      001234457889999999999999999999996  34444

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-37  Score=328.72  Aligned_cols=265  Identities=21%  Similarity=0.263  Sum_probs=202.1

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|++.+.||+|+||.||++++. +++.+|+|++...  .....+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999975 4788999998754  23345678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |++++.+..+..   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987766542   2346899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH--------HHHHhc-cCC
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH--------AWRLWT-EDR  659 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~--------~~~~~~-~~~  659 (751)
                      .. ......|++.|+|||++.+..++.++|||||||++|||++|+.||..............        .+..+. ...
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            21 12235789999999999999999999999999999999999999864332111000000        000000 000


Q ss_pred             hhhhcchhccC------ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          660 PVELIDKSLED------TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       660 ~~~~~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ......+....      ......+..+.+|+.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000000      011123456899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=330.98  Aligned_cols=241  Identities=27%  Similarity=0.420  Sum_probs=200.1

Q ss_pred             ccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          436 EENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       436 ~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      .++-||.|+.|.||+|++ .++.||||+++.-       -..+|.-|++|+|+||+.+.|+|....-++||||||..|-|
T Consensus       128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            346799999999999998 6789999998532       23578889999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccc
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR  595 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  595 (751)
                      .+.|.   ....+.......|..+||.|+.|||.+.   |||||||.-||||..+..|||+|||.++.....   .....
T Consensus       200 ~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS  270 (904)
T KOG4721|consen  200 YEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS  270 (904)
T ss_pred             HHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence            99995   3456788899999999999999999998   999999999999999999999999999876422   33456


Q ss_pred             cccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHH
Q 038934          596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS  675 (751)
Q Consensus       596 ~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  675 (751)
                      +.||..|||||++.+.+.++|+|||||||||||||||..|+.-.+.  -.-+       |.      +-...+.-..+..
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds--sAII-------wG------VGsNsL~LpvPst  335 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS--SAII-------WG------VGSNSLHLPVPST  335 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch--heeE-------Ee------ccCCcccccCccc
Confidence            8999999999999999999999999999999999999998432111  1000       00      0011122223445


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          676 EALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       676 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ....+.-|+.+|++-.|..||++++++..|+-.
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            567788899999999999999999999999754

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.3e-38  Score=351.24  Aligned_cols=259  Identities=28%  Similarity=0.434  Sum_probs=207.7

Q ss_pred             cCccccccccccccccEEEEEEcC------CcEEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      .+....+.||+|.||+||+|+...      .+.||||.++..... ..++|++|+++++.++|||||+++|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            344556789999999999998432      457999999877554 7789999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCe
Q 038934          505 LIYEYLPNKSLADFIFDGTR-----------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      +|+|||..|+|.++|.....           ..+|+..+.+.|+.|||.||.||-++.   +|||||...|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            99999999999999964211           334889999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHH
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ||+||||++..-..+.-.....-.-...|||||.+..++||.+||||||||+|||+++ |+.|...-..+       .+.
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------EVI  715 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------EVI  715 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------HHH
Confidence            9999999986533222221111233568999999999999999999999999999997 56663321111       111


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      .....+..         =..+...+.++..|+..|++.+|.+||+++||-..|+...
T Consensus       716 e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  716 ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            11222222         2234456678999999999999999999999999998653

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.2e-37  Score=327.17  Aligned_cols=264  Identities=23%  Similarity=0.319  Sum_probs=199.7

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|.+.++||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57899999999999999999965 58899999986542 23345778999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++ +|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            985 898888532  235789999999999999999999998   99999999999999999999999999976532221


Q ss_pred             cccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH-----HHhccC----C
Q 038934          590 EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW-----RLWTED----R  659 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~-----~~~~~~----~  659 (751)
                        ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||................     ..+..-    .
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence              1223567899999999875 568999999999999999999999986543322111110000     000000    0


Q ss_pred             hhhhcchhccCc----cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          660 PVELIDKSLEDT----YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       660 ~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ......+.....    .......++.+|+.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000000000    00112356789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=332.69  Aligned_cols=241  Identities=21%  Similarity=0.257  Sum_probs=193.8

Q ss_pred             ccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       440 IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      ||+|+||.||+++.. +++.||+|++.+.   .......+.+|+.++.+++||||+++++++.+.+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999975 4789999998653   234456788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccc
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR  595 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  595 (751)
                      .+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            999853   346899999999999999999999998   9999999999999999999999999998643221  12234


Q ss_pred             cccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHH
Q 038934          596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS  675 (751)
Q Consensus       596 ~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  675 (751)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ... .......          ...+..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~-~~~~~~~----------~~~~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMY-RKILQEP----------LRFPDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHH-HHHHcCC----------CCCCCc
Confidence            67999999999999999999999999999999999999997532211      001 1111100          011223


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          676 EALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       676 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                      ....+.+++.+||+.||.+||++..+.+.|
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            345778999999999999998654444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.8e-37  Score=324.64  Aligned_cols=258  Identities=28%  Similarity=0.448  Sum_probs=206.4

Q ss_pred             hcCccccccccccccccEEEEEEcC------CcEEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|.+.+.||+|+||.||+|...+      ++.||||.+...... ..+.+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568888999999999999998643      478999999765443 457899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC
Q 038934          504 MLIYEYLPNKSLADFIFDGT-----------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  572 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~  572 (751)
                      ++||||+++++|.+++....           ....+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999996432           2345789999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHH
Q 038934          573 PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHA  651 (751)
Q Consensus       573 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~  651 (751)
                      +||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+.......   ...  
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~--  235 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIE--  235 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--
Confidence            99999999976532222111222345788999999999999999999999999999998 988865332211   111  


Q ss_pred             HHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          652 WRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       652 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                        ....+..         ...+......+.+++.+||+.||++||++.||++.|++
T Consensus       236 --~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 --CITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence              1111111         11112234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.7e-38  Score=335.39  Aligned_cols=241  Identities=22%  Similarity=0.280  Sum_probs=196.3

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      +.||+|+||.||+++.. +++.||||++.+.   .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999964 5889999999754   2334567889999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccc
Q 038934          514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT  593 (751)
Q Consensus       514 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  593 (751)
                      +|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            99999853   456899999999999999999999998   999999999999999999999999998753221  1122


Q ss_pred             cccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccC
Q 038934          594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYS  673 (751)
Q Consensus       594 ~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  673 (751)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +.    .......          ..++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~----~~~~~~~----------~~~p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF----ELILMEE----------IRFP  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HH----HHHHcCC----------CCCC
Confidence            34679999999999999999999999999999999999999975322111   00    0011010          0112


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          674 LSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       674 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                      ......+.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            23455788999999999999999     7999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4e-37  Score=338.44  Aligned_cols=260  Identities=26%  Similarity=0.384  Sum_probs=205.1

Q ss_pred             hcCccccccccccccccEEEEEEcC------CcEEEEEEeccCC-cccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  502 (751)
                      .++|.+.++||+|+||.||+|+...      +..||||++.... ....+.+.+|+.+++++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            4688889999999999999998532      3469999996543 334567999999999996 9999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccC-----------------------------------------------------------
Q 038934          503 RMLIYEYLPNKSLADFIFDGT-----------------------------------------------------------  523 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  523 (751)
                      .++||||+++|+|.+++.+..                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999885421                                                           


Q ss_pred             ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC
Q 038934          524 ----------------------------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN  569 (751)
Q Consensus       524 ----------------------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~  569 (751)
                                                        ....+++..+..++.||++||.|||+.+   |+|+||||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                              0124778889999999999999999998   999999999999999


Q ss_pred             CCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchh
Q 038934          570 EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLL  648 (751)
Q Consensus       570 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~  648 (751)
                      ++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+.....+..    
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~----  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST----  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence            99999999999987643322222223456788999999999999999999999999999997 8888653221111    


Q ss_pred             HHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          649 GHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       649 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                        .......+.         ....+......+.+++.+||+.||++||++.+|+++|+.+
T Consensus       349 --~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         349 --FYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             --HHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence              111111110         0111223345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-38  Score=299.89  Aligned_cols=249  Identities=26%  Similarity=0.370  Sum_probs=208.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|++++.||+|-||.||.|+.+ ++--||+|++-+.   ..+...++.+|+++-..|+||||++++++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            468899999999999999999955 4678999999764   233456799999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      +||...|+|...|.+ .+.+.+++.....++.|+|.||.|+|.+.   +|||||||+|+|++.++.+||+|||-+..-+ 
T Consensus       101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999964 24456889999999999999999999998   9999999999999999999999999987643 


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                         .......+||..|.|||...+..++.++|+|++|++.||++.|.+||.-...++.       +..        +.. 
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-------Ykr--------I~k-  236 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-------YKR--------IRK-  236 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-------HHH--------HHH-
Confidence               2233458999999999999999999999999999999999999999763331111       100        000 


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       +.-.++......+.++|.+|+..+|.+|.+..|+++.
T Consensus       237 -~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  237 -VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence             1112234445678899999999999999999999864

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3e-37  Score=322.14  Aligned_cols=255  Identities=24%  Similarity=0.329  Sum_probs=202.6

Q ss_pred             cCccccccccccccccEEEEEEc----CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888899999999999999853    35689999987652 23446789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++...  ...+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+|++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            9999999999998542  346899999999999999999999998   99999999999999999999999998765422


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ... .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+.......   +..    .......     
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~----~~~~~~~-----  226 (266)
T cd05064         160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK----AVEDGFR-----  226 (266)
T ss_pred             cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH----HHHCCCC-----
Confidence            111 11112345678999999999999999999999999999775 988875322111   111    1111110     


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                          ...+......+.+++.+|++.+|.+||++.++++.|+++
T Consensus       227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                111223445788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-37  Score=335.66  Aligned_cols=263  Identities=21%  Similarity=0.291  Sum_probs=209.8

Q ss_pred             hcCccccccccccccccEEEEEEcC--CcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID--GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      .++|.+.+.||+|+||.||+|.+..  +..||+|++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4678999999999999999998544  368999998653   23345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++..   .+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999953   346899999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       .........      
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~------  244 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGI------  244 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCC------
Confidence            21     223679999999999999999999999999999999999999976432210       000111110      


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH--HhCC-------CCCCCCCCCCCcc
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVLM--LSGE-------RSLPQPKQPGFFT  721 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~--L~~~-------~~~~~p~~p~~~~  721 (751)
                          ...+......+.+++.+||+.||.+|+     +++++++.  +.++       ..++.|..|.+..
T Consensus       245 ----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~  310 (340)
T PTZ00426        245 ----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN  310 (340)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence                011222345678999999999999995     89998764  2221       3455666666543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.7e-37  Score=319.49  Aligned_cols=255  Identities=28%  Similarity=0.414  Sum_probs=206.2

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            578889999999999999999878889999998643 2346789999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++..........
T Consensus        85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            99999998543 2345788999999999999999999998   9999999999999999999999999998764322211


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....++..|+|||++.+..++.++|||||||++|+|++ |+.|+.......   ...    .......         .
T Consensus       161 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~----~~~~~~~---------~  223 (261)
T cd05072         161 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMS----ALQRGYR---------M  223 (261)
T ss_pred             -cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHH----HHHcCCC---------C
Confidence             122345678999999999999999999999999999998 888865322111   111    1111100         0


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .........+.+++.+|++.+|++||++++++++|+..
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11112345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-38  Score=319.88  Aligned_cols=260  Identities=22%  Similarity=0.293  Sum_probs=197.6

Q ss_pred             CccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC-----ceEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD-----ERMLI  506 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV  506 (751)
                      .|...+++|+|.||.||+|.... ++.||||++....+    --.+|+++|+.+.|||||+++.+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            46677899999999999999654 78999999865432    2247999999999999999998886542     34589


Q ss_pred             EEecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-CCeEEeeccCcccc
Q 038934          507 YEYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAF  584 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~  584 (751)
                      ||||+. +|.+.+.+- .....++.-.+.-+..||++||+|||+.+   |+||||||.|||+|.+ |.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999977 898888642 22456788888899999999999999988   9999999999999966 89999999999987


Q ss_pred             CCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh--
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV--  661 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  661 (751)
                      ......   .....|..|+|||.+.|. .|+.+.||||.||++.||+-|+.-|.......+...+.........++..  
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            654443   235678899999999875 69999999999999999999999887655433322221111111111100  


Q ss_pred             -----hhcchhcc-----CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 -----ELIDKSLE-----DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 -----~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           +...+.+.     .-.......++++|+.++|+.+|.+|.++.|++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                 11111111     1133445668899999999999999999999984

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.6e-37  Score=317.08  Aligned_cols=252  Identities=26%  Similarity=0.406  Sum_probs=202.2

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|++.+.||+|+||.||++.+.++..+|+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457788899999999999999888889999998643 3345678999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++...  ...+++..+..++.|++.||.|||+++   |+|+||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999998542  235889999999999999999999998   9999999999999999999999999988653222111


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....++..|+|||++.+..++.++||||||+++|||++ |+.|+......   .....    ...+...         
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~----i~~~~~~---------  220 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEM----ISRGFRL---------  220 (256)
T ss_pred             -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCCC---------
Confidence             112335568999999998899999999999999999999 88886533221   11111    1111100         


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ..+......+.+++.+|++.+|++||++.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            001112356889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-37  Score=317.74  Aligned_cols=255  Identities=27%  Similarity=0.436  Sum_probs=205.7

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .++|++.+.||+|++|.||+|...+++.||+|.+.... ...+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35688889999999999999998778899999986543 34577999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999996432 345899999999999999999999998   999999999999999999999999999876522111


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      . ......+..|+|||++.+..++.++||||||+++|||++ |+.|+......   .+    ........         .
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~---------~  222 (261)
T cd05068         160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EV----LQQVDQGY---------R  222 (261)
T ss_pred             c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCC---------C
Confidence            1 111223457999999999999999999999999999999 88886432211   11    11111110         0


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ...+......+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            01122234678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.4e-37  Score=324.10  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=207.5

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57888999999999999999842      245689999977666667789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEE
Q 038934          506 IYEYLPNKSLADFIFDGT----------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  575 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl  575 (751)
                      ||||+++++|.+++....          ....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999986422          2235899999999999999999999998   999999999999999999999


Q ss_pred             eeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHH
Q 038934          576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       576 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      +|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..|+.......   .    ...
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~----~~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V----IEC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHH
Confidence            99999986543222222223445778999999999999999999999999999998 888864322211   0    111


Q ss_pred             hccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      ...+....         .+......+.+++.+|++.||.+||++.++++.|+.+.
T Consensus       235 i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         235 ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            11111100         01123356889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4e-37  Score=319.97  Aligned_cols=256  Identities=28%  Similarity=0.453  Sum_probs=210.5

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      ..+|...++||.|+||.||+|...+++.+|+|.+........+++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45788899999999999999998889999999998766656778999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            999999999653 2345799999999999999999999998   999999999999999999999999999876432221


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      .  ....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+......   .....    ....         ..
T Consensus       161 ~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~----~~~~---------~~  222 (261)
T cd05148         161 S--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQ----ITAG---------YR  222 (261)
T ss_pred             c--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH----HHhC---------Cc
Confidence            1  12345678999999998899999999999999999998 78887533211   11110    1110         11


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...+......+.+++.+|++.||.+|||+.++++.|+.+
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            112233446788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.5e-37  Score=348.11  Aligned_cols=259  Identities=22%  Similarity=0.277  Sum_probs=207.0

Q ss_pred             HHHHhcCccccccccccccccEEEEEE-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC--
Q 038934          427 IANATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD--  501 (751)
Q Consensus       427 i~~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  501 (751)
                      +....++|.+.+.||+|+||+||+++. .+++.||||++...  .......+.+|+.++..++|+||++++..+...+  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            344567999999999999999999985 46899999998654  3344567889999999999999999988775433  


Q ss_pred             ------ceEEEEEecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeE
Q 038934          502 ------ERMLIYEYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK  574 (751)
Q Consensus       502 ------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k  574 (751)
                            .+++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence                  3679999999999999986432 2356899999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHH
Q 038934          575 ISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       575 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      |+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||......   .    ....
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~----~~~~  256 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---E----VMHK  256 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---H----HHHH
Confidence            99999998765433333334567999999999999999999999999999999999999997532211   0    0000


Q ss_pred             hccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ......         ...+......+.+++.+||+.||.+||++.++++.
T Consensus       257 ~~~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 TLAGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HhcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            111100         11122345678899999999999999999999853

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.7e-37  Score=312.47  Aligned_cols=265  Identities=25%  Similarity=0.325  Sum_probs=203.1

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcc--cHHHHHHHHHHHHHhcCCc-EEeEeceeeeCC-----
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQ--GVEEFKNEVLLIAKLQHRN-LVKLLGCCMKRD-----  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  501 (751)
                      ...|...++||+|+||+||+|+. .+|+.||+|+++...+.  .-....+|+.++++++|+| ||++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34567778899999999999995 46899999999865432  2345689999999999999 999999999887     


Q ss_pred             -ceEEEEEecCCCChhHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          502 -ERMLIYEYLPNKSLADFIFDGTRR-KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       502 -~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                       .+++|+||++. +|..++...... ..++...+..++.||++||+|||+++   |+||||||+||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             78999999965 999999654432 45777899999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhc--
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWT--  656 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~--  656 (751)
                      +|+.+......  ....++|..|+|||++.+. .|+..+||||+|||+.||++++.-|.......+   +....+...  
T Consensus       166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q---l~~If~~lGtP  240 (323)
T KOG0594|consen  166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ---LFRIFRLLGTP  240 (323)
T ss_pred             hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH---HHHHHHHcCCC
Confidence            99976543332  2345788999999999987 799999999999999999998887765444211   111111111  


Q ss_pred             -cCChhh---hcchh--ccCcc-C-------HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          657 -EDRPVE---LIDKS--LEDTY-S-------LSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       657 -~~~~~~---~~d~~--l~~~~-~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       +.....   +.+..  ..... +       ........+++.+||+.+|.+|.|++.++++
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence             111111   00110  00000 0       0111367899999999999999999999975

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.9e-37  Score=329.86  Aligned_cols=242  Identities=23%  Similarity=0.287  Sum_probs=196.6

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      +.||+|+||.||+++.. +++.||+|++.+.   .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999964 5899999999754   2344567889999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccc
Q 038934          514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT  593 (751)
Q Consensus       514 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  593 (751)
                      +|.+++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            9998884   3346899999999999999999999998   9999999999999999999999999987532211  122


Q ss_pred             cccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccC
Q 038934          594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYS  673 (751)
Q Consensus       594 ~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  673 (751)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||........   .    .......          ...+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~---~----~~~~~~~----------~~~p  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---F----ELILMED----------IKFP  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH---H----HHhccCC----------ccCC
Confidence            346799999999999999999999999999999999999999753222110   0    0000000          0112


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 038934          674 LSEALRCIQVGLLCVQQRPEDRP-----NMASVVLM  704 (751)
Q Consensus       674 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  704 (751)
                      ......+.+++.+||+.||.+||     ++.++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            23345788999999999999997     88988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=317.78  Aligned_cols=256  Identities=26%  Similarity=0.402  Sum_probs=204.7

Q ss_pred             cCccccccccccccccEEEEEEcC----CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|++.+.||+|+||.||+|.+..    ...||||.+.... .....++.+|+.++++++|+||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578889999999999999999743    3579999986543 33456789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+|||+++++.++|+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999998542  236899999999999999999999988   99999999999999999999999999988752


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ...........+++.|+|||.+.+..++.++||||||+++|+|++ |..|+......   .    .........      
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~----~~~~~~~~~------  225 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---D----VIKAVEDGY------  225 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---H----HHHHHHcCC------
Confidence            222222222345678999999999999999999999999999998 88886422111   0    111111110      


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                         ....+......+.+++.+|++.+|++||++.+|+++|+.+
T Consensus       226 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ---RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               0011223345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.4e-37  Score=320.70  Aligned_cols=259  Identities=25%  Similarity=0.409  Sum_probs=202.5

Q ss_pred             HhcCccccccccccccccEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  502 (751)
                      ..++|+..++||+|+||.||+|.+.      .+..||||++.... .....++.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999853      24679999986432 2345578899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEE
Q 038934          503 RMLIYEYLPNKSLADFIFDGTR-------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  575 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl  575 (751)
                      .++||||+++++|.+++.....       ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999854221       234678889999999999999999988   999999999999999999999


Q ss_pred             eeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHH
Q 038934          576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       576 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      +|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..|+......   .    ....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~----~~~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---Q----VLRF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHH
Confidence            99999876543222111112345778999999999999999999999999999999 67776432211   1    1111


Q ss_pred             hccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      .......         ..+......+.+++.+|++.||++||++.|+++.|+.
T Consensus       234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            1111110         1111234568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.6e-37  Score=329.20  Aligned_cols=258  Identities=25%  Similarity=0.441  Sum_probs=203.2

Q ss_pred             cCccccccccccccccEEEEEEcC-Cc----EEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQ----EIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      .+|+..+.||+|+||.||+|++.. +.    .||+|++.... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468899999999999999998643 33    48999986542 34556899999999999999999999999764 5789


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999998643  335789999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ............++..|+|||++.+..++.++||||||+++|||++ |+.|+.......   +    ........     
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~-----  228 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGE-----  228 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHhCCC-----
Confidence            4333222222344678999999999999999999999999999997 888865322111   1    11111110     


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSL  711 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  711 (751)
                          ....+......+.+++.+|++.+|++||++.+++..|..+..-
T Consensus       229 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         229 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence                0011112334678999999999999999999999998876433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.8e-37  Score=331.67  Aligned_cols=259  Identities=28%  Similarity=0.428  Sum_probs=203.3

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC-Cc
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR-DE  502 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  502 (751)
                      ++|++.++||+|+||.||+|...      .++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            57899999999999999999742      24789999986542 23346788999999999 799999999988654 56


Q ss_pred             eEEEEEecCCCChhHHHhccCC----------------------------------------------------------
Q 038934          503 RMLIYEYLPNKSLADFIFDGTR----------------------------------------------------------  524 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  524 (751)
                      .++||||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            8899999999999999854211                                                          


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccC
Q 038934          525 RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP  604 (751)
Q Consensus       525 ~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  604 (751)
                      ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            126789999999999999999999998   99999999999999999999999999987643332222333456778999


Q ss_pred             cccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHH
Q 038934          605 PEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQV  683 (751)
Q Consensus       605 PE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  683 (751)
                      ||++.+..++.++|||||||++|||++ |..|+........      ..........         ...+......+.++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~l  308 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTR---------MRAPEYATPEIYSI  308 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCC---------CCCCccCCHHHHHH
Confidence            999999999999999999999999998 9888753222110      1111111111         01112234578899


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          684 GLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       684 i~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      +.+|++.+|++||++.+++++|+.+
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.2e-37  Score=324.17  Aligned_cols=259  Identities=28%  Similarity=0.434  Sum_probs=208.6

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|.+.+.||+|+||.||+++..      ++..+++|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46778889999999999999843      345689999876665566789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC
Q 038934          506 IYEYLPNKSLADFIFDGT-------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  572 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~  572 (751)
                      ||||+++++|.+++....             ....+++..++.++.||+.||+|||+++   |+||||||+|||+++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999996432             1235889999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHH
Q 038934          573 PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHA  651 (751)
Q Consensus       573 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~  651 (751)
                      ++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......       .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence            99999999976543322222223456788999999999999999999999999999998 888865332211       1


Q ss_pred             HHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          652 WRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       652 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      ......+....         .....+..+.+++.+|++.||++||++.+|+++|+.+.
T Consensus       235 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         235 IECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             HHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            11111111111         11123456889999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.1e-37  Score=329.55  Aligned_cols=264  Identities=22%  Similarity=0.322  Sum_probs=203.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|++.++||+|+||.||++.+. ++..+|+|.+... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999999976 5788999988654 23345678999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++..   .+.+++..+..++.|++.||.|||+.+  +|+|+||||+|||+++++.+||+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999999853   345889999999999999999999752  3999999999999999999999999998765321 


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH----------------
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW----------------  652 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~----------------  652 (751)
                         ......|+..|+|||++.+..++.++|||||||++|+|++|+.|+................                
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence               1223578999999999999999999999999999999999999986433211100000000                


Q ss_pred             ----HHhc-cC----ChhhhcchhccCcc----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          653 ----RLWT-ED----RPVELIDKSLEDTY----SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       653 ----~~~~-~~----~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                          .... ..    ....+.+.......    ......++.+|+.+||+.||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                0000 00    00011111111110    0113456889999999999999999999985

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.8e-37  Score=330.75  Aligned_cols=241  Identities=22%  Similarity=0.276  Sum_probs=195.3

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      +.||+|+||.||+++.. +++.||+|++.+.   .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999964 5899999999754   2334556788999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccc
Q 038934          514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT  593 (751)
Q Consensus       514 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  593 (751)
                      +|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99988843   346899999999999999999999998   9999999999999999999999999987532211  112


Q ss_pred             cccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccC
Q 038934          594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYS  673 (751)
Q Consensus       594 ~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  673 (751)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.|+........   .    .......          ...+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~----~~~~~~~----------~~~p  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---F----ELILMEE----------IRFP  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---H----HHHhcCC----------CCCC
Confidence            335789999999999999999999999999999999999999753322110   0    0000000          0112


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          674 LSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       674 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                      ......+.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            23345778999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.2e-36  Score=320.64  Aligned_cols=257  Identities=29%  Similarity=0.444  Sum_probs=203.2

Q ss_pred             cCccccccccccccccEEEEEEc-----CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-----DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|++.++||+|+||.||+|...     .++.+|+|.+... .......+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            46778889999999999999842     3578999999753 33345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC
Q 038934          506 IYEYLPNKSLADFIFDGT--------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  571 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~  571 (751)
                      ||||+++++|.+++....              ....+++..+..++.|++.||.|||+++   |+|+||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999985321              1235788999999999999999999998   99999999999999999


Q ss_pred             CeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHH
Q 038934          572 NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGH  650 (751)
Q Consensus       572 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~  650 (751)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......   .+.  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~--  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVI--  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence            999999999987643322222233455778999999998899999999999999999998 88776432211   111  


Q ss_pred             HHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          651 AWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       651 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                        .........         ..+......+.+++.+|++.||++||++.+|++.|..
T Consensus       237 --~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 --EMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              111111110         1112234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.2e-36  Score=317.10  Aligned_cols=255  Identities=27%  Similarity=0.432  Sum_probs=205.0

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .+|.+.++||+|+||.||+|... .++.||+|++... ....+++.+|+++++.++|+||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35778889999999999999965 4888999998644 344678999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++.... ...+++..++.++.|+++||+|||+.+   ++|+||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999985432 345899999999999999999999998   999999999999999999999999999876432211


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      . .....+++.|+|||.+.+..++.++|||||||++|||++ |..|+.....+.       .+......         ..
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~~  223 (263)
T cd05052         161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKG---------YR  223 (263)
T ss_pred             c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCC---------CC
Confidence            1 111234568999999999999999999999999999998 888865322211       11111111         11


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...+...+..+.+++.+|++.||++||++.+++++|+.+
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            111222346788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-36  Score=314.58  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=196.1

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      ++||+|+||.||+|++. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999965 68899999886543 34456799999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccc
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR  595 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  595 (751)
                      .+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999853  2345889999999999999999999998   99999999999999999999999999876432111111111


Q ss_pred             cccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCH
Q 038934          596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSL  674 (751)
Q Consensus       596 ~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  674 (751)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..|+.......       .......         ......+.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~---------~~~~~~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQ---------GVRLPCPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHc---------CCCCCCcc
Confidence            223457999999999999999999999999999998 777764322110       0011111         11111222


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          675 SEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       675 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      .....+.+++.+|++.+|++||++.+|+++|.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            33457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-36  Score=322.49  Aligned_cols=263  Identities=24%  Similarity=0.343  Sum_probs=198.2

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|.+.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999975 588999999875432 233467889999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+. ++|.+++..  ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 577777743  2345889999999999999999999998   9999999999999999999999999987543221


Q ss_pred             ccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh------
Q 038934          589 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV------  661 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  661 (751)
                      .  ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.....  ....+.............      
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence            1  1223567899999999875 4589999999999999999999999864322  111111111111000000      


Q ss_pred             h--hcc-hhcc--CccC-------HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 E--LID-KSLE--DTYS-------LSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 ~--~~d-~~l~--~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .  ... ....  ....       ......+.+++.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0  000 0000  0000       011246779999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-36  Score=311.13  Aligned_cols=258  Identities=23%  Similarity=0.283  Sum_probs=209.8

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      +.|+..+.||+|.-|+||++++.+ +..+|+|++.+.   ......+++.|-+||+.++||.++.++..++.++..++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            467778899999999999999765 689999999875   3445567888999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC-
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV-  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~-  586 (751)
                      |||+||+|+.+.. .+..+.++++.+..++.+|+-||+|||-.|   ||+|||||+||||.++|++-|+||.|+..... 
T Consensus       157 eyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999874 356678999999999999999999999999   99999999999999999999999998664310 


Q ss_pred             --------------------------------CCc---------------------cccccccccccCccCcccccCCCC
Q 038934          587 --------------------------------DQT---------------------EANTNRVVGTYGYMPPEYAIDGLF  613 (751)
Q Consensus       587 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  613 (751)
                                                      ...                     ......++||-.|+|||++.|...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                     012235789999999999999999


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCC
Q 038934          614 SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPE  693 (751)
Q Consensus       614 t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~  693 (751)
                      +.++|.|+|||+|||||.|..||......+.               ...++.+.+.-.........+.+||++.|.+||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            9999999999999999999999865444322               1111111111112224456788999999999999


Q ss_pred             CCCC----HHHHHH--HHhCC
Q 038934          694 DRPN----MASVVL--MLSGE  708 (751)
Q Consensus       694 ~RPs----~~evl~--~L~~~  708 (751)
                      +|..    +.||-+  ..+++
T Consensus       378 kRlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             hhhccccchHHhhcCccccCC
Confidence            9999    888874  44554

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-36  Score=333.37  Aligned_cols=259  Identities=16%  Similarity=0.159  Sum_probs=196.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ..+|.+.++||+|+||.||++... .++.||+|+..      .+.+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            367999999999999999999964 58899999753      24578999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +. ++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            95 688888743   345889999999999999999999998   9999999999999999999999999997542211 


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc----cchhHHHHHHhccC-------
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHH----HNLLGHAWRLWTED-------  658 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~----~~~~~~~~~~~~~~-------  658 (751)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+-.......    ...+..........       
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            1122346799999999999999999999999999999999999987543221100    00011010000000       


Q ss_pred             ---Chhhhcchh----cc--Cc-----cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          659 ---RPVELIDKS----LE--DT-----YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       659 ---~~~~~~d~~----l~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         .........    ..  ..     ........+.+|+.+||+.||.+|||+.|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence               000000000    00  00     00123457889999999999999999999995

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-36  Score=315.23  Aligned_cols=252  Identities=26%  Similarity=0.411  Sum_probs=202.1

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|.+.+.||+|+||+||++...++..+|+|.+.... ...+++.+|+.++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4678888999999999999998777789999986442 345779999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++....  ..+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            999999985432  35899999999999999999999998   9999999999999999999999999988653322111


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+.......   ...    ....+..         .
T Consensus       158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~----~~~~~~~---------~  220 (256)
T cd05113         158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE----KVSQGLR---------L  220 (256)
T ss_pred             -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH----HHhcCCC---------C
Confidence             111235567999999998899999999999999999998 888865322111   001    1111110         0


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ..+......+.+++.+||+.+|.+||++.++++.|+
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            011123467889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-36  Score=323.73  Aligned_cols=240  Identities=27%  Similarity=0.347  Sum_probs=191.4

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||.||+|+.. +++.||||+++..   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999965 4788999999753   223445566777777755 799999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999998853   345899999999999999999999998   9999999999999999999999999997643222  22


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+.......   +..    .....          ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~----~i~~~----------~~~~  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFD----SILND----------RPHF  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHcC----------CCCC
Confidence            234679999999999999999999999999999999999999976432211   110    01100          0111


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMA-SVV  702 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  702 (751)
                      +......+.+++.+||+.||.+||++. +++
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            222345678999999999999999976 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-36  Score=331.68  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=195.0

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|+..++||+|+||.||++++. +++.||||++.... ....+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999999965 58999999986543 23456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+..       ...+..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986542       3567788899999999999999998   99999999999999999999999999987643221


Q ss_pred             cccccccccccCccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          590 EANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                        ......||..|+|||++..     ...+.++|||||||++|||++|+.||..........+...    ....      
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~~------  291 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----ICMS------  291 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhcc------
Confidence              1223578999999998743     2345799999999999999999999873322111111000    0000      


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                         ............+.+|+.+||+.||++||++.|+++.
T Consensus       292 ---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 ---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0011122345578899999999999999999999974

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.4e-37  Score=318.37  Aligned_cols=250  Identities=32%  Similarity=0.505  Sum_probs=192.8

Q ss_pred             ccccccccccccEEEEEEc-----CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          436 EENKLGEGGFGPVYKGMLI-----DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       436 ~~~~IG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ..+.||.|.||.||+|.+.     .+..|+||.+... .....+.+.+|++.+++++||||+++++++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999976     2678999999653 333478899999999999999999999999988889999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.++|... ....+++..+..|+.||++||.|||+++   ++|++|+++||++++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999764 2346899999999999999999999998   99999999999999999999999999987632222


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      ............|+|||.+.+..++.++||||||+++|||++ |+.|+.....   ..+.    ........        
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~----~~~~~~~~--------  223 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEII----EKLKQGQR--------  223 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHH----HHHHTTEE--------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc----cccccccc--------
Confidence            222233456778999999999999999999999999999999 6677432211   1111    11111111        


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                       ...+......+.+++.+|+..||++||++.++++.|
T Consensus       224 -~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 -LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             111222355688999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.1e-37  Score=331.34  Aligned_cols=265  Identities=20%  Similarity=0.312  Sum_probs=196.7

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC-----ceE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD-----ERM  504 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  504 (751)
                      +|++.++||+|+||.||+|+.. +++.||||++...  ......++.+|+.++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999965 5899999998643  2234457889999999999999999999886443     479


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+. ++|.+++.   ....+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68988884   3345899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCc-cccccccccccCccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH--------HHH
Q 038934          585 GVDQT-EANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH--------AWR  653 (751)
Q Consensus       585 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~--------~~~  653 (751)
                      ..... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+..        ...
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32221 111233578999999999876  6789999999999999999999999864332111100000        000


Q ss_pred             HhccCChhhhcchhccCc-cC-----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          654 LWTEDRPVELIDKSLEDT-YS-----LSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       654 ~~~~~~~~~~~d~~l~~~-~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..........+....... ..     ......+.+++.+||+.||++||+++|+++.
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000011111111000000 00     1123467899999999999999999999953

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-36  Score=320.02  Aligned_cols=257  Identities=28%  Similarity=0.414  Sum_probs=202.8

Q ss_pred             cCccccccccccccccEEEEEEcC------CcEEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      .+|.+.++||+|+||.||+|...+      ++.||||++...... ..+.+.+|+.++.+++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            356778899999999999998643      478999999755332 3467889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC
Q 038934          505 LIYEYLPNKSLADFIFDG-------------TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  571 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~  571 (751)
                      +++||+.+++|.+++...             .....+++..+..++.|++.||.|||+++   |+||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999998531             11235788899999999999999999998   99999999999999999


Q ss_pred             CeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHH
Q 038934          572 NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGH  650 (751)
Q Consensus       572 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~  650 (751)
                      .+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+......   .    
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~----  234 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D----  234 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---H----
Confidence            999999999886543322222233456789999999998899999999999999999998 77675422111   1    


Q ss_pred             HHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          651 AWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       651 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ..........         ...+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus       235 ~~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111111111         11122345568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1e-36  Score=335.06  Aligned_cols=253  Identities=20%  Similarity=0.315  Sum_probs=197.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .|...++||+|+||+||+|+.. +++.||||++.+.   .....+.+.+|+.++++++|+||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999964 5789999999754   23345678999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999853   345889999999999999999999998   9999999999999999999999999986432110


Q ss_pred             c---------------------------------------------cccccccccccCccCcccccCCCCCcchhhHHHH
Q 038934          589 T---------------------------------------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFG  623 (751)
Q Consensus       589 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG  623 (751)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhh--hcCCCCCCCCCHHHH
Q 038934          624 VLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLL--CVQQRPEDRPNMASV  701 (751)
Q Consensus       624 ~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~ev  701 (751)
                      |++|||++|+.||.........      ........       .+...........+.+++.+  |+..+|..||++.++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~------~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQ------LKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHH------HHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999998643321110      00000000       00001111234566778877  445666679999999


Q ss_pred             HHH
Q 038934          702 VLM  704 (751)
Q Consensus       702 l~~  704 (751)
                      ++.
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.7e-36  Score=320.53  Aligned_cols=261  Identities=22%  Similarity=0.347  Sum_probs=195.4

Q ss_pred             cCccccccccccccccEEEEEEc--CCcEEEEEEeccCC--cccHHHHHHHHHHHHHh---cCCcEEeEeceee-----e
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI--DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL---QHRNLVKLLGCCM-----K  499 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  499 (751)
                      ++|++.+.||+|+||.||+|+..  +++.||+|++....  ......+.+|+.+++++   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47888999999999999999863  36789999986542  22334567788887776   5999999999985     2


Q ss_pred             CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       500 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                      ....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456899999997 58988885432 335899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      +++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||........   +...........
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~  229 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG  229 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCC
Confidence            99875432   222345789999999999999999999999999999999999999865433211   111100000000


Q ss_pred             hhh------hcchhcc--C-----ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          660 PVE------LIDKSLE--D-----TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       660 ~~~------~~d~~l~--~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...      +....+.  .     .........+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000      0000000  0     011123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-37  Score=335.63  Aligned_cols=253  Identities=20%  Similarity=0.275  Sum_probs=197.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|.+.++||+|+||.||++... +++.||||++.+.   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47888999999999999999864 5889999998653   2334567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999853   356889999999999999999999998   999999999999999999999999999643210


Q ss_pred             Ccc---------------------------------------------ccccccccccCccCcccccCCCCCcchhhHHH
Q 038934          588 QTE---------------------------------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSF  622 (751)
Q Consensus       588 ~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSl  622 (751)
                      ...                                             .......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000                                             00012469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCC---CCHH
Q 038934          623 GVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDR---PNMA  699 (751)
Q Consensus       623 G~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~  699 (751)
                      ||++|||++|+.||........   .   ...........+       .........+.+++.+||+ +|.+|   +++.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~---~---~~i~~~~~~~~~-------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHET---Y---RKIINWRETLYF-------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHH---H---HHHHccCCccCC-------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            9999999999999864332111   0   000100000000       0011234567889999997 66665   6999


Q ss_pred             HHHHH
Q 038934          700 SVVLM  704 (751)
Q Consensus       700 evl~~  704 (751)
                      ++++.
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=325.51  Aligned_cols=253  Identities=24%  Similarity=0.289  Sum_probs=212.6

Q ss_pred             HHhcCccccccccccccccEEEEEEcC-CcEEEEEEeccCCcc---cHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCce
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQ---GVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDER  503 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  503 (751)
                      ...+.|.+.+.||+|.||.||+++.+. |+.+|+|.+.+....   ..+.+.+|+.+|+++. |||||++++++++...+
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            345678888999999999999999765 999999999876433   4568999999999998 99999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC----CCeEEeecc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE----MNPKISDFG  579 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~----~~~kl~DFG  579 (751)
                      ++|||++.||.|.+.|...    .+++..+..++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999999765    3899999999999999999999998   9999999999999643    479999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      ++.....   .......+||+.|+|||++...+|+..+||||+|+++|.|++|..||..........       ....++
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~  254 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGD  254 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCC
Confidence            9998764   334556899999999999999999999999999999999999999987554332211       011111


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .      .+....-......+.+++..|+..||.+|+++.++++.
T Consensus       255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1      12222233446678899999999999999999999983

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-36  Score=318.75  Aligned_cols=264  Identities=28%  Similarity=0.445  Sum_probs=202.3

Q ss_pred             cCccccccccccccccEEEEEEc-----CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--CceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-----DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  504 (751)
                      ++|++.+.||+|+||.||++...     +++.||+|++........+.+.+|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            47788899999999999999742     4789999999776666677899999999999999999999987543  4688


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998532  345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccc-ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC----
Q 038934          585 GVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR----  659 (751)
Q Consensus       585 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~----  659 (751)
                      ........ .....++..|+|||++.+..++.++||||||+++|||++|..+........        ........    
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--------~~~~~~~~~~~~  230 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF--------MRMMGNDKQGQM  230 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh--------hhhccccccccc
Confidence            43222111 111223456999999999899999999999999999999876643211100        00000000    


Q ss_pred             ----hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          660 ----PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       660 ----~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                          ..+.+.....-.........+.+|+.+|++.+|++|||+.+|++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                0001111001111223345788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-36  Score=313.02  Aligned_cols=251  Identities=27%  Similarity=0.413  Sum_probs=201.1

Q ss_pred             CccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          433 NFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +|++.+.||+|+||.||++.+..+..+|+|.+.+.. ...+.+.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            577888999999999999998777889999986432 2346788999999999999999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++......... 
T Consensus        84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-  157 (256)
T cd05059          84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-  157 (256)
T ss_pred             CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence            9999998543  236899999999999999999999998   9999999999999999999999999987653221111 


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+.......   ...    .....         ....
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~----~~~~~---------~~~~  221 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE----SVSAG---------YRLY  221 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH----HHHcC---------CcCC
Confidence            111223457999999999999999999999999999998 788765322211   111    11111         0111


Q ss_pred             cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       672 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      .+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            12234557889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.3e-36  Score=319.65  Aligned_cols=257  Identities=28%  Similarity=0.420  Sum_probs=202.9

Q ss_pred             CccccccccccccccEEEEEEcC------CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      +|.+.+.||+|+||.||+|....      ...+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46778899999999999998532      3568888886543 2345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCC
Q 038934          506 IYEYLPNKSLADFIFDGT---------------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN  564 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~N  564 (751)
                      |+||+.+++|.+++....                     ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999985421                     1235789999999999999999999998   9999999999


Q ss_pred             eEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 038934          565 VLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDH  643 (751)
Q Consensus       565 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~  643 (751)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+....+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986533222212222345678999999998899999999999999999998 888865322111


Q ss_pred             ccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          644 HHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       644 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                             .+......         .....+......+.+++.+|++.+|++||++.++++.|+++
T Consensus       238 -------~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         238 -------LFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             -------HHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence                   11111111         11111222345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-36  Score=318.60  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=204.0

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|...++||+|+||.||++...      ++..+|+|.+........+.+.+|+++++.++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778889999999999999742      356799999877666667789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCe
Q 038934          506 IYEYLPNKSLADFIFDGTR------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      ||||+++++|.+++.....            ...+++..++.++.|++.||+|||+.+   ++|+||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864321            135789999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHH
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.|+.......   ..    
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI----  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH----
Confidence            9999999976532222111222345678999999999999999999999999999998 888764211110   00    


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ........         ...+......+.+++.+|++.||.+||++.+|++.|+.
T Consensus       235 ~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         235 ECITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            00111100         01112234567899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.4e-37  Score=297.39  Aligned_cols=254  Identities=24%  Similarity=0.355  Sum_probs=203.4

Q ss_pred             HHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC-----C---cccHHHHHHHHHHHHHh-cCCcEEeEecee
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-----S---GQGVEEFKNEVLLIAKL-QHRNLVKLLGCC  497 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  497 (751)
                      +..-..|...+.||.|..++|-++.++ .++++|+|++...     .   ..-.++-..|+.||+++ .||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            445567888899999999999998865 5889999998642     1   12244567899999998 599999999999


Q ss_pred             eeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEee
Q 038934          498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  577 (751)
Q Consensus       498 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  577 (751)
                      +.+..+++|+|.|+.|.|.|++   ...-.+++++..+|++|+++|+.|||...   ||||||||+|||+|++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            9999999999999999999999   45557899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCccccccccccccCccCcccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAID------GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA  651 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~  651 (751)
                      ||+++.+....   .....+|||+|+|||.+..      ..|+..+|+|++||++|.||.|..||--+.     +++  .
T Consensus       167 FGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Qml--M  236 (411)
T KOG0599|consen  167 FGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QML--M  236 (411)
T ss_pred             cceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHH--H
Confidence            99999875332   2345899999999999853      358899999999999999999999964111     111  1


Q ss_pred             HHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          652 WRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       652 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .++..++...      +....=.+.+....+||.+|||.||.+|.|++|+++
T Consensus       237 LR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  237 LRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1112222110      111111234556789999999999999999999984

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-36  Score=326.94  Aligned_cols=241  Identities=24%  Similarity=0.336  Sum_probs=194.3

Q ss_pred             ccccccccccEEEEEEc----CCcEEEEEEeccC----CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          438 NKLGEGGFGPVYKGMLI----DGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++||+|+||.||+++..    .++.||||++.+.    .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999853    4788999998653    223345678999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++.   +.+.+.+..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            99999999984   3456788999999999999999999998   9999999999999999999999999987542221 


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .   . .......          
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~---~-~~~~~~~----------  216 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---T---I-DKILKGK----------  216 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---H---H-HHHHcCC----------
Confidence             11233578999999999999999999999999999999999999976432211   0   0 0011110          


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                      ...+......+.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            011222345678999999999999999     7888875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-37  Score=334.11  Aligned_cols=253  Identities=24%  Similarity=0.354  Sum_probs=204.1

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|.+.+.||+|+||.||+++.. +++.||||++.+.   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47889999999999999999965 5899999999754   2244567899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999543   56899999999999999999999998   999999999999999999999999999876433


Q ss_pred             C---------------------------ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 038934          588 Q---------------------------TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHH  640 (751)
Q Consensus       588 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~  640 (751)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.|+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0011233578999999999999999999999999999999999999976433


Q ss_pred             CccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHH
Q 038934          641 VDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN-MASVVLM  704 (751)
Q Consensus       641 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  704 (751)
                      ....       ........      ..+.-.........+.+++.+|++ ||.+||+ +.++++.
T Consensus       235 ~~~~-------~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQET-------YNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHH-------HHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            2110       00000000      000000011135678899999997 9999999 9999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-36  Score=313.38  Aligned_cols=260  Identities=22%  Similarity=0.352  Sum_probs=207.8

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.++||+|+||.||+|+.. +++.||||++...   .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999964 6899999988642   2334457889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          508 EYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      ||+++++|.+++.... ....+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999885432 2345789999999999999999999998   99999999999999999999999999887643


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.......    .... ........      
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~-~~~~~~~~------  225 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLC-QKIEQCDY------  225 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHH-HHHhcCCC------
Confidence            222  1123568889999999998889999999999999999999999964322110    1111 01111000      


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                        ...........+.+++.+|++.+|++||++.+|++.|++++
T Consensus       226 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 --PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             --CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence              00111233457889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=332.06  Aligned_cols=260  Identities=30%  Similarity=0.418  Sum_probs=205.4

Q ss_pred             CccccccccccccccEEEEEEcC--C--cE-EEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID--G--QE-IAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      +....++||+|+||.||+|++..  +  .. ||||..+..   ....+.+|.+|+++|++++|||||+++|++.....++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            33445799999999999999654  2  23 899998752   4567789999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +|||+|.||+|.++|.....  .++..++.+++.+.|.||+|||+++   +|||||...|+|++.++.+||+|||+++..
T Consensus       238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999964322  5899999999999999999999999   999999999999999999999999998764


Q ss_pred             CCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      .......  ....-...|+|||.+....|++++|||||||++||+++ |..|+.......       ....        +
T Consensus       313 ~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~k--------I  375 (474)
T KOG0194|consen  313 SQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAK--------I  375 (474)
T ss_pred             cceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHH--------H
Confidence            3111111  01123468999999999999999999999999999998 777754322210       0000        1


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCCC
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQP  714 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p  714 (751)
                      +........+......+..++.+|++.+|++||+|.++.+.|+.+.....+
T Consensus       376 ~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  376 VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            011111222334566778889999999999999999999999887555444

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.5e-36  Score=331.63  Aligned_cols=254  Identities=21%  Similarity=0.298  Sum_probs=195.9

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|+..+.||+|+||+||++... +++.||||++.+..   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47888999999999999999965 58899999997532   233457889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999953   456899999999999999999999998   999999999999999999999999998764321


Q ss_pred             Cc---------------------------------cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 038934          588 QT---------------------------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTR  634 (751)
Q Consensus       588 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~  634 (751)
                      ..                                 ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            10                                 000123579999999999999999999999999999999999999


Q ss_pred             CCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcC--CCCCCCCCHHHHHHH
Q 038934          635 NRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQ--QRPEDRPNMASVVLM  704 (751)
Q Consensus       635 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~  704 (751)
                      ||........   .    ........ .+.   +..  .......+.+++.+++.  .++..||++.|+++.
T Consensus       235 Pf~~~~~~~~---~----~~i~~~~~-~~~---~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSETPQET---Y----KKVMNWKE-TLI---FPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCHHHH---H----HHHHcCcC-ccc---CCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            9864332111   0    00100000 000   000  11123455666666443  344467999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.1e-36  Score=316.42  Aligned_cols=257  Identities=30%  Similarity=0.471  Sum_probs=202.0

Q ss_pred             hcCccccccccccccccEEEEEEcC------CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|.+.+.||+|++|.||+|.+..      +..||+|.+.... ......+.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678899999999999999999753      5678999886443 33445789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC---CeEEe
Q 038934          504 MLIYEYLPNKSLADFIFDGTR----RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKIS  576 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~  576 (751)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865321    235899999999999999999999998   99999999999998755   59999


Q ss_pred             eccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHh
Q 038934          577 DFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       577 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||.......   +.    ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~----~~~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VM----EFV  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHH
Confidence            9999987632221111112233568999999999999999999999999999997 888865332211   11    111


Q ss_pred             ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ...         .....+......+.+++.+|++.+|++||++.+|++.|+
T Consensus       235 ~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111         011122233457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-36  Score=318.52  Aligned_cols=263  Identities=24%  Similarity=0.371  Sum_probs=200.8

Q ss_pred             cCccccccccccccccEEEEEEcC---------------CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID---------------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLG  495 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~  495 (751)
                      ++|++.++||+|+||.||++....               ...||+|++... .....+.+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578899999999999999987532               234899998754 3334567999999999999999999999


Q ss_pred             eeeeCCceEEEEEecCCCChhHHHhccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeE
Q 038934          496 CCMKRDERMLIYEYLPNKSLADFIFDGT---------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL  566 (751)
Q Consensus       496 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIl  566 (751)
                      ++...+..++||||+++++|.+++....         ....+++..++.++.|++.||+|||+.+   ++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999985421         1124688999999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCC--CCCCCCCCccc
Q 038934          567 LDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT--RNRGFHHVDHH  644 (751)
Q Consensus       567 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~--~p~~~~~~~~~  644 (751)
                      +++++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|+++.  .|+......  
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence            9999999999999997654322222222234567899999999999999999999999999999854  444322211  


Q ss_pred             cchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          645 HNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       645 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                       .........+.....      ......+...+..+.+|+.+|++.||++||++.+|++.|+
T Consensus       240 -~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 -QVIENTGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -HHHHHHHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             111111111111000      0001111123457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.6e-36  Score=321.17  Aligned_cols=260  Identities=27%  Similarity=0.414  Sum_probs=206.2

Q ss_pred             HhcCccccccccccccccEEEEEEcC------CcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCC
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRD  501 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  501 (751)
                      ..++|+..+.||+|+||.||++.+..      ...+|+|.+... ......++.+|+.++.++ +|+||+++++++....
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34678888999999999999998643      367999998754 233456788999999999 7999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc
Q 038934          502 ERMLIYEYLPNKSLADFIFDG-------------TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  568 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~  568 (751)
                      ..++||||+++++|.+++...             .....+++..++.++.|++.||.|||+.+   |+|+||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998542             22346899999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccch
Q 038934          569 NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNL  647 (751)
Q Consensus       569 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~  647 (751)
                      +++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.......    
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  242 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----  242 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence            999999999999987643222222222345678999999999999999999999999999997 888764322111    


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                         .........         ....+......+.+|+.+|++.||++|||+.++++.|+.+
T Consensus       243 ---~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 ---LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             ---HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence               111111111         1112223355788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-36  Score=313.11  Aligned_cols=256  Identities=24%  Similarity=0.386  Sum_probs=200.5

Q ss_pred             ccccccccccccccEEEEEEcC----CcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc-----
Q 038934          434 FSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE-----  502 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  502 (751)
                      |.+.+.||+|+||.||+|.+..    +..||||++...  .....+++.+|+++++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998643    367999998754  23345689999999999999999999999876554     


Q ss_pred             -eEEEEEecCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeec
Q 038934          503 -RMLIYEYLPNKSLADFIFDGT---RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  578 (751)
Q Consensus       503 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF  578 (751)
                       .++|+||+++++|..++....   ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999999985422   2346899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhcc
Q 038934          579 GMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTE  657 (751)
Q Consensus       579 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~  657 (751)
                      |+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....   ..+..    ....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~----~~~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYD----YLRH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHc
Confidence            99987643322211222334678999999998999999999999999999999 7777643211   11111    1111


Q ss_pred             CChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       658 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      +..         ...+......+.+++.+|++.||++||++.++++.|+.+
T Consensus       231 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111         111223455788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.8e-36  Score=318.00  Aligned_cols=265  Identities=27%  Similarity=0.393  Sum_probs=205.5

Q ss_pred             hcCccccccccccccccEEEEEEcC-----------------CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-----------------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVK  492 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  492 (751)
                      .++|++.++||+|+||.||++....                 +..||+|++.... ....+.+.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578899999999999999988543                 2458999987553 345678999999999999999999


Q ss_pred             EeceeeeCCceEEEEEecCCCChhHHHhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCC
Q 038934          493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGT--------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN  564 (751)
Q Consensus       493 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~N  564 (751)
                      +++++..+...++|||++++++|.+++....        ....+++..++.++.|++.||+|||+.+   |+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986532        1236899999999999999999999998   9999999999


Q ss_pred             eEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCc
Q 038934          565 VLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY--GTRNRGFHHVD  642 (751)
Q Consensus       565 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~--G~~p~~~~~~~  642 (751)
                      |++++++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++  +..|+..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999986543322222233456788999999998899999999999999999998  4555432211 


Q ss_pred             cccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          643 HHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       643 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                        ..........+.........      ..+...+.++.+++.+|++.||.+||++.+|++.|+.
T Consensus       240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 --QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence              11111121111111111111      1112234578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.6e-36  Score=317.98  Aligned_cols=268  Identities=29%  Similarity=0.418  Sum_probs=202.3

Q ss_pred             Cc-cccccccccccccEEEEEE-----cCCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--Cce
Q 038934          433 NF-SEENKLGEGGFGPVYKGML-----IDGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DER  503 (751)
Q Consensus       433 ~y-~~~~~IG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  503 (751)
                      +| ...+.||+|+||+||++..     .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            44 7788999999999988652     357889999987543 23456788999999999999999999988764  357


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++..    ..+++..+..++.|++.||.|||+++   |+|+||||+|||+++++.+||+|||+++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence            899999999999999843    34899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccc-ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          584 FGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       584 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .................
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhh
Confidence            643222111 1123355679999999988999999999999999999999988643221100 00000000000111111


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .++.......+......+.+++.+|++.+|++||++++++++|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1211111122233456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.8e-36  Score=326.96  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             CccccccccccccccEEEEEEc----CCcEEEEEEeccC----CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCce
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  503 (751)
                      +|++.++||+|+||.||+++..    +++.||+|++.+.    .....+.+.+|+.++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788899999999999998853    4789999998653    223345688999999999 599999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999853   345899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      +...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.|+...........   ........    
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---~~~~~~~~----  226 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE---VSRRILKC----  226 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH---HHHHHhcC----
Confidence            5332221 22246799999999999875 478999999999999999999999864332211111   11100000    


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                            ....+......+.+++.+||+.||++||     ++.++++
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 ------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                  0111222345678999999999999999     6777774

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.4e-36  Score=326.11  Aligned_cols=242  Identities=24%  Similarity=0.348  Sum_probs=194.8

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      ++||+|+||.||+|+.. +++.||||++.+.   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999965 4789999999754   234456678899999876 799999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|...+..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            999998853   345889999999999999999999998   9999999999999999999999999987543221  12


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.|+........   ..   . ......          ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~---~-i~~~~~----------~~  215 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FE---S-ILHDDV----------LY  215 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HH---H-HHcCCC----------CC
Confidence            2346789999999999999999999999999999999999999864332111   10   0 111100          11


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCC-------CHHHHHHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRP-------NMASVVLM  704 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~  704 (751)
                      +......+.+++.+||+.||++||       ++.++++.
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            112345788999999999999999       78888743

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-36  Score=326.33  Aligned_cols=244  Identities=26%  Similarity=0.352  Sum_probs=194.0

Q ss_pred             ccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHH---HhcCCcEEeEeceeeeCCceEEE
Q 038934          434 FSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIA---KLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      |++.+.||+|+||.||++... +++.||||++.+.   .....+.+.+|++++.   .++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999965 5899999999754   2234456777776654   56799999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|..++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999998873    346899999999999999999999998   99999999999999999999999999875322


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      .  ........|++.|+|||++.+..++.++|||||||++|||++|+.|+........   .    .......       
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~----~~i~~~~-------  217 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---F----DSIVNDE-------  217 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHhCC-------
Confidence            1  1222346799999999999999999999999999999999999999764322110   0    0000000       


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                         ...+......+.+++.+||+.||.+||     ++.++++
T Consensus       218 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 ---VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence               011222345678999999999999999     5666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.1e-36  Score=321.71  Aligned_cols=240  Identities=27%  Similarity=0.358  Sum_probs=192.2

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||.||++++. +++.||+|++++..   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999975 58899999997542   23455677888888765 899999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|.+++..   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            999998853   345889999999999999999999998   9999999999999999999999999987532111  12


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+.    .......          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~----~~~~~~~----------~~~  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF----ESIRVDT----------PHY  215 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCC----------CCC
Confidence            23467899999999999999999999999999999999999997533221   111    1111000          011


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMA-SVV  702 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  702 (751)
                      +......+.+++.+||+.||++||++. +++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            122345678999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.8e-36  Score=311.20  Aligned_cols=253  Identities=29%  Similarity=0.473  Sum_probs=202.5

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|++.++||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            5788899999999999999998888899999986543 24567999999999999999999999875 456899999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++..+.......
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            99999998643 2345789999999999999999999998   9999999999999999999999999998764322111


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |..|+......   ....    .....         ...
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~----~~~~~---------~~~  222 (260)
T cd05070         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLE----QVERG---------YRM  222 (260)
T ss_pred             -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcC---------CCC
Confidence             112335568999999998899999999999999999999 78886432211   1111    11111         011


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ..+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1222344578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-36  Score=322.03  Aligned_cols=264  Identities=26%  Similarity=0.398  Sum_probs=208.5

Q ss_pred             hcCccccccccccccccEEEEEEc--------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR  500 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  500 (751)
                      .++|.+.+.||+|+||.||+++..        ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888999999999999999742        2457999998654 234457799999999999 899999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTR-------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  567 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll  567 (751)
                      ...++||||+++++|.+++.....             ...+++..+..++.||+.||.|||+++   |+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999965321             235788899999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 038934          568 DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHN  646 (751)
Q Consensus       568 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~  646 (751)
                      ++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..|+......    
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----  246 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  246 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence            9999999999999987643322222223445678999999999999999999999999999998 66665422111    


Q ss_pred             hhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCC
Q 038934          647 LLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQ  713 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  713 (751)
                         ...........         ...+......+.+++.+|++.+|++||++.++++.|+++..+..
T Consensus       247 ---~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         247 ---ELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             ---HHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence               11111111111         01122345678899999999999999999999999988765544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-37  Score=333.92  Aligned_cols=252  Identities=23%  Similarity=0.301  Sum_probs=199.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.++||+|+||.||+++.. +++.||||++.+.   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47888999999999999999965 5889999999753   2234556889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999853   346899999999999999999999998   999999999999999999999999998765321


Q ss_pred             Ccc------------------------------------ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh
Q 038934          588 QTE------------------------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY  631 (751)
Q Consensus       588 ~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~  631 (751)
                      ...                                    .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            110                                    00112469999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 038934          632 GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN---MASVVL  703 (751)
Q Consensus       632 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  703 (751)
                      |+.||........      ..........       +...........+.+++.+|+. +|.+|++   +.++++
T Consensus       235 G~~Pf~~~~~~~~------~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNPQET------YRKIINWKET-------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCHHHH------HHHHHcCCCc-------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999764322110      0000100000       0000111234567789999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.7e-36  Score=325.26  Aligned_cols=236  Identities=27%  Similarity=0.380  Sum_probs=191.4

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||.||+++.. +++.||||++.+.   .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999965 4889999998753   234456778899998877 699999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|.+++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            999998853   346899999999999999999999998   9999999999999999999999999987542211  12


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........       .........          ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~~----------~~  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-------FEAILNDEV----------VY  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCCC----------CC
Confidence            2346799999999999999999999999999999999999999764322110       111111100          11


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNM  698 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~  698 (751)
                      +......+.+++.+||+.||.+||++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            12234577899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-35  Score=309.71  Aligned_cols=259  Identities=24%  Similarity=0.381  Sum_probs=209.0

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..   .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999976 6899999988642   2334568899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          508 EYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      ||+++++|.+++.... ....+++..+..++.+++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999986532 2345899999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ....  .....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+......    ... .........       
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~-------  224 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEKCD-------  224 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-HHhhhhcCC-------
Confidence            2221  12356888999999999999999999999999999999999996432211    000 000011110       


Q ss_pred             hccCccC-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          667 SLEDTYS-LSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       667 ~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                        ....+ ......+.+++.+|++.+|++||++.+|+++|+.+.
T Consensus       225 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 --YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence              01111 134457889999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.6e-36  Score=320.55  Aligned_cols=240  Identities=28%  Similarity=0.386  Sum_probs=192.0

Q ss_pred             ccccccccccEEEEEEcC-CcEEEEEEeccCC---cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||.||+|++.. ++.||||++....   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            369999999999999754 7899999997542   23445677788888765 899999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            999999853   345889999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+.    .......          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~----~~i~~~~----------~~~  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELF----QSIRMDN----------PCY  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCC----------CCC
Confidence            23457899999999999999999999999999999999999997543221   111    1011000          011


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMA-SVV  702 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  702 (751)
                      +......+.+++.+||+.||++||++. +++
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            122345678999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.2e-36  Score=310.57  Aligned_cols=253  Identities=27%  Similarity=0.424  Sum_probs=202.0

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|++.++||+|+||.||+|++.+...||+|++.... ...+++.+|+++++.++|+||+++++++. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            5689999999999999999998777789999997532 34567899999999999999999999874 456899999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++.+.......
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            99999999542 2235789999999999999999999998   9999999999999999999999999998664322211


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....++..|+|||++.+..++.++||||||+++|+|++ |+.|+......   ..    ........         ..
T Consensus       160 -~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~----~~~~~~~~---------~~  222 (262)
T cd05071         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERGY---------RM  222 (262)
T ss_pred             -ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HH----HHHHhcCC---------CC
Confidence             122345678999999999999999999999999999999 77776432211   11    01111110         00


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      .........+.+++.+|++.||++||++.+++++|+.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            1122345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.4e-36  Score=324.70  Aligned_cols=241  Identities=27%  Similarity=0.336  Sum_probs=194.1

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcC-CcEEeEeceeeeCCceEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH-RNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~  507 (751)
                      +|++.+.||+|+||.||+|+.. +++.||||++.+.   .....+.+..|++++..+.| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999965 4789999999753   23455678899999999976 56889999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999999843   345789999999999999999999998   999999999999999999999999998753221


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      .  .......||+.|+|||++.+..++.++|||||||++|+|++|+.|+.......   +..    .....         
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~----~i~~~---------  216 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ----SIMEH---------  216 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH----HHHcC---------
Confidence            1  12234678999999999999999999999999999999999999976332211   110    01111         


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNM  698 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  698 (751)
                       ....+......+.+++.+||+.||.+|++.
T Consensus       217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             011122334577899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.6e-36  Score=312.31  Aligned_cols=255  Identities=24%  Similarity=0.404  Sum_probs=197.4

Q ss_pred             cccccccccccccEEEEEEcCC-c--EEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC------Cce
Q 038934          435 SEENKLGEGGFGPVYKGMLIDG-Q--EIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR------DER  503 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  503 (751)
                      .+.++||+|+||.||+|+.... +  .+|+|.++..  .....+.+.+|+++++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            4567899999999999997543 2  5899988654  334467789999999999999999999987532      246


Q ss_pred             EEEEEecCCCChhHHHhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccC
Q 038934          504 MLIYEYLPNKSLADFIFDG---TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  580 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl  580 (751)
                      ++||||+++++|.+++...   .....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987432   22345899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      ++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.....   ..+    ......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~----~~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEI----YDYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHHcCC
Confidence            987643222111122345678999999999999999999999999999999 7777643211   111    11111111


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..         .........+.+++.+|++.||++|||+.++++.|+.+
T Consensus       232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10         01122345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.7e-36  Score=310.76  Aligned_cols=246  Identities=28%  Similarity=0.412  Sum_probs=195.6

Q ss_pred             cccccccccEEEEEEc---CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCC
Q 038934          439 KLGEGGFGPVYKGMLI---DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      +||+|+||.||+|.+.   +++.+|+|++....  ....+++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6999999999999753   47889999986543  234567899999999999999999999885 45778999999999


Q ss_pred             ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc-
Q 038934          514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-  592 (751)
Q Consensus       514 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-  592 (751)
                      +|.+++..   ...+++..+..++.|++.||.|||+++   |+|+||||+||++++++.+||+|||+++.......... 
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999843   346899999999999999999999998   99999999999999999999999999987643322111 


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                      .....+++.|+|||.+.+..++.++|||||||++|||++ |+.|+......   .+    ........         ...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~i~~~~---------~~~  218 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EV----TQMIESGE---------RME  218 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCC---------CCC
Confidence            112234578999999988889999999999999999998 88887532221   11    11111111         111


Q ss_pred             cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       672 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      .+......+.+++.+|++.||++||++.+|.+.|+.
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            222345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.5e-36  Score=315.63  Aligned_cols=257  Identities=26%  Similarity=0.378  Sum_probs=200.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCc----EEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQ----EIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|++.+.||+|+||+||+|.+. +++    .+++|.+.... .....++..|+.+++++.||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46788899999999999999964 344    47778875432 233467888999999999999999999875 456789


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ++||+++++|.+++..  ....+++..+..++.||+.||.|||+++   ++|+||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999954  2346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ............++..|+|||++.+..++.++||||||+++|||++ |+.|+........       ......+....  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~--  231 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERLA--  231 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcCC--
Confidence            3322222333557788999999999999999999999999999998 8888653322111       11111111100  


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                             .+......+.+++.+|++.||++||++.|+++.|..+..
T Consensus       232 -------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         232 -------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                   011123456789999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5e-36  Score=315.18  Aligned_cols=261  Identities=27%  Similarity=0.427  Sum_probs=204.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCc----EEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      .++|+..++||+|+||+||+|++. +++    .||+|++... .....+++.+|+.++..++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            357888899999999999999854 444    4899998654 33345678999999999999999999999875 4578


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +++||+++|+|.+++.+.  ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999998542  346899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      .............+++.|+|||.+.+..++.++|||||||++|||++ |..|+.......   +.    ........   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~---  229 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP----DLLEKGER---  229 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCc---
Confidence            53322222222344678999999999999999999999999999998 888864322111   10    11111110   


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCC
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQ  713 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  713 (751)
                            ...+......+.+++.+|++.||++||++.++++.|+.+...+.
T Consensus       230 ------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         230 ------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             ------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence                  01112234567899999999999999999999999987765553

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.5e-36  Score=321.03  Aligned_cols=241  Identities=28%  Similarity=0.349  Sum_probs=195.0

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||+||++.+. +++.||||++.+.   .....+.+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999975 4789999999754   234456778899999888 699999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            999998843   346899999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.......       .........          ...
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~----------~~~  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDE----------VRY  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCC----------CCC
Confidence            233578999999999999999999999999999999999999975332111       111111110          011


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNM-----ASVVL  703 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  703 (751)
                      +......+.+++.+||+.||.+||++     .++++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            22234578899999999999999999     88875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.4e-36  Score=324.08  Aligned_cols=248  Identities=23%  Similarity=0.309  Sum_probs=195.1

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||.||+++.. +++.+|+|++.+.   .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999965 4789999999754   233455688899998877 799999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            999988843   346899999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc--cchhHHHHHHhccCChhhhcchhccC
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHH--HNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ...............          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------I  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------C
Confidence            2346789999999999999999999999999999999999999864222111  111111111111111          0


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCC------HHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPN------MASVVL  703 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~  703 (751)
                      ..+......+.+++.+||+.||++||+      +.++++
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            122234456789999999999999998      456653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.5e-36  Score=315.83  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=203.2

Q ss_pred             hcCccccccccccccccEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|+..+.||+|+||.||++.+.      ++..+|+|++.... ....+++.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            367889999999999999999863      36789999987543 34456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCC
Q 038934          504 MLIYEYLPNKSLADFIFDGT-------------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN  564 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~N  564 (751)
                      ++||||+++++|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999996421                   1234788899999999999999999998   9999999999


Q ss_pred             eEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 038934          565 VLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDH  643 (751)
Q Consensus       565 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~  643 (751)
                      |++++++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..|+...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876533221111122334667999999999999999999999999999997 77775321111 


Q ss_pred             ccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          644 HHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       644 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                        .    ...........         ..+......+.+++.+|++.||++||++.|+++.|++
T Consensus       240 --~----~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 --E----VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --H----HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              1    11111111110         0111234578899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.2e-36  Score=324.39  Aligned_cols=248  Identities=22%  Similarity=0.307  Sum_probs=196.0

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||.||++++. +++.||||++++.   .....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999965 5889999999754   233456688999999998 699999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|.+++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            999988843   356899999999999999999999998   999999999999999999999999998753211  112


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc--ccchhHHHHHHhccCChhhhcchhccC
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH--HHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ................        +  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~--  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I--  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--
Confidence            234679999999999999999999999999999999999999986432211  1011111111111110        0  


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCC------HHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPN------MASVVL  703 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~  703 (751)
                      ..+......+.+++.+||+.||.+||+      +.++++
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            112223456889999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-36  Score=332.73  Aligned_cols=254  Identities=20%  Similarity=0.246  Sum_probs=201.4

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ..++|++.++||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4578999999999999999999965 5889999999643   22344567899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999999843    34788999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCccccccccccccCccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDG----LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.......      ........... 
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~-  265 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKNS-  265 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCCc-
Confidence            3221 112335799999999998754    47899999999999999999999976433211      01111111000 


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPED--RPNMASVVLM  704 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  704 (751)
                            +.-......+..+.+++.+||+.+|.+  ||++.++++.
T Consensus       266 ------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 ------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                  000111123567889999999999988  9999999853

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.8e-37  Score=327.94  Aligned_cols=242  Identities=22%  Similarity=0.279  Sum_probs=195.2

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      +.||+|+||.||++... +++.||+|++.+.   .......+.+|++++..++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999964 5889999999754   2334567788999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       514 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      +|.+++.   ....+++..+..++.||+.||.|||+ .+   |+||||||+|||+++++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  152 (325)
T cd05594          81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T  152 (325)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence            9998884   34468999999999999999999997 67   99999999999999999999999999875422211  1


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....+..       ........          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-------~~~i~~~~----------~~~  215 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEE----------IRF  215 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-------HHHHhcCC----------CCC
Confidence            2235799999999999999999999999999999999999999753322111       00000000          011


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRP-----NMASVVLM  704 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  704 (751)
                      +......+.+++.+||+.||++|+     ++.++++.
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            222345678999999999999996     89998853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.3e-36  Score=329.39  Aligned_cols=259  Identities=25%  Similarity=0.392  Sum_probs=203.4

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCce
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDER  503 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  503 (751)
                      ++|.+.++||+|+||.||+|++.      .++.||||++.... ....+.+.+|+.++.++. ||||+++++++......
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46778899999999999999853      24689999997653 233457889999999997 99999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccC------------------------------------------------------------
Q 038934          504 MLIYEYLPNKSLADFIFDGT------------------------------------------------------------  523 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------  523 (751)
                      ++||||+++|+|.+++....                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999986421                                                            


Q ss_pred             -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc
Q 038934          524 -----------------------------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  568 (751)
Q Consensus       524 -----------------------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~  568 (751)
                                                         ....+++..+..++.|++.||.|||+.+   |+||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence                                               1124677788999999999999999988   99999999999999


Q ss_pred             CCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccch
Q 038934          569 NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNL  647 (751)
Q Consensus       569 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~  647 (751)
                      +++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..|+.......    
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~----  349 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE----  349 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH----
Confidence            999999999999986533222111222456788999999999899999999999999999998 788864322111    


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                        ........+.         ....+......+.+++.+|++.+|.+||++++|++.|+.+
T Consensus       350 --~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 --QFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             --HHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              0111111110         0111222346788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-36  Score=333.62  Aligned_cols=252  Identities=20%  Similarity=0.295  Sum_probs=196.9

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      +|++.++||+|+||.||+++.. +++.||||++.+.   .....+.+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888999999999999999964 5889999998653   22345678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999953   446889999999999999999999998   9999999999999999999999999985432100


Q ss_pred             c-----------------------------------------cccccccccccCccCcccccCCCCCcchhhHHHHHHHH
Q 038934          589 T-----------------------------------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVL  627 (751)
Q Consensus       589 ~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~  627 (751)
                      .                                         ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0                                         00112357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCC---CHHHHHHH
Q 038934          628 ELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRP---NMASVVLM  704 (751)
Q Consensus       628 ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~  704 (751)
                      ||++|+.||..........      ........       +...........+.+++.+|+ .+|.+|+   ++.++++.
T Consensus       236 ell~G~~Pf~~~~~~~~~~------~i~~~~~~-------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAETQL------KVINWETT-------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHH------HHhccCcc-------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999986443221100      00000000       000011123445667777766 5999999   88888854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-36  Score=313.95  Aligned_cols=258  Identities=24%  Similarity=0.413  Sum_probs=205.1

Q ss_pred             hcCccccccccccccccEEEEEEcC------CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|.+.+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578888999999999999998643      3689999986542 23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEe
Q 038934          504 MLIYEYLPNKSLADFIFDGT-------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  576 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~  576 (751)
                      ++||||+++++|.+++....       ....+++..+..++.|++.||.|||+.+   |+|+||||+|||+++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432       1234788999999999999999999998   9999999999999999999999


Q ss_pred             eccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHh
Q 038934          577 DFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       577 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+.......   ..    ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~----~~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VL----KFV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HH----HHH
Confidence            9999986543322222223456788999999998899999999999999999998 888865322211   11    111


Q ss_pred             ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ......         ..+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus       235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 IDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            111111         1112235678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.3e-36  Score=323.51  Aligned_cols=241  Identities=28%  Similarity=0.336  Sum_probs=194.2

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      +|.+.+.||+|+||.||+++.. +++.||||++.+..   ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778889999999999999965 47899999997542   23345677788888877 5899999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999998843   345889999999999999999999998   999999999999999999999999998754322


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.......   +..    ......        
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~----~i~~~~--------  217 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ----SIMEHN--------  217 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCC--------
Confidence            1  12234678999999999999999999999999999999999999976432211   111    011110        


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNM  698 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  698 (751)
                        ..++.....++.+++.+||+.||.+|++.
T Consensus       218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              11222345678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=312.48  Aligned_cols=261  Identities=23%  Similarity=0.321  Sum_probs=215.6

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ..-|...+.||+|.|.+|-++++. .|..||||++.+..  ......+..|++.|+.++|||||++|++......+|||.
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            455777889999999999999954 79999999998763  334557899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE-cCCCCeEEeeccCccccCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll-~~~~~~kl~DFGla~~~~~  586 (751)
                      |+-++|+|.++|.++.  ..+.+..+.+++.||+.|+.|+|+.+   +|||||||+|+.+ ..-|.|||.|||++..+..
T Consensus        97 ELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            9999999999997543  45899999999999999999999998   9999999999976 5678999999999987643


Q ss_pred             CCccccccccccccCccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFS-VKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      .   ......+|+..|.|||++.|..|+ +++||||||||||.|++|+.||.-....+.               ...++|
T Consensus       172 G---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImD  233 (864)
T KOG4717|consen  172 G---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMD  233 (864)
T ss_pred             c---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhc
Confidence            2   234457999999999999999986 689999999999999999999764333222               222333


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCCCCCCCCCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGERSLPQPKQ  716 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~p~~  716 (751)
                      .  .-..+.....++.+||..||+.||.+|.+.+||+.  .|+....-+....
T Consensus       234 C--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~i  284 (864)
T KOG4717|consen  234 C--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAI  284 (864)
T ss_pred             c--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccC
Confidence            2  22445667789999999999999999999999984  5655544333333

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6e-37  Score=328.58  Aligned_cols=238  Identities=24%  Similarity=0.274  Sum_probs=192.3

Q ss_pred             ccccccccccEEEEEE----cCCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          438 NKLGEGGFGPVYKGML----IDGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      +.||+|+||.||+++.    ..++.+|+|++.+..  ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    247899999997542  2234567889999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            9999999843   346899999999999999999999998   9999999999999999999999999987653221  1


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.|+.......   ...   . .....          ..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~---~-i~~~~----------~~  216 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMT---M-ILKAK----------LG  216 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHH---H-HHcCC----------CC
Confidence            2234678999999999999899999999999999999999999975432211   000   0 00000          01


Q ss_pred             cCHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 038934          672 YSLSEALRCIQVGLLCVQQRPEDRPNMAS  700 (751)
Q Consensus       672 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e  700 (751)
                      .+......+.+++.+||+.||++||++.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            12223456789999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=347.06  Aligned_cols=257  Identities=32%  Similarity=0.494  Sum_probs=206.2

Q ss_pred             CccccccccccccccEEEEEEcC--Cc----EEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID--GQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      +....+.||+|.||.||+|...+  +.    .||||.+.+. +.+.+.+|.+|..+|++++|||||+++|+|.+....++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            45667899999999999999543  43    3899999765 56677899999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          506 IYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ++|||++|+|..+|.+..    ....+.....+.++.|||+|+.|||+++   .|||||...|+||++...+||+|||||
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence            999999999999997642    2346889999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      +.+.............-...|||||.+..+.+|.|+|||||||+|||+++ |..|+...+..+.   +.   ....++  
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v---~~---~~~~gg--  921 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV---LL---DVLEGG--  921 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH---HH---HHHhCC--
Confidence            94432222111111122357999999999999999999999999999998 6667543222111   00   011111  


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                              +-..+......+.+|+.+|++.+|++||++..+++.+..+
T Consensus       922 --------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  922 --------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             --------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence                    1123444566788999999999999999999999988776

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.7e-36  Score=316.24  Aligned_cols=260  Identities=25%  Similarity=0.379  Sum_probs=206.5

Q ss_pred             HhcCccccccccccccccEEEEEEcC-----CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeee-CCc
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID-----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK-RDE  502 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  502 (751)
                      ..++|.+.+.||+|+||.||+|.+..     +..|++|++... .....+.+.+|+.+++.++|+||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34688899999999999999999765     688999998654 33445678999999999999999999998776 467


Q ss_pred             eEEEEEecCCCChhHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEee
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRR-----KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  577 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  577 (751)
                      .++++||+++++|.+++......     ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998653322     46899999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhc
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                      ||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.|+....+.   .+..    ...
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAA----YLK  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHH----HHH
Confidence            999986533222211222345678999999999899999999999999999998 98887532221   1111    111


Q ss_pred             cCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          657 EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       657 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .+..         ..........+.+++.+|++.||++||++.++++.|+.+
T Consensus       234 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         234 DGYR---------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             cCCC---------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1100         011112345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.9e-36  Score=326.34  Aligned_cols=198  Identities=24%  Similarity=0.355  Sum_probs=171.9

Q ss_pred             CccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-C-----CcEEeEeceeeeCCceEE
Q 038934          433 NFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-H-----RNLVKLLGCCMKRDERML  505 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  505 (751)
                      +|.+.+.||+|.||.|-+|.. ++++.||||++++. ..-..+...|+.+|..|+ |     -|+|+++++|...++++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            789999999999999999995 45899999999654 445677789999999997 4     489999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC--CCeEEeeccCccc
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE--MNPKISDFGMARA  583 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DFGla~~  583 (751)
                      |+|.++. +|.++|..+.- ..++...+..++.||+.||..||+.+   |||+||||+||||.+-  ..+||+|||.+..
T Consensus       266 VfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            9999955 99999977544 45899999999999999999999998   9999999999999753  4699999999987


Q ss_pred             cCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHV  641 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~  641 (751)
                      ....     ......+..|+|||++.|.+|+.+.||||||||+.||++|.+-|.....
T Consensus       341 ~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  341 ESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             cCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            5322     2246778899999999999999999999999999999999777665543

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-36  Score=334.21  Aligned_cols=251  Identities=21%  Similarity=0.311  Sum_probs=195.1

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      +|...++||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999964 58899999996542   2345678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999999853   346889999999999999999999998   9999999999999999999999999976432100


Q ss_pred             ---------------------------------------------ccccccccccccCccCcccccCCCCCcchhhHHHH
Q 038934          589 ---------------------------------------------TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFG  623 (751)
Q Consensus       589 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG  623 (751)
                                                                   .........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                         00011235789999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC---HHH
Q 038934          624 VLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN---MAS  700 (751)
Q Consensus       624 ~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~e  700 (751)
                      |+||||++|+.||....+...      .........       .+...........+.+++.+|+ .+|.+|++   +.+
T Consensus       236 vil~elltG~~Pf~~~~~~~~------~~~i~~~~~-------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLET------QMKVINWQT-------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHH------HHHHHccCC-------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            999999999999864332111      000000000       0000011122445667777766 49999998   777


Q ss_pred             HHH
Q 038934          701 VVL  703 (751)
Q Consensus       701 vl~  703 (751)
                      +++
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.7e-36  Score=317.55  Aligned_cols=258  Identities=27%  Similarity=0.415  Sum_probs=204.6

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCce
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  503 (751)
                      ++|.+.+.||+|+||.||++...      .+..+|+|+++... ....+.+.+|+.+++++ +|+||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            57889999999999999999742      24579999987543 33456789999999999 799999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++.... ...+++..+..++.|++.||.|||+++   |+|+||||+|||+++++.++|+|||+++.
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence            99999999999999985422 234899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ..............++..|+|||.+.+..++.++|||||||++|||++ |..|+........      .......+.   
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~~---  261 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGY---  261 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcCC---
Confidence            643322212222455778999999999999999999999999999998 8888643221110      111111110   


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                            ....+......+.+++.+|++.+|++||++.++++.|+..
T Consensus       262 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 ------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  0011112345788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.5e-36  Score=309.60  Aligned_cols=254  Identities=29%  Similarity=0.432  Sum_probs=204.0

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .++|.+.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            35788899999999999999998889999999986543 34578999999999999999999999874 56789999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999985432 346889999999999999999999998   999999999999999999999999999876422211


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      . .....++..|+|||++.+..++.++||||||+++|||++ |+.|+......   ....    .......         
T Consensus       159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~---------  221 (260)
T cd05067         159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQ----NLERGYR---------  221 (260)
T ss_pred             c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHH----HHHcCCC---------
Confidence            1 112345678999999999999999999999999999998 89887532211   1111    1111110         


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ...+......+.+++.+|++.+|++||++++++..|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            01112234578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.8e-36  Score=311.86  Aligned_cols=254  Identities=23%  Similarity=0.361  Sum_probs=202.1

Q ss_pred             cCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            5789999999999999999996 458899999997655555667889999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++........ 
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            99999999843   346899999999999999999999998   99999999999999999999999999986642211 


Q ss_pred             ccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          591 ANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                       ......+++.|+|||.+.   ...++.++|||||||++|||++|+.|+....+.....       ......   ...+.
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~---~~~~~  230 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN---FQPPK  230 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC---CCCCC
Confidence             122356888999999885   4457889999999999999999999864222111100       000000   00000


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                      +.  ........+.+++.+||+.+|++||+++++++.|
T Consensus       231 ~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         231 LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            10  0112345788999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.7e-36  Score=314.00  Aligned_cols=246  Identities=28%  Similarity=0.364  Sum_probs=196.0

Q ss_pred             ccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       440 IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      ||+|+||+||++... +++.+|+|++.+..   ....+.+..|+.+++.++|+||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999965 58899999986542   22345678899999999999999999999999999999999999999


Q ss_pred             hHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccccc
Q 038934          516 ADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN  594 (751)
Q Consensus       516 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  594 (751)
                      .+++... .....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++..+......  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            9887542 23456899999999999999999999998   999999999999999999999999999765432221  22


Q ss_pred             ccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCH
Q 038934          595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSL  674 (751)
Q Consensus       595 ~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  674 (751)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.|+..........   ....        ......  ...+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~--------~~~~~~--~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQ--------RILNDS--VTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---HHHH--------hhcccC--CCCcc
Confidence            3578999999999999999999999999999999999999976432211100   0000        000000  01222


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          675 SEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       675 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                      .....+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            3456788999999999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-35  Score=314.14  Aligned_cols=260  Identities=25%  Similarity=0.405  Sum_probs=202.4

Q ss_pred             HhcCccccccccccccccEEEEEEcC------CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  502 (751)
                      ..++|++.++||+|+||.||+|...+      +..||+|.+.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            35789999999999999999997542      4579999986442 2234568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEE
Q 038934          503 RMLIYEYLPNKSLADFIFDGT-------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  575 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl  575 (751)
                      .++||||+++++|.+++....       ....+.+..+..++.|++.||.|||+++   |+||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996422       1234577888999999999999999998   999999999999999999999


Q ss_pred             eeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHH
Q 038934          576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       576 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.......       ....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence            99999886532222111122345678999999999999999999999999999998 676754221110       0011


Q ss_pred             hccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...+...         ..+......+.+++.+|++.||++||++.++++.|...
T Consensus       234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 VMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            1111000         01112245788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5e-36  Score=318.26  Aligned_cols=262  Identities=28%  Similarity=0.428  Sum_probs=203.8

Q ss_pred             cCccccccccccccccEEEEEEcC-C--cEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-G--QEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|++++.++ +||||+++++++.+....++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            478888999999999999998754 3  34788888643 334456789999999999 799999999999999999999


Q ss_pred             EEecCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCe
Q 038934          507 YEYLPNKSLADFIFDGT-------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      +||+++++|.+++....             ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999996422             1235889999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHH
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ||+|||++......   ........+..|+|||++.+..++.++|||||||++|||++ |..|+.......       ..
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~  228 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LY  228 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence            99999998643211   11111223457999999999999999999999999999997 988875322211       11


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCCCC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPK  715 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~  715 (751)
                      .....+         .....+......+.+|+.+|++.+|.+||+++++++.|+.+.....+.
T Consensus       229 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~  282 (297)
T cd05089         229 EKLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY  282 (297)
T ss_pred             HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence            111111         111112223457889999999999999999999999998775544443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.6e-36  Score=319.40  Aligned_cols=259  Identities=27%  Similarity=0.399  Sum_probs=203.7

Q ss_pred             hcCccccccccccccccEEEEEEcC--------CcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID--------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR  500 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  500 (751)
                      .++|.+.+.||+|+||.||+++...        .+.+|+|.+... ......++.+|+.++..+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3679999999999999999998532        346999999754 234456788999999999 799999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTR-------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  567 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll  567 (751)
                      +..++||||+++++|.+++.....             ...+++..++.++.|++.||+|||+.+   ++|+||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999965321             235889999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 038934          568 DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHN  646 (751)
Q Consensus       568 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~  646 (751)
                      ++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..|+......    
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----  249 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  249 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence            9999999999999876542221111112234568999999999999999999999999999998 77776432211    


Q ss_pred             hhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          647 LLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                         ...........         ...+......+.+++.+|++.+|++||++.+|++.|+.+
T Consensus       250 ---~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         250 ---ELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             ---HHHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence               11111111111         111223345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.9e-36  Score=310.57  Aligned_cols=259  Identities=24%  Similarity=0.360  Sum_probs=207.5

Q ss_pred             cCccccccccccccccEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|.+.+.||+|+||.||+++. .+++.+|||.+...   .....+++.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999995 46899999988653   2234467889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          508 EYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      ||+++++|.+++.... ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 3456899999999999999999999998   99999999999999999999999999886643


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ....  .....++..|+|||++.+..++.++||||||+++|+|++|..|+.....+.. ..    ........       
T Consensus       159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~~~~~-------  224 (267)
T cd08229         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL----CKKIEQCD-------  224 (267)
T ss_pred             CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HH----hhhhhcCC-------
Confidence            2221  1235688999999999998999999999999999999999999753221100 00    00000000       


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                       ............+.+++.+|++.||++||||.+|+++++.+
T Consensus       225 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         225 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             -CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence             00011123456788999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2e-35  Score=310.68  Aligned_cols=251  Identities=21%  Similarity=0.322  Sum_probs=199.0

Q ss_pred             cCccccccccccccccEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|+..++||+|+||.||++.+ .+++.||+|.+... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577888999999999999995 46889999998654 233456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++..+...  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999997653       3688899999999999999999998   999999999999999999999999999765322  


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                        ......++..|+|||++.+..++.++||||||+++|+|++|+.|+.........................        
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------  218 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP--------  218 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC--------
Confidence              1223578999999999999999999999999999999999999976432221111000011111111000        


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .........++.+++.+|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00111234567899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-36  Score=314.53  Aligned_cols=252  Identities=26%  Similarity=0.329  Sum_probs=201.1

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      +|+..++||+|+||.||++... +++.||+|++....   ......+.+|+.++++++|+||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778889999999999999964 58899999986532   2233567889999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999888542 2345899999999999999999999998   9999999999999999999999999998653222


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      .   .....|++.|+|||++.+..++.++||||+||++|||++|+.||.........   .........          .
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~----------~  220 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKE----------D  220 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhh----------c
Confidence            1   12347899999999999999999999999999999999999998643221110   000000000          0


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVLM  704 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  704 (751)
                      ...++......+.+|+.+|++.||++||     ++.++++.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            1112233456788999999999999999     78888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.7e-36  Score=321.13  Aligned_cols=243  Identities=22%  Similarity=0.287  Sum_probs=193.3

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999965 4789999999754   223456688999999988 699999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence            999988843   346899999999999999999999998   999999999999999999999999998753211  112


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......................          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRI  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCC
Confidence            2346799999999999999999999999999999999999999864433222111111111111110          011


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNM  698 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~  698 (751)
                      +......+.+++.+||+.||.+||++
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            22234567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=309.10  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=202.0

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|...+.||+|++|.||++... +++.+|+|.+....     ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57888999999999999999964 58999999986432     1234578899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |+||+++++|.+++..   .+.+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999999853   345889999999999999999999998   9999999999999999999999999997654


Q ss_pred             CCCcccc-ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ....... .....++..|+|||++.+..++.++||||||+++|+|++|+.|+......      ..........      
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~------  223 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP------  223 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccC------
Confidence            2211111 12356788999999999999999999999999999999999986422110      0000000000      


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                         .....+......+.+++.+|++.+|.+||++.++++.
T Consensus       224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 ---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence               1111222345577899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-35  Score=310.03  Aligned_cols=256  Identities=26%  Similarity=0.434  Sum_probs=203.3

Q ss_pred             cCccccccccccccccEEEEEEcC-C---cEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-G---QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|+..+.||+|+||.||+|+... +   ..+|+|++... .....+.+.+|++++++++|+||+++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            577888999999999999999753 3   37999998654 234456789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            9999999999998542  346899999999999999999999998   99999999999999999999999999886643


Q ss_pred             CCccccc-cccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          587 DQTEANT-NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       587 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ....... .....++.|+|||++.+..++.++|||||||++|||++ |+.|+.......       .........     
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~-----  227 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGF-----  227 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCC-----
Confidence            2221111 11223457999999998899999999999999999997 999975322211       111111110     


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                          ...........+.+++.+|++.+|++||++.+|++.|+++
T Consensus       228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                1111122345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6e-36  Score=327.98  Aligned_cols=261  Identities=22%  Similarity=0.302  Sum_probs=198.5

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC-----ceE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD-----ERM  504 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  504 (751)
                      +|+..++||+|+||.||++... +++.||||++...  .....+++.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4678899999999999999964 6899999998654  2234567889999999999999999999998776     789


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +|+||+. ++|.+.+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 57877773   3456899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ....... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||...........   ............+
T Consensus       154 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~g~~~~~~~  229 (372)
T cd07853         154 EPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL---ITDLLGTPSLEAM  229 (372)
T ss_pred             ccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCCHHHH
Confidence            4322221 2234678999999999875 479999999999999999999999865443211111   1110000000000


Q ss_pred             ----------cchhc-c-------CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          664 ----------IDKSL-E-------DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       664 ----------~d~~l-~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                                +.... .       ..........+.+|+.+||+.||.+|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                      00000 0       00111224578899999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-35  Score=328.05  Aligned_cols=262  Identities=19%  Similarity=0.258  Sum_probs=201.3

Q ss_pred             hcCccccccccccccccEEEEEEc---CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI---DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ..+|.+.++||+|+||.||++...   .++.||+|.+...     +.+.+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999753   3578999988543     34568999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      |++. ++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 58888872   3456899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC-------h
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR-------P  660 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~  660 (751)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...........       .
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            333333346799999999999999999999999999999999999999865443221111111111111000       0


Q ss_pred             hhh------cchhccCccC-------HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          661 VEL------IDKSLEDTYS-------LSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       661 ~~~------~d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..+      ........+.       ......+.+++.+||+.||++||++.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000      0000000010       1123467789999999999999999999975

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-35  Score=305.25  Aligned_cols=248  Identities=28%  Similarity=0.394  Sum_probs=198.5

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCChh
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLA  516 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~  516 (751)
                      ++||+|+||.||++...+++.||+|++...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999998765433 5678999999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccccccc
Q 038934          517 DFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV  596 (751)
Q Consensus       517 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  596 (751)
                      +++...  ...+++..+..++.+++.+|.|||+++   ++|+||||+||+++.++.+||+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998542  235789999999999999999999998   999999999999999999999999999865422221111122


Q ss_pred             ccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHH
Q 038934          597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS  675 (751)
Q Consensus       597 ~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  675 (751)
                      ..+..|+|||.+.+..++.++||||||+++|+|++ |..|+........       .......         .....+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-------~~~~~~~---------~~~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-------RERIESG---------YRMPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-------HHHHhcC---------CCCCCCcc
Confidence            34567999999998899999999999999999999 7777543221110       0001110         00111222


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          676 EALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       676 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ....+.+++.+|++.+|++||++.|+++.|+
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.6e-36  Score=328.68  Aligned_cols=257  Identities=19%  Similarity=0.232  Sum_probs=200.7

Q ss_pred             HHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc
Q 038934          427 IANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       427 i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  502 (751)
                      +....++|++.++||+|+||.||++++. +++.+|+|++.+.   .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3344578999999999999999999975 4789999998642   22334568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||+++++|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence            9999999999999999843    34789999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      ....... .......||+.|+|||++.+..    ++.++|||||||++|+|++|+.||.......      .........
T Consensus       191 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~~  263 (370)
T cd05621         191 KMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDHK  263 (370)
T ss_pred             ecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC
Confidence            7642211 1223467999999999997643    7899999999999999999999986432211      011111100


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPED--RPNMASVVLM  704 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  704 (751)
                      ..       +.-.........+.+++..||+.++.+  ||++.++++.
T Consensus       264 ~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 NS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            00       000111223456778999999865544  8999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=307.69  Aligned_cols=250  Identities=27%  Similarity=0.413  Sum_probs=204.2

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|++.+.||+|+||.||++.. .++.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+....++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            5778889999999999999987 478999999976544 56789999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.......  
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            999999985432 236899999999999999999999998   99999999999999999999999999987632211  


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                         ....+..|+|||.+.+..++.++||||||+++++|++ |+.|+......   .+..    ......         ..
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~~---------~~  218 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----HVEKGY---------RM  218 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHhcCC---------CC
Confidence               1234568999999998899999999999999999997 88886432211   1111    111110         01


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..+...+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            11222346788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.8e-35  Score=305.41  Aligned_cols=247  Identities=27%  Similarity=0.380  Sum_probs=197.9

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCc-ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCChh
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLA  516 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~  516 (751)
                      ++||+|+||.||+|...+++.+|+|++..... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36999999999999988889999999876533 33457889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccccccc
Q 038934          517 DFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV  596 (751)
Q Consensus       517 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  596 (751)
                      +++...  ...+++..+..++.|++.+|.|||+.+   ++|+||||+||++++++.+||+|||++.......... ....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence            988542  345789999999999999999999998   9999999999999999999999999987543221111 1112


Q ss_pred             ccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHH
Q 038934          597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS  675 (751)
Q Consensus       597 ~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  675 (751)
                      .+++.|+|||++.+..++.++||||||+++|+|++ |..|+.......   ..    .......         ....+..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~----~~~~~~~---------~~~~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AR----EQVEKGY---------RMSCPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HH----HHHHcCC---------CCCCCCC
Confidence            34567999999998899999999999999999998 888865322111   00    1111110         1111223


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          676 EALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       676 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ....+.+++.+|++.+|++||++.++++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            3567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.2e-35  Score=306.92  Aligned_cols=253  Identities=28%  Similarity=0.451  Sum_probs=201.3

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|.+.++||+|++|.||++....+..+|+|++.... ...+.+.+|+.+++.++|+|++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688889999999999999998777789999886432 34567899999999999999999999875 456899999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.........
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            99999999643 2335789999999999999999999998   9999999999999999999999999998664322111


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+......   ...    .......         ..
T Consensus       160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~---------~~  222 (260)
T cd05069         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVL----EQVERGY---------RM  222 (260)
T ss_pred             -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCC---------CC
Confidence             112345678999999998899999999999999999999 88886532211   111    1111110         00


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ..+......+.+++.+|++.||++||++.+|++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1122334678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2e-35  Score=306.02  Aligned_cols=250  Identities=26%  Similarity=0.364  Sum_probs=204.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|...+.||+|++|.||++... +++.|++|.+...  .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999965 5889999998643  344567889999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998653 2356889999999999999999999998   99999999999999999999999999887643322


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      .  .....+++.|+|||++.+..++.++||||||+++++|++|+.|+......   ...    ........         
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~---------  218 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI----LKIIRGVF---------  218 (256)
T ss_pred             h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHcCCC---------
Confidence            1  12356889999999999999999999999999999999999997643311   100    00111100         


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..........+.+++.+|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            11112344578899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.5e-35  Score=314.39  Aligned_cols=264  Identities=24%  Similarity=0.362  Sum_probs=201.4

Q ss_pred             cCccccccccccccccEEEEEEc-----------------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-----------------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKL  493 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l  493 (751)
                      ++|++.++||+|+||.||++...                 +...+|+|++... .....+++.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46889999999999999998632                 2346899998754 33445689999999999999999999


Q ss_pred             eceeeeCCceEEEEEecCCCChhHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCe
Q 038934          494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTR--------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV  565 (751)
Q Consensus       494 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NI  565 (751)
                      ++++...+..++||||+++++|.+++.....        ...+++..+..++.|++.||+|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999865321        134778899999999999999999998   99999999999


Q ss_pred             EEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCcc
Q 038934          566 LLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY--GTRNRGFHHVDH  643 (751)
Q Consensus       566 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~--G~~p~~~~~~~~  643 (751)
                      |+++++.++|+|||+++.+.............+++.|+|||...+..++.++|||||||++|||++  |..|+...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence            999999999999999986543222111222344678999999888899999999999999999998  55565422211 


Q ss_pred             ccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          644 HHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       644 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                        .........+........      ...+......+.+++.+|++.||++||++.+|++.|+.
T Consensus       241 --~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 --QVIENTGEFFRDQGRQVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             --HHHHHHHHHHhhcccccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              111111111111100000      01112234678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-35  Score=307.50  Aligned_cols=250  Identities=32%  Similarity=0.489  Sum_probs=203.7

Q ss_pred             ccccccccccEEEEEEcC----CcEEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      ++||+|+||.||++....    +..+++|.+...... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999654    788999999765433 367899999999999999999999999999999999999999


Q ss_pred             CChhHHHhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          513 KSLADFIFDGTR------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       513 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      ++|.+++.....      ...+++..+..++.|++.||.|||+++   ++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965421      367899999999999999999999998   99999999999999999999999999987754


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ...........+++.|+|||.+....++.++||||||+++|+|++ |..|+......   .    .........      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~~~~~~------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---E----VLEYLRKGY------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCC------
Confidence            332222334567889999999998899999999999999999999 58887543211   1    111111111      


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                         ....+......+.+++.+|++.+|.+||++.++++.|+
T Consensus       225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               01112223567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-36  Score=327.29  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=200.7

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|.+.+.||+|+||.||++... +++.||+|++.+..   ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999965 58899999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999999543  246899999999999999999999998   999999999999999999999999999876433


Q ss_pred             CccccccccccccCccCccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAI------DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      ... ......||+.|+|||++.      +..++.++|||||||++|||++|+.||.......      ........... 
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~-  227 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRF-  227 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCc-
Confidence            221 122357899999999987      4567899999999999999999999975332211      01111111100 


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                            +.-.........+.+|+.+||+ +|.+||++.++++
T Consensus       228 ------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 ------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                  0001111234567889999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.4e-36  Score=318.00  Aligned_cols=264  Identities=23%  Similarity=0.354  Sum_probs=199.1

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|.+.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57889999999999999999965 57889999987543 23345678999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++ +|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            986 788877432  345789999999999999999999998   99999999999999999999999999976533222


Q ss_pred             cccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH--------HHHHhccCCh
Q 038934          590 EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH--------AWRLWTEDRP  660 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~  660 (751)
                      .  .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||..............        .|........
T Consensus       160 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 T--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             c--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            1  123467899999999865 4689999999999999999999999865443222111110        0100000000


Q ss_pred             hhhcc-hhccC----ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          661 VELID-KSLED----TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       661 ~~~~d-~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ....+ +....    .........+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000 00000    001123456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-35  Score=306.31  Aligned_cols=255  Identities=31%  Similarity=0.472  Sum_probs=205.6

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .++|.+.++||+|+||.||++...+++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46888999999999999999998788899999986543 34578999999999999999999999999989999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+......
T Consensus        84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            9999999996432 235899999999999999999999998   999999999999999999999999999876432111


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      . ......+..|+|||.+.+..++.++||||||+++|+|++ |+.|+......   .....    ....         ..
T Consensus       160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~----~~~~---------~~  222 (261)
T cd05034         160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQ----VERG---------YR  222 (261)
T ss_pred             h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcC---------CC
Confidence            1 111234568999999999999999999999999999998 88886432211   11111    1110         00


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ...+......+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            01111224578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.7e-36  Score=323.13  Aligned_cols=237  Identities=23%  Similarity=0.283  Sum_probs=188.1

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHH-HHHHhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVL-LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||+||+++.. +++.||||++.+..   ....+++.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999975 58999999996532   223345555555 45778999999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            999998843   446889999999999999999999998   999999999999999999999999998753221  112


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......       .........        +  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~--------~--~~  215 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNILNKP--------L--RL  215 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCC--------C--CC
Confidence            234678999999999999999999999999999999999999975322110       000000000        0  11


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMA  699 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~  699 (751)
                      .......+.+++.+||+.||.+||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            122356788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.5e-35  Score=318.30  Aligned_cols=260  Identities=26%  Similarity=0.397  Sum_probs=204.4

Q ss_pred             cCccccccccccccccEEEEEEcC--------CcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID--------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRD  501 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  501 (751)
                      .+|.+.+.||+|+||.||++....        ...||+|.+... .....+++.+|+++++++ +|+||+++++++.+.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468889999999999999997421        236899988654 234467899999999999 7999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGT-------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  568 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~  568 (751)
                      ..++|+||+++++|.+++....             ....+++..+..++.|++.||.|||+++   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986422             2235788999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccch
Q 038934          569 NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNL  647 (751)
Q Consensus       569 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~  647 (751)
                      +++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....+.    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  244 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----  244 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence            999999999999986543222211222334567999999999999999999999999999998 777754322111    


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                         ..........         ...+......+.+++.+|++.+|++||++.++++.|+.+..
T Consensus       245 ---~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         245 ---LFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             ---HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence               1111111111         11122334578899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.1e-36  Score=333.91  Aligned_cols=259  Identities=20%  Similarity=0.325  Sum_probs=192.9

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--------C
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--------D  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  501 (751)
                      .++|.+.++||+|+||.||+|... .++.||||++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            468999999999999999999965 58899999985432    2345799999999999999999876432        2


Q ss_pred             ceEEEEEecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC-CeEEeecc
Q 038934          502 ERMLIYEYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFG  579 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFG  579 (751)
                      .+++||||+++ +|.+++... .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            36789999985 677766432 23456899999999999999999999998   99999999999999665 69999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      +++.+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|..||........  + ..........
T Consensus       217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~-~~i~~~~~~p  290 (440)
T PTZ00036        217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--L-VRIIQVLGTP  290 (440)
T ss_pred             cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHhCCC
Confidence            9987643221   2235789999999998764 689999999999999999999999864432111  1 1111111000


Q ss_pred             Chh---------------hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          659 RPV---------------ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       659 ~~~---------------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...               ......+...++...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            000               000001111112223457889999999999999999999984

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.1e-36  Score=322.35  Aligned_cols=238  Identities=22%  Similarity=0.307  Sum_probs=188.7

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHH-HHHHhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVL-LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||.||+++.. +++.+|+|++.+.   ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999964 5899999999654   2233445566655 46678999999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            99998884   3456899999999999999999999998   999999999999999999999999998753211  112


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   +    ........        +  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~----~~~~~~~~--------~--~~  215 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---M----YDNILHKP--------L--VL  215 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---H----HHHHHcCC--------c--cC
Confidence            234679999999999999999999999999999999999999975332111   0    01111110        0  01


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMAS  700 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~e  700 (751)
                      .......+.+++.+||+.+|.+||++.+
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            1223456789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-35  Score=322.30  Aligned_cols=259  Identities=27%  Similarity=0.407  Sum_probs=200.0

Q ss_pred             cCccccccccccccccEEEEEE------cCCcEEEEEEeccCC-cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC-Cc
Q 038934          432 DNFSEENKLGEGGFGPVYKGML------IDGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR-DE  502 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  502 (751)
                      ++|++.++||+|+||.||+|.+      ..++.||||+++... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5799999999999999999973      246789999997543 33456788999999999 689999999988654 46


Q ss_pred             eEEEEEecCCCChhHHHhccCC----------------------------------------------------------
Q 038934          503 RMLIYEYLPNKSLADFIFDGTR----------------------------------------------------------  524 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  524 (751)
                      .++||||+++|+|.+++.....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999999854210                                                          


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccccccccc
Q 038934          525 ------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG  598 (751)
Q Consensus       525 ------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  598 (751)
                            ...+++..+..++.|+++||+|||+++   |+||||||+|||+++++.+||+|||++................+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                  124678888999999999999999998   99999999999999999999999999986533222222222345


Q ss_pred             ccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHH
Q 038934          599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEA  677 (751)
Q Consensus       599 t~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  677 (751)
                      ++.|+|||.+.+..++.++||||||+++|+|++ |..|+.......  .    .......+...         ..+....
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~~---------~~~~~~~  308 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E----FCRRLKEGTRM---------RAPDYTT  308 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H----HHHHHhccCCC---------CCCCCCC
Confidence            678999999999999999999999999999997 887764322110  0    01111111110         0011123


Q ss_pred             HHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          678 LRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       678 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..+.+++.+|++.||++||++.+|++.|+.+
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            4678999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.3e-35  Score=315.75  Aligned_cols=258  Identities=27%  Similarity=0.415  Sum_probs=202.9

Q ss_pred             cCccccccccccccccEEEEEEc--------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRD  501 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  501 (751)
                      ++|.+.++||+|+||.||+++..        ....+|+|++... .......+.+|+.+++++ +||||+++++++.+..
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57888999999999999999742        2456899998754 234456789999999999 6999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGT-------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  568 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~  568 (751)
                      ..++||||+++++|.+++....             ....+++..+..++.|++.||.|||+++   |+|+||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999996532             1245889999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccch
Q 038934          569 NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNL  647 (751)
Q Consensus       569 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~  647 (751)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..|+.......    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----  244 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE----  244 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999999986543222111112234567999999999999999999999999999999 777764322111    


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                         ...........         ..+......+.+++.+|++.+|++||++.++++.|+.+
T Consensus       245 ---~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         245 ---LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             ---HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence               11111111110         11222345678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.4e-35  Score=305.07  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=194.4

Q ss_pred             cccccccccEEEEEEc---CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCC
Q 038934          439 KLGEGGFGPVYKGMLI---DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKS  514 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs  514 (751)
                      .||+|+||.||+|.+.   .+..||+|++.... ....+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999864   35579999986553 233567999999999999999999999885 457899999999999


Q ss_pred             hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc-c
Q 038934          515 LADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-T  593 (751)
Q Consensus       515 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~  593 (751)
                      |.+++..  ....+++..+++++.|++.||.|||+++   ++|+||||+|||++.++.+||+|||++........... .
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999853  2346899999999999999999999998   99999999999999999999999999986543322111 1


Q ss_pred             cccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       594 ~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.|+.......       .......+.         ....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGK---------RLDC  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCC---------CCCC
Confidence            11233578999999998889999999999999999996 888865322110       111111111         1112


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      +......+.+++.+|++.+|++||++.+|++.|+.
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            23345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-35  Score=312.67  Aligned_cols=250  Identities=25%  Similarity=0.425  Sum_probs=203.9

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ..+|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.+.|+||+++++.+......++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            468888999999999999999954 5889999999776556667899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++..    ..+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            999999999842    34789999999999999999999998   99999999999999999999999999876532221


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      .  .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+...  +    ......... .     + 
T Consensus       172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~----~~~~~~~~~-~-----~-  236 (296)
T cd06654         172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L----YLIATNGTP-E-----L-  236 (296)
T ss_pred             c--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--H----HHHhcCCCC-C-----C-
Confidence            1  1234688999999999998899999999999999999999999754332110  0    000001100 0     0 


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       ..+......+.+++.+|++.||++||++.++++
T Consensus       237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             011223456789999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.5e-35  Score=308.47  Aligned_cols=245  Identities=26%  Similarity=0.338  Sum_probs=192.3

Q ss_pred             ccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       440 IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      ||+|+||.||+++.. +++.+|+|++....   ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999965 58999999986431   12334566799999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccc
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR  595 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  595 (751)
                      .+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++........   ...
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~  153 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ  153 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence            98885432 334889999999999999999999998   99999999999999999999999999886543211   123


Q ss_pred             cccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHH
Q 038934          596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS  675 (751)
Q Consensus       596 ~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  675 (751)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.|+..........  ....... ..        .+.. ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~~-~~--------~~~~-~~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTL-ED--------EVKF-EHQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHhh-cc--------cccc-cccc
Confidence            568899999999999999999999999999999999999975322211100  0000000 00        0000 0112


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          676 EALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       676 ~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...++.+++.+||+.||++||++.|+++
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            3456789999999999999999987664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.9e-35  Score=307.65  Aligned_cols=254  Identities=27%  Similarity=0.379  Sum_probs=192.3

Q ss_pred             ccccccccccEEEEEEcC---CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCC
Q 038934          438 NKLGEGGFGPVYKGMLID---GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      +.||+|+||.||+|...+   +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            369999999999998643   4579999986543 233457889999999999999999999999999999999999999


Q ss_pred             ChhHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          514 SLADFIFDGT--RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       514 sL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +|.+++....  ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999996432  2234677888899999999999999998   9999999999999999999999999997643322222


Q ss_pred             cccccccccCccCcccccCC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          592 NTNRVVGTYGYMPPEYAIDG-------LFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~-------~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.|+........   ....   .. ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~---~~-~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYT---VR-EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH---hh-cccCCC
Confidence            22234577889999998643       35789999999999999996 9988754322111   1100   00 111111


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ..+.    ........+.+++..|+ .+|++||++.||++.|+
T Consensus       231 ~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111    11123345778899998 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-35  Score=309.76  Aligned_cols=256  Identities=25%  Similarity=0.404  Sum_probs=201.3

Q ss_pred             cCccccccccccccccEEEEEEcC-C---cEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-G---QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ..|++.+.||+|+||.||+|.+.. +   ..||||.+... .....++|.+|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357788899999999999999653 3   36999998754 344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++...  .+.+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999998542  346889999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCcccccc-ccc--cccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          587 DQTEANTN-RVV--GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       587 ~~~~~~~~-~~~--gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ........ ...  .+..|+|||.+.+..++.++|||||||++|||++ |..|+......   ....    ......   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~----~i~~~~---  228 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIN----AIEQDY---  228 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHH----HHHcCC---
Confidence            22211111 111  2357999999999999999999999999999886 88886432211   1111    111100   


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                            .-..+...+..+.+++.+|++.+|++||++.+|+++|+.+
T Consensus       229 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  0011122345678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3e-35  Score=313.96  Aligned_cols=263  Identities=22%  Similarity=0.311  Sum_probs=201.6

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|++.++||+|+||.||++.+. ++..+|+|.+... .....+++.+|++++.+++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46888999999999999999965 4788899988654 233456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+. +   ++|+||||+|||+++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            999999999953   35689999999999999999999984 6   999999999999999999999999998754321 


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC----------
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED----------  658 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~----------  658 (751)
                         ......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+......................          
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence               1233578899999999988889999999999999999999999975433211110000000000000          


Q ss_pred             -------ChhhhcchhccCc---c-CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          659 -------RPVELIDKSLEDT---Y-SLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       659 -------~~~~~~d~~l~~~---~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                             ...+..+......   . .......+.+++.+||+.+|++||++.+|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   0001111111100   0 01134568899999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.6e-36  Score=322.04  Aligned_cols=240  Identities=21%  Similarity=0.250  Sum_probs=188.4

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHH-HHHHhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVL-LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||.||++++. +++.||+|++.+..   ......+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999965 47889999986532   222334444544 56778999999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|.+++..   ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            999999853   345788899999999999999999998   999999999999999999999999999754221  112


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ...    .....        .  ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~----~i~~~--------~--~~~  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD----NILNK--------P--LQL  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHH----HHHhC--------C--cCC
Confidence            234679999999999999999999999999999999999999975322211   000    00000        0  011


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMASVV  702 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl  702 (751)
                      .......+.+++.+||+.||.+||++.+.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            123345678999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.3e-35  Score=306.85  Aligned_cols=256  Identities=26%  Similarity=0.387  Sum_probs=202.7

Q ss_pred             cCccccccccccccccEEEEEEcC----CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|++.+.||+|+||.||+|.+..    +..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            578888999999999999998642    3379999986542 33456889999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+|||++.++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999999542  245799999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccc-ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          587 DQTEAN-TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       587 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ...... .....++..|+|||.+.+..++.++||||||+++||+++ |+.|+.......   ...    .......    
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~----~~~~~~~----  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIK----AIEEGYR----  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHH----HHhCCCc----
Confidence            222111 111233567999999999999999999999999999886 988864322211   111    1111100    


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                           .......+..+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                 011122345678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-35  Score=311.82  Aligned_cols=263  Identities=27%  Similarity=0.413  Sum_probs=202.2

Q ss_pred             cCccccccccccccccEEEEEE-----cCCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--Cce
Q 038934          432 DNFSEENKLGEGGFGPVYKGML-----IDGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DER  503 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  503 (751)
                      +.|.+.+.||+|+||.||+++.     ..+..||+|.+.... ....+.+.+|++++++++|+||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4567888999999999999974     247789999986542 34456799999999999999999999998875  568


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999998532  235899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc--------cccchhHHHHHH
Q 038934          584 FGVDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVD--------HHHNLLGHAWRL  654 (751)
Q Consensus       584 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~--------~~~~~~~~~~~~  654 (751)
                      +...... .......++..|+|||++.+..++.++||||||+++|||++++.|.......        ............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6433221 1112345677899999999889999999999999999999987653211100        000000000000


Q ss_pred             hccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...+.         ...........+.+|+.+|++.+|++||++.++++.|+.+
T Consensus       239 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11110         0111222456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.1e-36  Score=319.85  Aligned_cols=237  Identities=22%  Similarity=0.294  Sum_probs=187.5

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHH-HHHHhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVL-LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      ++||+|+||.||+++.. +++.||+|++.+..   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999975 58899999986532   223344555554 57788999999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|...+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            99998884   3456889999999999999999999998   999999999999999999999999998753221  112


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+    ........          -..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~----~~~i~~~~----------~~~  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QM----YDNILHKP----------LQL  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HH----HHHHhcCC----------CCC
Confidence            23467899999999999999999999999999999999999997533211   00    00010000          011


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMA  699 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~  699 (751)
                      +......+.+++.+||+.||.+||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            223445788999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-35  Score=308.90  Aligned_cols=252  Identities=30%  Similarity=0.462  Sum_probs=199.4

Q ss_pred             ccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHH--HHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          434 FSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVE--EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      |+..+.||+|+||+||+++... ++.+|+|++.........  ...+|+.++++++|+||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678899999999999999765 668999999876433322  3456999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++.   ....+++..+..++.|+++||.+||+.+   |+|+||||+||++++++.++|+|||.+....  ...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence            9999999995   4456899999999999999999999998   9999999999999999999999999997641  122


Q ss_pred             ccccccccccCccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~-~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      .......++..|+|||++. +..++.++||||+|+++++|++|..|+...............   ...    ..... . 
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~---~~~----~~~~~-~-  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKI---LKR----PLPSS-S-  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHH---HHT----HHHHH-T-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc---ccc----ccccc-c-
Confidence            2334467899999999998 888999999999999999999999987643111111100000   000    00000 0 


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       .........+.+++.+||+.||++||++.++++
T Consensus       224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000011268899999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-35  Score=319.02  Aligned_cols=241  Identities=27%  Similarity=0.356  Sum_probs=193.2

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  507 (751)
                      +|...+.||+|+||.||+++.. +++.||+|++.+.   .....+.+..|+.++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999965 5889999999754   2334566788999998885 577888999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999999843   345899999999999999999999998   999999999999999999999999998754322


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      ..  ......||+.|+|||++.+..++.++|||||||++|+|++|+.|+......   .+...    .....        
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~----i~~~~--------  217 (323)
T cd05615         155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQS----IMEHN--------  217 (323)
T ss_pred             Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCC--------
Confidence            11  123356899999999999999999999999999999999999997643221   11110    00000        


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNM  698 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  698 (751)
                        ...+......+.+++.+||+.+|.+|++.
T Consensus       218 --~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 --VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              01122334577899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-35  Score=326.19  Aligned_cols=262  Identities=19%  Similarity=0.231  Sum_probs=196.6

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ..+|.+.++||+|+||.||++.+.. ++.||||...      ...+.+|++++++++|+|||++++++......++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4579999999999999999999764 7889999642      23467899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +. ++|.+++..  ....+++..++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 688888753  2336899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-CccccchhHHHHHHhccC-----Chh--
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHH-VDHHHNLLGHAWRLWTED-----RPV--  661 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~-~~~~~~~~~~~~~~~~~~-----~~~--  661 (751)
                      ........||+.|+|||++.+..++.++|||||||+||||++|..++-... ..................     ...  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            222234679999999999999999999999999999999999876542211 111100000011111100     000  


Q ss_pred             ---hhcchh-------ccCccC-------HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          662 ---ELIDKS-------LEDTYS-------LSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       662 ---~~~d~~-------l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                         .+....       ......       ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence               000000       000000       0123367889999999999999999999975

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.9e-36  Score=326.57  Aligned_cols=252  Identities=22%  Similarity=0.302  Sum_probs=196.5

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|+..+.||+|+||.||+++.. +++.||||++...   .....+.+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999965 5889999999643   2334567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999853   446899999999999999999999998   999999999999999999999999998754321


Q ss_pred             Cc---------------------------------cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 038934          588 QT---------------------------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTR  634 (751)
Q Consensus       588 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~  634 (751)
                      ..                                 ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10                                 001123579999999999999999999999999999999999999


Q ss_pred             CCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 038934          635 NRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN---MASVVL  703 (751)
Q Consensus       635 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  703 (751)
                      ||....+...   ..   ........       +.-.........+.+++.+|+. ||.+|++   +.++++
T Consensus       235 Pf~~~~~~~~---~~---~i~~~~~~-------~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         235 PFCSETPQET---YR---KVMNWKET-------LVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCHHHH---HH---HHHcCCCc-------eecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            9864332211   00   00000000       0000011134567788888764 9999996   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.8e-35  Score=304.29  Aligned_cols=249  Identities=25%  Similarity=0.370  Sum_probs=198.9

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceee-eCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM-KRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~  510 (751)
                      ++|.+.+.||+|+||.||++.. .++.+|+|.+...  ...+.+.+|+.++++++|+|++++++++. .....++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4788889999999999999986 5788999998643  34567899999999999999999999764 456789999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+++   ++|+||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            9999999986432 235889999999999999999999998   9999999999999999999999999987643221  


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                         ....++..|+|||++.+..++.++|||||||++|+|++ |+.|+.......   +.    .....+.         .
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~----~~~~~~~---------~  217 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGY---------K  217 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCC---------C
Confidence               12344568999999999899999999999999999997 888865322111   10    0011110         0


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..........+.+++.+|++.+|++||++.++++.|+.+
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            111122345788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.5e-35  Score=314.75  Aligned_cols=198  Identities=26%  Similarity=0.410  Sum_probs=161.9

Q ss_pred             cccccccccccEEEEEEc---CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeee--CCceEEEEEecC
Q 038934          437 ENKLGEGGFGPVYKGMLI---DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK--RDERMLIYEYLP  511 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~  511 (751)
                      .++||+|+||.||+|+..   .++.+|+|++....  ....+.+|+.++++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999965   46789999986542  23567899999999999999999998864  456789999986


Q ss_pred             CCChhHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE----cCCCCeEEeeccCc
Q 038934          512 NKSLADFIFDGT------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMA  581 (751)
Q Consensus       512 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla  581 (751)
                      + +|.+++....      ....+++..+..++.||+.||.|||+++   |+||||||+|||+    +..+.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 7887764321      2235899999999999999999999998   9999999999999    45678999999999


Q ss_pred             cccCCCCcc-ccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 038934          582 RAFGVDQTE-ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHH  640 (751)
Q Consensus       582 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~  640 (751)
                      +.+...... .......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876433221 222346789999999999874 58999999999999999999999986433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.4e-35  Score=315.69  Aligned_cols=255  Identities=28%  Similarity=0.452  Sum_probs=199.7

Q ss_pred             cCccccccccccccccEEEEEEcC-Cc--EEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|++.+.||+|+||.||+|.+.. +.  .+|+|.+... .....+.+.+|++++.++ +|+||+++++++.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            478888999999999999999643 44  4688877543 334556789999999999 899999999999999999999


Q ss_pred             EEecCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCe
Q 038934          507 YEYLPNKSLADFIFDGT-------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      |||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999996432             1235889999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHH
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ||+|||+++.....   ........+..|+|||++.+..++.++|||||||++|||++ |..|+.......   ..    
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----  233 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY----  233 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HH----
Confidence            99999998643211   11111234567999999988889999999999999999998 888864322211   00    


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ......         .....+......+.+|+.+|++.+|++||++.++++.|+.+
T Consensus       234 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         234 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111111         00011122345678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-35  Score=325.19  Aligned_cols=258  Identities=19%  Similarity=0.235  Sum_probs=200.9

Q ss_pred             hHHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC
Q 038934          426 SIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD  501 (751)
Q Consensus       426 ~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  501 (751)
                      .+....++|++.+.||+|+||.||++++. +++.+|+|++.+.   .....+.+.+|+.+++.++||||+++++++.++.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34455689999999999999999999975 4788999998642   2233456789999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ..++||||+++++|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            99999999999999999843    34788999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhcc
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE  657 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  657 (751)
                      +....... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||......      .........
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~  262 (371)
T cd05622         190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNH  262 (371)
T ss_pred             eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcC
Confidence            87643221 1123467999999999987543    789999999999999999999998643221      111111111


Q ss_pred             CChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 038934          658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPED--RPNMASVVLM  704 (751)
Q Consensus       658 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  704 (751)
                      ......       .........+.+++.+||+.++.+  ||++.++++.
T Consensus       263 ~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         263 KNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            110000       111234556788999999854443  7899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-35  Score=303.92  Aligned_cols=249  Identities=31%  Similarity=0.477  Sum_probs=196.6

Q ss_pred             ccccccccccEEEEEEcC-C---cEEEEEEeccCCc-ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLID-G---QEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      ++||+|+||.||+|.... +   ..+|+|.+..... ...+++.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999998432 2   6899999876543 34567999999999999999999999876 5578999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|.+++...   ..+++..+..++.|++.||+|||..+   ++|+||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999999543   36899999999999999999999998   99999999999999999999999999987643322111


Q ss_pred             -ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          593 -TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       593 -~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+......   .+..    .......         .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~----~~~~~~~---------~  217 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIA----MLESGER---------L  217 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHH----HHHcCCc---------C
Confidence             111223467999999999999999999999999999998 88887533221   1111    1111111         0


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      ..+......+.+++.+|++.+|++||++.++++.|++..
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            112223457789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.2e-35  Score=304.01  Aligned_cols=249  Identities=29%  Similarity=0.424  Sum_probs=199.1

Q ss_pred             ccccccccccEEEEEEcC--C--cEEEEEEeccCCc-ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLID--G--QEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      ++||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            469999999999999643  2  3689999987655 566789999999999999999999999988 889999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc-c
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE-A  591 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~  591 (751)
                      ++|.+.+.+... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999965432 46899999999999999999999998   999999999999999999999999999876432221 1


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                      ......++..|+|||.+.+..++.++|||||||++|+|++ |+.|+.......   +....   ......         .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~---~~~~~~---------~  220 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKI---DKEGER---------L  220 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---HhcCCc---------C
Confidence            1123456789999999999999999999999999999998 998864322111   11100   000000         0


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ..+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            011123457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.6e-35  Score=304.34  Aligned_cols=240  Identities=20%  Similarity=0.339  Sum_probs=188.9

Q ss_pred             ccccccccccEEEEEEcC-------------CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          438 NKLGEGGFGPVYKGMLID-------------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      +.||+|+||.||+|++..             ...+++|.+..........+.+|+.++++++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            369999999999998532             2258899887655555668899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC-------eEEee
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-------PKISD  577 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-------~kl~D  577 (751)
                      +||||+++++|..++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988753  2345899999999999999999999998   999999999999987664       89999


Q ss_pred             ccCccccCCCCccccccccccccCccCccccc-CCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCccccchhHHHHHHh
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLELV-YGTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DVwSlG~ll~ell-~G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      ||++......      ....++..|+|||.+. +..++.++|||||||++|||+ .|..|+........       ....
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~  222 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY  222 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH
Confidence            9998754321      2245778899999887 467899999999999999998 47766542211110       0000


Q ss_pred             ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ...         .  .........+.+|+.+|++.||.+||++.++++.|+
T Consensus       223 ~~~---------~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQ---------C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcC---------c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            100         0  011112356789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.9e-35  Score=340.94  Aligned_cols=260  Identities=20%  Similarity=0.260  Sum_probs=201.3

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.++||+|+||.||+|... .++.||||++....   ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999965 48999999997542   233567899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          508 EYLPNKSLADFIFDGT--------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                      ||+++++|.+++....        ....+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999985421        1234567788999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCcc----------------ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc
Q 038934          580 MARAFGVDQTE----------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH  643 (751)
Q Consensus       580 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~  643 (751)
                      +++........                .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99876211100                01123569999999999999999999999999999999999999975422110


Q ss_pred             ccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHhCC
Q 038934          644 HHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRP-NMASVVLMLSGE  708 (751)
Q Consensus       644 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~  708 (751)
                      .   ..  ....  ..+...       ......+..+.+++.+|++.||++|| ++.++++.|+..
T Consensus       239 i---~~--~~~i--~~P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 I---SY--RDVI--LSPIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             h---hh--hhhc--cChhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0   00  0000  000000       00112335678899999999999996 566666666553

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=320.24  Aligned_cols=240  Identities=23%  Similarity=0.285  Sum_probs=186.4

Q ss_pred             ccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHh---cCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL---QHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       440 IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      ||+|+||+||+|+.. +++.||||++.+..   ......+..|..++..+   .||||+++++.+.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999965 58999999986531   22334455677777665   699999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|.+++.   ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            99999884   3456899999999999999999999998   9999999999999999999999999987543221  12


Q ss_pred             ccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          593 TNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......       .......+.. .     +.  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~-~-----~~--  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV-R-----FP--  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC-C-----CC--
Confidence            2346799999999998765 48999999999999999999999975432211       1111111100 0     00  


Q ss_pred             cCHHHHHHHHHHHhhhcCCCCCCCC----CHHHHHH
Q 038934          672 YSLSEALRCIQVGLLCVQQRPEDRP----NMASVVL  703 (751)
Q Consensus       672 ~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~  703 (751)
                       .......+.+++.+||+.||.+||    ++.++++
T Consensus       218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             011245678999999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.3e-35  Score=308.79  Aligned_cols=263  Identities=25%  Similarity=0.346  Sum_probs=198.6

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778889999999999999965 58899999986542  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      ++ ++|.+++........+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 588888865444467899999999999999999999998   99999999999999999999999999986543221


Q ss_pred             cccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH-------HHhccCC--
Q 038934          590 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW-------RLWTEDR--  659 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~-------~~~~~~~--  659 (751)
                      .  .....+++.|+|||++.+. .++.++||||||+++|+|++|+.|+........  ......       ..+....  
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         157 V--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             c--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhh
Confidence            1  1223568899999988754 578999999999999999999998764322110  000000       0000000  


Q ss_pred             --hhhhcchhcc---CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          660 --PVELIDKSLE---DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       660 --~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                        ..........   .........++.+++.+||+.||++|||+.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence              0000000000   0001123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.4e-35  Score=302.44  Aligned_cols=252  Identities=27%  Similarity=0.448  Sum_probs=201.2

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      .+|++.+.||+|+||.||++.+.+++.+|+|++.... ....++.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4677788999999999999998778899999986442 335678999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++...  ...+++..+..++.|++.+|+|||+.+   ++|+||||+||+++.++.+||+|||++..........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            99999998532  235789999999999999999999998   9999999999999999999999999987654322111


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......   .+..    ....+.  ...      
T Consensus       158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~--~~~------  221 (256)
T cd05112         158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVE----TINAGF--RLY------  221 (256)
T ss_pred             -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH----HHhCCC--CCC------
Confidence             111234578999999998899999999999999999998 88886532211   1111    011100  000      


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                       .+......+.+|+.+|++.+|++||++.++++.|.
T Consensus       222 -~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         222 -KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence             01112457889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7e-35  Score=302.15  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=204.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|+..+.||+|+||.||.++.. +++.+++|++...  .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5788899999999999999854 5889999998654  344566789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999986432 346899999999999999999999998   99999999999999999999999999987643332


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                        ......+++.|+|||.+.+..++.++||||||+++++|++|..|+......      ...... ..+...        
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~~~--------  219 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKI-VQGNYT--------  219 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-HcCCCC--------
Confidence              223356899999999999888999999999999999999999987532211      111111 111110        


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                       .........+.+++.+|++.+|++||++.++++.+
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence             01122345688999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.9e-35  Score=304.32  Aligned_cols=254  Identities=29%  Similarity=0.434  Sum_probs=203.4

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .++|.+.++||+|+||.||++...++..+|+|.+... ....+.+.+|+++++.++|+||+++++++.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            3678899999999999999999877888999988643 3345788999999999999999999999887 7789999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999999643 2345788899999999999999999988   999999999999999999999999999866432211


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      . .....++..|+|||++....++.++||||||+++|+|++ |+.|+......   .+    ..........        
T Consensus       159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~----~~~~~~~~~~--------  222 (260)
T cd05073         159 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EV----IRALERGYRM--------  222 (260)
T ss_pred             c-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHhCCCCC--------
Confidence            1 112345678999999998899999999999999999998 88886532211   11    1111111110        


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                       .........+.+++.+|++.+|++||++.+++++|+.
T Consensus       223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             1112234578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-35  Score=333.64  Aligned_cols=264  Identities=20%  Similarity=0.259  Sum_probs=193.7

Q ss_pred             HHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC------CcEEeEeceeee
Q 038934          427 IANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH------RNLVKLLGCCMK  499 (751)
Q Consensus       427 i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~  499 (751)
                      +....++|++.++||+|+||+||+|.+. .++.||||+++.. ......+..|+++++.++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445688999999999999999999965 4788999999643 2234556778888887765      458899988876


Q ss_pred             C-CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCC------
Q 038934          500 R-DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEM------  571 (751)
Q Consensus       500 ~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~------  571 (751)
                      . .+.++|||++ +++|.+++.+   ...+++..+..|+.||+.||.|||++ +   ||||||||+|||++.++      
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            5 4788999988 6788888853   34689999999999999999999984 7   99999999999998765      


Q ss_pred             ----------CeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 038934          572 ----------NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHV  641 (751)
Q Consensus       572 ----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~  641 (751)
                                .+||+|||++....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      49999999876422     112346899999999999999999999999999999999999999875443


Q ss_pred             ccccchhHHHH----HHhcc----CChhhhcch---------------hccCc--cCHHHHHHHHHHHhhhcCCCCCCCC
Q 038934          642 DHHHNLLGHAW----RLWTE----DRPVELIDK---------------SLEDT--YSLSEALRCIQVGLLCVQQRPEDRP  696 (751)
Q Consensus       642 ~~~~~~~~~~~----~~~~~----~~~~~~~d~---------------~l~~~--~~~~~~~~l~~li~~cl~~dP~~RP  696 (751)
                      ......+....    ..+..    .....+++.               .....  ........+.+|+.+||+.||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            22111111000    00000    000000000               00000  0011234678999999999999999


Q ss_pred             CHHHHHH
Q 038934          697 NMASVVL  703 (751)
Q Consensus       697 s~~evl~  703 (751)
                      |+.|+++
T Consensus       431 ta~e~L~  437 (467)
T PTZ00284        431 NARQMTT  437 (467)
T ss_pred             CHHHHhc
Confidence            9999996

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.5e-35  Score=306.52  Aligned_cols=253  Identities=23%  Similarity=0.388  Sum_probs=201.1

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      ++|...++||+|+||.||+++.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            57888899999999999999964 58899999987665555667889999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++..   .+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......  
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            99999999843   346899999999999999999999998   9999999999999999999999999987654221  


Q ss_pred             ccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          591 ANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      .......|++.|+|||++.   ...++.++|||||||++|+|++|+.|+....+...      ........ .   ....
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~-~---~~~~  230 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSN-F---QPPK  230 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccC-C---CCCc
Confidence            1123357899999999974   45688999999999999999999998643221110      00000000 0   0000


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ...  .......+.+++.+|++.+|++||+++++++.
T Consensus       231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            111  11223467899999999999999999998863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.7e-35  Score=310.09  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=204.6

Q ss_pred             HhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ...+|.+.++||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            347899999999999999999996 4689999999976655566778999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++.++|+|||++.......
T Consensus        97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999999842    35789999999999999999999998   9999999999999999999999999987654322


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      ..  .....+++.|+|||.+.+..++.++|||||||++|+|++|+.|+...........      ....+..        
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~~~--------  233 (297)
T cd06656         170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTP--------  233 (297)
T ss_pred             cC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCCCC--------
Confidence            21  1235688899999999999999999999999999999999999754332111000      0000000        


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ....+......+.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00011223456778999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.9e-35  Score=317.21  Aligned_cols=255  Identities=20%  Similarity=0.244  Sum_probs=197.0

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|.+.++||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999965 5788999998652   2233456888999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999542  346889999999999999999999998   999999999999999999999999999876433


Q ss_pred             CccccccccccccCccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ... ......||+.|+|||++.+     ..++.++|||||||+||+|++|+.||.......      .............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~  228 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ  228 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc
Confidence            221 1223579999999999876     468899999999999999999999975332211      0111111110000


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPED--RPNMASVVLM  704 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  704 (751)
                      + .     .........+.+++.+|++.++.+  |+++.++++.
T Consensus       229 ~-p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 F-P-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             C-C-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0 0     001123457788999998865544  5688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.6e-35  Score=306.44  Aligned_cols=253  Identities=27%  Similarity=0.412  Sum_probs=198.8

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC------
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR------  500 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  500 (751)
                      .+.+.|+..+.||+|+||.||+|... .++.+|+|++.... .....+.+|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888999999999999999965 47889999986543 4456789999999998 699999999998753      


Q ss_pred             CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccC
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  580 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl  580 (751)
                      ...++||||+.+++|.+++... ....+++..+..++.|++.||+|||+++   |+|+||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4578999999999999998642 2345889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      +........  ......|++.|+|||++.     +..++.++|||||||++|||++|+.|+........      .....
T Consensus       158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~------~~~~~  229 (272)
T cd06637         158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLIP  229 (272)
T ss_pred             ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH------HHHHh
Confidence            986532221  223367899999999986     34688899999999999999999999753221100      00000


Q ss_pred             ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      . .....        .........+.+|+.+||+.+|.+||++.++++
T Consensus       230 ~-~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 R-NPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             c-CCCCC--------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0 00000        011123346789999999999999999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.1e-35  Score=303.10  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=202.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      +|++.++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778889999999999999965 5889999998643 3345677889999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++... ....+++..+..++.|++.||.|||+++   |+|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999999988542 2345789999999999999999999998   99999999999999999999999999976543221 


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       ......+++.|+|||++.+..++.++||||||+++|+|++|+.|+......   ..   ... ...+...         
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~---~~~-~~~~~~~---------  218 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NL---ILK-VCQGSYK---------  218 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HH---HHH-HhcCCCC---------
Confidence             122356888999999999999999999999999999999999997532211   00   001 1111110         


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..+......+.+++.+||+.||++||++.+++..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1112234567899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-35  Score=304.80  Aligned_cols=249  Identities=29%  Similarity=0.455  Sum_probs=194.6

Q ss_pred             ccccccccccEEEEEEcC-Cc--EEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLID-GQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||.||+|++.+ +.  .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999999754 33  5788888643 334556889999999999 799999999999999999999999999


Q ss_pred             CChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          513 KSLADFIFDGT-------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       513 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                      ++|.+++....             ....+++..+..++.|++.||+|||+.+   ++|+||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986432             1235789999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      ++......   ........+..|+|||++.+..++.++||||||+++|||++ |..|+......   .    ........
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~----~~~~~~~~  227 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E----LYEKLPQG  227 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---H----HHHHHhCC
Confidence            98632211   01111233567999999998899999999999999999997 88886432211   0    11111111


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .         ....+......+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       228 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 Y---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             C---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            0         0011122345678999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.9e-35  Score=303.71  Aligned_cols=257  Identities=25%  Similarity=0.339  Sum_probs=200.9

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .+++++.....||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34556666678999999999999955 57789999987766666778999999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-CCCeEEeeccCccccCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGV  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~  586 (751)
                      ||+++++|.+++.........++..+..++.||+.||+|||+.+   |+|+||||+||+++. ++.++|+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999999964322212378888999999999999999998   999999999999986 67899999999876532


Q ss_pred             CCccccccccccccCccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ...  ......+++.|+|||++.+..  ++.++||||||+++|+|++|+.|+........     ..+.   ..      
T Consensus       162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~---~~------  225 (268)
T cd06624         162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFK---VG------  225 (268)
T ss_pred             CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhh---hh------
Confidence            221  122345789999999987643  78999999999999999999999643211000     0000   00      


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ........+......+.+++.+|++.+|.+||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            0000111223345678899999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.3e-35  Score=306.12  Aligned_cols=251  Identities=32%  Similarity=0.477  Sum_probs=197.8

Q ss_pred             ccccccccccEEEEEEcC-------CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          438 NKLGEGGFGPVYKGMLID-------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +.||+|+||.||+|+..+       ++.+|||.+.+.. .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998643       2579999886543 34566889999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC-----CeEEeeccC
Q 038934          510 LPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-----NPKISDFGM  580 (751)
Q Consensus       510 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~DFGl  580 (751)
                      +++++|.+++....    ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996532    2235788999999999999999999988   99999999999999887     899999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      ++...............++..|+|||++.+..++.++||||||+++|+|++ |+.|+......   ....    ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~----~~~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQ----HVTAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHH----HHhcCC
Confidence            976543222111222345678999999999999999999999999999998 88886532211   1110    011110


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                               ....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                     001122334678899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.6e-35  Score=309.18  Aligned_cols=260  Identities=23%  Similarity=0.332  Sum_probs=193.1

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHh---cCCcEEeEeceeee-----CC
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL---QHRNLVKLLGCCMK-----RD  501 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  501 (751)
                      +|++.+.||+|+||.||+|+.. +++.||+|.+....  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999965 58899999987542  22234566787777766   69999999998864     24


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ..++||||+.+ +|.+++... ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57999999985 888887542 2345899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      +......   ......+|..|+|||++.+..++.++|||||||++|+|++|+.||........   ..............
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~  229 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPED  229 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHHHHHHhCCCChh
Confidence            8764221   12235678999999999999999999999999999999999998754322111   11111100000000


Q ss_pred             h------hcchhcc-------CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 E------LIDKSLE-------DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 ~------~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .      .......       ..........+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0      0000000       0011123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.8e-35  Score=308.83  Aligned_cols=271  Identities=30%  Similarity=0.423  Sum_probs=204.3

Q ss_pred             cCccccccccccccccEEEEEEc-----CCcEEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeee--CCce
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-----DGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMK--RDER  503 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  503 (751)
                      +.|...+.||+|+||.||++++.     .++.+|||++...... ..+.+.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46677789999999999999853     3678999999765443 56789999999999999999999999887  5678


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999542  235899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCccc-cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          584 FGVDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       584 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ........ ......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ...............+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHH
Confidence            65322211 111234456799999999889999999999999999999999886432211100 0000000000000001


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .+........+......+.+++.+|++.+|++||+|.||+++|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111111111122335788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4e-35  Score=312.22  Aligned_cols=260  Identities=28%  Similarity=0.445  Sum_probs=201.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCc----EEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQ----EIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|+..+.||+|+||.||+|.+. ++.    .+|+|.+.... .....++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56778889999999999999864 343    57888886543 23345788999999999999999999998754 5679


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |+||+++|+|.+++...  ...+++..+..++.|++.||.|||+++   |+|+||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999998542  335789999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........       ......+..    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~----  229 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-------PDLLEKGER----  229 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCCCC----
Confidence            3332222223445678999999999999999999999999999997 8888643221111       111111110    


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQ  713 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  713 (751)
                           ...+......+.+++.+|+..+|++||++.++++.|+.+...+.
T Consensus       230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         230 -----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence                 00111223467899999999999999999999999987644433

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-35  Score=302.48  Aligned_cols=253  Identities=24%  Similarity=0.387  Sum_probs=204.9

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      ++|++.++||.|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999965 47889999998766567788999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++..+..... 
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            999999998542  246889999999999999999999998   99999999999999999999999999986543221 


Q ss_pred             ccccccccccCccCcccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          591 ANTNRVVGTYGYMPPEYAIDG---LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~---~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                       ......++..|+|||.+.+.   .++.++||||||+++|+|++|+.|+........  ...    .....    .....
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~----~~~~~----~~~~~  225 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL----ISKSN----FPPPK  225 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HHhcc----CCCcc
Confidence             12235678899999999877   889999999999999999999999753222111  000    00000    00000


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      +  .........+.+++.+|++.+|.+||++.+|+.
T Consensus       226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0  112234567889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6e-35  Score=318.57  Aligned_cols=260  Identities=22%  Similarity=0.282  Sum_probs=196.9

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC-----
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD-----  501 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  501 (751)
                      ..++|.+.+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999964 5899999999654  2334567889999999999999999999986543     


Q ss_pred             -ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccC
Q 038934          502 -ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  580 (751)
Q Consensus       502 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl  580 (751)
                       ..++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             47999999976 5655552     23788999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhc----
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWT----  656 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~----  656 (751)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........   .........    
T Consensus       170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~  243 (359)
T cd07876         170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ---WNKVIEQLGTPSA  243 (359)
T ss_pred             ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCcH
Confidence            9764322   112335789999999999999999999999999999999999999864432110   000000000    


Q ss_pred             ---------------cC------Chhhhcchhcc---CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          657 ---------------ED------RPVELIDKSLE---DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       657 ---------------~~------~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                                     ..      ...+.......   ..........+.+|+.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                           00      00000000000   00111123567899999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.1e-35  Score=308.38  Aligned_cols=260  Identities=25%  Similarity=0.405  Sum_probs=208.3

Q ss_pred             cCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .+|...+.||.|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4689999999999999999985 468999999997665556678899999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99999998842    35899999999999999999999998   999999999999999999999999998865432221


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                        .....+++.|+|||.+.+..++.++|||||||++|+|++|+.|+.........      ....... ...     +  
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~-~~~-----~--  235 (296)
T cd06655         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG-TPE-----L--  235 (296)
T ss_pred             --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcC-Ccc-----c--
Confidence              22356888999999999988999999999999999999999997543321110      0000000 000     0  


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCCCCCCCC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGERSLPQP  714 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~p  714 (751)
                      ..+......+.+++.+||+.||.+||++.++++  .+....++..+
T Consensus       236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~  281 (296)
T cd06655         236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSL  281 (296)
T ss_pred             CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccccC
Confidence            011223346778999999999999999999984  44444444333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-35  Score=305.29  Aligned_cols=247  Identities=27%  Similarity=0.424  Sum_probs=202.6

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|+..+.||.|++|.||+|+.. +++.+|+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999965 58899999987543 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999999843    26899999999999999999999998   99999999999999999999999999987653321


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                        ......+++.|+|||++.+..++.++||||||+++|+|++|+.|+....+...   ..    .......         
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~----~~~~~~~---------  215 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LF----LIPKNNP---------  215 (274)
T ss_pred             --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HH----HhhhcCC---------
Confidence              12235688899999999998999999999999999999999999753322110   00    0000101         


Q ss_pred             CccCHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          670 DTYSLS-EALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       670 ~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...... ....+.+++.+||+.+|++||+++++++
T Consensus       216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            011111 3456789999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=9.9e-35  Score=300.80  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=203.7

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      ++|+..++||+|+||.||++.+.+ ++.+++|.+.....  .+++.+|++++++++|+||+++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578889999999999999999765 78999999865432  678999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999999853  2346899999999999999999999998   99999999999999999999999999987643221 


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       ......++..|+|||++.+..++.++||||||+++|+|++|+.|+..........       .......     .  ..
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~-----~--~~  219 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNKPP-----P--TL  219 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccCCC-----C--CC
Confidence             1223557889999999999999999999999999999999999976432211100       0000000     0  00


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ..+......+.+++.+|++.||++||++.+|++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            111223457889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.5e-35  Score=303.92  Aligned_cols=249  Identities=27%  Similarity=0.441  Sum_probs=199.9

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCcc---------cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQ---------GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  502 (751)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+......         ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667789999999999999964 5789999988654221         23568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999943   356889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcc----ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          583 AFGVDQTE----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       583 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      ........    .......++..|+|||.+.+..++.++||||||+++|+|++|+.|+......      ....... . 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~-  226 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIG-E-  226 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHh-c-
Confidence            76422111    1112346788999999999989999999999999999999999997532110      0000000 0 


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                              ......+......+.+++.+||+.||.+||++.++++
T Consensus       227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 --------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                    0111222334567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.9e-35  Score=303.50  Aligned_cols=251  Identities=26%  Similarity=0.422  Sum_probs=200.6

Q ss_pred             CccccccccccccccEEEEEEcCCcEEEEEEeccCC------cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSS------GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      +|...+.||+|+||.||+|...+++.+|+|.+....      ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467788999999999999998789999999986432      12345688999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      +||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999953   245789999999999999999999998   99999999999999999999999999886532


Q ss_pred             CC----ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          587 DQ----TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       587 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ..    .........++..|+|||++.+..++.++||||||+++|+|++|+.|+........  .    ........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~----~~~~~~~~---  225 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--M----FYIGAHRG---  225 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--H----HHhhhccC---
Confidence            11    11112235688999999999999999999999999999999999999753221100  0    00000000   


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           .....+......+.+++.+||+.+|.+||++.++++
T Consensus       226 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 -----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 001112234567889999999999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.1e-35  Score=305.44  Aligned_cols=240  Identities=24%  Similarity=0.413  Sum_probs=190.0

Q ss_pred             ccccccccccEEEEEEcC--------CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          438 NKLGEGGFGPVYKGMLID--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +.||+|+||.||+|....        ...+|+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998643        234888888665555667889999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC--------eEEeeccCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--------PKISDFGMA  581 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~DFGla  581 (751)
                      +++++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998543  235789999999999999999999998   999999999999987765        689999988


Q ss_pred             cccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCC-CCCCCCCCccccchhHHHHHHhccCC
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGT-RNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~-~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      .....      .....+++.|+|||++.+. .++.++||||||+++|+|++|. .|+........   .    .....  
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~----~~~~~--  220 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L----QFYED--  220 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H----HHHHc--
Confidence            65421      1225678899999999874 5799999999999999999995 44322111100   0    00000  


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                               ....+......+.+++.+||+.||++|||++++++.|+
T Consensus       221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ---------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     01122223356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.5e-34  Score=306.09  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=201.8

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      +.|++.++||+|+||.||+|++.. ++.+++|.+........+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            578889999999999999999754 8899999998776666788999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|..++.+.  ...+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++......  .
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~  164 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--L  164 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--c
Confidence            999999887542  345899999999999999999999998   999999999999999999999999998754221  1


Q ss_pred             ccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      .......+++.|+|||++.     ...++.++|||||||++|+|++|+.|+......      ..... .........  
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~--  235 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSEPPTL--  235 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHH-HhcCCCccC--
Confidence            1123356788999999985     345788999999999999999999986532211      00111 111110000  


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                           ..+......+.+++.+|++.||++||++.++++.
T Consensus       236 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         236 -----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                 1112234567899999999999999999999863

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.5e-35  Score=310.83  Aligned_cols=265  Identities=22%  Similarity=0.328  Sum_probs=199.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|.+.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++......++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            367899999999999999999965 57899999986542 2334567899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |++ ++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+|||+++++.+||+|||++.......
T Consensus        85 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          85 YLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            997 5888887542  345789999999999999999999998   9999999999999999999999999997653222


Q ss_pred             ccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH--------HHHHhccCC
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH--------AWRLWTEDR  659 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~--------~~~~~~~~~  659 (751)
                      ..  .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||..............        .|.......
T Consensus       159 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         159 KT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             Cc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            11  1224568899999998754 578999999999999999999999865433211110000        000000000


Q ss_pred             hhhhcc-hhccC----ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          660 PVELID-KSLED----TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       660 ~~~~~d-~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .....+ +....    .........+.+|+.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000 00000    001122446789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.4e-35  Score=316.02  Aligned_cols=255  Identities=18%  Similarity=0.244  Sum_probs=196.1

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|.+.++||+|+||.||++++.. ++.+|+|++.+.   .....+.+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            478889999999999999999754 778999998642   2233445888999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999542  345889999999999999999999998   999999999999999999999999998765322


Q ss_pred             CccccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.......      .............
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~  228 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQ  228 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCcccc
Confidence            21 1122357999999999986     3468899999999999999999999976432211      1111111110000


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPED--RPNMASVVLM  704 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  704 (751)
                      .      ..........+.+++.+|+..++.+  |+++.++++.
T Consensus       229 ~------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 F------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             C------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0      0011123456778888888654444  7899999865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.9e-35  Score=308.07  Aligned_cols=250  Identities=27%  Similarity=0.365  Sum_probs=198.6

Q ss_pred             ccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          434 FSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      |+..+.||+|+||.||++... +++.||+|.+....   ....+.+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667788999999999999965 58899999986542   22335678899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            9999999988542 2235889999999999999999999998   99999999999999999999999999876532211


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                         .....|+..|+|||++.+..++.++||||||+++|+|++|+.|+..........   ........          ..
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~~~----------~~  221 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKE----------VQ  221 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhhhh----------hh
Confidence               123468999999999999999999999999999999999999986432211100   00000000          00


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                      ..........+.+|+.+||+.||++||+     +.|+++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            1112223456789999999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.4e-35  Score=304.98  Aligned_cols=254  Identities=25%  Similarity=0.356  Sum_probs=188.3

Q ss_pred             ccccccccccEEEEEEcC---CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCC
Q 038934          438 NKLGEGGFGPVYKGMLID---GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      ++||+|+||.||+|...+   ...+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+....++||||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   3568888876442 334457889999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          514 SLADFIFDGTR--RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       514 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +|.+++.....  ....++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999965332  234567888999999999999999998   9999999999999999999999999987543221111


Q ss_pred             cccccccccCccCccccc-------CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          592 NTNRVVGTYGYMPPEYAI-------DGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~-------~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ......+++.|+|||++.       ...++.++|||||||++|||++ |..|+......   ...   ....... ...+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~---~~~~~~~-~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVL---KQVVREQ-DIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH---HHHhhcc-CccC
Confidence            112234567899999874       3457889999999999999999 66675422111   011   1111111 1111


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ..+.    ........+.+++..|+ .||++||++++|++.|.
T Consensus       231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111    12223445667788888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=317.64  Aligned_cols=258  Identities=27%  Similarity=0.429  Sum_probs=210.9

Q ss_pred             cccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCChhH
Q 038934          439 KLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLAD  517 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~  517 (751)
                      +||+|.+|+||.|+..+ ...+|||.+.....+..+.+..|+.+.++|+|.|||+++|.+.++..+-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999665 55799999988887888889999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc-CCCCeEEeeccCccccCCCCcccccc
Q 038934          518 FIFDGTRRKLL--DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTN  594 (751)
Q Consensus       518 ~l~~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~  594 (751)
                      ++..  .=+++  ++.++-.+.+||++||.|||+..   |||||||-+|+||+ -.|.+||+|||.++.+..  -...+.
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence            9964  23344  78899999999999999999998   99999999999996 578999999999987743  233345


Q ss_pred             ccccccCccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          595 RVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       595 ~~~gt~~y~aPE~~~~~~--~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .+.||..|||||++..++  |..++|||||||++.||.||++||---...  +..      +++-+.      .......
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAA------MFkVGm------yKvHP~i  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAA------MFKVGM------YKVHPPI  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHh------hhhhcc------eecCCCC
Confidence            689999999999998764  889999999999999999999997421111  110      011110      0122334


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCCCCCCCCCCC
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGERSLPQPKQP  717 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~p~~p  717 (751)
                      +.+...++..+|.+|+..||.+||+++++++  +|..-...+.|+.+
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls  847 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS  847 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence            5666778999999999999999999999995  66655555666554

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.3e-35  Score=305.13  Aligned_cols=239  Identities=20%  Similarity=0.299  Sum_probs=187.4

Q ss_pred             cccccccccEEEEEEcC-------------------------CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeE
Q 038934          439 KLGEGGFGPVYKGMLID-------------------------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL  493 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  493 (751)
                      .||+|+||.||+|.+..                         ...||+|++.........++.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998521                         13588999866554555678899999999999999999


Q ss_pred             eceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC--
Q 038934          494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM--  571 (751)
Q Consensus       494 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~--  571 (751)
                      ++++.+....++||||+++++|..++..  ....+++..+..++.||++||+|||+++   |+||||||+|||+++.+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999998853  2346889999999999999999999998   99999999999997644  


Q ss_pred             -----CeEEeeccCccccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCccc
Q 038934          572 -----NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELV-YGTRNRGFHHVDHH  644 (751)
Q Consensus       572 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell-~G~~p~~~~~~~~~  644 (751)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 3899999988643211      12356778999998875 56899999999999999995 68887653322111


Q ss_pred             cchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          645 HNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       645 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ..    .   ....         .  ..+......+.+++.+|++.+|++||++.++++.|+
T Consensus       231 ~~----~---~~~~---------~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ER----F---YEKK---------H--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH----H---HHhc---------c--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            00    0   0000         0  011112246789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=312.92  Aligned_cols=264  Identities=27%  Similarity=0.421  Sum_probs=208.7

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCc-ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      +...+.++||+|-||.|.++....+..||||.++.... ....+|.+|+++|.+|+|||||+++|+|..++.+++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            34566789999999999999987789999999987643 44589999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++|+|.+++.++.... +......+|+.||+.||+||.+..   +|||||.+.|+|+|.++++||+|||+++-+-.....
T Consensus       618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999997653322 455666789999999999999988   999999999999999999999999999965433333


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY--GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      ......+-...|||||.+..+++|.++|||+||++|||+++  ..+|++....+   +.++.+-..+..+.....+    
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l----  766 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVL----  766 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceec----
Confidence            22233445678999999999999999999999999999875  45554422221   1122222222222221111    


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                        ..+.-....+.+++..|+..|-++||+++++...|...
T Consensus       767 --~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 --SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             --cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence              12344566788999999999999999999999988754

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-35  Score=305.65  Aligned_cols=255  Identities=27%  Similarity=0.441  Sum_probs=202.2

Q ss_pred             cCccccccccccccccEEEEEEcC-Cc----EEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQ----EIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|...+.||+|+||.||+|.+.. ++    .+|+|.+.... ....+++.+|+.+++.++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            567888999999999999999643 33    58999886553 3345678999999999999999999999987 78899


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998542  335899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ............++..|+|||.+....++.++||||||+++|||++ |+.|+.......   +.    ........    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~----  229 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IP----DLLEKGER----  229 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HH----HHHhCCCC----
Confidence            3322221122234568999999988899999999999999999998 998875432211   10    11111100    


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                           ...+......+.+++.+|+..||.+||++.++++.|+.+
T Consensus       230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                 111122334678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-35  Score=314.97  Aligned_cols=255  Identities=21%  Similarity=0.251  Sum_probs=195.7

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999965 4889999999642   2234556889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999853  2345889999999999999999999998   999999999999999999999999998765432


Q ss_pred             CccccccccccccCccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ... ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.......      .............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~  228 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQ  228 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCccc
Confidence            211 1122468999999999873     457889999999999999999999975322111      0111111110000


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCC--CCCCCHHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRP--EDRPNMASVVLM  704 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~  704 (751)
                      +.      .........+.+++.+||..++  ..||++.++++.
T Consensus       229 ~~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 FP------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CC------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            00      0011134567788888775433  348899999865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.5e-35  Score=319.92  Aligned_cols=264  Identities=22%  Similarity=0.304  Sum_probs=197.7

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-----
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-----  500 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  500 (751)
                      ...++|...+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34579999999999999999999864 5889999999754  223456788999999999999999999988644     


Q ss_pred             -CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          501 -DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       501 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                       ...++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence             357999999976 5666652     24788999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccc-hhHH-------H
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN-LLGH-------A  651 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~-~~~~-------~  651 (751)
                      +++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ....       .
T Consensus       165 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             ccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99865322   11233578999999999999999999999999999999999999986433211100 0000       0


Q ss_pred             H-------HHhccC--Chhhhc------chhc--cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          652 W-------RLWTED--RPVELI------DKSL--EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       652 ~-------~~~~~~--~~~~~~------d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      +       ..+...  ....+.      +...  ...........+.+|+.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0       000000  000000      0000  000111224567899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-34  Score=304.89  Aligned_cols=251  Identities=23%  Similarity=0.352  Sum_probs=200.1

Q ss_pred             CccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      .|++.++||+|+||.||++.... +..+++|.+........+.+.+|+++++.++|+||+++++++...+..++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            36777899999999999999654 77889999876666667789999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|..++..  ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......  .
T Consensus        86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            9999998753  2346899999999999999999999998   9999999999999999999999999987653221  1


Q ss_pred             cccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          592 NTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ......+++.|+|||++.     +..++.++|||||||++|+|++|+.|+......   ..   ...... ......   
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~---~~~~~~-~~~~~~---  228 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RV---LLKIAK-SEPPTL---  228 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HH---HHHHhh-cCCCCC---
Confidence            123356889999999984     456788999999999999999999986532211   00   000000 000000   


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                          ..+......+.+++.+|++.||.+||++.++++.
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 ----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0112234578899999999999999999998854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.6e-35  Score=306.81  Aligned_cols=248  Identities=27%  Similarity=0.437  Sum_probs=200.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++......++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34667788999999999999864 47889999987543 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++.    ...+++..+..++.|+++||.|||+++   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999999883    245789999999999999999999998   99999999999999999999999999986543221


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                        ......++..|+|||++.+..++.++||||||+++|||++|+.|+....+...   .   . .....         ..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~---~-~~~~~---------~~  218 (277)
T cd06642         157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---L---F-LIPKN---------SP  218 (277)
T ss_pred             --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---H---h-hhhcC---------CC
Confidence              12234678899999999999999999999999999999999998653221110   0   0 00000         01


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..........+.+++.+|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            11122334568899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.5e-35  Score=306.67  Aligned_cols=255  Identities=24%  Similarity=0.352  Sum_probs=203.1

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.....+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57888899999999999999965 58899999886543 34467899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      +++++|.+++..   .+.+++..+..++.+++.+|.|||+ .+   ++|+||||+||++++++.++|+|||++...... 
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            999999998843   3468999999999999999999997 46   999999999999999999999999998654221 


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc-----cchhHHHHHHhccCChhhh
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHH-----HNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  663 (751)
                         ......|+..|+|||++.+..++.++|||||||++|+|++|+.|+........     ..+...........     
T Consensus       158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  229 (284)
T cd06620         158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-----  229 (284)
T ss_pred             ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence               12235789999999999888999999999999999999999999874433211     01111110000000     


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                          ............+.+++.+|++.||++||++.|++++.
T Consensus       230 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 ----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                00000112345788999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-34  Score=305.99  Aligned_cols=252  Identities=23%  Similarity=0.386  Sum_probs=201.1

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|++.+.||+|+||.||++... .++.||+|.+... .....+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46788899999999999999975 6899999998654 333456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      +++++|..++........+++..+..++.|++.||.|||++ +   |+|+||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999886543345789999999999999999999974 6   9999999999999999999999999987653221


Q ss_pred             ccccccccccccCccCcccccCCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGL------FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~------~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                          .....+++.|+|||.+.+..      ++.++|||||||++|+|++|+.|+.......   ..... .......   
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~-~~~~~~~---  226 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQL-SAIVDGD---  226 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHH-HHHhhcC---
Confidence                12345788999999986543      5889999999999999999999975322111   11000 0000111   


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                            ....+......+.+++.+|++.+|++||++.+++.
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 ------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                  11122335667889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-34  Score=303.33  Aligned_cols=256  Identities=27%  Similarity=0.381  Sum_probs=202.0

Q ss_pred             cCccccccccccccccEEEEEEcC------CcEEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      ++|+..+.||+|+||.||+|+.+.      .+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            578888999999999999999642      467999988654433 4578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeec
Q 038934          505 LIYEYLPNKSLADFIFDGTRR------KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  578 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF  578 (751)
                      +||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999653321      26899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhcc
Q 038934          579 GMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTE  657 (751)
Q Consensus       579 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~  657 (751)
                      |++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..|+......   ...    .....
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~----~~~~~  233 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVL----NRLQA  233 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHH----HHHHc
Confidence            99875432211 11223456778999999998889999999999999999998 66675321111   011    01111


Q ss_pred             CChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       658 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      +..        ...........+.+++.+|++.+|.+||++.++++.|.
T Consensus       234 ~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            110        01112233457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-35  Score=318.43  Aligned_cols=259  Identities=23%  Similarity=0.314  Sum_probs=196.0

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-----
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-----  500 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  500 (751)
                      ...++|...+.||+|+||.||++... +++.||||++....  ....+.+.+|+.++++++|+||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            45678999999999999999999964 57899999987542  22345678999999999999999999987543     


Q ss_pred             -CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          501 -DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       501 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                       ...++++|++ +++|.+++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3568999988 778988773    345899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      +++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........   +........ .
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~-~  234 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVG-T  234 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhC-C
Confidence            99865321     223578999999999877 5789999999999999999999999754322111   110000000 0


Q ss_pred             Chhhhcch-----------hccCccC-------HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          659 RPVELIDK-----------SLEDTYS-------LSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       659 ~~~~~~d~-----------~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ...+....           .+.....       ......+.+|+.+||+.||.+|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000           0000000       0112356799999999999999999999953

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-34  Score=314.09  Aligned_cols=193  Identities=21%  Similarity=0.304  Sum_probs=165.3

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ....+|.+.+.||+|+||.||+|+.. .++.||+|+....      ....|+.++++++|+||+++++++.+....++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34468999999999999999999975 4678999975432      2356999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      |++. ++|.+++..  ....+++..+..|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 588887753  3346899999999999999999999998   999999999999999999999999999753221


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNR  636 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~  636 (751)
                         .......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1122357899999999999999999999999999999999876654

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.1e-34  Score=300.93  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=200.5

Q ss_pred             CccccccccccccccEEEEEEcC--CcEEEEEEeccC----------CcccHHHHHHHHHHHHH-hcCCcEEeEeceeee
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID--GQEIAVKRLSKS----------SGQGVEEFKNEVLLIAK-LQHRNLVKLLGCCMK  499 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  499 (751)
                      +|++.+.||+|+||.||++.+..  ++.+|+|.+...          ......++.+|+.++.+ ++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999765  678999988532          22234567788888875 699999999999999


Q ss_pred             CCceEEEEEecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeEEcCCCCeEEee
Q 038934          500 RDERMLIYEYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISD  577 (751)
Q Consensus       500 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~D  577 (751)
                      .+..++||||+++++|.+++... .....+++..++.++.|++.+|.|||+ .+   ++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999988542 234468999999999999999999996 55   99999999999999999999999


Q ss_pred             ccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhcc
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE  657 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  657 (751)
                      ||++.......   ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+......   ..   . .....
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~---~-~~~~~  227 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SL---A-TKIVE  227 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HH---H-HHHhh
Confidence            99998754332   223457889999999999988999999999999999999999986432111   00   0 00111


Q ss_pred             CChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       658 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ...        ...........+.+++.+|++.||++||++.|+.++|+
T Consensus       228 ~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 AVY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ccC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            110        00011123457889999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.3e-35  Score=318.04  Aligned_cols=263  Identities=21%  Similarity=0.286  Sum_probs=197.3

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC------
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR------  500 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  500 (751)
                      ..++|...+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999964 5889999999754  233456788999999999999999999987543      


Q ss_pred             CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccC
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  580 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl  580 (751)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999976 6776663     23788899999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH--------HH
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH--------AW  652 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~--------~~  652 (751)
                      ++......   ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..        ..
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            98653221   22335789999999999999999999999999999999999999864432111000000        00


Q ss_pred             H-------HhccCC-------hhhhcchhc---cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          653 R-------LWTEDR-------PVELIDKSL---EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       653 ~-------~~~~~~-------~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .       ......       ...+....+   ...........+.+++.+||+.||.+|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0       000000       000000000   000111123467899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-34  Score=300.21  Aligned_cols=238  Identities=22%  Similarity=0.408  Sum_probs=188.6

Q ss_pred             ccccccccccEEEEEEcCCc-----------EEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          438 NKLGEGGFGPVYKGMLIDGQ-----------EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999976533           5788877554333 6789999999999999999999999988 778999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC-------CeEEeecc
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-------NPKISDFG  579 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-------~~kl~DFG  579 (751)
                      |||+++++|.+++....  ..+++..+..++.||+.||+|||+++   |+|+||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999986432  26889999999999999999999998   99999999999999887       79999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCC--CCCcchhhHHHHHHHHHHHhC-CCCCCCCCCccccchhHHHHHHhc
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLELVYG-TRNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DVwSlG~ll~ell~G-~~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                      ++.....      .....++..|+|||++.+.  .++.++||||||+++|+|++| ..|+........    .   ..+.
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~----~---~~~~  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK----E---RFYQ  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH----H---HHHh
Confidence            9986532      1123566789999999876  789999999999999999995 555432221110    0   0011


Q ss_pred             cCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          657 EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       657 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ...           ..+......+.+++.+|++.+|.+||++.++++.|+
T Consensus       221 ~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000           011111267889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2e-34  Score=308.71  Aligned_cols=261  Identities=23%  Similarity=0.324  Sum_probs=188.7

Q ss_pred             cccccccccccEEEEEEcC---CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeee--CCceEEEEEecC
Q 038934          437 ENKLGEGGFGPVYKGMLID---GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK--RDERMLIYEYLP  511 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~  511 (751)
                      ..+||+|+||.||+|+..+   +..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3589999999999999653   5789999986542  23567899999999999999999998854  457789999987


Q ss_pred             CCChhHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE----cCCCCeEEeeccCc
Q 038934          512 NKSLADFIFDG------TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMA  581 (751)
Q Consensus       512 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla  581 (751)
                      + +|.+++...      .....+++..+..++.||+.||.|||+++   |+||||||+|||+    ++++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 777776421      12235889999999999999999999998   9999999999999    56678999999999


Q ss_pred             cccCCCCcc-ccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc------chhHH---
Q 038934          582 RAFGVDQTE-ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHH------NLLGH---  650 (751)
Q Consensus       582 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~------~~~~~---  650 (751)
                      +........ .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.....+...      .....   
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            876433221 122345789999999998764 5899999999999999999999998643322110      00000   


Q ss_pred             --------HHHHhccC-Chhhhcchhc------------cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          651 --------AWRLWTED-RPVELIDKSL------------EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       651 --------~~~~~~~~-~~~~~~d~~l------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                              .|...... ..........            ...........+.+|+.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                    00000000 0000000000            00011122345788999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-34  Score=308.27  Aligned_cols=253  Identities=24%  Similarity=0.295  Sum_probs=201.9

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccCCc---ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|...+.||+|++|.||++...+ ++.+|+|.+.....   ...+.+.+|+++++.++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            468888999999999999999754 89999999976532   24567899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+.+++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999998532 2356899999999999999999999998   999999999999999999999999998765321


Q ss_pred             Ccc---------------------------ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 038934          588 QTE---------------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHH  640 (751)
Q Consensus       588 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~  640 (751)
                      ...                           .......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           11123468889999999999999999999999999999999999975333


Q ss_pred             CccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC----HHHHHH
Q 038934          641 VDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN----MASVVL  703 (751)
Q Consensus       641 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  703 (751)
                      ....      ..         ...+....-.........+.+++.+|++.||++||+    +.+++.
T Consensus       237 ~~~~------~~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDET------FS---------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHH------HH---------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2111      00         011111111111114567899999999999999999    666664

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=305.01  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=203.1

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|.+.++||.|+||.||++.+. +++.+|+|.+........+.+.+|+.++++++|+||+++++++......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            357889999999999999999964 5889999999776666677899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            9999999998542  345899999999999999999999998   99999999999999999999999999876532211


Q ss_pred             cccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          590 EANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                        ......+++.|+|||++.     +..++.++||||||+++|+|++|+.|+.......   .   ... ........  
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~---~~~-~~~~~~~~--  227 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---V---LLK-ILKSEPPT--  227 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---H---HHH-HhcCCCCC--
Confidence              122356889999999975     3457889999999999999999999975322110   0   000 11110000  


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                         +  ..+......+.+++.+||+.+|.+||++.++++.
T Consensus       228 ---~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 ---L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ---c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence               0  0111234567899999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.6e-34  Score=301.84  Aligned_cols=248  Identities=27%  Similarity=0.418  Sum_probs=202.6

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ..|+..++||.|+||.||+|... .++.||||.+.... ....+.+.+|+.+++++.|+||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999965 58899999987542 34567789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999999842    35788999999999999999999998   99999999999999999999999999977643221


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                        ......++..|+|||++.+..++.++||||||+++|||++|+.|+....+....                ..+.....
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~  218 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKNNP  218 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcCCC
Confidence              122346788999999999989999999999999999999999986533221100                00000011


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..........+.+++.+|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            12233456678899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.5e-34  Score=299.59  Aligned_cols=250  Identities=22%  Similarity=0.344  Sum_probs=201.6

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|+..++||+|+||.||++... +++.+|+|++...  .....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999954 5889999998643  234456889999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999988542 2235789999999999999999999998   99999999999999999999999999986543221


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                        ......|++.|+|||++.+..++.++||||||+++++|++|+.|+......   .   ....... +..         
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~---~~~~~~~-~~~---------  218 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---N---LVLKIIR-GSY---------  218 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---H---HHHHHhc-CCC---------
Confidence              112346788999999999999999999999999999999999986532211   0   0100010 100         


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ...+......+.+++.+|++.+|++||++.+|++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            01122335578899999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.6e-34  Score=297.98  Aligned_cols=250  Identities=24%  Similarity=0.346  Sum_probs=200.4

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-CceEEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-DERMLIYE  508 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E  508 (751)
                      +|++.+.||+|++|.||++... +++.+|+|++...  .....+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999965 4788999998654  234456789999999999999999999887644 46789999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++... ....+++..+..++.+++.||++||+.+   |+|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999998642 2345899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      .  ......+++.|+|||++.+..++.++||||||+++++|++|+.|+......      ....... .+..        
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~-~~~~--------  219 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRII-EGKL--------  219 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH-hcCC--------
Confidence            2  223356889999999999999999999999999999999999987532211      0011111 1110        


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       ...+......+.+++.+|++.+|++||++.++++.
T Consensus       220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             11122345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.9e-34  Score=304.30  Aligned_cols=250  Identities=25%  Similarity=0.337  Sum_probs=197.5

Q ss_pred             ccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          434 FSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      |+..+.||+|+||+||++... +++.+|+|++....   ....+.+.+|++++++++|+|++++++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999964 58899999986542   22345678899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99999998885422 335899999999999999999999998   99999999999999999999999999876532211


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                         .....|+..|+|||++.+..++.++||||||+++|+|++|+.|+.........   ...........          
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~----------  221 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETE----------  221 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccc----------
Confidence               12357899999999999999999999999999999999999997643221110   00000000000          


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                      ..+.......+.+|+.+|++.||++||+     +.++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            0112223456789999999999999999     666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.5e-34  Score=304.90  Aligned_cols=260  Identities=25%  Similarity=0.346  Sum_probs=201.6

Q ss_pred             HhHHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceee----
Q 038934          425 KSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCM----  498 (751)
Q Consensus       425 ~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~----  498 (751)
                      ..+..+.++|++.+.||+|+||.||++... .++.+|+|++... ....+++.+|+.+++.+ +|+||+++++++.    
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            445667889999999999999999999964 4789999987543 22346788999999999 6999999999884    


Q ss_pred             -eCCceEEEEEecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEe
Q 038934          499 -KRDERMLIYEYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  576 (751)
Q Consensus       499 -~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~  576 (751)
                       .++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence             345689999999999999987542 23456889999999999999999999998   9999999999999999999999


Q ss_pred             eccCccccCCCCccccccccccccCccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH
Q 038934          577 DFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA  651 (751)
Q Consensus       577 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~  651 (751)
                      |||+++.......  ......|++.|+|||++..     ..++.++|||||||++|||++|+.|+........      .
T Consensus       167 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------~  238 (286)
T cd06638         167 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------L  238 (286)
T ss_pred             cCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------H
Confidence            9999886543221  1223568999999999853     4578999999999999999999999753221100      0


Q ss_pred             HHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          652 WRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       652 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      . ...........       .+......+.+++.+|++.||++||++.|+++.
T Consensus       239 ~-~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 F-KIPRNPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             h-hccccCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0 00011000110       011123468899999999999999999999975

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.9e-35  Score=308.66  Aligned_cols=249  Identities=23%  Similarity=0.361  Sum_probs=200.2

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      .|.....||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3444567999999999999964 588999999876655666789999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++.    ...+++..+..++.||+.||.|||+++   |+|+||||+||++++++.++|+|||++......... 
T Consensus       103 ~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-  174 (292)
T cd06658         103 GGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-  174 (292)
T ss_pred             CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-
Confidence            999999883    235789999999999999999999998   999999999999999999999999998765432221 


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                       .....+++.|+|||.+.+..++.++||||||+++|||++|+.|+........   ...    ...     .+...+.. 
T Consensus       175 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~----~~~-----~~~~~~~~-  240 (292)
T cd06658         175 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRR----IRD-----NLPPRVKD-  240 (292)
T ss_pred             -CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----HHh-----cCCCcccc-
Confidence             2235688999999999988999999999999999999999999753222110   000    000     01111111 


Q ss_pred             cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       672 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       .......+.+++.+|++.||.+|||+.++++.
T Consensus       241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             11234467789999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.8e-34  Score=299.30  Aligned_cols=258  Identities=28%  Similarity=0.422  Sum_probs=206.0

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47888999999999999999964 57889999986542 33567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++........+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999965444456899999999999999999999998   99999999999999999999999999887653322


Q ss_pred             cc--cccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          590 EA--NTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       590 ~~--~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ..  ......++..|+|||++... .++.++||||||+++++|++|+.|+.......      ......... .     .
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~-~-----~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND-P-----P  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC-C-----C
Confidence            21  22335688999999998877 78999999999999999999999975332211      011111110 0     0


Q ss_pred             hccCcc-CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          667 SLEDTY-SLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       667 ~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .+.... .......+.+++.+|++.||++||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            011100 12334677899999999999999999999863

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.9e-34  Score=303.91  Aligned_cols=265  Identities=22%  Similarity=0.304  Sum_probs=200.6

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|+..++||+|+||.||+++.. +++.||+|++....  ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999976 58999999986542  2334568899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|..++.   ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999998888763   3345899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             ccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH--------HHHhccCC
Q 038934          589 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA--------WRLWTEDR  659 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  659 (751)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+......+........        ...+....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1122457889999999876 56889999999999999999999997643322111100000        00000000


Q ss_pred             h-hhhcchhccCccC-----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          660 P-VELIDKSLEDTYS-----LSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       660 ~-~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      . .....+......+     ......+.+++.+|++.+|++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0 0000000000000     1124578899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-35  Score=309.85  Aligned_cols=256  Identities=25%  Similarity=0.337  Sum_probs=207.6

Q ss_pred             HHHhcCccccccccccccccEEEEEEcCCcEEEEEEecc--CCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceE
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  504 (751)
                      ......|++.++||+||.+.||++...+.+.+|+|++..  .+.+.+.-|.+|+..|.+|+ |.+||++++|-..++.+|
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            445578999999999999999999988888999998764  35667788999999999995 999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      ||||+- ..+|..+|.+..  ..++.-.+..+..|++.++.++|+++   |||.||||.|+|+-+ |.+||+|||+|..+
T Consensus       437 mvmE~G-d~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAI  509 (677)
T ss_pred             EEeecc-cccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence            999987 459999996432  23343478889999999999999999   999999999999865 58999999999999


Q ss_pred             CCCCccccccccccccCccCcccccCC-----------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHH
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDG-----------LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWR  653 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~  653 (751)
                      ..+.........+||+.||+||.+...           +.+.++||||||||||+|+.|+.||+...     +    .+ 
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n----~~-  579 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N----QI-  579 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H----HH-
Confidence            888888777788999999999998543           26689999999999999999999976211     0    11 


Q ss_pred             HhccCChhhhcchhccCccCHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          654 LWTEDRPVELIDKSLEDTYSLS-EALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       654 ~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                          .++..+.++...-.++.. ...++++++..||+.||++||++.++|+.
T Consensus       580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                122334444322222211 12238999999999999999999999974

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-34  Score=308.15  Aligned_cols=257  Identities=19%  Similarity=0.254  Sum_probs=201.8

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|...+.||+|+||.||++.+.. ++.||+|.+.+..   ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            368888999999999999999754 7899999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999953   345899999999999999999999998   999999999999999999999999998742110


Q ss_pred             Cc-------------cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHH
Q 038934          588 QT-------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       588 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      ..             ........++..|+|||.+.+..++.++||||||+++|||++|+.|+......   .+..    .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~----~  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFG----Q  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----H
Confidence            00             00111245788999999999889999999999999999999999997532211   1111    0


Q ss_pred             hccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ......   ..+    .........+.+++.+|++.||++||++.++.+.|+.-
T Consensus       228 ~~~~~~---~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         228 VISDDI---EWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHhccc---CCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            000000   000    00112345678999999999999999988888877763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-34  Score=298.95  Aligned_cols=247  Identities=28%  Similarity=0.424  Sum_probs=200.5

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     ....+.+.+|+.+++.++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999976 68999999986543     23556799999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      +||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999853   345889999999999999999999998   99999999999999999999999999887543


Q ss_pred             CCccccccccccccCccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..   ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.|+.....      .............     
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~-----  220 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKEL-----  220 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccC-----
Confidence            22   123356889999999988776 89999999999999999999999753221      0001110000000     


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                          ...+......+.+++.+|++.+|++||++.++++
T Consensus       221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                1112223467789999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-34  Score=302.16  Aligned_cols=255  Identities=23%  Similarity=0.358  Sum_probs=201.2

Q ss_pred             cCccccccccccccccEEEEEEcC----CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|.+.++||+|+||.||+|.+.+    ...||||...... ....+.+.+|+.+++.++|+||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            467888899999999999998643    2468999987654 4456789999999999999999999998875 567899


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999542  235899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..... .....++..|+|||.+....++.++||||||+++|||++ |+.|+.......   ....    .......    
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~----~~~~~~~----  227 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGR----IENGERL----  227 (270)
T ss_pred             cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH----HHcCCcC----
Confidence            32111 112234568999999988889999999999999999986 998875332211   1110    1111100    


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                           ..+...+..+.+++.+|+..+|++||++.++++.|+.+.
T Consensus       228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 111223457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-34  Score=337.62  Aligned_cols=256  Identities=20%  Similarity=0.306  Sum_probs=198.1

Q ss_pred             HHhcCccccccccccccccEEEEEEcC-CcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--Cce
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DER  503 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  503 (751)
                      ...++|.+.++||+|+||+||++++.. ++.+|+|++...  .......+..|+.++++++|||||++++++...  ..+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            345789999999999999999999654 678899988643  333456789999999999999999999988654  568


Q ss_pred             EEEEEecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCEEEccCCCCCeEEcCC--------
Q 038934          504 MLIYEYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSR----LRIIHRDLKASNVLLDNE--------  570 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~----~~ivH~Dikp~NIll~~~--------  570 (751)
                      +|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.+        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999999986432 23568999999999999999999998531    249999999999999642        


Q ss_pred             ---------CCeEEeeccCccccCCCCccccccccccccCccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 038934          571 ---------MNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYGTRNRGFH  639 (751)
Q Consensus       571 ---------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DVwSlG~ll~ell~G~~p~~~~  639 (751)
                               ..+||+|||++..+.....   .....||+.|+|||++.+  ..++.++||||||||||+|++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     3489999999987643221   233578999999999864  45899999999999999999999997532


Q ss_pred             CCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          640 HVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       640 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ..  ...++    ........       +   ........+.+||..||+.+|.+||++.++++
T Consensus       247 ~~--~~qli----~~lk~~p~-------l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NN--FSQLI----SELKRGPD-------L---PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             Cc--HHHHH----HHHhcCCC-------C---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            21  11111    11111100       0   00112457889999999999999999999983

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-34  Score=301.45  Aligned_cols=250  Identities=28%  Similarity=0.396  Sum_probs=190.8

Q ss_pred             ccccccccccEEEEEEcC----CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceee-eCCceEEEEEecC
Q 038934          438 NKLGEGGFGPVYKGMLID----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM-KRDERMLIYEYLP  511 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~~  511 (751)
                      +.||+|+||.||+|.+.+    ...+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            369999999999998542    357999998543 3344678889999999999999999999876 4556789999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc-
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE-  590 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~-  590 (751)
                      +++|.+++...  ...+.+..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998542  234677888999999999999999988   999999999999999999999999999765322110 


Q ss_pred             -ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          591 -ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRN-RGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       591 -~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                       .......++..|+|||.+.+..++.++||||||+++|||++|..| +....   ...+...    ...+..        
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~----~~~~~~--------  220 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVY----LLQGRR--------  220 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH----HhcCCC--------
Confidence             111123456789999999988999999999999999999996544 33211   1111111    111100        


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                       ...+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       221 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         221 -LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             -CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             000111234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.7e-34  Score=309.30  Aligned_cols=257  Identities=19%  Similarity=0.254  Sum_probs=193.1

Q ss_pred             cccccccc--ccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          436 EENKLGEG--GFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       436 ~~~~IG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      +.++||+|  +|++||++... +++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35689999  78899999864 68999999996542  234457888999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.++++||+.+.........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999985432 234889999999999999999999998   999999999999999999999999875443211110


Q ss_pred             -----ccccccccccCccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          591 -----ANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       591 -----~~~~~~~gt~~y~aPE~~~~--~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                           .......++..|+|||++.+  ..++.++|||||||++|||++|+.|+........  ...    ... ......
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~----~~~-~~~~~~  230 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLE----KLN-GTVPCL  230 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHH----Hhc-CCcccc
Confidence                 01122356778999999976  4689999999999999999999999863221110  000    000 000000


Q ss_pred             c-------------------ch-----------------hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          664 I-------------------DK-----------------SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       664 ~-------------------d~-----------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      +                   +.                 .............+.+++.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0                   00                 0000111223457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-34  Score=299.02  Aligned_cols=247  Identities=27%  Similarity=0.409  Sum_probs=197.9

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|.+.+.||+|+||.||++.. .++.+|+|++....  ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688889999999999999975 67889999986542  346789999999999999999999998654 5799999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            999999996532 335789999999999999999999988   9999999999999999999999999987643211   


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                        .....+..|+|||.+.+..++.++||||||+++|+|++ |+.|+.......       .........         ..
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~  216 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGY---------RM  216 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCC---------CC
Confidence              11234567999999998899999999999999999998 888865322211       111111110         11


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ......+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1112234677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.3e-34  Score=300.12  Aligned_cols=256  Identities=24%  Similarity=0.364  Sum_probs=198.0

Q ss_pred             ccccccccccccccEEEEEEc----CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC------
Q 038934          434 FSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD------  501 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  501 (751)
                      |.+.+.||+|+||.||+|.+.    .++.+|||++...  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556789999999999999853    3688999998654  2344667899999999999999999999886543      


Q ss_pred             ceEEEEEecCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeec
Q 038934          502 ERMLIYEYLPNKSLADFIFDGT---RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  578 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF  578 (751)
                      ..++++||+++++|.+++....   ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998875321   2235789999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhcc
Q 038934          579 GMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTE  657 (751)
Q Consensus       579 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~  657 (751)
                      |+++...............+++.|++||.+.+..++.++||||||+++|+|++ |+.|+.....   ..+.    .....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~----~~~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIY----NYLIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHH----HHHHc
Confidence            99987643322222222345678999999998899999999999999999999 7777642211   1111    11111


Q ss_pred             CChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       658 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...       +  ..+......+.+++.+|++.+|++||++.++++.|+.+
T Consensus       231 ~~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110       0  01122345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.1e-34  Score=299.36  Aligned_cols=253  Identities=25%  Similarity=0.438  Sum_probs=201.5

Q ss_pred             CccccccccccccccEEEEEE-cCCcEEEEEEeccCC------cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          433 NFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSS------GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      +|+..+.||+|++|.||++.. .+++.+|+|++....      ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477788999999999999985 468899999986532      1235678999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC-CeEEeeccCcccc
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF  584 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~  584 (751)
                      ||||+++++|.+++.+   ...+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   346889999999999999999999998   99999999999998776 5999999998876


Q ss_pred             CCCCcc--ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          585 GVDQTE--ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       585 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ......  .......++..|+|||.+.+..++.++||||+|+++++|++|+.|+...........   ...         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~---------  222 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFK---------  222 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHH---------
Confidence            433111  111235678899999999988999999999999999999999999753322111110   000         


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ..........+......+.+++.+|++.+|++||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            00001112233345567889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.6e-34  Score=298.81  Aligned_cols=249  Identities=26%  Similarity=0.404  Sum_probs=193.9

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--CceE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DERM  504 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  504 (751)
                      +|...+.||+|+||.||++... .++.||+|++....     ....+.+.+|+.++++++|+||+++++++.+.  ...+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            6888899999999999999965 58899999986432     22345688999999999999999999988753  5678


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +++||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++..
T Consensus        83 l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          83 IFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            99999999999999853   335789999999999999999999988   999999999999999999999999998765


Q ss_pred             CCCCc-cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          585 GVDQT-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       585 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ..... ........++..|+|||.+.+..++.++|||||||++|||++|+.|+.....  .    ..........     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--~----~~~~~~~~~~-----  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--M----AAIFKIATQP-----  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--H----HHHHHHhcCC-----
Confidence            32111 1112235678899999999999999999999999999999999999752211  0    0000000000     


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                          .....+......+..++ +|+..+|++||+++||++
T Consensus       226 ----~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 ----TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ----CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                01112222334555666 688889999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=291.01  Aligned_cols=251  Identities=24%  Similarity=0.362  Sum_probs=203.5

Q ss_pred             ccccccccccEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          438 NKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      +.||+|+++.|--+. +.++.++|||++.+.......++.+|++++.+.+ |+||++++++|+++...|||||.|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            479999999999988 6789999999999887788899999999999996 99999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC---eEEeeccCccccCCCC--c-
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGVDQ--T-  589 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGla~~~~~~~--~-  589 (751)
                      ..+|.   +++.+++.++.++..+|+.||.+||.+|   |.|||+||+|||..+-..   +||+||.+........  + 
T Consensus       164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            99994   5667899999999999999999999999   999999999999976544   8999999876542211  1 


Q ss_pred             --cccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          590 --EANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       590 --~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                        .......+|+..|||||+..     ...|+.+.|.||||||||-||+|..||......+-         .|..+...+
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---------GWdrGe~Cr  308 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---------GWDRGEVCR  308 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---------CccCCCccH
Confidence              11222467888999999863     23589999999999999999999999987655321         134444322


Q ss_pred             -----hcchhccCccC------HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 -----LIDKSLEDTYS------LSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 -----~~d~~l~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           ++..+-.+.+.      ...+.+..+++...|..|+.+|.++.+++.
T Consensus       309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                 22233333332      123446778999999999999999998875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-36  Score=324.84  Aligned_cols=254  Identities=27%  Similarity=0.436  Sum_probs=212.2

Q ss_pred             cccccccccccccEEEEEEcC----CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          435 SEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++++||.|.||.||+|+++.    ...||||.++.. .+.....|+.|+.||.+.+||||++|.|+.......++|.||
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy  711 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY  711 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence            566899999999999999753    346999999765 455667899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      |++|+|+.+|.++.  +.+..-+..-++++|+.|+.||-+.+   +|||||.+.||||+.+-..||+|||+++.+..+..
T Consensus       712 MENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  712 MENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            99999999997654  45888889999999999999999998   99999999999999999999999999997754432


Q ss_pred             ccccccccc--ccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          590 EANTNRVVG--TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       590 ~~~~~~~~g--t~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      .. ....-|  ...|.|||.+...++|.++||||||++|||.++ |.+|+-               + +...++...++.
T Consensus       787 ~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW---------------d-mSNQdVIkaIe~  849 (996)
T KOG0196|consen  787 AA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW---------------D-MSNQDVIKAIEQ  849 (996)
T ss_pred             cc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc---------------c-cchHHHHHHHHh
Confidence            21 111222  368999999999999999999999999999875 777732               1 122223333444


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                      ..+-..+++.+..|.+|++.|+|+|-.+||.+.+|+.+|+++..
T Consensus       850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            44445678888999999999999999999999999999998743

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.4e-34  Score=296.88  Aligned_cols=250  Identities=35%  Similarity=0.526  Sum_probs=198.9

Q ss_pred             cccccccccccccEEEEEEcC-----CcEEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          435 SEENKLGEGGFGPVYKGMLID-----GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .+.+.||+|+||.||+++...     +..||+|++...... ..+.+.+|+.++..++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456789999999999999754     378999999765433 56789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++..... ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++......
T Consensus        82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999854222 12899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      ..... ...+++.|+|||.+.+..++.++||||+|+++++|++ |+.|+......   ...    ........       
T Consensus       158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~-------  222 (258)
T smart00219      158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVL----EYLKKGYR-------  222 (258)
T ss_pred             ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHhcCCC-------
Confidence            21111 2336789999999988889999999999999999998 67775432111   111    11111111       


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                        ..........+.+++.+|+..||++|||+.++++.|
T Consensus       223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              011112455788999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-34  Score=305.68  Aligned_cols=265  Identities=22%  Similarity=0.350  Sum_probs=199.7

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|+..++||+|+||.||+|.+. .++.||+|++.+...  ...+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888899999999999999976 488999999865422  235678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.++...   ...+++..+..++.||+.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887632   334899999999999999999999998   9999999999999999999999999998754332


Q ss_pred             ccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc-chhH-------HHHHHhccCC
Q 038934          589 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHH-NLLG-------HAWRLWTEDR  659 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~-~~~~-------~~~~~~~~~~  659 (751)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+......... .+..       .....+....
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            2  1223567889999999875 45788999999999999999999887533221100 0000       0000000000


Q ss_pred             hh-hhcchhccCc-----cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          660 PV-ELIDKSLEDT-----YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       660 ~~-~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .. ....+.....     ........+.+++.+||+.+|++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00 0000000000     011234578899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.5e-34  Score=297.86  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=196.8

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--Cce
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DER  503 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  503 (751)
                      .+|++.+.||+|+||.||++... +++.||||++....     ....+.+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999999965 48899999885321     22356788999999999999999999998764  467


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||+++   ++|+||||+||++++++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999999853   345788999999999999999999998   99999999999999999999999999886


Q ss_pred             cCCCCc-cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          584 FGVDQT-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       584 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ...... ........++..|+|||.+.+..++.++||||||+++|+|++|+.|+......     .. ........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~----  225 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQP----  225 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-HHHHhcCC----
Confidence            532111 11223356888999999999888999999999999999999999997522110     00 00000000    


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                           .....+......+.+++.+|+. +|++||+++++++.
T Consensus       226 -----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         226 -----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             -----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                 1112233445577889999985 99999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=302.53  Aligned_cols=247  Identities=26%  Similarity=0.344  Sum_probs=206.7

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      ...+.|+.-++||+||||.||-++.. +|+.+|.|++.+.   ..++.....+|-+||.+++.+.||.+-..|+..+.++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            33467788889999999999999954 5999999998654   4456667899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      ||+..|.||+|.-+|.+... ..++++.+..++.+|+-||.+||...   ||.||+||+|||||+.|+++|+|+|||..+
T Consensus       262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999999976544 56899999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ...+..   ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||..+..                ..-.+-+
T Consensus       338 ~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke----------------Kvk~eEv  398 (591)
T KOG0986|consen  338 PEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE----------------KVKREEV  398 (591)
T ss_pred             CCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh----------------hhhHHHH
Confidence            644332   224899999999999999999999999999999999999999764322                1122223


Q ss_pred             chhcc---CccCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 038934          665 DKSLE---DTYSLSEALRCIQVGLLCVQQRPEDRPNM  698 (751)
Q Consensus       665 d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~  698 (751)
                      |.+..   ..++...++++..|....|+.||.+|..-
T Consensus       399 drr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  399 DRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            33222   23455567788899999999999999543

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.9e-34  Score=302.65  Aligned_cols=263  Identities=28%  Similarity=0.365  Sum_probs=203.4

Q ss_pred             ccHHhHHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeee
Q 038934          422 FDWKSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMK  499 (751)
Q Consensus       422 ~~~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  499 (751)
                      +...++..+.++|.+.+.||+|+||.||++... +++.+|+|++.... ...+++.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            334455667889999999999999999999964 58899999986432 2346788999999999 79999999999875


Q ss_pred             CC-----ceEEEEEecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCe
Q 038934          500 RD-----ERMLIYEYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       500 ~~-----~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      .+     ..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            43     589999999999999988542 23456899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchh
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-----LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLL  648 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~  648 (751)
                      ||+|||++.........  .....++..|+|||.+...     .++.++|||||||++|||++|+.|+.......  .  
T Consensus       168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~--  241 (291)
T cd06639         168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--T--  241 (291)
T ss_pred             EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--H--
Confidence            99999998865422211  1234678899999998643     36899999999999999999999975322110  0  


Q ss_pred             HHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          649 GHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       649 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                        ... ........+.       .+......+.+++.+|++.+|++||++.++++.
T Consensus       242 --~~~-~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 --LFK-IPRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             --HHH-HhcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence              001 1111111111       011223468899999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.6e-34  Score=350.14  Aligned_cols=264  Identities=25%  Similarity=0.443  Sum_probs=210.9

Q ss_pred             HHhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .....|...++||+|+||.||+|+. .+++.||||++.....    ....|++++++++|||||+++++|.+.+..++||
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            3445677888999999999999996 4689999999864432    1235688999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++.      .+++..+.+++.|+++||+|||..+..+|+||||||+||+++.++.+++. |+.+......
T Consensus       763 Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        763 EYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             eCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence            9999999999994      27899999999999999999996655569999999999999999888875 6655432211


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                            ....+|+.|+|||++.+..++.|+|||||||++|||++|+.|++..... ...+..+.............+++.
T Consensus       836 ------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        836 ------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             ------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCcc
Confidence                  1236789999999999999999999999999999999999998543222 233444444444444445556665


Q ss_pred             ccCc--cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          668 LEDT--YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       668 l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                      +...  ....+..++.+++.+|++.||++||+|.||++.|+.+..
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            5433  334556688899999999999999999999999987633

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.2e-34  Score=305.63  Aligned_cols=247  Identities=24%  Similarity=0.363  Sum_probs=199.5

Q ss_pred             cccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCC
Q 038934          435 SEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      ....+||+|+||.||++... +++.||+|++........+.+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            34457999999999999964 68999999997655556678899999999999999999999999999999999999999


Q ss_pred             ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccc
Q 038934          514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT  593 (751)
Q Consensus       514 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  593 (751)
                      +|.+++.    ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+......  .
T Consensus       104 ~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~  174 (297)
T cd06659         104 ALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--R  174 (297)
T ss_pred             CHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc--c
Confidence            9999873    245789999999999999999999998   999999999999999999999999998765432221  2


Q ss_pred             cccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccC
Q 038934          594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYS  673 (751)
Q Consensus       594 ~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  673 (751)
                      ....+++.|+|||++.+..++.++|||||||++|||++|+.|+........   .   . .........     .  ...
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~---~-~~~~~~~~~-----~--~~~  240 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---M---K-RLRDSPPPK-----L--KNA  240 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---H-HHhccCCCC-----c--ccc
Confidence            235688999999999998999999999999999999999999763322111   0   0 011110000     0  001


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          674 LSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       674 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ......+.+++.+|++.+|++||++.++++.
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            1223467899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.4e-34  Score=299.72  Aligned_cols=253  Identities=24%  Similarity=0.344  Sum_probs=202.9

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|+..+.||+|++|.||++.+. +++.+|+|++.... ....+++.+|+++++.++||||+++++++......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999975 58899999987653 34556789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      +++++|.+++....  ..+++..+..++.|++.||+|||+ .+   ++|+||||+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999985432  568999999999999999999999 77   9999999999999999999999999987653221


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      .    ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ ........ ......        
T Consensus       156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~--------  221 (265)
T cd06605         156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQY-IVNEPP--------  221 (265)
T ss_pred             h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHH-HhcCCC--------
Confidence            1    125678899999999999999999999999999999999999764322111 11111111 111100        


Q ss_pred             cCccCHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          669 EDTYSLS-EALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       669 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       ...... ....+.+++.+|+..||++||++.+++..
T Consensus       222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 -PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             -CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence             011111 45568899999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-34  Score=305.56  Aligned_cols=268  Identities=22%  Similarity=0.318  Sum_probs=199.5

Q ss_pred             CccccccccccccccEEEEEEcC---CcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--CceE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID---GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DERM  504 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  504 (751)
                      +|.+.++||+|+||.||+|....   ++.||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47778899999999999999654   7899999997633   44456788999999999999999999999988  7899


Q ss_pred             EEEEecCCCChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC----CCCeEEeec
Q 038934          505 LIYEYLPNKSLADFIFDGTR--RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----EMNPKISDF  578 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~----~~~~kl~DF  578 (751)
                      +||||+++ +|.+++.....  ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999976 67666643222  236899999999999999999999998   999999999999999    899999999


Q ss_pred             cCccccCCCCc-cccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc------chhHH
Q 038934          579 GMARAFGVDQT-EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHH------NLLGH  650 (751)
Q Consensus       579 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~------~~~~~  650 (751)
                      |++........ ........+++.|+|||.+.+. .++.++||||||+++++|++|+.|+.....+...      ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 1122335678899999988764 5799999999999999999999998754433210      00000


Q ss_pred             HHHHhccCC------------hhhhcchhccCccC---------H--HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          651 AWRLWTEDR------------PVELIDKSLEDTYS---------L--SEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       651 ~~~~~~~~~------------~~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ....+....            .....+.......+         .  .....+.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            101110000            00000000000001         0  234568899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=303.48  Aligned_cols=266  Identities=23%  Similarity=0.328  Sum_probs=202.0

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|+..++||+|+||.||+|.+. +++.||+|++...  .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999976 4789999998653  23345789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |++++.+..++.   ....+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999877776653   2345899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH--------HHhccCC
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW--------RLWTEDR  659 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  659 (751)
                      .. ......++..|+|||++.+. .++.++||||||+++|+|++|+.|+................        ..+....
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            21 12235678899999999888 88999999999999999999998875432211000000000        0000000


Q ss_pred             -hh--hhcch----hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          660 -PV--ELIDK----SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       660 -~~--~~~d~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       ..  +..+.    .+...++......+.+++.+||+.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence             00  00000    00001112235678999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.3e-34  Score=296.16  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=187.9

Q ss_pred             cccccccccEEEEEEcCC---cEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCC
Q 038934          439 KLGEGGFGPVYKGMLIDG---QEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKS  514 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs  514 (751)
                      +||+|+||.||++...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999985443   346677765432 3455789999999999999999999999999999999999999999


Q ss_pred             hhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccc
Q 038934          515 LADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT  593 (751)
Q Consensus       515 L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  593 (751)
                      |.+++.+.. .....++..+..++.||++||+|||+.+   ++|+||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999996532 2345677788899999999999999998   999999999999999999999999998643211111112


Q ss_pred             cccccccCccCcccccC-------CCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          594 NRVVGTYGYMPPEYAID-------GLFSVKSDVFSFGVLVLELVYG-TRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       594 ~~~~gt~~y~aPE~~~~-------~~~t~k~DVwSlG~ll~ell~G-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ ..|+.....   ......   .. .+....+.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~---~~-~~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNH---VI-KDQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---HH-hhcccccCC
Confidence            23567889999998743       3467899999999999999975 555432111   111111   11 111112222


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      +.+.    ......+.+++..|+ .+|++||++.+|++.|.
T Consensus       232 ~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222    223456778888999 57999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.2e-34  Score=299.24  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=199.2

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCc----------ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG----------QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD  501 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  501 (751)
                      +|...+.||+|+||.||+|... +++.+|+|.+.....          ...+.+.+|+.++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999854 588999998853211          12356888999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998543   56899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      +...............++..|+|||.+....  ++.++||||||+++++|++|..|+.....      ............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKRS  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhcccc
Confidence            8654322222223456889999999987654  88999999999999999999999642111      011111111110


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ...     +...........+.+++.+|++.+|++||++.+|++.
T Consensus       230 ~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APP-----IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCc-----CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            000     1111112235678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.7e-34  Score=303.11  Aligned_cols=261  Identities=23%  Similarity=0.325  Sum_probs=198.1

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCcc-----cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQ-----GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      +|...+.||+|++|.||+|... +++.||||++......     ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999965 5899999999755322     345678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+ +++|.+++....  ..+++..+..++.||++||.|||+++   |+|+||||+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999985422  36899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh-----
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP-----  660 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  660 (751)
                      ....  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..++.......   ..............     
T Consensus       155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhh
Confidence            3221  122356788999998865 467899999999999999999977654322211   11111110000000     


Q ss_pred             ----hhhcchhccCc-----cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          661 ----VELIDKSLEDT-----YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       661 ----~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                          ...........     ........+.+++.+||+.||++||++.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                00000000000     112234678899999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=311.68  Aligned_cols=244  Identities=30%  Similarity=0.462  Sum_probs=198.5

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCcc---cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQ---GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .|...+.||.|.||.||-++.. +.+.||||++.-...+   ....+..||..|+++.|||+|.+.|||..+...+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4566778999999999999954 5778999999755433   35578999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      ||-| |-.|++.  ..++++.+.++..|..+.+.||+|||+++   .||||||..||||++.|.|||+|||.|.....  
T Consensus       107 YClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  107 YCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             HHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            9955 7777774  34567889999999999999999999999   99999999999999999999999999876532  


Q ss_pred             ccccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          589 TEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                          .+.++|||.|||||++.   .+.|+-|+||||||++..||...++|.-..      +.....+..-..+.+ .+  
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMSALYHIAQNesP-tL--  245 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNESP-TL--  245 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHHHHHHHHhcCCC-CC--
Confidence                34589999999999986   457999999999999999999998884321      112222221111111 11  


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                            ...+-+..+.+++..||++-|.+|||..++++
T Consensus       246 ------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  246 ------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                  12345667889999999999999999998874

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.3e-34  Score=302.30  Aligned_cols=244  Identities=25%  Similarity=0.301  Sum_probs=200.6

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|.+.+.||+|+||.||++... +++.+|+|++.+..   ....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888899999999999999965 58999999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||+|+|||+++++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999853   356899999999999999999999998   999999999999999999999999999876433


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                           .....+++.|+|||.+.+...+.++||||||+++|+|++|+.|+......       ..........        
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~--------  214 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGK--------  214 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCC--------
Confidence                 22356889999999999888999999999999999999999997533211       0111111111        


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                        ...+......+.+++.+||+.||.+||     +++|+++
T Consensus       215 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 --VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              011222356788999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-34  Score=301.81  Aligned_cols=263  Identities=25%  Similarity=0.363  Sum_probs=197.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|+..+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            367889999999999999999965 588999999865432 223457789999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+.+ +|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++......
T Consensus        84 ~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          84 YLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9985 899888543  236789999999999999999999998   9999999999999999999999999987543221


Q ss_pred             ccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh---h-
Q 038934          589 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE---L-  663 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-  663 (751)
                      ..  .....++..|+|||++.+ ..++.++||||+|+++|+|++|+.|+.....  ........+..........   . 
T Consensus       158 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         158 KT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             cc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhh
Confidence            11  112346788999999876 4589999999999999999999998754331  1111111111111100000   0 


Q ss_pred             -----c--------chhccCc-cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          664 -----I--------DKSLEDT-YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       664 -----~--------d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           .        ...+... ........+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                 0        0000000 01111256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.5e-34  Score=301.79  Aligned_cols=261  Identities=23%  Similarity=0.326  Sum_probs=196.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|+..++||+|+||.||+++.. +|+.+|+|++....  ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778889999999999999965 58899999986532  22345678899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++ +|.+++..  ....+++..+..++.||++||.|||+++   |+|+||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            975 78777643  2345899999999999999999999998   99999999999999999999999999986543221


Q ss_pred             cccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh------hh
Q 038934          590 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP------VE  662 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~  662 (751)
                      .  .....+++.|+|||++.+. .++.++|||||||++|+|++|..|+......  ................      ..
T Consensus       155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhh
Confidence            1  1224578899999998775 4789999999999999999999885322211  1111111100000000      00


Q ss_pred             hcchh----cc-----CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 LIDKS----LE-----DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 ~~d~~----l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ..+..    ..     ..........+.+++.+||+.||.+|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000    00     0011123457789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-33  Score=296.44  Aligned_cols=260  Identities=24%  Similarity=0.291  Sum_probs=201.8

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--CceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  507 (751)
                      ++|...++||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.+.  ..+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999975 578899999875432 3456799999999999999999999998654  4689999


Q ss_pred             EecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          508 EYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      ||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999987532 23455889999999999999999999998   99999999999999999999999999876532


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ...    ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+......... ... ............+.+.
T Consensus       158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~  231 (287)
T cd06621         158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIE-LLSYIVNMPNPELKDE  231 (287)
T ss_pred             ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHH-HHHHHhcCCchhhccC
Confidence            211    1245788999999999999999999999999999999999998754321111 111 1111111111111111


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       .  .........+.+++.+|++.+|.+|||+.|+++
T Consensus       232 -~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 -P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             0  001223567889999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.2e-34  Score=300.65  Aligned_cols=262  Identities=22%  Similarity=0.305  Sum_probs=200.9

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999964 58999999997653  33456899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      + +++|.+++....  ..+++..+..++.||+.||.|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999985432  56899999999999999999999998   99999999999999999999999999987653322


Q ss_pred             cccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh--------
Q 038934          590 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP--------  660 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  660 (751)
                       .......++..|+|||.+.+. .++.++||||+|+++++|++|+.++......   ...............        
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccC
Confidence             112235688899999998754 4689999999999999999997766432221   111111111110000        


Q ss_pred             ----hhhcchhc----cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          661 ----VELIDKSL----EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       661 ----~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                          ..+.....    ...........+.+++.+||+.+|.+||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                00000000    000011234688899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.4e-34  Score=296.44  Aligned_cols=251  Identities=25%  Similarity=0.371  Sum_probs=201.3

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeee--CCceEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK--RDERMLIY  507 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~  507 (751)
                      +|++.+.||.|+||.||++... +++.+|+|.+...  .....+++.+|+++++.++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778889999999999999954 5789999998643  33445678899999999999999999998764  45678999


Q ss_pred             EecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          508 EYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLH-----QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       508 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH-----~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ||+++++|.+++... .....+++..+..++.|++.||.|||     +.+   ++|+||||+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999998653 22456899999999999999999999     665   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      .........  .....+++.|+|||.+.+..++.++||||||+++++|++|+.|+......   .+.    .......  
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~--  226 (265)
T cd08217         158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA----SKIKEGK--  226 (265)
T ss_pred             ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH----HHHhcCC--
Confidence            876543221  22356889999999999999999999999999999999999997643311   111    1111111  


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                             ....+......+.+++.+|++.+|++||++.+|+++
T Consensus       227 -------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 -------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                   111223345678899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-33  Score=298.24  Aligned_cols=262  Identities=25%  Similarity=0.365  Sum_probs=200.5

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      +|+..++||+|++|.||+|+.. +++.||||++..... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788899999999999999975 588999999976532 33567789999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            85 88888865544567899999999999999999999998   999999999999999999999999999765432211


Q ss_pred             ccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC---hh-----
Q 038934          591 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR---PV-----  661 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~-----  661 (751)
                        .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.|+......+.   ............   ..     
T Consensus       157 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         157 --FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             --cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhHHHHhcC
Confidence              1224568899999988664 578999999999999999999999764433211   110000000000   00     


Q ss_pred             -hhcchh------ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 -ELIDKS------LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 -~~~d~~------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       ......      ............+.+++.+|++.||.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             000000      000011123457789999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-33  Score=294.06  Aligned_cols=252  Identities=26%  Similarity=0.377  Sum_probs=206.2

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccCCc-ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|+..+.||+|++|.||+++... ++.|+||++..... ...+.+.+|+.++.+++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            367888999999999999999764 89999999876543 4567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      +++++|.+++...   ..+++..+..++.|+++||.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999543   568999999999999999999999 88   9999999999999999999999999998764332


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      ...  ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..............    ......        
T Consensus       155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----~~~~~~--------  220 (264)
T cd06623         155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----ICDGPP--------  220 (264)
T ss_pred             Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH----HhcCCC--------
Confidence            221  235678899999999999999999999999999999999999754432111111110    111100        


Q ss_pred             cCccCHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          669 EDTYSLS-EALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       669 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       ...+.. ....+.+++.+|++.+|++||++.++++.
T Consensus       221 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 -PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             111122 45678899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-35  Score=312.70  Aligned_cols=247  Identities=24%  Similarity=0.376  Sum_probs=194.7

Q ss_pred             cccccccccccEEEEEEc-CCcEEEEEEecc----CCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc--eEEEEEe
Q 038934          437 ENKLGEGGFGPVYKGMLI-DGQEIAVKRLSK----SSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE--RMLIYEY  509 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~E~  509 (751)
                      ..+||+|+|-+||+|.+. .|-+||--.++.    ..+...++|..|+.+|+.|+|+|||+++.++.+...  ..+|+|+
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            458999999999999964 477776443321    244556899999999999999999999999988766  7789999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-CCCeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~  588 (751)
                      |..|+|..++.   +.+.++.+.+..|++||++||.|||++. ++|||||||-+||||+. -|.|||+|+|||+......
T Consensus       125 ~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  125 FTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            99999999995   4456888999999999999999999986 78999999999999975 5899999999999875433


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      .    ..+.|||.|||||+.. ..|++.+|||||||.++||+|+..|+.--.     +..+ .+++...+....-+    
T Consensus       201 a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQ-IYKKV~SGiKP~sl----  265 (632)
T KOG0584|consen  201 A----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQ-IYKKVTSGIKPAAL----  265 (632)
T ss_pred             c----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHH-HHHHHHcCCCHHHh----
Confidence            3    3379999999999876 889999999999999999999998853111     1111 11222222111111    


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhC
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSG  707 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~  707 (751)
                          ..-...++.++|.+||.. ..+|||+.|+|+  +|..
T Consensus       266 ----~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  266 ----SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             ----hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                111245788999999998 999999999995  5544

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.5e-34  Score=293.45  Aligned_cols=249  Identities=25%  Similarity=0.368  Sum_probs=200.6

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|...+.||+|+||.||++... +++.+|||.+...  .....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778889999999999999964 5889999998654  234467899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-CCeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~~~~~  588 (751)
                      +++++|.+++.+.. ...+++..+..++.+++.+|.|||+++   ++|+||||+||+++++ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999996422 335789999999999999999999998   9999999999999865 458999999998764332


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      .   .....++..|+|||.+.+..++.++||||||+++++|++|+.|+.......   ...   . ......        
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~---~-~~~~~~--------  218 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVL---K-IMSGTF--------  218 (256)
T ss_pred             c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHH---H-HHhcCC--------
Confidence            2   123567889999999999889999999999999999999999875432211   110   0 000000        


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       ...+......+.+++.+|++.+|++|||+.++++.
T Consensus       219 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 -APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence             11112235578899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.1e-34  Score=299.21  Aligned_cols=258  Identities=26%  Similarity=0.404  Sum_probs=200.0

Q ss_pred             HHhHHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeee--
Q 038934          424 WKSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMK--  499 (751)
Q Consensus       424 ~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--  499 (751)
                      ...+....+.|++.++||+|+||.||+|.+. .++.+|+|++.... ....++..|+.++.++ +|+||+++++++..  
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            3344456688999999999999999999964 58899999986543 3446788999999998 69999999999853  


Q ss_pred             ----CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEE
Q 038934          500 ----RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  575 (751)
Q Consensus       500 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl  575 (751)
                          ....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.++|
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence                457899999999999999985422 345788889999999999999999998   999999999999999999999


Q ss_pred             eeccCccccCCCCccccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH
Q 038934          576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH  650 (751)
Q Consensus       576 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~  650 (751)
                      +|||++........  ......|++.|+|||.+.     +..++.++|||||||++|||++|+.|+....+...      
T Consensus       163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------  234 (282)
T cd06636         163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------  234 (282)
T ss_pred             eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------
Confidence            99999876532211  122356889999999986     35688899999999999999999999743221100      


Q ss_pred             HHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          651 AWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       651 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ... ......        ...........+.+++.+||+.||.+||++.|+++
T Consensus       235 ~~~-~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 LFL-IPRNPP--------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhh-HhhCCC--------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            000 000000        00011123457889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1e-33  Score=297.30  Aligned_cols=247  Identities=27%  Similarity=0.430  Sum_probs=199.7

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      -|...++||+|+||.||+|... +++.+|||.+.... ....+.+.+|+.++.+++|+||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4667789999999999999864 57899999986442 334567889999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++.    ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            9999999984    235889999999999999999999998   99999999999999999999999999876543211 


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       ......++..|+|||.+.+..++.++|||||||++|+|++|..|+.......   .   ... .....         ..
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~---~~~-~~~~~---------~~  219 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---V---LFL-IPKNN---------PP  219 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---H---HHH-HhcCC---------CC
Confidence             1223567889999999998889999999999999999999999865322110   0   000 00010         01


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .........+.+++.+|++.+|.+||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1122334567899999999999999999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-33  Score=294.39  Aligned_cols=252  Identities=27%  Similarity=0.450  Sum_probs=201.2

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|...+.||+|+||.||++... +++.|++|.+.....  ...+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5778899999999999999964 688999999976544  3677899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++..   ...+++..+..++.+++.||.|||+.+   |+|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999853   345789999999999999999999998   99999999999999999999999999987643322


Q ss_pred             ccc--ccccccccCccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          590 EAN--TNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       590 ~~~--~~~~~gt~~y~aPE~~~~~~---~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ...  .....+++.|+|||++.+..   ++.++||||||+++++|++|+.|+......  ..   ....... .....  
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~---~~~~~~~-~~~~~--  226 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQ---IMFHVGA-GHKPP--  226 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HH---HHHHHhc-CCCCC--
Confidence            111  12356788999999998766   899999999999999999999997532211  00   0100000 10000  


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         +.  ........+.+++.+|++.+|.+||++.+++.
T Consensus       227 ---~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         227 ---IP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ---CC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               00  01112456779999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.6e-33  Score=298.02  Aligned_cols=264  Identities=25%  Similarity=0.352  Sum_probs=197.5

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++++++..+...++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999864 588999999865432 33346789999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+. ++|.+.+...  ...+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 6777766432  245788889999999999999999998   999999999999999999999999999764322


Q ss_pred             CccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh------
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP------  660 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  660 (751)
                      ..  ......+++.|+|||++.+. .++.++||||||+++|+|++|+.|+......  ...+...+........      
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhh
Confidence            11  11234578899999998764 5789999999999999999999997643321  1111111111110000      


Q ss_pred             ---hhhcchhccC----c-----cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          661 ---VELIDKSLED----T-----YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       661 ---~~~~d~~l~~----~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         ..........    .     ........+.+++.+|++.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence               0000000000    0     00112456779999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.4e-34  Score=300.17  Aligned_cols=251  Identities=25%  Similarity=0.410  Sum_probs=203.8

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            468889999999999999999854 5789999998765555567889999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999843    34789999999999999999999998   99999999999999999999999999876543222


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                        ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........      .......        .
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~~--------~  234 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTP--------E  234 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCCC--------C
Confidence              12234688899999999988899999999999999999999999864332111000      0000000        0


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..........+.+++.+|++.+|++||++.+++.+
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00112234467899999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-36  Score=291.29  Aligned_cols=247  Identities=27%  Similarity=0.424  Sum_probs=205.6

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      -|.+.++||+|.||.||++.++ .|+.+|||++..  +...+++..|+.+++++..+++|+++|.+-....+++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3667789999999999999976 499999999854  4567899999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      .|+..+++.  .+++.+.+.++..+++..++||+|||...   -||||||..||||+-+|.+||+|||.|-.+..  ...
T Consensus       112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA  184 (502)
T KOG0574|consen  112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA  184 (502)
T ss_pred             CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence            999999996  46778999999999999999999999977   89999999999999999999999999977632  222


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                      ..+.+.|||.|||||++..-.|+.++||||||++..||..|++|+.--.+-..                --.+.......
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IFMIPT~PPPT  248 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IFMIPTKPPPT  248 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eEeccCCCCCC
Confidence            33458999999999999999999999999999999999999999642221100                00011111111


Q ss_pred             c--CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          672 Y--SLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       672 ~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      +  +..-+.++-+++++||.+.|++|.|+-++++.
T Consensus       249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            1  22335578899999999999999999888753

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-34  Score=296.90  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=200.4

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCC-----
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRD-----  501 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  501 (751)
                      ..+++|++.+.||+|++|.||+|... +++.+++|++.... ...+++.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            45689999999999999999999975 57889999986543 3457799999999999 6999999999997654     


Q ss_pred             -ceEEEEEecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          502 -ERMLIYEYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       502 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999985422 2456899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHH
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      ++........  ......++..|+|||++..     ..++.++||||||+++|+|++|+.|+......   ...   .. 
T Consensus       159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---~~-  229 (275)
T cd06608         159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RAL---FK-  229 (275)
T ss_pred             cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHH---HH-
Confidence            9876532221  1223568899999998753     34788999999999999999999997532111   000   00 


Q ss_pred             hccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ........     +  .........+.+++.+||..||++|||+.++++
T Consensus       230 ~~~~~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 IPRNPPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhccCCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11110100     0  111223457889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-34  Score=308.76  Aligned_cols=246  Identities=26%  Similarity=0.388  Sum_probs=209.7

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ....|.+.+.||+|.|++|.++++. ++..||||.+.+..  ....+.+.+|+++|..++|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3467888999999999999999965 58999999998763  23345689999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||..+|.+.+++..+.   ...+..+..++.|+.+|++|||+++   |+|||||++||||+.+.++||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999996544   4566889999999999999999999   99999999999999999999999999998752


Q ss_pred             CCccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                         .......+|++-|+|||++.+.+| ++.+|+||+|++||-|++|..||+.                   +...++-+
T Consensus       208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-------------------~~lk~Lr~  265 (596)
T KOG0586|consen  208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-------------------QNLKELRP  265 (596)
T ss_pred             ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-------------------cccccccc
Confidence               233445899999999999999887 6899999999999999999999663                   23333444


Q ss_pred             hhccCccCHH--HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          666 KSLEDTYSLS--EALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      +.+.+.+.+.  ...++.++++++|..+|.+|++++++.+
T Consensus       266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            4455554433  3457889999999999999999999975

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-33  Score=298.53  Aligned_cols=248  Identities=24%  Similarity=0.357  Sum_probs=200.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      .|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3444568999999999999964 688999999876555556778999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++..    ..+++..+..++.|++.||+|||+++   |+||||+|+||++++++.++|+|||++......... 
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-  171 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-  171 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence            9999999853    45889999999999999999999998   999999999999999999999999988765432221 


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                       .....|++.|+|||.+.+..++.++||||||+++|+|++|+.|+....+.   ....    .........     +.  
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~~----~~~~~~~~~-----~~--  236 (285)
T cd06648         172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMK----RIRDNLPPK-----LK--  236 (285)
T ss_pred             -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHHH----HHHhcCCCC-----Cc--
Confidence             12356889999999999989999999999999999999999997532211   1111    011111000     00  


Q ss_pred             cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       672 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ........+.+++.+|++.+|++||++.++++
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            01123457889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-33  Score=298.93  Aligned_cols=265  Identities=23%  Similarity=0.309  Sum_probs=199.6

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--CceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  506 (751)
                      ++|+..+.||+|+||.||+|... +++.+|+|+++...  ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999975 48899999997542  22234577899999999999999999999887  889999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+.+ +|.+++...  ...+++..+..++.||+.||+|||+++   ++|+||||+||++++++.+||+|||++.....
T Consensus        85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999975 898888542  236899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhH--------HHHHHhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLG--------HAWRLWTE  657 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~--------~~~~~~~~  657 (751)
                      ....  .....+++.|+|||.+.+. .++.++||||||+++|+|++|..|+...........+.        ..|..+..
T Consensus       159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            3211  1224578899999998765 46899999999999999999999976443211100000        00000000


Q ss_pred             ------CChhhhcchhccCccCHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          658 ------DRPVELIDKSLEDTYSLS-EALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       658 ------~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                            ..........+...++.. ....+.+++.+||+.||++||++.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                  000000111111122211 35667899999999999999999999853

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.3e-33  Score=289.10  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=205.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--CceEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DERMLIY  507 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  507 (751)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++|+||+++++.+.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677789999999999999976 588999999876542  4567899999999999999999999999988  8899999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++...   ..+++..+..++.|++.+|+|||+.+   ++|+||+|+||++++++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998543   37899999999999999999999988   999999999999999999999999999877544


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      ..........++..|+|||.+.+...+.++||||||+++++|++|+.|+.....     .....+.......        
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~--------  221 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGE--------  221 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCC--------
Confidence            321112335688899999999988899999999999999999999999764331     1111111111011        


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       ....+......+.+++.+|++.+|++||++.++++
T Consensus       222 -~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 -PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             11122233567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-33  Score=297.70  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=193.0

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHH-HHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLL-IAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|++.+.||+|+||.||+++.. +++.||||++.... .....++..|+.+ ++.++||||+++++++..+...++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999965 58999999987542 2334456667665 555689999999999999999999999


Q ss_pred             ecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          509 YLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       509 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |++ ++|.+++... .....+++..+..++.||+.||.|||++ +   ++||||||+||++++++.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 5888877542 2335689999999999999999999987 6   99999999999999999999999999986532


Q ss_pred             CCccccccccccccCccCcccccC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAID----GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ..   ......++..|+|||.+.+    ..++.++|+|||||++|+|++|+.|+.....  .   ........... ...
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~---~~~~~~~~~~~-~~~  227 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--P---FQQLKQVVEEP-SPQ  227 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--C---HHHHHHHHhcC-CCC
Confidence            21   1122467889999998865    4578999999999999999999999742111  0   01011111100 000


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      +        .....+..+.+++.+||+.+|++||++.++++
T Consensus       228 ~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         228 L--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             C--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0        01123456889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=295.68  Aligned_cols=247  Identities=26%  Similarity=0.442  Sum_probs=198.7

Q ss_pred             CccccccccccccccEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHHHHHhc---CCcEEeEeceeeeCCceEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQ---HRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .|+..+.||+|+||.||+|.+ .+++.+|+|.+... .....+++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999996 46889999998754 3345677899999999996   999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..    ..+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999999843    36889999999999999999999998   999999999999999999999999999876533


Q ss_pred             CccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ...  .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+..........       .........    
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~~~~~----  221 (277)
T cd06917         155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKSKPPR----  221 (277)
T ss_pred             ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccCCCCC----
Confidence            221  2235688999999998754 57899999999999999999999975332211100       000000000    


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       +...   .....+.+++.+|++.||++||++.++++
T Consensus       222 -~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         222 -LEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence             1110   13457889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-34  Score=308.05  Aligned_cols=267  Identities=21%  Similarity=0.300  Sum_probs=199.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC-----ce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD-----ER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  503 (751)
                      .++|.+.++||+|+||.||+|... +++.||||++... .......+.+|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            578999999999999999999964 5899999998643 2334567889999999999999999999876543     57


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++|+||+.+ +|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 7877773    346899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCccc-cccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh-
Q 038934          584 FGVDQTEA-NTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP-  660 (751)
Q Consensus       584 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  660 (751)
                      ........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+........   ............. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~  232 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQE  232 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHH
Confidence            54322211 1123568899999998755 5689999999999999999999999754322110   0000000110000 


Q ss_pred             --hhhcchh-------cc--Ccc-----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HhCC
Q 038934          661 --VELIDKS-------LE--DTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVLM--LSGE  708 (751)
Q Consensus       661 --~~~~d~~-------l~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  708 (751)
                        ..+....       +.  ...     .......+.+++.+||+.||++||++.++++.  ++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence              0000000       00  000     01124568899999999999999999999975  5554

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-33  Score=297.67  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=204.8

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ...+.|+..+.||+|++|.||++.+. +++.+++|++..... ..+.+.+|+++++.++|+|++++++++......++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            45678888899999999999999976 588999999976544 5678899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999996432  36899999999999999999999988   999999999999999999999999998765432


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      ..  ......++..|+|||++.+..++.++||||||+++|+|++|+.|+........      ... .........    
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~~----  236 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFL-ITTKGIPPL----  236 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhcCCCCC----
Confidence            21  12234578899999999998999999999999999999999999653222110      000 000000000    


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         .........+.+++.+|++.+|.+||++.++++
T Consensus       237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         237 ---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ---cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence               001113456889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-33  Score=299.39  Aligned_cols=263  Identities=22%  Similarity=0.305  Sum_probs=195.9

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCc-----
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDE-----  502 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  502 (751)
                      ++|+..+.||+|+||.||+|... +++.||||++....  ......+.+|+.+++.+. |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999965 58899999986542  223467889999999995 6999999999987766     


Q ss_pred             eEEEEEecCCCChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-CCCeEEeecc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTR--RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFG  579 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFG  579 (751)
                      .++||||+++ +|.+++.....  ...+++..+..++.||+.||.|||+++   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 78888754322  346899999999999999999999998   999999999999998 8899999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      +++.+.......  ....+++.|+|||++.+ ..++.++||||||+++|+|++|..|+........   ...........
T Consensus       157 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LLHIFKLLGTP  231 (295)
T ss_pred             cceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHhCCC
Confidence            988653322211  12356788999998865 4579999999999999999999988764322111   11111111000


Q ss_pred             Chh------hhcch----hcc----CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          659 RPV------ELIDK----SLE----DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       659 ~~~------~~~d~----~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...      .....    ...    ..........+.+++.+||+.||.+||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000      00000    000    0001123457889999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.8e-33  Score=288.43  Aligned_cols=250  Identities=30%  Similarity=0.456  Sum_probs=204.2

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      +|...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677889999999999999975 588999999977655567889999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++....  ..+++..+..++.|++.+|.+||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999985422  46899999999999999999999988   99999999999999999999999999987654322  


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+........   ..    ...........       
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~~~~-------  218 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LF----KIATNGPPGLR-------  218 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HH----HHHhcCCCCcC-------
Confidence             2345788999999999988899999999999999999999998753321111   00    00001010110       


Q ss_pred             cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       672 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ........+.+++.+|++.||++||++.++++.
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            011124578899999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-33  Score=297.70  Aligned_cols=261  Identities=24%  Similarity=0.345  Sum_probs=197.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|+..+.||.|++|.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778889999999999999965 58899999986542  22345789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +. ++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 5888887543 2346899999999999999999999998   99999999999999999999999999886543221


Q ss_pred             cccccccccccCccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh--------
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP--------  660 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  660 (751)
                      .  .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.|+........  +.. ..........        
T Consensus       156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFR-IFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHhCCCChhhhhhhhH
Confidence            1  12235678999999887654 68899999999999999999999764332111  100 0000000000        


Q ss_pred             --------hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          661 --------VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       661 --------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                              .......+. .........+.+++.+|++.||.+||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         231 LPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                    000000000 0011123467899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-35  Score=287.85  Aligned_cols=242  Identities=23%  Similarity=0.290  Sum_probs=200.2

Q ss_pred             HhcCccccccccccccccEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ..++|...++||+|.||+|.+++- ..++.+|||++++.   .......-..|-++|+..+||.+..+...|...+++++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            346788889999999999999995 46899999999876   33444556789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||..||.|.-+|   ++...+++.....+-..|..||.|||+++   ||.||||.+|.|||.+|++||+|||+++.-.
T Consensus       246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999999888   55667899999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      .  ....+..++|||.|+|||++....|..++|.|.+||++|||++|+.||...+.+....++..               
T Consensus       320 ~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~---------------  382 (516)
T KOG0690|consen  320 K--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM---------------  382 (516)
T ss_pred             c--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh---------------
Confidence            2  22334569999999999999999999999999999999999999999754332222111110               


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRP  696 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  696 (751)
                      .  .-.++.....+...|+.-.|.+||.+|.
T Consensus       383 e--d~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  383 E--DLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             h--hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            0  0123344455677888889999999995

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.6e-33  Score=304.98  Aligned_cols=262  Identities=24%  Similarity=0.332  Sum_probs=197.8

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC------
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR------  500 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  500 (751)
                      ..++|+..+.||+|+||.||++... +++.||||++.+.  .....+++.+|+.+++.++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999964 6899999998653  233456788899999999999999999988644      


Q ss_pred             CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccC
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  580 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl  580 (751)
                      ...++||||+.+ +|.+.+..     .++...+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            357999999965 78887732     2788999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchh------------
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLL------------  648 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~------------  648 (751)
                      ++.......   .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+            
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            987543221   22346788999999999999999999999999999999999998644321100000            


Q ss_pred             ---HHHHHHhccCC-------hhhhcchhc----cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          649 ---GHAWRLWTEDR-------PVELIDKSL----EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       649 ---~~~~~~~~~~~-------~~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         ......+....       ..++....+    ...........+.+++.+||+.||++||++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               00000000000       000110000    00011223556789999999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1e-33  Score=293.87  Aligned_cols=247  Identities=26%  Similarity=0.308  Sum_probs=202.2

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      +|.+.++||.|+||.||++... +++.+|+|.+.+..   ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5788899999999999999975 48899999997542   2456789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999853   246899999999999999999999998   9999999999999999999999999988764332


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                         ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+............    .....          .
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~----------~  217 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET----------A  217 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc----------c
Confidence               122356788999999999888999999999999999999999997654432111111    11110          1


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCH--HHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNM--ASVV  702 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl  702 (751)
                      ....+......+.+++.+|++.||.+||++  +|++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            111222334678899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.6e-34  Score=321.84  Aligned_cols=270  Identities=20%  Similarity=0.279  Sum_probs=189.2

Q ss_pred             HHhcCccccccccccccccEEEEEEcC--CcEEEEEE--------------ec---cCCcccHHHHHHHHHHHHHhcCCc
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLID--GQEIAVKR--------------LS---KSSGQGVEEFKNEVLLIAKLQHRN  489 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~n  489 (751)
                      ...++|++.++||+|+||.||++.++.  +...++|.              +.   .........+.+|+.++++++|+|
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999987532  22222221              10   112223456889999999999999


Q ss_pred             EEeEeceeeeCCceEEEEEecCCCChhHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE
Q 038934          490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTR--RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  567 (751)
Q Consensus       490 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll  567 (751)
                      |+++++++...+..++|+|++. ++|.+++.....  ........+..++.||+.||.|||+++   |+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999985 467777643221  222346677889999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC-ccccc
Q 038934          568 DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHV-DHHHN  646 (751)
Q Consensus       568 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~-~~~~~  646 (751)
                      +.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|..++..... .....
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            99999999999999876432221 12236799999999999999999999999999999999998754322221 11111


Q ss_pred             hhHHHHHHhc---c---CChhhhcchh---ccC----cc-----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          647 LLGHAWRLWT---E---DRPVELIDKS---LED----TY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       647 ~~~~~~~~~~---~---~~~~~~~d~~---l~~----~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      +.... ....   .   .....+.+..   ...    ..     .......+.+++.+||+.||.+|||+.|+++.
T Consensus       380 ~~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11110 0000   0   0000000000   000    00     00122356778999999999999999999863

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=295.20  Aligned_cols=261  Identities=23%  Similarity=0.367  Sum_probs=198.4

Q ss_pred             ccccccccccccccEEEEEEcC-CcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--CceEEEEE
Q 038934          434 FSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DERMLIYE  508 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~E  508 (751)
                      |++.++||+|++|.||+|...+ ++.+|+|++....  ....+.+.+|++++++++|+|++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            5667899999999999999764 8899999997653  33456788999999999999999999999988  88999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++ +|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9985 888888532  246899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             ccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC--------
Q 038934          589 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR--------  659 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  659 (751)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........   ............        
T Consensus       155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccc
Confidence            21 1222456788999998765 4679999999999999999999999764332211   111111000000        


Q ss_pred             ---------hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          660 ---------PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       660 ---------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                               ........+...........+.+++.+|++.+|.+||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                     000000011111111125678899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=302.81  Aligned_cols=253  Identities=28%  Similarity=0.442  Sum_probs=206.3

Q ss_pred             CccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      +....++||-|.||.||.|.|+. .-.||||.++. +.-..++|+.|+.+|+.++|||+|+++|+|..+..+|||.|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            34456799999999999999876 67899999954 45678999999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +|+|.++|.+..+ ..++.-..+.++.||+.|+.||..++   +|||||...|.||.++..|||+||||+++...+....
T Consensus       347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            9999999987544 45677788899999999999999998   9999999999999999999999999999875544333


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                      ... ..-.+-|.|||-+....++.|+|||+|||+||||.| |..|+...+       +...+.         ++++..+-
T Consensus       423 HAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY~---------LLEkgyRM  485 (1157)
T KOG4278|consen  423 HAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYG---------LLEKGYRM  485 (1157)
T ss_pred             ccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHH---------HHhccccc
Confidence            221 233567999999999999999999999999999997 455533211       112222         22222223


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ..+..+...+.+|++.|++..|.+||+++|+-+.+|.
T Consensus       486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence            3344456788999999999999999999998776654

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.3e-34  Score=280.87  Aligned_cols=283  Identities=23%  Similarity=0.308  Sum_probs=205.1

Q ss_pred             hcCccccccccccccccEEEEEEcC-----CcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeee-CCc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-----GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMK-RDE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  502 (751)
                      ...|+...+||+|.+|.||++...+     .+.+|||+++....  ..-....+|+.+++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3578888999999999999996332     34799999975422  223457899999999999999999999988 778


Q ss_pred             eEEEEEecCCCChhHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC----CCeEEe
Q 038934          503 RMLIYEYLPNKSLADFIFDG--TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE----MNPKIS  576 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~----~~~kl~  576 (751)
                      +++++||.+. +|.++|.-+  ...+.++...+..|+.||+.|+.|||+.=   |+||||||.||||..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            9999999987 888888543  33467999999999999999999999986   9999999999999877    899999


Q ss_pred             eccCccccCCCCccc-cccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc----c--cchh
Q 038934          577 DFGMARAFGVDQTEA-NTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH----H--HNLL  648 (751)
Q Consensus       577 DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~----~--~~~~  648 (751)
                      |||+++.+....... ....++-|..|+|||.+.|. .||.+.|||++|||+.|||+-++-|.....+-    .  ...+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999986543322 34557789999999999986 69999999999999999999877654322111    0  0111


Q ss_pred             HHHHHHhc---cCChh---------hhcchhccCcc-C--HH--------HHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          649 GHAWRLWT---EDRPV---------ELIDKSLEDTY-S--LS--------EALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       649 ~~~~~~~~---~~~~~---------~~~d~~l~~~~-~--~~--------~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                      ....+...   +.+..         .++...-...+ +  ..        .+....+|+.++|+.||.+|.|++++++..
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            11111110   00000         01100000011 0  00        112367899999999999999999988653


Q ss_pred             hCCCCCCCCCCCC
Q 038934          706 SGERSLPQPKQPG  718 (751)
Q Consensus       706 ~~~~~~~~p~~p~  718 (751)
                       -..+.+.|++|-
T Consensus       339 -yF~~d~lpp~pt  350 (438)
T KOG0666|consen  339 -YFTEDPLPPLPT  350 (438)
T ss_pred             -ccccCCCCCCcc
Confidence             235555555554

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.9e-33  Score=297.74  Aligned_cols=263  Identities=25%  Similarity=0.356  Sum_probs=196.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--CceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  505 (751)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467899999999999999999965 589999999864422  2233567899999999999999999998765  46899


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+.+ +|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 788887542  356899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC--hh-
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR--PV-  661 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~-  661 (751)
                      .....  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+........   ............  .. 
T Consensus       160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhch
Confidence            32211  122345788999999875 4579999999999999999999999764332211   111111000000  00 


Q ss_pred             -----hhcch-hccCc-c------CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          662 -----ELIDK-SLEDT-Y------SLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       662 -----~~~d~-~l~~~-~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                           ..... .+... .      .......+.+++.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                 00000 00000 0      01124567889999999999999999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.4e-34  Score=323.17  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=192.3

Q ss_pred             HHHhcCccccccccccccccEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeee------
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK------  499 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  499 (751)
                      .+...+|++.+.||+||||.||+++. -||+.||||++... .......+.+|+..|++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            46677899999999999999999994 48999999999765 34455678999999999999999999854320      


Q ss_pred             --------------------------------------------------------------------------------
Q 038934          500 --------------------------------------------------------------------------------  499 (751)
Q Consensus       500 --------------------------------------------------------------------------------  499 (751)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------C--------CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 038934          500 -------------------------R--------DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY  546 (751)
Q Consensus       500 -------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~y  546 (751)
                                               +        ..+|+-||||+..+|.+++.++....  .....++++++|+.||+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                     0        12467789999988888885433221  467889999999999999


Q ss_pred             HHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC----------------CCCccccccccccccCccCcccccC
Q 038934          547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG----------------VDQTEANTNRVVGTYGYMPPEYAID  610 (751)
Q Consensus       547 LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~  610 (751)
                      +|+++   ||||||||.||+||++..|||+|||+|+...                ...........+||.-|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99999   9999999999999999999999999998721                0011112345789999999999976


Q ss_pred             CC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhh
Q 038934          611 GL---FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLC  687 (751)
Q Consensus       611 ~~---~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~c  687 (751)
                      ..   |+.|+|+|||||||+||+   .||....  +....+.    .+..+....-      ..+..+....-..+|.+|
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsM--ERa~iL~----~LR~g~iP~~------~~f~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEML---YPFGTSM--ERASILT----NLRKGSIPEP------ADFFDPEHPEEASLIRWL  854 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHh---ccCCchH--HHHHHHH----hcccCCCCCC------cccccccchHHHHHHHHH
Confidence            54   999999999999999999   3443211  1111111    0111111110      222333444557899999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 038934          688 VQQRPEDRPNMASVVL  703 (751)
Q Consensus       688 l~~dP~~RPs~~evl~  703 (751)
                      ++.||.+|||+.|+|.
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999985

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.6e-33  Score=290.36  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=199.9

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|...+.||+|+||.||++... +++.+|+|.+...  .....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778889999999999999965 4889999998653  223456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC-eEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-~kl~DFGla~~~~~~~  588 (751)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999985422 235789999999999999999999998   999999999999998864 6999999998764322


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      ..  .....|++.|+|||++.+..++.++||||||+++++|++|+.|+......      ....... ....        
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~--------  219 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKIC-QGYF--------  219 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-cccC--------
Confidence            11  12346889999999999888999999999999999999999997532211      1111111 1100        


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       ..........+.+++.+|++.+|++||++.++++.
T Consensus       220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             01112234578899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-33  Score=292.02  Aligned_cols=247  Identities=26%  Similarity=0.334  Sum_probs=197.3

Q ss_pred             ccccccccEEEEEEcC-CcEEEEEEeccCCc---ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       440 IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      ||+|+||.||+++... ++.+++|.+.....   ...+.+.+|++++++++|+||+++++.+......++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999764 89999999865432   4566789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc------
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT------  589 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~------  589 (751)
                      .+++..   ...+++..+..++.||+.||+|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            999854   236899999999999999999999998   99999999999999999999999999876533211      


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      ........++..|+|||.+.+...+.++||||||+++|+|++|+.|+........      .. .......        .
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~-~~~~~~~--------~  219 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQ-NILNGKI--------E  219 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HH-HHhcCCc--------C
Confidence            1122335678899999999988899999999999999999999999754332111      00 0111000        0


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ..........+.+++.+|++.+|++||++.++.+.|+.
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            00001124677899999999999999999777776653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6e-33  Score=296.09  Aligned_cols=246  Identities=28%  Similarity=0.418  Sum_probs=195.0

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      +.|...+.||+|+||.||+|... +++.||+|++....   ....+++.+|+++++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888899999999999999965 58899999986432   233457889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+. ++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 477776643  2345899999999999999999999998   999999999999999999999999998764321


Q ss_pred             CccccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          588 QTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                            ....+++.|+|||++.   ...++.++||||||+++|||++|+.|+.......      ....... .....  
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~~-~~~~~--  233 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ-NDSPT--  233 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHhc-CCCCC--
Confidence                  2246788999999874   4568899999999999999999999864322110      0000000 00000  


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                            .........+.+++.+||+.+|++||++.+++..
T Consensus       234 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         234 ------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  0111234578899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=306.99  Aligned_cols=249  Identities=28%  Similarity=0.402  Sum_probs=204.6

Q ss_pred             ccccccccccccccEEEEEEcC--Cc--EEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          434 FSEENKLGEGGFGPVYKGMLID--GQ--EIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ....++||+|.||+|++|.|..  |+  .||||.++..... ....|.+|+.+|.+|+|+|++++||+..+ ....||||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            3455789999999999999764  44  5899999766443 67889999999999999999999999987 77899999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      +++.|+|.+.|.+ ..+..+.......++.|||.||.||.+++   +|||||...|+||-..-.|||+||||.+.++...
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999987 55667889999999999999999999998   9999999999999999999999999999887544


Q ss_pred             ccccc-cccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          589 TEANT-NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG-TRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       589 ~~~~~-~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ....+ ....-...|+|||.+....++.++|||+|||++|||+++ ..|+-.                ...-.+.+.+|.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G----------------~~g~qIL~~iD~  330 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG----------------CRGIQILKNIDA  330 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC----------------CCHHHHHHhccc
Confidence            43322 223335679999999999999999999999999999985 444221                111122333443


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .-+-.-+..+.+++.+++..|+..+|++|||+.++.+
T Consensus       331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            3333345667889999999999999999999999973

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.4e-33  Score=298.04  Aligned_cols=269  Identities=22%  Similarity=0.377  Sum_probs=195.8

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc----
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE----  502 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  502 (751)
                      ..++|+..++||+|+||.||++... +++.||||++....  ......+.+|++++++++||||+++++++.....    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3467999999999999999999965 58899999986542  2233456789999999999999999999876543    


Q ss_pred             ----eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeec
Q 038934          503 ----RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  578 (751)
Q Consensus       503 ----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF  578 (751)
                          .++||||+.+ +|.+.+..  ....+++..+..++.||+.||.|||+++   ++|+||||+||+++.++.+||+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence                4999999975 78777743  2235899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCcc--ccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHH-
Q 038934          579 GMARAFGVDQTE--ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRL-  654 (751)
Q Consensus       579 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~-  654 (751)
                      |++.........  .......++..|+|||++.+. .++.++||||||+++|+|++|+.|+...........+...... 
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999876432221  111234578889999988765 4789999999999999999999887644322111111111000 


Q ss_pred             ----hccCChhhhcch---------hccCc-cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          655 ----WTEDRPVELIDK---------SLEDT-YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       655 ----~~~~~~~~~~d~---------~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                          +.........+.         ..... ........+.+++.+||+.||.+||+++++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence                000000000000         00000 001123456789999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.1e-33  Score=288.76  Aligned_cols=242  Identities=25%  Similarity=0.332  Sum_probs=195.2

Q ss_pred             ccccccccEEEEEEcC-CcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       440 IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      ||.|++|.||+++... ++.+|+|++.+..   ....+.+.+|+.+++.++|+||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            7999999999999754 8899999997542   23456799999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccc
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR  595 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  595 (751)
                      .+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999943   345899999999999999999999998   9999999999999999999999999998764332   1223


Q ss_pred             cccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHH
Q 038934          596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS  675 (751)
Q Consensus       596 ~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  675 (751)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..|+.....+.. ..   . ..        ..........+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~---~-~~--------~~~~~~~~~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EI---Y-ND--------ILKGNGKLEFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HH---H-HH--------HhccCCCCCCCcc
Confidence            5678899999999888899999999999999999999999764332110 00   0 00        0000011112222


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          676 EALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       676 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                      ....+.+++.+||+.+|++||+     +.|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            3567899999999999999999     666664

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.2e-33  Score=296.00  Aligned_cols=255  Identities=27%  Similarity=0.423  Sum_probs=199.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .|...+.||+|+||.||+++.. +++.+|+|++....   ....+.+.+|++++++++|+|++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4677889999999999999964 58899999986442   2334578899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+.+ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9975 77777643  2345899999999999999999999998   99999999999999999999999999875432  


Q ss_pred             ccccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          589 TEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                          .....+++.|+|||++.   ...++.++|||||||++|+|++|+.|+......   ..   .........      
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~---~~~~~~~~~------  241 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SA---LYHIAQNES------  241 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HH---HHHHHhccC------
Confidence                12346788999999974   456899999999999999999999986432110   00   000001100      


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQP  714 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p  714 (751)
                         ...........+.+++.+|++.+|.+||++.++++.+-.....+.+
T Consensus       242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence               0011112345688999999999999999999999876554444433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=305.28  Aligned_cols=251  Identities=23%  Similarity=0.380  Sum_probs=203.0

Q ss_pred             cCccccccccccccccEEEEEEcCCc-EEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQ-EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      +.+.++..||-|+||.||++..++.. ..|.|++........+.+.-|++||..+.||+||++++.|..++.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            34566778999999999999976544 45778887777788899999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      .||-.+.++....  ..|.+..+..+++|++.||.|||++.   |||||||+.|||++-+|.++|+|||.+....  ...
T Consensus       112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR  184 (1187)
T ss_pred             CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence            9999999986533  35899999999999999999999998   9999999999999999999999999876532  122


Q ss_pred             ccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      .....+.|||.|||||++.     ..+|+.++||||||++|.||..+.+|..--.      . ...........+..++.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------p-MRVllKiaKSePPTLlq  257 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------P-MRVLLKIAKSEPPTLLQ  257 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------h-HHHHHHHhhcCCCcccC
Confidence            3345689999999999875     5689999999999999999999988832111      0 11111112222222221


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                             +..-...+.+++.+||.+||..||+++++++
T Consensus       258 -------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  258 -------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                   2344557889999999999999999999885

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.8e-33  Score=302.74  Aligned_cols=267  Identities=21%  Similarity=0.327  Sum_probs=198.8

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC--Cce
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR--DER  503 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  503 (751)
                      ..++|++.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578999999999999999999965 5889999998643  233455678899999999 999999999998654  368


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+. ++|.+++..    ..+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 489888843    26788999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc---ccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH--------
Q 038934          584 FGVDQTE---ANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA--------  651 (751)
Q Consensus       584 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~--------  651 (751)
                      .......   .......|++.|+|||++.+ ..++.++||||||+++|+|++|+.|+...............        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6433221   12234568999999998865 45789999999999999999999997543321110000000        


Q ss_pred             HHHhccCChhhhcchhccC------ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          652 WRLWTEDRPVELIDKSLED------TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       652 ~~~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      +..+.......+++.....      .........+.+++.+|++.||++||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000000011111100000      0011134578899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.7e-33  Score=291.47  Aligned_cols=242  Identities=24%  Similarity=0.307  Sum_probs=187.5

Q ss_pred             cccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHH---hcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          439 KLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAK---LQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      .||+|+||.||++... +++.+|+|.+.+..   ......+.+|..+++.   ..|+||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 58899999986542   1222334555544444   369999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++..   .+.+++..+..++.|++.||.|||+.+   |+|+||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999998853   346899999999999999999999998   9999999999999999999999999987653221   


Q ss_pred             cccccccccCccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~-~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....|++.|+|||.+. +..++.++|||||||++|+|++|+.||..........+ .   ....          ....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~---~~~~----------~~~~  216 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-D---RMTL----------TVNV  216 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-H---HHhh----------cCCc
Confidence             12246899999999986 45689999999999999999999999764332211110 0   0000          0011


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVLM  704 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  704 (751)
                      ..+.....++.+++.+||+.||.+||     ++.++++.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            12223456788999999999999999     59999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-33  Score=294.28  Aligned_cols=261  Identities=24%  Similarity=0.334  Sum_probs=196.3

Q ss_pred             ccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          434 FSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      |+..++||.|++|.||+|... +++.||+|++....  ....+.+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999965 68999999987543  223467889999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      + ++|.+++.... ...+++..+..++.|+++||.|||+++   ++|+||+|+||++++++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 68999885322 236899999999999999999999998   999999999999999999999999999765432211


Q ss_pred             ccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC---------h
Q 038934          591 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR---------P  660 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~  660 (751)
                        .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||........  +.. .........         .
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFR-IFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChHHhhhhhhc
Confidence              1223568899999988764 578999999999999999999998754332111  000 000000000         0


Q ss_pred             hhhcchhcc------CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          661 VELIDKSLE------DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       661 ~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .........      ..........+.+++.+|++.||.+||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000000      00112233578899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.3e-33  Score=292.91  Aligned_cols=254  Identities=23%  Similarity=0.352  Sum_probs=195.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|...++||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            5566778999999999999965 58999999987542 334567899999999996 99999999999999999999999


Q ss_pred             cCCCChhHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          510 LPNKSLADFIFD--GTRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       510 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      +.. ++.++...  ......+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 55554321  12235689999999999999999999975 6   99999999999999999999999999976543


Q ss_pred             CCccccccccccccCccCcccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDG---LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ...   .....+++.|+|||++.+.   .++.++|||||||++|+|++|+.|+....     ........... ...   
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~---  228 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDP---  228 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCC---
Confidence            221   1224678899999999876   68999999999999999999999975332     11111111111 111   


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                        +.+...........+.+++.+|++.||++||++.+|++.
T Consensus       229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              111111222345678899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.3e-33  Score=288.37  Aligned_cols=249  Identities=27%  Similarity=0.369  Sum_probs=203.1

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|++.++||+|++|.||+++.. +++.+|+|++...  ......++.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778889999999999999854 5789999998754  233456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      +++++|.+++.+.. ....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999985522 2356899999999999999999999998   999999999999999999999999999876543 


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                         ......+++.|+|||.+.+..++.++|+||||+++++|++|+.|+.......       .........         
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~---------  217 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGK---------  217 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCC---------
Confidence               1222467889999999999999999999999999999999999975332210       001111111         


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ...........+.+++.+|++.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            111222445678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-32  Score=289.39  Aligned_cols=244  Identities=26%  Similarity=0.350  Sum_probs=192.3

Q ss_pred             ccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       440 IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      ||+|+||+||++... +++.+|+|.+....   ....+.+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999854 58899999986532   22345678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccc
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR  595 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  595 (751)
                      .+++..... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......   ....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            999864322 36899999999999999999999998   9999999999999999999999999987654311   1123


Q ss_pred             cccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHH
Q 038934          596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS  675 (751)
Q Consensus       596 ~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  675 (751)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.|+...........+.       ...    ..  .....+..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~----~~--~~~~~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK-------RRT----LE--MAVEYPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-------hcc----cc--ccccCCcc
Confidence            467889999999998889999999999999999999999975433211100000       000    00  00111222


Q ss_pred             HHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          676 EALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       676 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                      ....+.+++.+||+.||.+||     ++.++++
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            356788999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-33  Score=289.44  Aligned_cols=267  Identities=26%  Similarity=0.416  Sum_probs=204.1

Q ss_pred             CccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHH--hcCCcEEeEeceeeeCC----ceEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK--LQHRNLVKLLGCCMKRD----ERMLI  506 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lV  506 (751)
                      .....+.||+|.||.||||++ +++.||||++..   +..+.|++|-+|.+.  ++|+||++++++-....    .++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            344566899999999999998 569999999854   456778888888776  58999999999876665    78999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCEEEccCCCCCeEEcCCCCeEEeeccC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNEMNPKISDFGM  580 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~------~~~~ivH~Dikp~NIll~~~~~~kl~DFGl  580 (751)
                      +||.+.|+|.++|.    ...++|....+|+..+++||+|||+.      .+++|+|||||.+||||..|++..|+|||+
T Consensus       287 t~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999999999994    34589999999999999999999963      356899999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCC-CC-----cchhhHHHHHHHHHHHhCCCCCCCCCCccccc--------
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL-FS-----VKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN--------  646 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-----~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~--------  646 (751)
                      |..+........+-..+||..|||||++.+.- +.     .+.||||+|.|||||++...........+.+.        
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            99887666655555689999999999997652 22     47999999999999999876553211111111        


Q ss_pred             --hhHHHHHHhccCChh-hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCC
Q 038934          647 --LLGHAWRLWTEDRPV-ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSL  711 (751)
Q Consensus       647 --~~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  711 (751)
                        -++..+.....++.. .+.+.....    .....+.+.+..|+..||+.|.|+.=|.+.+..+..+
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence              112222222222211 111211111    2345678899999999999999999988877665433

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-33  Score=292.12  Aligned_cols=260  Identities=24%  Similarity=0.346  Sum_probs=199.1

Q ss_pred             ccccccccccccccEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          434 FSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      |...+.||+|++|.||++... +++.+++|++.....  .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456778999999999999965 588999999875532  24567889999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++ +|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||.+........ 
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            76 888877542  246899999999999999999999998   99999999999999999999999999987654331 


Q ss_pred             ccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh---hhhcc-
Q 038934          591 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP---VELID-  665 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d-  665 (751)
                       ......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+........   .............   ....+ 
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhh
Confidence             11224577889999998877 789999999999999999999988754332111   0000000000000   00000 


Q ss_pred             -----hhcc-------CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          666 -----KSLE-------DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       666 -----~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                           ....       ..........+.+++.+||+.||.+||++.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                 0000       00112245688999999999999999999999863

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.4e-33  Score=302.76  Aligned_cols=267  Identities=20%  Similarity=0.316  Sum_probs=199.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeee----CCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK----RDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  503 (751)
                      .++|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999965 58999999987542  2345678899999999999999999998763    3468


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 58888884   3445899999999999999999999998   99999999999999999999999999976


Q ss_pred             cCCCCcc--ccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH--------HH
Q 038934          584 FGVDQTE--ANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH--------AW  652 (751)
Q Consensus       584 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~--------~~  652 (751)
                      .......  .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||..............        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5432221  11123578899999999865 4689999999999999999999999854332111000000        00


Q ss_pred             HHhccCChhhhcchhc-cCcc-----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          653 RLWTEDRPVELIDKSL-EDTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ............+... ....     .......+.+++.+||+.+|++||+++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0000011111111000 0001     11235678999999999999999999999863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-33  Score=288.14  Aligned_cols=245  Identities=25%  Similarity=0.281  Sum_probs=190.4

Q ss_pred             ccccccccccEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHH-HhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG---QGVEEFKNEVLLIA-KLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.||+|+||.||+|... +++.||+|.+.+...   .....+..|..++. ..+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            47999999999999964 588999999865422   22234455555444 45899999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999843   346899999999999999999999998   99999999999999999999999999876432      


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++|..|+.......       .+.........      .....
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN------WPEEV  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC------CCCcc
Confidence            123567889999999998889999999999999999999999975332211       11111111000      00011


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      .......+.+++.+||+.+|++||++.++.+.|..
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            11235678899999999999999988777666643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.6e-33  Score=293.50  Aligned_cols=244  Identities=23%  Similarity=0.353  Sum_probs=196.7

Q ss_pred             cccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          437 ENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      ..+||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            357999999999999864 6889999998665555667799999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccc
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR  595 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  595 (751)
                      .+++..    ..+++..+..++.|++.+|+|||+.+   ++|+||+|+||++++++.++|+|||++.........  ...
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~  175 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS  175 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence            998732    35789999999999999999999998   999999999999999999999999998765432211  223


Q ss_pred             cccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHH
Q 038934          596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS  675 (751)
Q Consensus       596 ~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  675 (751)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++|..|+........   ..    .....     ....+..  ...
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~----~~~~~-----~~~~~~~--~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MK----MIRDN-----LPPKLKN--LHK  241 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHhh-----CCcccCC--ccc
Confidence            5688999999999888899999999999999999999999753222111   00    00000     0000100  111


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          676 EALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       676 ~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ....+.+++.+||+.+|.+||++.++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            2346778999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1e-32  Score=293.42  Aligned_cols=265  Identities=23%  Similarity=0.352  Sum_probs=197.7

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC----
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD----  501 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  501 (751)
                      ...++|++.+.||+|+||.||+|.++ +++.||+|++....  ......+.+|+++++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999975 48899999996542  233456788999999999999999999987655    


Q ss_pred             ------ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEE
Q 038934          502 ------ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  575 (751)
Q Consensus       502 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl  575 (751)
                            ..++|+||+++ ++.+++..  ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999987 67666643  2346899999999999999999999998   999999999999999999999


Q ss_pred             eeccCccccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHH
Q 038934          576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       576 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      +|||++.......... .....++..|+|||.+.+. .++.++|||||||++++|++|+.|+........   +......
T Consensus       158 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~  233 (302)
T cd07864         158 ADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRL  233 (302)
T ss_pred             CcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHH
Confidence            9999998764332211 1123457789999988654 578999999999999999999988764322111   1111111


Q ss_pred             hccCChh---hh--------cc------hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          655 WTEDRPV---EL--------ID------KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       655 ~~~~~~~---~~--------~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .......   .+        .+      ..+.... ......+.+++.+||+.||.+||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111000   00        00      0000000 0124578899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.5e-33  Score=301.94  Aligned_cols=268  Identities=21%  Similarity=0.301  Sum_probs=199.4

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-----Cc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-----DE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  502 (751)
                      .++|.+.+.||+|+||+||+++.. +++.||||++...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457899999999999999999964 5899999998753  233455778899999999999999999988654     35


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++|+||+. ++|.+++.   ....+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 68888884   3346899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH--------HH
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA--------WR  653 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~--------~~  653 (751)
                      ......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|+...............        +.
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            764321  11223567889999998865 46899999999999999999999998643221110000000        00


Q ss_pred             HhccCChhhhcchhccC------ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HhC
Q 038934          654 LWTEDRPVELIDKSLED------TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM--LSG  707 (751)
Q Consensus       654 ~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~  707 (751)
                      ..........+......      .........+.+++.+||+.+|++||++.++++.  ++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence            00000000000000000      0011234578899999999999999999999965  544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=285.09  Aligned_cols=247  Identities=29%  Similarity=0.427  Sum_probs=202.1

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|+..++||+|++|.||+++.. +++.+++|.+.....  ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777889999999999999865 578999999976543  4567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999999853   356899999999999999999999998   99999999999999999999999999987653322


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      .  .....++..|+|||.+.+..++.++||||+|+++++|++|+.|+.....      ....+.... ..         .
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~~~-~~---------~  216 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIVQ-DD---------H  216 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-cC---------C
Confidence            1  2235678899999999888899999999999999999999998753221      000111100 00         0


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...+......+.+++.+||+.+|++||++.+++.
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            1112223457789999999999999999999984

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.8e-33  Score=293.28  Aligned_cols=260  Identities=18%  Similarity=0.196  Sum_probs=183.3

Q ss_pred             hcCccccccccccccccEEEEEEcCC----cEEEEEEeccCCcccHH-----------HHHHHHHHHHHhcCCcEEeEec
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDG----QEIAVKRLSKSSGQGVE-----------EFKNEVLLIAKLQHRNLVKLLG  495 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~l~~  495 (751)
                      .++|.+.++||+|+||.||+|.+.++    ..+|+|+..........           ....++..+..++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999996543    45666654322211111           1122334455568999999998


Q ss_pred             eeeeCC----ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC
Q 038934          496 CCMKRD----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  571 (751)
Q Consensus       496 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~  571 (751)
                      ++....    ..++++|++.. ++.+.+..   ....++..+..++.|++.||.|||+++   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            776544    34677777643 56666532   223578889999999999999999998   99999999999999999


Q ss_pred             CeEEeeccCccccCCCCc-----cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccc
Q 038934          572 NPKISDFGMARAFGVDQT-----EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN  646 (751)
Q Consensus       572 ~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~  646 (751)
                      .++|+|||+++.+.....     ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.......  .
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~  241 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N  241 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence            999999999987643211     111223579999999999999999999999999999999999999986432211  1


Q ss_pred             hhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          647 LLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      +.......+    ...+....+   ........+.+++..|++.+|++||++.++++.|+
T Consensus       242 ~~~~~~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDF----IKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHH----HHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111110000    000000000   01122467889999999999999999999998874

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-32  Score=292.15  Aligned_cols=262  Identities=24%  Similarity=0.325  Sum_probs=195.3

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|+..+.||+|++|.||+|... +++.||+|++....  ....+.+.+|++++++++|+||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57888999999999999999965 58899999986542  2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-CCCeEEeeccCccccCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGVD  587 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~  587 (751)
                      |+++ +|.+++.... ...+++..+..++.||+.||+|||+++   ++|+||+|+||++++ ++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cccc-cHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9964 7877774322 234578888999999999999999998   999999999999985 557999999999765432


Q ss_pred             CccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh-----
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV-----  661 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  661 (751)
                      ...  .....+++.|+|||++.+. .++.++||||||+++|+|++|+.|+.......   ...............     
T Consensus       157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        157 VRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             ccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhcccc
Confidence            111  1224568899999988764 57899999999999999999999976432211   111110000000000     


Q ss_pred             -hhcc-----hhccC----ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 -ELID-----KSLED----TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 -~~~d-----~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       .+.+     +....    .........+.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0000     00000    011123456789999999999999999999996

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.3e-32  Score=284.67  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=205.1

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|...+.||+|+||.||++... +++.+|+|++.....  ...+++.+|+++++.++|+|++++++.+......++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778889999999999999965 588999999976532  4567789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986532 2367899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                        .......+++.|+|||.+.+..++.++||||+|+++++|++|+.|+......   .+..    .......        
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~----~~~~~~~--------  220 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELAL----KILKGQY--------  220 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHH----HHhcCCC--------
Confidence              1223357888999999999999999999999999999999999997543211   1110    1111111        


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       ...+......+.+++.+||..+|++||++.++++.
T Consensus       221 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 -PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             11122334578899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=286.06  Aligned_cols=250  Identities=24%  Similarity=0.362  Sum_probs=197.3

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC-----CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--Cce
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DER  503 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  503 (751)
                      .+|++.+.||+|+||.||++... +++.+|+|.+...     .....+.+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47888999999999999999964 5889999987532     223456789999999999999999999998764  457


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++|+||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999999843   345789999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCc-cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          584 FGVDQT-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       584 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ...... ........++..|+|||++.+..++.++|||||||++|+|++|+.|+.....  .    ..........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~----~~~~~~~~~~----  225 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--M----AAIFKIATQP----  225 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--H----HHHHHHHcCC----
Confidence            532111 1112235688999999999998899999999999999999999999652111  0    0000000000    


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           .....+......+.+++.+|++ +|..||++.+++.
T Consensus       226 -----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 -----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                 1122333455678899999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=304.33  Aligned_cols=202  Identities=29%  Similarity=0.411  Sum_probs=175.6

Q ss_pred             cccccccccccccEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC------ceEEE
Q 038934          435 SEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD------ERMLI  506 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lV  506 (751)
                      ...+.||+|+||.||+|++ ..|+.||||.+++. .....+...+|+++|++++|+|||+++++=++..      ...+|
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            3456899999999999995 46999999999764 3445677889999999999999999998865544      56899


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc--CCC--CeEEeeccCcc
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEM--NPKISDFGMAR  582 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~--~~kl~DFGla~  582 (751)
                      ||||.+|||...+.+..+...|++.+.+.++.+++.||.|||+++   |+||||||.||++-  ++|  .-||+|||.|+
T Consensus        96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            999999999999988888888999999999999999999999998   99999999999983  334  37999999999


Q ss_pred             ccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVD  642 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~  642 (751)
                      .+..+.   ....+.||..|++||++.. +.|+..+|.|||||++|+++||..||......
T Consensus       173 el~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  173 ELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            886443   4556899999999999984 88999999999999999999999998754443

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.3e-32  Score=284.32  Aligned_cols=247  Identities=20%  Similarity=0.243  Sum_probs=190.3

Q ss_pred             HHHHhcCccccccc--cccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCc
Q 038934          427 IANATDNFSEENKL--GEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       427 i~~~~~~y~~~~~I--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  502 (751)
                      +....++|.+.+.+  |+|+||.||++..+ +++.+|+|.+.......     .|+.....+ +|+||+++++.+...+.
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390          9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            34445677777776  99999999999964 57889999986542211     123233323 69999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC-CeEEeeccCc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMA  581 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla  581 (751)
                      .++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++ .++|+|||++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            9999999999999999953   237899999999999999999999998   99999999999999988 9999999998


Q ss_pred             cccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      +.....      ....++..|+|||++.+..++.++||||||+++|+|++|+.|+........ ...... ...  ... 
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~~--~~~-  226 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLL-KRQ--QKK-  226 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHH-Hhh--ccc-
Confidence            765322      124678899999999999999999999999999999999999763322110 111100 000  000 


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHH
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN-MASVVL  703 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  703 (751)
                              ..........+.+++.+||+.+|.+||+ ++++++
T Consensus       227 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        227 --------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             --------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                    0111134567889999999999999996 688874

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.9e-32  Score=288.16  Aligned_cols=258  Identities=20%  Similarity=0.286  Sum_probs=192.4

Q ss_pred             ccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhc-CCcEEeEeceeeeC--CceEEEEE
Q 038934          434 FSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKR--DERMLIYE  508 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E  508 (751)
                      |++.++||+|+||.||++... +++.+|+|++.+.. ........+|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566789999999999999964 58899999987542 222234567999999985 99999999999988  88999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++ +|.+.+..  ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++ +.+||+|||+++......
T Consensus        81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9975 77777743  2346899999999999999999999998   999999999999999 999999999998764322


Q ss_pred             ccccccccccccCccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhcc----------
Q 038934          589 TEANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE----------  657 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~-~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~----------  657 (751)
                      .   .....++..|+|||++. +..++.++|||||||++|||++|+.|+........   ..........          
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhc
Confidence            1   12245788999999765 45678999999999999999999999864332111   1111000000          


Q ss_pred             -CChhhhcchhccC----ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          658 -DRPVELIDKSLED----TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       658 -~~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       ........+....    .........+.+++.+||+.+|++||++.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence             0000000000000    0011235688999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.1e-32  Score=289.37  Aligned_cols=251  Identities=24%  Similarity=0.337  Sum_probs=196.2

Q ss_pred             CccccccccccccccEEEEEEc----CCcEEEEEEeccCC----cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCce
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  503 (751)
                      +|++.+.||+|+||.||++...    +|+.||+|++....    ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4777889999999999999863    68899999986532    23346788999999999 599999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||+|+|||+++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999853   345789999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCccccccccccccCccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      ....... ......|+..|+|||.+.+.  .++.++||||||+++|+|++|+.|+........  ............   
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~---  228 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE---  228 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC---
Confidence            6432221 12235688999999998753  468899999999999999999999764322111  011111101100   


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                              ...+......+.+++.+|++.||++||     ++.+++.
T Consensus       229 --------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 --------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             --------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                    111223445778999999999999997     6666664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=328.45  Aligned_cols=257  Identities=26%  Similarity=0.383  Sum_probs=203.6

Q ss_pred             HHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          427 IANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       427 i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      +...+-++....+||.|.||.||.|... +|.-.|+|.+...  .......+.+|+.++..++|||+|+++|+=.+.+..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            3444566777789999999999999954 5788899988643  344566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      +|.||||++|+|.+++.   .....++.....+..|++.|++|||++|   ||||||||+||+|+.+|.+|++|||.|..
T Consensus      1310 ~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence            99999999999999994   3344677777788999999999999999   99999999999999999999999999998


Q ss_pred             cCCCC--ccccccccccccCccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          584 FGVDQ--TEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       584 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      +....  .........||+.|||||++.+..   ...++||||+|||+.||+||++|....  +....+..++    ..+
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~--dne~aIMy~V----~~g 1457 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL--DNEWAIMYHV----AAG 1457 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc--cchhHHHhHH----hcc
Confidence            75432  122334578999999999998653   567999999999999999999995422  2222221111    111


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .         ..+.+-.....-.+++.+||+.||++|-++.++++.
T Consensus      1458 h---------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 H---------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             C---------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1         112223345566789999999999999888888765

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.6e-32  Score=289.87  Aligned_cols=255  Identities=24%  Similarity=0.332  Sum_probs=200.2

Q ss_pred             CccccccccccccccEEEEEEc----CCcEEEEEEeccCC----cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCce
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  503 (751)
                      +|.+.+.||+|++|.||+++..    +++.||||.+.+..    ....+.+.+|+.++.++ +|+||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4677889999999999999843    46789999986532    23345688999999999 599999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999999853   345889999999999999999999988   99999999999999999999999999887


Q ss_pred             cCCCCccccccccccccCccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      +...... ......++..|+|||.+.+..  .+.++||||||+++|+|++|..|+.........  ..........    
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~----  227 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKS----  227 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHcc----
Confidence            5433221 122356889999999987765  788999999999999999999997532211110  0000000000    


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                             ....+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus       228 -------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                   011122234567899999999999999999999888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.4e-32  Score=294.12  Aligned_cols=265  Identities=22%  Similarity=0.338  Sum_probs=199.2

Q ss_pred             HHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeee-CCc
Q 038934          427 IANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK-RDE  502 (751)
Q Consensus       427 i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  502 (751)
                      +...+++|...+.||+|+||.||++... +++.||||++.+.  .....+.+.+|++++++++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456789999999999999999999955 6899999998653  22345678899999999999999999999866 567


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++|+||+ +++|.+++.    ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++.
T Consensus        85 ~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence            89999998 558888873    235788889999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhH--------HHHH
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLG--------HAWR  653 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~--------~~~~  653 (751)
                      .....     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+...........+.        ....
T Consensus       157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            54221     122467889999998866 568999999999999999999999876443211110000        0000


Q ss_pred             HhccCChhhhcchhc-cCccCH-----HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          654 LWTEDRPVELIDKSL-EDTYSL-----SEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       654 ~~~~~~~~~~~d~~l-~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ........+++.... ....+.     .....+.+++.+||+.+|++||++.+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            011111111111100 011111     124578899999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-33  Score=299.43  Aligned_cols=263  Identities=21%  Similarity=0.334  Sum_probs=196.6

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD------  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  501 (751)
                      .++|...+.||+|+||.||+|+.. +++.||||++.+.  .......+.+|+.++++++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999964 5899999998654  2233456889999999999999999999987553      


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999964 676654     235789999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh-----
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW-----  655 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~-----  655 (751)
                      +.....     .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||........   ........     
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~  236 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGP  236 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence            764321     123467889999999876 4689999999999999999999999864332111   11111000     


Q ss_pred             ------ccCChhhhcch---hccCcc---CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCCCC
Q 038934          656 ------TEDRPVELIDK---SLEDTY---SLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGERS  710 (751)
Q Consensus       656 ------~~~~~~~~~d~---~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  710 (751)
                            ........+..   ......   .......+.+++.+||+.||++||++.++++  .++....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                  00000000000   000000   0112346789999999999999999999994  4666543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-33  Score=298.37  Aligned_cols=269  Identities=22%  Similarity=0.317  Sum_probs=203.4

Q ss_pred             CccccccccccccccEEEEEEcC-CcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC-----ceE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD-----ERM  504 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  504 (751)
                      +|.+.++||+|++|.||+++... ++.+|||++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            57888999999999999999754 8999999997653  345568999999999999999999999998875     789


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+++ +|.+++..   ...+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999984 88888843   337899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCc-cccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH--------HHH
Q 038934          585 GVDQT-EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA--------WRL  654 (751)
Q Consensus       585 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~--------~~~  654 (751)
                      ..... ........+++.|+|||++.+. .++.++||||||+++|+|++|+.||...........+...        +..
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            54321 0112335678899999999888 8899999999999999999999997644432111100000        000


Q ss_pred             hccCChhhhcchhc-c-----CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HhCC
Q 038934          655 WTEDRPVELIDKSL-E-----DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM--LSGE  708 (751)
Q Consensus       655 ~~~~~~~~~~d~~l-~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  708 (751)
                      .........+.... .     ..........+.+++.+||+.+|++||++.++++.  +++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            00000111111000 0     00011134578899999999999999999999963  5443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.9e-32  Score=285.50  Aligned_cols=241  Identities=25%  Similarity=0.312  Sum_probs=187.0

Q ss_pred             cccccccccEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHH---HHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          439 KLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG---QGVEEFKNEVLLI---AKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      .||+|+||.||++... +++.||+|.+.+...   .....+..|..++   +...||+|+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999964 588999999875421   2222344454443   34579999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++.   ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            999999884   3456899999999999999999999998   9999999999999999999999999987653221   


Q ss_pred             cccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....|+..|+|||.+.+. .++.++||||+|+++|+|++|+.|+...........    ......          ...
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~----------~~~  216 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT----------MAV  216 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc----------cCC
Confidence             1235689999999998754 689999999999999999999999764322111110    000000          001


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                      ..+......+.+++.+||+.+|.+||     ++.++++
T Consensus       217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            11222356788999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.4e-32  Score=295.18  Aligned_cols=263  Identities=22%  Similarity=0.305  Sum_probs=196.3

Q ss_pred             hcCccc-cccccccccccEEEEEEc-CCcEEEEEEeccCCccc--------------HHHHHHHHHHHHHhcCCcEEeEe
Q 038934          431 TDNFSE-ENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQG--------------VEEFKNEVLLIAKLQHRNLVKLL  494 (751)
Q Consensus       431 ~~~y~~-~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~  494 (751)
                      .++|.. .+.||+|+||+||++... .++.||||++.......              ...+.+|+++++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356654 467999999999999965 58999999986542211              12477999999999999999999


Q ss_pred             ceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeE
Q 038934          495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK  574 (751)
Q Consensus       495 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k  574 (751)
                      +++..++..++||||+. ++|.+++.   ....+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            99999999999999997 58988884   3445899999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCC------------ccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 038934          575 ISDFGMARAFGVDQ------------TEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHV  641 (751)
Q Consensus       575 l~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~  641 (751)
                      |+|||+++......            .........+++.|+|||++.+. .++.++|||||||++|+|++|+.|+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999998764111            01111223567889999998765 468999999999999999999998764432


Q ss_pred             ccccchhHHHHHHhccCChhhh-----------c----chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          642 DHHHNLLGHAWRLWTEDRPVEL-----------I----DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       642 ~~~~~~~~~~~~~~~~~~~~~~-----------~----d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..   .................           .    ...+. .........+.+++.+||+.+|++||++++++..
T Consensus       240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            21   11111111111100000           0    00000 0011224568899999999999999999999963

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.2e-32  Score=293.23  Aligned_cols=260  Identities=22%  Similarity=0.269  Sum_probs=191.8

Q ss_pred             cccccc--ccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEG--GFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      ..||+|  +||+||++++. .++.||+|++...  .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            357766  89999999964 6899999998643  233457789999999999999999999999999999999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc-
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA-  591 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-  591 (751)
                      ++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999986532 234889999999999999999999998   9999999999999999999999998654332111110 


Q ss_pred             ----cccccccccCccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH-------------
Q 038934          592 ----NTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW-------------  652 (751)
Q Consensus       592 ----~~~~~~gt~~y~aPE~~~~~--~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~-------------  652 (751)
                          ......++..|+|||++.+.  .++.++|||||||++|+|++|+.|+........  ......             
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence                00112345679999999764  478999999999999999999999764321110  000000             


Q ss_pred             ---HHh-------ccCC---------hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          653 ---RLW-------TEDR---------PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       653 ---~~~-------~~~~---------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         ..+       ..+.         .....+..+...........+.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               000       0000         00001111111222345568899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-32  Score=295.83  Aligned_cols=272  Identities=20%  Similarity=0.309  Sum_probs=201.0

Q ss_pred             HHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC--
Q 038934          427 IANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD--  501 (751)
Q Consensus       427 i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  501 (751)
                      +....++|.+.+.||+|+||.||++... +++.||||++...  .....+.+.+|+.++++++|+||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3445788999999999999999999854 6899999998643  2233456889999999999999999999987654  


Q ss_pred             ----ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEee
Q 038934          502 ----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  577 (751)
Q Consensus       502 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  577 (751)
                          ..++||||+ +++|.+++.    ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence                358999999 779988873    245899999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc-chhH------
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHH-NLLG------  649 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~-~~~~------  649 (751)
                      ||++......     .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+......... .+..      
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999865321     123467889999999876 45889999999999999999999997643221100 0000      


Q ss_pred             -HHHHHhccCChhhhcchh--ccC----ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH--HHHhCCCCC
Q 038934          650 -HAWRLWTEDRPVELIDKS--LED----TYSLSEALRCIQVGLLCVQQRPEDRPNMASVV--LMLSGERSL  711 (751)
Q Consensus       650 -~~~~~~~~~~~~~~~d~~--l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl--~~L~~~~~~  711 (751)
                       ..............+...  ...    .........+.+++.+|++.||.+|||+.+++  ..++...+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence             000000001000110000  000    00112234678999999999999999999999  355554333

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=274.67  Aligned_cols=257  Identities=22%  Similarity=0.261  Sum_probs=200.6

Q ss_pred             HhcCcccc-ccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeee----CCc
Q 038934          430 ATDNFSEE-NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMK----RDE  502 (751)
Q Consensus       430 ~~~~y~~~-~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  502 (751)
                      .+++|.+. ++||-|-.|.|-.+.++ +++.+|+|++...     ...++|++..-+. .|||||.++++++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45677663 58999999999999975 4888999998543     5668899988777 59999999998864    356


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---CCCeEEeecc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFG  579 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFG  579 (751)
                      +++|||.|+||.|...|.+. ..+.+++.++..|++||+.|+.|||+..   |.||||||+|+|+..   +..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            78999999999999999653 3456899999999999999999999998   999999999999964   5569999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      +|+.-.   ........+-||.|+|||++-..+|+...|+||+||++|-||+|.+||--....   .+.--..       
T Consensus       210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk-------  276 (400)
T KOG0604|consen  210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMK-------  276 (400)
T ss_pred             cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHH-------
Confidence            998743   233445578899999999999999999999999999999999999997532211   1100000       


Q ss_pred             hhhhcchhccCcc--C----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCCCCCCC
Q 038934          660 PVELIDKSLEDTY--S----LSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGERSLPQ  713 (751)
Q Consensus       660 ~~~~~d~~l~~~~--~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~  713 (751)
                           .++..+.+  +    ...++...++|+.+|..+|.+|.|+.+++.  .+.+...+|.
T Consensus       277 -----~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~  333 (400)
T KOG0604|consen  277 -----RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ  333 (400)
T ss_pred             -----hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence                 11111222  1    223557788999999999999999999985  4444444433

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-32  Score=298.50  Aligned_cols=267  Identities=22%  Similarity=0.305  Sum_probs=198.3

Q ss_pred             HhHHHHhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-
Q 038934          425 KSIANATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-  500 (751)
Q Consensus       425 ~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  500 (751)
                      +++....++|...+.||+|+||.||++.. .+++.||+|++....  ....+.+.+|+.++++++|+||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            45667789999999999999999999985 468899999997542  22346788999999999999999999988643 


Q ss_pred             -----CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEE
Q 038934          501 -----DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  575 (751)
Q Consensus       501 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl  575 (751)
                           ...+++++++ +++|.+++.    ...+++..+..++.|+++||+|||+.+   |+|+||||+||++++++.+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 3467888876 779988773    235899999999999999999999998   999999999999999999999


Q ss_pred             eeccCccccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH----
Q 038934          576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH----  650 (751)
Q Consensus       576 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~----  650 (751)
                      +|||+++.....     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.|+..............    
T Consensus       162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999998764321     223567889999999876 5688999999999999999999999754332111000000    


Q ss_pred             ----HHHHhccCChhhhc---chhccC---ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          651 ----AWRLWTEDRPVELI---DKSLED---TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       651 ----~~~~~~~~~~~~~~---d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                          .............+   ......   .........+.+++.+||+.||.+||++.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                00000000000000   000000   0001124567899999999999999999999853

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-32  Score=289.09  Aligned_cols=249  Identities=26%  Similarity=0.356  Sum_probs=202.3

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|...+.||+|+||.||++... +++.+|+|++.+.   .....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999965 6899999998653   2233467889999999998 99999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      ||++++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999953   336899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcc------------------ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchh
Q 038934          587 DQTE------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLL  648 (751)
Q Consensus       587 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~  648 (751)
                      ....                  .......++..|+|||++.+..++.++||||||+++++|++|+.|+......   .. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~-  230 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LT-  230 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HH-
Confidence            2211                  1223356788999999999888999999999999999999999997643311   00 


Q ss_pred             HHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCH----HHHHH
Q 038934          649 GHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNM----ASVVL  703 (751)
Q Consensus       649 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~  703 (751)
                        .....           ......+......+.+++.+||+.+|.+||++    .++++
T Consensus       231 --~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 --FQKIL-----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --HHHHH-----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              00000           01112222335678899999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.2e-32  Score=290.45  Aligned_cols=261  Identities=19%  Similarity=0.233  Sum_probs=191.2

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCC
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKS  514 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs  514 (751)
                      .+.+|.|+++.||++.. +++.||||++...  .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            33445555555555544 6899999999754  34456789999999999999999999999999999999999999999


Q ss_pred             hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc-----
Q 038934          515 LADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT-----  589 (751)
Q Consensus       515 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~-----  589 (751)
                      |.+++.... ...+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||.+........     
T Consensus        86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999986432 235789999999999999999999998   99999999999999999999999998875532111     


Q ss_pred             cccccccccccCccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHH----hccC-----
Q 038934          590 EANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRL----WTED-----  658 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~----~~~~-----  658 (751)
                      ........++..|+|||++.+  ..++.++|||||||+++||++|+.||......  ..........    ....     
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhh
Confidence            111123456788999999876  35889999999999999999999997642211  1111100000    0000     


Q ss_pred             --Chhh----hcc----hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          659 --RPVE----LID----KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       659 --~~~~----~~d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                        ....    ..+    ..............+.+++.+||+.||++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence              0000    000    001111223345578899999999999999999999963

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-32  Score=293.81  Aligned_cols=264  Identities=23%  Similarity=0.321  Sum_probs=194.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD------  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  501 (751)
                      .++|++.++||+|+||.||+++.. +++.+|||++.....  .....+.+|+++++.++|+||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999965 588999999865422  22346789999999999999999999875543      


Q ss_pred             --ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          502 --ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       502 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                        .+++|+||+.+ +|...+..  ....+++..+..++.|+++||.|||+++   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999976 66666643  2346899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCccc---------cccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhH
Q 038934          580 MARAFGVDQTEA---------NTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLG  649 (751)
Q Consensus       580 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~  649 (751)
                      ++..........         ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+...........  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~--  238 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL--  238 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--
Confidence            998654322111         11234678889999988654 589999999999999999999998754332211111  


Q ss_pred             HHHHHhccCCh---------hhhcchhccCcc-------CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          650 HAWRLWTEDRP---------VELIDKSLEDTY-------SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       650 ~~~~~~~~~~~---------~~~~d~~l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       ..........         ....+.......       .......+.+++.+||+.||.+|||+.+++.
T Consensus       239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         239 -IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             -HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence             1110000000         000000000000       0112256889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-32  Score=283.81  Aligned_cols=259  Identities=22%  Similarity=0.347  Sum_probs=194.7

Q ss_pred             ccccccccccccccEEEEEEcC-CcEEEEEEeccCCc--ccHHHHHHHHHHHHHh---cCCcEEeEeceeeeCCc-----
Q 038934          434 FSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKL---QHRNLVKLLGCCMKRDE-----  502 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  502 (751)
                      |++.+.||+|+||.||++++.. ++.+|+|++.....  .....+.+|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5677899999999999999764 89999999975422  2234567888887776   59999999999988876     


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .+++|||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 7888875422 235899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh--
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP--  660 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  660 (751)
                      .......   .....++..|+|||++.+..++.++|||||||++|+|++|+.|+........   .............  
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  229 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEE  229 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHh
Confidence            7643322   1224578899999999999999999999999999999999888764332111   1111110000000  


Q ss_pred             --------hhhcchhcc---CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          661 --------VELIDKSLE---DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       661 --------~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                              .........   ..........+.+++.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                    000000000   0111223467789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=284.93  Aligned_cols=240  Identities=27%  Similarity=0.348  Sum_probs=199.4

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .+|....+||+|+||.|.++..+. ...+|||++++.   .....+--+.|-++|+.. +-|.+++++.+|..-+++|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            467788899999999999998654 567999999876   233455567788888877 468899999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+.||+|.-+|.   .-+.+.+..+..++.+||-||-+||+++   ||.||||.+|||||.+|++||+|||+++.--.
T Consensus       429 MEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999998884   4455778889999999999999999999   99999999999999999999999999986432


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                        ....+..++|||.|+|||++..++|+..+|.|||||+|||||.|+.||+..+.++...               .+.+.
T Consensus       503 --~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~---------------aI~eh  565 (683)
T KOG0696|consen  503 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---------------AIMEH  565 (683)
T ss_pred             --CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHHHc
Confidence              2334556899999999999999999999999999999999999999987655433211               11111


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCC
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRP  696 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  696 (751)
                        .-.++...+.+...++...|.++|.+|.
T Consensus       566 --nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 --NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             --cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence              2246667777888999999999999994

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.7e-32  Score=288.39  Aligned_cols=251  Identities=22%  Similarity=0.371  Sum_probs=193.5

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccCC-cccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|++.+.||+|+||.||++.+.. ++.||||++.+.. .....++..|+.++.++. |+||+++++++.+....++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            578888999999999999999765 8999999997542 234456777888777775 9999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      |+.+ +|.+++...  ...+++..+..++.|++.||+|||+ .+   |+|+||+|+||++++++.+||+|||++..+...
T Consensus        95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            9854 777776432  2368999999999999999999997 46   999999999999999999999999998765432


Q ss_pred             CccccccccccccCccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ...   ....++..|+|||.+.+..    ++.++||||||+++|+|++|+.|+......  ....   ....... ....
T Consensus       169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~---~~~~~~~-~~~~  239 (296)
T cd06618         169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVL---TKILQEE-PPSL  239 (296)
T ss_pred             Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHH---HHHhcCC-CCCC
Confidence            221   2235778999999987554    889999999999999999999997532111  0111   1111111 0000


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                           .  ........+.+++.+||+.||.+||++.++++.
T Consensus       240 -----~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         240 -----P--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -----C--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 0  011234578899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-32  Score=298.15  Aligned_cols=265  Identities=21%  Similarity=0.289  Sum_probs=194.6

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC---------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR---------  500 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  500 (751)
                      ..+|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999964 5889999999776666677899999999999999999999876554         


Q ss_pred             -----CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc-CCCCeE
Q 038934          501 -----DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPK  574 (751)
Q Consensus       501 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~k  574 (751)
                           ...++||||++ ++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+||+++ +++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 35789999997 48888873    235889999999999999999999998   99999999999997 456789


Q ss_pred             EeeccCccccCCCCcc-ccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH--
Q 038934          575 ISDFGMARAFGVDQTE-ANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH--  650 (751)
Q Consensus       575 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~--  650 (751)
                      |+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..............  
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999765322111 11122357889999998754 5688999999999999999999999864332111000000  


Q ss_pred             ------HHHHhccCChhhhcchhccCcc-----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          651 ------AWRLWTEDRPVELIDKSLEDTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       651 ------~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                            ......................     .......+.+++.+||+.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                  0000000000000000000000     1123356789999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-32  Score=284.62  Aligned_cols=260  Identities=24%  Similarity=0.294  Sum_probs=195.0

Q ss_pred             ccccccccccccccEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEEec
Q 038934          434 FSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      |.+.+.||+|++|.||+|+.. .++.|+||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999975 478899999865432 22234567999999998 999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                       +++|.+++.... ...+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||+++....... 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             789998885432 246899999999999999999999998   99999999999999999999999999986542211 


Q ss_pred             ccccccccccCccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC---------Ch
Q 038934          591 ANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED---------RP  660 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~-~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  660 (751)
                        .....++..|+|||++. +..++.++||||||+++++|++|+.|+.........   ..........         ..
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL---YKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH---HHHHHhcCCCChhhhhhHhhh
Confidence              12346788999999885 456799999999999999999999887544321110   0000000000         00


Q ss_pred             hhhcchhcc-------CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          661 VELIDKSLE-------DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       661 ~~~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ...++..+.       ..........+.+++.+|++.||++||++.|++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000       00011124578899999999999999999999853

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-33  Score=297.60  Aligned_cols=240  Identities=24%  Similarity=0.291  Sum_probs=198.1

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      +++.|.....+|.|+|+.|-.+.+. +++..++|++.+..    ....+|+.++... +||||+++.+.+.+..+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            4678888889999999999999854 58899999997652    2345677676666 6999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE-cCCCCeEEeeccCccccCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll-~~~~~~kl~DFGla~~~~~  586 (751)
                      |.+.++-|.+.+..    .......+..|+.+|+.|+.|||++|   +|||||||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRS----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHh----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            99999999888842    22333778889999999999999999   9999999999999 6899999999999988654


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      .     ....+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+                  .++...
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~  525 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTR  525 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHh
Confidence            3     23346688999999999999999999999999999999999997643322                  122222


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...+.+....+....+|+.+||+.||.+||+|.++..
T Consensus       526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            2233334555678889999999999999999999985

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.9e-32  Score=288.54  Aligned_cols=247  Identities=28%  Similarity=0.428  Sum_probs=194.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      +.|...+.||+|+||.||+|+.. +++.+|+|.+...   .....+++.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45777789999999999999965 5788999998642   2234557889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+. ++|.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 578777643  2345789999999999999999999998   999999999999999999999999998765321


Q ss_pred             CccccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          588 QTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                            ....+++.|+|||.+.   ...++.++|||||||++|+|++|+.|+........      ... ......    
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~~----  231 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-IAQNES----  231 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHH-HhhcCC----
Confidence                  2346788999999975   35678899999999999999999998642211100      000 000000    


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                          ...........+.+++.+||+.+|++||++.++++..
T Consensus       232 ----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 ----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             ----CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                0011123445678999999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-32  Score=290.34  Aligned_cols=254  Identities=24%  Similarity=0.396  Sum_probs=204.1

Q ss_pred             cCccccccccccccccEEEEEEc---CCc--EEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI---DGQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      +.....+.||.|-||.||+|...   +|.  .||||..+.. .....+.|..|..+|++++|||||+++|+|.+ ...++
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            34455678999999999999832   333  5899999874 55567889999999999999999999999975 46799


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |||+++.|.|..++..+  ...++......++.||+.||+|||++.   .|||||...||||....-+||+|||+++.+.
T Consensus       468 vmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            99999999999999653  345888899999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      .+..-... ...-..-|||||-+.-..++.++|||-|||.+||++. |.+||..-.                ..++-..+
T Consensus       543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk----------------NsDVI~~i  605 (974)
T KOG4257|consen  543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK----------------NSDVIGHI  605 (974)
T ss_pred             ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc----------------ccceEEEe
Confidence            44332222 2333567999999999999999999999999999874 888865321                12222222


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      +.--+-..+..++..+..|+.+|+..||.+||.+.++...|+.+
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            22222334566778889999999999999999999998766543

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.7e-32  Score=293.29  Aligned_cols=264  Identities=20%  Similarity=0.258  Sum_probs=192.3

Q ss_pred             CccccccccccccccEEEEEEc-C--CcEEEEEEeccC--CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC----Cc
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-D--GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR----DE  502 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  502 (751)
                      +|.+.+.||+|+||.||+++.. .  ++.||+|++...  .....+.+.+|+.+++++ +|+||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777889999999999999964 3  678999998653  222356788999999999 599999999875433    45


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++++|++. ++|.+.+.   ....+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788889886 58888884   3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCc--cccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhH--------HH
Q 038934          583 AFGVDQT--EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLG--------HA  651 (751)
Q Consensus       583 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~--------~~  651 (751)
                      .+.....  ........|++.|+|||++.+ ..++.++||||||+++|+|++|+.|+.............        ..
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6543221  111233578999999998765 468999999999999999999999876433211100000        00


Q ss_pred             HHHhccCChhhhcch---hc---cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          652 WRLWTEDRPVELIDK---SL---EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       652 ~~~~~~~~~~~~~d~---~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...............   ..   ...........+.+++.+||+.||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000000   00   00000112457889999999999999999999974

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-33  Score=315.12  Aligned_cols=277  Identities=21%  Similarity=0.262  Sum_probs=218.3

Q ss_pred             HhHHHHhcCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC
Q 038934          425 KSIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR  500 (751)
Q Consensus       425 ~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  500 (751)
                      .++....++|.+.++||+|+||.|..++++. ++.||+|++.+-   .......|..|-.+|...+.+-|++++..|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            3455566899999999999999999999764 788999999772   344556789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccC
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  580 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl  580 (751)
                      .++|+|||||+||+|..++   ++...+++..+..++..|..||.-||+.|   +|||||||+|||||..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLl---Sk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLL---SKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHH---hhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence            9999999999999999999   44447999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccCccCccccc----C-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAI----D-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      +-.+..+.. ......+|||.|++||++.    + +.|+..+|.||+||++||||.|..||-....      +.-.-...
T Consensus       222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KIm  294 (1317)
T KOG0612|consen  222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKIM  294 (1317)
T ss_pred             HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHHh
Confidence            877654332 3344578999999999995    3 5689999999999999999999999753222      11111111


Q ss_pred             ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHHH--H-----hCCCCCCCCCCCCCccc
Q 038934          656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN---MASVVLM--L-----SGERSLPQPKQPGFFTE  722 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~--L-----~~~~~~~~p~~p~~~~~  722 (751)
                      .......+       ....+.++.+.+||+..+. +|+.|..   +.++-..  .     +.+++...|..|.....
T Consensus       295 ~hk~~l~F-------P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd  363 (1317)
T KOG0612|consen  295 NHKESLSF-------PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSD  363 (1317)
T ss_pred             chhhhcCC-------CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCC
Confidence            11111111       1113356677888888774 7888888   8888642  2     45677777777776543

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=1.2e-31  Score=286.89  Aligned_cols=244  Identities=30%  Similarity=0.436  Sum_probs=191.4

Q ss_pred             ccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          434 FSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      |...++||+|+||.||+|+.. +++.|++|++....   ....+.+.+|+++++.++|+|++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566678999999999999964 58899999986532   23345788999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +. ++|.+++..  ....+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 477777643  2345899999999999999999999998   99999999999999999999999999864321   


Q ss_pred             cccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          590 EANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                         .....|+..|+|||++.   +..++.++||||||+++|+|++|..|+.......      ......... ....   
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~~---  240 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQND-SPTL---  240 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC-CCCC---
Confidence               22356888999999984   4568899999999999999999999864322110      011111111 1000   


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                           ........+.+++.+||+.+|.+||++.+++..
T Consensus       241 -----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 -----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 111123457889999999999999999999954

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=9.5e-33  Score=267.00  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=192.7

Q ss_pred             cccccccccccccEEEEEEcC-CcEEEEEEeccC-CcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEEecC
Q 038934          435 SEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      +....||.|..|.|++.+... |..+|||.+.+. .....+++...+.++.+.+ +|.||+.+|+|..+..+.+-||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            445679999999999999654 889999999876 4455677888888888775 8999999999999999999999984


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      - -++.++..  ..+++++.-+-++...+..||.||.+++  +|+|||+||+|||+|+.|++|++|||++-.+-..   .
T Consensus       175 ~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---k  246 (391)
T KOG0983|consen  175 T-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---K  246 (391)
T ss_pred             H-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc---c
Confidence            3 44555532  3446888888999999999999999876  6999999999999999999999999998765321   1


Q ss_pred             cccccccccCccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          592 NTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~---~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      ......|-+.|||||.+.-   ..|+.++||||||+.|+||.||+.|+..-..+-  ..+.    ......+     +.+
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~lt----kvln~eP-----P~L  315 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLT----KVLNEEP-----PLL  315 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHH----HHHhcCC-----CCC
Confidence            1223567889999999963   468999999999999999999999976433321  1111    1111111     111


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .+.  ...+..+.+++..||++|+.+||...++++.
T Consensus       316 ~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  316 PGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             Ccc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            111  1256678899999999999999999999863

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=7.4e-32  Score=283.47  Aligned_cols=259  Identities=25%  Similarity=0.343  Sum_probs=197.9

Q ss_pred             ccccccccccccccEEEEEEcC-CcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          434 FSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      |+..+.||+|++|.||+|+..+ ++.+|+|++....  ....+.+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            4566789999999999999764 8999999997653  334567889999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      + ++|.+++....  ..+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||+++........
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            8 48999985432  46899999999999999999999998   999999999999999999999999999876432221


Q ss_pred             ccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh---------
Q 038934          591 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP---------  660 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------  660 (751)
                        .....++..|+|||.+.+. .++.++||||||++++||++|+.|+........   .............         
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccc
Confidence              1223457789999998776 789999999999999999999888754332111   0000000000000         


Q ss_pred             ---hhhcchh---ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          661 ---VELIDKS---LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       661 ---~~~~d~~---l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         .......   ............+.+++.+||+.||++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence               0000000   000001112457899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=5.9e-32  Score=280.95  Aligned_cols=250  Identities=26%  Similarity=0.344  Sum_probs=194.9

Q ss_pred             CccccccccccccccEEEEEEcC-CcEEEEEEeccC-----CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      +|.+.++||+|+||.||++.... +..+++|.++..     ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788899999999999998654 445666665432     222344677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          507 YEYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++ +.++|+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642 23456899999999999999999999998   999999999999975 569999999987753


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ....  ......+++.|+|||.+.+..++.++||||||+++|+|++|..|+.....      ...... .....      
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~-~~~~~------  221 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR-IVEGP------  221 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-HHcCC------
Confidence            3221  12235678899999999888899999999999999999999998742211      111111 10110      


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                         ....+......+.+++.+|++.+|++||++.++++.
T Consensus       222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence               111223445678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=9.5e-32  Score=314.11  Aligned_cols=146  Identities=29%  Similarity=0.417  Sum_probs=131.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|.+.++||+|+||.||+|.+. .++.||||++....   ......+.+|+.++..++|+||+++++++......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            368899999999999999999975 58899999997542   23346788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      |||+.+++|.+++..   ...+++..++.|+.||+.||.|||.++   |+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999843   345889999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.9e-32  Score=295.39  Aligned_cols=263  Identities=22%  Similarity=0.317  Sum_probs=198.1

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc---
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE---  502 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  502 (751)
                      ...++|.+.+.||+|++|.||+|+.. +++.||||++...  .....+.+.+|+.++++++|+||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            45678999999999999999999975 5789999998653  22344667889999999999999999998876654   


Q ss_pred             ---eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          503 ---RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       503 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                         .++|+||+ +++|.+++..    ..+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               89999999 5699998842    45899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchh-H-------H
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLL-G-------H  650 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~-~-------~  650 (751)
                      ++......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+...........+ .       .
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence            99865322     223467889999999865 46789999999999999999999997643221110000 0       0


Q ss_pred             HHHHhccCChhhhcchhccC------ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          651 AWRLWTEDRPVELIDKSLED------TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       651 ~~~~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .+..+........+......      .........+.+++.+||+.||++|||+.+|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00000000000010000000      0001125678899999999999999999999853

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=7.7e-33  Score=287.99  Aligned_cols=243  Identities=26%  Similarity=0.366  Sum_probs=193.8

Q ss_pred             cccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCC
Q 038934          437 ENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      .+.||+|.||+||-|+++ +|+.||||++.+.  ......++++|+.||++++||.||.+.-.|+..++.++|||.+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            468999999999999965 5999999999764  445568899999999999999999999999999999999999966 


Q ss_pred             ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC---CCeEEeeccCccccCCCCcc
Q 038934          514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       514 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++.++|.. +..+.+++.....++.||+.||.|||.++   |+|+||||+||||.+.   -.+||+|||+|+.++.... 
T Consensus       648 DMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  648 DMLEMILS-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             hHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            55555532 34567899999999999999999999999   9999999999999643   4699999999999875433 


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                        ...++|||.|+|||++.++.|...-|+||+|||+|--|+|..||.-..  +....++.+.-++...            
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~------------  786 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPN------------  786 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCC------------
Confidence              334799999999999999999999999999999999999999975211  1111111110000000            


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVV  702 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  702 (751)
                       .=.+.....++||...||..-.+|-+....+
T Consensus       787 -PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  787 -PWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             -chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence             0122345678899999999999998887765

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-31  Score=275.12  Aligned_cols=236  Identities=26%  Similarity=0.336  Sum_probs=192.2

Q ss_pred             ccccccccEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       440 IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      ||+|+||.||++... +++.+|+|.+.+...   ...+.+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            799999999999975 488999999876432   2456889999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccc
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR  595 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  595 (751)
                      .+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            999953   335899999999999999999999988   9999999999999999999999999998764322  12234


Q ss_pred             cccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHH
Q 038934          596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS  675 (751)
Q Consensus       596 ~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  675 (751)
                      ..++..|+|||.+.+...+.++|+||||+++|+|++|+.|+.....   ......    ....          ....+..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~----~~~~----------~~~~~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEK----ILKD----------PLRFPEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHH----HhcC----------CCCCCCC
Confidence            5678899999999988899999999999999999999999753322   011000    0000          0111222


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHH
Q 038934          676 EALRCIQVGLLCVQQRPEDRPNMAS  700 (751)
Q Consensus       676 ~~~~l~~li~~cl~~dP~~RPs~~e  700 (751)
                      ....+.+++.+|++.||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2567789999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-32  Score=274.85  Aligned_cols=259  Identities=21%  Similarity=0.242  Sum_probs=201.1

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-C-C----cEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-H-R----NLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~  503 (751)
                      +.+|.+...+|+|.||.|-++... .+..||||+++. ...-.++.+-|+++|+++. + |    -+|++.++|.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            578999999999999999999854 478899999853 3445567788999999994 2 2    378899999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC--------------
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------------  569 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~--------------  569 (751)
                      ++|+|.+ |.|+.++|..+ ...+++...+..++.|+++++++||+.+   ++|.||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999999 66999999653 4456899999999999999999999998   999999999999832              


Q ss_pred             ------CCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc
Q 038934          570 ------EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH  643 (751)
Q Consensus       570 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~  643 (751)
                            +..++|+|||.|+.-...     ...++.|..|+|||++.+-.++.++||||+||||+||.+|..-|......+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                  235899999999874322     245788999999999999999999999999999999999988776555322


Q ss_pred             ccchhHHHHHHhccCChhhhcchh------------------------c---------cCccCHHHHHHHHHHHhhhcCC
Q 038934          644 HHNLLGHAWRLWTEDRPVELIDKS------------------------L---------EDTYSLSEALRCIQVGLLCVQQ  690 (751)
Q Consensus       644 ~~~~~~~~~~~~~~~~~~~~~d~~------------------------l---------~~~~~~~~~~~l~~li~~cl~~  690 (751)
                      ...+.+    ...+..+..++.+.                        .         .-.....+..+|.+|+..||..
T Consensus       317 HLaMMe----rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  317 HLAMME----RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             HHHHHH----HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            211111    11111111111111                        0         0011234556899999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 038934          691 RPEDRPNMASVVLM  704 (751)
Q Consensus       691 dP~~RPs~~evl~~  704 (751)
                      ||.+|+|+.|++..
T Consensus       393 DP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  393 DPARRITLREALSH  406 (415)
T ss_pred             CccccccHHHHhcC
Confidence            99999999999863

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=274.16  Aligned_cols=278  Identities=23%  Similarity=0.322  Sum_probs=205.9

Q ss_pred             ccCCcccHHhHHHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHH--HhcCCcEEeEe
Q 038934          417 MELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIA--KLQHRNLVKLL  494 (751)
Q Consensus       417 ~~l~~~~~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~  494 (751)
                      ..+|.+-..+|   .++....+.||+|.||.||+|.+ .|..||||++...   .++...+|.+|.+  .|+|+||+.++
T Consensus       199 SGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFI  271 (513)
T KOG2052|consen  199 SGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFI  271 (513)
T ss_pred             CCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhh
Confidence            35666655554   35677888999999999999999 8899999999654   3455677777765  46999999999


Q ss_pred             ceeeeCC----ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCEEEccCCCCCe
Q 038934          495 GCCMKRD----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH-----QDSRLRIIHRDLKASNV  565 (751)
Q Consensus       495 ~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-----~~~~~~ivH~Dikp~NI  565 (751)
                      +.-..+.    +++||.+|.+.|||.|+|    .+..++.+..+++++.+|.||+|||     .+|++.|.|||||..||
T Consensus       272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI  347 (513)
T KOG2052|consen  272 AADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  347 (513)
T ss_pred             hccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence            8876553    689999999999999999    3466899999999999999999999     46888999999999999


Q ss_pred             EEcCCCCeEEeeccCccccCCCCc--cccccccccccCccCcccccCC----CC--CcchhhHHHHHHHHHHHhCCC---
Q 038934          566 LLDNEMNPKISDFGMARAFGVDQT--EANTNRVVGTYGYMPPEYAIDG----LF--SVKSDVFSFGVLVLELVYGTR---  634 (751)
Q Consensus       566 ll~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~----~~--t~k~DVwSlG~ll~ell~G~~---  634 (751)
                      ||..++...|+|+|||.....+..  ....+..+||..|||||++...    .+  -..+||||||.|+||+.....   
T Consensus       348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg  427 (513)
T KOG2052|consen  348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG  427 (513)
T ss_pred             EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence            999999999999999987754422  3334567899999999998643    12  246999999999999985422   


Q ss_pred             -------CCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          635 -------NRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       635 -------p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                             ||.-.-+.++ . .+...+..-..+....+   -+.....+....+.+++..|+..+|..|.|+--+-+.|..
T Consensus       428 i~eey~~Pyyd~Vp~DP-s-~eeMrkVVCv~~~RP~i---pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  428 IVEEYQLPYYDVVPSDP-S-FEEMRKVVCVQKLRPNI---PNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             EehhhcCCcccCCCCCC-C-HHHHhcceeecccCCCC---CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence                   2111001000 0 00000000001111111   1112345667788999999999999999999999988877


Q ss_pred             CCC
Q 038934          708 ERS  710 (751)
Q Consensus       708 ~~~  710 (751)
                      +..
T Consensus       503 l~~  505 (513)
T KOG2052|consen  503 LSN  505 (513)
T ss_pred             Hhc
Confidence            654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-32  Score=297.45  Aligned_cols=253  Identities=28%  Similarity=0.432  Sum_probs=208.7

Q ss_pred             ccccccccccccccEEEEEE-cCC----cEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          434 FSEENKLGEGGFGPVYKGML-IDG----QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ....++||+|+||+||+|.+ ++|    -+||||++... ..+.-+++..|+.+|..++||||+|++++|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34567899999999999995 344    36899998754 4556688999999999999999999999998776 88999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      +||+.|+|.++++.  .+..+..+..+.|..|||+||.|||++.   ++||||-..||||..-..+||.|||+++.+..+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999975  4556889999999999999999999998   999999999999999999999999999998776


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ..+.......-.+-|||-|.+....|+.++|||||||.+|||+| |..|......++...+                +..
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl----------------le~  915 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL----------------LEK  915 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH----------------Hhc
Confidence            66665554455677999999999999999999999999999997 7777554333322221                111


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      -.+-..+.....++..++.+||..|++.||+++++...+.++
T Consensus       916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            111223455667888999999999999999999998777654

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=265.89  Aligned_cols=278  Identities=22%  Similarity=0.321  Sum_probs=216.0

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  505 (751)
                      .++|...++||+|.+.+|..++++. .+.+|+|++++.   ....+.-++.|-.+..+. +||.+|-++.+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            3678889999999999999999754 778999999764   455677788999999887 69999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |.||++||+|.-++   ++...++++.+..+...|+.||.|||+.|   ||.||||.+|+|+|..|++||+|+|+.+.--
T Consensus       329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999998777   55667999999999999999999999999   9999999999999999999999999998642


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccc-hhHHHHHHhccCChhhhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN-LLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  664 (751)
                      .  ....+..++|||.|+|||++.+..|...+|.|+|||+++||+.|+.||+....+.... ...+...        -++
T Consensus       403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq--------vil  472 (593)
T KOG0695|consen  403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ--------VIL  472 (593)
T ss_pred             C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH--------HHh
Confidence            2  2334567999999999999999999999999999999999999999998755433211 1111111        111


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCC------HHHHH----------HHHhCCCCCCCCCCCCCcccCCCCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN------MASVV----------LMLSGERSLPQPKQPGFFTERNLPE  727 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl----------~~L~~~~~~~~p~~p~~~~~~~~~~  727 (751)
                      ++.+  ..+...+.+...++..-|.+||.+|..      ++++.          ++||+. .+--|.+|+....+.+..
T Consensus       473 ekqi--riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk-~v~ppf~p~i~~d~~l~~  548 (593)
T KOG0695|consen  473 EKQI--RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQK-QVLPPFQPQITDDYGLDN  548 (593)
T ss_pred             hhcc--cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhc-ccCCCCCCccccccCccc
Confidence            1111  122333445667888889999999942      23332          344443 334467777766654433

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=243.08  Aligned_cols=262  Identities=25%  Similarity=0.339  Sum_probs=199.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +|...++||+|.+|+||+|+.. .++.||+|+++...  +..-....+|+-+++.++|.|||++++....++.+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4666789999999999999954 57889999997653  22345688999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      |.. +|..+..  +-.+.++.+.+..++.|+++||.++|++.   +.|||+||.|.|++.+|.+|++|||+++.++....
T Consensus        83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            955 7777763  34566899999999999999999999999   99999999999999999999999999998875543


Q ss_pred             cccccccccccCccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCC-CCCCCCccccchhHHHHH--HhccCC---hhh
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYGTRN-RGFHHVDHHHNLLGHAWR--LWTEDR---PVE  662 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DVwSlG~ll~ell~G~~p-~~~~~~~~~~~~~~~~~~--~~~~~~---~~~  662 (751)
                      ....  .+-|..|.+|.++.+.+ |+...|+||.||++.||....+| |...+.+++  +...++.  ...++.   +..
T Consensus       157 cysa--evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq--lkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  157 CYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             eeec--eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH--HHHHHHHhCCCccccCCcccc
Confidence            3222  35688999999998865 89999999999999999975555 333333322  2222221  112221   223


Q ss_pred             hcchhccCccCHH-----H----HHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          663 LIDKSLEDTYSLS-----E----ALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       663 ~~d~~l~~~~~~~-----~----~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      +.|......++..     .    ...=.+++.+.|.-+|..|.++++.++.
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            3343333333211     1    1122568888888899999999998864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=5.6e-31  Score=269.93  Aligned_cols=220  Identities=20%  Similarity=0.154  Sum_probs=176.0

Q ss_pred             cccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCChhHHHhc
Q 038934          443 GGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFD  521 (751)
Q Consensus       443 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  521 (751)
                      |.+|.||+++.. +++.+|+|++....     .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999964 58899999996542     334555566666799999999999999999999999999999999853


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccC
Q 038934          522 GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG  601 (751)
Q Consensus       522 ~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  601 (751)
                         ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++++|||.+......     .....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence               235899999999999999999999998   999999999999999999999999988665322     112345678


Q ss_pred             ccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHH
Q 038934          602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCI  681 (751)
Q Consensus       602 y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  681 (751)
                      |+|||.+.+..++.++||||+|+++|||++|+.++......            ....         ..-..+......+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~---------~~~~~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTH---------TTLNIPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cccc---------cccCCcccCCHHHH
Confidence            99999998888999999999999999999998775321110            0000         00011222345678


Q ss_pred             HHHhhhcCCCCCCCCCHH
Q 038934          682 QVGLLCVQQRPEDRPNMA  699 (751)
Q Consensus       682 ~li~~cl~~dP~~RPs~~  699 (751)
                      +++.+|++.||++||++.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-33  Score=267.63  Aligned_cols=256  Identities=23%  Similarity=0.330  Sum_probs=194.6

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +.+....||.|.||+|+|-.++ .|+.+|||+++... ....++++.|.+...+- +.||||+++|.+-.+...++-||+
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            3445568999999999998865 59999999998653 35667889999887766 699999999999999999999999


Q ss_pred             cCCCChhHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          510 LPNKSLADFIFD--GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       510 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      |+- ||+.+...  ......+++.-+-.|......||.||...-  .||||||||+||||+..|.+||+|||++-.+-..
T Consensus       145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            954 66665422  123446889988999999999999998754  5999999999999999999999999998765321


Q ss_pred             CccccccccccccCccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          588 QTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                         .....-.|-.-|||||.+..  ..|+.++||||||++|||+.||+.|......     ..+.. .....+++..+. 
T Consensus       222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql-~~Vv~gdpp~l~-  291 (361)
T KOG1006|consen  222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQL-CQVVIGDPPILL-  291 (361)
T ss_pred             ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHH-HHHHcCCCCeec-
Confidence               11222456678999999964  3589999999999999999999998542211     11111 112222222221 


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                         ......+....+++++..||.+|..+||+..+++++
T Consensus       292 ---~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  292 ---FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ---CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence               122234566789999999999999999999998753

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=271.77  Aligned_cols=258  Identities=27%  Similarity=0.364  Sum_probs=197.3

Q ss_pred             HhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCC-------cccHHHHHHHHHHHHHhcCCcEEeEeceeee-C
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSS-------GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK-R  500 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  500 (751)
                      ..++|-....||+|||+.||++.. ...+.||+|+-....       +.-.+...+|..|.+.|.||.||++++++.- .
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            346788889999999999999994 457889999864321       1123456789999999999999999999865 4


Q ss_pred             CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---CCCeEEee
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISD  577 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~D  577 (751)
                      +.++-|.||++|.+|+-+|.   ..+.++++++..|+.||+.||.||.+.. ++|||-||||.||||-+   -|.+||+|
T Consensus       541 dsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence            67889999999999999995   4556899999999999999999999875 78999999999999954   47899999


Q ss_pred             ccCccccCCCCcc-----ccccccccccCccCcccccC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchh
Q 038934          578 FGMARAFGVDQTE-----ANTNRVVGTYGYMPPEYAID----GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLL  648 (751)
Q Consensus       578 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~  648 (751)
                      ||+++....+...     ..+....||..|++||.+.-    .+.+.|+||||+|||+|.++.|++||+-....  +.++
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdIL  694 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDIL  694 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHH
Confidence            9999987543332     23455789999999998853    25789999999999999999999998743221  1111


Q ss_pred             HHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 038934          649 GHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV  702 (751)
Q Consensus       649 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  702 (751)
                      ...- .++...        +.-...+....+...+|++||+..-++|....++.
T Consensus       695 qeNT-IlkAtE--------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  695 QENT-ILKATE--------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hhhc-hhccee--------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            1110 000000        00111122344677899999999999998888776

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=5.4e-31  Score=279.60  Aligned_cols=207  Identities=23%  Similarity=0.379  Sum_probs=179.1

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .-|..++.||-|+||.|.+++..+ ...+|+|.+++.+   ......++.|-.||+..+.+-||+|+..|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            567778899999999999998554 5678999998763   344566889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      +|++||++..+|.   +.+.++++.+..++.++..|+.+.|..|   +|||||||+|||||.+|++||+||||++-+.-.
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999994   5567899999999999999999999998   999999999999999999999999998765210


Q ss_pred             ----------Cc------------------------------cccccccccccCccCcccccCCCCCcchhhHHHHHHHH
Q 038934          588 ----------QT------------------------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVL  627 (751)
Q Consensus       588 ----------~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~  627 (751)
                                ..                              .......+||+.|+|||++....++..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                      00                              00112367999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCccc
Q 038934          628 ELVYGTRNRGFHHVDHH  644 (751)
Q Consensus       628 ell~G~~p~~~~~~~~~  644 (751)
                      ||+.|+.||....+.+.
T Consensus       863 em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGET  879 (1034)
T ss_pred             HHhhCCCCccCCCCCcc
Confidence            99999999987666544

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.2e-32  Score=259.52  Aligned_cols=267  Identities=22%  Similarity=0.395  Sum_probs=195.5

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--------
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--------  500 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  500 (751)
                      ..|....+||+|.||.||+|+.++ ++.||+|++--.  ...--....+|+.+|..|.|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            345566789999999999999654 788899876432  122234568899999999999999999988543        


Q ss_pred             CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccC
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  580 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl  580 (751)
                      ..+++||.+++. +|.-++.  .....++..++.+++.++..||.|+|...   |+|||+||+|+|++.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            348999999976 7888773  23356899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCc--cccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH-----H
Q 038934          581 ARAFGVDQT--EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA-----W  652 (751)
Q Consensus       581 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~-----~  652 (751)
                      ++.+.....  .......+-|..|++||.+.|. .|+++.|||..|||+.||+++.+-+........-.++...     .
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            987753222  1222234568899999999875 6999999999999999999998876544333222221111     1


Q ss_pred             HHhccCChhhhcchh-----ccCcc--------CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          653 RLWTEDRPVELIDKS-----LEDTY--------SLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~-----l~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      +.|.+-+-..+....     ..+.+        +.......++|+.++|..||.+|+.+++++..
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            112221111111111     11111        11123367899999999999999999998854

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-30  Score=285.89  Aligned_cols=259  Identities=27%  Similarity=0.392  Sum_probs=207.2

Q ss_pred             HHhHHHHhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeee--
Q 038934          424 WKSIANATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMK--  499 (751)
Q Consensus       424 ~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--  499 (751)
                      +..+..-++-|++.+.||.|.+|.||+++. ++++..|||++... ....+++..|.+|++.+ .|||++.+++++..  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            334455567888999999999999999995 45888899987543 44557888999999988 69999999999864  


Q ss_pred             ---CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEe
Q 038934          500 ---RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  576 (751)
Q Consensus       500 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~  576 (751)
                         ++.++||||||.+||..|++..-. ...+.|..+..|++.+++||.+||...   ++|||||-.|||++.++.|||.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence               468999999999999999996544 567899999999999999999999988   9999999999999999999999


Q ss_pred             eccCccccCCCCccccccccccccCccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH
Q 038934          577 DFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-----LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA  651 (751)
Q Consensus       577 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~  651 (751)
                      |||++..+..  .........|||.|||||++...     .|+.++|+||||++..||.-|.+|+--..+-       .+
T Consensus       166 DFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------ra  236 (953)
T KOG0587|consen  166 DFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------RA  236 (953)
T ss_pred             eeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------hh
Confidence            9999987643  33344557999999999999754     4788999999999999999999885321110       00


Q ss_pred             HHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          652 WRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       652 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .-......+       ..-..+..-..++.++|..||.+|-.+||++.++++
T Consensus       237 LF~IpRNPP-------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  237 LFLIPRNPP-------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hccCCCCCC-------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            000111111       111223455678999999999999999999999885

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=7.2e-30  Score=261.04  Aligned_cols=238  Identities=27%  Similarity=0.363  Sum_probs=192.1

Q ss_pred             ccccEEEEEEcC-CcEEEEEEeccCCccc-HHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCChhHHHhc
Q 038934          444 GFGPVYKGMLID-GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFD  521 (751)
Q Consensus       444 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  521 (751)
                      +||.||++.... ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++|++++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999764 8999999997665444 78899999999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccC
Q 038934          522 GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG  601 (751)
Q Consensus       522 ~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  601 (751)
                      ..   .+++..+..++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            22   2889999999999999999999998   9999999999999999999999999998765332   2233567889


Q ss_pred             ccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHH
Q 038934          602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCI  681 (751)
Q Consensus       602 y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  681 (751)
                      |+|||.+.+..++.++||||||+++++|++|..|+.....  ...+..    .........       ..........+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~----~~~~~~~~~-------~~~~~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFK----KIGKPKPPF-------PPPEWKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHH----HHhccCCCC-------ccccccCCHHHH
Confidence            9999999988899999999999999999999988653211  111111    011110000       000000345788


Q ss_pred             HHHhhhcCCCCCCCCCHHHHHH
Q 038934          682 QVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       682 ~li~~cl~~dP~~RPs~~evl~  703 (751)
                      +++.+|+..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            9999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-32  Score=279.73  Aligned_cols=248  Identities=23%  Similarity=0.276  Sum_probs=203.5

Q ss_pred             cCccccccccccccccEEEEEEcCCc-EEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQ-EIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .++.....||-||||.|=++...... .+|+|.+++.   .....+.+..|-.+|.+.+.|.||+++..|.+...+|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45556667999999999988864433 4889988765   3445677899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      |-|-||.|...+.   .++.++..++..++..+++|+.|||+++   ||.|||||+|.+||.+|.+||.|||+|+.++..
T Consensus       500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999994   5667899999999999999999999999   999999999999999999999999999988643


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                         ..+-+++|||.|+|||++.+...+.++|.||||+++||||+|.+||...++-...+++-.      .-      |  
T Consensus       574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk------Gi------d--  636 (732)
T KOG0614|consen  574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK------GI------D--  636 (732)
T ss_pred             ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh------hh------h--
Confidence               334568999999999999999999999999999999999999999876554322221111      00      0  


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                       .-.++........+|+.+....+|.+|..     +.++-+
T Consensus       637 -~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  637 -KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             -hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence             01223334456678888988999999976     666654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=5e-30  Score=292.34  Aligned_cols=259  Identities=22%  Similarity=0.282  Sum_probs=167.8

Q ss_pred             HhcCccccccccccccccEEEEEEcC-----CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEece------ee
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID-----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC------CM  498 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  498 (751)
                      ..++|...++||+|+||.||+|++.+     +..||||++.....  .+...+|  .+.+..+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999999654     68999999864321  1111111  1122222222222211      24


Q ss_pred             eCCceEEEEEecCCCChhHHHhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCC
Q 038934          499 KRDERMLIYEYLPNKSLADFIFDGTRR-----------------KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK  561 (751)
Q Consensus       499 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dik  561 (751)
                      .+...++||||+.+++|.+++......                 .......+..++.||+.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            567889999999999999998543210                 11123446689999999999999998   9999999


Q ss_pred             CCCeEEcC-CCCeEEeeccCccccCCCCccccccccccccCccCcccccCC----------------------CCCcchh
Q 038934          562 ASNVLLDN-EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG----------------------LFSVKSD  618 (751)
Q Consensus       562 p~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~k~D  618 (751)
                      |+|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 578999999999865432221 12346789999999966322                      2345679


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhcc-C-Chh---hhcchhc----cCccC--HHHHHHHHHHHhhh
Q 038934          619 VFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE-D-RPV---ELIDKSL----EDTYS--LSEALRCIQVGLLC  687 (751)
Q Consensus       619 VwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~-~-~~~---~~~d~~l----~~~~~--~~~~~~l~~li~~c  687 (751)
                      ||||||+||||+++..+.+..       +.. ....+.. + ...   ..+....    ...+.  ........+|+.+|
T Consensus       362 VwSlGviL~el~~~~~~~~~~-------~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN-------LIQ-FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH-------HHH-HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence            999999999999876553211       000 0000000 0 000   0011100    00000  00112345899999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 038934          688 VQQRPEDRPNMASVVLM  704 (751)
Q Consensus       688 l~~dP~~RPs~~evl~~  704 (751)
                      |+.||.+|||+.++++.
T Consensus       434 L~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        434 MRFKGRQRISAKAALAH  450 (566)
T ss_pred             ccCCcccCCCHHHHhCC
Confidence            99999999999999963

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.4e-29  Score=281.43  Aligned_cols=263  Identities=19%  Similarity=0.277  Sum_probs=180.5

Q ss_pred             HhcCccccccccccccccEEEEEE-----------------cCCcEEEEEEeccCCcccHHH--------------HHHH
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGML-----------------IDGQEIAVKRLSKSSGQGVEE--------------FKNE  478 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  478 (751)
                      ..++|++.++||+|+||+||+|.+                 .+++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 235689999986543222223              3447


Q ss_pred             HHHHHHhcCCcE-----EeEeceeee--------CCceEEEEEecCCCChhHHHhccC---------------------C
Q 038934          479 VLLIAKLQHRNL-----VKLLGCCMK--------RDERMLIYEYLPNKSLADFIFDGT---------------------R  524 (751)
Q Consensus       479 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------~  524 (751)
                      +.++.+++|.++     ++++++|..        ....+|||||+++++|.+++....                     .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777788876654     667777653        356899999999999999885321                     1


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccC
Q 038934          525 RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP  604 (751)
Q Consensus       525 ~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  604 (751)
                      ...+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++......... ......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence            123467788999999999999999998   999999999999999999999999999765322111 1112334789999


Q ss_pred             cccccCCC--------------------C--CcchhhHHHHHHHHHHHhCCC-CCCCCCCccc----cchhHHHHHHhcc
Q 038934          605 PEYAIDGL--------------------F--SVKSDVFSFGVLVLELVYGTR-NRGFHHVDHH----HNLLGHAWRLWTE  657 (751)
Q Consensus       605 PE~~~~~~--------------------~--t~k~DVwSlG~ll~ell~G~~-p~~~~~~~~~----~~~~~~~~~~~~~  657 (751)
                      ||.+....                    +  ..+.||||+||++|+|++|.. |+........    ..-....|.....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99886432                    1  235799999999999999875 4321110000    0000111111111


Q ss_pred             CChhhhcchhccCccCHHHHHHHHHHHhhhcCCCC---CCCCCHHHHHHH
Q 038934          658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRP---EDRPNMASVVLM  704 (751)
Q Consensus       658 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~  704 (751)
                      ...        .-...........+|+.++|..+|   .+|+|++|+++.
T Consensus       459 ~~~--------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        459 QKY--------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             cCC--------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            111        000111224567889999998766   689999999864

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=290.22  Aligned_cols=258  Identities=28%  Similarity=0.398  Sum_probs=201.0

Q ss_pred             CccccccccccccccEEEEEEcC--------CcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCc
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID--------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  502 (751)
                      +..+.+.||+|.||.|++|....        ...||||.++.. .....+.+..|+++|..+ +|+||+.++|+|.....
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            33455589999999999998431        346999999765 334667899999999998 69999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccC-----C------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC
Q 038934          503 RMLIYEYLPNKSLADFIFDGT-----R------R--KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN  569 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~  569 (751)
                      .++|+||+..|+|.+++.+..     .      .  ..+.....+.++.|||.|++||++..   +|||||...|||+.+
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITK  453 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecC
Confidence            999999999999999997644     0      0  23889999999999999999999998   999999999999999


Q ss_pred             CCCeEEeeccCccccCCCCccccc-cccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccch
Q 038934          570 EMNPKISDFGMARAFGVDQTEANT-NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNL  647 (751)
Q Consensus       570 ~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~  647 (751)
                      +..+||+|||+|+........... ....-...|||||.+....|+.|+||||||++||||++ |..|+....      .
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~------~  527 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP------P  527 (609)
T ss_pred             CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC------c
Confidence            999999999999865433222211 10011345999999999999999999999999999998 455543200      0


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ....++...++...         ..+.....++.+++..|++.+|++||+++++++.++..
T Consensus       528 ~~~l~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 TEELLEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11112223333221         22334466788999999999999999999999999883

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-30  Score=250.94  Aligned_cols=264  Identities=20%  Similarity=0.293  Sum_probs=195.2

Q ss_pred             ccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-----CceEE
Q 038934          434 FSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-----DERML  505 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  505 (751)
                      .+..+.||-|+||+||..+.+ +|+.||+|++..-.  -...+.+.+|+.+|.-.+|.|++..+++..-.     .++|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            345679999999999999965 59999999986532  22456789999999999999999988876543     35678


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |.|+|. .+|+.+|   .....++...+.-++.||++||.|||+.+   |.||||||.|.|++.+..+||+|||+++.-.
T Consensus       135 ~TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence            888884 4888887   34556888999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH--------HHHhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA--------WRLWT  656 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~--------~~~~~  656 (751)
                      .++....+ ..+-|..|+|||+++|. .|+.++||||+|||+.||+..+--|....+-+...++...        .+.--
T Consensus       208 ~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  208 QRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            54444433 34568899999999986 6899999999999999999776665544443332222111        11001


Q ss_pred             cCChhhhcchhccC---------ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          657 EDRPVELIDKSLED---------TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       657 ~~~~~~~~d~~l~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                      ++-...++....+.         ..+.....+.+.+.++++..||++|.+..+.+..+
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            11111111100000         01122334667788899999999999999998654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=278.62  Aligned_cols=245  Identities=27%  Similarity=0.398  Sum_probs=186.5

Q ss_pred             cccccccccccccc-EEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEecC
Q 038934          434 FSEENKLGEGGFGP-VYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       434 y~~~~~IG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      |...+.+|.|.-|+ ||+|.. .+++||||++-..   ......+|+..|+.- +|||||++++.-.+...+|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            44456789999887 699997 7889999998543   344678999999998 59999999999888899999999995


Q ss_pred             CCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---C--CCeEEeeccCccccC
Q 038934          512 NKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---E--MNPKISDFGMARAFG  585 (751)
Q Consensus       512 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~--~~~kl~DFGla~~~~  585 (751)
                       .+|.+++... .......-.....+..|++.||++||+.+   ||||||||+||||+.   +  ..++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             5999999653 11111111345678899999999999988   999999999999975   3  469999999999987


Q ss_pred             CCCcccc-ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          586 VDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG-TRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       586 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      .+..... .....||-+|+|||++....-+.++||||+||++|+.++| .+||+-...- +.+++       .....   
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NIl-------~~~~~---  731 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANIL-------TGNYT---  731 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhhh-------cCccc---
Confidence            6544332 3457899999999999999889999999999999999987 8887622111 11111       00000   


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV  702 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  702 (751)
                          +..-.+.... +..+||.+|+..+|..||++.+|+
T Consensus       732 ----L~~L~~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  732 ----LVHLEPLPDC-EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ----eeeeccCchH-HHHHHHHHhcCCCcccCCCHHHHh
Confidence                0000011111 778999999999999999999997

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=6.3e-29  Score=234.79  Aligned_cols=258  Identities=20%  Similarity=0.342  Sum_probs=196.7

Q ss_pred             HhcCccccccccccccccEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCC--ceEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRD--ERML  505 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l  505 (751)
                      ..++|++.+++|+|-++.||.|. ..+++.++||+++.-   ..+.+.+|+.||..|. ||||+++++...+..  ...|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            35789999999999999999999 456889999999543   3467899999999997 999999999998764  5679


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-CCeEEeeccCcccc
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAF  584 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~  584 (751)
                      |+||+.+.+...+.      ..++...+..++.+++.||.|+|+.|   |+|||+||+|+++|.. -.++|+|+|+|..+
T Consensus       113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999998887765      34778889999999999999999999   9999999999999964 56999999999987


Q ss_pred             CCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh--------
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW--------  655 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~--------  655 (751)
                      .....   -+..+.+..|--||.+..- .|+..-|+|||||+|..|+..+.||-... +...+++..+.-+-        
T Consensus       184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhChHHHHHHH
Confidence            54332   2224566778899998764 58999999999999999999999985433 33333333222110        


Q ss_pred             c------cCChhhhcch--------hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          656 T------EDRPVELIDK--------SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       656 ~------~~~~~~~~d~--------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .      +.....++..        .+...-......++++++.+.|..|-.+|||+.|.+.
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            0      0011111111        0111111112357889999999999999999999875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=4.9e-27  Score=234.00  Aligned_cols=211  Identities=36%  Similarity=0.582  Sum_probs=184.2

Q ss_pred             ccccccccEEEEEEcC-CcEEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCChhH
Q 038934          440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLAD  517 (751)
Q Consensus       440 IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~  517 (751)
                      ||+|.+|.||++.... ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999999765332 45789999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-CCCeEEeeccCccccCCCCcccccccc
Q 038934          518 FIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGVDQTEANTNRV  596 (751)
Q Consensus       518 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~  596 (751)
                      ++....  ..++...+..++.+++++|.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            985432  35889999999999999999999998   999999999999999 89999999999987643321  12234


Q ss_pred             ccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHH
Q 038934          597 VGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLS  675 (751)
Q Consensus       597 ~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  675 (751)
                      .+...|++||.+... ..+.+.|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            577889999999887 889999999999999998                                              


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          676 EALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       676 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                        ..+.+++.+|++.||++||++.++++.|
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              5677999999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=244.05  Aligned_cols=272  Identities=24%  Similarity=0.309  Sum_probs=200.5

Q ss_pred             cCccccccccccccccEEEEE-EcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC------Cc
Q 038934          432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR------DE  502 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  502 (751)
                      .+|...+.+|.|.- .|-.+. ...+++||+|++...  .....++..+|...+..++|+||++++.++.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            56777788999988 555554 335899999998755  334567788999999999999999999998644      35


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .|+|||+|.. +|...+.     -.++-.++..|+.|++.|++|||+.+   |+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            7999999965 8888774     23667788999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc----------------c
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHH----------------N  646 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~----------------~  646 (751)
                      .-..+   ......+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|...+.-++.                .
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            64332   3445578899999999999999999999999999999999998876643321110                0


Q ss_pred             hhHHHHHHhccCChh-------h-hcchhccCc--cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--Hh---CCCCC
Q 038934          647 LLGHAWRLWTEDRPV-------E-LIDKSLEDT--YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM--LS---GERSL  711 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~-------~-~~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~---~~~~~  711 (751)
                      +...+..... ....       + +.|......  .+......+.+++.+||..||++|.++.++|..  ++   ...++
T Consensus       244 L~~~~r~yv~-~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev  322 (369)
T KOG0665|consen  244 LQPTVRNYVE-NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEV  322 (369)
T ss_pred             hhHHHHHHhh-cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccc
Confidence            0000110010 1000       0 111111111  112233456789999999999999999999963  34   45666


Q ss_pred             CCCCCC
Q 038934          712 PQPKQP  717 (751)
Q Consensus       712 ~~p~~p  717 (751)
                      +.|+.+
T Consensus       323 ~ap~pe  328 (369)
T KOG0665|consen  323 EAPPPE  328 (369)
T ss_pred             cCCCCc
Confidence            666666

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-28  Score=228.35  Aligned_cols=201  Identities=26%  Similarity=0.359  Sum_probs=164.8

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      +.......||+|++|.|-+-++. +|+..|+|++... ..+..++..+|+.+..+. .+|.+|+++|....+...++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            34445668999999999988864 6899999999765 345566788899887775 69999999999999999999999


Q ss_pred             ecCCCChhHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          509 YLPNKSLADFIFD-GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       509 ~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      .|.- ||..+..+ -.+.+.+++..+-+|+..+.+||.|||++-  .+||||+||+|||++.+|++|++|||++-.+-..
T Consensus       126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            9954 78777644 234567899999999999999999999864  6999999999999999999999999998765321


Q ss_pred             CccccccccccccCccCcccccC----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 038934          588 QTEANTNRVVGTYGYMPPEYAID----GLFSVKSDVFSFGVLVLELVYGTRNRGF  638 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~k~DVwSlG~ll~ell~G~~p~~~  638 (751)
                      -.   ...-.|-.-|||||.+..    ..|+.|+||||||+.+.||.+++.|++.
T Consensus       203 iA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  203 IA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             hH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            11   111345567999999854    3689999999999999999999999653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=1e-28  Score=257.47  Aligned_cols=266  Identities=18%  Similarity=0.193  Sum_probs=200.8

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc------CCcEEeEeceeeeCCc
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ------HRNLVKLLGCCMKRDE  502 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~  502 (751)
                      ...+|.+....|+|-|++|.+|... .|+.||||++... +.-.+.=+.|+++|.+|+      ..|+++++-.|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            4578999999999999999999954 4889999999654 233455578999999996      3589999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-CCeEEeeccCc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMA  581 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla  581 (751)
                      +|||+|-+ ..+|.++|..-...-.|....+..++.|++.||..|..-+   |+|.||||+||||.+. ..+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence            99999987 4489999876566667888999999999999999999888   9999999999999865 56899999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh------
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW------  655 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~------  655 (751)
                      .....+.   .+ .+.-+..|.|||++.|.+|+...|+||+||.||||.||+--|......+-..+.......+      
T Consensus       585 ~~~~ene---it-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  585 SFASENE---IT-PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccccccc---cc-HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            7654222   22 2445678999999999999999999999999999999998876544322111111110000      


Q ss_pred             ----cc--------------C--------------ChhhhcchhccCc--c---CHHHHHHHHHHHhhhcCCCCCCCCCH
Q 038934          656 ----TE--------------D--------------RPVELIDKSLEDT--Y---SLSEALRCIQVGLLCVQQRPEDRPNM  698 (751)
Q Consensus       656 ----~~--------------~--------------~~~~~~d~~l~~~--~---~~~~~~~l~~li~~cl~~dP~~RPs~  698 (751)
                          .+              +              .+..-+...+.+.  +   .......+.+|+.+||..||++|.|.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence                00              0              0000000111111  1   23344577889999999999999999


Q ss_pred             HHHHHH
Q 038934          699 ASVVLM  704 (751)
Q Consensus       699 ~evl~~  704 (751)
                      .++|+.
T Consensus       741 nqAL~H  746 (752)
T KOG0670|consen  741 NQALKH  746 (752)
T ss_pred             HHHhcC
Confidence            999864

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.95  E-value=3.8e-29  Score=222.67  Aligned_cols=110  Identities=48%  Similarity=0.806  Sum_probs=78.1

Q ss_pred             CCeEEEeecCCCCCCCC--CceeEEEecCCceEEEeCCCCCeeeee-cCCCCC-CCcEEEEecCCCEEEEcCCCCCCCCc
Q 038934           51 NGTVTWVANRNAPLPDR--SGVLSISSQGNGTLILQNSTNGIVWSS-NASRTA-QNPVAVLLESGNLVVKSGNDNDSDNF  126 (751)
Q Consensus        51 ~~t~vW~anr~~p~~~~--~~~l~~~~~g~g~l~l~~~~~~~vWst-~~~~~~-~~~~a~lldsGNlVl~~~~~~~~~~~  126 (751)
                      ++||||+|||+.|+...  ...|.|+.  ||+|+|+++.++++|++ ++.... ....|+|+|+|||||++..    +++
T Consensus         1 ~~tvvW~an~~~p~~~~s~~~~L~l~~--dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~----~~~   74 (114)
T PF01453_consen    1 PRTVVWVANRNSPLTSSSGNYTLILQS--DGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS----GNV   74 (114)
T ss_dssp             ---------TTEEEEECETTEEEEEET--TSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT----SEE
T ss_pred             CcccccccccccccccccccccceECC--CCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec----ceE
Confidence            47999999999999543  35666665  55999999999999999 544333 5778999999999999854    789


Q ss_pred             eeeecCCCccccCCCCeeeeeeecCCceEEEeccCCCCCC
Q 038934          127 LWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPA  166 (751)
Q Consensus       127 lWqSFd~PTDtlLpg~~lg~~~~tg~~~~l~sw~s~~dps  166 (751)
                      |||||||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus        75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             EEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             EEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            9999999999999999999988888777899999999996

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=259.61  Aligned_cols=199  Identities=27%  Similarity=0.411  Sum_probs=170.4

Q ss_pred             HHHhcCccccccccccccccEEEEEEcC-CcEEEEEEeccCC--------cccHHHHHHHHHHHHHhc---CCcEEeEec
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQ---HRNLVKLLG  495 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~  495 (751)
                      .+...+|...+++|+|+||.|+.+.++. ...|+||.+.+..        ....-.+-.|++||..++   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            3445678889999999999999999765 5678999886641        111223567999999997   999999999


Q ss_pred             eeeeCCceEEEEEec-CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeE
Q 038934          496 CCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK  574 (751)
Q Consensus       496 ~~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k  574 (751)
                      +|++++.+||+||.. ++-+|.++|   ..++.+++.++..|++||+.|+++||+++   |||||||-+|+.|+.+|-+|
T Consensus       637 fFEddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  637 FFEDDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             eeecCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEE
Confidence            999999999999974 667899999   45667999999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCC
Q 038934          575 ISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNR  636 (751)
Q Consensus       575 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~  636 (751)
                      |+|||.|....    ......++||.+|.|||++.|.+| ...-|||++|++||.++....|+
T Consensus       711 lidfgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  711 LIDFGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             Eeeccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99999997653    233456899999999999999987 56789999999999999777664

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6e-27  Score=243.54  Aligned_cols=131  Identities=28%  Similarity=0.398  Sum_probs=111.6

Q ss_pred             cCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-----C---CcEEeEeceeee---
Q 038934          432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----H---RNLVKLLGCCMK---  499 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~---  499 (751)
                      .+|.+.++||-|.|++||++.. ...+.||+|+.+ ....-.+....||.+|++++     |   .+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            6899999999999999999995 457789999984 44455677899999999984     2   379999999975   


Q ss_pred             -CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE
Q 038934          500 -RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  567 (751)
Q Consensus       500 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll  567 (751)
                       +.+++||+|++ |.+|..+|.. ...+.++...+.+|++||+.||.|||.++  +|||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             46899999999 5678887754 34456899999999999999999999987  79999999999999

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-27  Score=241.34  Aligned_cols=264  Identities=22%  Similarity=0.320  Sum_probs=206.4

Q ss_pred             HhHHHHhcCccccccccccccccEEEEEEcC------CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEecee
Q 038934          425 KSIANATDNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCC  497 (751)
Q Consensus       425 ~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  497 (751)
                      .++.....+++....+-+|.||.||+|.|.+      .+.|.+|.++.. +.-....+..|..++..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            3455566778888899999999999997653      345677777543 334556788999999999999999999998


Q ss_pred             eeC-CceEEEEEecCCCChhHHHh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC
Q 038934          498 MKR-DERMLIYEYLPNKSLADFIF-----DGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  571 (751)
Q Consensus       498 ~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~  571 (751)
                      .++ +..++.|.++.-|+|..++.     +....+.+...+...++.|++.|++|||.++   +||.||...|.++|+.-
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            765 56788899999999999997     3444556778888899999999999999999   99999999999999999


Q ss_pred             CeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHH
Q 038934          572 NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGH  650 (751)
Q Consensus       572 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~  650 (751)
                      .+||+|=.+++.+-................||+||.+.+..|+.++|||||||+||||++ |+.|..--++.       .
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-------E  506 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-------E  506 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-------H
Confidence            999999999986533223322222334567999999999999999999999999999997 67774322211       1


Q ss_pred             HHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          651 AWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       651 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ...+.+++         .+-..+...+.++..++.-|+..+|++||++++++.-|..
T Consensus       507 m~~ylkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  507 MEHYLKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             HHHHHhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            11112222         1123355677789999999999999999999999988764

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.94  E-value=1.9e-27  Score=211.35  Aligned_cols=110  Identities=46%  Similarity=0.994  Sum_probs=105.7

Q ss_pred             ecCCCCCccccccCCCCCCCCceEEEEeecCceEEEEEEeecCCcceEEEEcccCceeEEEEecCCccceeeEecccCcc
Q 038934          192 YRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSSVPSMMVVSPLGESQRYTWMEQTQKWAPFLSFSGLID  271 (751)
Q Consensus       192 ~~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~~~G~l~~~~w~~~~~~W~~~~~~~~~~~  271 (751)
                      ||+|+|||..|+|+|++..+..+.+.|+.++++.+++|.+.+.++++|++|+.+|++++|.|++..+.|..  .|.+|.+
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~--~~~~p~d   78 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSV--FWSAPKD   78 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEE--EEEeccc
Confidence            89999999999999999999999999999999999999999999999999999999999999999999998  9999999


Q ss_pred             cCCCCCccCCCccccCCCCCCcccccCCCccCC
Q 038934          272 QCDNYALCGTYAICKMNSNSAECECLEGFEPKS  304 (751)
Q Consensus       272 ~Cd~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~  304 (751)
                      +||+|+.||+||+|+.+ ..+.|+||+||+|++
T Consensus        79 ~Cd~y~~CG~~g~C~~~-~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   79 QCDVYGFCGPNGICNSN-NSPKCSCLPGFEPKN  110 (110)
T ss_pred             CCCCccccCCccEeCCC-CCCceECCCCcCCCc
Confidence            99999999999999876 678899999999974

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=7.4e-26  Score=228.94  Aligned_cols=198  Identities=34%  Similarity=0.484  Sum_probs=172.0

Q ss_pred             ccccccccccccccEEEEEEcC-CcEEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          434 FSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      |...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567789999999999999765 889999999866544 67889999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++.....  .+++..+..++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+......... 
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            9999999853221  1789999999999999999999998   999999999999999999999999999877543211 


Q ss_pred             cccccccccCccCcccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 038934          592 NTNRVVGTYGYMPPEYA-IDGLFSVKSDVFSFGVLVLELVYGTRNRG  637 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~-~~~~~t~k~DVwSlG~ll~ell~G~~p~~  637 (751)
                      ......++..|++||.+ ....++.++|||+||+++++|++|+.||.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22335678889999998 66778889999999999999999999974

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.93  E-value=1e-25  Score=202.60  Aligned_cols=115  Identities=46%  Similarity=0.779  Sum_probs=99.1

Q ss_pred             CccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEeCCCCCee
Q 038934           12 QSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIV   91 (751)
Q Consensus        12 ~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~~~~~~~v   91 (751)
                      ++|++|++|+|+++.|++|||.+......+.+|||.+++ +++||.|||+.|. ...+.|.|+.+|  +|+|.|.+|.+|
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~dG--nLvl~~~~g~~v   77 (116)
T cd00028           2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQSDG--NLVIYDGSGTVV   77 (116)
T ss_pred             cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEecCC--CeEEEcCCCcEE
Confidence            578899999999999999999987654588999999887 8999999999984 445677776655  999999999999


Q ss_pred             eeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCC
Q 038934           92 WSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYP  134 (751)
Q Consensus        92 Wst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~P  134 (751)
                      |+|++.......+|+|+|+|||||++.+    +++||||||||
T Consensus        78 W~S~~~~~~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~~P  116 (116)
T cd00028          78 WSSNTTRVNGNYVLVLLDDGNLVLYDSD----GNFLWQSFDYP  116 (116)
T ss_pred             EEecccCCCCceEEEEeCCCCEEEECCC----CCEEEcCCCCC
Confidence            9999875345568899999999999865    68999999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=4.2e-26  Score=234.81  Aligned_cols=267  Identities=24%  Similarity=0.369  Sum_probs=198.8

Q ss_pred             hHHHHhcCccccccccccccccEEEEEEc----CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeC
Q 038934          426 SIANATDNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKR  500 (751)
Q Consensus       426 ~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  500 (751)
                      .+....+.|...++||+|.|++||++.+.    ..+.||+|.+...  ..-.++.+|+++|..+. +.||+++.+++...
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            34556678899999999999999999853    3678999998654  33467899999999995 99999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-CCCeEEeecc
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFG  579 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFG  579 (751)
                      +...+|+||++.....+++..      ++...+..+++.++.||+++|.+|   ||||||||.|+|.+. -+.-.|.|||
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence            999999999999999998843      678999999999999999999999   999999999999985 4668899999


Q ss_pred             CccccCCCC-------------cc-----------------------------ccccccccccCccCcccccCC-CCCcc
Q 038934          580 MARAFGVDQ-------------TE-----------------------------ANTNRVVGTYGYMPPEYAIDG-LFSVK  616 (751)
Q Consensus       580 la~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~k  616 (751)
                      +|.......             ..                             .......||+||.|||++..- ..+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            998321000             00                             001125699999999998754 57899


Q ss_pred             hhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH-----------HH------HhccCCh---hhh------c--chhc
Q 038934          617 SDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA-----------WR------LWTEDRP---VEL------I--DKSL  668 (751)
Q Consensus       617 ~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~-----------~~------~~~~~~~---~~~------~--d~~l  668 (751)
                      +||||.|||++.+++++.||-....+-. .+...+           ..      .+.....   .++      +  ....
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             cceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            9999999999999999999865443322 111110           00      0110110   000      0  0000


Q ss_pred             cCcc--------CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          669 EDTY--------SLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       669 ~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ....        .......+.+++.+|+..||.+|.|++++|+.
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0000        11122367899999999999999999999964

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=7.7e-27  Score=250.60  Aligned_cols=253  Identities=24%  Similarity=0.347  Sum_probs=201.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|....++|.|.+|.|||++.. .++..|+|.++........-++.|+-+++..+|+|||.+++.+...+.+++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            467888899999999999999954 5889999999887777788889999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +.+|+|.+..   .-...+++.++....+..++||+|||+++   =+|||||-.|||+++.|.+|++|||.+-.+..-..
T Consensus        94 cgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~  167 (829)
T KOG0576|consen   94 CGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA  167 (829)
T ss_pred             cCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh
Confidence            9999999987   35667899999999999999999999999   89999999999999999999999999876643222


Q ss_pred             cccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          590 EANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                        ....+.||+.|||||+..   .+.|..++|||++|+...|+-.-+.|.--..+   +.  ......-...++..+-| 
T Consensus       168 --KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---mr--~l~LmTkS~~qpp~lkD-  239 (829)
T KOG0576|consen  168 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---MR--ALFLMTKSGFQPPTLKD-  239 (829)
T ss_pred             --hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---HH--HHHHhhccCCCCCcccC-
Confidence              223478999999999874   56799999999999999999876666221111   00  00000000111111111 


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                            ...-.+-+.++++.|+-++|++||++..+++
T Consensus       240 ------k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  240 ------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                  1223446778999999999999999987763

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6.4e-26  Score=219.65  Aligned_cols=253  Identities=19%  Similarity=0.312  Sum_probs=192.3

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEece-eeeCCceEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGC-CMKRDERMLIY  507 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~  507 (751)
                      .+.|.+.+.||+|-||.+-++.|+. .+.+|+|.+.+. ....++|.+|...--.| .|.||+.-++. |...+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4689999999999999999999765 678999998654 34567888988776666 48999987764 66677888999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc--CCCCeEEeeccCccccC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFG  585 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFGla~~~~  585 (751)
                      ||++.|+|..-+.    ...+.+....+++.|+++||.|||++.   +||||||.+||||-  +..++||+|||+.+..+
T Consensus       102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999998873    244778888899999999999999999   99999999999993  44579999999987654


Q ss_pred             CCCccccccccccccCccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDG-----LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      ..     ......+..|.|||.....     ...+.+|||.||+++|.+|+|+.|.........   ..+.|..|.....
T Consensus       175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKN  246 (378)
T ss_pred             ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccC
Confidence            21     2223456789999976432     357889999999999999999999653222222   2334555555544


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML  705 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  705 (751)
                      ..+.+.      -....+.+.++..+-|..++++|-...++.++.
T Consensus       247 ~~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  247 PALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ccCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            433222      112345677888999999999997777766544

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=3.6e-25  Score=265.13  Aligned_cols=196  Identities=18%  Similarity=0.227  Sum_probs=137.2

Q ss_pred             HhcC-CcEEeEecee-------eeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCE
Q 038934          484 KLQH-RNLVKLLGCC-------MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI  555 (751)
Q Consensus       484 ~l~h-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i  555 (751)
                      .++| .||+++++.|       .+...+++++|++ +++|.++|..  ....+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4455 5777777776       3334677888987 5599999953  2345899999999999999999999998   9


Q ss_pred             EEccCCCCCeEEcCC-------------------CCeEEeeccCccccCCCCc--------------cccccccccccCc
Q 038934          556 IHRDLKASNVLLDNE-------------------MNPKISDFGMARAFGVDQT--------------EANTNRVVGTYGY  602 (751)
Q Consensus       556 vH~Dikp~NIll~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y  602 (751)
                      +||||||+||||+..                   +.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   4456666666653211000              0000124578899


Q ss_pred             cCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHH
Q 038934          603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQ  682 (751)
Q Consensus       603 ~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  682 (751)
                      +|||++.+..++.++|||||||+||||++|..|+....     .....    ...    ..+.+     ...........
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~----~~~----~~~~~-----~~~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSS----LRH----RVLPP-----QILLNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHH----HHH----hhcCh-----hhhhcCHHHHH
Confidence            99999999999999999999999999999877643110     00000    000    00000     00112234567


Q ss_pred             HHhhhcCCCCCCCCCHHHHHH
Q 038934          683 VGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       683 li~~cl~~dP~~RPs~~evl~  703 (751)
                      ++.+||+.+|.+||+|.|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            889999999999999999986

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.91  E-value=3.9e-24  Score=191.80  Aligned_cols=113  Identities=47%  Similarity=0.804  Sum_probs=97.0

Q ss_pred             CccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEeCCCCCee
Q 038934           12 QSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIV   91 (751)
Q Consensus        12 ~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~~~~~~~v   91 (751)
                      +.|..|++|+|+++.|++|||.+... ..+.+|||++.+ +++||+|||+.|+.++ +.|.|..  ||+|+|.+.+|.+|
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~~--dGnLvl~~~~g~~v   76 (114)
T smart00108        2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQS--DGNLVLYDGDGRVV   76 (114)
T ss_pred             cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEeC--CCCEEEEeCCCCEE
Confidence            56889999999999999999988543 678999999987 8999999999998764 6677765  45999999999999


Q ss_pred             eeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCC
Q 038934           92 WSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDY  133 (751)
Q Consensus        92 Wst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~  133 (751)
                      |+|+++.+....+|+|+|+|||||++..    +++|||||||
T Consensus        77 W~S~t~~~~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~~  114 (114)
T smart00108       77 WSSNTTGANGNYVLVLLDDGNLVIYDSD----GNFLWQSFDY  114 (114)
T ss_pred             EEecccCCCCceEEEEeCCCCEEEECCC----CCEEeCCCCC
Confidence            9999863445568899999999999765    6799999997

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=3.3e-23  Score=201.93  Aligned_cols=166  Identities=19%  Similarity=0.156  Sum_probs=123.1

Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      |+|.+++..  +...+++..++.++.||+.||.|||+++         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            688898853  2346999999999999999999999875         999999999999999  99988654221    


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                         ..||+.|+|||++.+..++.++|||||||++|||++|+.|+......  .................       ....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~-------~~~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPR-------DRSN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCcc-------cccc
Confidence               25789999999999999999999999999999999999997532211  11111110000000000       0001


Q ss_pred             CHHHH--HHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          673 SLSEA--LRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       673 ~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      .....  ..+.+++.+|++.+|.+||++.++++.+..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            11122  268999999999999999999999988754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=4.1e-23  Score=220.55  Aligned_cols=167  Identities=19%  Similarity=0.207  Sum_probs=131.5

Q ss_pred             HHHhcCccccccccccccccEEEEEEc--CCcEEEEEEeccC-----CcccHHHHHHHHHHHHHhcCCcEEe-Eeceeee
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLI--DGQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVK-LLGCCMK  499 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~  499 (751)
                      ....++|...+.||+|+||+||+|.+.  +++.+|||++...     .....+.+.+|+++|++++|+|++. +++    
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----   89 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----   89 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence            445678999999999999999999865  4777899987533     1223567899999999999999985 443    


Q ss_pred             CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccC-CCCCeEEcCCCCeEEeec
Q 038934          500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNEMNPKISDF  578 (751)
Q Consensus       500 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Di-kp~NIll~~~~~~kl~DF  578 (751)
                      ....++||||+++++|....    ..   .   ...++.+++++|.|||+++   |+|||| ||+|||++.++.+||+||
T Consensus        90 ~~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             cCCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence            24689999999999997321    11   1   1467889999999999998   999999 999999999999999999


Q ss_pred             cCccccCCCCcccc------ccccccccCccCcccccCC
Q 038934          579 GMARAFGVDQTEAN------TNRVVGTYGYMPPEYAIDG  611 (751)
Q Consensus       579 Gla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  611 (751)
                      |+++.+........      .....+++.|+|||.+...
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99997754322111      1346788999999998654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.5e-21  Score=209.03  Aligned_cols=259  Identities=22%  Similarity=0.261  Sum_probs=191.2

Q ss_pred             CccccccccccccccEEEEEEcCC--cEEEEEEeccCCcccHHHHHHHHHHHHHhcC----CcEEeEecee-eeCCceEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLIDG--QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH----RNLVKLLGCC-MKRDERML  505 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  505 (751)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|+.++..+..    +++.++++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999996553  4788888766533333378889999999873    6888888888 47778899


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-----CCeEEeeccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-----MNPKISDFGM  580 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-----~~~kl~DFGl  580 (751)
                      ||+.+ |.+|.++..... .+.++..++++|+.|++.+|.+||+.|   ++||||||+|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 779999875443 567999999999999999999999999   9999999999999865     4599999999


Q ss_pred             cc--ccCCCCc----ccc--ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH
Q 038934          581 AR--AFGVDQT----EAN--TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       581 a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ++  .+.....    ...  ....+||..|++++...+...+.+.|+||++.++.+++.|..|...........      
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~------  247 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS------  247 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH------
Confidence            99  3322211    111  123669999999999999999999999999999999999998753221111100      


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                       .+...........     ........+.++...+-..+..++|....+...|...
T Consensus       248 -~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  248 -KFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             -HHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence             0000000011110     1111223444555555558999999999998887654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=1.9e-20  Score=199.64  Aligned_cols=261  Identities=29%  Similarity=0.374  Sum_probs=198.2

Q ss_pred             ccccccccccccccEEEEEEcCCcEEEEEEeccCCcc---cHHHHHHHHHHHHHhcCC-cEEeEeceeeeCCceEEEEEe
Q 038934          434 FSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQ---GVEEFKNEVLLIAKLQHR-NLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~  509 (751)
                      |...+.||.|+|+.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+++......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566778999999999999976  88999999765333   367899999999999988 799999999777778999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC-CeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~  588 (751)
                      +.++++.+++........+.......++.|++.++.|+|+.+   ++||||||+||+++..+ .++++|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977743221136889999999999999999999999   99999999999999988 79999999998664433


Q ss_pred             ccc----cccccccccCccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc-cccchhHHHHHHhccCCh
Q 038934          589 TEA----NTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVD-HHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       589 ~~~----~~~~~~gt~~y~aPE~~~~---~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  660 (751)
                      ...    ......|+..|+|||.+.+   .......|+||+|++++++++|..|+...... .........    .....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII----LELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH----HhcCC
Confidence            221    2355789999999999988   57899999999999999999999995443321 011111111    11110


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      . .................+.+++..|+..+|..|.++.+....
T Consensus       233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0 000000000002223567789999999999999999988763

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=5.4e-21  Score=190.67  Aligned_cols=199  Identities=21%  Similarity=0.320  Sum_probs=172.2

Q ss_pred             cCccccccccccccccEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      -+|+++++||+|.||+++.|+ +-++++||||.-...  ...-++..|.+..+.|. .++|..++.|-.++.+-.||+|+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            478999999999999999999 668999999985433  45578899999999985 79999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-----CCeEEeeccCcccc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-----MNPKISDFGMARAF  584 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-----~~~kl~DFGla~~~  584 (751)
                      + |-||+|++.-..  ..++.++++.+|.|++.-++|+|++.   +|.|||||+|+||..-     ..+.|+|||+|+.+
T Consensus       106 L-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 779999875433  35899999999999999999999999   9999999999999643     45899999999998


Q ss_pred             CCCCcccc-----ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 038934          585 GVDQTEAN-----TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGF  638 (751)
Q Consensus       585 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~  638 (751)
                      ....+...     .....||..||+=....|.+.+.+.|+=|||-+++..|-|..|+..
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            65544432     2347799999999999999999999999999999999999999653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.3e-20  Score=180.08  Aligned_cols=202  Identities=21%  Similarity=0.305  Sum_probs=169.4

Q ss_pred             hcCccccccccccccccEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC-CcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ...|.+.++||.|+||.+|.|. ..+|..||||.-+...  ...++..|..+.+.|+| ..|..+..+..+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4689999999999999999999 5579999999965443  33578889999999974 788888999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---CCCeEEeeccCccccC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFG  585 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~~~  585 (751)
                      .+ |-||++++.-..  ..++.++++.++-|++.-++|+|.++   .|||||||+|+|..-   ...+.++|||+|+.+.
T Consensus        92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 779999875433  34788999999999999999999999   999999999999864   3569999999999874


Q ss_pred             CCCccc-----cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 038934          586 VDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHH  640 (751)
Q Consensus       586 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~  640 (751)
                      ...+..     ......||..|++-....+...+.+.|+=|+|.+|..+..|..|+..-.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            322221     1234779999999888888888999999999999999999999965433

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=6e-22  Score=225.34  Aligned_cols=252  Identities=20%  Similarity=0.256  Sum_probs=186.9

Q ss_pred             cccccccccccccEEEEEEc-CCcEEEEEEecc---CCcc---cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          435 SEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSK---SSGQ---GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ...+.+|.|.+|.|+..... .....+.|....   ....   ....+..|+.+-..+.|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34568999999988777643 334444444321   1111   1112566777778889999998888887777777779


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++ +|..++.   ....+...++..++.|++.|+.|||+.|   |.||||||+|+++..+|.+||+|||.+..+..+
T Consensus       401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999984   3346888999999999999999999999   999999999999999999999999999988665


Q ss_pred             Ccc--ccccccccccCccCcccccCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          588 QTE--ANTNRVVGTYGYMPPEYAIDGLFSV-KSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       588 ~~~--~~~~~~~gt~~y~aPE~~~~~~~t~-k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ...  .....++|+..|+|||.+.+..|.+ .+||||.|+++..|++|+.|+......+....       ........  
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-------~~~~~~~~--  544 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-------TNNYSDQR--  544 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-------hhcccccc--
Confidence            554  4455688999999999999999976 59999999999999999988655443322110       00000000  


Q ss_pred             chhccCc--cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          665 DKSLEDT--YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       665 d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       ....+.  .......+...++.+||+.||.+|.|+.+|++
T Consensus       545 -~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  545 -NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             -ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence             000111  11223446678999999999999999999985

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.4e-21  Score=189.40  Aligned_cols=245  Identities=21%  Similarity=0.320  Sum_probs=189.2

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCC
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKS  514 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs  514 (751)
                      ..+|.+...|..|+|++ .|..+++|++...  .....+.|..|.-.|+...||||+.+++.|.....+.++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            44788999999999999 5566777877533  33344678899999999999999999999999999999999999999


Q ss_pred             hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEE-ccCCCCCeEEcCCCCeEEe--eccCccccCCCCccc
Q 038934          515 LADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH-RDLKASNVLLDNEMNPKIS--DFGMARAFGVDQTEA  591 (751)
Q Consensus       515 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH-~Dikp~NIll~~~~~~kl~--DFGla~~~~~~~~~~  591 (751)
                      |...+++. ..-.++..++.+++.++++|++|||+..  +++- --|....+++|++.+.+|.  |--++-         
T Consensus       274 lynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsf---------  341 (448)
T KOG0195|consen  274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------  341 (448)
T ss_pred             HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeee---------
Confidence            99999653 3345678889999999999999999987  3443 3588899999999887764  211110         


Q ss_pred             cccccccccCccCcccccCCCC---CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLF---SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~---t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      ......-.|.||+||.++..+-   -.++|+|||.++||||.|...||.--.+-+-               -.++.-.-+
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec---------------gmkialegl  406 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------------GMKIALEGL  406 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------------hhhhhhccc
Confidence            0111344688999999987764   3689999999999999999999753222111               111222234


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      +-..++.....+.+|+.-|+..||.+||.+..|+-+||++.
T Consensus       407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            45566777788999999999999999999999999998764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=1.5e-20  Score=186.75  Aligned_cols=171  Identities=13%  Similarity=0.181  Sum_probs=134.4

Q ss_pred             HhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHH---H------HHHHHHHHHHhcCCcEEeEeceeeeC
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVE---E------FKNEVLLIAKLQHRNLVKLLGCCMKR  500 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~~~~  500 (751)
                      ...+|+..+.||.|+||.||+... +++.+|||.+........+   .      +.+|+..+.+++|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            458999999999999999999665 6778999999754322222   2      68999999999999999998886543


Q ss_pred             --------CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC
Q 038934          501 --------DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  572 (751)
Q Consensus       501 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~  572 (751)
                              ...++||||++|.+|.++..       +++    ....+++.+|..||+.+   ++||||||.||++++++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999988741       222    24568999999999999   99999999999999988 


Q ss_pred             eEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHH
Q 038934          573 PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV  630 (751)
Q Consensus       573 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell  630 (751)
                      ++|+|||.......+....              .++....+..++|+|+||+.+..+.
T Consensus       173 i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence            9999999887542111111              1344455778999999999988765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=3.2e-20  Score=182.49  Aligned_cols=139  Identities=17%  Similarity=0.156  Sum_probs=108.4

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCCcc--c-------H-----------------HHHHHHHHHHHHhcCCcE
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQ--G-------V-----------------EEFKNEVLLIAKLQHRNL  490 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni  490 (751)
                      .+.||+|+||.||+|...+|+.||||+++.....  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4579999999999999878999999999754211  1       1                 122459999999987766


Q ss_pred             EeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCEEEccCCCCCeEEcC
Q 038934          491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL-HQDSRLRIIHRDLKASNVLLDN  569 (751)
Q Consensus       491 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivH~Dikp~NIll~~  569 (751)
                      .....+.  ....+|||||++++++...+.   ....++...+..++.|++.+|.+| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            4332221  223389999999987765542   234688999999999999999999 6888   99999999999998 


Q ss_pred             CCCeEEeeccCcccc
Q 038934          570 EMNPKISDFGMARAF  584 (751)
Q Consensus       570 ~~~~kl~DFGla~~~  584 (751)
                      ++.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=9.3e-21  Score=214.18  Aligned_cols=251  Identities=20%  Similarity=0.262  Sum_probs=186.4

Q ss_pred             CccccccccccccccEEEEEEcCCcEEEEEEeccCC-cccHHHHHHHHHH--HHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSS-GQGVEEFKNEVLL--IAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++...+.||.+.|=+|.+++++.|. |+||++-+.. .-..+.|.++++-  ...++|||.+.+...-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            6677889999999999999997877 9999987664 3344555554444  4445899999998887777888999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc--CCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVD  587 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~--~~~  587 (751)
                      ..+ +|.|.+   ..+..+..-+...|+.|++.||..+|..+   |+|+|||.+||||+.-+-+.|+||-.-+..  +.+
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            866 888888   67777888899999999999999999999   999999999999999999999999877643  222


Q ss_pred             Ccccc---ccccccccCccCcccccCC----------C-CCcchhhHHHHHHHHHHHhC-CCCCCCCCCccccchhHHHH
Q 038934          588 QTEAN---TNRVVGTYGYMPPEYAIDG----------L-FSVKSDVFSFGVLVLELVYG-TRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       588 ~~~~~---~~~~~gt~~y~aPE~~~~~----------~-~t~k~DVwSlG~ll~ell~G-~~p~~~~~~~~~~~~~~~~~  652 (751)
                      +...-   ..+...-.+|+|||.+...          + .+++.||||+||++.||++- +++|...      ++..  +
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a--Y  247 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA--Y  247 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh--H
Confidence            22111   1122334579999988531          2 67899999999999999875 6555421      1111  1


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      +.-....+..+++.+        +...+.+++..|++.||++|.++++.|+.-.+
T Consensus       248 r~~~~~~~e~~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  248 RSGNADDPEQLLEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             hccCccCHHHHHHhC--------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            111122222222221        12367899999999999999999999987544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.9e-19  Score=176.29  Aligned_cols=140  Identities=19%  Similarity=0.220  Sum_probs=111.1

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCCccc--------------------------HHHHHHHHHHHHHhcCCcE
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQG--------------------------VEEFKNEVLLIAKLQHRNL  490 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni  490 (751)
                      .+.||+|++|.||+|.+.+|+.||||+++......                          ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999997789999999997542110                          1224678999999999887


Q ss_pred             EeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeEEcC
Q 038934          491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN  569 (751)
Q Consensus       491 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIll~~  569 (751)
                      .....+...  ..+|||||++++++.....   ....++...+..++.|++.++.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544333322  3489999999986544322   22357788999999999999999999 88   99999999999999 


Q ss_pred             CCCeEEeeccCccccC
Q 038934          570 EMNPKISDFGMARAFG  585 (751)
Q Consensus       570 ~~~~kl~DFGla~~~~  585 (751)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            7899999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=4.1e-19  Score=181.82  Aligned_cols=233  Identities=21%  Similarity=0.291  Sum_probs=151.6

Q ss_pred             CccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHhc----------CCcEEeEecee-
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ----------HRNLVKLLGCC-  497 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~-  497 (751)
                      .+...+.||.|+++.||.+++.. ++++|+|+....   .....+++++|...+..+.          |-.++..++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            44567789999999999999865 899999998643   3345677777776554432          21222222221 


Q ss_pred             --------eeCC--------ceEEEEEecCCCChhHHHhc---cC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEE
Q 038934          498 --------MKRD--------ERMLIYEYLPNKSLADFIFD---GT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH  557 (751)
Q Consensus       498 --------~~~~--------~~~lV~E~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH  557 (751)
                              ....        ..+++|+-+ .++|.+++..   .. ....+....++.+..|+++.+++||..|   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                    1111        235677777 4588877532   11 1233445566777899999999999999   999


Q ss_pred             ccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccC--------CCCCcchhhHHHHHHHHHH
Q 038934          558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID--------GLFSVKSDVFSFGVLVLEL  629 (751)
Q Consensus       558 ~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~k~DVwSlG~ll~el  629 (751)
                      +||+|+|++++.+|.++|+||+.....+.....     ...+..|.+||....        ..++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999987765422111     234578999997643        2578999999999999999


Q ss_pred             HhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCC
Q 038934          630 VYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDR  695 (751)
Q Consensus       630 l~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R  695 (751)
                      +++..|++...+......                    .-..+. +.++.+..||..+|+.||.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999886544322111                    112334 667788899999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.4e-18  Score=168.91  Aligned_cols=183  Identities=20%  Similarity=0.141  Sum_probs=138.2

Q ss_pred             ccccccccccccEEEEEEcCCcEEEEEEeccCCcc----cHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEEec
Q 038934          436 EENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQ----GVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       436 ~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      +...|++|+||+||.+.. .+.+++.+.+.....-    ....+.+|+++|++|+ |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456899999999997765 6788888887554321    1125789999999995 5788888876    4569999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccC-CCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Di-kp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      .|.+|...+.         . ....++.|++++|.++|+++   |+|||| ||+|||+++++.++|+|||+|........
T Consensus        81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            9999876441         1 12357889999999999999   999999 79999999999999999999986543221


Q ss_pred             c----c--c-----ccccccccCccCcccccCC-CCC-cchhhHHHHHHHHHHHhCCCCC
Q 038934          590 E----A--N-----TNRVVGTYGYMPPEYAIDG-LFS-VKSDVFSFGVLVLELVYGTRNR  636 (751)
Q Consensus       590 ~----~--~-----~~~~~gt~~y~aPE~~~~~-~~t-~k~DVwSlG~ll~ell~G~~p~  636 (751)
                      .    .  .     ......++.|++|+...-- ..+ .+.+.++.|.-+|.++|++.+.
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            0    0  0     1112357788888754322 223 6789999999999999998774

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.1e-19  Score=196.98  Aligned_cols=230  Identities=27%  Similarity=0.307  Sum_probs=181.1

Q ss_pred             cccccccccEEEEE----EcCCcEEEEEEeccCCcc--cHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEEecC
Q 038934          439 KLGEGGFGPVYKGM----LIDGQEIAVKRLSKSSGQ--GVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      .+|+|.||.|++++    ...+.-+|+|.+.+....  .......|..++...+ ||.+|+++..+..+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999765    234777899988765221  1124567888888887 9999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +|.|...+   .......+.....+...++-++.++|+.+   |+|||+|++||+++.+|++++.|||+.+..-....  
T Consensus        81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            99998887   34455677777888889999999999998   99999999999999999999999999987532211  


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc--
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE--  669 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--  669 (751)
                          .+||..|||||++.  ....++|.||||++++||++|..||..                       +.+..++.  
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------------------~~~~~Il~~~  203 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------------------DTMKRILKAE  203 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------------------HHHHHHhhhc
Confidence                28999999999998  568899999999999999999999763                       11111111  


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCH--HHHHHHH
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNM--ASVVLML  705 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~L  705 (751)
                      -..+......+.+++..++..+|..|.-.  ..+.+.+
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik  241 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK  241 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence            22344555677788888899999999766  3444443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.7e-18  Score=200.51  Aligned_cols=199  Identities=21%  Similarity=0.276  Sum_probs=159.2

Q ss_pred             HHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc---CCcEEeEeceeeeCCceE
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  504 (751)
                      ....+.|.+.+.||+|+||.||+|...+++.||+|+-+....-.   |.--.+++.+|+   -+-|..+..++.-.+..+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            44457888999999999999999998889999999976553321   111112222222   244556666667788889


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-------CCCeEEee
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------EMNPKISD  577 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-------~~~~kl~D  577 (751)
                      ||+||.+.|+|.+++.   ..+.+++..+..++.|+++-+.+||..+   |||+||||+|+||..       ..-++|+|
T Consensus       771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999999994   6778999999999999999999999999   999999999999942       34599999


Q ss_pred             ccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRN  635 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p  635 (751)
                      ||.+-.+..-..........+|-.+-.+|+..|.+++..+|.|.|+.+++-||.|+.-
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9998654332233344557889999999999999999999999999999999999653

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=5.4e-18  Score=168.18  Aligned_cols=136  Identities=21%  Similarity=0.295  Sum_probs=106.8

Q ss_pred             cccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHh-----cCCcEEeEeceeeeCC---c-eEE
Q 038934          435 SEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-----QHRNLVKLLGCCMKRD---E-RML  505 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l  505 (751)
                      ...+.||+|+||.||.  ++.....+||++........+.+.+|+.+++++     .||||++++++++++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3456899999999996  544344479998765445567899999999999     5799999999998874   3 337


Q ss_pred             EEEe--cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCEEEccCCCCCeEEcC----CCCeEEeec
Q 038934          506 IYEY--LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL-LYLHQDSRLRIIHRDLKASNVLLDN----EMNPKISDF  578 (751)
Q Consensus       506 V~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~yLH~~~~~~ivH~Dikp~NIll~~----~~~~kl~DF  578 (751)
                      |+||  +.+++|.+++.+    ..+++.  ..++.+++.++ .|||+++   |+||||||+|||++.    +..++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  568999999954    224554  35677888777 9999999   999999999999974    347999995


Q ss_pred             cCc
Q 038934          579 GMA  581 (751)
Q Consensus       579 Gla  581 (751)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.72  E-value=2.1e-17  Score=179.61  Aligned_cols=216  Identities=23%  Similarity=0.389  Sum_probs=162.1

Q ss_pred             HHHhcCCcEEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCE-EEccC
Q 038934          482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI-IHRDL  560 (751)
Q Consensus       482 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i-vH~Di  560 (751)
                      |+++.|.|+.+++|.+.++...+.|.+|+..|+|.|.+..  ....+++.....++++|+.||.|||...   | .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence            3568899999999999999999999999999999999965  3456899999999999999999999876   4 99999


Q ss_pred             CCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCC-------CCCcchhhHHHHHHHHHHHhCC
Q 038934          561 KASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-------LFSVKSDVFSFGVLVLELVYGT  633 (751)
Q Consensus       561 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~k~DVwSlG~ll~ell~G~  633 (751)
                      +..|.++|....+||+|||+.................-..-|.|||.+.+.       ..+.+.||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998765321111111112234569999998764       2477899999999999999999


Q ss_pred             CCCCCCCCcccc-chhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          634 RNRGFHHVDHHH-NLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       634 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      .|++........ .++.....   .+.  ..+-+.+....  +....+..++..|+..+|.+||++..|-..++.+.
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~---~~~--~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK---GGS--NPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             CccccccccCChHHHHHHHHh---cCC--CCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            998765443322 22222211   011  11111111000  22336889999999999999999999998887653

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.3e-17  Score=170.02  Aligned_cols=197  Identities=19%  Similarity=0.251  Sum_probs=135.9

Q ss_pred             cCCcEEeEeceeee---------------------------CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHH
Q 038934          486 QHRNLVKLLGCCMK---------------------------RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG  538 (751)
Q Consensus       486 ~h~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  538 (751)
                      .|||||++.++|.+                           ...+|+||.-.+. +|.+++...    ..+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence            59999999988753                           2357889888755 888888432    346667778999


Q ss_pred             HHHHHHHHHHhCCCCCEEEccCCCCCeEE--cCCC--CeEEeeccCccccCC-----CCccccccccccccCccCccccc
Q 038934          539 GIARGLLYLHQDSRLRIIHRDLKASNVLL--DNEM--NPKISDFGMARAFGV-----DQTEANTNRVVGTYGYMPPEYAI  609 (751)
Q Consensus       539 ~i~~~L~yLH~~~~~~ivH~Dikp~NIll--~~~~--~~kl~DFGla~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~  609 (751)
                      |+++|+.|||.++   |.|||+|.+||||  |+++  .+.|+|||.+-.-..     +.... ....-|...-||||+..
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~-~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESD-EVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccc-cccCCCcceecchhhhh
Confidence            9999999999999   9999999999998  4444  478999998653221     11111 11234667789999987


Q ss_pred             CCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHH
Q 038934          610 DGL------FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQV  683 (751)
Q Consensus       610 ~~~------~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  683 (751)
                      ..+      .-.|+|.|+.|.+.||++....||-....    ..+...  .+.+...         ...+......+.++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe----m~L~~r--~Yqe~qL---------Palp~~vpp~~rql  489 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE----MLLDTR--TYQESQL---------PALPSRVPPVARQL  489 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch----heechh--hhhhhhC---------CCCcccCChHHHHH
Confidence            543      23689999999999999988888643111    000000  0111111         11222334567789


Q ss_pred             HhhhcCCCCCCCCCHHHHHHHHh
Q 038934          684 GLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       684 i~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      +...|+.||.+|++..-...+|+
T Consensus       490 V~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHHH
Confidence            99999999999999877665553

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=8.1e-17  Score=163.79  Aligned_cols=148  Identities=16%  Similarity=0.160  Sum_probs=114.2

Q ss_pred             HHHhcCccccccccccccccEEEEE--EcCCcEEEEEEeccCCcc------------------------cHHHHHHHHHH
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGM--LIDGQEIAVKRLSKSSGQ------------------------GVEEFKNEVLL  481 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~  481 (751)
                      .+....|.+.+.||+|+||.||+|.  ..+|+.||||++......                        ....+.+|+.+
T Consensus        24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            3444468888999999999999998  457999999998753210                        11235789999


Q ss_pred             HHHhcCC--cEEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEcc
Q 038934          482 IAKLQHR--NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD  559 (751)
Q Consensus       482 l~~l~h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~D  559 (751)
                      +.++.+.  .+.++++.    ...++||||+++.+|...+.   ....+....+..++.|++.+|.+||+++  .|+|+|
T Consensus       104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~D  174 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGD  174 (237)
T ss_pred             HHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCC
Confidence            9999753  34444442    23589999999988876652   2234556677899999999999999886  499999


Q ss_pred             CCCCCeEEcCCCCeEEeeccCccccC
Q 038934          560 LKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       560 ikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |||+||+++ ++.++|+|||.+...+
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhccC
Confidence            999999999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1.5e-16  Score=159.91  Aligned_cols=134  Identities=21%  Similarity=0.300  Sum_probs=113.5

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCcc--------cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQ--------GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +.||+|++|.||+|.+ .+..+++|+.......        ....+.+|+.++..+.|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 7788999986533211        124578899999999999988777777778889999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++|++|.+++...      .. .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998431      12 78899999999999999998   99999999999999 78899999998864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.69  E-value=6.9e-18  Score=179.70  Aligned_cols=175  Identities=23%  Similarity=0.331  Sum_probs=130.4

Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      .+++.|+++...+|.++|.........++...+.++.|++.|+.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999765555567888999999999999999   66   999999999999999999999999999


Q ss_pred             cccCCCC----ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCccccchhHHHHHHhc
Q 038934          582 RAFGVDQ----TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG-TRNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       582 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G-~~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                      .......    .........||..||+||.+.+..|+.|+||||||++|+||+.- ..+++          ...+..-+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhh
Confidence            8765443    12234457899999999999999999999999999999999962 21111          000111111


Q ss_pred             cCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 038934          657 EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV  701 (751)
Q Consensus       657 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  701 (751)
                      .+    .+.+.....     ...-..|+.+++...|.+||++.++
T Consensus       474 ~g----~ip~~~~~d-----~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  474 DG----IIPPEFLQD-----YPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             cC----CCChHHhhc-----CcHHHHHHHHhcCCCcccCchHHHH
Confidence            11    111111111     1233578899999999999954443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=1.6e-16  Score=157.90  Aligned_cols=145  Identities=19%  Similarity=0.222  Sum_probs=113.8

Q ss_pred             HhHHHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCc----------------------ccHHHHHHHHHHH
Q 038934          425 KSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG----------------------QGVEEFKNEVLLI  482 (751)
Q Consensus       425 ~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l  482 (751)
                      .++.+....|...+.||+|+||.||++...+|+.||||++.....                      .....+..|+.++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            344455555888899999999999999988899999998754321                      0112367889999


Q ss_pred             HHhcCCc--EEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccC
Q 038934          483 AKLQHRN--LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL  560 (751)
Q Consensus       483 ~~l~h~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Di  560 (751)
                      ..+.|++  ++..++    ....++||||+++++|..+..         ......++.+++.++.++|+.+   |+|+||
T Consensus        88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl  151 (198)
T cd05144          88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDL  151 (198)
T ss_pred             HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence            9998774  444443    245589999999999877542         1345678899999999999988   999999


Q ss_pred             CCCCeEEcCCCCeEEeeccCccccC
Q 038934          561 KASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       561 kp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||+||++++++.++|+|||++..+.
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.68  E-value=2.7e-16  Score=156.53  Aligned_cols=130  Identities=24%  Similarity=0.380  Sum_probs=107.0

Q ss_pred             cccccccccEEEEEEcCCcEEEEEEeccCCc--------ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .||+|+||.||+|.+ +++.+++|+......        ...+++.+|++++..++|+++....-++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999995 678899998654311        12356789999999999887665555556677789999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      +|++|.+++....          ..++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999873211          078999999999999998   99999999999999 78999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=2.6e-16  Score=180.16  Aligned_cols=145  Identities=19%  Similarity=0.334  Sum_probs=116.5

Q ss_pred             cHHhHHHHhcCccccccccccccccEEEEEEcCCcEEEEEEe-ccCC-------cccHHHHHHHHHHHHHhcCCcEEeEe
Q 038934          423 DWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRL-SKSS-------GQGVEEFKNEVLLIAKLQHRNLVKLL  494 (751)
Q Consensus       423 ~~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~  494 (751)
                      +|.........|...++||+|+||.||++.+... .+++|+. .+..       ....+++.+|++++.+++|++++...
T Consensus       324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~  402 (535)
T PRK09605        324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV  402 (535)
T ss_pred             eeccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence            3444444456667788999999999999987544 3444433 2211       11235688999999999999998888


Q ss_pred             ceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeE
Q 038934          495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK  574 (751)
Q Consensus       495 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k  574 (751)
                      .++......++||||+++++|.+++.           ....++.+++++|.+||+.+   ++||||||+|||+ +++.++
T Consensus       403 ~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~  467 (535)
T PRK09605        403 IYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLY  467 (535)
T ss_pred             EEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEE
Confidence            88877788899999999999999883           35679999999999999998   9999999999999 677899


Q ss_pred             EeeccCccc
Q 038934          575 ISDFGMARA  583 (751)
Q Consensus       575 l~DFGla~~  583 (751)
                      |+|||+++.
T Consensus       468 liDFGla~~  476 (535)
T PRK09605        468 LIDFGLGKY  476 (535)
T ss_pred             EEeCccccc
Confidence            999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=6.3e-17  Score=183.63  Aligned_cols=216  Identities=20%  Similarity=0.282  Sum_probs=147.0

Q ss_pred             HhcCccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ...+|..++.|..|++|.||..+++. .+.+|+ ++.+..-    -+++   ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l----ilRn---ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL----ILRN---ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhh-cccccch----hhhc---cccccCCccee-----------------
Confidence            34688889999999999999999864 677888 4433210    0011   22222334333                 


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                          |+=..++   ...+.++...        +.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+.+......
T Consensus       136 ----gDc~tll---k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----GDCATLL---KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----chhhhhc---ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                2323333   1223344333        67899999999   9999999999999999999999999988642111


Q ss_pred             -------------ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh
Q 038934          589 -------------TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       589 -------------~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                                   .+.....++||+.|+|||++....|...+|+|++|+|+||.+.|+.||....+++....+......|
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence                         1111234789999999999999999999999999999999999999987665543322111111111


Q ss_pred             ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 038934          656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV  702 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  702 (751)
                      .++              ......++.+++.+.|+.+|..|--....+
T Consensus       278 pE~--------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  278 PEE--------------DEALPPEAQDLIEQLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             ccc--------------CcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence            111              222334677889999999999995544443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=1.5e-14  Score=136.31  Aligned_cols=134  Identities=22%  Similarity=0.213  Sum_probs=114.4

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC--CcEEeEeceeeeCCceEEEEEecCCCC
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVKLLGCCMKRDERMLIYEYLPNKS  514 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gs  514 (751)
                      .+.||+|.++.||++...+ +.+++|.......  ...+.+|+.++..++|  .++++++.+....+..+++|||+++..
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4679999999999999744 7899999865433  5678999999999976  588999988888888999999999877


Q ss_pred             hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          515 LADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       515 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      +..+          +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            6543          4566678899999999999986545699999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.58  E-value=1.5e-15  Score=120.94  Aligned_cols=66  Identities=53%  Similarity=1.083  Sum_probs=58.7

Q ss_pred             cccCCceeEeecccCCCCcccccccCCCHHHHHHhhhccccccccccccccCCCcceeEeeeccccc
Q 038934          325 CERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGGGSGCLLWFHELTDM  391 (751)
Q Consensus       325 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~g~~gC~~w~~~L~~~  391 (751)
                      |+.+|+|+++++|++|++....++.++++++|+..|++||||+||+|.+.+ ++++|++|.++|+++
T Consensus         1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~   66 (66)
T PF08276_consen    1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL   66 (66)
T ss_pred             CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence            545689999999999999877777789999999999999999999998776 678999999999874

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=1.2e-14  Score=143.09  Aligned_cols=136  Identities=20%  Similarity=0.269  Sum_probs=98.2

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCCcc--cHHH----------------------HHHHHHHHHHhcCCc--E
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQ--GVEE----------------------FKNEVLLIAKLQHRN--L  490 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i  490 (751)
                      .+.||+|+||.||+|...+++.||||++......  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4579999999999999878999999998653211  1111                      135666666664432  3


Q ss_pred             EeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeEEcC
Q 038934          491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN  569 (751)
Q Consensus       491 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIll~~  569 (751)
                      .+.+++    ...++||||++++.+.........   . ...+..++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444433    246899999999544321111000   1 15677899999999999999 87   99999999999999 


Q ss_pred             CCCeEEeeccCcccc
Q 038934          570 EMNPKISDFGMARAF  584 (751)
Q Consensus       570 ~~~~kl~DFGla~~~  584 (751)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            889999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=2.9e-14  Score=145.40  Aligned_cols=134  Identities=19%  Similarity=0.266  Sum_probs=104.9

Q ss_pred             cccc-ccccccEEEEEEcCCcEEEEEEeccCC-------------cccHHHHHHHHHHHHHhcCCcE--EeEeceeeeCC
Q 038934          438 NKLG-EGGFGPVYKGMLIDGQEIAVKRLSKSS-------------GQGVEEFKNEVLLIAKLQHRNL--VKLLGCCMKRD  501 (751)
Q Consensus       438 ~~IG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~  501 (751)
                      ..|| .||.|+||++.. .+..+|||++....             ......+.+|++++.+|+|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 899999999987 47789999885321             1223568899999999998774  67777654432


Q ss_pred             c----eEEEEEecCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEe
Q 038934          502 E----RMLIYEYLPN-KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  576 (751)
Q Consensus       502 ~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~  576 (751)
                      .    .++|||++++ .+|.+++.+    ..++..    .+.+|+.+|.+||+.+   |+|+||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    2599999997 689988743    234443    3578999999999999   9999999999999998999999


Q ss_pred             eccCccc
Q 038934          577 DFGMARA  583 (751)
Q Consensus       577 DFGla~~  583 (751)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=6.2e-16  Score=176.32  Aligned_cols=254  Identities=22%  Similarity=0.271  Sum_probs=192.8

Q ss_pred             cCccccccccccccccEEEEEEcC--CcEEEEEEeccCC--cccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID--GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  506 (751)
                      ..|...+.||+|.|+.|-......  ...+|+|.+....  ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456777789999999998877543  4456777765443  334455666888888887 99999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCEEEccCCCCCeEEcCCC-CeEEeeccCcccc
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH-QDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF  584 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~  584 (751)
                      .|+..++++.+.+.. ......+...+-.++.|+..++.|+| ..+   +.|+||||+|.+++..+ .++++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999999998842 12213556677789999999999999 777   99999999999999999 9999999999988


Q ss_pred             CC-CCcccccccccc-ccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          585 GV-DQTEANTNRVVG-TYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       585 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      .. ..........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|.........              +..
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------------~~~  241 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------------RYS  241 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--------------cce
Confidence            76 555555566788 9999999999885 457889999999999999999998665443221              111


Q ss_pred             hhcchhcc--CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 ELIDKSLE--DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 ~~~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ..+.....  ...-........++..+++..+|..|.+.+++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  242 SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             eecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            11111100  0111122335567888899999999999988863

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.45  E-value=6.7e-14  Score=140.24  Aligned_cols=207  Identities=21%  Similarity=0.210  Sum_probs=142.8

Q ss_pred             HHHHHHHHhcCCcEEeEeceeeeC-----CceEEEEEecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 038934          477 NEVLLIAKLQHRNLVKLLGCCMKR-----DERMLIYEYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQD  550 (751)
Q Consensus       477 ~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~  550 (751)
                      .-..-|-++.|.|||+++.++.+.     .+..++.|||+.|+|..+|.+. ...+.+......+++.||+.||.|||+.
T Consensus       116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            334456677899999999998654     3578999999999999999763 3345678888889999999999999997


Q ss_pred             CCCCEEEccCCCCCeEEcCCCCeEEeeccCccc--cCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHH
Q 038934          551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA--FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE  628 (751)
Q Consensus       551 ~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~e  628 (751)
                      . ++|+|+++..+.|++..+|-+||.----...  .-.......+....+-++|.|||.=.....+.++|||+||+..+|
T Consensus       196 ~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  196 D-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             C-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence            5 7899999999999999999888753211110  000111112233456789999998777778889999999999999


Q ss_pred             HHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          629 LVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       629 ll~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      |..+............               ..+.+..    .....+...-..++.+|++..|..||+|.+++.
T Consensus       275 mailEiq~tnseS~~~---------------~ee~ia~----~i~~len~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVE---------------VEENIAN----VIIGLENGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHheeccCCCcceee---------------hhhhhhh----heeeccCccccCcCcccccCCCCCCcchhhhhc
Confidence            9877443111100000               0000111    001111112235778899999999999999874

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.44  E-value=9e-13  Score=146.03  Aligned_cols=140  Identities=23%  Similarity=0.314  Sum_probs=100.3

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCcccH----------------------------------------HHHHH
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGV----------------------------------------EEFKN  477 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~  477 (751)
                      +.||.|++|.||+|++++|+.||||+.+.......                                        -.|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            68999999999999999999999999864321110                                        02445


Q ss_pred             HHHHHHHhc----CCcEEeEeceee-eCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 038934          478 EVLLIAKLQ----HRNLVKLLGCCM-KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR-GLLYLHQDS  551 (751)
Q Consensus       478 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~yLH~~~  551 (751)
                      |+..+.++.    |.+-+.+-.++. .....+|||||++|++|.++......  ..   ....++..++. .+..+|..+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence            665555552    333334333332 24567999999999999987642111  11   23456666665 468889888


Q ss_pred             CCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       552 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                         ++|+|+||.||++++++.++++|||++..+.
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               9999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.29  E-value=2.8e-12  Score=105.37  Aligned_cols=71  Identities=25%  Similarity=0.425  Sum_probs=61.1

Q ss_pred             cccCCceeEeecccCCCCcccccccCCCHHHHHHhhhc---cccccccccccccCCCcceeEeeecc-ccccccccCccc
Q 038934          325 CERGDGFLKRESVKLPDTRFSRVDKNISLFECKELCSK---NCSCTAYANADVRGGGSGCLLWFHEL-TDMKILSEGGQD  400 (751)
Q Consensus       325 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---~CsC~a~~~~~~~~g~~gC~~w~~~L-~~~~~~~~~gqd  400 (751)
                      |....+|+++.+||+|++..      +++++|++.|++   ||||+||+|.+.   +.||++|.+.+ ++++.....+++
T Consensus         5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~   75 (80)
T cd00129           5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD   75 (80)
T ss_pred             eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence            33456899999999998754      689999999999   999999999754   25899999999 999888888999


Q ss_pred             ceee
Q 038934          401 LYIR  404 (751)
Q Consensus       401 l~i~  404 (751)
                      +|+|
T Consensus        76 Ly~r   79 (80)
T cd00129          76 LYEN   79 (80)
T ss_pred             eEeE
Confidence            9987

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.28  E-value=1.5e-11  Score=137.78  Aligned_cols=144  Identities=19%  Similarity=0.251  Sum_probs=95.9

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccCCccc----------------------------------HHH-
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQG----------------------------------VEE-  474 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~-  474 (751)
                      ...|+. +.||+|++|.||+|++++ |+.||||+++......                                  .+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 789999999999999887 9999999997542110                                  111 


Q ss_pred             -----HHHHHHHHHHhc----CCcEEeEeceeee-CCceEEEEEecCCCChhHHHh--cc-CCCCCCCHHHHHHHHHHHH
Q 038934          475 -----FKNEVLLIAKLQ----HRNLVKLLGCCMK-RDERMLIYEYLPNKSLADFIF--DG-TRRKLLDWSKRCQIIGGIA  541 (751)
Q Consensus       475 -----~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~--~~-~~~~~l~~~~~~~i~~~i~  541 (751)
                           +.+|+..+.++.    +.+.+.+-.++.+ ....+|||||++|+.+.++..  .. ...+.+....+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                 334444444442    3444444444433 456789999999999987531  11 111123333333344444 


Q ss_pred             HHHHHHHhCCCCCEEEccCCCCCeEEcCCC----CeEEeeccCccccC
Q 038934          542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFGMARAFG  585 (751)
Q Consensus       542 ~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DFGla~~~~  585 (751)
                            +..|   ++|+|+||.||+++.++    .++++|||++..+.
T Consensus       277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                  3456   99999999999999888    99999999998764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.28  E-value=1.6e-11  Score=118.53  Aligned_cols=131  Identities=21%  Similarity=0.142  Sum_probs=98.1

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEE-eEeceeeeCCceEEEEEecCCCCh
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-KLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      .+.|+.|.++.||+++. .++.+++|....... ....+.+|+.++..+.+.+++ +++.+.  ....++|||++++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            35789999999999987 478899999754432 233568899999998755544 444443  3446899999999887


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      .+..           .....++.+++++|+.||..+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            6431           011245678999999999987  23469999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.22  E-value=9.8e-12  Score=135.72  Aligned_cols=249  Identities=20%  Similarity=0.262  Sum_probs=178.7

Q ss_pred             cCccccccccc--cccccEEEEEE---cCCcEEEEEEeccC--CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCce
Q 038934          432 DNFSEENKLGE--GGFGPVYKGML---IDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       432 ~~y~~~~~IG~--G~fg~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  503 (751)
                      ..|-..+.+|.  |.+|.||.+..   .++..+|+|+-+..  .......=.+|+.....+ .|++.++.+..++..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34555678999  99999999885   34788999985433  223333345677777777 499999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCEEEccCCCCCeEEcCC-CCeEEeec
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDF  578 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DF  578 (751)
                      ++-.|++. .+|..+...  ....++...++.++.+..+    ||.++|+..   ++|-|+||.||+...+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            99999886 677777642  3334778888888888888    999999998   9999999999999999 88999999


Q ss_pred             cCccccCCCCccccc---cccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh
Q 038934          579 GMARAFGVDQTEANT---NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       579 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      |+...++........   ....|...|++||.. ...++.+.|+|++|.+..+-.++.+.........           |
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----------W  335 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----------W  335 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----------c
Confidence            999987644322111   123567789999965 4567899999999999999998866644321111           1


Q ss_pred             ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...+...+.+     ++......++..++.+|++.+|..|++.+.+..
T Consensus       336 ~~~r~~~ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  336 SQLRQGYIPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccccccCch-----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1111111111     111112234445888999999999999888763

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.13  E-value=8.7e-10  Score=107.60  Aligned_cols=137  Identities=12%  Similarity=0.085  Sum_probs=99.6

Q ss_pred             ccccccccccEEEEEEcC-------CcEEEEEEeccC-------------C---------cccHHHH----HHHHHHHHH
Q 038934          438 NKLGEGGFGPVYKGMLID-------GQEIAVKRLSKS-------------S---------GQGVEEF----KNEVLLIAK  484 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~----~~E~~~l~~  484 (751)
                      ..||.|-=+.||.|...+       +..+|||+.+..             .         ....+.+    ++|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999998543       479999988521             0         0112233    389999999


Q ss_pred             hc--CCcEEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCEEEccCC
Q 038934          485 LQ--HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL-HQDSRLRIIHRDLK  561 (751)
Q Consensus       485 l~--h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivH~Dik  561 (751)
                      +.  .-++.+++++    ..-+|||||+.+..+.....   +...++......+..+++.+|..| |..+   |+|+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            85  3456666654    56789999998754432211   112345566778889999999999 8888   9999999


Q ss_pred             CCCeEEcCCCCeEEeeccCccccC
Q 038934          562 ASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       562 p~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      +.|||+++ +.+.|+|||.+....
T Consensus       153 ~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEEC-CcEEEEECCCceeCC
Confidence            99999974 679999999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.12  E-value=1.2e-09  Score=120.45  Aligned_cols=166  Identities=19%  Similarity=0.247  Sum_probs=127.6

Q ss_pred             EcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHH
Q 038934          453 LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK  532 (751)
Q Consensus       453 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~  532 (751)
                      ..++.+|.|..++.......+...+-++.|+.++||||+++++..+.+.+.|+|+|-+.-  |..++.+      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH------hHHHH
Confidence            446889999988776654556678889999999999999999999999999999998743  4555532      33566


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCC
Q 038934          533 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL  612 (751)
Q Consensus       533 ~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  612 (751)
                      +..-+.||+.||.+||..+  .++|++|..+.|+|++.|.-||++|.++.....-..  ......--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            7778999999999999766  599999999999999999999999998865421111  111122223567777543222


Q ss_pred             CCcchhhHHHHHHHHHHHhC
Q 038934          613 FSVKSDVFSFGVLVLELVYG  632 (751)
Q Consensus       613 ~t~k~DVwSlG~ll~ell~G  632 (751)
                        -..|.|.||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              457999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.11  E-value=5.6e-11  Score=129.86  Aligned_cols=249  Identities=19%  Similarity=0.179  Sum_probs=179.4

Q ss_pred             HHhcCccccccccccccccEEEEEE--cCCcEEEEEEeccCCcccHHHH--HHHHHHHHHh-cCCcEEeEeceeeeCCce
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGML--IDGQEIAVKRLSKSSGQGVEEF--KNEVLLIAKL-QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~~~~~~~~~~  503 (751)
                      ....+|.....||.|.|+.|++...  .++..+++|.+.+.......++  ..|+.+...+ .|.++++....+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456788889999999999999774  3578899999876644433332  4677777777 599999988888888888


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-CCeEEeeccCcc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR  582 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~  582 (751)
                      ++--||++++++...+   .....+++..++++..|++.++.++|+..   ++|+|+||+||++..+ +.-++.|||.++
T Consensus       342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            8999999999988776   33445788889999999999999999988   9999999999999876 888999999987


Q ss_pred             ccCCCCccccccccccccCcc--CcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          583 AFGVDQTEANTNRVVGTYGYM--PPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      .+.....     ...+.-++.  +|+......+..+.|++|||.-+.+.+++..-..-     .             ...
T Consensus       416 ~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----~-------------~~~  472 (524)
T KOG0601|consen  416 RLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-----G-------------VQS  472 (524)
T ss_pred             ccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcc-----c-------------ccc
Confidence            5322111     112222333  55555667889999999999999999988543110     0             000


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..+..... ...+. ....+..+...++..++..||.+.++..+.+..
T Consensus       473 ~~i~~~~~-p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  473 LTIRSGDT-PNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             eeeecccc-cCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            00100000 00111 114555677778889999999999888765544

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.10  E-value=1.2e-10  Score=98.31  Aligned_cols=79  Identities=52%  Similarity=0.967  Sum_probs=63.0

Q ss_pred             ccccccC---CceeEeecccCCCCcccccccCCCHHHHHHhhhccccccccccccccCCCcceeEeeeccccccccccCc
Q 038934          322 KLDCERG---DGFLKRESVKLPDTRFSRVDKNISLFECKELCSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGG  398 (751)
Q Consensus       322 ~l~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~g~~gC~~w~~~L~~~~~~~~~g  398 (751)
                      +++|...   ++|+++.++++|+..+..  .+.++++|++.|++||+|.||+|.+   ++.+|.+|...+.+.+.....+
T Consensus         2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~   76 (84)
T cd01098           2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG   76 (84)
T ss_pred             CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence            4567554   689999999999876543  7789999999999999999999974   3568999988888766555555


Q ss_pred             ccceeee
Q 038934          399 QDLYIRM  405 (751)
Q Consensus       399 qdl~i~~  405 (751)
                      ..+|+|+
T Consensus        77 ~~~yiKv   83 (84)
T cd01098          77 GTLYLRL   83 (84)
T ss_pred             cEEEEEe
Confidence            7788775

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.10  E-value=6.8e-10  Score=112.14  Aligned_cols=142  Identities=19%  Similarity=0.259  Sum_probs=109.7

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCc-ccHHHHHHHHHHHHHhcC--CcEEeEeceeeeCC---ceEEEEEecC
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQH--RNLVKLLGCCMKRD---ERMLIYEYLP  511 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lV~E~~~  511 (751)
                      +.|+.|..+.||++...+|+.+++|....... .....+.+|+++++.+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            47899999999999986678999999765422 245678999999999975  34566777766542   6689999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS----------------------------------------  551 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~----------------------------------------  551 (751)
                      |.++.+.+..    ..++......++.++++.|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988776521    24567777788888888888888521                                        


Q ss_pred             -------------CCCEEEccCCCCCeEEcC--CCCeEEeeccCccc
Q 038934          552 -------------RLRIIHRDLKASNVLLDN--EMNPKISDFGMARA  583 (751)
Q Consensus       552 -------------~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~  583 (751)
                                   ...++|+|++|.||++++  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245899999999999998  66789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.05  E-value=5.3e-09  Score=111.79  Aligned_cols=169  Identities=24%  Similarity=0.345  Sum_probs=131.7

Q ss_pred             cccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceee----eCCceEEEEEecCC-CChhHH
Q 038934          445 FGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM----KRDERMLIYEYLPN-KSLADF  518 (751)
Q Consensus       445 fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~  518 (751)
                      -.+.||+.. .+|..|++|++.....+.......-+++++++.|+|+|++.+++.    .+..++|||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            456799984 479999999995544444444556788999999999999999887    34578999999886 578888


Q ss_pred             HhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          519 IFDGT------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       519 l~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      .+...            .....++..++.++.|+..||.++|+.|   +.-+-|.|.+|+++.+.+++|...|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            76532            2235788999999999999999999999   88899999999999999999998887765533


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRN  635 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p  635 (751)
                      +..                |-+..   -.+-|.=-||.+++.|.+|...
T Consensus       446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            220                01111   2356888999999999999765

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.04  E-value=1.8e-09  Score=101.65  Aligned_cols=130  Identities=22%  Similarity=0.303  Sum_probs=100.5

Q ss_pred             cccccccccEEEEEEcCCcEEEEEEeccCC---c-----ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSS---G-----QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .|++|+=+.+|.+.+ -|.++++|.-..+.   +     -..++..+|+.++.++.--.|....=+..+.+...++|||+
T Consensus         3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            578999999999976 34446666543221   1     12345678999999997655555555566788889999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      +|..|.+.+...          ...++..|-.-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999988432          2567778888889999999   99999999999998775 99999999874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.02  E-value=8.3e-11  Score=134.61  Aligned_cols=246  Identities=18%  Similarity=0.226  Sum_probs=171.4

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      ...+.+.+.+.+-+|.++.++.+.-. .+...++|.....   .....+....+-.++-...||.+++...-+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34567778888889999999877632 2433344433221   1122233333333333345677777666666677889


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      ||++|+.+++|...++.   ....+...+...+..+..++.|||...   +.|+|++|.|++...++..++.|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999998843   334566666677778889999999977   899999999999999999999999854332


Q ss_pred             CC-------------------------CCcc----ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 038934          585 GV-------------------------DQTE----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRN  635 (751)
Q Consensus       585 ~~-------------------------~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p  635 (751)
                      +.                         ....    .......+|+.|.+||.+.+......+|.|++|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            10                         0000    112246789999999999999999999999999999999999999


Q ss_pred             CCCCCCccccchhHHHHHHhccCChhhhcchhccCcc-----CHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 038934          636 RGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY-----SLSEALRCIQVGLLCVQQRPEDRPNMA  699 (751)
Q Consensus       636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~  699 (751)
                      +....+..                   +++..+....     +........+++...+..+|.+|-.|.
T Consensus      1035 ~na~tpq~-------------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQ-------------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhh-------------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            76444332                   2222222221     233344666788888889999998777

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.97  E-value=6.6e-09  Score=97.21  Aligned_cols=143  Identities=23%  Similarity=0.318  Sum_probs=105.8

Q ss_pred             ccccccccccccEEEEEEcCCcEEEEEEe-ccC-------CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          436 EENKLGEGGFGPVYKGMLIDGQEIAVKRL-SKS-------SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       436 ~~~~IG~G~fg~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ....|-||+=+.|+++.. .|+..+||.- .+.       ..-...+.++|+++|.++.--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            345788999999999987 6777667653 221       1123456789999999987555555555566777778999


Q ss_pred             EecCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC---eEEeeccCccc
Q 038934          508 EYLPN-KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARA  583 (751)
Q Consensus       508 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGla~~  583 (751)
                      ||+++ .++.+++........ .......++..|-+.+.-||..+   |+|+||..+||+|.+++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99988 577888754333222 22333678889999999999999   999999999999976553   58999999864

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.85  E-value=4.2e-08  Score=101.27  Aligned_cols=134  Identities=19%  Similarity=0.137  Sum_probs=97.9

Q ss_pred             cccEEEEEEcCCcEEEEEEeccCCcc-cHH----------HHHHHHHHHHHhcCC--cEEeEeceeee-----CCceEEE
Q 038934          445 FGPVYKGMLIDGQEIAVKRLSKSSGQ-GVE----------EFKNEVLLIAKLQHR--NLVKLLGCCMK-----RDERMLI  506 (751)
Q Consensus       445 fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~--niv~l~~~~~~-----~~~~~lV  506 (751)
                      ...|.+..+ +|+.+.||+....... ..+          .+.+|...+.++...  ..++++++.+.     ....+||
T Consensus        35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            334667655 6788999987433211 111          378999999998533  33445555543     2346899


Q ss_pred             EEecCCC-ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-------CCCeEEeec
Q 038934          507 YEYLPNK-SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------EMNPKISDF  578 (751)
Q Consensus       507 ~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-------~~~~kl~DF  578 (751)
                      +|++++. +|.+++.+.. ....+...+..++.+++..+.-||..|   |+|+|+++.|||++.       +..+.++||
T Consensus       114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            9999986 8999884322 234566777899999999999999999   999999999999975       467999999


Q ss_pred             cCccc
Q 038934          579 GMARA  583 (751)
Q Consensus       579 Gla~~  583 (751)
                      +.+..
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.84  E-value=2.1e-08  Score=97.53  Aligned_cols=124  Identities=26%  Similarity=0.330  Sum_probs=82.5

Q ss_pred             EEEEEEcCCcEEEEEEeccCC--------------c------------ccHHHHHHHHHHHHHhcCC--cEEeEeceeee
Q 038934          448 VYKGMLIDGQEIAVKRLSKSS--------------G------------QGVEEFKNEVLLIAKLQHR--NLVKLLGCCMK  499 (751)
Q Consensus       448 Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~  499 (751)
                      ||.|...++..+|||..+...              .            ......++|++.|.++..-  ++.+++++   
T Consensus         2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~---   78 (188)
T PF01163_consen    2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY---   78 (188)
T ss_dssp             EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE---
T ss_pred             EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE---
Confidence            899998899999999985310              0            0123467899999999754  45666644   


Q ss_pred             CCceEEEEEecC--CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCEEEccCCCCCeEEcCCCCeEEe
Q 038934          500 RDERMLIYEYLP--NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY-LHQDSRLRIIHRDLKASNVLLDNEMNPKIS  576 (751)
Q Consensus       500 ~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~y-LH~~~~~~ivH~Dikp~NIll~~~~~~kl~  576 (751)
                       ..-.|||||++  |..+..+....     ++......++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|+
T Consensus        79 -~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   79 -NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             -ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred             -eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence             24579999998  65555543211     1123445677777775555 57877   9999999999999988 99999


Q ss_pred             eccCcccc
Q 038934          577 DFGMARAF  584 (751)
Q Consensus       577 DFGla~~~  584 (751)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.78  E-value=1.4e-07  Score=98.64  Aligned_cols=258  Identities=16%  Similarity=0.135  Sum_probs=154.8

Q ss_pred             ccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEe--------EeceeeeCCceEEE
Q 038934          436 EENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVK--------LLGCCMKRDERMLI  506 (751)
Q Consensus       436 ~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------l~~~~~~~~~~~lV  506 (751)
                      ..+.||+|+-+.+|-.-  .-...+.|++.........+..   ..|... .||-+-.        ++|- ......-+.
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCC-CccceeEEe
Confidence            45689999999998643  2234567887765443333322   223332 4553322        1111 112235678


Q ss_pred             EEecCCCCh-hHHHhc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          507 YEYLPNKSL-ADFIFD---GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       507 ~E~~~~gsL-~~~l~~---~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      |..+++..= ..++..   ........|...++.++.++.+.+.||..|   .+-+|+.++||||.+++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            888877532 222221   123345789999999999999999999999   9999999999999999999999865443


Q ss_pred             ccCCCCccccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCC--ccccchh-HHHHH
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYG-TRNRGFHHV--DHHHNLL-GHAWR  653 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G-~~p~~~~~~--~~~~~~~-~~~~~  653 (751)
                      ..   .........+|...|.+||.-.     +..-+...|.|.||+++++||.| ++|+.....  +...... ..+..
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            32   1112222357889999999643     45567889999999999999987 888764321  1110000 00100


Q ss_pred             Hhcc--CChhhhcchhccCccCHHH-HHHHHHHHhhhcCC--CCCCCCCHHHHHHHHhC
Q 038934          654 LWTE--DRPVELIDKSLEDTYSLSE-ALRCIQVGLLCVQQ--RPEDRPNMASVVLMLSG  707 (751)
Q Consensus       654 ~~~~--~~~~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~  707 (751)
                      .+..  +......-  --...+... ...+..+..+|+..  .+.-||+++..+..|..
T Consensus       243 ~f~ya~~~~~g~~p--~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         243 RFAYASDQRRGLKP--PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             eeeechhccCCCCC--CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            0000  00000000  011122222 23455677788753  36789999988766543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.63  E-value=2.1e-07  Score=92.96  Aligned_cols=135  Identities=21%  Similarity=0.237  Sum_probs=97.1

Q ss_pred             ccccccccccccccEEEEEEcCCcEEEEEEeccC--------------------C--cccHHHHHHHHHHHHHhcCC--c
Q 038934          434 FSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--------------------S--GQGVEEFKNEVLLIAKLQHR--N  489 (751)
Q Consensus       434 y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~h~--n  489 (751)
                      ..+..+||.|-=+.||.|..++|.++|||.-+..                    +  .......++|.++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3456789999999999999999999999975321                    0  01133467899999999644  5


Q ss_pred             EEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC
Q 038934          490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN  569 (751)
Q Consensus       490 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~  569 (751)
                      +.+.++.    +.-.+|||+++|-.|...-        ++......++..|++-+..+-..|   |||+|+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            6665543    4567999999996665432        123333344445555555555566   999999999999999


Q ss_pred             CCCeEEeeccCccc
Q 038934          570 EMNPKISDFGMARA  583 (751)
Q Consensus       570 ~~~~kl~DFGla~~  583 (751)
                      +|.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999976543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=2.7e-07  Score=92.07  Aligned_cols=124  Identities=27%  Similarity=0.280  Sum_probs=93.0

Q ss_pred             CCcEEEEEEeccCC-------cccHHHHHHHHHHHHHhc--CCcEEeEeceeeeCC----ceEEEEEecCCC-ChhHHHh
Q 038934          455 DGQEIAVKRLSKSS-------GQGVEEFKNEVLLIAKLQ--HRNLVKLLGCCMKRD----ERMLIYEYLPNK-SLADFIF  520 (751)
Q Consensus       455 ~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~  520 (751)
                      .++.+.+|.+....       ........+|...+..|.  .-...+.+++.+...    ..+||+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            35566666543221       123456889999988885  344556666665532    358999999984 8999885


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC---CeEEeeccCcccc
Q 038934          521 DGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARAF  584 (751)
Q Consensus       521 ~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DFGla~~~  584 (751)
                      +...   ++......++.++++.++-||..+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       111 ~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 QWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            4222   566777899999999999999999   99999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.55  E-value=1.5e-06  Score=85.07  Aligned_cols=139  Identities=17%  Similarity=0.181  Sum_probs=105.5

Q ss_pred             cccccccccEEEEEEcCCcEEEEEEeccC------CcccHHHHHHHHHHHHHhcC--CcEEeEeceee-eC----CceEE
Q 038934          439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKS------SGQGVEEFKNEVLLIAKLQH--RNLVKLLGCCM-KR----DERML  505 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~-~~----~~~~l  505 (751)
                      --|+||.+-|++-.. +|+.+-+|+-...      .+.....|.+|+..|.+|..  ..+.++. ++. ..    -.-+|
T Consensus        25 N~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         25 NYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             CcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            457799999999776 4557999987521      14567889999999999953  3355555 332 21    23579


Q ss_pred             EEEecCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC--eEEeeccCcc
Q 038934          506 IYEYLPN-KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMAR  582 (751)
Q Consensus       506 V~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DFGla~  582 (751)
                      |+|-+.+ .+|.+++.+.. ....+......++.+|++.++-||+.+   +.|+|+.+.||+++.++.  ++++||.-++
T Consensus       103 VTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            9997764 58888874422 234677788899999999999999999   999999999999986667  9999998765


Q ss_pred             c
Q 038934          583 A  583 (751)
Q Consensus       583 ~  583 (751)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.47  E-value=1e-06  Score=98.48  Aligned_cols=145  Identities=19%  Similarity=0.294  Sum_probs=95.2

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCccc------------------------------HH--------
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQG------------------------------VE--------  473 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~--------  473 (751)
                      ..|.. +.|+.++-|.||+|++++|+.||||+.+......                              .+        
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            34443 5899999999999999999999999985431110                              11        


Q ss_pred             --HHHHHHHHHHHhc----CCcEEeEecee-eeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHH-HH
Q 038934          474 --EFKNEVLLIAKLQ----HRNLVKLLGCC-MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG-LL  545 (751)
Q Consensus       474 --~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~-L~  545 (751)
                        .+.+|..-+.++.    +..-+++-.++ .-.....|+|||++|-.+.+...-..  ..++.+.+.   ..++++ +.
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia---~~~~~~f~~  279 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELA---ELLVRAFLR  279 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHH---HHHHHHHHH
Confidence              1334555555442    22233333333 33567899999999999988853211  223433333   223322 22


Q ss_pred             HHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       546 yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      .+-..|   ++|+|.+|.||+++.++.+.+.|||+...+.
T Consensus       280 q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         280 QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            233345   9999999999999999999999999988764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.46  E-value=2.5e-06  Score=86.30  Aligned_cols=139  Identities=17%  Similarity=0.182  Sum_probs=86.8

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCc--EEeEeceeeeCCceEEEEEecCCCC-
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN--LVKLLGCCMKRDERMLIYEYLPNKS-  514 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E~~~~gs-  514 (751)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            47999999999984   35567888875432  3456789999999986433  4677888877888889999999973 


Q ss_pred             hhHHH--------------hc-----cCC-CCCCCHHHHH-HHHH----------HHHH-HHHHHHh-CCCCCEEEccCC
Q 038934          515 LADFI--------------FD-----GTR-RKLLDWSKRC-QIIG----------GIAR-GLLYLHQ-DSRLRIIHRDLK  561 (751)
Q Consensus       515 L~~~l--------------~~-----~~~-~~~l~~~~~~-~i~~----------~i~~-~L~yLH~-~~~~~ivH~Dik  561 (751)
                      +...+              .+     +.- .......... .+..          .+.+ ...+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            21111              00     000 0011111100 0100          0111 1122221 123457999999


Q ss_pred             CCCeEEcCCCCeEEeeccCcc
Q 038934          562 ASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       562 p~NIll~~~~~~kl~DFGla~  582 (751)
                      |.||++++++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999988 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.39  E-value=1e-07  Score=106.00  Aligned_cols=150  Identities=17%  Similarity=0.256  Sum_probs=99.7

Q ss_pred             HHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC------CCcccccc-ccccccCccCcccccC
Q 038934          538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV------DQTEANTN-RVVGTYGYMPPEYAID  610 (751)
Q Consensus       538 ~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~------~~~~~~~~-~~~gt~~y~aPE~~~~  610 (751)
                      .+++.||.|+|...  ++||+.|.|++|.++.++..||+.|+.+.....      ........ -......|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34569999999876  699999999999999999999999998764322      11111111 1234567999999999


Q ss_pred             CCCCcchhhHHHHHHHHHHHhCCCC-CCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcC
Q 038934          611 GLFSVKSDVFSFGVLVLELVYGTRN-RGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQ  689 (751)
Q Consensus       611 ~~~t~k~DVwSlG~ll~ell~G~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~  689 (751)
                      ...+.++|+||+|+++|.+..|..+ +..........             .....+..-...+......++.+=+.+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------FSRNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------hhhcccccccccccccCcHHHHHHHHHHhc
Confidence            8899999999999999999955544 22211110000             000111111111223344566777788899


Q ss_pred             CCCCCCCCHHHHH
Q 038934          690 QRPEDRPNMASVV  702 (751)
Q Consensus       690 ~dP~~RPs~~evl  702 (751)
                      .++.-||++.++.
T Consensus       251 ~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  251 GDSAVRPTLDLLL  263 (700)
T ss_pred             CCcccCcchhhhh
Confidence            9999999776665

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.25  E-value=1.2e-05  Score=79.01  Aligned_cols=138  Identities=17%  Similarity=0.180  Sum_probs=90.4

Q ss_pred             HhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHH---------HHHHHHHHHhcC---CcEEeEecee
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEF---------KNEVLLIAKLQH---RNLVKLLGCC  497 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~l~~~~  497 (751)
                      ...+|...+++-......|.+-.. +|+.+++|..+.......+.|         .+++..+..++.   ...+.++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346677777777766666666555 678999999865433322222         234444444432   2222222222


Q ss_pred             -----eeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC
Q 038934          498 -----MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  572 (751)
Q Consensus       498 -----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~  572 (751)
                           ......+|||||++|..|.++..       +++    .++..+.+++.-||..|   +.|+|++|.|+++++++ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence                 22244578999999988877541       222    24456778899999999   99999999999999665 


Q ss_pred             eEEeeccCccc
Q 038934          573 PKISDFGMARA  583 (751)
Q Consensus       573 ~kl~DFGla~~  583 (751)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.25  E-value=8.1e-06  Score=91.00  Aligned_cols=140  Identities=15%  Similarity=0.229  Sum_probs=90.0

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCccc-------------------------------HH------HHHHHHH
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQG-------------------------------VE------EFKNEVL  480 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~~  480 (751)
                      +.||.-..|.||+|++++|+.||||+-+...+..                               .+      .|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5899999999999999999999999975432111                               01      1334444


Q ss_pred             HHHH----hcCCc---EEeEeceee-eCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCC
Q 038934          481 LIAK----LQHRN---LVKLLGCCM-KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY-LHQDS  551 (751)
Q Consensus       481 ~l~~----l~h~n---iv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~y-LH~~~  551 (751)
                      -..+    +.|-+   =|++-.++. -...+.|+||||+|..+.|+-.-  ....++...+.   ..+.++... +=..|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~---~~l~~~~~~qIf~~G  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDIL---NKLVEAYLEQIFKTG  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHH---HHHHHHHHHHHHhcC
Confidence            3333    33555   122323332 23578999999999988776421  22234444433   333333222 22234


Q ss_pred             CCCEEEccCCCCCeEEcC----CCCeEEeeccCccccC
Q 038934          552 RLRIIHRDLKASNVLLDN----EMNPKISDFGMARAFG  585 (751)
Q Consensus       552 ~~~ivH~Dikp~NIll~~----~~~~kl~DFGla~~~~  585 (751)
                         ++|+|=+|.||+++.    ++.+.+.|||+...+.
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence               999999999999984    6789999999988664

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.22  E-value=6.8e-06  Score=73.57  Aligned_cols=87  Identities=23%  Similarity=0.372  Sum_probs=58.8

Q ss_pred             EEEecCCceEEEeCCC-CCeeeeecCCCC-CCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeeeee
Q 038934           72 SISSQGNGTLILQNST-NGIVWSSNASRT-AQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLV  149 (751)
Q Consensus        72 ~~~~~g~g~l~l~~~~-~~~vWst~~~~~-~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~~~  149 (751)
                      ++....+|+||+.+.. +.+||++++... .....+.|.++|||||.+.+    +.++|+|=   |.             
T Consensus        23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~---t~-------------   82 (114)
T smart00108       23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD----GRVVWSSN---TT-------------   82 (114)
T ss_pred             ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC----CCEEEEec---cc-------------
Confidence            4444567899999765 589999997533 22357889999999998765    57899981   11             


Q ss_pred             cCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecC
Q 038934          150 TGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRP  194 (751)
Q Consensus       150 tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~s  194 (751)
                                     ...+.+.+.++++|...++-. ...+.|.+
T Consensus        83 ---------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~S  111 (114)
T smart00108       83 ---------------GANGNYVLVLLDDGNLVIYDS-DGNFLWQS  111 (114)
T ss_pred             ---------------CCCCceEEEEeCCCCEEEECC-CCCEEeCC
Confidence                           123567888888887543322 23466755

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.16  E-value=2.2e-05  Score=80.58  Aligned_cols=140  Identities=15%  Similarity=0.124  Sum_probs=86.0

Q ss_pred             ccccccc-ccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEEecCCCChh
Q 038934          439 KLGEGGF-GPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYEYLPNKSLA  516 (751)
Q Consensus       439 ~IG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL~  516 (751)
                      .|-.|.. ..||+.... +..++||+.....   ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3445555 778998763 4788888875432   346778999999884 444567777777666789999999998876


Q ss_pred             HHHh----------------c-cC-C--CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----C
Q 038934          517 DFIF----------------D-GT-R--RKLLDW--SKRCQIIG--------------------GIARGLLYLHQ----D  550 (751)
Q Consensus       517 ~~l~----------------~-~~-~--~~~l~~--~~~~~i~~--------------------~i~~~L~yLH~----~  550 (751)
                      ....                + +. .  ......  ........                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4321                0 00 0  001110  00000000                    01111122211    1


Q ss_pred             CCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       551 ~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      ....++|+|+.|.|||++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23459999999999999998778899998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.14  E-value=2.3e-05  Score=79.45  Aligned_cols=142  Identities=20%  Similarity=0.218  Sum_probs=84.4

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCC--cEEeEeceeeeC---CceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVKLLGCCMKR---DERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lV~E~~~~  512 (751)
                      +.|+.|..+.||+....+ +.+++|.....  .....+.+|+.+++.+...  .+.+++.+....   ...+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            578999999999999866 69999997543  4567788999999998532  355666544332   346899999999


Q ss_pred             CChhH----------------HHhc---c-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 038934          513 KSLAD----------------FIFD---G-TRRKLLDWSK---------RCQI------------IGGIAR-GLLYLHQ-  549 (751)
Q Consensus       513 gsL~~----------------~l~~---~-~~~~~l~~~~---------~~~i------------~~~i~~-~L~yLH~-  549 (751)
                      ..+..                .+.+   . ..........         ....            ...+.+ .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            98877                1111   1 0111111100         0000            111222 2333332 


Q ss_pred             ---CCCCCEEEccCCCCCeEEc-CCCCeEEeeccCcc
Q 038934          550 ---DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMAR  582 (751)
Q Consensus       550 ---~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~  582 (751)
                         .....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               2345699999999999999 66666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.14  E-value=3e-05  Score=77.15  Aligned_cols=152  Identities=16%  Similarity=0.200  Sum_probs=101.3

Q ss_pred             ccHHhHHHHhcCcccccc---ccccccccEEEEEEcCCcEEEEEEeccCCcc-------------------cH-----HH
Q 038934          422 FDWKSIANATDNFSEENK---LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQ-------------------GV-----EE  474 (751)
Q Consensus       422 ~~~~~i~~~~~~y~~~~~---IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~-----~~  474 (751)
                      .+++.+.....+..+...   |..|--+.||+|...++..+|||++......                   ..     .-
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            445566666666655554   4566667899999878999999998532110                   11     12


Q ss_pred             HHHHHHHHHHhc--CCcEEeEeceeeeCCceEEEEEecCCCCh-hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 038934          475 FKNEVLLIAKLQ--HRNLVKLLGCCMKRDERMLIYEYLPNKSL-ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-D  550 (751)
Q Consensus       475 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~  550 (751)
                      ..+|+.-|.++.  +-.+.+.+.+.    .-.|||||+....+ .-.|    +.-.+.......+..++++.+.-|-. .
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            356777777773  44555555543    35799999866411 1111    11122333567778888888888776 4


Q ss_pred             CCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       551 ~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      +   +||+||+.-|||+. ++.+.|+||+-|....
T Consensus       187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             C---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            5   99999999999999 8899999999887543

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=98.14  E-value=2.7e-06  Score=61.96  Aligned_cols=44  Identities=52%  Similarity=0.829  Sum_probs=40.6

Q ss_pred             CCCCCCCCCCCCcccCCCCCCCCCCCCC--ccccccceEeeeeecC
Q 038934          708 ERSLPQPKQPGFFTERNLPESESSSSNQ--TFHSSNQITVSLIEGR  751 (751)
Q Consensus       708 ~~~~~~p~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  751 (751)
                      ...+|.|++|+|+..|...+..++++++  +.+++|++++|.|+||
T Consensus         3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            4679999999999999999988888877  8999999999999998

; GO: 0004674 protein serine/threonine kinase activity

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.12  E-value=1.5e-05  Score=74.90  Aligned_cols=129  Identities=21%  Similarity=0.270  Sum_probs=90.6

Q ss_pred             cccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEE-eEeceeeeCCceEEEEEecCCC
Q 038934          435 SEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-KLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      ...+.|++|.+|.||++.+ .|.++|+|+-+.+  .....+..|+++|..++-.++. +++.+-.    -.++|||+.|.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence            3456899999999999998 5568999986554  4457899999999999866654 3343322    23459999998


Q ss_pred             ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCC-CCCeEEcCCCCeEEeeccCccc
Q 038934          514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK-ASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       514 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dik-p~NIll~~~~~~kl~DFGla~~  583 (751)
                      .|.+.-...      +.+    -+..+++.-.-|...|   |-|..|. |..++|..++.+.|+||.-|+.
T Consensus        98 ~L~~~~~~~------~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG------DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc------cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            888765221      122    2334555555566666   9999987 5555555555999999998874

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.10  E-value=1.5e-05  Score=71.51  Aligned_cols=82  Identities=20%  Similarity=0.325  Sum_probs=57.1

Q ss_pred             CceEEEeCCC-CCeeeeecCCC-CCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeeeeecCCceE
Q 038934           78 NGTLILQNST-NGIVWSSNASR-TAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRF  155 (751)
Q Consensus        78 ~g~l~l~~~~-~~~vWst~~~~-~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~~~tg~~~~  155 (751)
                      +|+||+.+.. +.+||++|+.. ......+.|.++|||||.+.+    +.++|+|=-.                      
T Consensus        30 dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~~~----------------------   83 (116)
T cd00028          30 DYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS----GTVVWSSNTT----------------------   83 (116)
T ss_pred             eEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC----CcEEEEeccc----------------------
Confidence            7899999765 58999999754 234557889999999998765    5789997311                      


Q ss_pred             EEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCC
Q 038934          156 ISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPG  195 (751)
Q Consensus       156 l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg  195 (751)
                               .+.+.+.+.++.+|...++-. ...+.|.+.
T Consensus        84 ---------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf  113 (116)
T cd00028          84 ---------RVNGNYVLVLLDDGNLVLYDS-DGNFLWQSF  113 (116)
T ss_pred             ---------CCCCceEEEEeCCCCEEEECC-CCCEEEcCC
Confidence                     013567888888887543322 245567654

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.05  E-value=1.7e-05  Score=77.66  Aligned_cols=105  Identities=24%  Similarity=0.245  Sum_probs=84.3

Q ss_pred             HHHHHHHHHhcC-CcEEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 038934          476 KNEVLLIAKLQH-RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR  554 (751)
Q Consensus       476 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~  554 (751)
                      .+|..+++.+++ +++.+++|+|    ..++|.||...+++.............+|..+.+|+.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468889999976 6999999999    45789999988766432100012224689999999999999999999865556


Q ss_pred             EEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          555 IIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       555 ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +..+|++|+|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999877654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.01  E-value=8e-07  Score=97.73  Aligned_cols=191  Identities=18%  Similarity=0.126  Sum_probs=139.0

Q ss_pred             HHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCc-EEeEeceeeeCCceEEE
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVKLLGCCMKRDERMLI  506 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV  506 (751)
                      +..+.-+...+.+++++.++++|.+-...+....+.+...     ....-++++|.+++||| .++.++-+..++...++
T Consensus       238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence            3444455555678999999999987544455556665433     45677899999999999 77777778888889999


Q ss_pred             EEecCCC-ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          507 YEYLPNK-SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       507 ~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ++++..+ +-...+.  ...-.+.......+.+.-++++++||+..   =+|+|    ||+..+ +..+..||+.+..+.
T Consensus       313 ~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~  382 (829)
T KOG0576|consen  313 MRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT  382 (829)
T ss_pred             hhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence            9999887 2222110  11112334444556677778999999864   48888    777766 678999999988765


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNR  636 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~  636 (751)
                      ...   ......+++.++|||+.....+..+.|+|++|+-..++.-|-.|.
T Consensus       383 ~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  383 RTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            433   233467899999999999999999999999999888888776664

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.00  E-value=9.3e-06  Score=67.01  Aligned_cols=71  Identities=38%  Similarity=0.733  Sum_probs=52.0

Q ss_pred             CceeEeecccCCCCcccccccCCCHHHHHHhhhc-cccccccccccccCCCcceeEee-eccccccccccCccccee
Q 038934          329 DGFLKRESVKLPDTRFSRVDKNISLFECKELCSK-NCSCTAYANADVRGGGSGCLLWF-HELTDMKILSEGGQDLYI  403 (751)
Q Consensus       329 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-~CsC~a~~~~~~~~g~~gC~~w~-~~L~~~~~~~~~gqdl~i  403 (751)
                      ..|.++.++++++..... ....++++|+..|++ +|+|.||.|..   ++.+|.+|. ..+.+.......+.++|.
T Consensus         4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~   76 (78)
T smart00473        4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYE   76 (78)
T ss_pred             ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEE
Confidence            468899999998654432 456799999999999 99999999975   456899999 555555433333444443

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.99  E-value=8.9e-05  Score=72.87  Aligned_cols=132  Identities=17%  Similarity=0.259  Sum_probs=94.8

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCC----------------cccHHHHHHHHHHHHHhc------CCcEEeEe
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSS----------------GQGVEEFKNEVLLIAKLQ------HRNLVKLL  494 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~  494 (751)
                      ...||+|+.-.||.  +++.....||+.....                ....++..+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45799999999986  5667778889886554                223566777877777666      78999999


Q ss_pred             ceeeeCCceEEEEEecCC------CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc
Q 038934          495 GCCMKRDERMLIYEYLPN------KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  568 (751)
Q Consensus       495 ~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~  568 (751)
                      |+.+......+|+|.+.+      .+|.+++.    ...++. ...+.+.   +-..||-+.+   |+.+|++|+||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998643      35777773    233444 3334444   3445666666   99999999999996


Q ss_pred             CCC----CeEEee-ccCc
Q 038934          569 NEM----NPKISD-FGMA  581 (751)
Q Consensus       569 ~~~----~~kl~D-FGla  581 (751)
                      ...    .+.|+| ||-.
T Consensus       153 ~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ecCCCceEEEEEeCCCCc
Confidence            432    477777 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.98  E-value=8.7e-05  Score=89.62  Aligned_cols=79  Identities=18%  Similarity=0.344  Sum_probs=58.2

Q ss_pred             cccccccccccEEEEEEcCC---cEEEEEEeccCC-cccHHHHHHHHHHHHHhc-CCcE--EeEeceeeeC---CceEEE
Q 038934          437 ENKLGEGGFGPVYKGMLIDG---QEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNL--VKLLGCCMKR---DERMLI  506 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV  506 (751)
                      .+.|+.|.+..+|+.....+   ..+++|+..... ......+.+|+++++.+. |.++  .+++.+|.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45789999999999886553   467888764322 123457889999999995 6654  7778877664   467899


Q ss_pred             EEecCCCCh
Q 038934          507 YEYLPNKSL  515 (751)
Q Consensus       507 ~E~~~~gsL  515 (751)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.90  E-value=7.2e-05  Score=76.35  Aligned_cols=73  Identities=15%  Similarity=0.273  Sum_probs=47.2

Q ss_pred             ccccccccc-cEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCC---cEEeEeceeeeCC---ceEEEEEec
Q 038934          438 NKLGEGGFG-PVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR---NLVKLLGCCMKRD---ERMLIYEYL  510 (751)
Q Consensus       438 ~~IG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lV~E~~  510 (751)
                      +.|+.|+.. .||+.    +..+++|.....  .....+.+|++++..+...   .+.++++.....+   ..+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467877776 48875    245777875432  2345789999999988532   3344444433322   347899999


Q ss_pred             CCCChh
Q 038934          511 PNKSLA  516 (751)
Q Consensus       511 ~~gsL~  516 (751)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.74  E-value=0.00041  Score=73.37  Aligned_cols=78  Identities=13%  Similarity=0.106  Sum_probs=57.5

Q ss_pred             cccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC---CcEEeEeceeeeC---CceEEEEE
Q 038934          435 SEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH---RNLVKLLGCCMKR---DERMLIYE  508 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lV~E  508 (751)
                      ...+.||.|..+.||+....++ .+++|..+..  .....+.+|++.|+.|..   ..+.++++++..+   +..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3356799999999999876555 4666774321  123588999999999853   4677888877543   56899999


Q ss_pred             ecCCCCh
Q 038934          509 YLPNKSL  515 (751)
Q Consensus       509 ~~~~gsL  515 (751)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=97.73  E-value=0.0003  Score=62.78  Aligned_cols=100  Identities=23%  Similarity=0.418  Sum_probs=65.0

Q ss_pred             CCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEee-cCCCCCCCCCceeEEEecCCceEEEeCCCCCeeeeec
Q 038934           17 GETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVA-NRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSN   95 (751)
Q Consensus        17 ~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~a-nr~~p~~~~~~~l~~~~~g~g~l~l~~~~~~~vWst~   95 (751)
                      .+.+.+.+|.+.|-|-..|+     |-|. .  ...++||.+ +...... ....+.|..+|  ||||+|..+.++|+|.
T Consensus        11 ~~p~~~~s~~~~L~l~~dGn-----Lvl~-~--~~~~~iWss~~t~~~~~-~~~~~~L~~~G--Nlvl~d~~~~~lW~Sf   79 (114)
T PF01453_consen   11 NSPLTSSSGNYTLILQSDGN-----LVLY-D--SNGSVIWSSNNTSGRGN-SGCYLVLQDDG--NLVLYDSSGNVLWQSF   79 (114)
T ss_dssp             TEEEEECETTEEEEEETTSE-----EEEE-E--TTTEEEEE--S-TTSS--SSEEEEEETTS--EEEEEETTSEEEEEST
T ss_pred             ccccccccccccceECCCCe-----EEEE-c--CCCCEEEEecccCCccc-cCeEEEEeCCC--CEEEEeecceEEEeec
Confidence            34666656999999988776     6664 3  235789999 3333332 34567776655  9999999999999995


Q ss_pred             CCCCCCCcEEEEec--CCCEEEEcCCCCCCCCceeeecCCC
Q 038934           96 ASRTAQNPVAVLLE--SGNLVVKSGNDNDSDNFLWQSFDYP  134 (751)
Q Consensus        96 ~~~~~~~~~a~lld--sGNlVl~~~~~~~~~~~lWqSFd~P  134 (751)
                      .  ......+.+.+  .||++ ....    ..+.|.|=+.|
T Consensus        80 ~--~ptdt~L~~q~l~~~~~~-~~~~----~~~sw~s~~dp  113 (114)
T PF01453_consen   80 D--YPTDTLLPGQKLGDGNVT-GKND----SLTSWSSNTDP  113 (114)
T ss_dssp             T--SSS-EEEEEET--TSEEE-EEST----SSEEEESS---
T ss_pred             C--CCccEEEeccCcccCCCc-cccc----eEEeECCCCCC
Confidence            3  33455666777  88988 4322    45788886655

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.67  E-value=0.00037  Score=71.04  Aligned_cols=141  Identities=18%  Similarity=0.224  Sum_probs=82.3

Q ss_pred             ccccccccccEEEEEEcC--CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcE-EeEeceeeeCCceEEEEEecCCCC
Q 038934          438 NKLGEGGFGPVYKGMLID--GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VKLLGCCMKRDERMLIYEYLPNKS  514 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gs  514 (751)
                      +.|..|-...+|+....+  ++.+++|+....... .-...+|+.++..+...++ .++++...    -.+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            467788888999998654  678999977543222 1234579999998854333 34444332    247999999977


Q ss_pred             hhHH--------------Hh---ccCCC--------CCCC-HHHHHHHHH----------------------HHH---HH
Q 038934          515 LADF--------------IF---DGTRR--------KLLD-WSKRCQIIG----------------------GIA---RG  543 (751)
Q Consensus       515 L~~~--------------l~---~~~~~--------~~l~-~~~~~~i~~----------------------~i~---~~  543 (751)
                      +...              +.   .....        .... +..+..+..                      .+.   ..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321              11   00100        0111 122112111                      111   11


Q ss_pred             H-HHHHhC-CCCCEEEccCCCCCeEEcC-CCCeEEeeccCccc
Q 038934          544 L-LYLHQD-SRLRIIHRDLKASNVLLDN-EMNPKISDFGMARA  583 (751)
Q Consensus       544 L-~yLH~~-~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~  583 (751)
                      | ..+... ....++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            1 112211 2346999999999999998 57899999987753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.64  E-value=0.00031  Score=72.67  Aligned_cols=139  Identities=16%  Similarity=0.088  Sum_probs=79.8

Q ss_pred             cccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcE-EeEeceeeeCCceEEEEEecCCCChhH
Q 038934          439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VKLLGCCMKRDERMLIYEYLPNKSLAD  517 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~~  517 (751)
                      .+..|-...+|+... +++.+++|..........-...+|..+++.+....+ .+++....    -.+||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            456688889998874 577888988654322211235789999999864333 23333322    368999999876542


Q ss_pred             H--------------Hhc---cC-CCCCCCHH-HHHHHHHHH---------HHHHHHHHhC-----CCCCEEEccCCCCC
Q 038934          518 F--------------IFD---GT-RRKLLDWS-KRCQIIGGI---------ARGLLYLHQD-----SRLRIIHRDLKASN  564 (751)
Q Consensus       518 ~--------------l~~---~~-~~~~l~~~-~~~~i~~~i---------~~~L~yLH~~-----~~~~ivH~Dikp~N  564 (751)
                      .              +.+   .. ....++.. .+..+..++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1              111   00 01112221 111111111         1112222111     12358999999999


Q ss_pred             eEEcCCCCeEEeeccCccc
Q 038934          565 VLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       565 Ill~~~~~~kl~DFGla~~  583 (751)
                      |++++++ +.|+||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.59  E-value=0.00067  Score=66.19  Aligned_cols=126  Identities=26%  Similarity=0.383  Sum_probs=91.0

Q ss_pred             hcCcccccccccccc-ccEEEEEEcCCcEEEEEEecc---C--------Cc----------ccHHHHHHHHHHHHHhc--
Q 038934          431 TDNFSEENKLGEGGF-GPVYKGMLIDGQEIAVKRLSK---S--------SG----------QGVEEFKNEVLLIAKLQ--  486 (751)
Q Consensus       431 ~~~y~~~~~IG~G~f-g~Vy~~~~~~~~~vavK~~~~---~--------~~----------~~~~~~~~E~~~l~~l~--  486 (751)
                      +.+++..+.||.|.- |.||++++ +|+.+|+|....   .        ..          .-...|..|.+...+|+  
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            378888999999999 99999998 778999999321   0        00          11235788999888885  


Q ss_pred             -CCcE--EeEeceeeeC------------------CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHH
Q 038934          487 -HRNL--VKLLGCCMKR------------------DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL  545 (751)
Q Consensus       487 -h~ni--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~  545 (751)
                       +.++  |+.+|+..-.                  ..+.||.||++...                ....+-+.++.+-|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHH
Confidence             4466  8999987432                  12356777775532                112234566778888


Q ss_pred             HHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       546 yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      .+|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            999988   999999999986     3489999864

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.57  E-value=0.00081  Score=73.28  Aligned_cols=75  Identities=13%  Similarity=0.186  Sum_probs=55.3

Q ss_pred             ccccccccccEEEEEEcCC-cEEEEEEeccC-------CcccHHHHHHHHHHHHHhc---CCcEEeEeceeeeCCceEEE
Q 038934          438 NKLGEGGFGPVYKGMLIDG-QEIAVKRLSKS-------SGQGVEEFKNEVLLIAKLQ---HRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV  506 (751)
                      +.||-|.+..||++...+| +.++||.....       -+...+++..|.+.|..+.   -.++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999998776 58999986421       1234567888888888863   2456667766  44667899


Q ss_pred             EEecCCCC
Q 038934          507 YEYLPNKS  514 (751)
Q Consensus       507 ~E~~~~gs  514 (751)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.55  E-value=0.00029  Score=83.30  Aligned_cols=198  Identities=18%  Similarity=0.164  Sum_probs=136.8

Q ss_pred             HHHHHHHHHHHHhcCCcEEeEeceeeeCCceE----EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 038934          473 EEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM----LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH  548 (751)
Q Consensus       473 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH  548 (751)
                      ....-|+..+.++.|+|++.++.+-.+....-    +..|++..-++...+   ..-..++....+.+..++..||+|+|
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHH
Confidence            33456777888889999999998877665443    345788888888877   44556889999999999999999999


Q ss_pred             hCCCCCEEEccCCCC---CeEEcCCCCeEEe--eccCccccCCCCccccccccccccCccCcccccCCCCCc--chhhHH
Q 038934          549 QDSRLRIIHRDLKAS---NVLLDNEMNPKIS--DFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV--KSDVFS  621 (751)
Q Consensus       549 ~~~~~~ivH~Dikp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--k~DVwS  621 (751)
                      +..   ..|.-+..+   +--.+..+.+.+.  ||+..+.++......   ...-+..+.|||......+..  +.|+|.
T Consensus       304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHH
Confidence            986   555544444   4455666777777  998887764332221   123345677888776665544  479999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 038934          622 FGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV  701 (751)
Q Consensus       622 lG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  701 (751)
                      +|.++..+..|..+....                      ..+...+......    .+.+...+|+..++++|+++.++
T Consensus       378 lgll~~~~~~~~~i~~~~----------------------~~~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKS----------------------AVPVSLLDVLSTS----ELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHhhhhhcCcccccc----------------------cchhhhhccccch----hhhhhhhhhcchhhhhccchhhh
Confidence            999999999886652210                      1111111111111    45677888999999999999999


Q ss_pred             HHHH
Q 038934          702 VLML  705 (751)
Q Consensus       702 l~~L  705 (751)
                      +...
T Consensus       432 l~~~  435 (1351)
T KOG1035|consen  432 LTHP  435 (1351)
T ss_pred             hhch
Confidence            9654

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.53  E-value=0.00075  Score=71.44  Aligned_cols=142  Identities=19%  Similarity=0.187  Sum_probs=86.0

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCC--cEEeEece------eeeCCceEEEEE
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVKLLGC------CMKRDERMLIYE  508 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lV~E  508 (751)
                      .+.|..|....+|+.... +..+++|+...   ...+.+..|++++..+.+.  .+.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            456777888899998763 45788898754   3346677889988888533  24444432      233456689999


Q ss_pred             ecCCCChhH----H-------H---hccC-C--C-----CCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 038934          509 YLPNKSLAD----F-------I---FDGT-R--R-----KLLDWSKRC----------QIIGGIARGLLYLHQ----DSR  552 (751)
Q Consensus       509 ~~~~gsL~~----~-------l---~~~~-~--~-----~~l~~~~~~----------~i~~~i~~~L~yLH~----~~~  552 (751)
                      +++|..+..    .       +   +... .  .     ....|....          .....+..++.++..    .-.
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999977532    1       1   0000 0  0     001111110          011123334444443    112


Q ss_pred             CCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          553 LRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       553 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      ..++|+|+.|.||++++++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            359999999999999998777899998775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.29  E-value=0.0013  Score=69.75  Aligned_cols=141  Identities=27%  Similarity=0.344  Sum_probs=84.1

Q ss_pred             ccccccccccEEEEEEcC-------CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcE-EeEeceeeeCCceEEEEEe
Q 038934          438 NKLGEGGFGPVYKGMLID-------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~  509 (751)
                      +.|..|-...+|+....+       ++.+++|+..... .......+|++++..+....+ .++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            356667777899988654       5789999975543 233456789999988853333 345555432    358999


Q ss_pred             cCCCChhHH--------------Hh---ccCCCC------CCC--HHHHHH--------------------------HHH
Q 038934          510 LPNKSLADF--------------IF---DGTRRK------LLD--WSKRCQ--------------------------IIG  538 (751)
Q Consensus       510 ~~~gsL~~~--------------l~---~~~~~~------~l~--~~~~~~--------------------------i~~  538 (751)
                      ++|..+...              +.   ......      ..+  +..+..                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998776431              10   000000      000  111100                          111


Q ss_pred             HHHHHHHHHHh------CCCCCEEEccCCCCCeEEcCC----CCeEEeeccCccc
Q 038934          539 GIARGLLYLHQ------DSRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA  583 (751)
Q Consensus       539 ~i~~~L~yLH~------~~~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~~  583 (751)
                      .+...+..|..      .....++|+|+.|.|||++++    +.+.++||+.+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22223334432      234579999999999999985    8899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.29  E-value=0.0049  Score=66.00  Aligned_cols=141  Identities=19%  Similarity=0.231  Sum_probs=78.5

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCC--cEEeEec------eeeeCCceEEEEEe
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVKLLG------CCMKRDERMLIYEY  509 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~~~~lV~E~  509 (751)
                      +.|..|....+|+....+| .+++|+...   ...+.+..|+.++..|...  .+.+++.      +....+..++++|+
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4566777789999886555 688898752   2234555677777776422  2333332      12234567899999


Q ss_pred             cCCCChh-----------HHHhc---cCC--------CCCCCH-HHHH------------HHHHH-HHHHHHHHHhC---
Q 038934          510 LPNKSLA-----------DFIFD---GTR--------RKLLDW-SKRC------------QIIGG-IARGLLYLHQD---  550 (751)
Q Consensus       510 ~~~gsL~-----------~~l~~---~~~--------~~~l~~-~~~~------------~i~~~-i~~~L~yLH~~---  550 (751)
                      ++|..+.           +.+.+   ...        ...+.+ ....            ..+.+ +...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            9997542           11110   000        001111 1111            01111 11122333211   


Q ss_pred             -CCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          551 -SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       551 -~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                       -..+++|+|+.|.||+++++...-|+||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             13359999999999999976656899999875

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.25  E-value=0.0027  Score=66.77  Aligned_cols=136  Identities=16%  Similarity=0.229  Sum_probs=83.6

Q ss_pred             cccccccccEEEEEEcCCcEEEEEEec-cCCcccHHHHHHHHHHHHHhcC--CcEEeEeceeeeCC--ceEEEEEecCCC
Q 038934          439 KLGEGGFGPVYKGMLIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQH--RNLVKLLGCCMKRD--ERMLIYEYLPNK  513 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lV~E~~~~g  513 (751)
                      .+-.|..-.+|.... +++++++.+-. ...........+|+.+|+.+.-  .-+.+.++.|.++.  ..+.||++++|.
T Consensus        32 ~~~~G~sn~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe  110 (321)
T COG3173          32 EISGGWSNDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE  110 (321)
T ss_pred             eccCCcccceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence            343333334454443 37888888221 1223345567788888888743  34556677777776  679999999985


Q ss_pred             ChhHHHhccCCCCCCCHHHHHHHH-HHHHHHHHHHHh-------------------------------------------
Q 038934          514 SLADFIFDGTRRKLLDWSKRCQII-GGIARGLLYLHQ-------------------------------------------  549 (751)
Q Consensus       514 sL~~~l~~~~~~~~l~~~~~~~i~-~~i~~~L~yLH~-------------------------------------------  549 (751)
                      .+.+.+...      ...  .+++ ..+++.|+-||+                                           
T Consensus       111 ~~~~~~~~~------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         111 VVWSALPPE------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             eccCcCCcc------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            433222100      000  1111 234444444443                                           


Q ss_pred             ------------CCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          550 ------------DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       550 ------------~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                                  .++..++|+|+.+.||+++++.-+-|+||+++..
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                        2335799999999999999998899999999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.23  E-value=0.0075  Score=64.20  Aligned_cols=143  Identities=22%  Similarity=0.232  Sum_probs=82.6

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCC--cEEeEecee------eeCCceEEEEE
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVKLLGCC------MKRDERMLIYE  508 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lV~E  508 (751)
                      .+.++.|....+|+....++ .+++|+....  ...+.+..|++++..|...  .+.+++...      ...+..++|+|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            34567777789999876444 6778887542  1235567788888888422  234444321      22356789999


Q ss_pred             ecCCCChh-----------HHH---hccCCC------C---CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 038934          509 YLPNKSLA-----------DFI---FDGTRR------K---LLDWSKRC------------QIIGGIARGLLYLHQ----  549 (751)
Q Consensus       509 ~~~~gsL~-----------~~l---~~~~~~------~---~l~~~~~~------------~i~~~i~~~L~yLH~----  549 (751)
                      |++|..+.           ..+   +.....      .   .-.|....            .....+.+.+.++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99986542           111   100000      0   01111100            011123334555532    


Q ss_pred             CCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       550 ~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .-...++|+|+++.||++++++.+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            123469999999999999998877899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.00  E-value=0.0061  Score=63.67  Aligned_cols=31  Identities=23%  Similarity=0.506  Sum_probs=25.9

Q ss_pred             CCEEEccCCCCCeEEcCCCC-eEEeeccCccc
Q 038934          553 LRIIHRDLKASNVLLDNEMN-PKISDFGMARA  583 (751)
Q Consensus       553 ~~ivH~Dikp~NIll~~~~~-~kl~DFGla~~  583 (751)
                      ..++|+|++|.|||+++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45999999999999997555 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=96.93  E-value=0.0062  Score=65.80  Aligned_cols=141  Identities=16%  Similarity=0.240  Sum_probs=83.7

Q ss_pred             ccccccccccEEEEEEcC-----CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEE-eEeceeeeCCceEEEEEecC
Q 038934          438 NKLGEGGFGPVYKGMLID-----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-KLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ..|-.|-.-.+|+....+     ++.+++|+........+.+ .+|..++..+...++. ++++++..+    .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            356568888899987532     3679999886654444443 7899999998644443 455555332    5899998


Q ss_pred             CCChhHH--------------Hhc-cCCC----C-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 038934          512 NKSLADF--------------IFD-GTRR----K-LLDWSKRCQIIGGI-----------------ARGLLYL----HQ-  549 (751)
Q Consensus       512 ~gsL~~~--------------l~~-~~~~----~-~l~~~~~~~i~~~i-----------------~~~L~yL----H~-  549 (751)
                      +.+|...              +.+ +...    . ...+.++..+..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776421              100 0000    0 11123332332111                 1111122    22 


Q ss_pred             CCCCCEEEccCCCCCeEEcC-CCCeEEeeccCccc
Q 038934          550 DSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARA  583 (751)
Q Consensus       550 ~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~  583 (751)
                      .....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22346999999999999986 46799999998754

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.93  E-value=0.00012  Score=88.06  Aligned_cols=160  Identities=13%  Similarity=-0.031  Sum_probs=116.4

Q ss_pred             HHHHHHHHHHhcCCcEEeEeceeee--CCceEEEEEecCCCChhHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 038934          475 FKNEVLLIAKLQHRNLVKLLGCCMK--RDERMLIYEYLPNKSLADFIFDGTRR-KLLDWSKRCQIIGGIARGLLYLHQDS  551 (751)
Q Consensus       475 ~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~  551 (751)
                      ...|..-++...|+++.....-...  ....+.+++++..|.+.+.|..+..+ ..++...+...-.+...+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4445555666789988776554432  34568899999999999998765433 34444444444444366666666543


Q ss_pred             --CCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHH
Q 038934          552 --RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL  629 (751)
Q Consensus       552 --~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~el  629 (751)
                        ....+|+++|+-|.++..+.++|+.++|+.+....  .........+++.|++|++.....++.++|+|..|+.+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              23579999999999999999999999999984321  12223346778899999999999999999999999999999


Q ss_pred             HhCCCCC
Q 038934          630 VYGTRNR  636 (751)
Q Consensus       630 l~G~~p~  636 (751)
                      --|..++
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8776653

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.89  E-value=0.001  Score=68.55  Aligned_cols=134  Identities=16%  Similarity=0.197  Sum_probs=93.9

Q ss_pred             CccccccccccccccEEEEEEcCCcEEEEEEeccC---------C---------cc----cHHHHHHHHHHHHHhc-C-C
Q 038934          433 NFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS---------S---------GQ----GVEEFKNEVLLIAKLQ-H-R  488 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~---------~---------~~----~~~~~~~E~~~l~~l~-h-~  488 (751)
                      -+.+++.||-|--+.||.+-..+|++.++|.-+..         .         ..    ..-...+|+..|+.|. | -
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            45778899999999999999989999999864311         0         00    1123567888898885 3 3


Q ss_pred             cEEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc
Q 038934          489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  568 (751)
Q Consensus       489 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~  568 (751)
                      -+.+.+++    +.-++|||++.+-.|...-      ...+..+   +...+..-+.-|..+|   +||+|..-=||+++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence            34455544    4567899999887765532      1122223   3334444456667777   99999999999999


Q ss_pred             CCCCeEEeeccCcc
Q 038934          569 NEMNPKISDFGMAR  582 (751)
Q Consensus       569 ~~~~~kl~DFGla~  582 (751)
                      +++.++++||--..
T Consensus       237 dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMV  250 (465)
T ss_pred             cCCCEEEeechHhh
Confidence            99999999996543

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.82  E-value=0.0063  Score=63.63  Aligned_cols=73  Identities=22%  Similarity=0.266  Sum_probs=49.0

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc---CCcEEeEeceeeeCCceEEEEEecCCC
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVKLLGCCMKRDERMLIYEYLPNK  513 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~~~g  513 (751)
                      .+.|+.|....+|+.. .+++.+.||.-.   ......|..|++-|+.|.   -..+.+++++....+..+||+||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4578888889999877 578899999875   334467889999999883   445778888888777889999999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.69  E-value=0.02  Score=62.37  Aligned_cols=73  Identities=12%  Similarity=0.105  Sum_probs=51.6

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccC----C---cccHHHHHHHHHHHHHhc---CCcEEeEeceeeeCCceEEE
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS----S---GQGVEEFKNEVLLIAKLQ---HRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV  506 (751)
                      .+.||-|....||+... .++.++||+-...    .   +...++-..|++.|+.+.   ..++.+++.++.  +..++|
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            45789999999999886 4567999987521    1   123455566677777664   246778888876  456788


Q ss_pred             EEecCC
Q 038934          507 YEYLPN  512 (751)
Q Consensus       507 ~E~~~~  512 (751)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.39  E-value=0.027  Score=60.22  Aligned_cols=73  Identities=12%  Similarity=0.190  Sum_probs=49.8

Q ss_pred             cccccccccEEEEEEcCC-cEEEEEEeccC-------CcccHHHHHHHHHHHHHhc--CCc-EEeEeceeeeCCceEEEE
Q 038934          439 KLGEGGFGPVYKGMLIDG-QEIAVKRLSKS-------SGQGVEEFKNEVLLIAKLQ--HRN-LVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lV~  507 (751)
                      .||-|....||++...++ +.|+||.-...       -+...++..-|.+.|+...  -|. +.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            589999999999997654 68999986421       2344566677888887763  343 3444433  455667999


Q ss_pred             EecCCC
Q 038934          508 EYLPNK  513 (751)
Q Consensus       508 E~~~~g  513 (751)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.28  E-value=0.044  Score=57.84  Aligned_cols=140  Identities=21%  Similarity=0.211  Sum_probs=93.0

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCC-----c----cc-----------------HHHHHHHHHHHHHhcCCcE
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSS-----G----QG-----------------VEEFKNEVLLIAKLQHRNL  490 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~----~~-----------------~~~~~~E~~~l~~l~h~ni  490 (751)
                      ...|..|-=+-||.+.-.+|..+|||+++-..     .    .+                 .-....|++-|.+|+...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            34677888899999998899999999985320     0    00                 1123467777777753332


Q ss_pred             EeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC
Q 038934          491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE  570 (751)
Q Consensus       491 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~  570 (751)
                      .-.--+. - ..-.|||+|+.......-   ..+...++...+..+-++++.-+.-|-+.+  ++||.||+--|+|+-+ 
T Consensus       229 P~PePIl-L-k~hVLVM~FlGrdgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-  300 (520)
T KOG2270|consen  229 PCPEPIL-L-KNHVLVMEFLGRDGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-  300 (520)
T ss_pred             CCCCcee-e-ecceEeeeeccCCCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-
Confidence            1110000 0 123689999864222111   123345677788888899999999998877  5999999999999864 


Q ss_pred             CCeEEeeccCcccc
Q 038934          571 MNPKISDFGMARAF  584 (751)
Q Consensus       571 ~~~kl~DFGla~~~  584 (751)
                      |.+.|+|-+-+...
T Consensus       301 G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEH  314 (520)
T ss_pred             CEEEEEEccccccC
Confidence            57999998876654

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.20  E-value=0.018  Score=62.31  Aligned_cols=74  Identities=12%  Similarity=0.127  Sum_probs=51.7

Q ss_pred             cccccccccccEEEEEEcC-CcEEEEEEeccC------CcccHHHHHHHHHHHHHhc--CCc-EEeEeceeeeCCceEEE
Q 038934          437 ENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS------SGQGVEEFKNEVLLIAKLQ--HRN-LVKLLGCCMKRDERMLI  506 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lV  506 (751)
                      .+.||-|.-.-||++...+ ++.|+||.-...      -+...++..-|.++|+...  .|. +.+++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3578999999999999743 678999986421      2344667788888888763  353 4445443  45566789


Q ss_pred             EEecCC
Q 038934          507 YEYLPN  512 (751)
Q Consensus       507 ~E~~~~  512 (751)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998865

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.99  E-value=0.04  Score=59.23  Aligned_cols=141  Identities=15%  Similarity=0.215  Sum_probs=80.8

Q ss_pred             ccccccccccEEEEEEcC----CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcE-EeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      +.|..|-.-.+|+....+    +..|++|+........+ .-.+|..+++.+...++ .++++++..+    +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence            355557778889887543    23789998765443322 23689999999865444 3555555322    58999988


Q ss_pred             CChhHH-------H-------hc-cCC-----CCCCCHHHHHHHHHHH----------------------HHHHHH----
Q 038934          513 KSLADF-------I-------FD-GTR-----RKLLDWSKRCQIIGGI----------------------ARGLLY----  546 (751)
Q Consensus       513 gsL~~~-------l-------~~-~~~-----~~~l~~~~~~~i~~~i----------------------~~~L~y----  546 (751)
                      ..|...       +       .. +..     ...-.+..+.++..++                      .+-+..    
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            765321       1       11 010     0011223322222221                      111111    


Q ss_pred             HHh-CCCCCEEEccCCCCCeEEcC-CCCeEEeeccCccc
Q 038934          547 LHQ-DSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARA  583 (751)
Q Consensus       547 LH~-~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~  583 (751)
                      +.. .....++|.|+.+.|||+++ ++.++++||+.|-.
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            111 11235899999999999975 57899999998754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	751
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-53
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-39
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-38
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-38
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-24
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-23
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-22
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-21
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-20
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-20
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-19
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-19
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-19
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-19
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-19
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-19
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-19
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-19
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-19
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-19
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-19
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-19
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-19
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-19
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-19
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-19
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-19
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-19
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-19
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-19
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-19
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-19
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-19
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-19
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-19
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-19
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-18
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-18
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-18
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-18
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-18
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-18
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-18
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-18
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-18
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-18
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-18
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-18
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-18
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-18
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-18
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-18
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-18
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-18
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-18
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-18
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-18
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-18
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-18
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-18
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-18
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-17
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-17
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-17
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-14
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-11
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-09
3soa_A	444	Full-Length Human Camkii Length = 444		2e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-09
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-09
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-09
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		6e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  211 bits (537), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 124/296 (41%), Positives = 169/296 (57%), Gaps = 7/296 (2%)
Query: 418 ELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVE-EFK 476
           +L  F  + +  A+DNFS +N LG GGFG VYKG L DG  +AVKRL +   QG E +F+
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 477 NEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL-LDWSKRCQ 535
            EV +I+   HRNL++L G CM   ER+L+Y Y+ N S+A  + +    +  LDW KR +
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
           I  G ARGL YLH     +IIHRD+KA+N+LLD E    + DFG+A+   +D  + +   
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDXHVXX 201
Query: 596 VV-GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWR- 653
            V GT G++ PEY   G  S K+DVF +GV++LEL+ G R                 W  
Sbjct: 202 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261
Query: 654 -LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE 708
            L  E +   L+D  L+  Y   E  + IQV LLC Q  P +RP M+ VV ML G+
Sbjct: 262 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  207 bits (526), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 122/296 (41%), Positives = 167/296 (56%), Gaps = 7/296 (2%)
Query: 418 ELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVE-EFK 476
           +L  F  + +  A+DNF  +N LG GGFG VYKG L DG  +AVKRL +   QG E +F+
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 477 NEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL-LDWSKRCQ 535
            EV +I+   HRNL++L G CM   ER+L+Y Y+ N S+A  + +    +  LDW KR +
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
           I  G ARGL YLH     +IIHRD+KA+N+LLD E    + DFG+A+   +D  + +   
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDXHVXX 193
Query: 596 VV-GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWR- 653
            V G  G++ PEY   G  S K+DVF +GV++LEL+ G R                 W  
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 654 -LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE 708
            L  E +   L+D  L+  Y   E  + IQV LLC Q  P +RP M+ VV ML G+
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  165 bits (417), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/223 (43%), Positives = 133/223 (59%), Gaps = 19/223 (8%)
Query: 422 FDWKSIANATDNFSEE------NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEE- 474
           F +  + N T+NF E       NK+GEGGFG VYKG  ++   +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 475 ---FKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI--FDGTRRKLLD 529
              F  E+ ++AK QH NLV+LLG     D+  L+Y Y+PN SL D +   DGT    L 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LS 131
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
           W  RC+I  G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA      
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
               +R+VGT  YM PE A+ G  + KSD++SFGV++LE++ G
Sbjct: 189 TVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  164 bits (415), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/223 (43%), Positives = 132/223 (59%), Gaps = 19/223 (8%)
Query: 422 FDWKSIANATDNFSEE------NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEE- 474
           F +  + N T+NF E       NK+GEGGFG VYKG  ++   +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 475 ---FKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI--FDGTRRKLLD 529
              F  E+ ++AK QH NLV+LLG     D+  L+Y Y+PN SL D +   DGT    L 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LS 131
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
           W  RC+I  G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA      
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
                R+VGT  YM PE A+ G  + KSD++SFGV++LE++ G
Sbjct: 189 TVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  164 bits (415), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/223 (43%), Positives = 132/223 (59%), Gaps = 19/223 (8%)
Query: 422 FDWKSIANATDNFSEE------NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEE- 474
           F +  + N T+NF E       NK+GEGGFG VYKG  ++   +AVK+L+       EE 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 67
Query: 475 ---FKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI--FDGTRRKLLD 529
              F  E+ ++AK QH NLV+LLG     D+  L+Y Y+PN SL D +   DGT    L 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LS 125
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
           W  RC+I  G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA      
Sbjct: 126 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
                R+VGT  YM PE A+ G  + KSD++SFGV++LE++ G
Sbjct: 183 XVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  159 bits (402), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 95/223 (42%), Positives = 129/223 (57%), Gaps = 19/223 (8%)
Query: 422 FDWKSIANATDNFSEE------NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEE- 474
           F +  + N T+NF E       NK GEGGFG VYKG  ++   +AVK+L+       EE 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGY-VNNTTVAVKKLAAMVDITTEEL 64
Query: 475 ---FKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI--FDGTRRKLLD 529
              F  E+ + AK QH NLV+LLG     D+  L+Y Y PN SL D +   DGT    L 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP--LS 122
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
           W  RC+I  G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA      
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
               +R+VGT  Y  PE A+ G  + KSD++SFGV++LE++ G
Sbjct: 180 XVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  158 bits (400), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 163/292 (55%), Gaps = 13/292 (4%)
Query: 415 EEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEE 474
           E   +P+ D   +  AT+NF  +  +G G FG VYKG+L DG ++A+KR +  S QG+EE
Sbjct: 25  ESYRVPLVD---LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 475 FKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL-LDWSKR 533
           F+ E+  ++  +H +LV L+G C +R+E +LIY+Y+ N +L   ++      + + W +R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
            +I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++  G +  + + 
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHL 197
Query: 594 NRVV-GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAW 652
             VV GT GY+ PEY I G  + KSDV+SFGV++ E++                     W
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA--RSAIVQSLPREMVNLAEW 255
Query: 653 RLWTED--RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV 702
            + + +  +  +++D +L D        +     + C+    EDRP+M  V+
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  158 bits (399), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 163/292 (55%), Gaps = 13/292 (4%)
Query: 415 EEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEE 474
           E   +P+ D   +  AT+NF  +  +G G FG VYKG+L DG ++A+KR +  S QG+EE
Sbjct: 25  ESYRVPLVD---LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 475 FKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL-LDWSKR 533
           F+ E+  ++  +H +LV L+G C +R+E +LIY+Y+ N +L   ++      + + W +R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
            +I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++  G +  + + 
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHL 197
Query: 594 NRVV-GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAW 652
             VV GT GY+ PEY I G  + KSDV+SFGV++ E++                     W
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL--CARSAIVQSLPREMVNLAEW 255
Query: 653 RLWTED--RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV 702
            + + +  +  +++D +L D        +     + C+    EDRP+M  V+
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 76/218 (34%), Positives = 114/218 (52%), Gaps = 30/218 (13%)
Query: 433 NFSE---ENKLGEGGFGPVYKGMLIDGQEIAVKRL----SKSSGQGVEEFKNEVLLIAKL 485
           +F+E   E  +G GGFG VY+   I G E+AVK       +   Q +E  + E  L A L
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK---LLDWSKRCQIIGGIAR 542
           +H N++ L G C+K     L+ E+     L + +  G R     L++W+ +      IAR
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQ------IAR 116
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--------KISDFGMARAFGVDQTEANTN 594
           G+ YLH ++ + IIHRDLK+SN+L+  ++          KI+DFG+AR +          
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKM 172
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
              G Y +M PE     +FS  SDV+S+GVL+ EL+ G
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/246 (32%), Positives = 126/246 (51%), Gaps = 34/246 (13%)
Query: 417 MELPIFD------WKSIANATDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRL 464
           ME+P+ +       K I+ +   F EE  LGE  FG VYKG L         Q +A+K L
Sbjct: 7   MEMPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL 64
Query: 465 S-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIF--- 520
             K+ G   EEF++E +L A+LQH N+V LLG   K     +I+ Y  +  L +F+    
Sbjct: 65  KDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRS 124
Query: 521 ----------DGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE 570
                     D T +  L+      ++  IA G+ YL   S   ++H+DL   NVL+ ++
Sbjct: 125 PHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDK 181
Query: 571 MNPKISDFGMAR-AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           +N KISD G+ R  +  D  +   N ++    +M PE  + G FS+ SD++S+GV++ E+
Sbjct: 182 LNVKISDLGLFREVYAADYYKLLGNSLLPI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240
Query: 630 V-YGTR 634
             YG +
Sbjct: 241 FSYGLQ 246

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/232 (33%), Positives = 120/232 (51%), Gaps = 28/232 (12%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLS-KSSGQGVEEFKN 477
           K I+ +   F EE  LGE  FG VYKG L         Q +A+K L  K+ G   EEF++
Sbjct: 4   KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 478 EVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIF-------------DGTR 524
           E +L A+LQH N+V LLG   K     +I+ Y  +  L +F+              D T 
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 525 RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-A 583
           +  L+      ++  IA G+ YL   S   ++H+DL   NVL+ +++N KISD G+ R  
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           +  D  +   N ++    +M PE  + G FS+ SD++S+GV++ E+  YG +
Sbjct: 179 YAADYYKLLGNSLLPI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 106/196 (54%), Gaps = 6/196 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           + K+G G FG V++     G ++AVK L +     + V EF  EV ++ +L+H N+V  +
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G   +     ++ EYL   SL   +     R+ LD  +R  +   +A+G+ YLH +    
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           I+HR+LK+ N+L+D +   K+ DFG++R      T  ++    GT  +M PE   D   +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 615 VKSDVFSFGVLVLELV 630
            KSDV+SFGV++ EL 
Sbjct: 218 EKSDVYSFGVILWELA 233

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 104/196 (53%), Gaps = 6/196 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           + K+G G FG V++     G ++AVK L +     + V EF  EV ++ +L+H N+V  +
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G   +     ++ EYL   SL   +     R+ LD  +R  +   +A+G+ YLH +    
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           I+HRDLK+ N+L+D +   K+ DFG++R          +    GT  +M PE   D   +
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--SXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 615 VKSDVFSFGVLVLELV 630
            KSDV+SFGV++ EL 
Sbjct: 218 EKSDVYSFGVILWELA 233

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 134
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 190
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 191 SLTESKFSVASDVWSFGVVLYEL 213

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 162
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 218
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 219 SLTESKFSVASDVWSFGVVLYEL 241

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 136
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 192
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 193 SLTESKFSVASDVWSFGVVLYEL 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 138
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 194
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 195 SLTESKFSVASDVWSFGVVLYEL 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 137
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 193
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 194 SLTESKFSVASDVWSFGVVLYEL 216

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYL---G 134
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 190
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 191 SLTESKFSVASDVWSFGVVLYEL 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 130
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 186
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 187 SLTESKFSVASDVWSFGVVLYEL 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 129
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 185
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 186 SLTESKFSVASDVWSFGVVLYEL 208

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 131
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 187
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 188 SLTESKFSVASDVWSFGVVLYEL 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 131
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 187
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 188 SLTESKFSVASDVWSFGVVLYEL 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 149
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 205
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 206 SLTESKFSVASDVWSFGVVLYEL 228

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 135
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 191
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 192 SLTESKFSVASDVWSFGVVLYEL 214

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 149
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 205
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 206 SLTESKFSVASDVWSFGVVLYEL 228

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AVV 85
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 141
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 200
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 201 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 252
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 253 -------LCWKERPEDRPTF 265

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 192
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 193 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 244
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 245 -------LCWKERPEDRPTF 257

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 83
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 198
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 199 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 250
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 251 -------LCWKERPEDRPTF 263

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 86
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 142
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 201
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 202 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 253
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 254 -------LCWKERPEDRPTF 266

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 79
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 135
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 194
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 195 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 246
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 247 -------LCWKERPEDRPTF 259

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 78
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 134
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 193
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 194 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 245
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 246 -------LCWKERPEDRPTF 258

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 83
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 198
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 199 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 250
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 251 -------LCWKERPEDRPTF 263

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AVV 87
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 143
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 202
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 203 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 254
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 255 -------LCWKERPEDRPTF 267

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 192
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 193 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 244
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 245 -------LCWKERPEDRPTF 257

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 82
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 138
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 197
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 198 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 249
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 250 -------LCWKERPEDRPTF 262

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 70/196 (35%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            +LG G FG V+ G   +  ++AVK L K     V+ F  E  L+  LQH  LV+L    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + +   +I EY+   SL DF+      K+L   K       IA G+ Y+    R   IH
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIH 133
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL+A+NVL+   +  KI+DFG+AR    ++  A          +  PE    G F++KS
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKS 192
Query: 618 DVFSFGVLVLELV-YG 632
           DV+SFG+L+ E+V YG
Sbjct: 193 DVWSFGILLYEIVTYG 208

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 114/201 (56%), Gaps = 20/201 (9%)
Query: 440 LGEGGFGPVYKGMLIDGQE-----IAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVKL 493
           LG G FG VYKG+ +   E     +A+K L++++G     EF +E L++A + H +LV+L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIARGLLYLHQ 549
           LG C+    + L+ + +P+  L +++ +       + LL+W  +      IA+G++YL +
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
               R++HRDL A NVL+ +  + KI+DFG+AR    D+ E N +       +M  E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 610 DGLFSVKSDVFSFGVLVLELV 630
              F+ +SDV+S+GV + EL+
Sbjct: 216 YRKFTHQSDVWSYGVTIWELM 236

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 192
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 193 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 244
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 245 -------LCWKERPEDRPTF 257

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 72
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 128
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 187
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 188 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 239
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 240 -------LCWKERPEDRPTF 252

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 114/201 (56%), Gaps = 20/201 (9%)
Query: 440 LGEGGFGPVYKGMLIDGQE-----IAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVKL 493
           LG G FG VYKG+ +   E     +A+K L++++G     EF +E L++A + H +LV+L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIARGLLYLHQ 549
           LG C+    + L+ + +P+  L +++ +       + LL+W  +      IA+G++YL +
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
               R++HRDL A NVL+ +  + KI+DFG+AR    D+ E N +       +M  E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 610 DGLFSVKSDVFSFGVLVLELV 630
              F+ +SDV+S+GV + EL+
Sbjct: 193 YRKFTHQSDVWSYGVTIWELM 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 131
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK----VKEPGESPIFWYAPE 187
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 188 SLTESKFSVASDVWSFGVVLYEL 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 104/196 (53%), Gaps = 7/196 (3%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAV-V 73
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
             +   ++ EY+   SL DF+ DG  R L        +   +A G+ Y+    R+  IHR
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+++N+L+ N +  KI+DFG+AR    ++  A          +  PE A+ G F++KSD
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSD 188
Query: 619 VFSFGVLVLELVYGTR 634
           V+SFG+L+ ELV   R
Sbjct: 189 VWSFGILLTELVTKGR 204

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 132/283 (46%), Gaps = 23/283 (8%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 248 -VSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 361
Query: 617 SDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSE 676
           SDV+SFG+L+ EL   T+ R                R +    P E   +SL D      
Sbjct: 362 SDVWSFGILLTELT--TKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHD------ 412
Query: 677 ALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPK-QPG 718
            L C      C ++ PE+RP    +   L    +  +P+ QPG
Sbjct: 413 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 132/283 (46%), Gaps = 23/283 (8%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY-A 329
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444
Query: 617 SDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSE 676
           SDV+SFG+L+ EL   T+ R                R +    P E   +SL D      
Sbjct: 445 SDVWSFGILLTELT--TKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHD------ 495
Query: 677 ALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPK-QPG 718
            L C      C ++ PE+RP    +   L    +  +P+ QPG
Sbjct: 496 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 532

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 132/283 (46%), Gaps = 23/283 (8%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 248 -VSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 361
Query: 617 SDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSE 676
           SDV+SFG+L+ EL   T+ R                R +    P E   +SL D      
Sbjct: 362 SDVWSFGILLTELT--TKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHD------ 412
Query: 677 ALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPK-QPG 718
            L C      C ++ PE+RP    +   L    +  +P+ QPG
Sbjct: 413 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI EYLP  SL D++     R  +D  K  Q    I +G+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 132
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHR+L   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYK----VKEPGESPIFWYAPE 188
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 189 SLTESKFSVASDVWSFGVVLYEL 211

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/196 (35%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            KLG G FG V+ G   +  ++AVK L K     V+ F  E  L+  LQH  LV+L    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            K +   +I E++   SL DF+      K+L   K       IA G+ Y+    R   IH
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL+A+NVL+   +  KI+DFG+AR    ++  A          +  PE    G F++KS
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKS 191
Query: 618 DVFSFGVLVLELV-YG 632
           +V+SFG+L+ E+V YG
Sbjct: 192 NVWSFGILLYEIVTYG 207

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 73
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 129
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           +L+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F++KSD
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 188
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 189 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 240
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 241 -------LCWKERPEDRPTF 253

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 439 KLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +LG+G FG V    Y  +  + G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 494 LGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C     R   LI E+LP  SL +++     R  +D  K  Q    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 134
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 190
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
              +  FSV SDV+SFGV++ EL
Sbjct: 191 SLTESKFSVASDVWSFGVVLYEL 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 132/283 (46%), Gaps = 23/283 (8%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 248 -VSEEPIYIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 361
Query: 617 SDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSE 676
           SDV+SFG+L+ EL   T+ R                R +    P E   +SL D      
Sbjct: 362 SDVWSFGILLTELT--TKGRVPYPGMVNREVLDQVERGYRMPCPPE-CPESLHD------ 412
Query: 677 ALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPK-QPG 718
            L C      C ++ PE+RP    +   L    +  +P+ QPG
Sbjct: 413 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 13  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 72  -VSEEPIXIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 126
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIK 185
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 186 SDVWSFGILLTELTTKGR 203

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIK 195
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 16  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 75  -VSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 129
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 188
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 189 SDVWSFGILLTELTTKGR 206

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 14  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 73  -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 127
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 186
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 187 SDVWSFGILLTELTTKGR 204

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 134/279 (48%), Gaps = 42/279 (15%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG G FG V+        ++AVK + K     VE F  E  ++  LQH  LVKL   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 497 CMKRDERMLIYEYLPNKSLADFIF--DGTRR---KLLDWSKRCQIIGGIARGLLYLHQDS 551
             K +   +I E++   SL DF+   +G+++   KL+D+S +      IA G+ ++ Q +
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN 304
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL+A+N+L+   +  KI+DFG+AR    ++  A          +  PE    G
Sbjct: 305 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFG 360
Query: 612 LFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLED 670
            F++KSDV+SFG+L++E+V YG                    R+         + ++LE 
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYG--------------------RIPYPGMSNPEVIRALER 400
Query: 671 TYSLSEALRCIQ----VGLLCVQQRPEDRPNMASVVLML 705
            Y +     C +    + + C + RPE+RP    +  +L
Sbjct: 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 195
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 12  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 71  -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 125
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 184
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 185 SDVWSFGILLTELTTKGR 202

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 195
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 195
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 42/275 (15%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG G FG V+        ++AVK + K     VE F  E  ++  LQH  LVKL   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 497 CMKRDERMLIYEYLPNKSLADFIF--DGTRR---KLLDWSKRCQIIGGIARGLLYLHQDS 551
             K +   +I E++   SL DF+   +G+++   KL+D+S +      IA G+ ++ Q +
Sbjct: 79  VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN 131
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL+A+N+L+   +  KI+DFG+AR    ++  A          +  PE    G
Sbjct: 132 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFG 187
Query: 612 LFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLED 670
            F++KSDV+SFG+L++E+V YG                    R+         + ++LE 
Sbjct: 188 SFTIKSDVWSFGILLMEIVTYG--------------------RIPYPGMSNPEVIRALER 227
Query: 671 TYSLSEALRCIQ----VGLLCVQQRPEDRPNMASV 701
            Y +     C +    + + C + RPE+RP    +
Sbjct: 228 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYI 262

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 190 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 249 -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 303
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+ R    ++  A          +  PE A+ G F++K
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 362
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 363 SDVWSFGILLTELTTKGR 380

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 79  -VSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 192
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 79  -VSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPI-KWTAPEAALYGRFTIK 192
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ K++H  LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 195
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+   SL DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 195
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 126/260 (48%), Gaps = 22/260 (8%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +LG G  G V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV+L    +
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            ++   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 618
           DL+A+N+L+ + ++ KI+DFG+AR     +  A          +  PE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 192
Query: 619 VFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEAL 678
           V+SFG+L+ E+V  T  R                R +   RP    D   E+ Y L    
Sbjct: 193 VWSFGILLTEIV--THGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMR-- 244
Query: 679 RCIQVGLLCVQQRPEDRPNM 698
                  LC ++RPEDRP  
Sbjct: 245 -------LCWKERPEDRPTF 257

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+    L DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 195
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
            +  +   ++ EY+    L DF+  G   K L   +   +   IA G+ Y+    R+  +
Sbjct: 82  -VSEEPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIK 195
Query: 617 SDVFSFGVLVLELVYGTR 634
           SDV+SFG+L+ EL    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 133/282 (47%), Gaps = 58/282 (20%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG G FG V+        ++AVK + K     VE F  E  ++  LQH  LVKL   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 497 CMKRDERMLIYEYLPNKSLADFIF--DGTRR---KLLDWSKRCQIIGGIARGLLYLHQDS 551
             K +   +I E++   SL DF+   +G+++   KL+D+S +      IA G+ ++ Q +
Sbjct: 246 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN 298
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARA---FGVDQTEANTNRVVGTYGYMPPEYA 608
               IHRDL+A+N+L+   +  KI+DFG+AR    F +  T               PE  
Sbjct: 299 ---YIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWTA--------------PEAI 341
Query: 609 IDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKS 667
             G F++KSDV+SFG+L++E+V YG                    R+         + ++
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVTYG--------------------RIPYPGMSNPEVIRA 381
Query: 668 LEDTYSLSEALRCIQ----VGLLCVQQRPEDRPNMASVVLML 705
           LE  Y +     C +    + + C + RPE+RP    +  +L
Sbjct: 382 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 131/274 (47%), Gaps = 30/274 (10%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG V+ G  ++  ++A+K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
           +++    L++E++ +  L+D++   T+R L        +   +  G+ YL + S   +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L+      K+SDFGM R    DQ  ++T        +  PE      +S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKS 185
Query: 618 DVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSE- 676
           DV+SFGVL+ E+     + G               ++  E+R    + + +   + L + 
Sbjct: 186 DVWSFGVLMWEVF----SEG---------------KIPYENRSNSEVVEDISTGFRLYKP 226
Query: 677 ---ALRCIQVGLLCVQQRPEDRPNMASVVLMLSG 707
              +    Q+   C ++RPEDRP  + ++  L+ 
Sbjct: 227 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAA 260

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 136
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 192
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 193 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 246
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 247 YELMRA---------CWQWNPSDRPSFAEI 267

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 136
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 193 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 246
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 247 YELMRA---------CWQWNPSDRPSFAEI 267

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G FG VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ +       +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN 129
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 185
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 186 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKV 239
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 240 YELMRA---------CWQWNPSDRPSFAEI 260

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 131
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 188 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 242 YELMRA---------CWQWNPSDRPSFAEI 262

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 135/288 (46%), Gaps = 47/288 (16%)
Query: 435 SEENKLGEGGFGPVYKGMLIDGQ-----EIAVKRLSK--SSGQGVEEFKNEVLLIAKLQH 487
           + +  +G G FG VYKGML          +A+K L    +  Q V+ F  E  ++ +  H
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSH 105
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M+I EY+ N +L  F+    R K  ++S   Q++G   GIA G+
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFL----REKDGEFSV-LQLVGMLRGIAAGM 160
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG--Y 602
            YL   + +  +HRDL A N+L+++ +  K+SDFG++R    D  EA      G     +
Sbjct: 161 KYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRW 216
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLE-LVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPV 661
             PE      F+  SDV+SFG+++ E + YG R                 W L   +   
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHE--- 258
Query: 662 ELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
             + K++ D + L   + C     Q+ + C QQ    RP  A +V +L
Sbjct: 259 --VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 136
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 193 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 246
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 247 YELMRA---------CWQWNPSDRPSFAEI 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 135
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 136 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 191
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 192 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 246 YELMRA---------CWQWNPSDRPSFAEI 266

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 132
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 188
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 189 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 242
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 243 YELMRA---------CWQWNPSDRPSFAEI 263

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 131
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 188 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 242 YELMRA---------CWQWNPSDRPSFAEI 262

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 133
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 190 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 243
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 244 YELMRA---------CWQWNPSDRPSFAEI 264

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 136
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 193 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 246
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 247 YELMRA---------CWQWNPSDRPSFAEI 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 133
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 190 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 243
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 244 YELMRA---------CWQWNPSDRPSFAEI 264

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 111/208 (53%), Gaps = 10/208 (4%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+ +    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
            ++ N+V  L   +  DE  ++ EYL   SL D + +      +D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQAL 129
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++ +T  +VGT  +M 
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 184
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +  K D++S G++ +E++ G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ +       +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN 131
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 188 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 242 YELMRA---------CWQWNPSDRPSFAEI 262

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 85
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 144
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 145 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 200
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 201 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 254
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 255 YELMRA---------CWQWNPSDRPSFAEI 275

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ +       +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN 129
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 185
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 186 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKV 239
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 240 YELMRA---------CWQWNPSDRPSFAEI 260

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 10/200 (5%)
Query: 434 FSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           F    KLGEG +G VYK +  + GQ +A+K++   S   ++E   E+ ++ +    ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
             G   K  +  ++ EY    S++D I    R K L   +   I+    +GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLH---F 143
Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
           +R IHRD+KA N+LL+ E + K++DFG+A         A  N V+GT  +M PE   +  
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 613 FSVKSDVFSFGVLVLELVYG 632
           ++  +D++S G+  +E+  G
Sbjct: 202 YNCVADIWSLGITAIEMAEG 221

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ +       +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN 131
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 188 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 242 YELMRA---------CWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ +       +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN 136
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 193 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 246
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 247 YELMRA---------CWQWNPSDRPSFAEI 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ +       +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN 131
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 188 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 242 YELMRA---------CWQWNPSDRPSFAEI 262

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 30/273 (10%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG V+ G  ++  ++A+K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
           +++    L++E++ +  L+D++   T+R L        +   +  G+ YL +     +IH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L+      K+SDFGM R    DQ  ++T        +  PE      +S KS
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKS 188
Query: 618 DVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSE- 676
           DV+SFGVL+ E+     + G               ++  E+R    + + +   + L + 
Sbjct: 189 DVWSFGVLMWEVF----SEG---------------KIPYENRSNSEVVEDISTGFRLYKP 229
Query: 677 ---ALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
              +    Q+   C ++RPEDRP  + ++  L+
Sbjct: 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ +       +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN 131
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 188 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 242 YELMRA---------CWQWNPSDRPSFAEI 262

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 28/223 (12%)
Query: 433 NFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 486
           N   + +LGEG FG V+           D   +AVK L  +S    ++F  E  L+  LQ
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI----------FDGTRRKLLDWSKRCQI 536
           H ++VK  G C++ D  ++++EY+ +  L  F+           +G     L  S+   I
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
              IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D    +  RV
Sbjct: 134 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 186
Query: 597 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL-VYGTR 634
            G       +MPPE  +   F+ +SDV+S GV++ E+  YG +
Sbjct: 187 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 30/273 (10%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG V+ G  ++  ++A+K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
           +++    L++E++ +  L+D++   T+R L        +   +  G+ YL +     +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L+      K+SDFGM R    DQ  ++T        +  PE      +S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKS 185
Query: 618 DVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSE- 676
           DV+SFGVL+ E+     + G               ++  E+R    + + +   + L + 
Sbjct: 186 DVWSFGVLMWEVF----SEG---------------KIPYENRSNSEVVEDISTGFRLYKP 226
Query: 677 ---ALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
              +    Q+   C ++RPEDRP  + ++  L+
Sbjct: 227 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 259

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 134/287 (46%), Gaps = 50/287 (17%)
Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V  G L + G+    +A+K L    + +   +F +E  ++ +  H N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLH 548
            L G   K    M+I EY+ N SL  F+     R  +      Q++G   GI  G+ YL 
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGIGSGMKYL- 147
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP---- 604
             S +  +HRDL A N+L+++ +  K+SDFGM+R    D   A T R     G +P    
Sbjct: 148 --SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----GGKIPIRWT 201
Query: 605 -PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVE 662
            PE      F+  SDV+S+G+++ E++ YG R                 W +  +D    
Sbjct: 202 APEAIAYRKFTSASDVWSYGIVMWEVMSYGER---------------PYWDMSNQD---- 242
Query: 663 LIDKSLEDTYSLSEALRCI----QVGLLCVQQRPEDRPNMASVVLML 705
            + K++E+ Y L   + C     Q+ L C Q+   DRP    +V ML
Sbjct: 243 -VIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 132
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A          +  PE     
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYN 188
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 189 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 242
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 243 YELMRA---------CWQWNPSDRPSFAEI 263

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 30/273 (10%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG V+ G  ++  ++A+K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
           +++    L++E++ +  L+D++   T+R L        +   +  G+ YL +     +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L+      K+SDFGM R    DQ  ++T        +  PE      +S KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKS 183
Query: 618 DVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSE- 676
           DV+SFGVL+ E+     + G               ++  E+R    + + +   + L + 
Sbjct: 184 DVWSFGVLMWEVF----SEG---------------KIPYENRSNSEVVEDISTGFRLYKP 224
Query: 677 ---ALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
              +    Q+   C ++RPEDRP  + ++  L+
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ +       +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN 129
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYN 185
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 186 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKV 239
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 240 YELMRA---------CWQWNPSDRPSFAEI 260

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 133
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A          +  PE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYN 189
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 190 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 243
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 244 YELMRA---------CWQWNPSDRPSFAEI 264

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 318
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ ++      +   I+  + YL + +
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN 377
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHR+L A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 378 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 433
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 434 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 487
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 488 YELMRA---------CWQWNPSDRPSFAEI 508

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 134/287 (46%), Gaps = 50/287 (17%)
Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V  G L + G+    +A+K L    + +   +F +E  ++ +  H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLH 548
            L G   K    M+I EY+ N SL  F+     R  +      Q++G   GI  G+ YL 
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGIGSGMKYL- 126
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP---- 604
             S +  +HRDL A N+L+++ +  K+SDFGM+R    D   A T R     G +P    
Sbjct: 127 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----GGKIPIRWT 180
Query: 605 -PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVE 662
            PE      F+  SDV+S+G+++ E++ YG R                 W +  +D    
Sbjct: 181 APEAIAYRKFTSASDVWSYGIVMWEVMSYGER---------------PYWDMSNQD---- 221
Query: 663 LIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
            + K++E+ Y L   + C     Q+ L C Q+   DRP    +V ML
Sbjct: 222 -VIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 134/287 (46%), Gaps = 50/287 (17%)
Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V  G L + G+    +A+K L    + +   +F +E  ++ +  H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLH 548
            L G   K    M+I EY+ N SL  F+     R  +      Q++G   GI  G+ YL 
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGIGSGMKYL- 132
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP---- 604
             S +  +HRDL A N+L+++ +  K+SDFGM+R    D   A T R     G +P    
Sbjct: 133 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----GGKIPIRWT 186
Query: 605 -PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVE 662
            PE      F+  SDV+S+G+++ E++ YG R                 W +  +D    
Sbjct: 187 APEAIAYRKFTSASDVWSYGIVMWEVMSYGER---------------PYWDMSNQD---- 227
Query: 663 LIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
            + K++E+ Y L   + C     Q+ L C Q+   DRP    +V ML
Sbjct: 228 -VIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 279
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C +     +I E++   +L D++ +  R++ +       +   I+  + YL + +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN 338
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHR+L A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 394
Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDT 671
            FS+KSDV++FGVL+ E+        +             + L  +D  +E  +   E  
Sbjct: 395 KFSIKSDVWAFGVLLWEIA------TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 448
Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           Y L  A         C Q  P DRP+ A +
Sbjct: 449 YELMRA---------CWQWNPSDRPSFAEI 469

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L + +S +  +E  +E  ++A + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 132
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 133 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 222

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 31/222 (13%)
Query: 437 ENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           + +LGEG FG V+           D   +AVK L   +    ++F+ E  L+  LQH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADF----------IFDGTRRKL---LDWSKRCQII 537
           VK  G C   D  ++++EY+ +  L  F          + DG  R+    L  S+   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVV 597
             IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D    +  RV 
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 192
Query: 598 GT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL-VYGTR 634
           G       +MPPE  +   F+ +SDV+SFGV++ E+  YG +
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 129
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 130 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 219

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 76  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 79  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 220

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAK 129
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 130 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 219

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 220

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 110/208 (52%), Gaps = 10/208 (4%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+ +    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
            ++ N+V  L   +  DE  ++ EYL   SL D + +      +D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQAL 129
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++   + +VGT  +M 
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMA 184
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +  K D++S G++ +E++ G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L + +S +  +E  +E  ++A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L + +S +  +E  +E  ++A + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 82  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 134
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 135 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 224

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 110/208 (52%), Gaps = 10/208 (4%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+ +    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
            ++ N+V  L   +  DE  ++ EYL   SL D + +      +D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQAL 129
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++ +   +VGT  +M 
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYWMA 184
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +  K D++S G++ +E++ G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L + +S +  +E  +E  ++A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L + +S +  +E  +E  ++A + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 86  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 138
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 139 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 228

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L + +S +  +E  +E  ++A + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 122
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 123 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 131/273 (47%), Gaps = 30/273 (10%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG V+ G  ++  ++A+K + + S    ++F  E  ++ KL H  LV+L G C
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
           +++    L++E++ +  L+D++   T+R L        +   +  G+ YL +     +IH
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L+      K+SDFGM R    DQ  ++T        +  PE      +S KS
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKS 205
Query: 618 DVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSE- 676
           DV+SFGVL+ E+     + G               ++  E+R    + + +   + L + 
Sbjct: 206 DVWSFGVLMWEVF----SEG---------------KIPYENRSNSEVVEDISTGFRLYKP 246
Query: 677 ---ALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
              +    Q+   C ++RPEDRP  + ++  L+
Sbjct: 247 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 279

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L + +S +  +E  +E  ++A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 111/208 (53%), Gaps = 10/208 (4%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+ +    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 15  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
            ++ N+V  L   +  DE  ++ EYL   SL D + +      +D  +   +     + L
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQAL 130
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH +   ++IHR++K+ N+LL  + + K++DFG       +Q++ +T  +VGT  +M 
Sbjct: 131 EFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 185
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +  K D++S G++ +E++ G
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 225

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L + +S +  +E  +E  ++A + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 101 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 153
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 154 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 243

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 135/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ EY+ N SL  F+     RK        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG+AR    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR----GGKIP 213
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 258
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 110/208 (52%), Gaps = 10/208 (4%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+ +    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 15  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
            ++ N+V  L   +  DE  ++ EYL   SL D + +      +D  +   +     + L
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQAL 130
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++ +   +VGT  +M 
Sbjct: 131 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYWMA 185
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +  K D++S G++ +E++ G
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 129/273 (47%), Gaps = 30/273 (10%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG V+ G  ++  ++A+K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
           +++    L+ E++ +  L+D++   T+R L        +   +  G+ YL +     +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L+      K+SDFGM R    DQ  ++T        +  PE      +S KS
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKS 186
Query: 618 DVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSE- 676
           DV+SFGVL+ E+     + G               ++  E+R    + + +   + L + 
Sbjct: 187 DVWSFGVLMWEVF----SEG---------------KIPYENRSNSEVVEDISTGFRLYKP 227
Query: 677 ---ALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
              +    Q+   C ++RPEDRP  + ++  L+
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 8/202 (3%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           + + ++KLG G +G VY G+       +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +LLG C       ++ EY+P  +L D++ +  R ++        +   I+  + YL + +
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTA-VVLLYMATQISSAMEYLEKKN 150
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL A N L+      K++DFG++R    D   A+         +  PE     
Sbjct: 151 ---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 206
Query: 612 LFSVKSDVFSFGVLVLELV-YG 632
            FS+KSDV++FGVL+ E+  YG
Sbjct: 207 TFSIKSDVWAFGVLLWEIATYG 228

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCM 498
           +G G +G VYKG  +   ++A  ++   +G   EE K E+ ++ K   HRN+    G  +
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 499 KR------DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
           K+      D+  L+ E+    S+ D I   T+   L       I   I RGL +LHQ   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQH-- 148
Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI--- 609
            ++IHRD+K  NVLL      K+ DFG++    +D+T    N  +GT  +M PE      
Sbjct: 149 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDE 205
Query: 610 --DGLFSVKSDVFSFGVLVLELVYGT 633
             D  +  KSD++S G+  +E+  G 
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEGA 231

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 90/316 (28%), Positives = 140/316 (44%), Gaps = 68/316 (21%)
Query: 420 PIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLI-DG--QEIAVKRLSK-SSGQGVEEF 475
           P+ DW  I         ++ +GEG FG V K  +  DG   + A+KR+ + +S     +F
Sbjct: 10  PVLDWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 62
Query: 476 KNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-------------FD 521
             E+ ++ KL  H N++ LLG C  R    L  EY P+ +L DF+               
Sbjct: 63  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 122
Query: 522 GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
            +    L   +       +ARG+ YL Q    + IHRDL A N+L+      KI+DFG++
Sbjct: 123 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 179
Query: 582 RAFGVDQTEANTNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLELVY--GTR 634
           R   V         V  T G +P  + AI+ L    ++  SDV+S+GVL+ E+V   GT 
Sbjct: 180 RGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 231
Query: 635 NRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQ 690
             G                        EL +K L   Y L + L C      +   C ++
Sbjct: 232 YCGMTC--------------------AELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWRE 270
Query: 691 RPEDRPNMASVVLMLS 706
           +P +RP+ A +++ L+
Sbjct: 271 KPYERPSFAQILVSLN 286

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA 
Sbjct: 73  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAE 125
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 126 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 215

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 438 NKLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           ++LG+G FG V    Y  +  + G  +AVK+L  S      +F+ E+ ++  L    +VK
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 493 LLGCCMK--RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
             G      R E  L+ EYLP+  L DF+     R  LD S+       I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 128
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           SR R +HRDL A N+L+++E + KI+DFG+A+   +D+       VV   G  P     P
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXX----VVREPGQSPIFWYAP 183
Query: 606 EYAIDGLFSVKSDVFSFGVLVLEL 629
           E   D +FS +SDV+SFGV++ EL
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 135/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ EY+ N SL  F+     RK        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 258
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 111/201 (55%), Gaps = 20/201 (9%)
Query: 440 LGEGGFGPVYKGMLI-DGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG G FG VYKG+ I DG+ +    A+K L + +S +  +E  +E  ++A +    + +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQ 549
           LG C+    + L+ + +P   L D + +   R     LL+W  +      IA+G+ YL  
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
              +R++HRDL A NVL+ +  + KI+DFG+AR   +D+TE + +       +M  E  +
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 610 DGLFSVKSDVFSFGVLVLELV 630
              F+ +SDV+S+GV V EL+
Sbjct: 195 RRRFTHQSDVWSYGVTVWELM 215

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 121/218 (55%), Gaps = 25/218 (11%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQG-------VEEFKNEVLL 481
           A +    E ++G+GGFG V+KG L+ D   +A+K L     +G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           ++ L H N+VKL G  M    RM++ E++P   L   + D  +   + WS + +++  IA
Sbjct: 77  MSNLNHPNIVKLYG-LMHNPPRMVM-EFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNP---KISDFGMARAFGVDQTEANTNRV 596
            G+ Y+ Q+    I+HRDL++ N+ L   +E  P   K++DFG+++     Q+  + + +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGL 186
Query: 597 VGTYGYMPPEY--AIDGLFSVKSDVFSFGVLVLELVYG 632
           +G + +M PE   A +  ++ K+D +SF +++  ++ G
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 220

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/316 (28%), Positives = 140/316 (44%), Gaps = 68/316 (21%)
Query: 420 PIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLI-DG--QEIAVKRLSK-SSGQGVEEF 475
           P+ DW  I         ++ +GEG FG V K  +  DG   + A+KR+ + +S     +F
Sbjct: 20  PVLDWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 72
Query: 476 KNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-------------FD 521
             E+ ++ KL  H N++ LLG C  R    L  EY P+ +L DF+               
Sbjct: 73  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132
Query: 522 GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
            +    L   +       +ARG+ YL Q    + IHRDL A N+L+      KI+DFG++
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 189
Query: 582 RAFGVDQTEANTNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLELVY--GTR 634
           R   V         V  T G +P  + AI+ L    ++  SDV+S+GVL+ E+V   GT 
Sbjct: 190 RGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
Query: 635 NRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQ 690
             G                        EL +K L   Y L + L C      +   C ++
Sbjct: 242 YCGMTC--------------------AELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWRE 280
Query: 691 RPEDRPNMASVVLMLS 706
           +P +RP+ A +++ L+
Sbjct: 281 KPYERPSFAQILVSLN 296

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 132
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E +         +
Sbjct: 133 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 222

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 220

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L + +S +  +E  +E  ++A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 439 KLGEGGFGPVYKGM---LIDGQE---IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           +LGEG FG V+      L+  Q+   +AVK L ++S    ++F+ E  L+  LQH+++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFI-FDGTRRKL-----------LDWSKRCQIIGGI 540
             G C +    ++++EY+ +  L  F+   G   KL           L   +   +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R            R +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL-VYGTR 634
            +MPPE  +   F+ +SDV+SFGV++ E+  YG +
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 220

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 135/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ EY+ N SL  F+     RK        Q++G   GIA G+
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 158
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 159 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 211
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 212 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 256
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 257 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 135/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ EY+ N SL  F+     RK        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 258
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 135/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ EY+ N SL  F+     RK        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 258
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 439 KLGEGGFGPVYKGM---LIDGQE---IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           +LGEG FG V+      L+  Q+   +AVK L ++S    ++F+ E  L+  LQH+++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFI-FDGTRRKL-----------LDWSKRCQIIGGI 540
             G C +    ++++EY+ +  L  F+   G   KL           L   +   +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R            R +   
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL-VYGTR 634
            +MPPE  +   F+ +SDV+SFGV++ E+  YG +
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 236

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 439 KLGEGGFGPVYKGM---LIDGQE---IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           +LGEG FG V+      L+  Q+   +AVK L ++S    ++F+ E  L+  LQH+++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFI-FDGTRRKL-----------LDWSKRCQIIGGI 540
             G C +    ++++EY+ +  L  F+   G   KL           L   +   +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
           A G++YL   + L  +HRDL   N L+   +  KI DFGM+R            R +   
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL-VYGTR 634
            +MPPE  +   F+ +SDV+SFGV++ E+  YG +
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 230

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 135/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ EY+ N SL  F+     RK        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 258
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 135/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ EY+ N SL  F+     RK        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 258
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 135/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ EY+ N SL  F+     RK        Q++G   GIA G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 131
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 184
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 229
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 230 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 225

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 135/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ EY+ N SL  F+     RK        Q++G   GIA G+
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 148
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 149 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 201
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 246
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 247 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 134/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ EY+ N SL  F+     RK        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG+ R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR----GGKIP 213
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 258
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 120/218 (55%), Gaps = 25/218 (11%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQG-------VEEFKNEVLL 481
           A +    E ++G+GGFG V+KG L+ D   +A+K L     +G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           ++ L H N+VKL G  M    RM++ E++P   L   + D  +   + WS + +++  IA
Sbjct: 77  MSNLNHPNIVKLYG-LMHNPPRMVM-EFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNP---KISDFGMARAFGVDQTEANTNRV 596
            G+ Y+ Q+    I+HRDL++ N+ L   +E  P   K++DFG ++     Q+  + + +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGL 186
Query: 597 VGTYGYMPPEY--AIDGLFSVKSDVFSFGVLVLELVYG 632
           +G + +M PE   A +  ++ K+D +SF +++  ++ G
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 116/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   L  G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 83  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 225

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 116/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQ 486
            F +   L  G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  ++A + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 116/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 486
            F +   L  G FG VYKG+ I   E     +A+K L + +S +  +E  +E  ++A + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 225

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L DF+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 116/213 (54%), Gaps = 21/213 (9%)
Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 486
            F +   LG G FG VYKG+ I   E     +A+  L + +S +  +E  +E  ++A + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIAR 542
           + ++ +LLG C+    + LI + +P   L D++ +       + LL+W  +      IA+
Sbjct: 110 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 162
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +         +
Sbjct: 163 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 219
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           M  E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 252

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 107/204 (52%), Gaps = 21/204 (10%)
Query: 438 NKLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           ++LG+G FG V    Y  +  + G  +AVK+L  S      +F+ E+ ++  L    +VK
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 493 LLGCCMK--RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
             G      R    L+ EYLP+  L DF+     R  LD S+       I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 131
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           SR R +HRDL A N+L+++E + KI+DFG+A+   +D+       VV   G  P     P
Sbjct: 132 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAP 186
Query: 606 EYAIDGLFSVKSDVFSFGVLVLEL 629
           E   D +FS +SDV+SFGV++ EL
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 148
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNK---TGAKLPVKWMAL 205
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 111/207 (53%), Gaps = 11/207 (5%)
Query: 428 ANATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLS-KSSGQGVEEFKNEVLLIAKL 485
           A+  + F++  K+G+G FG V+KG+    Q++ A+K +  + +   +E+ + E+ ++++ 
Sbjct: 18  ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
               + K  G  +K  +  +I EYL   S  D +  G     LD ++   I+  I +GL 
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLD 133
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           YLH + +   IHRD+KA+NVLL      K++DFG+A    +  T+   N  VGT  +M P
Sbjct: 134 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAP 188
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E      +  K+D++S G+  +EL  G
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARG 215

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 89/316 (28%), Positives = 140/316 (44%), Gaps = 68/316 (21%)
Query: 420 PIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLI-DG--QEIAVKRLSK-SSGQGVEEF 475
           P+ DW  I         ++ +GEG FG V K  +  DG   + A+KR+ + +S     +F
Sbjct: 17  PVLDWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 69
Query: 476 KNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-------------FD 521
             E+ ++ KL  H N++ LLG C  R    L  EY P+ +L DF+               
Sbjct: 70  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 129
Query: 522 GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
            +    L   +       +ARG+ YL Q    + IHR+L A N+L+      KI+DFG++
Sbjct: 130 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLS 186
Query: 582 RAFGVDQTEANTNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLELVY--GTR 634
           R   V         V  T G +P  + AI+ L    ++  SDV+S+GVL+ E+V   GT 
Sbjct: 187 RGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 238
Query: 635 NRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQ 690
             G                        EL +K L   Y L + L C      +   C ++
Sbjct: 239 YCGMTC--------------------AELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWRE 277
Query: 691 RPEDRPNMASVVLMLS 706
           +P +RP+ A +++ L+
Sbjct: 278 KPYERPSFAQILVSLN 293

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 609 I-DGLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMV 198

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 174
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 609 I-DGLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMV 205

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 107/204 (52%), Gaps = 21/204 (10%)
Query: 438 NKLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           ++LG+G FG V    Y  +  + G  +AVK+L  S      +F+ E+ ++  L    +VK
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 493 LLGCCMK--RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
             G      R    L+ EYLP+  L DF+     R  LD S+       I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 132
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           SR R +HRDL A N+L+++E + KI+DFG+A+   +D+       VV   G  P     P
Sbjct: 133 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAP 187
Query: 606 EYAIDGLFSVKSDVFSFGVLVLEL 629
           E   D +FS +SDV+SFGV++ EL
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 107/204 (52%), Gaps = 21/204 (10%)
Query: 438 NKLGEGGFGPV----YKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           ++LG+G FG V    Y  +  + G  +AVK+L  S      +F+ E+ ++  L    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 493 LLGCCMK--RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
             G      R    L+ EYLP+  L DF+     R  LD S+       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 144
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           SR R +HRDL A N+L+++E + KI+DFG+A+   +D+       VV   G  P     P
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAP 199
Query: 606 EYAIDGLFSVKSDVFSFGVLVLEL 629
           E   D +FS +SDV+SFGV++ EL
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMV 205

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 179
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 120/218 (55%), Gaps = 25/218 (11%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQG-------VEEFKNEVLL 481
           A +    E ++G+GGFG V+KG L+ D   +A+K L     +G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           ++ L H N+VKL G  M    RM++ E++P   L   + D  +   + WS + +++  IA
Sbjct: 77  MSNLNHPNIVKLYG-LMHNPPRMVM-EFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNP---KISDFGMARAFGVDQTEANTNRV 596
            G+ Y+ Q+    I+HRDL++ N+ L   +E  P   K++DF +++     Q+  + + +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGL 186
Query: 597 VGTYGYMPPEY--AIDGLFSVKSDVFSFGVLVLELVYG 632
           +G + +M PE   A +  ++ K+D +SF +++  ++ G
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 110/201 (54%), Gaps = 11/201 (5%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLV 491
           F++ +++G+G FG VYKG+    +E+ A+K +  + +   +E+ + E+ ++++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +  G  +K  +  +I EYL   S  D +  G     L+ +    I+  I +GL YLH + 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE- 135
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
             R IHRD+KA+NVLL  + + K++DFG+A    +  T+   N  VGT  +M PE     
Sbjct: 136 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +  K+D++S G+  +EL  G
Sbjct: 192 AYDFKADIWSLGITAIELAKG 212

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAKLQHRN 489
           FS+  ++G G FG VY    +   E+ A+K++S S  Q  E++++   EV  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
            ++  GC ++     L+ EY    S +D +     +K L   +   +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
            +   +IHRD+KA N+LL      K+ DFG A         A  N  VGT  +M PE  +
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 223
Query: 610 ---DGLFSVKSDVFSFGVLVLELV 630
              +G +  K DV+S G+  +EL 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELA 247

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAKLQHRN 489
           FS+  ++G G FG VY    +   E+ A+K++S S  Q  E++++   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
            ++  GC ++     L+ EY    S +D +     +K L   +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
            +   +IHRD+KA N+LL      K+ DFG A         A  N  VGT  +M PE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 610 ---DGLFSVKSDVFSFGVLVLEL 629
              +G +  K DV+S G+  +EL
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 108/201 (53%), Gaps = 11/201 (5%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLV 491
           F++  K+G+G FG V+KG+    Q++ A+K +  + +   +E+ + E+ ++++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           K  G  +K  +  +I EYL   S  D +  G     LD ++   I+  I +GL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSEK 124
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
           +   IHRD+KA+NVLL      K++DFG+A      Q + NT   VGT  +M PE     
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 179
Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +  K+D++S G+  +EL  G
Sbjct: 180 AYDSKADIWSLGITAIELARG 200

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L +  L DF+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ YL   
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 168
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 225
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELM 250

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 50/287 (17%)
Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V  G L + G+    +A+K L    + +   +F  E  ++ +  H N++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLH 548
            L G   K    M++ EY+ N SL  F+     +K        Q++G   GI+ G+ YL 
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFL-----KKNDGQFTVIQLVGMLRGISAGMKYL- 140
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP---- 604
             S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P    
Sbjct: 141 --SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWT 194
Query: 605 -PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVE 662
            PE      F+  SDV+S+G+++ E+V YG R                 W +  +D    
Sbjct: 195 APEAIAFRKFTSASDVWSYGIVMWEVVSYGER---------------PYWEMTNQD---- 235
Query: 663 LIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
            + K++E+ Y L   + C     Q+ L C Q+    RP    +V ML
Sbjct: 236 -VIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L +  L DF+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ YL   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 144
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 201
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELM 226

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 148
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 205
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 113/211 (53%), Gaps = 15/211 (7%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGMLIDG---QEIAVKRLS-KSSGQGVEEFKNEVLL 481
           +IA+  + F++  ++G+G FG V+KG  ID    Q +A+K +  + +   +E+ + E+ +
Sbjct: 17  NIADPEELFTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITV 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           +++     + K  G  +K  +  +I EYL   S  D +  G      D  +   ++  I 
Sbjct: 75  LSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEIL 130
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL YLH + +   IHRD+KA+NVLL  + + K++DFG+A      Q + NT   VGT  
Sbjct: 131 KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPF 185
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           +M PE      +  K+D++S G+  +EL  G
Sbjct: 186 WMAPEVIQQSAYDSKADIWSLGITAIELAKG 216

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 149
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 206
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 149
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 206
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ YL   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 147
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 204
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ YL   
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 167
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 224
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELM 249

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ YL   
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 141
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 198
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELM 223

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 116/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ +L   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 147
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 204
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ YL   
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 146
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 203
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELM 228

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 26/206 (12%)
Query: 443 GGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE 502
           G FG V+K  L++ + +AVK       Q  +  + EV  +  ++H N+++ +G   KR  
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGA-EKRGT 91
Query: 503 RM-----LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD------- 550
            +     LI  +    SL+DF+    +  ++ W++ C I   +ARGL YLH+D       
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
            +  I HRD+K+ NVLL N +   I+DFG+A  F   ++  +T+  VGT  YM PE  ++
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VLE 206
Query: 611 GLFSVKSDVF------SFGVLVLELV 630
           G  + + D F      + G+++ EL 
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 116/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ +L   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 149
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 206
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 116/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ +L   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 149
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 206
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 116/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ +L   
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 208
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 265
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELM 290

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 116/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ +L   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 150
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 207
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 116/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ +L   
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 154
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 211
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELM 236

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 11/201 (5%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLV 491
           F++  K+G+G FG V+KG+    Q++ A+K +  + +   +E+ + E+ ++++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           K  G  +K  +  +I EYL   S  D +  G     LD ++   I+  I +GL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSEK 124
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
           +   IHRD+KA+NVLL      K++DFG+A    +  T+   N  VGT  +M PE     
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +  K+D++S G+  +EL  G
Sbjct: 180 AYDSKADIWSLGITAIELARG 200

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 108/201 (53%), Gaps = 11/201 (5%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLV 491
           F++  K+G+G FG V+KG+    Q++ A+K +  + +   +E+ + E+ ++++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           K  G  +K  +  +I EYL   S  D +  G     LD ++   I+  I +GL YLH + 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSEK 144
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
           +   IHRD+KA+NVLL      K++DFG+A      Q + NT   VGT  +M PE     
Sbjct: 145 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 199
Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +  K+D++S G+  +EL  G
Sbjct: 200 AYDSKADIWSLGITAIELARG 220

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 116/205 (56%), Gaps = 25/205 (12%)
Query: 440 LGEGGFGPVYKGMLID--GQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +G G FG VY G L+D  G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLHQD 550
           G C++ +   +++  Y+ +  L +FI + T    +       +IG    +A+G+ +L   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 150
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-AI 609
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNK---TGAKLPVKWMAL 207
Query: 610 DGL----FSVKSDVFSFGVLVLELV 630
           + L    F+ KSDV+SFGVL+ EL+
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 427 IANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS---GQGVEEFKNEVLLI 482
           I    ++F   N LG+G F  VY+   I  G E+A+K + K +      V+  +NEV + 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
            +L+H ++++L       +   L+ E   N  +  ++    R K    ++    +  I  
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIIT 123
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+LYLH      I+HRDL  SN+LL   MN KI+DFG+A    +   +  T  + GT  Y
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNY 178
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           + PE A      ++SDV+S G +   L+ G
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIG 208

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ E + N SL  F+     RK        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 258
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E++ ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ E + N SL  F+     RK        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 258
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           K+GEG +G VYK     G+  A+K  RL K           E+ ++ +L+H N+VKL   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 497 CMKRDERMLIYEYLPN--KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
              +   +L++E+L    K L D + +G    +   S   Q++ GIA    Y H     R
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIA----YCHDR---R 120
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           ++HRDLK  N+L++ E   KI+DFG+ARAFG+      T+ VV  +   P        +S
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 615 VKSDVFSFGVLVLELVYGT 633
              D++S G +  E+V GT
Sbjct: 180 TTIDIWSVGCIFAEMVNGT 198

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 50/291 (17%)
Query: 433 NFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQH 487
           N S +  +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGL 544
            N+++L G   K    M++ E + N SL  F+     RK        Q++G   GIA G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 131
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 184
Query: 605 -----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTED 658
                PE      F+  SDV+S+G+++ E++ YG R                 W +  +D
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD 229
Query: 659 RPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
                + K++++ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 230 -----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 174
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 174
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 177
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+ ++   +  +GV      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+ ++   +  +GV      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           K+GEG +G VYK     G+  A+K  RL K           E+ ++ +L+H N+VKL   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 497 CMKRDERMLIYEYLPN--KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
              +   +L++E+L    K L D + +G    +   S   Q++ GIA    Y H     R
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIA----YCHDR---R 120
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           ++HRDLK  N+L++ E   KI+DFG+ARAFG+      T+ +V  +   P        +S
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 615 VKSDVFSFGVLVLELVYGT 633
              D++S G +  E+V GT
Sbjct: 180 TTIDIWSVGCIFAEMVNGT 198

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 176
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 609 ID-GLFSVKSDVFSFGVLVLELV 630
           +    +S   D++S G +  E+V
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 99/192 (51%), Gaps = 7/192 (3%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            +LG G FG V  G      ++A+K + + S    +EF  E  ++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            K+    +I EY+ N  L +++ +   R      +  ++   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L++++   K+SDFG++R + +D  E ++        + PPE  +   FS KS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 618 DVFSFGVLVLEL 629
           D+++FGVL+ E+
Sbjct: 203 DIWAFGVLMWEI 214

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 18  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            K  +  ++ ++    SL   +     +   +  K   I    ARG+ YLH  S   IIH
Sbjct: 78  TK-PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIH 131
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE---YAIDGLFS 614
           RDLK++N+ L  +   KI DFG+A             ++ G+  +M PE         +S
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 615 VKSDVFSFGVLVLELVYG 632
            +SDV++FG+++ EL+ G
Sbjct: 192 FQSDVYAFGIVLYELMTG 209

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            K  +  ++ ++    SL   +     +   +  K   I    ARG+ YLH  S   IIH
Sbjct: 90  TK-PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 558 RDLKASNVLLDNEMNPKISDFGMA----RAFGVDQTEANTNRVVGTYGYMPPE---YAID 610
           RDLK++N+ L  +   KI DFG+A    R  G  Q E    ++ G+  +M PE       
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDS 199
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +S +SDV++FG+++ EL+ G
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTG 221

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 128/284 (45%), Gaps = 44/284 (15%)
Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G  G V  G L + GQ    +A+K L    + +   +F +E  ++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L G   +    M++ EY+ N SL  F+   T        +   ++ G+  G+ YL   S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
            L  +HRDL A NVL+D+ +  K+SDFG++R    D   A T     T G +P     PE
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPE 224
Query: 607 YAIDGLFSVKSDVFSFGVLVLE-LVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELID 665
                 FS  SDV+SFGV++ E L YG R                 W +   D     + 
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGER---------------PYWNMTNRD-----VI 264
Query: 666 KSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
            S+E+ Y L   + C     Q+ L C  +    RP  + +V +L
Sbjct: 265 SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 128/284 (45%), Gaps = 44/284 (15%)
Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G  G V  G L + GQ    +A+K L    + +   +F +E  ++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L G   +    M++ EY+ N SL  F+   T        +   ++ G+  G+ YL   S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
            L  +HRDL A NVL+D+ +  K+SDFG++R    D   A T     T G +P     PE
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPE 224
Query: 607 YAIDGLFSVKSDVFSFGVLVLE-LVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELID 665
                 FS  SDV+SFGV++ E L YG R                 W +   D     + 
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGER---------------PYWNMTNRD-----VI 264
Query: 666 KSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
            S+E+ Y L   + C     Q+ L C  +    RP  + +V +L
Sbjct: 265 SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 43/288 (14%)
Query: 429 NATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSK---SSGQGVEEFKNEVLLIAK 484
           N   NF  E K+G G F  VY+   L+DG  +A+K++        +   +   E+ L+ +
Sbjct: 29  NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD-----WSKRCQIIGG 539
           L H N++K     ++ +E  ++ E      L+  I    ++K L      W    Q+   
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +       H  SR R++HRD+K +NV +      K+ D G+ R F    T A++  +VGT
Sbjct: 149 LE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLELV------YGTRNRGFXXXXXXXXXXXXAWR 653
             YM PE   +  ++ KSD++S G L+ E+       YG +                   
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------------MN 242
Query: 654 LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           L++  + +E  D     +   SE LR  Q+  +C+   PE RP++  V
Sbjct: 243 LYSLCKKIEQCDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDVTYV 288

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 440 LGEGGFGPVYKGMLI-----DGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LGEG FG V            G+++AVK L  +S G  + + K E+ ++  L H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 494 LGCCMKR--DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C +   +   LI E+LP+ SL +++     +  ++  ++ +    I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYL--GS 144
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT--NRVVGTYGYMPPEYAI 609
           R + +HRDL A NVL+++E   KI DFG+ +A   D+       +R    + Y  PE  +
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLM 202
Query: 610 DGLFSVKSDVFSFGVLVLELV 630
              F + SDV+SFGV + EL+
Sbjct: 203 QSKFYIASDVWSFGVTLHELL 223

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 440 LGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G  + G        ++AVK L +  S Q   +F  E L+I+KL H+N+V
Sbjct: 53  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIV 111
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK-------LLDWSKRCQIIGGIARGL 544
           + +G  ++   R ++ E +    L  F+ +   R        +LD      +   IA G 
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGC 168
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G   
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 221
Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 109/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L +  L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 122 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 440 LGEGGFGPVYKGMLI-----DGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LGEG FG V            G+++AVK L  +S G  + + K E+ ++  L H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 494 LGCCMKR--DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            G C +   +   LI E+LP+ SL +++     +  ++  ++ +    I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYL--GS 132
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT--NRVVGTYGYMPPEYAI 609
           R + +HRDL A NVL+++E   KI DFG+ +A   D+       +R    + Y  PE  +
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLM 190
Query: 610 DGLFSVKSDVFSFGVLVLELV 630
              F + SDV+SFGV + EL+
Sbjct: 191 QSKFYIASDVWSFGVTLHELL 211

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 109/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E+L +  L  F+ D +    +        +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 174
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 440 LGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G  + G        ++AVK L +  S Q   +F  E L+I+KL H+N+V
Sbjct: 39  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIV 97
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK-------LLDWSKRCQIIGGIARGL 544
           + +G  ++   R ++ E +    L  F+ +   R        +LD      +   IA G 
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGC 154
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G   
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 207
Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           K+GEG +G VYK     G+  A+K  RL K           E+ ++ +L+H N+VKL   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 497 CMKRDERMLIYEYLPN--KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
              +   +L++E+L    K L D + +G    +   S   Q++ GIA    Y H     R
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIA----YCHDR---R 120
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           ++HRDLK  N+L++ E   KI+DFG+ARAFG+      T+ VV  +   P        +S
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 615 VKSDVFSFGVLVLELVYGT 633
              D++S G +  E+V G 
Sbjct: 180 TTIDIWSVGCIFAEMVNGA 198

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQ 486
           + +NF +  K+GEG +G VYK    + G+ +A+K++   +  +GV      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N+VKLL      ++  L++E++ ++ L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H     R++HRDLK  N+L++ E   K++DFG+ARAFGV       + VV T  Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 607 YAID-GLFSVKSDVFSFGVLVLELV 630
             +    +S   D++S G +  E+V
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 107/205 (52%), Gaps = 25/205 (12%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           ++G G FG VYKG       + + ++   + +  + F+NEV ++ K +H N++  +G  M
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG-YM 101
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
            +D   ++ ++    SL   +     +    +L+D +++       A+G+ YLH  +   
Sbjct: 102 TKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQT------AQGMDYLHAKN--- 152
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMA----RAFGVDQTEANTNRVVGTYGYMPPEYAI- 609
           IIHRD+K++N+ L   +  KI DFG+A    R  G  Q E  T  V+    +M PE    
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL----WMAPEVIRM 208
Query: 610 --DGLFSVKSDVFSFGVLVLELVYG 632
             +  FS +SDV+S+G+++ EL+ G
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 440 LGEGGFG--------PVYKGMLIDGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNL 490
           LGEG FG        P   G    G+ +AVK L    G Q    +K E+ ++  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 491 VKLLGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           +K  GCC  + E+   L+ EY+P  SL D++     R  +  ++       I  G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPE 606
                  IHR+L A NVLLDN+   KI DFG+A+A   G +      +     + Y  PE
Sbjct: 135 SQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PE 190
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV 630
              +  F   SDV+SFGV + EL+
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 440 LGEGGFG--------PVYKGMLIDGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNL 490
           LGEG FG        P   G    G+ +AVK L    G Q    +K E+ ++  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 491 VKLLGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           +K  GCC  + E+   L+ EY+P  SL D++     R  +  ++       I  G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPE 606
                  IHR+L A NVLLDN+   KI DFG+A+A   G +      +     + Y  PE
Sbjct: 135 AQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PE 190
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV 630
              +  F   SDV+SFGV + EL+
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 110/231 (47%), Gaps = 35/231 (15%)
Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGV 472
           I D K +     N +    LG G FG VY+G  + G        ++AVK L +  S Q  
Sbjct: 38  ISDLKEVPR--KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDE 94
Query: 473 EEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK------ 526
            +F  E L+I+K  H+N+V+ +G  ++   R ++ E +    L  F+ +   R       
Sbjct: 95  LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 154
Query: 527 -LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMAR 582
            +LD      +   IA G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 155 AMLDL---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208
Query: 583 AFGVDQTEANTNRVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               D   A+  R  G       +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 209 ----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 104/212 (49%), Gaps = 33/212 (15%)
Query: 440 LGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G  + G        ++AVK L +  S Q   +F  E L+I+K  H+N+V
Sbjct: 65  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK-------LLDWSKRCQIIGGIARGL 544
           + +G  ++   R ++ E +    L  F+ +   R        +LD      +   IA G 
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGC 180
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G   
Sbjct: 181 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 233
Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 104/212 (49%), Gaps = 33/212 (15%)
Query: 440 LGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G  + G        ++AVK L +  S Q   +F  E L+I+K  H+N+V
Sbjct: 53  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 111
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK-------LLDWSKRCQIIGGIARGL 544
           + +G  ++   R ++ E +    L  F+ +   R        +LD      +   IA G 
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGC 168
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G   
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 221
Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 104/212 (49%), Gaps = 33/212 (15%)
Query: 440 LGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G  + G        ++AVK L +  S Q   +F  E L+I+K  H+N+V
Sbjct: 38  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK-------LLDWSKRCQIIGGIARGL 544
           + +G  ++   R ++ E +    L  F+ +   R        +LD      +   IA G 
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGC 153
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G   
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 206
Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 104/212 (49%), Gaps = 33/212 (15%)
Query: 440 LGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G  + G        ++AVK L +  S Q   +F  E L+I+K  H+N+V
Sbjct: 39  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK-------LLDWSKRCQIIGGIARGL 544
           + +G  ++   R ++ E +    L  F+ +   R        +LD      +   IA G 
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGC 154
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G   
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 207
Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 9/203 (4%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRN 489
           + + +  K+GEG +G VYK     G+ +A+KR+   +  +G+      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +V L+          L++E++  K L   + D  +  L D   +  +   + RG+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
               RI+HRDLK  N+L++++   K++DFG+ARAFG+    + T+ VV  +   P     
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMG 193
Query: 610 DGLFSVKSDVFSFGVLVLELVYG 632
              +S   D++S G +  E++ G
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITG 216

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 104/212 (49%), Gaps = 33/212 (15%)
Query: 440 LGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G  + G        ++AVK L +  S Q   +F  E L+I+K  H+N+V
Sbjct: 45  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 103
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK-------LLDWSKRCQIIGGIARGL 544
           + +G  ++   R ++ E +    L  F+ +   R        +LD      +   IA G 
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGC 160
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G   
Sbjct: 161 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 213
Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 214 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 9/203 (4%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRN 489
           + + +  K+GEG +G VYK     G+ +A+KR+   +  +G+      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +V L+          L++E++  K L   + D  +  L D   +  +   + RG+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
               RI+HRDLK  N+L++++   K++DFG+ARAFG+    + T+ VV  +   P     
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMG 193
Query: 610 DGLFSVKSDVFSFGVLVLELVYG 632
              +S   D++S G +  E++ G
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITG 216

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            +LG G FG V  G      ++A+K + K      +EF  E  ++  L H  LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            K+    +I EY+ N  L +++ +   R      +  ++   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L++++   K+SDFG++R + +D    ++        + PPE  +   FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 618 DVFSFGVLVLEL 629
           D+++FGVL+ E+
Sbjct: 188 DIWAFGVLMWEI 199

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 104/212 (49%), Gaps = 33/212 (15%)
Query: 440 LGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G  + G        ++AVK L +  S Q   +F  E L+I+K  H+N+V
Sbjct: 38  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK-------LLDWSKRCQIIGGIARGL 544
           + +G  ++   R ++ E +    L  F+ +   R        +LD      +   IA G 
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGC 153
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G   
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 206
Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 110/231 (47%), Gaps = 35/231 (15%)
Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGV 472
           I D K +     N +    LG G FG VY+G  + G        ++AVK L +  S Q  
Sbjct: 13  ISDLKEVPR--KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDE 69
Query: 473 EEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK------ 526
            +F  E L+I+K  H+N+V+ +G  ++   R ++ E +    L  F+ +   R       
Sbjct: 70  LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 129
Query: 527 -LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMAR 582
            +LD      +   IA G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 130 AMLDL---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183
Query: 583 AFGVDQTEANTNRVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               D   A+  R  G       +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 184 ----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
               +  ++ ++    SL   +     +   +  K   I    ARG+ YLH  S   IIH
Sbjct: 90  TA-PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 558 RDLKASNVLLDNEMNPKISDFGMA----RAFGVDQTEANTNRVVGTYGYMPPE---YAID 610
           RDLK++N+ L  +   KI DFG+A    R  G  Q E    ++ G+  +M PE       
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDS 199
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +S +SDV++FG+++ EL+ G
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTG 221

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 440 LGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G  + G        ++AVK L +  S Q   +F  E L+I+K  H+N+V
Sbjct: 79  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK-------LLDWSKRCQIIGGIARGL 544
           + +G  ++   R ++ E +    L  F+ +   R        +LD      +   IA G 
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGC 194
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            YL ++     IHRD+ A N LL         KI DFGMAR    D   A   R  G   
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAM 247
Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            +LG G FG V  G      ++A+K + + S    +EF  E  ++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            K+    +I EY+ N  L +++ +   R      +  ++   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L++++   K+SDFG++R    D+  ++         + PPE  +   FS KS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 202
Query: 618 DVFSFGVLVLEL 629
           D+++FGVL+ E+
Sbjct: 203 DIWAFGVLMWEI 214

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            +LG G FG V  G      ++A+K + K      +EF  E  ++  L H  LV+L G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            K+    +I EY+ N  L +++ +   R      +  ++   +   + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L++++   K+SDFG++R    D+  ++         + PPE  +   FS KS
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 186
Query: 618 DVFSFGVLVLEL 629
           D+++FGVL+ E+
Sbjct: 187 DIWAFGVLMWEI 198

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 438 NKLGEGGFGPVYKGM-LIDGQEIAVKRL---SKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +KLG GG   VY     I   ++A+K +    +   + ++ F+ EV   ++L H+N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
           +    + D   L+ EY+   +L+++I        L           I  G+ + H    +
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD---M 130
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
           RI+HRD+K  N+L+D+    KI DFG+A+A   + +   TN V+GT  Y  PE A     
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 614 SVKSDVFSFGVLVLELVYG 632
              +D++S G+++ E++ G
Sbjct: 190 DECTDIYSIGIVLYEMLVG 208

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            +LG G FG V  G      ++A+K + + S    +EF  E  ++  L H  LV+L G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            K+    +I EY+ N  L +++ +   R      +  ++   +   + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 134
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L++++   K+SDFG++R    D+  ++         + PPE  +   FS KS
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 193
Query: 618 DVFSFGVLVLEL 629
           D+++FGVL+ E+
Sbjct: 194 DIWAFGVLMWEI 205

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 109/231 (47%), Gaps = 35/231 (15%)
Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGV 472
           I D K +     N +    LG G FG VY+G  + G        ++AVK L +  S Q  
Sbjct: 39  ISDLKEVPR--KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDE 95
Query: 473 EEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK------ 526
            +F  E L+I+K  H+N+V+ +G  ++   R ++ E +    L  F+ +   R       
Sbjct: 96  LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 155
Query: 527 -LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMAR 582
            +LD      +   IA G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 156 AMLDL---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209
Query: 583 AFGVDQTEANTNRVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               D   A   R  G       +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 210 ----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            +LG G FG V  G      ++A+K + K      +EF  E  ++  L H  LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            K+    +I EY+ N  L +++ +   R      +  ++   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L++++   K+SDFG++R    D+  ++         + PPE  +   FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 187
Query: 618 DVFSFGVLVLEL 629
           D+++FGVL+ E+
Sbjct: 188 DIWAFGVLMWEI 199

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            +LG G FG V  G      ++AVK + K      +EF  E   + KL H  LVK  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            K     ++ EY+ N  L +++   +  K L+ S+  ++   +  G+ +L      + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEYAIDGLFS 614
           RDL A N L+D ++  K+SDFGM R    DQ  ++    VGT     +  PE      +S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYFKYS 183
Query: 615 VKSDVFSFGVLVLEL 629
            KSDV++FG+L+ E+
Sbjct: 184 SKSDVWAFGILMWEV 198

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 128/292 (43%), Gaps = 62/292 (21%)
Query: 440 LGEGGFGPVYKGMLIDGQ-------EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G  + G        ++AVK L +  S Q   +F  E L+I+K  H+N+V
Sbjct: 53  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIV 111
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK-------LLDWSKRCQIIGGIARGL 544
           + +G  ++   R ++ E +    L  F+ +   R        +LD      +   IA G 
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGC 168
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G   
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 221
Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTE 657
               +MPPE  ++G+F+ K+D +SFGVL+ E+                      + L   
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI----------------------FSLGYM 259
Query: 658 DRPVELIDKSLEDTYS---LSEALRC----IQVGLLCVQQRPEDRPNMASVV 702
             P +   + LE   S   +     C     ++   C Q +PEDRPN A ++
Sbjct: 260 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAV-KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           LG+G FG   K    +  E+ V K L +   +    F  EV ++  L+H N++K +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
           K      I EY+   +L   I   +      WS+R      IA G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 559 DLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR------------VVGTYGYMPPE 606
           DL + N L+    N  ++DFG+AR    ++T+    R            VVG   +M PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV 630
                 +  K DVFSFG+++ E++
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 440 LGEGGFG--------PVYKGMLIDGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNL 490
           LGEG FG        P   G    G+ +AVK L +  G  +   ++ E+ ++  L H ++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 491 VKLLGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           VK  GCC  + E+   L+ EY+P  SL D++     R  +  ++       I  G+ YLH
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPE 606
                  IHR L A NVLLDN+   KI DFG+A+A   G +      +     + Y  PE
Sbjct: 130 AQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PE 185
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV 630
              +  F   SDV+SFGV + EL+
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELL 209

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQDSRL 553
            K  +  ++ ++    SL   +     +    KL+D +++       A+G+ YLH  S  
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT------AQGMDYLHAKS-- 129
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI---D 610
            IIHRDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE       
Sbjct: 130 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 188
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +S +SDV++FG+++ EL+ G
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTG 210

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            +LG G FG V  G      ++A+K + K      +EF  E  ++  L H  LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            K+    +I EY+ N  L +++ +   R      +  ++   +   + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RDL A N L++++   K+SDFG++R    D+  ++         + PPE  +   FS KS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 182
Query: 618 DVFSFGVLVLEL 629
           D+++FGVL+ E+
Sbjct: 183 DIWAFGVLMWEI 194

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 27/219 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R ++ +         SK  
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 135
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXX 188
Query: 595 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R  G       +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQDSRL 553
            K  +  ++ ++    SL   +     +    KL+D +++       A+G+ YLH  S  
Sbjct: 76  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT------AQGMDYLHAKS-- 126
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI---D 610
            IIHRDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE       
Sbjct: 127 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 185
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +S +SDV++FG+++ EL+ G
Sbjct: 186 NPYSFQSDVYAFGIVLYELMTG 207

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 440 LGEGGFG--------PVYKGMLIDGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNL 490
           LGEG FG        P   G    G+ +AVK L +  G  +   ++ E+ ++  L H ++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 491 VKLLGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           VK  GCC  + E+   L+ EY+P  SL D++     R  +  ++       I  G+ YLH
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPE 606
                  IHR L A NVLLDN+   KI DFG+A+A   G +      +     + Y  PE
Sbjct: 129 AQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PE 184
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV 630
              +  F   SDV+SFGV + EL+
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELL 208

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R ++ +         SK  
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 126
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R            
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           + +    +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQDSRL 553
            K  +  ++ ++    SL   +     +    KL+D +++       A+G+ YLH  S  
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT------AQGMDYLHAKS-- 129
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI---D 610
            IIHRDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE       
Sbjct: 130 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 188
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +S +SDV++FG+++ EL+ G
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTG 210

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 109/224 (48%), Gaps = 31/224 (13%)
Query: 426 SIANATD------NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFK 476
           SI +ATD      N+  +  +G+G F  V     ++ G+E+AVK + K+  +   +++  
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 477 NEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW-SKRCQ 535
            EV ++  L H N+VKL           L+ EY     + D++    R K  +  +K  Q
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 122
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
           I+  +     Y HQ     I+HRDLKA N+LLD +MN KI+DFG +  F V         
Sbjct: 123 IVSAVQ----YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK------ 169
Query: 596 VVGTYGYMPPEYAIDGLFSVKS------DVFSFGVLVLELVYGT 633
            + T+   PP YA   LF  K       DV+S GV++  LV G+
Sbjct: 170 -LDTFCGSPP-YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQDSRL 553
            K  +  ++ ++    SL   +     +    KL+D +++       A+G+ YLH  S  
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT------AQGMDYLHAKS-- 124
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI---D 610
            IIHRDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE       
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +S +SDV++FG+++ EL+ G
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTG 205

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQDSRL 553
            K  +  ++ ++    SL   +     +    KL+D +++       A+G+ YLH  S  
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT------AQGMDYLHAKS-- 152
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI---D 610
            IIHRDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE       
Sbjct: 153 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 211
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +S +SDV++FG+++ EL+ G
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTG 233

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 41  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQDSRL 553
            K  +  ++ ++    SL   +     +    KL+D +++       A+G+ YLH  S  
Sbjct: 101 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT------AQGMDYLHAKS-- 151
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI---D 610
            IIHRDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE       
Sbjct: 152 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 210
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +S +SDV++FG+++ EL+ G
Sbjct: 211 NPYSFQSDVYAFGIVLYELMTG 232

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQDSRL 553
            K  +  ++ ++    SL   +     +    KL+D +++       A+G+ YLH  S  
Sbjct: 94  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT------AQGMDYLHAKS-- 144
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMA----RAFGVDQTEANTNRVVGTYGYMPPEYAI 609
            IIHRDLK++N+ L  ++  KI DFG+A    R  G  Q E    ++ G+  +M PE   
Sbjct: 145 -IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIR 199
Query: 610 ---DGLFSVKSDVFSFGVLVLELVYG 632
                 +S +SDV++FG+++ EL+ G
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTG 225

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQDSRL 553
            K  +  ++ ++    SL   +     +    KL+D +++       A+G+ YLH  S  
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT------AQGMDYLHAKS-- 152
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMA----RAFGVDQTEANTNRVVGTYGYMPPEYAI 609
            IIHRDLK++N+ L  ++  KI DFG+A    R  G  Q E    ++ G+  +M PE   
Sbjct: 153 -IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIR 207
Query: 610 ---DGLFSVKSDVFSFGVLVLELVYG 632
                 +S +SDV++FG+++ EL+ G
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTG 233

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQDSRL 553
            K  +  ++ ++    SL   +     +    KL+D +++       A+G+ YLH  S  
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT------AQGMDYLHAKS-- 124
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMA----RAFGVDQTEANTNRVVGTYGYMPPEYAI 609
            IIHRDLK++N+ L  ++  KI DFG+A    R  G  Q E    ++ G+  +M PE   
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIR 179
Query: 610 ---DGLFSVKSDVFSFGVLVLELVYG 632
                 +S +SDV++FG+++ EL+ G
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 48/284 (16%)
Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V  G L + G+    +A+K L S  + +   +F +E  ++ +  H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLH 548
            L G   K    M+I E++ N SL  F+     R+        Q++G   GIA G+ YL 
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFL-----RQNDGQFTVIQLVGMLRGIAAGMKYL- 151
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP---- 604
             + +  +HRDL A N+L+++ +  K+SDFG++R    D ++      +G  G +P    
Sbjct: 152 --ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWT 207
Query: 605 -PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVE 662
            PE      F+  SDV+S+G+++ E++ YG R                 W +  +D    
Sbjct: 208 APEAIQYRKFTSASDVWSYGIVMWEVMSYGER---------------PYWDMTNQD---- 248
Query: 663 LIDKSLEDTYSLSEALRCI----QVGLLCVQQRPEDRPNMASVV 702
            +  ++E  Y L   + C     Q+ L C Q+    RP    +V
Sbjct: 249 -VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 291

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 137/305 (44%), Gaps = 52/305 (17%)
Query: 432 DNFSEENKLGEGGFGPVYK----GMLI--DGQEIAVKRLSKSSGQGVE-EFKNEVLLIAK 484
           +N      +GEG FG V++    G+L       +AVK L + +   ++ +F+ E  L+A+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFD--------------GTRRKL--- 527
             + N+VKLLG C       L++EY+    L +F+                 TR ++   
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 528 ----LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR- 582
               L  +++  I   +A G+ YL   S  + +HRDL   N L+   M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTRN-RGFXX 640
            +  D  +A+ N  +    +MPPE      ++ +SDV+++GV++ E+  YG +   G   
Sbjct: 224 IYSADYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 641 XXXXXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMAS 700
                           E+ P+EL        Y+L           LC  + P DRP+  S
Sbjct: 283 EEVIYYVRDGNILACPENCPLEL--------YNLMR---------LCWSKLPADRPSFCS 325
Query: 701 VVLML 705
           +  +L
Sbjct: 326 IHRIL 330

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 33/212 (15%)
Query: 440 LGEGGFGPVYKGMLIDGQ-------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG G FG VY+G  + G        ++AVK L +  S Q   +F  E L+I+K  H+N+V
Sbjct: 39  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK-------LLDWSKRCQIIGGIARGL 544
           + +G  ++   R ++ E +    L  F+ +   R        +LD      +   IA G 
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGC 154
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGT-- 599
            YL ++     IHRD+ A N LL         KI DFGMA+    D   A+  R  G   
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYYRKGGCAM 207
Query: 600 --YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
               +MPPE  ++G+F+ K+D +SFGVL+ E+
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 440 LGEGGFG--------PVYKGMLIDGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNL 490
           LGEG FG        P   G    G+ +AVK L   +G Q    +K E+ ++  L H ++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 491 VKLLGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           +K  GCC         L+ EY+P  SL D++     R  +  ++       I  G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPE 606
                  IHRDL A NVLLDN+   KI DFG+A+A   G +      +     + Y  PE
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYA-PE 207
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV 630
              +  F   SDV+SFGV + EL+
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELL 231

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 27/219 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R  + +         SK  
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMI 131
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 184
Query: 595 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R  G       +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 27/219 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R  + +         SK  
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMI 141
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 194
Query: 595 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R  G       +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 27/219 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R ++ +         SK  
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 135
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 188
Query: 595 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R  G       +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 27/219 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R ++ +         SK  
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 141
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 194
Query: 595 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R  G       +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 27/219 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R ++ +         SK  
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 134
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 187
Query: 595 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R  G       +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 27/219 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R ++ +         SK  
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 128
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 181
Query: 595 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R  G       +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 27/219 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R ++ +         SK  
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 132
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 185
Query: 595 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R  G       +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 186 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 27/219 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R ++ +         SK  
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 134
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 187
Query: 595 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R  G       +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 27/219 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R ++ +         SK  
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 163
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 216
Query: 595 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R  G       +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 217 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG--VEEFKNEVLLIAKLQHRNLVKLLGC 496
           LG+G FG V K    I  QE AVK ++K+S +         EV L+ KL H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
                   ++ E      L D I    +RK        +II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IV 143
Query: 557 HRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
           HRDLK  N+LL++   + + KI DFG++  F   Q        +GT  Y+ PE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 614 SVKSDVFSFGVLVLELVYGT 633
             K DV+S GV++  L+ GT
Sbjct: 200 DEKCDVWSAGVILYILLSGT 219

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG--VEEFKNEVLLIAKLQHRNLVKLLGC 496
           LG+G FG V K    I  QE AVK ++K+S +         EV L+ KL H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
                   ++ E      L D I    +RK        +II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IV 143
Query: 557 HRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
           HRDLK  N+LL++   + + KI DFG++  F   Q        +GT  Y+ PE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 614 SVKSDVFSFGVLVLELVYGT 633
             K DV+S GV++  L+ GT
Sbjct: 200 DEKCDVWSAGVILYILLSGT 219

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG--VEEFKNEVLLIAKLQHRNLVKLLGC 496
           LG+G FG V K    I  QE AVK ++K+S +         EV L+ KL H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
                   ++ E      L D I    +RK        +II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IV 143
Query: 557 HRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
           HRDLK  N+LL++   + + KI DFG++  F   Q        +GT  Y+ PE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 614 SVKSDVFSFGVLVLELVYGT 633
             K DV+S GV++  L+ GT
Sbjct: 200 DEKCDVWSAGVILYILLSGT 219

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
            ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLLYLHQDSRL 553
               +  ++ ++    SL   +     +    KL+D +++       A+G+ YLH  S  
Sbjct: 74  TA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT------AQGMDYLHAKS-- 124
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI---D 610
            IIHRDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE       
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +S +SDV++FG+++ EL+ G
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTG 205

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 43/301 (14%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E  +G G FG V K      +++A+K++   S +  + F  E+  ++++ H N+VKL G 
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDG------TRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           C+  +   L+ EY    SL + +         T    + W  +C      ++G+ YLH  
Sbjct: 71  CL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSM 122
Query: 551 SRLRIIHRDLKASNVLL-DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
               +IHRDLK  N+LL       KI DFG A      QT    N+  G+  +M PE   
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPEVFE 177
Query: 610 DGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRP--VELIDKS 667
              +S K DVFS+G+++ E++  TR + F             W +    RP  ++ + K 
Sbjct: 178 GSNYSEKCDVFSWGIILWEVI--TRRKPFDEIGGPAFRIM--WAVHNGTRPPLIKNLPKP 233
Query: 668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV-LMLSGERSLPQPKQP-GFFTERNL 725
           +E   +             C  + P  RP+M  +V +M    R  P   +P  +  + +L
Sbjct: 234 IESLMT------------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSL 281
Query: 726 P 726
           P
Sbjct: 282 P 282

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 484
           +N      LG G FG V +      G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 485 L-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-------FDGTRRKLLDWSKRCQI 536
           L QH N+V LLG C      ++I EY     L +F+        D    + L+       
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
              +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D         
Sbjct: 158 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                +M PE   D +++V+SDV+S+G+L+ E+
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 20/201 (9%)
Query: 440 LGEGGFGPVYKGMLIDGQE-----IAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKL 493
           LG G FG V+KG+ I   E     + +K +   SG Q  +   + +L I  L H ++V+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIARGLLYLHQ 549
           LG C       L+ +YLP  SL D +         + LL+W  +      IA+G+ YL +
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 151
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
                ++HR+L A NVLL +    +++DFG+A     D  +   +       +M  E   
Sbjct: 152 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 610 DGLFSVKSDVFSFGVLVLELV 630
            G ++ +SDV+S+GV V EL+
Sbjct: 209 FGKYTHQSDVWSYGVTVWELM 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 20/201 (9%)
Query: 440 LGEGGFGPVYKGMLIDGQE-----IAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKL 493
           LG G FG V+KG+ I   E     + +K +   SG Q  +   + +L I  L H ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIARGLLYLHQ 549
           LG C       L+ +YLP  SL D +         + LL+W  +      IA+G+ YL +
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 133
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
                ++HR+L A NVLL +    +++DFG+A     D  +   +       +M  E   
Sbjct: 134 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 610 DGLFSVKSDVFSFGVLVLELV 630
            G ++ +SDV+S+GV V EL+
Sbjct: 191 FGKYTHQSDVWSYGVTVWELM 211

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 27/285 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQE-IAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRN 489
           D++  +  +G G    V        +E +A+KR++    Q  ++E   E+  +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFI----FDGTRRK-LLDWSKRCQIIGGIARGL 544
           +V      + +DE  L+ + L   S+ D I      G  +  +LD S    I+  +  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV----VGTY 600
            YLH++ +   IHRD+KA N+LL  + + +I+DFG++ AF     +   N+V    VGT 
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITRNKVRKTFVGTP 185
Query: 601 GYMPPEYA--IDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTED 658
            +M PE    + G +  K+D++SFG+  +EL  G                     L  ++
Sbjct: 186 CWMAPEVMEQVRG-YDFKADIWSFGITAIELATGA-------APYHKYPPMKVLMLTLQN 237
Query: 659 RPVELIDKSLEDTYSLSEALRCIQVGL-LCVQQRPEDRPNMASVV 702
            P  L +  ++D   L +  +  +  + LC+Q+ PE RP  A ++
Sbjct: 238 DPPSL-ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 433 NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 489
           N+     +G+G F  V     ++ G+E+A+K + K+  +   +++   EV ++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW-SKRCQIIGGIARGLLYLH 548
           +VKL           LI EY     + D++    R K  +  SK  QI+  +     Y H
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH 128
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           Q    RI+HRDLKA N+LLD +MN KI+DFG +  F V          + T+   PP YA
Sbjct: 129 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-------LDTFCGSPP-YA 177
Query: 609 IDGLFSVKS------DVFSFGVLVLELVYGT 633
              LF  K       DV+S GV++  LV G+
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGS 208

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 43/301 (14%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E  +G G FG V K      +++A+K++   S +  + F  E+  ++++ H N+VKL G 
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDG------TRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           C+  +   L+ EY    SL + +         T    + W  +C      ++G+ YLH  
Sbjct: 70  CL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSM 121
Query: 551 SRLRIIHRDLKASNVLL-DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
               +IHRDLK  N+LL       KI DFG A      QT    N+  G+  +M PE   
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPEVFE 176
Query: 610 DGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRP--VELIDKS 667
              +S K DVFS+G+++ E++  TR + F             W +    RP  ++ + K 
Sbjct: 177 GSNYSEKCDVFSWGIILWEVI--TRRKPFDEIGGPAFRIM--WAVHNGTRPPLIKNLPKP 232
Query: 668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV-LMLSGERSLPQPKQP-GFFTERNL 725
           +E   +             C  + P  RP+M  +V +M    R  P   +P  +  + +L
Sbjct: 233 IESLMT------------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSL 280
Query: 726 P 726
           P
Sbjct: 281 P 281

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 40/236 (16%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+  A+D F E   LG+G FG V K    +D +  A+K++ + + + +    +EV+L+A 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS 58
Query: 485 LQH-------------RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD-- 529
           L H             RN VK +    K+    +  EY  N++L D I      +  D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY 118
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA----RAFG 585
           W    QI+  ++    Y+H      IIHRDLK  N+ +D   N KI DFG+A    R+  
Sbjct: 119 WRLFRQILEALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 586 VDQTEA--------NTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLELVY 631
           + + ++        N    +GT  Y+  E  +DG   ++ K D++S G++  E++Y
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY 226

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 27/285 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQE-IAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRN 489
           D++  +  +G G    V        +E +A+KR++    Q  ++E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFI----FDGTRRK-LLDWSKRCQIIGGIARGL 544
           +V      + +DE  L+ + L   S+ D I      G  +  +LD S    I+  +  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV----VGTY 600
            YLH++ +   IHRD+KA N+LL  + + +I+DFG++ AF     +   N+V    VGT 
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITRNKVRKTFVGTP 190
Query: 601 GYMPPEYA--IDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTED 658
            +M PE    + G +  K+D++SFG+  +EL  G                     L  ++
Sbjct: 191 CWMAPEVMEQVRG-YDFKADIWSFGITAIELATGA-------APYHKYPPMKVLMLTLQN 242
Query: 659 RPVELIDKSLEDTYSLSEALRCIQVGL-LCVQQRPEDRPNMASVV 702
            P  L +  ++D   L +  +  +  + LC+Q+ PE RP  A ++
Sbjct: 243 DPPSL-ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 484
           +N      LG G FG V +      G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 485 L-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-------FDGTRRKLLDWSKRCQI 536
           L QH N+V LLG C      ++I EY     L +F+        D    + L+       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
              +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D         
Sbjct: 166 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                +M PE   D +++V+SDV+S+G+L+ E+
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 10/209 (4%)
Query: 429 NATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQ 486
           +++  F +  KLG G +  VYKG+    G  +A+K +   S +G       E+ L+ +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPN--KSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           H N+V+L       ++  L++E++ N  K   D    G   + L+ +        + +GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            + H++   +I+HRDLK  N+L++     K+ DFG+ARAFG+     ++  V  T  Y  
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRA 176
Query: 605 PEYAIDG-LFSVKSDVFSFGVLVLELVYG 632
           P+  +    +S   D++S G ++ E++ G
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITG 205

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 106/224 (47%), Gaps = 31/224 (13%)
Query: 426 SIANATD------NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFK 476
           SIA+  D      N+     +G+G F  V     ++ G+E+A+K + K+  +   +++  
Sbjct: 3   SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 477 NEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW-SKRCQ 535
            EV ++  L H N+VKL           LI EY     + D++    R K  +  SK  Q
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
           I+  +     Y HQ    RI+HRDLKA N+LLD +MN KI+DFG +  F V       + 
Sbjct: 123 IVSAVQ----YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDA 172
Query: 596 VVGTYGYMPPEYAIDGLFSVKS------DVFSFGVLVLELVYGT 633
             G   Y  PE     LF  K       DV+S GV++  LV G+
Sbjct: 173 FCGAPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 27/219 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVY----KGMLIDGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 482
           A +  +   +LG+G FG VY    KG++ D  E  +A+K +++++      EF NE  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD--------WSKRC 534
            +    ++V+LLG   +    ++I E +    L  ++    R ++ +         SK  
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 128
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           Q+ G IA G+ YL+ +   + +HRDL A N  +  +   KI DFGM R    D  E +  
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYETDYY 181
Query: 595 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R  G       +M PE   DG+F+  SDV+SFGV++ E+
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL   C + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 150
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 151 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 207
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 208 PELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 109/217 (50%), Gaps = 22/217 (10%)
Query: 428 ANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAK 484
           A + D +    KLGEG +G VYK +  +  + +A+KR+  +   +GV      EV L+ +
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPN--KSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
           LQHRN+++L           LI+EY  N  K   D   D + R +  +    Q+I G+  
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSF--LYQLINGVN- 146
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLL---DNEMNP--KISDFGMARAFGVDQTEANTNRVV 597
              + H  SR R +HRDLK  N+LL   D    P  KI DFG+ARAFG+      T+ ++
Sbjct: 147 ---FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII 199
Query: 598 GTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGT 633
            T  Y PPE  +    +S   D++S   +  E++  T
Sbjct: 200 -TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 103/223 (46%), Gaps = 34/223 (15%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 484
           +N      LG G FG V +      G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 485 L-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTR-----------------RK 526
           L QH N+V LLG C      ++I EY     L +F+   +R                 R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 527 LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV 586
           LL +S +      +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    
Sbjct: 166 LLHFSSQ------VAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           D              +M PE   D +++V+SDV+S+G+L+ E+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 103/223 (46%), Gaps = 34/223 (15%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 484
           +N      LG G FG V +      G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 485 L-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTR-----------------RK 526
           L QH N+V LLG C      ++I EY     L +F+   +R                 R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 527 LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV 586
           LL +S +      +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    
Sbjct: 166 LLHFSSQ------VAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           D              +M PE   D +++V+SDV+S+G+L+ E+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 439 KLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +LG G FG V +G   M     ++A+K L + + +   EE   E  ++ +L +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G C + +  ML+ E      L  F+    +R+ +  S   +++  ++ G+ YL + +   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY--GYMPPEYAIDGL 612
            +HRDL A NVLL N    KISDFG+++A G D +   T R  G +   +  PE      
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 189
Query: 613 FSVKSDVFSFGVLVLE-LVYGTR 634
           FS +SDV+S+GV + E L YG +
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQK 212

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 108/223 (48%), Gaps = 32/223 (14%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           DN      +G G +G VYKG L D + +AVK  S ++ Q     KN +  +  ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIA 70
Query: 492 KLLG-----CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           + +          R E +L+ EY PN SL  ++   T     DW   C++   + RGL Y
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAY 126
Query: 547 LHQD------SRLRIIHRDLKASNVLLDNEMNPKISDFGMA-RAFG---VDQTEANTNRV 596
           LH +       +  I HRDL + NVL+ N+    ISDFG++ R  G   V   E +   +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 597 --VGTYGYMPPEYAIDGLFSVKS--------DVFSFGVLVLEL 629
             VGT  YM PE  ++G  +++         D+++ G++  E+
Sbjct: 187 SEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKGML----IDGQEIAVKRLSKSSGQ---GVE 473
           +F   S A  +D +  +  LG+G FG V   +L    I GQE AVK +SK   +     E
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKE 77
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
               EV L+ +L H N++KL      +    L+ E      L D I    R   +D ++ 
Sbjct: 78  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 136
Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTE 590
             II  +  G+ Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +  
Sbjct: 137 --IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 188
Query: 591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
                 +GT  Y+ PE  + G +  K DV+S GV++  L+ G
Sbjct: 189 KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSK---SSGQGVEEFK 476
           +F   S A  +D +  +  LG+G FG V      I GQE AVK +SK         E   
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 477 NEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI 536
            EV L+ +L H N++KL      +    L+ E      L D I    R   +D ++   I
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---I 131
Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTEANT 593
           I  +  G+ Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +     
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKM 185
Query: 594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
              +GT  Y+ PE  + G +  K DV+S GV++  L+ G
Sbjct: 186 KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 19/228 (8%)
Query: 409 ELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS 467
           EL ++++  E     W     A ++F     LG+G FG VY       + I A+K L K+
Sbjct: 16  ELASKQKNEESKKRQW-----ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA 70
Query: 468 SGQ--GVE-EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTR 524
             +  GVE + + EV + + L+H N+++L G         LI EY P   L     +  +
Sbjct: 71  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQK 127
Query: 525 RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 584
               D  +    I  +A  L Y H     R+IHRD+K  N+LL +    KI+DFG    +
Sbjct: 128 LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----W 180
Query: 585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            V    +    + GT  Y+PPE     +   K D++S GVL  E + G
Sbjct: 181 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 228

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 109/222 (49%), Gaps = 23/222 (10%)
Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKGML----IDGQEIAVKRLSK---SSGQGVE 473
           +F   S A  +D +  +  LG+G FG V   +L    I GQE AVK +SK         E
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKE 95
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
               EV L+ +L H N++KL      +    L+ E      L D I    R   +D ++ 
Sbjct: 96  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 154
Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTE 590
             II  +  G+ Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +  
Sbjct: 155 --IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 206
Query: 591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
                 +GT  Y+ PE  + G +  K DV+S GV++  L+ G
Sbjct: 207 KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 109/222 (49%), Gaps = 23/222 (10%)
Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKGML----IDGQEIAVKRLSK---SSGQGVE 473
           +F   S A  +D +  +  LG+G FG V   +L    I GQE AVK +SK         E
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKE 94
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
               EV L+ +L H N++KL      +    L+ E      L D I    R   +D ++ 
Sbjct: 95  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 153
Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTE 590
             II  +  G+ Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +  
Sbjct: 154 --IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 205
Query: 591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
                 +GT  Y+ PE  + G +  K DV+S GV++  L+ G
Sbjct: 206 KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 133/287 (46%), Gaps = 50/287 (17%)
Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V  G L + G+    +A+K L    + +   +F  E  ++ +  H N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLH 548
            L G   +    M++ E++ N +L  F+     RK        Q++G   GIA G+ YL 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFL-----RKHDGQFTVIQLVGMLRGIAAGMRYL- 161
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP---- 604
             + +  +HRDL A N+L+++ +  K+SDFG++R    D     T     T G +P    
Sbjct: 162 --ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT----TGGKIPVRWT 215
Query: 605 -PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVE 662
            PE      F+  SDV+S+G+++ E++ YG R                 W +  +D    
Sbjct: 216 APEAIQYRKFTSASDVWSYGIVMWEVMSYGER---------------PYWDMSNQD---- 256
Query: 663 LIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
            + K++E+ Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 257 -VIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +  + + GT  Y+PP
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 409 ELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS 467
           EL ++++  E     W     A ++F     LG+G FG VY       + I A+K L K+
Sbjct: 16  ELASKQKNEESKKRQW-----ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA 70
Query: 468 SGQ--GVE-EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTR 524
             +  GVE + + EV + + L+H N+++L G         LI EY P   L     +  +
Sbjct: 71  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQK 127
Query: 525 RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 584
               D  +    I  +A  L Y H     R+IHRD+K  N+LL +    KI+DFG    +
Sbjct: 128 LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----W 180
Query: 585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            V    +  + + GT  Y+PPE     +   K D++S GVL  E + G
Sbjct: 181 SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 228

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 19/228 (8%)
Query: 409 ELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS 467
           EL ++++  E     W     A ++F     LG+G FG VY       + I A+K L K+
Sbjct: 7   ELASKQKNEESKKRQW-----ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA 61
Query: 468 SGQ--GVE-EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTR 524
             +  GVE + + EV + + L+H N+++L G         LI EY P   L     +  +
Sbjct: 62  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQK 118
Query: 525 RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 584
               D  +    I  +A  L Y H     R+IHRD+K  N+LL +    KI+DFG    +
Sbjct: 119 LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----W 171
Query: 585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            V    +    + GT  Y+PPE     +   K D++S GVL  E + G
Sbjct: 172 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 219

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 439 KLGEGGFGPVYKGM---LIDGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 491
           +LG+G FG VY+G    +I G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF-------DGTRRKLLDWSKRCQIIGGIARGL 544
           +LLG   K    +++ E + +  L  ++        +   R      +  Q+   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT----Y 600
            YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R  G      
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 196
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +M PE   DG+F+  SD++SFGV++ E+
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 439 KLGEGGFGPVYKGM---LIDGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 491
           +LG+G FG VY+G    +I G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF-------DGTRRKLLDWSKRCQIIGGIARGL 544
           +LLG   K    +++ E + +  L  ++        +   R      +  Q+   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT----Y 600
            YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R  G      
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 196
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +M PE   DG+F+  SD++SFGV++ E+
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 111/236 (47%), Gaps = 40/236 (16%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+  A+D F E   LG+G FG V K    +D +  A+K++ + + + +    +EV+L+A 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS 58
Query: 485 LQH-------------RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD-- 529
           L H             RN VK +    K+    +  EY  N +L D I      +  D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA----RAFG 585
           W    QI+  ++    Y+H      IIHRDLK  N+ +D   N KI DFG+A    R+  
Sbjct: 119 WRLFRQILEALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 586 VDQTEA--------NTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLELVY 631
           + + ++        N    +GT  Y+  E  +DG   ++ K D++S G++  E++Y
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY 226

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 131/284 (46%), Gaps = 48/284 (16%)
Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V  G L + G+    +A+K L S  + +   +F +E  ++ +  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---GIARGLLYLH 548
            L G   K    M+I E++ N SL  F+     +  +      Q++G   GIA G+ YL 
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV-----IQLVGMLRGIAAGMKYL- 125
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP---- 604
             + +  +HR L A N+L+++ +  K+SDFG++R    D ++      +G  G +P    
Sbjct: 126 --ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWT 181
Query: 605 -PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVE 662
            PE      F+  SDV+S+G+++ E++ YG R                 W +  +D    
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGER---------------PYWDMTNQD---- 222
Query: 663 LIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVV 702
            +  ++E  Y L   + C     Q+ L C Q+    RP    +V
Sbjct: 223 -VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 265

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 438 NKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVKLLG 495
            ++G G FG V+ G L  D   +AVK   ++    ++ +F  E  ++ +  H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 496 CCMKRDERMLIYEYLPNKSLADFI-FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
            C ++    ++ E +       F+  +G R ++       Q++G  A G+ YL       
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYLESKC--- 233
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMAR--AFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
            IHRDL A N L+  +   KISDFGM+R  A GV        +V     +  PE    G 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV--PVKWTAPEALNYGR 291
Query: 613 FSVKSDVFSFGVLVLE 628
           +S +SDV+SFG+L+ E
Sbjct: 292 YSSESDVWSFGILLWE 307

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 439 KLGEGGFGPVYKGM---LIDGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 491
           +LG+G FG VY+G    +I G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF-------DGTRRKLLDWSKRCQIIGGIARGL 544
           +LLG   K    +++ E + +  L  ++        +   R      +  Q+   IA G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT----Y 600
            YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R  G      
Sbjct: 141 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 193
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +M PE   DG+F+  SD++SFGV++ E+
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 439 KLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
           +LG G FG V +G   M     ++A+K L + + +   EE   E  ++ +L +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G C + +  ML+ E      L  F+    +R+ +  S   +++  ++ G+ YL + +   
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY--GYMPPEYAIDGL 612
            +HR+L A NVLL N    KISDFG+++A G D +   T R  G +   +  PE      
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 515
Query: 613 FSVKSDVFSFGVLVLE-LVYGTR 634
           FS +SDV+S+GV + E L YG +
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK 538

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           K+GEG  G V        G+++AVK +     Q  E   NEV+++   QH N+V++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
           +  +E  ++ E+L   +L D +     +  L+  +   +   + + L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K+ ++LL  +   K+SDFG       D  +     +VGT  +M PE     L++ + 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX--LVGTPYWMAPEVISRSLYATEV 222
Query: 618 DVFSFGVLVLELVYG 632
           D++S G++V+E+V G
Sbjct: 223 DIWSLGIMVIEMVDG 237

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVG 204

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 133/301 (44%), Gaps = 49/301 (16%)
Query: 433 NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +F E   +G GGFG V+K    IDG+   +KR+  ++    E+ + EV  +AKL H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 492 KLLGC----------CMKRDER------MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ 535
              GC            K   R       +  E+    +L  +I +  R + LD     +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
           +   I +G+ Y+H     ++I+RDLK SN+ L +    KI DFG+  +    + +    R
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXR 180
Query: 596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLW 655
             GT  YM PE      +  + D+++ G+++ EL++                     + +
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH------------VCDTAFETSKFF 228
Query: 656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPK 715
           T     +L D  + D +   E     ++    + ++PEDRPN + ++  L+  +  P+  
Sbjct: 229 T-----DLRDGIISDIFDKKEKTLLQKL----LSKKPEDRPNTSEILRTLTVWKKSPEKN 279
Query: 716 Q 716
           +
Sbjct: 280 E 280

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 134/313 (42%), Gaps = 60/313 (19%)
Query: 433 NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +F E   +G GGFG V+K    IDG+   ++R+  ++    E+ + EV  +AKL H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIV 68
Query: 492 KLLGC-------CMKRDERMLIYEYLPNKS-------------LADFIFDGT-------- 523
              GC           D+ +   +Y P  S               +F   GT        
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 524 RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 583
           R + LD     ++   I +G+ Y+H     ++IHRDLK SN+ L +    KI DFG+  +
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXX 643
               + +    R  GT  YM PE      +  + D+++ G+++ EL++            
Sbjct: 186 L---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH------------ 230
Query: 644 XXXXXXXAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL 703
                    + +T     +L D  + D +   E     ++    + ++PEDRPN + ++ 
Sbjct: 231 VCDTAFETSKFFT-----DLRDGIISDIFDKKEKTLLQKL----LSKKPEDRPNTSEILR 281
Query: 704 MLSGERSLPQPKQ 716
            L+  +  P+  +
Sbjct: 282 TLTVWKKSPEKNE 294

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 440 LGEGGFGPVYK-GMLIDGQEIAVKRLSKSSGQGVEE--FKNEVLLIAKLQHRNLVKLLGC 496
           +G G +G   K     DG+ +  K L   S    E+    +EV L+ +L+H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 497 CMKRDERML--IYEYLPNKSLADFIFDGTR-RKLLDWSKRCQIIGGIARGLLYLHQ--DS 551
            + R    L  + EY     LA  I  GT+ R+ LD     +++  +   L   H+  D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              ++HRDLK +NV LD + N K+ DFG+AR    D + A T   VGT  YM PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRM 191
Query: 612 LFSVKSDVFSFGVLVLEL 629
            ++ KSD++S G L+ EL
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYI-----RKIGSFDETCTRFYTAEIVSAL 145
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 146 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +   S  SD+++ G ++ +LV G
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVG 201

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 438 NKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVKLLG 495
            ++G G FG V+ G L  D   +AVK   ++    ++ +F  E  ++ +  H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 496 CCMKRDERMLIYEYLPNKSLADFI-FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
            C ++    ++ E +       F+  +G R ++       Q++G  A G+ YL       
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYLESKC--- 233
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMAR--AFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
            IHRDL A N L+  +   KISDFGM+R  A GV        +V     +  PE    G 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEALNYGR 291
Query: 613 FSVKSDVFSFGVLVLE 628
           +S +SDV+SFG+L+ E
Sbjct: 292 YSSESDVWSFGILLWE 307

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 443 GGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD- 501
           G FG V+K  L++   +AVK       Q  +  + E+     ++H NL++ +    +   
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 502 ---ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-------- 550
              E  LI  +    SL D++    +  ++ W++ C +   ++RGL YLH+D        
Sbjct: 84  LEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
            +  I HRD K+ NVLL +++   ++DFG+A  F   +   +T+  VGT  YM PE  ++
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VLE 198
Query: 611 GLFSVKSDVF------SFGVLVLELV 630
           G  + + D F      + G+++ ELV
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   +   +   ++    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 109/206 (52%), Gaps = 27/206 (13%)
Query: 440 LGEGGFGPVYKGMLIDGQE----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G+G FG VY G  ID  +     A+K LS+ +  Q VE F  E LL+  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 495 GCCMKRDE-RMLIYEYLPNKSLADFIFDGTR----RKLLDWSKRCQIIGGIARGLLYLHQ 549
           G  +  +    ++  Y+ +  L  FI    R    + L+ +  +      +ARG+ YL +
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ------VARGMEYLAE 142
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY-A 608
               + +HRDL A N +LD     K++DFG+AR   +D+   +  +    +  +P ++ A
Sbjct: 143 Q---KFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQ--HRHARLPVKWTA 196
Query: 609 IDGL----FSVKSDVFSFGVLVLELV 630
           ++ L    F+ KSDV+SFGVL+ EL+
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +  + + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   +   +   ++    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 439 KLGEGGFGPVYKGM---LIDGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 491
           +LG+G FG VY+G    +I G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF-------DGTRRKLLDWSKRCQIIGGIARGL 544
           +LLG   K    +++ E + +  L  ++        +   R      +  Q+   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT----Y 600
            YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R  G      
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 196
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +M PE   DG+F+  SD++SFGV++ E+
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 17/218 (7%)
Query: 422 FDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSK---SSGQGVEEFKN 477
           F   S A  +D +  +  LG+G FG V      I GQE AVK +SK         E    
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 478 EVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQII 537
           EV L+ +L H N+ KL      +    L+ E      L D I    R   +D ++   II
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---II 132
Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTEANTN 594
             +  G+ Y H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +   +  
Sbjct: 133 RQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK- 188
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             +GT  Y+ PE  + G +  K DV+S GV++  L+ G
Sbjct: 189 --IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E         K D++S GVL  E + G
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVG 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 439 KLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           K+GEG  G V        G+++AVK++     Q  E   NEV+++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
           +  DE  ++ E+L   +L D I   TR   ++  +   +   + R L YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K+ ++LL ++   K+SDFG      V +       +VGT  +M PE      +  + 
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 618 DVFSFGVLVLELVYG 632
           D++S G++V+E++ G
Sbjct: 223 DIWSLGIMVIEMIDG 237

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 432 DNFSEENKLGEGGFGPV-YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           DNF    K+GEG  G V    +   G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 154 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V++    +  DE  ++ E+L   +L D I   TR   ++  +   +   + + L  LH  
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIAAVCLAVLQALSVLHAQ 266
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
               +IHRD+K+ ++LL ++   K+SDFG      V +       +VGT  +M PE    
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 321
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +  + D++S G++V+E+V G
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDG 343

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 439 KLGEGGFGPVYKGM---LIDGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 491
           +LG+G FG VY+G    +I G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF-------DGTRRKLLDWSKRCQIIGGIARGL 544
           +LLG   K    +++ E + +  L  ++        +   R      +  Q+   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YL+     + +HRDL A N ++ ++   KI DFGM R            + +    +M 
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLEL 629
           PE   DG+F+  SD++SFGV++ E+
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 433 NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 489
           N+     +G+G F  V     ++ G+E+AVK + K+  +   +++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW-SKRCQIIGGIARGLLYLH 548
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YCH 130
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F    T  N    + T+   PP YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNK---LDTFCGSPP-YA 179
Query: 609 IDGLFSVKS------DVFSFGVLVLELVYGT 633
              LF  K       DV+S GV++  LV G+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGS 210

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 433 NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 489
           N+     +G+G F  V     ++ G+E+AVK + K+  +   +++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW-SKRCQIIGGIARGLLYLH 548
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YCH 130
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F    T  N    + T+   PP YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNK---LDTFCGSPP-YA 179
Query: 609 IDGLFSVKS------DVFSFGVLVLELVYGT 633
              LF  K       DV+S GV++  LV G+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGS 210

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVG 199

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 439 KLGEGGFGPVYKGM---LIDGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 491
           +LG+G FG VY+G    +I G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF-------DGTRRKLLDWSKRCQIIGGIARGL 544
           +LLG   K    +++ E + +  L  ++        +   R      +  Q+   IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT----Y 600
            YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R  G      
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 195
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +M PE   DG+F+  SD++SFGV++ E+
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI++FG    + V    +    + GT  Y+PP
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVG 204

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           DNF    K+GEG  G V    +   G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 32  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V++    +  DE  ++ E+L   +L D I   TR   ++  +   +   + + L  LH  
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIAAVCLAVLQALSVLHAQ 144
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
               +IHRD+K+ ++LL ++   K+SDFG      V +       +VGT  +M PE    
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 199
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +  + D++S G++V+E+V G
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDG 221

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK 499
           +G+G FG VY G       I +  + + +   ++ FK EV+   + +H N+V  +G CM 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 559
                +I      ++L   + D   + +LD +K  QI   I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 560 LKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY-----------MPPEYA 608
           LK+ NV  DN     I+DFG+    GV Q     +++    G+           + P+  
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 609 IDGL-FSVKSDVFSFGVLVLEL 629
            D L FS  SDVF+ G +  EL
Sbjct: 215 EDKLPFSKHSDVFALGTIWYEL 236

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           DNF    K+GEG  G V    +   G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 34  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V++    +  DE  ++ E+L   +L D I   TR   ++  +   +   + + L  LH  
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIAAVCLAVLQALSVLHAQ 146
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
               +IHRD+K+ ++LL ++   K+SDFG      V +       +VGT  +M PE    
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 201
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +  + D++S G++V+E+V G
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDG 223

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKLQH 487
           ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+++L G         LI EY P   L     +  +    D  +    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H     R+IHRD+K  N+LL +    KI+DFG    + V    +  + + GT  Y+PPE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 181
Query: 608 AIDGLFSVKSDVFSFGVLVLELVYG 632
               +   K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           DNF    K+GEG  G V    +   G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V++    +  DE  ++ E+L   +L D I   TR   ++  +   +   + + L  LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIAAVCLAVLQALSVLHAQ 135
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
               +IHRD+K+ ++LL ++   K+SDFG      V +       +VGT  +M PE    
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 190
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +  + D++S G++V+E+V G
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDG 212

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     ++IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PP
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           DNF    K+GEG  G V    +   G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 27  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V++    +  DE  ++ E+L   +L D I   TR   ++  +   +   + + L  LH  
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIAAVCLAVLQALSVLHAQ 139
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
               +IHRD+K+ ++LL ++   K+SDFG      V +       +VGT  +M PE    
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 194
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +  + D++S G++V+E+V G
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDG 216

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 143
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 144 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           DNF    K+GEG  G V    +   G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 77  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V++    +  DE  ++ E+L   +L D I   TR   ++  +   +   + + L  LH  
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIAAVCLAVLQALSVLHAQ 189
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
               +IHRD+K+ ++LL ++   K+SDFG      V +       +VGT  +M PE    
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 244
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +  + D++S G++V+E+V G
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDG 266

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 146
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 147 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 203
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 36/225 (16%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 484
           +N      LG G FG V +      G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 485 L-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDG-------------------TR 524
           L QH N+V LLG C      ++I EY     L +F+                      + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 525 RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 584
           R LL +S +      +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR  
Sbjct: 166 RDLLHFSSQ------VAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDI 216
Query: 585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             D              +M PE   D +++V+SDV+S+G+L+ E+
Sbjct: 217 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 261

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 145
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 146 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI++FG    + V    +    + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 70  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 123
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 124 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 180
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 181 PELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 95  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 148
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 149 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 205
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 146
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 147 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 203
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 145
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 146 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 145
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 146 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKLQH 487
           ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+++L G         LI EY P   L     +  +    D  +    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+PPE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 608 AIDGLFSVKSDVFSFGVLVLELVYG 632
               +   K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 122
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 123 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 179
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 180 PELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 143
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 144 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVS 200
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 67  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 120
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 121 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 177
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 178 PELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 94/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ + A L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 128
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 433 NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 489
           N+     +G+G F  V     ++ G+E+AVK + K+  +   +++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW-SKRCQIIGGIARGLLYLH 548
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YCH 130
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F         N++    G   P YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG------NKLDAFCG--APPYA 179
Query: 609 IDGLFSVKS------DVFSFGVLVLELVYGT 633
              LF  K       DV+S GV++  LV G+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGS 210

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 143
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 144 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 121
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 122 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 178
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 440 LGEGGFGPVYK-GMLIDGQEIAVKRLSKSSGQGVEE--FKNEVLLIAKLQHRNLVKLLGC 496
           +G G +G   K     DG+ +  K L   S    E+    +EV L+ +L+H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 497 CMKRDERML--IYEYLPNKSLADFIFDGTR-RKLLDWSKRCQIIGGIARGLLYLHQ--DS 551
            + R    L  + EY     LA  I  GT+ R+ LD     +++  +   L   H+  D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              ++HRDLK +NV LD + N K+ DFG+AR    D + A     VGT  YM PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRM 191
Query: 612 LFSVKSDVFSFGVLVLEL 629
            ++ KSD++S G L+ EL
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 145
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 146 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 145
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 146 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 485
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N+++L G         LI EY P   L     +  +    D  +    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H     R+IHRD+K  N+LL +    KI+DFG    +      +    + GT  Y+PP
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E     +   K D++S GVL  E + G
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 433 NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 489
           N+     +G+G F  V     ++ G+E+AV+ + K+  +   +++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW-SKRCQIIGGIARGLLYLH 548
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YCH 130
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F    T  N    + T+   PP YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNK---LDTFCGSPP-YA 179
Query: 609 IDGLFSVKS------DVFSFGVLVLELVYGT 633
              LF  K       DV+S GV++  LV G+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGS 210

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 484
           +N      LG G FG V +      G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 485 L-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI--------------------FDGT 523
           L QH N+V LLG C      ++I EY     L +F+                     D  
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 524 RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 583
             + L+          +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
              D              +M PE   D +++V+SDV+S+G+L+ E+
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 253

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 142
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 143 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 199
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 127
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 128 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 184
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 185 PELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGP-VYKGMLIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F   V    L   +E A+K L K        V     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 143
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 144 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM--LIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQH 487
           + + + +KLGEG +  VYKG   L D   +A+K  RL    G      + EV L+  L+H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKH 59
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V L           L++EYL +K L  ++ D     +++       +  + RGL Y 
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYC 116
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H   R +++HRDLK  N+L++     K++DFG+ARA  +  T+   N VV T  Y PP+ 
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPPDI 171
Query: 608 AIDGL-FSVKSDVFSFGVLVLELVYG 632
            +    +S + D++  G +  E+  G
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATG 197

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 440 LGEGGFGPVYK-GMLIDGQEIAVKRLSKSSGQGVEE--FKNEVLLIAKLQHRNLVKLLGC 496
           +G G +G   K     DG+ +  K L   S    E+    +EV L+ +L+H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 497 CMKRDERML--IYEYLPNKSLADFIFDGTR-RKLLDWSKRCQIIGGIARGLLYLHQ--DS 551
            + R    L  + EY     LA  I  GT+ R+ LD     +++  +   L   H+  D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              ++HRDLK +NV LD + N K+ DFG+AR    D+  A     VGT  YM PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMNRM 191
Query: 612 LFSVKSDVFSFGVLVLEL 629
            ++ KSD++S G L+ EL
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 439 KLGEGGFGPVYKGM---LIDGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 491
           +LG+G FG VY+G    +I G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF-------DGTRRKLLDWSKRCQIIGGIARGL 544
           +LLG   K    +++ E + +  L  ++        +   R      +  Q+   IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT----Y 600
            YL+     + +HR+L A N ++ ++   KI DFGM R    D  E +  R  G      
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 197
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +M PE   DG+F+  SD++SFGV++ E+
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 439 KLGEGGFGPVYKGM---LIDGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 491
           +LG+G FG VY+G    +I G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF-------DGTRRKLLDWSKRCQIIGGIARGL 544
           +LLG   K    +++ E + +  L  ++        +   R      +  Q+   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT----Y 600
            YL+     + +HR+L A N ++ ++   KI DFGM R    D  E +  R  G      
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 196
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +M PE   DG+F+  SD++SFGV++ E+
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 488 RNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQ--IIGGIARGL 544
              VKL     + DE++     Y  N  L  +I     RK+  + + C       I   L
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSAL 142
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ 
Sbjct: 143 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 199
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +      SD+++ G ++ +LV G
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 212 XXKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 128
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 212 XXKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 433 NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 489
           N+     +G+G F  V     ++ G+E+AVK + K+  +   +++   EV ++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIF-DGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           +VKL           L+ EY     + D++   G  ++    +K  QI+  +     Y H
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ----YCH 123
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F    T  N    + T+   PP YA
Sbjct: 124 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNK---LDTFCGSPP-YA 172
Query: 609 IDGLFSVKS------DVFSFGVLVLELVYGT 633
              LF  K       DV+S GV++  LV G+
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGS 203

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 440 LGEGGFGPVYKGMLIDGQ-EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           LG+G +G VY G  +  Q  IA+K + +   +  +    E+ L   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIARGLLYLHQDSRLR 554
           +     +  E +P  SL+  +    R K        Q IG     I  GL YLH +   +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 555 IIHRDLKASNVLLDNEMNP-KISDFGMA-RAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
           I+HRD+K  NVL++      KISDFG + R  G++     T    GT  YM PE    G 
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDKGP 199
Query: 613 --FSVKSDVFSFGVLVLELVYG 632
             +   +D++S G  ++E+  G
Sbjct: 200 RGYGKAADIWSLGCTIIEMATG 221

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 126
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 187 VDVWSCGIVLTAMLAG 202

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 433 NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 489
           N+     +G+G F  V     ++ G+E+AV+ + K+  +   +++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW-SKRCQIIGGIARGLLYLH 548
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YCH 130
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F         +   G+     P YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDEFCGS-----PPYA 179
Query: 609 IDGLFSVKS------DVFSFGVLVLELVYGT 633
              LF  K       DV+S GV++  LV G+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGS 210

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 128
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 128
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 128
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+  A+D F E   LG+G FG V K    +D +  A+K++ + + + +    +EV L+A 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLAS 58
Query: 485 LQH-------------RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLD-- 529
           L H             RN VK      K+    +  EY  N++L D I      +  D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY 118
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA----RAFG 585
           W    QI+  ++    Y+H      IIHR+LK  N+ +D   N KI DFG+A    R+  
Sbjct: 119 WRLFRQILEALS----YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 586 VDQTEA--------NTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLELVY 631
           + + ++        N    +GT  Y+  E  +DG   ++ K D +S G++  E +Y
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXIY 226

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
              NT        +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 128
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 128
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 440 LGEGGFGPVYKGMLIDGQ-EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           LG+G +G VY G  +  Q  IA+K + +   +  +    E+ L   L+H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIARGLLYLHQDSRLR 554
           +     +  E +P  SL+  +    R K        Q IG     I  GL YLH +   +
Sbjct: 76  ENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 128
Query: 555 IIHRDLKASNVLLDNEMNP-KISDFGMA-RAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
           I+HRD+K  NVL++      KISDFG + R  G++     T    GT  YM PE    G 
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDKGP 185
Query: 613 --FSVKSDVFSFGVLVLELVYG 632
             +   +D++S G  ++E+  G
Sbjct: 186 RGYGKAADIWSLGCTIIEMATG 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 437 ENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKL- 493
           + +LG GGFG V + +  D G+++A+K+  +  S +  E +  E+ ++ KL H N+V   
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 494 -----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC---------QIIGG 539
                L      D  +L  EY            G  RK L+  + C          ++  
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEG---------GDLRKYLNQFENCCGLKEGPIRTLLSD 130
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGVDQTEANTNRV 596
           I+  L YLH++   RIIHRDLK  N++L      +  KI D G A+    DQ E  T   
Sbjct: 131 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-F 184
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTR 634
           VGT  Y+ PE      ++V  D +SFG L  E + G R
Sbjct: 185 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 128
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 188
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 189 VDVWSCGIVLTAMLAG 204

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 437 ENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKL- 493
           + +LG GGFG V + +  D G+++A+K+  +  S +  E +  E+ ++ KL H N+V   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 494 -----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC---------QIIGG 539
                L      D  +L  EY            G  RK L+  + C          ++  
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEG---------GDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGVDQTEANTNRV 596
           I+  L YLH++   RIIHRDLK  N++L      +  KI D G A+    DQ E  T   
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-F 183
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTR 634
           VGT  Y+ PE      ++V  D +SFG L  E + G R
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 17/199 (8%)
Query: 439 KLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +LG+G FG VYK    + G   A K +   S + +E++  E+ ++A   H  +VKLLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQII-GGIARGLLYLHQDSRLRII 556
               +  ++ E+ P  ++ D I     R L +   + Q++   +   L +LH     RII
Sbjct: 86  YHDGKLWIMIEFCPGGAV-DAIMLELDRGLTE--PQIQVVCRQMLEALNFLHSK---RII 139
Query: 557 HRDLKASNVLLDNEMNPKISDFGM-ARAFGVDQTEANTNRVVGTYGYMPPEYAI-----D 610
           HRDLKA NVL+  E + +++DFG+ A+     +T    +  +GT  +M PE  +     D
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 611 GLFSVKSDVFSFGVLVLEL 629
             +  K+D++S G+ ++E+
Sbjct: 197 TPYDYKADIWSLGITLIEM 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 17/199 (8%)
Query: 439 KLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +LG+G FG VYK    + G   A K +   S + +E++  E+ ++A   H  +VKLLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQII-GGIARGLLYLHQDSRLRII 556
               +  ++ E+ P  ++ D I     R L +   + Q++   +   L +LH     RII
Sbjct: 78  YHDGKLWIMIEFCPGGAV-DAIMLELDRGLTE--PQIQVVCRQMLEALNFLHSK---RII 131
Query: 557 HRDLKASNVLLDNEMNPKISDFGM-ARAFGVDQTEANTNRVVGTYGYMPPEYAI-----D 610
           HRDLKA NVL+  E + +++DFG+ A+     +T    +  +GT  +M PE  +     D
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 611 GLFSVKSDVFSFGVLVLEL 629
             +  K+D++S G+ ++E+
Sbjct: 189 TPYDYKADIWSLGITLIEM 207

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 108/214 (50%), Gaps = 28/214 (13%)
Query: 440 LGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V     I           ++AVK L S ++ + + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTRRKLLDWSKRCQIIG 538
           ++ LLG C +     +I EY    +L +++           F+ +       S +  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 539 G--IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANTNR 595
              +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D  +  TN 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 213 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 31/219 (14%)
Query: 440 LGEGGFGPVYKGMLIDGQ------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVK 492
           LGEG FG V K      +       +AVK L + +S   + +  +E  ++ ++ H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFI---------------------FDGTRRKLLDWS 531
           L G C +    +LI EY    SL  F+                      D    + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
                   I++G+ YL   + ++++HRDL A N+L+      KISDFG++R    + +  
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
             ++      +M  E   D +++ +SDV+SFGVL+ E+V
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 30/215 (13%)
Query: 440 LGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V     I           ++AVK L S ++ + + +  +E+ ++  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR--------------CQ 535
           ++ LLG C +     +I EY    +L +++    R   L++S                  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANTN 594
               +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D  +  TN
Sbjct: 144 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 201 GRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 30/215 (13%)
Query: 440 LGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V     I           ++AVK L S ++ + + +  +E+ ++  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR--------------CQ 535
           ++ LLG C +     +I EY    +L +++    R   L++S                  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANTN 594
               +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D  +  TN
Sbjct: 148 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 205 GRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 30/215 (13%)
Query: 440 LGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V     I           ++AVK L S ++ + + +  +E+ ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR--------------CQ 535
           ++ LLG C +     +I EY    +L +++    R   L++S                  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANTN 594
               +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D  +  TN
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 253 GRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 30/215 (13%)
Query: 440 LGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V     I           ++AVK L S ++ + + +  +E+ ++  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR--------------CQ 535
           ++ LLG C +     +I EY    +L +++    R   L++S                  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKDLVS 146
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANTN 594
               +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D  +  TN
Sbjct: 147 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 204 GRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 30/215 (13%)
Query: 440 LGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V     I           ++AVK L S ++ + + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR--------------CQ 535
           ++ LLG C +     +I EY    +L +++    R   L++S                  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANTN 594
               +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D  +  TN
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 212 GRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 199 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 258 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 432 DNFSEENKLGEGGFGPVY-----KGMLIDGQEIAVKRLSKSS--GQGVE-EFKNEVLLIA 483
           D+F     LG+G FG VY     K   I    +A+K L KS    +GVE + + E+ + A
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFI----VALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 484 KLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG 543
            L H N+++L      R    LI EY P   L     +  +    D  +   I+  +A  
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGELYK---ELQKSCTFDEQRTATIMEELADA 135
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L+Y H     ++IHRD+K  N+LL  +   KI+DFG    + V         + GT  Y+
Sbjct: 136 LMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYL 188
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PPE     + + K D++  GVL  EL+ G
Sbjct: 189 PPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 31/219 (14%)
Query: 440 LGEGGFGPVYKGMLIDGQ------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVK 492
           LGEG FG V K      +       +AVK L + +S   + +  +E  ++ ++ H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFI---------------------FDGTRRKLLDWS 531
           L G C +    +LI EY    SL  F+                      D    + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
                   I++G+ YL   + ++++HRDL A N+L+      KISDFG++R    + +  
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
             ++      +M  E   D +++ +SDV+SFGVL+ E+V
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 204 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      +I+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 439 KLGEGGFGPVYKGMLIDGQ-EIAVKRLSKSS---------GQGVEEFK----NEVLLIAK 484
           KLG G +G V      +G  E A+K + KS           + +E+F     NE+ L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           L H N++KL      +    L+ E+     L + I +   R   D      I+  I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGI 159
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
            YLH+ +   I+HRD+K  N+LL+N+   +N KI DFG++  F  D    +    +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAY 213
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           Y+ PE  +   ++ K DV+S GV++  L+ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I EY    +L +++           +D  R   + +
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 201 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LG GGFG V++    +D    A+KR+   + +   E+   EV  +AKL+H  +V+     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW-SKRC-----------QIIGGIARGLL 545
           ++++    +    P   L   +    +  L DW + RC            I   IA  + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE----------ANTNR 595
           +LH      ++HRDLK SN+    +   K+ DFG+  A   D+ E          A    
Sbjct: 133 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY 631
            VGT  YM PE      +S K D+FS G+++ EL+Y
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 21/202 (10%)
Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKLQ 486
           N+     LGEG FG V        GQ++A+K      L+KS  QG    + E+  +  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 71
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H +++KL      +DE +++ EY  N+ L D+I    R K+ +   R +    I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYIVQ--RDKMSEQEAR-RFFQQIISAVEY 127
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV-VGTYGYMPP 605
            H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  +   G+  Y  P
Sbjct: 128 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 180
Query: 606 EYAIDGLFS-VKSDVFSFGVLV 626
           E     L++  + DV+S GV++
Sbjct: 181 EVISGKLYAGPEVDVWSCGVIL 202

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 133/288 (46%), Gaps = 50/288 (17%)
Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V +G L   G++   +A+K L    + +   EF +E  ++ + +H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWS-KRCQIIG---GIARGLLYL 547
           +L G        M++ E++ N +L  F+      +L D      Q++G   GIA G+ YL
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFL------RLNDGQFTVIQLVGMLRGIASGMRYL 134
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP--- 604
              + +  +HRDL A N+L+++ +  K+SDFG++R    + ++      +G  G +P   
Sbjct: 135 ---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG--GKIPIRW 189
Query: 605 --PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRPV 661
             PE      F+  SD +S+G+++ E++ +G R                 W +  +D   
Sbjct: 190 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGER---------------PYWDMSNQD--- 231
Query: 662 ELIDKSLEDTYSLSEALRCI----QVGLLCVQQRPEDRPNMASVVLML 705
             +  ++E  Y L     C     Q+ L C Q+    RP    VV  L
Sbjct: 232 --VINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 433 NFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 489
           N+     +G+G F  V     ++ G+E+AVK + K+  +   +++   EV +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW-SKRCQIIGGIARGLLYLH 548
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ----YCH 130
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           Q     I+HRDLKA N+LLD + N KI+DFG +  F         N++    G   P YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFG------NKLDAFCG--APPYA 179
Query: 609 IDGLFSVKS------DVFSFGVLVLELVYGT 633
              LF  K       DV+S GV++  LV G+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGS 210

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 21/202 (10%)
Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKLQ 486
           N+     LGEG FG V        GQ++A+K      L+KS  QG    + E+  +  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 72
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H +++KL      +DE +++ EY  N+ L D+I    R K+ +   R +    I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYIVQ--RDKMSEQEAR-RFFQQIISAVEY 128
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV-VGTYGYMPP 605
            H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  +   G+  Y  P
Sbjct: 129 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 181
Query: 606 EYAIDGLFS-VKSDVFSFGVLV 626
           E     L++  + DV+S GV++
Sbjct: 182 EVISGKLYAGPEVDVWSCGVIL 203

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 9/196 (4%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG  G V   +  +  + +AVK +  K +    E  K E+ +   L H N+VK  G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
            + + + L  EY     L D I         D  +       +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHG---IGITH 127
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 617
           RD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 618 -DVFSFGVLVLELVYG 632
            DV+S G+++  ++ G
Sbjct: 188 VDVWSCGIVLTAMLAG 203

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 21/202 (10%)
Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKLQ 486
           N+     LGEG FG V        GQ++A+K      L+KS  QG    + E+  +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 62
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H +++KL      +DE +++ EY  N+ L D+I    R K+ +   R +    I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYIVQ--RDKMSEQEAR-RFFQQIISAVEY 118
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV-VGTYGYMPP 605
            H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  +   G+  Y  P
Sbjct: 119 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 171
Query: 606 EYAIDGLFS-VKSDVFSFGVLV 626
           E     L++  + DV+S GV++
Sbjct: 172 EVISGKLYAGPEVDVWSCGVIL 193

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 437 ENKLGEGGFGPVYKGML-IDGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G FG V +G L   G++   +A+K L    + +   EF +E  ++ + +H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIF--DGTRRKLLDWSKRCQIIG---GIARGLLY 546
           +L G        M++ E++ N +L  F+   DG    +       Q++G   GIA G+ Y
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI-------QLVGMLRGIASGMRY 131
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-- 604
           L +   +  +HRDL A N+L+++ +  K+SDFG++R    + ++      +G  G +P  
Sbjct: 132 LAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG--GKIPIR 186
Query: 605 ---PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFXXXXXXXXXXXXAWRLWTEDRP 660
              PE      F+  SD +S+G+++ E++ +G R                 W +  +D  
Sbjct: 187 WTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGER---------------PYWDMSNQD-- 229
Query: 661 VELIDKSLEDTYSLSEALRCI----QVGLLCVQQRPEDRPNMASVVLML 705
              +  ++E  Y L     C     Q+ L C Q+    RP    VV  L
Sbjct: 230 ---VINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 31/219 (14%)
Query: 440 LGEGGFGPVYKGMLIDGQ------EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVK 492
           LGEG FG V K      +       +AVK L + +S   + +  +E  ++ ++ H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFI---------------------FDGTRRKLLDWS 531
           L G C +    +LI EY    SL  F+                      D    + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
                   I++G+ YL   + + ++HRDL A N+L+      KISDFG++R    + +  
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
             ++      +M  E   D +++ +SDV+SFGVL+ E+V
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 438 NKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQHRNLVKL 493
           + LG G FG V  G   + G ++AVK L++   + ++   + + E+  +   +H +++KL
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
                   +  ++ EY+    L D+I    R   LD  +  ++   I  G+ Y H   R 
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCH---RH 135
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            ++HRDLK  NVLLD  MN KI+DFG++      +    +    G+  Y  PE     L+
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRLY 192
Query: 614 S-VKSDVFSFGVLVLELVYGT 633
           +  + D++S GV++  L+ GT
Sbjct: 193 AGPEVDIWSSGVILYALLCGT 213

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 21/195 (10%)
Query: 440 LGEGGFGPVYKGMLID--GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +G+G FG V   ML D  G ++AVK +   +    + F  E  ++ +L+H NLV+LLG  
Sbjct: 20  IGKGEFGDV---MLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 498 MKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
           ++    + ++ EY+   SL D++     R +L      +    +   + YL  ++    +
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 130
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT--YGYMPPEYAIDGLFS 614
           HRDL A NVL+  +   K+SDFG+ +       EA++ +  G     +  PE   +  FS
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREAAFS 183
Query: 615 VKSDVFSFGVLVLEL 629
            KSDV+SFG+L+ E+
Sbjct: 184 TKSDVWSFGILLWEI 198

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 32/216 (14%)
Query: 440 LGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V     I           ++AVK L S ++ + + +  +E+ ++  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR---------------KLLDWSKRC 534
           ++ LLG C +     +I EY    +L +++    RR               + L      
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANT 593
                +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D  +  T
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           N  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 196 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 21/202 (10%)
Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKLQ 486
           N+     LGEG FG V        GQ++A+K      L+KS  QG    + E+  +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 66
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H +++KL      +DE +++ EY  N+ L D+I    R K+ +   R +    I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYIVQ--RDKMSEQEAR-RFFQQIISAVEY 122
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV-VGTYGYMPP 605
            H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  +   G+  Y  P
Sbjct: 123 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 175
Query: 606 EYAIDGLFS-VKSDVFSFGVLV 626
           E     L++  + DV+S GV++
Sbjct: 176 EVISGKLYAGPEVDVWSCGVIL 197

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAV-KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +LG+G FG VYK    +   +A  K +   S + +E++  E+ ++A   H N+VKLL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
              +   ++ E+    ++   + +  R   L  S+   +       L YLH +   +IIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-----DGL 612
           RDLKA N+L   + + K++DFG++      +T    +  +GT  +M PE  +     D  
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 613 FSVKSDVFSFGVLVLEL 629
           +  K+DV+S G+ ++E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNL 490
           + +  K+GEG +G V+K    +  EI A+KR+      +GV      E+ L+ +L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+L        +  L++E+  ++ L  + FD     L D       +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDL-DPEIVKSFLFQLLKGLGFCHSR 120
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
           +   ++HRDLK  N+L++     K++DFG+ARAFG+      +  VV T  Y PP+    
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFG 175
Query: 611 G-LFSVKSDVFSFGVLVLELVYGTR 634
             L+S   D++S G +  EL    R
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 116/278 (41%), Gaps = 40/278 (14%)
Query: 438 NKLGEGGFGPVYKGM--LIDGQ--EIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 490
            KLG+G FG V +G      G+   +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           ++L G  +    +M + E  P  SL D +       LL    R  +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPEYA 608
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 196
Query: 609 IDGLFSVKSDVFSFGVLVLEL-VYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKS 667
               FS  SD + FGV + E+  YG                      W      +++ K 
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP-------------------WIGLNGSQILHKI 237
Query: 668 LEDTYSLSEALRCIQ----VGLLCVQQRPEDRPNMASV 701
            ++   L     C Q    V + C   +PEDRP   ++
Sbjct: 238 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 32/216 (14%)
Query: 440 LGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V     I           ++AVK L S ++ + + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR---------------KLLDWSKRC 534
           ++ LLG C +     +I EY    +L +++    RR               + L      
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANT 593
                +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D  +  T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           N  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 211 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 28/214 (13%)
Query: 440 LGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRN 489
           LGEG FG V     I           ++AVK L S ++ + + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTRRKLLDWSKRCQIIG 538
           ++ LLG C +     +I EY    +L +++           ++ +       S +  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 539 G--IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGVDQTEANTNR 595
              +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D  +  TN 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 213 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I  Y    +L +++           +D  R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 116/277 (41%), Gaps = 40/277 (14%)
Query: 439 KLGEGGFGPVYKGM--LIDGQ--EIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNLV 491
           KLG+G FG V +G      G+   +AVK L     S  + +++F  EV  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L G  +    +M + E  P  SL D +       LL    R  +   +A G+ YL    
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPEYAI 609
             R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE   
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLK 191
Query: 610 DGLFSVKSDVFSFGVLVLEL-VYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKSL 668
              FS  SD + FGV + E+  YG                   W      + +  IDK  
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQE----------------PWIGLNGSQILHKIDKEG 235
Query: 669 EDTYSLSEALRCIQ----VGLLCVQQRPEDRPNMASV 701
           E    L     C Q    V + C   +PEDRP   ++
Sbjct: 236 E---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 21/195 (10%)
Query: 440 LGEGGFGPVYKGMLID--GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +G+G FG V   ML D  G ++AVK +   +    + F  E  ++ +L+H NLV+LLG  
Sbjct: 201 IGKGEFGDV---MLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 498 MKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
           ++    + ++ EY+   SL D++     R +L      +    +   + YL  ++    +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT--YGYMPPEYAIDGLFS 614
           HRDL A NVL+  +   K+SDFG+ +       EA++ +  G     +  PE   +  FS
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 615 VKSDVFSFGVLVLEL 629
            KSDV+SFG+L+ E+
Sbjct: 365 TKSDVWSFGILLWEI 379

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 116/278 (41%), Gaps = 40/278 (14%)
Query: 438 NKLGEGGFGPVYKGM--LIDGQ--EIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 490
            KLG+G FG V +G      G+   +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           ++L G  +    +M + E  P  SL D +       LL    R  +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPEYA 608
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 186
Query: 609 IDGLFSVKSDVFSFGVLVLEL-VYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKS 667
               FS  SD + FGV + E+  YG                      W      +++ K 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP-------------------WIGLNGSQILHKI 227
Query: 668 LEDTYSLSEALRCIQ----VGLLCVQQRPEDRPNMASV 701
            ++   L     C Q    V + C   +PEDRP   ++
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 116/278 (41%), Gaps = 40/278 (14%)
Query: 438 NKLGEGGFGPVYKGM--LIDGQ--EIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 490
            KLG+G FG V +G      G+   +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           ++L G  +    +M + E  P  SL D +       LL    R  +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPEYA 608
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 196
Query: 609 IDGLFSVKSDVFSFGVLVLEL-VYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKS 667
               FS  SD + FGV + E+  YG                   W      + +  IDK 
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE----------------PWIGLNGSQILHKIDKE 240
Query: 668 LEDTYSLSEALRCIQ----VGLLCVQQRPEDRPNMASV 701
            E    L     C Q    V + C   +PEDRP   ++
Sbjct: 241 GE---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 116/278 (41%), Gaps = 40/278 (14%)
Query: 438 NKLGEGGFGPVYKGM--LIDGQ--EIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 490
            KLG+G FG V +G      G+   +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           ++L G  +    +M + E  P  SL D +       LL    R  +   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPEYA 608
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 609 IDGLFSVKSDVFSFGVLVLEL-VYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKS 667
               FS  SD + FGV + E+  YG                      W      +++ K 
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEP-------------------WIGLNGSQILHKI 231
Query: 668 LEDTYSLSEALRCIQ----VGLLCVQQRPEDRPNMASV 701
            ++   L     C Q    V + C   +PEDRP   ++
Sbjct: 232 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 440 LGEGGFGPVYK-GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           LG G FG V+K      G ++A K +     +  EE KNE+ ++ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
            +++ +L+ EY+    L D I D +    L        +  I  G+ ++HQ   + I+H 
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ---MYILHL 211
Query: 559 DLKASNVLLDNE--MNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           DLK  N+L  N      KI DFG+AR +   +         GT  ++ PE       S  
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFLAPEVVNYDFVSFP 268
Query: 617 SDVFSFGVLVLELVYG 632
           +D++S GV+   L+ G
Sbjct: 269 TDMWSVGVIAYMLLSG 284

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 116/278 (41%), Gaps = 40/278 (14%)
Query: 438 NKLGEGGFGPVYKGM--LIDGQ--EIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 490
            KLG+G FG V +G      G+   +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           ++L G  +    +M + E  P  SL D +       LL    R  +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPEYA 608
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 609 IDGLFSVKSDVFSFGVLVLEL-VYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKS 667
               FS  SD + FGV + E+  YG                   W      + +  IDK 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQE----------------PWIGLNGSQILHKIDKE 230
Query: 668 LEDTYSLSEALRCIQ----VGLLCVQQRPEDRPNMASV 701
            E    L     C Q    V + C   +PEDRP   ++
Sbjct: 231 GE---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 440 LGEGGFGPVYK----GMLIDGQ--EIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRNLV 491
           LG G FG V      G+   G   ++AVK L  K+     E   +E+ ++ +L  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFI-------------FDGTRR-------KLLDWS 531
            LLG C       LI+EY     L +++             ++  +R        +L + 
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
                   +A+G+ +L   S    +HRDL A NVL+ +    KI DFG+AR    D    
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                     +M PE   +G++++KSDV+S+G+L+ E+
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 21/195 (10%)
Query: 440 LGEGGFGPVYKGMLID--GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +G+G FG V   ML D  G ++AVK +   +    + F  E  ++ +L+H NLV+LLG  
Sbjct: 29  IGKGEFGDV---MLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 498 MKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
           ++    + ++ EY+   SL D++     R +L      +    +   + YL  ++    +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT--YGYMPPEYAIDGLFS 614
           HRDL A NVL+  +   K+SDFG+ +       EA++ +  G     +  PE   +  FS
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 615 VKSDVFSFGVLVLEL 629
            KSDV+SFG+L+ E+
Sbjct: 193 TKSDVWSFGILLWEI 207

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +        +   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----------FDGTR--RKLL 528
             + +H+N++ LLG C +     +I  Y    +L +++           +D  R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVD 587
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +  TN  +    +M PE   D +++ +SDV+SFGVL+ E+
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 116/278 (41%), Gaps = 40/278 (14%)
Query: 438 NKLGEGGFGPVYKGM--LIDGQ--EIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 490
            KLG+G FG V +G      G+   +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           ++L G  +    +M + E  P  SL D +       LL    R  +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPEYA 608
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 609 IDGLFSVKSDVFSFGVLVLEL-VYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKS 667
               FS  SD + FGV + E+  YG                      W      +++ K 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP-------------------WIGLNGSQILHKI 227
Query: 668 LEDTYSLSEALRCIQ----VGLLCVQQRPEDRPNMASV 701
            ++   L     C Q    V + C   +PEDRP   ++
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 440 LGEGGFGPVYKGMLI--DGQ--EIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           LGEG FG V +G L   DG   ++AVK  +L  SS + +EEF +E   +    H N+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 494 LGCCMKRDER-----MLIYEYLPNKSLADFIFDG---TRRKLLDWSKRCQIIGGIARGLL 545
           LG C++   +     M+I  ++    L  ++      T  K +      + +  IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           YL   S    +HRDL A N +L ++M   ++DFG+++                   ++  
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTE--DRPVEL 663
           E   D +++ KSDV++FGV + E+      RG              + L      +P + 
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIA----TRGMTPYPGVQNHEMYDYLLHGHRLKQPEDC 274
Query: 664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
           +D+  E  YS             C +  P DRP  + + L L
Sbjct: 275 LDELYEIMYS-------------CWRTDPLDRPTFSVLRLQL 303

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 21/195 (10%)
Query: 440 LGEGGFGPVYKGMLID--GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +G+G FG V   ML D  G ++AVK +   +    + F  E  ++ +L+H NLV+LLG  
Sbjct: 14  IGKGEFGDV---MLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 498 MKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
           ++    + ++ EY+   SL D++     R +L      +    +   + YL  ++    +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 124
Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT--YGYMPPEYAIDGLFS 614
           HRDL A NVL+  +   K+SDFG+ +       EA++ +  G     +  PE   +  FS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 615 VKSDVFSFGVLVLEL 629
            KSDV+SFG+L+ E+
Sbjct: 178 TKSDVWSFGILLWEI 192

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 99/183 (54%), Gaps = 23/183 (12%)
Query: 439 KLGEGGFGPVYKG-MLIDGQEIAVKRL---SKSSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           K+G+G FG V+K      GQ++A+K++   ++  G  +   + E+ ++  L+H N+V L+
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 83
Query: 495 GCCMKRDERM--------LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
             C  +            L++++  +  LA  + +   +  L   KR  ++  +  GL Y
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYY 140
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV---DQTEANTNRVVGTYGYM 603
           +H++   +I+HRD+KA+NVL+  +   K++DFG+ARAF +    Q     NRVV T  Y 
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYR 196
Query: 604 PPE 606
           PPE
Sbjct: 197 PPE 199

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL 485
             DNF     LG+G FG V    + + G   AVK L K        VE    E  +++  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           ++   +  L CC +  +R+       N    D +F   + +  D ++       I   L+
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNG--GDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           +LH      II+RDLK  NVLLD+E + K++DFGM +  G+      T    GT  Y+ P
Sbjct: 139 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GI-CNGVTTATFCGTPDYIAP 193
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E   + L+    D ++ GVL+ E++ G
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAV-KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +LG+G FG VYK    +   +A  K +   S + +E++  E+ ++A   H N+VKLL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
              +   ++ E+    ++   + +  R   L  S+   +       L YLH +   +IIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-----DGL 612
           RDLKA N+L   + + K++DFG++      +     +  +GT  +M PE  +     D  
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNT--RXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 613 FSVKSDVFSFGVLVLEL 629
           +  K+DV+S G+ ++E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 102/193 (52%), Gaps = 23/193 (11%)
Query: 429 NATDNFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRL---SKSSGQGVEEFKNEVLLIAK 484
           +    + +  K+G+G FG V+K      GQ++A+K++   ++  G  +   + E+ ++  
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQL 72
Query: 485 LQHRNLVKLLGCCMKRDERM--------LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI 536
           L+H N+V L+  C  +            L++++  +  LA  + +   +  L   KR  +
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--V 129
Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV---DQTEANT 593
           +  +  GL Y+H++   +I+HRD+KA+NVL+  +   K++DFG+ARAF +    Q     
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 594 NRVVGTYGYMPPE 606
           NRVV T  Y PPE
Sbjct: 187 NRVV-TLWYRPPE 198

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 102/193 (52%), Gaps = 23/193 (11%)
Query: 429 NATDNFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRL---SKSSGQGVEEFKNEVLLIAK 484
           +    + +  K+G+G FG V+K      GQ++A+K++   ++  G  +   + E+ ++  
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQL 73
Query: 485 LQHRNLVKLLGCCMKRDERM--------LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI 536
           L+H N+V L+  C  +            L++++  +  LA  + +   +  L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--V 130
Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV---DQTEANT 593
           +  +  GL Y+H++   +I+HRD+KA+NVL+  +   K++DFG+ARAF +    Q     
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 594 NRVVGTYGYMPPE 606
           NRVV T  Y PPE
Sbjct: 188 NRVV-TLWYRPPE 199

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAV-KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +LG+G FG VYK    +   +A  K +   S + +E++  E+ ++A   H N+VKLL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
              +   ++ E+    ++   + +  R   L  S+   +       L YLH +   +IIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-----DGL 612
           RDLKA N+L   + + K++DFG++      +     +  +GT  +M PE  +     D  
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNT--RXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 613 FSVKSDVFSFGVLVLEL 629
           +  K+DV+S G+ ++E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 102/193 (52%), Gaps = 23/193 (11%)
Query: 429 NATDNFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRL---SKSSGQGVEEFKNEVLLIAK 484
           +    + +  K+G+G FG V+K      GQ++A+K++   ++  G  +   + E+ ++  
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQL 73
Query: 485 LQHRNLVKLLGCCMKRDERM--------LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI 536
           L+H N+V L+  C  +            L++++  +  LA  + +   +  L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--V 130
Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV---DQTEANT 593
           +  +  GL Y+H++   +I+HRD+KA+NVL+  +   K++DFG+ARAF +    Q     
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 594 NRVVGTYGYMPPE 606
           NRVV T  Y PPE
Sbjct: 188 NRVV-TLWYRPPE 199

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 42/228 (18%)
Query: 432 DNFSEENKLGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVL 480
           D  +    LG G FG V +     ID     + +AVK L + +        + E K   +
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 84
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIY------------------EYLPNKSLADFIFDG 522
           LI    H N+V LLG C K    +++                   E++P K+  D   D 
Sbjct: 85  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF 144
Query: 523 -TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
            T   L+ +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+A
Sbjct: 145 LTLEHLICYSFQ------VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R    D              +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 97/222 (43%), Gaps = 47/222 (21%)
Query: 440 LGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVLLIAKLQHR 488
           LG G FG V +     ID     + +AVK L + +        + E K   +LI    H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 93
Query: 489 NLVKLLGCCMK---------------------RDERMLIYEYLPNKSLADFIFDGTRRKL 527
           N+V LLG C K                     R +R     Y P     DF+   T   L
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFL---TLEHL 150
Query: 528 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD 587
           + +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D
Sbjct: 151 IXYSFQ------VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                         +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNL 490
           + +  K+GEG +G V+K    +  EI A+KR+      +GV      E+ L+ +L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+L        +  L++E+  ++ L  + FD     L D       +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDL-DPEIVKSFLFQLLKGLGFCHSR 120
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
           +   ++HRDLK  N+L++     K+++FG+ARAFG+      +  VV T  Y PP+    
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFG 175
Query: 611 G-LFSVKSDVFSFGVLVLELVYGTR 634
             L+S   D++S G +  EL    R
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   Y+   +D +E+ A K + KS        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
                D   ++ E    +SL +      RRK +   +    +    +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDLK  N+ L+++M+ KI DFG+A     D     T  + GT  Y+ PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSF 221
Query: 616 KSDVFSFGVLVLELVYG 632
           + D++S G ++  L+ G
Sbjct: 222 EVDIWSLGCILYTLLVG 238

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 87/177 (49%), Gaps = 19/177 (10%)
Query: 467 SSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK 526
           S     ++FKNE+ +I  +++   +   G     DE  +IYEY+ N S+  F        
Sbjct: 82  SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF---DEYFF 138
Query: 527 LLDWSKRC----QIIGGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 578
           +LD +  C    Q+I  I + +L    Y+H +    I HRD+K SN+L+D     K+SDF
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDF 196
Query: 579 GMARAFGVDQTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYGT 633
           G +  + VD+    +    GTY +MPPE+  +       K D++S G+ +  + Y  
Sbjct: 197 GESE-YMVDKKIKGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 65
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 122
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 176
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 65
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 122
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 176
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSS--GQGVE-EFKNEVLLIAKL 485
             D+F     LG+G FG VY       + I A+K L KS    +GVE + + E+ + + L
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N++++      R    L+ E+ P   L   +    R    D  +    +  +A  L 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALH 128
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H+    ++IHRD+K  N+L+  +   KI+DFG    + V         + GT  Y+PP
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPP 181
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E         K D++  GVL  E + G
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSS--GQGVE-EFKNEVLLIAKL 485
             D+F     LG+G FG VY       + I A+K L KS    +GVE + + E+ + + L
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 72
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N++++      R    L+ E+ P   L   +    R    D  +    +  +A  L 
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALH 129
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           Y H+    ++IHRD+K  N+L+  +   KI+DFG    + V         + GT  Y+PP
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPP 182
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E         K D++  GVL  E + G
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 45/228 (19%)
Query: 432 DNFSEENKLGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVL 480
           D  +    LG G FG V +     ID     + +AVK L + +        + E K   +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---I 83
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIY------------------EYLPNKSL-ADFIFD 521
           LI    H N+V LLG C K    +++                   E++P K L  DF+  
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL-- 141
Query: 522 GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
            T   L+ +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+A
Sbjct: 142 -TLEHLIXYSFQ------VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLA 191
Query: 582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R    D              +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 192 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 487
           +DN+  + +LG+G F  V + +    G E A K ++  K S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V+L     +     L+++ +    L +   D   R+    +     I  I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQQILESIAYC 121
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           H +    I+HR+LK  N+LL ++      K++DFG+  A  V+ +EA  +   GT GY+ 
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEA-WHGFAGTPGYLS 175
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +S   D+++ GV++  L+ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 487
           +DN+  + +LG+G F  V + +    G E A K ++  K S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V+L     +     L+++ +    L +   D   R+    +     I  I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQQILESIAYC 121
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           H +    I+HR+LK  N+LL ++      K++DFG+  A  V+ +EA  +   GT GY+ 
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEA-WHGFAGTPGYLS 175
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +S   D+++ GV++  L+ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   ++    D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
                D   ++ E    +SL +      RRK L   +    +  I  G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDLK  N+ L+ ++  KI DFG+A     D     T  + GT  Y+ PE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 616 KSDVFSFGVLVLELVYG 632
           + DV+S G ++  L+ G
Sbjct: 197 EVDVWSIGCIMYTLLVG 213

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEE--FKNEVLLIAKLQHRNLVKLLGC 496
           +GEG +G V K    D G+ +A+K+  +S    + +     E+ L+ +L+H NLV LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 497 CMKRDERMLIYEYLPNKSLADF-IFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
           C K+    L++E++ +  L D  +F       LD+    + +  I  G+ + H  +   I
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNG----LDYQVVQKYLFQIINGIGFCHSHN---I 145
Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-DGLFS 614
           IHRD+K  N+L+      K+ DFG AR         +    V T  Y  PE  + D  + 
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAPELLVGDVKYG 203
Query: 615 VKSDVFSFGVLVLELVYG 632
              DV++ G LV E+  G
Sbjct: 204 KAVDVWAIGCLVTEMFMG 221

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   ++    D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
                D   ++ E    +SL +      RRK L   +    +  I  G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDLK  N+ L+ ++  KI DFG+A     D     T  + GT  Y+ PE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 616 KSDVFSFGVLVLELVYG 632
           + DV+S G ++  L+ G
Sbjct: 197 EVDVWSIGCIMYTLLVG 213

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   ++    D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
                D   ++ E    +SL +      RRK L   +    +  I  G  YLH++   R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDLK  N+ L+ ++  KI DFG+A     D     T  + GT  Y+ PE       S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 616 KSDVFSFGVLVLELVYG 632
           + DV+S G ++  L+ G
Sbjct: 201 EVDVWSIGCIMYTLLVG 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 487
           +DN+  + +LG+G F  V + +    G E A K ++  K S +  ++ + E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V+L     +     L+++ +    L +   D   R+    +     I  I   + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQQILESIAYC 120
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           H +    I+HR+LK  N+LL ++      K++DFG+  A  V+ +EA  +   GT GY+ 
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEA-WHGFAGTPGYLS 174
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +S   D+++ GV++  L+ G
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 45/228 (19%)
Query: 432 DNFSEENKLGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVL 480
           D  +    LG G FG V +     ID     + +AVK L + +        + E K   +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---I 83
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIY------------------EYLPNKSL-ADFIFD 521
           LI    H N+V LLG C K    +++                   E++P K L  DF+  
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL-- 141
Query: 522 GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
            T   L+ +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+A
Sbjct: 142 -TLEHLICYSFQ------VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLA 191
Query: 582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           R    D              +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 192 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 487
           +DN+  + +LG+G F  V + +    G E A K ++  K S +  ++ + E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V+L     +     L+++ +    L +   D   R+    +     I  I   + Y 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQQILESIAYC 144
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           H +    I+HR+LK  N+LL ++      K++DFG+  A  V+ +EA  +   GT GY+ 
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEA-WHGFAGTPGYLS 198
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +S   D+++ GV++  L+ G
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 429 NATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVL 480
           N  D +    +LG G F  V K      G+    + I  KR +KSS +GV  E+ + EV 
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVS 66
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 26/228 (11%)
Query: 419 LPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNE 478
           LP+   ++IA       +   +G+G +G V+ G    G+++AVK    ++ +     + E
Sbjct: 27  LPLLVQRTIAKQIQMVKQ---IGKGRYGEVWMGKW-RGEKVAVKVFF-TTEEASWFRETE 81
Query: 479 VLLIAKLQHRNLVKLLGCCMKRD----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC 534
           +     ++H N++  +   +K      +  LI +Y  N SL D++   T    LD     
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSML 137
Query: 535 QIIGGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
           ++      GL +LH +      +  I HRDLK+ N+L+       I+D G+A  F  D  
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 590 EANT--NRVVGTYGYMPPEYAIDGL------FSVKSDVFSFGVLVLEL 629
           E +   N  VGT  YMPPE   + L        + +D++SFG+++ E+
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 15/213 (7%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVE--EFKNEV 479
            I    ++F     LG+G FG V+        Q  A+K L K        VE    +  V
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 480 LLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG 539
           L +A  +H  L  +      ++    + EYL      D ++        D S+       
Sbjct: 72  LSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNG---GDLMYHIQSCHKFDLSRATFYAAE 127
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           I  GL +LH      I++RDLK  N+LLD + + KI+DFGM +   +   +A TN   GT
Sbjct: 128 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNEFCGT 182
Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             Y+ PE  +   ++   D +SFGVL+ E++ G
Sbjct: 183 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 215

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 438 NKLGEGGFGPVYKG-MLIDGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQHRNLVKL 493
           + LG G FG V  G   + G ++AVK L++   + ++   + K E+  +   +H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
                   +  ++ EY+    L D+I    R + ++  +  Q    I   + Y H   R 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCH---RH 130
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            ++HRDLK  NVLLD  MN KI+DFG++     D     T+   G+  Y  PE     L+
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS--CGSPNYAAPEVISGRLY 187
Query: 614 S-VKSDVFSFGVLVLELVYGT 633
           +  + D++S GV++  L+ GT
Sbjct: 188 AGPEVDIWSCGVILYALLCGT 208

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V     +  G +IAVK+LS+     +   +   E+ L
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P  SL +F  ++  T     D +   +CQ  
Sbjct: 104 LKHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKL 151
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 152 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 203
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + +++  D++S G ++ EL+ G
Sbjct: 204 TDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 438 NKLGEGGFGPVYKG-MLIDGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQHRNLVKL 493
           + LG G FG V  G   + G ++AVK L++   + ++   + K E+  +   +H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
                   +  ++ EY+    L D+I    R + ++  +  Q    I   + Y H   R 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCH---RH 130
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            ++HRDLK  NVLLD  MN KI+DFG++      +   ++    G+  Y  PE     L+
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVISGRLY 187
Query: 614 S-VKSDVFSFGVLVLELVYGT 633
           +  + D++S GV++  L+ GT
Sbjct: 188 AGPEVDIWSCGVILYALLCGT 208

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 440 LGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +GEG FG V++G+ +        +A+K     +   V E+F  E L + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  +  +   +I E      L  F+    R+  LD +        ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 615 VKSDVFSFGVLVLE-LVYGTR 634
             SDV+ FGV + E L++G +
Sbjct: 191 SASDVWMFGVCMWEILMHGVK 211

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 440 LGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVLLIAKLQHR 488
           LG G FG V +     ID     + +AVK L + +        + E K   +LI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 489 NLVKLLGCCMKRDERMLIY------------------EYLPNKSLADFIFDG--TRRKLL 528
           N+V LLG C K    +++                   E++P K   + ++    T   L+
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
            +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D 
Sbjct: 152 CYSFQ------VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                        +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   Y+   +D +E+ A K + KS        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
                D   ++ E    +SL +      RRK +   +    +    +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDLK  N+ L+++M+ KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX--LCGTPNYIAPEVLCKKGHSF 221
Query: 616 KSDVFSFGVLVLELVYG 632
           + D++S G ++  L+ G
Sbjct: 222 EVDIWSLGCILYTLLVG 238

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 429 NATDNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRL--SKSSGQGVEEFKNEVLLI 482
            + + +    K+GEG FG   K +L+    DG++  +K +  S+ S +  EE + EV ++
Sbjct: 21  QSMEKYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL 77
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT-----RRKLLDWSKRCQII 537
           A ++H N+V+      +     ++ +Y     L   I           ++LDW  +    
Sbjct: 78  ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ---- 133
Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVV 597
             I   L ++H     +I+HRD+K+ N+ L  +   ++ DFG+AR   ++ T       +
Sbjct: 134 --ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACI 186
Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           GT  Y+ PE   +  ++ KSD+++ G ++ EL
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 15/213 (7%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVE--EFKNEV 479
            I    ++F     LG+G FG V+        Q  A+K L K        VE    +  V
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 480 LLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG 539
           L +A  +H  L  +      ++    + EYL      D ++        D S+       
Sbjct: 71  LSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNG---GDLMYHIQSCHKFDLSRATFYAAE 126
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           I  GL +LH      I++RDLK  N+LLD + + KI+DFGM +   +   +A TN   GT
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNXFCGT 181
Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             Y+ PE  +   ++   D +SFGVL+ E++ G
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 440 LGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +GEG FG V++G+ +        +A+K     +   V E+F  E L + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  +  +   +I E      L  F+    R+  LD +        ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 615 VKSDVFSFGVLVLE-LVYGTR 634
             SDV+ FGV + E L++G +
Sbjct: 191 SASDVWMFGVCMWEILMHGVK 211

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 440 LGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVLLIAKLQHR 488
           LG G FG V +     ID     + +AVK L + +        + E K   +LI    H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 82
Query: 489 NLVKLLGCCMKRDERMLIY------------------EYLPNKSLADFIFDG--TRRKLL 528
           N+V LLG C K    +++                   E++P K   + ++    T   L+
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
            +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D 
Sbjct: 143 CYSFQ------VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                        +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   Y+   +D +E+ A K + KS        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
                D   ++ E    +SL +      RRK +   +    +    +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDLK  N+ L+++M+ KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGTPNYIAPEVLCKKGHSF 221
Query: 616 KSDVFSFGVLVLELVYG 632
           + D++S G ++  L+ G
Sbjct: 222 EVDIWSLGCILYTLLVG 238

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 440 LGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVLLIAKLQHR 488
           LG G FG V +     ID     + +AVK L + +        + E K   +LI    H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 82
Query: 489 NLVKLLGCCMKRDERMLIY------------------EYLPNKSLADFIFDG--TRRKLL 528
           N+V LLG C K    +++                   E++P K   + ++    T   L+
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
            +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D 
Sbjct: 143 CYSFQ------VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                        +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   Y+   +D +E+ A K + KS        E+   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
                D   ++ E    +SL +      RRK +   +    +    +G+ YLH +   R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 147
Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDLK  N+ L+++M+ KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGTPNYIAPEVLCKKGHSF 205
Query: 616 KSDVFSFGVLVLELVYG 632
           + D++S G ++  L+ G
Sbjct: 206 EVDIWSLGCILYTLLVG 222

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +GEG FG V++G+ +  +     +A+K     +   V E+F  E L + +  H ++VKL+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  +  +   +I E      L  F+    R+  LD +        ++  L YL      R
Sbjct: 75  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 615 VKSDVFSFGVLVLE-LVYGTR 634
             SDV+ FGV + E L++G +
Sbjct: 188 SASDVWMFGVCMWEILMHGVK 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +GEG FG V++G+ +  +     +A+K     +   V E+F  E L + +  H ++VKL+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  +  +   +I E      L  F+    R+  LD +        ++  L YL      R
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 615 VKSDVFSFGVLVLE-LVYGTR 634
             SDV+ FGV + E L++G +
Sbjct: 194 SASDVWMFGVCMWEILMHGVK 214

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +GEG FG V++G+ +  +     +A+K     +   V E+F  E L + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  +  +   +I E      L  F+    R+  LD +        ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 615 VKSDVFSFGVLVLE-LVYGTR 634
             SDV+ FGV + E L++G +
Sbjct: 191 SASDVWMFGVCMWEILMHGVK 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +GEG FG V++G+ +  +     +A+K     +   V E+F  E L + +  H ++VKL+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  +  +   +I E      L  F+    R+  LD +        ++  L YL      R
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 615 VKSDVFSFGVLVLE-LVYGTR 634
             SDV+ FGV + E L++G +
Sbjct: 193 SASDVWMFGVCMWEILMHGVK 213

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 439 KLGEGGFGPVYKGMLID--GQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ---HRNLV 491
           ++GEG +G V+K   +   G+ +A+KR+   +G+         EV ++  L+   H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 492 KLLGCC-MKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           +L   C + R +R     L++E++ ++ L  ++ D      +       ++  + RGL +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH     R++HRDLK  N+L+ +    K++DFG+AR +     +     VV T  Y  PE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 189
Query: 607 YAIDGLFSVKSDVFSFGVLVLEL 629
             +   ++   D++S G +  E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +GEG FG V++G+ +  +     +A+K     +   V E+F  E L + +  H ++VKL+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  +  +   +I E      L  F+    R+  LD +        ++  L YL      R
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 615 VKSDVFSFGVLVLE-LVYGTR 634
             SDV+ FGV + E L++G +
Sbjct: 196 SASDVWMFGVCMWEILMHGVK 216

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +GEG FG V++G+ +  +     +A+K     +   V E+F  E L + +  H ++VKL+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  +  +   +I E      L  F+    R+  LD +        ++  L YL      R
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 615 VKSDVFSFGVLVLE-LVYGTR 634
             SDV+ FGV + E L++G +
Sbjct: 219 SASDVWMFGVCMWEILMHGVK 239

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQ 486
           +D +     LG GG   V+    L D +++AVK L     +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 487 HRNLVKLLGCCMKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
           H  +V +               ++ EY+   +L D +        +   +  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----VDQTEANTNRVV 597
            L + HQ+    IIHRD+K +N+L+      K+ DFG+ARA       V QT A    V+
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA----VI 180
Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           GT  Y+ PE A       +SDV+S G ++ E++ G
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQ 486
           D F  + KLG G FG V+   L++    G E  +K ++K   Q  +E+ + E+ ++  L 
Sbjct: 22  DLFIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR-KLLDWSKRCQIIGGIARGLL 545
           H N++K+           ++ E      L + I     R K L      +++  +   L 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNE--MNP-KISDFGMARAFGVDQTEANTNRVVGTYGY 602
           Y H      ++H+DLK  N+L  +    +P KI DFG+A  F  D+   N     GT  Y
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALY 192
Query: 603 MPPE-YAIDGLFSVKSDVFSFGVLVLELVYG 632
           M PE +  D  F  K D++S GV++  L+ G
Sbjct: 193 MAPEVFKRDVTF--KCDIWSAGVVMYFLLTG 221

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   ++    D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
                D   ++ E    +SL +      RRK L   +    +  I  G  YLH++   R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDLK  N+ L+ ++  KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 218
Query: 616 KSDVFSFGVLVLELVYG 632
           + DV+S G ++  L+ G
Sbjct: 219 EVDVWSIGCIMYTLLVG 235

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   ++    D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
                D   ++ E    +SL +      RRK L   +    +  I  G  YLH++   R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDLK  N+ L+ ++  KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 220
Query: 616 KSDVFSFGVLVLELVYG 632
           + DV+S G ++  L+ G
Sbjct: 221 EVDVWSIGCIMYTLLVG 237

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 427 IANATDNFSEENKLGEGGFGPVYKGMLID--GQEIAVKRLSKSSGQGVEEFKN--EVLLI 482
           +  A   +    ++GEG +G V+K   +   G+ +A+KR+   +G+         EV ++
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 483 AKLQ---HRNLVKLLGCC-MKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRC 534
             L+   H N+V+L   C + R +R     L++E++ ++ L  ++ D      +      
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
            ++  + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +     +    
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 177
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            VV T  Y  PE  +   ++   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 440 LGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVLLIAKLQHR 488
           LG G FG V +     ID     + +AVK L + +        + E K   +LI    H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 93
Query: 489 NLVKLLGCCMKRDERMLIY------------------EYLPNKSLADFIFDG--TRRKLL 528
           N+V LLG C K    +++                   E++P K   + ++    T   L+
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
            +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D 
Sbjct: 154 CYSFQ------VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 204
Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                        +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 440 LGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVLLIAKLQHR 488
           LG G FG V +     ID     + +AVK L + +        + E K   +LI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 489 NLVKLLGCCMKRDERMLIY------------------EYLPNKSLADFIFDG--TRRKLL 528
           N+V LLG C K    +++                   E++P K   + ++    T   L+
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
            +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D 
Sbjct: 152 CYSFQ------VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                        +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 427 IANATDNFSEENKLGEGGFGPVYKGMLID--GQEIAVKRLSKSSGQGVEEFKN--EVLLI 482
           +  A   +    ++GEG +G V+K   +   G+ +A+KR+   +G+         EV ++
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 483 AKLQ---HRNLVKLLGCC-MKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRC 534
             L+   H N+V+L   C + R +R     L++E++ ++ L  ++ D      +      
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
            ++  + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +     +    
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 177
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
            VV T  Y  PE  +   ++   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 424 WKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQE-IAVKRLSKSSGQGVE-EFKNEVLL 481
           WK   +  D +   + LG G F  V        Q+ +A+K ++K + +G E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 69
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           + K++H N+V L           LI + +    L D I +       D S+   +I  + 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVL 126
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVL---LDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
             + YLH    L I+HRDLK  N+L   LD +    ISDFG+++   ++   +  +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACG 180
Query: 599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T GY+ PE      +S   D +S GV+   L+ G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   ++    D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
                D   ++ E    +SL +      RRK L   +    +  I  G  YLH++   R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHRDLK  N+ L+ ++  KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 194
Query: 616 KSDVFSFGVLVLELVYG 632
           + DV+S G ++  L+ G
Sbjct: 195 EVDVWSIGCIMYTLLVG 211

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 440 LGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVLLIAKLQHR 488
           LG G FG V +     ID     + +AVK L + +        + E K   +LI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 489 NLVKLLGCCMKRDERMLIY------------------EYLPNKSLADFIFDG--TRRKLL 528
           N+V LLG C K    +++                   E++P K   + ++    T   L+
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
            +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D 
Sbjct: 152 CYSFQ------VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                        +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 440 LGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVLLIAKLQHR 488
           LG G FG V +     ID     + +AVK L + +        + E K   +LI    H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 82
Query: 489 NLVKLLGCCMKRDERMLIY------------------EYLPNKSLADFIFDG--TRRKLL 528
           N+V LLG C K    +++                   E++P K   + ++    T   L+
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
            +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D 
Sbjct: 143 CYSFQ------VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                        +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 424 WKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQE-IAVKRLSKSSGQGVE-EFKNEVLL 481
           WK   +  D +   + LG G F  V        Q+ +A+K ++K + +G E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           + K++H N+V L           LI + +    L D I +       D S+   +I  + 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVL 126
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVL---LDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
             + YLH    L I+HRDLK  N+L   LD +    ISDFG+++   ++   +  +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACG 180
Query: 599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T GY+ PE      +S   D +S GV+   L+ G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 440 LGEGGFGPVYKG--MLIDG----QEIAVKRLSKSSGQG-----VEEFKNEVLLIAKLQHR 488
           LG G FG V +     ID     + +AVK L + +        + E K   +LI    H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 82
Query: 489 NLVKLLGCCMKRDERMLIY------------------EYLPNKSLADFIFDG--TRRKLL 528
           N+V LLG C K    +++                   E++P K   + ++    T   L+
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
            +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D 
Sbjct: 143 CYSFQ------VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                        +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 424 WKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQE-IAVKRLSKSSGQGVE-EFKNEVLL 481
           WK   +  D +   + LG G F  V        Q+ +A+K ++K + +G E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           + K++H N+V L           LI + +    L D I +       D S+   +I  + 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVL 126
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVL---LDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
             + YLH    L I+HRDLK  N+L   LD +    ISDFG+++   ++   +  +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACG 180
Query: 599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T GY+ PE      +S   D +S GV+   L+ G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 424 WKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQE-IAVKRLSKSSGQGVE-EFKNEVLL 481
           WK   +  D +   + LG G F  V        Q+ +A+K ++K + +G E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           + K++H N+V L           LI + +    L D I +       D S+   +I  + 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVL 126
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVL---LDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
             + YLH    L I+HRDLK  N+L   LD +    ISDFG+++   ++   +  +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACG 180
Query: 599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T GY+ PE      +S   D +S GV+   L+ G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 111/260 (42%), Gaps = 44/260 (16%)
Query: 401 LYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKG--MLIDG-- 456
           L I M   EL   +    LP +D        D       LG G FG V +     ID   
Sbjct: 34  LSIVMDPDELPLDEHCERLP-YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTA 92
Query: 457 --QEIAVKRLSKSSGQG-----VEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY-- 507
             + +AVK L + +        + E K   +LI    H N+V LLG C K    +++   
Sbjct: 93  TCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHLNVVNLLGACTKPGGPLMVIVE 149
Query: 508 ----------------EYLPNKSLADFIFDG--TRRKLLDWSKRCQIIGGIARGLLYLHQ 549
                           E++P K   + ++    T   L+ +S +      +A+G+ +L  
Sbjct: 150 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ------VAKGMEFL-- 201
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
            +  + IHRDL A N+LL  +   KI DFG+AR    D              +M PE   
Sbjct: 202 -ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 260
Query: 610 DGLFSVKSDVFSFGVLVLEL 629
           D +++++SDV+SFGVL+ E+
Sbjct: 261 DRVYTIQSDVWSFGVLLWEI 280

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQ 486
           +D +     LG GG   V+    L D +++AVK L     +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 487 HRNLVKLLGCCMKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
           H  +V +               ++ EY+   +L D +        +   +  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----VDQTEANTNRVV 597
            L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       V QT A    V+
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA----VI 180
Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           GT  Y+ PE A       +SDV+S G ++ E++ G
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 440 LGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +GEG FG V++G+ +        +A+K     +   V E+F  E L + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  +  +   +I E      L  F+    R+  LD +        ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            +HRD+ A NVL+      K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 615 VKSDVFSFGVLVLE-LVYGTR 634
             SDV+ FGV + E L++G +
Sbjct: 191 SASDVWMFGVCMWEILMHGVK 211

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQ 486
           +D +     LG GG   V+    L D +++AVK L     +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 487 HRNLVKLLGCCMKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
           H  +V +               ++ EY+   +L D +        +   +  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----VDQTEANTNRVV 597
            L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       V QT A    V+
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA----VI 180
Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           GT  Y+ PE A       +SDV+S G ++ E++ G
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 193
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LSK     +   +   E+ L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 15/215 (6%)
Query: 424 WKSIANATDN-FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEE-FKNEVL 480
           WK  A      F  +  LG G F  V        G+  AVK + K + +G E   +NE+ 
Sbjct: 13  WKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIA 72
Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ K++H N+V L       +   L+ + +    L D I +       D S    +I  +
Sbjct: 73  VLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---TLIRQV 129
Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGVDQTEANTNRVV 597
              + YLH   R+ I+HRDLK  N+L    D E    ISDFG+++  G        +   
Sbjct: 130 LDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV---MSTAC 183
Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           GT GY+ PE      +S   D +S GV+   L+ G
Sbjct: 184 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G+G +G V++G L  G+ +AVK  S    Q      E  N VLL    +H N++  +  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNILGFIAS 70
Query: 497 CM----KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-- 550
            M       +  LI  Y  + SL DF+    +R+ L+     ++    A GL +LH +  
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 551 ---SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGVDQTEANTNRVVGTYGYMPP 605
               +  I HRD K+ NVL+ + +   I+D G+A   + G D  +   N  VGT  YM P
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 606 EYA-----IDGLFSVK-SDVFSFGVLVLELVYGTRNRGF 638
           E        D   S K +D+++FG+++ E+   T   G 
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGI 225

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 440 LGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +GEG FG V++G+ +        +A+K     +   V E+F  E L + +  H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  +  +   +I E      L  F+    R+  LD +        ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 615 VKSDVFSFGVLVLE-LVYGTR 634
             SDV+ FGV + E L++G +
Sbjct: 571 SASDVWMFGVCMWEILMHGVK 591

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 171 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ 486
           AT  +    ++G G +G VYK      G  +A+K +   +G+         EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 487 ---HRNLVKLLG-CCMKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG 538
              H N+V+L+  C   R +R     L++E++ ++ L  ++ D      L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
              RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +      A    VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VVV 173
Query: 599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           T  Y  PE  +   ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 429 NATDNFSEENKLGEGGFGPVYK-GMLIDGQEIAVKRLSK----SSGQGV--EEFKNEVLL 481
           +  D++    +LG G F  V K      G+E A K + K    SS +GV  EE + EV +
Sbjct: 9   DVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           + +++H N++ L      + + +LI E +    L DF+     ++ L   +  Q +  I 
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQIL 125
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLL--DNEMNPKIS--DFGMARAFGVDQTEANTNRVV 597
            G+ YLH     RI H DLK  N++L   N  NP+I   DFG+A          N   + 
Sbjct: 126 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IF 179
Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
           GT  ++ PE        +++D++S GV+   L+ G 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----H 179
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 195 TDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +     +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 85  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 132
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 133 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 184
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 185 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 440 LGEGGFGPVY-KGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           LG G F  V+     + G+  A+K + KS        +NE+ ++ K++H N+V L     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 499 KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 558
                 L+ + +    L D I +   R +        +I  +   + YLH++    I+HR
Sbjct: 77  STTHYYLVMQLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHR 130
Query: 559 DLKASNVL-LDNEMNPKISDFGMARAFGVDQTEAN--TNRVVGTYGYMPPEYAIDGLFSV 615
           DLK  N+L L  E N KI    M   FG+ + E N   +   GT GY+ PE      +S 
Sbjct: 131 DLKPENLLYLTPEENSKI----MITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSK 186
Query: 616 KSDVFSFGVLVLELVYG 632
             D +S GV+   L+ G
Sbjct: 187 AVDCWSIGVITYILLCG 203

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 432 DNFSEENKLGEGGFGPVYK-GMLIDGQEIAVKRLSK----SSGQGV--EEFKNEVLLIAK 484
           D++    +LG G F  V K      G+E A K + K    SS +GV  EE + EV ++ +
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           ++H N++ L      + + +LI E +    L DF+     ++ L   +  Q +  I  G+
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 121
Query: 545 LYLHQDSRLRIIHRDLKASNVLL--DNEMNPKIS--DFGMARAFGVDQTEANTNRVVGTY 600
            YLH     RI H DLK  N++L   N  NP+I   DFG+A          N   + GT 
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTP 175
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            ++ PE        +++D++S GV+   L+ G 
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 208

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-----EVLLIAKLQHRNLVKL 493
           LGEG F  VYK    +  Q +A+K++        ++  N     E+ L+ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
           L     +    L+++++    L   I D +   +L  S     +    +GL YLHQ    
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-L 612
            I+HRDLK +N+LLD     K++DFG+A++FG     A  ++VV T  Y  PE      +
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVV-TRWYRAPELLFGARM 189
Query: 613 FSVKSDVFSFGVLVLELV 630
           + V  D+++ G ++ EL+
Sbjct: 190 YGVGVDMWAVGCILAELL 207

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----H 179
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ 486
           AT  +    ++G G +G VYK      G  +A+K +   +G+         EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 487 ---HRNLVKLLG-CCMKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG 538
              H N+V+L+  C   R +R     L++E++ ++ L  ++ D      L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
              RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +     +   + VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVVV 173
Query: 599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           T  Y  PE  +   ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 182 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 436 EENKLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG   M    + +AVK L   +      +E   E  ++ +L +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+++G C + +  ML+ E      L  ++     R + D     +++  ++ G+ YL + 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 130
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 131 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ----THGKWPVKWYAP 183
Query: 606 EYAIDGLFSVKSDVFSFGVLVLE-LVYGTR 634
           E      FS KSDV+SFGVL+ E   YG +
Sbjct: 184 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 179
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 74  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 121
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 122 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 173
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 174 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 440 LGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLL 494
           +GEG FG V++G+ +        +A+K     +   V E+F  E L + +  H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  +  +   +I E      L  F+    R+  LD +        ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
            +HRD+ A NVL+      K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 615 VKSDVFSFGVLVLE-LVYGTR 634
             SDV+ FGV + E L++G +
Sbjct: 571 SASDVWMFGVCMWEILMHGVK 591

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 436 EENKLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG   M    + +AVK L   +      +E   E  ++ +L +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+++G C + +  ML+ E      L  ++     R + D     +++  ++ G+ YL + 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 146
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 199
Query: 606 EYAIDGLFSVKSDVFSFGVLVLE-LVYGTR 634
           E      FS KSDV+SFGVL+ E   YG +
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 436 EENKLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG   M    + +AVK L   +      +E   E  ++ +L +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+++G C + +  ML+ E      L  ++     R + D     +++  ++ G+ YL + 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 146
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 199
Query: 606 EYAIDGLFSVKSDVFSFGVLVLE-LVYGTR 634
           E      FS KSDV+SFGVL+ E   YG +
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 171
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 440 LGEGGFGPVYKGM---LID---GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLV 491
           LG G FG V +     LI       +AVK L  S+     E   +E+ +++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG------------ 539
            LLG C      ++I EY     L +F+    +R     SK    I              
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 540 -----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
                +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D       
Sbjct: 172 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKG 228
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                  +M PE   + +++ +SDV+S+G+ + EL
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 440 LGEGGFGPVYKGMLIDGQE----IAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLV 491
           LG+GG+G V++   + G       A+K L K+    + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            L+       +  LI EYL   S  +      R  +      C  +  I+  L +LHQ  
Sbjct: 85  DLIYAFQTGGKLYLILEYL---SGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              II+RDLK  N++L+++ + K++DFG+ +    D T  +T    GT  YM PE  +  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRS 196
Query: 612 LFSVKSDVFSFGVLVLELVYGT 633
             +   D +S G L+ +++ G 
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGA 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----H 185
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 171
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 432 DNFSEENKLGEGGFGPVYK-GMLIDGQEIAVKRLSK----SSGQGV--EEFKNEVLLIAK 484
           D++    +LG G F  V K      G+E A K + K    SS +GV  EE + EV ++ +
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           ++H N++ L      + + +LI E +    L DF+     ++ L   +  Q +  I  G+
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 142
Query: 545 LYLHQDSRLRIIHRDLKASNVLL--DNEMNPKIS--DFGMARAFGVDQTEANTNRVVGTY 600
            YLH     RI H DLK  N++L   N  NP+I   DFG+A          N   + GT 
Sbjct: 143 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTP 196
Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
            ++ PE        +++D++S GV+   L+ G 
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 229

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 436 EENKLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG   M    + +AVK L   +      +E   E  ++ +L +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+++G C + +  ML+ E      L  ++     R + D     +++  ++ G+ YL + 
Sbjct: 89  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 144
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 145 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 197
Query: 606 EYAIDGLFSVKSDVFSFGVLVLE-LVYGTR 634
           E      FS KSDV+SFGVL+ E   YG +
Sbjct: 198 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 73  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 120
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 121 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 172
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 173 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 440 LGEGGFGPVYKGM---LID---GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLV 491
           LG G FG V +     LI       +AVK L  S+     E   +E+ +++ L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG------------ 539
            LLG C      ++I EY     L +F+    +R     SK    I              
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 540 -----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
                +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D       
Sbjct: 165 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 221
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                  +M PE   + +++ +SDV+S+G+ + EL
Sbjct: 222 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 256

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----H 176
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 193
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 179
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 185
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 440 LGEGGFGPVYKGMLIDG----QEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQHRNLVKL 493
           LG+G FG V+    I G    Q  A+K L K++ +  +    K E  ++ ++ H  +VKL
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIARGLLYLHQDSR 552
                   +  LI ++L    L    F    ++++   +  +  +  +A  L +LH    
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 144
Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
           L II+RDLK  N+LLD E + K++DFG+++   +D  E       GT  YM PE      
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVVNRRG 202
Query: 613 FSVKSDVFSFGVLVLELVYGT 633
            +  +D +SFGVL+ E++ GT
Sbjct: 203 HTQSADWWSFGVLMFEMLTGT 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 436 EENKLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG   M    + +AVK L   +      +E   E  ++ +L +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+++G C + +  ML+ E      L  ++     R + D     +++  ++ G+ YL + 
Sbjct: 433 VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 488
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 489 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 541
Query: 606 EYAIDGLFSVKSDVFSFGVLVLE-LVYGTR 634
           E      FS KSDV+SFGVL+ E   YG +
Sbjct: 542 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 571

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 440 LGEGGFGPVYKGM---LID---GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLV 491
           LG G FG V +     LI       +AVK L  S+     E   +E+ +++ L  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG------------ 539
            LLG C      ++I EY     L +F+    +R     SK    I              
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALDLEDLL 166
Query: 540 -----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
                +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D       
Sbjct: 167 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 223
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                  +M PE   + +++ +SDV+S+G+ + EL
Sbjct: 224 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 258

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 146 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 197
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 198 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 436 EENKLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG   M    + +AVK L   +      +E   E  ++ +L +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+++G C + +  ML+ E      L  ++     R + D     +++  ++ G+ YL + 
Sbjct: 434 VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 489
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 490 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 542
Query: 606 EYAIDGLFSVKSDVFSFGVLVLE-LVYGTR 634
           E      FS KSDV+SFGVL+ E   YG +
Sbjct: 543 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 572

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 436 EENKLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG   M    + +AVK L   +      +E   E  ++ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+++G C + +  ML+ E      L  ++     R + D     +++  ++ G+ YL + 
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 126
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 179
Query: 606 EYAIDGLFSVKSDVFSFGVLVLE-LVYGTR 634
           E      FS KSDV+SFGVL+ E   YG +
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 440 LGEGGFGPVYKGM---LID---GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLV 491
           LG G FG V +     LI       +AVK L  S+     E   +E+ +++ L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG------------ 539
            LLG C      ++I EY     L +F+    +R     SK    I              
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 540 -----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
                +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D       
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                  +M PE   + +++ +SDV+S+G+ + EL
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 436 EENKLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG   M    + +AVK L   +      +E   E  ++ +L +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+++G C + +  ML+ E      L  ++     R + D     +++  ++ G+ YL + 
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 136
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 189
Query: 606 EYAIDGLFSVKSDVFSFGVLVLE-LVYGTR 634
           E      FS KSDV+SFGVL+ E   YG +
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----H 180
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 436 EENKLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG   M    + +AVK L   +      +E   E  ++ +L +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+++G C + +  ML+ E      L  ++     R + D     +++  ++ G+ YL + 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 130
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 131 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 183
Query: 606 EYAIDGLFSVKSDVFSFGVLVLE-LVYGTR 634
           E      FS KSDV+SFGVL+ E   YG +
Sbjct: 184 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 440 LGEGGFGPVYKGMLIDGQE----IAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLV 491
           LG+GG+G V++   + G       A+K L K+    + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            L+       +  LI EYL   S  +      R  +      C  +  I+  L +LHQ  
Sbjct: 85  DLIYAFQTGGKLYLILEYL---SGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              II+RDLK  N++L+++ + K++DFG+ +    D T   T+   GT  YM PE  +  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEYMAPEILMRS 196
Query: 612 LFSVKSDVFSFGVLVLELVYGT 633
             +   D +S G L+ +++ G 
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGA 218

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 436 EENKLGEGGFGPVYKG---MLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG   M    + +AVK L   +      +E   E  ++ +L +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+++G C + +  ML+ E      L  ++     R + D     +++  ++ G+ YL + 
Sbjct: 69  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEES 124
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----P 605
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 125 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 177
Query: 606 EYAIDGLFSVKSDVFSFGVLVLE-LVYGTR 634
           E      FS KSDV+SFGVL+ E   YG +
Sbjct: 178 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 207

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 440 LGEGGFGPVYKGM---LID---GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLV 491
           LG G FG V +     LI       +AVK L  S+     E   +E+ +++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG------------ 539
            LLG C      ++I EY     L +F+    +R     SK    I              
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 540 -----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
                +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D       
Sbjct: 172 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 228
Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
                  +M PE   + +++ +SDV+S+G+ + EL
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 146 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 197
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 198 TDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T       V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T       V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 27/218 (12%)
Query: 440 LGEGGFGPVYKGMLID-GQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +G+G F  V + +  + GQ+ AVK     + + S G   E+ K E  +   L+H ++V+L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK----LLDWSKRCQIIGGIARGLLYLHQ 549
           L          +++E++     AD  F+  +R     +   +     +  I   L Y H 
Sbjct: 92  LETYSSDGMLYMVFEFMDG---ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 550 DSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           ++   IIHRD+K  NVLL ++ N    K+ DFG+A   G     A     VGT  +M PE
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPE 203
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV------YGTRNRGF 638
                 +    DV+  GV++  L+      YGT+ R F
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI--AVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           ++ EN +G G +G V K  +  G  I  A K++ K   + V+ FK E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L        +  L+ E      L + +     +++   S   +I+  +   + Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 552 RLRIIHRDLKASNVLL--DNEMNP-KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           +L + HRDLK  N L   D+  +P K+ DFG+A  F   +        VGT  Y+ P+  
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ-V 179
Query: 609 IDGLFSVKSDVFSFGVLVLELVYG 632
           ++GL+  + D +S GV++  L+ G
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T       V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 440 LGEGGFGPVYKGMLIDG----QEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQHRNLVKL 493
           LG+G FG V+    I G    Q  A+K L K++ +  +    K E  ++ ++ H  +VKL
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIARGLLYLHQDSR 552
                   +  LI ++L    L    F    ++++   +  +  +  +A  L +LH    
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 145
Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
           L II+RDLK  N+LLD E + K++DFG+++   +D  E       GT  YM PE      
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVVNRRG 203
Query: 613 FSVKSDVFSFGVLVLELVYGT 633
            +  +D +SFGVL+ E++ GT
Sbjct: 204 HTQSADWWSFGVLMFEMLTGT 224

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEI--AVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           ++ EN +G G +G V K  +  G  I  A K++ K   + V+ FK E+ ++  L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L        +  L+ E      L + +     +++   S   +I+  +   + Y H   
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAYCH--- 140
Query: 552 RLRIIHRDLKASNVLL--DNEMNP-KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           +L + HRDLK  N L   D+  +P K+ DFG+A  F   +        VGT  Y+ P+  
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ-V 196
Query: 609 IDGLFSVKSDVFSFGVLVLELVYG 632
           ++GL+  + D +S GV++  L+ G
Sbjct: 197 LEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 440 LGEGGFGPVYKGMLIDG----QEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQHRNLVKL 493
           LG+G FG V+    I G    Q  A+K L K++ +  +    K E  ++ ++ H  +VKL
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIARGLLYLHQDSR 552
                   +  LI ++L    L    F    ++++   +  +  +  +A  L +LH    
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 144
Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
           L II+RDLK  N+LLD E + K++DFG+++   +D  E       GT  YM PE      
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVVNRRG 202
Query: 613 FSVKSDVFSFGVLVLELVYGT 633
            +  +D +SFGVL+ E++ GT
Sbjct: 203 HTQSADWWSFGVLMFEMLTGT 223

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 30/227 (13%)
Query: 430 ATDNFS---------EENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEV 479
           +TD+FS         +E+ LGEG    V   + LI  QE AVK + K  G        EV
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 480 LLIAKLQ-HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG 538
            ++ + Q HRN+++L+    + D   L++E +   S+   I    +R+  +  +   ++ 
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQ 118
Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNP-KISDFGMARAFGV--DQTEANT 593
            +A  L +LH      I HRDLK  N+L +  N+++P KI DFG+     +  D +  +T
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIST 175
Query: 594 NRVV---GTYGYMPPEYA-----IDGLFSVKSDVFSFGVLVLELVYG 632
             ++   G+  YM PE          ++  + D++S GV++  L+ G
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 440 LGEGGFGPVYKGMLI----DGQEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQHRNLVKL 493
           LG+G FG V+    +     G   A+K L K++ +  +    K E  ++A + H  +VKL
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIARGLLYLHQDSR 552
                   +  LI ++L    L    F    ++++   +  +  +  +A GL +LH    
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALGLDHLHS--- 148
Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
           L II+RDLK  N+LLD E + K++DFG+++   +D  E       GT  YM PE      
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-AIDH-EKKAYSFCGTVEYMAPEVVNRQG 206
Query: 613 FSVKSDVFSFGVLVLELVYGT 633
            S  +D +S+GVL+ E++ G+
Sbjct: 207 HSHSADWWSYGVLMFEMLTGS 227

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 432 DNFSEENKLGEGGFGPVYK-GMLIDGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQH 487
           D F +   LG GGFG V+   M   G+  A K+L+K   +  + ++  ++   ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIARGLLY 546
           R +V L      + +  L+   +    +   I++           R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LHQ +   II+RDLK  NVLLD++ N +ISD G+A      QT+  T    GT G+M PE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV 630
             +   +    D F+ GV + E++
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMI 383

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 432 DNFSEENKLGEGGFGPVYK-GMLIDGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQH 487
           D F +   LG GGFG V+   M   G+  A K+L+K   +  + ++  ++   ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIARGLLY 546
           R +V L      + +  L+   +    +   I++           R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LHQ +   II+RDLK  NVLLD++ N +ISD G+A      QT+  T    GT G+M PE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV 630
             +   +    D F+ GV + E++
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMI 383

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 432 DNFSEENKLGEGGFGPVYK-GMLIDGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQH 487
           D F +   LG GGFG V+   M   G+  A K+L+K   +  + ++  ++   ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIARGLLY 546
           R +V L      + +  L+   +    +   I++           R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LHQ +   II+RDLK  NVLLD++ N +ISD G+A      QT+  T    GT G+M PE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV 630
             +   +    D F+ GV + E++
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMI 383

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 432 DNFSEENKLGEGGFGPVYK-GMLIDGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQH 487
           D F +   LG GGFG V+   M   G+  A K+L+K   +  + ++  ++   ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIARGLLY 546
           R +V L      + +  L+   +    +   I++           R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LHQ +   II+RDLK  NVLLD++ N +ISD G+A      QT+  T    GT G+M PE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV 630
             +   +    D F+ GV + E++
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMI 383

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +C   
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKL 118
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D+G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ 486
           AT  +    ++G G +G VYK      G  +A+K +   +G+         EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 487 ---HRNLVKLLG-CCMKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG 538
              H N+V+L+  C   R +R     L++E++ ++ L  ++ D      L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
              RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +     +     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVVV 173
Query: 599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           T  Y  PE  +   ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 7/201 (3%)
Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 491
           ++  + +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            +           +   YL    +   ++   + + L     C  +  I RGL Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAID 610
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 165 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 611 GLFSVKS-DVFSFGVLVLELV 630
                KS D++S G ++ E++
Sbjct: 222 SKGYTKSIDIWSVGCILAEML 242

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 87/155 (56%), Gaps = 20/155 (12%)
Query: 439 KLGEGGFGPVYKGMLID---GQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQ-HRNLV 491
           KLG+G +G V+K   ID   G+ +AVK++    ++S      F+ E++++ +L  H N+V
Sbjct: 16  KLGKGAYGIVWKS--IDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIV 72
Query: 492 KLLGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
            LL      ++R   L+++Y+     A       R  +L+   +  ++  + + + YLH 
Sbjct: 73  NLLNVLRADNDRDVYLVFDYMETDLHA-----VIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 584
                ++HRD+K SN+LL+ E + K++DFG++R+F
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 118/261 (45%), Gaps = 35/261 (13%)
Query: 390 DMKILSEGG--QDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGP 447
           D   +SEG   +DL   M TS  G+      LP+   ++IA        +  +G+G FG 
Sbjct: 6   DRPFISEGTTLKDLIYDMTTSGSGS-----GLPLLVQRTIAR---TIVLQESIGKGRFGE 57
Query: 448 VYKGMLIDGQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVKLLGCCMKRD----E 502
           V++G    G+E+AVK  S  S +    F+  E+     L+H N++  +    K +    +
Sbjct: 58  VWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114
Query: 503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-----SRLRIIH 557
             L+ +Y  + SL D++     R  +      ++    A GL +LH +      +  I H
Sbjct: 115 LWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 558 RDLKASNVLLDNEMNPKISDFGMA--RAFGVDQTEANTNRVVGTYGYMPPEYAIDGL--- 612
           RDLK+ N+L+       I+D G+A       D  +   N  VGT  YM PE   D +   
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230
Query: 613 -FSV--KSDVFSFGVLVLELV 630
            F    ++D+++ G++  E+ 
Sbjct: 231 HFESFKRADIYAMGLVFWEIA 251

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQ 486
           +D +     LG GG   V+    L   +++AVK L     +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 487 HRNLVKLLGCCMKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
           H  +V +               ++ EY+   +L D +        +   +  ++I    +
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQ 127
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----VDQTEANTNRVV 597
            L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       V QT A    V+
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA----VI 180
Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           GT  Y+ PE A       +SDV+S G ++ E++ G
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 41/212 (19%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHRNLVKLL 494
           +G G +G V   Y   L   Q++AVK+LS+     +   +   E+ L+  L+H N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 495 GCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ---------IIGGIA 541
                         + P  S+ DF  ++  T     D +   +CQ         ++  + 
Sbjct: 86  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR     Q +      V T  
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRW 185
Query: 602 YMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 433 NFSEENKLGEGGFGPVYKGMLI--DGQ--EIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ 486
            F+    LG+G FG V +  L   DG   ++AVK L     +   +EEF  E   + +  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 487 HRNLVKLLGCCMKRDER------MLIYEYLPNKSLADFIFD---GTRRKLLDWSKRCQII 537
           H ++ KL+G  ++   +      M+I  ++ +  L  F+     G     L      + +
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVV 597
             IA G+ YL   S    IHRDL A N +L  +M   ++DFG++R               
Sbjct: 144 VDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
               ++  E   D L++V SDV++FGV + E++
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 431 TDNFSEENKLGEGGFGPVY--KGMLIDGQEIAVKRLSKSSGQGVEE---FKNEVLLIAKL 485
           +D +    KLG G +G V   K  L  G E A+K + KSS           +EV ++ +L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
            H N++KL      +    L+ E      L D I    R+K  +      I+  +  G  
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII--LRQKFSEVDAAV-IMKQVLSGTT 118
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGVDQTEANTNRVVGTYGY 602
           YLH+ +   I+HRDLK  N+LL+++      KI DFG++  F V          +GT  Y
Sbjct: 119 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGTAYY 172
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           + PE  +   +  K DV+S GV++  L+ G
Sbjct: 173 IAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTR------------RKL 527
           +  ++H N++ LL              + P +SL +F  ++  T             +KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 528 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD 587
            D   +  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR     
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----- 173
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
            T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 41/212 (19%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHRNLVKLL 494
           +G G +G V   Y   L   Q++AVK+LS+     +   +   E+ L+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 495 GCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ---------IIGGIA 541
                         + P  S+ DF  ++  T     D +   +CQ         ++  + 
Sbjct: 94  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR     Q +      V T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRW 193
Query: 602 YMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 7/201 (3%)
Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 491
           ++  + +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            +           +   Y+    +   ++   + + L     C  +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAID 610
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 611 GLFSVKS-DVFSFGVLVLELV 630
                KS D++S G ++ E++
Sbjct: 204 SKGYTKSIDIWSVGCILAEML 224

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 208 SIDIWSVGCILAEML 222

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 208 SIDIWSVGCILAEML 222

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTR------------RKL 527
           +  ++H N++ LL              + P +SL +F  ++  T             +KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 528 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD 587
            D   +  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR     
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----- 173
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
            T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 431 TDNFSEENKLGEGGFGPVY--KGMLIDGQEIAVKRLSKSSGQGVEE---FKNEVLLIAKL 485
           +D +    KLG G +G V   K  L  G E A+K + KSS           +EV ++ +L
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
            H N++KL      +    L+ E      L D I    +   +D +    I+  +  G  
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQVLSGTT 135
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGVDQTEANTNRVVGTYGY 602
           YLH+ +   I+HRDLK  N+LL+++      KI DFG++  F V          +GT  Y
Sbjct: 136 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGTAYY 189
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           + PE  +   +  K DV+S GV++  L+ G
Sbjct: 190 IAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 155
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 216 SIDIWSVGCILAEML 230

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 208 SIDIWSVGCILAEML 222

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 208 SIDIWSVGCILAEML 222

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQ 486
           +D +     LG GG   V+    L   +++AVK L     +       F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 487 HRNLVKLLGCCMKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
           H  +V +               ++ EY+   +L D +        +   +  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----VDQTEANTNRVV 597
            L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       V QT A    V+
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA----VI 180
Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           GT  Y+ PE A       +SDV+S G ++ E++ G
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 208 SIDIWSVGCILAEML 222

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 438 NKLGEGGFGPVYKGM-LIDGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
            +LG+G F  V + + ++ GQE A K ++  K S +  ++ + E  +   L+H N+V+L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
               +     LI++ +    L +   D   R+    +     I  I   +L+ HQ   + 
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFE---DIVAREYYSEADASHCIQQILEAVLHCHQ---MG 141
Query: 555 IIHRDLKASNVLLDNEMN---PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
           ++HRDLK  N+LL +++     K++DFG+  A  V+  +       GT GY+ PE     
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGL--AIEVEGEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +    D+++ GV++  L+ G
Sbjct: 200 PYGKPVDLWACGVILYILLVG 220

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 7/201 (3%)
Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 491
           ++  + +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            +           +   Y+    +   ++   + + L     C  +  I RGL Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAID 610
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 165 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 611 GLFSVKS-DVFSFGVLVLELV 630
                KS D++S G ++ E++
Sbjct: 222 SKGYTKSIDIWSVGCILAEML 242

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI  FG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 212 SIDIWSVGCILAEML 226

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 430 ATDNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIA 483
           AT  +    ++G G +G VYK      G  +  + + V       G        EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 484 KLQ---HRNLVKLLG-CCMKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ 535
           +L+   H N+V+L+  C   R +R     L++E++ ++ L  ++ D      L       
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
           ++    RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +     +     
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTP 178
Query: 596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
           VV T  Y  PE  +   ++   D++S G +  E+
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 212 SIDIWSVGCILAEML 226

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G+G +G V++G    G+ +AVK  S    +      E  N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 497 CM----KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-- 550
            M       +  LI  Y    SL D++   T    LD     +I+  IA GL +LH +  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 551 ---SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGVDQTEANTNRVVGTYGYMPP 605
               +  I HRDLK+ N+L+       I+D G+A   +   +Q +   N  VGT  YM P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 606 EY-----AIDGLFSVKS-DVFSFGVLVLEL 629
           E       +D   S K  D+++FG+++ E+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 213 SIDIWSVGCILAEML 227

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 153
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 214 SIDIWSVGCILAEML 228

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 144
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 205 SIDIWSVGCILAEML 219

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 212 SIDIWSVGCILAEML 226

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 112/246 (45%), Gaps = 43/246 (17%)
Query: 405 MATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKR 463
           M+ S++ N+   +E+      S       + +   +G G  G V      + G  +AVK+
Sbjct: 1   MSKSKVDNQFYSVEVA----DSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKK 56
Query: 464 LSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT 523
           LS+        F+N+    AK  +R LV LL C   ++   L+  + P K+L +F     
Sbjct: 57  LSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYL 106
Query: 524 RRKLLDWSKRCQIIG-------------GIARGLLYLHQDSRLRIIHRDLKASNVLLDNE 570
             +L+D +  CQ+I               +  G+ +LH      IIHRDLK SN+++ ++
Sbjct: 107 VMELMD-ANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 162
Query: 571 MNPKISDFGMARAFGVDQTEANTNRVVGTYG----YMPPEYAIDGLFSVKSDVFSFGVLV 626
              KI DFG+AR        A TN ++  Y     Y  PE  +   ++   D++S G ++
Sbjct: 163 CTLKILDFGLART-------ACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIM 215
Query: 627 LELVYG 632
            ELV G
Sbjct: 216 GELVKG 221

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 7/201 (3%)
Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 491
           ++  + +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            +           +   Y+    +   ++   + + L     C  +  I RGL Y+H  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAID 610
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 611 GLFSVKS-DVFSFGVLVLELV 630
                KS D++S G ++ E++
Sbjct: 200 SKGYTKSIDIWSVGCILAEML 220

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G+G +G V++G    G+ +AVK  S    +      E  N V+L    +H N++  +  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 99
Query: 497 CM----KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-- 550
            M       +  LI  Y    SL D++    +   LD     +I+  IA GL +LH +  
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 551 ---SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGVDQTEANTNRVVGTYGYMPP 605
               +  I HRDLK+ N+L+       I+D G+A   +   +Q +   N  VGT  YM P
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 606 EY-----AIDGLFSVKS-DVFSFGVLVLEL 629
           E       +D   S K  D+++FG+++ E+
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G+G +G V++G    G+ +AVK  S    +      E  N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 497 CM----KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-- 550
            M       +  LI  Y    SL D++   T    LD     +I+  IA GL +LH +  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 551 ---SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGVDQTEANTNRVVGTYGYMPP 605
               +  I HRDLK+ N+L+       I+D G+A   +   +Q +   N  VGT  YM P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 606 EY-----AIDGLFSVKS-DVFSFGVLVLEL 629
           E       +D   S K  D+++FG+++ E+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 206 SIDIWSVGCILAEML 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 88/167 (52%), Gaps = 16/167 (9%)
Query: 472 VEEFKNEVLLIAKLQHRNLVKLLGCC--MKRDERMLIYEYLPNKSLADFIFDGTRRKLLD 529
           +E+   E+ ++ KL H N+VKL+        D   +++E +    + +     T + L +
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSE 136
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVDQ 588
              R      + +G+ YLH     +IIHRD+K SN+L+  + + KI+DFG++  F G D 
Sbjct: 137 DQARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 589 TEANTNRVVGTYGYMPPEYAID--GLFSVKS-DVFSFGVLVLELVYG 632
             +NT   VGT  +M PE   +   +FS K+ DV++ GV +   V+G
Sbjct: 193 LLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE   +Y  L    + D++ +   R    +S+  Q +  I      
Sbjct: 110 VRLRYFFYSSGEKKDE---VYLNL----VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 163 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXI 217
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 218 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 103
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 104 VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 156
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 157 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYI 211
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 212 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 247

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 212 SIDIWSVGCILAEML 226

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 213 SIDIWSVGCILAEML 227

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQ 486
           +D +     LG GG   V+    L   +++AVK L     +       F+ E    A L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 487 HRNLVKLLGCCMKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
           H  +V +               ++ EY+   +L D +        +   +  ++I    +
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQ 144
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----VDQTEANTNRVV 597
            L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       V QT A    V+
Sbjct: 145 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA----VI 197
Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           GT  Y+ PE A       +SDV+S G ++ E++ G
Sbjct: 198 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 33/213 (15%)
Query: 433 NFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL 485
           +F     LG G FG V+   LI    +G+  A+K L K      + VE   +E L+++ +
Sbjct: 7   DFQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ------IIGG 539
            H  ++++ G      +  +I          D+I  G    LL  S+R            
Sbjct: 64  THPFIIRMWGTFQDAQQIFMI---------MDYIEGGELFSLLRKSQRFPNPVAKFYAAE 114
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +   L YLH      II+RDLK  N+LLD   + KI+DFG A+          T  + GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGT 166
Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             Y+ PE      ++   D +SFG+L+ E++ G
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 30/227 (13%)
Query: 430 ATDNFS---------EENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEV 479
           +TD+FS         +E+ LGEG    V   + LI  QE AVK + K  G        EV
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 480 LLIAKLQ-HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG 538
            ++ + Q HRN+++L+    + D   L++E +   S+   I    +R+  +  +   ++ 
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQ 118
Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNP-KISDFGMARAFGV--DQTEANT 593
            +A  L +LH      I HRDLK  N+L +  N+++P KI DF +     +  D +  +T
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 594 NRVV---GTYGYMPPEYA-----IDGLFSVKSDVFSFGVLVLELVYG 632
             ++   G+  YM PE          ++  + D++S GV++  L+ G
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI----AVKRLSKSS----GQGVEEFKNEVLLIA 483
           +NF     LG G +G V+    I G +     A+K L K++     +  E  + E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 484 KLQHRNLVKLLGCCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIA 541
            ++    +  L    + + ++ LI +Y+    L  F     R +  +     QI +G I 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTE--HEVQIYVGEIV 169
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
             L +LH   +L II+RD+K  N+LLD+  +  ++DFG+++ F  D+TE   +   GT  
Sbjct: 170 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIE 225
Query: 602 YMPPEYAI--DGLFSVKSDVFSFGVLVLELVYGT 633
           YM P+     D       D +S GVL+ EL+ G 
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 69/117 (58%), Gaps = 12/117 (10%)
Query: 522 GTRRKLLDWSKRC--QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 575
           G+  ++L  +KR   +I+G ++    RGL YL +  + +I+HRD+K SN+L+++    K+
Sbjct: 99  GSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKL 156
Query: 576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            DFG++        ++  N  VGT  YM PE      +SV+SD++S G+ ++EL  G
Sbjct: 157 CDFGVSGQL----IDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 113
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 114 VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 166
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N + +
Sbjct: 167 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYI 221
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 222 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 257

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 154
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 155 VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 207
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N + +
Sbjct: 208 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYI 262
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 263 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 298

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 110 VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 163 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYI 217
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 218 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 431 TDNFSEENKLGEGGFGPVYKGMLIDGQE-IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
           +D F  E++LG G    VY+      Q+  A+K L K+  + +   + E+ ++ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPN 109
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDG---TRRKLLDWSKRCQIIGGIARGLLY 546
           ++KL        E  L+ E +    L D I +    + R   D  K  QI+  +A    Y
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK--QILEAVA----Y 163
Query: 547 LHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           LH++    I+HRDLK  N+L      +   KI+DFG+++   + + +     V GT GY 
Sbjct: 164 LHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCGTPGYC 217
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE      +  + D++S G++   L+ G
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 7/201 (3%)
Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 491
           ++  + +GEG +G V      ++   +A+K++S    Q   +    E+ ++   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            +           +   Y+    +   ++   + + L     C  +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAID 610
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 611 GLFSVKS-DVFSFGVLVLELV 630
                KS D++S G ++ E++
Sbjct: 204 SKGYTKSIDIWSVGCILAEML 224

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 111
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 112 VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 164
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 165 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYI 219
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 220 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 255

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 487
           TD +     +G+G F  V + + L  G E A K ++  K S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V+L     +     L+++ +    L +   D   R+    +     I  I   +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCIQQILEAVLHC 119
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           HQ   + ++HRDLK  N+LL ++      K++DFG+A     DQ         GT GY+ 
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +    D+++ GV++  L+ G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 212 SIDIWSVGCILAEML 226

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 113/251 (45%), Gaps = 35/251 (13%)
Query: 399 QDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQE 458
           +DL   M TS  G+      LP+   ++IA        +  +G+G FG V++G    G+E
Sbjct: 4   KDLIYDMTTSGSGS-----GLPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEE 54
Query: 459 IAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVKLLGCCMKRD----ERMLIYEYLPNK 513
           +AVK  S  S +    F+  E+     L+H N++  +    K +    +  L+ +Y  + 
Sbjct: 55  VAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 112
Query: 514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-----SRLRIIHRDLKASNVLLD 568
           SL D++     R  +      ++    A GL +LH +      +  I HRDLK+ N+L+ 
Sbjct: 113 SLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 168
Query: 569 NEMNPKISDFGMA--RAFGVDQTEANTNRVVGTYGYMPPEYAIDGL-------FSVKSDV 619
                 I+D G+A       D  +   N  VGT  YM PE   D +       F  ++D+
Sbjct: 169 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK-RADI 227
Query: 620 FSFGVLVLELV 630
           ++ G++  E+ 
Sbjct: 228 YAMGLVFWEIA 238

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 432 DNFSEENKLGEGGFGPVYK-GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           D++    +LG G FG V++      G   A K +        E  + E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V L       +E ++IYE++    L + + D   +   D  +  + +  + +GL ++H++
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 274
Query: 551 SRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           +    +H DLK  N++      NE+  K+ DFG+       Q+   T    GT  +  PE
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNEL--KLIDFGLTAHLDPKQSVKVT---TGTAEFAAPE 326
Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYG 632
            A        +D++S GVL   L+ G
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 80
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 81  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 133
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 134 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYI 188
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 189 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 224

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 7/201 (3%)
Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 491
           ++  + +GEG +G V      ++   +A+K++S    Q   +    E+ ++   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            +           +   Y+    +   ++   + + L     C  +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAID 610
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 611 GLFSVKS-DVFSFGVLVLELV 630
                KS D++S G ++ E++
Sbjct: 204 SKGYTKSIDIWSVGCILAEML 224

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTRRKLLDWSK--RCQ-- 535
           +  ++H N++ LL              + P +SL +F  ++  T     D +   +CQ  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 536 -------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----H 174
Query: 589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 94
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 95  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 147
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 148 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXI 202
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 203 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 238

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +GEG +G V      ++   +A++++S    Q   +    E+ ++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  +   Y+    +   ++   + + L     C  +  I RGL Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVK 616
           RDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++     K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 617 S-DVFSFGVLVLELV 630
           S D++S G ++ E++
Sbjct: 212 SIDIWSVGCILAEML 226

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 29/205 (14%)
Query: 440 LGEGGFGPV-----YKGMLIDGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQHRNLV 491
           LGEG FG V     YK      Q++A+K +S+   +  +     + E+  +  L+H +++
Sbjct: 17  LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC--QIIGGIARGLLYLHQ 549
           KL        + +++ EY     L D+I +  +R   D  +R   QII  I     Y H 
Sbjct: 73  KLYDVITTPTDIVMVIEY-AGGELFDYIVE-KKRMTEDEGRRFFQQIICAIE----YCH- 125
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV-VGTYGYMPPEYA 608
             R +I+HRDLK  N+LLD+ +N KI+DFG++       T+ N  +   G+  Y  PE  
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPEVI 179
Query: 609 IDGLFS-VKSDVFSFGVLVLELVYG 632
              L++  + DV+S G+++  ++ G
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVG 204

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           + +   +G G  G V      + G  +AVK+LS+        F+N+    AK  +R LV 
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQNQTH--AKRAYRELV- 73
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------G 539
           LL C   ++   L+  + P K+L +F       +L+D +  CQ+I               
Sbjct: 74  LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSYLLYQ 132
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR        A+TN ++  
Sbjct: 133 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-------ASTNFMMTP 182
Query: 600 YG----YMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
           Y     Y  PE  +   +    D++S G ++ ELV G+
Sbjct: 183 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGS 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 83
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 84  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 136
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 137 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXI 191
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 192 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 227

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 439 KLGEGGFGPVYKGML----IDGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKLQHRNLVK 492
           KLG G +G V   +L    +   E A+K + K+S       K   EV ++  L H N++K
Sbjct: 44  KLGSGAYGEV---LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
           L      +    L+ E      L D I    +   +D +    II  +  G+ YLH+ + 
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA---VIIKQVLSGVTYLHKHN- 156
Query: 553 LRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
             I+HRDLK  N+LL+++      KI DFG++  F   + +      +GT  Y+ PE  +
Sbjct: 157 --IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPE-VL 210
Query: 610 DGLFSVKSDVFSFGVLVLELVYG 632
              +  K DV+S GV++  L+ G
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAG 233

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 439 KLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           +LG G F  V K      G+    + I  KR S++S +GV  EE + EV ++ ++ H N+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           + L      R + +LI E +    L DF+    +++ L   +    I  I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 551 SRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
              +I H DLK  N++L ++  P    K+ DFG+A      +       + GT  ++ PE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPE 188
Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYGT 633
                   +++D++S GV+   L+ G 
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 88  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 141 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXI 195
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 196 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 439 KLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           +LG G F  V K      G+    + I  KR S++S +GV  EE + EV ++ ++ H N+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           + L      R + +LI E +    L DF+    +++ L   +    I  I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 551 SRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
              +I H DLK  N++L ++  P    K+ DFG+A      +       + GT  ++ PE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPE 188
Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYGT 633
                   +++D++S GV+   L+ G 
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +S   ++G GG   V++ +    Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 115
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG------LL 545
                    D+ + +Y+Y         + +     L  W K+ + I    R       L 
Sbjct: 116 ---------DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 166
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
            +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  YMPP
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 225
Query: 606 EYAIDGLFSVKS------------DVFSFGVLVLELVYG 632
           E AI  + S +             DV+S G ++  + YG
Sbjct: 226 E-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 37/210 (17%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 495 GCCMKRDERMLIYEYLPNKSLADF--------IFDGTRRKL----LDWSKRCQIIGGIAR 542
                         + P KSL +F        + D    ++    LD  +   ++  +  
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             PE  +   +    D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 88  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 141 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXI 195
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 196 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 432 DNFSEENKLGEGGFGPVYK-GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           D++    +LG G FG V++      G   A K +        E  + E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V L       +E ++IYE++    L + + D   +   D  +  + +  + +GL ++H++
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 168
Query: 551 SRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           +    +H DLK  N++      NE+  K+ DFG+       Q+   T    GT  +  PE
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNEL--KLIDFGLTAHLDPKQSVKVT---TGTAEFAAPE 220
Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYG 632
            A        +D++S GVL   L+ G
Sbjct: 221 VAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEE--FKNEVLLIAKLQHR 488
           + + +  K+GEG +G V+K    D GQ +A+K+  +S    V +     E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           NLV LL    ++    L++EY  +  L +   D  +R + +   +  I     + + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVK-SITWQTLQAVNFCH 119
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           + +    IHRD+K  N+L+      K+ DFG AR         +    V T  Y  PE  
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELL 174
Query: 609 I-DGLFSVKSDVFSFGVLVLELVYGT 633
           + D  +    DV++ G +  EL+ G 
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 37/210 (17%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVVAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 495 GCCMKRDERMLIYEYLPNKSLADF--------IFDGTRRKL----LDWSKRCQIIGGIAR 542
                         + P KSL +F        + D    ++    LD  +   ++  +  
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             PE  +   +    D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +S   ++G GG   V++ +    Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 71
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG------LL 545
                    D+ + +Y+Y         + +     L  W K+ + I    R       L 
Sbjct: 72  ---------DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 122
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
            +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  YMPP
Sbjct: 123 AVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 181
Query: 606 EYAIDGLFSVKS------------DVFSFGVLVLELVYG 632
           E AI  + S +             DV+S G ++  + YG
Sbjct: 182 E-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 219

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 424 WKSIANATDN-FSEENKLGEGGFGPV------YKGMLIDGQEIAVKRLSKSSGQGVEEFK 476
           W      T N F +   LG+GGFG V        G +   +++  KR+ K  G+ +    
Sbjct: 175 WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--L 232
Query: 477 NEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI 536
           NE  ++ K+  R +V L      +D   L+   +    L   I+   +    + ++    
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE-ARAVFY 291
Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
              I  GL  LH   R RI++RDLK  N+LLD+  + +ISD G+A      QT       
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR 345
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           VGT GYM PE   +  ++   D ++ G L+ E++ G
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 76  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXI 183
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 440 LGEGGFGPVYKGMLIDGQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           LGEG FG VY+G+  + +     +AVK   K  +    E+F +E +++  L H ++VKL+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  ++ +   +I E  P   L  ++     +  L           I + + YL     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 129
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAF-GVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            +HRD+   N+L+ +    K+ DFG++R     D  +A+  R+     +M PE      F
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 187
Query: 614 SVKSDVFSFGVLVLELV 630
           +  SDV+ F V + E++
Sbjct: 188 TTASDVWMFAVCMWEIL 204

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 88
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 89  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 141
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 142 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYI 196
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 197 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 76
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 77  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 129
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 130 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXI 184
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 185 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 220

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 439 KLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           +LG G F  V K      G+    + I  KR S++S +GV  EE + EV ++ ++ H N+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           + L      R + +LI E +    L DF+    +++ L   +    I  I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 551 SRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
              +I H DLK  N++L ++  P    K+ DFG+A      +       + GT  ++ PE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPE 188
Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYGT 633
                   +++D++S GV+   L+ G 
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 76  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXI 183
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 439 KLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           +LG G F  V K      G+    + I  KR S++S +GV  EE + EV ++ ++ H N+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           + L      R + +LI E +    L DF+    +++ L   +    I  I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 551 SRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
              +I H DLK  N++L ++  P    K+ DFG+A      +       + GT  ++ PE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPE 188
Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYGT 633
                   +++D++S GV+   L+ G 
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 440 LGEGGFGPVYKGMLIDGQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           LGEG FG VY+G+  + +     +AVK   K  +    E+F +E +++  L H ++VKL+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  ++ +   +I E  P   L  ++     +  L           I + + YL     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 145
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAF-GVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            +HRD+   N+L+ +    K+ DFG++R     D  +A+  R+     +M PE      F
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 203
Query: 614 SVKSDVFSFGVLVLELV 630
           +  SDV+ F V + E++
Sbjct: 204 TTASDVWMFAVCMWEIL 220

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 424 WKSIANATDN-FSEENKLGEGGFGPV------YKGMLIDGQEIAVKRLSKSSGQGVEEFK 476
           W      T N F +   LG+GGFG V        G +   +++  KR+ K  G+ +    
Sbjct: 175 WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--L 232
Query: 477 NEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI 536
           NE  ++ K+  R +V L      +D   L+   +    L   I+   +    + ++    
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE-ARAVFY 291
Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
              I  GL  LH   R RI++RDLK  N+LLD+  + +ISD G+A      QT       
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR 345
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           VGT GYM PE   +  ++   D ++ G L+ E++ G
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 439 KLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNL 490
           +LG G F  V K      G+    + I  KR S++S +GV  EE + EV ++ ++ H N+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           + L      R + +LI E +    L DF+    +++ L   +    I  I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 551 SRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAF--GVDQTEANTNRVVGTYGYMP 604
              +I H DLK  N++L ++  P    K+ DFG+A     GV+        + GT  ++ 
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTPEFVA 186
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
           PE        +++D++S GV+   L+ G 
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 79
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 80  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 132
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 133 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXI 187
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 188 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 92/201 (45%), Gaps = 7/201 (3%)
Query: 434 FSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 491
           +++   +GEG +G V      +    +A+K++S    Q   +    E+ ++ + +H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            +           +   Y+    +   ++   + + L     C  +  I RGL Y+H  +
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYMPPEYAID 610
              ++HRDLK SN+L++   + KI DFG+AR    +          V T  Y  PE  ++
Sbjct: 165 ---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 611 GLFSVKS-DVFSFGVLVLELV 630
                KS D++S G ++ E++
Sbjct: 222 SKGYTKSIDIWSVGCILAEML 242

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 104/227 (45%), Gaps = 24/227 (10%)
Query: 419 LPIFDWKSIANATD-----NFSEENKLGEGGFGPVYKGMLID--GQE--IAVKRLSKS-- 467
           +P  D K  +N  D     +F+    LG+G FG V   ML D  G E   A+K L K   
Sbjct: 1   MPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVV 57
Query: 468 -SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM-LIYEYLPNKSLADFIFDGTRR 525
                VE    E  ++A L     +  L  C +  +R+  + EY+   +  D ++   + 
Sbjct: 58  IQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYV---NGGDLMYHIQQV 114
Query: 526 KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 585
                 +       I+ GL +LH+     II+RDLK  NV+LD+E + KI+DFGM +   
Sbjct: 115 GKFKEPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 171
Query: 586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           +D     T    GT  Y+ PE      +    D +++GVL+ E++ G
Sbjct: 172 MDGV--TTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 216

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +S   ++G GG   V++ +    Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 68
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG------LL 545
                    D+ + +Y+Y         + +     L  W K+ + I    R       L 
Sbjct: 69  ---------DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 119
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
            +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  YMPP
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 606 EYAIDGLFSVKS------------DVFSFGVLVLELVYG 632
           E AI  + S +             DV+S G ++  + YG
Sbjct: 179 E-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 438 NKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRN 489
            +LG G F  V K      G+    + I  KR S++S +GV  EE + EV ++ ++ H N
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++ L      R + +LI E +    L DF+    +++ L   +    I  I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 550 DSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
               +I H DLK  N++L ++  P    K+ DFG+A      +       + GT  ++ P
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAP 187
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYGT 633
           E        +++D++S GV+   L+ G 
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +S   ++G GG   V++ +    Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 87
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG------LL 545
                    D+ + +Y+Y         + +     L  W K+ + I    R       L 
Sbjct: 88  ---------DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 138
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
            +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  YMPP
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 606 EYAIDGLFSVKS------------DVFSFGVLVLELVYG 632
           E AI  + S +             DV+S G ++  + YG
Sbjct: 198 E-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +S   ++G GG   V++ +    Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 115
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG------LL 545
                    D+ + +Y+Y         + +     L  W K+ + I    R       L 
Sbjct: 116 ---------DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 166
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
            +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  YMPP
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 225
Query: 606 EYAIDGLFSVKS------------DVFSFGVLVLELVYG 632
           E AI  + S +             DV+S G ++  + YG
Sbjct: 226 E-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 30/220 (13%)
Query: 426 SIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+    D+     +LG G +G V K   +  GQ +AVKR+  +      + +  +L+   
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS---QEQKRLLMDLD 57
Query: 485 LQHRNL-----VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC--QII 537
           +  R +     V   G   +  +  +  E      L D   D   ++++D  +     I+
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICME------LMDTSLDKFYKQVIDKGQTIPEDIL 111
Query: 538 GGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
           G IA    + L +LH  S+L +IHRD+K SNVL++     K+ DFG++  + VD    + 
Sbjct: 112 GKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDDVAKDI 168
Query: 594 NRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLEL 629
           +   G   YM PE     L    +SVKSD++S G+ ++EL
Sbjct: 169 D--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 76  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYI 183
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 440 LGEGGFGPVYKGMLIDGQ----EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLL 494
           LGEG FG VY+G+  + +     +AVK   K       E+F +E +++  L H ++VKL+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G  ++ +   +I E  P   L  ++     +  L           I + + YL     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAF-GVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            +HRD+   N+L+ +    K+ DFG++R     D  +A+  R+     +M PE      F
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 191
Query: 614 SVKSDVFSFGVLVLELV 630
           +  SDV+ F V + E++
Sbjct: 192 TTASDVWMFAVCMWEIL 208

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +        FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 76  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYI 183
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +S   ++G GG   V++ +    Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 67
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG------LL 545
                    D+ + +Y+Y         + +     L  W K+ + I    R       L 
Sbjct: 68  ---------DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 118
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
            +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  YMPP
Sbjct: 119 AVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 177
Query: 606 EYAIDGLFSVKS------------DVFSFGVLVLELVYG 632
           E AI  + S +             DV+S G ++  + YG
Sbjct: 178 E-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 215

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 432 DNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 485
           D+F + ++LG G  G V+K      G+++  + I ++       Q + E +    ++ + 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 123
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIA 541
               +V   G      E  +  E++   SL   +    R          QI+G     + 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVI 176
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        ++  N  VGT  
Sbjct: 177 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 230
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           YM PE      +SV+SD++S G+ ++E+  G
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 491 VKLLGCCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA-------- 541
           V+L        E+  ++Y  L    + D++ +   R    +S+  Q +  I         
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNL----VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 542 -RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRVVGT 599
            R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 186
Query: 600 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +        FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++ +   R    +S+  Q +  I      
Sbjct: 76  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYI 183
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 424 WKS----IANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNE 478
           WK+    I    ++FS    +G GGFG VY     D G+  A+K L K     ++  + E
Sbjct: 176 WKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGE 232
Query: 479 VLLIAKLQHRNLVKLLGC----CMKR-----DERMLIYEYLPNKSLADFIFDGTRRKLLD 529
            L + +    +LV    C    CM       D+   I + +      D  +  ++  +  
Sbjct: 233 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG---GDLHYHLSQHGVFS 289
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
            +        I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   + 
Sbjct: 290 EADMRFYAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 346
Query: 590 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
            A+    VGT+GYM PE    G+ +   +D FS G ++ +L+ G
Sbjct: 347 HAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
            D+     +LG G +G V K   +  GQ +AVKR+  +      + +  +L+   +  R 
Sbjct: 50  ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRT 106
Query: 490 L-----VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC--QIIGGIA- 541
           +     V   G   +  +  +  E      L D   D   ++++D  +     I+G IA 
Sbjct: 107 VDCPFTVTFYGALFREGDVWICME------LMDTSLDKFYKQVIDKGQTIPEDILGKIAV 160
Query: 542 ---RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
              + L +LH  S+L +IHRD+K SNVL++     K+ DFG++  + VD      +   G
Sbjct: 161 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDSVAKTID--AG 215
Query: 599 TYGYMPPEYAIDGL----FSVKSDVFSFGVLVLEL 629
              YM PE     L    +SVKSD++S G+ ++EL
Sbjct: 216 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 432 DNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 485
           D+F + ++LG G  G V+K      G+++  + I ++       Q + E +    ++ + 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 64
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIA 541
               +V   G      E  +  E++   SL   +    R          QI+G     + 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVI 117
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++    +D+     N  VGT  
Sbjct: 118 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEM---ANEFVGTRS 171
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNR 636
           YM PE      +SV+SD++S G+ ++E+  G   R
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPR 206

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 424 WKS----IANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNE 478
           WK+    I    ++FS    +G GGFG VY     D G+  A+K L K     ++  + E
Sbjct: 177 WKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGE 233
Query: 479 VLLIAKLQHRNLVKLLGC----CMKR-----DERMLIYEYLPNKSLADFIFDGTRRKLLD 529
            L + +    +LV    C    CM       D+   I + +      D  +  ++  +  
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG---GDLHYHLSQHGVFS 290
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
            +        I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   + 
Sbjct: 291 EADMRFYAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 590 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
            A+    VGT+GYM PE    G+ +   +D FS G ++ +L+ G
Sbjct: 348 HAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 424 WKS----IANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNE 478
           WK+    I    ++FS    +G GGFG VY     D G+  A+K L K     ++  + E
Sbjct: 177 WKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGE 233
Query: 479 VLLIAKLQHRNLVKLLGC----CMKR-----DERMLIYEYLPNKSLADFIFDGTRRKLLD 529
            L + +    +LV    C    CM       D+   I + +      D  +  ++  +  
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG---GDLHYHLSQHGVFS 290
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
            +        I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   + 
Sbjct: 291 EADMRFYAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 590 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
            A+    VGT+GYM PE    G+ +   +D FS G ++ +L+ G
Sbjct: 348 HAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 424 WKS----IANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNE 478
           WK+    I    ++FS    +G GGFG VY     D G+  A+K L K     ++  + E
Sbjct: 177 WKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGE 233
Query: 479 VLLIAKLQHRNLVKLLGC----CMKR-----DERMLIYEYLPNKSLADFIFDGTRRKLLD 529
            L + +    +LV    C    CM       D+   I + +      D  +  ++  +  
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG---GDLHYHLSQHGVFS 290
Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
            +        I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   + 
Sbjct: 291 EADMRFYAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 590 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
            A+    VGT+GYM PE    G+ +   +D FS G ++ +L+ G
Sbjct: 348 HAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 39/226 (17%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--EVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+     +   +   E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF--IFDGTR------------RKL 527
           +  ++H N++ LL              + P +SL +F  ++  T             +KL
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKL 122
Query: 528 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD 587
            D   +  +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+ R     
Sbjct: 123 TDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR----- 173
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
            T+      V T  Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 174 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 432 DNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 485
           D+F + ++LG G  G V+K      G+++  + I ++       Q + E +    ++ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIA 541
               +V   G      E  +  E++   SL   +    R          QI+G     + 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVI 114
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        ++  N  VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           YM PE      +SV+SD++S G+ ++E+  G
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIA--VKRLSKSSGQGVEEFKNEVLLIAKLQH 487
           T+ +    +LG+G F  V + + ++ GQE A  +    K S +  ++ + E  +   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V+L     +     LI++ +    L +   D   R+    +     I  I   +L+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFE---DIVAREYYSEADASHCIQQILEAVLHC 126
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           HQ   + ++HR+LK  N+LL +++     K++DFG+A    V+  +       GT GY+ 
Sbjct: 127 HQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLS 181
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +    D+++ GV++  L+ G
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 41/212 (19%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHRNLVKLL 494
           +G G +G V   Y   L   Q++AVK+LS+     +   +   E+ L+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 495 GCCMKRDERMLIYEYLPNKSLADF-------------IFDGTRRKLLDWSKRCQIIGGIA 541
                         + P  S+ DF             + +  + + L       ++  + 
Sbjct: 94  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLL 141
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR     Q +      V T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRW 193
Query: 602 YMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           Y  PE  ++ + ++   D++S G ++ EL+ G
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 432 DNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 485
           D+F + ++LG G  G V+K      G+++  + I ++       Q + E +    ++ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIA 541
               +V   G      E  +  E++   SL   +    R          QI+G     + 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVI 114
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        ++  N  VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           YM PE      +SV+SD++S G+ ++E+  G
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 432 DNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 485
           D+F + ++LG G  G V+K      G+++  + I ++       Q + E +    ++ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIA 541
               +V   G      E  +  E++   SL   +    R          QI+G     + 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVI 114
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        ++  N  VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           YM PE      +SV+SD++S G+ ++E+  G
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 432 DNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 485
           D+F + ++LG G  G V+K      G+++  + I ++       Q + E +    ++ + 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 88
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIA 541
               +V   G      E  +  E++   SL   +    R          QI+G     + 
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVI 141
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        ++  N  VGT  
Sbjct: 142 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 195
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           YM PE      +SV+SD++S G+ ++E+  G
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W+S A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 23  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 79
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWS 531
              NE  ++  +    LVKL           ++ EY+P   +    F   RR  +  +  
Sbjct: 80  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPH 135
Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
            R      I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + + 
Sbjct: 136 ARF-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKG 186
Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 187 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 72/165 (43%), Gaps = 21/165 (12%)
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +ARG+ +L   S  + IHRDL A N+LL      KI DFG+AR    +            
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL--VYGTRNRGFXXXXXXXXXXXXAWRLWTE 657
             +M PE   D ++S KSDV+S+GVL+ E+  + G+   G               R+   
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAP 324
Query: 658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV 702
           +             YS  E     Q+ L C  + P++RP  A +V
Sbjct: 325 E-------------YSTPE---IYQIMLDCWHRDPKERPRFAELV 353

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNL 490
           ++++   +G G FG VY+  L D G+ +A+K++ +        FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 491 VKL----LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA----- 541
           V+L         K+DE  L         + D++     R    +S+  Q +  I      
Sbjct: 76  VRLRYFFYSSGEKKDEVYL-------NLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 542 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N + +
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSXI 183
Query: 597 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       ++   DV+S G ++ EL+ G
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 432 DNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 485
           D+F + ++LG G  G V+K      G+++  + I ++       Q + E +    ++ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIA 541
               +V   G      E  +  E++   SL   +    R          QI+G     + 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVI 114
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        ++  N  VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           YM PE      +SV+SD++S G+ ++E+  G
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 432 DNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 485
           D+F + ++LG G  G V+K      G+++  + I ++       Q + E +    ++ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIA 541
               +V   G      E  +  E++   SL   +    R          QI+G     + 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVI 114
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        ++  N  VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           YM PE      +SV+SD++S G+ ++E+  G
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 432 DNFSEENKLGEGGFGPVYK------GMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 485
           D+F + ++LG G  G V+K      G+++  + I ++       Q + E +    ++ + 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 80
Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG----GIA 541
               +V   G      E  +  E++   SL   +    R          QI+G     + 
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVI 133
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        ++  N  VGT  
Sbjct: 134 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 187
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           YM PE      +SV+SD++S G+ ++E+  G
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 218

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 33/206 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 497 CMKRDERMLIYEYLPNKSLADF--------IFDGTRRKL----LDWSKRCQIIGGIARGL 544
              ++   L+  + P K+L +F        + D    ++    LD  +   ++  +  G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y  
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRA 193
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELV 630
           PE  +   +    D++S G ++ E+V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W+S A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 143
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 144 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 195
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 33/208 (15%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 497 CMKRDERMLIYEYLPNKSLADF--------IFDGTRRKL----LDWSKRCQIIGGIARGL 544
              ++   L+  + P KSL +F        + D    ++    LD  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y  
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRA 193
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE  +   +    D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W+S A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 143
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 144 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 195
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W+S A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 23  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 79
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 80  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 135
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 136 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 187
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 188 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W+S A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 143
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 144 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 195
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 35/209 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P KSL +F       +L+D +  CQ+I               +  G
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPEVVTRY-YR 192
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   +    D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 48/229 (20%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKL-Q 486
           T  F E  K+G G FG V+K +  +DG   A+KR  K     V+E     EV   A L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ---IIGGIARG 543
           H ++V+      + D  ++  EY    SLAD I +  R  ++ + K  +   ++  + RG
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRG 125
Query: 544 LLYLHQDSRLRIIHRDLKASNVLL-------------------DNEMNPKISDFGMARAF 584
           L Y+H    + ++H D+K SN+ +                    N++  KI D G     
Sbjct: 126 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 182
Query: 585 GVDQTEANTNRVVG------TYGYMPPEYAIDGLFSVKSDVFSFGVLVL 627
              Q E   +R +        Y ++P           K+D+F+  + V+
Sbjct: 183 SSPQVEEGDSRFLANEVLQENYTHLP-----------KADIFALALTVV 220

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W+S A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 51  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 107
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 108 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 163
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 164 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 215
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 216 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 495 GCCMKRDERMLIYEYLPNKSLADF--------IFDGTRRKL----LDWSKRCQIIGGIAR 542
                         + P K+L +F        + D    ++    LD  +   ++  +  
Sbjct: 90  NV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLX 137
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV 630
             PE  +   +    D++S G ++ E+V
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 48/229 (20%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKL-Q 486
           T  F E  K+G G FG V+K +  +DG   A+KR  K     V+E     EV   A L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ---IIGGIARG 543
           H ++V+      + D  ++  EY    SLAD I +  R  ++ + K  +   ++  + RG
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRG 125
Query: 544 LLYLHQDSRLRIIHRDLKASNVLL-------------------DNEMNPKISDFGMARAF 584
           L Y+H    + ++H D+K SN+ +                    N++  KI D G     
Sbjct: 126 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 182
Query: 585 GVDQTEANTNRVVG------TYGYMPPEYAIDGLFSVKSDVFSFGVLVL 627
              Q E   +R +        Y ++P           K+D+F+  + V+
Sbjct: 183 SSPQVEEGDSRFLANEVLQENYTHLP-----------KADIFALALTVV 220

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 33/206 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 72
Query: 497 CMKRDERMLIYEYLPNKSLADF--------IFDGTRRKL----LDWSKRCQIIGGIARGL 544
              ++   L+  + P K+L +F        + D    ++    LD  +   ++  +  G+
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 132
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y  
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRA 186
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELV 630
           PE  +   +    D++S G ++ E+V
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 48/229 (20%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKL-Q 486
           T  F E  K+G G FG V+K +  +DG   A+KR  K     V+E     EV   A L Q
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ---IIGGIARG 543
           H ++V+      + D  ++  EY    SLAD I +  R  ++ + K  +   ++  + RG
Sbjct: 66  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRG 123
Query: 544 LLYLHQDSRLRIIHRDLKASNVLL-------------------DNEMNPKISDFGMARAF 584
           L Y+H    + ++H D+K SN+ +                    N++  KI D G     
Sbjct: 124 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 180
Query: 585 GVDQTEANTNRVVG------TYGYMPPEYAIDGLFSVKSDVFSFGVLVL 627
              Q E   +R +        Y ++P           K+D+F+  + V+
Sbjct: 181 SSPQVEEGDSRFLANEVLQENYTHLP-----------KADIFALALTVV 218

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 33/208 (15%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 497 CMKRDERMLIYEYLPNKSLADF--------IFDGTRRKL----LDWSKRCQIIGGIARGL 544
              ++   L+  + P KSL +F        + D    ++    LD  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y  
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRA 193
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE  +   +    D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W+S A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY P   +    F   RR        
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPH 143
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+++D +   K++DFG A+     + +  
Sbjct: 144 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGR 195
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P KSL +F       +L+D +  CQ+I               +  G
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   +    D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 48/229 (20%)
Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKL-Q 486
           T  F E  K+G G FG V+K +  +DG   A+KR  K     V+E     EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ---IIGGIARG 543
           H ++V+      + D  ++  EY    SLAD I +  R  ++ + K  +   ++  + RG
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRG 127
Query: 544 LLYLHQDSRLRIIHRDLKASNVLL-------------------DNEMNPKISDFGMARAF 584
           L Y+H    + ++H D+K SN+ +                    N++  KI D G     
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 585 GVDQTEANTNRVVG------TYGYMPPEYAIDGLFSVKSDVFSFGVLVL 627
              Q E   +R +        Y ++P           K+D+F+  + V+
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLP-----------KADIFALALTVV 222

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 33  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 80
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P KSL +F       +L+D +  CQ+I               +  G
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 193
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   +    D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 37/210 (17%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 495 GCCMKRDERMLIYEYLPNKSLADF--------IFDGTRRKL----LDWSKRCQIIGGIAR 542
                         + P KSL +F        + D    ++    LD  +   ++  +  
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             PE  +   +    D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 123/280 (43%), Gaps = 51/280 (18%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ----HR 488
           LG+GGFG V+ G  L D  ++A+K + ++   G     +      EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 489 NLVKLLGCCMKRDERMLIYEY-LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            +++LL     ++  ML+ E  LP + L D+I +  +  L +   RC   G +   + + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRC-FFGQVVAAIQHC 155
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           H      ++HRD+K  N+L+D      K+ DFG + A   D+   + +   GT  Y PPE
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPYTDFD---GTRVYSPPE 208
Query: 607 YAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELID 665
           +     + ++ + V+S G+L+ ++V G                         D P E   
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCG-------------------------DIPFERDQ 243
Query: 666 KSLEDTYSLSEALR--CIQVGLLCVQQRPEDRPNMASVVL 703
           + LE        +   C  +   C+  +P  RP++  ++L
Sbjct: 244 EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +S   ++G GG   V++ +    Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 115
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG------LL 545
                    D+ + +Y+Y         + +     L  W K+ + I    R       L 
Sbjct: 116 ---------DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 166
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
            +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VG   YMPP
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 606 EYAIDGLFSVKS------------DVFSFGVLVLELVYG 632
           E AI  + S +             DV+S G ++  + YG
Sbjct: 226 E-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P KSL +F       +L+D +  CQ+I               +  G
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   +    D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     +G G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTIGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   K++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +S   ++G GG   V++ +    Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 87
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG------LL 545
                    D+ + +Y+Y         + +     L  W K+ + I    R       L 
Sbjct: 88  ---------DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 138
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
            +H   +  I+H DLK +N L+ + M  K+ DFG+A     D      +  VGT  YMPP
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPP 197
Query: 606 EYAIDGLFSVKS------------DVFSFGVLVLELVYG 632
           E AI  + S +             DV+S G ++  + YG
Sbjct: 198 E-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 295

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 41/212 (19%)
Query: 440 LGEGGFGPVYKGMLIDGQ---EIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G G +G V     +DG+   ++A+K+L +   S    +    E+ L+  ++H N++ LL
Sbjct: 33  VGSGAYGAVCSA--VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 495 GCCMKRDERMLIYEYLPNKSLADFI-------FDGTRR-KLLDWSK----RCQ-IIGGIA 541
                         + P+++L DF        F GT   KL+   K    R Q ++  + 
Sbjct: 91  DV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     Q ++     V T  
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRW 190
Query: 602 YMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           Y  PE  ++ + ++   D++S G ++ E++ G
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVKLLG 495
           +  +G+G FG V++G    G+E+AVK  S  S +    F+  E+     L+H N++  + 
Sbjct: 9   QESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 496 CCMKRD----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD- 550
              K +    +  L+ +Y  + SL    FD   R  +      ++    A GL +LH + 
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 121
Query: 551 ----SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGVDQTEANTNRVVGTYGYMP 604
                +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM 
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 605 PEYAIDGL-------FSVKSDVFSFGVLVLEL 629
           PE   D +       F  ++D+++ G++  E+
Sbjct: 182 PEVLDDSINMKHFESFK-RADIYAMGLVFWEI 212

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 293

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     +G G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTIGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   K++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEL 629
             +M PE   D +++++SDV+SFGVL+ E+
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 286

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 487
           TD +    +LG+G F  V + M I  GQE A K ++  K S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V+L     +     L+++ +    L +   D   R+    +     I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCIQQILESVNHC 119
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           H +    I+HRDLK  N+LL ++      K++DFG+A     DQ         GT GY+ 
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +    D+++ GV++  L+ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVKLLG 495
           +  +G+G FG V++G    G+E+AVK  S  S +    F+  E+     L+H N++  + 
Sbjct: 14  QESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 496 CCMKRD----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD- 550
              K +    +  L+ +Y  + SL D++     R  +      ++    A GL +LH + 
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 126
Query: 551 ----SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGVDQTEANTNRVVGTYGYMP 604
                +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM 
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 605 PEYAIDGL-------FSVKSDVFSFGVLVLELV 630
           PE   D +       F  ++D+++ G++  E+ 
Sbjct: 187 PEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 218

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 487
           TD +    +LG+G F  V + M I  GQE A K ++  K S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V+L     +     L+++ +    L +   D   R+    +     I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCIQQILESVNHC 119
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           H +    I+HRDLK  N+LL ++      K++DFG+A     DQ         GT GY+ 
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +    D+++ GV++  L+ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWS 531
              NE  ++  +    LVKL           ++ EY+P   +    F   RR  +  +  
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPH 143
Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
            R      I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + + 
Sbjct: 144 ARF-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKG 194
Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWS 531
              NE  ++  +    LVKL           ++ EY+P   +    F   RR  +  +  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPH 142
Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
            R      I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + + 
Sbjct: 143 ARF-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKG 193
Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGVEEFK 476
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K     ++E +
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKEIE 86
Query: 477 ---NEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+++D +   K++DFG+A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 37/210 (17%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 495 GCCMKRDERMLIYEYLPNKSLADF--------IFDGTRRKL----LDWSKRCQIIGGIAR 542
                         + P KSL +F        + D    ++    LD  +   ++  +  
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             PE  +   +    D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVKLLG 495
           +  +G+G FG V++G    G+E+AVK  S  S +    F+  E+     L+H N++  + 
Sbjct: 11  QESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 496 CCMKRD----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD- 550
              K +    +  L+ +Y  + SL D++     R  +      ++    A GL +LH + 
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 123
Query: 551 ----SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGVDQTEANTNRVVGTYGYMP 604
                +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM 
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 605 PEYAIDGL-------FSVKSDVFSFGVLVLEL 629
           PE   D +       F  ++D+++ G++  E+
Sbjct: 184 PEVLDDSINMKHFESFK-RADIYAMGLVFWEI 214

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVKLLG 495
           +  +G+G FG V++G    G+E+AVK  S  S +    F+  E+     L+H N++  + 
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 496 CCMKRD----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD- 550
              K +    +  L+ +Y  + SL    FD   R  +      ++    A GL +LH + 
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 551 ----SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGVDQTEANTNRVVGTYGYMP 604
                +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 605 PEYAIDGL-------FSVKSDVFSFGVLVLEL 629
           PE   D +       F  ++D+++ G++  E+
Sbjct: 181 PEVLDDSINMKHFESFK-RADIYAMGLVFWEI 211

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWS 531
              NE  ++  +    LVKL           ++ EY+P   +    F   RR  +  +  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPH 142
Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
            R      I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + + 
Sbjct: 143 ARF-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKG 193
Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 417 MELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQE---IAVKRLSKSSGQGVE 473
           M+LPI       + +D +     +G G FG     ++ D Q    +AVK + +  G+ ++
Sbjct: 10  MDLPIM------HDSDRYELVKDIGAGNFG--VARLMRDKQANELVAVKYIER--GEKID 59
Query: 474 E-FKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK 532
           E  K E++    L+H N+V+     +      ++ EY     L + I +  R    +   
Sbjct: 60  ENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEA 117
Query: 533 RC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVD 587
           R    Q+I G++    Y H    +++ HRDLK  N LLD    P  KI+DFG ++A    
Sbjct: 118 RFFFQQLISGVS----YAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA---S 167
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLELVYGT 633
              +     VGT  Y+ PE  +   +  K +DV+S GV +  ++ G 
Sbjct: 168 VLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     +G G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTIGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   K++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 34  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 81
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P KSL +F       +L+D +  CQ+I               +  G
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 140
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 141 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMVPFVVTRYYR 194
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   +    D++S G ++ E++ G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWS 531
              NE  ++  +    LVKL           ++ EY P   +    F   RR  +  +  
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPH 142
Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
            R      I     YLH    L +I+RDLK  N+++D +   K++DFG A+     + + 
Sbjct: 143 ARF-YAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKG 193
Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 495 GCCMKRDERMLIYEYLPNKSLADF--------IFDGTRRKL----LDWSKRCQIIGGIAR 542
                         + P K+L +F        + D    ++    LD  +   ++  +  
Sbjct: 90  NV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLC 137
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV 630
             PE  +   +    D++S G ++ E+V
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 117
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P K+L +F       +L+D +  CQ+I               +  G
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 176
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 177 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 230
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 16  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 72
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 73  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 128
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 129 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 180
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 181 TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 143
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 144 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 195
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+P   +    F   RR        
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPH 143
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 144 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 195
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E + P + L DFI   T R  L           +   + + H 
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 132
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 133 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 185
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 440 LGEGGFGPVYKGMLID-GQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +G+G F  V + +  + GQ+ AVK     + + S G   E+ K E  +   L+H ++V+L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK----LLDWSKRCQIIGGIARGLLYLHQ 549
           L          +++E++     AD  F+  +R     +   +     +  I   L Y H 
Sbjct: 94  LETYSSDGMLYMVFEFMDG---ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 150
Query: 550 DSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           ++   IIHRD+K   VLL   +N    K+  FG+A   G     A     VGT  +M PE
Sbjct: 151 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPE 205
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV------YGTRNRGF 638
                 +    DV+  GV++  L+      YGT+ R F
Sbjct: 206 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 243

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+++D +   K++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 440 LGEGGFGPVYKGMLID-GQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL 493
           +G+G F  V + +  + GQ+ AVK     + + S G   E+ K E  +   L+H ++V+L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK----LLDWSKRCQIIGGIARGLLYLHQ 549
           L          +++E++     AD  F+  +R     +   +     +  I   L Y H 
Sbjct: 92  LETYSSDGMLYMVFEFMDG---ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 550 DSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           ++   IIHRD+K   VLL   +N    K+  FG+A   G     A     VGT  +M PE
Sbjct: 149 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPE 203
Query: 607 YAIDGLFSVKSDVFSFGVLVLELV------YGTRNRGF 638
                 +    DV+  GV++  L+      YGT+ R F
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W+S A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 31  WESPAQNTAHLDQFERIRTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  +   +    LVKL           ++ EY P   +    F   RR        
Sbjct: 88  HTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRRIGRFSEPH 143
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   K++DFG A+     + +  
Sbjct: 144 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGR 195
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 78
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P K+L +F       +L+D +  CQ+I               +  G
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 137
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 138 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 191
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 39/209 (18%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIA 541
                         + P K+L +F       +L+D +  CQ+I               + 
Sbjct: 90  NV------------FTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQML 136
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
            G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRY 190
Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
           Y  PE  +   +    D++S G ++ E+V
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 29/228 (12%)
Query: 420 PIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSSGQGVEEFKN- 477
           P+FD     N  D+F     +G+G FG V      D +++ A+K ++K       E +N 
Sbjct: 4   PVFDENEDVNF-DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62
Query: 478 --EVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ 535
             E+ ++  L+H  LV L       ++  ++          D +  G  R  L  +   +
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMV---------VDLLLGGDLRYHLQQNVHFK 113
Query: 536 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
                  I  +   L YL      RIIHRD+K  N+LLD   +  I+DF +A        
Sbjct: 114 EETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---R 167
Query: 590 EANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLELVYGTR 634
           E     + GT  YM PE         +S   D +S GV   EL+ G R
Sbjct: 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P K+L +F       +L+D +  CQ+I               +  G
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 59/131 (45%), Gaps = 25/131 (19%)
Query: 524 RRKLLDW-SKRC-----------QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM 571
           +  L DW ++RC            I   IA  + +LH      ++HRDLK SN+    + 
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDD 201
Query: 572 NPKISDFGMARAFGVDQTE----------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFS 621
             K+ DFG+  A   D+ E          A     VGT  YM PE      +S K D+FS
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFS 261
Query: 622 FGVLVLELVYG 632
            G+++ EL+Y 
Sbjct: 262 LGLILFELLYS 272

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 117
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P K+L +F       +L+D +  CQ+I               +  G
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 176
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 177 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 230
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P K+L +F       +L+D +  CQ+I               +  G
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 73
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P K+L +F       +L+D +  CQ+I               +  G
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 132
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 186
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 38/211 (18%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCM 498
           +G G FG V++  L++  E+A+K++ +      + FKN  L I ++ +H N+V L     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 499 ----KRDERM--LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG---------GIARG 543
               K+DE    L+ EY+P     + ++  +R     ++K  Q +           + R 
Sbjct: 103 SNGDKKDEVFLNLVLEYVP-----ETVYRASRH----YAKLKQTMPMLLIKLYMYQLLRS 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRVVGTYGY 602
           L Y+H    + I HRD+K  N+LLD      K+ DFG A+       E N + +   Y Y
Sbjct: 154 LAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSXICSRY-Y 207
Query: 603 MPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
             PE       ++   D++S G ++ EL+ G
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 80
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P K+L +F       +L+D +  CQ+I               +  G
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 193
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 80
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P K+L +F       +L+D +  CQ+I               +  G
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 193
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 72
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P K+L +F       +L+D +  CQ+I               +  G
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 131
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 185
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 73
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P K+L +F       +L+D +  CQ+I               +  G
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 132
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 186
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 108/234 (46%), Gaps = 27/234 (11%)
Query: 416 EMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVK-------RLSKS 467
           E ELP  DW +       +  ++ +G G    V + +    G E AVK       RLS  
Sbjct: 80  EDELP--DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPE 137
Query: 468 SGQGVEEF-KNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR 525
             + V E  + E  ++ ++  H +++ L+          L+++ +    L D++   T +
Sbjct: 138 QLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEK 194
Query: 526 KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 585
             L   +   I+  +   + +LH ++   I+HRDLK  N+LLD+ M  ++SDFG +    
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL- 250
Query: 586 VDQTEANTNRVVGTYGYMPPEY---AIDGL---FSVKSDVFSFGVLVLELVYGT 633
             +       + GT GY+ PE    ++D     +  + D+++ GV++  L+ G+
Sbjct: 251 --EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 433 NFSEENKLGEGGFGPVYKGMLID---GQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQH 487
            +     +G G +G V     ID   G+++A+K+LS+   S    +    E+LL+  +QH
Sbjct: 43  TYVSPTHVGSGAYGSVCSA--IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 100
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N++ LL            Y++                      K   ++  + +GL Y+
Sbjct: 101 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYI 160
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H      ++HRDLK  N+ ++ +   KI DFG+AR       +A     V T  Y  PE 
Sbjct: 161 HSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEV 212
Query: 608 AIDGL-FSVKSDVFSFGVLVLELVYG 632
            +  + ++   D++S G ++ E++ G
Sbjct: 213 ILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGVEEFK 476
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K     ++E +
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKEIE 86
Query: 477 ---NEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+++D +   +++DFG+A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P KSL +F       +L+D +  CQ+I               +  G
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVTRYYR 192
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 37  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 84
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P KSL +F       +L+D +  CQ+I               +  G
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 143
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 144 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 197
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 26  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 73
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P KSL +F       +L+D +  CQ+I               +  G
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 132
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 186
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 16/199 (8%)
Query: 440 LGEGGFGPVYKGMLID---GQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           +G G +G V     ID   G+++A+K+LS+   S    +    E+LL+  +QH N++ LL
Sbjct: 32  VGSGAYGSVCSA--IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
                       Y++                      K   ++  + +GL Y+H      
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG--- 146
Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL-F 613
           ++HRDLK  N+ ++ +   KI DFG+AR       +A     V T  Y  PE  +  + +
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHY 201
Query: 614 SVKSDVFSFGVLVLELVYG 632
           +   D++S G ++ E++ G
Sbjct: 202 NQTVDIWSVGCIMAEMLTG 220

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 129 XG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 181
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 487
           TD++    +LG+G F  V + +     QE A K ++  K S +  ++ + E  +   L+H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V+L     +     L+++ +    L +   D   R+    +     I  I   + ++
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCIHQILESVNHI 146
Query: 548 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           HQ     I+HRDLK  N+LL ++      K++DFG+A    V   +       GT GY+ 
Sbjct: 147 HQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLS 201
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +    D+++ GV++  L+ G
Sbjct: 202 PEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 430 ATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR 488
             ++  +  ++G G +G V K +    GQ +AVKR+  +     E+ + ++L+   +  R
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMR 76
Query: 489 N-----LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR---KLLDWSKRCQIIGGI 540
           +     +V+  G   +  +  +  E +         FD   +    +LD     +I+G I
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICMELMSTS------FDKFYKYVYSVLDDVIPEEILGKI 130
Query: 541 ARGLLYL--HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
               +    H    L+IIHRD+K SN+LLD   N K+ DFG++    VD       R  G
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIA--KTRDAG 187
Query: 599 TYGYMPPEY----AIDGLFSVKSDVFSFGVLVLELVYG 632
              YM PE     A    + V+SDV+S G+ + EL  G
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 438 NKLGEGGFGPV--YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
            KLGEGGF  V   +G L DG   A+KR+     Q  EE + E  +     H N+++L+ 
Sbjct: 35  QKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 496 CCMK----RDERMLIYEYLPNKSLADFIFD-GTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
            C++    + E  L+  +    +L + I     +   L   +   ++ GI RGL  +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVV--------GTYGY 602
                 HRDLK +N+LL +E  P + D G      +   E +   +          T  Y
Sbjct: 154 G---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACI-HVEGSRQALTLQDWAAQRCTISY 209
Query: 603 MPPEYAIDGLFSVKS--------DVFSFGVLVLELVYG 632
             PE     LFSV+S        DV+S G ++  +++G
Sbjct: 210 RAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 28/221 (12%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWS 531
              NE  ++  +    L KL           ++ EY P   +    F   RR  +  +  
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPH 143
Query: 532 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA 591
            R      I     YLH    L +I+RDLK  N+++D +   K++DFG A+     + + 
Sbjct: 144 ARF-YAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKG 194
Query: 592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY P   +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+++D +   +++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 147
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 148 ---CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 200
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 440 LGEGGFGPV---YKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG-------------GIARG 543
              ++   L+  + P KSL +F       +L+D +  CQ+I               +  G
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVTRYYR 192
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELV 630
            PE  +   +    D++S G ++ E+V
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 133
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 134 ---CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 186
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    L KL           ++ EY P   +    F   RR        
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPH 143
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+++D +   K++DFG A+     + +  
Sbjct: 144 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGR 195
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 148
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 149 ---CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 201
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 148
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 149 ---CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 201
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 147
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 148 ---CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 200
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 69/146 (47%), Gaps = 8/146 (5%)
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H  LV L  C         + EY+      D +F   R++ L           I+  L Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH+     II+RDLK  NVLLD+E + K++D+GM +  G+   +  T+   GT  Y+ PE
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSTFCGTPNYIAPE 223
Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYG 632
                 +    D ++ GVL+ E++ G
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAG 249

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 76  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 132
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 133 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 185
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 69/146 (47%), Gaps = 8/146 (5%)
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H  LV L  C         + EY+      D +F   R++ L           I+  L Y
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH+     II+RDLK  NVLLD+E + K++D+GM +  G+   +  T+   GT  Y+ PE
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 191
Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYG 632
                 +    D ++ GVL+ E++ G
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAG 217

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 148
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 149 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 201
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 427 IANATDNFSEENKLGEGGFGPVYKGMLIDGQE---IAVKRLSKSSGQGVEE-FKNEVLLI 482
           I + +D +     +G G FG     ++ D Q    +AVK + +  G+ ++E  K E++  
Sbjct: 13  IMHDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINH 68
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC---QIIGG 539
             L+H N+V+     +      ++ EY     L + I +  R    +   R    Q+I G
Sbjct: 69  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISG 126
Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTEANTNRVV 597
           ++    Y H    +++ HRDLK  N LLD    P  KI DFG +++  +     +T   V
Sbjct: 127 VS----YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---V 176
Query: 598 GTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLELVYGT 633
           GT  Y+ PE  +   +  K +DV+S GV +  ++ G 
Sbjct: 177 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 213

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 133
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 134 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 186
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    L KL           ++ EY P   +    F   RR        
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPH 143
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+++D +   K++DFG A+     + +  
Sbjct: 144 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGR 195
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 439 KLGEGGFGPVYKGMLIDGQ---EIAVKRLSKSSGQGVEEFKNEVLL-IAKLQHRNLVKLL 494
           +LG G FG V++  + D Q   + AVK++       +E F+ E L+  A L    +V L 
Sbjct: 100 RLGRGSFGEVHR--MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
           G   +     +  E L   SL   + +   +  L   +    +G    GL YLH  SR R
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKE---QGCLPEDRALYYLGQALEGLEYLH--SR-R 205
Query: 555 IIHRDLKASNVLLDNE-MNPKISDFGMARAF---GVDQTEANTNRVVGTYGYMPPEYAID 610
           I+H D+KA NVLL ++  +  + DFG A      G+ ++    + + GT  +M PE  + 
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
                K DV+S   ++L ++ G
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 133
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 134 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 186
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 75  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 131
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 132 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 184
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 181
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 167
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 168 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 220
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 160
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 161 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 213
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 161
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 162 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 214
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 161
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 162 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 214
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 175
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 176 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 228
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 181
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 160
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 161 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 213
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 161
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 162 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 214
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 161
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 162 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 214
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 160
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 161 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 213
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 175
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 176 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 228
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 160
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG + A   D    + +   GT  Y PPE+ 
Sbjct: 161 CG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRVYSPPEWI 213
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 124 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 180
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 181 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 233
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 69/146 (47%), Gaps = 8/146 (5%)
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H  LV L  C         + EY+      D +F   R++ L           I+  L Y
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH+     II+RDLK  NVLLD+E + K++D+GM +  G+   +  T+   GT  Y+ PE
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 176
Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYG 632
                 +    D ++ GVL+ E++ G
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAG 202

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 69/146 (47%), Gaps = 8/146 (5%)
Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H  LV L  C         + EY+      D +F   R++ L           I+  L Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH+     II+RDLK  NVLLD+E + K++D+GM +  G+   +  T+   GT  Y+ PE
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 180
Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYG 632
                 +    D ++ GVL+ E++ G
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAG 206

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 25/193 (12%)
Query: 457 QEIAVKRLSKSSG-----QGVEEFK----NEVLLIAKLQ-HRNLVKLLGCCMKRDERMLI 506
           +E AVK +  + G     + V+E +     EV ++ K+  H N+++L           L+
Sbjct: 30  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 89
Query: 507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 566
           ++ +    L D++   T +  L   +  +I+  +   +  LH   +L I+HRDLK  N+L
Sbjct: 90  FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 143
Query: 567 LDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL------FSVKSDVF 620
           LD++MN K++DFG +    +D  E     V GT  Y+ PE     +      +  + D++
Sbjct: 144 LDDDMNIKLTDFGFSCQ--LDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 200
Query: 621 SFGVLVLELVYGT 633
           S GV++  L+ G+
Sbjct: 201 STGVIMYTLLAGS 213

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 491 VKLLGCCMKRDERMLIYEYL-PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++LL    + D  +LI E   P + L DFI   T R  L           +   + + H 
Sbjct: 99  IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 155
Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y PPE+ 
Sbjct: 156 CG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWI 208
Query: 609 IDGLFSVKS-DVFSFGVLVLELVYG 632
               +  +S  V+S G+L+ ++V G
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSG-------QGVEEFKNEVLLIAKLQHRNLVK 492
           LGEG +G V +  ++D + +  + +             G    K E+ L+ +L+H+N+++
Sbjct: 13  LGEGSYGKVKE--VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR----CQIIGGIAR---GLL 545
           L+   +  +E+  +Y       + ++   G +  L    ++    CQ  G   +   GL 
Sbjct: 71  LVDV-LYNEEKQKMY------MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           YLH      I+H+D+K  N+LL      KIS  G+A A      +       G+  + PP
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 606 EYA--IDGLFSVKSDVFSFGVLVLELVYG 632
           E A  +D     K D++S GV +  +  G
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 427 IANATDNFSEENKLGEGGFGPVYKGML--IDGQEIAVKRLSKSSGQGVEE-FKNEVLLIA 483
           I + +D +     +G G FG V + M   +  + +AVK + +  G  ++E  + E++   
Sbjct: 15  IMHDSDRYDFVKDIGSGNFG-VARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHR 71
Query: 484 KLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG 543
            L+H N+V+     +      +I EY     L + I +  R       +       +  G
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSG 128
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTEANTNRVVGTYG 601
           + Y H    ++I HRDLK  N LLD    P  KI DFG +++  +     +T   VGT  
Sbjct: 129 VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPA 182
Query: 602 YMPPEYAIDGLFSVK-SDVFSFGVLVLELVYGT 633
           Y+ PE  +   +  K +DV+S GV +  ++ G 
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 25/193 (12%)
Query: 457 QEIAVKRLSKSSG-----QGVEEFK----NEVLLIAKLQ-HRNLVKLLGCCMKRDERMLI 506
           +E AVK +  + G     + V+E +     EV ++ K+  H N+++L           L+
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 566
           ++ +    L D++   T +  L   +  +I+  +   +  LH   +L I+HRDLK  N+L
Sbjct: 103 FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 156
Query: 567 LDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL------FSVKSDVF 620
           LD++MN K++DFG   +  +D  E     V GT  Y+ PE     +      +  + D++
Sbjct: 157 LDDDMNIKLTDFGF--SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 213
Query: 621 SFGVLVLELVYGT 633
           S GV++  L+ G+
Sbjct: 214 STGVIMYTLLAGS 226

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
            D+     +LG G +G V K   +  GQ  AVKR+  +      + +  +L    +  R 
Sbjct: 33  ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNS---QEQKRLLXDLDISXRT 89
Query: 490 L-----VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC--QIIGGIA- 541
           +     V   G   +  +  +  E      L D   D   ++++D  +     I+G IA 
Sbjct: 90  VDCPFTVTFYGALFREGDVWICXE------LXDTSLDKFYKQVIDKGQTIPEDILGKIAV 143
Query: 542 ---RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
              + L +LH  S+L +IHRD+K SNVL++     K  DFG++  + VD    + +   G
Sbjct: 144 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS-GYLVDDVAKDID--AG 198
Query: 599 TYGYMPPEYAIDGL----FSVKSDVFSFGVLVLEL 629
              Y  PE     L    +SVKSD++S G+  +EL
Sbjct: 199 CKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLVKLLGCC 497
           K+G G +G VYK    DG++     L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 498 MKRDERM--LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY-----LHQD 550
           +   +R   L+++Y  +       F    +      K  Q+  G+ + LLY     +H  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 551 SRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGVD-QTEANTNRVVGTYGYMP 604
               ++HRDLK +N+L+  E  P     KI+D G AR F    +  A+ + VV T+ Y  
Sbjct: 145 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 605 PEYAIDGLFSVKS-DVFSFGVLVLELV 630
           PE  +      K+ D+++ G +  EL+
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELL 230

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 10/151 (6%)
Query: 440 LGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCC 497
           L EGGF  VY+   +  G+E A+KRL  +  +       EV  + KL  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 498 -MKRDE------RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
            + ++E        L+   L    L +F+     R  L      +I     R + ++H+ 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
            +  IIHRDLK  N+LL N+   K+ DFG A
Sbjct: 156 -KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 64/143 (44%), Gaps = 8/143 (5%)
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           L +L  C    D    + EY+   +  D ++   +               IA GL +L  
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYV---NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
                II+RDLK  NV+LD+E + KI+DFGM +    D     T    GT  Y+ PE   
Sbjct: 461 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGTPDYIAPEIIA 515
Query: 610 DGLFSVKSDVFSFGVLVLELVYG 632
              +    D ++FGVL+ E++ G
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAG 538

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 25/193 (12%)
Query: 457 QEIAVKRLSKSSG-----QGVEEFK----NEVLLIAKLQ-HRNLVKLLGCCMKRDERMLI 506
           +E AVK +  + G     + V+E +     EV ++ K+  H N+++L           L+
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 566
           ++ +    L D++   T +  L   +  +I+  +   +  LH   +L I+HRDLK  N+L
Sbjct: 103 FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 156
Query: 567 LDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL------FSVKSDVF 620
           LD++MN K++DFG   +  +D  E     V GT  Y+ PE     +      +  + D++
Sbjct: 157 LDDDMNIKLTDFGF--SCQLDPGE-KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 213
Query: 621 SFGVLVLELVYGT 633
           S GV++  L+ G+
Sbjct: 214 STGVIMYTLLAGS 226

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 440 LGEGGFGPVYKGMLIDGQEI--AVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVKL 493
           +G+G FG V        +E+  AVK L K +    +E K+ +    +L+  ++H  LV L
Sbjct: 46  IGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLHQDSR 552
                  D+   + +Y+    L    F   +R+      R +     IA  L YLH    
Sbjct: 105 HFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS--- 157
Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN--TNRVVGTYGYMPPEYAID 610
           L I++RDLK  N+LLD++ +  ++DFG+ +    +  E N  T+   GT  Y+ PE    
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +    D +  G ++ E++YG
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYG 235

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQ---EIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRN 489
            + + +LG G FG V++  + D Q   + AVK++       +E F+  E++  A L    
Sbjct: 74  MTHQPRLGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPR 125
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +V L G   +     +  E L   SL   I    +   L   +    +G    GL YLH 
Sbjct: 126 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT 182
Query: 550 DSRLRIIHRDLKASNVLLDNEMN-PKISDFGMARAF---GVDQTEANTNRVVGTYGYMPP 605
               RI+H D+KA NVLL ++ +   + DFG A      G+ ++    + + GT  +M P
Sbjct: 183 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 239
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYGTR 634
           E  +      K D++S   ++L ++ G  
Sbjct: 240 EVVMGKPCDAKVDIWSSCCMMLHMLNGCH 268

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 417 MELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQE---IAVKRLSKSSGQGVE 473
           M+LPI       + +D +     +G G FG     ++ D Q    +AVK + +  G+ ++
Sbjct: 10  MDLPIM------HDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER--GEKID 59
Query: 474 E-FKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK 532
           E  K E++    L+H N+V+     +      ++ EY     L + I +  R    +   
Sbjct: 60  ENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEA 117
Query: 533 RC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVD 587
           R    Q+I G++    Y H    +++ HRDLK  N LLD    P  KI  FG +++  + 
Sbjct: 118 RFFFQQLISGVS----YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH 170
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLELVYGT 633
               +T   VGT  Y+ PE  +   +  K +DV+S GV +  ++ G 
Sbjct: 171 SQPKDT---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 29/204 (14%)
Query: 439 KLGEGGFGPVYKGMLIDGQ------EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           ++G G F  VYKG+  +        E+  ++L+KS  Q    FK E   +  LQH N+V+
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 493 LL----GCCMKRDERMLIYEYLPNKSLADFI--FDGTRRKLL-DWSKRCQIIGGIARGLL 545
                      +   +L+ E   + +L  ++  F   + K+L  W ++      I +GL 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQ 143
Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           +LH  +   IIHRDLK  N+ +     + KI D G+A        +A    V+GT  +  
Sbjct: 144 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFXA 198
Query: 605 PEYAIDGLFSVKSDVFSFGVLVLE 628
           PE   +  +    DV++FG   LE
Sbjct: 199 PE-XYEEKYDESVDVYAFGXCXLE 221

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 424 WKSIANAT---DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSG---QGVE 473
           W++ A  T   D F     LG G FG V   ML+     G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
              NE  ++  +    LVKL           ++ EY+    +    F   RR        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPH 142
Query: 534 CQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            +     I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 194
Query: 593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWSKRCQIIGGIAR 542
           +    LVKL           ++ EY+    +    F   RR  +  +   R      I  
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARF-YAAQIVL 152
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
              YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           + PE  +   ++   D ++ GVL+ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWSKRCQIIGGIAR 542
           +    LVKL           ++ EY+    +    F   RR  +  +   R      I  
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARF-YAAQIVL 152
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
              YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           + PE  +   ++   D ++ GVL+ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 417 MELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQE---IAVKRLSKSSGQGVE 473
           M+LPI       + +D +     +G G FG     ++ D Q    +AVK + +  G+ ++
Sbjct: 10  MDLPIM------HDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER--GEKID 59
Query: 474 E-FKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK 532
           E  K E++    L+H N+V+     +      ++ EY     L + I +  R    +   
Sbjct: 60  ENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEA 117
Query: 533 RC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVD 587
           R    Q+I G++    Y H    +++ HRDLK  N LLD    P  KI  FG +++  + 
Sbjct: 118 RFFFQQLISGVS----YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH 170
Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLELVYGT 633
               +T   VGT  Y+ PE  +   +  K +DV+S GV +  ++ G 
Sbjct: 171 SQPKST---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYL 205
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 435 SEENKLGEGGFGPVYKGMLIDGQ---EIAVKRLSKSSGQGVEEFKNEVLL-IAKLQHRNL 490
           + + +LG G FG V++  + D Q   + AVK++       +E F+ E L+  A L    +
Sbjct: 77  THQLRLGRGSFGEVHR--MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRI 128
Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V L G   +     +  E L   SL   + +   +  L   +    +G    GL YLH  
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSLGQLVKE---QGCLPEDRALYYLGQALEGLEYLH-- 183
Query: 551 SRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAF---GVDQTEANTNRVVGTYGYMPPE 606
           SR RI+H D+KA NVLL ++  +  + DFG A      G+ +     + + GT  +M PE
Sbjct: 184 SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPE 242
Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYG 632
             +      K DV+S   ++L ++ G
Sbjct: 243 VVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWSKRCQIIGGIAR 542
           +    LVKL           ++ EY+    +    F   RR  +  +   R      I  
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARF-YAAQIVL 152
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
              YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           + PE  +   ++   D ++ GVL+ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+++D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  I   ++   D ++ GVL+ E+  G
Sbjct: 206 APEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 36  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWSKRCQIIGGIAR 542
           +    LVKL           ++ EY+    +    F   RR  +  +   R      I  
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARF-YAAQIVL 147
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
              YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y
Sbjct: 148 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 199
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           + PE  +   ++   D ++ GVL+ E+  G
Sbjct: 200 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWSKRCQIIGGIAR 542
           +    LVKL           ++ EY+    +    F   RR  +  +   R      I  
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFAEPHARF-YAAQIVL 152
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
              YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 204
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           + PE  +   ++   D ++ GVL+ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR--KLLDWSKRCQIIGGIAR 542
           +    LVKL           ++ EY+    +    F   RR  +  +   R      I  
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARF-YAAQIVL 173
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
              YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y
Sbjct: 174 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEY 225
Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           + PE  +   ++   D ++ GVL+ E+  G
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 417 MELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQE---IAVKRLSKSSGQGVE 473
           M+LPI       + +D +     +G G FG     ++ D Q    +AVK + +   +   
Sbjct: 10  MDLPIM------HDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIERGE-KIAA 60
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
             K E++    L+H N+V+     +      ++ EY     L + I +  R    +   R
Sbjct: 61  NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEAR 118
Query: 534 C---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQ 588
               Q+I G++    Y H    +++ HRDLK  N LLD    P  KI DFG +++  +  
Sbjct: 119 FFFQQLISGVS----YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 171
Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLELVYGT 633
              +T   VGT  Y+ PE  +   +  K +DV+S GV +  ++ G 
Sbjct: 172 QPKST---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYL 205
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 63/143 (44%), Gaps = 8/143 (5%)
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           L +L  C    D    + EY+    L   I    R K             IA GL +L  
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHAVFYAAEIAIGLFFLQS 139
Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
                II+RDLK  NV+LD+E + KI+DFGM +    D     T    GT  Y+ PE   
Sbjct: 140 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGTPDYIAPEIIA 194
Query: 610 DGLFSVKSDVFSFGVLVLELVYG 632
              +    D ++FGVL+ E++ G
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAG 217

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 42  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 206
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQ---EIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRN 489
            + + ++G G FG V++  + D Q   + AVK++       +E F+  E++  A L    
Sbjct: 60  MTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPR 111
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +V L G   +     +  E L   SL   I    +   L   +    +G    GL YLH 
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 550 DSRLRIIHRDLKASNVLLDNEMN-PKISDFGMARAF---GVDQTEANTNRVVGTYGYMPP 605
               RI+H D+KA NVLL ++ +   + DFG A      G+ ++    + + GT  +M P
Sbjct: 169 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYGTR 634
           E  +      K D++S   ++L ++ G  
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
           TD +  +  +G G +    + +      E AVK + KS     EE +   +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++ L           ++ E +    L D I    R+K     +   ++  I + + YLH 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHA 134
Query: 550 DSRLRIIHRDLKASNVL-LDNEMNP---KISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
                ++HRDLK SN+L +D   NP   +I DFG A+    +     T     T  ++ P
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--CYTANFVAP 189
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E      +    D++S GVL+  ++ G
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 28  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 140
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 141 FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 192
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ E+  G
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 20/226 (8%)
Query: 415 EEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQ 470
           EEME+ +   K      + F     LG+G FG V   +L+     G+  A+K L K    
Sbjct: 132 EEMEVSLAKPKHRVTMNE-FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIV 187
Query: 471 GVEEFKN---EVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL 527
             +E  +   E  ++   +H  L  L       D    + EY     L    F  +R ++
Sbjct: 188 AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV 244
Query: 528 LDWSKRCQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV 586
                R +  G  I   L YLH  S   +++RDLK  N++LD + + KI+DFG+ +  G+
Sbjct: 245 FS-EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI 300
Query: 587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            +  A      GT  Y+ PE   D  +    D +  GV++ E++ G
Sbjct: 301 -KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 24/159 (15%)
Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL----- 493
           LG GG G V+  +  D  + +A+K++  +  Q V+    E+ +I +L H N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 494 ---------LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
                    +G   + +   ++ EY+    LA+ +  G    LL+   R   +  + RGL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQG---PLLEEHARL-FMYQLLRGL 133
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR 582
            Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+AR
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 20/226 (8%)
Query: 415 EEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQ 470
           EEME+ +   K      + F     LG+G FG V   +L+     G+  A+K L K    
Sbjct: 135 EEMEVSLAKPKHRVTMNE-FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIV 190
Query: 471 GVEEFKN---EVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL 527
             +E  +   E  ++   +H  L  L       D    + EY     L    F  +R ++
Sbjct: 191 AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERV 247
Query: 528 LDWSKRCQIIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV 586
                R +  G  I   L YLH  S   +++RDLK  N++LD + + KI+DFG+ +  G+
Sbjct: 248 FS-EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI 303
Query: 587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            +  A      GT  Y+ PE   D  +    D +  GV++ E++ G
Sbjct: 304 -KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 348

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCC 497
           LGEG +  V   + L +G+E AVK + K +G        EV  + + Q ++N+++L+   
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
                  L++E L   S+   I    ++K  +  +  +++  +A  L +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 558 RDLKASNVLLDN--EMNP-KISDFGMARAFGVDQ-----TEANTNRVVGTYGYMPPEYA- 608
           RDLK  N+L ++  +++P KI DF +     ++      T        G+  YM PE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 609 ----IDGLFSVKSDVFSFGVLVLELVYG 632
                   +  + D++S GV++  ++ G
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 174
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYL 226
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ E+  G
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQ---EIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRN 489
            + + ++G G FG V++  + D Q   + AVK++       +E F+  E++  A L    
Sbjct: 76  MTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPR 127
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +V L G   +     +  E L   SL   I    +   L   +    +G    GL YLH 
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT 184
Query: 550 DSRLRIIHRDLKASNVLLDNEMN-PKISDFGMARAF---GVDQTEANTNRVVGTYGYMPP 605
               RI+H D+KA NVLL ++ +   + DFG A      G+ ++    + + GT  +M P
Sbjct: 185 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 241
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYGTR 634
           E  +      K D++S   ++L ++ G  
Sbjct: 242 EVVMGKPCDAKVDIWSSCCMMLHMLNGCH 270

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 439 KLGEGGFGPVYKGMLID-GQEIAVKRLSKSS-GQGVE-EFKNE--VLLIAKLQHRNLVKL 493
           +LG G F  V + +    GQE A K L K   GQ    E  +E  VL +AK   R ++ L
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR-VINL 94
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
                   E +LI EY     +          +++  +   ++I  I  G+ YLHQ++  
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQNN-- 151
Query: 554 RIIHRDLKASNVLLDNEM---NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
            I+H DLK  N+LL +     + KI DFGM+R  G          ++GT  Y+ PE    
Sbjct: 152 -IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG---HACELREIMGTPEYLAPEILNY 207
Query: 611 GLFSVKSDVFSFGVLVLELVYGT 633
              +  +D+++ G++   L+  T
Sbjct: 208 DPITTATDMWNIGIIAYMLLTHT 230

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ ++  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 12/100 (12%)
Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
            I + L YL +  +  +IHRD+K SN+LLD     K+ DFG++     D+ +   +R  G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAG 186
Query: 599 TYGYMPPEYAIDGL------FSVKSDVFSFGVLVLELVYG 632
              YM PE  ID        + +++DV+S G+ ++EL  G
Sbjct: 187 CAAYMAPE-RIDPPDPTKPDYDIRADVWSLGISLVELATG 225

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/281 (20%), Positives = 118/281 (41%), Gaps = 47/281 (16%)
Query: 440 LGEGGFGPVYKGM--------LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG+G F  ++KG+         +   E+ +K L K+     E F     +++KL H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
              G C+  DE +L+ E++   SL  ++        + W  + ++   +A  + +L +++
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT 133
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISD--FGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
              +IH ++ A N+LL  E + K  +  F      G+  T    + +     ++PPE   
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 610 DGL-FSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKS- 667
           +    ++ +D +SFG  + E+  G                         D+P+  +D   
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSGG------------------------DKPLSALDSQR 226
Query: 668 ----LEDTYSLSEALRCIQVGLL--CVQQRPEDRPNMASVV 702
                ED + L          L+  C+   P+ RP+  +++
Sbjct: 227 KLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAII 267

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           +LG G FG V++ +    G+    K ++          KNE+ ++ +L H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 498 MKRDERMLIYEYLPNKSLADFI----FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
             + E +LI E+L    L D I    +  +  +++++ ++         GL ++H+ S  
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA------CEGLKHMHEHS-- 169
Query: 554 RIIHRDLKASNVLLDNEM--NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
            I+H D+K  N++ + +   + KI DFG+A     D+    T     T  +  PE     
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDRE 225
Query: 612 LFSVKSDVFSFGVLVLELVYG 632
                +D+++ GVL   L+ G
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSG 246

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/281 (20%), Positives = 117/281 (41%), Gaps = 47/281 (16%)
Query: 440 LGEGGFGPVYKGM--------LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           LG+G F  ++KG+         +   E+ +K L K+     E F     +++KL H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
              G C   DE +L+ E++   SL  ++        + W  + ++   +A  + +L +++
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT 133
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISD--FGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
              +IH ++ A N+LL  E + K  +  F      G+  T    + +     ++PPE   
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 610 DGL-FSVKSDVFSFGVLVLELVYGTRNRGFXXXXXXXXXXXXAWRLWTEDRPVELIDKS- 667
           +    ++ +D +SFG  + E+  G                         D+P+  +D   
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSGG------------------------DKPLSALDSQR 226
Query: 668 ----LEDTYSLSEALRCIQVGLL--CVQQRPEDRPNMASVV 702
                ED + L          L+  C+   P+ RP+  +++
Sbjct: 227 KLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAII 267

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 16/207 (7%)
Query: 431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
           TD +  +  +G G +    + +      E AVK + KS     EE +   +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++ L           ++ E      L D I    R+K     +   ++  I + + YLH 
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHA 134
Query: 550 DSRLRIIHRDLKASNVL-LDNEMNP---KISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
                ++HRDLK SN+L +D   NP   +I DFG A+    +     T     T  ++ P
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTP--CYTANFVAP 189
Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E      +    D++S GVL+   + G
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 426 SIANATDN-FSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGVEEFKN--- 477
           ++A  T N F     LG+G FG V   +L+     G+  A+K L K      +E  +   
Sbjct: 2   AMARVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 58
Query: 478 EVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQII 537
           E  ++   +H  L  L       D    + EY     L    F  +R ++     R +  
Sbjct: 59  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFY 114
Query: 538 GG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
           G  I   L YLH  S   +++RDLK  N++LD + + KI+DFG+ +  G+ +  A     
Sbjct: 115 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKXF 170
Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            GT  Y+ PE   D  +    D +  GV++ E++ G
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G G FG V        Q++ A+K LSK     +    F  E   I    +   V  L C
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 497 CMKRDERM-LIYEYLPNKSLADFI--FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
             + D+ + ++ EY+P   L + +  +D   +    W+K        A  +L L     +
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AEVVLALDAIHSM 193
Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT-EANTNRVVGTYGYMPPEY----A 608
            +IHRD+K  N+LLD   + K++DFG      +D+T   + +  VGT  Y+ PE      
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 609 IDGLFSVKSDVFSFGVLVLELVYG 632
            DG +  + D +S GV + E++ G
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 15/179 (8%)
Query: 458 EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLAD 517
           E AVK + KS     EE +   +L+   QH N++ L           L+ E +    L D
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLD 110
Query: 518 FIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL-LDNEMNP--- 573
            I    R+K     +   ++  I + + YLH      ++HRDLK SN+L +D   NP   
Sbjct: 111 KIL---RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           +I DFG A+    +     T     T  ++ PE      +    D++S G+L+  ++ G
Sbjct: 165 RICDFGFAKQLRAENGLLMTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 440 LGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVK 492
           LG+G FG V   +L+     G+  A+K L K      +E  +   E  ++   +H  L  
Sbjct: 16  LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 72
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLHQDS 551
           L       D    + EY     L    F  +R ++     R +  G  I   L YLH  S
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH--S 126
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              +++RDLK  N++LD + + KI+DFG+ +  G+ +  A      GT  Y+ PE   D 
Sbjct: 127 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKXFCGTPEYLAPEVLEDN 184
Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +    D +  GV++ E++ G
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCG 205

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            P   +   ++   D ++ GVL+ E+  G
Sbjct: 206 APAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 440 LGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVK 492
           LG+G FG V   +L+     G+  A+K L K      +E  +   E  ++   +H  L  
Sbjct: 18  LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 74
Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLYLHQDS 551
           L       D    + EY     L    F  +R ++     R +  G  I   L YLH  S
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH--S 128
Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              +++RDLK  N++LD + + KI+DFG+ +  G+ +  A      GT  Y+ PE   D 
Sbjct: 129 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKXFCGTPEYLAPEVLEDN 186
Query: 612 LFSVKSDVFSFGVLVLELVYG 632
            +    D +  GV++ E++ G
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCG 207

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 15/179 (8%)
Query: 458 EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLAD 517
           E AVK + KS     EE +   +L+   QH N++ L           L+ E +    L D
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLD 110
Query: 518 FIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL-LDNEMNP--- 573
            I    R+K     +   ++  I + + YLH      ++HRDLK SN+L +D   NP   
Sbjct: 111 KIL---RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           +I DFG A+    +     T     T  ++ PE      +    D++S G+L+  ++ G
Sbjct: 165 RICDFGFAKQLRAENGLLMTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSGQGVEEFKNEVL---LIAK 484
           ++F     LG+G FG V   +L+     G+  A+K L K      +E  + V    ++  
Sbjct: 10  NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
            +H  L  L       D    + EY     L    F  +R ++    +R +  G  I   
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSA 122
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L YLH      +++RD+K  N++LD + + KI+DFG+ +  G+    A      GT  Y+
Sbjct: 123 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYL 177
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE   D  +    D +  GV++ E++ G
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSGQGVEEFKNEVL---LIAK 484
           ++F     LG+G FG V   +L+     G+  A+K L K      +E  + V    ++  
Sbjct: 8   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
            +H  L  L       D    + EY     L    F  +R ++    +R +  G  I   
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSA 120
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L YLH      +++RD+K  N++LD + + KI+DFG+ +  G+    A      GT  Y+
Sbjct: 121 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKTFCGTPEYL 175
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE   D  +    D +  GV++ E++ G
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCG 204

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSGQGVEEFKNEVL---LIAK 484
           ++F     LG+G FG V   +L+     G+  A+K L K      +E  + V    ++  
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
            +H  L  L       D    + EY     L    F  +R ++    +R +  G  I   
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSA 117
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L YLH      +++RD+K  N++LD + + KI+DFG+ +  G+    A      GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKTFCGTPEYL 172
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE   D  +    D +  GV++ E++ G
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSGQGVEEFKNEVL---LIAK 484
           ++F     LG+G FG V   +L+     G+  A+K L K      +E  + V    ++  
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
            +H  L  L       D    + EY     L    F  +R ++    +R +  G  I   
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSA 117
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L YLH      +++RD+K  N++LD + + KI+DFG+ +  G+    A      GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYL 172
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE   D  +    D +  GV++ E++ G
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSGQGVEEFKNEVL---LIAK 484
           ++F     LG+G FG V   +L+     G+  A+K L K      +E  + V    ++  
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
            +H  L  L       D    + EY     L    F  +R ++    +R +  G  I   
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSA 117
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L YLH      +++RD+K  N++LD + + KI+DFG+ +  G+    A      GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYL 172
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE   D  +    D +  GV++ E++ G
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSGQGVEEFKNEVL---LIAK 484
           ++F     LG+G FG V   +L+     G+  A+K L K      +E  + V    ++  
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
            +H  L  L       D    + EY     L    F  +R ++    +R +  G  I   
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSA 117
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L YLH      +++RD+K  N++LD + + KI+DFG+ +  G+    A      GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKTFCGTPEYL 172
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE   D  +    D +  GV++ E++ G
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSGQGVEEFKNEVL---LIAK 484
           ++F     LG+G FG V   +L+     G+  A+K L K      +E  + V    ++  
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
            +H  L  L       D    + EY     L    F  +R ++    +R +  G  I   
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSA 117
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L YLH      +++RD+K  N++LD + + KI+DFG+ +  G+    A      GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYL 172
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE   D  +    D +  GV++ E++ G
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK 484
           D F     LG G FG V   ML+     G   A+K L K      + +E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARG 543
           +    LVKL           ++ EY+    +    F   RR         +     I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT   +
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEAL 205
Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
            PE  +   ++   D ++ GVL+ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 91/185 (49%), Gaps = 24/185 (12%)
Query: 433 NFSEENKLGEGGFGP-VYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +F  ++ LG G  G  VY+GM  D +++AVKR+        +  +   LL    +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVI 81
Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWS----KRCQIIGGIARGLLYL 547
           +    C ++D +   ++Y+  +  A  + +   +K  D++    +   ++     GL +L
Sbjct: 82  RYF--CTEKDRQ---FQYIAIELCAATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHL 134
Query: 548 HQDSRLRIIHRDLKASNVLL-----DNEMNPKISDFGMARAFGVDQTE-ANTNRVVGTYG 601
           H    L I+HRDLK  N+L+       ++   ISDFG+ +   V +   +  + V GT G
Sbjct: 135 HS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 602 YMPPE 606
           ++ PE
Sbjct: 192 WIAPE 196

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVKRL--SKSSGQGVEEFKN---------EVLLI 482
           ++ +  +  G +G V  G+  +G  +A+KR+  + S G+ V    +         E+ L+
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 483 AKLQHRNLVKLLGCCMKRDE----RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG 538
               H N++ L    +  +E    ++ +   L    LA  I D  +R ++        + 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD--QRIVISPQHIQYFMY 141
Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
            I  GL  LH+     ++HRDL   N+LL +  +  I DF +AR    D  +AN    V 
Sbjct: 142 HILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARE---DTADANKTHYVT 195
Query: 599 TYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEL 629
              Y  PE  +    F+   D++S G ++ E+
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 434 FSEENKLGEGGFGPVYKGMLIDGQEIAVKRL--SKSSGQGVEEFKN---------EVLLI 482
           ++ +  +  G +G V  G+  +G  +A+KR+  + S G+ V    +         E+ L+
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 483 AKLQHRNLVKLLGCCMKRDE----RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG 538
               H N++ L    +  +E    ++ +   L    LA  I D  +R ++        + 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD--QRIVISPQHIQYFMY 141
Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
            I  GL  LH+     ++HRDL   N+LL +  +  I DF +AR    D  +AN    V 
Sbjct: 142 HILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARE---DTADANKTHYVT 195
Query: 599 TYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEL 629
              Y  PE  +    F+   D++S G ++ E+
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 88/199 (44%), Gaps = 18/199 (9%)
Query: 440 LGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK 499
           LG G FG V++ +    ++  + +  K  G      K E+ ++   +HRN++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 500 RDERMLIYEYLPNKSLADFI----FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
            +E ++I+E++    + + I    F+   R+++ +      +  +   L +LH  +   I
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSY------VHQVCEALQFLHSHN---I 123
Query: 556 IHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            H D++  N++     +   KI +FG AR     +   N   +     Y  PE     + 
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 614 SVKSDVFSFGVLVLELVYG 632
           S  +D++S G LV  L+ G
Sbjct: 181 STATDMWSLGTLVYVLLSG 199

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLI----AKLQ 486
           D F  E   G+G FG V  G     G  +A+K++ +        F+N  L I    A L 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLH 77
Query: 487 HRNLVKL------LGCCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IG 538
           H N+V+L      LG   +RD  + ++ EY+P+ +L     +  RR++       ++ + 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGVDQTEANTNRVV 597
            + R +  LH  S + + HRD+K  NVL++  +   K+ DFG A+      +E N   + 
Sbjct: 137 QLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS--PSEPNVAYIC 193
Query: 598 GTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLELVYG 632
             Y Y  PE    +  ++   D++S G +  E++ G
Sbjct: 194 SRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 15/209 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHR 488
           D +     +G G +G V      + GQ++A+K++  +       +    E+ ++   +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 489 NLVKL---LGCCMKRDERMLIYEYLP-NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           N++ +   L   +   E   +Y  L   +S    I   ++   L+  +    +  + RGL
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVR--YFLYQLLRGL 172
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN--TNRVVGTYGY 602
            Y+H     ++IHRDLK SN+L++     KI DFGMAR       E        V T  Y
Sbjct: 173 KYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 229
Query: 603 MPPEYAID-GLFSVKSDVFSFGVLVLELV 630
             PE  +    ++   D++S G +  E++
Sbjct: 230 RAPELMLSLHEYTQAIDLWSVGCIFGEML 258

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 101/245 (41%), Gaps = 50/245 (20%)
Query: 424 WKSIANATDNFSEENKLGEGGFGPVY--KGMLIDGQE--IAVKRLSKSSGQGVEEFKNEV 479
           ++++   ++ F  E+K+GEG F  VY     L  G E  IA+K L  +S       + + 
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQC 72
Query: 480 LLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI----FDGTRRKLLDWSKRCQ 535
           L +A  Q  N++ +  C  K D  ++   YL ++S  D +    F   R  +L+  K   
Sbjct: 73  LTVAGGQD-NVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFK--- 128
Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARA--------FGV 586
                   L  +HQ     I+HRD+K SN L +  +    + DFG+A+            
Sbjct: 129 -------ALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKF 178
Query: 587 DQTEANTNRV------------------VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVL 627
            Q+EA   R                    GT G+  PE          + D++S GV+ L
Sbjct: 179 VQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238
Query: 628 ELVYG 632
            L+ G
Sbjct: 239 SLLSG 243

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 18/218 (8%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKN--EVLLI 482
           + + N + +F  ++ LGEG +G V         EI   +  +   + +   +   E+ ++
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
              +H N++ +               Y+  + +   +      ++L        I    R
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN-------- 594
            +  LH  +   +IHRDLK SN+L+++  + K+ DFG+AR   +D++ A+ +        
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSG 178
Query: 595 --RVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEL 629
               V T  Y  PE  +    +S   DV+S G ++ EL
Sbjct: 179 MTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 96/219 (43%), Gaps = 20/219 (9%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQ--GVEEFKNEVLL 481
           + + N + +F  ++ LGEG +G V        G+ +A+K++         +   + E+ +
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKI 62
Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           +   +H N++ +               Y+  + +   +      ++L        I    
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN------- 594
           R +  LH  +   +IHRDLK SN+L+++  + K+ DFG+AR   +D++ A+ +       
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQS 177
Query: 595 ---RVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEL 629
                V T  Y  PE  +    +S   DV+S G ++ EL
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 18/218 (8%)
Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKN--EVLLI 482
           + + N + +F  ++ LGEG +G V         EI   +  +   + +   +   E+ ++
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63
Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
              +H N++ +               Y+  + +   +      ++L        I    R
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN-------- 594
            +  LH  +   +IHRDLK SN+L+++  + K+ DFG+AR   +D++ A+ +        
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSG 178
Query: 595 --RVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEL 629
               V T  Y  PE  +    +S   DV+S G ++ EL
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
           IG +   +  +HQ   L  +HRD+K  NVLLD   + +++DFG       D T   ++  
Sbjct: 197 IGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSVA 252
Query: 597 VGTYGYMPPEY--AID---GLFSVKSDVFSFGVLVLELVYG 632
           VGT  Y+ PE   A++   G +  + D +S GV + E++YG
Sbjct: 253 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 15/209 (7%)
Query: 432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHR 488
           D +     +G G +G V      + GQ++A+K++  +       +    E+ ++   +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 489 NLVKL---LGCCMKRDERMLIYEYLP-NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           N++ +   L   +   E   +Y  L   +S    I   ++   L+  +    +  + RGL
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVR--YFLYQLLRGL 171
Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN--TNRVVGTYGY 602
            Y+H     ++IHRDLK SN+L++     KI DFGMAR       E        V T  Y
Sbjct: 172 KYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228
Query: 603 MPPEYAID-GLFSVKSDVFSFGVLVLELV 630
             PE  +    ++   D++S G +  E++
Sbjct: 229 RAPELMLSLHEYTQAIDLWSVGCIFGEML 257

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
           IG +   +  +HQ   L  +HRD+K  NVLLD   + +++DFG       D T   ++  
Sbjct: 181 IGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSVA 236
Query: 597 VGTYGYMPPEY--AID---GLFSVKSDVFSFGVLVLELVYG 632
           VGT  Y+ PE   A++   G +  + D +S GV + E++YG
Sbjct: 237 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNL 490
           D++    KLG G +  V++ + I   E  V ++ K   +   + K E+ ++  L+   N+
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKN--KIKREIKILENLRGGPNI 94
Query: 491 VKLLGCCMKRDERM--LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           + L         R   L++E++ N       F    + L D+  R  +   I + L Y H
Sbjct: 95  ITLADIVKDPVSRTPALVFEHVNNTD-----FKQLYQTLTDYDIRFYMYE-ILKALDYCH 148
Query: 549 QDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
               + I+HRD+K  NV++D+E    ++ D+G+A  +   Q E N  RV   Y +  PE 
Sbjct: 149 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVASRY-FKGPEL 202
Query: 608 AID-GLFSVKSDVFSFGVLVLELVY 631
            +D  ++    D++S G ++  +++
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIF 227

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 16/202 (7%)
Query: 436 EENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKL 493
           ++  LGEG F    K +     Q  AVK +SK      ++   E+  +   + H N+VKL
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKL 71
Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
                 +    L+ E L    L + I    ++K    ++   I+  +   + ++H    +
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 554 RIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
            ++HRDLK  N+L  +E   +  KI DFG AR    D     T     T  Y  PE    
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP--CFTLHYAAPELLNQ 183
Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +    D++S GV++  ++ G
Sbjct: 184 NGYDESCDLWSLGVILYTMLSG 205

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 411 GNRKEEMELPIFD-WKSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS 468
           G   E ++ P +D  +  +    +F   ++LG G +G V+K     DG+  AVKR S S 
Sbjct: 35  GEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSP 93
Query: 469 GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER------MLIYEYLPNKSLADFIFDG 522
            +G    K+    +A++     V    CC++ ++       + +   L   SL       
Sbjct: 94  FRGP---KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSL------- 143
Query: 523 TRRKLLDWSK---RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 579
            ++    W       Q+ G +   LL L       ++H D+K +N+ L      K+ DFG
Sbjct: 144 -QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFG 202
Query: 580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
           +    G   T        G   YM PE  + G +   +DVFS G+ +LE+ 
Sbjct: 203 LLVELG---TAGAGEVQEGDPRYMAPEL-LQGSYGTAADVFSLGLTILEVA 249

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 84/174 (48%), Gaps = 17/174 (9%)
Query: 417 MELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVE-- 473
           M  P  DW+      D +   + +G G +G V +    ++ + +A+K++ +     ++  
Sbjct: 42  MPRPHSDWQ----IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK 97
Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERML--IYEYLPNKSLADFIFDGTRRKLLDWS 531
               E+ ++ +L H ++VK+L   + +D      +Y  L    +AD  F    R  +  +
Sbjct: 98  RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL---EIADSDFKKLFRTPVYLT 154
Query: 532 KRC--QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 583
           +     ++  +  G+ Y+H      I+HRDLK +N L++ + + K+ DFG+AR 
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 76/190 (40%), Gaps = 27/190 (14%)
Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKR-LSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           E  LG G  G V       G+ +AVKR L       + E K   LL     H N+++   
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY- 75
Query: 496 CCMKRDERMLIYEYLPNKSLADFI----FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           C    D  + I   L N +L D +          KL        ++  IA G+ +LH   
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133
Query: 552 RLRIIHRDLKASNVLLDNE-------------MNPKISDFGMARAFGVDQT--EANTNRV 596
            L+IIHRDLK  N+L+                +   ISDFG+ +     Q+    N N  
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 597 VGTYGYMPPE 606
            GT G+  PE
Sbjct: 193 SGTSGWRAPE 202

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 432 DNFSEENKLGEGGFGPVYKGMLIDG-QEIAVKRLSKSSGQGVE--EFKNEVLLIAKLQHR 488
           DN+  ++ +G G +G VY     +  + +A+K++++     ++      E+ ++ +L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 489 NLVKLLGCC-----MKRDERMLIYEYLPNKSLADFIFDGTRRKL------LDWSKRCQII 537
            +++L         +K DE  ++ E          I D   +KL      L       I+
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE----------IADSDLKKLFKTPIFLTEQHVKTIL 137
Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
             +  G  ++H+     IIHRDLK +N LL+ + + KI DFG+AR    D+
Sbjct: 138 YNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 86/183 (46%), Gaps = 30/183 (16%)
Query: 428 ANATDNFSEENKLGEGGFGPVYKGMLIDGQE-IAVKRLSKSSGQGVE--EFKNEVLLIAK 484
            +  DN+  ++ +G G +G VY     + ++ +A+K++++     ++      E+ ++ +
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 485 LQHRNLVKLLGCC-----MKRDERMLIYEYLPNKSLADFIFDGTRRKL------LDWSKR 533
           L+   +++L         +K DE  ++ E          I D   +KL      L     
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLE----------IADSDLKKLFKTPIFLTEEHI 131
Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
             I+  +  G  ++H+     IIHRDLK +N LL+ + + K+ DFG+AR      +E +T
Sbjct: 132 KTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN---SEKDT 185
Query: 594 NRV 596
           N V
Sbjct: 186 NIV 188

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 14/175 (8%)
Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVKLLGCC 497
           LG+G    V++G     G   A+K  +  S  + V+    E  ++ KL H+N+VKL    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 498 MKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
            +   R  +LI E+ P  SL   + + +    L  S+   ++  +  G+ +L ++    I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 556 IHRDLKASNVLL----DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           +HR++K  N++     D +   K++DFG AR    D+   +   + GT  Y+ P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPD 185
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	751
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-146
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-143
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-121
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-75
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-50
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-47
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-46
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-46
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-46
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-44
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-43
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-43
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-43
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-42
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-42
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-42
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-42
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-42
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-41
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-41
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-41
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-41
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-40
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-40
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-40
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-40
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-39
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-39
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-39
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-39
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-39
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-39
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-39
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-39
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-38
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-38
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-38
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-38
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-36
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-36
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-35
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-35
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-31
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-31
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-29
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-29
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-29
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-28
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-28
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-28
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-28
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-27
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-26
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-12
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	5e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-11
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-10
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	3e-10
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	9e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-09
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	5e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-08
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	5e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-08
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	1e-07
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	1e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-07
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	7e-07
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	7e-07
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	5e-05
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	2e-06
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	4e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	3e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	9e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  430 bits (1107), Expect = e-146
 Identities = 108/307 (35%), Positives = 163/307 (53%), Gaps = 25/307 (8%)

Query: 418 ELPIFDWKSIANATDNFSEE------NKLGEGGFGPVYKGMLIDGQEIAVKRLSK----S 467
               F +  + N T+NF E       NK+GEGGFG VYKG  ++   +AVK+L+     +
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDIT 69

Query: 468 SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL 527
           + +  ++F  E+ ++AK QH NLV+LLG     D+  L+Y Y+PN SL D +        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 528 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD 587
           L W  RC+I  G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA    
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHH--- 644
                T+R+VGT  YM PE  + G  + KSD++SFGV++LE++ G        VD H   
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA-----VDEHREP 240

Query: 645 HNLLGHAWRLWTEDRPVE-LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL 703
             LL     +  E++ +E  IDK + D    +       V   C+ ++   RP++  V  
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299

Query: 704 MLSGERS 710
           +L    +
Sbjct: 300 LLQEMTA 306

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  421 bits (1086), Expect = e-143
 Identities = 126/292 (43%), Positives = 167/292 (57%), Gaps = 5/292 (1%)

Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVE-EFKNEV 479
            F  + +  A+DNFS +N LG GGFG VYKG L DG  +AVKRL +   QG E +F+ EV
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 480 LLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL-LDWSKRCQIIG 538
            +I+   HRNL++L G CM   ER+L+Y Y+ N S+A  + +    +  LDW KR +I  
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
           G ARGL YLH     +IIHRD+KA+N+LLD E    + DFG+A+      T   T  V G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRG 197

Query: 599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRN--RGFHHVDHHHNLLGHAWRLWT 656
           T G++ PEY   G  S K+DVF +GV++LEL+ G R         D    LL     L  
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257

Query: 657 EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE 708
           E +   L+D  L+  Y   E  + IQV LLC Q  P +RP M+ VV ML G+
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  364 bits (938), Expect = e-121
 Identities = 104/295 (35%), Positives = 161/295 (54%), Gaps = 6/295 (2%)

Query: 422 FDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLL 481
                +  AT+NF  +  +G G FG VYKG+L DG ++A+KR +  S QG+EEF+ E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL-LDWSKRCQIIGGI 540
           ++  +H +LV L+G C +R+E +LIY+Y+ N +L   ++      + + W +R +I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GVDQTEANTNRVVGT 599
           ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++    +DQT  +T  V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR 659
            GY+ PEY I G  + KSDV+SFGV++ E++               NL   A       +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264

Query: 660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQP 714
             +++D +L D        +     + C+    EDRP+M  V+  L     L + 
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  294 bits (755), Expect = 5e-94
 Identities = 66/307 (21%), Positives = 128/307 (41%), Gaps = 28/307 (9%)

Query: 422 FDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLL 481
              +++   +           G FG V+K   +  + +AVK       Q   + + EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 482 IAKLQHRNLVKLLGCCMKRD----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQII 537
           +  ++H N+++ +G   +      +  LI  +    SL+DF+    +  ++ W++ C I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 538 GGIARGLLYLHQD-------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE 590
             +ARGL YLH+D        +  I HRD+K+ NVLL N +   I+DFG+A  F   ++ 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 591 ANTNRVVGTYGYMPPEYAIDGL-----FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHH 645
            +T+  VGT  YM PE     +       ++ D+++ G+++ EL            ++  
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 646 NLLGHAWRLWTEDRPVELIDK-----SLEDTYSLSEALRCI-QVGLLCVQQRPEDRPNMA 699
                  +  + +   E++        L D +     +  + +    C     E R +  
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 700 SVVLMLS 706
            V   ++
Sbjct: 308 CVGERIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  246 bits (629), Expect = 2e-75
 Identities = 71/339 (20%), Positives = 127/339 (37%), Gaps = 51/339 (15%)

Query: 417 MELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFK 476
           ME    +    +   DN      +G G +G VYKG L D + +AVK  S ++ Q    F 
Sbjct: 1   MEAAASEP---SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFI 53

Query: 477 NE--VLLIAKLQHRNLVKLLGCCMK-----RDERMLIYEYLPNKSLADFIFDGTRRKLLD 529
           NE  +  +  ++H N+ + +    +     R E +L+ EY PN SL  ++         D
Sbjct: 54  NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSD 109

Query: 530 WSKRCQIIGGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 583
           W   C++   + RGL YLH +       +  I HRDL + NVL+ N+    ISDFG++  
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169

Query: 584 F------GVDQTEANTNRVVGTYGYMPPEYAIDGLFSV--------KSDVFSFGVLVLEL 629
                     + +      VGT  YM PE  ++G  ++        + D+++ G++  E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 630 VYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK--------SLEDTYSLSEALRCI 681
                +         + +      +       ++              + +  +      
Sbjct: 229 FMRCTDLFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 682 QVGLL--CVQQRPEDRPNMASVVLMLSG-ERSLPQPKQP 717
               +  C  Q  E R         ++       + K  
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  209 bits (534), Expect = 5e-62
 Identities = 77/289 (26%), Positives = 138/289 (47%), Gaps = 26/289 (8%)

Query: 433 NFSE---ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQH 487
            + +   + K+G G FG V++     G ++AVK L +     + V EF  EV ++ +L+H
Sbjct: 35  PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V  +G   +     ++ EYL   SL   +     R+ LD  +R  +   +A+G+ YL
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H      I+HR+LK+ N+L+D +   K+ DFG++R      T  ++    GT  +M PE 
Sbjct: 154 HN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEV 210

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
             D   + KSDV+SFGV++ EL   T  + + ++    N       +  + + +E+    
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELA--TLQQPWGNL----NPAQVVAAVGFKCKRLEIPRNL 264

Query: 668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG--ERSLPQP 714
                ++ E          C    P  RP+ A+++ +L    + ++P P
Sbjct: 265 NPQVAAIIEG---------CWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  204 bits (522), Expect = 2e-60
 Identities = 80/301 (26%), Positives = 126/301 (41%), Gaps = 27/301 (8%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
                E  +G G FG V K      +++A+K++   S    + F  E+  ++++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           KL G C+      L+ EY    SL + +           +         ++G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 552 RLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
              +IHRDLK  N+LL       KI DFG A     D     TN   G+  +M PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVFEG 177

Query: 611 GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED 670
             +S K DVFS+G+++ E++  TR + F  +          W +    RP  LI    + 
Sbjct: 178 SNYSEKCDVFSWGIILWEVI--TRRKPFDEIG--GPAFRIMWAVHNGTRP-PLIKNLPKP 232

Query: 671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML-SGERSLPQPKQP-GFFTERNLPES 728
             SL            C  + P  RP+M  +V ++    R  P   +P  +  + +LP  
Sbjct: 233 IESLMTR---------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPG 283

Query: 729 E 729
           E
Sbjct: 284 E 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  202 bits (516), Expect = 8e-60
 Identities = 85/288 (29%), Positives = 128/288 (44%), Gaps = 39/288 (13%)

Query: 433 NFSE---ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKL 485
           +F+E   E  +G GGFG VY+     G E+AVK           Q +E  + E  L A L
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
           +H N++ L G C+K     L+ E+     L   +      K +           IARG+ 
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMN 119

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNP--------KISDFGMARAFGVDQTEANTNRVV 597
           YLH ++ + IIHRDLK+SN+L+  ++          KI+DFG+AR     +T   +    
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSA--A 175

Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE 657
           G Y +M PE     +FS  SDV+S+GVL+ EL+  T    F  +D     L  A+ +   
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL--TGEVPFRGIDG----LAVAYGVAMN 229

Query: 658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
              + +     E    L E          C    P  RP+  +++  L
Sbjct: 230 KLALPIPSTCPEPFAKLMED---------CWNPDPHSRPSFTNILDQL 268

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  196 bits (500), Expect = 2e-57
 Identities = 73/314 (23%), Positives = 142/314 (45%), Gaps = 47/314 (14%)

Query: 408 SELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSK 466
           +  G+   +  LP      I         E ++G+GGFG V+KG L+ D   +A+K L  
Sbjct: 2   AMGGSEFPKSRLPTLADNEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL 54

Query: 467 SSGQG-------VEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI 519
              +G        +EF+ EV +++ L H N+VKL G         ++ E++P   L   +
Sbjct: 55  GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRL 112

Query: 520 FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----EMNPK 574
            D  +   + WS + +++  IA G+ Y+       I+HRDL++ N+ L +      +  K
Sbjct: 113 LD--KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169

Query: 575 ISDFGMARAFGVDQTEANTNRVVGTYGYMPPE--YAIDGLFSVKSDVFSFGVLVLELVYG 632
           ++DFG+++     Q+  + + ++G + +M PE   A +  ++ K+D +SF +++  ++  
Sbjct: 170 VADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL-- 222

Query: 633 TRNRGFHHVDHHHNLLGHAWRLWTED-RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQR 691
           T    F    +    +     +  E  RP  + +       ++ E          C    
Sbjct: 223 TGEGPFDEYSYGK--IKFINMIREEGLRP-TIPEDCPPRLRNVIEL---------CWSGD 270

Query: 692 PEDRPNMASVVLML 705
           P+ RP+ + +V  L
Sbjct: 271 PKKRPHFSYIVKEL 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  193 bits (493), Expect = 1e-56
 Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 51/291 (17%)

Query: 433 NFSE---ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQH 487
           +F +     KL E   G ++KG    G +I VK L     S +   +F  E   +    H
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66

Query: 488 RNLVKLLGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
            N++ +LG C         LI  ++P  SL + + +GT   + D S+  +    +ARG+ 
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMA 125

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           +LH    L I    L + +V++D +M  +IS   +  +F        +   +    ++ P
Sbjct: 126 FLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAP 177

Query: 606 EYAIDG----LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV 661
           E A+           +D++SF VL+ ELV  TR   F  +                   +
Sbjct: 178 E-ALQKKPEDTNRRSADMWSFAVLLWELV--TREVPFADLS-----------------NM 217

Query: 662 ELIDKSLEDTY------SLSEALRC-IQVGLLCVQQRPEDRPNMASVVLML 705
           E+  K   +         +S  +   ++   +C+ + P  RP    +V +L
Sbjct: 218 EIGMKVALEGLRPTIPPGISPHVSKLMK---ICMNEDPAKRPKFDMIVPIL 265

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  193 bits (493), Expect = 4e-56
 Identities = 77/299 (25%), Positives = 116/299 (38%), Gaps = 37/299 (12%)

Query: 437 ENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
              LG+G FG   K      G+ + +K L +   +    F  EV ++  L+H N++K +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
              K      I EY+   +L   I          WS+R      IA G+ YLH    + I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR------------VVGTYGYM 603
           IHRDL + N L+    N  ++DFG+AR    ++T+    R            VVG   +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
            PE      +  K DVFSFG+++ E++   R              G   R + +      
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII--GRVNADPDYLPRTMDFGLNVRGFLDRYCPPN 247

Query: 664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML-----SGERSLPQPKQP 717
              S    + +   +RC      C    PE RP+   +   L          LP   Q 
Sbjct: 248 CPPSF---FPI--TVRC------C-DLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQL 294

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  190 bits (486), Expect = 2e-55
 Identities = 65/279 (23%), Positives = 126/279 (45%), Gaps = 24/279 (8%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 489
              +   ++G G FG VYKG      ++AVK L+ +  + Q ++ FKNEV ++ K +H N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++  +G      +  ++ ++    SL   +         +  K   I    ARG+ YLH 
Sbjct: 82  ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA 138

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE--- 606
                IIHRDLK++N+ L  +   KI DFG+A             ++ G+  +M PE   
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK 666
                 +S +SDV++FG+++ EL+  T    + ++++   ++    R        ++   
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELM--TGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253

Query: 667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
             +    L            C++++ ++RP+   ++  +
Sbjct: 254 CPKRMKRLMAE---------CLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  189 bits (483), Expect = 1e-54
 Identities = 80/310 (25%), Positives = 125/310 (40%), Gaps = 47/310 (15%)

Query: 433 NFSE---ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQH 487
            F +      +G+G FG VY G      E+A++ +     +   ++ FK EV+   + +H
Sbjct: 31  PFEQLEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+V  +G CM      +I      ++L   + D   + +LD +K  QI   I +G+ YL
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYL 146

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR---VVGTYGYMP 604
           H      I+H+DLK+ NV  DN     I+DFG+    GV Q     ++     G   ++ 
Sbjct: 147 HA---KGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 605 PE---------YAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW 655
           PE               FS  SDVF+ G +  EL    R   F             W++ 
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH--AREWPFKTQ----PAEAIIWQMG 256

Query: 656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQ-- 713
           T  +P  L          + + +  I   L C     E+RP    ++ ML     LP+  
Sbjct: 257 TGMKP-NLSQI------GMGKEISDIL--LFCWAFEQEERPTFTKLMDML---EKLPKRN 304

Query: 714 --PKQPGFFT 721
                PG F 
Sbjct: 305 RRLSHPGHFW 314

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  183 bits (467), Expect = 3e-52
 Identities = 73/320 (22%), Positives = 127/320 (39%), Gaps = 51/320 (15%)

Query: 419 LPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNE 478
           LP+   ++IA          ++G+G +G V+ G    G+++AVK            +  E
Sbjct: 27  LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRE 79

Query: 479 --VLLIAKLQHRNLVKLLGCCMK----RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK 532
             +     ++H N++  +   +K      +  LI +Y  N SL D++    +   LD   
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKS 135

Query: 533 RCQIIGGIARGLLYLHQDSRLR-----IIHRDLKASNVLLDNEMNPKISDFGMARAF--G 585
             ++      GL +LH +         I HRDLK+ N+L+       I+D G+A  F   
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195

Query: 586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSV-------KSDVFSFGVLVLELVYGTRNRG- 637
            ++ +   N  VGT  YMPPE  +D   +         +D++SFG+++ E+     + G 
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254

Query: 638 -------FHHVDHHHNLLGHAWRLWTED--RPVELIDKSLEDTYSLSEALRCIQVGLL-- 686
                  +H +            +      RP      S  + +S  E LR +   L+  
Sbjct: 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP------SFPNRWSSDECLRQM-GKLMTE 307

Query: 687 CVQQRPEDRPNMASVVLMLS 706
           C    P  R     V   L+
Sbjct: 308 CWAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (457), Expect = 3e-51
 Identities = 68/299 (22%), Positives = 119/299 (39%), Gaps = 42/299 (14%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNE--VLLIAKLQHRNLVKLL 494
              +G+G +G V++G    G+ +AVK  S    +  + +  E  +     L+H N++  +
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68

Query: 495 GCCMKRD----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
              M       +  LI  Y    SL D++    +   LD     +I+  IA GL +LH +
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 551 SRLR-----IIHRDLKASNVLLDNEMNPKISDFGMAR--AFGVDQTEANTNRVVGTYGYM 603
                    I HRDLK+ N+L+       I+D G+A   +   +Q +   N  VGT  YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 604 PPE------YAIDGLFSVKSDVFSFGVLVLELVYGTRNRG--------FHHVDHHHNLLG 649
            PE               + D+++FG+++ E+     + G        F+ V  +     
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 650 HAWRLWTED--RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
              ++   D  RP   I        +L+   + ++    C  Q P  R     +   L+
Sbjct: 245 DMRKVVCVDQQRPN--IPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  178 bits (453), Expect = 3e-50
 Identities = 77/349 (22%), Positives = 138/349 (39%), Gaps = 54/349 (15%)

Query: 390 DMKILSEGG--QDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGP 447
           D   +SEG   +DL   M TS  G       LP+   ++IA        +  +G+G FG 
Sbjct: 6   DRPFISEGTTLKDLIYDMTTSGSG-----SGLPLLVQRTIA---RTIVLQESIGKGRFGE 57

Query: 448 VYKGMLIDGQEIAVKRLSKSSGQGVEEFKNE--VLLIAKLQHRNLVKLLGCCMKRD---- 501
           V++G    G+E+AVK  S    +    +  E  +     L+H N++  +    K +    
Sbjct: 58  VWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113

Query: 502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-----SRLRII 556
           +  L+ +Y  + SL D++     R  +      ++    A GL +LH +      +  I 
Sbjct: 114 QLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169

Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM PE  +D   +
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSIN 228

Query: 615 V-------KSDVFSFGVLVLELVYGTRNRG--------FHHVDHHHNLLGHAWRLWTED- 658
           +       ++D+++ G++  E+       G        ++ +      +    ++  E  
Sbjct: 229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288

Query: 659 -RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
            RP   I    +   +L    + ++    C       R     +   LS
Sbjct: 289 LRPN--IPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  169 bits (429), Expect = 5e-47
 Identities = 85/332 (25%), Positives = 136/332 (40%), Gaps = 66/332 (19%)

Query: 437 ENKLGEGGFGPVYKGMLI-----DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
            ++LG+G FG V            G  +AVK+L  S      +F+ E+ ++  L    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 492 KLLGCCMKRDER--MLIYEYLPNKSLADFIFDG----TRRKLLDWSKRCQIIGGIARGLL 545
           K  G       +   L+ EYLP+  L DF+          +LL +S        I +G+ 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QICKGME 141

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP- 604
           YL      R +HRDL A N+L+++E + KI+DFG+A+   +D+       VV   G  P 
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPI 194

Query: 605 ----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFHHVDHHHNLLGHAWRLWTEDR 659
               PE   D +FS +SDV+SFGV++ EL  Y  ++                    +   
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS-------------------CSPSA 235

Query: 660 PVELIDKSLEDTYSLSEALRCIQVG-----------------LLCVQQRPEDRPNMASVV 702
               +     D  +LS  L  ++ G                  LC    P+DRP+ +++ 
Sbjct: 236 EFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALG 295

Query: 703 LMLSGERSLPQPKQPGFFTERNLPESESSSSN 734
             L    S  +  +   FT     +  S S +
Sbjct: 296 PQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  167 bits (424), Expect = 1e-46
 Identities = 81/286 (28%), Positives = 121/286 (42%), Gaps = 29/286 (10%)

Query: 437 ENKLGEGGFGPVYKGMLI-----DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
             +LG+G FG V            G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 492 KLLGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           K  G C     R   LI EYLP  SL D++     ++ +D  K  Q    I +G+ YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL-- 130

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP----- 604
               R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYA 185

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI 664
           PE   +  FSV SDV+SFGV++ EL            +    +               LI
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV---FHLI 242

Query: 665 DKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLMLS 706
           +  L++   L     C      +   C       RP+   + L + 
Sbjct: 243 EL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  167 bits (425), Expect = 2e-46
 Identities = 80/286 (27%), Positives = 121/286 (42%), Gaps = 29/286 (10%)

Query: 437 ENKLGEGGFGPVYKGMLI-----DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
             +LG+G FG V            G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 492 KLLGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           K  G C     R   LI EYLP  SL D++     ++ +D  K  Q    I +G+ YL  
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL-- 161

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG-----YMP 604
               R IHRDL   N+L++NE   KI DFG+ +    D+        V   G     +  
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYA 216

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI 664
           PE   +  FSV SDV+SFGV++ EL            +    +               LI
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI---VFHLI 273

Query: 665 DKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLMLS 706
           +  L++   L     C      +   C       RP+   + L + 
Sbjct: 274 EL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  167 bits (424), Expect = 2e-46
 Identities = 83/303 (27%), Positives = 119/303 (39%), Gaps = 43/303 (14%)

Query: 437 ENKLGEGGFGPVYKGMLI---DGQEI--AVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNL 490
              LGEG FG V         DG     AVK L   +G Q    +K E+ ++  L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 491 VKLLGCCMKRDER--MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           +K  GCC         L+ EY+P  SL D++     R  +  ++       I  G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP---- 604
                  IHRDL A NVLLDN+   KI DFG+A+A             V   G  P    
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWY 204

Query: 605 -PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFHHVDHHHNLLGHAWRLWTEDRP-- 660
            PE   +  F   SDV+SFGV + EL+ +          D   +       L    +   
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHC---------DSSQSPPTKFLELIGIAQGQM 255

Query: 661 --VELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQP 714
             + L +  LE    L    +C      +   C +     RP   +++ +L       Q 
Sbjct: 256 TVLRLTEL-LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314

Query: 715 KQP 717
           + P
Sbjct: 315 QAP 317

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  164 bits (417), Expect = 1e-45
 Identities = 74/297 (24%), Positives = 123/297 (41%), Gaps = 41/297 (13%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI-----DGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL 485
                   LGEG FG V            G+++AVK L  +S G  + + K E+ ++  L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 486 QHRNLVKLLGCCMKRDER--MLIYEYLPNKSLADFIFDG----TRRKLLDWSKRCQIIGG 539
            H N+VK  G C +       LI E+LP+ SL +++         ++ L ++        
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV------Q 134

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           I +G+ YL      + +HRDL A NVL+++E   KI DFG+ +A   D+        V  
Sbjct: 135 ICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKD 187

Query: 600 YG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFHHVDHHHNLLGHAWR 653
                  +  PE  +   F + SDV+SFGV + EL+ Y   +           L      
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS------PMALFLKMIG 241

Query: 654 LWTEDRPVELIDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLMLS 706
                  V  +  +L++   L     C     Q+   C + +P +R +  +++    
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  161 bits (410), Expect = 2e-44
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 31/214 (14%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNL 490
              LG G FG VYKG+ I   E     +A+K L +++     +E  +E  ++A + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDG----TRRKLLDWSKRCQIIGGIARGLLY 546
            +LLG C+      LI + +P   L D++ +       + LL+W         IA+G+ Y
Sbjct: 80  CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNY 132

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-- 604
           L      R++HRDL A NVL+    + KI+DFG+A+  G ++ E +        G +P  
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIK 184

Query: 605 ---PEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
               E  +  +++ +SDV+S+GV V EL+ +G++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  160 bits (408), Expect = 1e-43
 Identities = 72/292 (24%), Positives = 114/292 (39%), Gaps = 38/292 (13%)

Query: 432 DNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRN 489
           ++     ++G G FG V+ G L  D   +AVK            +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +V+L+G C ++    ++ E +       F+   T    L      Q++G  A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
                 IHRDL A N L+  +   KISDFGM+R        A+         +  PE   
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 610 DGLFSVKSDVFSFGVLVLELV-YGTR------NRG-FHHVDHHHNLLGHAWRLWTEDRPV 661
            G +S +SDV+SFG+L+ E    G        N+     V+      G   RL     P 
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-----GG--RL---PCP- 337

Query: 662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQ 713
              +   +  + L            C    P  RP+ +++   L   R   +
Sbjct: 338 ---ELCPDAVFRLM---------EQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  158 bits (401), Expect = 2e-43
 Identities = 76/318 (23%), Positives = 126/318 (39%), Gaps = 58/318 (18%)

Query: 408 SELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQE----IAVKR 463
           S L    +++ +P  +             +  +G+G FG VY G  ID  +     A+K 
Sbjct: 5   SALLAEVKDVLIP-HERVVT-------HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS 56

Query: 464 LSK-SSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER-MLIYEYLPNKSLADFIFD 521
           LS+ +  Q VE F  E LL+  L H N++ L+G  +  +    ++  Y+ +  L  FI  
Sbjct: 57  LSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS 116

Query: 522 GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
              ++             +ARG+ YL   +  + +HRDL A N +LD     K++DFG+A
Sbjct: 117 --PQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLA 171

Query: 582 RAFGVDQTEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV------ 630
           R   +   E  + +    +      +   E      F+ KSDV+SFGVL+ EL+      
Sbjct: 172 R--DILDREYYSVQ-QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

Query: 631 -YGTRNRG-FHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCV 688
                     H +       G   RL    +P    +   +  Y +            C 
Sbjct: 229 YRHIDPFDLTHFLAQ-----GR--RL---PQP----EYCPDSLYQVM---------QQCW 265

Query: 689 QQRPEDRPNMASVVLMLS 706
           +  P  RP    +V  + 
Sbjct: 266 EADPAVRPTFRVLVGEVE 283

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  156 bits (396), Expect = 3e-43
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 14/202 (6%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
             ++G G FG V+ G  ++  ++A+K + +      E+F  E  ++ KL H  LV+L G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
           C+++    L+ E++ +  L+D++   T+R L        +   +  G+ YL       +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEYAIDGLF 613
           HRDL A N L+      K+SDFGM R    DQ  ++T    GT     +  PE      +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRY 182

Query: 614 SVKSDVFSFGVLVLELV-YGTR 634
           S KSDV+SFGVL+ E+   G  
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKI 204

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  156 bits (397), Expect = 7e-43
 Identities = 76/327 (23%), Positives = 132/327 (40%), Gaps = 62/327 (18%)

Query: 402 YIRMAT--SELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDG--- 456
           +I ++    EL    + + +       +            +G G FG VY G L+D    
Sbjct: 1   HIDLSALNPELVQAVQHVVIGP-SSLIV-------HFNEVIGRGHFGCVYHGTLLDNDGK 52

Query: 457 -QEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE-RMLIYEYLPNK 513
               AVK L++ +    V +F  E +++    H N++ LLG C++ +   +++  Y+ + 
Sbjct: 53  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 112

Query: 514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 573
            L +FI +                  +A+G+ YL   +  + +HRDL A N +LD +   
Sbjct: 113 DLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTV 167

Query: 574 KISDFGMARAFGVDQTEANTNRVVGTYG------YMPPEYAIDGLFSVKSDVFSFGVLVL 627
           K++DFG+AR    D  +     V    G      +M  E      F+ KSDV+SFGVL+ 
Sbjct: 168 KVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 223

Query: 628 ELV-------YGTRNRG-FHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALR 679
           EL+                 ++       G   RL    +P    +   +  Y +     
Sbjct: 224 ELMTRGAPPYPDVNTFDITVYLLQ-----GR--RL---LQP----EYCPDPLYEVM---- 265

Query: 680 CIQVGLLCVQQRPEDRPNMASVVLMLS 706
                L C   + E RP+ + +V  +S
Sbjct: 266 -----LKCWHPKAEMRPSFSELVSRIS 287

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  157 bits (398), Expect = 1e-42
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 31/214 (14%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNL 490
              LG G FG V+KG+ I   E     + +K +   SG Q  +   + +L I  L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDG----TRRKLLDWSKRCQIIGGIARGLLY 546
           V+LLG C       L+ +YLP  SL D +         + LL+W         IA+G+ Y
Sbjct: 78  VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYY 130

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-- 604
           L       ++HR+L A NVLL +    +++DFG+A     D  +   +         P  
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIK 182

Query: 605 ---PEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
               E    G ++ +SDV+S+GV V EL+ +G  
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  156 bits (396), Expect = 2e-42
 Identities = 66/259 (25%), Positives = 114/259 (44%), Gaps = 39/259 (15%)

Query: 398 GQDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQ 457
           G+   ++    E      +  +     + I         + +LGEG FG V+     +  
Sbjct: 14  GKGSGLQGHIIENPQYFSDACVHHIKRRDI-------VLKWELGEGAFGKVFLAECHNLL 66

Query: 458 E------IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP 511
                  +AVK L ++S    ++F+ E  L+  LQH+++V+  G C +    ++++EY+ 
Sbjct: 67  PEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMR 126

Query: 512 NKSLADF------------IFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 559
           +  L  F              +      L   +   +   +A G++YL   + L  +HRD
Sbjct: 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRD 183

Query: 560 LKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG-----YMPPEYAIDGLFS 614
           L   N L+   +  KI DFGM+R    D    +  R VG        +MPPE  +   F+
Sbjct: 184 LATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VGGRTMLPIRWMPPESILYRKFT 238

Query: 615 VKSDVFSFGVLVLELV-YG 632
            +SDV+SFGV++ E+  YG
Sbjct: 239 TESDVWSFGVVLWEIFTYG 257

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  154 bits (392), Expect = 2e-42
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 14/202 (6%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
             +LG G FG V  G      ++A+K + K      +EF  E  ++  L H  LV+L G 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
           C K+    +I EY+ N  L +++     R      +  ++   +   + YL      + +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142

Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEYAIDGLF 613
           HRDL A N L++++   K+SDFG++R    D+  ++     G+     + PPE  +   F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKF 198

Query: 614 SVKSDVFSFGVLVLELV-YGTR 634
           S KSD+++FGVL+ E+   G  
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKM 220

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  153 bits (389), Expect = 3e-42
 Identities = 64/202 (31%), Positives = 98/202 (48%), Gaps = 14/202 (6%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
             +LG G FG V  G      ++AVK + K      +EF  E   + KL H  LVK  G 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
           C K     ++ EY+ N  L +++   +  K L+ S+  ++   +  G+ +L      + I
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126

Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEYAIDGLF 613
           HRDL A N L+D ++  K+SDFGM R    DQ  ++     GT     +  PE      +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKY 182

Query: 614 SVKSDVFSFGVLVLELV-YGTR 634
           S KSDV++FG+L+ E+   G  
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKM 204

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  154 bits (392), Expect = 6e-42
 Identities = 76/327 (23%), Positives = 139/327 (42%), Gaps = 59/327 (18%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAKL 485
             F +   LG G FG VYKG+ I   E     +A+K L   +S +  +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDG----TRRKLLDWSKRCQIIGGIA 541
            + ++ +LLG C+      LI + +P   L D++ +       + LL+W         IA
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           +G+ YL      R++HRDL A NVL+    + KI+DFG+A+  G ++ E +        G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179

Query: 602 YMP-----PEYAIDGLFSVKSDVFSFGVLVLELV-YGTR------NRG-FHHVDH----- 643
            +P      E  +  +++ +SDV+S+GV V EL+ +G++             ++      
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239

Query: 644 --------HHNLLGHAWRLWTEDRPV-ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPED 694
                    + ++   W +  + RP    +           +    IQ         P D
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 299

Query: 695 RPNMASVV-------LMLSGERSLPQP 714
                +++       ++ + E  +PQ 
Sbjct: 300 SNFYRALMDEEDMDDVVDADEYLIPQQ 326

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  153 bits (388), Expect = 1e-41
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 33/221 (14%)

Query: 437 ENKLGEGGFGPVYKGMLIDG------QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           + +LGEG FG V+     +         +AVK L   +    ++F+ E  L+  LQH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADF-------------IFDGTRRKLLDWSKRCQII 537
           VK  G C   D  ++++EY+ +  L  F                   +  L  S+   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVV 597
             IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D    +  R V
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR-V 191

Query: 598 GTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV-YG 632
           G +      +MPPE  +   F+ +SDV+SFGV++ E+  YG
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  152 bits (387), Expect = 1e-41
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 49/287 (17%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
            +F E   +G GGFG V+K    IDG+   +KR+  ++    E+ + EV  +AKL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 491 VKLLGCCMKRDERM----------------LIYEYLPNKSLADFIFDGTRRKLLDWSKRC 534
           V   GC    D                   +  E+    +L  +I +  R + LD     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
           ++   I +G+ Y+H     ++I+RDLK SN+ L +    KI DFG+  +    + +    
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179

Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRL 654
           R  GT  YM PE      +  + D+++ G+++ EL++          +            
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV----CDTAFETSKFFT------ 229

Query: 655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
                  +L D  + D +   +  + +   LL  +  PEDRPN + +
Sbjct: 230 -------DLRDGIISDIF--DKKEKTLLQKLLSKK--PEDRPNTSEI 265

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  152 bits (387), Expect = 1e-41
 Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 48/284 (16%)

Query: 437 ENKLGEGGFGPVYKGMLIDG-QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           ++KLG G +G VY+G+       +AVK L K     VEEF  E  ++ +++H NLV+LLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
            C +     +I E++   +L D++ +   R+ +       +   I+  + YL    +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN-----RVVGTYGYMPPEYAID 610
           IHRDL A N L+      K++DFG++R    D   A+       +      +  PE    
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAY 186

Query: 611 GLFSVKSDVFSFGVLVLELV-YGTR------NRG-FHHVDHHHNLLGHAWRLWTEDRPVE 662
             FS+KSDV++FGVL+ E+  YG            +  ++       +  R+   +RP  
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----DY--RM---ERP-- 234

Query: 663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
             +   E  Y L            C Q  P DRP+ A +     
Sbjct: 235 --EGCPEKVYELM---------RACWQWNPSDRPSFAEIHQAFE 267

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  153 bits (389), Expect = 1e-41
 Identities = 84/321 (26%), Positives = 137/321 (42%), Gaps = 59/321 (18%)

Query: 438 NKLGEGGFGPVYKGMLIDGQE------IAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNL 490
            +LG+G FG VY+G+     +      +A+K +++ +S +   EF NE  ++ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADF-------IFDGTRRKLLDWSKRCQIIGGIARG 543
           V+LLG   +    ++I E +    L  +       + +         SK  Q+ G IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY- 602
           + YL   +  + +HRDL A N ++  +   KI DFGM R    D  E +  R  G  G  
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGKGLL 202

Query: 603 ----MPPEYAIDGLFSVKSDVFSFGVLVLELV-------YGTRNRG-FHHVDHHHNLLGH 650
               M PE   DG+F+  SDV+SFGV++ E+         G  N      V       G 
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME-----GG 257

Query: 651 AWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS 710
              L   D+P    D   +  + L           +C Q  P+ RP+   ++  +  E  
Sbjct: 258 --LL---DKP----DNCPDMLFELM---------RMCWQYNPKMRPSFLEIISSIKEEME 299

Query: 711 LPQPKQPGFFTERN-LPESES 730
               +   +++E N LPE E 
Sbjct: 300 PGFREVSFYYSEENKLPEPEE 320

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  150 bits (382), Expect = 4e-41
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 26/204 (12%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
              +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV+LLG 
Sbjct: 26  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82

Query: 497 CMKRDER-MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
            ++      ++ EY+   SL D++     R +L      +    +   + YL        
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG------YMPPEYAI 609
           +HRDL A NVL+  +   K+SDFG+ +    + +                  +  PE   
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTAPEALR 187

Query: 610 DGLFSVKSDVFSFGVLVLELV-YG 632
           +  FS KSDV+SFG+L+ E+  +G
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFG 211

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  151 bits (383), Expect = 4e-41
 Identities = 71/222 (31%), Positives = 110/222 (49%), Gaps = 34/222 (15%)

Query: 437 ENKLGEGGFGPVYKGMLIDG------QEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRN 489
             +LGE  FG VYKG L         Q +A+K L   + G   EEF++E +L A+LQH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADF-------------IFDGTRRKLLDWSKRCQI 536
           +V LLG   K     +I+ Y  +  L +F               D T +  L+      +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
           +  IA G+ YL   S   ++H+DL   NVL+ +++N KISD G+ R    +   A+  + 
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYK- 185

Query: 597 VGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV-YG 632
           +         +M PE  + G FS+ SD++S+GV++ E+  YG
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 227

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  150 bits (382), Expect = 5e-41
 Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 35/265 (13%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
             +LG G FG V+ G      ++AVK L K      + F  E  L+ +LQH+ LV+L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
             + +   +I EY+ N SL DF+        L  +K   +   IA G+ ++        I
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131

Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEYAIDGLF 613
           HRDL+A+N+L+ + ++ KI+DFG+AR    ++  A      G      +  PE    G F
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTF 187

Query: 614 SVKSDVFSFGVLVLELV-YGTR------NRG-FHHV-------------DHHHNLLGHAW 652
           ++KSDV+SFG+L+ E+V +G        N     ++             +  + L+   W
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247

Query: 653 RLWTEDRPV-ELIDKSLEDTYSLSE 676
           +   EDRP  + +   LED ++ +E
Sbjct: 248 KERPEDRPTFDYLRSVLEDFFTATE 272

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  150 bits (382), Expect = 6e-41
 Identities = 78/286 (27%), Positives = 115/286 (40%), Gaps = 44/286 (15%)

Query: 437 ENKLGEGGFGPVYKGML--IDGQEI--AVKRL---SKSSGQGVEEFKNEVLLIAKLQHRN 489
             KLG+G FG V +G      G+ +  AVK L     S  + +++F  EV  +  L HRN
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR----KLLDWSKRCQIIGGIARGLL 545
           L++L G  +      ++ E  P  SL D +           L  ++        +A G+ 
Sbjct: 83  LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMG 135

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGY 602
           YL      R IHRDL A N+LL      KI DFG+ RA   +               + +
Sbjct: 136 YL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAW 190

Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTRN-RGFHHVDHHHNLLGHAWRLWTEDRP 660
             PE      FS  SD + FGV + E+  YG     G +     H +     RL    RP
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---PRP 247

Query: 661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
               +   +D Y++          + C   +PEDRP   ++   L 
Sbjct: 248 ----EDCPQDIYNVM---------VQCWAHKPEDRPTFVALRDFLL 280

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  156 bits (395), Expect = 6e-41
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 38/279 (13%)

Query: 437 ENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           ++KLG G +G VY+G+       +AVK L K     VEEF  E  ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
            C +     +I E++   +L D++ +   R+ +       +   I+  + YL    +   
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNF 339

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSV 615
           IHR+L A N L+      K++DFG++R    D   A+         +  PE      FS+
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 398

Query: 616 KSDVFSFGVLVLELV-YGTR------NRG-FHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
           KSDV++FGVL+ E+  YG            +  ++       +  R+   +RP    +  
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----DY--RM---ERP----EGC 444

Query: 668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
            E  Y L            C Q  P DRP+ A +     
Sbjct: 445 PEKVYELM---------RACWQWNPSDRPSFAEIHQAFE 474

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  151 bits (384), Expect = 7e-41
 Identities = 77/282 (27%), Positives = 120/282 (42%), Gaps = 51/282 (18%)

Query: 437 ENKLGEGGFGPVYKGMLI--DGQEI--AVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           E  +G G  G V  G L     +++  A+K L +  + +   +F +E  ++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDG----TRRKLLDWSKRCQIIGGIARGLLYL 547
           +L G   +    M++ EY+ N SL  F+       T  +L+   +      G+  G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR------GVGAGMRYL 167

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG------ 601
              S L  +HRDL A NVL+D+ +  K+SDFG++R    D   A T     T G      
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIR 219

Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR--------------NRGF------HH 640
           +  PE      FS  SDV+SFGV++ E++ YG R                G+        
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGC 279

Query: 641 VDHHHNLLGHAWRLWTEDRPV-ELIDKSLEDTYSLSEALRCI 681
               H L+   W      RP    I   L+      E+LR  
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRAT 321

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  152 bits (387), Expect = 8e-41
 Identities = 74/285 (25%), Positives = 125/285 (43%), Gaps = 42/285 (14%)

Query: 437 ENKLGEGGFGPVYKGMLIDG----QEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
              +G G FG VY G L+D        AVK L++ +    V +F  E +++    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 492 KLLGCCMKRDE-RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
            LLG C++ +   +++  Y+ +  L +FI +                  +A+G+ +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL--- 208

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG------YMP 604
           +  + +HRDL A N +LD +   K++DFG+AR    D  +   + V    G      +M 
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMA 264

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELV-YGTRNRGFHHVDHHH--NLLGHAWRLWTEDRPV 661
            E      F+ KSDV+SFGVL+ EL+  G     +  V+       L    RL    +P 
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDITVYLLQGRRL---LQP- 318

Query: 662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
              +   +  Y +          L C   + E RP+ + +V  +S
Sbjct: 319 ---EYCPDPLYEVM---------LKCWHPKAEMRPSFSELVSRIS 351

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  150 bits (382), Expect = 1e-40
 Identities = 75/311 (24%), Positives = 129/311 (41%), Gaps = 44/311 (14%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRL---SKSSGQGVEEFKNEVLLIAKLQH 487
            NF  E K+G G F  VY+   L+DG  +A+K++        +   +   E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-FDGTRRKLLDWSKRCQIIGGIARGLLY 546
            N++K     ++ +E  ++ E      L+  I     +++L+      +    +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           +H     R++HRD+K +NV +      K+ D G+ R F    T A++  +VGT  YM PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206

Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK 666
              +  ++ KSD++S G L+ E+        F+      NL               L  K
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMA--ALQSPFY--GDKMNLY-------------SLCKK 249

Query: 667 SLEDTYS------LSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFF 720
             +  Y        SE LR  Q+  +C+   PE RP++  V             K+    
Sbjct: 250 IEQCDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDVTYV---------YDVAKRMHAC 298

Query: 721 TERNLPESESS 731
           T  +L      
Sbjct: 299 TASSLEHHHHH 309

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  154 bits (390), Expect = 1e-40
 Identities = 81/281 (28%), Positives = 126/281 (44%), Gaps = 44/281 (15%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG G FG V+        ++AVK + K     VE F  E  ++  LQH  LVKL   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
             K +   +I E++   SL DF+            K       IA G+ ++    +   I
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYI 306

Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEYAIDGLF 613
           HRDL+A+N+L+   +  KI+DFG+AR    ++  A      G      +  PE    G F
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSF 362

Query: 614 SVKSDVFSFGVLVLELV-YGTR------NRG-FHHVDHHHNLLGHAWRLWTEDRPVELID 665
           ++KSDV+SFG+L++E+V YG        N      ++      G+  R+    RP    +
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-----GY--RM---PRP----E 408

Query: 666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
              E+ Y++          + C + RPE+RP    +  +L 
Sbjct: 409 NCPEELYNIM---------MRCWKNRPEERPTFEYIQSVLD 440

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  149 bits (379), Expect = 2e-40
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 28/213 (13%)

Query: 436 EENKLGEGGFGPVYKGMLIDG---QEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG        + +AVK L    +     +E   E  ++ +L +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDG---TRRKLLDWSKRCQIIGGIARGLLYL 547
           V+++G C   +  ML+ E      L  ++        + +++          ++ G+ YL
Sbjct: 81  VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH------QVSMGMKYL 133

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP--- 604
                   +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P   
Sbjct: 134 ---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKW 186

Query: 605 --PEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
             PE      FS KSDV+SFGVL+ E   YG +
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  153 bits (389), Expect = 2e-40
 Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 38/278 (13%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
             + +   ++ EY+   SL DF+      K L   +   +   IA G+ Y+    R+  +
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302

Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361

Query: 617 SDVFSFGVLVLELV-YGTR------NRG-FHHVDHHHNLLGHAWRLWTEDRPVELIDKSL 668
           SDV+SFG+L+ EL   G        NR     V+      G+  R+     P     +  
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----GY--RM---PCP----PECP 407

Query: 669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
           E  + L            C ++ PE+RP    +   L 
Sbjct: 408 ESLHDLM---------CQCWRKEPEERPTFEYLQAFLE 436

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  150 bits (382), Expect = 2e-40
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 23/211 (10%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNL 490
           +  +G G FG VYKGML          +A+K L    + +   +F  E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           ++L G   K    M+I EY+ N +L  F+    +       +   ++ GIA G+ YL   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL--- 163

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG------YMP 604
           + +  +HRDL A N+L+++ +  K+SDFG++R    D     T     T G      +  
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRWTA 218

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           PE      F+  SDV+SFG+++ E++ YG R
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  153 bits (389), Expect = 2e-40
 Identities = 69/281 (24%), Positives = 113/281 (40%), Gaps = 48/281 (17%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
              +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV+LLG 
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 497 CMKRDER-MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI 555
            ++      ++ EY+   SL D++     R +L      +    +   + YL        
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 310

Query: 556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY--MPPEYAIDGLF 613
           +HRDL A NVL+  +   K+SDFG+ +       EA++ +  G        PE   +  F
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363

Query: 614 SVKSDVFSFGVLVLELV-YG-------TRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID 665
           S KSDV+SFG+L+ E+  +G               V+      G+  ++   D P    D
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-----GY--KM---DAP----D 409

Query: 666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
                 Y +            C       RP    +   L 
Sbjct: 410 GCPPAVYDVM---------KNCWHLDAATRPTFLQLREQLE 441

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  148 bits (377), Expect = 3e-40
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 20/209 (9%)

Query: 436 EENKLGEGGFGPVYKGMLIDGQE---IAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
            + +LG G FG V +G+    ++   +A+K L + +     EE   E  ++ +L +  +V
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L+G C   +  ML+ E      L  F+    +R+ +  S   +++  ++ G+ YL    
Sbjct: 74  RLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PE 606
               +HRDL A NVLL N    KISDFG+++A G D +         + G  P     PE
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGKWPLKWYAPE 183

Query: 607 YAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
                 FS +SDV+S+GV + E + YG +
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  150 bits (380), Expect = 3e-40
 Identities = 83/296 (28%), Positives = 121/296 (40%), Gaps = 58/296 (19%)

Query: 437 ENKLGEGGFGPVYKGMLIDG------QEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRN 489
              LG G FG VY+G +          ++AVK L +  S Q   +F  E L+I+K  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFI----FDGTRRKLLDWSKRCQIIGGIARGLL 545
           +V+ +G  ++   R ++ E +    L  F+       ++   L       +   IA G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           YL        IHRD+ A N LL         KI DFGMAR    D   A+  R  G    
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAM 206

Query: 603 -----MPPEYAIDGLFSVKSDVFSFGVLVLELV-------YGTRNRG-FHHVDHHHNLLG 649
                MPPE  ++G+F+ K+D +SFGVL+ E+            N+     V       G
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-----G 261

Query: 650 HAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
              R+   D P           Y +            C Q +PEDRPN A ++  +
Sbjct: 262 G--RM---DPP----KNCPGPVYRIM---------TQCWQHQPEDRPNFAIILERI 299

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  149 bits (378), Expect = 4e-40
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 23/225 (10%)

Query: 424 WKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLL 481
           ++S++     +S   ++G GG   V++ +    Q  A+K ++      Q ++ ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79

Query: 482 IAKLQHRNL--VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG 539
           + KLQ  +   ++L    +      ++ E   N  L  ++    ++K +D  +R      
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKN 135

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +   +  +HQ     I+H DLK +N L+ +    K+ DFG+A     D T    +  VGT
Sbjct: 136 MLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 600 YGYMPPE-----------YAIDGLFSVKSDVFSFGVLVLELVYGT 633
             YMPPE                  S KSDV+S G ++  + YG 
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (379), Expect = 6e-40
 Identities = 70/332 (21%), Positives = 134/332 (40%), Gaps = 39/332 (11%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHR 488
           + +    K+GEG FG         DG++  +K   +S+ S +  EE + EV ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+V+      +     ++ +Y     L   I +  +  L    +       I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                +I+HRD+K+ N+ L  +   ++ DFG+AR        A     +GT  Y+ PE  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL 668
            +  ++ KSD+++ G ++ EL   T    F                        L+ K +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELC--TLKHAFEAGSMK-----------------NLVLKII 238

Query: 669 EDTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASV----VLMLSGERSLPQPKQPGF 719
             ++       S  LR +   L   ++ P DRP++ S+     +    E+ L        
Sbjct: 239 SGSFPPVSLHYSYDLRSLVSQLF--KRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEE 296

Query: 720 FTERNLPESESSSSNQTFHSSNQITVSLIEGR 751
           F  +   +  S        +S Q ++S++  +
Sbjct: 297 FCLKTFSKFGSQPIPAKRPASGQNSISVMPAQ 328

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  148 bits (376), Expect = 6e-40
 Identities = 75/297 (25%), Positives = 128/297 (43%), Gaps = 58/297 (19%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQE----IAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNL 490
              LGEG FG V +G L         +AVK +    SS + +EEF +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 491 VKLLGCCMKRD-----ERMLIYEYLPNKSLADFI---FDGTRRKLLDWSKRCQIIGGIAR 542
           ++LLG C++       + M+I  ++    L  ++      T  K +      + +  IA 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG- 601
           G+ YL   S    +HRDL A N +L ++M   ++DFG+++         +  R  G    
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYR-QGRIAK 210

Query: 602 ----YMPPEYAIDGLFSVKSDVFSFGVLVLELV-------YGTRNRG-FHHVDHHHNLLG 649
               ++  E   D +++ KSDV++FGV + E+         G +N   + ++ H     G
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH-----G 265

Query: 650 HAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
           H  RL    +P    +  L++ Y +            C +  P DRP  + + L L 
Sbjct: 266 H--RL---KQP----EDCLDELYEIM---------YSCWRTDPLDRPTFSVLRLQLE 304

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  150 bits (380), Expect = 7e-40
 Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 42/300 (14%)

Query: 437 ENKLGEGGFGPVYKGMLI--DGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
           +  +G G FG V  G L     +EI  A+K L    + +   +F  E  ++ +  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L G   K    M++ EY+ N SL  F+            +   ++ GIA G+ YL   S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT---YGYMPPEYA 608
            +  +HRDL A N+L+++ +  K+SDFG+ R    D   A T R  G      +  PE  
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAI 222

Query: 609 IDGLFSVKSDVFSFGVLVLELV-YGTR------NRG-FHHVDH-------------HHNL 647
               F+  SDV+S+G+++ E++ YG R      N+     VD               + L
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL 282

Query: 648 LGHAWRLWTEDRP-----VELIDKSLEDTYSLSEALR-CIQVGLLCVQQRPEDRPNMASV 701
           +   W+    +RP     V ++DK + +  SL        +   L + Q   D     + 
Sbjct: 283 MLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTT 342

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  153 bits (388), Expect = 9e-40
 Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 38/278 (13%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           E KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRII 556
             + +   ++ EY+   SL DF+      K L   +   +   IA G+ Y+    R+  +
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 385

Query: 557 HRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 616
           HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444

Query: 617 SDVFSFGVLVLELV-YGTR------NRG-FHHVDHHHNLLGHAWRLWTEDRPVELIDKSL 668
           SDV+SFG+L+ EL   G        NR     V+      G+  R+     P     +  
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----GY--RM---PCP----PECP 490

Query: 669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
           E  + L            C ++ PE+RP    +   L 
Sbjct: 491 ESLHDLM---------CQCWRKEPEERPTFEYLQAFLE 519

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  148 bits (376), Expect = 1e-39
 Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 65/300 (21%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQE---IAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRNLV 491
           ++ +GEG FG V K  +         A+KR+   +S     +F  E+ ++ KL  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADF-------------IFDGTRRKLLDWSKRCQIIG 538
            LLG C  R    L  EY P+ +L DF                 +    L   +      
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN---- 594
            +ARG+ YL   S+ + IHRDL A N+L+      KI+DFG++R  G +     T     
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 204

Query: 595 -RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR-------NRGFHHVDHHH 645
            R      +M  E     +++  SDV+S+GVL+ E+V  G            +  +    
Sbjct: 205 VR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 256

Query: 646 NLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
              G+  RL   ++P        ++ Y L            C +++P +RP+ A +++ L
Sbjct: 257 ---GY--RL---EKP----LNCDDEVYDLM---------RQCWREKPYERPSFAQILVSL 295

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  148 bits (375), Expect = 1e-39
 Identities = 71/298 (23%), Positives = 122/298 (40%), Gaps = 59/298 (19%)

Query: 437 ENKLGEGGFGPVYKGMLIDG----QEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNL 490
              LG+G FG V +  L        ++AVK L     +   +EEF  E   + +  H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 491 VKLLGCCMKRDER------MLIYEYLPNKSLADFIFD---GTRRKLLDWSKRCQIIGGIA 541
            KL+G  ++   +      M+I  ++ +  L  F+     G     L      + +  IA
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
            G+ YL   S    IHRDL A N +L  +M   ++DFG++R         +  R  G   
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYR-QGCAS 199

Query: 602 -----YMPPEYAIDGLFSVKSDVFSFGVLVLELV-------YGTRNRG-FHHVDHHHNLL 648
                ++  E   D L++V SDV++FGV + E++        G  N   ++++       
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG----- 254

Query: 649 GHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
           G+  RL    +P     + +E+ Y L            C    P+ RP+   + + L 
Sbjct: 255 GN--RL---KQP----PECMEEVYDLM---------YQCWSADPKQRPSFTCLRMELE 294

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  147 bits (374), Expect = 1e-39
 Identities = 65/296 (21%), Positives = 115/296 (38%), Gaps = 52/296 (17%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
             +F E   LG+G FG V K    +D +  A+K++  +  + +    +EV+L+A L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 490 LVKLLGC----------CMKRDERMLIY---EYLPNKSLADFIFDGTRRKLLDWSKRCQI 536
           +V+                   ++  ++   EY  N +L D I   +        +  ++
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF------------ 584
              I   L Y+H      IIHRDLK  N+ +D   N KI DFG+A+              
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 585 GVDQTEANTNRVVGTYGYMPPE-YAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH 643
            +  +  N    +GT  Y+  E     G ++ K D++S G++  E++Y      F     
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-----PFSTGME 233

Query: 644 HHNLLGHAWRLWTEDRPVELIDKSLEDTYS--LSEALRCIQVGLLCVQQRPEDRPN 697
             N+L          + +  +       +     +  + I   L+     P  RP 
Sbjct: 234 RVNIL----------KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH--DPNKRPG 277

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  147 bits (372), Expect = 1e-39
 Identities = 50/226 (22%), Positives = 93/226 (41%), Gaps = 49/226 (21%)

Query: 437 ENKLGEGGFGPVYKGML--------IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR 488
              LG+G F  ++KG+         +   E+ +K L K+     E F     +++KL H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDG----TRRKLLDWSKRCQIIGGIARGL 544
           +LV   G C+  DE +L+ E++   SL  ++            L+ +K       +A  +
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK------QLAAAM 126

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNP--------KISDFGMARAFGVDQTEANTNRV 596
            +L       +IH ++ A N+LL  E +         K+SD G++              V
Sbjct: 127 HFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------V 171

Query: 597 VGTYGY------MPPEYAIDG-LFSVKSDVFSFGVLVLELV-YGTR 634
           +           +PPE   +    ++ +D +SFG  + E+   G +
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  148 bits (375), Expect = 1e-39
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 23/211 (10%)

Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNL--VKL 493
            ++G GG   V++ +    Q  A+K ++      Q ++ ++NE+  + KLQ  +   ++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
               +      ++ E   N  L  ++    ++K +D  +R      +   +  +HQ    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE------- 606
            I+H DLK +N L+ +    K+ DFG+A     D T    +  VGT  YMPPE       
Sbjct: 128 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 607 ----YAIDGLFSVKSDVFSFGVLVLELVYGT 633
                      S KSDV+S G ++  + YG 
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  149 bits (377), Expect = 2e-39
 Identities = 83/296 (28%), Positives = 120/296 (40%), Gaps = 58/296 (19%)

Query: 437 ENKLGEGGFGPVYKGMLIDG------QEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRN 489
              LG G FG VY+G +          ++AVK L +  S Q   +F  E L+I+K  H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFI----FDGTRRKLLDWSKRCQIIGGIARGLL 545
           +V+ +G  ++   R ++ E +    L  F+       ++   L       +   IA G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           YL        IHRD+ A N LL         KI DFGMAR    D   A   R  G    
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-KGGCAM 247

Query: 603 -----MPPEYAIDGLFSVKSDVFSFGVLVLELV-------YGTRNRG-FHHVDHHHNLLG 649
                MPPE  ++G+F+ K+D +SFGVL+ E+            N+     V       G
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-----G 302

Query: 650 HAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
              R+   D P           Y +            C Q +PEDRPN A ++  +
Sbjct: 303 G--RM---DPP----KNCPGPVYRIM---------TQCWQHQPEDRPNFAIILERI 340

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  146 bits (371), Expect = 2e-39
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 33/214 (15%)

Query: 437 ENKLGEGGFGPVYKGMLI--DGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
              LGEG FG VY+G+     G++I  AVK   K  +    E+F +E +++  L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDG----TRRKLLDWSKRCQIIGGIARGLLYL 547
           KL+G   + +   +I E  P   L  ++           L+ +S        I + + YL
Sbjct: 77  KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICKAMAYL 129

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG------ 601
                +  +HRD+   N+L+ +    K+ DFG++R    +     +              
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-------VTRLPIK 179

Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
           +M PE      F+  SDV+ F V + E++ +G +
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  149 bits (377), Expect = 2e-39
 Identities = 77/345 (22%), Positives = 137/345 (39%), Gaps = 48/345 (13%)

Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNL 490
            +S   ++G GG   V++ +    Q  A+K ++      Q ++ ++NE+  + KLQ  + 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 491 --VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
             ++L    +      ++ E   N  L  ++    ++K +D  +R      +   +  +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE-- 606
           Q     I+H DLK +N L+ +    K+ DFG+A     D T    +  VG   YMPPE  
Sbjct: 173 Q---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 607 ---------YAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE 657
                           S KSDV+S G ++  + YG     F  + +  + L     +   
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKL---HAIIDP 283

Query: 658 DRPVEL---IDKSLEDT------------YSLSEALRC--IQVGLLCVQQRPED-RPNMA 699
           +  +E     +K L+D              S+ E L    +Q+    V Q  +     M 
Sbjct: 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMK 343

Query: 700 SVVLMLSGERSLPQPKQPG--FFTERNLPESESSSSNQTFHSSNQ 742
            V+  L G  S     +     +   +  ES +SSS++TF     
Sbjct: 344 YVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 388

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  146 bits (370), Expect = 3e-39
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 27/224 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRN 489
            +F     LG GGFG V++    +D    A+KR+         E+   EV  +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 490 LVKLLGC---------CMKRDERMLIY---EYLPNKSLADFIFDGTRRKLLDWSKRCQII 537
           +V+                   ++ +Y   +    ++L D++      +  + S    I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV- 596
             IA  + +LH      ++HRDLK SN+    +   K+ DFG+  A   D+ E       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 597 ---------VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY 631
                    VGT  YM PE      +S K D+FS G+++ EL+Y
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  145 bits (368), Expect = 4e-39
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 437 ENKLGEGGFGPVYKGMLI--DGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 491
              +GEG FG V++G+ +  +   +  A+K     +S    E+F  E L + +  H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           KL+G   + +   +I E      L  F+    R+  LD +        ++  L YL    
Sbjct: 80  KLIGVITE-NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYL---E 133

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN-----RVVGTYGYMPPE 606
             R +HRD+ A NVL+ +    K+ DFG++R          +      +      +M PE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAPE 187

Query: 607 YAIDGLFSVKSDVFSFGVLVLELV-YGTR 634
                 F+  SDV+ FGV + E++ +G +
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  147 bits (372), Expect = 4e-39
 Identities = 74/310 (23%), Positives = 123/310 (39%), Gaps = 67/310 (21%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +            +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF-------------IFDGTRRKLL 528
             + +H+N++ LLG C +     +I EY    +L ++               +    + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    D 
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207

Query: 589 TEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV-------YGTRNR 636
              +  +   T G     +M PE   D +++ +SDV+SFGVL+ E+         G    
Sbjct: 208 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

Query: 637 G-FHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDR 695
             F  +       GH  R+   D+P         + Y +            C    P  R
Sbjct: 267 ELFKLLKE-----GH--RM---DKP----ANCTNELYMMM---------RDCWHAVPSQR 303

Query: 696 PNMASVVLML 705
           P    +V  L
Sbjct: 304 PTFKQLVEDL 313

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  146 bits (370), Expect = 4e-39
 Identities = 83/315 (26%), Positives = 131/315 (41%), Gaps = 72/315 (22%)

Query: 432 DNFSEENKLGEGGFGPVYKGML--IDGQE----IAVKRL-SKSSGQGVEEFKNEVLLIAK 484
            N      LGEG FG V K     + G+     +AVK L   +S   + +  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF---------------------IFDGT 523
           + H +++KL G C +    +LI EY    SL  F                       D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 524 RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 583
             + L           I++G+ YL   + ++++HRDL A N+L+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198

Query: 584 FGVDQTEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV-------Y 631
              D  E ++     + G     +M  E   D +++ +SDV+SFGVL+ E+V        
Sbjct: 199 ---DVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254

Query: 632 GTRNRG-FHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQ 690
           G      F+ +       GH  R+   +RP    D   E+ Y L          L C +Q
Sbjct: 255 GIPPERLFNLLKT-----GH--RM---ERP----DNCSEEMYRLM---------LQCWKQ 291

Query: 691 RPEDRPNMASVVLML 705
            P+ RP  A +   L
Sbjct: 292 EPDKRPVFADISKDL 306

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  146 bits (371), Expect = 5e-39
 Identities = 74/310 (23%), Positives = 124/310 (40%), Gaps = 72/310 (23%)

Query: 437 ENKLGEGGFGPVYKGMLIDG------QEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRN 489
              +GEG FG V++              +AVK L  ++S     +F+ E  L+A+  + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADF---------------------IFDGTRRKLL 528
           +VKLLG C       L++EY+    L +F                              L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
             +++  I   +A G+ YL   S  + +HRDL   N L+   M  KI+DFG++R    + 
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NI 224

Query: 589 TEANTNRVVGTYGY-----MPPEYAIDGLFSVKSDVFSFGVLVLELV-------YGTRNR 636
             A+  +            MPPE      ++ +SDV+++GV++ E+        YG  + 
Sbjct: 225 YSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283

Query: 637 G-FHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDR 695
              ++V       G+   L     P    +    + Y+L           LC  + P DR
Sbjct: 284 EVIYYVRD-----GN--IL---ACP----ENCPLELYNLM---------RLCWSKLPADR 320

Query: 696 PNMASVVLML 705
           P+  S+  +L
Sbjct: 321 PSFCSIHRIL 330

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  147 bits (374), Expect = 6e-39
 Identities = 80/339 (23%), Positives = 139/339 (41%), Gaps = 69/339 (20%)

Query: 437 ENKLGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-Q 486
              LGEG FG V     I           ++AVK L S ++ + + +  +E+ ++  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG------- 539
           H+N++ LLG C +     +I EY    +L +++    R   L++S               
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 540 -------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    D    +
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 245

Query: 593 TNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV-YG-------TRNRGFH 639
             +   T G     +M PE   D +++ +SDV+SFGVL+ E+   G            F 
Sbjct: 246 YYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

Query: 640 HVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMA 699
            +       GH  R+   D+P         + Y +            C    P  RP   
Sbjct: 305 LLKE-----GH--RM---DKP----SNCTNELYMMM---------RDCWHAVPSQRPTFK 341

Query: 700 SVVLMLSGERSLPQPKQPGFFTERNLPESESSSSNQTFH 738
            +V  L    +L   ++ G++   +  + +  ++   + 
Sbjct: 342 QLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYF 380

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  144 bits (366), Expect = 9e-39
 Identities = 66/294 (22%), Positives = 117/294 (39%), Gaps = 35/294 (11%)

Query: 408 SELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSK 466
            +  +   E +    +            +   LG+G +G VY G  L +   IA+K + +
Sbjct: 8   GDCESDLLEYDYEYDENG----------DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE 57

Query: 467 SSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK 526
              +  +    E+ L   L+H+N+V+ LG   +     +  E +P  SL+  +       
Sbjct: 58  RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL 117

Query: 527 LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFG 585
             +          I  GL YLH +   +I+HRD+K  NVL++      KISDFG ++   
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174

Query: 586 VDQTEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLELVYGTRNRGFHHVD 642
                  T    GT  YM PE  ID     +   +D++S G  ++E+   T    F+ + 
Sbjct: 175 GINPCTET--FTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMA--TGKPPFYELG 229

Query: 643 HHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRP 696
                +   +++       E+ +       S+S   +     L C +  P+ R 
Sbjct: 230 EPQAAM---FKVGMFKVHPEIPE-------SMSAEAK--AFILKCFEPDPDKRA 271

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  151 bits (382), Expect = 1e-38
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 20/208 (9%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQE---IAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVK 492
           + +LG G FG V +G+    ++   +A+K L   +     EE   E  ++ +L +  +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
           L+G C + +  ML+ E      L  F+    +R+ +  S   +++  ++ G+ YL     
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 454

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP-----PEY 607
              +HR+L A NVLL N    KISDFG+++A G D +         + G  P     PE 
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGKWPLKWYAPEC 510

Query: 608 AIDGLFSVKSDVFSFGVLVLELV-YGTR 634
                FS +SDV+S+GV + E + YG +
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQK 538

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  144 bits (364), Expect = 1e-38
 Identities = 62/266 (23%), Positives = 112/266 (42%), Gaps = 31/266 (11%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           ++G G F  VYKG+      E+A    +  K +    + FK E  ++  LQH N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 496 CCM---KRDERMLIY-EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
                 K  + +++  E + + +L  ++    R K++           I +GL +LH  +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 552 RLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
              IIHRDLK  N+ +     + KI D G+A      +  +    V+GT  +M PE   +
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM-YE 203

Query: 611 GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED 670
             +    DV++FG+ +LE+   T    +    +   +    +R  T        DK    
Sbjct: 204 EKYDESVDVYAFGMCMLEMA--TSEYPYSECQNAAQI----YRRVTSGVKPASFDKVA-- 255

Query: 671 TYSLSEALRCIQVGLLCVQQRPEDRP 696
                  ++ I     C++Q  ++R 
Sbjct: 256 ----IPEVKEII--EGCIRQNKDERY 275

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  144 bits (366), Expect = 2e-38
 Identities = 72/304 (23%), Positives = 115/304 (37%), Gaps = 67/304 (22%)

Query: 438 NKLGEGGFGPVYKGML--IDGQE----IAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRN 489
             LG G FG V +     ID       +AVK L   ++        +E+ ++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 490 LVKLLGCCMKRDE-RMLIYEYLPNKSLADF-------------IFDGTRRKLLDWSKRCQ 535
           +V LLG C K     M+I E+    +L+ +               +   +  L       
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
               +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D  +     
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYV 205

Query: 596 VVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV-YG-------TRNRG-FHHV 641
                      +M PE   D +++++SDV+SFGVL+ E+   G         +      +
Sbjct: 206 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

Query: 642 DHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
                  G   R+     P    D +  + Y            L C    P  RP  + +
Sbjct: 265 KE-----GT--RM---RAP----DYTTPEMYQTM---------LDCWHGEPSQRPTFSEL 301

Query: 702 VLML 705
           V  L
Sbjct: 302 VEHL 305

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  143 bits (362), Expect = 2e-38
 Identities = 74/283 (26%), Positives = 118/283 (41%), Gaps = 36/283 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 488
           +++     +G G +G   K     DG+ +  K L     +    +   +EV L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 489 NLVKLLGCCMKRDERML--IYEYLPNKSLADFIFDGTRRK-LLDWSKRCQIIGGIARGLL 545
           N+V+     + R    L  + EY     LA  I  GT+ +  LD     +++  +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 546 YLHQ--DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             H+  D    ++HRDLK +NV LD + N K+ DFG+AR    D + A T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
            PE      ++ KSD++S G L+ EL        F                       EL
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELC--ALMPPFTAFSQK-----------------EL 224

Query: 664 IDKSLEDTYS-----LSEALRCIQVGLLCVQQRPEDRPNMASV 701
             K  E  +       S+ L  I   +L ++     RP++  +
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLK--DYHRPSVEEI 265

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  145 bits (368), Expect = 2e-38
 Identities = 74/310 (23%), Positives = 123/310 (39%), Gaps = 67/310 (21%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID--------GQEIAVKRL-SKSSGQGVEEFKNEVLLI 482
           D  +    LGEG FG V     +            +AVK L   ++ + + +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF-------------IFDGTRRKLL 528
             + +H+N++ LLG C +     +I EY    +L ++               +    + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    D 
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253

Query: 589 TEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV-------YGTRNR 636
              +  +   T G     +M PE   D +++ +SDV+SFGVL+ E+         G    
Sbjct: 254 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312

Query: 637 G-FHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDR 695
             F  +       GH  R+   D+P         + Y +            C    P  R
Sbjct: 313 ELFKLLKE-----GH--RM---DKP----ANCTNELYMMM---------RDCWHAVPSQR 349

Query: 696 PNMASVVLML 705
           P    +V  L
Sbjct: 350 PTFKQLVEDL 359

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  144 bits (366), Expect = 3e-38
 Identities = 63/226 (27%), Positives = 95/226 (42%), Gaps = 33/226 (14%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQE------IAVKRL-SKSSGQGVEEFKNEVLLIAK 484
           +N      LG G FG V +       +      +AVK L S +     E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 485 L-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF-----------IFDGTRRKLLDWSK 532
           L QH N+V LLG C      ++I EY     L +F                         
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 533 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
                  +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D    +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDS 218

Query: 593 TNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV-YG 632
               V         +M PE   D +++V+SDV+S+G+L+ E+   G
Sbjct: 219 NYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 263

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  143 bits (362), Expect = 5e-38
 Identities = 67/304 (22%), Positives = 117/304 (38%), Gaps = 40/304 (13%)

Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           ++    KLGEGGF  V     L DG   A+KR+     Q  EE + E  +     H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 492 KLLGCCMKRDERM----LIYEYLPNKSLADFIFDGTRRK-LLDWSKRCQIIGGIARGLLY 546
           +L+  C++         L+  +    +L + I     +   L   +   ++ GI RGL  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVV-------GT 599
           +H        HRDLK +N+LL +E  P + D G      +    +     +        T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 600 YGYMPPEYAIDG----LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW 655
             Y  PE         +   ++DV+S G ++  +++G     +  V    + +  A    
Sbjct: 207 ISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE--GPYDMVFQKGDSVALA---- 259

Query: 656 TEDRPVELIDKSLE--DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQ 713
                   +   L    +   S AL  +   ++ V   P  RP++  ++  L   +  P 
Sbjct: 260 --------VQNQLSIPQSPRHSSALWQLLNSMMTVD--PHQRPHIPLLLSQLEALQP-PA 308

Query: 714 PKQP 717
           P Q 
Sbjct: 309 PGQH 312

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  141 bits (358), Expect = 2e-37
 Identities = 63/233 (27%), Positives = 98/233 (42%), Gaps = 48/233 (20%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQE------IAVKRLSKS-SGQGVEEFKNEVLLIAK 484
           +  S    LG G FG V +       +      +AVK L  S      E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 485 L-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF---------------------IFDG 522
           L  H N+V LLG C      ++I EY     L +F                         
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 523 TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 582
               LL +S   Q+    A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR
Sbjct: 143 DLEDLLSFSY--QV----AKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 583 AFGVDQTEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
                  + ++N VV         +M PE   + +++ +SDV+S+G+ + EL 
Sbjct: 194 -----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  145 bits (368), Expect = 1e-36
 Identities = 68/292 (23%), Positives = 115/292 (39%), Gaps = 43/292 (14%)

Query: 437 ENKLGEGGFGPVYKGMLI--DGQEI--AVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLV 491
              +GEG FG V++G+ +  +   +  A+K   + +S    E+F  E L + +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           KL+G   + +   +I E      L  F+    R+  LD +        ++  L YL    
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
             R +HRD+ A NVL+ +    K+ DFG++R          +   +    +M PE     
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFR 567

Query: 612 LFSVKSDVFSFGVLVLELV-YGTR------NRG-FHHVDHHHNLLGHAWRLWTEDRPVEL 663
            F+  SDV+ FGV + E++ +G +      N      +++     G   RL     P   
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-----GE--RL---PMP--- 614

Query: 664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPK 715
                   YSL            C    P  RP    +   LS      + +
Sbjct: 615 -PNCPPTLYSLM---------TKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  138 bits (351), Expect = 2e-36
 Identities = 63/271 (23%), Positives = 99/271 (36%), Gaps = 36/271 (13%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL-QH 487
            +F   ++LG G +G V+K     DG+  AVKR        +       EV    K+ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
              V+L     +     L  E     SL            L  ++    +      L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H      ++H D+K +N+ L      K+ DFG+    G            G   YM PE 
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGDPRYMAPE- 226

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
            + G +   +DVFS G+ +LE+               H   G  W+        +L    
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME--------LPHG--GEGWQ--------QLRQGY 268

Query: 668 LEDTYS--LSEALRCIQVGLLCVQQRPEDRP 696
           L   ++  LS  LR   V ++ ++  P+ R 
Sbjct: 269 LPPEFTAGLSSELR--SVLVMMLEPDPKLRA 297

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  139 bits (353), Expect = 2e-36
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 41/227 (18%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQE------IAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHR 488
              LG G FG V         +      +AVK L +       E   +E+ ++ +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADF-----------IFDGTRRKLLDWSKRCQII 537
           N+V LLG C       LI+EY     L ++             +   +K L+  +   ++
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 538 GG---------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                      +A+G+ +L        +HRDL A NVL+ +    KI DFG+AR    D 
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR----DI 222

Query: 589 TEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
              +    V         +M PE   +G++++KSDV+S+G+L+ E+ 
Sbjct: 223 MSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  137 bits (348), Expect = 6e-36
 Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 30/237 (12%)

Query: 405 MATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKR 463
           + T +L     E    +               + ++G G FG V++      G + AVK+
Sbjct: 41  LLTEKLKPVDYEYREEVHWMT----------HQPRVGRGSFGEVHRMKDKQTGFQCAVKK 90

Query: 464 LSKSSGQGVEEFK-NEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDG 522
           +       +E F+  E++  A L    +V L G   +     +  E L   SL   I   
Sbjct: 91  VR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--- 141

Query: 523 TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMA 581
            +   L   +    +G    GL YLH     RI+H D+KA NVLL ++ +   + DFG A
Sbjct: 142 KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHA 198

Query: 582 R---AFGVDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYGTR 634
                 G+ ++    + + GT  +M PE  + G     K D++S   ++L ++ G  
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  135 bits (342), Expect = 1e-35
 Identities = 57/208 (27%), Positives = 110/208 (52%), Gaps = 10/208 (4%)

Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+ +    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
            ++ N+V  L   +  DE  ++ EYL   SL D +        +D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQAL 129

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++ +T  +VGT  +M 
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 184

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE      +  K D++S G++ +E++ G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  133 bits (338), Expect = 4e-35
 Identities = 66/294 (22%), Positives = 107/294 (36%), Gaps = 57/294 (19%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKL-Q 486
           T  F E  K+G G FG V+K +  +DG   A+KR     +     +    EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 487 HRNLVKLLGCCMKRDERMLIY-EYLPNKSLADFIFDGTRR-KLLDWSKRCQIIGGIARGL 544
           H ++V+      + D  MLI  EY    SLAD I +  R       ++   ++  + RGL
Sbjct: 70  HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNP-------------------KISDFGMARAFG 585
            Y+H      ++H D+K SN+ +     P                   KI D G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 586 VDQTEANTNRVVGTYGYMPPEYAIDGLFS--VKSDVFSFGVLVLELVYGTRNRGFHHVDH 643
             Q E       G   ++  E  +   ++   K+D+F+  + V+                
Sbjct: 186 SPQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGA----------E 228

Query: 644 HHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN 697
                G  W    + R   +          LS+     ++  + +   PE RP+
Sbjct: 229 PLPRNGDQWHEIRQGRLPRIPQV-------LSQEFT--ELLKVMIHPDPERRPS 273

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  134 bits (340), Expect = 5e-35
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 10/208 (4%)

Query: 426 SIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
              +         K+GEG  G V        G+++AVK +     Q  E   NEV+++  
Sbjct: 39  DQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 98

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
            QH N+V++    +  +E  ++ E+L   +L D +     +  L+  +   +   + + L
Sbjct: 99  YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQAL 154

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH      +IHRD+K+ ++LL  +   K+SDFG       D  +  +  +VGT  +M 
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMA 209

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE     L++ + D++S G++V+E+V G
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDG 237

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  131 bits (332), Expect = 4e-34
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 17/230 (7%)

Query: 405 MATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKR 463
           MA S + +    M+         A+  + F++  K+G+G FG V+KG+     + +A+K 
Sbjct: 1   MAHSPVQSGLPGMQ------NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI 54

Query: 464 LS-KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDG 522
           +  + +   +E+ + E+ ++++     + K  G  +K  +  +I EYL   S  D +   
Sbjct: 55  IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--- 111

Query: 523 TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 582
                LD ++   I+  I +GL YLH +   + IHRD+KA+NVLL      K++DFG+A 
Sbjct: 112 -EPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 167

Query: 583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
                Q + NT   VGT  +M PE      +  K+D++S G+  +EL  G
Sbjct: 168 QLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  131 bits (332), Expect = 6e-34
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 10/208 (4%)

Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
                 + F    KLGEG +G VYK +    GQ +A+K++       ++E   E+ ++ +
Sbjct: 23  LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQ 80

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
               ++VK  G   K  +  ++ EY    S++D I    R K L   +   I+    +GL
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGL 138

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            YLH     R IHRD+KA N+LL+ E + K++DFG+A        + NT  V+GT  +M 
Sbjct: 139 EYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMA 193

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE   +  ++  +D++S G+  +E+  G
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEG 221

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  130 bits (329), Expect = 1e-33
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 13/208 (6%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
            + +    +LG+G FG VYK      G   A K +   S + +E++  E+ ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +VKLLG      +  ++ E+ P  ++   +      + L   +   +   +   L +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE--- 606
               RIIHRDLKA NVL+  E + +++DFG++        + ++   +GT  +M PE   
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190

Query: 607 --YAIDGLFSVKSDVFSFGVLVLELVYG 632
                D  +  K+D++S G+ ++E+   
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQI 218

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  129 bits (327), Expect = 3e-33
 Identities = 70/335 (20%), Positives = 119/335 (35%), Gaps = 67/335 (20%)

Query: 437 ENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLL 494
              L EGGF  VY+   +  G+E A+KRL  +  +       EV  + KL  H N+V+  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 495 GCCMKRDERM-------LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
                  E         L+   L    L +F+     R  L      +I     R + ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR----------VV 597
           H+  +  IIHRDLK  N+LL N+   K+ DFG A         + + +            
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 598 GTYGYMPPEYAIDGLFSV--------KSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLG 649
            T  Y  PE     +  +        K D+++ G ++  L +                  
Sbjct: 212 TTPMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQ---------------- 250

Query: 650 HAWRLWTEDRPVELIDKSLEDTYSL------SEALRCIQVGLLCVQQRPEDRPNMASV-- 701
           H +    ED       + +   YS+            +   +L V   PE+R ++A V  
Sbjct: 251 HPF----ED---GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEERLSIAEVVH 301

Query: 702 -VLMLSGERSLPQPKQPGFFTERNLPESESSSSNQ 735
            +  ++  R++          E+N     ++ S  
Sbjct: 302 QLQEIAAARNVNPKSPITELLEQNGGYGSATLSRG 336

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  128 bits (323), Expect = 9e-33
 Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 22/221 (9%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ 486
            +   +   + LG+G    V++G     G   A+K  +  S  + V+    E  ++ KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 487 HRNLVKLLGCCMKRDERM--LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           H+N+VKL     +   R   LI E+ P  SL   + + +    L  S+   ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 545 LYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
            +L +     I+HR++K  N++     D +   K++DFG AR    D  +  +  + GT 
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179

Query: 601 GYMPPE--------YAIDGLFSVKSDVFSFGVLVLELVYGT 633
            Y+ P+              +    D++S GV       G+
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  126 bits (319), Expect = 5e-32
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)

Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   ++    D  +  A K + KS        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 496 CCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
              + ++ + ++ E    +SL +      RRK L   +    +  I  G  YLH+    R
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHR---NR 161

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           +IHRDLK  N+ L+ ++  KI DFG+A     D        + GT  Y+ PE       S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 219

Query: 615 VKSDVFSFGVLVLELVYGT 633
            + DV+S G ++  L+ G 
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  125 bits (315), Expect = 6e-32
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)

Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+GGF   ++    D  +  A K + KS        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 496 CCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
              + ++ + ++ E    +SL +      RRK L   +    +  I  G  YLH   R R
Sbjct: 83  F-FEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNR 135

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS 614
           +IHRDLK  N+ L+ ++  KI DFG+A     D        + GT  Y+ PE       S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 193

Query: 615 VKSDVFSFGVLVLELVYGT 633
            + DV+S G ++  L+ G 
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  128 bits (323), Expect = 6e-32
 Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 21/208 (10%)

Query: 433 NFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEV-LLIAKLQHRNLV 491
           +F  ++ LG G  G +    + D +++AVKR+             EV LL    +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC-QIIGGIARGLLYLHQD 550
           +       R  + +  E     +L +++    ++           ++     GL +LH  
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136

Query: 551 SRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAFGVDQTE-ANTNRVVGTYGYMP 604
             L I+HRDLK  N+L+       ++   ISDFG+ +   V +   +  + V GT G++ 
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 605 PEY---AIDGLFSVKSDVFSFGVLVLEL 629
           PE          +   D+FS G +   +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYV 222

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  124 bits (313), Expect = 1e-31
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 19/204 (9%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQHRNLVKLL 494
           KLG GG   VY     I   ++A+K +    +   + ++ F+ EV   ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 495 --GCCMKRDERM--LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
                   ++    L+ EY+   +L+++I        L           I  G+ + H  
Sbjct: 78  DVD----EEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH-- 128

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
             +RI+HRD+K  N+L+D+    KI DFG+A+A   + +   TN V+GT  Y  PE A  
Sbjct: 129 -DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKG 186

Query: 611 GLFSVKSDVFSFGVLVLELVYGTR 634
                 +D++S G+++ E++ G  
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEP 210

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (319), Expect = 1e-31
 Identities = 52/225 (23%), Positives = 97/225 (43%), Gaps = 24/225 (10%)

Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSS-GQGVEEFKNEVLLI 482
           +S +N    +   + LG+G    V++G     G   A+K  +  S  + V+    E  ++
Sbjct: 4   QSTSN--HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVL 61

Query: 483 AKLQHRNLVKLLGC--CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
            KL H+N+VKL           ++LI E+ P  SL   + + +    L  S+   ++  +
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGVDQTEANTNRV 596
             G+ +L +     I+HR++K  N++     D +   K++DFG AR    D  +  +  +
Sbjct: 122 VGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--L 175

Query: 597 VGTYGYMPPE--------YAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  Y+ P+              +    D++S GV       G+
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  124 bits (313), Expect = 2e-31
 Identities = 70/241 (29%), Positives = 112/241 (46%), Gaps = 25/241 (10%)

Query: 405 MATSELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKR 463
           MA+       +E++L      ++ +    F     +G G +G VYKG  +  GQ  A+K 
Sbjct: 2   MASDSPARSLDEIDL-----SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV 56

Query: 464 LSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERM------LIYEYLPNKSLA 516
           +   +G   EE K E+ ++ K   HRN+    G  +K++         L+ E+    S+ 
Sbjct: 57  M-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115

Query: 517 DFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 576
           D +   T+   L       I   I RGL +LHQ    ++IHRD+K  NVLL      K+ 
Sbjct: 116 D-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171

Query: 577 DFGMARAFGVDQTEANTNRVVGTYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLELVY 631
           DFG++    +D+T    N  +GT  +M PE        D  +  KSD++S G+  +E+  
Sbjct: 172 DFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229

Query: 632 G 632
           G
Sbjct: 230 G 230

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (308), Expect = 5e-31
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 19/201 (9%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSS--GQGVEE-FKNEVLLIAKLQHRNLVKLLG 495
           LG+G F  VY+   +  G E+A+K + K +    G+ +  +NEV +  +L+H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 496 CCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
              +    + L+ E   N  +  ++    R K    ++    +  I  G+LYLH      
Sbjct: 79  Y-FEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLH---SHG 132

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR---VVGTYGYMPPEYAIDG 611
           I+HRDL  SN+LL   MN KI+DFG+A      Q +    +   + GT  Y+ PE A   
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 612 LFSVKSDVFSFGVLVLELVYG 632
              ++SDV+S G +   L+ G
Sbjct: 188 AHGLESDVWSLGCMFYTLLIG 208

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  124 bits (312), Expect = 5e-31
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 19/226 (8%)

Query: 413 RKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQG 471
           RK          K      D+F + ++LG G  G V+K      G  +A K +       
Sbjct: 14  RKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 73

Query: 472 V-EEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDW 530
           +  +   E+ ++ +     +V   G      E  +  E++   SL   +    R      
Sbjct: 74  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--- 130

Query: 531 SKRCQIIGGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV 586
               QI+G ++     GL YL    + +I+HRD+K SN+L+++    K+ DFG++    +
Sbjct: 131 ----QILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QL 182

Query: 587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             + AN+   VGT  YM PE      +SV+SD++S G+ ++E+  G
Sbjct: 183 IDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (324), Expect = 5e-31
 Identities = 55/291 (18%), Positives = 100/291 (34%), Gaps = 51/291 (17%)

Query: 439 KLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL- 494
            +  GG G +Y      ++G+ + +K L  S           E   +A++ H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 495 -GCCMKRDERMLIY---EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
                 R    + Y   EY+  +SL          + L  ++    +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
             + +++ DLK  N++L  E   K+ D G      ++        + GT G+  PE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INS----FGYLYGTPGFQAPEIV-R 250

Query: 611 GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED 670
              +V +D+++ G  +  L      R   +VD              ED PV     S   
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-----------EDDPVLKTYDSYGR 299

Query: 671 TYSLSEALRCIQVGLLCVQQRPEDRPN----MASVVLMLSGERSLPQPKQP 717
                       +    +   P  R      M++ +  +  E        P
Sbjct: 300 ------------LLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  123 bits (311), Expect = 6e-31
 Identities = 68/237 (28%), Positives = 110/237 (46%), Gaps = 20/237 (8%)

Query: 404 RMATSELGNRKEEMELP-IFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAV 461
            M     G R   ++ P + +     +    FS+  ++G G FG VY    + + + +A+
Sbjct: 25  AMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAI 84

Query: 462 KRLS---KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADF 518
           K++S   K S +  ++   EV  + KL+H N ++  GC ++     L+ EY    S +D 
Sbjct: 85  KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDL 143

Query: 519 IFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 578
           +     +K L   +   +  G  +GL YLH      +IHRD+KA N+LL      K+ DF
Sbjct: 144 LE--VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF 198

Query: 579 GMARAFGVDQTEANTNRVVGTYGYMPPE---YAIDGLFSVKSDVFSFGVLVLELVYG 632
           G A         AN+   VGT  +M PE      +G +  K DV+S G+  +EL   
Sbjct: 199 GSA----SIMAPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  123 bits (309), Expect = 8e-31
 Identities = 59/270 (21%), Positives = 91/270 (33%), Gaps = 72/270 (26%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRN 489
            +F     +G GGFG V++    +D    A+KR+   +     E+   EV  +AKL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT-------------------------- 523
           +V+     ++        E        +                                
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 524 -------------------RRKLLDWSKRCQ------------IIGGIARGLLYLHQDSR 552
                              +  L DW  R              I   IA  + +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN----------RVVGTYGY 602
             ++HRDLK SN+    +   K+ DFG+  A   D+ E                VGT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           M PE      +S K D+FS G+++ EL+Y 
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS 272

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  123 bits (310), Expect = 8e-31
 Identities = 36/228 (15%), Positives = 72/228 (31%), Gaps = 22/228 (9%)

Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSSGQGVEEFKNE 478
                 +      + LGEG F  VY+    D       Q+  +K    ++          
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 479 VLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI--FDGTRRKLLDWSKRCQI 536
           +  +        +K     + ++  +L+ E     +L + I  +  T  K++        
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-----------KISDFGMARAFG 585
              +   +  +H      IIH D+K  N +L N                + D G +    
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
           +            T G+   E   +  ++ + D F     V  +++GT
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  127 bits (320), Expect = 1e-30
 Identities = 72/311 (23%), Positives = 108/311 (34%), Gaps = 39/311 (12%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHR 488
              +  + +LG GGFG V + +    G+++A+K+  +       E +  E+ ++ KL H 
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72

Query: 489 NLVKLL------GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
           N+V               D  +L  EY     L  ++        L       ++  I+ 
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
            L YLH+    RIIHRDLK  N++L      +  KI D G A+              VGT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGT 186

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTR--NRGFHHVDHHHNLLG----HAWR 653
             Y+ PE      ++V  D +SFG L  E + G R     +  V  H  +      H   
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246

Query: 654 LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCV--QQRPEDRPNMASVVLMLSGERSL 711
                  V+     L     LS  L       L          R              + 
Sbjct: 247 YDDLTGAVKFSSV-LPTPNHLSGILAGKLERWLQCMLMWHQRQRG-------------TD 292

Query: 712 PQPKQPGFFTE 722
           PQ    G F  
Sbjct: 293 PQNPNVGCFQA 303

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  120 bits (302), Expect = 3e-30
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 30/217 (13%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKN-----EVLLIAKL 485
           D+     +LG G +G V K   +  GQ +AVKR+  +     +E K      ++ +   +
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDISM-RTV 63

Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC--QIIGGIAR- 542
                V   G   +  +  +  E + + SL  F      ++++D  +     I+G IA  
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVS 117

Query: 543 ---GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
               L +LH  S+L +IHRD+K SNVL++     K+ DFG++    VD    + +   G 
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGC 172

Query: 600 YGYMPPE----YAIDGLFSVKSDVFSFGVLVLELVYG 632
             YM PE          +SVKSD++S G+ ++EL   
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (308), Expect = 6e-30
 Identities = 54/225 (24%), Positives = 81/225 (36%), Gaps = 34/225 (15%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEV-LLIAKLQHRNL 490
           +    E  LG G  G V       G+ +AVKR+        +    E+ LL     H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFI----FDGTRRKLLDWSKRCQIIGGIARGLLY 546
           ++            +  E   N +L D +          KL        ++  IA G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNP-------------KISDFGMARAFGVDQT--EA 591
           LH    L+IIHRDLK  N+L+                    ISDFG+ +     Q+    
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 592 NTNRVVGTYGYMPPEYAIDGLFSV-------KSDVFSFGVLVLEL 629
           N N   GT G+  PE   +              D+FS G +   +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  119 bits (300), Expect = 1e-29
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVK--RLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLL 494
            LG GG   V+    L D +++AVK  R   +        F+ E    A L H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 495 --GCCMKRDERM--LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
             G        +  ++ EY+   +L D +        +   +  ++I    + L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-VDQTEANTNRVVGTYGYMPPEYAI 609
            +  IIHRD+K +N+++      K+ DFG+ARA      +   T  V+GT  Y+ PE A 
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 610 DGLFSVKSDVFSFGVLVLELVYGTR 634
                 +SDV+S G ++ E++ G  
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEP 217

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  119 bits (300), Expect = 1e-29
 Identities = 53/186 (28%), Positives = 94/186 (50%), Gaps = 17/186 (9%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN-----EVLLI 482
           +++  F +  KLG G +  VYKG+    G  +A+K +   S +G           E+ L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57

Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPN--KSLADFIFDGTRRKLLDWSKRCQIIGGI 540
            +L+H N+V+L       ++  L++E++ N  K   D    G   + L+ +        +
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
            +GL + H++   +I+HRDLK  N+L++     K+ DFG+ARAFG+      ++ VV T 
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV-TL 172

Query: 601 GYMPPE 606
            Y  P+
Sbjct: 173 WYRAPD 178

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  121 bits (304), Expect = 1e-29
 Identities = 40/303 (13%), Positives = 84/303 (27%), Gaps = 66/303 (21%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH-------- 487
           LG+       +      G+   V     +       +++ K EVL +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 488 --------RNLVKLLGCC-----MKRDERMLIYEYL--------PNKSLADFIFD-GTRR 525
                    +LVK             +  M +              ++  + +    +  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 526 KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 585
           K L    R Q+   + R L  LH      ++H  L+  +++LD      ++ F      G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 586 VDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHH 640
                +   R                     L +   D ++ G+ +  +           
Sbjct: 263 -ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA-------- 313

Query: 641 VDHHHNLLGHAWRL-WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMA 699
                        L  T+D  +   +       ++ + +R +  G L  +   EDR    
Sbjct: 314 ------------DLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFL--RYPKEDRLLPL 359

Query: 700 SVV 702
             +
Sbjct: 360 QAM 362

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  120 bits (301), Expect = 2e-29
 Identities = 40/309 (12%), Positives = 88/309 (28%), Gaps = 77/309 (24%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ--------- 486
           LG+       +      G+   V     +       +++ K EVL +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 487 ----------------HRNLVKLLGCCMKRDERMLIYEYL----PNKSLADFIFD-GTRR 525
                            + ++++             + Y       ++  + +    +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 526 KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 585
           K L    R Q+   + R L  LH      ++H  L+  +++LD      ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 586 VDQTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLELVYGTR 634
                        + G+ PPE                L +   D ++ G+++  +     
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA-- 309

Query: 635 NRGFHHVDHHHNLLGHAWRL-WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPE 693
                              L  T+D  +   +       ++ + +R +  G L      E
Sbjct: 310 ------------------DLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--PKE 349

Query: 694 DRPNMASVV 702
           DR      +
Sbjct: 350 DRLLPLQAM 358

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  118 bits (297), Expect = 3e-29
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 31/218 (14%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVL-----LIAKL 485
           ++  +  ++G G +G V K +    GQ +AVKR+  +     E+ + ++L     ++   
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSS 78

Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC---QIIGGIAR 542
               +V+  G   +  +  +  E + + S   F      + +          +I+G I  
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELM-STSFDKFY-----KYVYSVLDDVIPEEILGKITL 132

Query: 543 ----GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
                L +L     L+IIHRD+K SN+LLD   N K+ DFG++    +  + A T    G
Sbjct: 133 ATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTR-DAG 187

Query: 599 TYGYMPPE----YAIDGLFSVKSDVFSFGVLVLELVYG 632
              YM PE     A    + V+SDV+S G+ + EL  G
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  117 bits (296), Expect = 3e-29
 Identities = 57/184 (30%), Positives = 95/184 (51%), Gaps = 22/184 (11%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--------EVLLI 482
           +NF +  K+GEG +G VYK    + G+ +A+K++       ++            E+ L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56

Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
            +L H N+VKLL      ++  L++E+L  + L  F+ D +    +        +  + +
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQ 114

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
           GL + H     R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV T  Y
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWY 169

Query: 603 MPPE 606
             PE
Sbjct: 170 RAPE 173

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (293), Expect = 4e-29
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 20/208 (9%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LG+G FG VY          +A+K L K+         + + EV + + L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+++L G         LI EY P  ++   +    +    D  +    I  +A  L Y 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 125

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR---VVGTYGYMP 604
           H     R+IHRD+K  N+LL +    KI+DFG +         A ++R   + GT  Y+P
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLP 175

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE     +   K D++S GVL  E + G
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  117 bits (295), Expect = 4e-29
 Identities = 55/186 (29%), Positives = 95/186 (51%), Gaps = 28/186 (15%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKN--------EVLLIA 483
           + + +  K+GEG +G VYK     G+ +A+KR+       ++            E+ L+ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74

Query: 484 KLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC---QIIGGI 540
           +L H N+V L+          L++E++  K L   + D  +  L D   +    Q++   
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQDSQIKIYLYQLL--- 129

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
            RG+ + HQ    RI+HRDLK  N+L++++   K++DFG+ARAFG+    + T+ VV T 
Sbjct: 130 -RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TL 183

Query: 601 GYMPPE 606
            Y  P+
Sbjct: 184 WYRAPD 189

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (294), Expect = 5e-29
 Identities = 46/207 (22%), Positives = 84/207 (40%), Gaps = 21/207 (10%)

Query: 437 ENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVK 492
              +G GG G VY+    +  + +A+K +S++           + E     +LQ  ++V 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 493 L--LGCCMKRDERMLIY---EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
           +   G      +  L Y     +    LA  +    R+  L   +   I+  I   L   
Sbjct: 99  IHDFG----EIDGQL-YVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAA 150

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H        HRD+K  N+L+  +    + DFG+A A   D+        VGT  YM PE 
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPER 206

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTR 634
             +   + ++D+++   ++ E + G+ 
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSP 233

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (293), Expect = 6e-29
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 26/221 (11%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQ 486
              D++  +  +G G    V         +++A+KR++ +     ++E   E+  +++  
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK-RCQIIGGIAR--- 542
           H N+V      + +DE  L+ + L   S+ D I     +            I  I R   
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 543 -GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA---RAFGVDQTEANTNRVVG 598
            GL YLH++     IHRD+KA N+LL  + + +I+DFG++      G           VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 599 TYGYMPPE-------YAIDGLFSVKSDVFSFGVLVLELVYG 632
           T  +M PE       Y        K+D++SFG+  +EL  G
Sbjct: 189 TPCWMAPEVMEQVRGY------DFKADIWSFGITAIELATG 223

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (296), Expect = 6e-29
 Identities = 31/299 (10%), Positives = 66/299 (22%), Gaps = 53/299 (17%)

Query: 440 LGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           L  G    V+    ++  ++ A+K  +     S   +E         A+L   +  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 496 CC--------------------------MKRDERMLIYEYLPNKSLADFI----FDGTRR 525
                                             +L+     +  L        F    R
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFR 188

Query: 526 KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 585
                     +   + R    L       ++H      N+ +  +    + D       G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 586 VDQTEANTNRVVGTYGYMPPEY--AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH 643
                           Y P E+  A    F+   + +  G+ +  +        F  V  
Sbjct: 246 -----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL--FLPFGLVTP 298

Query: 644 HHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV 702
                     L            +      L + ++ +    L        R      +
Sbjct: 299 GIKGSWKRPSLRVPGTD----SLAFGSCTPLPDFVKTLIGRFLNFD--RRRRLLPLEAM 351

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  115 bits (290), Expect = 1e-28
 Identities = 48/189 (25%), Positives = 88/189 (46%), Gaps = 33/189 (17%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--------EVLLI 482
             + +  K+GEG +G V+K       + +A+KR+       +++           E+ L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPN--KSLAD---FIFDGTRRKLLDWSKRCQII 537
            +L+H+N+V+L        +  L++E+     K   D      D    K   +    Q++
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF----QLL 111

Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVV 597
               +GL + H      ++HRDLK  N+L++     K+++FG+ARAFG+      +  VV
Sbjct: 112 ----KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV 163

Query: 598 GTYGYMPPE 606
            T  Y PP+
Sbjct: 164 -TLWYRPPD 171

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  117 bits (295), Expect = 1e-28
 Identities = 40/219 (18%), Positives = 78/219 (35%), Gaps = 16/219 (7%)

Query: 426 SIANATDNFSEENKLGEG--GFGPVYKGM-LIDGQEIAVKR--LSKSSGQGVEEFKNEVL 480
           S       +     +G+G      V        G+ + V+R  L   S + V   + E+ 
Sbjct: 19  SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELH 78

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           +     H N+V      +  +E  ++  ++   S  D +        ++      I+ G+
Sbjct: 79  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGV 137

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT-----NR 595
            + L Y+H       +HR +KAS++L+  +    +S      +                 
Sbjct: 138 LKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 596 VVGTYGYMPPE--YAIDGLFSVKSDVFSFGVLVLELVYG 632
            V    ++ PE        +  KSD++S G+   EL  G
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  114 bits (287), Expect = 3e-28
 Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 26/185 (14%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKN--------EVLLIA 483
           + +    K+GEG +G VYK     G+  A+K++       +E+           E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 484 KLQHRNLVKLLGCCMKRDERMLIYEYLPN--KSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           +L+H N+VKL      +   +L++E+L    K L D          L+       +  + 
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-----VCEGGLESVTAKSFLLQLL 110

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
            G+ Y H     R++HRDLK  N+L++ E   KI+DFG+ARAFG+      T+ +V T  
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLW 165

Query: 602 YMPPE 606
           Y  P+
Sbjct: 166 YRAPD 170

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  118 bits (297), Expect = 3e-28
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 16/220 (7%)

Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFKN 477
           +F      + ++ +    KLG G +G V      +   E A+K + K+  S     +   
Sbjct: 26  MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85

Query: 478 EVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQII 537
           EV ++  L H N++KL      +    L+ E      L D I     R   +      II
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVII 142

Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTEANTN 594
             +  G+ YLH+     I+HRDLK  N+LL++   +   KI DFG++  F   +      
Sbjct: 143 KQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MK 196

Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTR 634
             +GT  Y+ PE  +   +  K DV+S GV++  L+ G  
Sbjct: 197 ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  115 bits (290), Expect = 3e-28
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 24/186 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--------EVLLI 482
             + + + LGEG F  VYK       Q +A+K++         E K+        E+ L+
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66

Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPN--KSLADFIFDGTRRKLLDWSKRCQIIGGI 540
            +L H N++ LL     +    L+++++    + +           +L  S     +   
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK-----DNSLVLTPSHIKAYMLMT 121

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
            +GL YLHQ     I+HRDLK +N+LLD     K++DFG+A++FG     A T++VV T 
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TR 176

Query: 601 GYMPPE 606
            Y  PE
Sbjct: 177 WYRAPE 182

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  113 bits (286), Expect = 9e-28
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 22/183 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-----EVLLIAKL 485
           + + + +KLGEG +  VYKG        +A+K +     +G           EV L+  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57

Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPN--KSLADFIFDGTRRKLLDWSKRCQIIGGIARG 543
           +H N+V L           L++EYL    K   D         +++       +  + RG
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD-----DCGNIINMHNVKLFLFQLLRG 112

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L Y H+    +++HRDLK  N+L++     K++DFG+ARA  +  T+   N VV T  Y 
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYR 167

Query: 604 PPE 606
           PP+
Sbjct: 168 PPD 170

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  116 bits (293), Expect = 9e-28
 Identities = 69/219 (31%), Positives = 104/219 (47%), Gaps = 17/219 (7%)

Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS---SGQGVEEFK 476
           +F   S A  +D +  +  LG+G FG V      I GQE AVK +SK         E   
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74

Query: 477 NEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI 536
            EV L+ +L H N++KL      +    L+ E      L D I     RK        +I
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARI 131

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTEANT 593
           I  +  G+ Y+H+    +I+HRDLK  N+LL++   + N +I DFG++  F   +     
Sbjct: 132 IRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---M 185

Query: 594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
              +GT  Y+ PE  + G +  K DV+S GV++  L+ G
Sbjct: 186 KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  112 bits (282), Expect = 3e-27
 Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 37/221 (16%)

Query: 439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKS-----------------SGQGVEEFKNEVLL 481
            L +G F  +      D +  A+K+  KS                      ++FKNE+ +
Sbjct: 38  TLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI-----FDGTRRKLLDWSKRCQI 536
           I  +++   +   G     DE  +IYEY+ N S+  F       D      +       I
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
           I  +     Y+H  +   I HRD+K SN+L+D     K+SDFG +        +      
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGES----EYMVDKKIKGS 210

Query: 597 VGTYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLELVYG 632
            GTY +MPPE      + +G    K D++S G+ +  + Y 
Sbjct: 211 RGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYN 248

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  112 bits (282), Expect = 4e-27
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 15/180 (8%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQ 486
           + +     +GEG +G V K    D G+ +A+K+  +S     +  K     E+ L+ +L+
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLR 82

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H NLV LL  C K+    L++E++ + ++ D +        LD+    + +  I  G+ +
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGF 139

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
            H      IIHRD+K  N+L+      K+ DFG AR       E   + V  T  Y  PE
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAPE 194

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  111 bits (279), Expect = 5e-27
 Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 31/236 (13%)

Query: 412 NRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQ 470
           + K+   L I   +  A   D      ++G G  G V+K      G  IAVK++ +S   
Sbjct: 6   SGKQTGYLTIGGQRYQAEIND-LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN- 63

Query: 471 GVEEFKNEVL-----LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR 525
             +E    +L     ++       +V+  G  +   +  +  E +               
Sbjct: 64  --KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK------ 114

Query: 526 KLLDWSKRCQIIGGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
           K +      +I+G +       L YL    +  +IHRD+K SN+LLD     K+ DFG++
Sbjct: 115 KRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

Query: 582 RAFGVDQTEANTNRVVGTYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLELVYG 632
               VD    + +   G   YM PE           + +++DV+S G+ ++EL  G
Sbjct: 173 -GRLVDDKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  113 bits (285), Expect = 9e-27
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 16/208 (7%)

Query: 423 DWKSIANATDNFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS--SGQGVEEFKNEV 479
           +        + ++    LG+G FG V K    I  QE AVK ++K+    +       EV
Sbjct: 13  NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72

Query: 480 LLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG 539
            L+ KL H N++KL           ++ E      L D I    +RK        +II  
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQ 129

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTEANTNRV 596
           +  G+ Y+H+     I+HRDLK  N+LL++   + + KI DFG++  F  +         
Sbjct: 130 VFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDR 183

Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGV 624
           +GT  Y+ PE  + G +  K DV+S GV
Sbjct: 184 IGTAYYIAPE-VLRGTYDEKCDVWSAGV 210

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  109 bits (275), Expect = 1e-26
 Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 14/204 (6%)

Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIA 483
            +  +    ++ EN +G G +G V   +        A K++ K   + V+ FK E+ ++ 
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61

Query: 484 KLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG 543
            L H N+++L        +  L+ E      L + +     +++   S   +I+  +   
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSA 118

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
           + Y H+   L + HRDLK  N L      +   K+ DFG+A  F   +        VGT 
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTP 172

Query: 601 GYMPPEYAIDGLFSVKSDVFSFGV 624
            Y+ P+  ++GL+  + D +S GV
Sbjct: 173 YYVSPQ-VLEGLYGPECDEWSAGV 195

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  109 bits (276), Expect = 1e-26
 Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 11/178 (6%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHR 488
           + + +  K+GEG +G V+K    D GQ +A+K+  +S    V +     E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           NLV LL    ++    L++EY  + ++   +     ++ +       I     + + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           +      IHRD+K  N+L+      K+ DFG AR      ++   + V  T  Y  PE
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPE 172

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (273), Expect = 2e-26
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 22/209 (10%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           D+F     LG+G FG VY          +A+K L KS         + + E+ + + L+H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 488 RNLVKLLGCCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
            N++++        +R+ L+ E+ P   L   +    +    D  +    +  +A  L Y
Sbjct: 74  PNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHY 129

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR---VVGTYGYM 603
            H     ++IHRD+K  N+L+  +   KI+DFG +         A + R   + GT  Y+
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRTMCGTLDYL 179

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           PPE         K D++  GVL  E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (272), Expect = 2e-26
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 13/203 (6%)

Query: 428 ANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKL 485
               D F  + KLG G FG V+       G E  +K ++K   Q  +E+ + E+ ++  L
Sbjct: 18  GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77

Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFD-GTRRKLLDWSKRCQIIGGIARGL 544
            H N++K+           ++ E      L + I     R K L      +++  +   L
Sbjct: 78  DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
            Y H      ++H+DLK  N+L  +       KI DFG+A  F  D+    +    GT  
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTAL 191

Query: 602 YMPPEYAIDGLFSVKSDVFSFGV 624
           YM PE       + K D++S GV
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGV 213

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  109 bits (274), Expect = 4e-26
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 43/200 (21%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--------EVLLI 482
             + +  K+G+G FG V+K      GQ++A+K++       +E  K         E+ ++
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70

Query: 483 AKLQHRNLVKLLGCCMKRDERM--------LIYEYLPN--KSLAD---FIFDGTRRKLLD 529
             L+H N+V L+  C  +            L++++  +    L       F  +  K + 
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130

Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
                 ++     GL Y+H++   +I+HRD+KA+NVL+  +   K++DFG+ARAF + + 
Sbjct: 131 Q----MLL----NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 590 EAN---TNRVVGTYGYMPPE 606
                 TNRVV T  Y PPE
Sbjct: 180 SQPNRYTNRVV-TLWYRPPE 198

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  108 bits (272), Expect = 6e-26
 Identities = 57/191 (29%), Positives = 86/191 (45%), Gaps = 33/191 (17%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN--------EVLLI 482
           D +    KLGEG +G VYK +  +  + +A+KR+       +E  +         EV L+
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87

Query: 483 AKLQHRNLVKLLGCCMKRDERMLIYEYLPN--KSLADFIFDGTRRKLLDWSKRCQIIGGI 540
            +LQHRN+++L           LI+EY  N  K   D      +   +        +  +
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMD------KNPDVSMRVIKSFLYQL 141

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGVDQTEANTNR 595
             G+ + H     R +HRDLK  N+LL           KI DFG+ARAFG+      T+ 
Sbjct: 142 INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHE 197

Query: 596 VVGTYGYMPPE 606
           ++ T  Y PPE
Sbjct: 198 II-TLWYRPPE 207

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  107 bits (269), Expect = 7e-26
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 16/209 (7%)

Query: 422 FDWKSIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS--SGQGVEEFKNE 478
            +        + ++    LG+G FG V K       QE AVK ++K+    +       E
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71

Query: 479 VLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIG 538
           V L+ KL H N++KL           ++ E      L D I    +RK        +II 
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIK 128

Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGVDQTEANTNR 595
            +  G+ Y+H+     I+HRDLK  N+LL   + + + KI DFG++  F  +        
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKD 182

Query: 596 VVGTYGYMPPEYAIDGLFSVKSDVFSFGV 624
            +GT  Y+ PE  + G +  K DV+S GV
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  107 bits (270), Expect = 9e-26
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 22/191 (11%)

Query: 430 ATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLS-KSSGQGVEEFKN----EVLLIA 483
           AT  +    ++G G +G VYK      G  +A+K +   + G G          EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 484 KLQ---HRNLVKLLGCCMKRDER-----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ 535
           +L+   H N+V+L+  C            L++E++ ++ L  ++ D      L       
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124

Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR 595
           ++    RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +        T  
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179

Query: 596 VVGTYGYMPPE 606
           VV T  Y  PE
Sbjct: 180 VV-TLWYRAPE 189

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  108 bits (272), Expect = 1e-25
 Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 11/201 (5%)

Query: 428 ANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 486
            +  D +    +LG G FG V++ +    G+    K ++          KNE+ ++ +L 
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H  L+ L      + E +LI E+L    L D I        +  ++    +     GL +
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKH 164

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
           +H+     I+H D+K  N++ + +     KI DFG+A     D+          T  +  
Sbjct: 165 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAA 218

Query: 605 PEYAIDGLFSVKSDVFSFGVL 625
           PE          +D+++ GVL
Sbjct: 219 PEIVDREPVGFYTDMWAIGVL 239

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  110 bits (276), Expect = 2e-25
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 27/222 (12%)

Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKG-MLIDGQEIAVKRLSKS------------ 467
           ++  K      +++ +  KLG G +G V          E A+K + KS            
Sbjct: 25  MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84

Query: 468 -SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRK 526
              +  EE  NE+ L+  L H N++KL      +    L+ E+     L + I     R 
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRH 141

Query: 527 LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARA 583
             D      I+  I  G+ YLH+     I+HRD+K  N+LL+N    +N KI DFG++  
Sbjct: 142 KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198

Query: 584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 625
           F  D         +GT  Y+ PE  +   ++ K DV+S GV+
Sbjct: 199 FSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVI 236

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  106 bits (268), Expect = 2e-25
 Identities = 49/193 (25%), Positives = 89/193 (46%), Gaps = 32/193 (16%)

Query: 432 DNFSEENKLGEGGFGPVYKG--MLIDGQEIAVKRLSKSSGQGVEEFKN--------EVLL 481
             +    ++GEG +G V+K   +   G+ +A+KR+       V+  +         EV +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64

Query: 482 IAKLQ---HRNLVKLLGCCMKRDER-----MLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
           +  L+   H N+V+L   C            L++E++ ++ L  ++ D      +     
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122

Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
             ++  + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +        T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177

Query: 594 NRVVGTYGYMPPE 606
           + VV T  Y  PE
Sbjct: 178 SVVV-TLWYRAPE 189

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  109 bits (274), Expect = 4e-25
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 11/199 (5%)

Query: 431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
            D++    +LG G FG V++      G   A K +        E  + E+  ++ L+H  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           LV L       +E ++IYE++    L + + D      +   +  + +  + +GL ++H+
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE 273

Query: 550 DSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
                 +H DLK  N++   + +   K+ DFG+       Q   +     GT  +  PE 
Sbjct: 274 ---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEV 327

Query: 608 AIDGLFSVKSDVFSFGVLV 626
           A        +D++S GVL 
Sbjct: 328 AEGKPVGYYTDMWSVGVLS 346

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  106 bits (266), Expect = 5e-25
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 15/205 (7%)

Query: 431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVK-----RLSKSSGQGVEEFKNEVLLIAK 484
            D +     +G+G F  V + +  + GQ+ AVK     + + S G   E+ K E  +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFD-GTRRKLLDWSKRCQIIGGIARG 543
           L+H ++V+LL          +++E++    L   I        +   +     +  I   
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGVDQTEANTNRVVGTY 600
           L Y H      IIHRD+K   VLL ++ N    K+  FG+A   G     A     VGT 
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTP 197

Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVL 625
            +M PE      +    DV+  GV+
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVI 222

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  105 bits (263), Expect = 6e-25
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 36/213 (16%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVKLL 494
           LGEG +G V + +        AVK L K        G    K E+ L+ +L+H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 495 GCCMKRDERMLIY---EYLPN--KSLADFIFDGTRRKLLDWSKR---CQIIGGIARGLLY 546
              +  +E+  +Y   EY     + + D +     ++          CQ+I G+     Y
Sbjct: 73  DV-LYNEEKQKMYMVMEYCVCGMQEMLDSV---PEKRFPVCQAHGYFCQLIDGLE----Y 124

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH      I+H+D+K  N+LL      KIS  G+A A      +       G+  + PPE
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 607 -------YAIDGLFSVKSDVFSFGVLVLELVYG 632
                  +   G    K D++S GV +  +  G
Sbjct: 182 IANGLDTF--SGF---KVDIWSAGVTLYNITTG 209

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  106 bits (267), Expect = 6e-25
 Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)

Query: 423 DWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKN-EVLL 481
           D K+       ++    +G G FG V++  L++  E+A+K++ +      + FKN E+ +
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQI 85

Query: 482 IAKLQHRNLVKLLGCCMKRDERM------LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ 535
           +  ++H N+V L        ++       L+ EY+P +++        + K        +
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIK 144

Query: 536 IIG-GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANT 593
           +    + R L Y+H    + I HRD+K  N+LLD      K+ DFG A+       E N 
Sbjct: 145 LYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNV 199

Query: 594 NRVVGTYGYMPPEYAIDGLF-----SVKSDVFSFGVLVLELVYG 632
           + +   Y Y  PE     +F     +   D++S G ++ EL+ G
Sbjct: 200 SYICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQG 238

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  105 bits (263), Expect = 1e-24
 Identities = 54/270 (20%), Positives = 88/270 (32%), Gaps = 52/270 (19%)

Query: 412 NRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVK-----RLS 465
           +     E   F   S+      +  +  +G+G +G V   +        A+K     ++ 
Sbjct: 6   HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65

Query: 466 KSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR 525
           + + + VE  K EV L+ KL H N+ +L           L+ E      L D +      
Sbjct: 66  QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125

Query: 526 KLLDWSKRC-------------------------------------QIIGGIARGLLYLH 548
                +                                         I+  I   L YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185

Query: 549 QDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAFGVDQTEANT--NRVVGTYGYMP 604
                 I HRD+K  N L   +     K+ DFG+++ F               GT  ++ 
Sbjct: 186 N---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

Query: 605 PE--YAIDGLFSVKSDVFSFGVLVLELVYG 632
           PE     +  +  K D +S GVL+  L+ G
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  106 bits (265), Expect = 1e-24
 Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 21/191 (10%)

Query: 432 DNFSEEN-KLGEGGFGPVYKGMLID---GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 487
           D F  E  K+G G +G VYK    D    ++ A+K++ + +G  +   + E+ L+ +L+H
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKH 77

Query: 488 RNLVKLLGCCMKRDER--MLIYEYLPN--KSLADFIFDGTRRKL---LDWSKRCQIIGGI 540
            N++ L    +   +R   L+++Y  +    +  F       K    L       ++  I
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGV-DQTEANTNR 595
             G+ YLH +    ++HRDLK +N+L+  E       KI+D G AR F    +  A+ + 
Sbjct: 138 LDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 596 VVGTYGYMPPE 606
           VV T+ Y  PE
Sbjct: 195 VVVTFWYRAPE 205

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (263), Expect = 1e-24
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 17/215 (7%)

Query: 420 PIFDWKSIANATDNFSE------ENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGV 472
             FD + +       +          LG G FG V+K      G ++A K +     +  
Sbjct: 71  APFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK 130

Query: 473 EEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK 532
           EE KNE+ ++ +L H NL++L      +++ +L+ EY+    L D I D      L    
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID--ESYNLTELD 188

Query: 533 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTE 590
               +  I  G+ ++HQ   + I+H DLK  N+L  N      KI DFG+AR +   +  
Sbjct: 189 TILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-- 243

Query: 591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 625
                  GT  ++ PE       S  +D++S GV+
Sbjct: 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  103 bits (258), Expect = 2e-24
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 19/204 (9%)

Query: 431 TDNFSEE----NKLGEGGFGPVYKGMLID-GQEIAVKRLSKS--SGQGVEEFKNEVLLIA 483
           +  FS+      +LG+G F  V + +    G E A K ++    S +  ++ + E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 484 KLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG 543
           KLQH N+V+L     +     L+++ +    L + I     R+    +     I  I   
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILES 117

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGVDQTEANTNRVVGTY 600
           + Y H      I+HR+LK  N+LL ++      K++DFG+A      +     +   GT 
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTP 171

Query: 601 GYMPPEYAIDGLFSVKSDVFSFGV 624
           GY+ PE      +S   D+++ GV
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGV 195

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  103 bits (259), Expect = 3e-24
 Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 35/209 (16%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +G+G F  V     ++ G+E+A+K + K+  +   +++   EV ++  L H N+VKL   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTR------RKLLDWSKRCQIIGGIARGLLYLHQD 550
                   LI EY     + D++    R      R         QI+  +     Y H  
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-----RQIVSAVQ----YCH-- 131

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE---- 606
            + RI+HRDLKA N+LLD +MN KI+DFG +  F V       +   G   Y  PE    
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQG 187

Query: 607 --YAIDGLFSVKSDVFSFGVLVLELVYGT 633
             Y  DG    + DV+S GV++  LV G+
Sbjct: 188 KKY--DGP---EVDVWSLGVILYTLVSGS 211

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  103 bits (258), Expect = 3e-24
 Identities = 40/200 (20%), Positives = 77/200 (38%), Gaps = 12/200 (6%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 487
              + +     LG G FG V++ +     +    K +    G      K E+ ++   +H
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARH 60

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
           RN++ L       +E ++I+E++    + + I        L+  +    +  +   L +L
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFL 118

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           H      I H D++  N++     +   KI +FG AR             +     Y  P
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAP 172

Query: 606 EYAIDGLFSVKSDVFSFGVL 625
           E     + S  +D++S G L
Sbjct: 173 EVHQHDVVSTATDMWSLGTL 192

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  102 bits (257), Expect = 5e-24
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)

Query: 428 ANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS------SGQGVEEFKNEVL 480
               D +    +LG G F  V K      G E A K + K        G   EE + EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++ H N++ L      R + +LI E +    L DF+    +++ L   +    I  I
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQI 124

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH     +I H DLK  N++L ++  P    K+ DFG+A              +
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178

Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVL 625
            GT  ++ PE        +++D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  102 bits (256), Expect = 1e-23
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)

Query: 428 ANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS------GQGVEEFKNEVL 480
               D +    +LG G F  V K      G E A K + K        G   EE + EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ ++ H N++ L      R + +LI E +    L DF+    +++ L   +    I  I
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQI 124

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH     +I H DLK  N++L ++  P    K+ DFG+A              +
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178

Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVL 625
            GT  ++ PE        +++D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  102 bits (256), Expect = 1e-23
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 19/208 (9%)

Query: 427 IANATDNFSEE----NKLGEGGFGPVYKGMLID-GQEIAVKRLSKS--SGQGVEEFKNEV 479
           + NA+  FS+      +LG+G F  V + +    G E A K ++    S +  ++ + E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 480 LLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG 539
            +  KLQH N+V+L     +     L+++ +    L + I     R+    +     I  
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQ 136

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGVDQTEANTNRV 596
           I   + Y H      I+HR+LK  N+LL ++      K++DFG+A      +     +  
Sbjct: 137 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGF 190

Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGV 624
            GT GY+ PE      +S   D+++ GV
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGV 218

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  100 bits (252), Expect = 1e-23
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 20/209 (9%)

Query: 428 ANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS------SGQGVEEFKNEVL 480
           +   D++    +LG G F  V K      G+E A K + K        G   EE + EV 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++ +++H N++ L      + + +LI E +    L DF+     ++ L   +  Q +  I
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQI 117

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRV 596
             G+ YLH     RI H DLK  N++L ++  P    K+ DFG+A              +
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 171

Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVL 625
            GT  ++ PE        +++D++S GV+
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  100 bits (252), Expect = 1e-23
 Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 28/226 (12%)

Query: 416 EMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGV-- 472
           +  LP     S     +N+  +  LG G    V + +     +E AVK +  + G     
Sbjct: 3   DAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60

Query: 473 -------EEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTR 524
                  E    EV ++ K+  H N+++L           L+++ +    L D++   T 
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TE 117

Query: 525 RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 584
           +  L   +  +I+  +   +  LH+   L I+HRDLK  N+LLD++MN K++DFG +   
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

Query: 585 GVDQTEANTNRVVGTYGYMPPE------YAIDGLFSVKSDVFSFGV 624
              +       V GT  Y+ PE            +  + D++S GV
Sbjct: 175 DPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  101 bits (253), Expect = 2e-23
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 44/217 (20%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQHR--NL 490
           LG GGFG VY G+ + D   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 491 VKLLGCCMKRDERMLIYEY-LPNKSLADFIFDGTR------RKLLDWSKRCQIIGGIARG 543
           ++LL    + D  +LI E   P + L DFI +         R         Q++  +   
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQVLEAVR-- 163

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
             + H      ++HRD+K  N+L+D N    K+ DFG          +       GT  Y
Sbjct: 164 --HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVY 214

Query: 603 MPPE------YAIDGLFSVKSDVFSFGVLVLELVYGT 633
            PPE      Y   G     + V+S G+L+ ++V G 
Sbjct: 215 SPPEWIRYHRY--HGR---SAAVWSLGILLYDMVCGD 246

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =   99 bits (250), Expect = 2e-23
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 25/204 (12%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +         E  K E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR---CQIIGGIARGLLYLHQDSRLR 554
            + + + L  EY     L D I       + +   +    Q++ G+     YLH    + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVV----YLH---GIG 125

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE------YA 608
           I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF- 184

Query: 609 IDGLFSVKSDVFSFGVLVLELVYG 632
                    DV+S G+++  ++ G
Sbjct: 185 -HAE---PVDVWSCGIVLTAMLAG 204

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  100 bits (252), Expect = 2e-23
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 21/204 (10%)

Query: 437 ENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLL 494
           E+ LGEG    V   + LI  QE AVK + K  G        EV ++ + Q HRN+++L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
               + D   L++E +   S+   I    +R+  +  +   ++  +A  L +LH      
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHI---HKRRHFNELEASVVVQDVASALDFLHN---KG 131

Query: 555 IIHRDLKASNVLLDNEMNP---KISDFGMARAF--GVDQTEANTNR---VVGTYGYMPPE 606
           I HRDLK  N+L ++       KI DF +        D +  +T       G+  YM PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 607 -----YAIDGLFSVKSDVFSFGVL 625
                     ++  + D++S GV+
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVI 215

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (251), Expect = 2e-23
 Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 51/231 (22%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKS--------------------------SGQGV 472
           +G+G +G V       D    A+K LSK                               +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 473 EEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY---EYLPNKSLADFIFDGTRRKLLD 529
           E+   E+ ++ KL H N+VKL+   +       +Y   E +    + +         L +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSE 136

Query: 530 WSKRC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV 586
              R     +I GI     YLH     +IIHRD+K SN+L+  + + KI+DFG++  F  
Sbjct: 137 DQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 587 DQTEANTNRVVGTYGYMPPEYAIDGLFSV----KSDVFSFGVLVLELVYGT 633
                +    VGT  +M PE ++     +      DV++ GV +   V+G 
Sbjct: 190 SDALLSN--TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  100 bits (252), Expect = 2e-23
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 20/208 (9%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS------SGQGVEEFKNEVLL 481
           N  D +    +LG G F  V K      G + A K + K        G   E+ + EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           + ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRVV 597
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A              + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178

Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVL 625
           GT  ++ PE        +++D++S GV+
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 50/198 (25%), Positives = 80/198 (40%), Gaps = 14/198 (7%)

Query: 431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
              F     LG G F  V+       G+  A+K + KS        +NE+ ++ K++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +V L           L+ + +    L D I     R +        +I  +   + YLH+
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSAVKYLHE 124

Query: 550 DSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
                I+HRDLK  N+L    +      I+DFG+++           +   GT GY+ PE
Sbjct: 125 ---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPE 177

Query: 607 YAIDGLFSVKSDVFSFGV 624
                 +S   D +S GV
Sbjct: 178 VLAQKPYSKAVDCWSIGV 195

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 25/204 (12%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVKLLGCC 497
           LGEG +G V   +  +  + +AVK +         E  K E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC---QIIGGIARGLLYLHQDSRLR 554
            + + + L  EY     L D I       + +   +    Q++ G+     YLH    + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVV----YLH---GIG 125

Query: 555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE------YA 608
           I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF- 184

Query: 609 IDGLFSVKSDVFSFGVLVLELVYG 632
                    DV+S G+++  ++ G
Sbjct: 185 -HAE---PVDVWSCGIVLTAMLAG 204

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 99.3 bits (248), Expect = 7e-23
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 36/214 (16%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN------EV----LLIAKLQHR 488
           LG+GGFG V+ G  L D  ++A+K + ++   G     +      EV     + A   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 489 NLVKLLGCCMKRDERMLIYEY-LPNKSLADFIFDGTR------RKLLDWSKRCQIIGGIA 541
            +++LL     ++  ML+ E  LP + L D+I +         R         Q++  I 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF-----GQVVAAIQ 153

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRVVGTY 600
               + H      ++HRD+K  N+L+D      K+ DFG   A   D          GT 
Sbjct: 154 ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHD-EPYTD--FDGTR 202

Query: 601 GYMPPEYAIDGLFS-VKSDVFSFGVLVLELVYGT 633
            Y PPE+     +  + + V+S G+L+ ++V G 
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.8 bits (249), Expect = 9e-23
 Identities = 47/223 (21%), Positives = 94/223 (42%), Gaps = 25/223 (11%)

Query: 418 ELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQG----- 471
           E  + DW +       +  ++ +G G    V + +    G E AVK +  ++ +      
Sbjct: 80  EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139

Query: 472 ---VEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL 527
               E  + E  ++ ++  H +++ L+          L+++ +    L D++   T +  
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVA 196

Query: 528 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD 587
           L   +   I+  +   + +LH      I+HRDLK  N+LLD+ M  ++SDFG +      
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253

Query: 588 QTEANTNRVVGTYGYMPPE------YAIDGLFSVKSDVFSFGV 624
           +       + GT GY+ PE            +  + D+++ GV
Sbjct: 254 EK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  100 bits (251), Expect = 9e-23
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 43/223 (19%)

Query: 431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHR 488
             ++++   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 489 NLVKLLGCCMKRDERM------LIYEYLPNKSLADFI--FDGTRRKLLDWSKRC---QII 537
           N+V+L        E+       L+ +Y+P +++      +   ++ L     +    Q+ 
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQTEANTNRV 596
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +
Sbjct: 167 ----RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYI 217

Query: 597 VGTYGYMPPE-------YAIDGLFSVKSDVFSFGVLVLELVYG 632
              Y Y  PE       Y      +   DV+S G ++ EL+ G
Sbjct: 218 CSRY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLG 253

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 97.9 bits (244), Expect = 3e-22
 Identities = 49/223 (21%), Positives = 88/223 (39%), Gaps = 42/223 (18%)

Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS--------SGQGVEEFKNEVLLIA 483
            +S  + LG G FG V+  +     +E+ VK + K             + +   E+ +++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 484 KLQHRNLVKLLGCCMKRDERMLIYE-YLPNKSLADFIFDGTR------RKLLDWSKRCQI 536
           +++H N++K+L     +    L+ E +     L  FI    R        +       Q+
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF-----RQL 139

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
           +  +     YL       IIHRD+K  N+++  +   K+ DFG A      +        
Sbjct: 140 VSAVG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTF 189

Query: 597 VGTYGYMPPE------YAIDGLFSVKSDVFSFGVLVLELVYGT 633
            GT  Y  PE      Y   G    + +++S GV +  LV+  
Sbjct: 190 CGTIEYCAPEVLMGNPY--RGP---ELEMWSLGVTLYTLVFEE 227

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.5 bits (246), Expect = 6e-22
 Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 14/203 (6%)

Query: 428 ANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAK 484
              T+ +    +LG+G F  V + + +  GQE A   ++    S +  ++ + E  +   
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           L+H N+V+L     +     LI++ +    L + I     R+    +     I  I   +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAV 123

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGVDQTEANTNRVVGTYG 601
           L+ HQ   + ++HR+LK  N+LL +++     K++DFG+A     +Q         GT G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPG 178

Query: 602 YMPPEYAIDGLFSVKSDVFSFGV 624
           Y+ PE      +    D+++ GV
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGV 201

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 97.5 bits (243), Expect = 1e-21
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 25/211 (11%)

Query: 431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQG--------VEEFKNEVLL 481
            D +     LG G  G V         +++A++ +SK                 + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           + KL H  ++K+       D   ++ E +    L D +      K L  +        + 
Sbjct: 194 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQML 249

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGVDQTEANTNRVVG 598
             + YLH+     IIHRDLK  NVLL ++      KI+DFG ++  G + +   T  + G
Sbjct: 250 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT--LCG 303

Query: 599 TYGYMPPE---YAIDGLFSVKSDVFSFGVLV 626
           T  Y+ PE         ++   D +S GV++
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 97.2 bits (242), Expect = 3e-21
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 26/214 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           D F +   LG GGFG V+   +    ++ A K+L+K      +G +    E  ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 488 RNLVKLLGCCMKRDERMLIYEY---------LPNKSLADFIFDGTRRKLLDWSKRCQIIG 538
           R +V L      + +  L+            + N    +  F   R              
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY--------TA 296

Query: 539 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
            I  GL +LHQ     II+RDLK  NVLLD++ N +ISD G+A      QT+       G
Sbjct: 297 QIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAG 351

Query: 599 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
           T G+M PE  +   +    D F+ GV + E++  
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 92.7 bits (231), Expect = 6e-21
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 30/207 (14%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG G FG V  G   + G ++AVK L++    S   V + K E+  +   +H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC---QIIGGIARGLLYLHQDSR 552
                 +  ++ EY+    L D+I      ++ +   R    QI+  +     Y H   R
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYIC--KHGRVEEMEARRLFQQILSAVD----YCH---R 129

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE------ 606
             ++HRDLK  NVLLD  MN KI+DFG++     D     T    G+  Y  PE      
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRT--SCGSPNYAAPEVISGRL 186

Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYGT 633
           Y   G    + D++S GV++  L+ GT
Sbjct: 187 Y--AGP---EVDIWSCGVILYALLCGT 208

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 96.9 bits (241), Expect = 6e-21
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNE--VL-LIAK 484
           ++FS    +G GGFG VY     D  ++ A+K L K      QG     NE  +L L++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
                +V +       D+   I + +      D  +  ++  +   +        I  GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNG---GDLHYHLSQHGVFSEADMRFYAAEIILGL 305

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            ++H      +++RDLK +N+LLD   + +ISD G+A     D ++   +  VGT+GYM 
Sbjct: 306 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMA 358

Query: 605 PEYAIDGL---FSVKSDVFSFGVLVLELVYG 632
           PE    G+    S   D FS G ++ +L+ G
Sbjct: 359 PEVLQKGVAYDSSA--DWFSLGCMLFKLLRG 387

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 25/209 (11%)

Query: 431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEE--------FKNEVLL 481
            D +     LG G  G V         +++A+K +SK                 + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           + KL H  ++K+       ++  ++ E +    L D +      K L  +        + 
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQML 124

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGVDQTEANTNRVVG 598
             + YLH      IIHRDLK  NVLL   + +   KI+DFG ++  G          + G
Sbjct: 125 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 178

Query: 599 TYGYMPPE---YAIDGLFSVKSDVFSFGV 624
           T  Y+ PE         ++   D +S GV
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 96.4 bits (240), Expect = 7e-21
 Identities = 62/215 (28%), Positives = 90/215 (41%), Gaps = 31/215 (14%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           + F +   LG+GGFG V    +    ++ A K+L K      +G     NE  ++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSL-------ADFIFDGTRRKLLDWSKRCQIIGGI 540
           R +V L      +D   L+   +    L           F   R               I
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--------AAEI 295

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
             GL  LH   R RI++RDLK  N+LLD+  + +ISD G+A      QT       VGT 
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTV 349

Query: 601 GYMPPEYAIDGL---FSVKSDVFSFGVLVLELVYG 632
           GYM PE  +      FS   D ++ G L+ E++ G
Sbjct: 350 GYMAPE-VVKNERYTFSP--DWWALGCLLYEMIAG 381

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 92.7 bits (231), Expect = 9e-21
 Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 16/200 (8%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LGEG F  V     +      A+K L K        V     E  ++++L H   VKL  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR---CQIIGGIARGLLYLHQDSR 552
                ++      Y  N  L    +        +   R    +I+      L YLH    
Sbjct: 98  TFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAEIV----SALEYLHG--- 148

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
             IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ PE   +  
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208

Query: 613 FSVKSDVFSFGVLVLELVYG 632
               SD+++ G ++ +LV G
Sbjct: 209 ACKSSDLWALGCIIYQLVAG 228

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 23/209 (11%)

Query: 431 TDNFSE-----ENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS--SGQGVEEFKNEVLLI 482
            +NF+        +LG G F  V + +    GQE A K L K         E  +E+ ++
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 483 AKLQHR-NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR--CQIIGG 539
              +    ++ L        E +LI EY     +               S+    ++I  
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQ 139

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGVDQTEANTNRV 596
           I  G+ YLHQ     I+H DLK  N+LL +     + KI DFGM+R  G          +
Sbjct: 140 ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREI 193

Query: 597 VGTYGYMPPEYAIDGLFSVKSDVFSFGVL 625
           +GT  Y+ PE       +  +D+++ G++
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGII 222

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 28/206 (13%)

Query: 431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 489
           TD +  +  +G G +    + +      E AVK + KS     EE     +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           ++ L           ++ E +    L D I    R+K     +   ++  I + + YLH 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKI---LRQKFFSEREASAVLFTITKTVEYLHA 134

Query: 550 DSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
                ++HRDLK SN+L      N  + +I DFG A+    +     T     T  ++ P
Sbjct: 135 ---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAP 189

Query: 606 E------YAIDGLFSVKSDVFSFGVL 625
           E      Y          D++S GVL
Sbjct: 190 EVLERQGY------DAACDIWSLGVL 209

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 56/230 (24%), Positives = 90/230 (39%), Gaps = 47/230 (20%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKR-LSKSSGQGVEEFKN----EVLLI 482
              D F  E   G+G FG V  G     G  +A+K+ +          F+N     +  +
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDL 73

Query: 483 AKLQHRNLVKLLGCCMKRDER-------MLIYEYLPNKSLADFI--FDGTRRKLLDWSKR 533
           A L H N+V+L        ER        ++ EY+P  +L      +   +        +
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIK 132

Query: 534 C---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGVDQT 589
               Q+I    R +  LH  S + + HRD+K  NVL++      K+ DFG A+      +
Sbjct: 133 VFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185

Query: 590 EANTNRVVGTYGYMPPE-------YAIDGLFSVKSDVFSFGVLVLELVYG 632
           E N   +   Y Y  PE       Y      +   D++S G +  E++ G
Sbjct: 186 EPNVAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLG 228

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 51/194 (26%), Positives = 81/194 (41%), Gaps = 16/194 (8%)

Query: 437 ENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLL 494
           +  LGEG F    K +     Q  AVK +SK         + E+  +   + H N+VKL 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72

Query: 495 GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLR 554
                +    L+ E L    L + I    ++K    ++   I+  +   + ++H    + 
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVSHMHD---VG 126

Query: 555 IIHRDLKASNVLLDNEMNP---KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
           ++HRDLK  N+L  +E +    KI DFG AR    D     T     T  Y  PE     
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQN 184

Query: 612 LFSVKSDVFSFGVL 625
            +    D++S GV+
Sbjct: 185 GYDESCDLWSLGVI 198

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 57/240 (23%), Positives = 100/240 (41%), Gaps = 23/240 (9%)

Query: 395 SEGGQDLYIRMATSELGNRKEEMELPIFDWKSIANATDNFSEE----NKLGEGGFGPVYK 450
             G ++LY +  +S   +        + D+    +  D  S+     ++LG G    VY+
Sbjct: 12  DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYR 71

Query: 451 GMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY 509
                  +  A+K L K+     +  + E+ ++ +L H N++KL        E  L+ E 
Sbjct: 72  CKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129

Query: 510 LPNKSLADFIFDGTRRKLLDWSKR--CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 567
           +    L D I +        +S+R     +  I   + YLH+     I+HRDLK  N+L 
Sbjct: 130 VTGGELFDRIVEKGY-----YSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLY 181

Query: 568 ---DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGV 624
                +   KI+DFG+++             V GT GY  PE      +  + D++S G+
Sbjct: 182 ATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.2 bits (229), Expect = 8e-20
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 36/210 (17%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG G FG V  G   + G ++AVK L++    S   V + + E+  +   +H +++KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTR------RKLLDWSKRCQIIGGIARGLLYLHQ 549
                 +  ++ EY+    L D+I    R      R+L       QI+ G+     Y H 
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF-----QQILSGVD----YCH- 133

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE--- 606
             R  ++HRDLK  NVLLD  MN KI+DFG++      +    T+   G+  Y  PE   
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPEVIS 188

Query: 607 ---YAIDGLFSVKSDVFSFGVLVLELVYGT 633
              Y   G    + D++S GV++  L+ GT
Sbjct: 189 GRLY--AGP---EVDIWSSGVILYALLCGT 213

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 31/207 (14%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LGEG FG V         Q++A+K +S+            + E+  +  L+H +++KL  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC---QIIGGIARGLLYLHQDSR 552
                 + +++ EY     L D+I    ++++ +   R    QII  I     Y H   R
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIV--EKKRMTEDEGRRFFQQIICAIE----YCH---R 126

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE------ 606
            +I+HRDLK  N+LLD+ +N KI+DFG++     D     T+   G+  Y  PE      
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTS--CGSPNYAAPEVINGKL 183

Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYGT 633
           Y   G    + DV+S G+++  ++ G 
Sbjct: 184 Y--AGP---EVDVWSCGIVLYVMLVGR 205

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 88.6 bits (220), Expect = 5e-19
 Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 36/209 (17%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM 498
           +G G FG        +  + +AVK + + +    E  + E++    L+H N+V+     +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 499 KRDERMLIYEYLPNKSLADFIFDGTR------RKLLDWSKRCQIIGGIARGLLYLHQDSR 552
                 +I EY     L + I +  R      R         Q++ G++    Y H    
Sbjct: 87  TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-----QLLSGVS----YCH---S 134

Query: 553 LRIIHRDLKASNVLLD--NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE---- 606
           ++I HRDLK  N LLD       KI DFG +++  +      +   VGT  Y+ PE    
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS--TVGTPAYIAPEVLLR 191

Query: 607 --YAIDGLFSVKSDVFSFGVLVLELVYGT 633
             Y  DG     +DV+S GV +  ++ G 
Sbjct: 192 QEY--DGK---IADVWSCGVTLYVMLVGA 215

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 53/237 (22%), Positives = 104/237 (43%), Gaps = 44/237 (18%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ- 486
              D++    KLG G +  V++ + + + +++ VK L     +   + K E+ ++  L+ 
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRG 89

Query: 487 HRNLVKLLGCCMKRDERM--LIYEYLPNKSLADFIFDGTRRKLLDWSKRC---QIIGGIA 541
             N++ L         R   L++E++ N            + L D+  R    +I+    
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL---- 140

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGVDQTEANTNRVVGTY 600
           + L Y H  S   I+HRD+K  NV++D+E    ++ D+G+A  F     E    RV   Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQE-YNVRVASRY 195

Query: 601 GYMPPE---------YAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLL 648
            +  PE         Y++        D++S G ++  +++  +   FH  D++  L+
Sbjct: 196 -FKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFR-KEPFFHGHDNYDQLV 242

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 47/200 (23%), Positives = 79/200 (39%), Gaps = 26/200 (13%)

Query: 437 ENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEV-LLIAKLQHRNLVKLL 494
           +  LG G  G V +      GQ+ A+K L  S      + + EV          ++V +L
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88

Query: 495 GCC----MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR--CQIIGGIARGLLYLH 548
                    +   ++I E +    L   I     R    +++R   +I+  I   + +LH
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRI---QERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 549 QDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
                 I HRD+K  N+L    + +   K++DFG A+     Q    T     T  Y+ P
Sbjct: 146 S---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQT--PCYTPYYVAP 198

Query: 606 EYAIDGLFSVKSDVFSFGVL 625
           E      +    D++S GV+
Sbjct: 199 EVLGPEKYDKSCDMWSLGVI 218

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 85.2 bits (211), Expect = 9e-18
 Identities = 46/201 (22%), Positives = 80/201 (39%), Gaps = 27/201 (13%)

Query: 437 ENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEV-LLIAKLQHRNLVKLL 494
              LG G  G V +       ++ A+K L         + + EV L     Q  ++V+++
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 121

Query: 495 G----CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR--CQIIGGIARGLLYLH 548
                    R   +++ E L    L   I     R    +++R   +I+  I   + YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLH 178

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
               + I HRD+K  N+L  ++  P    K++DFG A+      +         T  Y+ 
Sbjct: 179 S---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVA 231

Query: 605 PEYAIDGLFSVKSDVFSFGVL 625
           PE      +    D++S GV+
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVI 252

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 82.7 bits (204), Expect = 4e-17
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 9/108 (8%)

Query: 523 TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 582
           T   L+ +S +      +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR
Sbjct: 191 TLEHLICYSFQ------VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
               D              +M PE   D +++++SDV+SFGVL+ E+ 
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 34/160 (21%), Positives = 60/160 (37%), Gaps = 19/160 (11%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 484
           D       LG G FG V +            + +AVK L + +         +E+ ++  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 485 L-QHRNLVKLLGCCMKRDER-MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
           +  H N+V LLG C K     M+I E+    +L+ ++           SKR + +    +
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 582
           G  +      +  I  DLK     + +  +   S F   +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 82.1 bits (203), Expect = 7e-17
 Identities = 50/252 (19%), Positives = 99/252 (39%), Gaps = 65/252 (25%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQ 486
            ++  +S    LG G FG V +   I+ G+  A+K++ +        +KN E+ ++  L 
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLD 58

Query: 487 HRNLVKLLGC--------------------CMKRDERMLIYEYLPNKSLADFIF------ 520
           H N++KL+                         ++  +  +      + +   +      
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 521 --DGTRRKLLD-WSKRCQIIGG---------IARGLLYLHQDSRLRIIHRDLKASNVLLD 568
               T  K+L  + +  + I           + R + ++H    L I HRD+K  N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175

Query: 569 NEMNP-KISDFGMARAFGVDQTEANTNRVVGTYGYMPPE-------YAIDGLFSVKSDVF 620
           ++ N  K+ DFG A+      +E +   +   + Y  PE       Y      +   D++
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEY------TPSIDLW 226

Query: 621 SFGVLVLELVYG 632
           S G +  EL+ G
Sbjct: 227 SIGCVFGELILG 238

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 31/287 (10%), Positives = 75/287 (26%), Gaps = 55/287 (19%)

Query: 439 KLGEGGFGPVYKGMLID---GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVK 492
             G       ++ +  D    +++A+  +          ++E  +  L ++++    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
           +L     R   +++ E++   SL +                 + +  +A      H   R
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---R 147

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
             +       S V         +S  G                V+     MP        
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA------ 179

Query: 613 FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY 672
            + + D+   G  +  L+                L         +      ID+      
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLAPAERDTAGQPIEPADIDR------ 230

Query: 673 SLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGF 719
            +   +  +    +  Q     R     + LM        + +  G 
Sbjct: 231 DIPFQISAVAARSV--QGDGGIRSASTLLNLMQQATAVADRTEVLGP 275

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 47/207 (22%), Positives = 85/207 (41%), Gaps = 23/207 (11%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           +G G F  V    +    ++ A+K ++K        V  F+ E  ++     R + +L  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127

Query: 496 CCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSK--RCQIIGGIARGLLYLHQDSR 552
              + +  + L+ EY     L   +     R   + ++    +I+  I      +H+   
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID----SVHR--- 180

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE------ 606
           L  +HRD+K  N+LLD   + +++DFG       D T   +   VGT  Y+ PE      
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVG 239

Query: 607 -YAIDGLFSVKSDVFSFGVLVLELVYG 632
                G +  + D ++ GV   E+ YG
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYG 266

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 36/220 (16%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           D+F     +G+G FG V      D +++ A+K ++K        V     E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 488 RNLVKLLGCCMKRDERM-LIYEYLPNKSLADF-------IFDGTRRKLLDWSKRCQIIGG 539
             LV L     + +E M ++ + L    L           F     KL         I  
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLF--------ICE 123

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +   L YL      RIIHRD+K  N+LLD   +  I+DF +A      +T+  T  + GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGT 177

Query: 600 YGYMPPE--YAIDGL---FSVKSDVFSFGVLVLELVYGTR 634
             YM PE   +  G    F+V  D +S GV   EL+ G R
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRR 215

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 80.2 bits (198), Expect = 6e-16
 Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 19/212 (8%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     +G G FG V    L +  ++ A+K L+K           F+ E  ++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK--RCQIIGGIARGLL 545
           + +  L       +   L+ +Y     L   +     R   + ++    +++  I     
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID---- 189

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
            +HQ   L  +HRD+K  N+L+D   + +++DFG       D T   ++  VGT  Y+ P
Sbjct: 190 SVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISP 245

Query: 606 E-----YAIDGLFSVKSDVFSFGVLVLELVYG 632
           E         G +  + D +S GV + E++YG
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 36/207 (17%), Positives = 80/207 (38%), Gaps = 57/207 (27%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVL 480
            D +   + +G G +G V +    ++ + +A+K++ +        F++         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 481 LIAKLQHRNLVKLLGCCMKRDERM-----LIYEYLP---------NKSLAD-----FIFD 521
           ++ +L H ++VK+L   + +D        ++ E               L +      ++ 
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY- 163

Query: 522 GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 581
                         ++     G+ Y+H  S   I+HRDLK +N L++ + + K+ DFG+A
Sbjct: 164 -------------NLL----VGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLA 203

Query: 582 RAFGVDQTEANTNRVVGTYGYMPPEYA 608
           R     +   +   +      M     
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTF 230

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 20/212 (9%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           +++     +G G FG V        +++ A+K LSK           F  E  ++A    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSK--RCQIIGGIARGLL 545
             +V+L           ++ EY+P   L              W++    +++  +     
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFYTAEVVLALD---- 182

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
            +H    +  IHRD+K  N+LLD   + K++DFG       +      +  VGT  Y+ P
Sbjct: 183 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISP 238

Query: 606 E----YAIDGLFSVKSDVFSFGVLVLELVYGT 633
           E       DG +  + D +S GV + E++ G 
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 75.9 bits (187), Expect = 8e-15
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 39/234 (16%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVL 480
              +     +G G  G V      I  + +A+K+LS+        F+N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76

Query: 481 LIAKLQHRNLVKLL------GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC 534
           L+  + H+N++ LL          +  +  ++ E +   +L   I    + +L    +R 
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDH--ERM 129

Query: 535 Q-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
             ++  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR      +   T
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 184

Query: 594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL 647
             VV T  Y  PE  +   +    D++S G ++ E++       F   DH    
Sbjct: 185 PYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI--KGGVLFPGTDHIDQW 235

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.8 bits (187), Expect = 8e-15
 Identities = 45/194 (23%), Positives = 83/194 (42%), Gaps = 41/194 (21%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVL 480
              +     +G G +G V   +    G+++A+K+LS+        F++         E+L
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 481 LIAKLQHRNLVKLLGCCMKRDERM-------LIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
           L+  +QH N++ LL         +       L+  ++    L   +      K  +  ++
Sbjct: 76  LLKHMQHENVIGLLDV-FTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSE--EK 127

Query: 534 CQ-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN 592
            Q ++  + +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR    + T   
Sbjct: 128 IQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-- 182

Query: 593 TNRVVGTYGYMPPE 606
               V T  Y  PE
Sbjct: 183 ---YVVTRWYRAPE 193

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 40/173 (23%), Positives = 67/173 (38%), Gaps = 22/173 (12%)

Query: 420 PIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNE 478
                K  A   D       LG G  G V +       ++ A+K L         + + E
Sbjct: 6   SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60

Query: 479 V-LLIAKLQHRNLVKLLGCC----MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
           V L     Q  ++V+++         R   +++ E L    L   I     R    +++R
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTER 117

Query: 534 --CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMA 581
              +I+  I   + YLH    + I HRD+K  N+L  ++      K++DFG A
Sbjct: 118 EASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 44/193 (22%), Positives = 77/193 (39%), Gaps = 27/193 (13%)

Query: 431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEE--FKN---------EV 479
              ++ +  +  G +G V  G+  +G  +A+KR+  +   G       +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 480 LLIAKLQHRNLVKLLGCCMKRDERM-----LIYEYLPNKSLADFIFDGTRRKLLDWSKRC 534
            L+    H N++ L    +  +E       L+ E +    LA  I    +R ++   +  
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVIS-PQHI 136

Query: 535 Q-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
           Q  +  I  GL  LH+     ++HRDL   N+LL +  +  I DF +AR          T
Sbjct: 137 QYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKT 191

Query: 594 NRVVGTYGYMPPE 606
           + V     Y  PE
Sbjct: 192 HYVT-HRWYRAPE 203

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 73.4 bits (179), Expect = 4e-14
 Identities = 35/209 (16%), Positives = 62/209 (29%), Gaps = 47/209 (22%)

Query: 421 IFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRL--------SKSSGQGV 472
              +      T+      K+GEG FG V++ +  D   +A+K +        + S  +  
Sbjct: 10  PVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTF 67

Query: 473 EEFKNEVLLIAKLQ---------HRNLVKLLGCCM-------------------KRDERM 504
           EE   E+++  +L              + L                        K     
Sbjct: 68  EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127

Query: 505 LIYEYLPNKSLADFIFDGT-------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 557
               +  ++      F+         R KL   +    I+  +   L        LR  H
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEH 185

Query: 558 RDLKASNVLLDNEMNPKISDFGMARAFGV 586
           RDL   NVLL      K+      ++  +
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTI 214

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 73.5 bits (181), Expect = 4e-14
 Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 17/206 (8%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           D F     LG G FG V      +     A+K L K      + +E   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGG-IARGLLY 546
             LVKL           ++ EY+    +    F   RR         +     I     Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT   + PE
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPE 208

Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYG 632
             +   ++   D ++ GVL+ E+  G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.1 bits (182), Expect = 5e-14
 Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 37/233 (15%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVL 480
              +     +G G  G V      +  + +A+K+LS+        F+N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113

Query: 481 LIAKLQHRNLVKLL------GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC 534
           L+  + H+N++ LL          +  +  L+ E +    L   I     +  LD  +  
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-----QMELDHERMS 167

Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
            ++  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR      +   T 
Sbjct: 168 YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTP 222

Query: 595 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL 647
            VV T  Y  PE  +   +    D++S G ++ E+V       F   D+    
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYIDQW 272

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 52/202 (25%), Positives = 79/202 (39%), Gaps = 21/202 (10%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+G FG V            A+K L K    +   V     E  ++   +H  L  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 496 CCMKRDERMLIYEYLPNKSL-----ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
                D    + EY     L      + +F   R +             I   L YLH  
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--------GAEIVSALDYLH-- 265

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
           S   +++RDLK  N++LD + + KI+DFG+ +    D     T    GT  Y+ PE   D
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLED 323

Query: 611 GLFSVKSDVFSFGVLVLELVYG 632
             +    D +  GV++ E++ G
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCG 345

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 45/193 (23%), Positives = 81/193 (41%), Gaps = 34/193 (17%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVL 480
              ++  + +GEG +G V      ++   +A+K++S         F++         E+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 481 LIAKLQHRNLVKLLGCCMKRDERM-----LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ 535
           ++ + +H N++ +                ++ + +    L   +    + + L     C 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICY 132

Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN--T 593
            +  I RGL Y+H  S   ++HRDLK SN+LL+   + KI DFG+AR    D       T
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 594 NRVVGTYGYMPPE 606
             V  T  Y  PE
Sbjct: 190 EYVA-TRWYRAPE 201

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 70.6 bits (174), Expect = 3e-13
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)

Query: 440 LGEGGFGPVY---KGMLIDGQEI-AVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLV 491
           LG+GG+G V+   K    +  +I A+K L K+      +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 492 KLLGCCMKRDERM-LIYEYLPNKSL-----ADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
            L+    +   ++ LI EYL    L      + IF                +  I+  L 
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAEISMALG 135

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPP 605
           +LHQ     II+RDLK  N++L+++ + K++DFG+ +    D T  +T    GT  YM P
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAP 190

Query: 606 EYAIDGLFSVKSDVFSFGVLVLELVYG 632
           E  +    +   D +S G L+ +++ G
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTG 217

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 32/208 (15%)

Query: 440 LGEGGFGPVY---KGMLIDGQEI-AVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKL 493
           LG+G FG V+   K    D +++ A+K L K++   +     K E  ++ ++ H  +VKL
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 494 LGCCMKRDERM-LIYEYLPNKSL-----ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
                + + ++ LI ++L    L      + +F     K          +  +A  L +L
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALDHL 142

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H    L II+RDLK  N+LLD E + K++DFG+++     + +A +    GT  YM PE 
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE- 196

Query: 608 AIDGL---FSVKSDVFSFGVLVLELVYG 632
            ++      S   D +SFGVL+ E++ G
Sbjct: 197 VVNRRGHTQSA--DWWSFGVLMFEMLTG 222

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 39/197 (19%), Positives = 81/197 (41%), Gaps = 31/197 (15%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVL 480
            DN+  ++ +G G +G VY        + +A+K++++        F++         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREIT 77

Query: 481 LIAKLQHRNLVKLLGCCMKRDERM-----LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ 535
           ++ +L+   +++L    +  D        ++ E      L       T   L +  +  +
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTE--EHIK 132

Query: 536 -IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
            I+  +  G  ++H      IIHRDLK +N LL+ + + K+ DFG+AR    ++     N
Sbjct: 133 TILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 595 RVVGTYGYMPPEYAIDG 611
            +       P    +  
Sbjct: 190 DLEENEEPGPHNKNLKK 206

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 42/199 (21%), Positives = 77/199 (38%), Gaps = 37/199 (18%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVL 480
              + +   LG GG G V+  +     + +A+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLAD--FIFD--GT------RRKLLDW 530
           +I +L H N+VK+    +      L  +      L     + +   T       +  L  
Sbjct: 61  IIRRLDHDNIVKVFEI-LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119

Query: 531 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGVDQT 589
                 +  + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+AR      +
Sbjct: 120 EHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 590 EAN--TNRVVGTYGYMPPE 606
                +  +V T  Y  P 
Sbjct: 177 HKGHLSEGLV-TKWYRSPR 194

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 43/192 (22%), Positives = 80/192 (41%), Gaps = 36/192 (18%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVL 480
              + +   +G G +G V   +    G ++A+K+L +        F++         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76

Query: 481 LIAKLQHRNLVKLL------GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC 534
           L+  ++H N++ LL             +  L+  ++    L   +    + + L   +  
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQ 131

Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
            ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR    + T     
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--- 185

Query: 595 RVVGTYGYMPPE 606
             V T  Y  PE
Sbjct: 186 --VVTRWYRAPE 195

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 69.2 bits (170), Expect = 8e-13
 Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 24/203 (11%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
           LG+G FG V            A+K L K    +   V     E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71

Query: 496 CCMKRDERM-LIYEYLPNKSL-----ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
              +  +R+  + EY     L      + +F   R +             I   L YLH 
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--------GAEIVSALEYLHS 123

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
                +++RD+K  N++LD + + KI+DFG+ +    D     T    GT  Y+ PE   
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLE 178

Query: 610 DGLFSVKSDVFSFGVLVLELVYG 632
           D  +    D +  GV++ E++ G
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCG 201

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.7 bits (169), Expect = 1e-12
 Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 37/216 (17%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEI-AVKRLSKSS----GQGVEEFKNEVLLIAKLQ 486
            +F     LG G FG V+           A+K L K       Q VE   +E L+++ + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADF-------IFDGTRRKLLDWSKRCQIIGG 539
           H  ++++ G      +  +I +Y+    L  F        F     K             
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFY--------AAE 114

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           +   L YLH      II+RDLK  N+LLD   + KI+DFG A+          T  + GT
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166

Query: 600 YGYMPPEYAIDGL---FSVKSDVFSFGVLVLELVYG 632
             Y+ PE  +       S+  D +SFG+L+ E++ G
Sbjct: 167 PDYIAPE-VVSTKPYNKSI--DWWSFGILIYEMLAG 199

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 60/200 (30%), Positives = 87/200 (43%), Gaps = 17/200 (8%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNLVKL 493
           LG+G FG V         E+ AVK L K        VE    E  VL +   +   L +L
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQL 86

Query: 494 LGCCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSR 552
              C +  +R+  + EY+      D ++   +               IA GL +L     
Sbjct: 87  H-SCFQTMDRLYFVMEYVNG---GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS--- 139

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
             II+RDLK  NV+LD+E + KI+DFGM +    D     T    GT  Y+ PE      
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQP 197

Query: 613 FSVKSDVFSFGVLVLELVYG 632
           +    D ++FGVL+ E++ G
Sbjct: 198 YGKSVDWWAFGVLLYEMLAG 217

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.1 bits (171), Expect = 2e-12
 Identities = 60/199 (30%), Positives = 84/199 (42%), Gaps = 15/199 (7%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNLVKL 493
           LG+G FG V         E+ AVK L K        VE    E  VL +   +   L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-GKPPFLTQL 407

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
             C    D    + EY+      D ++   +               IA GL +L      
Sbjct: 408 HSCFQTMDRLYFVMEYVNG---GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---K 461

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            II+RDLK  NV+LD+E + KI+DFGM +    D     T    GT  Y+ PE      +
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQPY 519

Query: 614 SVKSDVFSFGVLVLELVYG 632
               D ++FGVL+ E++ G
Sbjct: 520 GKSVDWWAFGVLLYEMLAG 538

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 23/203 (11%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNLVKL 493
           +G G +  V    L     I A+K + K      + ++  + E  V   A   H  LV L
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 75

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQI-IGGIARGLLYLHQDSR 552
             C         + EY+    L        +RKL +  +  +     I+  L YLH+   
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPE--EHARFYSAEISLALNYLHE--- 128

Query: 553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL 612
             II+RDLK  NVLLD+E + K++D+GM +         +T    GT  Y+ PE  + G 
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPE-ILRGE 185

Query: 613 ---FSVKSDVFSFGVLVLELVYG 632
              FSV  D ++ GVL+ E++ G
Sbjct: 186 DYGFSV--DWWALGVLMFEMMAG 206

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNLVKL 493
           LG+G FG V    + +  ++ AVK L K        VE    E  +L +A+  H  L +L
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 89

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
             C    D    + E++      D +F   + +  D ++       I   L++LH     
Sbjct: 90  FCCFQTPDRLFFVMEFVNG---GDLMFHIQKSRRFDEARARFYAAEIISALMFLHD---K 143

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            II+RDLK  NVLLD+E + K++DFGM +    +     T    GT  Y+ PE   + L+
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEMLY 201

Query: 614 SVKSDVFSFGVLVLELVYG 632
               D ++ GVL+ E++ G
Sbjct: 202 GPAVDWWAMGVLLYEMLCG 220

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 15/199 (7%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNLVKL 493
           LG+G FG V+        +  A+K L K        VE    E  VL +A  +H  L  +
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 83

Query: 494 LGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRL 553
                 ++    + EYL      D ++        D S+       I  GL +LH     
Sbjct: 84  FCTFQTKENLFFVMEYLNG---GDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---K 137

Query: 554 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF 613
            I++RDLK  N+LLD + + KI+DFGM +   +   + NT    GT  Y+ PE  +   +
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKY 195

Query: 614 SVKSDVFSFGVLVLELVYG 632
           +   D +SFGVL+ E++ G
Sbjct: 196 NHSVDWWSFGVLLYEMLIG 214

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 51/204 (25%), Positives = 80/204 (39%), Gaps = 25/204 (12%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNLVKL 493
           +G G +  V    L     I A++ + K      + ++  + E  V   A   H  LV L
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 118

Query: 494 LGCCMKRDERMLIYEYLPNKSL-----ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
             C         + EY+    L               +             I+  L YLH
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYLH 170

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
           +     II+RDLK  NVLLD+E + K++D+GM +         +T    GT  Y+ PE  
Sbjct: 171 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEIL 225

Query: 609 IDGLFSVKSDVFSFGVLVLELVYG 632
               +    D ++ GVL+ E++ G
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAG 249

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 36/192 (18%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVL 480
            + +   + +G G +G V        G  +AVK+LS+        F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 481 LIAKLQHRNLVKLL------GCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC 534
           L+  ++H N++ LL          + ++  L+   +    L + +    + + L      
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV----KCQKLTDDHVQ 135

Query: 535 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN 594
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR    + T     
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY--- 189

Query: 595 RVVGTYGYMPPE 606
             V T  Y  PE
Sbjct: 190 --VATRWYRAPE 199

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 33/208 (15%)

Query: 440 LGEGGFGPVYKGMLIDGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNLVKL 493
           +G+G FG V        +   AVK L K      +  +   +E  VLL   ++H  LV L
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN-VKHPFLVGL 104

Query: 494 LGCCMKRDERM-LIYEYLPNKSL-----ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
                +  +++  + +Y+    L      +  F   R +             IA  L YL
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY--------AAEIASALGYL 155

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H    L I++RDLK  N+LLD++ +  ++DFG+ +      +  +T    GT  Y+ PE 
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPE- 209

Query: 608 AIDGL---FSVKSDVFSFGVLVLELVYG 632
            +       +V  D +  G ++ E++YG
Sbjct: 210 VLHKQPYDRTV--DWWCLGAVLYEMLYG 235

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 62.2 bits (151), Expect = 5e-12
 Identities = 23/129 (17%), Positives = 47/129 (36%), Gaps = 21/129 (16%)

Query: 5   QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPL 64
           ++ L  G+ +  G++L      +                + Y    + T  W +N     
Sbjct: 1   RNLLTNGEGLYAGQSLDVEP--YHFIMQEDCNL------VLYD---HSTSVWASNTGIL- 48

Query: 65  PDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSD 124
                      Q +G  ++ ++    +W+S++ R   N V VL E GN+V+         
Sbjct: 49  --GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI-------YG 99

Query: 125 NFLWQSFDY 133
           + +W +  Y
Sbjct: 100 SDIWSTGTY 108

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.9 bits (164), Expect = 6e-12
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 38/214 (17%)

Query: 440 LGEGGFGPVY---KGMLIDGQEI-AVKRLSKSS----GQGVEEFKNE--VLLIAKLQHRN 489
           LG G +G V+   K    D  ++ A+K L K++     +  E  + E  VL   + Q   
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPF 120

Query: 490 LVKLLGCCMKRDERM-LIYEYLPNKSL-----ADFIFDGTRRKLLDWSKRCQIIGGIARG 543
           LV L     + + ++ LI +Y+    L         F     ++         +G I   
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--------YVGEIVLA 171

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
           L +LH+   L II+RD+K  N+LLD+  +  ++DFG+++   V           GT  YM
Sbjct: 172 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYM 227

Query: 604 PPEYAIDGL-----FSVKSDVFSFGVLVLELVYG 632
            P+  + G       +V  D +S GVL+ EL+ G
Sbjct: 228 APD-IVRGGDSGHDKAV--DWWSLGVLMYELLTG 258

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 45/194 (23%), Positives = 83/194 (42%), Gaps = 38/194 (19%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVL 480
           + +F  ++ LGEG +G V        G+ +A+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 481 LIAKLQHRNLVKLLGCCMKRDERM------LIYEYLPNKSLADFIFDGTRRKLLDWSKRC 534
           ++   +H N++ +     + D         +I E +    L   I      ++L      
Sbjct: 62  ILKHFKHENIITIFNI-QRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLS-DDHI 114

Query: 535 Q-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
           Q  I    R +  LH  +   +IHRDLK SN+L+++  + K+ DFG+AR   +D++ A+ 
Sbjct: 115 QYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADN 169

Query: 594 NRVVGTYGYMPPEY 607
           +   G    M  E+
Sbjct: 170 SEPTGQQSGM-VEF 182

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 60.6 bits (147), Expect = 2e-11
 Identities = 22/125 (17%), Positives = 44/125 (35%), Gaps = 21/125 (16%)

Query: 6   DTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLP 65
           ++L    S+  G +L     S+ L              + Y    +G   W +N      
Sbjct: 2   NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYD---SGKPVWASNTGGLGS 51

Query: 66  DRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDN 125
                L      NG L++ + +N ++W +  +    + V VL +  N+V+          
Sbjct: 52  GCRLTL----HNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVI-------YGP 100

Query: 126 FLWQS 130
            +W +
Sbjct: 101 VVWAT 105

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 30/196 (15%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKN---------EVL 480
              +    KLG+G +G V+K +    G+ +AVK++  +       F+N         E++
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60

Query: 481 LIAKLQ-HRNLVKLLGCCM--KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ-I 536
           ++ +L  H N+V LL         +  L+++Y+    L   I    R  +L+     Q +
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI----RANILE-PVHKQYV 114

Query: 537 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRV 596
           +  + + + YLH  S   ++HRD+K SN+LL+ E + K++DFG++R+F   +   N   +
Sbjct: 115 VYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

Query: 597 VGTYGYMPPEYAIDGL 612
                    +     L
Sbjct: 172 SINENTENFDDDQPIL 187

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 41/236 (17%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ----------- 486
           KLG G F  V+    +++   +A+K + +      E  ++E+ L+ ++            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 487 HRNLVKLLGCCMKRDERM----LIYEYLPNKSLADFIFDGTRRKL-LDWSKRCQIIGGIA 541
             +++KLL     +        +++E L  ++L   I     R + L + K+  I   + 
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQLL 141

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP------KISDFGMARAFGVDQTEANTNR 595
            GL Y+H   R  IIH D+K  NVL++   +P      KI+D G A        + +   
Sbjct: 142 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-----WYDEHYTN 194

Query: 596 VVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG-----TRNRGFHHVDHHH 645
            + T  Y  PE  + G  +   +D++S   L+ EL+ G           +  D  H
Sbjct: 195 SIQTREYRSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 57.2 bits (138), Expect = 3e-10
 Identities = 23/125 (18%), Positives = 47/125 (37%), Gaps = 20/125 (16%)

Query: 6   DTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLP 65
           D L  G  +  G +L      +     +        L ++     N    W +  N    
Sbjct: 2   DRLNSGHQLDTGGSLA--EGGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS 50

Query: 66  DRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDN 125
                +    Q +G L++ +  +  +W+SN +R   N   +L    N+V+     ++S+N
Sbjct: 51  GCVLKM----QNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIY----DNSNN 101

Query: 126 FLWQS 130
            +W +
Sbjct: 102 AIWAT 106

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 56.1 bits (135), Expect = 9e-10
 Identities = 25/125 (20%), Positives = 43/125 (34%), Gaps = 22/125 (17%)

Query: 6   DTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLP 65
           + L  GQ++    +L +    + L   +          + Y+   NG   W +N +    
Sbjct: 3   NVLLSGQTLHADHSLQAGA--YTLTIQNKCNL------VKYQ---NGRQIWASNTDRR-- 49

Query: 66  DRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDN 125
                L++ S GN  L++ +  N  VW S           VL + G  V+          
Sbjct: 50  GSGCRLTLLSDGN--LVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVI-------YGP 100

Query: 126 FLWQS 130
            LW  
Sbjct: 101 VLWSL 105

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 73/359 (20%), Positives = 117/359 (32%), Gaps = 119/359 (33%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ--------HRN 489
           KLG G F  V+    +   + +A+K + KS+    E   +E+ L+  ++           
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 490 LVKLLGC-----------CMKRDERMLIYEYLPNKSLADFIFDGTRRKL-LDWSKRCQII 537
           +V+LL             CM       ++E L    L  +I     + L L   K  +II
Sbjct: 103 VVQLLDDFKISGVNGTHICM-------VFEVL-GHHLLKWIIKSNYQGLPLPCVK--KII 152

Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE--------------------------- 570
             + +GL YLH  ++ RIIH D+K  N+LL                              
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 571 ----------------------MNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                                 +  KI+D G A       TE      + T  Y   E  
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVL 265

Query: 609 IDGLFSVKSDVFSFGVLVLELVYG-----TRNRGFHHVDHHH-----NLLG--------- 649
           I   ++  +D++S   +  EL  G       +   +  D  H      LLG         
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325

Query: 650 --HAWRLWTED----RPVELIDKSLED----TYSLS--EALRCIQVGLLCVQQRPEDRP 696
             ++   +T+        +L    L +     Y  S  EA       L  ++  PE R 
Sbjct: 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 35/175 (20%), Positives = 68/175 (38%), Gaps = 41/175 (23%)

Query: 439 KLGEGGFGPVYKGMLIDGQEI------AVKRLSKSSGQGVEEFK-----NEVLLIAKLQH 487
            +G+GGFG +Y   +   + +       VK     +G    E K      +   I K   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 488 RNLVKLLG----------CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC--- 534
              +K LG              +  R +I +      L   I++   ++    S++    
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRF---SRKTVLQ 156

Query: 535 ---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAF 584
              +I+  +     Y+H+      +H D+KASN+LL+ +   ++   D+G+A  +
Sbjct: 157 LSLRILDILE----YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 42/216 (19%)

Query: 438 NKLGEGGFGPVYKGM-LIDGQEIAVK---RLSKSSGQGVEEFKNEVLLIAKLQHR----- 488
           + +G+G FG V K    ++ + +A+K          Q     + EV L+  +        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115

Query: 489 -NLVKLLGCCMKRDERMLIYEYLPNKSLADFI----FDGTRRKLLDWSKRCQIIGGIARG 543
             +V L    M R+   L++E L + +L D +    F G    L       +    +   
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLT-----RKFAQQMCTA 169

Query: 544 LLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTEANTNRVVGTY- 600
           LL+L     L IIH DLK  N+LL N      KI DFG +             + +  Y 
Sbjct: 170 LLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---------CQLGQRIYQYI 219

Query: 601 ---GYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
               Y  PE  + G+ + +  D++S G +++E+  G
Sbjct: 220 QSRFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTG 254

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 29/171 (16%), Positives = 58/171 (33%), Gaps = 29/171 (16%)

Query: 437 ENKLGEGGFGPVYKGM---------LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 487
           ++       G +Y+               Q+ ++K L    G+   E          LQ 
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQV 105

Query: 488 RNLVKLLGC------------CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ 535
               KL                 +   R L+   L  +SL     D + + +L      Q
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQ 163

Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAF 584
           +   +   L +LH++     +H ++ A N+ +D E   ++  + +G A  +
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 53.3 bits (128), Expect = 5e-09
 Identities = 23/125 (18%), Positives = 40/125 (32%), Gaps = 22/125 (17%)

Query: 6   DTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLP 65
           + L  G+++  GE L   N  +                + Y         W  N      
Sbjct: 2   NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYD---VDKPIWATNTGGLDR 50

Query: 66  DRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDN 125
                +    Q +G L++ +  N  +W+SN      N V VL +  N+V+          
Sbjct: 51  RCHLSM----QSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIY-------GT 99

Query: 126 FLWQS 130
             W +
Sbjct: 100 ARWAT 104

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 30/182 (16%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVKLLGC 496
           K+G G FG +Y G  +  G+E+A+K     +         E  +   +Q    +  +  C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC------QIIGGIARGLLYLHQD 550
             + D  +++ E L   SL D +F+   RK    S +       Q+I  I     Y+H  
Sbjct: 74  GAEGDYNVMVMELL-GPSLED-LFNFCSRKF---SLKTVLLLADQMISRIE----YIHSK 124

Query: 551 SRLRIIHRDLKASNVLLDNEMNPK---ISDFGMARAFGVDQTEA-----NTNRVVGTYGY 602
           +    IHRD+K  N L+          I DFG+A+ +   +T           + GT  Y
Sbjct: 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

Query: 603 MP 604
             
Sbjct: 182 AS 183

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 36/164 (21%), Positives = 60/164 (36%), Gaps = 25/164 (15%)

Query: 433 NFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           NF    K+G G FG +  G  L   + +A+K     S       +             + 
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC------QIIGGIARGLL 545
           ++           ++ E L   SL D +FD   R     S +       Q+I  +     
Sbjct: 69  QVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTF---SLKTVLMIAIQLISRME---- 119

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPK-----ISDFGMARAF 584
           Y+H  +   +I+RD+K  N L+    N       I DF +A+ +
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 43/182 (23%), Positives = 73/182 (40%), Gaps = 30/182 (16%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-KLLGC 496
           K+G G FG +Y G  +   +E+A+K  +  +         E  +   LQ    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71

Query: 497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC------QIIGGIARGLLYLHQD 550
            ++ D  +L+ + L   SL D +F+   RKL   S +       Q+I  +     ++H  
Sbjct: 72  GVEGDYNVLVMDLL-GPSLED-LFNFCSRKL---SLKTVLMLADQMINRVE----FVHSK 122

Query: 551 SRLRIIHRDLKASNVLLDNEMNPK---ISDFGMARAFGVDQTEA-----NTNRVVGTYGY 602
           S    +HRD+K  N L+          I DFG+A+ +    T           + GT  Y
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 603 MP 604
             
Sbjct: 180 AS 181

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 50.6 bits (121), Expect = 5e-08
 Identities = 27/125 (21%), Positives = 41/125 (32%), Gaps = 25/125 (20%)

Query: 6   DTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLP 65
           + L  GQ++     L   N  F+L           Y G W       + T    R+  L 
Sbjct: 4   NYLLSGQTLDTEGHLK--NGDFDLVMQDDCNL-VLYNGNWQ------SNTANNGRDCKL- 53

Query: 66  DRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDN 125
                   +    G L+++N     VW S A     N  AV+   G LVV          
Sbjct: 54  --------TLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVV-------FGP 98

Query: 126 FLWQS 130
            +++ 
Sbjct: 99  SVFKI 103

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 36/210 (17%)

Query: 440 LGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR------NLVK 492
           +G+G FG V K       Q +A+K + ++  +   +   E+ ++  L+ +      N++ 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 493 LLGCCMKRDERMLIYEYLPNKSLADFI----FDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           +L     R+   + +E L + +L + I    F G    L+      +    I + L  LH
Sbjct: 164 MLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLV-----RKFAHSILQCLDALH 217

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTEANTNRVVGTY----GY 602
              + RIIH DLK  N+LL  +     K+ DFG +            ++ V TY     Y
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---------CYEHQRVYTYIQSRFY 265

Query: 603 MPPEYAIDGLFSVKSDVFSFGVLVLELVYG 632
             PE  +   + +  D++S G ++ EL+ G
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTG 295

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 32/165 (19%), Positives = 69/165 (41%), Gaps = 25/165 (15%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
            ++    ++GEG FG +++G  L++ Q++A+K   + S       +     +       +
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA-GCTGI 68

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRC------QIIGGIARGL 544
             +     +    +L+ + L   SL D + D   RK    S +       Q++  +    
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGRKF---SVKTVAMAAKQMLARVQ--- 120

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPK-----ISDFGMARAF 584
             +H+ S   +++RD+K  N L+    +       + DFGM + +
Sbjct: 121 -SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 49.5 bits (118), Expect = 1e-07
 Identities = 22/112 (19%), Positives = 38/112 (33%), Gaps = 16/112 (14%)

Query: 4   TQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAP 63
           T + L  GQ +     L + N   +L            L ++  K    + T     +  
Sbjct: 5   TNNLLFSGQVLYGDGRLTAKN--HQLVMQGDCN-----LVLYGGKYGWQSNTHGNGEHCF 57

Query: 64  LPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVV 115
           L              G LI+++     +WSS +S      V +L + G  V+
Sbjct: 58  L---------RLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 41.4 bits (97), Expect = 1e-04
 Identities = 14/60 (23%), Positives = 22/60 (36%), Gaps = 10/60 (16%)

Query: 77  GNGTLILQNSTN------GIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQS 130
            N  L++Q   N         W SN     ++    L   G L++K    +D    +W S
Sbjct: 24  KNHQLVMQGDCNLVLYGGKYGWQSNTHGNGEHCFLRLNHKGELIIK----DDDFKTIWSS 79

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 34/182 (18%), Positives = 66/182 (36%), Gaps = 48/182 (26%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIA---VKRLSKSSGQGVEEFK-----NEVLLIAKLQHRN 489
           K+G GGFG +Y        ++ A   VK   + +G    E K      +   I K   R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 490 LVKLLG----------CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR------ 533
            +  LG              R  R ++ E L    L           +   +        
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK---------ISGQNGTFKKSTV 153

Query: 534 ----CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAFGVD 587
                +++  +     Y+H++     +H D+KA+N+LL  +   ++  +D+G++  +  +
Sbjct: 154 LQLGIRMLDVLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206

Query: 588 QT 589
             
Sbjct: 207 GN 208

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 47.6 bits (113), Expect = 7e-07
 Identities = 26/132 (19%), Positives = 42/132 (31%), Gaps = 22/132 (16%)

Query: 1   TTSTQDTLRLGQSIRDGETL--VSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVA 58
             S Q      Q +   E+L  +     +     +          + Y    N    W  
Sbjct: 4   IFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYD---NNNPIWAT 54

Query: 59  NRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSG 118
           N          VL    Q +G L++  + N  VW S  +  A + V VL    N+V+   
Sbjct: 55  NTGGLGNGCRAVL----QPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI--- 107

Query: 119 NDNDSDNFLWQS 130
                 + LW +
Sbjct: 108 ----YGDALWAT 115

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 50.4 bits (119), Expect = 7e-07
 Identities = 31/169 (18%), Positives = 57/169 (33%), Gaps = 18/169 (10%)

Query: 1   TTSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKS--KSRYLGIWYKKIANGTVTWVA 58
                  L   Q++  G+ L+S N+ F+L     G    +     +W         + + 
Sbjct: 10  NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIP 69

Query: 59  NRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQN-----PVAVLLESGNL 113
            RN   P       ++        L + +   VW ++ S    N        VL + GN+
Sbjct: 70  LRNKKAP-------LAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122

Query: 114 VVKSGND--NDSDNFLWQSFDYPTHVLLPGMKL--GVNLVTGLNRFISS 158
           V+       N +           + +L PG +L  GV    G ++ +  
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQ 171

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 44.7 bits (104), Expect = 5e-05
 Identities = 19/85 (22%), Positives = 34/85 (40%), Gaps = 12/85 (14%)

Query: 50  ANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLE 109
            NG  TW A          G +    QG+G L++  + N ++W S+    A + V  L  
Sbjct: 181 PNGAATWNAGTQ-----GKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHA-SAVLRLQA 234

Query: 110 SGNLVVKSGNDNDSDNFLWQSFDYP 134
           +G++ +           +W  F + 
Sbjct: 235 NGSIAILDEKP------VWARFGFQ 253

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 46.0 bits (109), Expect = 2e-06
 Identities = 18/112 (16%), Positives = 36/112 (32%), Gaps = 13/112 (11%)

Query: 4   TQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAP 63
            ++ L   Q + D   L + +  + L              +  K  +   + W +     
Sbjct: 5   VRNVLFSSQVMYDNAQLATRD--YSLVMRDDCNL------VLTKG-SKTNIVWESGT--- 52

Query: 64  LPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVV 115
              R     +    +G L + +     V+ SN      + V +L  +G  VV
Sbjct: 53  -SGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 39.8 bits (93), Expect = 4e-04
 Identities = 16/56 (28%), Positives = 25/56 (44%), Gaps = 5/56 (8%)

Query: 76  QGNGTLIL-QNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQS 130
           + +  L+L + S   IVW S  S   Q+    L  SG L +     +D  N ++ S
Sbjct: 31  RDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDIT----DDRLNTVFVS 82

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 3e-06
 Identities = 68/618 (11%), Positives = 154/618 (24%), Gaps = 181/618 (29%)

Query: 114 VVKSGND-NDSDNFLWQSFDYPTHVLLPGMKLGVNLVTGLN-RFI-SSWKSAD-DPAQDD 169
           ++ S +  + +    W        ++    +  V  V  +N +F+ S  K+    P+   
Sbjct: 54  IIMSKDAVSGTLRLFWTLLSKQEEMV----QKFVEEVLRINYKFLMSPIKTEQRQPSMMT 109

Query: 170 YMYE------------IDPRGVP--QAML-LKGSTIRYRPGSWNGLHWTGMP-------- 206
            MY                  V   Q  L L+ + +  RP     +   G+         
Sbjct: 110 RMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID--GVLGSGKTWVA 167

Query: 207 ----------QLQPNPVY--TFEYVSNEKEV-------FYRFTLIKSSVPSMMVVSPLGE 247
                           ++    +  ++ + V        Y+     +S         L  
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227

Query: 248 SQRYTWMEQTQKWAPF---LSFSGLI--DQCDNYALCGTYAICKMNSNSAECECLEGFEP 302
                 + +  K  P+   L    L+  +  +                    +    F  
Sbjct: 228 HSIQAELRRLLKSKPYENCL----LVLLNVQNA-------------------KAWNAFNL 264

Query: 303 KSP-----RDWKLLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISLFECK 357
                   R  ++ D                      E                     K
Sbjct: 265 SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV--------------------K 304

Query: 358 ELCSKNCSCTAYANADVRGGGSGCLLWFHELTDMKILSEGGQDLYIRMATSELGNRKEEM 417
            L  K      Y +                  D+           + +    +     + 
Sbjct: 305 SLLLK------YLD--------------CRPQDLPREVLTTNPRRLSI----IAESIRDG 340

Query: 418 ELPIFDWKSIANATDNFSEE-----NKLGEGGFGPVYKGMLI--DGQEIAVKRLS----K 466
                +WK +    D  +       N L    +  ++  + +      I    LS     
Sbjct: 341 LATWDNWKHVNC--DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD 398

Query: 467 SSGQGVEEFKNEV---LLIAKLQHRNLVKLLGC----CMKRDE-----RMLIYEYLPNKS 514
                V    N++    L+ K    + + +        +K +      R ++  Y   K+
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT 458

Query: 515 LADFIFDGTRRKLLD--WSKRCQIIG----GIARG-------LLYLHQDSRLRIIHRDLK 561
              F  D      LD  +      IG     I          +++L  D   R + + ++
Sbjct: 459 ---FDSDDLIPPYLDQYF---YSHIGHHLKNIEHPERMTLFRMVFL--D--FRFLEQKIR 508

Query: 562 ASNVLLD--NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDV 619
             +   +    +   +      + +  D       R+V       P+   + + S  +D+
Sbjct: 509 HDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE-RLVNAILDFLPKIEENLICSKYTDL 567

Query: 620 FSFGVLV-LELVYGTRNR 636
               ++   E ++   ++
Sbjct: 568 LRIALMAEDEAIFEEAHK 585

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.7 bits (102), Expect = 2e-04
 Identities = 50/353 (14%), Positives = 109/353 (30%), Gaps = 105/353 (29%)

Query: 29  LGFFSPGKS-----KSRYLGIWYKKIANGTVTW--VANRNAPLPDRSGVLSISSQGNGTL 81
           LG    GK+           +  +   +  + W  + N N+P      VL +       L
Sbjct: 159 LGS---GKTWVALDVCLSYKV--QCKMDFKIFWLNLKNCNSP----ETVLEMLQ----KL 205

Query: 82  ILQNSTNGIVWSSNASRTAQNPVAV------LLESGN-----LVVKSGNDNDSDNFLWQS 130
           + Q   N    S ++S       ++      LL+S       LV+     N  +   W +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL----LNVQNAKAWNA 261

Query: 131 FD---------------------YPTHVLLPGMKLGVNLVTGLNRFISSW---KSADDPA 166
           F+                       TH+ L    + +      +     +   +  D P 
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL-LKYLDCRPQDLPR 320

Query: 167 QDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNGLHW-------------TGMPQLQPNPV 213
           +   +   +PR +  +++    +IR    +W+  +W             + +  L+P   
Sbjct: 321 E---VLTTNPRRL--SII--AESIRDGLATWD--NWKHVNCDKLTTIIESSLNVLEPA-- 369

Query: 214 YTFEYVSNEKEVFYRFTLIKSSVP-SMMVVSPL-GESQRYTWMEQTQKWAPFLSFSGLID 271
              EY    +++F R ++   S     +++S +  +  +   M    K      +S L++
Sbjct: 370 ---EY----RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK---LHKYS-LVE 418

Query: 272 QCDNYALCGTYAI----CKMNSNSAEC--ECLEGFEPKSPRDW--KLLDKTDG 316
           +    +     +I         N        ++ +      D    +    D 
Sbjct: 419 KQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 6e-04
 Identities = 59/509 (11%), Positives = 127/509 (24%), Gaps = 164/509 (32%)

Query: 297 LEGFEPKSPRDWK---LLDKTDGCVRRTKLDCERGDGFLKRESVKLPDTRFSRVDKNISL 353
           L  FE     ++    + D     + + ++D            +   D   S   +   L
Sbjct: 22  LSVFEDAFVDNFDCKDVQDMPKSILSKEEID----------HIIMSKD-AVSGTLR---L 67

Query: 354 FECKELCSKNCSCTAYANADVRGGGSGCLLWFHE-LTDMKILSEGGQDLYIRMATSELGN 412
           F    L SK          +V         +    +   +        +YI      L N
Sbjct: 68  FWT--LLSKQEEMVQKFVEEVLRINYK---FLMSPIKTEQRQPSMMTRMYIE-QRDRLYN 121

Query: 413 -----------RKEEMELPIFDWKSIANATDNFSEENKL---GEGGFGPVYKGMLIDGQE 458
                      R +           +  A         +   G  G G   K  +     
Sbjct: 122 DNQVFAKYNVSRLQPY-------LKLRQALLELRPAKNVLIDGVLGSG---KTWVA---- 167

Query: 459 IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKL----LGCCMKRDERM-----LIYEY 509
                              +V L  K+Q +   K+    L  C   +  +     L+Y+ 
Sbjct: 168 ------------------LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209

Query: 510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 569
            PN +         + ++                        RL +  +  +   ++L N
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAE----------------LRRL-LKSKPYENCLLVLLN 252

Query: 570 EMNPKISDFGMARAFGVD-QT------EANTNRVVG-TYGYMPPEYAIDGLFSVKS-DVF 620
             N K        AF +  +       +  T+ +   T  ++  ++    L   +   + 
Sbjct: 253 VQNAKA-----WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 621 S--FGV--------------LVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI 664
                                 L ++     R    +    N     W+    D+   +I
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSII-AESIR--DGLATWDN-----WKHVNCDKLTTII 359

Query: 665 DKSLE--DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTE 722
           + SL   +     +     ++ +      P        ++ ++  +              
Sbjct: 360 ESSLNVLEPAEYRKMFD--RLSVF-----PPSAHIPTILLSLIWFD-------------- 398

Query: 723 RNLPESESSSSNQTFHSSNQITVSLIEGR 751
             + +S+        H       SL+E +
Sbjct: 399 --VIKSDVMVVVNKLHKY-----SLVEKQ 420

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 41.8 bits (97), Expect = 3e-04
 Identities = 21/80 (26%), Positives = 28/80 (35%), Gaps = 11/80 (13%)

Query: 51  NGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLES 110
                W  N          VL    Q NG + +  + N  VW+S  SR+A   V VL   
Sbjct: 167 RDDRVWSTNTAGKGTGCRAVL----QPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPD 222

Query: 111 GNLVVKSGNDNDSDNFLWQS 130
            NL +           LW +
Sbjct: 223 RNLAI-------YGGALWTT 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 54/233 (23%), Positives = 88/233 (37%), Gaps = 62/233 (26%)

Query: 439 KLGEGGFGPVYKG--MLIDGQEIAVK------RLSKSSGQGVEEFKNEVLLIAKLQHR-- 488
            LGEG FG V +       G+ +AVK      R  +++       ++E+ ++  L     
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVLEHLNTTDP 73

Query: 489 ----NLVKLLGCCMKRDERMLIYEYLPNKSLADFI----FDGTRRKLL-DWSKRCQIIGG 539
                 V++L          +++E L   S  DFI    F   R   +   +   QI   
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAY--QIC-- 128

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-------------------KISDFGM 580
             + + +LH     ++ H DLK  N+L                          K+ DFG 
Sbjct: 129 --KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183

Query: 581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
           A  +  D+     + +V T  Y  PE  I  L +S   DV+S G +++E   G
Sbjct: 184 A-TY-DDEHH---STLVSTRHYRAPE-VILALGWSQPCDVWSIGCILIEYYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.5 bits (98), Expect = 7e-04
 Identities = 58/229 (25%), Positives = 91/229 (39%), Gaps = 50/229 (21%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVK---RLSKSSGQGVEEFKNEVLLIAKLQHR-----N 489
           K+G+G FG V     + + +  AVK    + K +       K E  ++ K+Q+      N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFI----FDGTRRKLLDWSKRCQIIGG-IARGL 544
           +VK  G  M  D   LI+E L   SL + I    ++G   + +      ++    I + L
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI------KLYCIEILKAL 150

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR--------- 595
            YL    ++ + H DLK  N+LLD+    K          G       T           
Sbjct: 151 NYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

Query: 596 -----------VVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYG 632
                      ++ T  Y  PE  I  L + V SD++SFG ++ EL  G
Sbjct: 208 CATFKSDYHGSIINTRQYRAPE-VILNLGWDVSSDMWSFGCVLAELYTG 255

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.5 bits (98), Expect = 9e-04
 Identities = 32/177 (18%), Positives = 60/177 (33%), Gaps = 26/177 (14%)

Query: 413 RKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS----- 467
           R + +E+    W            E+ +G+G    + +   +D   I  +R+ K      
Sbjct: 320 RTDMVEVN---WIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDER 376

Query: 468 --SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR 525
                       E   +A ++   +       +  D + ++  Y+  K   D I      
Sbjct: 377 LDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVI------ 430

Query: 526 KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 582
                     I   I   +  LH   +  +IH DL  SN + D ++   I DFG+ +
Sbjct: 431 -----EDNLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDKDL--YIIDFGLGK 477

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	751
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.84
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.84
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.83
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.81
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.79
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.75
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.71
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.67
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.64
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.63
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.57
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.53
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.51
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.48
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.47
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	99.16
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.09
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	98.97
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.95
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	98.87
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	98.83
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.83
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	98.76
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.54
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	98.47
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.41
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.39
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.31
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.22
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.22
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	98.03
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.97
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.89
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.74
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.6
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.42
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.25
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.18
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.16
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.16
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.06
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.04
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.0
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.82
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.66
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.41
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.92
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.21
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.04
3no2_A	276	Uncharacterized protein; six-bladed beta-propeller	84.58
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.8
1edm_B	39	Factor IX; epidermal growth factor, EGF, calcium-	81.93
3no2_A	276	Uncharacterized protein; six-bladed beta-propeller	80.38

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.1e-52  Score=437.35  Aligned_cols=258  Identities=28%  Similarity=0.441  Sum_probs=214.0

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888899999999999999864      367899999987777778899999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhcc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEE
Q 038934          506 IYEYLPNKSLADFIFDG----------TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  575 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl  575 (751)
                      |||||++|+|.++|...          .....+++..++.|+.||++||.|||+++   ||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            99999999999999653          23457999999999999999999999998   999999999999999999999


Q ss_pred             eeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHH
Q 038934          576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       576 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      +|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||......   .+..    .
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~----~  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE----C  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH----H
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----H
Confidence            99999987654433333344679999999999999999999999999999999998 89997643221   1111    1


Q ss_pred             hccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...+..         ...+...+..+.+|+.+||+.||++|||+++|++.|+.+
T Consensus       243 i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          243 ITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111111         112233456788999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.2e-52  Score=442.56  Aligned_cols=260  Identities=26%  Similarity=0.402  Sum_probs=208.0

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46777889999999999999864      378899999987777778899999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCe
Q 038934          506 IYEYLPNKSLADFIFDGT------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      |||||++|+|.+++....            ....+++..++.|+.||++||+|||+++   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999996532            2346899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHH
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||......   .+..   
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~---  271 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAID---  271 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHH---
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHH---
Confidence            9999999997654433333445689999999999999999999999999999999999 89997643221   1111   


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                       ....+..         ...+...+..+.+|+.+||+.||++||||.||++.|+.+..
T Consensus       272 -~i~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          272 -CITQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             -HHHHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -HHHcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence             1111111         11222345678899999999999999999999999988743

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-51  Score=435.35  Aligned_cols=259  Identities=27%  Similarity=0.423  Sum_probs=212.5

Q ss_pred             CccccccccccccccEEEEEEc------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++++.++||+|+||+||+|++.      +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999863      4678999999754 33456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC
Q 038934          506 IYEYLPNKSLADFIFDGTR-------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  572 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~  572 (751)
                      |||||++|+|.++|.....             ...+++..+++|+.|||+||+|||+++   ||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            9999999999999965321             246899999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHH
Q 038934          573 PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHA  651 (751)
Q Consensus       573 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~  651 (751)
                      +||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||......   .+..  
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~--  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVE--  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHH--
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence            99999999987654443334445789999999999999999999999999999999998 88897543221   1111  


Q ss_pred             HHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          652 WRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       652 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                        ....+..         ...+...+..+.+|+.+||+.||++||||+||++.|+....
T Consensus       259 --~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          259 --MIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             --HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             --HHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence              1111111         11223345678899999999999999999999999987644

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-51  Score=427.98  Aligned_cols=258  Identities=25%  Similarity=0.398  Sum_probs=201.9

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      +++.+.++||+|+||+||+|++.+  .||||+++..  .....++|.+|+.++++++|||||++++++.+ +.++|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            577888999999999999998643  6999998643  34456789999999999999999999998864 568999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      |++|+|.++|..  ....+++..+..|+.|||+||+|||+++   ||||||||+||||++++.+||+|||+|+.......
T Consensus       113 ~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999964  3346999999999999999999999998   99999999999999999999999999987654433


Q ss_pred             cccccccccccCccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          590 EANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ........||+.|||||++.+   .+|+.++|||||||+||||++|+.||.......  .+..    ....+..    .+
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~~----~~~~~~~----~p  257 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QIIF----MVGRGYA----SP  257 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHH----HHHTTCC----CC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHHH----HHhcCCC----CC
Confidence            334455789999999999964   468999999999999999999999986332211  1111    1111110    00


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .+ ...+...+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus       258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            00 111223456788999999999999999999999998865

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.8e-51  Score=434.13  Aligned_cols=250  Identities=23%  Similarity=0.366  Sum_probs=202.9

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|++.++||+|+||+||+|++. +|+.||||++.+.  .....+.+.+|+++|++++|||||++++++.+++.++||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999965 5899999999754  33456789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++|+|.++|... +...+++..++.|+.||+.||.|||+++   ||||||||+||||++++.+||+|||+|+.+... 
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            99999999999642 3345789999999999999999999999   999999999999999999999999999876422 


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                       .......+||+.|||||++.+..|+.++|||||||+||||++|+.||......   .+.   ....... .        
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~---~~i~~~~-~--------  242 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLV---LKIISGS-F--------  242 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HHHHHTC-C--------
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH---HHHHcCC-C--------
Confidence             12233468999999999999999999999999999999999999998643321   111   1111111 1        


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       ...+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0112233567889999999999999999999985

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-50  Score=431.42  Aligned_cols=249  Identities=23%  Similarity=0.345  Sum_probs=209.2

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      +.|+..++||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.++||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56899999999999999999975 58999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++|+|.+++..    ..+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+..... 
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            99999999853    35899999999999999999999999   99999999999999999999999999997753322 


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   ...    .......     ..+  
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~----~i~~~~~-----~~~--  290 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----MIRDNLP-----PRL--  290 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH----HHHHSSC-----CCC--
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH----HHHcCCC-----CCC--
Confidence             2345789999999999999999999999999999999999999986432211   111    1111100     000  


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111233467889999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.8e-51  Score=429.98  Aligned_cols=248  Identities=24%  Similarity=0.317  Sum_probs=210.3

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.+.||+|+||+||+|++. +++.||||++.+.   .....+.+.+|+++|++++|||||++++++.+++.++|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            67999999999999999999965 5899999999753   3345678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++|+|.++|.+   .+.+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999954   356999999999999999999999999   999999999999999999999999999987655


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      .........+||+.|||||++.+..|+.++||||+||+||||++|+.||......   .+...    ......       
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~----i~~~~~-------  251 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFAK----IIKLEY-------  251 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCC-------
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHcCCC-------
Confidence            4444555689999999999999999999999999999999999999998643221   11110    111110       


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV  702 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  702 (751)
                         .++...+.++.+|+.+||+.||++|||+.|++
T Consensus       252 ---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               11222345788999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-50  Score=428.52  Aligned_cols=266  Identities=23%  Similarity=0.248  Sum_probs=211.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .+.|...++||+|+||+||+|++. +|+.||||+++....     ..+|+.++++++|||||++++++.+++.++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356888889999999999999975 589999999975422     24799999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC-CeEEeeccCccccCCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGVDQ  588 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~  588 (751)
                      |+||+|.++|.+   .+.+++..+..++.||+.||.|||+++   ||||||||+||||+.++ .+||+|||+|+.+....
T Consensus       132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999954   346999999999999999999999998   99999999999999987 69999999999875432


Q ss_pred             cc---ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          589 TE---ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       589 ~~---~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..   ......+||+.|||||++.+..|+.++|||||||+||||++|+.||........   ....   .......    
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i---~~~~~~~----  275 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKI---ASEPPPI----  275 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHH---HHSCCGG----
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHH---HcCCCCc----
Confidence            21   122346899999999999999999999999999999999999999865433221   1111   1111110    


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC----CCCCCCCCCCCCcc
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG----ERSLPQPKQPGFFT  721 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~----~~~~~~p~~p~~~~  721 (751)
                          ...+...+..+.+++.+||+.||++|||+.|+++.|..    ...+.-|....+..
T Consensus       276 ----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          276 ----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             ----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             ----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence                11223345678899999999999999999999877654    34555665554443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-49  Score=432.84  Aligned_cols=249  Identities=23%  Similarity=0.345  Sum_probs=209.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      +.|+..++||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            57999999999999999999975 58999999998776666778999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++|+|.+++..    ..+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+..... 
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-  302 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  302 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence            99999999843    35899999999999999999999999   99999999999999999999999999987753322 


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   +..    .......     ..+  
T Consensus       303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~----~i~~~~~-----~~~--  367 (423)
T 4fie_A          303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----MIRDNLP-----PRL--  367 (423)
T ss_dssp             -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH----HHHHSCC-----CCC--
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH----HHHcCCC-----CCC--
Confidence             2345789999999999999999999999999999999999999986432211   111    1111100     000  


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111223457889999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.4e-49  Score=408.63  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=191.4

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|++.+.||+|+||+||+|++. +++.||||++.+.   .....+.+.+|++++++++|||||++++++.+++..++|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            368999999999999999999964 5899999999754   233456799999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+ +|+|.+++.+   ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+....
T Consensus        92 mEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 6799999854   456999999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..   .....+||+.|||||++.+..+ +.++||||+||++|+|++|+.||......   .+..    ....+..     
T Consensus       165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~----~i~~~~~-----  229 (275)
T 3hyh_A          165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFK----NISNGVY-----  229 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCC-----
T ss_pred             CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCC-----
Confidence            22   2234789999999999998886 58999999999999999999998643211   1111    1111110     


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus       230 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 112223457889999999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-49  Score=411.46  Aligned_cols=246  Identities=23%  Similarity=0.355  Sum_probs=197.1

Q ss_pred             cccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeee----CCceEEEE
Q 038934          435 SEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK----RDERMLIY  507 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~  507 (751)
                      +..++||+|+||+||+|++. +++.||||++...  .....+.|.+|++++++++|||||++++++.+    ...++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999975 4889999999654  33456789999999999999999999999875    34589999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc-CCCCeEEeeccCccccCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGV  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~  586 (751)
                      |||++|+|.+++.+   ...+++..+..++.||+.||+|||+++ .+||||||||+||||+ +++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999954   356899999999999999999999875 3599999999999998 479999999999986432


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                          ......+||+.|||||++.+ +|+.++|||||||+||||++|+.||.....  ...    .......+.....   
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~----~~~~i~~~~~~~~---  250 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQ----IYRRVTSGVKPAS---  250 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHH----HHHHHTTTCCCGG---
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHH----HHHHHHcCCCCCC---
Confidence                22345789999999998865 699999999999999999999999853221  111    1111111111111   


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           .+.....++.+|+.+||+.||++|||+.|+++
T Consensus       251 -----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          251 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 11112346789999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.8e-49  Score=423.03  Aligned_cols=260  Identities=27%  Similarity=0.393  Sum_probs=212.3

Q ss_pred             hcCccccccccccccccEEEEEEcC------CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcC-CcEEeEeceeeeC-C
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQH-RNLVKLLGCCMKR-D  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~  501 (751)
                      .++|++.++||+|+||+||+|++..      ++.||||++.... ....++|.+|+++|.++.| ||||+++++|.+. +
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            4789999999999999999999643      3579999997653 3445679999999999965 8999999999765 5


Q ss_pred             ceEEEEEecCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGT-------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  568 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~  568 (751)
                      .+++|||||++|+|.++|....             ....+++..++.++.|||+||.|||+++   ||||||||+||||+
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeC
Confidence            6899999999999999996532             1345899999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccch
Q 038934          569 NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNL  647 (751)
Q Consensus       569 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~  647 (751)
                      +++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||++ |+.||.......  . 
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~--~-  296 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E-  296 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--H-
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--H-
Confidence            999999999999998765444444455789999999999999999999999999999999998 899976433221  1 


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                         .......+..         ...+...+.++.+++.+||+.||++|||+++|++.|+.+
T Consensus       297 ---~~~~i~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          297 ---FCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             ---HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence               1111111111         112223345788999999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-49  Score=416.66  Aligned_cols=247  Identities=24%  Similarity=0.273  Sum_probs=196.8

Q ss_pred             cCccccccccccccccEEEEEEc----CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|++.+.||+|+||+||+|+..    .++.||||++.+..  .....++.+|+++|++++|||||++++++.+++.+++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999863    36789999997542  2334568899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||++||+|.+++.+   .+.+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999954   456899999999999999999999999   9999999999999999999999999998653


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ...  ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   +...    ......     
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~----i~~~~~-----  243 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTM----ILKAKL-----  243 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHCCC-----
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHH----HHcCCC-----
Confidence            322  22334789999999999999999999999999999999999999986433211   1110    111100     


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNM-----ASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  703 (751)
                           ..+...+.++.+|+.+||+.||++|||+     +|+++
T Consensus       244 -----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 -----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                 1122234678899999999999999984     56664

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.5e-49  Score=416.67  Aligned_cols=267  Identities=22%  Similarity=0.294  Sum_probs=199.9

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC----ceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD----ERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~  507 (751)
                      ++|.+.++||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||++++++.+++    .++|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4678889999999999999998 689999999965422 1222345666667889999999999998764    579999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      |||++|+|.+++..    ..+++..+.+++.|+++||+|||+++     ..+||||||||+||||++++.+||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999953    35899999999999999999999871     2349999999999999999999999999998


Q ss_pred             ccCCCCcc--ccccccccccCccCcccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc--------c
Q 038934          583 AFGVDQTE--ANTNRVVGTYGYMPPEYAIDG------LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHH--------N  646 (751)
Q Consensus       583 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~--------~  646 (751)
                      ........  .......||+.|||||++.+.      .++.++|||||||+||||++|+.|+.........        .
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76543222  222346899999999999764      4788999999999999999998886543321110        0


Q ss_pred             hhHHHHHHhccCChhhhcchhccC-ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          647 LLGHAWRLWTEDRPVELIDKSLED-TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .............    +.+.+.. ....+....+.+|+.+||+.||++||||.||++.|+.+
T Consensus       237 ~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            0111111111111    0111111 11234566788999999999999999999999999865

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-47  Score=403.94  Aligned_cols=252  Identities=24%  Similarity=0.344  Sum_probs=190.6

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC-------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD-------  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  501 (751)
                      .++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            356899999999999999999965 58999999997543 334567999999999999999999999987654       


Q ss_pred             -----ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEe
Q 038934          502 -----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  576 (751)
Q Consensus       502 -----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~  576 (751)
                           .+++||||+++|+|.+++.........++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                 36899999999999999976554455677889999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCccc----------cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccc
Q 038934          577 DFGMARAFGVDQTEA----------NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN  646 (751)
Q Consensus       577 DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~  646 (751)
                      |||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||+||||++   ||..  ..   .
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~--~~---~  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST--QM---E  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS--HH---H
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC--cc---H
Confidence            999999875432211          1233679999999999999999999999999999999996   5431  10   0


Q ss_pred             hhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          647 LLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ... ............         ........+.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~-~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 RVR-TLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHH-HHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHH-HHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000 001111111100         01122335678999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=403.34  Aligned_cols=266  Identities=20%  Similarity=0.285  Sum_probs=202.4

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeee------CC
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK------RD  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  501 (751)
                      .++|++.++||+|+||+||+|++. +|+.||||++.+..  ....+.+.+|+++|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            368999999999999999999975 59999999997542  3345678899999999999999999998764      36


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      .+|||||||+ |+|.+++.   ..+.+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 67999984   4567999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCC--ccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh---
Q 038934          582 RAFGVDQ--TEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW---  655 (751)
Q Consensus       582 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~---  655 (751)
                      +.+....  ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||...........+.......   
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            8764321  22233457899999999998875 56999999999999999999999987544322211111000000   


Q ss_pred             -----ccCChhhhcchhcc-Ccc-----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          656 -----TEDRPVELIDKSLE-DTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       656 -----~~~~~~~~~d~~l~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           ........+..... ...     .......+.+|+.+||+.||++|||+.|+++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                 00000000000000 000     0112457889999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.8e-45  Score=388.23  Aligned_cols=285  Identities=35%  Similarity=0.581  Sum_probs=244.3

Q ss_pred             HHhHHHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          424 WKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       424 ~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      +.++...+++|...+.||+|+||.||+|++.+++.||||++........+.+.+|+.++++++||||+++++++.+.+..
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            33455678999999999999999999999888999999999877667788999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          504 MLIYEYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      ++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999999999986432 2235899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ...............||+.|+|||++.+..++.++||||||+++|||++|+.|+....+........+.......+....
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            75433333333446789999999999999999999999999999999999999887666555555555444455555566


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCC
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSL  711 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  711 (751)
                      .+++.+...........+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            6666666677788889999999999999999999999999999876443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8e-45  Score=392.73  Aligned_cols=203  Identities=25%  Similarity=0.364  Sum_probs=173.7

Q ss_pred             hHHHHhcCccccccccccccccEEEEEEc----CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC
Q 038934          426 SIANATDNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR  500 (751)
Q Consensus       426 ~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  500 (751)
                      .+....++|++.++||+|+||+||+|+.+    .++.||||++.+.  ....++.+|+++|+.+ +|||||++++++.+.
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            34456789999999999999999999864    3678999998654  3346788999999998 699999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-CCeEEeecc
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFG  579 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFG  579 (751)
                      ++.++||||+++++|.+++.      .+++..+..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            99999999999999999982      3899999999999999999999999   9999999999999876 799999999


Q ss_pred             CccccCCCCcc--------------------------ccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhC
Q 038934          580 MARAFGVDQTE--------------------------ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYG  632 (751)
Q Consensus       580 la~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G  632 (751)
                      +|+........                          ......+||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            99865322110                          112235799999999999876 489999999999999999999


Q ss_pred             CCCCCCC
Q 038934          633 TRNRGFH  639 (751)
Q Consensus       633 ~~p~~~~  639 (751)
                      +.||...
T Consensus       244 ~~Pf~~~  250 (361)
T 4f9c_A          244 RYPFYKA  250 (361)
T ss_dssp             CSSSSCC
T ss_pred             CCCCCCC
Confidence            9998543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.9e-44  Score=408.41  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=209.4

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+...++|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999975 5899999999877666678899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC--CCeEEeeccCccccCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE--MNPKISDFGMARAFGVD  587 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DFGla~~~~~~  587 (751)
                      |++|+|.++|..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+|+.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999853  3356899999999999999999999999   9999999999999854  89999999999987432


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      .   .....+||+.|||||++.+..|+.++|||||||+||||++|+.||........   ..    .......      .
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~----~i~~~~~------~  374 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LR----NVKSCDW------N  374 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH----HHHTTCC------C
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HH----HHHhCCC------C
Confidence            2   23346899999999999999999999999999999999999999864332111   11    0111100      0


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      +........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001111123457789999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-43  Score=380.37  Aligned_cols=290  Identities=43%  Similarity=0.706  Sum_probs=243.5

Q ss_pred             cCCcccHHhHHHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEece
Q 038934          418 ELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGC  496 (751)
Q Consensus       418 ~l~~~~~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~  496 (751)
                      .+..++..++....++|...+.||+|+||.||+|++.+++.||||++.... ......+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            456688899999999999999999999999999998789999999997643 2233468999999999999999999999


Q ss_pred             eeeCCceEEEEEecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEE
Q 038934          497 CMKRDERMLIYEYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  575 (751)
Q Consensus       497 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl  575 (751)
                      +...+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||++...+|+||||||+|||+++++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999997643 3345899999999999999999999992222999999999999999999999


Q ss_pred             eeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC--ccccchhHHHHH
Q 038934          576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHV--DHHHNLLGHAWR  653 (751)
Q Consensus       576 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~--~~~~~~~~~~~~  653 (751)
                      +|||+++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+.....  ........+...
T Consensus       176 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            9999998765333222 2335699999999999999999999999999999999999999863321  122233344444


Q ss_pred             HhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          654 LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       654 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .........+.+..+...........+.+++.+||+.||.+|||+.+|+++|++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            4556666677777777788888899999999999999999999999999999975

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.6e-44  Score=406.35  Aligned_cols=249  Identities=25%  Similarity=0.296  Sum_probs=200.8

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHH---HHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNE---VLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|++.++||+|+||+||+|++. +|+.||||++.+.   .......+.+|   +.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            478999999999999999999975 5899999999653   12233344444   4555566899999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ||||||++||+|.++|.+   .+.+++..+..++.||+.||.|||+++   ||||||||+||||+.+|++||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999954   356899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      +...    .....+||+.|||||++.+ ..|+.++|||||||+||||++|+.||..........+....   .. .    
T Consensus       342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~~-~----  409 (689)
T 3v5w_A          342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT-M----  409 (689)
T ss_dssp             CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---HH-C----
T ss_pred             cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---cC-C----
Confidence            6432    2334789999999999974 57999999999999999999999998643332221111100   00 0    


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                            ...++...+..+.+|+.+||+.||.+|++     +.||++
T Consensus       410 ------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 ------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                  01122334567889999999999999998     678764

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=100.00  E-value=4.7e-43  Score=361.32  Aligned_cols=231  Identities=16%  Similarity=0.189  Sum_probs=178.9

Q ss_pred             CccccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCC----CceeEEEecC
Q 038934            2 TSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDR----SGVLSISSQG   77 (751)
Q Consensus         2 ~~~~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~----~~~l~~~~~g   77 (751)
                      +++.|+|++||+|++|++|+|++|.|+||||+++   ++||   |+  +.+ |||+|||++|+.++    +++|+|+.+|
T Consensus        11 ~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G   81 (276)
T 3m7h_A           11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV   81 (276)
T ss_dssp             CTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred             cccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence            5678999999999999999999999999999543   6777   76  777 99999999999885    7789998866


Q ss_pred             CceEEE--eCCCCCeeeeecCCCC-----CCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeeeeec
Q 038934           78 NGTLIL--QNSTNGIVWSSNASRT-----AQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVT  150 (751)
Q Consensus        78 ~g~l~l--~~~~~~~vWst~~~~~-----~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~~~t  150 (751)
                        +|||  .|++|.+||+|+++..     ..+.+|+|+|+|||||++      +.+||||  |||||||||||||.++++
T Consensus        82 --~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~------~~~lWqS--~ptdtlLpg~~~~~~l~~  151 (276)
T 3m7h_A           82 --QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD------SLALWNG--TPAIPLVPGAIDSLLLAP  151 (276)
T ss_dssp             --SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE------EEEEEES--CTTSCCCCSCTTCEEECS
T ss_pred             --cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC------CceeeCc--cccccccccccccccccc
Confidence              8999  7888999999997642     235689999999999996      4699999  999999999999999998


Q ss_pred             CCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEe-CCeeeecCCCCCccccccCCCCCCCCceEEEEeecC-ceEEEE
Q 038934          151 GLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLK-GSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNE-KEVFYR  228 (751)
Q Consensus       151 g~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~-~~~~~~~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  228 (751)
                      |..  |   ++.+||++|.|+++++++|.  +++++ +..+||++|.|++...  .-.++...  .+.+.+++ ..+..+
T Consensus       152 g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~--~l~l~~dG--nLvl~d~~~~~vWsS  220 (276)
T 3m7h_A          152 GSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAV--RAVFQGDG--NLVVYGAGNAVLWHS  220 (276)
T ss_dssp             SEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCC--EEEECTTS--CEEEECTTSCEEEEC
T ss_pred             Ccc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccE--EEEEcCCC--eEEEEeCCCcEEEEe
Confidence            865  5   67899999999999999995  44454 4689999999975321  00111111  12233332 234333


Q ss_pred             EEeecCCcceEEEEcccCceeEEEEecCCccceeeEecccC
Q 038934          229 FTLIKSSVPSMMVVSPLGESQRYTWMEQTQKWAPFLSFSGL  269 (751)
Q Consensus       229 ~~~~~~s~~~~~~l~~~G~l~~~~w~~~~~~W~~~~~~~~~  269 (751)
                      ++  .....+|++|+.||++++|.|   ...|..  .+.+|
T Consensus       221 ~t--~~~~~~rl~Ld~dGnLvly~~---~~~Wqs--f~~~P  254 (276)
T 3m7h_A          221 HT--GGHASAVLRLQANGSIAILDE---KPVWAR--FGFQP  254 (276)
T ss_dssp             SC--TTCTTCEEEECTTSCEEEEEE---EEEEES--SSCCT
T ss_pred             cC--CCCCCEEEEEcCCccEEEEcC---CCeEEc--cCccC
Confidence            32  233458999999999999999   356765  44444

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.4e-41  Score=359.04  Aligned_cols=285  Identities=35%  Similarity=0.573  Sum_probs=233.0

Q ss_pred             ccCCcccHHhHHHHhcCcccc------ccccccccccEEEEEEcCCcEEEEEEeccC----CcccHHHHHHHHHHHHHhc
Q 038934          417 MELPIFDWKSIANATDNFSEE------NKLGEGGFGPVYKGMLIDGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQ  486 (751)
Q Consensus       417 ~~l~~~~~~~i~~~~~~y~~~------~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~  486 (751)
                      ...+.|++.++..++++|...      ++||+|+||.||+|.. +++.||||++...    .....+.+.+|+.++++++
T Consensus        10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            356778999999999999887      8899999999999987 6889999998653    2344678999999999999


Q ss_pred             CCcEEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeE
Q 038934          487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL  566 (751)
Q Consensus       487 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIl  566 (751)
                      ||||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+++   |+||||||+||+
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence            99999999999999999999999999999999976555567999999999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccc
Q 038934          567 LDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN  646 (751)
Q Consensus       567 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~  646 (751)
                      +++++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|+|++|+.|+..........
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  244 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL  244 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence            99999999999999987654333333344679999999998865 58999999999999999999999987544332211


Q ss_pred             hhHHHHHHh-ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          647 LLGHAWRLW-TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       647 ~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                        ....... ........++..+ ..........+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       245 --~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          245 --DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             --HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             --HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence              1111111 1222333344333 2345667788999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.5e-42  Score=367.13  Aligned_cols=266  Identities=27%  Similarity=0.407  Sum_probs=205.0

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|++.++||+|+||+||+|+. +++.||||++....  ....+++.+|+.++++++||||+++++++.+....++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            46889999999999999999987 68899999997553  3445679999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++........+++..++.++.||+.||+|||+++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  193 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF  193 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence            9999999999965443345899999999999999999999875 349999999999999999999999999998653322


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........   ....   ....         .
T Consensus       194 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~---~~~~---~~~~---------~  256 (309)
T 3p86_A          194 L--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---VAAV---GFKC---------K  256 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH---HHHH---HHSC---------C
T ss_pred             c--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH---HhcC---------C
Confidence            1  12346799999999999999999999999999999999999999764322111   0000   0000         0


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCCCC
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPK  715 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~  715 (751)
                      ....+......+.+|+.+||+.||.+|||+.++++.|+.+..-..|+
T Consensus       257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence            11122233457889999999999999999999999999875444443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-41  Score=371.33  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=212.2

Q ss_pred             hcCccccccccccccccEEEEEEc--------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR  500 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  500 (751)
                      .++|.+.+.||+|+||.||+|++.        ++..||||++... .....+++.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            368899999999999999999863        3457999999765 334567899999999999 899999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTR-------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  567 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll  567 (751)
                      +..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+++   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999975331             245899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 038934          568 DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHN  646 (751)
Q Consensus       568 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~  646 (751)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+.......   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999987654333333334567889999999999999999999999999999999 888876432211   


Q ss_pred             hhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          647 LLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      +..    ....+.         ....+......+.+++.+||+.||.+||++.|+++.|+.+
T Consensus       314 ~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          314 LFK----LLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             HHH----HHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH----HHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111    111111         1112233455788999999999999999999999999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=360.48  Aligned_cols=259  Identities=27%  Similarity=0.402  Sum_probs=212.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|...++||+|+||.||++.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            367899999999999999999975 5899999999777777788899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999999652  346899999999999999999999999   99999999999999999999999999987643222


Q ss_pred             cc------------cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhcc
Q 038934          590 EA------------NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE  657 (751)
Q Consensus       590 ~~------------~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  657 (751)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..|+............         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------  234 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------  234 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---------
Confidence            11            111467999999999999999999999999999999999999887643332211000         


Q ss_pred             CChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       658 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                       ......+.    ..+......+.+++.+|++.||++|||+.++++.|+.+
T Consensus       235 -~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          235 -NVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             -CHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -hhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             00111111    11222334678999999999999999999999999876

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.5e-41  Score=357.37  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=209.0

Q ss_pred             HhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ..++|+..++||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            346899999999999999999995 4689999999977666667889999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++..    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999954    35899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      ..  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........      ..........        
T Consensus       171 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~--------  234 (297)
T 3fxz_A          171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP--------  234 (297)
T ss_dssp             CC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC--------
T ss_pred             cc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC--------
Confidence            22  2346799999999999999999999999999999999999999754322111      1111111100        


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ....+......+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            01112233456889999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7e-41  Score=357.99  Aligned_cols=263  Identities=24%  Similarity=0.348  Sum_probs=215.0

Q ss_pred             CCcccHHhHHHHhcC----------ccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC
Q 038934          419 LPIFDWKSIANATDN----------FSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH  487 (751)
Q Consensus       419 l~~~~~~~i~~~~~~----------y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  487 (751)
                      .+.++.+++..+++.          |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            355777777777764          677789999999999999976 699999999987766777889999999999999


Q ss_pred             CcEEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE
Q 038934          488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  567 (751)
Q Consensus       488 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll  567 (751)
                      |||+++++++...+..++||||+++++|.+++.    ...+++..+..++.|++.||.|||+++   |+||||||+|||+
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll  174 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL  174 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence            999999999999999999999999999999984    345899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccch
Q 038934          568 DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL  647 (751)
Q Consensus       568 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~  647 (751)
                      +.++.+||+|||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+.......   .
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~  249 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---A  249 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H
T ss_pred             CCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence            99999999999999876543222  234679999999999999999999999999999999999999976432211   1


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..    .........     +  .........+.+++.+||+.||++|||+.++++.
T Consensus       250 ~~----~~~~~~~~~-----~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          250 MK----RLRDSPPPK-----L--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HH----HHHHSSCCC-----C--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HH----HHhcCCCCC-----c--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11    011110000     0  0111234568899999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.1e-42  Score=365.92  Aligned_cols=266  Identities=24%  Similarity=0.356  Sum_probs=208.5

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC----ceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD----ERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV  506 (751)
                      .++|++.++||+|+||.||+|++ .++.||||++.... .....+.+|+.++++++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            36889999999999999999987 47999999996543 33445677999999999999999999998754    36999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCEEEccCCCCCeEEcCCCCeEEe
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD----------SRLRIIHRDLKASNVLLDNEMNPKIS  576 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~----------~~~~ivH~Dikp~NIll~~~~~~kl~  576 (751)
                      |||+++++|.+++..    ..+++..+..++.|++.||.|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            999999999999954    3489999999999999999999998          7   9999999999999999999999


Q ss_pred             eccCccccCCCCccccccccccccCccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH
Q 038934          577 DFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA  651 (751)
Q Consensus       577 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~  651 (751)
                      |||+++.+.............||+.|+|||++.+     ..++.++|||||||++|||++|+.||.............. 
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-  252 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE-  252 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH-
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh-
Confidence            9999987765444333444689999999999987     3567789999999999999999999875443222111110 


Q ss_pred             HHHhccCChhhhcch--------hccCc-cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          652 WRLWTEDRPVELIDK--------SLEDT-YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       652 ~~~~~~~~~~~~~d~--------~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                        .........+.+.        .+... ........+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       253 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          253 --IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             --HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              0001111111110        01110 1223456789999999999999999999999999865

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-41  Score=362.56  Aligned_cols=249  Identities=25%  Similarity=0.378  Sum_probs=207.0

Q ss_pred             HhcCccccccccccccccEEEEEE-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ..++|.+.+.||+|+||.||+|++ .+++.||||++.+.  .....+.+.+|++++++++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            346899999999999999999997 46999999999754  334567789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            9999999999999543   45899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccCccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFS-VKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..   ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||........   ..    ....+.      
T Consensus       167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~----~i~~~~------  230 (328)
T 3fe3_A          167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL---RE----RVLRGK------  230 (328)
T ss_dssp             SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHCC------
T ss_pred             CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH---HH----HHHhCC------
Confidence            22   23446899999999999988875 899999999999999999999864332111   00    011110      


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                          ...+......+.+|+.+||+.||.+|||+.|+++.
T Consensus       231 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 ----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                01122234578899999999999999999999863

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.3e-41  Score=359.19  Aligned_cols=254  Identities=25%  Similarity=0.332  Sum_probs=205.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 68999999996542 2334678999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999983   4456899999999999999999999998   9999999999999999999999999998765443


Q ss_pred             ccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........  .    ..+.....       
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~----~~~~~~~~-------  226 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--Y----SDWKEKKT-------  226 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--H----HHHHTTCT-------
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--H----HHHhcccc-------
Confidence            3333445789999999999988775 78999999999999999999998643332110  0    00111100       


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       ...........+.+|+.+||+.||++|||+.|+++.
T Consensus       227 -~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             000012234567899999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=368.87  Aligned_cols=270  Identities=27%  Similarity=0.397  Sum_probs=216.7

Q ss_pred             hcCccccccccccccccEEEEEEc--------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR  500 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  500 (751)
                      .++|.+.++||+|+||.||+|+..        .+..||||++... .....+++.+|+++++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468999999999999999999853        2357999999765 334557899999999999 899999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTR-------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  567 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll  567 (751)
                      +..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+++   |+||||||+||||
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999975331             245899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 038934          568 DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHN  646 (751)
Q Consensus       568 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~  646 (751)
                      ++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |+.|+.......   
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999987654433333344567899999999999999999999999999999999 988875332211   


Q ss_pred             hhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCC
Q 038934          647 LLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGF  719 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~p~~  719 (751)
                          .........         ....+......+.+|+.+||+.||++||++.+|++.|+.+..........+
T Consensus       302 ----~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~  361 (382)
T 3tt0_A          302 ----LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY  361 (382)
T ss_dssp             ----HHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred             ----HHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence                111111111         111122334578899999999999999999999999998855444433333

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.7e-41  Score=365.78  Aligned_cols=269  Identities=26%  Similarity=0.388  Sum_probs=214.2

Q ss_pred             ccHHhHHHHhcCccccccccccccccEEEEEEc------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeE
Q 038934          422 FDWKSIANATDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKL  493 (751)
Q Consensus       422 ~~~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l  493 (751)
                      ++........++|.+.++||+|+||.||+|++.      +++.||||++... .....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            344444556789999999999999999999842      3578999999764 334456799999999999 79999999


Q ss_pred             eceeeeCCc-eEEEEEecCCCChhHHHhccCC------------------------------------------------
Q 038934          494 LGCCMKRDE-RMLIYEYLPNKSLADFIFDGTR------------------------------------------------  524 (751)
Q Consensus       494 ~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------  524 (751)
                      ++++.+.+. .++||||+++++|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 8999999999999999965432                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          525 ---------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       525 ---------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                                     ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           122899999999999999999999998   99999999999999999999999999987654433


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      ........||+.|+|||++.+..++.++||||||+++|||++ |+.|+........      .........         
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~---------  313 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGT---------  313 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTC---------
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCC---------
Confidence            333445678999999999999999999999999999999998 9999764332211      111111111         


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ....+......+.+++.+||+.||.+|||+.+++++|+.+
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            1111222345688999999999999999999999999764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-40  Score=358.25  Aligned_cols=248  Identities=22%  Similarity=0.283  Sum_probs=206.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|++.+.||+|+||.||+++.. +++.||||++.+.   .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            368999999999999999999975 5899999999754   234567889999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999999853   346899999999999999999999998   99999999999999999999999999986432


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..    ......       
T Consensus       158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~----~i~~~~-------  221 (337)
T 1o6l_A          158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE----LILMEE-------  221 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCC-------
T ss_pred             CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHH----HHHcCC-------
Confidence            22  22344789999999999999999999999999999999999999975332111   110    010010       


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                         ..++......+.+|+.+||+.||.+||     ++.|+++
T Consensus       222 ---~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          222 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence               011223356788999999999999999     8999985

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-40  Score=346.97  Aligned_cols=258  Identities=27%  Similarity=0.367  Sum_probs=211.5

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .++|++.+.||+|+||.||++.+.++..||+|++.... ...+++.+|++++.+++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            46889999999999999999999888899999996543 34577999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999999642  345899999999999999999999998   999999999999999999999999999876433222


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      . .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+........   .    .......         .
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~~---------~  223 (268)
T 3sxs_A          161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV---V----LKVSQGH---------R  223 (268)
T ss_dssp             E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---H----HHHHTTC---------C
T ss_pred             c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH---H----HHHHcCC---------C
Confidence            2 223456778999999999999999999999999999999 9988753322111   0    0011110         0


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSL  711 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  711 (751)
                      ...+......+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            011112245688999999999999999999999999987553

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=360.64  Aligned_cols=259  Identities=26%  Similarity=0.382  Sum_probs=208.6

Q ss_pred             hcCccccccccccccccEEEEEEc----CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      .++|.+.+.||+|+||.||+|++.    .+..||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            367889999999999999999974    3456999999764 34456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999954  2346899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccc-cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          586 VDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       586 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+.......   +..    .....     
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~~~~~-----  270 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VIS----SVEEG-----  270 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHH----HHHTT-----
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHH----HHHcC-----
Confidence            432211 2223456778999999999999999999999999999999 999975322211   111    01111     


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                          .....+......+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       271 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          271 ----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                1111223345678899999999999999999999999988643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.7e-40  Score=358.55  Aligned_cols=252  Identities=23%  Similarity=0.301  Sum_probs=205.6

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  502 (751)
                      ..++|.+.+.||+|+||.||+++.. +++.||+|++.+...      ...+.+.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3578999999999999999999975 589999999976432      135789999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC----CeEEeec
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDF  578 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DF  578 (751)
                      .++||||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||+++++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999994   3456899999999999999999999998   99999999999998877    7999999


Q ss_pred             cCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          579 GMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       579 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      |+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ...    .....
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~----~i~~~  233 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA----NITAV  233 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH----HHHTT
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhc
Confidence            9998764322   2234679999999999999999999999999999999999999975432211   110    01110


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...  ++.    .........+.+|+.+||+.||.+|||+.|+++
T Consensus       234 ~~~--~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          234 SYD--FDE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCC--CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCC--CCc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000  000    000112356789999999999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.2e-41  Score=348.35  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=209.6

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|.+.+.||+|+||.||++.+.+++.||+|++.... ...+++.+|+.++++++||||+++++++.+....++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            5788999999999999999999889999999997543 345789999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++..  ....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++........ 
T Consensus        89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  162 (269)
T 4hcu_A           89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  162 (269)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred             CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence            9999999954  3346899999999999999999999999   999999999999999999999999999875432211 


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                      ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+.......   ...    .....         ...
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~----~~~~~---------~~~  226 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVE----DISTG---------FRL  226 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH----HHHTT---------CCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHH----HHhcC---------ccC
Confidence            1223456788999999999999999999999999999999 888875432211   111    01111         011


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            11222345688999999999999999999999999865

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-40  Score=350.19  Aligned_cols=264  Identities=23%  Similarity=0.340  Sum_probs=208.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|++.+.||+|+||.||++++. +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            368999999999999999999965 5889999998654   233456789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999954   346899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......      ........... ..   
T Consensus       164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~-~~---  232 (294)
T 4eqm_A          164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDSVP-NV---  232 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSCCC-CH---
T ss_pred             ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhccCC-Cc---
Confidence            222 12234679999999999999999999999999999999999999976432211      11111111111 00   


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHhCCCCCCC
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRP-NMASVVLMLSGERSLPQ  713 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~  713 (751)
                        ........+..+.+++.+||+.||.+|| ++.++++.|+....-..
T Consensus       233 --~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          233 --TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             --HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             --chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence              0111222345788999999999999998 99999999988754433

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-41  Score=359.07  Aligned_cols=265  Identities=28%  Similarity=0.423  Sum_probs=206.6

Q ss_pred             hcCccccccccccccccEEEEEE-----cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--Cce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-----IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  503 (751)
                      .++|++.++||+|+||.||++++     .+++.||||++........+.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            36889999999999999999984     25889999999877767778899999999999999999999998654  458


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999643  335899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC---
Q 038934          584 FGVDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR---  659 (751)
Q Consensus       584 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~---  659 (751)
                      ....... .......++..|+|||++.+..++.++||||||+++|+|++|..|+......        .........   
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~  235 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQ  235 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------HHHHHCTTCCTH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------HHhhhcCccccc
Confidence            6533221 1122345777899999999999999999999999999999999886532111        000000000   


Q ss_pred             -----hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          660 -----PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       660 -----~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                           ....+........+......+.+++.+||+.||++|||+.++++.|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                 0011111111122334456788999999999999999999999999865

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.3e-41  Score=357.27  Aligned_cols=259  Identities=27%  Similarity=0.402  Sum_probs=212.6

Q ss_pred             hcCccccccccccccccEEEEEEc------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|.+.+.||+|+||.||++.+.      +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            578999999999999999999862      3478999999754 344567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCC
Q 038934          504 MLIYEYLPNKSLADFIFDGTR---------------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKA  562 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp  562 (751)
                      ++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+++   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999975432                     234899999999999999999999998   99999999


Q ss_pred             CCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 038934          563 SNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHV  641 (751)
Q Consensus       563 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~  641 (751)
                      +|||+++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |+.|+.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654433333334567889999999999999999999999999999999 9998764332


Q ss_pred             ccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          642 DHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       642 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...   .    .......         ....+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       259 ~~~---~----~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          259 ERL---F----NLLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             GGH---H----HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH---H----HHhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            211   1    1111111         1112223456788999999999999999999999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.8e-41  Score=360.28  Aligned_cols=255  Identities=26%  Similarity=0.460  Sum_probs=201.2

Q ss_pred             cCccccccccccccccEEEEEEc-CCc----EEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|+..++||+|+||.||+|++. +++    .||+|.+... .....+++.+|+.++++++||||+++++++.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            57899999999999999999964 344    3588887543 3355678999999999999999999999998754 789


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |+||+.+++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            99999999999999653  346899999999999999999999998   9999999999999999999999999998876


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+.........                ..+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----------------~~~  232 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----------------SIL  232 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------HHH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH----------------HHH
Confidence            5444433344567889999999999999999999999999999999 99997643322111                111


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ........+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          233 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11111112233445788999999999999999999999998765

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.9e-40  Score=351.60  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=204.2

Q ss_pred             HhcCccccccccccccccEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ..++|++.++||+|+||+||+|++.+++.||||++....  ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            347899999999999999999999889999999997542  233567899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++ +|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99985 78887753  3345899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh---
Q 038934          588 QTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL---  663 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  663 (751)
                      ...  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........   .............   
T Consensus       173 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          173 VRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQV  247 (311)
T ss_dssp             CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGG
T ss_pred             ccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhhh
Confidence            222  223578999999999876 5689999999999999999999999875444332111   1111111111000   


Q ss_pred             -------------cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          664 -------------IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       664 -------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                                   ...............++.+|+.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                         0000000011122357789999999999999999999986

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.3e-40  Score=354.98  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=201.9

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc-----
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE-----  502 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  502 (751)
                      ..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+...     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4578999999999999999999976 68999999997543 3456789999999999999999999999866542     


Q ss_pred             ----------------------------------------------------eEEEEEecCCCChhHHHhccCCCCCCCH
Q 038934          503 ----------------------------------------------------RMLIYEYLPNKSLADFIFDGTRRKLLDW  530 (751)
Q Consensus       503 ----------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~~~~l~~  530 (751)
                                                                          .++||||+++++|.+++.........++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                                7999999999999999987666666788


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc----------cccccccccc
Q 038934          531 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE----------ANTNRVVGTY  600 (751)
Q Consensus       531 ~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~  600 (751)
                      ..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            889999999999999999998   999999999999999999999999999887543221          1123357999


Q ss_pred             CccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHH
Q 038934          601 GYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRC  680 (751)
Q Consensus       601 ~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  680 (751)
                      .|+|||++.+..++.++|||||||++|||++|..|+.        ... ...........         ..........+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~-~~~~~~~~~~~---------~~~~~~~~~~~  302 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERV-RIITDVRNLKF---------PLLFTQKYPQE  302 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHH-HHHHHHHTTCC---------CHHHHHHCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHH-HHHHHhhccCC---------CcccccCChhH
Confidence            9999999999999999999999999999999866521        000 00000111100         00112233467


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          681 IQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       681 ~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .+++.+||+.||++|||+.|+++.
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHccCCCCcCCCHHHHhhc
Confidence            899999999999999999999863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.1e-41  Score=368.99  Aligned_cols=257  Identities=25%  Similarity=0.359  Sum_probs=208.4

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|.+.++||+|+||.||+|++. +++.||||++.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            357888999999999999999976 68999999997543 3344578999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999642  235899999999999999999999999   9999999999999999999999999998654322


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      .........+++.|+|||++.+..++.++|||||||++|||++ |..|+........       ......+.        
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~--------  332 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------REFVEKGG--------  332 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HHHHHTTC--------
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC--------
Confidence            2221222346778999999999999999999999999999998 8888754322111       11111111        


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                       ....+......+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       333 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          333 -RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence             1111222345788999999999999999999999999865

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=360.39  Aligned_cols=248  Identities=27%  Similarity=0.354  Sum_probs=201.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  505 (751)
                      .++|++.++||+|+||.||++++. +++.||||++.+.   .....+.+.+|+.++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999975 4899999999754   334566788999999998 69999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999954   345899999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..    ......      
T Consensus       176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~----~i~~~~------  240 (353)
T 3txo_A          176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL---FE----AILNDE------  240 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHCC------
T ss_pred             cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH---HH----HHHcCC------
Confidence            22  2223446899999999999999999999999999999999999999864332111   10    011110      


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNM------ASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  703 (751)
                          ..++......+.+++.+||+.||.+||++      .++++
T Consensus       241 ----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 ----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                01222244578899999999999999998      67764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=347.78  Aligned_cols=272  Identities=21%  Similarity=0.249  Sum_probs=213.9

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC--ceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD--ERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV  506 (751)
                      .++|.+.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            3689999999999999999999764 8999999997542 345677899999999999999999999998766  77999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE----cCCCCeEEeeccCcc
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMAR  582 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla~  582 (751)
                      |||+++++|.+++........+++..++.++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976555555999999999999999999999998   9999999999999    778889999999998


Q ss_pred             ccCCCCccccccccccccCccCccccc--------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc-ccchhHHHHH
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAI--------DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH-HHNLLGHAWR  653 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~-~~~~~~~~~~  653 (751)
                      .......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||....... ..........
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            7643322   22357899999999986        5788999999999999999999999986433221 1111111111


Q ss_pred             HhccCChhhh-------c----chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          654 LWTEDRPVEL-------I----DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       654 ~~~~~~~~~~-------~----d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .........+       +    +..............+.+++.+||+.||++|||++|+++.....
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            1100000000       0    00011233456677889999999999999999999999988654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-40  Score=357.18  Aligned_cols=261  Identities=26%  Similarity=0.415  Sum_probs=210.4

Q ss_pred             hcCccccccccccccccEEEEEEc------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  502 (751)
                      .++|.+.+.||+|+||.||+|++.      .++.||||++... .....+.+.+|+.++.++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            478999999999999999999962      3568999999754 334557899999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCC
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRR--------------------KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKA  562 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp  562 (751)
                      .++||||+++++|.+++......                    ..+++..++.++.||+.||.|||+++   |+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence            99999999999999999653321                    34799999999999999999999998   99999999


Q ss_pred             CCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 038934          563 SNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHV  641 (751)
Q Consensus       563 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~  641 (751)
                      +|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..|+.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999999987654433333344667889999999999999999999999999999998 9999764332


Q ss_pred             ccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          642 DHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       642 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      ...      ........         .....+......+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus       281 ~~~------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          281 DAN------FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             SHH------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHH------HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            211      11111111         111122233567889999999999999999999999998753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-40  Score=352.72  Aligned_cols=251  Identities=18%  Similarity=0.276  Sum_probs=204.7

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|.+.+.||+|+||.||++.+. +++.+|+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            478999999999999999999975 4889999998644 33456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC--CCCeEEeeccCccccCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGVD  587 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~~~~~  587 (751)
                      +++++|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999943  2346899999999999999999999998   999999999999987  789999999999876432


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   .....   ......   ... 
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i---~~~~~~---~~~-  224 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENI---MNAEYT---FDE-  224 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---HHTCCC---CCH-
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHH---HcCCCC---CCh-
Confidence            2   2234678999999999999999999999999999999999999976432211   11100   000000   000 


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         ......+..+.+++.+||+.||.+|||+.|+++
T Consensus       225 ---~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          225 ---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               000122457889999999999999999999996

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-40  Score=358.33  Aligned_cols=263  Identities=25%  Similarity=0.405  Sum_probs=213.1

Q ss_pred             HHhcCccccccccccccccEEEEEEcC------CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD  501 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  501 (751)
                      ...++|.+.+.||+|+||.||+|++..      ++.||||++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            345789999999999999999999753      478999999765 3344677999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccC
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTR---------------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL  560 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Di  560 (751)
                      ..++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+++   |+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            99999999999999999965321                     256899999999999999999999998   999999


Q ss_pred             CCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 038934          561 KASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFH  639 (751)
Q Consensus       561 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~  639 (751)
                      ||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999987643332222334568899999999999999999999999999999999 98887532


Q ss_pred             CCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          640 HVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       640 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                      ....   +    ......+...         ..+......+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       281 ~~~~---~----~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          281 AHEE---V----IYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             CHHH---H----HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ChHH---H----HHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            2111   1    1111111110         1122334578899999999999999999999999998744

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.4e-40  Score=344.63  Aligned_cols=254  Identities=30%  Similarity=0.446  Sum_probs=197.8

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCC----cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|+..++||+|+||.||+|.+ .++.||||++....    ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            36889999999999999999997 58899999987542    23457899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC--------CCCeEEeec
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------EMNPKISDF  578 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~--------~~~~kl~DF  578 (751)
                      |||+++++|.+++.    ...+++..+..++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999983    446899999999999999999999988666899999999999986        678999999


Q ss_pred             cCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          579 GMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       579 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      |+++.......    ....||+.|+|||.+.+..++.++||||||+++|+|++|+.|+........      ........
T Consensus       161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~  230 (271)
T 3dtc_A          161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAMNK  230 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHTSC
T ss_pred             Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhcCC
Confidence            99986543221    235789999999999999999999999999999999999999753221110      11111111


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                               .....+......+.+++.+|++.||.+|||+.|+++.|+.+
T Consensus       231 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          231 ---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                     11112223346788999999999999999999999999863

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=362.10  Aligned_cols=258  Identities=29%  Similarity=0.437  Sum_probs=208.4

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      ++|.+.++||+|+||.||+|++.      +++.||||++... ......++.+|+.++++++||||+++++++.+....+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            57889999999999999999943      3678999999654 3445567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC---CeEEee
Q 038934          505 LIYEYLPNKSLADFIFDGT----RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKISD  577 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~D  577 (751)
                      +||||+++++|.+++....    ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999996532    2245899999999999999999999999   99999999999999555   599999


Q ss_pred             ccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhc
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                      ||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..|+.......   +.    ....
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~----~~i~  300 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VL----EFVT  300 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH----HHHH
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHH
Confidence            999986543322223334578899999999999999999999999999999998 988875432211   11    1111


Q ss_pred             cCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          657 EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       657 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...         ....+......+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus       301 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          301 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            111         1111223345688999999999999999999999999765

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.1e-40  Score=360.63  Aligned_cols=250  Identities=22%  Similarity=0.310  Sum_probs=200.1

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  505 (751)
                      .++|++.++||+|+||.||++++.. ++.||||++.+.   .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4689999999999999999999764 788999999764   223345688999999987 89999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999999854   346899999999999999999999999   9999999999999999999999999998632


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc--cchhHHHHHHhccCChhhh
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHH--HNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  663 (751)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...............    
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----  278 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  278 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence            22  1223457899999999999999999999999999999999999999864332111  000111111111110    


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNM  698 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  698 (751)
                            -..+......+.+|+.+||+.||.+||++
T Consensus       279 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 ------IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                  11223345678899999999999999995

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.4e-40  Score=350.86  Aligned_cols=260  Identities=26%  Similarity=0.402  Sum_probs=212.3

Q ss_pred             hcCccccccccccccccEEEEEE------cCCcEEEEEEeccCC-cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML------IDGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  502 (751)
                      .++|.+.+.||+|+||.||+|++      .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46899999999999999999985      236789999997553 23457899999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE
Q 038934          503 RMLIYEYLPNKSLADFIFDGTR---------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  567 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll  567 (751)
                      .++||||+++++|.+++.....               ...+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999965432               225899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 038934          568 DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHN  646 (751)
Q Consensus       568 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~  646 (751)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+........  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence            9999999999999987755443333344567889999999999999999999999999999998 9988754332211  


Q ss_pred             hhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          647 LLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .    .....         .......+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       257 ~----~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          257 F----YKMIK---------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             H----HHHHH---------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----HHHhc---------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            1    11111         1111111223346788999999999999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-40  Score=363.84  Aligned_cols=256  Identities=27%  Similarity=0.430  Sum_probs=197.6

Q ss_pred             cCccccccccccccccEEEEEEc----CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|.+.+.||+|+||.||+|++.    ++..||||++... .....+++.+|+.++++++||||+++++++.+....++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            58899999999999999999965    4678999999754 334567899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       125 ~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          125 TEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999964  2346899999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCccc-cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          587 DQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       587 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+......   .+..             .+
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~-------------~i  263 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIK-------------AV  263 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHH-------------HH
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-------------HH
Confidence            32211 1122345778999999999999999999999999999998 99997532211   1111             11


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ........+......+.+++.+||+.||.+||++.+|+++|+.+
T Consensus       264 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            11111122233456788999999999999999999999999876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=348.91  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=205.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|.+.+.||+|+||.||+++.. +++.||||++.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467999999999999999999975 589999999975422      2467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC----CeEEeecc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFG  579 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DFG  579 (751)
                      ++||||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999994   3456899999999999999999999998   99999999999999887    79999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      +++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....... .....
T Consensus       164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~-~~~~~  236 (326)
T 2y0a_A          164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVSA-VNYEF  236 (326)
T ss_dssp             TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH-TCCCC
T ss_pred             CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHh-cCCCc
Confidence            9987643221   234679999999999999999999999999999999999999975432211   1110000 00000


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .         ..........+.+|+.+||+.||.+|||+.++++.
T Consensus       237 ~---------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          237 E---------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             C---------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             C---------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0         00001123567899999999999999999999973

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=366.76  Aligned_cols=255  Identities=21%  Similarity=0.280  Sum_probs=205.1

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ...++|++.++||+|+||.||++... +++.+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            45678999999999999999999964 58999999997543  3345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc---CCCCeEEeeccCcc
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMAR  582 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~  582 (751)
                      ||||+++++|.+.+..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++   +++.+||+|||+++
T Consensus        88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999999854   346899999999999999999999998   99999999999998   56789999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      .......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .+..    ....+... 
T Consensus       162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~----~i~~~~~~-  231 (444)
T 3soa_A          162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQ----QIKAGAYD-  231 (444)
T ss_dssp             CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH----HHHHTCCC-
T ss_pred             EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHH----HHHhCCCC-
Confidence            7643322  223467999999999999999999999999999999999999997533221   1111    11111000 


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                           ............+.+|+.+||+.||.+|||+.|+++.
T Consensus       232 -----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          232 -----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                 0000011234578899999999999999999999973

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.3e-40  Score=347.08  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=206.8

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .++|++.+.||+|+||.||++.+.+++.||||++.... ...+++.+|++++.+++||||+++++++.+....++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            46889999999999999999999888899999997543 34578999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+++........
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A          102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence            999999999642  345899999999999999999999998   999999999999999999999999999876432211


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                       ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+........   ..    .....         ..
T Consensus       177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~---~~----~~~~~---------~~  239 (283)
T 3gen_A          177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---AE----HIAQG---------LR  239 (283)
T ss_dssp             -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HH----HHHTT---------CC
T ss_pred             -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH---HH----HHhcc---------cC
Confidence             1223456788999999999999999999999999999998 9999754322111   00    01111         11


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            111222245788999999999999999999999999764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.2e-40  Score=357.80  Aligned_cols=253  Identities=22%  Similarity=0.324  Sum_probs=205.0

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ...++|.+.+.||+|+||.||++.+. +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34578999999999999999999975 5899999999754  23445678999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC---CeEEeeccCcc
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMAR  582 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DFGla~  582 (751)
                      ||||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||+++
T Consensus       106 v~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999999984   3456899999999999999999999998   99999999999998654   59999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .+..    ....+... 
T Consensus       180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~----~i~~~~~~-  248 (362)
T 2bdw_A          180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYA----QIKAGAYD-  248 (362)
T ss_dssp             CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCCC-
T ss_pred             EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHhCCCC-
Confidence            764322   123467999999999999999999999999999999999999997533211   1111    11111000 


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           ............+.+|+.+||+.||++||++.++++
T Consensus       249 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          249 -----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             -----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 000001123457889999999999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.2e-40  Score=355.72  Aligned_cols=254  Identities=22%  Similarity=0.284  Sum_probs=203.9

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC-----CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      .++|++.+.||+|+||.||++++. +++.||||++...     .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999999999999965 5899999998642     1224678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC---eEEeeccC
Q 038934          505 LIYEYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGM  580 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGl  580 (751)
                      +||||+++++|.+.+.... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999998885432 3345899999999999999999999998   999999999999987655   99999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....    .+..    .......
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~----~i~~~~~  249 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE----GIIKGKY  249 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH----HHHHTCC
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH----HHHcCCC
Confidence            987653322  22346799999999999999999999999999999999999999764211    1111    0110100


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .  .....    .......+.+|+.+||+.||++|||+.++++
T Consensus       250 ~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 K--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  00000    0112457889999999999999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.7e-40  Score=372.27  Aligned_cols=256  Identities=27%  Similarity=0.430  Sum_probs=211.5

Q ss_pred             cCccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      ++|.+.++||+|+||.||+|++.. ++.||||++.... ...++|.+|+.+|++++||||+++++++.+....++||||+
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            568888999999999999999765 8899999996543 45688999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++........
T Consensus       299 ~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  374 (495)
T 1opk_A          299 TYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT  374 (495)
T ss_dssp             TTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred             CCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence            999999999653 2345899999999999999999999998   999999999999999999999999999876432221


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                       ......+++.|+|||++.+..++.++|||||||+||||++ |+.|+.......   +..             .+.....
T Consensus       375 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~-------------~~~~~~~  437 (495)
T 1opk_A          375 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE-------------LLEKDYR  437 (495)
T ss_dssp             -CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH-------------HHHTTCC
T ss_pred             -ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH-------------HHHcCCC
Confidence             1223456788999999999999999999999999999999 888875433211   111             1111111


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      ...+......+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            1222334567889999999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-39  Score=348.12  Aligned_cols=260  Identities=17%  Similarity=0.173  Sum_probs=208.3

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|.+.+.||+|+||.||+|+. .+++.||||++....  ..+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36899999999999999999996 468999999986543  235688999999999 89999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC-----eEEeeccCccc
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-----PKISDFGMARA  583 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~DFGla~~  583 (751)
                      |+ +++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999999643  356899999999999999999999998   999999999999998887     99999999987


Q ss_pred             cCCCCccc-----cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          584 FGVDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       584 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      +.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            64332221     1234689999999999999999999999999999999999999987544332222111110000000


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..     ..+...    .+ .+.+++.+|++.||.+||++.+|++.|+.+
T Consensus       240 ~~-----~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          240 PI-----EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             CH-----HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CH-----HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            00     000011    12 788999999999999999999999988643

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.1e-39  Score=344.82  Aligned_cols=261  Identities=23%  Similarity=0.309  Sum_probs=202.1

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHH--hcCCcEEeEeceeeeC----CceE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK--LQHRNLVKLLGCCMKR----DERM  504 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~  504 (751)
                      .++|.+.+.||+|+||.||+|++ +++.||||++...   ..+.+..|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            47899999999999999999998 7899999998643   34566778888777  7899999999987653    4589


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCEEEccCCCCCeEEcCCCCeEEe
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNEMNPKIS  576 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivH~Dikp~NIll~~~~~~kl~  576 (751)
                      +||||+++++|.+++.    ...+++..++.++.|++.||.|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999993    346899999999999999999999        777   9999999999999999999999


Q ss_pred             eccCccccCCCCccc--cccccccccCccCcccccCC------CCCcchhhHHHHHHHHHHHhC----------CCCCCC
Q 038934          577 DFGMARAFGVDQTEA--NTNRVVGTYGYMPPEYAIDG------LFSVKSDVFSFGVLVLELVYG----------TRNRGF  638 (751)
Q Consensus       577 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~k~DVwSlG~ll~ell~G----------~~p~~~  638 (751)
                      |||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          +.|+..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999998764332221  12335799999999999877      566899999999999999999          666543


Q ss_pred             CCCccccchhHHHHHHhc-cCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          639 HHVDHHHNLLGHAWRLWT-EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       639 ~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ........  ........ ........    ...........+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       236 ~~~~~~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPSF--EDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCCH--HHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcch--hhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            22221111  11111111 11111110    1112234667899999999999999999999999999753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.9e-40  Score=344.45  Aligned_cols=262  Identities=23%  Similarity=0.308  Sum_probs=201.6

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|++.++||+|+||+||+|++. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999975 58899999997542  3345778999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++ +|.+.+..  ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 55555532  3456899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             ccccccccccccCccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh------
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV------  661 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  661 (751)
                      ..  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..|+......  .................      
T Consensus       156 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhc
Confidence            22  23357899999999998766 899999999999999999998885322211  11111111111111000      


Q ss_pred             hhcc---------hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 ELID---------KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 ~~~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...+         ..............+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000         00000111234567889999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-40  Score=349.15  Aligned_cols=245  Identities=23%  Similarity=0.289  Sum_probs=204.7

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            368999999999999999999975 5899999999754   224567788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999954   345899999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                           ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .   ....... .       
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~---~~~i~~~-~-------  219 (318)
T 1fot_A          159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---T---YEKILNA-E-------  219 (318)
T ss_dssp             -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHHC-C-------
T ss_pred             -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhC-C-------
Confidence                 1234689999999999999999999999999999999999999975322111   0   1111111 0       


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                         -.++......+.+++.+||+.||.+||     ++.++++
T Consensus       220 ---~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 ---LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence               011223345788999999999999999     8999984

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=346.72  Aligned_cols=263  Identities=24%  Similarity=0.385  Sum_probs=203.1

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|++.+.||+|+||.||++++ .++.||||++...  ...+.+.+|++++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            5788899999999999999997 5789999998643  45678999999999999999999999887  45899999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC-eEEeeccCccccCCCCcc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGVDQTE  590 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-~kl~DFGla~~~~~~~~~  590 (751)
                      +++|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976554456889999999999999999999932223999999999999998887 799999999765322   


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.|+........    ...+...... .         .
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~-~---------~  223 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVHNGT-R---------P  223 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHHTTC-C---------C
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHhcCC-C---------C
Confidence              1234689999999999999999999999999999999999999763322111    1111111111 1         1


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC-CCCCCCCCCC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE-RSLPQPKQPG  718 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~-~~~~~p~~p~  718 (751)
                      .........+.+++.+||+.||.+|||+.++++.|+.+ ...+.+..|.
T Consensus       224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~  272 (307)
T 2eva_A          224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL  272 (307)
T ss_dssp             CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred             CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence            11122345678999999999999999999999999876 4444444443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=355.23  Aligned_cols=250  Identities=23%  Similarity=0.313  Sum_probs=205.9

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|.+.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            368999999999999999999965 4889999999653   234567889999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+.+++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999953   456899999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCccccccccccccCccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      .   .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||..........+....    ...     
T Consensus       168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~~~-----  235 (384)
T 4fr4_A          168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF----ETT-----  235 (384)
T ss_dssp             T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH----HHC-----
T ss_pred             C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hhc-----
Confidence            2   22344689999999999974   45899999999999999999999998654433222211111    000     


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN-MASVVL  703 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  703 (751)
                           ...++......+.+|+.+||+.||.+||+ +.++++
T Consensus       236 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 -----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                 01122233567889999999999999999 777764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.8e-40  Score=345.18  Aligned_cols=249  Identities=25%  Similarity=0.338  Sum_probs=196.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc--------------------------ccHHHHHHHHHHHH
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG--------------------------QGVEEFKNEVLLIA  483 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  483 (751)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            368999999999999999999965 588999999965421                          12356899999999


Q ss_pred             HhcCCcEEeEeceeee--CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCC
Q 038934          484 KLQHRNLVKLLGCCMK--RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK  561 (751)
Q Consensus       484 ~l~h~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dik  561 (751)
                      +++||||+++++++.+  ....++||||+++++|.+++    ....+++..+..++.||+.||.|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  56789999999999998865    3456899999999999999999999998   9999999


Q ss_pred             CCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCC
Q 038934          562 ASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLELVYGTRNRGF  638 (751)
Q Consensus       562 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~k~DVwSlG~ll~ell~G~~p~~~  638 (751)
                      |+|||++.++.+||+|||+++.......  ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987643322  223467999999999998765   47899999999999999999999753


Q ss_pred             CCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          639 HHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       639 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ....   .+.    .......        ............+.+++.+||+.||++||++.|+++
T Consensus       243 ~~~~---~~~----~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIM---CLH----SKIKSQA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHH---HHH----HHHHHCC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHH---HHH----HHHhccc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            2211   000    0011110        000111123456889999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-40  Score=355.13  Aligned_cols=256  Identities=26%  Similarity=0.378  Sum_probs=203.8

Q ss_pred             cCccccccccccccccEEEEEEcC-CcE----EEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQE----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|++.++||+|+||.||+|++.. ++.    ||+|.+... .....+.+.+|+.++++++||||+++++++. +...++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            578899999999999999999643 443    788887543 2344567889999999999999999999986 567899


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999642  346899999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ............+++.|+|||++.+..++.++||||||+++|+|++ |+.|+..........       ......     
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~-----  234 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-------LLEKGE-----  234 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-------HHHTTC-----
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-------HHHcCC-----
Confidence            5444444445678889999999999999999999999999999999 999976433221111       111111     


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                          ....+......+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       235 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          235 ----RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             ----BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             ----CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                01111112335678999999999999999999999998764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6e-40  Score=364.01  Aligned_cols=262  Identities=19%  Similarity=0.239  Sum_probs=208.5

Q ss_pred             HHhHHHHhcCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeee
Q 038934          424 WKSIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK  499 (751)
Q Consensus       424 ~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  499 (751)
                      ..++....++|++.++||+|+||+||++++.. ++.||||++.+.   .....+.+.+|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            44455667899999999999999999999765 788999999653   12233458899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       500 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                      .+..++||||+++|+|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence            9999999999999999999954  2356899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCccccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHH
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      +++........ .....+||+.|+|||++.     +..++.++|||||||++|||++|+.||........   ....   
T Consensus       221 la~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i---  293 (437)
T 4aw2_A          221 SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKI---  293 (437)
T ss_dssp             TCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH---
T ss_pred             hhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhh---
Confidence            99876433222 223368999999999997     56799999999999999999999999864332211   1100   


Q ss_pred             hccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 038934          655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPED--RPNMASVVL  703 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  703 (751)
                      .....  ..    ............+.+|+.+||+.+|++  ||+++|+++
T Consensus       294 ~~~~~--~~----~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          294 MNHKE--RF----QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HTHHH--HC----CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hhccc--cc----cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            00000  00    000011123457889999999988888  999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7e-40  Score=352.25  Aligned_cols=260  Identities=27%  Similarity=0.410  Sum_probs=210.7

Q ss_pred             hcCccccccccccccccEEEEEEc--------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR  500 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  500 (751)
                      .++|.+.+.||+|+||.||+|++.        +++.||||++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999999863        4678999999754 334567799999999999 899999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTR-------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  567 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll  567 (751)
                      +..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999965332             234899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccc
Q 038934          568 DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHN  646 (751)
Q Consensus       568 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~  646 (751)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+.......   
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence            9999999999999987654333233334567889999999999999999999999999999999 988875332211   


Q ss_pred             hhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          647 LLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      +.    .......         ....+......+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       268 ~~----~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          268 LF----KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             HH----HHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH----HHHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11    1111110         11122233457889999999999999999999999998763

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.6e-40  Score=355.39  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=204.7

Q ss_pred             HHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCc
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  502 (751)
                      ....++|.+.+.||+|+||.||+|++. +++.||||++.+..   ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345689999999999999999999975 58899999997542   34567788999999987 89999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            9999999999999999954   345899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..    ......   
T Consensus       167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~----~i~~~~---  234 (345)
T 1xjd_A          167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFH----SIRMDN---  234 (345)
T ss_dssp             CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCC---
T ss_pred             hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHhCC---
Confidence            643222  22344789999999999999999999999999999999999999976432211   111    111110   


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMA-SVV  702 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  702 (751)
                             ..++......+.+|+.+||+.||.+||++. +++
T Consensus       235 -------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 -------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                   111222345788999999999999999998 665

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.4e-40  Score=369.71  Aligned_cols=257  Identities=28%  Similarity=0.419  Sum_probs=209.2

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .++|.+.++||+|+||.||+|.+.+++.||||++.... ...+++.+|+.++++++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            35788889999999999999999888999999997543 45788999999999999999999999986 66789999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus       265 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~  340 (454)
T 1qcf_A          265 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  340 (454)
T ss_dssp             TTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence            999999999532 1235789999999999999999999998   999999999999999999999999999876432111


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                       ......+++.|+|||++.+..++.++|||||||+||||++ |+.|+......   .+..    ....+         ..
T Consensus       341 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~----~i~~~---------~~  403 (454)
T 1qcf_A          341 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIR----ALERG---------YR  403 (454)
T ss_dssp             -TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH----HHHHT---------CC
T ss_pred             -ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcC---------CC
Confidence             1122456788999999999999999999999999999999 99997532221   1111    11111         11


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                      ...+......+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            11122335678899999999999999999999999998743

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.4e-40  Score=344.41  Aligned_cols=261  Identities=24%  Similarity=0.361  Sum_probs=201.1

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|++.++||+|+||.||+|+..+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5789999999999999999999779999999996543  23357789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            986 89888853  2356899999999999999999999998   99999999999999999999999999987643222


Q ss_pred             cccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh------h
Q 038934          590 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV------E  662 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~  662 (751)
                        ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........   ..............      +
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhc
Confidence              12235789999999999764 589999999999999999999999864332111   11111111110000      0


Q ss_pred             --hcchhcc-------CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 --LIDKSLE-------DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 --~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                        ..++.+.       ..........+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0000000       0111223457789999999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4e-40  Score=352.27  Aligned_cols=260  Identities=23%  Similarity=0.372  Sum_probs=193.9

Q ss_pred             HhcCccccccccccccccEEEEEEcC-Cc---EEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID-GQ---EIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      ..++|.+.+.||+|+||.||+|++.. ++   .||||++...  .....+++.+|+.++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34689999999999999999999654 32   7999999754  344567899999999999999999999999887665


Q ss_pred             ------EEEEEecCCCChhHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeE
Q 038934          504 ------MLIYEYLPNKSLADFIFDGT---RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK  574 (751)
Q Consensus       504 ------~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k  574 (751)
                            ++||||+++++|.+++....   ....+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                  99999999999999986432   2235899999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHH
Q 038934          575 ISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWR  653 (751)
Q Consensus       575 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~  653 (751)
                      |+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |+.|+........   ..    
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~----  250 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---YN----  250 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---HH----
Confidence            999999987644333222333556789999999999999999999999999999999 8888764332111   11    


Q ss_pred             HhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          654 LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       654 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ......         ....+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       251 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          251 YLIGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            011110         0111223345788999999999999999999999999876

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-40  Score=354.54  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=197.9

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcC--CcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQH--RNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++|  +||+++++++......++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4679999999999999999999888999999998754  33445789999999999976  9999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      || +.+++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899999954   356899999999999999999999998   99999999999997 57899999999987754


Q ss_pred             CCccccccccccccCccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      ...........||+.|+|||++.+           ..++.++|||||||++|+|++|+.||......     .....   
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~---  231 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLH---  231 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHH---
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHH---
Confidence            433333345689999999999865           67899999999999999999999997532110     11111   


Q ss_pred             ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                            ..++.......+......+.+|+.+||+.||.+|||+.++++.
T Consensus       232 ------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          232 ------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                  1111111122222234568899999999999999999999863

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.6e-39  Score=338.42  Aligned_cols=261  Identities=16%  Similarity=0.195  Sum_probs=210.6

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|.+.+.||+|+||.||+|+. .+++.||||++....  ..+.+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46899999999999999999996 468999999986542  335688999999999 79999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC-----eEEeeccCccc
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-----PKISDFGMARA  583 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~DFGla~~  583 (751)
                      |+ +++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999643  335899999999999999999999998   999999999999987776     99999999987


Q ss_pred             cCCCCcc-----ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          584 FGVDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       584 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      .......     .......||+.|+|||++.+..++.++||||||+++|||++|+.|+......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543222     12234679999999999999999999999999999999999999987544332222222111111111


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ....+         ....+..+.+++.+|++.||++||++.+|++.|+.+
T Consensus       241 ~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          241 PLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             CHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            11111         112245788999999999999999999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-39  Score=351.13  Aligned_cols=254  Identities=23%  Similarity=0.303  Sum_probs=203.5

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|.+.+.||+|+||.||++++. +++.||||++.+.   .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57899999999999999999975 4889999999764   233456788999999998 899999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999999954   345899999999999999999999998   99999999999999999999999999986432


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc--chhHHHHHHhccCChhhhc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHH--NLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  664 (751)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ..............     
T Consensus       163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  235 (345)
T 3a8x_A          163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  235 (345)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred             CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence            21  2234468999999999999999999999999999999999999998643221110  00011111111110     


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNM------ASVVL  703 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  703 (751)
                           ...+......+.+|+.+||+.||.+||++      .++++
T Consensus       236 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          236 -----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence                 11222345678899999999999999995      56653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.1e-40  Score=348.08  Aligned_cols=268  Identities=26%  Similarity=0.386  Sum_probs=213.4

Q ss_pred             cHHhHHHHhcCccccccccccccccEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHHHh-cCCcEEeEe
Q 038934          423 DWKSIANATDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVKLL  494 (751)
Q Consensus       423 ~~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~  494 (751)
                      .........++|.+.+.||+|+||.||+|++.      +++.||||++.... ....+.+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            33344455689999999999999999999842      36789999997653 33456799999999999 799999999


Q ss_pred             ceeeeCC-ceEEEEEecCCCChhHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccC
Q 038934          495 GCCMKRD-ERMLIYEYLPNKSLADFIFDGTR-------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL  560 (751)
Q Consensus       495 ~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Di  560 (751)
                      +++...+ ..++||||+++++|.+++.....             ...+++..+..++.|++.||.|||+++   |+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence            9987765 48999999999999999965332             223889999999999999999999998   999999


Q ss_pred             CCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 038934          561 KASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFH  639 (751)
Q Consensus       561 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~  639 (751)
                      ||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987654433333344678899999999999999999999999999999998 99987543


Q ss_pred             CCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          640 HVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       640 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .....  ..    ........         ...+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       255 ~~~~~--~~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          255 KIDEE--FC----RRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCSHH--HH----HHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhHH--HH----HHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            32211  11    11111110         111222345788999999999999999999999999764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.7e-40  Score=366.07  Aligned_cols=257  Identities=27%  Similarity=0.417  Sum_probs=204.1

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|.+.++||+|+||.||+|.+..+..||||++.... ...++|.+|+.++++++||||+++++++.+ +..++||||++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            5788889999999999999999888889999997543 346789999999999999999999999876 77899999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++... ....+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++........ 
T Consensus       262 ~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-  336 (452)
T 1fmk_A          262 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  336 (452)
T ss_dssp             TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee-
Confidence            99999999532 1235899999999999999999999998   999999999999999999999999999876432211 


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                      ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+......   ...    .....+         ...
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~----~~i~~~---------~~~  400 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERG---------YRM  400 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTT---------CCC
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcC---------CCC
Confidence            1223456788999999999999999999999999999999 88887532211   111    111111         111


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSL  711 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  711 (751)
                      ..+......+.+|+.+||+.||++|||+.++++.|+.+..-
T Consensus       401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            12233456788999999999999999999999999987433

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.1e-39  Score=352.66  Aligned_cols=245  Identities=21%  Similarity=0.235  Sum_probs=205.2

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|.+.+.||+|+||.||++++. +++.||||++.+.   .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            368999999999999999999975 5899999999654   224567889999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999999954   245899999999999999999999999   99999999999999999999999999987642


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      .     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+    ......+..      
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~----~~~i~~~~~------  255 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QI----YEKIVSGKV------  255 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC------
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HH----HHHHHcCCC------
Confidence            2     23468999999999999999999999999999999999999997643221   11    111111110      


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                          ..+......+.+++.+||+.||.+||+     +.++++
T Consensus       256 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                112233567889999999999999998     888874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.3e-39  Score=342.11  Aligned_cols=257  Identities=27%  Similarity=0.427  Sum_probs=212.3

Q ss_pred             HhcCccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ..++|.+.++||+|+||.||+|.+.. ++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            45789999999999999999999765 888999999654 3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++... ....+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            99999999999653 3356899999999999999999999998   9999999999999999999999999998765333


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      .. ......+|+.|+|||++.+..++.++||||||+++|+|++ |..|+........   ..             .+...
T Consensus       166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~-------------~~~~~  228 (288)
T 3kfa_A          166 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YE-------------LLEKD  228 (288)
T ss_dssp             SE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH-------------HHHTT
T ss_pred             cc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH-------------HHhcc
Confidence            22 2233567889999999999999999999999999999999 8888754332211   11             11111


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .....+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            11122233346788999999999999999999999998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.1e-39  Score=345.95  Aligned_cols=264  Identities=22%  Similarity=0.345  Sum_probs=191.4

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999965 58999999997543 3345778999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          509 YLPNKSLADFIFDG---TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       509 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |++ ++|.+++...   .....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5999988542   22245899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC--h-h
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR--P-V  661 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~--~-~  661 (751)
                      ....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.........   ...........  . .
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWP  234 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhh
Confidence            3222  12335789999999999864 6899999999999999999999998654332211   11111100000  0 0


Q ss_pred             h-----------------hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 E-----------------LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 ~-----------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .                 .+...+...........+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0                 00000011111123457889999999999999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.8e-40  Score=362.79  Aligned_cols=259  Identities=19%  Similarity=0.226  Sum_probs=207.6

Q ss_pred             HhHHHHhcCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC
Q 038934          425 KSIANATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR  500 (751)
Q Consensus       425 ~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  500 (751)
                      .++....++|.+.++||+|+||.||++++.. ++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            3455567899999999999999999999764 889999999653   122345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccC
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  580 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl  580 (751)
                      ...++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999999853    35899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhc
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                      ++....... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||........   ....   ..
T Consensus       215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i---~~  287 (410)
T 3v8s_A          215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKI---MN  287 (410)
T ss_dssp             CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH---HT
T ss_pred             eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---HHHH---Hh
Confidence            987643321 1233468999999999998765    88999999999999999999999864332111   0000   00


Q ss_pred             cCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 038934          657 EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPED--RPNMASVVLM  704 (751)
Q Consensus       657 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  704 (751)
                      ..       ..+.-.........+.+|+.+||+.+|.+  ||++.||++.
T Consensus       288 ~~-------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          288 HK-------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HH-------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cc-------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            00       00000011123467889999999999988  9999999963

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.8e-40  Score=351.72  Aligned_cols=273  Identities=25%  Similarity=0.327  Sum_probs=203.7

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce---
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER---  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  503 (751)
                      .++|++.+.||+|+||.||++++ .+++.||||++....   ....+.+.+|+.++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            47899999999999999999996 468999999997642   23456789999999999999999999998876654   


Q ss_pred             -EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          504 -MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       504 -~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                       ++||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             999999999999999954   345899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcc-ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          583 AFGVDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       583 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      .+...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......      ............
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCC
Confidence            76433221 22234678999999999999999999999999999999999999975432211      111111111100


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH-HHHhCCCCCCCCCCCCCccc
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV-LMLSGERSLPQPKQPGFFTE  722 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~~~~~~~p~~p~~~~~  722 (751)
                      ..       .........+.+++.+||+.||.+||++.+++ +.|........|..|.....
T Consensus       239 ~~-------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~~  293 (311)
T 3ork_A          239 PS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTD  293 (311)
T ss_dssp             HH-------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCCCCC
T ss_pred             cc-------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCccccc
Confidence            00       00111345688999999999999999766655 55555544444444444443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.9e-40  Score=351.82  Aligned_cols=246  Identities=22%  Similarity=0.333  Sum_probs=202.7

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|.+.+.||+|+||.||+|++ .+++.||||++.+.   .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999997 46899999998653   223346789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+ +|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 6789888854   345899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........                +.
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------------i~  221 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------------VN  221 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----------------CC
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----------------HH
Confidence            22   2234679999999999998876 7899999999999999999999764332211100                00


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      . .....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       222 ~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          222 S-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             S-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             c-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0 000112223457789999999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.6e-40  Score=351.27  Aligned_cols=261  Identities=26%  Similarity=0.427  Sum_probs=210.3

Q ss_pred             HhcCccccccccccccccEEEEEEcC-C-----cEEEEEEeccCC-cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCC
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID-G-----QEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRD  501 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  501 (751)
                      ..++|.+.+.||+|+||.||+|.+.. +     +.||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            35789999999999999999999643 2     479999997653 34567799999999999 8999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC
Q 038934          502 ERMLIYEYLPNKSLADFIFDGT-----------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE  570 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~  570 (751)
                      ..++||||+++++|.+++....           ....+++..++.++.||+.||.|||+++   |+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            9999999999999999986432           1345799999999999999999999998   9999999999999999


Q ss_pred             CCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhH
Q 038934          571 MNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLG  649 (751)
Q Consensus       571 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~  649 (751)
                      +.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..|+........  .  
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~--  276 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F--  276 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H--
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H--
Confidence            9999999999987654433333334567889999999999999999999999999999998 8888754322111  1  


Q ss_pred             HHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          650 HAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       650 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                        .......         .....+......+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       277 --~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          277 --YKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             --HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence              1111111         11111222345788999999999999999999999999754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-39  Score=354.46  Aligned_cols=253  Identities=21%  Similarity=0.269  Sum_probs=207.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|.+.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999975 5889999999876655667899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC--CCCeEEeeccCccccCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGVD  587 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~~~~~  587 (751)
                      +++++|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.  .+.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999853  2346899999999999999999999998   999999999999974  577999999999876433


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......   ......    .....      .
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i----~~~~~------~  268 (387)
T 1kob_A          205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNV----KRCDW------E  268 (387)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHH----HHCCC------C
T ss_pred             cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHH----HhCCC------C
Confidence            22   22357899999999999999999999999999999999999997643221   111111    00000      0


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ............+.+|+.+||+.||.+|||+.++++.
T Consensus       269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            0111112234578899999999999999999999973

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.9e-40  Score=351.35  Aligned_cols=264  Identities=25%  Similarity=0.391  Sum_probs=212.7

Q ss_pred             HHHhcCccccccccccccccEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR  500 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  500 (751)
                      ....++|.+.+.||+|+||.||+|++.      .++.||||++.... ......+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            345678999999999999999999864      36789999997543 33456789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCe
Q 038934          501 DERMLIYEYLPNKSLADFIFDGT-------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      +..++||||+++++|.+++....       ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence            99999999999999999986421       1245789999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHH
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+.......   .    .
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~  250 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---V----L  250 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---H----H
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---H----H
Confidence            9999999987643332222334567889999999999999999999999999999999 788865322111   1    1


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                      ........         ...+......+.+++.+||+.||.+||++.++++.|+....
T Consensus       251 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            11111111         11122334568899999999999999999999999988644

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-39  Score=352.76  Aligned_cols=249  Identities=27%  Similarity=0.320  Sum_probs=204.2

Q ss_pred             HhcCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  504 (751)
                      ..++|.+.+.||+|+||.||+++... ++.||||++.+.   .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34789999999999999999999764 789999999754   234567788999999988 7999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999954   245899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+..   . .....     
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~-i~~~~-----  237 (353)
T 2i0e_A          172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---S-IMEHN-----  237 (353)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H-HHHCC-----
T ss_pred             ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHH---H-HHhCC-----
Confidence            3221  2234468999999999999999999999999999999999999997643221   1111   0 11110     


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                           -.++......+.+|+.+||+.||.+||+     +.++++
T Consensus       238 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 0122234567889999999999999995     577764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-39  Score=348.37  Aligned_cols=248  Identities=23%  Similarity=0.301  Sum_probs=194.6

Q ss_pred             hcCccccccccccccccEEEEEE----cCCcEEEEEEeccCC----cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML----IDGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  502 (751)
                      .++|++.+.||+|+||.||+++.    .+++.||||++.+..    ......+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36899999999999999999997    368999999997642    2345568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999954   345889999999999999999999998   9999999999999999999999999997


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......   .....   .. ..   
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i---~~-~~---  237 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TIDKI---LK-CK---  237 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH---HH-TC---
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HHHHH---Hh-CC---
Confidence            643221  12234679999999999999999999999999999999999999976432211   11100   00 00   


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                             ...+......+.+++.+||+.||.+||     ++.++++
T Consensus       238 -------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 -------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                   011222345788999999999999999     7778875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-39  Score=340.49  Aligned_cols=255  Identities=29%  Similarity=0.438  Sum_probs=207.0

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .++|++.+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            36889999999999999999998888899999996543 34678999999999999999999999986 45689999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++... ....+++..+..++.|++.||.|||+++   |+|+||||+|||+++++.+||+|||++.........
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            999999998431 1125899999999999999999999998   999999999999999999999999999876533221


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                       ......+++.|+|||++.+..++.++||||||+++|+|++ |+.|+......   ....    .....         ..
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~~~~~---------~~  228 (279)
T 1qpc_A          166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQ----NLERG---------YR  228 (279)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTT---------CC
T ss_pred             -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHH----HHhcc---------cC
Confidence             1223456789999999998999999999999999999999 88887532221   1111    11111         01


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...+......+.+++.+|++.||++|||+.++++.|+.+
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            111223345788999999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.2e-39  Score=361.26  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=205.2

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC-ceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD-ERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~  509 (751)
                      .++|.+.++||+|+||.||+|.+ .++.||||+++...  ..+.|.+|+.++++++||||+++++++.+.. ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            36788899999999999999998 47899999997543  5578999999999999999999999987765 78999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....  
T Consensus       269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            9999999999653 2334789999999999999999999998   999999999999999999999999999864321  


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                         .....+++.|+|||++.+..++.++|||||||++|||++ |+.|+........   ..    ....+         .
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~----~i~~~---------~  403 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP----RVEKG---------Y  403 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH----HHHTT---------C
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcC---------C
Confidence               112356889999999999999999999999999999998 9999764332211   11    11111         1


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ....+......+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1112233456788999999999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=345.45  Aligned_cols=245  Identities=22%  Similarity=0.271  Sum_probs=194.6

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|+..++||+|+||+||+|++. +++.||||++....  .....++..|+..+.++ +|+||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            368999999999999999999976 68999999986542  23344556677666666 899999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+ +++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 66898888643  345899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ...   .....||+.|+|||++.+ .++.++|||||||++|||++|..++....          .+........      
T Consensus       210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~------  269 (311)
T 3p1a_A          210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYL------  269 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCC------
T ss_pred             CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCC------
Confidence            222   233568999999999876 79999999999999999999977643210          1111111111      


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                        ...........+.+++.+||+.||++|||+.|+++
T Consensus       270 --~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 --PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             --CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence              01111123457889999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.3e-40  Score=344.77  Aligned_cols=252  Identities=22%  Similarity=0.391  Sum_probs=204.7

Q ss_pred             hcCccccccccccccccEEEEEEcC-C-------cEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-G-------QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  502 (751)
                      .++|.+.+.||+|+||.||+|+... +       +.||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3688999999999999999999653 3       4799999987766777889999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC--------eE
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--------PK  574 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--------~k  574 (751)
                      .++||||+++++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999642  334899999999999999999999999   999999999999998887        99


Q ss_pred             EeeccCccccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHH
Q 038934          575 ISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWR  653 (751)
Q Consensus       575 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~  653 (751)
                      |+|||++.....      .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..|+.......  ...    .
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~----~  229 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKL----Q  229 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH----H
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHH----H
Confidence            999999875421      123568899999999987 779999999999999999999755532211110  000    0


Q ss_pred             HhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          654 LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       654 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                      .....           ...+......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       230 ~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          230 FYEDR-----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHTT-----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             Hhhcc-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            00000           01111123457899999999999999999999999998755

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-39  Score=357.63  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=198.1

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhc--CCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ--HRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|.+.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3569999999999999999999878999999999654  3345678999999999996  59999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      || +.+++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 678899999964   346889999999999999999999998   99999999999996 57899999999987754


Q ss_pred             CCccccccccccccCccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      ...........||+.|+|||++.+           ..++.++|||||||+||||++|+.||......     .....   
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~---  278 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLH---  278 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHH---
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHH---
Confidence            433333345679999999999875           46899999999999999999999997532110     11111   


Q ss_pred             ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                            .+++.......+......+.+|+.+||+.||.+||++.|+++
T Consensus       279 ------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          279 ------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             ------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                  111111111122222457889999999999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.5e-40  Score=353.54  Aligned_cols=269  Identities=28%  Similarity=0.392  Sum_probs=212.1

Q ss_pred             cCccccccccccccccEEEEEE-----cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceee--eCCceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGML-----IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM--KRDERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  504 (751)
                      ++|++.+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            6889999999999999999984     358899999998776667788999999999999999999999887  445689


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999999642  235899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC----C
Q 038934          585 GVDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED----R  659 (751)
Q Consensus       585 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~----~  659 (751)
                      ...... .......+|+.|+|||++.+..++.++||||||+++|+|++|+.|+.........     ........    .
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~  252 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGCERDVPALSR  252 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC----CCHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hcccccccccHHH
Confidence            533222 1223356788899999999999999999999999999999999986532211000     00000000    0


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                      ....+........+......+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            011111112222334455678999999999999999999999999998744

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.5e-39  Score=337.32  Aligned_cols=255  Identities=26%  Similarity=0.479  Sum_probs=203.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcc-------cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQ-------GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  502 (751)
                      .++|++.+.||+|+||.||+|++. +++.||||++......       ..+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            368999999999999999999974 6899999998654221       1267899999999999999999999986554 


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC-----eEEee
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-----PKISD  577 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~D  577 (751)
                       ++||||+++++|.+++..  ....+++..+..++.|++.||.|||+++ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999998864  3446899999999999999999999875 34999999999999988776     99999


Q ss_pred             ccCccccCCCCccccccccccccCccCccccc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAI--DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      ||+++....     ......||+.|+|||++.  ...++.++||||||+++|+|++|+.||.......... ..   ...
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~---~~~  243 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-IN---MIR  243 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HH---HHH
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HH---HHh
Confidence            999975432     223367899999999984  5568999999999999999999999986433221110 00   000


Q ss_pred             ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .         .......+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       244 ~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 E---------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             H---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             c---------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1         1111122233456788999999999999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.7e-39  Score=336.82  Aligned_cols=251  Identities=21%  Similarity=0.305  Sum_probs=204.9

Q ss_pred             HhcCccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ..++|.+.++||+|+||.||+|.... +..+|+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            45789999999999999999999754 77899999987766677899999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE---cCCCCeEEeeccCccccC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG  585 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~  585 (751)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+++   |+|+||||+|||+   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999999854   345899999999999999999999999   9999999999999   788999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ...   ......||+.|+|||++.+. ++.++||||||+++|+|++|+.|+.......   ...    ........ ...
T Consensus       161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~-~~~  228 (277)
T 3f3z_A          161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VML----KIREGTFT-FPE  228 (277)
T ss_dssp             TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCCC-CCH
T ss_pred             Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHH----HHHhCCCC-CCc
Confidence            322   22335789999999998765 8999999999999999999999976432211   000    01111000 000


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .     ........+.+++.+||+.||.+||++.++++
T Consensus       229 ~-----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          229 K-----DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             H-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             h-----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0     00012457889999999999999999999985

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-39  Score=349.74  Aligned_cols=261  Identities=21%  Similarity=0.232  Sum_probs=203.1

Q ss_pred             HHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC-----CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC
Q 038934          427 IANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR  500 (751)
Q Consensus       427 i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  500 (751)
                      +....++|.+.+.||+|+||.||+|... +++.||||++.+.     .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            5567789999999999999999999964 5889999998643     345567899999999999999999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhcc-------------------------------------CCCCCCCHHHHHHHHHHHHHH
Q 038934          501 DERMLIYEYLPNKSLADFIFDG-------------------------------------TRRKLLDWSKRCQIIGGIARG  543 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~-------------------------------------~~~~~l~~~~~~~i~~~i~~~  543 (751)
                      +..++||||+++++|.+++...                                     .....+++..+..++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999998421                                     012234677888999999999


Q ss_pred             HHHHHhCCCCCEEEccCCCCCeEEcCCC--CeEEeeccCccccCCCCcc--ccccccccccCccCcccccC--CCCCcch
Q 038934          544 LLYLHQDSRLRIIHRDLKASNVLLDNEM--NPKISDFGMARAFGVDQTE--ANTNRVVGTYGYMPPEYAID--GLFSVKS  617 (751)
Q Consensus       544 L~yLH~~~~~~ivH~Dikp~NIll~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~k~  617 (751)
                      |.|||+++   |+||||||+|||++.++  .+||+|||+++.+......  .......||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999998   99999999999998776  8999999999876432211  12234679999999999975  6789999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC
Q 038934          618 DVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN  697 (751)
Q Consensus       618 DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  697 (751)
                      |||||||++|||++|+.||........      ...........       ...........+.+|+.+||+.||.+||+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence            999999999999999999754332111      11111111100       00011123457889999999999999999


Q ss_pred             HHHHHH
Q 038934          698 MASVVL  703 (751)
Q Consensus       698 ~~evl~  703 (751)
                      +.++++
T Consensus       325 ~~~~l~  330 (345)
T 3hko_A          325 AMRALQ  330 (345)
T ss_dssp             HHHHHH
T ss_pred             HHHHhc
Confidence            999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-39  Score=347.59  Aligned_cols=250  Identities=22%  Similarity=0.261  Sum_probs=180.1

Q ss_pred             cccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEEecCCCC
Q 038934          437 ENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYEYLPNKS  514 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gs  514 (751)
                      .++||+|+||.||++.+. +++.||||++.+.   ....+.+|+.++..+. ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999975 5899999999643   4567889999999997 9999999999999999999999999999


Q ss_pred             hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC---CeEEeeccCccccCCCCccc
Q 038934          515 LADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       515 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DFGla~~~~~~~~~~  591 (751)
                      |.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||+++.......  
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--  164 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--  164 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence            9999954   356899999999999999999999998   99999999999998765   799999999987543322  


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....................+...      ....
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~  238 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGE  238 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSH
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcc
Confidence            2233578999999999999999999999999999999999999986543321111111111111111110      0000


Q ss_pred             cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       672 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ........+.+|+.+||+.||.+|||++++++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            00123457889999999999999999999984

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=344.68  Aligned_cols=262  Identities=23%  Similarity=0.310  Sum_probs=206.8

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeee----CCceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK----RDERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  505 (751)
                      .++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46899999999999999999996 4689999999977666677889999999999999999999999873    347899


Q ss_pred             EEEecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          506 IYEYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      ||||+++++|.+++... .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999998652 23456899999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCccc-------cccccccccCccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHH
Q 038934          585 GVDQTEA-------NTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       585 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      .......       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.|+........          
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----------  254 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD----------  254 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS----------
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc----------
Confidence            3211110       112345799999999987654   78999999999999999999999642111100          


Q ss_pred             hccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                          .....+...............+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       255 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          255 ----SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             ----CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             ----hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence                011111111111112233457889999999999999999999999999874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.4e-39  Score=353.64  Aligned_cols=275  Identities=17%  Similarity=0.224  Sum_probs=206.9

Q ss_pred             HhcCcccccccccc--ccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          430 ATDNFSEENKLGEG--GFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       430 ~~~~y~~~~~IG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      ..++|++.++||+|  +||.||+++.. +++.||||++....  ....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34789999999999  99999999976 58999999997542  344567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+++++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999996532 245899999999999999999999998   999999999999999999999999998754


Q ss_pred             CCCCc-----cccccccccccCccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccch-hHHHHHHh-
Q 038934          585 GVDQT-----EANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL-LGHAWRLW-  655 (751)
Q Consensus       585 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~-~~~~~~~~-  655 (751)
                      .....     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........... ........ 
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            22111     111223478999999999987  6799999999999999999999999864332211100 00000000 


Q ss_pred             cc-----CC-------------hhhhcc---------hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--Hh
Q 038934          656 TE-----DR-------------PVELID---------KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM--LS  706 (751)
Q Consensus       656 ~~-----~~-------------~~~~~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~  706 (751)
                      ..     ..             ....+.         ..............+.+|+.+||+.||++|||+.|+++.  +.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence            00     00             000000         000001112234568899999999999999999999853  54


Q ss_pred             CC
Q 038934          707 GE  708 (751)
Q Consensus       707 ~~  708 (751)
                      .+
T Consensus       339 ~~  340 (389)
T 3gni_B          339 QI  340 (389)
T ss_dssp             GC
T ss_pred             HH
Confidence            44

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-39  Score=346.76  Aligned_cols=264  Identities=22%  Similarity=0.304  Sum_probs=200.0

Q ss_pred             hcCcccc-ccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEE
Q 038934          431 TDNFSEE-NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       431 ~~~y~~~-~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .+.|.+. +.||+|+||.||+++.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4678874 78999999999999954 6899999999877666778899999999995 7999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC---eEEeeccCcccc
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAF  584 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGla~~~  584 (751)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||++...
T Consensus        91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999954   345899999999999999999999998   999999999999998776   999999999865


Q ss_pred             CCCCc-----cccccccccccCccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHH
Q 038934          585 GVDQT-----EANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       585 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      .....     ........||+.|+|||++.+     ..++.++|||||||++|+|++|+.||................  
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--  242 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC--  242 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC--
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc--
Confidence            42211     111223568999999999875     568999999999999999999999987544322100000000  


Q ss_pred             hccCChhhhcchhccCc--cCH----HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          655 WTEDRPVELIDKSLEDT--YSL----SEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~--~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                        ......+........  .+.    .....+.+|+.+||+.||.+|||+.|+++.
T Consensus       243 --~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          243 --PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             --HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              000000001101111  111    124578899999999999999999999973

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=352.18  Aligned_cols=259  Identities=25%  Similarity=0.444  Sum_probs=201.1

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcE----EEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQE----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      .++|++.++||+|+||.||+|++. +++.    ||+|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            368999999999999999999964 3443    577777543 4456788999999999999999999999998754 88


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +|+|++.+++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999999653  345899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      .............+|+.|+|||++.+..++.++|||||||++|+|++ |+.|+..........                .
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----------------~  231 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----------------I  231 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----------------H
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----------------H
Confidence            54433333334567889999999999999999999999999999999 999976433221111                1


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCC
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSL  711 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  711 (751)
                      +........+......+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            111111112223345688999999999999999999999999887443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=349.57  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=189.9

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ..++|.+.+.||+|+||.||+|++. +++.||||++....  ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4578999999999999999999976 47899999997543  34678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---CCCeEEeeccCccccC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFG  585 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~~~  585 (751)
                      |+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999999994   3456899999999999999999999998   999999999999975   8899999999998754


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..   .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.......  .+.    .........    
T Consensus       203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~----~~i~~~~~~----  269 (349)
T 2w4o_A          203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMF----RRILNCEYY----  269 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHH----HHHHTTCCC----
T ss_pred             cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHH----HHHHhCCCc----
Confidence            32   12234678999999999999999999999999999999999999975332211  011    111111000    


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                        ............+.+|+.+||+.||++|||+.++++.
T Consensus       270 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 --FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             --CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0001112234578899999999999999999999873

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.4e-39  Score=351.92  Aligned_cols=247  Identities=25%  Similarity=0.304  Sum_probs=196.9

Q ss_pred             ccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCCCC
Q 038934          436 EENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKS  514 (751)
Q Consensus       436 ~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs  514 (751)
                      ..+.||+|+||.||+|+.. +++.||+|++........+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3568999999999999964 589999999987666667889999999999999999999999999999999999999999


Q ss_pred             hhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE--cCCCCeEEeeccCccccCCCCcccc
Q 038934          515 LADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       515 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll--~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      |.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||+  ++++.+||+|||+++.+.....   
T Consensus       173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            9998864  2345899999999999999999999998   9999999999999  5678899999999987643322   


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCcc
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTY  672 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  672 (751)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....   .... .      .+....
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i---~~~~-~------~~~~~~  311 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TLNNI---LACR-W------DLEDEE  311 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---HHTC-C------CSCSGG
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---Hhcc-C------CCChhh
Confidence            223579999999999999999999999999999999999999976433211   11100   1000 0      000001


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .......+.+|+.+||+.||.+||++.|+++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1123457889999999999999999999996

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-39  Score=340.07  Aligned_cols=255  Identities=23%  Similarity=0.327  Sum_probs=195.6

Q ss_pred             hcCccccccccccccccEEEEEEcC----CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      .++|++.+.||+|+||.||+|.+..    +..||+|++... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4689999999999999999999643    457999998754 3345667999999999999999999999984 567899


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999642  345899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ..... ......+++.|+|||++.+..++.++||||||+++|||++ |..|+........   ...    .....     
T Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~----i~~~~-----  234 (281)
T 1mp8_A          168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR----IENGE-----  234 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH----HHTTC-----
T ss_pred             ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHH----HHcCC-----
Confidence            32221 1223456789999999999999999999999999999996 8888764332211   110    11111     


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                          ....+......+.+++.+||+.||++||++.++++.|+.+
T Consensus       235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          235 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                0112223456788999999999999999999999999764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.1e-39  Score=359.53  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=206.9

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++.+..   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            368999999999999999999975 68999999996542   23456789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999994   3456899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......   .+.    .....+..     
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~----~~i~~~~~-----  233 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLF----KKICDGIF-----  233 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHH----HHHHTTCC-----
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHH----HHHhcCCc-----
Confidence            22   2234679999999999998776 78999999999999999999997643221   111    11111100     


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSG  707 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~  707 (751)
                           ..+......+.+|+.+||+.||.+|||+.++++  .+..
T Consensus       234 -----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          234 -----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             -----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                 111123456889999999999999999999996  4543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.7e-39  Score=352.92  Aligned_cols=272  Identities=27%  Similarity=0.319  Sum_probs=211.4

Q ss_pred             ccCCcccHHhHHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-----CCcE
Q 038934          417 MELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----HRNL  490 (751)
Q Consensus       417 ~~l~~~~~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni  490 (751)
                      .++..+++..-....++|.+.++||+|+||.||+|++. +++.||||++.. .....+.+..|+.+++.++     ||||
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            34455666666667789999999999999999999974 588999999964 3344567888999999997     9999


Q ss_pred             EeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-
Q 038934          491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-  569 (751)
Q Consensus       491 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-  569 (751)
                      +++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+|||++. 
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~  173 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP  173 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence            99999999999999999999 999999996532 235899999999999999999999998   999999999999975 


Q ss_pred             ------------------------CCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHH
Q 038934          570 ------------------------EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL  625 (751)
Q Consensus       570 ------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~l  625 (751)
                                              ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                                    788999999999864322     223678999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh-------------c----c-------------C---cc
Q 038934          626 VLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS-------------L----E-------------D---TY  672 (751)
Q Consensus       626 l~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-------------l----~-------------~---~~  672 (751)
                      +|+|++|+.||...........   ..... ...+.......             +    .             .   ..
T Consensus       249 l~ell~g~~pf~~~~~~~~~~~---~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  324 (360)
T 3llt_A          249 LAELYTGSLLFRTHEHMEHLAM---MESII-QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY  324 (360)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHH---HHHHT-CCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred             HHHHHHCCCCCCCCcHHHHHHH---HHHhc-CCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence            9999999999865432211111   10100 00000000000             0    0             0   00


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          673 SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       673 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .......+.+|+.+||+.||++|||++|+++
T Consensus       325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          325 KIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0111256779999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.9e-39  Score=350.12  Aligned_cols=252  Identities=21%  Similarity=0.287  Sum_probs=194.2

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|.+.++||+|+||+||+++.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            478999999999999999999976 68999999996543 3346789999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC--eEEeeccCccccCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMARAFGVD  587 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DFGla~~~~~~  587 (751)
                      +++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999854   345899999999999999999999998   999999999999987765  999999999753221


Q ss_pred             CccccccccccccCccCcccccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                         .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.........  .........         .
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~---------~  237 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILS---------V  237 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHT---------T
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhc---------C
Confidence               12233579999999999998888665 89999999999999999998643322111  111110000         0


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .............+.+|+.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            0000011123457889999999999999999999996

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-39  Score=335.67  Aligned_cols=254  Identities=27%  Similarity=0.410  Sum_probs=208.8

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|...+.||+|+||.||++.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            5788999999999999999999888999999997653 345789999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +++|.+++...  ...+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||+++....... .
T Consensus        87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  160 (267)
T 3t9t_A           87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  160 (267)
T ss_dssp             TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence            99999999642  346899999999999999999999998   99999999999999999999999999987542211 1


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                      ......+++.|+|||++.+..++.++||||||+++|+|++ |+.|+.......   ..    .......         ..
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~i~~~~---------~~  224 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV----EDISTGF---------RL  224 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH----HHHHTTC---------CC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HH----HHHhcCC---------cC
Confidence            1123456788999999999999999999999999999999 888875432211   11    1111110         01


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..+......+.+++.+|++.||.+||++.++++.|+.+
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11222345788999999999999999999999999865

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2e-39  Score=341.27  Aligned_cols=260  Identities=25%  Similarity=0.424  Sum_probs=195.2

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|++.++||+|+||.||+|+..  ..+|||++...  .....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            468999999999999999999853  35999999654  334567899999999999999999999965 5567899999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999999853  3456899999999999999999999998   9999999999999999999999999998665333


Q ss_pred             ccccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          589 TEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      .........||+.|+|||++.   +..++.++||||||+++|+|++|+.|+.......  .+..    ..........+ 
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~~~~~~~~~~-  247 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIE----MVGRGSLSPDL-  247 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHH----HHHHTSCCCCT-
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHH----HhcccccCcch-
Confidence            333334467999999999987   6678999999999999999999999975432211  1111    11111110000 


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                          ..........+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus       248 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          248 ----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                0111233467889999999999999999999999998763

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6e-39  Score=334.82  Aligned_cols=254  Identities=25%  Similarity=0.338  Sum_probs=207.0

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3578999999999999999999975 5899999999654 3345678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999984   3456899999999999999999999998   999999999999999999999999999876433


Q ss_pred             CccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ..........||+.|+|||++.+..+ +.++||||||+++|+|++|+.|+........  .    ...+......     
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~~-----  227 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKTY-----  227 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--H----HHHHHTTCTT-----
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHhhhcccc-----
Confidence            33333344678999999999988765 7899999999999999999999864332211  0    0111111100     


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         ..........+.+++.+||+.||.+|||+.++++
T Consensus       228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               0001123456789999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.3e-39  Score=341.24  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=200.3

Q ss_pred             HhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHHHHHhc---CCcEEeEeceeeeC
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQ---HRNLVKLLGCCMKR  500 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  500 (751)
                      ..++|++.++||+|+||+||+|++ .+++.||||++....     ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457999999999999999999996 468999999986432     122356778888887775   99999999999876


Q ss_pred             C-----ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEE
Q 038934          501 D-----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  575 (751)
Q Consensus       501 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl  575 (751)
                      .     ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     5799999997 59999986432 234899999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHh
Q 038934          576 SDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       576 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      +|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ........
T Consensus       162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~  235 (308)
T 3g33_A          162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLI  235 (308)
T ss_dssp             CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHHH
T ss_pred             eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHh
Confidence            9999998764322   22346789999999999999999999999999999999999999864433221   11111111


Q ss_pred             ccCChhh------hcchhccC-------ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          656 TEDRPVE------LIDKSLED-------TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       656 ~~~~~~~------~~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .......      +....+..       .........+.+|+.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            1000000      00000000       0111234578899999999999999999999863

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=356.46  Aligned_cols=261  Identities=21%  Similarity=0.239  Sum_probs=206.7

Q ss_pred             HHhHHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeee
Q 038934          424 WKSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK  499 (751)
Q Consensus       424 ~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  499 (751)
                      .+++....++|++.++||+|+||.||++++. +++.||||++.+.   .....+.+.+|+.++.+++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            4445556789999999999999999999975 5899999999753   22334568899999999999999999999999


Q ss_pred             CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       500 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                      .+..++||||+++|+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence            99999999999999999999642  236899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCccccccccccccCccCccccc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAI-------DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      +++....... ......+||+.|+|||++.       +..++.++|||||||++|||++|+.||........   .... 
T Consensus       208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i-  282 (412)
T 2vd5_A          208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET---YGKI-  282 (412)
T ss_dssp             TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH-
T ss_pred             hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH---HHHH-
Confidence            9987653322 1223468999999999997       45789999999999999999999999864332111   0000 


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCC---CCHHHHHH
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDR---PNMASVVL  703 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~  703 (751)
                        ....  ....    ........+..+.+|+.+||+ +|.+|   |+++|+++
T Consensus       283 --~~~~--~~~~----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          283 --VHYK--EHLS----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             --HTHH--HHCC----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             --Hhcc--cCcC----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence              0000  0000    000112234578899999999 99998   68999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.6e-39  Score=341.41  Aligned_cols=253  Identities=23%  Similarity=0.300  Sum_probs=205.8

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE  502 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  502 (751)
                      ..++|.+.+.||+|+||.||+++.. +++.||||++.....      ...+++.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3568999999999999999999975 589999999975422      136789999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC----CeEEeec
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDF  578 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DF  578 (751)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999953   446899999999999999999999998   99999999999999888    7999999


Q ss_pred             cCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          579 GMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       579 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      |+++......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+.......   ...    .....
T Consensus       164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~----~i~~~  233 (321)
T 2a2a_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA----NITSV  233 (321)
T ss_dssp             TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH----HHHTT
T ss_pred             ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHH----HHHhc
Confidence            9998764322   1233578999999999999999999999999999999999999975432211   110    01110


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..  .....    ........+.+++.+||+.||++|||+.++++.
T Consensus       234 ~~--~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          234 SY--DFDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CC--CCCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             cc--ccChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00  00000    001223567899999999999999999999873

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.2e-39  Score=351.39  Aligned_cols=267  Identities=18%  Similarity=0.188  Sum_probs=204.0

Q ss_pred             HhcCccccccccccccccEEEEEEcC------CcEEEEEEeccCCcccH-----------HHHHHHHHHHHHhcCCcEEe
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSSGQGV-----------EEFKNEVLLIAKLQHRNLVK  492 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  492 (751)
                      ..++|.+.++||+|+||.||+|.+..      ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999999765      47899999876532111           12334555666678999999


Q ss_pred             EeceeeeC----CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc
Q 038934          493 LLGCCMKR----DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  568 (751)
Q Consensus       493 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~  568 (751)
                      +++++...    ...++||||+ +++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99999875    4589999999 9999999964  2356899999999999999999999998   99999999999999


Q ss_pred             --CCCCeEEeeccCccccCCCCccc-----cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 038934          569 --NEMNPKISDFGMARAFGVDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHV  641 (751)
Q Consensus       569 --~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~  641 (751)
                        .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999998764322211     11235699999999999999999999999999999999999999864322


Q ss_pred             ccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          642 DHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       642 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      +..  ....... ........+++..+..   ......+.+++.+|++.||.+||++.+|++.|+.+
T Consensus       267 ~~~--~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 DPK--YVRDSKI-RYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             CHH--HHHHHHH-HHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CHH--HHHHHHH-HhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            211  1111111 1112233344433321   12245788999999999999999999999998765

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-39  Score=342.72  Aligned_cols=265  Identities=22%  Similarity=0.307  Sum_probs=199.5

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .++|++.++||+|+||.||+|++.. ++.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            3689999999999999999999754 89999999865432  33567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999999884   3345899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH--------HHHhccC
Q 038934          588 QTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA--------WRLWTED  658 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~--------~~~~~~~  658 (751)
                      ..  ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+...............        ...+...
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            22  1233578999999999976 67899999999999999999999998654432221111100        0000000


Q ss_pred             Chhhhcc-hhccCcc-----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          659 RPVELID-KSLEDTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       659 ~~~~~~d-~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ....... +......     .......+.+|+.+||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000000 0000000     0123446889999999999999999999995

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4e-39  Score=353.81  Aligned_cols=265  Identities=21%  Similarity=0.349  Sum_probs=193.9

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCC--c
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRD--E  502 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  502 (751)
                      ...++|.+.++||+|+||.||+|.+. +++.||||++.+.  .....+.+.+|+.++.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34679999999999999999999964 5899999999654  3345567889999999997 999999999997654  6


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||++ ++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999998 589998853    36899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCC-------------------ccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc
Q 038934          583 AFGVDQ-------------------TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVD  642 (751)
Q Consensus       583 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~  642 (751)
                      .+....                   .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            753210                   1112234679999999999987 67999999999999999999999998654322


Q ss_pred             cccchhHHHHHHhccCCh-----------hhhcch----------hccCc------------cCHHHHHHHHHHHhhhcC
Q 038934          643 HHHNLLGHAWRLWTEDRP-----------VELIDK----------SLEDT------------YSLSEALRCIQVGLLCVQ  689 (751)
Q Consensus       643 ~~~~~~~~~~~~~~~~~~-----------~~~~d~----------~l~~~------------~~~~~~~~l~~li~~cl~  689 (751)
                      ...   ............           ...+..          .....            ........+.+|+.+||+
T Consensus       238 ~~~---~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          238 NQL---ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HHH---HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HHH---HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            111   111111110000           000000          00000            001224578899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 038934          690 QRPEDRPNMASVVLM  704 (751)
Q Consensus       690 ~dP~~RPs~~evl~~  704 (751)
                      .||++|||+.|+++.
T Consensus       315 ~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          315 FNPNKRISANDALKH  329 (388)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             cCcccCCCHHHHhCC
Confidence            999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.7e-40  Score=351.15  Aligned_cols=269  Identities=28%  Similarity=0.380  Sum_probs=207.5

Q ss_pred             cCc-cccccccccccccEEEEEEc-----CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--Cc
Q 038934          432 DNF-SEENKLGEGGFGPVYKGMLI-----DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DE  502 (751)
Q Consensus       432 ~~y-~~~~~IG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  502 (751)
                      ++| ++.++||+|+||.||++...     +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.  ..
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            344 88999999999999988642     57899999997653 34467799999999999999999999999884  57


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||+++++|.+++..    ..+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||+++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence            8999999999999999943    34899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCcc-ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          583 AFGVDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       583 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      ........ .......+|+.|+|||++.+..++.++||||||+++|+|++|+.|+........ ................
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHH
Confidence            77543221 122335678889999999999999999999999999999999998653211000 0000000000000111


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..+........+......+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            12222222223334456789999999999999999999999999876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.6e-39  Score=336.37  Aligned_cols=254  Identities=23%  Similarity=0.342  Sum_probs=205.1

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--CceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  506 (751)
                      .++|.+.++||+|+||.||+|++ +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            36789999999999999999998 5889999999754  334456799999999999999999999999887  788999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++... ....+++..+..++.|++.||.|||+++ .+|+||||||+|||+++++.++|.|||++.... 
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            9999999999999642 2235899999999999999999999865 349999999999999999999999998875432 


Q ss_pred             CCccccccccccccCccCcccccCCCCCc---chhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSV---KSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                            .....||+.|+|||++.+..++.   ++||||||+++|||++|+.|+........      ........     
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~-----  227 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEG-----  227 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSC-----
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcC-----
Confidence                  12346899999999998765544   89999999999999999999753322110      11111111     


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                          .....+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          228 ----LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                111222334557889999999999999999999999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.1e-39  Score=335.42  Aligned_cols=252  Identities=22%  Similarity=0.327  Sum_probs=204.2

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ..++|++.++||+|+||.||+|.+. +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            3578999999999999999999975 4889999999654  334457789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC---eEEeeccCccc
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARA  583 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGla~~  583 (751)
                      |||+++++|.+.+..   ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999998854   345899999999999999999999998   999999999999986655   99999999987


Q ss_pred             cCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+.......   ...    ........  
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~----~~~~~~~~--  225 (284)
T 3kk8_A          158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYA----QIKAGAYD--  225 (284)
T ss_dssp             CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTCCC--
T ss_pred             cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHH----HHHhcccc--
Confidence            643222   233678999999999999999999999999999999999999975332211   111    01111000  


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                          ............+.+++.+||+.||++|||+.|+++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          226 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                000001123456889999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-39  Score=344.69  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=206.3

Q ss_pred             cCccccccccccccccEEEEEE-----cCCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC--Cce
Q 038934          432 DNFSEENKLGEGGFGPVYKGML-----IDGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR--DER  503 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  503 (751)
                      ++|+..++||+|+||.||++++     .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            5688999999999999999983     35889999999754 344567899999999999999999999999877  668


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            9999999999999999542  345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhcc---CC
Q 038934          584 FGVDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE---DR  659 (751)
Q Consensus       584 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~---~~  659 (751)
                      ....... .......+|..|+|||++.+..++.++||||||+++|+|++|+.|+.....        ........   ..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~  247 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA--------LFLKMIGPTHGQM  247 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--------HHHHHHCSCCGGG
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh--------HHhhccCCccccc
Confidence            6543321 222345688889999999999999999999999999999999887432110        00000000   00


Q ss_pred             ----hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          660 ----PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       660 ----~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                          ....+........+......+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence                0001111111122334456788999999999999999999999999764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=348.12  Aligned_cols=266  Identities=19%  Similarity=0.230  Sum_probs=200.3

Q ss_pred             hcCccccccccccccccEEEEEEc----CCcEEEEEEeccCCcc-----------cHHHHHHHHHHHHHhcCCcEEeEec
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSSGQ-----------GVEEFKNEVLLIAKLQHRNLVKLLG  495 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  495 (751)
                      .++|.+.+.||+|+||.||+|...    .+..+|||++......           ..+.+.+|+.++..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            368999999999999999999975    5778999998765321           1233667888899999999999999


Q ss_pred             eeee----CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC
Q 038934          496 CCMK----RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  571 (751)
Q Consensus       496 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~  571 (751)
                      ++..    ....++||||+ +++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    77899999999 9999999853   337899999999999999999999998   99999999999999887


Q ss_pred             --CeEEeeccCccccCCCCcc-----ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc
Q 038934          572 --NPKISDFGMARAFGVDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHH  644 (751)
Q Consensus       572 --~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~  644 (751)
                        .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876432211     111345799999999999999999999999999999999999999753222111


Q ss_pred             cchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          645 HNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       645 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                        ................+. ....   .......+.+++.+||+.||++||++.+|++.|+...
T Consensus       269 --~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          269 --AVQTAKTNLLDELPQSVL-KWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             --HHHHHHHHHHHTTTHHHH-HHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             --HHHHHHHhhcccccHHHH-hhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence              111111111111111111 0000   1123457889999999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.8e-39  Score=343.06  Aligned_cols=262  Identities=24%  Similarity=0.368  Sum_probs=198.5

Q ss_pred             HHHhcCccccccccccccccEEEEEEcC----CcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD  501 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  501 (751)
                      ....++|.+.+.||+|+||.||+|....    ++.||||++...  .....+.+.+|+.++++++||||+++++++.+..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            3445789999999999999999998643    458999998754  3344577999999999999999999999998765


Q ss_pred             c-----eEEEEEecCCCChhHHHhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCe
Q 038934          502 E-----RMLIYEYLPNKSLADFIFDG---TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       502 ~-----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      .     .++||||+++++|.+++...   .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence            3     59999999999999998542   23456899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHH
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..|+.......   ....  
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~--  261 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDY--  261 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH--
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHH--
Confidence            9999999987644332222333567889999999999999999999999999999999 888865432211   1110  


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                        .....         ....+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       262 --~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          262 --LLHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             --HHTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              11110         0111223345788999999999999999999999999865

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-39  Score=336.81  Aligned_cols=255  Identities=26%  Similarity=0.418  Sum_probs=206.7

Q ss_pred             cCccccc-cccccccccEEEEEEc---CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEEN-KLGEGGFGPVYKGMLI---DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~-~IG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|.+.+ .||+|+||.||+|...   +++.||||++... .....+++.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566665 8999999999999853   5788999999764 334567899999999999999999999999 56679999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++..  ....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999853  3456899999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCcc-ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          587 DQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       587 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      .... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+.......   ..    .......     
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~i~~~~-----  230 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGK-----  230 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTTC-----
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HH----HHHhcCC-----
Confidence            3222 11223456889999999998899999999999999999998 999975433211   11    1111111     


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                          ....+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       231 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          231 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                1112233456788999999999999999999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.4e-39  Score=364.05  Aligned_cols=248  Identities=22%  Similarity=0.276  Sum_probs=194.9

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|++.++||+|+||.||+++.. +++.||||++.+.   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            468999999999999999999965 5899999999753   334456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999854   3468999999999999999999998 88   9999999999999999999999999998643


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..   ......       
T Consensus       301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~---~i~~~~-------  365 (446)
T 4ejn_A          301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FE---LILMEE-------  365 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHCC-------
T ss_pred             CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HH---HHHhCC-------
Confidence            222  223346899999999999999999999999999999999999999754322111   10   000000       


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                          ..++......+.+|+.+||+.||.+||     ++.|+++
T Consensus       366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                011222345788999999999999999     9999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-39  Score=353.70  Aligned_cols=245  Identities=21%  Similarity=0.266  Sum_probs=191.7

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHH-HHHhcCCcEEeEeceeeeCCceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLL-IAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      .++|++.+.||+|+||.||++++. +++.||||++.+..   ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            468999999999999999999976 48899999997652   2334556777776 466899999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999954   345889999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..   .... ..      
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~-~~------  255 (373)
T 2r5t_A          191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD---NILN-KP------  255 (373)
T ss_dssp             CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHH---HHHH-SC------
T ss_pred             cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHHh-cc------
Confidence            221  22345789999999999999999999999999999999999999975432211   110   0011 00      


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMAS  700 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  700 (751)
                        +  ..+......+.+|+.+||+.||.+||++.+
T Consensus       256 --~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          256 --L--QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             --C--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             --c--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence              0  112223457889999999999999999853

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.2e-39  Score=336.86  Aligned_cols=248  Identities=26%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             HhcCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      +.++|++.+.||+|+||.||+|.+.. ++.||||++...   .....+.+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            35789999999999999999999654 779999998653   22345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++...   ..+++..+..++.||+.||.|||+++   |+|+||||+|||++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            99999999999998543   45899999999999999999999998   9999999999999999999999999986543


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ...    .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+........   .    .....        
T Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~----~~~~~--------  221 (279)
T 3fdn_A          161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---Y----KRISR--------  221 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H----HHHHH--------
T ss_pred             ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---H----HHHHh--------
Confidence            221    2335789999999999999999999999999999999999999763322111   0    00000        


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                        .....+......+.+|+.+||+.||.+||++.|+++.
T Consensus       222 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             --TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             --CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              0111122234567899999999999999999999963

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=350.99  Aligned_cols=268  Identities=21%  Similarity=0.278  Sum_probs=212.5

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC--ceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD--ERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV  506 (751)
                      .++|.+.++||+|+||.||+|++.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            3689999999999999999999764 8999999997542 345677889999999999999999999998765  67999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE----cCCCCeEEeeccCcc
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMAR  582 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla~  582 (751)
                      |||+++++|.+++........+++..++.++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999965444445999999999999999999999998   9999999999999    777889999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc-ccchhHHHHH
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAID--------GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH-HHNLLGHAWR  653 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~-~~~~~~~~~~  653 (751)
                      ......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||....... ......   .
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~---~  238 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY---K  238 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH---H
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH---H
Confidence            764322   2233679999999999875        567899999999999999999999986433221 111111   1


Q ss_pred             HhccCChhhhcc---------------hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          654 LWTEDRPVELID---------------KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       654 ~~~~~~~~~~~d---------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .... .+...+.               ..............+.+++.+||+.||++||++.++++.|+.+
T Consensus       239 ~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          239 IITG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HHHS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HhcC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            1111 1111000               0011123356677889999999999999999999999888765

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.4e-39  Score=336.50  Aligned_cols=252  Identities=27%  Similarity=0.410  Sum_probs=205.0

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeee---------
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK---------  499 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  499 (751)
                      ..++|++.+.||+|+||.||++++. +++.||||++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4568999999999999999999976 68999999997543    457889999999999999999998864         


Q ss_pred             -------CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC
Q 038934          500 -------RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  572 (751)
Q Consensus       500 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~  572 (751)
                             ....++||||+++++|.+++... ....+++..+..++.||+.||.|||+++   |+|+||||+|||+++++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   45589999999999999999643 2346899999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH
Q 038934          573 PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       573 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      +||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..|+..         .....
T Consensus       161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFF  228 (284)
T ss_dssp             EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHH
T ss_pred             EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHH
Confidence            99999999987653322   2235789999999999999999999999999999999999887320         00011


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCCCCC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQ  713 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  713 (751)
                      ......            ..+......+.+++.+||+.||.+||++.++++.|+.+..-+.
T Consensus       229 ~~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          229 TDLRDG------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHTT------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHhhcc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            111111            1112233467899999999999999999999999987654443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.4e-39  Score=345.59  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=201.5

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ..++|.+.+.||+|+||.||++.+. +++.||||++.+...    ...+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4578999999999999999999975 588999999976532    245788889888 7999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC----CCeEEeeccCccc
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA  583 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~~  583 (751)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+.++    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999953   456899999999999999999999998   9999999999998543    3499999999987


Q ss_pred             cCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....+....+...    ...+..   
T Consensus       170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~~---  240 (342)
T 2qr7_A          170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR----IGSGKF---  240 (342)
T ss_dssp             CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH----HHHCCC---
T ss_pred             CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH----HccCCc---
Confidence            643322  22346789999999999988899999999999999999999999864322222111111    111110   


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         .+...........+.+|+.+||+.||++||++.++++
T Consensus       241 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 ---SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ---CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               0111111234567889999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=348.08  Aligned_cols=257  Identities=24%  Similarity=0.284  Sum_probs=191.1

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceee--------eC
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCM--------KR  500 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~  500 (751)
                      ..+|++.++||+|+||.||++++. +++.||||++........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            468999999999999999999965 58999999997776666788999999999996 999999999984        33


Q ss_pred             CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccC
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  580 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl  580 (751)
                      ...++||||+. |+|.+++........+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence            45799999996 699998866445567999999999999999999999875 3499999999999999999999999999


Q ss_pred             ccccCCCCccc----------cccccccccCccCcccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccch
Q 038934          581 ARAFGVDQTEA----------NTNRVVGTYGYMPPEYA---IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL  647 (751)
Q Consensus       581 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~  647 (751)
                      ++.........          ......||+.|+|||++   .+..++.++||||||+++|+|++|+.|+.......    
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----  260 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----  260 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence            98765322211          11135689999999998   56778999999999999999999999975322110    


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                                     ++...............+.+|+.+||+.||.+||++.|+++.|+.+
T Consensus       261 ---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          261 ---------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                           0111111111111223467899999999999999999999999876

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.4e-39  Score=335.20  Aligned_cols=251  Identities=27%  Similarity=0.437  Sum_probs=185.7

Q ss_pred             HHhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      ...++|.+.+.||+|+||.||+|+. .+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence            3457899999999999999999996 468999999996532   234578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+++++|.+++..  ....+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++...
T Consensus        88 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             EEEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            99999999999999964  3356899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+..........               ...
T Consensus       163 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~  225 (278)
T 3cok_A          163 KMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVV  225 (278)
T ss_dssp             C------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CC
T ss_pred             cCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHh
Confidence            432221  223578999999999999999999999999999999999999976443221100               000


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...  ...+......+.+++.+||+.||++||++.++++
T Consensus       226 ~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          226 LAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            000  0112223457789999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-38  Score=343.14  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=207.8

Q ss_pred             HhcCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ..++|.+.+.||+|+||.||++++.. ++.+|+|++...   .....+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            34789999999999999999999754 789999998654   23456778999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999999854   346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ....  ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+........       ........      
T Consensus       193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~------  257 (335)
T 2owb_A          193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLRIKKNE------  257 (335)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTC------
T ss_pred             cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHhcCC------
Confidence            3222  22336789999999999999999999999999999999999999764322111       00011110      


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSG  707 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~  707 (751)
                          ...+......+.+|+.+||+.||++||++.++++  .+..
T Consensus       258 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          258 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                0111223456789999999999999999999996  4544

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.3e-39  Score=334.64  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=202.8

Q ss_pred             hcCccccccccccccccEEEEEEcC----CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      .++|.+.+.||+|+||.||+|++..    +..||+|++... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4689999999999999999998643    336999999765 33456789999999999999999999999865 45789


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999999642  345899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ..... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.|+........   ...    .....     
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~----~~~~~-----  231 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGV----LEKGD-----  231 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHH----HHHTC-----
T ss_pred             ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHH----HhcCC-----
Confidence            32221 1223457889999999999999999999999999999998 9999764332211   110    01010     


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                          ....+......+.+++.+||+.||++||++.++++.|+.+
T Consensus       232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          232 ----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                0111122345688999999999999999999999999764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.8e-38  Score=330.70  Aligned_cols=263  Identities=18%  Similarity=0.244  Sum_probs=202.8

Q ss_pred             HHhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEecee-eeCCceEEE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC-MKRDERMLI  506 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV  506 (751)
                      ...++|.+.+.||+|+||.||+|++ .+++.||||++....  ..+++.+|+.+++.++|++++..+..+ .+.+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3457899999999999999999996 468899999875442  224688999999999987766655554 677788999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE---cCCCCeEEeeccCccc
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARA  583 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~  583 (751)
                      |||+ +++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||+   ++++.+||+|||+++.
T Consensus        84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999 99999998642  345899999999999999999999999   9999999999999   7889999999999987


Q ss_pred             cCCCCccc-----cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          584 FGVDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       584 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      ........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            65432211     2234678999999999999999999999999999999999999987544433322222111111111


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ....     +.    ...+..+.+++.+|++.||++||++.++++.|+.+
T Consensus       238 ~~~~-----~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          238 PIEV-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             CHHH-----HT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hhhh-----hh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            1000     00    11235788999999999999999999999999865

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=344.93  Aligned_cols=244  Identities=22%  Similarity=0.329  Sum_probs=203.1

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc--------ccHHHHHHHHHHHHHhcCCcEEeEeceeee
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKLQHRNLVKLLGCCMK  499 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  499 (751)
                      ...++|.+.+.||+|+||.||+|++. +++.||||++.....        ...+.+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            45678999999999999999999964 588999999976421        134467889999999999999999999999


Q ss_pred             CCceEEEEEecCCC-ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeec
Q 038934          500 RDERMLIYEYLPNK-SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  578 (751)
Q Consensus       500 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF  578 (751)
                      .+..++||||+.++ +|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999777 9999985   3446899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhcc
Q 038934          579 GMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE  657 (751)
Q Consensus       579 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  657 (751)
                      |+++.......   .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....                
T Consensus       175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------  235 (335)
T 3dls_A          175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------  235 (335)
T ss_dssp             TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------------
T ss_pred             ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------------
Confidence            99987643322   233679999999999998877 8899999999999999999999752110                


Q ss_pred             CChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       658 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                           ......  ..+......+.+|+.+||+.||++|||+.++++.
T Consensus       236 -----~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 -----TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000000  0111234568899999999999999999999974

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-39  Score=345.71  Aligned_cols=257  Identities=27%  Similarity=0.423  Sum_probs=200.8

Q ss_pred             cCccccccccccccccEEEEEEcC-----CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|...+.||+|+||.||+|.+..     +..||||++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            577888999999999999998653     235999999754 33345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999964  2346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc-ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          586 VDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       586 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......   .+.    .......    
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~----~~~~~~~----  267 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVM----KAINDGF----  267 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHTTC----
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHH----HHHHCCC----
Confidence            33221 11222346788999999999999999999999999999998 99987532211   111    1111110    


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                           ....+......+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       268 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          268 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 11112233457889999999999999999999999998753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2e-38  Score=355.69  Aligned_cols=262  Identities=22%  Similarity=0.264  Sum_probs=195.8

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD------  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  501 (751)
                      .++|++.++||+|+||+||+|.+. +++.||||++.+.  .....+++.+|+.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999965 5889999999754  3345677899999999999999999999996553      


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ..++||||++++ |.+.+.     ..+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999874 666652     23899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH-----------
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH-----------  650 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~-----------  650 (751)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..           
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            876432   223346899999999999999999999999999999999999999865432211110000           


Q ss_pred             -----HHHHhcc------CChhhhcchhccCc---cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          651 -----AWRLWTE------DRPVELIDKSLEDT---YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       651 -----~~~~~~~------~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                           .......      ......+...+...   ........+.+|+.+||+.||++|||++|+++.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 0000000      00000000000000   011225678999999999999999999999963

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=341.62  Aligned_cols=266  Identities=24%  Similarity=0.327  Sum_probs=200.5

Q ss_pred             HHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHh--cCCcEEeEeceeeeC----C
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL--QHRNLVKLLGCCMKR----D  501 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~  501 (751)
                      ....++|++.++||+|+||.||+|++ .++.||||++...   ....+..|.+++..+  +||||+++++++...    .
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            34457899999999999999999997 4899999998543   234555666666554  899999999999887    6


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCEEEccCCCCCeEEcCCCCe
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD--------SRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      ..++||||+++++|.+++..    ..+++..++.++.|++.||.|||++        +   |+||||||+|||++.++.+
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred             ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence            78999999999999999953    3589999999999999999999998        6   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccc--cccccccccCccCcccccCCCCCcc------hhhHHHHHHHHHHHhCCCCC---------
Q 038934          574 KISDFGMARAFGVDQTEA--NTNRVVGTYGYMPPEYAIDGLFSVK------SDVFSFGVLVLELVYGTRNR---------  636 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~k------~DVwSlG~ll~ell~G~~p~---------  636 (751)
                      ||+|||+++.+.......  ......||+.|+|||++.+...+.+      +|||||||++|||++|..|+         
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999998764332221  1224579999999999988776665      99999999999999995443         


Q ss_pred             -CCCCCccccchhHHHHHHhccCChhhhcchhccCc-cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          637 -GFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT-YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       637 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                       .........  .............    .+.+... ........+.+|+.+||+.||.+|||+.+|++.|+.+.+
T Consensus       262 ~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          262 YHDLVPSDPS--YEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             TTTTSCSSCC--HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhhhcCCCCc--hhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence             222111110  0001111110000    0000000 112566789999999999999999999999999987643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.2e-39  Score=335.49  Aligned_cols=248  Identities=25%  Similarity=0.341  Sum_probs=200.5

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  504 (751)
                      ...++|++.+.||+|+||.||+|++. +++.||||++...  ......++.+|+.++..+ +||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            34578999999999999999999976 6899999999764  233456788999999999 8999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-------------
Q 038934          505 LIYEYLPNKSLADFIFDGTR-RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-------------  570 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-------------  570 (751)
                      +||||+++++|.+++..... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999999965321 256899999999999999999999998   9999999999999844             


Q ss_pred             ------CCeEEeeccCccccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc
Q 038934          571 ------MNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH  643 (751)
Q Consensus       571 ------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~  643 (751)
                            ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|..++....   
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---  235 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---  235 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred             cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence                  479999999998764322      24589999999999876 66789999999999999999987643111   


Q ss_pred             ccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          644 HHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       644 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                             .+........         ...+......+.+++.+||+.||++|||+.++++.
T Consensus       236 -------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          236 -------QWHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -------HHHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -------HHHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence                   0111111111         11122234578899999999999999999999863

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4e-39  Score=368.01  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=209.3

Q ss_pred             HhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ..++|.+.++||+|+||.||+|.+..+..||||++.... ...++|.+|+++|++++|+||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            346788999999999999999999888899999997543 346789999999999999999999999876 778999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.......
T Consensus       343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            9999999999532 1235899999999999999999999998   99999999999999999999999999987643211


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      . ......++..|+|||++.+..++.++|||||||+||||++ |+.|+......   .+.    .....+.         
T Consensus       419 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~----~~i~~~~---------  481 (535)
T 2h8h_A          419 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERGY---------  481 (535)
T ss_dssp             H-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHH----HHHHTTC---------
T ss_pred             e-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCC---------
Confidence            1 1122456788999999999999999999999999999999 88887532211   111    1111110         


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                      ....+......+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus       482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            111122345578899999999999999999999999998743

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.4e-38  Score=342.67  Aligned_cols=268  Identities=22%  Similarity=0.342  Sum_probs=201.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-------  500 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  500 (751)
                      .++|++.++||+|+||.||+|+.. +++.||||++....  ......+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999974 68999999986542  23356788999999999999999999999874       


Q ss_pred             -CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          501 -DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       501 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                       +..++||||+++ +|.+.+..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             468999999986 77777643  3345899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCc--cccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhc
Q 038934          580 MARAFGVDQT--EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       580 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                      +++.+.....  ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.|+...........+........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9987643222  122234678999999999876 4589999999999999999999999875433222111111100000


Q ss_pred             cCChhhh-----cch---hccCccCHH-------HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          657 EDRPVEL-----IDK---SLEDTYSLS-------EALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       657 ~~~~~~~-----~d~---~l~~~~~~~-------~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .......     .+.   .........       ....+.+|+.+||+.||++|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            0000000     000   000000011       13457899999999999999999999964

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-39  Score=337.10  Aligned_cols=256  Identities=28%  Similarity=0.353  Sum_probs=203.0

Q ss_pred             CccccccccccccccEEEEEEcC-C---cEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce-EEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLID-G---QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER-MLI  506 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV  506 (751)
                      .|...++||+|+||.||+|.+.+ +   ..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            56667899999999999998543 2   37999999754 334567899999999999999999999999877665 999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+.+++|.+++..  ....+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999964  3456899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CC--ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          587 DQ--TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       587 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ..  .........+++.|+|||.+.+..++.++||||||+++|+|++|..|+......  ......    .....     
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~----~~~~~-----  245 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHF----LAQGR-----  245 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHH----HHTTC-----
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHH----hhcCC-----
Confidence            22  112223456789999999999999999999999999999999976664321111  111110    11110     


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                          ....+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       246 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                1111222345788999999999999999999999998875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.1e-39  Score=341.03  Aligned_cols=262  Identities=23%  Similarity=0.346  Sum_probs=199.8

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46899999999999999999996 46899999999753   234566789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          507 YEYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |||+++++|.+++... .....+++..++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998642 23456899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ....  ......|++.|+|||++.+..++.++||||||+++|+|++|+.|+.......    .... .........    
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~-~~~~~~~~~----  256 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLC-KKIEQCDYP----  256 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHH-HHHHTTCSC----
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHH-HHhhcccCC----
Confidence            3222  1223578999999999999999999999999999999999999975322111    1111 111111110    


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                          ..........+.+++.+||+.||.+||++.+|++.|+.+.+
T Consensus       257 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          257 ----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             ----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence                00112234578899999999999999999999999988743

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=344.98  Aligned_cols=266  Identities=22%  Similarity=0.341  Sum_probs=197.6

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcc-cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|.+.++||+|+||.||+|+.. +++.||||++...... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999975 6899999999654322 222456799999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++ +|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             ccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            985 888888643  346899999999999999999999998   99999999999999999999999999986543222


Q ss_pred             cccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC---hhhhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR---PVELID  665 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d  665 (751)
                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........   ..........   ......
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGG
T ss_pred             --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHhchhhhc
Confidence              2233578999999999886 568999999999999999999999987544322111   1111111110   000000


Q ss_pred             h---------hccC----ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCC
Q 038934          666 K---------SLED----TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGE  708 (751)
Q Consensus       666 ~---------~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  708 (751)
                      .         ....    .........+.+|+.+||+.||.+|||++|+++  .+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence            0         0000    001123456789999999999999999999996  44443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.9e-39  Score=342.21  Aligned_cols=259  Identities=29%  Similarity=0.435  Sum_probs=204.3

Q ss_pred             hcCccccccccccccccEEEEEE------cCCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML------IDGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|.+.+.||+|+||.||+|++      .+++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999984      24678999999654 344566799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---CCCeEEe
Q 038934          504 MLIYEYLPNKSLADFIFDGTR----RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKIS  576 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~  576 (751)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975432    245899999999999999999999998   999999999999984   4569999


Q ss_pred             eccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHh
Q 038934          577 DFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLW  655 (751)
Q Consensus       577 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~  655 (751)
                      |||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+......   ...    ...
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~----~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL----EFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHH----HHH
Confidence            9999986543333223334567899999999999999999999999999999998 88887533211   111    111


Q ss_pred             ccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          656 TEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       656 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ....         ....+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       259 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          259 TSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1111         0111223345788999999999999999999999998865

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.9e-39  Score=339.41  Aligned_cols=255  Identities=26%  Similarity=0.374  Sum_probs=203.4

Q ss_pred             hcCccccc-cccccccccEEEEEEc---CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          431 TDNFSEEN-KLGEGGFGPVYKGMLI---DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       431 ~~~y~~~~-~IG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      .++|.+.+ .||+|+||.||+|...   .++.||||++....  ....+++.+|+.++++++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            46788877 9999999999999642   36889999997542  23367899999999999999999999999 667889


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+|+||||+|||++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999964   345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccc-cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          585 GVDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       585 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.|+.......   .    ........   
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~~---  237 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V----TAMLEKGE---  237 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTTC---
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHHcCC---
Confidence            5433221 1122446788999999999899999999999999999999 999976432211   1    11111111   


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                            ....+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       238 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          238 ------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  1112233456788999999999999999999999999764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.9e-39  Score=337.32  Aligned_cols=258  Identities=26%  Similarity=0.356  Sum_probs=201.5

Q ss_pred             HhcCccccccccccccccEEEEEEcC----CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceee-eCCce
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM-KRDER  503 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~  503 (751)
                      ...+|.+.++||+|+||.||+|++.+    ...+|+|.+... .....+.+.+|+.++++++||||+++++++. .+...
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            34678889999999999999999643    235899998754 3345678999999999999999999999864 45678


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++..  ....+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+++.
T Consensus       103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence            999999999999999964  3456899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc--ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCC-CCCCCCCccccchhHHHHHHhccCCh
Q 038934          584 FGVDQTE--ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTR-NRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       584 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~-p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      .......  .......+|+.|+|||.+.+..++.++||||||+++|+|++|.. |+........   ...    ..... 
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~----~~~~~-  249 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY----LLQGR-  249 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHH----HHTTC-
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHH----HhcCC-
Confidence            6432211  11223567889999999999999999999999999999999554 4332221111   110    00110 


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                              ....+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                    0111122245688999999999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4e-38  Score=342.71  Aligned_cols=259  Identities=20%  Similarity=0.355  Sum_probs=206.7

Q ss_pred             cHHhHHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc--------ccHHHHHHHHHHHHHh-cCCcEEe
Q 038934          423 DWKSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKL-QHRNLVK  492 (751)
Q Consensus       423 ~~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~  492 (751)
                      .+.......++|.+.+.||+|+||.||+|++. +|+.||||++.....        ...+.+.+|+.+++++ +||||++
T Consensus        85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  164 (365)
T 2y7j_A           85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT  164 (365)
T ss_dssp             HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            34445666788999999999999999999975 699999999875431        1245688999999999 7999999


Q ss_pred             EeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC
Q 038934          493 LLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  572 (751)
Q Consensus       493 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~  572 (751)
                      +++++......++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+|+||||+|||+++++.
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            99999999999999999999999999954   345899999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCccccCCCCccccccccccccCccCcccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccc
Q 038934          573 PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID------GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN  646 (751)
Q Consensus       573 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~  646 (751)
                      +||+|||++..+....   ......||+.|+|||++.+      ..++.++|||||||++|+|++|+.||......   .
T Consensus       239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~  312 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---L  312 (365)
T ss_dssp             EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H
T ss_pred             EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---H
Confidence            9999999998764322   2234679999999999863      36889999999999999999999997532211   1


Q ss_pred             hhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          647 LLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...    ........ ...+..     ......+.+++.+||+.||++||++.++++
T Consensus       313 ~~~----~i~~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          313 MLR----MIMEGQYQ-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHH----HHHHTCCC-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHH----HHHhCCCC-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            110    01111000 000000     012346889999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=347.90  Aligned_cols=265  Identities=28%  Similarity=0.419  Sum_probs=208.7

Q ss_pred             hcCccccccccccccccEEEEEE-----cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC--ce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-----IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD--ER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  503 (751)
                      .++|++.+.||+|+||.||+++.     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            36788999999999999999984     358899999998776667788999999999999999999999987654  78


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999643  345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCccc-cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC---
Q 038934          584 FGVDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR---  659 (751)
Q Consensus       584 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~---  659 (751)
                      ........ ......++..|+|||++.+..++.++||||||+++|+|++|..|+.....        ..........   
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--------~~~~~~~~~~~~~  266 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------EFMRMIGNDKQGQ  266 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--------HHHHHHCTTCCTH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--------HHHHhhccccchh
Confidence            65432211 12234567789999999999999999999999999999999888542110        0000000000   


Q ss_pred             -----hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          660 -----PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       660 -----~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                           ..+.+........+......+.+++.+||+.||++||++.++++.|+.+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                 0011111111112233456788999999999999999999999999865

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-37  Score=328.77  Aligned_cols=261  Identities=18%  Similarity=0.250  Sum_probs=205.7

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEecee-eeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCC-MKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~E  508 (751)
                      .++|++.+.||+|+||.||+|++ .+++.||||++.....  .+++.+|+.+++.++|++++..+.++ .+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            57899999999999999999996 5689999999865432  35689999999999987766555544 66778899999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE---cCCCCeEEeeccCccccC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG  585 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~  585 (751)
                      |+ +++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||+   ++++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999999532  346899999999999999999999998   9999999999999   488899999999998765


Q ss_pred             CCCccc-----cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          586 VDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       586 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      ......     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........................
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            433211     123467999999999999999999999999999999999999998754433322222211111111100


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..     +    ....+..+.+++.+||+.||.+||++.++++.|+.+
T Consensus       240 ~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          240 EV-----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HH-----H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             HH-----H----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            00     0    111235688999999999999999999999999875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.4e-38  Score=359.60  Aligned_cols=254  Identities=26%  Similarity=0.349  Sum_probs=208.3

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ..++|...+.||+|+||.||++++. +++.||||++.+.   .....+.+.+|+.+|++++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3578999999999999999999975 5899999999653   23445678999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++|+|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            999999999999986432 335899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.   ......       
T Consensus       338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~---~~i~~~-------  404 (576)
T 2acx_A          338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKEV-------  404 (576)
T ss_dssp             TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH---HHHHHC-------
T ss_pred             cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH---HHhhcc-------
Confidence            3221   233589999999999999999999999999999999999999986543321111111   101000       


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                         ...++......+.+|+.+||+.||.+||     ++.||++
T Consensus       405 ---~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 ---PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ---cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence               1112233456788999999999999999     7888874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-38  Score=334.41  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=199.2

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ..++|.+.++||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            3468999999999999999999965 58899999997653 345688999999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE---cCCCCeEEeeccCccc
Q 038934          508 EYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARA  583 (751)
Q Consensus       508 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~  583 (751)
                      ||+++++|.+++... .....+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999998543 23356899999999999999999999998   9999999999999   4567899999999987


Q ss_pred             cCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ......   .....||+.|+|||++. ..++.++||||||+++|+|++|+.||........   ...  .........  
T Consensus       177 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~---~~~--~~~~~~~~~--  245 (285)
T 3is5_A          177 FKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV---QQK--ATYKEPNYA--  245 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH--HHHCCCCCC--
T ss_pred             cCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH---Hhh--hccCCcccc--
Confidence            643222   23467899999999876 5689999999999999999999999764322111   000  000000000  


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                             .........+.+++.+||+.||++|||+.|+++
T Consensus       246 -------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 -------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   000112356789999999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.5e-38  Score=337.11  Aligned_cols=259  Identities=23%  Similarity=0.330  Sum_probs=206.7

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ..++|.+.+.||+|+||.||+++.. +++.||||++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3568999999999999999999975 689999999986655556778999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE---cCCCCeEEeeccCccccC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG  585 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~  585 (751)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+++   |+|+||||+||++   ++++.+||+|||+++...
T Consensus        87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999999854   345899999999999999999999998   9999999999999   788999999999997643


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..    ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+......   .+..    .......     
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----~i~~~~~-----  224 (304)
T 2jam_A          161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFE----KIKEGYY-----  224 (304)
T ss_dssp             CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH----HHHHCCC-----
T ss_pred             CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCC-----
Confidence            21    223357899999999999999999999999999999999999997543221   1111    1111100     


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCCCCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGERSL  711 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~  711 (751)
                       .............+.+++.+||+.||.+||++.++++  .+.+...+
T Consensus       225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (304)
T 2jam_A          225 -EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL  271 (304)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred             -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence             0001111223457889999999999999999999996  56554443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.2e-39  Score=343.93  Aligned_cols=265  Identities=24%  Similarity=0.362  Sum_probs=200.4

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccCCc--ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .++|++.+.||+|+||.||+++... ++.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3689999999999999999999754 89999999865432  33456889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999998874   3345899999999999999999999998   999999999999999999999999999875432


Q ss_pred             CccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH--------HHHHhccC
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH--------AWRLWTED  658 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~--------~~~~~~~~  658 (751)
                      ..  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..............        ....+...
T Consensus       178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            22  22335789999999999875 789999999999999999999999865433211100000        00000000


Q ss_pred             Ch-hhhcchhccCcc-----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          659 RP-VELIDKSLEDTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       659 ~~-~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .. .....+.+....     .......+.+|+.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00 000000011111     1123567889999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.4e-39  Score=344.64  Aligned_cols=263  Identities=24%  Similarity=0.326  Sum_probs=194.2

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ...++|.+.++||+|+||.||+++.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            44578999999999999999999965 58899999997543  2234567899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc-----CCCCeEEeeccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-----NEMNPKISDFGM  580 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~-----~~~~~kl~DFGl  580 (751)
                      ||||+++ +|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++     +++.+||+|||+
T Consensus       111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999985 99999854   345899999999999999999999998   99999999999994     455699999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      ++.+.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........   ............
T Consensus       184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~  258 (329)
T 3gbz_A          184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---LFKIFEVLGLPD  258 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCC
T ss_pred             ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---HHHHHHHhCCCc
Confidence            987643222  12335789999999999875 489999999999999999999999864432211   111111100000


Q ss_pred             ---hhh-------------hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          660 ---PVE-------------LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       660 ---~~~-------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         ...             .....+...........+.+|+.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence               000             00000000011113457789999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-38  Score=335.13  Aligned_cols=249  Identities=27%  Similarity=0.425  Sum_probs=205.9

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .+.|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            357899999999999999999964 58899999997543 4456889999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++.    ...+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999984    346899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             ccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+.......   ...   . .....         
T Consensus       174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~~---------  235 (303)
T 3a7i_A          174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLF---L-IPKNN---------  235 (303)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---H-HHHSC---------
T ss_pred             c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHH---H-hhcCC---------
Confidence            2  2234678999999999999999999999999999999999999975322111   000   0 00010         


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ...........+.+++.+||+.||.+|||+.++++.
T Consensus       236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            011112234568899999999999999999999863

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.6e-38  Score=344.56  Aligned_cols=253  Identities=20%  Similarity=0.219  Sum_probs=192.2

Q ss_pred             hcCcccc-ccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeee----CCce
Q 038934          431 TDNFSEE-NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMK----RDER  503 (751)
Q Consensus       431 ~~~y~~~-~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  503 (751)
                      .++|.+. ++||+|+||+||++.+. +++.||||++...     ..+.+|+.++.++ +||||+++++++..    ...+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3567665 68999999999999975 5889999999632     5678899988554 89999999999876    5678


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---CCCeEEeeccC
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGM  580 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGl  580 (751)
                      ++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            9999999999999999642 2345899999999999999999999998   999999999999997   78899999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............   ...+..
T Consensus       211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~~~~~  284 (400)
T 1nxk_A          211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IRMGQY  284 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HHHTCC
T ss_pred             ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HHcCcc
Confidence            98754221   223467899999999999999999999999999999999999998654332211100000   000000


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                            .+...........+.+|+.+||+.||.+|||+.++++.
T Consensus       285 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  00000011234578899999999999999999999973

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5e-38  Score=356.22  Aligned_cols=254  Identities=27%  Similarity=0.358  Sum_probs=207.2

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|...+.||+|+||.||++++. +++.||||++.+.   .....+.+.+|+.++++++||||+++++++.....+++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            478999999999999999999975 5899999999654   224457789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          507 YEYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      |||+++++|.+++.... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999986533 2456999999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+  ...... .       
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~--~~~i~~-~-------  408 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRVLE-Q-------  408 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH--HHHHHH-C-------
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH--HHHHhh-c-------
Confidence            3322  223368999999999999999999999999999999999999998654322111100  000000 0       


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNM-----ASVV  702 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl  702 (751)
                         ...++......+.+|+.+||+.||.+||++     .+++
T Consensus       409 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~  447 (543)
T 3c4z_A          409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR  447 (543)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred             ---ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence               011223345678899999999999999975     5665

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=345.46  Aligned_cols=252  Identities=16%  Similarity=0.154  Sum_probs=204.6

Q ss_pred             HhcCccccccccccccccEEEEE------EcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc---CCcEEeEeceeeeC
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGM------LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVKLLGCCMKR  500 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  500 (751)
                      ..++|.+.++||+|+||.||+|.      ...++.||||++...   ...++..|++++..++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45789999999999999999994      445889999999654   3457888888888886   99999999999999


Q ss_pred             CceEEEEEecCCCChhHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---------
Q 038934          501 DERMLIYEYLPNKSLADFIFDG--TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---------  569 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---------  569 (751)
                      +..++||||+++++|.+++...  .....+++..+..++.||+.||+|||+++   |+||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            9999999999999999999642  23456999999999999999999999998   999999999999998         


Q ss_pred             --CCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccch
Q 038934          570 --EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL  647 (751)
Q Consensus       570 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~  647 (751)
                        ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence              899999999999865433333334456899999999999999999999999999999999999999642221100   


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCC-CCHHHHHHHHhCC
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDR-PNMASVVLMLSGE  708 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~  708 (751)
                                     .+...+...   .....+.+++..||+.+|.+| |++.++.+.|+..
T Consensus       294 ---------------~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          294 ---------------KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             ---------------EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ---------------eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                           011111111   124466789999999999998 6788888777654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-38  Score=344.66  Aligned_cols=247  Identities=28%  Similarity=0.432  Sum_probs=199.8

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .+.|...+.||+|+||.||+|+. .+++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35688899999999999999996 468999999997542   23346789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+. |+|.+++..  ....+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 578887753  2346899999999999999999999998   99999999999999999999999999986532


Q ss_pred             CCccccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      .      ....||+.|+|||++.   +..++.++|||||||++|||++|+.|+......      ............ . 
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~~~-~-  272 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP-A-  272 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCC-C-
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCCC-C-
Confidence            1      2357899999999984   567899999999999999999999997532211      111111111111 0 


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                             .........+.+++.+||+.||++|||+.++++.
T Consensus       273 -------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          273 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                   0111224567899999999999999999999863

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.7e-38  Score=332.29  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=205.9

Q ss_pred             HhcCccccccccccccccEEEEEEcC-CcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ..++|.+.+.||+|+||.||++.... ++.+|+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            34689999999999999999999764 789999998654   23456678999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++..   ...+++..+..++.|++.||.|||+++   |+|+||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999999999998853   346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      .....  .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+........       ........      
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~------  231 (294)
T 2rku_A          167 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLRIKKNE------  231 (294)
T ss_dssp             STTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTC------
T ss_pred             cCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhhcc------
Confidence            32222  2336789999999999999999999999999999999999999764332111       00111110      


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                          ...+......+.+++.+||+.||++||++.++++
T Consensus       232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          232 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                0111223456789999999999999999999996

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.5e-38  Score=350.70  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=192.6

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--------cccHHHHHHHHHHHHHhcCCcEEeEeceeee
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK  499 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  499 (751)
                      ...++|.+.++||+|+||.||+|... +++.||||++.+..        ......+.+|+.++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            45689999999999999999999965 47899999996531        122335889999999999999999999975 


Q ss_pred             CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC---CeEEe
Q 038934          500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKIS  576 (751)
Q Consensus       500 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~  576 (751)
                      .+..++||||+++++|.+++.   ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++   .+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            456899999999999999884   4456899999999999999999999998   99999999999997544   59999


Q ss_pred             eccCccccCCCCccccccccccccCccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHH
Q 038934          577 DFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWR  653 (751)
Q Consensus       577 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~  653 (751)
                      |||+++.....   .......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||........  +...   
T Consensus       285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~---  356 (419)
T 3i6u_A          285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ---  356 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH---
T ss_pred             ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH---
Confidence            99999876432   22234679999999999864   5788999999999999999999999864322211  1110   


Q ss_pred             HhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          654 LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       654 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                       ....... ....     ........+.+|+.+||+.||++||++.|+++.
T Consensus       357 -i~~~~~~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          357 -ITSGKYN-FIPE-----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             -HHTTCCC-CCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -HhcCCCC-CCch-----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             1111000 0000     001124578899999999999999999999863

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.6e-38  Score=328.87  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=201.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|.+.+.||+|+||.||+++.. +++.||+|++.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            367999999999999999999976 589999999875421      2467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC----CeEEeecc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFG  579 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DFG  579 (751)
                      ++||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+|+||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999954   345899999999999999999999998   99999999999998877    79999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      ++........   .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+.......   ..    .......
T Consensus       158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~  227 (283)
T 3bhy_A          158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TL----TNISAVN  227 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HHHHTTC
T ss_pred             cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HH----HHhHhcc
Confidence            9987643221   233568999999999999999999999999999999999999976432211   00    0011100


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ..  ...    .........+.+++.+||+.||.+||++.++++
T Consensus       228 ~~--~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          228 YD--FDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CC--CCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cC--Ccc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00  000    000122356789999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-38  Score=345.48  Aligned_cols=255  Identities=25%  Similarity=0.337  Sum_probs=203.9

Q ss_pred             hcCccccccccccccccEEEEEE----cCCcEEEEEEeccCC----cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCC
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML----IDGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRD  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  501 (751)
                      .++|.+.++||+|+||.||+++.    .+++.||||++.+..    ....+.+.+|++++.++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36899999999999999999997    368999999996532    23456778899999999 6999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999954   345899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      +.+...... ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+  .......  
T Consensus       207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~--  281 (355)
T 1vzo_A          207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKS--  281 (355)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHC--
T ss_pred             eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhcc--
Confidence            876432222 2234679999999999986  35789999999999999999999998654332221111  1110100  


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHHH
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVLML  705 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  705 (751)
                               ....+......+.+|+.+||+.||.+||     ++.++++..
T Consensus       282 ---------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 ---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                     1112223345678999999999999999     999998643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.6e-38  Score=338.91  Aligned_cols=256  Identities=28%  Similarity=0.449  Sum_probs=203.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcE--EEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQE--IAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|.+.+.||+|+||.||+|++. +++.  +|||++... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57899999999999999999965 4554  499998753 334556789999999999 899999999999999999999


Q ss_pred             EEecCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCe
Q 038934          507 YEYLPNKSLADFIFDGT-------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996532             2346899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHH
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ||+|||+++.....   .......+++.|+|||++.+..++.++||||||+++|+|++ |+.|+.......       ..
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~  251 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY  251 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HH
Confidence            99999999753221   11222456889999999999999999999999999999998 999975332211       11


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      ......         .....+......+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus       252 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          252 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            111111         111122233467889999999999999999999999988753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.5e-38  Score=332.40  Aligned_cols=252  Identities=24%  Similarity=0.357  Sum_probs=200.6

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      +|.....||+|+||.||+|... +++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4555568999999999999964 588999999987766667889999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-CCCeEEeeccCccccCCCCcc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~~~  590 (751)
                      +++|.+++........+++..+..++.|++.||.|||+++   |+|+||||+||+++. ++.+||+|||+++....... 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            9999999976544456789999999999999999999998   999999999999987 89999999999987643221 


Q ss_pred             ccccccccccCccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~--~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                       ......|++.|+|||++.+..  ++.++||||||+++|+|++|+.|+........  .   ......         ...
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~---~~~~~~---------~~~  243 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--A---MFKVGM---------FKV  243 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--H---HHHHHH---------HCC
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--H---HHhhcc---------ccc
Confidence             123457899999999997654  89999999999999999999999753211100  0   000000         001


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ....+......+.+++.+||+.||++||++.++++
T Consensus       244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11122334567889999999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.6e-38  Score=354.00  Aligned_cols=196  Identities=23%  Similarity=0.402  Sum_probs=156.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-----Cc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-----DE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  502 (751)
                      .++|.+.++||+|+||+||+|++. +++.||||++.+.  .....+++.+|+.+|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999965 5899999999654  333457789999999999999999999998543     56


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||+. ++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            899999985 68999884   3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcc-------------------------ccccccccccCccCcccc-cCCCCCcchhhHHHHHHHHHHHhCC
Q 038934          583 AFGVDQTE-------------------------ANTNRVVGTYGYMPPEYA-IDGLFSVKSDVFSFGVLVLELVYGT  633 (751)
Q Consensus       583 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~k~DVwSlG~ll~ell~G~  633 (751)
                      ........                         ......+||+.|+|||++ .+..++.++|||||||+||||++|.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            76432111                         122346789999999976 5667999999999999999999943

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.3e-38  Score=338.16  Aligned_cols=260  Identities=23%  Similarity=0.305  Sum_probs=205.0

Q ss_pred             HhHHHHhcCcccc-ccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhc-CCcEEeEeceeee
Q 038934          425 KSIANATDNFSEE-NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMK  499 (751)
Q Consensus       425 ~~i~~~~~~y~~~-~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  499 (751)
                      .......++|.+. +.||+|+||.||+|+.. +++.||||++...  .....+++.+|+.++.++. ||||+++++++.+
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3445666788887 88999999999999975 5899999999754  3344678999999999994 6999999999999


Q ss_pred             CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---CCCeEEe
Q 038934          500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKIS  576 (751)
Q Consensus       500 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~  576 (751)
                      ....++||||+++++|.+++... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.   ++.+||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence            99999999999999999998432 2356899999999999999999999998   999999999999997   7899999


Q ss_pred             eccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhc
Q 038934          577 DFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       577 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                      |||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+........   ..... ...
T Consensus       177 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~-~~~  249 (327)
T 3lm5_A          177 DFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YLNIS-QVN  249 (327)
T ss_dssp             CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH-HTC
T ss_pred             eCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHH-hcc
Confidence            9999987643221   2336799999999999999999999999999999999999999754332111   00000 000


Q ss_pred             cCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          657 EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       657 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..         ............+.+++.+||+.||.+|||+.++++.
T Consensus       250 ~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          250 VD---------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             CC---------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             cc---------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            00         0111112234568899999999999999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-38  Score=344.70  Aligned_cols=262  Identities=20%  Similarity=0.327  Sum_probs=198.6

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD------  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  501 (751)
                      .++|...+.||+|+||.||+|.+. +++.||||++...  .....+++.+|+.++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999974 5899999999654  2334567899999999999999999999998764      


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899999853    45899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      +.....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........   +....... ....
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~-g~~~  246 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVT-GTPP  246 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHH-CCCC
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhc-CCCC
Confidence            875422     233578999999999987 6899999999999999999999999864432211   11110000 0000


Q ss_pred             hhhcch-----------hc-------cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCCC
Q 038934          661 VELIDK-----------SL-------EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGER  709 (751)
Q Consensus       661 ~~~~d~-----------~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  709 (751)
                      .+.+..           .+       ...........+.+|+.+||+.||.+|||+.++++  .++...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            000000           00       00111223467889999999999999999999997  455543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=342.48  Aligned_cols=265  Identities=25%  Similarity=0.372  Sum_probs=195.3

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHH--HHHhcCCcEEeEeceeee-----CCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLL--IAKLQHRNLVKLLGCCMK-----RDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~  503 (751)
                      .++|.+.+.||+|+||.||+|+. +++.||||++...   ....+..|.++  +..++|+||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46899999999999999999987 7899999999643   23444445544  445799999999975532     3357


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCEEEccCCCCCeEEcCCCCeE
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD---------SRLRIIHRDLKASNVLLDNEMNPK  574 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~---------~~~~ivH~Dikp~NIll~~~~~~k  574 (751)
                      ++||||+++++|.+++..    ...++..+..++.||++||.|||+.         +   |+||||||+|||++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            899999999999999953    2358899999999999999999998         7   99999999999999999999


Q ss_pred             EeeccCccccCCCCc------cccccccccccCccCcccccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 038934          575 ISDFGMARAFGVDQT------EANTNRVVGTYGYMPPEYAID-------GLFSVKSDVFSFGVLVLELVYGTRNRGFHHV  641 (751)
Q Consensus       575 l~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~  641 (751)
                      |+|||+++.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987643211      111224579999999999987       4677899999999999999999777543322


Q ss_pred             ccc-cchhHH----------HHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          642 DHH-HNLLGH----------AWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       642 ~~~-~~~~~~----------~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ... ......          .............+....  .........+.+|+.+||+.||++|||+.|+++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            111 111100          000000000000000000  11233566799999999999999999999999998875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.1e-38  Score=331.17  Aligned_cols=246  Identities=23%  Similarity=0.321  Sum_probs=204.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            368999999999999999999975 4788999998653   223456789999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999999543   35899999999999999999999998   99999999999999999999999999876542


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ..    .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+........       ........       
T Consensus       167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~-------  228 (284)
T 2vgo_A          167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-------HRRIVNVD-------  228 (284)
T ss_dssp             SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTC-------
T ss_pred             cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-------HHHHhccc-------
Confidence            21    2335789999999999999999999999999999999999999764322111       00011100       


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                         ...+......+.+++.+||+.||.+||++.++++
T Consensus       229 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          229 ---LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence               1112223457789999999999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.5e-39  Score=347.93  Aligned_cols=263  Identities=22%  Similarity=0.316  Sum_probs=205.2

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|.+.++||+|+||.||++.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            368999999999999999999975 5899999999765 33445779999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999954   34589999999999999999999986 7   999999999999999999999999999765321


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH-----------------
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH-----------------  650 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~-----------------  650 (751)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............                 
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence                22336789999999999999999999999999999999999999865332211000000                 


Q ss_pred             ------HHHHhccCChhhhcchhccCc----cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          651 ------AWRLWTEDRPVELIDKSLEDT----YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       651 ------~~~~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                            ...........+.++......    ........+.+|+.+||+.||++|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                  000000011111122111111    11123457889999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.7e-38  Score=350.06  Aligned_cols=200  Identities=23%  Similarity=0.395  Sum_probs=168.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-----Cc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-----DE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  502 (751)
                      .++|.+.+.||+|+||.||+|++. +++.||||++...  .....+++.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            478999999999999999999965 4789999999754  333456889999999999999999999999876     57


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||++ ++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999987 59999984   3456899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCcc--------------------ccccccccccCccCcccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 038934          583 AFGVDQTE--------------------ANTNRVVGTYGYMPPEYA-IDGLFSVKSDVFSFGVLVLELVYGTRNRG  637 (751)
Q Consensus       583 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~k~DVwSlG~ll~ell~G~~p~~  637 (751)
                      ........                    .......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            76432211                    122456899999999986 56679999999999999999998765543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.8e-38  Score=369.64  Aligned_cols=249  Identities=27%  Similarity=0.320  Sum_probs=205.5

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  504 (751)
                      ..++|.+.++||+|+||.||++++. +++.||||++.+.   .....+.+..|..++..+ +||+|+++++++.+.+.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3578999999999999999999965 4889999999753   234567788999999987 7999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      |||||+++++|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999999543   45899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ....  .......||+.|+|||++.+..++.++|||||||+||||++|+.||.......   +.    .......     
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~----~~i~~~~-----  558 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LF----QSIMEHN-----  558 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHSSC-----
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HH----HHHHhCC-----
Confidence            3222  22345789999999999999999999999999999999999999986432211   11    1111110     


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNM-----ASVVL  703 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  703 (751)
                           ..++......+.+|+.+||+.||++||++     .||++
T Consensus       559 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                 11223345678899999999999999997     77763

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-38  Score=336.43  Aligned_cols=262  Identities=18%  Similarity=0.212  Sum_probs=200.1

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ..++|.+.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999975 58899999997542   2335778999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++..   ...+++..+..++.|++.||.|||+++   |+|+||||+|||++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999999954   245899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ..... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......       ............    
T Consensus       186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~----  253 (309)
T 2h34_A          186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR----  253 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC----
T ss_pred             ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC----
Confidence            32221 122357899999999999999999999999999999999999997643221       011111111000    


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHhCCCCCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRP-NMASVVLMLSGERSLP  712 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~  712 (751)
                         ........+..+.+++.+||+.||++|| ++.++++.|+......
T Consensus       254 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 ---PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ---GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ---ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence               0011122344688999999999999999 9999999998764443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.3e-38  Score=339.13  Aligned_cols=264  Identities=22%  Similarity=0.288  Sum_probs=205.9

Q ss_pred             HHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHH--hcCCcEEeEeceeeeCC----
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK--LQHRNLVKLLGCCMKRD----  501 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----  501 (751)
                      ....++|.+.+.||+|+||.||+|++ +++.||||++...   ..+.+.+|++++..  ++||||+++++++....    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            44567899999999999999999998 6899999998643   34678889999988  68999999999998876    


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCEEEccCCCCCeEEcCCCCe
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      ..++||||+++++|.+++..    ..+++..++.++.|++.||.|||        +.+   |+||||||+|||++.++.+
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred             eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence            78999999999999999953    35899999999999999999999        677   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccc--cccccccccCccCcccccCC------CCCcchhhHHHHHHHHHHHhC----------CCC
Q 038934          574 KISDFGMARAFGVDQTEA--NTNRVVGTYGYMPPEYAIDG------LFSVKSDVFSFGVLVLELVYG----------TRN  635 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~k~DVwSlG~ll~ell~G----------~~p  635 (751)
                      ||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          +.|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            999999998764332211  22345799999999999876      344789999999999999999          455


Q ss_pred             CCCCCCccccchhHHHHHHhccCChhhhcchhccCc-cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          636 RGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT-YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      +.........  .............    .+.+... ........+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       267 ~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          267 YYDLVPSDPS--VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             TTTTSCSSCC--HHHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCcCccc--HHHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            4332221110  1111111111111    0111111 1235667899999999999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=329.33  Aligned_cols=257  Identities=21%  Similarity=0.276  Sum_probs=202.0

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC----cccHHHHHHHHHHHHHhcCCcEEeEeceee--eCCc
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVKLLGCCM--KRDE  502 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~  502 (751)
                      ..++|.+.+.||+|+||.||++... +++.||+|++....    ....+.+.+|+.++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3578999999999999999999964 58899999996542    345678999999999999999999999984  4568


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||++++ |.+++... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999887 77766543 3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      ...............||+.|+|||++.+..  ++.++||||||+++|+|++|+.|+.......   .    .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~----~~~i~~~~~  230 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---L----FENIGKGSY  230 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H----HHHHHHCCC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---H----HHHHhcCCC
Confidence            765333333334467899999999998654  4789999999999999999999976432111   1    111111110


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCC
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGE  708 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  708 (751)
                                ..+......+.+++.+||+.||.+||++.++++  .+...
T Consensus       231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence                      111223456789999999999999999999996  45544

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.4e-38  Score=355.92  Aligned_cols=253  Identities=26%  Similarity=0.327  Sum_probs=203.0

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ...++|.+.++||+|+||+||++++. +++.||||++.+.  .....+.+.+|+.++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            34578999999999999999999975 5899999998643  23456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc---CCCCeEEeeccCcc
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMAR  582 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~  582 (751)
                      ||||+++++|.+.+..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            9999999999998854   345899999999999999999999998   99999999999995   45679999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      .+....   ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.......   +..    .........
T Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~----~i~~~~~~~  241 (486)
T 3mwu_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILK----RVETGKYAF  241 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTCCCS
T ss_pred             ECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCCCCC
Confidence            764322   2234579999999999876 59999999999999999999999975432211   111    011110000


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                            ........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       242 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          242 ------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  000011234578899999999999999999999973

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=346.52  Aligned_cols=256  Identities=27%  Similarity=0.382  Sum_probs=193.1

Q ss_pred             cCccccccccccccccEEEEEEcC--C--cEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeee-CCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID--G--QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK-RDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  505 (751)
                      ..|...++||+|+||.||+|++.+  +  ..||||.+... .....+++.+|+.++++++||||+++++++.+ ++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            457778899999999999999643  2  36899998654 33456789999999999999999999998754 567899


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+++++|.+++..  ....+++..+..++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus       169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999954  3345789999999999999999999998   9999999999999999999999999998664


Q ss_pred             CCCcc--ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          586 VDQTE--ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       586 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      .....  .......+|+.|+|||++.+..++.++|||||||++|||++ |..|+........   ...    ...+..  
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~----~~~~~~--  314 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY----LLQGRR--  314 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHH----HHTTCC--
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHH----HHcCCC--
Confidence            32211  11223457788999999999999999999999999999999 5666543322111   111    111110  


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                             ...+......+.+++.+||+.||++||++.++++.|+.+
T Consensus       315 -------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          315 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   011122345688999999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=366.71  Aligned_cols=254  Identities=26%  Similarity=0.403  Sum_probs=200.8

Q ss_pred             Cccccc-cccccccccEEEEEEc---CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          433 NFSEEN-KLGEGGFGPVYKGMLI---DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       433 ~y~~~~-~IG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++.+.+ +||+|+||.||+|.+.   ++..||||+++.. .....+++.+|+++|++++|||||++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            444444 7999999999999864   4567999999765 33467889999999999999999999999976 5699999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.+...
T Consensus       415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999953  3456899999999999999999999998   999999999999999999999999999876433


Q ss_pred             Cccc-cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          588 QTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       588 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      .... ......+++.|+|||++.+..++.++|||||||+||||++ |+.|+.......   +.    .....+.      
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~~------  556 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGK------  556 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH----HHHHTTC------
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCC------
Confidence            2211 1122345689999999999999999999999999999998 999976433211   11    1111111      


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                         ....+......+.+|+.+||+.||++||++.+|++.|+.+
T Consensus       557 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          557 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               1112233456788999999999999999999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-38  Score=332.85  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=197.6

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-CceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-DERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E~  509 (751)
                      .++|++.+.||+|+||.||++.. +++.||||++...  ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46899999999999999999987 5889999998654  3557899999999999999999999997654 478999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++......  
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            99999999995421 223789999999999999999999998   999999999999999999999999999765322  


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                         .....+++.|+|||++.+..++.++||||||+++|+|++ |+.|+.......   ...    .....         .
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~----~~~~~---------~  231 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKG---------Y  231 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH----HHTTT---------C
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhcC---------C
Confidence               122457889999999999999999999999999999998 998876432211   111    11111         1


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ....+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            1112223356788999999999999999999999999865

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2e-38  Score=346.00  Aligned_cols=254  Identities=10%  Similarity=0.054  Sum_probs=183.6

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHHHh--cCCcEEeEe-------cee
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKL--QHRNLVKLL-------GCC  497 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  497 (751)
                      ..+|...++||+|+||.||+|++. +++.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346888999999999999999965 689999999987532   3456788897766666  599988855       343


Q ss_pred             eeC-----------------CceEEEEEecCCCChhHHHhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 038934          498 MKR-----------------DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR------CQIIGGIARGLLYLHQDSRLR  554 (751)
Q Consensus       498 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~yLH~~~~~~  554 (751)
                      ...                 ...++||||++ ++|.+++....  ..+++..+      ..++.||+.||+|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            332                 34799999999 89999996532  22344555      678899999999999999   


Q ss_pred             EEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccC--CCCCcchhhHHHHHHHHHHHhC
Q 038934          555 IIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYG  632 (751)
Q Consensus       555 ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~k~DVwSlG~ll~ell~G  632 (751)
                      |+||||||+||||+.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999875421     113466799999999987  7899999999999999999999


Q ss_pred             CCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          633 TRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       633 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      +.||..........        +........................+.+|+.+||+.||++|||+.++++
T Consensus       290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99987553322111        0000000000011111111233567889999999999999999999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.3e-39  Score=334.44  Aligned_cols=260  Identities=25%  Similarity=0.318  Sum_probs=204.9

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeee--CCceE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK--RDERM  504 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  504 (751)
                      ..++|++.+.||+|+||.||+++.. +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            3578999999999999999999975 5899999999754  33456679999999999999999999998854  56789


Q ss_pred             EEEEecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          505 LIYEYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      +||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+|+|+||||+|||++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999999996532 2345899999999999999999999875  234999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      +.......  ......|++.|+|||++.+..++.++||||||+++|+|++|+.|+......   .+.    .....+.. 
T Consensus       164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~i~~~~~-  233 (279)
T 2w5a_A          164 RILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA----GKIREGKF-  233 (279)
T ss_dssp             HHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCC-
T ss_pred             eeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHH----HHHhhccc-
Confidence            87643221  122357899999999999999999999999999999999999997643221   111    11111111 


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                              ...+......+.+++.+||+.||.+||++.++++.+..
T Consensus       234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          234 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                    11122334678899999999999999999999987643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-38  Score=340.52  Aligned_cols=266  Identities=24%  Similarity=0.296  Sum_probs=197.8

Q ss_pred             HHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG-----QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD  501 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  501 (751)
                      ....++|.+.+.||+|+||.||+|++. +++.||||++.....     ...+.+.+|+.++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            345678999999999999999999965 589999999965322     12346889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ..++||||+++ +|.+++..  ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999986 88888853  3346888999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      +.+.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..|+.......   ..............
T Consensus       160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTE  234 (346)
T ss_dssp             STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCT
T ss_pred             eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCCh
Confidence            87643322  22335789999999999764 58999999999999999999998876433211   11111111111100


Q ss_pred             h------hhcchhccC---ccC-----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          661 V------ELIDKSLED---TYS-----LSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       661 ~------~~~d~~l~~---~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .      .+.+.....   ..+     ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0      000000000   001     1234578899999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.7e-38  Score=354.60  Aligned_cols=251  Identities=27%  Similarity=0.354  Sum_probs=200.1

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc-------------ccHHHHHHHHHHHHHhcCCcEEeEec
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG-------------QGVEEFKNEVLLIAKLQHRNLVKLLG  495 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  495 (751)
                      ..++|.+.++||+|+||+||+|+.. +++.||||++.+...             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999975 478999999975421             34578999999999999999999999


Q ss_pred             eeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC---C
Q 038934          496 CCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---N  572 (751)
Q Consensus       496 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~  572 (751)
                      ++.+....++||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999999854   345899999999999999999999998   99999999999998776   6


Q ss_pred             eEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH
Q 038934          573 PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       573 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      +||+|||+++......   ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.......   +..   
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---IIK---  257 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---
Confidence            9999999998765332   223467999999999987 469999999999999999999999976433211   111   


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       .........  ..    ......+..+.+|+.+||+.||.+|||+.|+++
T Consensus       258 -~i~~~~~~~--~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          258 -KVEKGKYYF--DF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             -HHHHCCCCC--CH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHcCCCCC--Cc----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             011111000  00    000112357889999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.7e-37  Score=332.84  Aligned_cols=256  Identities=18%  Similarity=0.284  Sum_probs=200.6

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeee--CCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMK--RDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV  506 (751)
                      .++|++.++||+|+||.||+|+. .+++.||||++...   ..+.+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36899999999999999999996 46899999998643   3577899999999997 9999999999988  6678999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC-CeEEeeccCccccC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFG  585 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~  585 (751)
                      |||+++++|.+++.      .+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999883      3889999999999999999999998   99999999999999776 89999999998764


Q ss_pred             CCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh---
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV---  661 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  661 (751)
                      ....   .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.|+........ .+ .............   
T Consensus       183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l-~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QL-VRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HH-HHHHHHHCHHHHHHHH
T ss_pred             CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HH-HHHHHhcCCchhhhHH
Confidence            3322   233578999999999987 6789999999999999999999999853322111 11 0000000000000   


Q ss_pred             --------------------hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 --------------------ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 --------------------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                                          ..................+.+|+.+||+.||.+|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                                000111111112224567899999999999999999999996

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.4e-38  Score=355.20  Aligned_cols=251  Identities=25%  Similarity=0.336  Sum_probs=198.2

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ..++|.+.++||+|+||+||+|+.. +++.||||++.+..  ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3467999999999999999999975 58899999997642  34467899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC---CCeEEeeccCccc
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARA  583 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla~~  583 (751)
                      |||+++++|.+.+..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++..   +.+||+|||+++.
T Consensus       115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            999999999998854   345899999999999999999999998   9999999999999764   4599999999987


Q ss_pred             cCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      +....   ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.......   +..    ........  
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~----~i~~~~~~--  255 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILR----KVEKGKYT--  255 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTCCC--
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCCCC--
Confidence            64322   223467999999999886 569999999999999999999999986433211   111    11111000  


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                          .........+..+.+|+.+||+.||.+|||+.++++
T Consensus       256 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          256 ----FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             ----CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                000000123456889999999999999999999984

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.6e-38  Score=336.23  Aligned_cols=264  Identities=25%  Similarity=0.386  Sum_probs=187.6

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ..++|.+.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3578999999999999999999954 68999999986542 344567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          508 EYLPNKSLADFIFDG-----TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       508 E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      ||+++++|.+++...     .....+++..+..++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999998641     23456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCc---cccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          583 AFGVDQT---EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       583 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      .......   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+........   ..   ......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~---~~~~~~  243 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LM---LTLQND  243 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HH---HHHTSS
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HH---HHhccC
Confidence            7643211   111234578999999999876 5689999999999999999999999764332211   10   011111


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       ....................+.+++.+||+.||.+||++.++++
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 -PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             -CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             10000000001111223456789999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.4e-37  Score=346.03  Aligned_cols=261  Identities=18%  Similarity=0.241  Sum_probs=206.9

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC-CcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|.+.++||+|+||.||+|++ .+++.||||++.....  .+++.+|+++++.++| +++..+..++.+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            47899999999999999999996 4589999998865432  3468899999999976 666677777788889999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE---cCCCCeEEeeccCccccC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG  585 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~  585 (751)
                      |+ +++|.+++...  ...+++..++.|+.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999999642  346899999999999999999999998   9999999999999   688999999999998765


Q ss_pred             CCCccc-----cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          586 VDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       586 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      ......     ......||+.|+|||++.+..++.++|||||||+||||++|+.||........................
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            433221     122467999999999999999999999999999999999999998754433222222111111111111


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..+.         .....++.+|+.+||+.||++||++.+|+++|+.+
T Consensus       238 ~~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          238 EALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1110         11235788999999999999999999999988764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.1e-38  Score=357.02  Aligned_cols=251  Identities=27%  Similarity=0.352  Sum_probs=204.6

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ..++|++.++||+|+||.||+++.. +++.||||++.+..   ....+.+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3468999999999999999999975 68999999996542   3457789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE---cCCCCeEEeeccCcc
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMAR  582 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~  582 (751)
                      ||||+.+++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999999853   456899999999999999999999998   9999999999999   567899999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      .+....   ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.......   +..    ........ 
T Consensus       178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~----~i~~~~~~-  245 (484)
T 3nyv_A          178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILK----KVEKGKYT-  245 (484)
T ss_dssp             HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCCC-
T ss_pred             Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHH----HHHcCCCC-
Confidence            764322   2234579999999999876 69999999999999999999999976433211   111    11111100 


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           .........+..+.+|+.+||+.||.+|||+.++++
T Consensus       246 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 -----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                 000011223457889999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=343.65  Aligned_cols=262  Identities=15%  Similarity=0.187  Sum_probs=203.9

Q ss_pred             hcCccccccccccccccEEEEEEcC---------CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEe---------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID---------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVK---------  492 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  492 (751)
                      .++|.+.+.||+|+||.||+|+...         ++.||||++...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999764         789999998654     46889999999999999988         


Q ss_pred             ------Eeceeee-CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCe
Q 038934          493 ------LLGCCMK-RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV  565 (751)
Q Consensus       493 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NI  565 (751)
                            +++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5667766 67889999999 99999999643 2356899999999999999999999998   99999999999


Q ss_pred             EEcCCC--CeEEeeccCccccCCCCcc-----ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 038934          566 LLDNEM--NPKISDFGMARAFGVDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGF  638 (751)
Q Consensus       566 ll~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~  638 (751)
                      |++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999876532211     112335799999999999999999999999999999999999999764


Q ss_pred             CCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          639 HHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       639 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...... .+ ......+... ...+.+....   .......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       271 ~~~~~~-~~-~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          271 CLPNTE-DI-MKQKQKFVDK-PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             GTTCHH-HH-HHHHHHHHHS-CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CCcCHH-HH-HHHHHhccCC-hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            432211 11 1111111111 1111111000   011246788999999999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-37  Score=340.57  Aligned_cols=261  Identities=24%  Similarity=0.290  Sum_probs=202.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc--------CCcEEeEeceee---
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ--------HRNLVKLLGCCM---  498 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  498 (751)
                      .++|.+.++||+|+||+||+|+.. +++.||||++... ....+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            368999999999999999999964 5889999999643 345677899999999996        788999999987   


Q ss_pred             -eCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCC-----
Q 038934          499 -KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEM-----  571 (751)
Q Consensus       499 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~-----  571 (751)
                       .....++||||+ +++|.+.+... ....+++..+..++.||+.||.|||++ +   |+||||||+||||+.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             556889999999 55666666432 234689999999999999999999998 8   99999999999999775     


Q ss_pred             --------------------------------------------CeEEeeccCccccCCCCccccccccccccCccCccc
Q 038934          572 --------------------------------------------NPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY  607 (751)
Q Consensus       572 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~  607 (751)
                                                                  .+||+|||+++.....     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999876432     223578999999999


Q ss_pred             ccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccch---hHHHHHHhccCChhhh----------cch--------
Q 038934          608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL---LGHAWRLWTEDRPVEL----------IDK--------  666 (751)
Q Consensus       608 ~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~----------~d~--------  666 (751)
                      +.+..++.++|||||||+||||++|+.||...........   +........ ..+...          ...        
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG-KVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHC-SCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcC-CCChHHhhcccccccccCCcccccccc
Confidence            9999999999999999999999999999876544322111   111111111 000000          000        


Q ss_pred             ---------hc--cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 ---------SL--EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ---------~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                               .+  ....+......+.+|+.+||+.||++|||+.|+++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                     00  01234556678999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3e-38  Score=332.16  Aligned_cols=258  Identities=27%  Similarity=0.376  Sum_probs=197.4

Q ss_pred             hcCccccccccccccccEEEEEEcC--Cc--EEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID--GQ--EIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~--~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|++.+.||+|+||.||+|++..  ++  .||||++...   .....+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3689999999999999999998532  33  6899998754   2345678999999999999999999999998765 8


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||+++   |+|+||||+|||++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            9999999999999999643  345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCccc-cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          584 FGVDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       584 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      ........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+......   ...   ........  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~~~~~~~--  242 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QIL---HKIDKEGE--  242 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---HHHHTSCC--
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHH---HHHHccCC--
Confidence            65432221 2223567888999999999899999999999999999999 99997533221   111   11111110  


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                             ....+......+.+++.+||+.||.+||++.++++.|+...
T Consensus       243 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          243 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                   01112233467889999999999999999999999998754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.8e-39  Score=352.51  Aligned_cols=242  Identities=16%  Similarity=0.170  Sum_probs=189.8

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHH---HHHHhcCCcEEeEe-------ce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKS---SGQGVEEFKNEVL---LIAKLQHRNLVKLL-------GC  496 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~  496 (751)
                      .++|.+.+.||+|+||.||+|++ .+++.||||++...   .....+.+.+|+.   ++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46889999999999999999996 46999999999743   3445678999995   55555799999998       55


Q ss_pred             eeeCC-----------------ceEEEEEecCCCChhHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCE
Q 038934          497 CMKRD-----------------ERMLIYEYLPNKSLADFIFDGTR----RKLLDWSKRCQIIGGIARGLLYLHQDSRLRI  555 (751)
Q Consensus       497 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i  555 (751)
                      +.+.+                 ..++||||+ +|+|.+++.....    ...+++..++.|+.||+.||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 378999999 6799999964211    123446888899999999999999998   9


Q ss_pred             EEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCC-----------CCCcchhhHHHHH
Q 038934          556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-----------LFSVKSDVFSFGV  624 (751)
Q Consensus       556 vH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~k~DVwSlG~  624 (751)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986432     2233567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          625 LVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       625 ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ++|||++|+.||..........               .+    ...  .......+.+|+.+||+.||++||++.++++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~---------------~~----~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSE---------------WI----FRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCSG---------------GG----GSS--CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccchh---------------hh----hhh--ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999975433211110               00    000  0122456889999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.7e-38  Score=328.15  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=196.4

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|.+.+.||+|+||.||+|++. +++.||||++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            368999999999999999999976 6899999999653   233466889999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999999543   45899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      ...   .....+++.|+|||++.+..+ +.++||||||+++|+|++|+.|+......   ..    .........     
T Consensus       164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~----~~~~~~~~~-----  228 (276)
T 2h6d_A          164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TL----FKKIRGGVF-----  228 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC-----
T ss_pred             Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HH----HHHhhcCcc-----
Confidence            221   223578999999999988765 68999999999999999999997542211   11    111111100     


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                           ..+......+.+++.+||+.||.+|||+.++++.
T Consensus       229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 0112234567899999999999999999999973

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.9e-38  Score=329.58  Aligned_cols=249  Identities=23%  Similarity=0.353  Sum_probs=197.9

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeee----CCceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK----RDERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  504 (751)
                      +.|.+.+.||+|+||.||+|.+. ++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45788889999999999999965 5788999998754  34456779999999999999999999999875    35689


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc-CCCCeEEeeccCccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARA  583 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~  583 (751)
                      +||||+++++|.+++..   ...+++..+..++.||+.||.|||+++ .+|+|+||||+|||++ +++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999954   345899999999999999999999875 3499999999999998 789999999999976


Q ss_pred             cCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ....    ......||+.|+|||++.+ .++.++||||||+++|+|++|+.|+.......  .    ............ 
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~----~~~~~~~~~~~~-  249 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--Q----IYRRVTSGVKPA-  249 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--H----HHHHHTTTCCCG-
T ss_pred             cccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--H----HHHHHhccCCcc-
Confidence            4322    2233578999999998864 58999999999999999999999975322211  1    111111111111 


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                             ..+......+.+++.+||+.||.+|||+.++++
T Consensus       250 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   111122346889999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.6e-38  Score=367.40  Aligned_cols=248  Identities=27%  Similarity=0.376  Sum_probs=197.2

Q ss_pred             ccccccccccEEEEEEc---CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLI---DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      ++||+|+||.||+|.+.   .++.||||+++...  ....+++.+|++++++++|||||++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999753   36789999997642  334678999999999999999999999996 4568999999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc-c
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE-A  591 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~  591 (751)
                      ++|.+++..   ...+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999953   346899999999999999999999998   999999999999999999999999999876543221 1


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                      ......+|+.|+|||++.+..++.++|||||||+||||++ |+.|+.......       .......+.         ..
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~---------~~  591 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE---------RM  591 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC---------CC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------CC
Confidence            1223456788999999999999999999999999999998 999975432211       111111111         11


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..+......+.+|+.+||+.||++||++.+|++.|+.+
T Consensus       592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            12233456788999999999999999999999999753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.6e-38  Score=345.14  Aligned_cols=265  Identities=18%  Similarity=0.269  Sum_probs=198.8

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc------eE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE------RM  504 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~  504 (751)
                      ..+|...++||+|+||+||+|++..+..+|+|++.....    ...+|+++++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            357999999999999999999988877899999865432    22479999999999999999999965543      78


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc-CCCCeEEeeccCccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARA  583 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~  583 (751)
                      +||||++++.+..+.........+++..+..++.||++||.|||+++   |+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999988655444332334557899999999999999999999998   99999999999999 799999999999987


Q ss_pred             cCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          584 FGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ......   .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||........  + ..............
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l-~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--L-VEIIKVLGTPSREQ  265 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCCCCHHH
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHhCCCCHHH
Confidence            643322   2235789999999998765 589999999999999999999999865432211  1 11111111110000


Q ss_pred             ---------------hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HhCC
Q 038934          663 ---------------LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM--LSGE  708 (751)
Q Consensus       663 ---------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  708 (751)
                                     .....+...+.......+.+|+.+||+.||.+|||+.|+++.  ++.+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence                           000000011122244578999999999999999999999963  4443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.6e-38  Score=332.10  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=199.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            468999999999999999999976 4889999999877667788999999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++++|.+++...  ...+++..+..++.||+.||.|||+++   |+|+||||+|||++.++.+||+|||++....... 
T Consensus        98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            9999999998542  345899999999999999999999998   9999999999999999999999999876432111 


Q ss_pred             cccccccccccCccCcccc-----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          590 EANTNRVVGTYGYMPPEYA-----IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~-----~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                       .......||+.|+|||++     .+..++.++||||||+++|+|++|+.|+.......      ............ . 
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~-~-  242 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDPPT-L-  242 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCCC-C-
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccCCcc-c-
Confidence             112235789999999998     46778999999999999999999999976432211      011111111110 0 


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                            ..+......+.+++.+||+.||.+|||+.++++
T Consensus       243 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 ------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                  111223456889999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.6e-38  Score=342.71  Aligned_cols=268  Identities=20%  Similarity=0.283  Sum_probs=200.1

Q ss_pred             HHhHHHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCc-----------ccHHHHHHHHHHHHHhcCCcEEe
Q 038934          424 WKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG-----------QGVEEFKNEVLLIAKLQHRNLVK  492 (751)
Q Consensus       424 ~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~  492 (751)
                      ..++....++|.+.+.||+|+||.||+|...+++.||||++.....           ...+.+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4567788899999999999999999999988899999999864321           12378999999999999999999


Q ss_pred             EeceeeeC-----CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE
Q 038934          493 LLGCCMKR-----DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  567 (751)
Q Consensus       493 l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll  567 (751)
                      +++++...     ...++||||++ ++|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            99998543     35799999998 588888753  3446899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCccccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccc
Q 038934          568 DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN  646 (751)
Q Consensus       568 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~  646 (751)
                      +.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........  
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--  242 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ--  242 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--
T ss_pred             cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH--
Confidence            999999999999997543222   2233578999999999887 6789999999999999999999999865432211  


Q ss_pred             hhHHHHHHhccCChh-----------hhcchhccC-------ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          647 LLGHAWRLWTEDRPV-----------ELIDKSLED-------TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       647 ~~~~~~~~~~~~~~~-----------~~~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       ..............           ..+...+..       .........+.+|+.+||+.||.+|||+.++++
T Consensus       243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          243 -LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             -HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence             11111111111110           000000000       011122456889999999999999999999996

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-38  Score=336.66  Aligned_cols=261  Identities=27%  Similarity=0.412  Sum_probs=200.3

Q ss_pred             cccHHhHHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceee
Q 038934          421 IFDWKSIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCM  498 (751)
Q Consensus       421 ~~~~~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  498 (751)
                      .+++..+....++|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            3444455567789999999999999999999974 68999999996543 3457899999999999 7999999999998


Q ss_pred             e------CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC
Q 038934          499 K------RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  572 (751)
Q Consensus       499 ~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~  572 (751)
                      .      ....++||||+++++|.+++... ....+++..+..++.||+.||.|||+++   |+|+||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence            7      46789999999999999999653 2346899999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCccccCCCCccccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccch
Q 038934          573 PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL  647 (751)
Q Consensus       573 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~  647 (751)
                      +||+|||++........  ......||+.|+|||++.     +..++.++|||||||++|+|++|+.|+.......    
T Consensus       168 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----  241 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----  241 (326)
T ss_dssp             EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----
T ss_pred             EEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----
Confidence            99999999987643211  123357899999999987     5678999999999999999999999975322111    


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                        ........... .        .........+.+++.+||+.||.+||++.++++
T Consensus       242 --~~~~~~~~~~~-~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          242 --ALFLIPRNPAP-R--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             --HHHHHHHSCCC-C--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --HHHHhhcCccc-c--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence              01111111100 0        011122457889999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.9e-38  Score=336.39  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=198.3

Q ss_pred             HHHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhc--CCcEEeEeceeeeCCc
Q 038934          427 IANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ--HRNLVKLLGCCMKRDE  502 (751)
Q Consensus       427 i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  502 (751)
                      +....++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++  |+||+++++++...+.
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            34456789999999999999999999888999999999654  3345678999999999997  5999999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||| +.+++|.+++..   ...+++..+..++.|+++||.|||+++   |+||||||+|||+++ +.+||+|||+++
T Consensus       103 ~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~  174 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN  174 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred             EEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence            999999 678899999964   346899999999999999999999998   999999999999975 899999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA  651 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~  651 (751)
                      ...............||+.|+|||++.+           ..++.++||||||+++|+|++|+.|+......     ....
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~  249 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL  249 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHH
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHH
Confidence            7654433333334678999999999876           47889999999999999999999997532211     0111


Q ss_pred             HHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          652 WRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       652 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .         ..++.......+......+.+++.+||+.||.+||++.++++
T Consensus       250 ~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          250 H---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             H---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H---------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            1         111111111122222457889999999999999999999995

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.9e-37  Score=327.42  Aligned_cols=253  Identities=22%  Similarity=0.302  Sum_probs=203.3

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---------cccHHHHHHHHHHHHHhc-CCcEEeEecee
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---------GQGVEEFKNEVLLIAKLQ-HRNLVKLLGCC  497 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  497 (751)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++....         ....+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            44579999999999999999999975 58899999996542         123456889999999995 99999999999


Q ss_pred             eeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEee
Q 038934          498 MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  577 (751)
Q Consensus       498 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  577 (751)
                      ......++||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+|+||||+||+++.++.+||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence            999999999999999999999954   346899999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCCccccccccccccCccCccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAI------DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA  651 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~  651 (751)
                      ||++.......   ......+++.|+|||++.      ...++.++||||||+++|+|++|+.|+.......   ..   
T Consensus       168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~---  238 (298)
T 1phk_A          168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---ML---  238 (298)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---
T ss_pred             ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HH---
Confidence            99998764322   123357899999999985      4568999999999999999999999975332111   00   


Q ss_pred             HHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          652 WRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       652 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       .........      ............+.+++.+||+.||.+||++.++++
T Consensus       239 -~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 -RMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -HHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HHHhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence             011111000      000011223457889999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.6e-37  Score=332.05  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=196.3

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--------cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR  500 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  500 (751)
                      ..++|.+.+.||+|+||.||+|++. +++.||||++....        ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999975 47899999986532        12234688999999999999999999998765


Q ss_pred             CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC---eEEee
Q 038934          501 DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISD  577 (751)
Q Consensus       501 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~D  577 (751)
                      . .++||||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 899999999999999984   3456899999999999999999999998   999999999999987664   99999


Q ss_pred             ccCccccCCCCccccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHH
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRL  654 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~  654 (751)
                      ||+++......   ......||+.|+|||++.   ...++.++|||||||++|+|++|+.|+........  +....   
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~---  232 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI---  232 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH---
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH---
Confidence            99998764321   123357899999999974   56789999999999999999999999864332211  11100   


Q ss_pred             hccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          655 WTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       655 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                       ...... .. +..    .......+.+++.+||+.||++||++.++++
T Consensus       233 -~~~~~~-~~-~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 -TSGKYN-FI-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -HHTCCC-CC-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HhCccc-cC-chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             111000 00 000    0112457889999999999999999999984

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.5e-38  Score=340.16  Aligned_cols=262  Identities=19%  Similarity=0.315  Sum_probs=201.7

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-----Cce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-----DER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  503 (751)
                      .++|++.++||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999965 58889999997543 33457789999999999999999999999765     368


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++||||+.+ +|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            999999985 89998843    35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCccc-cccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          584 FGVDQTEA-NTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       584 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      ........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........   ............
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~  254 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQE  254 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH---HHHHHHCSCCHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH---HHHHHhCCCCHH
Confidence            65332211 1234689999999998764 458999999999999999999999986544322211   111111111100


Q ss_pred             h-----------hcchhc-cCc-----cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 E-----------LIDKSL-EDT-----YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 ~-----------~~d~~l-~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .           ...... ...     ........+.+|+.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0           000000 000     01122456889999999999999999999996

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2e-37  Score=338.10  Aligned_cols=258  Identities=21%  Similarity=0.260  Sum_probs=192.6

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD------  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  501 (751)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999965 5889999999754  3344567899999999999999999999997665      


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ..++||||+++ +|.+.+.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            68999999975 7888773     24889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhc-----
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWT-----  656 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~-----  656 (751)
                      +......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........   .........     
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCPE  248 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHC-CCCCCHH
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence            8754221   22346789999999999999999999999999999999999999865432111   000000000     


Q ss_pred             --------------c------CChhhhcchhccCc---cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          657 --------------E------DRPVELIDKSLEDT---YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       657 --------------~------~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                                    .      ......+.......   ........+.+|+.+||+.||.+|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                          0      00000010000000   11223567899999999999999999999996

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.4e-38  Score=343.06  Aligned_cols=262  Identities=19%  Similarity=0.270  Sum_probs=196.6

Q ss_pred             HHHhcCccccccccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC------
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR------  500 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  500 (751)
                      ....++|.+.++||+|+||+||+|++ .+++.||||++.....    ...+|+++++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999996 4689999999865432    234799999999999999999998543      


Q ss_pred             --------------------------------CceEEEEEecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 038934          501 --------------------------------DERMLIYEYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYL  547 (751)
Q Consensus       501 --------------------------------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yL  547 (751)
                                                      ...++||||+++ +|.+.+... .....+++..+..++.||++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            347899999985 887777531 2345689999999999999999999


Q ss_pred             HhCCCCCEEEccCCCCCeEEc-CCCCeEEeeccCccccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHH
Q 038934          548 HQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVL  625 (751)
Q Consensus       548 H~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~l  625 (751)
                      |+++   |+||||||+|||++ +++.+||+|||+++.+.....   .....+|+.|+|||++.+. .++.++|||||||+
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9998   99999999999998 688999999999987643322   2235789999999998875 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh---------------cchhccCccCHHHHHHHHHHHhhhcCC
Q 038934          626 VLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL---------------IDKSLEDTYSLSEALRCIQVGLLCVQQ  690 (751)
Q Consensus       626 l~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~d~~l~~~~~~~~~~~l~~li~~cl~~  690 (751)
                      +|||++|+.||........   +..............+               .........+......+.+|+.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            9999999999875433211   1111111111100000               000111112223445688999999999


Q ss_pred             CCCCCCCHHHHHH
Q 038934          691 RPEDRPNMASVVL  703 (751)
Q Consensus       691 dP~~RPs~~evl~  703 (751)
                      ||.+|||+.|+++
T Consensus       309 dP~~R~t~~e~l~  321 (383)
T 3eb0_A          309 EPDLRINPYEAMA  321 (383)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999984

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.9e-38  Score=342.79  Aligned_cols=256  Identities=25%  Similarity=0.354  Sum_probs=184.1

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC------C
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR------D  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  501 (751)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999964 5889999999654  233456788999999999999999999998754      5


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      ..++|+|++ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 689998884    246899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........   +.......... .
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p-~  250 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTP-G  250 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSC-C
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCC-C
Confidence            865321     233678999999999987 6799999999999999999999999865432211   11111111000 0


Q ss_pred             hhhcch-----------hccC--ccC-----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          661 VELIDK-----------SLED--TYS-----LSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       661 ~~~~d~-----------~l~~--~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .+.+..           .+..  ...     ......+.+|+.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            000000           0000  001     112356889999999999999999999996

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.8e-38  Score=337.64  Aligned_cols=258  Identities=22%  Similarity=0.331  Sum_probs=204.2

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCccc-----------------HHHHHHHHHHHHHhcCCcEEeE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQG-----------------VEEFKNEVLLIAKLQHRNLVKL  493 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  493 (751)
                      .++|.+.+.||+|+||.||+|+. +++.||||++.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 99999999996542111                 1789999999999999999999


Q ss_pred             eceeeeCCceEEEEEecCCCChhHH------HhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeE
Q 038934          494 LGCCMKRDERMLIYEYLPNKSLADF------IFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVL  566 (751)
Q Consensus       494 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIl  566 (751)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..+..++.||+.||.|||+ ++   |+|+||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      422 224679999999999999999999999 88   999999999999


Q ss_pred             EcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCCCccc
Q 038934          567 LDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSV-KSDVFSFGVLVLELVYGTRNRGFHHVDHH  644 (751)
Q Consensus       567 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-k~DVwSlG~ll~ell~G~~p~~~~~~~~~  644 (751)
                      ++.++.+||+|||++......    ......|++.|+|||++.+. .++. ++||||||+++|+|++|+.|+......  
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence            999999999999999876432    23346789999999999887 6666 999999999999999999998644331  


Q ss_pred             cchhHHHHHHhccCChhh------hcchhc---cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          645 HNLLGHAWRLWTEDRPVE------LIDKSL---EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       645 ~~~~~~~~~~~~~~~~~~------~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ....    ..........      ......   ...........+.+|+.+||+.||.+||++.|+++
T Consensus       259 ~~~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 VELF----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHH----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHH----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111    1111111000      000000   00001223457889999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.3e-37  Score=327.30  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=200.0

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++...  ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34578999999999999999999975 4899999999754  34578899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999999853  2346899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      ..  ......|++.|+|||++.+..++.++||||||+++|+|++|+.|+.......      ........... .     
T Consensus       179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~-~-----  244 (314)
T 3com_A          179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTNPPP-T-----  244 (314)
T ss_dssp             BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCC-C-----
T ss_pred             cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCc-c-----
Confidence            22  1233578999999999999999999999999999999999999975322110      01110011000 0     


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                        -..+......+.+++.+||+.||.+||++.++++
T Consensus       245 --~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 --FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             --CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              0011223457889999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.1e-38  Score=330.27  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=186.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-ccc-HHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQG-VEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .++|++.++||+|+||.||+++.. +++.||||++.... ... .+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            478999999999999999999964 68999999997542 222 233445555577789999999999999999999999


Q ss_pred             EecCCCChhHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          508 EYLPNKSLADFIFDG-TRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       508 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||+++ +|.+++... .....+++..+..++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99985 888877542 2345789999999999999999999998 8   9999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccCcccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYA----IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      ....   .....||+.|+|||++    .+..++.++||||||+++|+|++|+.|+.......     ............ 
T Consensus       162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~-  232 (290)
T 3fme_A          162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEPSP-  232 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSCCC-
T ss_pred             cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccCCC-
Confidence            3222   2234789999999996    56678999999999999999999999975322110     111111111111 


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                              ..........+.+++.+||+.||++|||+.++++
T Consensus       233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 --------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             --------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                    1111123456889999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.6e-37  Score=337.16  Aligned_cols=266  Identities=22%  Similarity=0.274  Sum_probs=191.7

Q ss_pred             hHHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc--
Q 038934          426 SIANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE--  502 (751)
Q Consensus       426 ~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  502 (751)
                      ......++|.+.++||+|+||.||+|++. +++.||||++.... ...+.+.+|++.+..++||||+++++++.....  
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            34567789999999999999999999975 58999999986542 334566788889999999999999999976443  


Q ss_pred             -----eEEEEEecCCCChhHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCEEEccCCCCCeEEcC-CCCe
Q 038934          503 -----RMLIYEYLPNKSLADFIFD-GTRRKLLDWSKRCQIIGGIARGLLYLH--QDSRLRIIHRDLKASNVLLDN-EMNP  573 (751)
Q Consensus       503 -----~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~yLH--~~~~~~ivH~Dikp~NIll~~-~~~~  573 (751)
                           .++||||+++ +|.+.+.. ......+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                 7899999987 44444322 244567899999999999999999999  887   999999999999996 8999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||........   .....
T Consensus       172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~~  245 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEIV  245 (360)
T ss_dssp             EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred             EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHHH
Confidence            9999999987653322   2235789999999998765 489999999999999999999999865433211   11111


Q ss_pred             HHhccCChhhhcch-------------------hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          653 RLWTEDRPVELIDK-------------------SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       653 ~~~~~~~~~~~~d~-------------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...... ..+.+..                   .............+.+|+.+||+.||.+|||+.|+++
T Consensus       246 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          246 RVLGCP-SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHCCC-CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHcCCC-CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            111000 0000000                   0011112234668899999999999999999999996

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.2e-37  Score=341.87  Aligned_cols=199  Identities=22%  Similarity=0.290  Sum_probs=172.9

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHh------cCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL------QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  503 (751)
                      ..+|++.++||+|+||.||+|... +++.||||++... ....+++.+|+.+++.+      .|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            467999999999999999999965 4889999999653 34456788899999888      467999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC--eEEeeccCc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMA  581 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DFGla  581 (751)
                      ++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 58999886532 335899999999999999999999998   999999999999999887  999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHH  640 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~  640 (751)
                      +.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            764321     223578999999999999999999999999999999999999986544

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=330.49  Aligned_cols=262  Identities=20%  Similarity=0.304  Sum_probs=195.2

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceee-----------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCM-----------  498 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  498 (751)
                      .++|.+.+.||+|+||.||+|.... ++.||||++........+++.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4689999999999999999999764 8999999998776677788999999999999999999998873           


Q ss_pred             ---eCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc-CCCCeE
Q 038934          499 ---KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPK  574 (751)
Q Consensus       499 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~k  574 (751)
                         +....++||||++ ++|.+++.    ...+++..+..++.|++.||+|||+++   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               4467899999998 59999983    346899999999999999999999998   99999999999997 567999


Q ss_pred             EeeccCccccCCCCc-cccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH
Q 038934          575 ISDFGMARAFGVDQT-EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       575 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      |+|||+++....... ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||........   .....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~  238 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLIL  238 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence            999999987643211 122233567899999998865 6789999999999999999999999865432111   11000


Q ss_pred             HHhccCC---hh-------hhcchhcc-Cc-----cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          653 RLWTEDR---PV-------ELIDKSLE-DT-----YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       653 ~~~~~~~---~~-------~~~d~~l~-~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .......   ..       ..+..... ..     ........+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0000000   00       00000000 00     01123457889999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.4e-37  Score=330.22  Aligned_cols=258  Identities=22%  Similarity=0.324  Sum_probs=203.3

Q ss_pred             hcCccccccccccccccEEEEEE-c-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCc------EEeEeceeeeCCc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-I-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN------LVKLLGCCMKRDE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  502 (751)
                      .++|++.+.||+|+||.||++.. . +++.||||++... ....+.+.+|+.++++++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999986 3 5889999999643 345677899999999997654      9999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-------------
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------------  569 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-------------  569 (751)
                      .++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88999998653 2245889999999999999999999998   999999999999987             


Q ss_pred             ------CCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc
Q 038934          570 ------EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH  643 (751)
Q Consensus       570 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~  643 (751)
                            ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  668999999999864322     223578999999999999999999999999999999999999987544322


Q ss_pred             ccchhHHHHHHhccCChhhhcc--------------------------hh---c--cCccCHHHHHHHHHHHhhhcCCCC
Q 038934          644 HHNLLGHAWRLWTEDRPVELID--------------------------KS---L--EDTYSLSEALRCIQVGLLCVQQRP  692 (751)
Q Consensus       644 ~~~~~~~~~~~~~~~~~~~~~d--------------------------~~---l--~~~~~~~~~~~l~~li~~cl~~dP  692 (751)
                      ......   ... ...+...+.                          ..   +  ...........+.+|+.+||+.||
T Consensus       242 ~~~~~~---~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          242 HLAMME---RIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             HHHHHH---HHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             HHHHHH---HHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            111111   000 000000000                          00   0  001123456788999999999999


Q ss_pred             CCCCCHHHHHH
Q 038934          693 EDRPNMASVVL  703 (751)
Q Consensus       693 ~~RPs~~evl~  703 (751)
                      .+|||+.|+++
T Consensus       318 ~~Rpt~~ell~  328 (339)
T 1z57_A          318 AKRITLREALK  328 (339)
T ss_dssp             TTSCCHHHHTT
T ss_pred             ccccCHHHHhc
Confidence            99999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=335.89  Aligned_cols=257  Identities=27%  Similarity=0.410  Sum_probs=199.4

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|.+.+.||+|+||.||+|++..  .+|+|++...  .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            4789999999999999999998744  4999998654  23345678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++++|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++......
T Consensus       110 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          110 LCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             cccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            9999999999953  2346899999999999999999999998   99999999999998 6799999999987653211


Q ss_pred             ---ccccccccccccCccCcccccC---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhc
Q 038934          589 ---TEANTNRVVGTYGYMPPEYAID---------GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       589 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                         .........||+.|+|||++.+         ..++.++||||||+++|+|++|+.|+........      .+. ..
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~-~~  256 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------IWQ-MG  256 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH------HHH-HH
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-hc
Confidence               1122233568999999999875         4578999999999999999999999764322111      111 11


Q ss_pred             cCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          657 EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       657 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                      .......        ........+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       257 ~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          257 TGMKPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             TTCCCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             cCCCCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            1111000        011123457899999999999999999999999998743

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.6e-38  Score=346.15  Aligned_cols=258  Identities=21%  Similarity=0.299  Sum_probs=193.5

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC------ceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD------ERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  504 (751)
                      .+|...+.||+|+||.||+|++. +++.||||++....    +.+.+|++++++++|||||++++++....      .++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999975 58999999986542    22347999999999999999999985432      367


Q ss_pred             EEEEecCCCChhHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-CCeEEeeccCcc
Q 038934          505 LIYEYLPNKSLADFIFD-GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR  582 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~  582 (751)
                      +||||+++ +|.+++.. ......+++..+..++.||++||.|||+++   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 66665533 123456899999999999999999999998   9999999999999965 568999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      .+.....   .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.......  .+.... .........
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~-~~lg~p~~~  279 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEII-KVLGTPTRE  279 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HHHCSCCHH
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCCCHH
Confidence            7643222   2235789999999999765 79999999999999999999999986543211  111111 111100000


Q ss_pred             ----------hhcchhc-----cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 ----------ELIDKSL-----EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 ----------~~~d~~l-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                                +...+.+     ...+.......+.+|+.+||+.||.+||++.|+++
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                      0000000     00112233467899999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.6e-38  Score=344.79  Aligned_cols=267  Identities=22%  Similarity=0.332  Sum_probs=183.9

Q ss_pred             hcCccc-cccccccccccEEEEEEc---CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeee--CCceE
Q 038934          431 TDNFSE-ENKLGEGGFGPVYKGMLI---DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK--RDERM  504 (751)
Q Consensus       431 ~~~y~~-~~~IG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  504 (751)
                      .+.|.+ .++||+|+||.||+|++.   +++.||||++....  ..+.+.+|+.++++++||||+++++++..  ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            345665 458999999999999965   47889999996542  33578899999999999999999999954  67889


Q ss_pred             EEEEecCCCChhHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE----cCCCCeE
Q 038934          505 LIYEYLPNKSLADFIFDG------TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPK  574 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~k  574 (751)
                      +||||+.+ +|.+++...      .....+++..+..++.||+.||.|||+++   |+||||||+||||    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999975 787777431      12235899999999999999999999999   9999999999999    6788999


Q ss_pred             EeeccCccccCCCCc-cccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc------cc
Q 038934          575 ISDFGMARAFGVDQT-EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHH------HN  646 (751)
Q Consensus       575 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~------~~  646 (751)
                      |+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....+..      ..
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999999987653221 1223346889999999999874 589999999999999999999999865433210      01


Q ss_pred             hhHHHHHHhccCCh------------hhhcchhccCc------------cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 038934          647 LLGHAWRLWTEDRP------------VELIDKSLEDT------------YSLSEALRCIQVGLLCVQQRPEDRPNMASVV  702 (751)
Q Consensus       647 ~~~~~~~~~~~~~~------------~~~~d~~l~~~------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  702 (751)
                      .+............            ..+........            ........+.+|+.+||+.||.+|||+.|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            11111111100000            00000000000            0011134678999999999999999999999


Q ss_pred             H
Q 038934          703 L  703 (751)
Q Consensus       703 ~  703 (751)
                      +
T Consensus       333 ~  333 (405)
T 3rgf_A          333 Q  333 (405)
T ss_dssp             T
T ss_pred             c
Confidence            6

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.4e-37  Score=334.92  Aligned_cols=263  Identities=21%  Similarity=0.280  Sum_probs=199.9

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-----Cc
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-----DE  502 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  502 (751)
                      ..++|.+.+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3578999999999999999999975 5889999999654 333456788999999999999999999988764     67


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||+. ++|.+++..    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            899999997 589998853    45899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCccc--------cccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHH
Q 038934          583 AFGVDQTEA--------NTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWR  653 (751)
Q Consensus       583 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~  653 (751)
                      .........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........   ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~  237 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFG  237 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHH
Confidence            764322111        1223578999999998764 678999999999999999999999986543221111   0111


Q ss_pred             HhccCC---h---------hhhcchhcc------CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          654 LWTEDR---P---------VELIDKSLE------DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       654 ~~~~~~---~---------~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ......   .         .+.+.....      ..........+.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            010000   0         000000000      0001123457789999999999999999999996

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.7e-37  Score=328.74  Aligned_cols=264  Identities=22%  Similarity=0.335  Sum_probs=202.1

Q ss_pred             HHhcCccccccccccccccEEEEEEc--CCcEEEEEEeccCC--cccHHHHHHHHHHHHHh---cCCcEEeEeceee---
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI--DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL---QHRNLVKLLGCCM---  498 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---  498 (751)
                      .+.++|++.+.||+|+||.||+|++.  +++.||||++....  ......+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            45578999999999999999999973  57899999986432  22234677888888777   7999999999987   


Q ss_pred             --eCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEe
Q 038934          499 --KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  576 (751)
Q Consensus       499 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~  576 (751)
                        .....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+++   |+|+||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence              5567899999998 59999986532 335899999999999999999999998   9999999999999999999999


Q ss_pred             eccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhc
Q 038934          577 DFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       577 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                      |||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........   .........
T Consensus       163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~  236 (326)
T 1blx_A          163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIG  236 (326)
T ss_dssp             SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred             cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcC
Confidence            999998764221   22346789999999999999999999999999999999999999864432211   111111100


Q ss_pred             cCChh----------hhcch---hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          657 EDRPV----------ELIDK---SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       657 ~~~~~----------~~~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .....          .....   .............+.+|+.+||+.||.+||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000          00000   0001111233457889999999999999999999995

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.1e-37  Score=322.51  Aligned_cols=252  Identities=25%  Similarity=0.313  Sum_probs=202.5

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ...++|.+.+.||+|+||.||+++.. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            45578999999999999999999975 5899999998654  23456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC---CCeEEeeccCcc
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMAR  582 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla~  582 (751)
                      ||||+++++|.+++...   ..+++..+..++.||+.||.|||+++   |+|+||||+||+++.+   +.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999999988542   35899999999999999999999998   9999999999999764   469999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      .......   .....+++.|+|||++.+ .++.++||||||+++|+|++|+.|+......   ....    .........
T Consensus       173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~~  241 (287)
T 2wei_A          173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK----RVETGKYAF  241 (287)
T ss_dssp             TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCCCC
T ss_pred             eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCCCCC
Confidence            7643221   223468999999998876 4899999999999999999999997543221   1111    111111000


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .      ..........+.+++.+||+.||.+|||+.++++
T Consensus       242 ~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 D------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             C------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            0      0000122456889999999999999999999996

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.8e-37  Score=324.55  Aligned_cols=254  Identities=24%  Similarity=0.401  Sum_probs=193.7

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeee---------
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK---------  499 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  499 (751)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4578999999999999999999965 6899999999643 3456788999999999999999999998865         


Q ss_pred             ----CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEE
Q 038934          500 ----RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  575 (751)
Q Consensus       500 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl  575 (751)
                          ....++||||+++++|.+++..  ....+++..++.++.|++.||.|||+++   |+|+||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                4568999999999999999964  2345788999999999999999999998   999999999999999999999


Q ss_pred             eeccCccccCCCCc------------cccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCc
Q 038934          576 SDFGMARAFGVDQT------------EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVD  642 (751)
Q Consensus       576 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~  642 (751)
                      +|||+++.......            ........||+.|+|||++.+. .++.++|||||||++|+|++   |+..  ..
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~--~~  232 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST--GM  232 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS--HH
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC--ch
Confidence            99999987642211            1122345789999999999865 78999999999999999998   3221  00


Q ss_pred             cccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          643 HHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       643 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .....    .......      ...+...........+.+++.+||+.||.+|||+.++++.
T Consensus       233 ~~~~~----~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          233 ERVNI----LKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHH----HHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hHHHH----HHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            00010    1111111      0011122233344567899999999999999999999973

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.4e-36  Score=329.57  Aligned_cols=267  Identities=22%  Similarity=0.298  Sum_probs=202.1

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-----------CCcEEeEeceee
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----------HRNLVKLLGCCM  498 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  498 (751)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            368999999999999999999964 6889999999643 334567889999999886           889999999998


Q ss_pred             eCC----ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEc-----
Q 038934          499 KRD----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLD-----  568 (751)
Q Consensus       499 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~-----  568 (751)
                      ..+    ..++|||++ +++|.+++.... ...+++..+..++.||+.||.|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            755    789999999 889999986532 34589999999999999999999998 8   99999999999994     


Q ss_pred             -CCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccc-
Q 038934          569 -NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN-  646 (751)
Q Consensus       569 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~-  646 (751)
                       ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... 
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4447999999999876422     223578999999999999999999999999999999999999987544221111 


Q ss_pred             --hhHHHHHHhccCCh---------hhhc-----------------chhc--cCccCHHHHHHHHHHHhhhcCCCCCCCC
Q 038934          647 --LLGHAWRLWTEDRP---------VELI-----------------DKSL--EDTYSLSEALRCIQVGLLCVQQRPEDRP  696 (751)
Q Consensus       647 --~~~~~~~~~~~~~~---------~~~~-----------------d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RP  696 (751)
                        .+............         ...+                 ...+  ....+......+.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence              11111111100000         0000                 0000  1123456677899999999999999999


Q ss_pred             CHHHHHH--HHhCC
Q 038934          697 NMASVVL--MLSGE  708 (751)
Q Consensus       697 s~~evl~--~L~~~  708 (751)
                      |+.|+++  .+...
T Consensus       327 t~~ell~hp~f~~~  340 (373)
T 1q8y_A          327 DAGGLVNHPWLKDT  340 (373)
T ss_dssp             CHHHHHTCGGGTTC
T ss_pred             CHHHHhhChhhhcc
Confidence            9999996  44444

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=100.00  E-value=1.1e-36  Score=309.07  Aligned_cols=217  Identities=16%  Similarity=0.180  Sum_probs=168.6

Q ss_pred             ccccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEE
Q 038934            3 STQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLI   82 (751)
Q Consensus         3 ~~~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~   82 (751)
                      ++.|||++||+|.+|++|  ++|.|+|||+.+++     +.+ |..   +|+||+|||+.|   ..+.|+|+.+|  +||
T Consensus         6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~---~~~vW~an~~~~---~~~~l~l~~dG--nLv   69 (236)
T 1dlp_A            6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS---DVRVWASNTAGA---TGCRAVLQSDG--LLV   69 (236)
T ss_dssp             CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES---SSEEECCCCCSC---SCCBCCBCSSS--CBC
T ss_pred             eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC---CEEEEECCCCCC---CCeEEEEcCCC--cEE
Confidence            567999999999999999  59999999997765     344 442   799999999998   45678887655  999


Q ss_pred             EeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCcccc-CCCCeeeeee-ecCC-----ceE
Q 038934           83 LQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVL-LPGMKLGVNL-VTGL-----NRF  155 (751)
Q Consensus        83 l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtl-Lpg~~lg~~~-~tg~-----~~~  155 (751)
                      |+|++|.+||+|++.......+|+|+|+|||||++       .++||||||||||+ ||+|  |.|. .+|.     ++.
T Consensus        70 l~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~-------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~  140 (236)
T 1dlp_A           70 ILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG-------PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQT  140 (236)
T ss_dssp             CBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC-------SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCE
T ss_pred             EEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEec-------CCEEECCCCCCcccccCCc--cceEEecCCcCCCccce
Confidence            99999999999997644445689999999999983       28999999999887 6665  5554 5555     567


Q ss_pred             EEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCCCCCccccccCCCCCCCCceEEEEeecCceEEEEEEeecCC
Q 038934          156 ISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNGLHWTGMPQLQPNPVYTFEYVSNEKEVFYRFTLIKSS  235 (751)
Q Consensus       156 l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  235 (751)
                      |++   .+||++|.|+|.++++|  +++++++..++|++++|++. +...+++.....+ +.|..++.+++..+..... 
T Consensus       141 L~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~ly~~~~~~vw~s~~~~~~-  212 (236)
T 1dlp_A          141 LHA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-DVLTNQNIAVWTSGNSRSA-  212 (236)
T ss_dssp             ECS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-EEEETTTEEEEECCCCCSS-
T ss_pred             EEc---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-EEEeCCCcEEEEeCCCCCC-
Confidence            764   78999999999999999  57778888899999999753 4455555444432 2233455566666654433 


Q ss_pred             cceEEEEcccCceeEEE
Q 038934          236 VPSMMVVSPLGESQRYT  252 (751)
Q Consensus       236 ~~~~~~l~~~G~l~~~~  252 (751)
                      ...|++|+.+|++++|.
T Consensus       213 ~~~rl~Ld~dG~l~ly~  229 (236)
T 1dlp_A          213 GRYVFVLQPDRNLAIYG  229 (236)
T ss_dssp             SCCEEEECSSSCEEEEC
T ss_pred             CCEEEEEcCCCcEEEeC
Confidence            46899999999999984

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.8e-37  Score=334.47  Aligned_cols=256  Identities=21%  Similarity=0.317  Sum_probs=196.7

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce----
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER----  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  503 (751)
                      .++|...+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999965 5899999999764  233457789999999999999999999999887765    


Q ss_pred             --EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          504 --MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       504 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                        ++||||+. ++|.+++.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999998 58888772     24899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........   ......... ...
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~-~~~  262 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTG-VPG  262 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC-CCC
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhC-CCc
Confidence            865322     233578999999999987 7899999999999999999999999864432111   111100000 000


Q ss_pred             hhh------------cchhccC------ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          661 VEL------------IDKSLED------TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       661 ~~~------------~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .+.            +......      .........+.+|+.+||+.||++|||+.|+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            000            0000000      0011234678899999999999999999999863

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.8e-36  Score=329.32  Aligned_cols=203  Identities=24%  Similarity=0.353  Sum_probs=172.0

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CC-----cEEeEeceeeeCC
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HR-----NLVKLLGCCMKRD  501 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~  501 (751)
                      ...++|.+.++||+|+||.||+|+.. +++.||||++... ....+++..|+.+++.++ |+     +|+++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34579999999999999999999965 5789999999643 344567888999999885 55     4999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc--CCCCeEEeecc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNPKISDFG  579 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFG  579 (751)
                      ..++||||+++ +|.+++.... ...+++..+..++.|++.||.|||.+. .+|+||||||+||||+  .++.+||+|||
T Consensus       130 ~~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          130 HLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             EEEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ceEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            99999999965 9999986532 245899999999999999999999521 2399999999999995  57889999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHH  640 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~  640 (751)
                      +++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99876422     223678999999999999999999999999999999999999987543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.2e-36  Score=354.88  Aligned_cols=256  Identities=23%  Similarity=0.326  Sum_probs=202.9

Q ss_pred             HhcCccccccccccccccEEEEEEcC----CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      ..++|.+.+.||+|+||.||+|.+..    +..||||++... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            45789999999999999999999643    457999998754 3344578999999999999999999999985 56789


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+++++|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            999999999999999642  345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......   ...    ......    
T Consensus       542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~----~i~~~~----  609 (656)
T 2j0j_A          542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIENGE----  609 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH----HHHHTC----
T ss_pred             CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH----HHHcCC----
Confidence            433221 1223456789999999999999999999999999999997 888875332211   111    111111    


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                           ....+......+.+++.+||+.||.+||++.++++.|+.+
T Consensus       610 -----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          610 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                 0112223346788999999999999999999999998764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=328.29  Aligned_cols=256  Identities=20%  Similarity=0.309  Sum_probs=196.2

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc-----
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE-----  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  502 (751)
                      .++|...+.||+|+||.||+|++. +|+.||||++...  .....+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            368999999999999999999975 5899999999754  23345678999999999999999999999987754     


Q ss_pred             -eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          503 -RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       503 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                       .++||||+. ++|.+++.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999998 58887762     24899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC-
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR-  659 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~-  659 (751)
                      +.....     .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||........   +........... 
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~  245 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGT  245 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCH
Confidence            865322     223578999999999887 6789999999999999999999999864332111   111111000000 


Q ss_pred             ----------hhhhcchh---cc---CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          660 ----------PVELIDKS---LE---DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       660 ----------~~~~~d~~---l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                                ....+...   ..   ..........+.+|+.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                      00000000   00   0111234567889999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.6e-36  Score=325.42  Aligned_cols=258  Identities=21%  Similarity=0.313  Sum_probs=200.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CC-cEEEEEEeccCCcccHHHHHHHHHHHHHhcCCc------EEeEeceeeeCCc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DG-QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN------LVKLLGCCMKRDE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  502 (751)
                      .++|.+.+.||+|+||.||++... ++ +.||||++... ....+.+.+|+.++++++|++      ++.+++++.....
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999964 34 68999999643 345577889999999998765      9999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEE---------------
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---------------  567 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll---------------  567 (751)
                      .++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 56777766542 2246899999999999999999999998   9999999999999               


Q ss_pred             ----cCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc
Q 038934          568 ----DNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH  643 (751)
Q Consensus       568 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~  643 (751)
                          +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                56789999999999864322     223578999999999999999999999999999999999999987543321


Q ss_pred             ccchhHHHHHHhccCChhhhcch-------------------------------hccCccCHHHHHHHHHHHhhhcCCCC
Q 038934          644 HHNLLGHAWRLWTEDRPVELIDK-------------------------------SLEDTYSLSEALRCIQVGLLCVQQRP  692 (751)
Q Consensus       644 ~~~~~~~~~~~~~~~~~~~~~d~-------------------------------~l~~~~~~~~~~~l~~li~~cl~~dP  692 (751)
                      ....   ..... ...+...+..                               .............+.+|+.+||+.||
T Consensus       247 ~~~~---~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          247 HLVM---MEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             HHHH---HHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             HHHH---HHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            1111   11100 1101000000                               00001123345688999999999999


Q ss_pred             CCCCCHHHHHH
Q 038934          693 EDRPNMASVVL  703 (751)
Q Consensus       693 ~~RPs~~evl~  703 (751)
                      ++|||+.|+++
T Consensus       323 ~~Rpt~~e~l~  333 (355)
T 2eu9_A          323 AQRITLAEALL  333 (355)
T ss_dssp             TTSCCHHHHTT
T ss_pred             hhCcCHHHHhc
Confidence            99999999984

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.3e-36  Score=325.07  Aligned_cols=257  Identities=20%  Similarity=0.234  Sum_probs=175.7

Q ss_pred             HhcCccccc-cccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHH-HHHHhcCCcEEeEeceeee----CCc
Q 038934          430 ATDNFSEEN-KLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVL-LIAKLQHRNLVKLLGCCMK----RDE  502 (751)
Q Consensus       430 ~~~~y~~~~-~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~----~~~  502 (751)
                      ..++|.+.+ .||+|+||.||+|++. +++.||||++...     ....+|+. .++.+.||||+++++++..    ...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            357888854 6999999999999976 5899999999653     22233333 4566789999999999976    445


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---CCCeEEeecc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFG  579 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFG  579 (751)
                      .++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence            899999999999999996432 246899999999999999999999998   999999999999986   4559999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      +++.....    ......+|+.|+|||++.+..++.++||||||+++|+|++|+.|+.............   ...... 
T Consensus       177 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~-  248 (336)
T 3fhr_A          177 FAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLG-  248 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhcc-
Confidence            99865422    1233578999999999999999999999999999999999999975433221100000   000000 


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCC
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGE  708 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  708 (751)
                           ...............+.+|+.+||+.||.+|||+.++++  .+...
T Consensus       249 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          249 -----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             -----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence                 000000111223457889999999999999999999997  55443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.5e-36  Score=336.23  Aligned_cols=253  Identities=23%  Similarity=0.269  Sum_probs=187.4

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      +.|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+.++.++ +||||+++++++.+....++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            445567889999999998776668999999998653   345678999999987 8999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC-------------CCe
Q 038934          511 PNKSLADFIFDGTRRK----LLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-------------MNP  573 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-------------~~~  573 (751)
                      . ++|.+++.......    ...+..++.++.||+.||.|||+++   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 59999996532211    1133356789999999999999998   9999999999999754             479


Q ss_pred             EEeeccCccccCCCCccc--cccccccccCccCcccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 038934          574 KISDFGMARAFGVDQTEA--NTNRVVGTYGYMPPEYAID-------GLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDH  643 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~  643 (751)
                      ||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.|+.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999999875432221  1234679999999999976       678999999999999999999 899975332211


Q ss_pred             ccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          644 HHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       644 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                          ...    .......    ..+...........+.+++.+||+.||.+|||+.+|++
T Consensus       248 ----~~i----~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ----SNI----IRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ----HHH----HHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHH----hcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                000    0000000    00111123455678899999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-36  Score=325.64  Aligned_cols=255  Identities=22%  Similarity=0.340  Sum_probs=179.2

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHH-HHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVL-LIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .++|...+.||+|+||.||++... +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            368889999999999999999975 58999999997653 334455666666 666679999999999999999999999


Q ss_pred             EecCCCChhHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          508 EYLPNKSLADFIFD--GTRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       508 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      ||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 88877743  12245689999999999999999999998 8   999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccCcccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYA----IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      .....   .....||+.|+|||++    .+..++.++||||||+++|+|++|+.|+........     .... ......
T Consensus       177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~~  247 (327)
T 3aln_A          177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQ-VVKGDP  247 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSCC
T ss_pred             ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHH-HhcCCC
Confidence            43221   2234789999999998    466789999999999999999999999763221100     0000 000000


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           ..+...........+.+|+.+||+.||++||++.++++
T Consensus       248 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 -----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                 01111111223457889999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-37  Score=326.09  Aligned_cols=245  Identities=24%  Similarity=0.432  Sum_probs=191.6

Q ss_pred             HHHHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHHHHHh----cCCcEEeEec
Q 038934          427 IANATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKL----QHRNLVKLLG  495 (751)
Q Consensus       427 i~~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~  495 (751)
                      .....++|.+.+.||+|+||.||+|+.. +++.||||++.....      .....+.+|+.++.++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3455689999999999999999999964 588999999965432      1233467899999999    8999999999


Q ss_pred             eeeeCCceEEEEEe-cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc-CCCCe
Q 038934          496 CCMKRDERMLIYEY-LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNP  573 (751)
Q Consensus       496 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~  573 (751)
                      ++...+..++|||+ +.+++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+||+++ +++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence            99999999999999 899999999954   345899999999999999999999998   99999999999999 88999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHH
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFS-VKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~  652 (751)
                      ||+|||+++......    .....|++.|+|||++.+..+. .++||||||+++|+|++|+.|+....     .      
T Consensus       180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~------  244 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E------  244 (312)
T ss_dssp             EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H------
T ss_pred             EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H------
Confidence            999999998764322    2335789999999999877664 59999999999999999999975211     0      


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                                .....  ...+......+.+++.+||+.||++||++.++++.
T Consensus       245 ----------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          245 ----------ILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ----------HHHTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----------Hhhhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      00000  01122234567899999999999999999999973

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.5e-37  Score=326.21  Aligned_cols=243  Identities=25%  Similarity=0.400  Sum_probs=199.5

Q ss_pred             HHhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcc------cHHHHHHHHHHHHHhc--CCcEEeEeceeee
Q 038934          429 NATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQ------GVEEFKNEVLLIAKLQ--HRNLVKLLGCCMK  499 (751)
Q Consensus       429 ~~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~  499 (751)
                      ...++|.+.+.||+|+||.||+|+.. +++.||||++......      ..+.+.+|+.++++++  |+||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            44578999999999999999999964 5889999999754221      2356788999999996  5999999999999


Q ss_pred             CCceEEEEEecCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc-CCCCeEEee
Q 038934          500 RDERMLIYEYLPN-KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISD  577 (751)
Q Consensus       500 ~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~D  577 (751)
                      .+..++|||++.+ ++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++ +++.+||+|
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence            9999999999986 899999854   346899999999999999999999998   99999999999999 789999999


Q ss_pred             ccCccccCCCCccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhc
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                      ||+++......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.....            ...
T Consensus       194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~  257 (320)
T 3a99_A          194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIR  257 (320)
T ss_dssp             CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH
T ss_pred             Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhc
Confidence            99998764321    223578999999999987766 7889999999999999999999753110            000


Q ss_pred             cCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          657 EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       657 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ..           ..........+.+|+.+||+.||++||++.++++.
T Consensus       258 ~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          258 GQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cc-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00           00111234568899999999999999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.1e-36  Score=318.26  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=178.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc-cc-HHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG-QG-VEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      .++|+..+.||+|+||.||+|++. +++.||||++..... .. .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            468889999999999999999975 589999999976532 22 233445555677789999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      ||+ ++.+..+...  ....+++..+..++.|++.||.|||++ +   |+|+||||+|||++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 5555555432  234689999999999999999999995 8   99999999999999999999999999976543


Q ss_pred             CCccccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      ...   .....||+.|+|||++.     +..++.++||||||+++|+|++|+.|+......  .....   ........ 
T Consensus       178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~---~~~~~~~~-  248 (318)
T 2dyl_A          178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLT---KVLQEEPP-  248 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHH---HHHHSCCC-
T ss_pred             Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHH---HHhccCCC-
Confidence            221   22357899999999994     557899999999999999999999997632211  11111   11111100 


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .     +.  ........+.+++.+||+.||.+||++.++++
T Consensus       249 ~-----~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 L-----LP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C-----CC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-----CC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0     00  01123456889999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=330.27  Aligned_cols=250  Identities=22%  Similarity=0.310  Sum_probs=186.8

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ..+|...++||+|+||+|+.....+++.||||++.....   +.+.+|+.+++++ +|||||++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            356888899999999997655566899999999965432   3457899999999 799999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-----CCCeEEeeccCcccc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAF  584 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DFGla~~~  584 (751)
                      +. ++|.+++....  ..+.+..+..++.||+.||.|||+++   |+||||||+|||++.     ...+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            97 59999986432  23444566789999999999999998   999999999999953     235889999999876


Q ss_pred             CCCCcc-ccccccccccCccCccccc---CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          585 GVDQTE-ANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       585 ~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      ...... .......||+.|+|||++.   ...++.++|||||||++|||++ |..|+.......       .........
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACS  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCC
Confidence            533221 2233467999999999998   4567889999999999999999 888874322111       000011100


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      . ...      .........+.+|+.+||+.||.+|||+.+|++
T Consensus       247 ~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 L-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             C-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0 000      112234556789999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.3e-36  Score=343.65  Aligned_cols=265  Identities=24%  Similarity=0.299  Sum_probs=199.4

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeee------CCc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK------RDE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  502 (751)
                      .++|.+.++||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            478999999999999999999964 5899999998754 34456779999999999999999999998765      677


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCC---eEEeecc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFG  579 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFG  579 (751)
                      .++||||+++++|.+++........+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555556899999999999999999999998   999999999999997765   9999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc-cc-hhHHH-HHHhc
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHH-HN-LLGHA-WRLWT  656 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~-~~-~~~~~-~~~~~  656 (751)
                      ++........   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .. ..... .....
T Consensus       170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            9987643322   2346789999999999999999999999999999999999999864321100 00 00000 00000


Q ss_pred             cCChhh--hcchh--ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 038934          657 EDRPVE--LIDKS--LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV  701 (751)
Q Consensus       657 ~~~~~~--~~d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  701 (751)
                      ......  .....  ............+.+++.+||+.||++|||+.++
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            000000  00000  0112334467789999999999999999999773

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.6e-35  Score=345.38  Aligned_cols=238  Identities=22%  Similarity=0.330  Sum_probs=191.9

Q ss_pred             hcCccccccccccccccEEEEEEc--CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc-----
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI--DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE-----  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  502 (751)
                      .++|.+.++||+|+||.||++.+.  +++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999975  5899999998654 33445678999999999999999999999988766     


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||+++++|.+++..     .+++..++.++.||+.||.|||+++   |+||||||+|||++++ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            7999999999999987732     6899999999999999999999998   9999999999999986 89999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      .....      ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+........               .  
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------~--  285 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------P--  285 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------C--
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------c--
Confidence            76432      3367999999999987654 8999999999999999999877542111100               0  


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHHHhC
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN-MASVVLMLSG  707 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~  707 (751)
                            ...........+.+|+.+||+.||.+||+ +.++.+.|.+
T Consensus       286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                  00011122356789999999999999995 5555555543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-34  Score=304.79  Aligned_cols=231  Identities=11%  Similarity=0.087  Sum_probs=183.7

Q ss_pred             hcCccccccccccccccEEEEEEcC-CcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|++.+.||+|+||.||+|++.. ++.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            3679999999999999999999754 8999999997653   23457899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++++|.+++..    . .....+.+++.||+.||.|||+++   |+||||||+|||+++++.+||++++       
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999999832    2 355678899999999999999999   9999999999999999999997443       


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                                     |++|       ++.++|||||||++|||++|+.||.............   .... ....   . 
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~-~~~~---~-  224 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTA-GQPI---E-  224 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTT-SCBC---C-
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhc-cCCC---C-
Confidence                           3333       6899999999999999999999987544322110000   0000 0000   0 


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                        ...........+.+|+.+||+.||++| |+.|+++.|+...
T Consensus       225 --~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          225 --PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             --HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             --hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence              000111234568899999999999999 9999999998863

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-34  Score=320.53  Aligned_cols=241  Identities=17%  Similarity=0.183  Sum_probs=179.9

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcC-Cc---------------E
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH-RN---------------L  490 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~n---------------i  490 (751)
                      .++|...+.||+|+||+||+|++. +++.||||++...   .....+.+.+|+.+++.++| +|               +
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            456778889999999999999954 5899999998743   22346789999999999977 21               1


Q ss_pred             EeE------eceeee-----CCceEEEEEecCCCChhHHHhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCE
Q 038934          491 VKL------LGCCMK-----RDERMLIYEYLPNKSLADFIFD----GTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRI  555 (751)
Q Consensus       491 v~l------~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i  555 (751)
                      +.+      ..++..     ....+++|+++ +++|.+++..    ......+++..++.++.||++||.|||+++   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence            111      111111     12356666655 6799998842    223456788899999999999999999998   9


Q ss_pred             EEccCCCCCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccc----------cCCCCCcchhhHHHHHH
Q 038934          556 IHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA----------IDGLFSVKSDVFSFGVL  625 (751)
Q Consensus       556 vH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~k~DVwSlG~l  625 (751)
                      +||||||+||||+.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999999875422     333567 999999999          66678999999999999


Q ss_pred             HHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 038934          626 VLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV  702 (751)
Q Consensus       626 l~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  702 (751)
                      +|||++|+.||........                   ....+....  ..+..+.+|+.+||+.||++||++.+++
T Consensus       307 l~elltg~~Pf~~~~~~~~-------------------~~~~~~~~~--~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG-------------------SEWIFRSCK--NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC-------------------SGGGGSSCC--CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhhh-------------------HHHHHhhcc--cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999999864332211                   111111111  1235688999999999999999977764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8.1e-34  Score=300.04  Aligned_cols=233  Identities=20%  Similarity=0.248  Sum_probs=180.8

Q ss_pred             hcCcccc-ccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHH-HHhcCCcEEeEeceeee----CCce
Q 038934          431 TDNFSEE-NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLI-AKLQHRNLVKLLGCCMK----RDER  503 (751)
Q Consensus       431 ~~~y~~~-~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~  503 (751)
                      .++|.+. +.||+|+||.||++... +++.||||++...     ..+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4577776 77999999999999964 5889999999542     5678899988 45589999999999987    6778


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---CCCeEEeeccC
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGM  580 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGl  580 (751)
                      ++||||+++++|.+++... ....+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            9999999999999999653 2346899999999999999999999998   999999999999998   78899999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      +....                        +..++.++|||||||++|+|++|+.||..........           ...
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~~  211 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GMK  211 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CSC
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HHH
Confidence            86532                        2446789999999999999999999975432211100           000


Q ss_pred             hhhcchhccCccC----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCCC
Q 038934          661 VELIDKSLEDTYS----LSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGER  709 (751)
Q Consensus       661 ~~~~d~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  709 (751)
                      ..+...  ....+    ......+.+++.+||+.||.+|||+.|+++  .+....
T Consensus       212 ~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          212 TRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             CSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            000000  00011    123457889999999999999999999996  444443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.2e-35  Score=313.42  Aligned_cols=241  Identities=16%  Similarity=0.131  Sum_probs=183.2

Q ss_pred             hcCccccccccccccccEEEEEEcCCcEEEEEEeccCC--------cccHHHHHHHHHHHHHhc---------CCcEEeE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQ---------HRNLVKL  493 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  493 (751)
                      .++|.+.++||+|+||.||+|++ +++.||||++....        ....+.+.+|+.++++++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999998 78999999997642        234578999999999986         6666655


Q ss_pred             ece-----------------eee-------------CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 038934          494 LGC-----------------CMK-------------RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARG  543 (751)
Q Consensus       494 ~~~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~  543 (751)
                      .++                 +.+             ....++||||+++|++.+.+.    ...+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence            554                 333             678999999999998777663    2468999999999999999


Q ss_pred             HHHHH-hCCCCCEEEccCCCCCeEEcCCC--------------------CeEEeeccCccccCCCCccccccccccccCc
Q 038934          544 LLYLH-QDSRLRIIHRDLKASNVLLDNEM--------------------NPKISDFGMARAFGVDQTEANTNRVVGTYGY  602 (751)
Q Consensus       544 L~yLH-~~~~~~ivH~Dikp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  602 (751)
                      |.||| +++   |+||||||+||||+.++                    .+||+|||+++....       ....||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence            99999 888   99999999999999887                    899999999987542       135799999


Q ss_pred             cCcccccCCCCCcchhhHHHHHH-HHHHHhCCCCCCCCCCccccchhHHHH-HHhccCChhhhcchhccCccCHHHHHHH
Q 038934          603 MPPEYAIDGLFSVKSDVFSFGVL-VLELVYGTRNRGFHHVDHHHNLLGHAW-RLWTEDRPVELIDKSLEDTYSLSEALRC  680 (751)
Q Consensus       603 ~aPE~~~~~~~t~k~DVwSlG~l-l~ell~G~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~l  680 (751)
                      +|||++.+.. +.++||||++++ .++++.|..|+...      ....... ........    ...............+
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTF----KTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCC----SSCCCSHHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhcc----CcccchhhhhhcCHHH
Confidence            9999998777 899999998777 77888898885210      0000000 00000000    0000111123456789


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHH
Q 038934          681 IQVGLLCVQQRPEDRPNMASVV  702 (751)
Q Consensus       681 ~~li~~cl~~dP~~RPs~~evl  702 (751)
                      .+|+.+||+.|     |+.|++
T Consensus       313 ~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHhccC-----CHHHHH
Confidence            99999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.9e-29  Score=288.84  Aligned_cols=185  Identities=19%  Similarity=0.190  Sum_probs=131.7

Q ss_pred             cccccccccEEEEEE-cCCcEEEEEEeccCC----------cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEE
Q 038934          439 KLGEGGFGPVYKGML-IDGQEIAVKRLSKSS----------GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++.|+.|.+..++. --|+.+|+|.+.+..          +...++|.+|+++|+++ .|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            466777777766553 348899999997541          23356799999999999 799999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||++|++|.++|.+   .+.++..   +|+.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+....
T Consensus       321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999954   3456554   58899999999999999   99999999999999999999999999987654


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRN  635 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p  635 (751)
                      ...  .....+||++|+|||++.+. +..++|+||+|+++++|.++..+
T Consensus       392 ~~~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc--cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            322  23347899999999998764 67789999999999988766443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=8.5e-26  Score=257.12  Aligned_cols=186  Identities=19%  Similarity=0.186  Sum_probs=146.0

Q ss_pred             CccccccccccccccEEEEEEcCCcEEEEEEeccCCc--------ccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      .+...++||+|+||.||++.. .++.+++|+......        ...+++.+|++++++++||||+++..++...+..+
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             -----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred             cCCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence            334567899999999999954 678899998754311        12345899999999999999997777777888899


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+++++|.+++..           +..++.|+++||.|||+++   |+||||||+|||+++  .+||+|||+++..
T Consensus       416 lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            99999999999999843           5689999999999999998   999999999999999  9999999999987


Q ss_pred             CCCCccc-----cccccccccCccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCC
Q 038934          585 GVDQTEA-----NTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLELVYGTRN  635 (751)
Q Consensus       585 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~k~DVwSlG~ll~ell~G~~p  635 (751)
                      .......     ......||+.|+|||++..  ..|+.++|+|+..+-..+.+.++.+
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence            5432211     1235789999999999987  5688899999999999888877655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=1.3e-22  Score=211.78  Aligned_cols=153  Identities=18%  Similarity=0.137  Sum_probs=123.4

Q ss_pred             HhHHHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCc------------------ccHHHHHHHHHHHHHhc
Q 038934          425 KSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG------------------QGVEEFKNEVLLIAKLQ  486 (751)
Q Consensus       425 ~~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~  486 (751)
                      ..+......|.+.+.||+|+||.||+|.+.+++.||||+++....                  .....+.+|+.++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344555667777899999999999999997799999999964321                  13457899999999999


Q ss_pred             CCcEEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeE
Q 038934          487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL  566 (751)
Q Consensus       487 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIl  566 (751)
                        | +++.+++. .+..++||||+++++|.+ +.   .      .....++.|++.||.|||+.+   |+||||||+|||
T Consensus       163 --~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~---~------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL  225 (282)
T 1zar_A          163 --G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR---V------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL  225 (282)
T ss_dssp             --T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC---C------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             --C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc---h------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence              5 66777554 466799999999999998 41   1      224479999999999999999   999999999999


Q ss_pred             EcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccC
Q 038934          567 LDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID  610 (751)
Q Consensus       567 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  610 (751)
                      ++ ++.+||+|||+++.               +..++|||++..
T Consensus       226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             EE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             EE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            99 99999999999863               335788998743

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.84  E-value=8.7e-21  Score=165.48  Aligned_cols=105  Identities=19%  Similarity=0.424  Sum_probs=89.5

Q ss_pred             ccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEe
Q 038934            5 QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQ   84 (751)
Q Consensus         5 ~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~   84 (751)
                      .|+|.+||.|.+|++|+|  |.|.|.|...|+     |.++.    ..++||+|||+.|... .+.|+|+.  ||+|||+
T Consensus         1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~-~~~L~l~~--dGnLvL~   66 (105)
T 4h3o_A            1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKS-GCSAVLQS--DGNFVVY   66 (105)
T ss_dssp             CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-SCEEEECT--TSCEEEE
T ss_pred             CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCc-cEEEEEeC--CccEEEE
Confidence            489999999999999988  889999998887     77864    4699999999999765 45677765  5599999


Q ss_pred             CCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeee
Q 038934           85 NSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQS  130 (751)
Q Consensus        85 ~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqS  130 (751)
                      |+++.+||+|++.......+|+|+|+|||||++       ..||||
T Consensus        67 d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~-------~~~W~S  105 (105)
T 4h3o_A           67 DSSGRSLWASHSTRGSGNYILILQDDGNVIIYG-------SDIWST  105 (105)
T ss_dssp             CTTCCEEEECCCCCCSSCEEEEECTTSCEEEEE-------SEEEEC
T ss_pred             CCCcEEEEEecCCCCCCCEEEEEeCCCeEEEEC-------CcEecC
Confidence            999999999998765566789999999999984       369998

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.84  E-value=1.1e-20  Score=168.95  Aligned_cols=108  Identities=21%  Similarity=0.331  Sum_probs=91.5

Q ss_pred             ccccccCCCCccCCCCeEe--eCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCce
Q 038934            3 STQDTLRLGQSIRDGETLV--SANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGT   80 (751)
Q Consensus         3 ~~~~~~~~~~~l~~~~~l~--S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~   80 (751)
                      ++.|+|++||+|.+|++|+  |++|.|+|+|+.+|+     + +||++   +++||+|||+.|  +..+.|+|..+|  |
T Consensus         6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~---~~~vW~sn~~~~--~~~~~l~l~~dG--N   72 (119)
T 1b2p_A            6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN---NNPIWATNTGGL--GNGCRAVLQPDG--V   72 (119)
T ss_dssp             CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSCEEEECTTS--C
T ss_pred             ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC---CEEEEeCCCccC--CCceEEEEccCC--E
Confidence            5689999999999999999  999999999998876     3 57875   799999999876  334677776544  9


Q ss_pred             EEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeee
Q 038934           81 LILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQS  130 (751)
Q Consensus        81 l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqS  130 (751)
                      |||+|.++.+||+|++.......+++|+|+|||||++       .++|||
T Consensus        73 LVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~-------~~~W~S  115 (119)
T 1b2p_A           73 LVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-------DALWAT  115 (119)
T ss_dssp             EEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-------SEEEEC
T ss_pred             EEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC-------ccEeCC
Confidence            9999999999999997644445678999999999985       279998

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.83  E-value=5.3e-20  Score=162.33  Aligned_cols=110  Identities=20%  Similarity=0.419  Sum_probs=91.9

Q ss_pred             ccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEe
Q 038934            5 QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQ   84 (751)
Q Consensus         5 ~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~   84 (751)
                      +|+|.+||+|.+|++|+ ++|.|+|+|+..|+     | |+|+   .+++||.||++.|-  ..+.+.|..+|  ||||+
T Consensus         1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~~dG--NLVl~   66 (110)
T 3a0c_A            1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG--SGCRLTLHNNG--NLVIY   66 (110)
T ss_dssp             CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC--SSCEEEECTTS--CEEEE
T ss_pred             CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC--CcEEEEEeCCC--CEEEE
Confidence            48999999999999999 99999999998876     4 6676   37999999998763  34567776544  99999


Q ss_pred             CCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCc
Q 038934           85 NSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPT  135 (751)
Q Consensus        85 ~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PT  135 (751)
                      |.++.+||+|++.......+++|+|+|||||++       ..+||||+||.
T Consensus        67 ~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~-------~~~W~S~~~~~  110 (110)
T 3a0c_A           67 DQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYG-------PVVWATGSGPA  110 (110)
T ss_dssp             CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC-------SEEEECSCCC-
T ss_pred             CCCCcEEEecCCCCCCCCEEEEEeCCccEEEEC-------CCEecCCCcCC
Confidence            999999999997654445589999999999974       17999999983

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.81  E-value=1.5e-19  Score=161.04  Aligned_cols=110  Identities=23%  Similarity=0.368  Sum_probs=90.6

Q ss_pred             ccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEe
Q 038934            5 QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQ   84 (751)
Q Consensus         5 ~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~   84 (751)
                      .|||.+||+|.+|++|+  +|.|+|+|+.+|+     |. +|.   ..++||+|||+.|.  ..+.|.|..  +|||||+
T Consensus         2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~---~~~~vW~sn~~~~~--~~~~l~l~~--~GnLvl~   66 (115)
T 2dpf_A            2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ---NGRQIWASNTDRRG--SGCRLTLLS--DGNLVIY   66 (115)
T ss_dssp             CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EE-EEE---TTEEEEECSCTTSC--SSCEEEECT--TSCEEEE
T ss_pred             CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe---CCEEEEeCCCCCCC--CceEEEECC--CCcEEEE
Confidence            58999999999999998  8999999988775     33 365   47999999999883  346677765  4599999


Q ss_pred             CCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCcc
Q 038934           85 NSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTH  136 (751)
Q Consensus        85 ~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTD  136 (751)
                      |.++.+||+|++.......+++|+++|||||++      . ++||||.+++.
T Consensus        67 d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~------~-~~W~S~~~~~~  111 (115)
T 2dpf_A           67 DHNNNDVWGSACWGDNGKYALVLQKDGRFVIYG------P-VLWSLGPNGCR  111 (115)
T ss_dssp             CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC------S-EEECSSTTCBC
T ss_pred             CCCceEEEEcCCCCCCCCEEEEEeCCCeEEEEC------C-CEEECCCCCCc
Confidence            998999999997644445679999999999983      1 79999998764

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.79  E-value=3e-19  Score=158.36  Aligned_cols=110  Identities=22%  Similarity=0.464  Sum_probs=89.7

Q ss_pred             ccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEe
Q 038934            5 QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQ   84 (751)
Q Consensus         5 ~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~   84 (751)
                      +|||.+||+|.+|++|  ++|.|+|+|+.+|+     | +||.+   +++||+||++.+  +..+.+.|..  +|||||+
T Consensus         1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~---~~~vW~sn~~~~--~~~~~l~l~~--~GNLvl~   65 (112)
T 1xd5_A            1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN---NRAVWASGTNGK--ASGCVLKMQN--DGNLVIY   65 (112)
T ss_dssp             CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSEEEEECT--TSCEEEE
T ss_pred             CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC---CEEEEeCCCcCC--CCCEEEEEeC--CCCEEEE
Confidence            4899999999999999  58999999999887     3 45764   699999999753  3345677765  5599999


Q ss_pred             CCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCC
Q 038934           85 NSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYP  134 (751)
Q Consensus        85 ~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~P  134 (751)
                      | ++.++|+|++.......+++|+++|||||++.+    +.++||||++.
T Consensus        66 d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~----~~~~W~S~~~~  110 (112)
T 1xd5_A           66 S-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS----NNAIWATHTNV  110 (112)
T ss_dssp             E-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTT----SCEEEECCCCC
T ss_pred             c-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCC----CceEEECCCcc
Confidence            9 888999998764444568999999999998643    57999999984

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=1.3e-18  Score=179.17  Aligned_cols=137  Identities=15%  Similarity=0.187  Sum_probs=107.0

Q ss_pred             CccccccccccccccEEEEEE-cCCcE--EEEEEeccCCcc------------------------cHHHHHHHHHHHHHh
Q 038934          433 NFSEENKLGEGGFGPVYKGML-IDGQE--IAVKRLSKSSGQ------------------------GVEEFKNEVLLIAKL  485 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  485 (751)
                      -|.+.+.||+|+||.||+|.+ .+|+.  ||||+++.....                        ....+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356788999999999999997 67888  999987543111                        113688999999999


Q ss_pred             cCCcE--EeEeceeeeCCceEEEEEecCC-C----ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCEEE
Q 038934          486 QHRNL--VKLLGCCMKRDERMLIYEYLPN-K----SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH-QDSRLRIIH  557 (751)
Q Consensus       486 ~h~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~~~ivH  557 (751)
                      .|+++  ..++.+    ...+|||||+.+ |    +|.++...      .++..+..++.|++.+|.||| +.+   |+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH  194 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH  194 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence            88754  333332    467899999942 3    66665422      234567789999999999999 888   999


Q ss_pred             ccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          558 RDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       558 ~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      |||||+|||+++  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999764

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.75  E-value=3.4e-18  Score=150.53  Aligned_cols=105  Identities=27%  Similarity=0.433  Sum_probs=85.2

Q ss_pred             ccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEe
Q 038934            5 QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQ   84 (751)
Q Consensus         5 ~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~   84 (751)
                      .+||.|||+|.+|++|+  +|.|+|+|+..|+     |.+ |..   .++||+||++.+  +..+.|.|..  ||||||+
T Consensus         1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~---~~~vW~snt~~~--~~~~~l~l~~--dGNLvl~   65 (109)
T 3dzw_A            1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV---DKPIWATNTGGL--DRRCHLSMQS--DGNLVVY   65 (109)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET---TEEEEECCCTTS--SSSCEEEECT--TSCEEEE
T ss_pred             CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC---CEEEEECCcccC--CCCEEEEEeC--CCCEEEE
Confidence            37999999999999997  7999999998876     444 654   699999999876  3345677765  4599999


Q ss_pred             CCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeec
Q 038934           85 NSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSF  131 (751)
Q Consensus        85 ~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSF  131 (751)
                      |.++.++|+|++.......+|+|+|+|||||++       ..+|||=
T Consensus        66 ~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~-------~~~W~s~  105 (109)
T 3dzw_A           66 SPRNNPIWASNTGGENGNYVCVLQKDRNVVIYG-------TARWATG  105 (109)
T ss_dssp             CTTSCEEEECCCCCSSSCEEEEECTTSCEEEEE-------SCCCCCC
T ss_pred             CCCCCEEEECCCCCCCCCEEEEEeCCCEEEEEC-------CCEEeCC
Confidence            999999999997644444689999999999985       2789983

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.71  E-value=2.8e-17  Score=144.62  Aligned_cols=106  Identities=21%  Similarity=0.338  Sum_probs=84.2

Q ss_pred             CccccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceE
Q 038934            2 TSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTL   81 (751)
Q Consensus         2 ~~~~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l   81 (751)
                      -+++|||.+||+|..|+.|+|  |.|.|-|...|+     |.+ |..    ++||.+|++..  +..+.|.|..  ||||
T Consensus         3 ~~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~--dGNL   66 (110)
T 3r0e_B            3 PFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNH--KGEL   66 (110)
T ss_dssp             CCBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECT--TSCE
T ss_pred             ccccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeC--CCcE
Confidence            368899999999999999998  459998766665     666 543    58999999862  2345667755  5599


Q ss_pred             EEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeee
Q 038934           82 ILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQS  130 (751)
Q Consensus        82 ~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqS  130 (751)
                      ||+|.++.++|+|++.......+|+|+|+|||||++       ..+|+|
T Consensus        67 vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~-------~~~W~t  108 (110)
T 3r0e_B           67 IIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG-------PAIFET  108 (110)
T ss_dssp             EEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC-------SEEEES
T ss_pred             EEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec-------CCEecC
Confidence            999999999999997544444689999999999984       379987

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.67  E-value=3.3e-16  Score=138.53  Aligned_cols=108  Identities=17%  Similarity=0.263  Sum_probs=87.0

Q ss_pred             ccccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEE
Q 038934            3 STQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLI   82 (751)
Q Consensus         3 ~~~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~   82 (751)
                      .+.|||.+||.|.+|+.|.+  |.|.|-|...|+     |.++..+  ..++||.+|+..+-  ..+.|.|..  +||||
T Consensus         4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~~--~~~~vWssnt~~~~--~~~~l~l~~--dGNLV   70 (113)
T 3mez_B            4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKGS--KTNIVWESGTSGRG--QHCFMRLGH--SGELD   70 (113)
T ss_dssp             CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEETT--TTEEEEECCCTTSC--SSCEEEECT--TSCEE
T ss_pred             ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEECC--CCEEEEECCcccCC--cCEEEEEeC--CCcEE
Confidence            46899999999999999974  889999988777     7775321  36899999998652  345666655  55999


Q ss_pred             EeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeee
Q 038934           83 LQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQS  130 (751)
Q Consensus        83 l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqS  130 (751)
                      |+|.++.++|+|++.......+|+|+|+|||||++       ..||+|
T Consensus        71 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~-------~~~W~s  111 (113)
T 3mez_B           71 ITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG-------PAVWST  111 (113)
T ss_dssp             EECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC-------SEEEES
T ss_pred             EECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec-------CCEecC
Confidence            99999999999998644444689999999999984       479997

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.64  E-value=9.6e-17  Score=171.87  Aligned_cols=141  Identities=14%  Similarity=0.200  Sum_probs=101.1

Q ss_pred             HHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCc--------------ccHHH--------HHHHHHHHHHh
Q 038934          428 ANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG--------------QGVEE--------FKNEVLLIAKL  485 (751)
Q Consensus       428 ~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l  485 (751)
                      ....--|++.+.||+|+||.||+|...+|+.||||+++....              .....        ..+|...|.++
T Consensus        91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            333344899999999999999999998999999998753210              01111        23455556665


Q ss_pred             cCCcEE--eEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCC
Q 038934          486 QHRNLV--KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKAS  563 (751)
Q Consensus       486 ~h~niv--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~  563 (751)
                      .+.++.  ..++    ....+|||||+++.+|..+..         ......++.||+.+|.+||+.+   ||||||||.
T Consensus       171 ~~~gv~vp~p~~----~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~  234 (397)
T 4gyi_A          171 YEEGFPVPEPIA----QSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEF  234 (397)
T ss_dssp             HHTTCSCCCEEE----EETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred             HhcCCCCCeeee----ccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence            433321  2221    123479999999988876541         1234568899999999999998   999999999


Q ss_pred             CeEEcCCC----------CeEEeeccCcccc
Q 038934          564 NVLLDNEM----------NPKISDFGMARAF  584 (751)
Q Consensus       564 NIll~~~~----------~~kl~DFGla~~~  584 (751)
                      ||||++++          .+.|+||+-+...
T Consensus       235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          235 NILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            99998776          3899999977543

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.63  E-value=1.1e-15  Score=134.22  Aligned_cols=109  Identities=26%  Similarity=0.408  Sum_probs=85.9

Q ss_pred             ccccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEE
Q 038934            3 STQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLI   82 (751)
Q Consensus         3 ~~~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~   82 (751)
                      +|.|||.|||.|..|+.|  .+|.|.|.|...|+     |-+ |..      +|.+|+..+  +..+.|+|..  ||+||
T Consensus         1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~------~Wssnt~~~--~~~~~l~l~~--dGnLv   62 (109)
T 3r0e_A            1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG------NWQSNTANN--GRDCKLTLTD--YGELV   62 (109)
T ss_dssp             CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT------TEECCCTTS--CSSCEEEECT--TSCEE
T ss_pred             CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC------eEEcCCCCC--CCcEEEEEcC--CCeEE
Confidence            478999999999999999  57999999988776     444 431      699998764  2345666655  55999


Q ss_pred             EeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCC
Q 038934           83 LQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPG  141 (751)
Q Consensus        83 l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg  141 (751)
                      |.|.++.++|++++.......+|+|+|+|||||++       ..+|+|     .|.+||
T Consensus        63 l~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~-------~~~W~s-----~t~~~~  109 (109)
T 3r0e_A           63 IKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG-------PSVFKI-----DPWVRG  109 (109)
T ss_dssp             EECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC-------SEEEEE-----CTTSCC
T ss_pred             EEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe-------cCEECC-----CCccCC
Confidence            99999999999997644445689999999999984       479998     555554

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.57  E-value=6e-15  Score=130.54  Aligned_cols=96  Identities=20%  Similarity=0.356  Sum_probs=74.2

Q ss_pred             CCCCCCceeEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCC
Q 038934           63 PLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGM  142 (751)
Q Consensus        63 p~~~~~~~l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~  142 (751)
                      |+.+....|.|..  ||+|+|++. +.+||++++.......+|+|+++|||||++ +    +.++||||+          
T Consensus        15 ~L~~~~~~L~~~~--dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~----~~~~W~S~~----------   76 (112)
T 1xd5_A           15 SLAEGGYLFIIQN--DCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G----SRAIWASNT----------   76 (112)
T ss_dssp             EEEETTEEEEECT--TSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T----TEEEEECCC----------
T ss_pred             EEeCCCEEEEEcC--CCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C----CEEEEECCc----------
Confidence            3433345566654  559999987 789999997644445689999999999997 4    579999994          


Q ss_pred             eeeeeeecCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEe-CCeeeecCCCCCc
Q 038934          143 KLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLK-GSTIRYRPGSWNG  199 (751)
Q Consensus       143 ~lg~~~~tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~-~~~~~~~sg~w~~  199 (751)
                                           +|++|.|++.++++|.  ++++. ...++|++++|+|
T Consensus        77 ---------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g  111 (112)
T 1xd5_A           77 ---------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG  111 (112)
T ss_dssp             ---------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred             ---------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence                                 4556889999999997  45554 5679999999986

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.53  E-value=1.9e-14  Score=126.62  Aligned_cols=88  Identities=22%  Similarity=0.394  Sum_probs=69.0

Q ss_pred             CceeEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeee
Q 038934           68 SGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVN  147 (751)
Q Consensus        68 ~~~l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~  147 (751)
                      ...|.|+  .||+|||++ .+.+||++++.......+++|+++|||||++.+    +.+|||||                
T Consensus        21 ~~~l~~~--~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~----~~~~W~S~----------------   77 (110)
T 3a0c_A           21 SYRLIMQ--GDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS----NRVIWQTK----------------   77 (110)
T ss_dssp             TEEEEEC--TTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEECC----------------
T ss_pred             CEEEEEc--CCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC----CcEEEecC----------------
Confidence            4456664  456999998 589999999764444568999999999999754    67999999                


Q ss_pred             eecCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCCCC
Q 038934          148 LVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSW  197 (751)
Q Consensus       148 ~~tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~w  197 (751)
                                     +++++|.|++.++++|.  ++++++  .||+++++
T Consensus        78 ---------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~  108 (110)
T 3a0c_A           78 ---------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG  108 (110)
T ss_dssp             ---------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred             ---------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence                           24567899999999997  455654  79998865

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.51  E-value=9e-14  Score=123.92  Aligned_cols=88  Identities=22%  Similarity=0.338  Sum_probs=69.3

Q ss_pred             ceeEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeeee
Q 038934           69 GVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNL  148 (751)
Q Consensus        69 ~~l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~~  148 (751)
                      +..+|....||+|+|++. +.+||++++.......+|+|+|+|||||++.+    +++|||||                 
T Consensus        30 g~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~----~~~lW~S~-----------------   87 (119)
T 1b2p_A           30 HVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE----NVTVWQSP-----------------   87 (119)
T ss_dssp             EEEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEECS-----------------
T ss_pred             CCEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC----CcEEEcCC-----------------
Confidence            344555556679999987 89999999764444578999999999999754    67999999                 


Q ss_pred             ecCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCCC
Q 038934          149 VTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGS  196 (751)
Q Consensus       149 ~tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  196 (751)
                                    .+|++|.|++.++++|.  +++++  ..||++|+
T Consensus        88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~  117 (119)
T 1b2p_A           88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT  117 (119)
T ss_dssp             --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred             --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence                          35667899999999997  45555  38999885

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.48  E-value=2e-13  Score=121.18  Aligned_cols=89  Identities=24%  Similarity=0.369  Sum_probs=70.1

Q ss_pred             ceeEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeeee
Q 038934           69 GVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNL  148 (751)
Q Consensus        69 ~~l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~~  148 (751)
                      ..|.|  ..||+|+|++ .+.+||++++.....+..++|+++|||||++.+    +.++||||++               
T Consensus        22 ~~L~~--~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~----~~~vW~S~~~---------------   79 (115)
T 2dpf_A           22 YTLTI--QNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN----NNDVWGSACW---------------   79 (115)
T ss_dssp             EEEEE--CTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT----CCEEEECCCC---------------
T ss_pred             EEEEE--cCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC----ceEEEEcCCC---------------
Confidence            34455  4566999998 578999999764444568999999999999754    5799999997               


Q ss_pred             ecCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCCCCCc
Q 038934          149 VTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSWNG  199 (751)
Q Consensus       149 ~tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~w~~  199 (751)
                                      +++|.|++.++++|.  +++++.  .+|++++|..
T Consensus        80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~  110 (115)
T 2dpf_A           80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGC  110 (115)
T ss_dssp             ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCB
T ss_pred             ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCC
Confidence                            345789999999997  455654  8999999975

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.47  E-value=1.8e-13  Score=120.48  Aligned_cols=103  Identities=18%  Similarity=0.293  Sum_probs=80.2

Q ss_pred             ccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEe
Q 038934            5 QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQ   84 (751)
Q Consensus         5 ~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~   84 (751)
                      +|||.+||.|.+|+.|  .+|.|.|.|...|+     |.+ |..   .. ||.+|+..+  .....|.|..  +|||||+
T Consensus         2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~--dGNLVl~   65 (111)
T 3mez_A            2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNN--RGQLEIH   65 (111)
T ss_dssp             TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTS--CSSCEEEECT--TSCEEEE
T ss_pred             cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccC--CcCEEEEEcC--CCcEEEE
Confidence            6899999999999999  47999999988776     555 443   23 999999876  2245666655  5599999


Q ss_pred             CCCCC-eeeeecCCC--CCCCcEEEEecCCCEEEEcCCCCCCCCceeee
Q 038934           85 NSTNG-IVWSSNASR--TAQNPVAVLLESGNLVVKSGNDNDSDNFLWQS  130 (751)
Q Consensus        85 ~~~~~-~vWst~~~~--~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqS  130 (751)
                      |.++. ++|+|++..  .....+++|+++|||||++       ..+|+|
T Consensus        66 ~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~-------~~~W~s  107 (111)
T 3mez_A           66 SANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG-------PAIWST  107 (111)
T ss_dssp             CSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC-------SEEEEC
T ss_pred             eCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec-------cCEEcc
Confidence            98876 599999632  2234579999999999984       479998

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.32  E-value=4.7e-12  Score=130.14  Aligned_cols=147  Identities=15%  Similarity=0.094  Sum_probs=116.2

Q ss_pred             HHHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEE
Q 038934          427 IANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       427 i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  505 (751)
                      +....+.|.....++.|+.+.||+... .++.+++|+...........+.+|+.+++.+. +..+.++++++...+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            345567888888889899999999985 46899999986532233456899999999995 6778899999998889999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-----------------------------------  550 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-----------------------------------  550 (751)
                      |||+++|.+|.+.+.        +......++.+++++|+.||+.                                   
T Consensus        88 v~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999999987641        1122346888999999999981                                   


Q ss_pred             ---------------------CCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          551 ---------------------SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       551 ---------------------~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                                           ....++|+|++|.|||++++..+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 11349999999999999876666799999764

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=99.16  E-value=4.4e-11  Score=122.80  Aligned_cols=113  Identities=19%  Similarity=0.353  Sum_probs=83.4

Q ss_pred             ccccccCCCCc----cCCCCeEeeCCCeEEEeeeCCC--CCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEec
Q 038934            3 STQDTLRLGQS----IRDGETLVSANESFELGFFSPG--KSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQ   76 (751)
Q Consensus         3 ~~~~~~~~~~~----l~~~~~l~S~~g~f~~gf~~~~--~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~   76 (751)
                      ..+|||.|||.    |..|+.|+|+ ..++.|+|...  .....  -+| .+  ..+++|.+++.++-   ...|.+.  
T Consensus       134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnl--vLy-~~--~~~~yW~Sgt~~~~---~~~l~l~--  202 (276)
T 3m7h_A          134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNL--VAY-GP--NGAATWNAGTQGKG---AVRAVFQ--  202 (276)
T ss_dssp             CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCE--EEE-CT--TSSEEEECCCTTTT---CCEEEEC--
T ss_pred             ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceE--EEE-eC--CCeEEEECCCCCCc---cEEEEEc--
Confidence            46799999999    8899999664 56666666431  22233  343 32  35899999998762   2455554  


Q ss_pred             CCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCC
Q 038934           77 GNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDY  133 (751)
Q Consensus        77 g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~  133 (751)
                      .+|+|+++|.++.++|++++... ...+|+|+++|||||++.      +.+||||||
T Consensus       203 ~dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~------~~~Wqsf~~  252 (276)
T 3m7h_A          203 GDGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE------KPVWARFGF  252 (276)
T ss_dssp             TTSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE------EEEEESSSC
T ss_pred             CCCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC------CCeEEccCc
Confidence            45699999998899999997633 357899999999999853      489999997

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=5.3e-11  Score=121.79  Aligned_cols=140  Identities=15%  Similarity=0.143  Sum_probs=103.2

Q ss_pred             HhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCc--EEeEeceeeeCCceEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN--LVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~  507 (751)
                      ...++.+....+.|..+.||++...+|+.+++|.....   ....+.+|+.+++.+.+.+  +.+++++...++..++||
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            33455554333455669999998767888999997543   2356889999999996544  556888888888899999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS------------------------------------  551 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------------------------------------  551 (751)
                      ||++|.+|.  ..   .   ..   ...++.++++.|..||+..                                    
T Consensus        95 e~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999998884  21   1   11   1256777888888888643                                    


Q ss_pred             -------------------CCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          552 -------------------RLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       552 -------------------~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                                         ...++|+|++|.|||++++..+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                               12399999999999998876677999998753

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.09  E-value=2.5e-10  Score=100.69  Aligned_cols=95  Identities=23%  Similarity=0.309  Sum_probs=66.9

Q ss_pred             CCCCCCCCceeEEEecCCceEEEeCC-CCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccC
Q 038934           61 NAPLPDRSGVLSISSQGNGTLILQNS-TNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLL  139 (751)
Q Consensus        61 ~~p~~~~~~~l~~~~~g~g~l~l~~~-~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlL  139 (751)
                      +.|+.+....|.++  .||||||++. .+.++|++++........++|+++|||||++.+    +.++|||=.+      
T Consensus        18 g~~L~~g~~~L~~q--~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~----~~~iW~S~t~------   85 (113)
T 3mez_B           18 NAQLATRDYSLVMR--DDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR----LNTVFVSNTV------   85 (113)
T ss_dssp             TCEEEETTEEEEEC--TTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT----SCEEEECSCC------
T ss_pred             CCEeEcCCEEEEEc--CCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC----CCEEEECCCc------
Confidence            44444444555664  5669999998 589999999764434568999999999999754    5789998321      


Q ss_pred             CCCeeeeeeecCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCCC
Q 038934          140 PGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGS  196 (751)
Q Consensus       140 pg~~lg~~~~tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  196 (751)
                                               ...|.|.+.++.+|...+  ++  ...|.+|+
T Consensus        86 -------------------------~~~~~~~~~L~~dGnlvl--y~--~~~W~s~~  113 (113)
T 3mez_B           86 -------------------------GQEGDYVLILQINGQAVV--YG--PAVWSTAA  113 (113)
T ss_dssp             -------------------------CSSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred             -------------------------CCCCCEEEEEcCCceEEE--ec--CCEecCCC
Confidence                                     012458899999997543  33  57788764

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=98.97  E-value=1.5e-09  Score=95.24  Aligned_cols=87  Identities=18%  Similarity=0.268  Sum_probs=62.1

Q ss_pred             ceeEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCC-ceeeecCCCccccCCCCeeeee
Q 038934           69 GVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDN-FLWQSFDYPTHVLLPGMKLGVN  147 (751)
Q Consensus        69 ~~l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~-~lWqSFd~PTDtlLpg~~lg~~  147 (751)
                      ..|.+  ..||||||++.++  +|++++........++|+++|||||++.+    ++ ++|||.-+              
T Consensus        22 ~~L~~--q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~----~~~~vW~S~t~--------------   79 (111)
T 3mez_A           22 AAFVM--QGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSAN----SNTPVWVYPRS--------------   79 (111)
T ss_dssp             EEEEE--CTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSS----CSSCSEEESSS--------------
T ss_pred             EEEEE--ccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCC----CCEEEEEeccc--------------
Confidence            34555  5566999999877  99999764444568999999999999754    33 59999721              


Q ss_pred             eecCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCCC
Q 038934          148 LVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGS  196 (751)
Q Consensus       148 ~~tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  196 (751)
                                     .....|.|.+.++.+|...+  +.  ..+|.++.
T Consensus        80 ---------------~~~~~~~~~l~Lq~dGNlvl--y~--~~~W~s~t  109 (111)
T 3mez_A           80 ---------------VNTVRGNYAATLGPDQHVTI--YG--PAIWSTPA  109 (111)
T ss_dssp             ---------------CCCCSSCCEEEECTTSCEEE--EC--SEEEECCC
T ss_pred             ---------------cCCCCcCEEEEECCCCeEEE--ec--cCEEccCC
Confidence                           01123678999999997543  33  67787763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.95  E-value=2e-09  Score=115.82  Aligned_cols=142  Identities=17%  Similarity=0.258  Sum_probs=107.7

Q ss_pred             ccccccccccccEEEEEEcCCcEEEEEEec--cCC-cccHHHHHHHHHHHHHhc--CCcEEeEeceeeeC---CceEEEE
Q 038934          436 EENKLGEGGFGPVYKGMLIDGQEIAVKRLS--KSS-GQGVEEFKNEVLLIAKLQ--HRNLVKLLGCCMKR---DERMLIY  507 (751)
Q Consensus       436 ~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~  507 (751)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+.   ...++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567999999999998864 4688899875  221 123457889999999997  45678888888776   3489999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS------------------------------------  551 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------------------------------------  551 (751)
                      |+++|..+.+..     ...++...+..++.++++.|+.||...                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998875422     123678888899999999999999731                                    


Q ss_pred             -------------------CCCEEEccCCCCCeEEcCCCC--eEEeeccCccc
Q 038934          552 -------------------RLRIIHRDLKASNVLLDNEMN--PKISDFGMARA  583 (751)
Q Consensus       552 -------------------~~~ivH~Dikp~NIll~~~~~--~kl~DFGla~~  583 (751)
                                         ...++|+|++|.|||+++++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999997753  68999998875

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=98.87  E-value=1.2e-08  Score=89.24  Aligned_cols=85  Identities=20%  Similarity=0.323  Sum_probs=60.6

Q ss_pred             EEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeeeeecC
Q 038934           72 SISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTG  151 (751)
Q Consensus        72 ~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~~~tg  151 (751)
                      +|....||+|||++. +.+||++++........++|+++|||||++.+    +.++|||....                 
T Consensus        22 ~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~----~~~~W~S~t~~-----------------   79 (109)
T 3dzw_A           22 VFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR----NNPIWASNTGG-----------------   79 (109)
T ss_dssp             EEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT----SCEEEECCCCC-----------------
T ss_pred             EEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC----CCEEEECCCCC-----------------
Confidence            444456669999987 78999999764434568899999999999754    57999985321                 


Q ss_pred             CceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCCC
Q 038934          152 LNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGS  196 (751)
Q Consensus       152 ~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  196 (751)
                                    ..+.|.+.++.+|...  ++..  ..|.+|.
T Consensus        80 --------------~~~~~~~~L~ddGNlv--ly~~--~~W~s~t  106 (109)
T 3dzw_A           80 --------------ENGNYVCVLQKDRNVV--IYGT--ARWATGT  106 (109)
T ss_dssp             --------------SSSCEEEEECTTSCEE--EEES--CCCCCCC
T ss_pred             --------------CCCCEEEEEeCCCEEE--EECC--CEEeCCC
Confidence                          1245788899999744  3332  6677663

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=98.83  E-value=9.2e-09  Score=90.04  Aligned_cols=84  Identities=20%  Similarity=0.354  Sum_probs=59.8

Q ss_pred             ceeEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeeee
Q 038934           69 GVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNL  148 (751)
Q Consensus        69 ~~l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~~  148 (751)
                      ..|.+  ..||+|||++.  .++|++++........++|+++|||||++.+    +.++|||-.+-              
T Consensus        26 ~~L~~--q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~----~~~iW~S~t~~--------------   83 (110)
T 3r0e_B           26 HQLVM--QGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD----FKTIWSSRSSS--------------   83 (110)
T ss_dssp             CEEEE--CTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT----CCEEEECCCCC--------------
T ss_pred             EEEEE--cCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC----CCEEEEcCCcC--------------
Confidence            34445  45669999987  5899999764444468999999999999754    57999995310              


Q ss_pred             ecCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCC
Q 038934          149 VTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPG  195 (751)
Q Consensus       149 ~tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg  195 (751)
                                       ..|.|.+.++.+|....  +.  ...|.+|
T Consensus        84 -----------------~~~~~~~~L~~dGNlvl--y~--~~~W~t~  109 (110)
T 3r0e_B           84 -----------------KQGEYVLILQDDGFGVI--YG--PAIFETS  109 (110)
T ss_dssp             -----------------SSSCCEEEECTTSCEEE--EC--SEEEESC
T ss_pred             -----------------CCCCEEEEEcCCccEEE--ec--CCEecCC
Confidence                             12458889999997543  33  3678776

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.83  E-value=2.3e-09  Score=112.63  Aligned_cols=186  Identities=20%  Similarity=0.252  Sum_probs=122.1

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCc--EEeEeceeeeCC---ceEEEEEec
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRN--LVKLLGCCMKRD---ERMLIYEYL  510 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~E~~  510 (751)
                      .+.++.|....||+..    ..+++|+....  .....+.+|+++++.+. +..  +.+++.......   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3468899999999853    56889986432  34567899999999884 332  344444443333   347899999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD----------------------------------------  550 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~----------------------------------------  550 (751)
                      +|.+|.+...     ..++...+..++.++++.|+.||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998876432     2356777788888888888888861                                        


Q ss_pred             ---------------CCCCEEEccCCCCCeEEcC--CCCeEEeeccCccccCCCCcccc------------ccccccccC
Q 038934          551 ---------------SRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGVDQTEAN------------TNRVVGTYG  601 (751)
Q Consensus       551 ---------------~~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~------------~~~~~gt~~  601 (751)
                                     ....++|+|++|.||++++  ...+.|+||+.+..-.....-..            ...+....+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                           1235899999999999998  55688999998865321100000            000111111


Q ss_pred             ccC-cccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 038934          602 YMP-PEYAIDGLFSVKSDVFSFGVLVLELVYGTRN  635 (751)
Q Consensus       602 y~a-PE~~~~~~~t~k~DVwSlG~ll~ell~G~~p  635 (751)
                      ... |+....  .....+.|+++.+++.+.+|..+
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence            222 222211  12236899999999999999765

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=98.76  E-value=1.4e-08  Score=88.69  Aligned_cols=91  Identities=23%  Similarity=0.440  Sum_probs=62.7

Q ss_pred             CCCCCCCceeEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCC
Q 038934           62 APLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPG  141 (751)
Q Consensus        62 ~p~~~~~~~l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg  141 (751)
                      .|+.+....|.+  ..||||||+++    +|+|++........++|+++|||||++.+    +.++|+|-..        
T Consensus        16 ~~L~~g~~~L~~--q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~----~~~vWss~t~--------   77 (109)
T 3r0e_A           16 GHLKNGDFDLVM--QDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD----GSTVWKSGAQ--------   77 (109)
T ss_dssp             CEEEETTEEEEE--CTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT----SCEEEECCCC--------
T ss_pred             CEeECCCEEEEE--ecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC----CCEEEcCCCc--------
Confidence            333333344555  55669999985    89999865444568899999999999754    5789976210        


Q ss_pred             CeeeeeeecCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCCCC
Q 038934          142 MKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGSW  197 (751)
Q Consensus       142 ~~lg~~~~tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~w  197 (751)
                                             ...+.|.+.++++|....  +.  ...|.+++|
T Consensus        78 -----------------------~~~~~~~~~L~~dGNlvl--y~--~~~W~s~t~  106 (109)
T 3r0e_A           78 -----------------------SVKGNYAAVVHPDGRLVV--FG--PSVFKIDPW  106 (109)
T ss_dssp             -----------------------CSSSCCEEEEETTTEEEE--EC--SEEEEECTT
T ss_pred             -----------------------CCCcCEEEEEcCCCeEEE--Ee--cCEECCCCc
Confidence                                   012567899999996443  33  578988876

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=98.47  E-value=8.3e-07  Score=76.76  Aligned_cols=54  Identities=30%  Similarity=0.438  Sum_probs=41.8

Q ss_pred             EEEecCCceEEEeCCCCCeeeeecCCCC-CCCcEEEEecCCCEEEEcCCCCCCCCceeee
Q 038934           72 SISSQGNGTLILQNSTNGIVWSSNASRT-AQNPVAVLLESGNLVVKSGNDNDSDNFLWQS  130 (751)
Q Consensus        72 ~~~~~g~g~l~l~~~~~~~vWst~~~~~-~~~~~a~lldsGNlVl~~~~~~~~~~~lWqS  130 (751)
                      +|....||||||++. +.+||++++... .....+.|.++|||||.+.+    ++++|.|
T Consensus        22 ~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~----~~~vWss   76 (105)
T 4h3o_A           22 HFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS----GRSLWAS   76 (105)
T ss_dssp             EEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT----CCEEEEC
T ss_pred             EEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC----cEEEEEe
Confidence            455566779999974 579999997532 23457899999999999765    6789987

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.39  E-value=1.1e-06  Score=90.26  Aligned_cols=135  Identities=18%  Similarity=0.171  Sum_probs=98.3

Q ss_pred             cccccccc-cEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          439 KLGEGGFG-PVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       439 ~IG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      .+..|..+ .||+.... ++..+++|+-...   ....+.+|+.+|+.+. +--+.+++.++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 58987754 4677999986432   3457889999999885 44567888899999999999999999988


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS--------------------------------------------  551 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--------------------------------------------  551 (751)
                      .+.....       ......+..++++.|+.||...                                            
T Consensus       108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            7765321       1223345666667777777421                                            


Q ss_pred             -----------CCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          552 -----------RLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       552 -----------~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                                 ...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       12489999999999999887778999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.31  E-value=2.6e-06  Score=89.27  Aligned_cols=135  Identities=21%  Similarity=0.186  Sum_probs=93.9

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCC---cEEeEeceee-eCCceEEEEEecCCC
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR---NLVKLLGCCM-KRDERMLIYEYLPNK  513 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~E~~~~g  513 (751)
                      +.++.|....||+.    ++.+++|+..  .......+.+|+++|+.+.+.   .+.+++.+.. ..+..++|||+++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            45778888889987    5778888853  223456789999999999642   3556666654 345678999999999


Q ss_pred             ChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 038934          514 SLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-------------------------------------------  550 (751)
Q Consensus       514 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-------------------------------------------  550 (751)
                      .|.+....     .++......++.++++.|+.||+.                                           
T Consensus        99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88764211     134444555555555555555542                                           


Q ss_pred             --------------CCCCEEEccCCCCCeEEcC---CCC-eEEeeccCccc
Q 038934          551 --------------SRLRIIHRDLKASNVLLDN---EMN-PKISDFGMARA  583 (751)
Q Consensus       551 --------------~~~~ivH~Dikp~NIll~~---~~~-~kl~DFGla~~  583 (751)
                                    ....++|+|++|.||++++   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          2235799999999999997   455 48999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.22  E-value=2.1e-06  Score=91.97  Aligned_cols=81  Identities=7%  Similarity=0.000  Sum_probs=57.2

Q ss_pred             cccc-cccccccEEEEEEc-------CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhc-C--CcEEeEeceeeeC--
Q 038934          437 ENKL-GEGGFGPVYKGMLI-------DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQ-H--RNLVKLLGCCMKR--  500 (751)
Q Consensus       437 ~~~I-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  500 (751)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.+. +  ..+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3467 88889999998764       26789999864322   111256788999999884 3  3567788777655  


Q ss_pred             -CceEEEEEecCCCChhH
Q 038934          501 -DERMLIYEYLPNKSLAD  517 (751)
Q Consensus       501 -~~~~lV~E~~~~gsL~~  517 (751)
                       ...++|||+++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999977653

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=98.03  E-value=8.9e-06  Score=81.58  Aligned_cols=104  Identities=21%  Similarity=0.319  Sum_probs=63.6

Q ss_pred             ccccCCCC-------ccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecC
Q 038934            5 QDTLRLGQ-------SIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQG   77 (751)
Q Consensus         5 ~~~~~~~~-------~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g   77 (751)
                      .|+|.+||       .|..++.+.  .|.|.|.|-+.|+     |-+|..    .+++|.++..+..  ..+.+++..+ 
T Consensus       125 ~d~L~~gq~~~~~~~~L~s~~d~s--~G~~~l~l~~dG~-----LvL~~~----~~~~W~s~~~~~~--~~~~~~L~~~-  190 (236)
T 1dlp_A          125 NSILYSTQGNDNHPQTLHATQSLQ--LSPYRLSMETDCN-----LVLFDR----DDRVWSTNTAGKG--TGCRAVLQPN-  190 (236)
T ss_dssp             CEECCCC--CCCCCCEECSSCCCB--CSSCEEEEETTTE-----EEEEBT----TBCCSCCCCCSSC--SSCEEEEETT-
T ss_pred             ceEEecCCcCCCccceEEcCcEee--cCcEEEEECCCCc-----EEEEcC----CEeEEeCCCcCCC--CceEEEECCC-
Confidence            57778888       455455443  5788888765442     445422    2577877653321  2345566544 


Q ss_pred             CceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeee
Q 038934           78 NGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQS  130 (751)
Q Consensus        78 ~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqS  130 (751)
                       |+|++++.++.++|.+.+.......+++|.++|||++..       ..+|+|
T Consensus       191 -Gnl~ly~~~~~~vw~s~~~~~~~~~rl~Ld~dG~l~ly~-------~~~W~s  235 (236)
T 1dlp_A          191 -GRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG-------GALWTT  235 (236)
T ss_dssp             -TEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC-------CCCCBC
T ss_pred             -CcEEEEeCCCcEEEEeCCCCCCCCEEEEEcCCCcEEEeC-------CCCccC
Confidence             488888777778888775433334567788888888863       256765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.97  E-value=2.4e-05  Score=85.07  Aligned_cols=75  Identities=9%  Similarity=0.165  Sum_probs=50.9

Q ss_pred             cccccccccccEEEEEEc-CCcEEEEEEeccCCc-------ccHHHHHHHHHHHHHhcC--Cc-EEeEeceeeeCCceEE
Q 038934          437 ENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG-------QGVEEFKNEVLLIAKLQH--RN-LVKLLGCCMKRDERML  505 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  505 (751)
                      .+.||.|..+.||++... +++.++||.......       ...+++..|+++++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457999999999999754 468899998653211       234567889999998842  33 3455543  4556789


Q ss_pred             EEEecCCC
Q 038934          506 IYEYLPNK  513 (751)
Q Consensus       506 V~E~~~~g  513 (751)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.89  E-value=4.2e-05  Score=81.00  Aligned_cols=140  Identities=16%  Similarity=0.197  Sum_probs=81.2

Q ss_pred             ccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc--CCcEEeEec------eeeeCCceEEEEEe
Q 038934          438 NKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ--HRNLVKLLG------CCMKRDERMLIYEY  509 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lV~E~  509 (751)
                      +.|+.|....||+....++ .+++|+....    .+++..|+.+++.|.  .-.+.+++.      +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677889999887544 5899998652    244556677777664  222334443      22345678899999


Q ss_pred             cCCCChh-----------HHH---hcc-CCC----------CCCCHHHH-------------------------------
Q 038934          510 LPNKSLA-----------DFI---FDG-TRR----------KLLDWSKR-------------------------------  533 (751)
Q Consensus       510 ~~~gsL~-----------~~l---~~~-~~~----------~~l~~~~~-------------------------------  533 (751)
                      ++|..+.           ..+   +.. ...          ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9987542           111   110 000          01122110                               


Q ss_pred             HHHHHHHHHHHHHHHh----------CCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          534 CQIIGGIARGLLYLHQ----------DSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       534 ~~i~~~i~~~L~yLH~----------~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      ..+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111223445666653          123459999999999999888899999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.74  E-value=9.3e-05  Score=76.48  Aligned_cols=79  Identities=22%  Similarity=0.275  Sum_probs=58.4

Q ss_pred             CccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC---CcEEeEeceeeeCCceEEEEEe
Q 038934          433 NFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH---RNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .....+.+|.|..+.||+.+..+|+.+++|+...........|..|+..|+.|..   -.+.++++.    +.-++|||+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            3445668999999999999999999999999765544445568899999999842   223444443    234789999


Q ss_pred             cCCCCh
Q 038934          510 LPNKSL  515 (751)
Q Consensus       510 ~~~gsL  515 (751)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.71  E-value=0.00016  Score=75.47  Aligned_cols=139  Identities=19%  Similarity=0.154  Sum_probs=93.0

Q ss_pred             ccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc---CCcEEeEeceeeeCCceEEEEEecCC
Q 038934          436 EENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       436 ~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      ..+.|+.|....+|+... +++.+++|+....   ....+..|+..|+.|.   ...+.+++.+....+..++|||++++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            345789999999999886 5678899987532   3567899999999884   35678888888888889999999999


Q ss_pred             CChh--------HHH---hccCC---CC----------------CCCHHHHH---HHH----------------HHHHHH
Q 038934          513 KSLA--------DFI---FDGTR---RK----------------LLDWSKRC---QII----------------GGIARG  543 (751)
Q Consensus       513 gsL~--------~~l---~~~~~---~~----------------~l~~~~~~---~i~----------------~~i~~~  543 (751)
                      ..+.        +.|   +....   .+                .-+|....   ++.                ..++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            8652        111   11111   00                11343321   111                112222


Q ss_pred             H-HHHHh-CCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          544 L-LYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       544 L-~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                      + ..|.. ..+..++|+|+.+.||+++.++ +.|+||.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            2 23432 2346799999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.60  E-value=0.00025  Score=77.51  Aligned_cols=76  Identities=12%  Similarity=0.105  Sum_probs=47.0

Q ss_pred             CCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccccccccc--ccCccCcccccCC---CCCcchhhHHHHHHHH
Q 038934          553 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVG--TYGYMPPEYAIDG---LFSVKSDVFSFGVLVL  627 (751)
Q Consensus       553 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~t~k~DVwSlG~ll~  627 (751)
                      ..++|+|++|.|||+++++ ++|+||+.+..-...   ........  ...|++|+.....   .-....++......++
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            4599999999999999876 999999988753211   00000111  1346666654321   1123455667788888


Q ss_pred             HHHhC
Q 038934          628 ELVYG  632 (751)
Q Consensus       628 ell~G  632 (751)
                      +.+.+
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.42  E-value=0.00054  Score=71.80  Aligned_cols=158  Identities=15%  Similarity=0.118  Sum_probs=87.5

Q ss_pred             ccHHhHHHHhcCccc-----cccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCc--EEeEe
Q 038934          422 FDWKSIANATDNFSE-----ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN--LVKLL  494 (751)
Q Consensus       422 ~~~~~i~~~~~~y~~-----~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  494 (751)
                      ++.+++.....+|..     .+.|+.|....+|+....++ .+++|+....  ...+.+..|+.++..+....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            344455555555543     24566788889999887555 6889988652  12245677888888875222  33333


Q ss_pred             ce------eeeCCceEEEEEecCCCChhH-----------H---HhccC-C--CC---CC---CHHHHHH----------
Q 038934          495 GC------CMKRDERMLIYEYLPNKSLAD-----------F---IFDGT-R--RK---LL---DWSKRCQ----------  535 (751)
Q Consensus       495 ~~------~~~~~~~~lV~E~~~~gsL~~-----------~---l~~~~-~--~~---~l---~~~~~~~----------  535 (751)
                      ..      ....+..++|+++++|..+..           .   ++... .  ..   ..   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      123456789999999875421           0   11100 0  00   01   1221100          


Q ss_pred             --HHHHHHHHHHHHHhC----CCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          536 --IIGGIARGLLYLHQD----SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       536 --i~~~i~~~L~yLH~~----~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                        +...+.+.+..++..    ....++|+|+++.|||++++..+.|+||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              001133445555421    23469999999999999987666899998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.25  E-value=0.00087  Score=71.84  Aligned_cols=141  Identities=19%  Similarity=0.225  Sum_probs=83.8

Q ss_pred             ccccccccccEEEEEEcC--------CcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEE
Q 038934          438 NKLGEGGFGPVYKGMLID--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      +.|..|-...+|+....+        ++.+++|+.... ......+.+|.++++.|. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            467778889999988642        478999986432 234566779999999885 3223566666543    29999


Q ss_pred             ecCCCChhHH--------------Hhc-cCC----CCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 038934          509 YLPNKSLADF--------------IFD-GTR----RKLLD--WSKRCQIIGGIAR-------------------GLLY--  546 (751)
Q Consensus       509 ~~~~gsL~~~--------------l~~-~~~----~~~l~--~~~~~~i~~~i~~-------------------~L~y--  546 (751)
                      |++|..|..-              |.+ +..    .+...  +..+.++..++..                   .+..  
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665311              111 000    11122  3444445443321                   1222  


Q ss_pred             --HHhC-CCCCEEEccCCCCCeEEcCC----CCeEEeeccCccc
Q 038934          547 --LHQD-SRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA  583 (751)
Q Consensus       547 --LH~~-~~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~~  583 (751)
                        |... ....++|+|+.+.|||++++    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              3222 23469999999999999876    7899999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.18  E-value=0.00081  Score=69.80  Aligned_cols=138  Identities=12%  Similarity=0.109  Sum_probs=76.7

Q ss_pred             cccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcE-EeEeceeeeCCceEEEEEec-CCCC
Q 038934          437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VKLLGCCMKRDERMLIYEYL-PNKS  514 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~-~~gs  514 (751)
                      .+.|+.|....+|+.     +.+++|+........ ....+|+.+++.+....+ .+++++  +.+.-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            567888999999998     568889876432211 223578888888752222 355544  344567899999 6655


Q ss_pred             hhHH---------------Hhc-cCCCC----CCC-HHHHHHHHHH--------------HHHHH----HHHHh-CCCCC
Q 038934          515 LADF---------------IFD-GTRRK----LLD-WSKRCQIIGG--------------IARGL----LYLHQ-DSRLR  554 (751)
Q Consensus       515 L~~~---------------l~~-~~~~~----~l~-~~~~~~i~~~--------------i~~~L----~yLH~-~~~~~  554 (751)
                      +...               +.+ +....    ... +..+..+...              +.+.+    ..+.. .....
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            5321               000 00000    001 1111111100              11111    11111 22345


Q ss_pred             EEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          555 IIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       555 ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ++|+|+.|.||+ .+++.+.|+||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5666789999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.16  E-value=0.00064  Score=74.40  Aligned_cols=73  Identities=18%  Similarity=0.282  Sum_probs=50.4

Q ss_pred             cccccccccccEEEEEEcC--------CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcE-EeEeceeeeCCceEEEE
Q 038934          437 ENKLGEGGFGPVYKGMLID--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VKLLGCCMKRDERMLIY  507 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~  507 (751)
                      .+.|+.|....||+....+        ++.+++|+....  ...+.+.+|+.+++.|...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3468888889999998753        578999998432  122556689999998853333 456665532    3899


Q ss_pred             EecCCCCh
Q 038934          508 EYLPNKSL  515 (751)
Q Consensus       508 E~~~~gsL  515 (751)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.16  E-value=0.0033  Score=65.86  Aligned_cols=141  Identities=14%  Similarity=0.168  Sum_probs=82.4

Q ss_pred             cccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC--CcEEeEece-----eeeCCceEEEEEecC
Q 038934          439 KLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVKLLGC-----CMKRDERMLIYEYLP  511 (751)
Q Consensus       439 ~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~-----~~~~~~~~lV~E~~~  511 (751)
                      .|+ |....||+....+|+.+++|..... ....+.+..|+.++..+..  -.+++++..     ....+..++|||+++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            466 7788999987767778999998532 1234677889999888852  224445443     122445678999998


Q ss_pred             CCChh----H-------HH---hc---cC---CCCCCCHHHH----------------------HHHHHHHHHHHHHHHh
Q 038934          512 NKSLA----D-------FI---FD---GT---RRKLLDWSKR----------------------CQIIGGIARGLLYLHQ  549 (751)
Q Consensus       512 ~gsL~----~-------~l---~~---~~---~~~~l~~~~~----------------------~~i~~~i~~~L~yLH~  549 (751)
                      |..+.    +       .+   +.   ..   .....++...                      ...+..++..+.-+..
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            86532    1       11   10   00   0111222111                      1111222222222211


Q ss_pred             -CCCCCEEEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          550 -DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       550 -~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                       .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence             1234589999999999999 4 899999987753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.06  E-value=0.0028  Score=66.66  Aligned_cols=141  Identities=16%  Similarity=0.113  Sum_probs=73.6

Q ss_pred             cccccccccc-EEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC--CcEEeEeceeeeCCceEEEEEecCCCC
Q 038934          438 NKLGEGGFGP-VYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVKLLGCCMKRDERMLIYEYLPNKS  514 (751)
Q Consensus       438 ~~IG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gs  514 (751)
                      +.|+.|.... +|+....+++.+++|......   .+.+..|+.+++.+..  -.+.+++.+..  +.-++|||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence            4566665554 667765446778887654322   1345567788777742  23455665532  22378999998776


Q ss_pred             hhHHHhcc---------------------CC--CCCCCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 038934          515 LADFIFDG---------------------TR--RKLLDWSKRC-------Q-I------------IGGIARGLLYLH---  548 (751)
Q Consensus       515 L~~~l~~~---------------------~~--~~~l~~~~~~-------~-i------------~~~i~~~L~yLH---  548 (751)
                      +.+.+...                     ..  ...++.....       . +            ...+...+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            65433210                     00  0111111100       0 0            001111222221   


Q ss_pred             hCCCCCEEEccCCCCCeEEcCC----CCeEEeeccCccc
Q 038934          549 QDSRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA  583 (751)
Q Consensus       549 ~~~~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~~  583 (751)
                      ......++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1223469999999999999875    6799999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.04  E-value=0.0015  Score=71.91  Aligned_cols=74  Identities=12%  Similarity=0.087  Sum_probs=48.7

Q ss_pred             cccccccccccEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcE-EeEeceeeeCCceEEEEEecCCCC
Q 038934          437 ENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VKLLGCCMKRDERMLIYEYLPNKS  514 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gs  514 (751)
                      .+.|+.|-...+|+....+ ++.+++|+........+ ...+|+.+++.|...++ .++++++.  +  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3468888889999998755 47889998754322211 12689999999965444 46666652  2  35999999865


Q ss_pred             h
Q 038934          515 L  515 (751)
Q Consensus       515 L  515 (751)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.00  E-value=0.0027  Score=61.42  Aligned_cols=103  Identities=9%  Similarity=0.013  Sum_probs=66.8

Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcccc
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN  592 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  592 (751)
                      -+|.++|.  ....++++++++.++.|.+.+|.-+-... . -..+=+.|..|+|..+|.|.+.+ ..+.          
T Consensus        33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc----------
Confidence            47888885  34568999999999999999987762211 0 11233457899999999988764 1110          


Q ss_pred             ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 038934          593 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRN  635 (751)
Q Consensus       593 ~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p  635 (751)
                          .....+.|||... ...+.+.=|||||++||.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                1122466888763 4567899999999999999854433

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.82  E-value=0.0019  Score=69.01  Aligned_cols=73  Identities=14%  Similarity=0.131  Sum_probs=44.8

Q ss_pred             ccccccccccEEEEEEcC---------CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCc-EEeEeceeeeCCceEEEE
Q 038934          438 NKLGEGGFGPVYKGMLID---------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~  507 (751)
                      +.|+.|....+|+....+         ++.+++|+....... ......|+.+++.+...+ ..++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            467888888999988654         268889987543221 123467888888885333 33555443  2  36899


Q ss_pred             EecCCCCh
Q 038934          508 EYLPNKSL  515 (751)
Q Consensus       508 E~~~~gsL  515 (751)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.66  E-value=0.0069  Score=63.91  Aligned_cols=68  Identities=9%  Similarity=0.095  Sum_probs=44.7

Q ss_pred             cccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC---CcEEeEece------eeeCCceEEEEEecC
Q 038934          441 GEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH---RNLVKLLGC------CMKRDERMLIYEYLP  511 (751)
Q Consensus       441 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~------~~~~~~~~lV~E~~~  511 (751)
                      |.|....||+....++ .+++|+......      ..|+.+++.|..   +.+++++..      ....+..++||+|++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            3344678999987666 899998765431      457777777632   224455432      233567789999999


Q ss_pred             CCCh
Q 038934          512 NKSL  515 (751)
Q Consensus       512 ~gsL  515 (751)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.92  E-value=0.078  Score=57.45  Aligned_cols=73  Identities=15%  Similarity=0.159  Sum_probs=48.0

Q ss_pred             ccccccccccEEEEEEcC--------CcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCc-EEeEeceeeeCCceEEEEE
Q 038934          438 NKLGEGGFGPVYKGMLID--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E  508 (751)
                      +.|..|-...+|+....+        ++.+++|+........ -...+|..+++.+...+ ..++++.+  .  -++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence            467778888899988753        5789999875433222 23467888888885222 33455433  2  378999


Q ss_pred             ecCCCCh
Q 038934          509 YLPNKSL  515 (751)
Q Consensus       509 ~~~~gsL  515 (751)
                      |++|..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9999764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.21  E-value=0.25  Score=53.07  Aligned_cols=30  Identities=23%  Similarity=0.371  Sum_probs=25.5

Q ss_pred             CEEEccCCCCCeEE------cCCCCeEEeeccCccc
Q 038934          554 RIIHRDLKASNVLL------DNEMNPKISDFGMARA  583 (751)
Q Consensus       554 ~ivH~Dikp~NIll------~~~~~~kl~DFGla~~  583 (751)
                      .++|+|+.+.|||+      +++..+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567799999998864

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.04  E-value=1.2  Score=42.97  Aligned_cols=114  Identities=11%  Similarity=0.062  Sum_probs=76.7

Q ss_pred             cCCcEEeEeceeeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCEEEccCCCCC
Q 038934          486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL-YLHQDSRLRIIHRDLKASN  564 (751)
Q Consensus       486 ~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~-yLH~~~~~~ivH~Dikp~N  564 (751)
                      .||++  -..+-.+++.+.+.++.-+++.=...+      +.++...+++++.+|+.... +++.     -+|--|+|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57877  444557777888878776443333333      23678899999988887666 5544     6788899999


Q ss_pred             eEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 038934          565 VLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNR  636 (751)
Q Consensus       565 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~  636 (751)
                      |+++.++.++|.-.|+-.                   -++|.-+     ++.-=.-++=+++..++.++..|
T Consensus       115 L~f~~~~~p~i~hRGi~~-------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKE-------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             EEECTTCCEEESCCEETT-------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             EEEeCCCcEEEEEcCCcc-------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCH
Confidence            999999999998777532                   2333321     22222345667888888887764

>3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae}

Probab=84.58  E-value=5.3  Score=39.99  Aligned_cols=68  Identities=19%  Similarity=0.184  Sum_probs=43.2

Q ss_pred             CCCeEEEeecCCC-CCC---CCCceeEEEecCCceEEEeCCC-CCeeeeecCCC--C---CCCcEEEEecCCCEEEEc
Q 038934           50 ANGTVTWVANRNA-PLP---DRSGVLSISSQGNGTLILQNST-NGIVWSSNASR--T---AQNPVAVLLESGNLVVKS  117 (751)
Q Consensus        50 ~~~t~vW~anr~~-p~~---~~~~~l~~~~~g~g~l~l~~~~-~~~vWst~~~~--~---~~~~~a~lldsGNlVl~~  117 (751)
                      +...++|...+.. |..   ...+.+-+...+++.++.+|.+ |.++|+-....  .   .....+.++.+||+++.+
T Consensus       153 ~~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~  230 (276)
T 3no2_A          153 PNGQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN  230 (276)
T ss_dssp             TTSCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred             CCCCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence            3478899888753 321   1233444544444568888887 99999976321  1   112346788999999987

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.80  E-value=0.93  Score=43.65  Aligned_cols=115  Identities=12%  Similarity=0.085  Sum_probs=79.4

Q ss_pred             cCCcEEeEeceeeeCCceEEEEEecCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCC
Q 038934          486 QHRNLVKLLGCCMKRDERMLIYEYLPN-KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN  564 (751)
Q Consensus       486 ~h~niv~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~N  564 (751)
                      .||+++.. .+-.+++.+.+.|+.-+. .++.. +      +.++...+++++.+|+....+++.     -+|--|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            58888866 466667777777766542 23333 3      347889999999999988766654     5788899999


Q ss_pred             eEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 038934          565 VLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRG  637 (751)
Q Consensus       565 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~  637 (751)
                      |+++.++.+++.-.|+-..                   ++|.     ..++..=.-.+=+++..+++++..|+
T Consensus       110 L~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999987775332                   2232     12223334467788888998877743

>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A

Probab=81.93  E-value=0.53  Score=31.68  Aligned_cols=32  Identities=44%  Similarity=0.651  Sum_probs=24.6

Q ss_pred             cccCCCCCccCCCccccCCCCCCcccccCCCcc
Q 038934          270 IDQCDNYALCGTYAICKMNSNSAECECLEGFEP  302 (751)
Q Consensus       270 ~~~Cd~~~~CG~~g~C~~~~~~~~C~C~~gf~~  302 (751)
                      .++|. ...|...|.|.....+..|.|++||..
T Consensus         3 ~d~C~-~~pC~ngg~C~~~~~~~~C~C~~G~~G   34 (39)
T 1edm_B            3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEG   34 (39)
T ss_dssp             CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCS
T ss_pred             cccCC-CCCCCCCCEeEcCCCceEeECCCCCcC
Confidence            36786 467988899975545678999999974

>3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae}

Probab=80.38  E-value=13  Score=37.03  Aligned_cols=48  Identities=17%  Similarity=0.186  Sum_probs=33.9

Q ss_pred             ceeEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcC
Q 038934           69 GVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSG  118 (751)
Q Consensus        69 ~~l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~  118 (751)
                      +.+-++..++|.++.+|.+|.++|+-.....  ...+..+.+||+++.+.
T Consensus       136 G~~lv~~~~~~~v~~~d~~G~~~w~~~~~~~--~~~~~~~~~g~~~v~~~  183 (276)
T 3no2_A          136 GNYLVPLFATSEVREIAPNGQLLNSVKLSGT--PFSSAFLDNGDCLVACG  183 (276)
T ss_dssp             SCEEEEETTTTEEEEECTTSCEEEEEECSSC--CCEEEECTTSCEEEECB
T ss_pred             CCEEEEecCCCEEEEECCCCCEEEEEECCCC--ccceeEcCCCCEEEEeC
Confidence            4455666667789999999999999875422  12244578899888654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	751
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-73
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-66
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-62
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-60
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-60
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-58
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-57
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-56
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-50
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-24
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	9e-21
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	2e-15
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	3e-14
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	1e-13
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	3e-11
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	4e-10

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (608), Expect = 1e-73
 Identities = 64/286 (22%), Positives = 130/286 (45%), Gaps = 21/286 (7%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
              +   ++G G FG VYKG       + +  ++  + Q ++ FKNEV ++ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
             +G      +  ++ ++    SL   +         +  K   I    A+G+ YLH  S
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA--- 608
              IIHRDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL 668
               +S +SDV++FG+++ EL+ G     + ++++   ++    R +      ++     
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG-ERSLPQ 713
           +            ++   C++++ ++RP    ++  +    RSLP+
Sbjct: 240 KA---------MKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 1e-66
 Identities = 77/274 (28%), Positives = 131/274 (47%), Gaps = 22/274 (8%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
           +      +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L     + +   +I EY+ N SL DF+   +  KL   +K   +   IA G+ ++ + +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
               IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT 671
            F++KSDV+SFG+L+ E+V   R                 +   T    ++ +++     
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR---------------IPYPGMTNPEVIQNLERGYRMV 230

Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
              +      Q+  LC ++RPEDRP    +  +L
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 4e-66
 Identities = 63/292 (21%), Positives = 117/292 (40%), Gaps = 28/292 (9%)

Query: 437 ENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGC 496
           +  +G+G FG V++G    G+E+AVK  S    +     + E+     L+H N++  +  
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65

Query: 497 CMKRD----ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-- 550
             K +    +  L+ +Y  + SL D++     R  +      ++    A GL +LH +  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 551 ---SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GVDQTEANTNRVVGTYGYMPP 605
               +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 606 EYAIDGL------FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHH----NLLGHAWRLW 655
           E   D +         ++D+++ G++  E+       G H               +    
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 656 TEDRPVELIDKSLEDTYSLSEALRCI-QVGLLCVQQRPEDRPNMASVVLMLS 706
            +    + +  ++ + +   EALR + ++   C       R     +   LS
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (552), Expect = 8e-66
 Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 22/275 (8%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
              +   ++G G FG V+ G  ++  ++A+K + + +    E+F  E  ++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L G C+++    L++E++ +  L+D++    +R L        +   +  G+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
              +IHRDL A N L+      K+SDFGM R    DQ   ++        +  PE     
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT 671
            +S KSDV+SFGVL+ E+   +  +  +    +  ++      +   +P           
Sbjct: 178 RYSSKSDVWSFGVLMWEVF--SEGKIPYENRSNSEVVEDISTGFRLYKPRLAST------ 229

Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
                     Q+   C ++RPEDRP  + ++  L+
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 6e-65
 Identities = 63/274 (22%), Positives = 121/274 (44%), Gaps = 22/274 (8%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
            + +   +LG G FG V  G      ++A+K + + S    +EF  E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
           +L G C K+    +I EY+ N  L +++ +   R      +  ++   +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDG 611
             + +HRDL A N L++++   K+SDFG++R + +D    ++        + PPE  +  
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 612 LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT 671
            FS KSD+++FGVL+ E+    +                 +  +T     E I + L   
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221

Query: 672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
                + +   +   C  ++ ++RP    ++  +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 8e-65
 Identities = 77/306 (25%), Positives = 133/306 (43%), Gaps = 33/306 (10%)

Query: 414 KEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVE 473
           K+  E+P           ++   E KLG+G FG V+ G       +A+K L   +    E
Sbjct: 9   KDAWEIPR----------ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPE 57

Query: 474 EFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKR 533
            F  E  ++ KL+H  LV+L       +   ++ EY+   SL DF+  G   K L   + 
Sbjct: 58  AFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQL 115

Query: 534 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT 593
             +   IA G+ Y+ +   +  +HRDL+A+N+L+   +  K++DFG+AR    ++  A  
Sbjct: 116 VDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172

Query: 594 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWR 653
                   +  PE A+ G F++KSDV+SFG+L+ EL    R                 + 
Sbjct: 173 G-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR---------------VPYP 216

Query: 654 LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQ 713
                  ++ +++                +   C ++ PE+RP    +   L    +  +
Sbjct: 217 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276

Query: 714 PK-QPG 718
           P+ QPG
Sbjct: 277 PQYQPG 282

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  211 bits (538), Expect = 3e-63
 Identities = 68/301 (22%), Positives = 123/301 (40%), Gaps = 37/301 (12%)

Query: 422 FDWKSIANATDNFSEE---------NKLGEGGFGPVYKGMLI----DGQEIAVKRLSKS- 467
           F ++    A   F++E           +G G FG V  G L         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 468 SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL 527
           + +   +F +E  ++ +  H N++ L G   K    M+I E++ N SL  F+     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 528 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD 587
               +   ++ GIA G+ YL     +  +HRDL A N+L+++ +  K+SDFG++R    D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 588 QTEANTNRVVG---TYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHH 644
            ++      +G      +  PE      F+  SDV+S+G+++ E++              
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 645 HNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM 704
                  +   T    +  I++       +       Q+ L C Q+    RP    +V  
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 705 L 705
           L
Sbjct: 287 L 287

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  210 bits (535), Expect = 5e-63
 Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 22/275 (8%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
            + + ++KLG G +G VY+G+       +AVK L + + + VEEF  E  ++ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+LLG C +     +I E++   +L D++ +   R+ +       +   I+  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE-- 132

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
            +   IHRDL A N L+      K++DFG++R    D   A+         +  PE    
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190

Query: 611 GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED 670
             FS+KSDV++FGVL+ E+     +                +      +  EL++K    
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRM 235

Query: 671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
                   +  ++   C Q  P DRP+ A +    
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 2e-62
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 11/207 (5%)

Query: 430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQH 487
             D+F + ++LG G  G V+K      G  +A K +       +  +   E+ ++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
             +V   G      E  +  E++   SL   +    +   +      ++   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
               + +I+HRD+K SN+L+++    K+ DFG++        ++  N  VGT  YM PE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTR 634
                +SV+SD++S G+ ++E+  G  
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  208 bits (531), Expect = 3e-62
 Identities = 68/319 (21%), Positives = 121/319 (37%), Gaps = 56/319 (17%)

Query: 415 EEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSK-S 467
             +E P           +N      +GEG FG V++              +AVK L + +
Sbjct: 6   LSLEYP----------RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA 55

Query: 468 SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL 527
           S     +F+ E  L+A+  + N+VKLLG C       L++EY+    L +F+   +   +
Sbjct: 56  SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115

Query: 528 ---------------------LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 566
                                L  +++  I   +A G+ YL +    + +HRDL   N L
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 172

Query: 567 LDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLV 626
           +   M  KI+DFG++R                   +MPPE      ++ +SDV+++GV++
Sbjct: 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232

Query: 627 LELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLL 686
            E+                      +     +  +  +          +  L    +  L
Sbjct: 233 WEIFSYGL---------------QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRL 277

Query: 687 CVQQRPEDRPNMASVVLML 705
           C  + P DRP+  S+  +L
Sbjct: 278 CWSKLPADRPSFCSIHRIL 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 2e-61
 Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 28/276 (10%)

Query: 436 EENKLGEGGFGPVYKGMLID---GQEIAVKRLSKSSGQG--VEEFKNEVLLIAKLQHRNL 490
           E+ +LG G FG V KG        + +AVK L   +      +E   E  ++ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V+++G C   +  ML+ E      L  ++    + + +      +++  ++ G+ YL + 
Sbjct: 71  VRMIGICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES 126

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTN-RVVGTYGYMPPEYAI 609
                +HRDL A NVLL  +   KISDFG+++A   D+              +  PE   
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 610 DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE 669
              FS KSDV+SFGVL+ E     +                 +R         +++K   
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGER 228

Query: 670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
                        +  LC     E+RP  A+V L L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 4e-61
 Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 37/287 (12%)

Query: 430 ATDNFS-EENKLGEGGFGPVYKGMLI---DGQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 484
             DN    + +LG G FG V +G+        ++A+K L + + +   EE   E  ++ +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           L +  +V+L+G C + +  ML+ E      L  F+    +R+ +  S   +++  ++ G+
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEAN-TNRVVGTYGYM 603
            YL +      +HRDL A NVLL N    KISDFG+++A G D +     +       + 
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
            PE      FS +SDV+S+GV + E                   L +  + + + +  E+
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWE------------------ALSYGQKPYKKMKGPEV 221

Query: 664 IDKSLEDTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
           +    +             L    +   C   + EDRP+  +V   +
Sbjct: 222 MAFIEQGKRMECPPECPPELY--ALMSDCWIYKWEDRPDFLTVEQRM 266

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 6e-61
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 28/275 (10%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 491
                   +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 492 KLLGCCMKRDERM-LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           +LLG  ++    + ++ EY+   SL D++     R +L      +    +   + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 551 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID 610
                +HRDL A NVL+  +   K+SDFG+ +     Q             +  PE   +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALRE 174

Query: 611 GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED 670
             FS KSDV+SFG+L+ E+   +  R  +      +++    + +  D P          
Sbjct: 175 KKFSTKSDVWSFGILLWEIY--SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA---- 228

Query: 671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
                      +V   C       RP+   +   L
Sbjct: 229 ---------VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 1e-60
 Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 27/288 (9%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKSSGQG-VEEFKNEVLLIAKL 485
              + +  +G G FG VYKGML          +A+K L     +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 486 QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLL 545
            H N+++L G   K    M+I EY+ N +L  F+ +  +       +   ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 546 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT-NRVVGTYGYMP 604
           YL     +  +HRDL A N+L+++ +  K+SDFG++R    D     T +       +  
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI 664
           PE      F+  SDV+SFG+++ E++  T     +    +H ++             + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVM--TYGERPYWELSNHEVM-------------KAI 226

Query: 665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLP 712
           +        +       Q+ + C QQ    RP  A +V +L      P
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 1e-60
 Identities = 78/334 (23%), Positives = 135/334 (40%), Gaps = 51/334 (15%)

Query: 418 ELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLIDG---QEIAVKRLSK-SSGQGVE 473
             P+ DW       ++   ++ +GEG FG V K  +       + A+KR+ + +S     
Sbjct: 3   IYPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55

Query: 474 EFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFI------------- 519
           +F  E+ ++ KL  H N++ LLG C  R    L  EY P+ +L DF+             
Sbjct: 56  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115

Query: 520 FDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 579
              +    L   +       +ARG+ YL Q    + IHRDL A N+L+      KI+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 172

Query: 580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFH 639
           ++R     +             +M  E     +++  SDV+S+GVL+ E+V         
Sbjct: 173 LSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--- 226

Query: 640 HVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMA 699
                       +   T     E + +       L+       +   C +++P +RP+ A
Sbjct: 227 ------------YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 274

Query: 700 SVVLMLSGERSLPQPKQPGFFTERNLPESESSSS 733
            +++ L   R L + K    +    L E  + + 
Sbjct: 275 QILVSL--NRMLEERKT---YVNTTLYEKFTYAG 303

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 2e-60
 Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 23/273 (8%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRN 489
           +++     LGEG +G V   +  +  + +AVK +         E  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +VK  G   + + + L  EY     L D I        +      +    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
              + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 610 DGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL 668
              F +   DV+S G+++  ++ G             +     +  W E +      K +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAG------ELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232

Query: 669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
           +        L  +      + + P  R  +  +
Sbjct: 233 DS-----APLALLH---KILVENPSARITIPDI 257

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-60
 Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 36/284 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHR 488
           +++     +G G +G   K     DG+ +  K L   S      +   +EV L+ +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 489 NLVKLLGCCMKRDERML--IYEYLPNKSLADFIFDGTR-RKLLDWSKRCQIIGGIARGLL 545
           N+V+     + R    L  + EY     LA  I  GT+ R+ LD     +++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 546 YLHQ--DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
             H+  D    ++HRDLK +NV LD + N K+ DFG+AR    D + A     VGT  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
            PE      ++ KSD++S G L+ EL                         +T     EL
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCAL-------------------MPPFTAFSQKEL 222

Query: 664 IDKSLEDTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVV 702
             K  E  +       S+ L   ++    +  +   RP++  ++
Sbjct: 223 AGKIREGKFRRIPYRYSDELN--EIITRMLNLKDYHRPSVEEIL 264

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-60
 Identities = 75/324 (23%), Positives = 136/324 (41%), Gaps = 29/324 (8%)

Query: 427 IANATDNFSEENKLGEGGFGPVYKGMLIDGQE-----IAVKRLSKS-SGQGVEEFKNEVL 480
           I   T+ F +   LG G FG VYKG+ I   E     +A+K L ++ S +  +E  +E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 481 LIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           ++A + + ++ +LLG C+      LI + +P   L D++ +   +  +           I
Sbjct: 64  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQI 120

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
           A+G+ YL      R++HRDL A NVL+    + KI+DFG+A+  G ++ E +        
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP 660
            +M  E  +  +++ +SDV+S+GV V EL+                     +        
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEI 222

Query: 661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFF 720
             +++K           +    + + C     + RP    +++  S     PQ       
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282

Query: 721 TER-NLPESESSSSNQTFHSSNQI 743
            ER +LP    S+  +       +
Sbjct: 283 DERMHLPSPTDSNFYRALMDEEDM 306

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (516), Expect = 6e-60
 Identities = 77/320 (24%), Positives = 127/320 (39%), Gaps = 47/320 (14%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQ 486
              FS+  ++G G FG VY    + + + +A+K++S S  Q     ++   EV  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N ++  GC ++     L+ EY    +          +K L   +   +  G  +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH      +IHRD+KA N+LL      K+ DFG A         A  N  VGT  +M PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181

Query: 607 YAI---DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
             +   +G +  K DV+S G+  +EL              + N +   + +   + P   
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAER------KPPLFNMNAMSALYHIAQNESP--- 232

Query: 664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTER 723
                  +   SE  R       C+Q+ P+DRP    ++            K   F    
Sbjct: 233 ----ALQSGHWSEYFR--NFVDSCLQKIPQDRPTSEVLL------------KHR-FVLRE 273

Query: 724 NLPESESSSSNQTFHSSNQI 743
             P        +T  +  ++
Sbjct: 274 RPPTVIMDLIQRTKDAVREL 293

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 3e-59
 Identities = 66/302 (21%), Positives = 112/302 (37%), Gaps = 40/302 (13%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 484
           +  S    LG G FG V +              +AVK L  S+     E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 485 L-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKL---------------L 528
           L  H N+V LLG C      ++I EY     L +F+       +               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
           D          +A+G+ +L        IHRDL A N+LL +    KI DFG+AR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLL 648
                        +M PE   + +++ +SDV+S+G+ + EL     +           + 
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVD 254

Query: 649 GHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE 708
              +++  E   +   + +  +            +   C    P  RP    +V ++  +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

Query: 709 RS 710
            S
Sbjct: 306 IS 307

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-59
 Identities = 63/279 (22%), Positives = 119/279 (42%), Gaps = 27/279 (9%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 487
           N  D +    +LG+G FG VYK    +     A K +   S + +E++  E+ ++A   H
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+VKLL      +   ++ E+    ++   + +    + L  S+   +       L YL
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H     +IIHRDLKA N+L   + + K++DFG++          ++   +GT  +M PE 
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181

Query: 608 AI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE 662
            +     D  +  K+DV+S G+ ++E+         H ++    LL    ++   + P  
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIE--PPHHELNPMRVLL----KIAKSEPP-- 233

Query: 663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
               +L      S   +      L  ++  + R   + +
Sbjct: 234 ----TLAQPSRWSSNFKDFLKKCL--EKNVDARWTTSQL 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 4e-59
 Identities = 75/316 (23%), Positives = 132/316 (41%), Gaps = 38/316 (12%)

Query: 401 LYIRMAT--SELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGMLID--- 455
           ++I ++    EL    + + +             +F+E   +G G FG VY G L+D   
Sbjct: 2   VHIDLSALNPELVQAVQHVVIGPSSL------IVHFNE--VIGRGHFGCVYHGTLLDNDG 53

Query: 456 -GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER-MLIYEYLPN 512
                AVK L++ +  G V +F  E +++    H N++ LLG C++ +   +++  Y+ +
Sbjct: 54  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 113

Query: 513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 572
             L +FI +                  +A+G+      +  + +HRDL A N +LD +  
Sbjct: 114 GDLRNFIRN--ETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFT 168

Query: 573 PKISDFGMARAFGVDQTEANTNR--VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELV 630
            K++DFG+AR     + ++  N+        +M  E      F+ KSDV+SFGVL+ EL+
Sbjct: 169 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 228

Query: 631 YGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQ 690
                          N       L    R                + L   +V L C   
Sbjct: 229 TRGA-----PPYPDVNTFDITVYLLQGRRL--------LQPEYCPDPLY--EVMLKCWHP 273

Query: 691 RPEDRPNMASVVLMLS 706
           + E RP+ + +V  +S
Sbjct: 274 KAEMRPSFSELVSRIS 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 5e-58
 Identities = 65/305 (21%), Positives = 113/305 (37%), Gaps = 45/305 (14%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 484
           +N      LG G FG V               ++AVK L + +     E   +E+ ++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 485 L-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRR------------------ 525
           L  H N+V LLG C       LI+EY     L +++     +                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 526 --KLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 583
              +L +         +A+G+ +L        +HRDL A NVL+ +    KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH 643
              D              +M PE   +G++++KSDV+S+G+L+ E+        +  +  
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272

Query: 644 HHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL 703
             N        +  D+P    ++                +   C       RP+  ++  
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEE-------------IYIIMQSCWAFDSRKRPSFPNLTS 319

Query: 704 MLSGE 708
            L  +
Sbjct: 320 FLGCQ 324

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 6e-58
 Identities = 71/308 (23%), Positives = 134/308 (43%), Gaps = 34/308 (11%)

Query: 432 DNFSEENKLGEGGFGPVYKGML------IDGQEIAVKRLSKS-SGQGVEEFKNEVLLIAK 484
           +  +   +LG+G FG VY+G+            +A+K ++++ S +   EF NE  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIF-------DGTRRKLLDWSKRCQII 537
               ++V+LLG   +    ++I E +    L  ++        +         SK  Q+ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 538 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVV 597
           G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R            + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE 657
               +M PE   DG+F+  SDV+SFGV++ E+      + +  + +         R   E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNE-----QVLRFVME 250

Query: 658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQP 717
              ++  D   +            ++  +C Q  P+ RP+   ++  +  E   P  ++ 
Sbjct: 251 GGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSIKEEME-PGFREV 300

Query: 718 GFF-TERN 724
            F+ +E N
Sbjct: 301 SFYYSEEN 308

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 7e-58
 Identities = 56/274 (20%), Positives = 111/274 (40%), Gaps = 31/274 (11%)

Query: 437 ENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKL 493
           + ++G G F  VYKG+  +   E+A   L     +    + FK E  ++  LQH N+V+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 494 LGCCM----KRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
                     +   +L+ E + + +L  ++    R K++           I +GL +LH 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 550 DSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
            +   IIHRDLK  N+ +     + KI D G+A              V+GT  +M PE  
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM- 184

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL 668
            +  +    DV++FG+ +LE+        +    +   +              ++    +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV 702
           ++            +   C++Q  ++R ++  ++
Sbjct: 243 KE------------IIEGCIRQNKDERYSIKDLL 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 1e-57
 Identities = 72/286 (25%), Positives = 109/286 (38%), Gaps = 36/286 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSK---SSGQGVEEFKNEVLLIAK 484
            +     KLG+G FG V +G           +AVK L     S  + +++F  EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           L HRNL++L G  +    +M + E  P  SL D +     +         +    +A G+
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE-ANTNRVVGTYGYM 603
            YL      R IHRDL A N+LL      KI DFG+ RA   +             + + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
            PE      FS  SD + FGV + E                  +  +    W      ++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQI 223

Query: 664 IDKSLEDTYSLSEALRC----IQVGLLCVQQRPEDRPNMASVVLML 705
           + K  ++   L     C      V + C   +PEDRP   ++   L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 1e-57
 Identities = 68/277 (24%), Positives = 127/277 (45%), Gaps = 24/277 (8%)

Query: 426 SIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 484
           S+ +    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 485 LQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
            ++ N+V  L   +  DE  ++ EYL   SL D + +       D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQAL 129

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            +LH     ++IHRD+K+ N+LL  + + K++DFG       +Q++ +T  +VGT  +M 
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 184

Query: 605 PEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI 664
           PE      +  K D++S G++ +E++ G           + N L   + + T   P    
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG------EPPYLNENPLRALYLIATNGTP---- 234

Query: 665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
              L++   LS   R      L      E R +   +
Sbjct: 235 --ELQNPEKLSAIFRDFLNRCL--DMDVEKRGSAKEL 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-56
 Identities = 63/277 (22%), Positives = 108/277 (38%), Gaps = 35/277 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LG+G FG VY          +A+K L K+         + + EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
            N+++L G         LI EY P  ++   +    +    D  +    I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H     R+IHRD+K  N+LL +    KI+DFG +      +       + GT  Y+PPE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
               +   K D++S GVL  E + G                      +  +   E   + 
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK-------------------PPFEANTYQETYKRI 216

Query: 668 LEDTYSLSEAL--RCIQVGLLCVQQRPEDRPNMASVV 702
               ++  + +      +    ++  P  RP +  V+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-54
 Identities = 71/297 (23%), Positives = 111/297 (37%), Gaps = 39/297 (13%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSSGQG-VEEFKNEV-LLIA 483
           D       LG G FG V +            + +AVK L + +         +E+ +LI 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 484 KLQHRNLVKLLGCCMKRDER-MLIYEYLPNKSLADFIF-------------DGTRRKLLD 529
              H N+V LLG C K     M+I E+    +L+ ++              +   +  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 530 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT 589
                     +A+G+ +L      + IHRDL A N+LL  +   KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLG 649
                       +M PE   D +++++SDV+SFGVL+ E+                 +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----SLGASPYPGVKIDE 244

Query: 650 HAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
              R   E   +   D +  +           Q  L C    P  RP  + +V  L 
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 6e-53
 Identities = 63/280 (22%), Positives = 108/280 (38%), Gaps = 27/280 (9%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQ 486
           +       +GEG FG V++G+ +        +A+K     +   V E+F  E L + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H ++VKL+G   + +   +I E      L  F+        LD +        ++  L Y
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           L      R +HRD+ A NVL+ +    K+ DFG++R    D T    ++      +M PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179

Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK 666
                 F+  SDV+ FGV + E++             +++++G          P      
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEIL--MHGVKPFQGVKNNDVIGRIENGERLPMP------ 231

Query: 667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
                 +    L    +   C    P  RP    +   LS
Sbjct: 232 -----PNCPPTLY--SLMTKCWAYDPSRRPRFTELKAQLS 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 4e-52
 Identities = 64/274 (23%), Positives = 101/274 (36%), Gaps = 31/274 (11%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
              VKL       ++      Y  N  L  +I    +    D +        I   L YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ PE 
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
             +      SD+++ G ++ +LV G                      +       +  K 
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIFQKI 222

Query: 668 LEDTYSLSEAL--RCIQVGLLCVQQRPEDRPNMA 699
           ++  Y   E    +   +    +      R    
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCE 256

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  180 bits (457), Expect = 3e-51
 Identities = 61/315 (19%), Positives = 112/315 (35%), Gaps = 39/315 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           D++    +LG G FG V++      G   A K +        E  + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           V L       +E ++IYE++    L + + D      +   +  + +  + +GL ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141

Query: 551 SRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                +H DLK  N++   + +   K+ DFG+       Q+        GT  +  PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 197

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGTR-NRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
                   +D++S GVL   L+ G     G +  +   N+    W +             
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS------- 250

Query: 668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPE 727
                 +SE  +     LL     P  R  +                 +  + T  N P 
Sbjct: 251 -----GISEDGKDFIRKLL--LADPNTRMTIHQA-------------LEHPWLTPGNAPG 290

Query: 728 SESSSSNQTFHSSNQ 742
            +S   +  +     
Sbjct: 291 RDSQIPSSRYTKIRD 305

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-50
 Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 41/298 (13%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI--------DGQEIAVKRLSK-SSGQGVEEFKNEVLLI 482
           D       LGEG FG V     I           ++AVK L   ++ + + +  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 483 AKL-QHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIF-------------DGTRRKLL 528
             + +H+N++ LLG C +     +I EY    +L +++                   + L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 529 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ 588
                      +ARG+ YL      + IHRDL A NVL+  +   KI+DFG+AR      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 589 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLL 648
               T        +M PE   D +++ +SDV+SFGVL+ E+   T     +       L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF--TLGGSPYPGVPVEEL- 246

Query: 649 GHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
              ++L  E   ++       +            +   C    P  RP    +V  L 
Sbjct: 247 ---FKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  177 bits (449), Expect = 5e-50
 Identities = 61/310 (19%), Positives = 113/310 (36%), Gaps = 28/310 (9%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           D +    +LG G FG V++ +    G+    K ++          KNE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           + L      + E +LI E+L    L D I        +  ++    +     GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 551 SRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
               I+H D+K  N++ + +     KI DFG+A     D+          T  +  PE  
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGTRN-RGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
                   +D+++ GVL   L+ G     G   ++   N+    W    +          
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS------- 253

Query: 668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM--LSGERSLPQPKQPGFFTERNL 725
                S+S   +     LL  +  P  R  +   +    L G+ S    + P     +  
Sbjct: 254 -----SVSPEAKDFIKNLLQKE--PRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIR 306

Query: 726 PESESSSSNQ 735
            + +   ++ 
Sbjct: 307 QKIKEKYADW 316

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (435), Expect = 1e-48
 Identities = 61/327 (18%), Positives = 118/327 (36%), Gaps = 36/327 (11%)

Query: 424 WKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEE-FKNEVLL 481
           WK   +  D +   + LG G F  V         + +A+K ++K + +G E   +NE+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           + K++H N+V L           LI + +    L D I     +         ++I  + 
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
             + YLH    +    +        LD +    ISDFG+++           +   GT G
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPG 174

Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV 661
           Y+ PE      +S   D +S GV+   L+ G                      + ++   
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY-------------------PPFYDENDA 215

Query: 662 ELIDKSLEDTYSLSEALR------CIQVGLLCVQQRPEDRPNMASVVLM--LSGERSLPQ 713
           +L ++ L+  Y                     +++ PE R      +    ++G+ +L +
Sbjct: 216 KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 714 PKQPGFFTERNLPESESSSSNQTFHSS 740
                  +E+       S   Q F+++
Sbjct: 276 NIHQ-SVSEQIKKNFAKSKWKQAFNAT 301

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  166 bits (422), Expect = 4e-47
 Identities = 64/288 (22%), Positives = 111/288 (38%), Gaps = 40/288 (13%)

Query: 431 TDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQ 486
           +D +     LG GG   V+    L   +++AVK L     +       F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 487 HRNLVKLLGCCMKRDER----MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
           H  +V +               ++ EY+   +L D +        +   +  ++I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE-ANTNRVVGTYG 601
            L + H   +  IIHRD+K +N+++      K+ DFG+ARA          T  V+GT  
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV 661
           Y+ PE A       +SDV+S G ++ E++ G                      +T D PV
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE-------------------PPFTGDSPV 220

Query: 662 ELIDKSLEDTYSLSEALR------CIQVGLLCVQQRPEDRPNMASVVL 703
            +  + + +      A           V L  + + PE+R   A+ + 
Sbjct: 221 SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 7e-47
 Identities = 65/294 (22%), Positives = 119/294 (40%), Gaps = 27/294 (9%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQ 486
           +    ++  + +GEG +G V      ++   +A+K++S    Q   +    E+ ++ + +
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H N++ +           +   YL    +   ++   + + L     C  +  I RGL Y
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANT-NRVVGTYGYMPP 605
           +H      ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  P
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 606 EYAIDGLFSVKS-DVFSFGVLVLELVYGTR-NRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
           E  ++     KS D++S G ++ E++       G H++D  +++LG       ED    +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 664 IDKSLEDTYSL----------------SEALRCIQVGLLCVQQRPEDRPNMASV 701
             K+     SL                S+AL  +      +   P  R  +   
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  167 bits (423), Expect = 2e-46
 Identities = 67/277 (24%), Positives = 108/277 (38%), Gaps = 32/277 (11%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ- 486
           ++FS    +G GGFG VY     D G+  A+K L K      QG     NE ++++ +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 487 --HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
                +V +       D+   I + +    L   +    +  +   +        I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMP 604
            ++H      +++RDLK +N+LLD   + +ISD G+A  F   +     +  VGT+GYM 
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 605 PEYAIDGL-FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL 663
           PE    G+ +   +D FS G ++ +L+ G          H         R+         
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH----SPFRQHKTKDKHEIDRMTLTMAV--- 226

Query: 664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMAS 700
                E   S S  LR +  GLL        R     
Sbjct: 227 -----ELPDSFSPELRSLLEGLLQRD--VNRRLGCLG 256

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-46
 Identities = 67/279 (24%), Positives = 103/279 (36%), Gaps = 34/279 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG---QGVEEFKNEV-LLIAKLQ 486
           ++F     LG+G FG V+        Q  A+K L K        VE    E  +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 487 HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLY 546
           H  L  +      ++    + EYL    L   I         D S+       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 547 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           LH      I++RDLK  N+LLD + + KI+DFGM +   +   + NT    GT  Y+ PE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 607 YAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK 666
             +   ++   D +SFGVL+ E++ G                      +      EL   
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ-------------------SPFHGQDEEELFHS 214

Query: 667 SLEDTYSLSEAL--RCIQVGLLCVQQRPEDRPNMASVVL 703
              D       L      + +    + PE R  +   + 
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  163 bits (414), Expect = 4e-46
 Identities = 60/288 (20%), Positives = 118/288 (40%), Gaps = 41/288 (14%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSG---------QGVEEFKNEVLL 481
           +N+  +  LG G    V + +     +E AVK +  + G         +  E    EV +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 482 IAKLQ-HRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           + K+  H N+++L           L+++ +    L D++   T +  L   +  +I+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
              +  LH   +L I+HRDLK  N+LLD++MN K++DFG +      +       V GT 
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173

Query: 601 GYMPPEYAIDGL------FSVKSDVFSFGVLVLELVYGTR-NRGFHHVDHHHNLLGHAWR 653
            Y+ PE     +      +  + D++S GV++  L+ G+        +     ++   ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233

Query: 654 LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
             + +                S+ ++ +    L VQ  P+ R      
Sbjct: 234 FGSPEWD------------DYSDTVKDLVSRFLVVQ--PQKRYTAEEA 267

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 7e-46
 Identities = 57/338 (16%), Positives = 119/338 (35%), Gaps = 51/338 (15%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
           + +     LG G FG V++ +     +    K + K  G      K E+ ++   +HRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           + L       +E ++I+E++    + + I   T    L+  +    +  +   L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 551 SRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
               I H D++  N++     +   KI +FG AR         N   +     Y  PE  
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL 668
              + S  +D++S G LV  L+ G                      +  +   ++I+  +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI-------------------NPFLAETNQQIIENIM 216

Query: 669 EDTYSLSEALR------CIQVGLLCVQQRPEDRPNMASV---------VLMLSGE--RSL 711
              Y+  E          +      + +  + R   +           +  +S +  R+L
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276

Query: 712 PQPKQPGFFTERNL---PESESSSSNQTFHSSNQITVS 746
              +      +++L     +   S      S   ++V+
Sbjct: 277 KHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVA 314

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  162 bits (412), Expect = 2e-45
 Identities = 60/282 (21%), Positives = 106/282 (37%), Gaps = 40/282 (14%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
            +F     LG G FG V+      +G+  A+K L K      + VE   +E L+++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
             ++++ G      +  +I +Y+    L   +    R            +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
                  II+RDLK  N+LLD   + KI+DFG A+             + GT  Y+ PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
                ++   D +SFG+L+ E++ G                      + +   ++  +K 
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY-------------------TPFYDSNTMKTYEKI 213

Query: 668 LEDTY----SLSEALRCIQVGLLCV--QQRPEDRPNMASVVL 703
           L          +E ++ +   L+     QR  +  N    V 
Sbjct: 214 LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 5e-45
 Identities = 50/298 (16%), Positives = 96/298 (32%), Gaps = 34/298 (11%)

Query: 417 MELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEF 475
           MEL +          + +    K+G G FG +Y G  +  G+E+A+K     +     + 
Sbjct: 1   MELRV---------GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQL 49

Query: 476 KNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQ 535
             E  +   +Q    +  +  C    +  ++   L   SL D     +R+          
Sbjct: 50  HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLL 107

Query: 536 IIGGIARGLLYLHQDSRLRIIHRDLKASNVL---LDNEMNPKISDFGMARAFGVDQTEAN 592
           +   +   + Y+H       IHRD+K  N L           I DFG+A+ +   +T  +
Sbjct: 108 LADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164

Query: 593 -----TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNL 647
                   + GT  Y      +    S + D+ S G +++    G+              
Sbjct: 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224

Query: 648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLML 705
                          L      +  +             C   R +D+P+ + +  + 
Sbjct: 225 YERISEKKMSTPIEVLCKGYPSEFATYLNF---------CRSLRFDDKPDYSYLRQLF 273

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  156 bits (394), Expect = 2e-43
 Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 21/284 (7%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRN 489
           + +    K+GEG +G VYK     G+  A+K  RL K           E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +VKL      +   +L++E+L                 L+       +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 550 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAI 609
               R++HRDLK  N+L++ E   KI+DFG+ARAFG+   +     +V  +   P     
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMG 174

Query: 610 DGLFSVKSDVFSFGVLVLELVYGTR-NRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL 668
              +S   D++S G +  E+V GT    G    D    +        +++ P        
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 669 EDTYSLSEALRCIQVG---------LL--CVQQRPEDRPNMASV 701
           +  +++ E L               LL   ++  P  R      
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 7e-42
 Identities = 64/292 (21%), Positives = 113/292 (38%), Gaps = 26/292 (8%)

Query: 430 ATDNFSEENKLGEGGFGPVYKGMLI--DGQEIAVKRLSKSSGQG--VEEFKNEVLLIAKL 485
           A   +    ++GEG +G V+K   +   G+ +A+KR+   +G+         EV ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 486 ---QHRNLVKLLGCCMKRDERMLIYEYLPNKSLA---DFIFDGTRRKLLDWSKRCQIIGG 539
              +H N+V+L   C            L  + +        D      +       ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 540 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGT 599
           + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +           VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178

Query: 600 YGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRN-RGFHHVDHHHNLLGHAWRLWTED 658
             Y  PE  +   ++   D++S G +  E+       RG   VD    +L        ED
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 659 RPVELIDKSLEDTYSLSEALR---------CIQVGLLCVQQRPEDRPNMASV 701
            P ++           ++ +             + L C+   P  R +  S 
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 2e-41
 Identities = 66/315 (20%), Positives = 113/315 (35%), Gaps = 45/315 (14%)

Query: 438 NKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEE-----FKNEVLLIAKLQHRNLV 491
           + LGEG F  VYK       Q +A+K++        ++        E+ L+ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 492 KLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS 551
            LL     +    L+++++                +L  S     +    +GL YLHQ  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 552 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAID- 610
              I+HRDLK +N+LLD     K++DFG+A++FG           V T  Y  PE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175

Query: 611 GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED 670
            ++ V  D+++ G ++ EL+       F   D   + L   +         +  D     
Sbjct: 176 RMYGVGVDMWAVGCILAELLLR---VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 671 TYSLSEALRCIQVGLL--------------CVQQRPEDRPNMASVVLMLSGERSLPQPKQ 716
            Y   ++   I +  +                   P  R      +            K 
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL------------KM 280

Query: 717 PGFFTERNLPESESS 731
             +F+ R  P     
Sbjct: 281 K-YFSNRPGPTPGCQ 294

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  151 bits (381), Expect = 2e-41
 Identities = 40/286 (13%), Positives = 96/286 (33%), Gaps = 27/286 (9%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
            ++    ++GEG FG +++G  L++ Q++A+K   + S     + ++E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 491 VKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
           +  +    +     ++   L   SL D +      +             +   +  +H+ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119

Query: 551 SRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGVDQTEAN-----TNRVVGTY 600
               +++RD+K  N L+    +       + DFGM + +    T+ +        + GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP 660
            YM     +    S + D+ + G + +  + G+                  +    E + 
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS----LPWQGLKAATNKQKYERIGEKKQ 233

Query: 661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS 706
              + +         E     +          +  P+   +  + S
Sbjct: 234 STPLRELCAG---FPEEFY--KYMHYARNLAFDATPDYDYLQGLFS 274

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-41
 Identities = 64/285 (22%), Positives = 116/285 (40%), Gaps = 21/285 (7%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 488
           +NF +  K+GEG +G VYK    + G+ +A+K++     +         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+VKLL      ++  L++E+L          D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                R++HRDLK  N+L++ E   K++DFG+ARAFGV      T+ VV  +   P    
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILL 175

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGTRN-RGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
               +S   D++S G +  E+V       G   +D    +            P       
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 668 LEDTY------SLSEALRCIQVGLL-----CVQQRPEDRPNMASV 701
            + ++        S+ +  +           +   P  R +  + 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-41
 Identities = 60/293 (20%), Positives = 109/293 (37%), Gaps = 35/293 (11%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLID-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 490
            ++++   +G G FG VY+  L D G+ +A+K++ +           E+ ++ KL H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75

Query: 491 VKLLGCCMKRDERM------LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGL 544
           V+L        E+       L+ +Y+P             ++ L        +  + R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 545 LYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGVDQTEANTNRVVGTYGYM 603
            Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y   
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRA 190

Query: 604 PPEYAIDGLFSVKSDVFSFGVLVLELVYGTR----NRGFHHVDHHHNLLGHAWRLWTEDR 659
           P        ++   DV+S G ++ EL+ G      + G   +     +LG   R    + 
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 660 PVELIDKSLEDTYSLS-----------EALRCIQVGLLCVQQRPEDRPNMASV 701
                +       +             EA+         ++  P  R      
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEA 300

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-40
 Identities = 65/284 (22%), Positives = 112/284 (39%), Gaps = 33/284 (11%)

Query: 429 NATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSS------GQGVEEFKNEVLL 481
           N  D +    +LG G F  V K      G + A K + K        G   E+ + EV +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 482 IAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIA 541
           + ++QH N++ L      + + +LI E +    L DF+     ++ L   +  + +  I 
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQIL 123

Query: 542 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGVDQTEANTNRVV 597
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A              + 
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177

Query: 598 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE 657
           GT  ++ PE        +++D++S GV+   L+ G         D     L +   +  E
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTKQETLANVSAVNYE 234

Query: 658 DRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
                  + S       + A   I+     + + P+ R  +   
Sbjct: 235 FEDEYFSNTS-------ALAKDFIR---RLLVKDPKKRMTIQDS 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-39
 Identities = 62/307 (20%), Positives = 114/307 (37%), Gaps = 31/307 (10%)

Query: 437 ENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLL 494
              LG G  G V +       ++ A+K L         + + EV L  +  Q  ++V+++
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71

Query: 495 GCC----MKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD 550
                    R   +++ E L    L   I D    +     +  +I+  I   + YLH  
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS- 129

Query: 551 SRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
             + I HRD+K  N+L  ++      K++DFG A+      +         T  Y+ PE 
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEV 184

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
                +    D++S GV++  L+ G      +H       +    R+   + P     + 
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE- 243

Query: 668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERSLPQPKQPGFFTERNLPE 727
                 +SE ++ +   LL  +  P  R  +   +      +S   P+ P   T R L E
Sbjct: 244 ------VSEEVKMLIRNLL--KTEPTQRMTITEFMNHPWIMQSTKVPQTP-LHTSRVLKE 294

Query: 728 SESSSSN 734
            +    +
Sbjct: 295 DKERWED 301

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-39
 Identities = 63/274 (22%), Positives = 98/274 (35%), Gaps = 43/274 (15%)

Query: 439 KLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEE------FKNEVLLIAKLQ--HRN 489
            LG GGFG VY G+ + D   +A+K + K       E         EV+L+ K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 490 LVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ 549
           +++LL    + D  +LI E              T R  L           +   + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 550 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY- 607
                ++HRD+K  N+L+D N    K+ DFG          +       GT  Y PPE+ 
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
                    + V+S G+L+ ++V G                      +  D  +      
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD-------------------IPFEHDEEIIRGQVF 222

Query: 668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASV 701
                S SE    I+    C+  RP DRP    +
Sbjct: 223 FRQRVS-SECQHLIR---WCLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 5e-39
 Identities = 55/275 (20%), Positives = 96/275 (34%), Gaps = 33/275 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 487
           ++F     LG+G FG V        G+  A+K L K    +   V     E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
             L  L       D    + EY     L   +   +R ++    +       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H      +++RD+K  N++LD + + KI+DFG+ +    D          GT  Y+ PE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176

Query: 608 AIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS 667
             D  +    D +  GV++ E++ G                      +       L +  
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR-------------------LPFYNQDHERLFELI 217

Query: 668 LEDTYSLSEAL--RCIQVGLLCVQQRPEDRPNMAS 700
           L +       L      +    +++ P+ R     
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 5e-38
 Identities = 59/299 (19%), Positives = 117/299 (39%), Gaps = 35/299 (11%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQG--VEEFKNEVLLIAKLQHR 488
             + +  K+G+G FG V+K      GQ++A+K++   + +         E+ ++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 489 NLVKLLGCCMKRDERM--------LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           N+V L+  C  +            L++++  +           +  L +  +  Q++   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNR--VVG 598
              L  L+   R +I+HRD+KA+NVL+  +   K++DFG+ARAF + +          V 
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 599 TYGYMPPEYAI-DGLFSVKSDVFSFGVLVLELVYGTR----NRGFHHVDHHHNLLG---- 649
           T  Y PPE  + +  +    D++  G ++ E+   +     N   H +     L G    
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 650 HAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLL-------CVQQRPEDRPNMASV 701
             W         E ++        + + L+               +   P  R +    
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-37
 Identities = 62/286 (21%), Positives = 110/286 (38%), Gaps = 23/286 (8%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 488
             + +  K+GEG +G V+K       + +A+KR+               E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N+V+L        +  L++E+        F         LD       +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                 ++HRDLK  N+L++     K+++FG+ARAFG+      +  VV  +   P    
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLF 174

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGTR--NRGFHHVDHHHNLLGHAWRLWTEDRP--VELI 664
              L+S   D++S G +  EL    R    G    D    +         E  P   +L 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 665 DKSLEDTYSLSEALRCIQVGL---------LCVQQRPEDRPNMASV 701
           D      Y  + +L  +   L           ++  P  R +    
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (349), Expect = 1e-36
 Identities = 64/306 (20%), Positives = 109/306 (35%), Gaps = 40/306 (13%)

Query: 408 SELGNRKEEMELPIFDWKSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSK 466
             L   KE+               D F     LG G FG V        G   A+K L K
Sbjct: 17  EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76

Query: 467 S---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGT 523
                 + +E   NE  ++  +    LVKL           ++ EY+    +   +    
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--- 133

Query: 524 RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 583
           R               I     YLH    L +I+RDLK  N+L+D +   +++DFG A+ 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK- 189

Query: 584 FGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDH 643
               + +  T  + GT   + PE  +   ++   D ++ GVL+ E+  G           
Sbjct: 190 ----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY---------- 235

Query: 644 HHNLLGHAWRLWTEDRPVELIDKSLEDTY----SLSEALRCIQVGLLCV--QQRPEDRPN 697
                      +  D+P+++ +K +          S  L+ +   LL V   +R  +  N
Sbjct: 236 ---------PPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKN 286

Query: 698 MASVVL 703
             + + 
Sbjct: 287 GVNDIK 292

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 1e-34
 Identities = 61/322 (18%), Positives = 120/322 (37%), Gaps = 40/322 (12%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 488
             + +   +G G +G V   +    G ++A+K+L +   S    +    E+ L+  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 489 NLVKLLGCCMKRDERMLIYE-YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
           N++ LL      +      + YL    +   +    + + L   +   ++  + +GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEY 607
           H      IIHRDLK  N+ ++ +   KI DFG+AR     Q ++     V T  Y  PE 
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189

Query: 608 AIDGL-FSVKSDVFSFGVLVLELVYGTR-NRGFHHVDHHHNLLGHAWRLWTEDRPVELID 665
            ++ + ++   D++S G ++ E++ G    +G  H+D    ++        E       D
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 666 KSLEDTYSLSEALRCIQVGLL-------------CVQQRPEDRPNMASVVLMLSGERSLP 712
           ++      L E  +     +L              +    E R                 
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG------------- 296

Query: 713 QPKQPGFFTERNLPESESSSSN 734
           +     +F   +  E E     
Sbjct: 297 EALAHPYFESLHDTEDEPQVQK 318

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 4e-33
 Identities = 68/279 (24%), Positives = 113/279 (40%), Gaps = 31/279 (11%)

Query: 432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKSS----GQGVEEFKNEVLLIA 483
           +NF     LG G +G V+    I     G+  A+K L K++     +  E  + E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 484 KLQHR-NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIAR 542
            ++    LV L        +  LI +Y+    L   +    R       +    +G I  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGY 602
            L +LH   +L II+RD+K  N+LLD+  +  ++DFG+++ F  D+TE       GT  Y
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 603 MPPEYAIDGL--FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP 660
           M P+    G        D +S GVL+ EL+ G     F      ++    + R+   + P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPP 254

Query: 661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMA 699
                       S + A   IQ     + + P+ R    
Sbjct: 255 -------YPQEMS-ALAKDLIQ---RLLMKDPKKRLGCG 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  128 bits (321), Expect = 4e-33
 Identities = 50/241 (20%), Positives = 106/241 (43%), Gaps = 23/241 (9%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRN 489
           D++    KLG G +  V++ + + + +++ VK L        ++ K E+ ++  L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 490 LVKLLGCCMKRDERM--LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
           ++ L         R   L++E++ N             + L        +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 548 HQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPE 606
           H    + I+HRD+K  NV++D+E    ++ D+G+A  +   Q     N  V +  +  PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199

Query: 607 YAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID 665
             +D  ++    D++S G ++  +++      F H   +++ L    ++   +   + ID
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 666 K 666
           K
Sbjct: 258 K 258

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 5e-32
 Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 9/205 (4%)

Query: 432 DNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 488
             +     +G G  G V      +  + +A+K+LS+   +    +    E++L+  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 489 NLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLH 548
           N++ LL     +       +      L D       +  LD  +   ++  +  G+ +LH
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 549 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYA 608
                 IIHRDLK SN+++ ++   KI DFG+AR  G           V T  Y  PE  
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVI 190

Query: 609 IDGLFSVKSDVFSFGVLVLELVYGT 633
           +   +    D++S G ++ E+V   
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 7e-31
 Identities = 67/327 (20%), Positives = 119/327 (36%), Gaps = 38/327 (11%)

Query: 425 KSIANATDNFSEENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKS--SGQGVEEFKNEVLL 481
           K+I    + +   + +G G +G V        G  +AVK+LS+   S    +    E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 482 IAKLQHRNLVKLLGCCMKRDERMLI-YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGI 540
           +  ++H N++ LL               YL    +   + +  + + L       +I  I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 541 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTY 600
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR    + T     R    +
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----W 183

Query: 601 GYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRN-RGFHHVDHHHNLLGHAWRLWTEDR 659
              P        ++   D++S G ++ EL+ G     G  H+D    +L        E  
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243

Query: 660 PVELIDKSLEDTYSLSEALRCIQVGLL-------------CVQQRPEDRPNMASVVLMLS 706
                + +     SL++  +     +               +    + R   A       
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA----- 298

Query: 707 GERSLPQPKQPGFFTERNLPESESSSS 733
               L       +F + + P+ E  + 
Sbjct: 299 ----LAHA----YFAQYHDPDDEPVAD 317

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (284), Expect = 6e-28
 Identities = 39/212 (18%), Positives = 79/212 (37%), Gaps = 18/212 (8%)

Query: 437 ENKLGEGGFGPVYKGM-LIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLG 495
             KLG G F  V+    +++   +A+K +        E  ++E+ L+ ++   +  K   
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDS 76

Query: 496 CCMKRDERMLIYEYLPNKSL-------------ADFIFDGTRRKLLDWSKRCQIIGGIAR 542
                  ++L +      +                 +      + +      QI   +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 543 GLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGVDQTEANTNRVVGTYG 601
           GL Y+H+  R  IIH D+K  NVL++  +    +    +A        + +    + T  
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 602 YMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT 633
           Y  PE  +   +   +D++S   L+ EL+ G 
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 98.3 bits (244), Expect = 3e-24
 Identities = 32/155 (20%), Positives = 56/155 (36%), Gaps = 20/155 (12%)

Query: 438 NKLGEGGFGPVYKGMLIDGQEIAVK--RLSKSSGQGV--------EEFKNEVLLIAKLQH 487
             +GEG    V+        E  VK  ++  +S + V          F    +  A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 488 RNLVKLLGCCMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYL 547
           R L KL G  + +      Y +  N  L + I      ++   +   +++  I   +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 548 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 582
           +      I+H DL   NVL+  E    I DF  + 
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 85.8 bits (212), Expect = 9e-21
 Identities = 24/129 (18%), Positives = 49/129 (37%), Gaps = 21/129 (16%)

Query: 5   QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPL 64
           ++ L  G+ +  G++L      +              L ++     + T  W +N     
Sbjct: 1   RNLLTNGEGLYAGQSLDVEP--YHFIMQEDC-----NLVLYD----HSTSVWASNTGILG 49

Query: 65  PDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSD 124
                   + S GN   ++ ++    +W+S++ R   N V VL E GN+V+         
Sbjct: 50  KKGCK-AVLQSDGN--FVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY-------G 99

Query: 125 NFLWQSFDY 133
           + +W +  Y
Sbjct: 100 SDIWSTGTY 108

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 70.8 bits (173), Expect = 2e-15
 Identities = 28/129 (21%), Positives = 48/129 (37%), Gaps = 22/129 (17%)

Query: 5   QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPL 64
            + L  G+++  GE L     SF              L ++          W  N     
Sbjct: 1   DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGL- 48

Query: 65  PDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSD 124
             RS  LS+ + GN  L++ N +N  +W+SN      N V +L +  N+V+   +     
Sbjct: 49  -SRSCFLSMQTDGN--LVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD----- 100

Query: 125 NFLWQSFDY 133
              W +  +
Sbjct: 101 --RWATGTH 107

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 67.6 bits (165), Expect = 3e-14
 Identities = 20/89 (22%), Positives = 34/89 (38%), Gaps = 7/89 (7%)

Query: 44  IWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNP 103
           I Y    N       +    L      LS+ +  N  L+L +  +  VWS+N +      
Sbjct: 12  ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCN--LVLFDR-DDRVWSTNTAGKGTGC 68

Query: 104 VAVLLESGNLVVKSGNDNDSDNFLWQSFD 132
            AVL  +G + V      + +  +W S +
Sbjct: 69  RAVLQPNGRMDVL----TNQNIAVWTSGN 93

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 65.6 bits (159), Expect = 1e-13
 Identities = 23/129 (17%), Positives = 43/129 (33%), Gaps = 20/129 (15%)

Query: 6   DTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLP 65
           D L  G  +  G +L      +     +          + Y    N    W +  N    
Sbjct: 2   DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNL------VLYD---NNRAVWASGTNGKAS 50

Query: 66  DRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDN 125
               VL + + GN  +   +     +W+SN +R   N   +L    N+V+   +    +N
Sbjct: 51  GC--VLKMQNDGNLVIYSGS---RAIWASNTNRQNGNYYLILQRDRNVVIYDNS----NN 101

Query: 126 FLWQSFDYP 134
            +W +    
Sbjct: 102 AIWATHTNV 110

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 59.3 bits (143), Expect = 3e-11
 Identities = 23/132 (17%), Positives = 42/132 (31%), Gaps = 24/132 (18%)

Query: 2   TSTQDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRN 61
            +    L   +S+     ++     +     +        L ++     N    W  N  
Sbjct: 11  DNHPQILHATESL----EILFGTHVYRFIMQTDCN-----LVLY----DNNNPIWATNTG 57

Query: 62  APLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDN 121
                   VL    Q +G L++  + N  VW S  +  A + V VL    N+V+      
Sbjct: 58  GLGNGCRAVL----QPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI------ 107

Query: 122 DSDNFLWQSFDY 133
              + LW +   
Sbjct: 108 -YGDALWATQTV 118

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 55.7 bits (134), Expect = 4e-10
 Identities = 21/88 (23%), Positives = 33/88 (37%), Gaps = 8/88 (9%)

Query: 44  IWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNP 103
           I +     G+     +    L   S   ++ S  N  L+L +S +  VW+SN +      
Sbjct: 3   ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCN--LVLFDS-DVRVWASNTAGAT-GC 58

Query: 104 VAVLLESGNLVVKSGNDNDSDNFLWQSF 131
            AVL   G LV+        +   W S 
Sbjct: 59  RAVLQSDGLLVIL----TAQNTIRWSSG 82

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	751
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.83
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.81
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.81
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.64
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.54
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.42
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.32
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	98.99
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.74
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.67
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.64
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.53
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.21
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.0
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.56
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.02
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.53
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.04
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	95.88
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	91.95
d1emoa1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	90.8
d1xkba1	39	Factor X, N-terminal module {Human (Homo sapiens)	88.87
d1uzka1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	88.6
d1i0ua2	41	Low density lipoprotein (LDL) receptor, different	88.55
d1lmja1	44	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	87.84
d1edmb_	39	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	85.59
d2vj3a2	39	Neurogenic locus notch homolog protein 1, Notch1 {	85.38
d1lmja2	42	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	85.24
d1gl4a2	40	EGF-like domain of nidogen-1 {Mouse (Mus musculus)	84.18
d1dx5i3	40	Thrombomodulin, different EGF-like domains {Human	82.24
d1uzka2	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	82.22
d1apqa_	53	Complement protease C1R {Human (Homo sapiens) [Tax	81.62
d1szba2	45	Mannose-binding protein associated serine protease	80.85

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-50  Score=413.08  Aligned_cols=253  Identities=25%  Similarity=0.336  Sum_probs=206.1

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|++.++||+|+||+||+|++. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            468999999999999999999975 58999999997653 3345679999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+|+.+....
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999984   4557999999999999999999999998   9999999999999999999999999999875444


Q ss_pred             ccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      ........+||+.|+|||++.+..+ +.++|||||||+||||++|+.||........  ...    ........      
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~----~~~~~~~~------  225 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYS----DWKEKKTY------  225 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHH----HHHTTCTT------
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHH----HHhcCCCC------
Confidence            4444455789999999999998876 6789999999999999999999864332211  100    01111100      


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                        .......+..+.+|+.+||+.||++|||++|+++
T Consensus       226 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0011122456789999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=407.31  Aligned_cols=255  Identities=26%  Similarity=0.424  Sum_probs=200.1

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|+..++||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||++++++.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            478889999999999999999988899999999754 3456789999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+||||++++.+||+|||+++.........
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999999854  3456899999999999999999999998   9999999999999999999999999998764332222


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                       .....||+.|+|||++.+..++.++|||||||++|||+++..|+.....  ...+...    ...+         ....
T Consensus       159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~----i~~~---------~~~~  222 (263)
T d1sm2a_         159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVED----ISTG---------FRLY  222 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHH----HHHT---------CCCC
T ss_pred             -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHH----HHhc---------CCCC
Confidence             2335789999999999999999999999999999999996554321111  1111111    1111         1111


Q ss_pred             cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       672 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .+.....++.+|+.+||+.||++||||++|++.|+++
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1223345788999999999999999999999999865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-49  Score=405.15  Aligned_cols=245  Identities=25%  Similarity=0.365  Sum_probs=206.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.+.||+|+||+||+|+++ +++.||||++.+.   .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999975 5889999998643   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999953   346899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                          ......||+.|+|||++.+..++.++|||||||+||||++|+.||.......   +.    .......        
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~----~~i~~~~--------  220 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TY----KRISRVE--------  220 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HHHHTTC--------
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCC--------
Confidence                2234689999999999999999999999999999999999999986432211   11    1111111        


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                        ...+...+..+.+|+.+||+.||++|||++|+++
T Consensus       221 --~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              0112223467889999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-49  Score=407.67  Aligned_cols=258  Identities=25%  Similarity=0.393  Sum_probs=202.3

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|.+.++||+|+||+||+|++.  ..||||+++..  .....+.|.+|+.++++++|||||++++++.+ +..++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            67889999999999999999863  36999998654  45567889999999999999999999998754 568999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++|+|.+++..  ....+++..++.++.||++||+|||+++   ||||||||+||||+.++.+||+|||+|+.......
T Consensus        85 ~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          85 CEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             CCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999954  3346899999999999999999999998   99999999999999999999999999987754444


Q ss_pred             cccccccccccCccCcccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          590 EANTNRVVGTYGYMPPEYAIDG---LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~---~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ........||+.|+|||++.+.   .++.++|||||||+||||++|+.||.......  .+.............      
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~p~~------  231 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDL------  231 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCCCCG------
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCCCCcc------
Confidence            4444557899999999999643   58999999999999999999999976332211  111111111111111      


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                         ...+...+..+.+|+.+||+.||++|||+++|++.|+.+
T Consensus       232 ---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         232 ---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             ---GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               111223346788999999999999999999999999876

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=407.14  Aligned_cols=249  Identities=24%  Similarity=0.409  Sum_probs=208.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      ++|+..++||+|+||+||+|++. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999964 59999999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++|+|.+++.+    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..... 
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            99999998843    35899999999999999999999998   99999999999999999999999999987643322 


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ...........        .-
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~--------~~  236 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP--------EL  236 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC--------CC
T ss_pred             -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCC--------CC
Confidence             2334689999999999999999999999999999999999999985322211      11111111110        01


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            112233567889999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.8e-49  Score=409.49  Aligned_cols=257  Identities=27%  Similarity=0.399  Sum_probs=212.1

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|++.++||+|+||+||+|++. +++.||||+++.. ....++|.+|+++|++++|||||++++++.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            367888999999999999999976 4889999999654 34567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +++|+|.+++... ....+++..++.++.||++||.|||+++   |+||||||+||||++++.+||+|||+|+.......
T Consensus        95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            9999999998653 3356899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          590 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                      .. .....|++.|+|||++.+..++.++|||||||++|||++|..|+.....  ...    .......         ...
T Consensus       171 ~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~----~~~~i~~---------~~~  234 (287)
T d1opja_         171 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQ----VYELLEK---------DYR  234 (287)
T ss_dssp             EE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHH----HHHHHHT---------TCC
T ss_pred             ee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHH----HHHHHhc---------CCC
Confidence            22 2235688999999999999999999999999999999998776432211  111    1111111         111


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...+...+..+.+|+.+||+.||++||||++|++.|+.+
T Consensus       235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            222333456788999999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=404.63  Aligned_cols=254  Identities=29%  Similarity=0.440  Sum_probs=206.1

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|++.++||+|+||.||+|++++++.||||++... ....++|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            578899999999999999999988899999999654 3456789999999999999999999998854 56799999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +|+|.+++... ....+++..++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+|+.+...... 
T Consensus        91 ~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-  165 (272)
T d1qpca_          91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-  165 (272)
T ss_dssp             TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred             CCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc-
Confidence            99999987432 2235899999999999999999999998   999999999999999999999999999987543222 


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..|+.....  ...+..    ....+         ....
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~----~i~~~---------~~~~  230 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQ----NLERG---------YRMV  230 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHH----HHHTT---------CCCC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHH----HHHhc---------CCCC
Confidence            22346789999999999999999999999999999999997665432111  111111    11111         1111


Q ss_pred             cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       672 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      .+...+..+.+|+.+||+.||++||||++|+++|+.
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            122334578899999999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-49  Score=409.99  Aligned_cols=248  Identities=24%  Similarity=0.308  Sum_probs=204.1

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.+.||+|+||+||+|++. +++.||||++.+.   .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999999975 5899999999653   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++|+|.+++..   .+.+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999999853   456899999999999999999999999   999999999999999999999999999987654


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      ..........||+.|+|||++.+..++.++|||||||+||||++|+.||.......   +..    .......       
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~----~i~~~~~-------  227 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQ----KIIKLEY-------  227 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHTTCC-------
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHH----HHHcCCC-------
Confidence            44444455789999999999999999999999999999999999999986432211   111    0111110       


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVV  702 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  702 (751)
                         .++.....++.+|+.+||+.||++|||++|++
T Consensus       228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence               11223345788999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-48  Score=409.61  Aligned_cols=256  Identities=26%  Similarity=0.392  Sum_probs=197.9

Q ss_pred             cCccccccccccccccEEEEEEcC-C---cEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-G---QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|++.++||+|+||+||+|++.. +   ..||||++... .....++|.+|+++|++++|||||++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456777899999999999999753 3   25899998654 444567899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998853  3446899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccc---ccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          587 DQTEAN---TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       587 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ......   .....||+.|+|||.+.+..++.++|||||||+||||++ |+.|+......   .+..    ....+    
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~----~i~~~----  249 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVIN----AIEQD----  249 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTT----
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcC----
Confidence            322211   122457899999999999999999999999999999998 88887533221   1111    11111    


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                           .....+...+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus       250 -----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         250 -----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 11112333456788999999999999999999999999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=404.65  Aligned_cols=251  Identities=23%  Similarity=0.340  Sum_probs=207.3

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      +.|++.++||+|+||+||+|++. +++.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56899999999999999999975 58899999998777777789999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++|+|.+++.+.  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+......  
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            999999998542  346899999999999999999999999   9999999999999999999999999997653221  


Q ss_pred             ccccccccccCccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~-----~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      .......||+.|+|||++.     +..|+.++|||||||++|||++|+.||.......   ...   ........ .   
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~---~i~~~~~~-~---  234 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL---KIAKSEPP-T---  234 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHHSCCC-C---
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH---HHHcCCCC-C---
Confidence            1223468999999999984     4568999999999999999999999976433221   111   11111100 0   


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                          -..+...+..+.+|+.+||+.||++|||++|+++
T Consensus       235 ----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 ----LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ----CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0112233567889999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=410.51  Aligned_cols=257  Identities=26%  Similarity=0.428  Sum_probs=207.6

Q ss_pred             cCccccccccccccccEEEEEEcC-C-----cEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCce
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-G-----QEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  503 (751)
                      ++|++.++||+|+||+||+|++.. +     ..||+|++... .....+.+.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            578999999999999999999653 2     36999998654 344556899999999998 899999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCC
Q 038934          504 MLIYEYLPNKSLADFIFDGTR--------------------RKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKAS  563 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~  563 (751)
                      ++||||+++|+|.++|.....                    ...+++..++.++.||++||+|||+++   |+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence            999999999999999965321                    235899999999999999999999998   999999999


Q ss_pred             CeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCc
Q 038934          564 NVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVD  642 (751)
Q Consensus       564 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~  642 (751)
                      |||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||+||||++ |+.||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654444333445678999999999999999999999999999999997 89997543322


Q ss_pred             cccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 038934          643 HHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLS  706 (751)
Q Consensus       643 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  706 (751)
                      ..  +    ......+         .....+...+..+.+|+.+||+.||++|||++||+++|.
T Consensus       274 ~~--~----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 AN--F----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HH--H----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH--H----HHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            11  1    1111111         111223334567889999999999999999999999985

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=393.91  Aligned_cols=254  Identities=24%  Similarity=0.382  Sum_probs=212.0

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|+..++||+|+||+||+|++++++.||||++++.. ...++|.+|+.++++++|||||++++++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            5788999999999999999999888899999997643 456789999999999999999999999999999999999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +|+|.+++..  ....+++..+.+++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+++.+...... 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            9999999753  3446889999999999999999999998   999999999999999999999999999876543332 


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                      ......||+.|+|||++.+..++.++|||||||++|||++ |+.|+......+   +..    ....+.         ..
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~----~i~~~~---------~~  220 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAE----HIAQGL---------RL  220 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHH----HHHTTC---------CC
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHH----HHHhCC---------CC
Confidence            2233678999999999999999999999999999999998 788876433221   111    111111         11


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ..+......+.+|+.+||+.||++|||++++++.|..+
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            12223345788999999999999999999999998653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=403.02  Aligned_cols=255  Identities=25%  Similarity=0.338  Sum_probs=196.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeee--CCceEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK--RDERML  505 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  505 (751)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++...  .+...+.+.+|++++++++|||||++++++.+  ...+++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            368999999999999999999965 5899999999754  33446679999999999999999999999865  456899


Q ss_pred             EEEecCCCChhHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          506 IYEYLPNKSLADFIFDGT-RRKLLDWSKRCQIIGGIARGLLYLHQDSR--LRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~--~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      ||||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+++.  .+|+||||||+||||+.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999986432 34569999999999999999999998642  359999999999999999999999999999


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      .+.....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+.    ......... 
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~----~~i~~~~~~-  232 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA----GKIREGKFR-  232 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----HHHHHTCCC-
T ss_pred             ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHH----HHHHcCCCC-
Confidence            8653322  223478999999999999999999999999999999999999998643221   111    111111111 


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                              ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus       233 --------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                    112233457889999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-48  Score=411.60  Aligned_cols=263  Identities=22%  Similarity=0.312  Sum_probs=206.1

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|++.++||+|+||+||+|++. +|+.||+|+++.. .....+++.+|+.+|++++|||||++++++.+.++.++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            478999999999999999999975 5899999999765 33445789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      |+++|+|.+++.+   ...+++..+..++.|++.||.|||++ +   |+||||||+||||++++.+||+|||+|+.+.. 
T Consensus        85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  157 (322)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence            9999999999954   34589999999999999999999974 7   99999999999999999999999999987532 


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHH-H--------------
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHA-W--------------  652 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~-~--------------  652 (751)
                         ......+||+.|+|||++.+.+|+.++||||+||++|||++|+.||............... .              
T Consensus       158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence               1223468999999999999999999999999999999999999998654332110000000 0              


Q ss_pred             --------HHhccCChhhhcchhccCc----cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          653 --------RLWTEDRPVELIDKSLEDT----YSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       653 --------~~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                              .........+..+......    .....+.++.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                    0000000011111111100    01112457889999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=399.39  Aligned_cols=256  Identities=27%  Similarity=0.427  Sum_probs=203.8

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLP  511 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  511 (751)
                      ++|++.+.||+|+||.||+|++.+++.||||++... ....+.|.+|+.++++++|||||++++++. ++..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            689999999999999999999988889999999654 345678999999999999999999999985 456899999999


Q ss_pred             CCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc
Q 038934          512 NKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA  591 (751)
Q Consensus       512 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  591 (751)
                      +|+|.+++... ..+.+++..++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++........ 
T Consensus        95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-  169 (285)
T d1fmka3          95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  169 (285)
T ss_dssp             TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence            99999988542 2235899999999999999999999998   999999999999999999999999999876433222 


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccCc
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLEDT  671 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  671 (751)
                      ......||+.|+|||++.++.++.++|||||||++|||++|..|+......  ..+...    ...+         ....
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~----i~~~---------~~~~  234 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ----VERG---------YRMP  234 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTT---------CCCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHH----HHhc---------CCCC
Confidence            223357899999999999999999999999999999999987764432221  111111    1111         1112


Q ss_pred             cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          672 YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       672 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      .+...+.++.+++.+||+.||++||+|++|+++|+..-
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            22334567889999999999999999999999999863

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.2e-48  Score=404.42  Aligned_cols=253  Identities=22%  Similarity=0.281  Sum_probs=191.5

Q ss_pred             HhcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ..+.|++.+.||+|+||+||+|++. +++.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3467999999999999999999975 58999999997653 233456889999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc---CCCCeEEeeccCcccc
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAF  584 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~~~  584 (751)
                      ||+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999995   3456999999999999999999999998   99999999999994   5789999999999875


Q ss_pred             CCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ....   ......||+.|+|||++.+..++.++|||||||+||||++|+.||.......   +..    .......    
T Consensus       161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~----~i~~~~~----  226 (307)
T d1a06a_         161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFE----QILKAEY----  226 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH----HHHTTCC----
T ss_pred             cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHH----HHhccCC----
Confidence            4322   2234689999999999999999999999999999999999999986332211   111    1111100    


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                        ..........+..+.+|+.+||+.||++|||++|+++.
T Consensus       227 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         227 --EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              00111112334678899999999999999999999973

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=399.30  Aligned_cols=259  Identities=26%  Similarity=0.432  Sum_probs=202.2

Q ss_pred             cCccccccccccccccEEEEEEcCC-----cEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDG-----QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      +.|+..++||+|+||.||+|.+...     ..||||++... .....++|.+|+.++++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4678889999999999999997542     36999999654 33445679999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ||||+.++++.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999998854  3346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc-ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|..|+......  ..+.    .....+      
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~----~~i~~~------  229 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM----KAINDG------  229 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH----HHHHTT------
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHH----HHHhcc------
Confidence            33222 2223356899999999999999999999999999999999976664322211  1111    111111      


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                         .....+...+..+.+|+.+||+.||++||||.||+++|+.+..
T Consensus       230 ---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         230 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence               1122233345678899999999999999999999999987643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=396.94  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=205.8

Q ss_pred             cCccccc-cccccccccEEEEEEc---CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEEN-KLGEGGFGPVYKGMLI---DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~-~IG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|.+.+ +||+|+||+||+|.+.   ++..||||+++.. .....++|.+|+++|++++|||||++++++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 4999999999999864   3557999999765 33456789999999999999999999999864 568999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++|+|.+++..  .+..+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999999843  3456899999999999999999999998   99999999999999999999999999998754


Q ss_pred             CCcc-ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          587 DQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       587 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......   .+.    .....+..    
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~----~~i~~~~~----  230 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKR----  230 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHHHTTCC----
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCC----
Confidence            3322 22234578999999999999999999999999999999998 89997643221   111    11112211    


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                           ...+...+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       231 -----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         231 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                 11223344678899999999999999999999998874

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-47  Score=391.07  Aligned_cols=246  Identities=23%  Similarity=0.355  Sum_probs=196.3

Q ss_pred             cccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeee----CCceEEEE
Q 038934          435 SEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK----RDERMLIY  507 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~  507 (751)
                      +..++||+|+||+||+|++. +++.||+|++...  .....+.+.+|+++|++++|||||++++++.+    ...+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999975 5889999998654  34456779999999999999999999999875    34679999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc-CCCCeEEeeccCccccCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGV  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~  586 (751)
                      ||+++|+|.+++.+   ...+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999954   346899999999999999999999875 4599999999999996 578999999999986432


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      .    ......||+.|+|||++.+ +++.++|||||||++|||++|+.||......  ..    .......+.....   
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~----~~~~i~~~~~~~~---  233 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQ----IYRRVTSGVKPAS---  233 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HH----HHHHHTTTCCCGG---
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HH----HHHHHHcCCCCcc---
Confidence            2    2234689999999998875 5999999999999999999999997532211  11    1111111111111   


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           .+.....++.+|+.+||+.||++|||+.|+++
T Consensus       234 -----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         234 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                 11122346789999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=397.22  Aligned_cols=247  Identities=27%  Similarity=0.380  Sum_probs=197.8

Q ss_pred             ccccccccccEEEEEEcC---CcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEecCC
Q 038934          438 NKLGEGGFGPVYKGMLID---GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYLPN  512 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  512 (751)
                      ++||+|+||+||+|.+..   ++.||||+++..  .....++|.+|+.+|++++|||||+++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998643   468999999654  23345689999999999999999999999864 567899999999


Q ss_pred             CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCccc-
Q 038934          513 KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTEA-  591 (751)
Q Consensus       513 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-  591 (751)
                      |+|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+....... 
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999854   345899999999999999999999998   9999999999999999999999999998765433222 


Q ss_pred             cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhccC
Q 038934          592 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLED  670 (751)
Q Consensus       592 ~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  670 (751)
                      ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||......   .+    ......+..         .
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~----~~~i~~~~~---------~  229 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV----TAMLEKGER---------M  229 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCC---------C
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HH----HHHHHcCCC---------C
Confidence            2234678999999999999999999999999999999998 89997633221   11    111111111         1


Q ss_pred             ccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          671 TYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       671 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                      ..+...+..+.+|+.+||+.||++|||+++|++.|+.
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            1222334678899999999999999999999988864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.7e-47  Score=403.43  Aligned_cols=253  Identities=21%  Similarity=0.318  Sum_probs=209.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999975 5899999999877666678899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc--CCCCeEEeeccCccccCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFGla~~~~~~  587 (751)
                      +++|+|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999853  3346999999999999999999999999   99999999999996  4678999999999876533


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....    .....      .
T Consensus       180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i----~~~~~------~  243 (350)
T d1koaa2         180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNV----KSCDW------N  243 (350)
T ss_dssp             SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHTCC------C
T ss_pred             cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH----HhCCC------C
Confidence            22   234689999999999999999999999999999999999999986432211   11110    00000      0


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      +........+..+.+|+.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0011112234578899999999999999999999974

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-47  Score=400.77  Aligned_cols=245  Identities=28%  Similarity=0.429  Sum_probs=200.9

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      +.|+..++||+|+||+||+|++. +++.||||++....   ....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35899999999999999999965 58899999997653   234467899999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+.... 
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999999877643   356899999999999999999999999   99999999999999999999999999986532 


Q ss_pred             CccccccccccccCccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          588 QTEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                           .....||+.|+|||++.+   ..|+.++|||||||++|||++|+.||......      ............    
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~~~----  232 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP----  232 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCC----
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCC----
Confidence                 223679999999999864   46899999999999999999999997532211      111111111111    


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                           ...+...+..+.+|+.+||+.||.+|||++|+++
T Consensus       233 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 -----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                 0111223457889999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.8e-46  Score=401.74  Aligned_cols=257  Identities=22%  Similarity=0.277  Sum_probs=211.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            367999999999999999999964 6999999999877666667889999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc--CCCCeEEeeccCccccCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFGla~~~~~~  587 (751)
                      +++|+|.+++..  ....+++..+..|+.||+.||.|||+++   |+||||||+||||+  .++.+||+|||+|+.+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999988743  3346899999999999999999999998   99999999999998  6789999999999987543


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      ..   .....||+.|+|||++.+..++.++|||||||+||+|++|+.||.......   ...   . ......      .
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~---~-i~~~~~------~  246 (352)
T d1koba_         183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQ---N-VKRCDW------E  246 (352)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---H-HHHCCC------C
T ss_pred             Cc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhCCC------C
Confidence            22   234679999999999999999999999999999999999999986332211   111   0 000000      0


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HhCC
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM--LSGE  708 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  708 (751)
                      .........+..+.+|+.+||+.||.+|||+.|+++.  +.+.
T Consensus       247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            1111122334578899999999999999999999873  5443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-46  Score=388.99  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=205.2

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS------GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.+..      ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            468999999999999999999974 58999999996531      22467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC----CeEEeecc
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFG  579 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DFG  579 (751)
                      ++||||+++|+|.+++.+   .+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999954   346999999999999999999999999   99999999999998776    49999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR  659 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~  659 (751)
                      +++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ...    ......
T Consensus       163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~----~i~~~~  232 (293)
T d1jksa_         163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA----NVSAVN  232 (293)
T ss_dssp             TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHTTC
T ss_pred             hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHH----HHHhcC
Confidence            9987643322   234678999999999999999999999999999999999999976432211   110    011110


Q ss_pred             hhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          660 PVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       660 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .      ..........+..+.+|+.+||+.||++|||++|+++
T Consensus       233 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 Y------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             C------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0      0000011123456789999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-46  Score=395.53  Aligned_cols=260  Identities=25%  Similarity=0.394  Sum_probs=210.2

Q ss_pred             hcCccccccccccccccEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCce
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  503 (751)
                      .++|++.++||+|+||+||+|++.      +++.||||++.... ....++|.+|++++++++||||+++++++...+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            468999999999999999999964      35789999997653 33456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCC
Q 038934          504 MLIYEYLPNKSLADFIFDGT---------------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKA  562 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp  562 (751)
                      ++||||+++|+|.+++....                     ....+++..++.|+.||+.||+|||+++   ||||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence            99999999999999996422                     1234889999999999999999999998   99999999


Q ss_pred             CCeEEcCCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCC-CCCCCCC
Q 038934          563 SNVLLDNEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTR-NRGFHHV  641 (751)
Q Consensus       563 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~-p~~~~~~  641 (751)
                      +||||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|.. |+.....
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            999999999999999999987654433334445678999999999999999999999999999999999965 5443221


Q ss_pred             ccccchhHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          642 DHHHNLLGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       642 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                      .   .+..    ....+...         ..+...+.++.+|+.+||+.||++||||.||+++|+++.
T Consensus       249 ~---e~~~----~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         249 E---EVIY----YVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             H---HHHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             H---HHHH----HHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            1   1111    11122111         112233457889999999999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=396.98  Aligned_cols=248  Identities=22%  Similarity=0.278  Sum_probs=207.5

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.+.   .....+.+.+|+.+|++++|||||++++++.+.+.+++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            368999999999999999999964 6899999999754   234567899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++++|.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999999854   446899999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ...  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......   +..    ......       
T Consensus       158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~----~i~~~~-------  221 (337)
T d1o6la_         158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE----LILMEE-------  221 (337)
T ss_dssp             TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCC-------
T ss_pred             CCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHH----HHhcCC-------
Confidence            222  2344789999999999999999999999999999999999999976443211   111    111111       


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                         -.++...+.++.+|+.+||+.||.+||+     +.|+++
T Consensus       222 ---~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               0122234557889999999999999995     788875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.8e-46  Score=392.86  Aligned_cols=244  Identities=23%  Similarity=0.298  Sum_probs=204.9

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.+.   .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999975 5899999999753   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+++++|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999999853   445789999999999999999999998   999999999999999999999999999876432


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                           .....||+.|+|||++.+..++.++|||||||+||||++|+.||.......   +..   .... ..        
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~~-~~--------  217 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYE---KILN-AE--------  217 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHH-CC--------
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HHH---HHHc-CC--------
Confidence                 234689999999999999999999999999999999999999986432211   110   0001 00        


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  703 (751)
                        ...+...+.++.+++.+||+.||.+||     |++++++
T Consensus       218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence              112223345788999999999999996     8999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-46  Score=392.76  Aligned_cols=255  Identities=25%  Similarity=0.455  Sum_probs=202.3

Q ss_pred             cCccccccccccccccEEEEEEc-CCc----EEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  505 (751)
                      ++|++.++||+|+||+||+|++. +|+    .||+|++... .....++|.+|+.++++++|||||+++++|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999964 344    5899988654 445678899999999999999999999999864 5678


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  585 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~  585 (751)
                      ++|++.+++|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999998864  3456899999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhc
Q 038934          586 VDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELI  664 (751)
Q Consensus       586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  664 (751)
                      ............||+.|+|||++.++.++.++|||||||+||||++ |+.|+.......   +..    ....+      
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~------  229 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKG------  229 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHT------
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcC------
Confidence            5544444445678999999999999999999999999999999998 777765433221   111    11111      


Q ss_pred             chhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          665 DKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       665 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                         .....+...+..+.+|+.+|++.||.+|||+.||++.|+.+
T Consensus       230 ---~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         230 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             ---CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence               11112223446788999999999999999999999988765

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-45  Score=393.56  Aligned_cols=261  Identities=21%  Similarity=0.249  Sum_probs=212.9

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  507 (751)
                      ++|++.++||+|+||.||+|++. +|+.||||++.+.   .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            68999999999999999999975 5999999998643   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVD  587 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~  587 (751)
                      ||+.+|+|.+++..   .+.+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999954   346899999999999999999999999   999999999999999999999999999876422


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                           .....||+.|+|||++.+..++.++|||||||+||||++|+.||......   .+..   .... ..        
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~---~i~~-~~--------  254 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYE---KIVS-GK--------  254 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH-CC--------
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHH---HHhc-CC--------
Confidence                 23468999999999999999999999999999999999999998643221   1111   0011 10        


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH--HHhCC-------CCCCCCCCCCCc
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRP-----NMASVVL--MLSGE-------RSLPQPKQPGFF  720 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~--~L~~~-------~~~~~p~~p~~~  720 (751)
                        ...+...+..+.+|+.+||+.||.+|+     |++++++  .+.++       ..++.|..|.+.
T Consensus       255 --~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~  319 (350)
T d1rdqe_         255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK  319 (350)
T ss_dssp             --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred             --CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCC
Confidence              011223345788999999999999994     8999985  23221       344556666544

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-46  Score=390.20  Aligned_cols=259  Identities=27%  Similarity=0.387  Sum_probs=199.3

Q ss_pred             cCccccccccccccccEEEEEEcC------CcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeC-Cc
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKR-DE  502 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  502 (751)
                      ++|++.++||+|+||.||+|++..      ++.||||++... .....+++.+|+.++.++ +|+|||++++++.+. ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            679999999999999999999642      468999999754 334456788899988887 689999999998765 46


Q ss_pred             eEEEEEecCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC
Q 038934          503 RMLIYEYLPNKSLADFIFDGT-------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN  569 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~  569 (751)
                      .++||||+++|+|.+++....             ....+++..++.++.||++||.|||+++   |+||||||+||||++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence            899999999999999996432             1345899999999999999999999998   999999999999999


Q ss_pred             CCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCC-CCCCCCCccccchh
Q 038934          570 EMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTR-NRGFHHVDHHHNLL  648 (751)
Q Consensus       570 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~-p~~~~~~~~~~~~~  648 (751)
                      ++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|.. |+.......  .+ 
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~~-  246 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF-  246 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HH-
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--HH-
Confidence            99999999999987755444444455789999999999999999999999999999999999754 554322211  11 


Q ss_pred             HHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          649 GHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       649 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                         ......+..         ...+...+.++.+|+.+||+.||++|||++||+++|+.+
T Consensus       247 ---~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         247 ---CRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             ---HHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               111111111         111222345788999999999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=383.62  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=196.9

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeee-CCceEEEEEec
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK-RDERMLIYEYL  510 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~  510 (751)
                      ++|++.++||+|+||.||+|++ +|+.||||++++.  ...+++.+|++++++++|||||++++++.+ .+.+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            5678889999999999999998 5789999999654  455789999999999999999999999865 45689999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++|+|.+++... ....+++..+++|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            999999999642 2235899999999999999999999998   999999999999999999999999999865322   


Q ss_pred             ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcchhcc
Q 038934          591 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSLE  669 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  669 (751)
                        .....+|+.|+|||++.+..++.++|||||||++|||++ |+.|+......+   +...    ...+         ..
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~---------~~  218 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKG---------YK  218 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTT---------CC
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcC---------CC
Confidence              223567899999999999999999999999999999998 566654332211   1111    1111         11


Q ss_pred             CccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          670 DTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       670 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...+......+.+|+.+||+.||++||||.+++++|+.+
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            122333446788999999999999999999999999865

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=382.83  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=196.3

Q ss_pred             cCccccccccccccccEEEEEEcC----CcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|++.+.||+|+||.||+|++..    +..||||+++.. .....+.+.+|+.++++++|||||++++++. ++..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            578999999999999999998643    356899998654 3444677999999999999999999999986 5678999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+||++++++.+||+|||+++.+..
T Consensus        86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence            999999999998754  3456899999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhhhcc
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELID  665 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  665 (751)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++ |..|+.......   +..    ....+..     
T Consensus       161 ~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~----~i~~~~~-----  227 (273)
T d1mp8a_         161 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIENGER-----  227 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCC-----
T ss_pred             Ccce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCCC-----
Confidence            3222 2234678999999999999999999999999999999998 788875433221   111    1111111     


Q ss_pred             hhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          666 KSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       666 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                          ...+...+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus       228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                112233456788999999999999999999999988754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-46  Score=391.31  Aligned_cols=247  Identities=27%  Similarity=0.388  Sum_probs=203.5

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHH-HhcCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNEVLLIA-KLQHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|.+.+.||+|+||+||+|++. +++.||||++++.   .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999975 5899999999753   2345567777877765 57999999999999999999999


Q ss_pred             EEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCC
Q 038934          507 YEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGV  586 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~  586 (751)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999954   345899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcch
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDK  666 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  666 (751)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..    ......+      
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~----~i~~~~~------  220 (320)
T d1xjda_         156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFH----SIRMDNP------  220 (320)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCC------
T ss_pred             ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHH----HHHcCCC------
Confidence            322  2334689999999999999999999999999999999999999986433221   111    1111110      


Q ss_pred             hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 038934          667 SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMA-SVVL  703 (751)
Q Consensus       667 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  703 (751)
                          ..+...+..+.+|+.+||+.||++||++. ++++
T Consensus       221 ----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                11222346788999999999999999996 6753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=386.92  Aligned_cols=259  Identities=27%  Similarity=0.390  Sum_probs=208.4

Q ss_pred             cCccccccccccccccEEEEEEcC--------CcEEEEEEeccCC-cccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCC
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID--------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRD  501 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  501 (751)
                      ++|.+.+.||+|+||.||+|+...        +..||||++++.. .....++.+|+..+.++ +|||||+++++|.++.
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            688899999999999999998532        2479999997653 34567899999999998 7999999999999999


Q ss_pred             ceEEEEEecCCCChhHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGT-------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  568 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~  568 (751)
                      ..++||||+++|+|.++|....             ....+++..++.++.||+.||+|||+++   ||||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence            9999999999999999996532             2346899999999999999999999999   99999999999999


Q ss_pred             CCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccch
Q 038934          569 NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNL  647 (751)
Q Consensus       569 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~  647 (751)
                      .++.+||+|||+++...............+|+.|+|||.+.++.++.++|||||||++|||++ |..|+......     
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-----  244 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-----  244 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-----
Confidence            999999999999998765544444555789999999999999999999999999999999998 67776432221     


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                        ........+..         ...+...+..+.+|+.+||+.||.+|||+.||++.|+++.
T Consensus       245 --~~~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         245 --ELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             --HHHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHHcCCC---------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence              11112222211         1122233457889999999999999999999999998763

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=388.14  Aligned_cols=259  Identities=26%  Similarity=0.393  Sum_probs=211.3

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCce
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDER  503 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  503 (751)
                      ++|++.++||+|+||.||+|++.      .++.||||+++.. ......++.+|+.+++++ +|||||++++++.+....
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            68889999999999999999853      3568999999764 334556799999999999 699999999999999999


Q ss_pred             EEEEEecCCCChhHHHhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc
Q 038934          504 MLIYEYLPNKSLADFIFDGT---------------RRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  568 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~  568 (751)
                      ++||||+++|+|.+++....               ....+++..+..++.||++||+|||+++   |+||||||+|||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence            99999999999999996532               2336899999999999999999999999   99999999999999


Q ss_pred             CCCCeEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCCccccch
Q 038934          569 NEMNPKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRN-RGFHHVDHHHNL  647 (751)
Q Consensus       569 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p-~~~~~~~~~~~~  647 (751)
                      .++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+++..| +........   
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---  256 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---  256 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            9999999999999987654444444557899999999999999999999999999999999995555 332221111   


Q ss_pred             hHHHHHHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          648 LGHAWRLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       648 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                         ...         ++........+...+..+.+|+.+||+.||++||||++|+++|+++
T Consensus       257 ---~~~---------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         257 ---FYK---------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             ---HHH---------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHH---------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence               111         1111112222233456789999999999999999999999999864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-45  Score=383.38  Aligned_cols=259  Identities=24%  Similarity=0.316  Sum_probs=201.8

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCc----
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDE----  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  502 (751)
                      .++|++.+.||+|+||.||+|++. +++.||||++++..   ....+.+.+|+++++.++|||||++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            468999999999999999999964 68999999997542   3345679999999999999999999999987543    


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||+++++|.+++..   .+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.++|+|||.++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999998853   346899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCc-cccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          583 AFGVDQT-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       583 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      ....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......      .............
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCC
Confidence            6543222 22334468999999999999999999999999999999999999998643221      1111111111110


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHhCC
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRP-NMASVVLMLSGE  708 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~  708 (751)
                             ........+..+.+++.+||+.||++|| |++++++.|.++
T Consensus       234 -------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         234 -------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             -------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                   0011122345788999999999999999 899999888654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=380.66  Aligned_cols=255  Identities=27%  Similarity=0.370  Sum_probs=196.1

Q ss_pred             cCccccccccccccccEEEEEEcC--C--cEEEEEEeccC---CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID--G--QEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      ++|++.+.||+|+||.||+|++..  +  ..||||++.+.   .....++|.+|+.+|++++|||||++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            578999999999999999998542  2  37899998754   33446789999999999999999999999965 5678


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+++++|.+++..  +...+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999998854  3346899999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCccc-cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          585 GVDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVY-GTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       585 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ....... ......|+..|+|||.+.+..++.++|||||||++|||++ |+.||.......   .   .......+..  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~---~~~i~~~~~~--  233 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---I---LHKIDKEGER--  233 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHHHHTSCCC--
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---H---HHHHHhCCCC--
Confidence            5443322 2234567889999999999999999999999999999998 899875322211   1   1111111111  


Q ss_pred             hcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhC
Q 038934          663 LIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSG  707 (751)
Q Consensus       663 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  707 (751)
                             ...+...+..+.+|+.+||+.||++|||+++|++.|+.
T Consensus       234 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         234 -------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                   11122234578899999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=388.84  Aligned_cols=256  Identities=28%  Similarity=0.433  Sum_probs=203.9

Q ss_pred             cCccccccccccccccEEEEEEcC-Cc--EEEEEEeccC-CcccHHHHHHHHHHHHHh-cCCcEEeEeceeeeCCceEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLID-GQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  506 (751)
                      ++|++.++||+|+||+||+|++.+ +.  .||||++... .....++|.+|+++|.++ +|||||++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            578889999999999999999754 43  5788888644 344567899999999998 799999999999999999999


Q ss_pred             EEecCCCChhHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCe
Q 038934          507 YEYLPNKSLADFIFDG-------------TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  573 (751)
Q Consensus       507 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~  573 (751)
                      |||+++|+|.++|...             .....+++..+.+++.||++||.|||+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999643             23467999999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCCccccchhHHHH
Q 038934          574 KISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRN-RGFHHVDHHHNLLGHAW  652 (751)
Q Consensus       574 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p-~~~~~~~~~~~~~~~~~  652 (751)
                      ||+|||+++......   ......||+.|+|||.+.+..++.++|||||||++|||++|..| +.....   ..+..   
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~---  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE---  237 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH---
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHH---
Confidence            999999998654222   22335789999999999999999999999999999999998654 432111   11111   


Q ss_pred             HHhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCC
Q 038934          653 RLWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGER  709 (751)
Q Consensus       653 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  709 (751)
                       ....+         .....+...+.++.+|+.+||+.||++||||+||++.|+++.
T Consensus       238 -~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         238 -KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             -HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             11111         111222334567889999999999999999999999998863

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.7e-45  Score=376.70  Aligned_cols=251  Identities=22%  Similarity=0.305  Sum_probs=204.2

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc---------ccHHHHHHHHHHHHHhc-CCcEEeEeceeee
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG---------QGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMK  499 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  499 (751)
                      .++|++.+.||+|+||+||+|++. +++.||||++.+...         ...+.+.+|+.++++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999964 689999999976421         12346889999999997 9999999999999


Q ss_pred             CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       500 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                      .+..++||||+++|+|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999954   346899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHH
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAID------GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWR  653 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~  653 (751)
                      +++.+.....   .....||+.|+|||++.+      ..++.++||||+||+||||++|+.||.......   ...   .
T Consensus       156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~~---~  226 (277)
T d1phka_         156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLR---M  226 (277)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H
T ss_pred             heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HHH---H
Confidence            9998754322   233679999999999863      357889999999999999999999986433211   111   1


Q ss_pred             HhccCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          654 LWTEDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       654 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ... +...      .........+..+.+|+.+||+.||.+|||+.||++
T Consensus       227 i~~-~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         227 IMS-GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHH-TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHh-CCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111 1100      011112234567889999999999999999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=383.32  Aligned_cols=251  Identities=18%  Similarity=0.257  Sum_probs=204.0

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      .++|++.+.||+|+||+||+|++. +++.||||+++... .....+.+|+++|++++|||||++++++.+.+.+++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            478999999999999999999975 58899999997653 3345688999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCC--CCeEEeeccCccccCCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE--MNPKISDFGMARAFGVD  587 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DFGla~~~~~~  587 (751)
                      +++++|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999943  2336899999999999999999999999   9999999999999854  57999999999876432


Q ss_pred             CccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchh
Q 038934          588 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKS  667 (751)
Q Consensus       588 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  667 (751)
                      .   ......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||........   ..   . .......  +.  
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~---~~---~-i~~~~~~--~~--  223 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IE---N-IMNAEYT--FD--  223 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---H-HHHTCCC--CC--
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH---HH---H-HHhCCCC--CC--
Confidence            2   22346789999999999999999999999999999999999999864332111   10   0 0000000  00  


Q ss_pred             ccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          668 LEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       668 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                        .......+.++.+|+.+||+.||++|||+.|+++
T Consensus       224 --~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 --EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0000112456889999999999999999999997

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.8e-45  Score=390.55  Aligned_cols=248  Identities=25%  Similarity=0.295  Sum_probs=199.0

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHH---HHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS---SGQGVEEFKNE---VLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      ++|++.+.||+|+||.||+|++. +|+.||||++.+.   .......+.+|   +.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            68999999999999999999975 5899999998643   12233445555   55556667999999999999999999


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      +||||+++|+|.++|..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999954   345789999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhh
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVEL  663 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (751)
                      ....    .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||..........+..    .....     
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~~~~~-----  224 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTM-----  224 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----HSSSC-----
T ss_pred             CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcccC-----
Confidence            5332    234689999999999975 568999999999999999999999987544332211110    00000     


Q ss_pred             cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          664 IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       664 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                           ....+...+..+.+|+.+||+.||.+|||     ++|+++
T Consensus       225 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                 01112223457889999999999999999     688874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-45  Score=384.70  Aligned_cols=260  Identities=26%  Similarity=0.407  Sum_probs=211.3

Q ss_pred             cCccccccccccccccEEEEEEc------CCcEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI------DGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  504 (751)
                      ++|...++||+|+||.||+|.+.      +++.||||++++. .......|.+|+.++++++|||||++++++..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            67888999999999999999864      2578999999754 3344557899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEee
Q 038934          505 LIYEYLPNKSLADFIFDG-------TRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  577 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  577 (751)
                      +||||+++|+|.+++...       .....+++..+.+++.|+++||.|||+++   |+||||||+||||++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence            999999999999998542       22345789999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCccccchhHHHHHHhc
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGT-RNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~-~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                      ||+++...............||+.|+|||.+.+..++.++||||||+++|||++|. .|+......   ...    ....
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~----~~i~  249 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVL----RFVM  249 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHH----HHHH
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHH
Confidence            99998775444444444567899999999999999999999999999999999995 444321111   111    1111


Q ss_pred             cCChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCCCC
Q 038934          657 EDRPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGERS  710 (751)
Q Consensus       657 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  710 (751)
                      .+...         ..+...+..+.+|+.+||+.||++||||.+|+++|+...+
T Consensus       250 ~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             hCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11111         1122234578999999999999999999999999987643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=380.96  Aligned_cols=256  Identities=23%  Similarity=0.280  Sum_probs=195.3

Q ss_pred             cccccccccccEEEEEEc-CCcEEEEEEeccCCcc-----cHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEec
Q 038934          437 ENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQ-----GVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEYL  510 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  510 (751)
                      .++||+|+||+||+|++. +|+.||||++......     ..+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999965 5899999999654221     2346889999999999999999999999999999999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      .++++..++   .....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus        83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            998777665   34556899999999999999999999999   999999999999999999999999999876543222


Q ss_pred             ccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh------hh
Q 038934          591 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV------EL  663 (751)
Q Consensus       591 ~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~  663 (751)
                        .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.   +....+........      ..
T Consensus       157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSS
T ss_pred             --ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhcc
Confidence              2336799999999998754 679999999999999999999999865433211   11111111000000      00


Q ss_pred             cchh-cc--Ccc-----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          664 IDKS-LE--DTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       664 ~d~~-l~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .... ..  ...     .......+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0000 00  000     1123457889999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=381.71  Aligned_cols=252  Identities=20%  Similarity=0.218  Sum_probs=198.1

Q ss_pred             hcCccccc-cccccccccEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHHHh-cCCcEEeEeceeee----CCce
Q 038934          431 TDNFSEEN-KLGEGGFGPVYKGML-IDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVKLLGCCMK----RDER  503 (751)
Q Consensus       431 ~~~y~~~~-~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  503 (751)
                      .++|.+.+ .||+|+||+||+|++ .+++.||||++++.     +.+.+|+.++.++ +|||||++++++.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46888765 599999999999996 45899999999643     5678899987665 89999999999876    4678


Q ss_pred             EEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC---CCCeEEeeccC
Q 038934          504 MLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGM  580 (751)
Q Consensus       504 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGl  580 (751)
                      ++|||||++|+|.++|.+. ....+++..+..++.||+.||+|||+++   |+||||||+|||+++   .+.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999999642 2346899999999999999999999999   999999999999985   56799999999


Q ss_pred             ccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          581 ARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       581 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      |+.......   .....||+.|+|||++.+..|+.++|||||||+||+|++|+.||...........+   .........
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~~  234 (335)
T d2ozaa1         161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQY  234 (335)
T ss_dssp             CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred             eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCCC
Confidence            987654322   23468999999999999999999999999999999999999998643322111000   000000000


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                            .+........+.++.+|+.+||+.||++|||+.|+++
T Consensus       235 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         235 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                  0000011223457889999999999999999999997

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-45  Score=384.03  Aligned_cols=265  Identities=22%  Similarity=0.312  Sum_probs=198.7

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHH--HHHHHHHHhcCCcEEeEeceeeeCC----ceEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKLQHRNLVKLLGCCMKRD----ERML  505 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  505 (751)
                      ++|...++||+|+||.||+|++ +|+.||||+++...   .+++.  .|+..+.+++|||||++++++.+.+    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            5678889999999999999997 78999999996432   23333  4555556789999999999998764    5789


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCEEEccCCCCCeEEcCCCCeEEeeccC
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNEMNPKISDFGM  580 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~DFGl  580 (751)
                      ||||+++|+|.+++.+    ..+++..++.++.|++.||+|||+..     ..+|+||||||+||||++++.+||+|||+
T Consensus        79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            9999999999999954    35899999999999999999999741     23599999999999999999999999999


Q ss_pred             ccccCCCCc--cccccccccccCccCcccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccc------
Q 038934          581 ARAFGVDQT--EANTNRVVGTYGYMPPEYAIDG------LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHN------  646 (751)
Q Consensus       581 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~------  646 (751)
                      ++.......  ........||+.|+|||++.+.      .++.|+|||||||+||||++|..|+..........      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            997754322  2223457899999999998765      36789999999999999999988865433221100      


Q ss_pred             --hhHHHHHHhccCChhhhcchhccCc-cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          647 --LLGHAWRLWTEDRPVELIDKSLEDT-YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       647 --~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                        ..............    .+.+... ........+.+|+.+||+.||++|||+.||++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             SCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence              00111111111110    1111111 1233556788999999999999999999999999764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=379.29  Aligned_cols=252  Identities=27%  Similarity=0.393  Sum_probs=201.2

Q ss_pred             cccccccccccEEEEEEcCC----cEEEEEEeccC-CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-CceEEEEEec
Q 038934          437 ENKLGEGGFGPVYKGMLIDG----QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-DERMLIYEYL  510 (751)
Q Consensus       437 ~~~IG~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E~~  510 (751)
                      .++||+|+||+||+|++.++    ..||||++++. .....++|.+|+++|++++|||||++++++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997542    25899999753 445667899999999999999999999998764 5789999999


Q ss_pred             CCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCcc
Q 038934          511 PNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQTE  590 (751)
Q Consensus       511 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~  590 (751)
                      ++++|.+++..  ....+++..+++++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999853  3445788899999999999999999998   999999999999999999999999999976543222


Q ss_pred             c--cccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhhhcchhc
Q 038934          591 A--NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVELIDKSL  668 (751)
Q Consensus       591 ~--~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  668 (751)
                      .  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......  ..+...    ...+..        
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~----i~~g~~--------  252 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY----LLQGRR--------  252 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCC--------
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHH----HHcCCC--------
Confidence            1  222357899999999999999999999999999999999988886532211  111111    111111        


Q ss_pred             cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          669 EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       669 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                       ...+......+.+|+.+||+.||++||+|.||++.|+.+
T Consensus       253 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         253 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             011122345788999999999999999999999999876

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-44  Score=375.30  Aligned_cols=263  Identities=24%  Similarity=0.322  Sum_probs=200.5

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|++.++||+|+||+||+|++. +++.||||++....  ....+++.+|++++++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999964 58999999996542  2346789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      |+.++.+. ++.. .....+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765444 4432 23456899999999999999999999999   9999999999999999999999999998764332


Q ss_pred             ccccccccccccCccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC--hhhhcc
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR--PVELID  665 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d  665 (751)
                      .  ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||........   +...........  ....+.
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGG
T ss_pred             c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhccccc
Confidence            2  233468999999999887765 58899999999999999999999864432111   111111000000  000000


Q ss_pred             h--hccCc-----------cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          666 K--SLEDT-----------YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       666 ~--~l~~~-----------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      .  .....           .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0  00000           011234578899999999999999999999974

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.4e-44  Score=373.76  Aligned_cols=261  Identities=23%  Similarity=0.337  Sum_probs=202.7

Q ss_pred             cCccccccccccccccEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|++.++||+|+||+||+|++++++.||||++...  .....+++.+|+.+|++++|||||++++++...+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            689999999999999999999988999999999654  333467899999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCCc
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQT  589 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~  589 (751)
                      +.++.+..+.   ...+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9887777776   34567999999999999999999999998   99999999999999999999999999987643322


Q ss_pred             cccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh------h
Q 038934          590 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV------E  662 (751)
Q Consensus       590 ~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~  662 (751)
                        ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||........   ..............      .
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhccchhh
Confidence              22335789999999998764 579999999999999999999999864332111   11111111100000      0


Q ss_pred             h---------cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          663 L---------IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       663 ~---------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      .         ..+.............+.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0         0000001112223457889999999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-44  Score=368.79  Aligned_cols=240  Identities=25%  Similarity=0.403  Sum_probs=196.2

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHHHHHhc--CCcEEeEeceeeeCC
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQ--HRNLVKLLGCCMKRD  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  501 (751)
                      .++|++.+.||+|+||+||+|++. +++.||||++.+...      ....++.+|+.++++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            368999999999999999999965 589999999975321      12245778999999996  899999999999999


Q ss_pred             ceEEEEEecCC-CChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-CCCeEEeecc
Q 038934          502 ERMLIYEYLPN-KSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFG  579 (751)
Q Consensus       502 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFG  579 (751)
                      ..++||||+.+ +++.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 577777743   346899999999999999999999999   999999999999985 5789999999


Q ss_pred             CccccCCCCccccccccccccCccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          580 MARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       580 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      +|+.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....     .+       ....
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-------~~~~  220 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------IRGQ  220 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------HHCC
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH-------hhcc
Confidence            99875422    2234689999999999987765 677999999999999999999975311     00       0000


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                                 -..+...+.++.+|+.+||+.||++|||++|+++
T Consensus       221 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 -----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                       0111123457889999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=370.86  Aligned_cols=263  Identities=21%  Similarity=0.309  Sum_probs=199.5

Q ss_pred             HhcCccccccccccccccEEEEEEc-C-CcEEEEEEeccC--CcccHHHHHHHHHHHHHh---cCCcEEeEeceeee---
Q 038934          430 ATDNFSEENKLGEGGFGPVYKGMLI-D-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL---QHRNLVKLLGCCMK---  499 (751)
Q Consensus       430 ~~~~y~~~~~IG~G~fg~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---  499 (751)
                      ..++|++.++||+|+||+||+|++. + ++.||||++...  .......+.+|+.+++.|   +||||+++++++..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            3478999999999999999999974 4 567999998653  222334577888888776   79999999999853   


Q ss_pred             --CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEee
Q 038934          500 --RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  577 (751)
Q Consensus       500 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  577 (751)
                        ....+++|||++++.+.....  .....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             ccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence              346899999999887765443  34456899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhcc
Q 038934          578 FGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTE  657 (751)
Q Consensus       578 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~  657 (751)
                      ||+++.....   .......||+.|+|||++.+.+++.++||||+||++|||++|+.||........   +.........
T Consensus       160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~  233 (305)
T d1blxa_         160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGL  233 (305)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred             hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCC
Confidence            9999865422   223457899999999999999999999999999999999999999875433221   1111110000


Q ss_pred             CCh----------hhhcch---hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          658 DRP----------VELIDK---SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       658 ~~~----------~~~~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...          ......   .............+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000          000000   0001112223457789999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-42  Score=364.76  Aligned_cols=268  Identities=21%  Similarity=0.321  Sum_probs=198.3

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeee--------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK--------  499 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  499 (751)
                      .++|++.++||+|+||+||+|++. +|+.||||++...  .....+++.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999974 6899999998654  33456778999999999999999999998855        


Q ss_pred             CCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeecc
Q 038934          500 RDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  579 (751)
Q Consensus       500 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG  579 (751)
                      ....++||||+.++.+....   .....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            34689999999887766554   34556899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCcc--ccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhc
Q 038934          580 MARAFGVDQTE--ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWT  656 (751)
Q Consensus       580 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~  656 (751)
                      +++.+......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....................
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99876533221  122335799999999998765 689999999999999999999999864333222111111110000


Q ss_pred             cCC--------hhhhcchhccCccCH-------HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          657 EDR--------PVELIDKSLEDTYSL-------SEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       657 ~~~--------~~~~~d~~l~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                      ...        ....+..........       .....+.+|+.+||+.||++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            000        000000000000111       113366789999999999999999999964

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-42  Score=368.56  Aligned_cols=261  Identities=20%  Similarity=0.267  Sum_probs=195.0

Q ss_pred             CccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcEEeEeceeeeC------CceEE
Q 038934          433 NFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR------DERML  505 (751)
Q Consensus       433 ~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  505 (751)
                      +|...++||+|+||+||+|++. +++.||||++.+...    .+.+|+++|++++||||+++++++...      ..+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6888899999999999999975 589999999976432    234799999999999999999998643      34789


Q ss_pred             EEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC-CeEEeeccCcccc
Q 038934          506 IYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF  584 (751)
Q Consensus       506 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~  584 (751)
                      ||||++++.+..+.........+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987655544433334557999999999999999999999998   99999999999999775 8999999999876


Q ss_pred             CCCCccccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhH--------HHHHHh
Q 038934          585 GVDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLG--------HAWRLW  655 (751)
Q Consensus       585 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~--------~~~~~~  655 (751)
                      .....   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.............        ..+...
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            43322   233679999999998875 578999999999999999999999986543221100000        000000


Q ss_pred             ccC----ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          656 TED----RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       656 ~~~----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...    ....................++.+|+.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000    000000000111112234557889999999999999999999996

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-42  Score=368.81  Aligned_cols=264  Identities=19%  Similarity=0.302  Sum_probs=198.2

Q ss_pred             hcCccccccccccccccEEEEEE-cCCcEEEEEEeccCC-cccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC----ceE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGML-IDGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD----ERM  504 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  504 (751)
                      .++|++.++||+|+||+||+|+. .+++.||||++.+.. ....+++.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999996 469999999997543 344668899999999999999999999997654    235


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcccc
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  584 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~  584 (751)
                      ++++++.+++|.+++..    ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            56677789999999953    35899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-ccccccccccCccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChhh
Q 038934          585 GVDQTE-ANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPVE  662 (751)
Q Consensus       585 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (751)
                      ...... .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||............   ...........
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~  236 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQED  236 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH---hhhccCCChhh
Confidence            433222 22345679999999999854 56789999999999999999999998654332111110   00000000000


Q ss_pred             -----------hcchhc-cCcc-----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          663 -----------LIDKSL-EDTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       663 -----------~~d~~l-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                                 ...... ....     ......++.+|+.+||+.||.+|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       000000 0000     11123468899999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-42  Score=367.38  Aligned_cols=262  Identities=20%  Similarity=0.314  Sum_probs=196.7

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCC------
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRD------  501 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  501 (751)
                      .++|++.++||+|+||+||+|++. +|+.||||++.+.  .....+.+.+|+++|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999965 5999999999754  3344567899999999999999999999998765      


Q ss_pred             ceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCc
Q 038934          502 ERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  581 (751)
Q Consensus       502 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla  581 (751)
                      .+++||||+ +.+|..++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            569999999 567777763    345899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          582 RAFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       582 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      +.....     .....||+.|+|||++.+. .++.++||||+||++|+|++|+.|+.........   ....... ....
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~---~~~~~~~-~~~~  239 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL---KEIMKVT-GTPP  239 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHH-CCCC
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH---HHHHhcc-CCCc
Confidence            876432     2346799999999998764 5799999999999999999999998644321110   0000000 0000


Q ss_pred             hhhc-----------chhc-------cCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HhCCC
Q 038934          661 VELI-----------DKSL-------EDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM--LSGER  709 (751)
Q Consensus       661 ~~~~-----------d~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  709 (751)
                      .+..           ...+       ...........+.+|+.+||+.||.+|||+.|+++.  ++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            0000           0000       001112234567899999999999999999999974  65554

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-41  Score=352.72  Aligned_cols=260  Identities=19%  Similarity=0.252  Sum_probs=197.7

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCc-EEeEeceeeeCCceEEEEEe
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVKLLGCCMKRDERMLIYEY  509 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E~  509 (751)
                      ++|++.++||+|+||.||+|++. +++.||||++....  ..+++..|++++++++|+| |+.+..+..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999964 58999999986543  2346889999999998766 55566667888889999999


Q ss_pred             cCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEc---CCCCeEEeeccCccccCC
Q 038934          510 LPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGV  586 (751)
Q Consensus       510 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~~~~~  586 (751)
                      +. ++|.+.+..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+.+..
T Consensus        85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            95 566665543  3446899999999999999999999999   99999999999986   355799999999998753


Q ss_pred             CCcc-----ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCChh
Q 038934          587 DQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRPV  661 (751)
Q Consensus       587 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  661 (751)
                      ....     .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.........................
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            3221     12234689999999999999999999999999999999999999986544333222111111111111111


Q ss_pred             hhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          662 ELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       662 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      .     +    ....+.++.+++.+|++.||++||+++++.+.|+..
T Consensus       239 ~-----~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         239 V-----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             H-----H----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             H-----h----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            1     1    112235688999999999999999999998888753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-41  Score=354.11  Aligned_cols=262  Identities=23%  Similarity=0.286  Sum_probs=204.6

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeeeCCceEEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      ++|++.++||+|+||+||+|++. +++.||||+++..  .....+++.+|+.++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999964 5889999999654  33456789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCccccCCCC
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGVDQ  588 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~  588 (751)
                      ++.+++|..++.   ..+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988874   4456899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             ccccccccccccCccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCC---h---h
Q 038934          589 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDR---P---V  661 (751)
Q Consensus       589 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~  661 (751)
                      ..  .....+++.|+|||++.+.. ++.++|||||||++|||++|+.|+......  ...............   .   .
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhh
Confidence            22  22346778899999988765 699999999999999999999996432221  111111111111100   0   0


Q ss_pred             hhcch---------hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          662 ELIDK---------SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       662 ~~~d~---------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ...+.         .-...........+.+|+.+||+.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000         0001112233457889999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-40  Score=347.87  Aligned_cols=261  Identities=16%  Similarity=0.190  Sum_probs=206.4

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC-CcEEeEeceeeeCCceEEEEE
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E  508 (751)
                      .++|++.++||+|+||+||+|++. +++.||||++....  ..+.+.+|+++++.++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            368999999999999999999965 58899999986543  23467889999999975 899999999999999999999


Q ss_pred             ecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcC-----CCCeEEeeccCccc
Q 038934          509 YLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARA  583 (751)
Q Consensus       509 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DFGla~~  583 (751)
                      |+ +++|.+++..  ....+++..+..++.|++.||.|||+++   |+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 6899998854  2346899999999999999999999999   999999999999974     57899999999998


Q ss_pred             cCCCCcc-----ccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccC
Q 038934          584 FGVDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTED  658 (751)
Q Consensus       584 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~  658 (751)
                      +......     .......||+.|+|||++.+..++.++|||||||++|||++|+.|+......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6532221     12334689999999999999999999999999999999999999987544433322221111111111


Q ss_pred             ChhhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhCC
Q 038934          659 RPVELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVLMLSGE  708 (751)
Q Consensus       659 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  708 (751)
                      ...++     ..    ..+.++.+++..|++.+|++||+++.+.+.|+.+
T Consensus       236 ~~~~l-----~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         236 PLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             CHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ChHHh-----cC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            11111     11    1235688899999999999999999988877653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-41  Score=358.97  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=202.8

Q ss_pred             cCccccccccccccccEEEEEEc----CCcEEEEEEeccC----CcccHHHHHHHHHHHHHhcC-CcEEeEeceeeeCCc
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI----DGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQH-RNLVKLLGCCMKRDE  502 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  502 (751)
                      ++|++.++||+|+||+||+|+..    +|+.||||++.+.    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999853    3789999998653    22345678999999999976 899999999999999


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||+.+++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999854   345788999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccCccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHHHhccCCh
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWRLWTEDRP  660 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  660 (751)
                      .+....... .....|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||...........+...   ....  
T Consensus       178 ~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~---~~~~--  251 (322)
T d1vzoa_         178 EFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR---ILKS--  251 (322)
T ss_dssp             ECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---HHHC--
T ss_pred             hhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---cccC--
Confidence            764332222 2346799999999999765  4788999999999999999999998655443322211111   1000  


Q ss_pred             hhhcchhccCccCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 038934          661 VELIDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPN-----MASVVL  703 (751)
Q Consensus       661 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  703 (751)
                              ....+...+.++.+|+.+||+.||++|||     ++|+++
T Consensus       252 --------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                    01122334568889999999999999994     788875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.5e-41  Score=356.22  Aligned_cols=257  Identities=18%  Similarity=0.285  Sum_probs=197.9

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeC--CceEEEE
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKR--DERMLIY  507 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~  507 (751)
                      ++|++.++||+|+||+||+|++. +++.||||+++..   ..+++.+|+++|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            68999999999999999999974 5899999999653   3567899999999995 99999999999754  5689999


Q ss_pred             EecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCC-CeEEeeccCccccCC
Q 038934          508 EYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGV  586 (751)
Q Consensus       508 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~  586 (751)
                      ||+++++|..+.      +.+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999998764      35899999999999999999999999   99999999999998655 699999999987643


Q ss_pred             CCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchh-HH---------HHHHh
Q 038934          587 DQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLL-GH---------AWRLW  655 (751)
Q Consensus       587 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~-~~---------~~~~~  655 (751)
                      ...   .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.|+............ ..         .....
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            322   2346789999999998865 4799999999999999999999998654432111000 00         00000


Q ss_pred             ccCChhhh-----------cchhccCccCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 038934          656 TEDRPVEL-----------IDKSLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMASVVL  703 (751)
Q Consensus       656 ~~~~~~~~-----------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  703 (751)
                      ........           ...............++.+|+.+||+.||.+|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000           0001111111223457889999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-41  Score=359.00  Aligned_cols=266  Identities=22%  Similarity=0.280  Sum_probs=197.9

Q ss_pred             hcCccccccccccccccEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHHHhcCCcEEeEeceeeeC-----Cc
Q 038934          431 TDNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVKLLGCCMKR-----DE  502 (751)
Q Consensus       431 ~~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  502 (751)
                      .++|++.++||+|+||+||+|++. +|+.||||++.+..  ....+++.+|+++|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            578999999999999999999964 69999999997653  33456789999999999999999999998643     34


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .+++++++.+++|.+++.    .+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            577788889999999983    346999999999999999999999999   9999999999999999999999999997


Q ss_pred             ccCCCCccccccccccccCccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHHHHH-----Hhc
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGHAWR-----LWT  656 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~~~~-----~~~  656 (751)
                      ....     ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.....     ...
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            6432     22346789999999987765 468999999999999999999999865432211111100000     000


Q ss_pred             cCCh---hhhcchhcc-Ccc-----CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhCC
Q 038934          657 EDRP---VELIDKSLE-DTY-----SLSEALRCIQVGLLCVQQRPEDRPNMASVVL--MLSGE  708 (751)
Q Consensus       657 ~~~~---~~~~d~~l~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  708 (751)
                      ....   ......... ...     .......+.+|+.+||+.||.+|||+.|+++  .+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            0000   000000000 000     1123456789999999999999999999997  45544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-40  Score=355.80  Aligned_cols=261  Identities=21%  Similarity=0.248  Sum_probs=191.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHHHhcCCcEEeEeceeee------CCc
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVKLLGCCMK------RDE  502 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  502 (751)
                      ++|++.++||+|+||+||+|++. +|+.||||++.+.  .....+++.+|+.++++++|||||++++++..      ..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999975 5999999999754  23445678999999999999999999999864      367


Q ss_pred             eEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          503 RMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       503 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .++||||+.++.+. .+.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            89999999775554 441     34799999999999999999999999   9999999999999999999999999988


Q ss_pred             ccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhH-------------
Q 038934          583 AFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLG-------------  649 (751)
Q Consensus       583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~-------------  649 (751)
                      ......   ......+|+.|+|||++.+..++.++||||+||++++|++|+.||.............             
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            764322   2234678999999999999999999999999999999999999986443211100000             


Q ss_pred             ---HHHHHhcc------CChhhhcchhccCc---cCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 038934          650 ---HAWRLWTE------DRPVELIDKSLEDT---YSLSEALRCIQVGLLCVQQRPEDRPNMASVVLM  704 (751)
Q Consensus       650 ---~~~~~~~~------~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  704 (751)
                         ........      ..............   ........+.+|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               00000000      00011111111111   123356688999999999999999999999854

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.5e-36  Score=324.55  Aligned_cols=283  Identities=20%  Similarity=0.233  Sum_probs=203.4

Q ss_pred             cCccccccccccccccEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-----------CCcEEeEeceeee
Q 038934          432 DNFSEENKLGEGGFGPVYKGMLI-DGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----------HRNLVKLLGCCMK  499 (751)
Q Consensus       432 ~~y~~~~~IG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  499 (751)
                      .+|++.++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999964 68999999997542 33467889999998875           4789999988765


Q ss_pred             C--CceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEEccCCCCCeEEcCCCC----
Q 038934          500 R--DERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMN----  572 (751)
Q Consensus       500 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~----  572 (751)
                      .  ...+++++++.................+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            4  4567777777666555444444556678999999999999999999998 66   999999999999986653    


Q ss_pred             --eEEeeccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccccchhHH
Q 038934          573 --PKISDFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLELVYGTRNRGFHHVDHHHNLLGH  650 (751)
Q Consensus       573 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll~ell~G~~p~~~~~~~~~~~~~~~  650 (751)
                        ++++|||.+......     .....||+.|+|||++.+..++.++||||+||++++|++|+.||..............
T Consensus       169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              999999999865322     2346799999999999999999999999999999999999999864432211111000


Q ss_pred             ---HHHHhcc---------CChhhhcch-------------------hccCccCHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 038934          651 ---AWRLWTE---------DRPVELIDK-------------------SLEDTYSLSEALRCIQVGLLCVQQRPEDRPNMA  699 (751)
Q Consensus       651 ---~~~~~~~---------~~~~~~~d~-------------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  699 (751)
                         ....+..         .......+.                   .............+.+|+.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence               0000000         000000000                   001123345677899999999999999999999


Q ss_pred             HHHHH--Hh---CCCCCCCCCCCCCcccC
Q 038934          700 SVVLM--LS---GERSLPQPKQPGFFTER  723 (751)
Q Consensus       700 evl~~--L~---~~~~~~~p~~p~~~~~~  723 (751)
                      |+++.  +.   ...+++.|..|-+...+
T Consensus       324 e~L~Hp~f~~~~~~~~~~~p~~~~~~~~~  352 (362)
T d1q8ya_         324 GLVNHPWLKDTLGMEEIRVPDRELYGSGS  352 (362)
T ss_dssp             HHHTCGGGTTCTTCTTCCCTTSCTTCBST
T ss_pred             HHhcCcccCCCCCcccCCCCCcccCCCCC
Confidence            99973  43   23555566665554333

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=9.7e-23  Score=197.76  Aligned_cols=169  Identities=20%  Similarity=0.175  Sum_probs=121.2

Q ss_pred             cccccccccccccEEEEEEcCCcEEEEEEeccCCc------------------ccHHHHHHHHHHHHHhcCCcEEeEece
Q 038934          435 SEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSG------------------QGVEEFKNEVLLIAKLQHRNLVKLLGC  496 (751)
Q Consensus       435 ~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~  496 (751)
                      .+.++||+|+||+||+|+..+|+.||||+++....                  .....+.+|+..+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            46789999999999999988899999998753210                  012335678889999999999887765


Q ss_pred             eeeCCceEEEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEEccCCCCCeEEcCCCCeEEe
Q 038934          497 CMKRDERMLIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  576 (751)
Q Consensus       497 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~  576 (751)
                      .    ..++||||+++..+.+          ++...+..++.|++++|.|||+++   |+||||||+|||+++++ ++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence            3    3479999999865543          334456689999999999999999   99999999999999764 8999


Q ss_pred             eccCccccCCCCccccccccccccCccCcccccCCCCCcchhhHHHHHHH
Q 038934          577 DFGMARAFGVDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLV  626 (751)
Q Consensus       577 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k~DVwSlG~ll  626 (751)
                      |||+|+.............   .... -.|. ....|+.++|+||+.--+
T Consensus       145 DFG~a~~~~~~~~~~~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWREILER---DVRN-IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHH---HHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence            9999976542221110000   0000 0111 135678899999975443

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.83  E-value=9.6e-21  Score=165.65  Aligned_cols=112  Identities=21%  Similarity=0.436  Sum_probs=91.7

Q ss_pred             ccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEe
Q 038934            5 QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQ   84 (751)
Q Consensus         5 ~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~   84 (751)
                      +|||.|||.|..|++|+|  |.|+|+|+..|+     |.|++    ..++||.||++.|..+  +.|.|  +.||+|+|+
T Consensus         1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~~--~~l~l--~~dGnLvl~   65 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKASG--CVLKM--QNDGNLVIY   65 (112)
T ss_dssp             CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCSS--EEEEE--CTTSCEEEE
T ss_pred             CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCCC--cEEEE--eccccEEEE
Confidence            599999999999999975  999999998887     77765    4689999999987543  44555  456699999


Q ss_pred             CCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCcc
Q 038934           85 NSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTH  136 (751)
Q Consensus        85 ~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTD  136 (751)
                      +. +..+|++++.......+|+|+|+|||||++.+    ++++|||+.+|++
T Consensus        66 ~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~----~~~~W~S~t~~~n  112 (112)
T d1xd5a_          66 SG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS----NNAIWATHTNVGN  112 (112)
T ss_dssp             ET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTT----SCEEEECCCCCCC
T ss_pred             ec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCC----CcEEecCCCccCC
Confidence            86 56777777665555668999999999999754    6799999999985

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.81  E-value=6.5e-20  Score=158.71  Aligned_cols=108  Identities=21%  Similarity=0.399  Sum_probs=89.7

Q ss_pred             ccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEe
Q 038934            5 QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQ   84 (751)
Q Consensus         5 ~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~   84 (751)
                      .|+|.+||.|.+|+.|+  +|.|.|+|...|+     |.++.    ..++||+||++.|... .+.|.|.  .||+|||.
T Consensus         1 ~~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~--~dGnLvl~   66 (109)
T d1kj1a_           1 RNLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKK-GCKAVLQ--SDGNFVVY   66 (109)
T ss_dssp             CCEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-CCEEEEC--TTSCEEEE
T ss_pred             CCCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCce-eEEEEEc--CCceEEEE
Confidence            48999999999999996  5889999998777     66654    4689999999999876 3456665  45699999


Q ss_pred             CCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCC
Q 038934           85 NSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDY  133 (751)
Q Consensus        85 ~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~  133 (751)
                      |++|.+||+|+++......+|+|+|+|||||++       ..+|||+-|
T Consensus        67 ~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~-------~~~W~S~t~  108 (109)
T d1kj1a_          67 DAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYG-------SDIWSTGTY  108 (109)
T ss_dssp             CSSSCEEEECCCCCCSSCCEEEECTTSCEEEEC-------CEEEECCCC
T ss_pred             eCCCcEEEEEeeECCCCCEEEEEeCCCcEEEEC-------CCEecCCCc
Confidence            999999999997755556689999999999984       359999865

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.81  E-value=2.9e-20  Score=160.98  Aligned_cols=107  Identities=24%  Similarity=0.362  Sum_probs=89.8

Q ss_pred             ccccCCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEe
Q 038934            5 QDTLRLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQ   84 (751)
Q Consensus         5 ~~~~~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~   84 (751)
                      .|+|.+||+|.+|+.|.  +|.|+|.|+.+|+     |.||.    ..++||.||++.|-.  .+.|.+.  .+|+|+|.
T Consensus         1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~--~~Gnlvl~   65 (108)
T d1jpca_           1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLSR--SCFLSMQ--TDGNLVVY   65 (108)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SCEEEEC--TTSCEEEE
T ss_pred             CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCCC--ccEEEEe--ccceEEEE
Confidence            48999999999999995  6999999999988     88875    358999999998743  3456665  45599999


Q ss_pred             CCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCC
Q 038934           85 NSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDY  133 (751)
Q Consensus        85 ~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~  133 (751)
                      +++|.+||+|++.......+|+|+|+|||||.+       ..+||||+|
T Consensus        66 ~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~-------~~~W~S~t~  107 (108)
T d1jpca_          66 NPSNKPIWASNTGGQNGNYVCILQKDRNVVIYG-------TDRWATGTH  107 (108)
T ss_dssp             CTTCCEEEECCCCCSCSCEEEEECTTSCEEEEE-------CCCCCCCCC
T ss_pred             CCCccceEEccccCCCCcEEEEEcCCCCEEEeC-------CCcccCCCC
Confidence            999999999997655556678999999999984       358999987

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.64  E-value=2.5e-16  Score=138.19  Aligned_cols=101  Identities=21%  Similarity=0.322  Sum_probs=82.4

Q ss_pred             EEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCC
Q 038934           43 GIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDND  122 (751)
Q Consensus        43 ~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~  122 (751)
                      -|||.++++++.+|++|++.|+....-.|.|+.  ||||||.+. +.++|++++.......+|.|+++|||||++.+   
T Consensus        11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~--DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~---   84 (120)
T d1dlpa2          11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMET--DCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ---   84 (120)
T ss_dssp             EECCCC--CCCCCCEECSSCCCBCSSCEEEEET--TTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT---
T ss_pred             eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcC--CCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC---
Confidence            599999999999999999999987666677765  559999986 67899999876556678999999999999865   


Q ss_pred             CCCceeeecCCCccccCCCCeeeeeeecCCceEEEeccCCCCCCCCCceEEeCCCCCce
Q 038934          123 SDNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQ  181 (751)
Q Consensus       123 ~~~~lWqSFd~PTDtlLpg~~lg~~~~tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~  181 (751)
                       +++|||||.                               +.++|.|.+.++++|...
T Consensus        85 -~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlv  111 (120)
T d1dlpa2          85 -NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLA  111 (120)
T ss_dssp             -TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEE
T ss_pred             -CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEE
Confidence             689999983                               235678999999999754

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.54  E-value=1.8e-14  Score=125.75  Aligned_cols=101  Identities=21%  Similarity=0.334  Sum_probs=78.3

Q ss_pred             CccCCCCeE--eeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEeCCCCC
Q 038934           12 QSIRDGETL--VSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNG   89 (751)
Q Consensus        12 ~~l~~~~~l--~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~~~~~~   89 (751)
                      |.|.++|.|  .+..|.|.|.|...|+     |.++ .   ..++||.||+..|..  ...|.|.  .||+|+|.|++|.
T Consensus        15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVLy-~---~~~~vWssnt~~~~~--~~~l~l~--~dGnLvL~d~~g~   81 (119)
T d1b2pa_          15 QILHATESLEILFGTHVYRFIMQTDCN-----LVLY-D---NNNPIWATNTGGLGN--GCRAVLQ--PDGVLVVITNENV   81 (119)
T ss_dssp             CEEETTCEEEEEETTEEEEEEECTTSC-----EEEE-E---TTEEEEECCCTTSCS--SCEEEEC--TTSCEEEECTTCC
T ss_pred             CEEeCCCeEEEecCCceEEEEECCCCc-----EEEE-E---CCeEEEEecCCCCCc--ceEEEEE--eCCCEEEECCCCc
Confidence            455555554  6679999999999888     7664 3   468999999987643  3455554  5669999999999


Q ss_pred             eeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecC
Q 038934           90 IVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFD  132 (751)
Q Consensus        90 ~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd  132 (751)
                      +||++++.......+|+|+|+|||||.+       ..+|||-.
T Consensus        82 ~vWsS~t~~~~~~~~l~Lq~DGNlvlYg-------~~~W~S~T  117 (119)
T d1b2pa_          82 TVWQSPVAGKAGHYVLVLQPDRNVVIYG-------DALWATQT  117 (119)
T ss_dssp             EEEECSCCCCSSCEEEEECTTSCEEEEE-------SEEEECCC
T ss_pred             EEEECCCcCCCCceEEEEcCCCCEEEEC-------CCEeccCC
Confidence            9999997755555678999999999973       47999964

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.42  E-value=3.7e-14  Score=122.72  Aligned_cols=110  Identities=20%  Similarity=0.308  Sum_probs=86.2

Q ss_pred             EEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCC
Q 038934           44 IWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDS  123 (751)
Q Consensus        44 iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~  123 (751)
                      |||.-..+.+..|+.+.+.++....-.|.|+  .||||||.+ .+.++|++++.. .....|.|+++|||||++.+    
T Consensus         3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q--~DGNLvL~~-~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~----   74 (115)
T d1dlpa1           3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQ--SDCNLVLFD-SDVRVWASNTAG-ATGCRAVLQSDGLLVILTAQ----   74 (115)
T ss_dssp             CCBCSSSSSCSCSCCCTTCEECSTTEEEEEC--TTSCEEEEE-SSSEEECCCCCS-CSCCBCCBCSSSCBCCBCTT----
T ss_pred             EEEecCCCCCCcceecCCCcEEcCCEEEEEC--CCCeEEEEc-CCeeEEEcccCC-CCceEEEEeccCCEEEEccC----
Confidence            7888778889999999999998765556555  566999998 468899999764 45678899999999998765    


Q ss_pred             CCceeeecCCCccccCCCCeeeeeeecCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCCC
Q 038934          124 DNFLWQSFDYPTHVLLPGMKLGVNLVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGS  196 (751)
Q Consensus       124 ~~~lWqSFd~PTDtlLpg~~lg~~~~tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  196 (751)
                      +.+||||+.                               +.+.|.|.+.++++|...  ++  ...+|.+|.
T Consensus        75 ~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY--~~~~Wssgt  112 (115)
T d1dlpa1          75 NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVT--IY--GPGLWDSGT  112 (115)
T ss_dssp             TCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEE--EE--CSEEEECSC
T ss_pred             CCEEEEcCC-------------------------------CCCCCCEEEEECCCCcEE--Ee--CCCeecCCC
Confidence            679999863                               345789999999999853  33  346787764

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.32  E-value=2.1e-12  Score=111.55  Aligned_cols=101  Identities=23%  Similarity=0.339  Sum_probs=78.0

Q ss_pred             CCCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEeCCCC
Q 038934            9 RLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTN   88 (751)
Q Consensus         9 ~~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~~~~~   88 (751)
                      +..|+|.+++.|  .+|.|.|.|...|+     |.|+.    ..++||.+|...+   ..+.+.|..  +|+|||.|.++
T Consensus        12 ~~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~~--dGNLvl~d~~~   75 (115)
T d1dlpa1          12 SHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQS--DGLLVILTAQN   75 (115)
T ss_dssp             CSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBCS--SSCBCCBCTTT
T ss_pred             CCcceecCCCcE--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCCC---CceEEEEec--cCCEEEEccCC
Confidence            344677777777  57889999999888     88864    3578999997542   245566655  55999999999


Q ss_pred             CeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecC
Q 038934           89 GIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFD  132 (751)
Q Consensus        89 ~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd  132 (751)
                      .+||++.+.......+++|+++|||||.+       ..+|+|-.
T Consensus        76 ~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~-------~~~Wssgt  112 (115)
T d1dlpa1          76 TIRWSSGTKGSIGNYVLVLQPDRTVTIYG-------PGLWDSGT  112 (115)
T ss_dssp             CCSCCCCCCCCSSCCEEEECSSSCEEEEC-------SEEEECSC
T ss_pred             CEEEEcCCCCCCCCEEEEECCCCcEEEeC-------CCeecCCC
Confidence            99999997655556679999999999973       47999853

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.99  E-value=5.5e-10  Score=97.06  Aligned_cols=99  Identities=22%  Similarity=0.330  Sum_probs=71.5

Q ss_pred             CCCccCCCCeEeeCCCeEEEeeeCCCCCCceEEEEEEeecCCCeEEEeecCCCCCCCCCceeEEEecCCceEEEeCCCCC
Q 038934           10 LGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIANGTVTWVANRNAPLPDRSGVLSISSQGNGTLILQNSTNG   89 (751)
Q Consensus        10 ~~~~l~~~~~l~S~~g~f~~gf~~~~~~~~~y~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~g~l~l~~~~~~   89 (751)
                      +.+.|..++.|  ..|.|.|.|-..|+     |.|+.    ...+||.+|-.  -.+....+.|..  +|||||.|.++.
T Consensus        22 ~~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t~--~~~~~~~~~l~~--~GnLvl~d~~~~   86 (120)
T d1dlpa2          22 HPQTLHATQSL--QLSPYRLSMETDCN-----LVLFD----RDDRVWSTNTA--GKGTGCRAVLQP--NGRMDVLTNQNI   86 (120)
T ss_dssp             CCCEECSSCCC--BCSSCEEEEETTTE-----EEEEB----TTBCCSCCCCC--SSCSSCEEEEET--TTEEEEEETTTE
T ss_pred             cccEEcCCCee--EcCCEEEEEcCCCc-----EEEec----CCcEEEEEccc--cCCCcEEEEEeC--CeeEEEEcCCCC
Confidence            34455555555  35778998887776     77753    35778998743  333345566655  459999999999


Q ss_pred             eeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeee
Q 038934           90 IVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQS  130 (751)
Q Consensus        90 ~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqS  130 (751)
                      +||+|++.......+++|.++|||||.+       ..+|.|
T Consensus        87 ~lW~S~t~~~~~~~~l~Lq~DGnlvlY~-------~~~W~t  120 (120)
T d1dlpa2          87 AVWTSGNSRSAGRYVFVLQPDRNLAIYG-------GALWTT  120 (120)
T ss_dssp             EEEECCCCCSSSCCEEEECSSSCEEEEC-------CCCCBC
T ss_pred             EEEEeCCCCCCCcEEEEECCCCcEEEeC-------CCcccC
Confidence            9999998655556678999999999983       357875

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.74  E-value=2.8e-08  Score=85.80  Aligned_cols=89  Identities=21%  Similarity=0.307  Sum_probs=66.0

Q ss_pred             CceeEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeee
Q 038934           68 SGVLSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVN  147 (751)
Q Consensus        68 ~~~l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~  147 (751)
                      .+..+|...+||||||.++ +.++|++++........+.|.++|||||.+.+    +.+||+|.-               
T Consensus        29 ~~~y~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~----g~~vWsS~t---------------   88 (119)
T d1b2pa_          29 THVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE----NVTVWQSPV---------------   88 (119)
T ss_dssp             TEEEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEECSC---------------
T ss_pred             CceEEEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC----CcEEEECCC---------------
Confidence            4556777788889999975 56899999875555678999999999999765    679998631               


Q ss_pred             eecCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCCC
Q 038934          148 LVTGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGS  196 (751)
Q Consensus       148 ~~tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  196 (751)
                                      .-+.|.|.+.++++|...+  +.  ...|.++.
T Consensus        89 ----------------~~~~~~~~l~Lq~DGNlvl--Yg--~~~W~S~T  117 (119)
T d1b2pa_          89 ----------------AGKAGHYVLVLQPDRNVVI--YG--DALWATQT  117 (119)
T ss_dssp             ----------------CCCSSCEEEEECTTSCEEE--EE--SEEEECCC
T ss_pred             ----------------cCCCCceEEEEcCCCCEEE--EC--CCEeccCC
Confidence                            1134678899999997543  32  35787763

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.67  E-value=5.6e-08  Score=82.58  Aligned_cols=84  Identities=19%  Similarity=0.326  Sum_probs=60.0

Q ss_pred             EEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeeeeecC
Q 038934           72 SISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVTG  151 (751)
Q Consensus        72 ~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~~~tg  151 (751)
                      +|....||||||.+ .+.+||++++........+.|.++|||||.+.+    +.+||+|=                    
T Consensus        22 ~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~----g~~vWsS~--------------------   76 (108)
T d1jpca_          22 VFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS----NKPIWASN--------------------   76 (108)
T ss_dssp             EEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEECC--------------------
T ss_pred             EEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCC----ccceEEcc--------------------
Confidence            45555677999997 457899999765555668999999999999765    68999861                    


Q ss_pred             CceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCC
Q 038934          152 LNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPG  195 (751)
Q Consensus       152 ~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg  195 (751)
                                 .....+.|.+.++++|...+  +.  ...|.++
T Consensus        77 -----------t~~~~~~~~l~L~ddGNlVl--y~--~~~W~S~  105 (108)
T d1jpca_          77 -----------TGGQNGNYVCILQKDRNVVI--YG--TDRWATG  105 (108)
T ss_dssp             -----------CCCSCSCEEEEECTTSCEEE--EE--CCCCCCC
T ss_pred             -----------ccCCCCcEEEEEcCCCCEEE--eC--CCcccCC
Confidence                       11134678889999997543  32  2356554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.64  E-value=5.8e-08  Score=96.82  Aligned_cols=148  Identities=15%  Similarity=0.102  Sum_probs=105.6

Q ss_pred             hHHHHhcCccccccccccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceE
Q 038934          426 SIANATDNFSEENKLGEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERM  504 (751)
Q Consensus       426 ~i~~~~~~y~~~~~IG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  504 (751)
                      ++.+..+.|+..+..+-+....||+... +++.++||+...........+.+|+.++..+. +--+.+++.+..+++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4566667888776654444568998864 66778899886655445556888999998884 444667788888888899


Q ss_pred             EEEEecCCCChhHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 038934          505 LIYEYLPNKSLADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQDS---------------------------------  551 (751)
Q Consensus       505 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~---------------------------------  551 (751)
                      +||++++|.++.+.....        .....++.++++.++.||+..                                 
T Consensus        87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            999999998886654211        112234555666666666421                                 


Q ss_pred             -----------------------CCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          552 -----------------------RLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       552 -----------------------~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                                             ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                   1248999999999999987767799999775

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.53  E-value=3e-07  Score=77.98  Aligned_cols=86  Identities=23%  Similarity=0.368  Sum_probs=60.2

Q ss_pred             eEEEecCCceEEEeCCCCCeeeeecCCCC-CCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeeeee
Q 038934           71 LSISSQGNGTLILQNSTNGIVWSSNASRT-AQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLV  149 (751)
Q Consensus        71 l~~~~~g~g~l~l~~~~~~~vWst~~~~~-~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~~~  149 (751)
                      .+|...+||||||.. .+.+||++++... .....+.|.++|||||++.+    +.++|+|=                  
T Consensus        21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~s~------------------   77 (109)
T d1kj1a_          21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE----GRSLWASH------------------   77 (109)
T ss_dssp             EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS----SCEEEECC------------------
T ss_pred             EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC----CcEEEEEe------------------
Confidence            345556677999986 5678999997532 33457889999999999765    68999871                  


Q ss_pred             cCCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeCCeeeecCCC
Q 038934          150 TGLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKGSTIRYRPGS  196 (751)
Q Consensus       150 tg~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  196 (751)
                                   ...+.|.|.+.++++|...  ++.  ...|.|+.
T Consensus        78 -------------t~~~~~~~~l~L~ddGNlv--ly~--~~~W~S~t  107 (109)
T d1kj1a_          78 -------------SVRGNGNYVLVLQEDGNVV--IYG--SDIWSTGT  107 (109)
T ss_dssp             -------------CCCCSSCCEEEECTTSCEE--EEC--CEEEECCC
T ss_pred             -------------eECCCCCEEEEEeCCCcEE--EEC--CCEecCCC
Confidence                         1112466889999999753  333  34677664

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.21  E-value=4.9e-06  Score=70.79  Aligned_cols=87  Identities=21%  Similarity=0.360  Sum_probs=60.9

Q ss_pred             eEEEecCCceEEEeCCCCCeeeeecCCCCCCCcEEEEecCCCEEEEcCCCCCCCCceeeecCCCccccCCCCeeeeeeec
Q 038934           71 LSISSQGNGTLILQNSTNGIVWSSNASRTAQNPVAVLLESGNLVVKSGNDNDSDNFLWQSFDYPTHVLLPGMKLGVNLVT  150 (751)
Q Consensus        71 l~~~~~g~g~l~l~~~~~~~vWst~~~~~~~~~~a~lldsGNlVl~~~~~~~~~~~lWqSFd~PTDtlLpg~~lg~~~~t  150 (751)
                      .+|....||||||.. .+.+||++++........+.|..+|||||++.     ++.+|-|                    
T Consensus        21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-----~~~~w~s--------------------   74 (112)
T d1xd5a_          21 YLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-----SRAIWAS--------------------   74 (112)
T ss_dssp             EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-----TEEEEEC--------------------
T ss_pred             EEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec-----CCeEEEE--------------------
Confidence            355556777999986 56799999976555566889999999999874     3466754                    


Q ss_pred             CCceEEEeccCCCCCCCCCceEEeCCCCCceeEEEeC-CeeeecCCC
Q 038934          151 GLNRFISSWKSADDPAQDDYMYEIDPRGVPQAMLLKG-STIRYRPGS  196 (751)
Q Consensus       151 g~~~~l~sw~s~~dps~G~f~~~~~~~g~~~~~~~~~-~~~~~~sg~  196 (751)
                                 ...-..|.|.+.++.+|...  +++. ..+.|.|+.
T Consensus        75 -----------~t~~~~~~~~l~L~ddGNlv--ly~~~~~~~W~S~t  108 (112)
T d1xd5a_          75 -----------NTNRQNGNYYLILQRDRNVV--IYDNSNNAIWATHT  108 (112)
T ss_dssp             -----------CCCCSCCCCEEEECTTSCEE--EECTTSCEEEECCC
T ss_pred             -----------eeccCCCceEEEEcCCCCEE--EECCCCcEEecCCC
Confidence                       11123467889999999753  3333 456788764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.00  E-value=6.7e-06  Score=80.86  Aligned_cols=130  Identities=17%  Similarity=0.178  Sum_probs=86.6

Q ss_pred             ccccccc-ccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcC--CcEEeEeceeeeCCceEEEEEecCCCCh
Q 038934          439 KLGEGGF-GPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVKLLGCCMKRDERMLIYEYLPNKSL  515 (751)
Q Consensus       439 ~IG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL  515 (751)
                      .+..|.. +.||+....++..+++|......   ...+..|+..++.+..  ..+.+++.+..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455554 56899988778888999865432   2357788888888753  3456778888888889999999998765


Q ss_pred             hHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 038934          516 ADFIFDGTRRKLLDWSKRCQIIGGIARGLLYLHQ----------------------------------------------  549 (751)
Q Consensus       516 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~----------------------------------------------  549 (751)
                      .+..        ...   ..++.++++.|+-||+                                              
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4321        010   0111222233333332                                              


Q ss_pred             -----C----CCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          550 -----D----SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       550 -----~----~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                           .    ....++|+|+.|.|||++++..+-|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                 1    12248999999999999987667899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.56  E-value=7.9e-05  Score=78.12  Aligned_cols=76  Identities=11%  Similarity=0.190  Sum_probs=50.7

Q ss_pred             ccccccccccEEEEEEcC-CcEEEEEEeccC-------CcccHHHHHHHHHHHHHhc-C--CcEEeEeceeeeCCceEEE
Q 038934          438 NKLGEGGFGPVYKGMLID-GQEIAVKRLSKS-------SGQGVEEFKNEVLLIAKLQ-H--RNLVKLLGCCMKRDERMLI  506 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lV  506 (751)
                      +.||.|....||+....+ ++.++||.....       .+...++...|++.|+.+. +  ..+.+++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998654 678999976421       1223455677888888773 3  334555544  55677899


Q ss_pred             EEecCCCCh
Q 038934          507 YEYLPNKSL  515 (751)
Q Consensus       507 ~E~~~~gsL  515 (751)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.02  E-value=0.0014  Score=66.40  Aligned_cols=135  Identities=13%  Similarity=0.156  Sum_probs=79.2

Q ss_pred             ccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCcE--EeEe-----ceeeeCCceEEEEEecCCCChhH-
Q 038934          446 GPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL--VKLL-----GCCMKRDERMLIYEYLPNKSLAD-  517 (751)
Q Consensus       446 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~E~~~~gsL~~-  517 (751)
                      -.||++...+|+.+++|+.+.. ....+++..|...+..|....+  +..+     ..+......+.|+++++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            4699999989999999998543 3456778899999988853222  2222     12344566788999988754321 


Q ss_pred             ----------HH---hc------cCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCCCE
Q 038934          518 ----------FI---FD------GTRRKLLDWS----------------------KRCQIIGGIARGLLYL-HQDSRLRI  555 (751)
Q Consensus       518 ----------~l---~~------~~~~~~l~~~----------------------~~~~i~~~i~~~L~yL-H~~~~~~i  555 (751)
                                .+   +.      ...+...+..                      .....+.++...+.-+ .+.....+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                      01   00      0111111111                      1122223333322222 12223468


Q ss_pred             EEccCCCCCeEEcCCCCeEEeeccCccc
Q 038934          556 IHRDLKASNVLLDNEMNPKISDFGMARA  583 (751)
Q Consensus       556 vH~Dikp~NIll~~~~~~kl~DFGla~~  583 (751)
                      ||+|+.|.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  46899997753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.53  E-value=0.0027  Score=66.02  Aligned_cols=72  Identities=15%  Similarity=0.223  Sum_probs=49.2

Q ss_pred             ccccccccccEEEEEEcC--------CcEEEEEEeccCCcccHHHHHHHHHHHHHhc-CCcEEeEeceeeeCCceEEEEE
Q 038934          438 NKLGEGGFGPVYKGMLID--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVKLLGCCMKRDERMLIYE  508 (751)
Q Consensus       438 ~~IG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E  508 (751)
                      +.|+-|-.-.+|+....+        .+.|++++.. .. .......+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            478888888999998654        2457777664 32 23345678999999885 4333467777643    68999


Q ss_pred             ecCCCCh
Q 038934          509 YLPNKSL  515 (751)
Q Consensus       509 ~~~~gsL  515 (751)
                      |+++..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.04  E-value=0.018  Score=57.29  Aligned_cols=157  Identities=13%  Similarity=-0.004  Sum_probs=84.1

Q ss_pred             cHHhHHHHhcCccccccc-----cccccccEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHHHhcCCc--EEeEec
Q 038934          423 DWKSIANATDNFSEENKL-----GEGGFGPVYKGMLIDGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN--LVKLLG  495 (751)
Q Consensus       423 ~~~~i~~~~~~y~~~~~I-----G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~  495 (751)
                      +.+++.....+|.+++..     ..|---+.|+.+..+| .+++|+.....  ..+++..|+.++..|...+  +...+.
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            456677777788764433     3555577899887555 48999985432  2345666777888774322  222111


Q ss_pred             ------eeeeCCceEEEEEecCCCChhHH-----------H---hc------cCCCC------------------CCCHH
Q 038934          496 ------CCMKRDERMLIYEYLPNKSLADF-----------I---FD------GTRRK------------------LLDWS  531 (751)
Q Consensus       496 ------~~~~~~~~~lV~E~~~~gsL~~~-----------l---~~------~~~~~------------------~l~~~  531 (751)
                            +.........++.++.+......           +   ..      .....                  .....
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence                  12233455666777666433210           0   00      00000                  00011


Q ss_pred             HHHHHHHHHHHHHHHHHhC-CCCCEEEccCCCCCeEEcCCCCeEEeeccCcc
Q 038934          532 KRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  582 (751)
Q Consensus       532 ~~~~i~~~i~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~  582 (751)
                      .....+..+...+...+.. -+.++||+|+.++||+++++...-|+||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1122233333333333322 23469999999999999988777899999875

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.88  E-value=0.0017  Score=40.25  Aligned_cols=33  Identities=42%  Similarity=0.854  Sum_probs=28.2

Q ss_pred             ccCCCCCccCCCccccCCCCCCcccccCCCccCC
Q 038934          271 DQCDNYALCGTYAICKMNSNSAECECLEGFEPKS  304 (751)
Q Consensus       271 ~~Cd~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~  304 (751)
                      |+|.+-..|| +|.|++-...-.|.|-.||+|..
T Consensus         2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp   34 (39)
T d1emoa2           2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP   34 (39)
T ss_dssp             CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred             CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence            7899999999 78998655667899999999864

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.95  E-value=0.026  Score=37.49  Aligned_cols=33  Identities=30%  Similarity=0.709  Sum_probs=27.2

Q ss_pred             cccCCC-CCccCCCccccCCCCCCcccccCCCcc
Q 038934          270 IDQCDN-YALCGTYAICKMNSNSAECECLEGFEP  302 (751)
Q Consensus       270 ~~~Cd~-~~~CG~~g~C~~~~~~~~C~C~~gf~~  302 (751)
                      .|+|.. ...|..+|.|.....+..|.|++||+.
T Consensus         3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G   36 (42)
T d2vj3a1           3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYTG   36 (42)
T ss_dssp             CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred             CccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence            477875 578999999987667789999999974

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.80  E-value=0.074  Score=35.38  Aligned_cols=32  Identities=25%  Similarity=0.511  Sum_probs=26.3

Q ss_pred             cccCCCCCccCCCccccCCCCCCcccccCCCcc
Q 038934          270 IDQCDNYALCGTYAICKMNSNSAECECLEGFEP  302 (751)
Q Consensus       270 ~~~Cd~~~~CG~~g~C~~~~~~~~C~C~~gf~~  302 (751)
                      .|+|.... |+.++.|.+...+..|.|++||+.
T Consensus         5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~   36 (43)
T d1emoa1           5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL   36 (43)
T ss_dssp             CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred             eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence            58898654 557899988777889999999975

>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.87  E-value=0.11  Score=33.60  Aligned_cols=32  Identities=44%  Similarity=0.872  Sum_probs=24.8

Q ss_pred             ccCCCCCccCCCccccCCCCCCcccccCCCccC
Q 038934          271 DQCDNYALCGTYAICKMNSNSAECECLEGFEPK  303 (751)
Q Consensus       271 ~~Cd~~~~CG~~g~C~~~~~~~~C~C~~gf~~~  303 (751)
                      |+|. ...|...|.|........|.|++||...
T Consensus         1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~   32 (39)
T d1xkba1           1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGK   32 (39)
T ss_dssp             CTTT-TCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred             CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence            4565 4678889999766567899999999753

>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.60  E-value=0.052  Score=36.16  Aligned_cols=33  Identities=24%  Similarity=0.585  Sum_probs=26.8

Q ss_pred             cccCCCCCccCCCccccCCCCCCcccccCCCccC
Q 038934          270 IDQCDNYALCGTYAICKMNSNSAECECLEGFEPK  303 (751)
Q Consensus       270 ~~~Cd~~~~CG~~g~C~~~~~~~~C~C~~gf~~~  303 (751)
                      .|+|.....| ..++|.+...+..|+|++||+..
T Consensus         3 idEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~   35 (43)
T d1uzka1           3 VNECLDPTTC-ISGNCVNTPGSYICDCPPDFELN   35 (43)
T ss_dssp             CCGGGSTTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred             ccccCCCCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence            4789877666 57999877678899999999874

>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.55  E-value=0.11  Score=34.17  Aligned_cols=31  Identities=29%  Similarity=0.775  Sum_probs=25.1

Q ss_pred             ccCCCCCccCCCccccCCCCCCcccccCCCccC
Q 038934          271 DQCDNYALCGTYAICKMNSNSAECECLEGFEPK  303 (751)
Q Consensus       271 ~~Cd~~~~CG~~g~C~~~~~~~~C~C~~gf~~~  303 (751)
                      |+|...+.|  ..+|.+...+..|+|++||...
T Consensus         2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~   32 (41)
T d1i0ua2           2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD   32 (41)
T ss_dssp             CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred             ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence            688877777  4689877678899999999864

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.84  E-value=0.078  Score=35.37  Aligned_cols=34  Identities=35%  Similarity=0.727  Sum_probs=26.2

Q ss_pred             cccCCCC-CccCCCccccCCCCCCcccccCCCccCC
Q 038934          270 IDQCDNY-ALCGTYAICKMNSNSAECECLEGFEPKS  304 (751)
Q Consensus       270 ~~~Cd~~-~~CG~~g~C~~~~~~~~C~C~~gf~~~~  304 (751)
                      .|+|... ..| .++.|.+...+..|.|++||+...
T Consensus         3 idEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~~~   37 (44)
T d1lmja1           3 IDECRISPDLC-GRGQCVNTPGDFECKCDEGYESGF   37 (44)
T ss_dssp             CCTTTTCSSTT-TTSCEEEETTEEEECCCSSEEECT
T ss_pred             ccccCCCCCCC-CCCEeEcCCCCeEEeCCCCCccCC
Confidence            4788764 455 479998776788999999998643

>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.59  E-value=0.14  Score=33.07  Aligned_cols=32  Identities=44%  Similarity=0.651  Sum_probs=26.1

Q ss_pred             cccCCCCCccCCCccccCCCCCCcccccCCCcc
Q 038934          270 IDQCDNYALCGTYAICKMNSNSAECECLEGFEP  302 (751)
Q Consensus       270 ~~~Cd~~~~CG~~g~C~~~~~~~~C~C~~gf~~  302 (751)
                      .|+|. ...|...|.|........|.|++||+.
T Consensus         3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G   34 (39)
T d1edmb_           3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEG   34 (39)
T ss_dssp             CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCS
T ss_pred             cccCC-CCCCCCCcEEEcCCCCEEEECCCCCCC
Confidence            46787 477999999976657789999999974

>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.38  E-value=0.16  Score=32.89  Aligned_cols=32  Identities=25%  Similarity=0.633  Sum_probs=24.7

Q ss_pred             ccCCCCCccCCCccccCCCCCCcccccCCCccC
Q 038934          271 DQCDNYALCGTYAICKMNSNSAECECLEGFEPK  303 (751)
Q Consensus       271 ~~Cd~~~~CG~~g~C~~~~~~~~C~C~~gf~~~  303 (751)
                      |+|.. .-|...|.|.....+..|.|++||...
T Consensus         2 d~C~~-~PC~n~g~C~~~~~~y~C~C~~G~~G~   33 (39)
T d2vj3a2           2 NECVS-NPCQNDATCLDQIGEFQCICMPGYEGV   33 (39)
T ss_dssp             CTTTT-CCCCSSCEEEECSSCEEEECCTTEESS
T ss_pred             cCCcC-CCCCCCCEEECCCCCEEEeCCCCCccC
Confidence            56643 579999999766567899999999753

>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.24  E-value=0.061  Score=35.58  Aligned_cols=33  Identities=30%  Similarity=0.731  Sum_probs=24.9

Q ss_pred             ccCC-CCCccCCCccccCCCCCCcccccCCCccCC
Q 038934          271 DQCD-NYALCGTYAICKMNSNSAECECLEGFEPKS  304 (751)
Q Consensus       271 ~~Cd-~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~  304 (751)
                      |+|. .++.|. +++|.+...+..|.|++||....
T Consensus         3 dEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~~   36 (42)
T d1lmja2           3 DECQRDPLLCR-GGVCHNTEGSYRCECPPGHQLSP   36 (42)
T ss_dssp             CHHHHCSSTTT-TSEEEEETTEEEEESCTTSCCCS
T ss_pred             cccCCCCCCCC-CCEeECCCCCeEEeCCCCCeECc
Confidence            4553 356674 78998776788999999999643

>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-like domain of nidogen-1
domain: EGF-like domain of nidogen-1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=84.18  E-value=0.1  Score=34.03  Aligned_cols=26  Identities=19%  Similarity=0.545  Sum_probs=21.4

Q ss_pred             CccCCCccccCCCCCCcccccCCCcc
Q 038934          277 ALCGTYAICKMNSNSAECECLEGFEP  302 (751)
Q Consensus       277 ~~CG~~g~C~~~~~~~~C~C~~gf~~  302 (751)
                      ..|.+++.|.+...+..|.|.+||..
T Consensus         7 ~~C~~~A~C~Nt~Gsy~C~C~~Gy~G   32 (40)
T d1gl4a2           7 HQCSVHAECRDYATGFCCRCVANYTG   32 (40)
T ss_dssp             GGSCTTEEEEECSSCEEEEECTTEEE
T ss_pred             CCCCCCCEeecCCCCeEeECCCCCcC
Confidence            35888899987667889999999974

>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Thrombomodulin, different EGF-like domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=82.24  E-value=0.1  Score=33.94  Aligned_cols=32  Identities=25%  Similarity=0.618  Sum_probs=24.7

Q ss_pred             ccCCCCCccCCCccccCCCCCCcccccCCCccCC
Q 038934          271 DQCDNYALCGTYAICKMNSNSAECECLEGFEPKS  304 (751)
Q Consensus       271 ~~Cd~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~  304 (751)
                      |+|...+.|.  .+|.+...+..|.|++||....
T Consensus         3 dEC~~~~~C~--~~C~N~~Gsy~C~C~~Gy~l~g   34 (40)
T d1dx5i3           3 DECENGGFCS--GVCHNLPGTFECICGPDSALAG   34 (40)
T ss_dssp             CHHHHCSSCS--SEEEECSSSEEEEECSSSSCEE
T ss_pred             cccCCCcCcc--CEeeCCCCCeEeECCCCCeeCC
Confidence            6676666674  6898776788999999998743

>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=82.22  E-value=0.11  Score=34.50  Aligned_cols=34  Identities=29%  Similarity=0.605  Sum_probs=25.9

Q ss_pred             cccCC-CCCccCCCccccCCCCCCcccccCCCccCC
Q 038934          270 IDQCD-NYALCGTYAICKMNSNSAECECLEGFEPKS  304 (751)
Q Consensus       270 ~~~Cd-~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~  304 (751)
                      .|+|. .++.|. ++.|.+...+..|.|++||....
T Consensus         3 inEC~~~~~~c~-~~~C~Nt~Gsy~C~C~~Gy~l~~   37 (43)
T d1uzka2           3 IDECQELPGLCQ-GGKCINTFGSFQCRCPTGYYLNE   37 (43)
T ss_dssp             CCHHHHCGGGGB-TSEEEECSSCEEEECCTTCCBCT
T ss_pred             cccccCCCCCcC-CCEEECCCCCeEeECCCCCeECc
Confidence            35675 356675 78998777788999999998643

>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Complement protease C1R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.62  E-value=0.25  Score=34.32  Aligned_cols=32  Identities=16%  Similarity=0.320  Sum_probs=23.3

Q ss_pred             CCCCCccCCCccccCCCCCCcccccCCCccCC
Q 038934          273 CDNYALCGTYAICKMNSNSAECECLEGFEPKS  304 (751)
Q Consensus       273 Cd~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~  304 (751)
                      |.....|+...+|.+...+..|+|++||+...
T Consensus        14 c~~~~~~~c~~~C~Nt~GsY~C~C~~Gy~l~~   45 (53)
T d1apqa_          14 GEEDPQPQCQHLCHNYVGGYFCSCRPGYELQE   45 (53)
T ss_dssp             CCCSSSCTTSSEEEEETTEEEEECSTTCEECT
T ss_pred             cccCCCCCccCEeEcCCCCeEeECCCCCeECC
Confidence            33344556666898777788999999998643

>d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Mannose-binding protein associated serine protease 2, MASP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=80.85  E-value=0.22  Score=33.31  Aligned_cols=34  Identities=18%  Similarity=0.358  Sum_probs=25.2

Q ss_pred             ccCCCC--CccCCCccccCCCCCCcccccCCCccCC
Q 038934          271 DQCDNY--ALCGTYAICKMNSNSAECECLEGFEPKS  304 (751)
Q Consensus       271 ~~Cd~~--~~CG~~g~C~~~~~~~~C~C~~gf~~~~  304 (751)
                      |+|...  ..+|-..+|.+...+..|+|++||+...
T Consensus         2 dEC~~~~~~~~~C~~~C~Nt~Gsy~C~C~~Gy~l~~   37 (45)
T d1szba2           2 DECQVAPGEAPTCDHHCHNHLGGFYCSCRAGYVLHR   37 (45)
T ss_dssp             CTTCCCTTSCCSSSSEEEEETTEEEEECCTTEEECT
T ss_pred             cCCcCCCCCCCCCCCCCccCCCCeEEECCCCCeECC
Confidence            677654  2345577898776788999999999744